PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Makarieva, AM; Gorshkov, VG; Li, BL				Makarieva, Anastassia M.; Gorshkov, Victor G.; Li, Bai-Lian			Comment on "Energy Uptake and Allocation During Ontogeny"	SCIENCE			English	Editorial Material							METABOLIC-RATES	We demonstrate that the model of energy allocation during ontogeny of Hou et al. (Reports, 31 October 2008, p. 736) fails to account for the observed elevation of metabolic rate in growing organisms compared with similarly sized adults of different species. The basic model assumptions of the three-quarter power scaling for resting metabolism and constancy of the mass-specific maintenance metabolism need to be reassessed.	[Makarieva, Anastassia M.; Gorshkov, Victor G.] Petersburg Nucl Phys Inst, Div Theoret Phys, St Petersburg, Russia; [Makarieva, Anastassia M.; Gorshkov, Victor G.; Li, Bai-Lian] Univ Calif Riverside, Dept Bot & Plant Sci, Ecol Complex & Modeling Lab, Riverside, CA 92521 USA	National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute; University of California System; University of California Riverside	Makarieva, AM (corresponding author), Petersburg Nucl Phys Inst, Div Theoret Phys, St Petersburg, Russia.	elba@peterlink.ru	Makarieva, Anastassia M./O-4660-2016; Domingos, Tiago/D-4558-2012; dos Santos Costa e Sousa, Tânia Alexandra/D-8180-2013	Makarieva, Anastassia M./0000-0002-8598-5851; Domingos, Tiago/0000-0002-6194-0405; dos Santos Costa e Sousa, Tânia Alexandra/0000-0002-3502-3371; Marques, Goncalo/0000-0002-1693-9042; Gorshkov, Victor/0000-0002-0596-4576				Brody S, 1964, BIOENERGETICS GROWTH; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; LAVIGNE DM, 1986, CAN J ZOOL, V64, P279, DOI 10.1139/z86-047; Makarieva AM, 2006, FUNCT ECOL, V20, P83, DOI 10.1111/j.1365-2435.2006.01070.x; Makarieva AM, 2004, ECOL MODEL, V176, P15, DOI 10.1016/j.ecolmodel.2003.09.037; Makarieva AM, 2008, P NATL ACAD SCI USA, V105, P16994, DOI 10.1073/pnas.0802148105; POCZOPKO P, 1979, ACTA THERIOL, V24, P125, DOI 10.4098/AT.arch.79-16; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; White CR, 2006, BIOL LETTERS, V2, P125, DOI 10.1098/rsbl.2005.0378; WIESER W, 1984, RESP PHYSIOL, V55, P1, DOI 10.1016/0034-5687(84)90112-9	11	13	14	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945								10.1126/science.1171303	http://dx.doi.org/10.1126/science.1171303			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729640	Green Submitted			2022-12-28	WOS:000269523200017
J	Sousa, T; Marques, GM; Domingos, T				Sousa, Tania; Marques, Goncalo M.; Domingos, Tiago			Comment on "Energy Uptake and Allocation During Ontogeny"	SCIENCE			English	Editorial Material								Hou et al. (Reports, 31 October 2008, p. 736) presented a model for energy uptake and allocation over an organism's growth and development. However, their model does not account for allocation to reproduction (essential to adults) and growth without assimilation (essential to embryos) and is therefore only applicable to organisms growing with abundant food in the juvenile stage.	[Marques, Goncalo M.] Univ Tecn Lisboa, Environm & Energy Sect, DEM, Inst Super Tecn, Lisbon, Portugal; Univ Tecn Lisboa, IN Ctr Innovat Technol & Policy Res, Inst Super Tecn, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico	Marques, GM (corresponding author), Univ Tecn Lisboa, Environm & Energy Sect, DEM, Inst Super Tecn, Lisbon, Portugal.	goncalo.marques@ist.utl.pt	Makarieva, Anastassia M./O-4660-2016; Domingos, Tiago/D-4558-2012; dos Santos Costa e Sousa, Tânia Alexandra/D-8180-2013	Makarieva, Anastassia M./0000-0002-8598-5851; Domingos, Tiago/0000-0002-6194-0405; dos Santos Costa e Sousa, Tânia Alexandra/0000-0002-3502-3371; Marques, Goncalo/0000-0002-1693-9042; Gorshkov, Victor/0000-0002-0596-4576				Hou C, 2008, SCIENCE, V322, P736, DOI 10.1126/science.1162302; Kooijman S.A.L.M., 1993, DYNAMIC ENERGY BUDGE; KOOIJMAN SALM, 1986, J THEOR BIOL, V121, P269, DOI 10.1016/S0022-5193(86)80107-2; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Sousa T, 2008, PHILOS T R SOC B, V363, P2453, DOI 10.1098/rstb.2007.2230; van der Meer J, 2006, TRENDS ECOL EVOL, V21, P136, DOI 10.1016/j.tree.2005.11.004	6	13	14	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945								10.1126/science.1169523	http://dx.doi.org/10.1126/science.1169523			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729640				2022-12-28	WOS:000269523200018
J	Chandrashekhar, Y; Westaby, S; Narula, J				Chandrashekhar, Y.; Westaby, Stephen; Narula, Jagat			Mitral stenosis	LANCET			English	Review							TERM-FOLLOW-UP; VALVULAR HEART-DISEASE; PERCUTANEOUS BALLOON VALVULOPLASTY; VENTRICULAR EJECTION FRACTION; PULMONARY VASCULAR CHANGES; C-REACTIVE PROTEIN; ATRIAL V-WAVE; VALVE AREA; EXERCISE CAPACITY; NATURAL-HISTORY	Mitral stenosis is a common disease that causes substantial morbidity worldwide. The disease is most prevalent in developing countries, but is increasingly being identified in an atypical form in developed countries. All treatments that increase valve area improve morbidity. Mortality improves with surgery; the benefit of percutaneous balloon valvuloplasty to mortality might be similar to that of surgery but needs further study. Percutaneous balloon valvuloplasty is the treatment of choice for patients in whom treatment is indicated, except for those with suboptimum valve morphology, and even these patients are sometimes treated with this procedure if surgery is not feasible or if surgical risk is prohibitive. We review the pathology, diagnosis, and treatment options for patients with mitral stenosis.	[Chandrashekhar, Y.] Univ Minnesota, Div Cardiol 111C, VA Med Ctr, Minneapolis, MN 55417 USA; [Westaby, Stephen] Univ Oxford, Oxford, England; [Narula, Jagat] Univ Calif Irvine, Irvine, CA USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Oxford; University of California System; University of California Irvine	Chandrashekhar, Y (corresponding author), Univ Minnesota, Div Cardiol 111C, VA Med Ctr, 1 Vet Dr, Minneapolis, MN 55417 USA.	shekh003@umn.edu						ABASCAL VM, 1988, J AM COLL CARDIOL, V11, P257, DOI 10.1016/0735-1097(88)90089-7; Arora R, 2002, CATHETER CARDIO INTE, V55, P450, DOI 10.1002/ccd.10109; Bax JJ, 2006, J AM COLL CARDIOL, V48, P754, DOI 10.1016/j.jacc.2006.04.077; Ben Farhat M, 1998, CIRCULATION, V97, P245, DOI 10.1161/01.CIR.97.3.245; Ben-Farhat M, 2001, AM HEART J, V142, P1072, DOI 10.1067/mhj.2001.118470; Bhatla N, 2003, INT J GYNECOL OBSTET, V82, P153, DOI 10.1016/S0020-7292(03)00159-0; BITAR JN, 1995, AM J CARDIOL, V76, P287, DOI 10.1016/S0002-9149(99)80083-6; Burger W, 1997, INT J CARDIOL, V58, P7, DOI 10.1016/S0167-5273(96)02860-4; Cannan CR, 1997, J AM COLL CARDIOL, V29, P175, DOI 10.1016/S0735-1097(96)00422-6; Carabello BA, 2005, CIRCULATION, V112, P432, DOI 10.1161/CIRCULATIONAHA.104.532498; CARROLL JD, 1993, JAMA-J AM MED ASSOC, V270, P1731, DOI 10.1001/jama.270.14.1731; CHANDRASHEKHAR Y, 1999, TXB RHEUMATIC FEVER, P299; CHEN CR, 1995, AM HEART J, V129, P1197, DOI 10.1016/0002-8703(95)90404-2; Chiang CW, 1998, ANN INTERN MED, V128, P885, DOI 10.7326/0003-4819-128-11-199806010-00001; Chockalingam A, 2005, ANGIOLOGY, V56, P151, DOI 10.1177/000331970505600205; COHEN DJ, 1992, NEW ENGL J MED, V327, P1329, DOI 10.1056/NEJM199211053271901; Cutler EC, 1923, BOSTON MED SURG J, V188, P1023, DOI 10.1056/NEJM192306281882601; de Souza JAM, 2001, J AM COLL CARDIOL, V37, P900, DOI 10.1016/S0735-1097(00)01184-0; Desai DK, 2000, BRIT J OBSTET GYNAEC, V107, P953, DOI 10.1111/j.1471-0528.2000.tb10395.x; Djavidani B, 2005, J AM COLL CARDIOL, V45, P2048, DOI 10.1016/j.jacc.2005.03.036; Dogan S, 2006, J AM SOC ECHOCARDIOG, V19, P243, DOI 10.1016/j.echo.2005.09.014; DOUARD H, 1995, EUR HEART J, V16, P1375, DOI 10.1093/oxfordjournals.eurheartj.a060745; Elkayam U, 2005, J AM COLL CARDIOL, V46, P223, DOI 10.1016/j.jacc.2005.02.085; Elliott CG, 2004, THORAX, V59, P536, DOI 10.1136/thx.2003.008193; Fann JI, 1996, ANN THORAC SURG, V62, P1301, DOI 10.1016/0003-4975(96)00629-7; Fawzy ME, 2005, EUR HEART J, V26, P1647, DOI 10.1093/eurheartj/ehi226; Gamra H, 2003, EUR HEART J, V24, P1349, DOI 10.1016/S0195-668X(03)00257-4; GASH AK, 1983, CIRCULATION, V67, P148, DOI 10.1161/01.CIR.67.1.148; GEORGESON S, 1993, AM HEART J, V125, P1374, DOI 10.1016/0002-8703(93)91010-C; Golbasi Z, 2002, EUR J HEART FAIL, V4, P593, DOI 10.1016/S1388-9842(02)00102-2; GOODALE F, 1955, NEW ENGL J MED, V252, P979, DOI 10.1056/NEJM195506092522303; GORDON SPF, 1992, J AM COLL CARDIOL, V19, P968, DOI 10.1016/0735-1097(92)90280-Z; Gupta A, 1998, J AM COLL SURGEONS, V187, P409, DOI 10.1016/S1072-7515(98)00201-4; Ha JW, 2000, AM J CARDIOL, V85, P986, DOI 10.1016/S0002-9149(99)00915-7; Hameed A, 2001, J AM COLL CARDIOL, V37, P893, DOI 10.1016/S0735-1097(00)01198-0; Hernandez R, 1999, CIRCULATION, V99, P1580, DOI 10.1161/01.CIR.99.12.1580; HERRMANN HC, 1993, J AM COLL CARDIOL, V22, P783, DOI 10.1016/0735-1097(93)90191-3; HORSTKOTTE D, 1991, EUR HEART J, V12, P55, DOI 10.1093/eurheartj/12.suppl_B.55; Hu CL, 2006, HEART, V92, P1096, DOI 10.1136/hrt.2005.080325; HUNG JS, 1991, AM J CARDIOL, V67, P854, DOI 10.1016/0002-9149(91)90619-V; INOUE K, 1984, J THORAC CARDIOV SUR, V87, P394; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Iung B, 2002, EUR HEART J, V23, P1253, DOI 10.1053/euhj.2002.3320; IUNG B, 1995, EUR HEART J, V16, P1092, DOI 10.1093/oxfordjournals.eurheartj.a061052; Iung B, 1999, CIRCULATION, V99, P3272, DOI 10.1161/01.CIR.99.25.3272; Iung B, 1998, CIRCULATION, V98, P352; Iung B, 2000, J AM COLL CARDIOL, V35, P1295, DOI 10.1016/S0735-1097(00)00512-X; JOHN S, 1983, CIRCULATION, V68, P891, DOI 10.1161/01.CIR.68.5.891; JOSWIG BC, 1982, AM HEART J, V104, P1400, DOI 10.1016/0002-8703(82)90185-5; Kang DH, 2000, J AM COLL CARDIOL, V35, P169, DOI 10.1016/S0735-1097(99)00502-1; KAWANISHI DT, 1990, SURG HEART VALVE DIS, P73; KIRKLIN J, 1993, CARDIAC SURG; Klein LL, 2004, OBSTET GYN CLIN N AM, V31, P429, DOI 10.1016/j.ogc.2004.03.001; KOLLING K, 1995, CHEST, V108, P1206, DOI 10.1378/chest.108.5.1206; Kothari SS, 1998, CATHETER CARDIO DIAG, V43, P408, DOI 10.1002/(SICI)1097-0304(199804)43:4<408::AID-CCD10>3.0.CO;2-F; Krasuski RA, 2003, AM HEART J, V146, P1099, DOI 10.1016/S0002-8703(03)00506-4; Krasuski RA, 2001, AM J CARDIOL, V88, P994, DOI 10.1016/S0002-9149(01)01976-2; Krishnamoorthy KM, 2004, INT J CARDIOL, V96, P241, DOI 10.1016/j.ijcard.2003.07.015; LABOVITZ AJ, 1985, AM J CARDIOL, V55, P133, DOI 10.1016/0002-9149(85)90314-5; Langerveld J, 2003, EUROPACE, V5, P47, DOI 10.1053/eupc.2002.0286; LEAVITT JI, 1991, J AM COLL CARDIOL, V17, P1520, DOI 10.1016/0735-1097(91)90641-L; Lee TM, 1996, INT J CARDIOL, V56, P211; Leon MN, 1999, J AM COLL CARDIOL, V34, P1145, DOI 10.1016/S0735-1097(99)00310-1; LEVINE MJ, 1989, CIRCULATION, V79, P1061, DOI 10.1161/01.CIR.79.5.1061; Li MZ, 2005, AM J CARDIOL, V96, P432, DOI 10.1016/j.amjcard.2005.03.094; Lin SJ, 2004, J AM COLL CARDIOL, V44, P133, DOI 10.1016/j.jacc.2004.03.038; LIU CP, 1992, CIRCULATION, V85, P1447, DOI 10.1161/01.CIR.85.4.1447; Lung B, 2004, EUR HEART J, V25, P701, DOI 10.1016/j.ehj.2004.02.026; Lung B, 2000, AM J CARDIOL, V85, P1308, DOI 10.1016/S0002-9149(00)00761-X; LUNG B, 1996, CIRCULATION, V94, P2124; Magne J, 2007, CIRCULATION, V115, P1417, DOI 10.1161/CIRCULATIONAHA.106.631549; Mahoney PD, 2001, AM J CARDIOL, V87, P188, DOI 10.1016/S0002-9149(00)01314-X; Mangione JA, 2000, CATHETER CARDIO INTE, V50, P413, DOI 10.1002/1522-726X(200008)50:4<413::AID-CCD9>3.0.CO;2-9; MARZO KP, 1993, J AM COLL CARDIOL, V21, P856, DOI 10.1016/0735-1097(93)90340-7; Matsuyama K, 2003, ANN THORAC SURG, V75, P1826, DOI 10.1016/S0003-4975(03)00028-6; Messika-Zeitoun D, 2003, EUR HEART J, V24, P1244, DOI 10.1016/S0195-668X(03)00208-2; Messika-Zeitoun D, 2007, EUR HEART J, V28, P72, DOI 10.1093/eurheartj/ehl206; Messika-Zeitoun D, 2006, J AM COLL CARDIOL, V48, P411, DOI 10.1016/j.jacc.2006.04.035; Mohan JC, 1999, INT J CARDIOL, V68, P217, DOI 10.1016/S0167-5273(98)00358-1; Mohan JC, 2002, J AM COLL CARDIOL, V40, P1809, DOI 10.1016/S0735-1097(02)02487-7; Nakajima H, 2004, ANN THORAC SURG, V78, P800, DOI 10.1016/j.athoracsur.2004.04.019; NAKATANI S, 1988, CIRCULATION, V77, P78, DOI 10.1161/01.CIR.77.1.78; Nishikimi T, 1997, HEART, V78, P390, DOI 10.1136/hrt.78.4.390; Nkomo VT, 2006, LANCET, V368, P1005, DOI 10.1016/S0140-6736(06)69208-8; OLESEN KH, 1962, BRIT HEART J, V24, P349; ORRANGE SE, 1997, CIRCULATION, V97, P245; Padmavati S, 2001, Indian Heart J, V53, P35; PALACIOS IF, 1994, CATHETER CARDIO DIAG, V33, P315, DOI 10.1002/ccd.1810330405; Palacios IF, 2002, CIRCULATION, V105, P1465, DOI 10.1161/01.CIR.0000012143.27196.F4; PAN M, 1991, CATHETER CARDIO DIAG, V24, P1, DOI 10.1002/ccd.1810240102; Park S, 2004, AM J CARDIOL, V94, P243, DOI 10.1016/j.amjcard.2004.03.076; PARRIS TM, 1988, AM J CARDIOL, V61, P1135, DOI 10.1016/0002-9149(88)90147-6; PAULUS WJ, 1992, J AM COLL CARDIOL, V20, P1524, DOI 10.1016/0735-1097(92)90446-T; PAVANKUMAR P, 1988, SCAND J THORAC CARD, V22, P11, DOI 10.3109/14017438809106043; Rahimtoola SH, 2002, CIRCULATION, V106, P1183, DOI 10.1161/01.CIR.0000029210.14716.01; Rapp AH, 2001, AM J CARDIOL, V88, P1212, DOI 10.1016/S0002-9149(01)02068-9; Reis G, 2004, J AM COLL CARDIOL, V43, P393, DOI 10.1016/j.jacc.2003.09.037; REYES VP, 1994, NEW ENGL J MED, V331, P961, DOI 10.1056/NEJM199410133311501; ROBERTS WC, 1972, ANN INTERN MED, V77, P939, DOI 10.7326/0003-4819-77-6-939; ROWE JC, 1960, ANN INTERN MED, V52, P741, DOI 10.7326/0003-4819-52-4-741; ROY SB, 1968, CIRCULATION, V38, pV68; SAGIE A, 1994, J THORAC CARDIOV SUR, V108, P727; Sebag IA, 2005, AM J CARDIOL, V96, P1151, DOI 10.1016/j.amjcard.2005.06.046; Serraf A, 2000, CIRCULATION, V102, P166; Shaw TRD, 2003, HEART, V89, P1430, DOI 10.1136/heart.89.12.1430; SHAW TRD, 1992, BRIT HEART J, V67, P454; Silversides CK, 2003, AM J CARDIOL, V91, P1382, DOI 10.1016/S0002-9149(03)00339-4; Siu SC, 1997, CIRCULATION, V96, P2789; SNYDER RW, 1994, AM J CARDIOL, V73, P65, DOI 10.1016/0002-9149(94)90728-5; SOLOMON RE, 1992, CIRCULATION, V85, P448; Song H, 2007, CIRCULATION, V116, pI246, DOI 10.1161/CIRCULATIONAHA.107.678151; Song JK, 1996, AM J CARDIOL, V78, P1060, DOI 10.1016/S0002-9149(96)00539-5; Stefanadis C, 1998, J AM COLL CARDIOL, V32, P159, DOI 10.1016/S0735-1097(98)00178-8; Surdacki A, 1996, J HEART VALVE DIS, V5, P1; Sutaria N, 2000, HEART, V84, P7; Sutaria N, 2000, HEART, V83, P433, DOI 10.1136/heart.83.4.433; Tamai J, 1993, J Heart Valve Dis, V2, P623; TANDON HD, 1975, BRIT HEART J, V37, P26; TUZCU EM, 1992, CIRCULATION, V85, P963, DOI 10.1161/01.CIR.85.3.963; Vahanian A, 2004, CIRCULATION, V109, P1572, DOI 10.1161/01.CIR.0000124794.16806.E3; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; VIJAYKUMAR M, 1994, INT J CARDIOL, V43, P221, DOI 10.1016/0167-5273(94)90199-6; Vora Amit, 2004, Indian Heart J, V56, P110; WALLER BF, 1994, CLIN CARDIOL, V17, P330, DOI 10.1002/clc.4960170611; Wellnhofer E, 2000, INT J CARDIOL, V75, P217, DOI 10.1016/S0167-5273(00)00327-2; WILKINS GT, 1988, BRIT HEART J, V60, P299; WISENBAUGH T, 1992, J AM COLL CARDIOL, V20, P1339, DOI 10.1016/0735-1097(92)90246-J; WOOD P, 1954, BMJ-BRIT MED J, V4870, P1051; World Health Organization, 1988, WHO TECHN REP SER, V764; YAMAMOTO K, 1994, CIRCULATION, V89, P2093, DOI 10.1161/01.CIR.89.5.2093; YAMAMOTO K, 1995, J AM COLL CARDIOL, V25, P107, DOI 10.1016/0735-1097(94)00322-H; ZAKY A, 1968, CIRCULATION, V37, P789, DOI 10.1161/01.CIR.37.5.789; Zamorano J, 2004, EUR HEART J, V25, P2086, DOI 10.1016/j.ehj.2004.09.041; Zamorano J, 2004, J AM COLL CARDIOL, V43, P2091, DOI 10.1016/j.jacc.2004.01.046	134	124	130	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 10	2009	374	9697					1271	1283		10.1016/S0140-6736(09)60994-6	http://dx.doi.org/10.1016/S0140-6736(09)60994-6			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	507KQ	19747723				2022-12-28	WOS:000270852500033
J	Jiang, L; Hodges, JS; Maze, JR; Maurer, P; Taylor, JM; Cory, DG; Hemmer, PR; Walsworth, RL; Yacoby, A; Zibrov, AS; Lukin, MD				Jiang, L.; Hodges, J. S.; Maze, J. R.; Maurer, P.; Taylor, J. M.; Cory, D. G.; Hemmer, P. R.; Walsworth, R. L.; Yacoby, A.; Zibrov, A. S.; Lukin, M. D.			Repetitive Readout of a Single Electronic Spin via Quantum Logic with Nuclear Spin Ancillae	SCIENCE			English	Article							DIAMOND; ENTANGLEMENT; ALGORITHMS; DYNAMICS; QUBITS	Robust measurement of single quantum bits plays a key role in the realization of quantum computation and communication as well as in quantum metrology and sensing. We have implemented a method for the improved readout of single electronic spin qubits in solid-state systems. The method makes use of quantum logic operations on a system consisting of a single electronic spin and several proximal nuclear spin ancillae in order to repetitively readout the state of the electronic spin. Using coherent manipulation of a single nitrogen vacancy center in room-temperature diamond, full quantum control of an electronic-nuclear system consisting of up to three spins was achieved. We took advantage of a single nuclear-spin memory in order to obtain a 10-fold enhancement in the signal amplitude of the electronic spin readout. We also present a two-level, concatenated procedure to improve the readout by use of a pair of nuclear spin ancillae, an important step toward the realization of robust quantum information processors using electronic-and nuclear-spin qubits. Our technique can be used to improve the sensitivity and speed of spin-based nanoscale diamond magnetometers.	[Jiang, L.; Hodges, J. S.; Maze, J. R.; Maurer, P.; Walsworth, R. L.; Yacoby, A.; Zibrov, A. S.; Lukin, M. D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Hodges, J. S.; Cory, D. G.] MIT, Dept Nucl Sci & Engn, Cambridge, MA 02139 USA; [Taylor, J. M.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Hemmer, P. R.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Walsworth, R. L.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Texas A&M University System; Texas A&M University College Station; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Lukin, MD (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.	lukin@fas.harvard.edu	Zibrov, Alexander S/G-7419-2014; Jiang, Liang/A-9847-2008; Taylor, Jacob/O-1670-2019; Hodges, Jonathan/G-1034-2010; Jiang, Liang/GVU-8654-2022; Taylor, Jacob M/B-7826-2011; Maze, Jeronimo/E-7422-2013	Jiang, Liang/0000-0002-0000-9342; Taylor, Jacob/0000-0003-0493-5594; Jiang, Liang/0000-0002-0000-9342; Taylor, Jacob M/0000-0003-0493-5594; Hodges, Jonathan/0000-0002-3487-6698; Maze, Jeronimo/0000-0003-0751-9182	Defense Advanced Research Projects Agency; NSF; Packard Foundation; Pappalardo Fellowship	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Pappalardo Fellowship	We thank P. Cappellaro, L. Childress, J. Doyle, M. V. G. Dutt, J. MacArthur, A. Sorenson, P. Stanwix, E. Togan, and A. Trifonov for many stimulating discussions and experimental help. This work was supported by the Defense Advanced Research Projects Agency, NSF, the Packard Foundation, and the Pappalardo Fellowship. The content of the information does not necessarily reflect the position or the policy of the U.S. Government, and no official endorsement should be inferred.	Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Batalov A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195506; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Cappellaro P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.210502; Coish WA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.125329; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Fuchs GD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117601; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Hanson R, 2008, SCIENCE, V320, P352, DOI 10.1126/science.1155400; Hanson R, 2008, NATURE, V453, P1043, DOI 10.1038/nature07129; Haroche S., 2006, EXPLORING QUANTUM; Hodges JS, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.010303; Hume DB, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120502; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Jiang L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073001; Jiang L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.062323; Manson NB, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.104303; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Maze JR, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.094303; Morton JJL, 2006, NAT PHYS, V2, P40, DOI 10.1038/nphys192; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Reichle R, 2006, NATURE, V443, P838, DOI 10.1038/nature05146; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622; Ryan CA, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.012328; Sarovar M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.245302; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Witzel WM, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.165319	31	250	259	4	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					267	272		10.1126/science.1176496	http://dx.doi.org/10.1126/science.1176496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19745117				2022-12-28	WOS:000270599500037
J	Torii, M; Hashimoto-Torii, K; Levitt, P; Rakic, P				Torii, Masaaki; Hashimoto-Torii, Kazue; Levitt, Pat; Rakic, Pasko			Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling	NATURE			English	Article							DEVELOPING CEREBRAL-CORTEX; NEURAL PRECURSORS; DIPHTHERIA-TOXIN; CELL-MIGRATION; EXPRESSION; NEOCORTEX; BRAIN; PROGENITORS; RECEPTORS; REPRESENTATION	The cerebral cortex is a laminated sheet of neurons composed of the arrays of intersecting radial columns(1-3). During development, excitatory projection neurons originating from the proliferative units at the ventricular surface of the embryonic cerebral vesicles migrate along elongated radial glial fibres(4) to form a cellular infrastructure of radial (vertical) ontogenetic columns in the overlaying cortical plate(5). However, a subpopulation of these clonally related neurons also undergoes a short lateral shift and transfers from their parental to the neighbouring radial glial fibres(6), and intermixes with neurons originating from neighbouring proliferative units(5,7). This columnar organization acts as the primary information processing unit in the cortex(1,8,9). The molecular mechanisms, role and significance of this lateral dispersion for cortical development are not understood. Here we show that an Eph receptor A (EphA) and ephrin A (Efna) signalling-dependent shift in the allocation of clonally related neurons is essential for the proper assembly of cortical columns. In contrast to the relatively uniform labelling of the developing cortical plate by various molecular markers and retrograde tracers in wild-type mice, we found alternating labelling of columnar compartments in Efna knockout mice that are caused by impaired lateral dispersion of migrating neurons rather than by altered cell production or death. Furthermore, in utero electroporation showed that lateral dispersion depends on the expression levels of EphAs and ephrin-As during neuronal migration. This so far unrecognized mechanism for lateral neuronal dispersion seems to be essential for the proper intermixing of neuronal types in the cortical columns, which, when disrupted, might contribute to neuropsychiatric disorders associated with abnormal columnar organization(8,10).	[Torii, Masaaki; Hashimoto-Torii, Kazue; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Torii, Masaaki; Hashimoto-Torii, Kazue; Rakic, Pasko] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Torii, Masaaki; Levitt, Pat] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Torii, Masaaki; Levitt, Pat] Univ So Calif, Keck Sch Med, Dept Cell & Neurobiol, Los Angeles, CA 90089 USA	Yale University; Yale University; University of Southern California; University of Southern California	Rakic, P (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	masaaki.torii@yale.edu; pasko.rakic@yale.edu			NARSAD Young Investigator Award; Kavli Institute for Neuroscience at Yale; National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038296, R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999, R01DA022785] Funding Source: NIH RePORTER	NARSAD Young Investigator Award(NARSAD); Kavli Institute for Neuroscience at Yale; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to T. Cutforth, D. A. Feldheim, J. G. Flanagan, J. Frisen, F. H. Gage, N. Y. Ip, K. Kohno, L. F. Kromer, C. Redies, J. L. R. Rubenstein and T. Saito for providing materials. We also thank M. R. Sarkisian and A. Bonnin for helpful comments, and M. Pappy, J. Bao, C. Anderson and S. Ellis for technical assistance. This work was supported by the NARSAD Young Investigator Award ( M. T.), the Kavli Institute for Neuroscience at Yale ( P. R.) and the National Institutes of Health ( P. L. and P. R.)	Ang ESBC, 2003, J NEUROSCI, V23, P5805; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bonnin A, 2007, NAT NEUROSCI, V10, P588, DOI 10.1038/nn1896; Buxhoeveden DP, 2002, BRAIN, V125, P935, DOI 10.1093/brain/awf110; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Casanova MF, 2008, NEUROSCIENTIST, V14, P101, DOI 10.1177/1073858407309091; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; de Kock CPJ, 2007, J PHYSIOL-LONDON, V581, P139, DOI 10.1113/jphysiol.2006.124321; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; Gamble JA, 2005, J NEUROSCI, V25, P3142, DOI 10.1523/JNEUROSCI.4759-04.2005; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; GOLDMANRAKIC PS, 1987, HDB PHYSL NERVOUS SY, P373; Grove EA, 1998, DEVELOPMENT, V125, P2315; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Herculano-Houzel S, 2005, J NEUROSCI, V25, P2518, DOI 10.1523/JNEUROSCI.4526-04.2005; Jones EG, 2000, P NATL ACAD SCI USA, V97, P5019, DOI 10.1073/pnas.97.10.5019; Kimura Y, 2007, J BIOCHEM, V142, P105, DOI 10.1093/jb/mvm115; MAXWELL IH, 1986, CANCER RES, V46, P4660; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Passante L, 2008, DEVELOPMENT, V135, P3281, DOI 10.1242/dev.024778; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Sanada K, 2004, NEURON, V42, P197, DOI 10.1016/S0896-6273(04)00222-3; SORIANO E, 1995, P NATL ACAD SCI USA, V92, P11676, DOI 10.1073/pnas.92.25.11676; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; SZENTAGOTHAI J, 1978, PROC R SOC SER B-BIO, V201, P219, DOI 10.1098/rspb.1978.0043; Tabata H, 2003, J NEUROSCI, V23, P9996; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Torii M, 2005, NEURON, V48, P563, DOI 10.1016/j.neuron.2005.09.021; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Walkenhorst J, 2000, MOL CELL NEUROSCI, V16, P365, DOI 10.1006/mcne.2000.0878; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722	45	109	109	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					524	U86		10.1038/nature08362	http://dx.doi.org/10.1038/nature08362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19759535	Green Accepted			2022-12-28	WOS:000270082900040
J	Ciccone, DN; Su, H; Hevi, S; Gay, F; Lei, H; Bajko, J; Xu, GL; Li, E; Chen, TP				Ciccone, David N.; Su, Hui; Hevi, Sarah; Gay, Frederique; Lei, Hong; Bajko, Jeffrey; Xu, Guoliang; Li, En; Chen, Taiping			KDM1B is a histone H3K4 demethylase required to establish maternal genomic imprints	NATURE			English	Article							CONTROLS DNA METHYLATION; CRYSTAL-STRUCTURE; DNMT3L; METHYLTRANSFERASE; MAINTENANCE; GENE; LSD1	Differential DNA methylation of the paternal and maternal alleles regulates the parental origin-specific expression of imprinted genes in mammals(1,2). The methylation imprints are established in male and female germ cells during gametogenesis, and the de novo DNA methyltransferase DNMT3A and its cofactor DNMT3L are required in this process(3-5). However, the mechanisms underlying locus-and parental-specific targeting of the de novo DNA methylation machinery in germline imprinting are poorly understood. Here we show that amine oxidase (flavin-containing) domain 1 (AOF1), a protein related to the lysine demethylase KDM1 (also known as LSD1)(6), functions as a histone H3 lysine 4 (H3K4) demethylase and is required for de novo DNA methylation of some imprinted genes in oocytes. AOF1, now renamed lysine demethylase 1B (KDM1B) following a new nomenclature(7), is highly expressed in growing oocytes where genomic imprints are established. Targeted disruption of the gene encoding KDM1B had no effect on mouse development and oogenesis. However, oocytes from KDM1B-deficient females showed a substantial increase in H3K4 methylation and failed to set up the DNA methylation marks at four out of seven imprinted genes examined. Embryos derived from these oocytes showed biallelic expression or biallelic suppression of the affected genes and died before mid-gestation. Our results suggest that demethylation of H3K4 is critical for establishing the DNA methylation imprints during oogenesis.	[Ciccone, David N.; Su, Hui; Hevi, Sarah; Gay, Frederique; Lei, Hong; Bajko, Jeffrey; Li, En; Chen, Taiping] Novartis Inst Biomed Res, Epigenet Program, Cambridge, MA 02139 USA; [Xu, Guoliang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Novartis; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, TP (corresponding author), Novartis Inst Biomed Res, Epigenet Program, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	taiping.chen@novartis.com						Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen Y, 2006, P NATL ACAD SCI USA, V103, P13956, DOI 10.1073/pnas.0606381103; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Hata K, 2002, DEVELOPMENT, V129, P1983; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Obata Y, 2002, J BIOL CHEM, V277, P5285, DOI 10.1074/jbc.M108586200; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stavropoulos P, 2006, NAT STRUCT MOL BIOL, V13, P626, DOI 10.1038/nsmb1113; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268	23	351	374	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					415	U115		10.1038/nature08315	http://dx.doi.org/10.1038/nature08315			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19727073				2022-12-28	WOS:000269828100044
J	Karim, SSA; Churchyard, GJ; Karim, QA; Lawn, SD				Karim, Salim S. Abdool; Churchyard, Gavin J.; Karim, Quarraisha Abdool; Lawn, Stephen D.			Health in South Africa 3 HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; MALE CIRCUMCISION; IMPACT; MIGRANT; PREVALENCE; PREVENTION; EPIDEMICS	One of the greatest challenges facing post-apartheid South Africa is the control of the concomitant HIV and tuberculosis epidemics. HIV continues to spread relentlessly, and tuberculosis has been declared a national emergency. In 2007, South Africa, with 0.7% of the world's population, had 17% of the global burden of HIV infection, and one of the world's worst tuberculosis epidemics, compounded by rising drug resistance and HIV co-infection. Until recently, the South African Government's response to these diseases has been marked by denial, lack of political will, and poor implementation of policies and programmes. Nonetheless, there have been notable achievements in disease management, including substantial improvements in access to condoms, expansion of tuberculosis control efforts, and scale-up of free antiretroviral therapy (ART). Care for acutely ill AIDS patients and long-term provision of ART are two issues that dominate medical practice and the health-care system. Decisive action is needed to implement evidence-based priorities for the control of the HIV and tuberculosis epidemics. By use of the framework of the Strategic Plans for South Africa for tuberculosis and HIV/AIDS, we provide prioritised four-step approaches for tuberculosis control, HIV prevention, and HIV treatment. Strong leadership, political will, social mobilisation, adequate human and financial resources, and sustainable development of health-care services are needed for successful implementation of these approaches.	[Karim, Salim S. Abdool] Univ KwaZulu Natal, Nelson R Mandela Sch Med, CAPRISA, Doris Duke Med Res Inst, ZA-4013 Congella, South Africa; [Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, New York, NY USA; [Churchyard, Gavin J.] Aurum Inst Hlth Res, Johannesburg, South Africa; [Churchyard, Gavin J.] London Sch Hyg & Trop Med, Dept Trop Med & Infect Dis, London WC1, England; [Lawn, Stephen D.] Univ Cape Town, Desmond Tutu HIV Ctr, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa	University of Kwazulu Natal; Columbia University; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Karim, SSA (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, CAPRISA, Doris Duke Med Res Inst, 2nd Floor,Private Bag X7, ZA-4013 Congella, South Africa.	karims1@ukzn.ac.za	Karim, Salim Abdool/P-3117-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Karim, Salim Abdool/AAE-7118-2019; Abdool Karim, Quarraisha/GVS-1160-2022	Karim, Salim Abdool/0000-0002-4986-2133; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Abdool Karim, Quarraisha/0000-0002-0985-477X; Churchyard, Gavin/0000-0002-4269-3699	Wellcome Trust, London, UK; National Institutes of Health [A1069469, A151794]; President's Emergency Plan For AIDS Relief [U2GPS001350, U2GPS000811, SU062PS024055]; Fogarty International Center [TW00231]; HIV Prevention Trials Network [A1068619]; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [U2GPS001350] Funding Source: NIH RePORTER; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS024055, U2GPS000811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068619, UM1AI068619, U01AI069469, U19AI051794, UM1AI069469] Funding Source: NIH RePORTER	Wellcome Trust, London, UK(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); President's Emergency Plan For AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); HIV Prevention Trials Network; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The AIDS mathematical model on the impact of early treatment initiation was developed by Eleanor Gouws and Brian Williams. We thank Cheryl Baxter and Nomonde Xundu for their assistance with the report, and Gary Maartens and Gerald Friedland for reviewing the report. Stephen Lawn is funded by the Wellcome Trust, London, UK. Support from the the National Institutes of Health (grants A1069469 and A151794) is gratefully acknowledged by GJC as well as SSAK and QAK. Funding from the President's Emergency Plan For AIDS Relief is gratefully acknowledged by SSAK and QAK (grant U2GPS001350) and GJC (U2GPS000811, SU062PS024055). Additionally, QAK is funded by the Fogarty International Center (grant TW00231) and the HIV Prevention Trials Network (grant A1068619), and GJC is funded by the Consortium to respond effectively to the AIDS/TB Epidemic.	Abdool Karim Q, 2005, HIV AIDS S AFRICA, P48; Achmat Z, 1995, S Afr Labour Bull, V19, P8; *ACT SOC S AFR, ASSA2003 AIDS DEM MO; *AD GUID COMM, 2008, J SO AFRICAN HIV JAN, P18; *AIDS ACC INT, AIDS ACC COUNTR SCOR; Andrews JR, 2008, J INFECT DIS, V198, P1582, DOI 10.1086/592991; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bacaer N, 2008, J MATH BIOL, V57, P557, DOI 10.1007/s00285-008-0177-z; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Coetzee D, 2004, TROP MED INT HEALTH, V9, pA11, DOI 10.1111/j.1365-3156.2004.01259.x; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Cullinan Kerry, 2009, VIRUS VITAMINS VEGET; Currie CSM, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-130; Currie CSM, 2003, AIDS, V17, P2501, DOI 10.1097/00002030-200311210-00013; *DEP HLTH, 2006, SAV MOTH REP CONF EN; *DEP HLTH, 2008, PROGR REP DECL COMM; Dowdy DW, 2008, P NATL ACAD SCI USA, V105, P11293, DOI 10.1073/pnas.0800965105; DUSHEIKO GM, 1989, AM J EPIDEMIOL, V129, P138, DOI 10.1093/oxfordjournals.aje.a115102; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Friedberg JW, 2008, BLOOD, V112, P3; Friedland G, 2007, J INFECT DIS, V196, pS114, DOI 10.1086/518664; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Global HIV Prevention Working Group, 2004, HIV PREV ER EXP TREA; GOUWS E, 2007, THESIS U KWAZULU NAT; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; *HLTH SYST TRUST, DISTR HLTH BAR 2006; IJSSELMUIDEN CB, 1988, S AFR MED J, V73, P455; JINABHAI CC, 1986, INT J HEALTH SERV, V16, P163, DOI 10.2190/JTNM-2D1H-8TK8-63DV; JOCHELSON K, 1991, INT J HEALTH SERV, V21, P157, DOI 10.2190/11UE-L88J-46HN-HR0K; KARIM QA, 1992, AIDS, V6, P1535, DOI 10.1097/00002030-199212000-00018; Karim S. S. Abdool, 2005, HIV AIDS S AFRICA; Karim SA, 2009, 16 C RETR OPP INF MO; Karim SSA, 2003, LANCET, V362, P1499, DOI 10.1016/S0140-6736(03)14700-9; KARIM SSA, 1992, S AFR MED J, V82, P484; KARK S. L., 1949, South African Medical Journal, V23, P77; Lawn SD, 2006, CLIN INFECT DIS, V42, P1040, DOI 10.1086/501018; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2007, CLIN INFECT DIS, V45, P803, DOI 10.1086/521173; Lurie MN, 2003, SEX TRANSM DIS, V30, P149, DOI 10.1097/00007435-200302000-00011; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; PACKARD RM, 1987, J S AFR STUD, V13, P187, DOI 10.1080/03057078708708141; Pillay M, 2007, CLIN INFECT DIS, V45, P1409, DOI 10.1086/522987; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; *S AFR DEP HLTH, 2007, NAT HIV SYPH PREV SU; Salomon JA, 2005, PLOS MED, V2, P50, DOI 10.1371/journal.pmed.0020016; SHISANA O, 2005, S AFRICAN NATL HIV P; South Africa Department of Health, 2007, TUB STRAT PLAN S AFR; South Sudan Ministry of Health, 2007, STRAT PLAN HUM RES H; *STATS SA, 2008, MID POP EST STAT REL; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; UNAIDS, PRACT GUID INT HIV P; *UNAIDS WHO, 2007, 207 AIDS EP UPD; van Harmelen J, 2001, AIDS RES HUM RETROV, V17, P1527, DOI 10.1089/08892220152644232; Whiteside A, 2001, BRIT MED BULL, V58, P73, DOI 10.1093/bmb/58.1.73; *WHO IUATLD, 2008, 4 WHOIUATLD; Williams BG, 2006, PLOS MED, V3, P1032, DOI 10.1371/journal.pmed.0030262; WOLDEHANNA S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000171.PUB2; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2008, JOINT WHO HIV AIDS T; World Health Organization, 2009, GLOB TUB CONTR EP ST	62	334	342	1	47	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					921	933		10.1016/S0140-6736(09)60916-8	http://dx.doi.org/10.1016/S0140-6736(09)60916-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19709731	Green Accepted			2022-12-28	WOS:000269943100031
J	Smith, CA; Roeszler, KN; Ohnesorg, T; Cummins, DM; Farlie, PG; Doran, TJ; Sinclair, AH				Smith, Craig A.; Roeszler, Kelly N.; Ohnesorg, Thomas; Cummins, David M.; Farlie, Peter G.; Doran, Timothy J.; Sinclair, Andrew H.			The avian Z-linked gene DMRT1 is required for male sex determination in the chicken	NATURE			English	Article							MALE REGULATORY GENE; DM-DOMAIN GENE; CONSERVED SYNTENY; EXPRESSION; CHROMOSOME; EVOLUTION; AROMATASE; EMBRYOS; GONADS; SOX9	Sex in birds is chromosomally based, as in mammals, but the sex chromosomes are different and the mechanism of avian sex determination has been a long-standing mystery(1-3). In the chicken and all other birds, the homogametic sex is male (ZZ) and the heterogametic sex is female (ZW). Two hypotheses have been proposed for the mechanism of avian sex determination. The W ( female) chromosome may carry a dominant-acting ovary determinant(4-6). Alternatively, the dosage of a Z-linked gene may mediate sex determination, two doses being required for male development (ZZ)(7,8). A strong candidate avian sex-determinant under the dosage hypothesis is the conserved Z-linked gene, DMRT1 (doublesex and mab-3-related transcription factor 1)(9-11). Here we used RNA interference (RNAi) to knock down DMRT1 in early chicken embryos. Reduction of DMRT1 protein expression in ovo leads to feminization of the embryonic gonads in genetically male (ZZ) embryos. Affected males show partial sex reversal, characterized by feminization of the gonads. The feminized left gonad shows female-like histology, disorganized testis cords and a decline in the testicular marker, SOX9. The ovarian marker, aromatase, is ectopically activated. The feminized right gonad shows a more variable loss of DMRT1 and ectopic aromatase activation, suggesting differential sensitivity to DMRT1 between left and right gonads. Germ cells also show a female pattern of distribution in the feminized male gonads. These results indicate that DMRT1 is required for testis determination in the chicken. Our data support the Z dosage hypothesis for avian sex determination.	[Smith, Craig A.; Roeszler, Kelly N.; Ohnesorg, Thomas; Farlie, Peter G.; Sinclair, Andrew H.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Smith, Craig A.; Roeszler, Kelly N.; Ohnesorg, Thomas; Farlie, Peter G.; Sinclair, Andrew H.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3052, Australia; [Cummins, David M.; Doran, Timothy J.] CSIRO Livestock Ind, Australian Anim Hlth Lab, Geelong, Vic 3220, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Smith, CA (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	craig.smith@mcri.edu.au	Sinclair, Andrew H/A-3598-2010; Doran, Timothy J/B-3824-2011	Sinclair, Andrew H/0000-0003-2741-7992; Doran, Timothy J/0000-0002-9716-5148; Ohnesorg, Thomas/0000-0001-9225-8911; Smith, Craig/0000-0002-1670-5545; Roeszler, Kelly/0000-0002-9809-1507	Australian Research Council (ARC) DP; NH MRC Program	Australian Research Council (ARC) DP(Australian Research Council); NH MRC Program(National Health and Medical Research Council (NHMRC) of Australia)	We thank C. Tabin for providing the RCASBP retroviral vectors, and X.- J. Yang for advice on viral preparation. We also thank M. Clinton and H. Sang for methods of manipulating early chicken embryos, S. White for statistical advice and P. Farmer for the histology. P. Koopman provided comments on the manuscript. This work was supported by an Australian Research Council (ARC) DP grant held by C. A. S. and A. H. S., and an NH& MRC Program grant jointly held by A. H. S.	Arlt D, 2004, P ROY SOC B-BIOL SCI, V271, pS249, DOI 10.1098/rsbl.2003.0155; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Ellegren H, 2000, TRENDS ECOL EVOL, V15, P188, DOI 10.1016/S0169-5347(00)01821-8; Govoroun MS, 2004, DEV DYNAM, V231, P859, DOI 10.1002/dvdy.20189; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; Hori T, 2000, MOL BIOL CELL, V11, P3645, DOI 10.1091/mbc.11.10.3645; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Kent J, 1996, DEVELOPMENT, V122, P2813; Kettlewell JR, 2000, GENESIS, V26, P174, DOI 10.1002/(SICI)1526-968X(200003)26:3<174::AID-GENE2>3.0.CO;2-J; Logan M, 1998, METHODS, V14, P407, DOI 10.1006/meth.1998.0595; Matsuda M, 2002, NATURE, V417, P559, DOI 10.1038/nature751; Mizuno S, 2002, CYTOGENET GENOME RES, V99, P236, DOI 10.1159/000071599; Nanda I, 2008, CYTOGENET GENOME RES, V122, P150, DOI 10.1159/000163092; Nanda I, 1999, NAT GENET, V21, P258, DOI 10.1038/6769; Nanda I, 2000, CYTOGENET CELL GENET, V89, P67, DOI 10.1159/000015567; Ounap K, 2004, AM J MED GENET A, V130A, P415, DOI 10.1002/ajmg.a.30269; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Shan Z, 2000, CYTOGENET CELL GENET, V89, P252, DOI 10.1159/000015626; Shetty S, 2002, CYTOGENET GENOME RES, V99, P245, DOI 10.1159/000071600; Shoemaker C, 2007, DEV DYNAM, V236, P1055, DOI 10.1002/dvdy.21096; Smith CA, 2007, CYTOGENET GENOME RES, V117, P165, DOI 10.1159/000103177; Smith CA, 1999, NATURE, V402, P601, DOI 10.1038/45130; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Smith CA, 2003, BIOL REPROD, V68, P560, DOI 10.1095/biolreprod.102.007294; Smith CA, 2007, SEX DEV, V1, P279, DOI 10.1159/000108934; Smith CA, 2009, DIFFERENTIATION, V77, P473, DOI 10.1016/j.diff.2009.02.001; Smith CA, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-72; Wise TG, 2007, ANIM BIOTECHNOL, V18, P153, DOI 10.1080/10495390600867515; Yoshimoto S, 2008, P NATL ACAD SCI USA, V105, P2469, DOI 10.1073/pnas.0712244105; Zhao Y, 2007, DEV GENES EVOL, V217, P119, DOI 10.1007/s00427-006-0117-0	30	558	610	6	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					267	271		10.1038/nature08298	http://dx.doi.org/10.1038/nature08298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19710650				2022-12-28	WOS:000269654600045
J	Pucadyil, TJ; Schmid, SL				Pucadyil, Thomas J.; Schmid, Sandra L.			Conserved Functions of Membrane Active GTPases in Coated Vesicle Formation	SCIENCE			English	Review							ARF FAMILY; MEDIATED ENDOCYTOSIS; MOLECULAR-MECHANISM; PROTEIN-TRANSPORT; EXCHANGE FACTOR; GTP-BINDING; CLATHRIN; DYNAMIN; CURVATURE; CARGO	Coated vesicles concentrate and package cargo molecules to mediate their efficient transport between intracellular compartments. Cytosolic coat proteins such as clathrin and adaptor complexes and coat protein complex I (COPI) and COPII self-assemble to deform the membrane and interact directly with cargo molecules to capture them in nascent buds. The guanosine triphosphatases (GTPases) Arf, Sar1, and dynamin are core components of the coated vesicle machinery. These GTPases, which associate with and dissociate from donor membranes in a guanosine triphosphate-dependent manner, can also actively remodel membranes. Recent evidence suggests that, although structurally diverse, Arf family GTPases and dynamin may play mechanistically similar roles as fidelity monitors that govern cargo packaging and coated vesicle maturation and as components of the fission machinery to mediate vesicle release.	[Pucadyil, Thomas J.; Schmid, Sandra L.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schmid, SL (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slschmid@scripps.edu	Pucadyil, Thomas/AAJ-3974-2020	Pucadyil, Thomas/0000-0002-2907-9889; Schmid, Sandra/0000-0002-1690-7024	Leukemia and Lymphoma Society; NIH [GM42455, MH61345, GM73165]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073165, R01GM042455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH061345, R01MH061345] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank members of the Schmid lab, A. Razvi, and S. Kalipatnapu for critical comments on the manuscript. We apologize to those authors whose work we could not cite because of space constraints. This work was supported by a career development grant from the Leukemia and Lymphoma Society to T.J.P. and NIH grants (GM42455, MH61345, and GM73165) to S.L.S. This is TSRI manuscript number 20182.	BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Burger KNJ, 2000, BIOCHEMISTRY-US, V39, P12485, DOI 10.1021/bi000971r; CARTER LL, 1993, J CELL BIOL, V120, P37, DOI 10.1083/jcb.120.1.37; Chappie JS, 2009, MOL BIOL CELL, V20, P3561, DOI 10.1091/mbc.E09-04-0318; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; Liu YZ, 2009, STRUCTURE, V17, P79, DOI 10.1016/j.str.2008.10.020; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sato K, 2007, FEBS LETT, V581, P2076, DOI 10.1016/j.febslet.2007.01.091; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457; Shiba T, 2003, NAT STRUCT BIOL, V10, P386, DOI 10.1038/nsb920; Shpetner HS, 1996, J BIOL CHEM, V271, P13, DOI 10.1074/jbc.271.1.13; Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h; Spang A, 2008, CELL MOL LIFE SCI, V65, P2781, DOI 10.1007/s00018-008-8349-y; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015	50	131	133	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1217	1220		10.1126/science.1171004	http://dx.doi.org/10.1126/science.1171004			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729648	Green Accepted			2022-12-28	WOS:000269523200028
J	Mathieu, S; Boutron, I; Moher, D; Altman, DG; Ravaud, P				Mathieu, Sylvain; Boutron, Isabelle; Moher, David; Altman, Douglas G.; Ravaud, Philippe			Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIALS; INTERNATIONAL-COMMITTEE; EMPIRICAL-EVIDENCE; PUBLICATION BIAS; REPORTING BIAS; REGISTRATION; PROTOCOLS; CONSORT; STATEMENT; QUALITY	Context As of 2005, the International Committee of Medical Journal Editors required investigators to register their trials prior to participant enrollment as a precondition for publishing the trial's findings in member journals. Objective To assess the proportion of registered trials with results recently published in journals with high impact factors; to compare the primary outcomes specified in trial registries with those reported in the published articles; and to determine whether primary outcome reporting bias favored significant outcomes. Data Sources and Study Selection MEDLINE via PubMed was searched for reports of randomized controlled trials (RCTs) in 3 medical areas (cardiology, rheumatology, and gastroenterology) indexed in 2008 in the 10 general medical journals and specialty journals with the highest impact factors. Data Extraction For each included article, we obtained the trial registration information using a standardized data extraction form. Results Of the 323 included trials, 147 (45.5%) were adequately registered (ie, registered before the end of the trial, with the primary outcome clearly specified). Trial registration was lacking for 89 published reports (27.6%), 45 trials (13.9%) were registered after the completion of the study, 35 (10.8%) were registered with no or an unclear description of the primary outcome, 39 (12%) were registered with no or an unclear description of the primary outcome, and 3 (0.9%) were registered after the completion of the study and had an unclear description of the primary outcome. Among articles with trials adequately registered, 31% ( 6 of 147) showed some evidence of discrepancies between the outcomes registered and the outcomes published. The influence of these discrepancies could be assessed in only half of them and in these statistically significant results were favored in 82.6% (19 of 23). Conclusion Comparison of the primary outcomes of RCTs registered with their subsequent publication indicated that selective outcome reporting is prevalent. JAMA. 2009;302(9):977-984 www.jama.com	[Mathieu, Sylvain; Boutron, Isabelle; Ravaud, Philippe] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris 18, France; [Mathieu, Sylvain; Boutron, Isabelle; Ravaud, Philippe] INSERM, U738, Paris, France; [Mathieu, Sylvain; Boutron, Isabelle; Ravaud, Philippe] Univ Paris Diderot, Fac Med, Paris, France; [Mathieu, Sylvain] Univ Clermont 1, Serv Rhumatol, Hop Gabriel Montpied, Fac Med, Clermont Ferrand, France; [Moher, David] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa Methods Ctr, Ottawa, ON, Canada; [Moher, David] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Clermont Ferrand; Universite Clermont Auvergne (UCA); University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Oxford	Ravaud, P (corresponding author), Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris 18, France.	philippe.ravaud@bch.aphp.fr	Altman, Douglas G/A-9714-2012; ravaud, philippe/C-1694-2009	Moher, David/0000-0003-2434-4206; Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241				Al-Marzouki S, 2008, LANCET, V372, P201, DOI 10.1016/S0140-6736(08)61060-0; Berg JO, 2007, JAMA-J AM MED ASSOC, V298, P1514, DOI 10.1001/jama.298.13.1514-b; Bero L, 2007, PLOS MED, V4, P1001, DOI 10.1371/journal.pmed.0040184; Chan AW, 2008, PLOS MED, V5, P1533, DOI 10.1371/journal.pmed.0050230; Chan AW, 2005, LANCET, V365, P1159, DOI 10.1016/S0140-6736(05)71879-1; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; De Angelis CD, 2005, NEW ENGL J MED, V352, P2436, DOI 10.1056/NEJMe058127; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Dwan K, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-66; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Evans T, 2004, LANCET, V363, P1413, DOI 10.1016/S0140-6736(04)16136-9; Godlee F, 2001, BMC NEWS VIEWS, V2; Goldbeck-Wood S, 2001, BRIT MED J, V322, P1460; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Horton R, 1999, BRIT MED J, V319, P865, DOI 10.1136/bmj.319.7214.865; Laine C, 2007, NEW ENGL J MED, V356, P2734, DOI 10.1056/NEJMe078110; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Levin LA, 2007, ARCH INTERN MED, V167, P1576, DOI 10.1001/archinte.167.15.1576; Mills E, 2005, J CLIN EPIDEMIOL, V58, P662, DOI 10.1016/j.jclinepi.2005.01.004; Mills EJ, 2005, CONTEMP CLIN TRIALS, V26, P480, DOI 10.1016/j.cct.2005.02.008; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Rennie D, 2004, JAMA-J AM MED ASSOC, V292, P1359, DOI 10.1001/jama.292.11.1359; Reviz L, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-30; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; Sekeres M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001610; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Tannock IF, 1996, J NATL CANCER I, V88, P206, DOI 10.1093/jnci/88.3-4.206; Tonks L, 1999, BMJ-BRIT MED J, V319, P1565, DOI 10.1136/bmj.319.7224.1565; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	34	460	467	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					977	984		10.1001/jama.2009.1242	http://dx.doi.org/10.1001/jama.2009.1242			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724045	Bronze			2022-12-28	WOS:000269444900023
J	Esposito, K; Maiorino, MI; Ciotola, M; Di Palo, C; Scognamiglio, P; Gicchino, M; Petrizzo, M; Saccomanno, F; Beneduce, F; Ceriello, A; Giugliano, D				Esposito, Katherine; Maiorino, Maria Ida; Ciotola, Miryam; Di Palo, Carmen; Scognamiglio, Paola; Gicchino, Maurizio; Petrizzo, Michela; Saccomanno, Franco; Beneduce, Flora; Ceriello, Antonio; Giugliano, Dario			Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							WEIGHT-LOSS; LOW-CARBOHYDRATE; RISK-FACTORS; FOLLOW-UP; ADHERENCE; MELLITUS; GLUCOSE; INFLAMMATION; ADIPONECTIN; STATEMENT	Background: Low-carbohydrate and low-fat calorie-restricted diets are recommended for weight loss in overweight and obese people with type 2 diabetes. Objective: To compare the effects of a low-carbohydrate Mediterranean-style or a low-fat diet on the need for antihyperglycemic drug therapy in patients with newly diagnosed type 2 diabetes. Design: Single-center, randomized trial. Randomization was computer-generated and unstratified. Allocation was concealed in sealed study folders held in a central, secure location until participants gave informed consent. Participants and investigators were aware of treatment assignment, and assessors of the primary outcome were blinded. Setting: Teaching hospital in Naples, Italy. Patients: 215 overweight people with newly diagnosed type 2 diabetes who were never treated with antihyperglycemic drugs and had hemoglobin A(1c) (HbA(1c)) levels less than 11%. Intervention: Mediterranean-style diet (<50% of daily calories from carbohydrates) (n = 108) or a low-fat diet (<30% of daily calories from fat) (n = 107). Measurements: Start of antihyperglycemic drug therapy, defined by protocol as indicated for follow-up HbA1c level greater than 7% primary outcome), and changes in weight, glycemic control, and coronary risk factors ( secondary outcomes). Results: After 4 years, 44% of patients in the Mediterranean-style diet group and 70% in the low-fat diet group required treatment ( absolute difference, -26.0 percentage points [95% CI, -31.1 to -20.1 percentage points]; hazard ratio, 0.63 [ CI, 0.51 to 0.86]; hazard ratio adjusted for weight change, 0.70 [ CI, 0.59 to 0.90]; P < 0.001). Participants assigned to the Mediterranean-style diet lost more weight and experienced greater improvements in some glycemic control and coronary risk measures than did those assigned to the low-fat diet. Limitations: Investigators responsible for initiating drug therapy were not blinded to treatment assignment. Dietary intake was self-reported. Conclusion: Compared with a low-fat diet, a low-carbohydrate, Mediterranean-style diet led to more favorable changes in glycemic control and coronary risk factors and delayed the need for antihyperglycemic drug therapy in overweight patients with newly diagnosed type 2 diabetes.	Vico Equense Sorrento, ASLNA5, Naples, Italy; Warwick Med Sch, Coventry, W Midlands, England; Univ Naples 2, I-80138 Naples, Italy	University of Warwick; Universita della Campania Vanvitelli	Giugliano, D (corresponding author), Univ Naples 2, Div Metab Dis, Azienda Osped Univ, I-80138 Naples, Italy.	dario.giugliano@unina2.it	Esposito, Katherine/AHE-2564-2022; Maiorino, Maria Ida/AHE-9986-2022	Esposito, Katherine/0000-0002-3652-5154; Maiorino, Maria Ida/0000-0003-4659-7546; Petrizzo, Michela/0000-0002-7843-5608; Ceriello, Antonio/0000-0001-8122-3203; Gicchino, Maurizio/0000-0002-2976-7948; Giugliano, Dario/0000-0002-9377-873X	Second University of Naples	Second University of Naples	Second University of Naples.	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; Angell M, 2008, JAMA-J AM MED ASSOC, V300, P1069, DOI 10.1001/jama.300.9.1069; Bazzano LA, 2008, DIABETES CARE, V31, P1311, DOI 10.2337/dc08-0080; Due A, 2008, AM J CLIN NUTR, V88, P1232, DOI 10.3945/ajcn.2007.25695; Esposito K, 2006, EUR HEART J, V27, P15, DOI 10.1093/eurheartj/ehi605; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Esposito K, 2007, NEW ENGL J MED, V356, P750; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Giugliano D, 2008, CURR OPIN LIPIDOL, V19, P63, DOI 10.1097/MOL.0b013e3282f2fa4d; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; Harding AH, 2008, ARCH INTERN MED, V168, P1493, DOI 10.1001/archinte.168.14.1493; Havas S, 2009, ARCH INTERN MED, V169, P150, DOI 10.1001/archinternmed.2008.518; Heidemann C, 2008, ANN INTERN MED, V149, P307, DOI 10.7326/0003-4819-149-5-200809020-00005; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; *INT DIAB FED, 2006, DIAB ATL; Krauss RM, 2000, CIRCULATION, V102, P2284; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Manley SE, 2000, DIABETIC MED, V17, P518; Mantzoros CS, 2006, AM J CLIN NUTR, V84, P328; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mozaffarian D, 2007, LANCET, V370, P667, DOI 10.1016/S0140-6736(07)61343-9; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nettleton JA, 2008, DIABETES CARE, V31, P1777, DOI 10.2337/dc08-0760; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Shai I, 2008, NEW ENGL J MED, V359, P229, DOI 10.1056/NEJMoa0708681; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Yamaoka K, 2005, DIABETES CARE, V28, P2780, DOI 10.2337/diacare.28.11.2780	33	289	292	2	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					306	U29		10.7326/0003-4819-151-5-200909010-00004	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492KB	19721018				2022-12-28	WOS:000269653100002
J	Wiedemann, N; van der Laan, M; Pfanner, N				Wiedemann, Nils; van der Laan, Martin; Pfanner, Nikolaus			SnapShot: Import and Sorting of Mitochondrial Proteins	CELL			English	Editorial Material							INTERMEMBRANE SPACE; MEMBRANE INSERTION		[Wiedemann, Nils; van der Laan, Martin; Pfanner, Nikolaus] Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany	University of Freiburg	Wiedemann, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, ZBMZ, D-79104 Freiburg, Germany.		Pfanner, Nikolaus/AAV-7878-2021	van der Laan, Martin/0000-0003-0789-9912; Wiedemann, Nils/0000-0001-8305-6728				Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025	10	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					808	U7		10.1016/j.cell.2009.08.004	http://dx.doi.org/10.1016/j.cell.2009.08.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703404	Bronze			2022-12-28	WOS:000269156100022
J	Decramer, M; Celli, B; Kesten, S; Lystig, T; Mehra, S; Tashkin, DP				Decramer, Marc; Celli, Bartolome; Kesten, Steven; Lystig, Theodore; Mehra, Sunil; Tashkin, Donald P.		UPLIFT Investigators	Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial	LANCET			English	Article							FLUTICASONE PROPIONATE; INHALED BUDESONIDE; LUNG-FUNCTION; COPD; DECLINE; SALMETEROL; MECHANISMS; MILD	Background The beneficial effects of pharmacotherapy for chronic obstructive pulmonary disease (COPD) are well established. However, there are few data for treatment in the early stages of the disease. We examined the effect of tiotropium on outcomes in a large subgroup of patients with moderate COPD. Methods The Understanding Potential Long-Term Impacts on Function with Tiotropium (UPLIFT) study was a randomised, double-blind, placebo-controlled trial undertaken in 487 centres in 37 countries. 5993 patients aged 40 years or more with COPD were randomly assigned to receive 4 years of treatment with either once daily tiotropium (18 mu g; n=2987) or matching placebo (n=3006), delivered by an inhalation device. Randomisation was by computer-generated blocks of four, with stratification according to study site. In a prespecified subgroup analysis, we investigated the effects of tiotropium in patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage II disease. Primary endpoints were the yearly rates of decline in prebronchodilator forced expiratory volume in 1 s (FEV(1)) and in postbronchodilator FEV beginning on day 30 until completion of double-blind treatment. The analysis included all patients who had at least three measurements of pulmonary function. This study is registered with ClinicalTrials.gov, number NCT00144339. Findings 2739 participants (mean age 64 years [SD 9]) had GOLD stage II disease at randomisation (tiotropium, n=1384; control, n=1355), with a mean postbronchodilator FEV(1) of 1.63 L (SD 0.37; 59% of predicted value). 1218 patients in the tiotropium group and 1157 in the control group had three or more measurements of postbronchodilator pulmonary function after day 30 and were included in the analysis. The rate of decline of mean postbronchodilator FEV(1) was lower in the tiotropium group than in the control group (43 mL per year [SE 2] vs 49 mL per year [SE 2], p=0024). For prebronchodilator pulmonary function, 1221 patients in the tiotropium group and 1158 in the control group had three or more measurements and were included in the analysis. The rate of decline of mean prebronchodilator FEV(1) did not differ between groups (35 mL per year [SE 2] vs 37 mL per year [SE 2]; p=0.38). Health status, measured with the St George's Respiratory Questionnaire, was better at all timepoints in the tiotropium group than in the control group (p <= 0.006 for all timepoints). Time to first exacerbation and time to exacerbation resulting in hospital admission were also longer in the tiotropium group than in the control group (hazard ratio 0.82, 95% CI 0.75-0.90, and 0.74, 0.62-0.88, respectively). Interpretation Tiotropium seemed to reduce the rate of decline of postbronchodilator FEV(1) in patients with GOLD stage II COPD. This finding and the other improvements in outcomes suggest that treatment of COPD should begin at an early stage of the disease. Funding Boehringer Ingelheiln and Pfizer Pharmaceuticals.	[Decramer, Marc] Univ Louvain, Div Resp, Louvain, Belgium; [Celli, Bartolome] Caritas St Elizabeths Med Ctr, Boston, MA USA; [Kesten, Steven; Lystig, Theodore] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Mehra, Sunil] Pfizer Pharmaceut Inc, New York, NY USA; [Tashkin, Donald P.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	St. Elizabeth's Medical Center; Boehringer Ingelheim; Pfizer; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Decramer, M (corresponding author), Univ Louvain, Univ Hosp, Div Resp, Herestr 49, B-3000 Louvain, Belgium.	Marc.Decramer@uzleuven.be	Barbara, C./AAF-3397-2020; Cukier, Alberto/C-6101-2012; Lystig, Theodore/E-4149-2015	Barbara, C./0000-0003-0915-4105; Cukier, Alberto/0000-0002-7217-9498; Lystig, Theodore/0000-0002-4523-0761; Epton, Michael/0000-0003-4644-366X; Driesen, Peter/0000-0002-8509-8750; Pothirat, Chaicharn/0000-0003-0616-7066; PAPI, ALBERTO/0000-0002-6924-4500; burghuber, otto/0000-0002-8419-621X; Rodriguez Gonzalez-Moro, Jose Miguel/0000-0002-8446-3373; Kuschner, Ware/0000-0002-9732-1366; Kesten, Steven/0000-0002-5522-7910	Boehringer Ingelheim; Pfizer	Boehringer Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer)	This trial was supported by Boehringer Ingelheim and Pfizer. We thank Deborah Burkhart (clinical trial coordinator), for support with the UPLIFT trial and this report, Shailendra Menjoje (member of advisory committee), and Steven Senn (member of advisory committee), who contributed to the study design.	Altose MD, 2000, NEW ENGL J MED, V343, P1902; BEAUCAGE F, 2008, AM J RESP CRIT CARE, V177, pA401; Buffels J, 2004, CHEST, V125, P1394, DOI 10.1378/chest.125.4.1394; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Decramer M, 2008, COPD, V5, P235, DOI 10.1080/15412550802237531; Decramer Marc, 2004, COPD, V1, P303, DOI 10.1081/COPD-200026934; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; HARTSFIELD CL, 2005, P AM THORAC SOC, V2, pA541; Johansson Gunnar, 2008, Prim Care Respir J, V17, P169, DOI 10.3132/pcrj.2008.00037; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; O'Donnell DE, 2009, THORAX, V64, P216, DOI 10.1136/thx.2008.103598; Ofir D, 2008, AM J RESP CRIT CARE, V177, P622, DOI 10.1164/rccm.200707-1064OC; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Pitta F, 2005, AM J RESP CRIT CARE, V171, P972, DOI 10.1164/rccm.200407-855OC; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Takahashi TU, 2003, RESPIROLOGY, V8, P504, DOI 10.1046/j.1440-1843.2003.00501.x; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; TROOSTERS T, 2007, AM J RESP CRIT CARE, V175, pA368; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Vincken W, 2002, EUR RESPIR J, V19, P209, DOI 10.1183/09031936.02.00238702; Watz H, 2008, AM J RESP CRIT CARE, V177, P743, DOI 10.1164/rccm.200707-1011OC; Zaas D, 2004, CHEST, V125, P106, DOI 10.1378/chest.125.1.106	27	357	386	0	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 3	2009	374	9696					1171	1178		10.1016/S0140-6736(09)61298-8	http://dx.doi.org/10.1016/S0140-6736(09)61298-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505IZ	19716598				2022-12-28	WOS:000270688200033
J	Rudin, CM; Hann, CL; Laterra, J; Yauch, RL; Callahan, CA; Fu, L; Holcomb, T; Stinson, J; Gould, SE; Coleman, B; LoRusso, PM; Von Hoff, DD; de Sauvage, FJ; Low, JA				Rudin, Charles M.; Hann, Christine L.; Laterra, John; Yauch, Robert L.; Callahan, Christopher A.; Fu, Ling; Holcomb, Thomas; Stinson, Jeremy; Gould, Stephen E.; Coleman, Barbara; LoRusso, Patricia M.; Von Hoff, Daniel D.; de Sauvage, Frederic J.; Low, Jennifer A.			Brief Report: Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; CELL LUNG-CANCER; SONIC HEDGEHOG; TUMOR; RESISTANCE; MUTATIONS; IMATINIB; GEFITINIB; STAGE; MICE	Medulloblastoma is the most common malignant brain tumor in children. Aberrant activation of the hedgehog signaling pathway is strongly implicated in the development of some cases of medulloblastoma. A 26-year-old man with metastatic medulloblastoma that was refractory to multiple therapies was treated with a novel hedgehog pathway inhibitor, GDC-0449; treatment resulted in rapid (although transient) regression of the tumor and reduction of symptoms. Molecular analyses of tumor specimens obtained before treatment suggested that there was activation of the hedgehog pathway, with loss of heterozygosity and somatic mutation of the gene encoding patched homologue 1 (PTCH1), a key negative regulator of hedgehog signaling.	[Rudin, Charles M.; Hann, Christine L.; Laterra, John; Coleman, Barbara] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Yauch, Robert L.; Callahan, Christopher A.; Fu, Ling; Holcomb, Thomas; Stinson, Jeremy; Gould, Stephen E.; de Sauvage, Frederic J.; Low, Jennifer A.] Genentech Inc, San Francisco, CA 94080 USA; [LoRusso, Patricia M.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA; [Von Hoff, Daniel D.] Scottsdale Clin Res Inst, Scottsdale, AZ USA	Johns Hopkins University; Johns Hopkins Medicine; Roche Holding; Genentech; Barbara Ann Karmanos Cancer Institute; Wayne State University	Rudin, CM (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, David H Koch Canc Res Bldg,Rm 544,1550 Orleans St, Baltimore, MD 21231 USA.	rudin@jhmi.edu	Rudin, Charles/R-2530-2019; de Sauvage, Frederic/ABE-8400-2020	Rudin, Charles/0000-0001-5204-3465; de Sauvage, Frederic/0000-0002-5275-2584	Genentech.; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Genentech.(Roche HoldingGenentech); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Genentech. GDC-0449 was developed under a collaborative agreement between Genentech and Curis. Genentech and Roche collaborate on the clinical development of GDC-0449. Also supported by a Clinical Scientist Award in Translational Research from the Burroughs Wellcome Fund (to Dr. Rudin).	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Cowan R, 1997, BRIT J CANCER, V76, P141, DOI 10.1038/bjc.1997.354; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Kantarjian HM, 2006, ANN INTERN MED, V145, P913, DOI 10.7326/0003-4819-145-12-200612190-00008; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kimura H, 2008, CANCER CELL, V13, P249, DOI 10.1016/j.ccr.2008.01.027; Lee Y, 2003, CANCER RES, V63, P5428; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rudin CM, 2008, EJC SUPPL, V6, P112, DOI 10.1016/S1359-6349(08)72289-4; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Von Hoff DD, 2009, NEW ENGL J MED, V361, P1164, DOI 10.1056/NEJMoa0905360; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832	24	792	835	2	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1173	1178		10.1056/NEJMoa0902903	http://dx.doi.org/10.1056/NEJMoa0902903			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494QA	19726761	Green Accepted			2022-12-28	WOS:000269828000008
J	Victor, D				Victor, David			Plan B for Copenhagen	NATURE			English	Editorial Material									Univ Calif San Diego, Sch Int Relat & Pacific Studies, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Victor, D (corresponding author), Univ Calif San Diego, Sch Int Relat & Pacific Studies, 9500 Gilman Dr,MC 0519, La Jolla, CA 92093 USA.	david.victor@ucsd.edu						Barrett Scott, 2003, ENV STATECRAFT STRAT; Benedick R. E., 1998, OZONE DIPLOMACY NEW; Commission of the European Communities, 2008, 2020 2020 EUR CLIM C; Downs GW, 1996, INT ORGAN, V50, P379, DOI 10.1017/S0020818300033427; International Energy Agency, 2009, CLEAN COAL CHIN; Keohane R., 1989, POWER INTERDEPENDENC; Parson E.A., 2003, PROTECTING OZONE LAY; Schneider L., 2007, IS CDM FULFILLING IT; UNFCCC, 2009, FCCCKPAWG20088; UNFCCC, 2008, REP C PART 13 SESS H; *UNFCCC, 2009, NEG TEXT; *UNFCCC, 2009, PROP AM KYOT PROT PU; Victor D, 2008, REALISTIC POLICY INT; Victor D.G., 2001, COLLAPSE KYOTO PROTO; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a	15	21	21	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 17	2009	461	7262					342	344		10.1038/461342a	http://dx.doi.org/10.1038/461342a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	494QB	19759601				2022-12-28	WOS:000269828100019
J	Charakida, M; Besler, C; Batuca, JR; Sangle, S; Marques, S; Sousa, M; Wang, GS; Tousoulis, D; Alves, JD; Loukogeorgakis, SP; Mackworth-Young, C; D'Cruz, D; Luscher, T; Landmesser, U; Deanfield, JE				Charakida, Marietta; Besler, Christian; Batuca, Joana R.; Sangle, Shirish; Marques, Susanna; Sousa, Miguel; Wang, Guosu; Tousoulis, Dimitris; Alves, Jose Delgado; Loukogeorgakis, Stavros P.; Mackworth-Young, Charles; D'Cruz, David; Luscher, Thomas; Landmesser, Ulf; Deanfield, John E.			Vascular Abnormalities, Paraoxonase Activity, and Dysfunctional HDL in Primary Antiphospholipid Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIGH-DENSITY-LIPOPROTEIN; INTIMA-MEDIA THICKNESS; AUTOIMMUNE RHEUMATIC-DISEASES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACCELERATED ATHEROSCLEROSIS; ANTIINFLAMMATORY PROPERTIES; PREMATURE ATHEROSCLEROSIS; SERUM PARAOXONASE; CAROTID ARTERIES; OXIDATIVE STRESS	Context Accelerated atherosclerosis has been described in antiphospholipid syndrome, but the vascular abnormalities and the underlying mechanisms remain unclear. Objectives To compare vascular structure and function in patients with positive antiphospholipid antibodies (aPL) with controls and to assess their relationship with paraoxonase activity. Design, Setting, and Participants A cross-sectional study of 77 women with positive antiphospholipid antibodies from a lupus outpatient clinic in London, England (90% of the eligible population) and 77 controls matched on frequency basis for age and cardiovascular risk factors between June 2006 and April 2009. Carotid intima media thickness (CIMT), flow-mediated dilatation, pulse wave velocity, and paraoxonase activity were measured in all patients. Anti-inflammatory and antioxidant properties of high-density lipoprotein (HDL) were examined. Main Outcome Measures CIMT, pulse wave velocity, flow-mediated dilatation, and paraoxonase. Results Women with aPL had greater CIMT and pulse wave velocity compared with controls (mean [SD], 0.75 [0.16] vs 0.64 [0.09] mm; 95% confidence interval [CI],-0.14 to-0.06; P<.001; and 9.2 [1.6] vs 8.5 [1.8] m/s; 95% CI,-1.14 to-0.06; P=.04) and lower flow-mediated dilatation (6.2% [4.1%] vs 9.6% [4.2%]; 95% CI, 2.02%-4.69%; P<.001). Paraoxonase activity was lower in women with aPL vs controls (median [interquartile range], 91.2 [64.3-105.1] vs 103.0 [80.5-111.5] mu mol p-nitrophenol/L/serum/min; 95% CI, 0.004-0.007; P=.005) and was inversely associated with CIMT and pulse wave velocity in women with aPL (standardized beta coefficient=-0.4 and-0.3, respectively; P<.05 for both), but not in the control group. High-density lipoprotein from women with aPL inhibited endothelial nitric oxide production in human aortic endothelial cells, in contrast with controls. The beneficial effects of HDL from women with aPL on vascular cell adhesion molecule 1 expression, superoxide production, and monocyte adhesion following activation of human aortic endothelial cells were largely blunted. Conclusions Compared with controls, women with aPL had greater functional and structural arterial abnormalities, which were associated with lower activity of paraoxonase. In patients with aPL, HDL reduced nitric oxide bioavailability and had impaired anti-inflammatory and antioxidant properties. JAMA. 2009; 302(11): 1210-1217	[Charakida, Marietta; Wang, Guosu; Loukogeorgakis, Stavros P.; Deanfield, John E.] UCL, Inst Child Hlth, Dept Vasc Physiol, London WC1N 1EH, England; [Besler, Christian; Luscher, Thomas; Landmesser, Ulf] Univ Zurich Hosp, Ctr Cardiovasc, CH-8091 Zurich, Switzerland; [Batuca, Joana R.; Alves, Jose Delgado] Univ Nova Lisboa, Dept Pharmacol, Lisbon, Portugal; [Sangle, Shirish; Marques, Susanna; Sousa, Miguel; D'Cruz, David] St Thomas Hosp, Rayne Inst, Lupus Res Unit, London SE1 7EH, England; [Tousoulis, Dimitris] Univ Athens, Sch Med, Dept Cardiol, Hippokrat Hosp, GR-11527 Athens, Greece; [Mackworth-Young, Charles] Charing Cross Hosp, Dept Rheumatol, London, England	University of London; University College London; University of Zurich; University Zurich Hospital; Universidade Nova de Lisboa; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Athens Medical School; Hippokration General Hospital; National & Kapodistrian University of Athens; Imperial College London	Charakida, M (corresponding author), UCL, Inst Child Hlth, Dept Vasc Physiol, 34 Great Ormond St, London WC1N 1EH, England.	charakidadoc@gmail.com	Alves, José/AAB-2894-2019	Delgado Alves, Jose/0000-0002-5216-4125; Charakida, Marietta/0000-0003-4214-5059; Deanfield, John/0000-0001-8806-6052; Batuca, Joana/0000-0002-0804-6279	Department of Vascular Physiology; Institute of Child Health, University College London, London, England; Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland; Department of Pharmacology, New University of Lisbon, Lisbon, Portugal	Department of Vascular Physiology; Institute of Child Health, University College London, London, England; Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland; Department of Pharmacology, New University of Lisbon, Lisbon, Portugal	Funding/Support: This study was supported by funds from the Department of Vascular Physiology, The Institute of Child Health, University College London, London, England; Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland; and Department of Pharmacology, New University of Lisbon, Lisbon, Portugal.	Alves JD, 2005, RHEUMATOLOGY, V44, P1238, DOI 10.1093/rheumatology/keh722; Alves JD, 2003, RHEUMATOLOGY, V42, P893, DOI 10.1093/rheumatology/keg248; Ames PRJ, 2006, CLIN DEV IMMUNOL, V13, P1, DOI 10.1080/17402520600554930; Ames PRJ, 2005, ANN RHEUM DIS, V64, P315, DOI 10.1136/ard.2004.023952; Ames PRJ, 2002, LUPUS, V11, P208, DOI 10.1191/0961203302lu165oa; Ansell BJ, 2007, CURR OPIN LIPIDOL, V18, P427, DOI 10.1097/MOL.0b013e3282364a17; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Aviram Michael, 2008, V477, P259, DOI 10.1007/978-1-60327-517-0_20; Batuca JR, 2009, RHEUMATOLOGY, V48, P26, DOI 10.1093/rheumatology/ken397; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Charakida M, 2005, CIRCULATION, V112, P103, DOI 10.1161/CIRCULATIONAHA.104.517144; DELGADO AJ, 2002, ARTHRITIS RHEUM, V46, P2686, DOI DOI 10.1371/JOURNAL.PONE.0186513; Dinu AR, 1998, LUPUS, V7, P355, DOI 10.1191/096120398678920262; Donald AE, 2006, J AM COLL CARDIOL, V48, P1846, DOI 10.1016/j.jacc.2006.07.039; Dropinski Jerzy, 2003, Kardiol Pol, V59, P475; Dropinski Jerzy, 2003, Med Sci Monit, V9, pBR105; Feng H, 2009, CURR OPIN ENDOCRINOL, V16, P156, DOI 10.1097/MED.0b013e32832922fc; Fichtlscherer S, 2004, CIRCULATION, V110, P1926, DOI 10.1161/01.CIR.0000143378.58099.8C; Florentin M, 2008, CURR OPIN CARDIOL, V23, P370, DOI 10.1097/HCO.0b013e3283043806; Gordon PA, 2001, LUPUS, V10, P249, DOI 10.1191/096120301680416922; Hughes G, 2007, CLIN REV ALLERG IMMU, V32, P3, DOI 10.1007/BF02686077; Jara LJ, 2006, AUTOIMMUN REV, V5, P195, DOI 10.1016/j.autrev.2005.06.005; Lambert M, 2000, LUPUS, V9, P299, DOI 10.1191/096120300680198980; LEVY PJ, 1995, ANGIOLOGY, V46, P853, DOI 10.1177/000331979504600914; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Mackworth-Young C, 2006, AUTOIMMUN REV, V5, P70, DOI 10.1016/j.autrev.2005.08.001; Matsuura E, 2006, RHEUM DIS CLIN N AM, V32, P537, DOI 10.1016/j.rdc.2006.05.006; Medina G, 2003, ANN RHEUM DIS, V62, P607, DOI 10.1136/ard.62.7.607; Nicolo D, 2004, CLIN IMMUNOL, V112, P183, DOI 10.1016/j.clim.2004.02.016; Pahor A, 2006, IMMUNOBIOLOGY, V211, P689, DOI 10.1016/j.imbio.2006.01.004; Sherer Y, 2006, NAT CLIN PRACT RHEUM, V2, P99, DOI 10.1038/ncprheum0092; Sherer Y, 2003, IMMUNOBIOLOGY, V207, P13, DOI 10.1078/0171-2985-00212; Shih DM, 1998, NATURE, V394, P284, DOI 10.1038/28406; Shoenfeld Y, 2005, CIRCULATION, V112, P3337, DOI 10.1161/CIRCULATIONAHA.104.507996; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Tward A, 2002, CIRCULATION, V106, P484, DOI 10.1161/01.CIR.0000023623.87083.4F; Van Lenten BJ, 2001, CIRCULATION, V103, P2283; Vlachoyiannopoulous PG, 2004, THROMB RES, V114, P509, DOI 10.1016/j.thromres.2004.06.027; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986	39	108	110	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1210	1217		10.1001/jama.2009.1346	http://dx.doi.org/10.1001/jama.2009.1346			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755700	Bronze			2022-12-28	WOS:000269797600031
J	Fisk, Z				Fisk, Zachary			The Thermodynamics of Quantum Critical Points	SCIENCE			English	Editorial Material									Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	University of California System; University of California Irvine	Fisk, Z (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	zfisk@uci.edu						Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; MAENO Y, 1994, NATURE, V372, P532, DOI 10.1038/372532a0; Meissner W, 1933, NATURWISSENSCHAFTEN, V21, P787, DOI 10.1007/BF01504252; *NAT SCI FDN, NSFDMR0854781; Ouboter RD, 1997, SCI AM, V276, P98; Rost AW, 2009, SCIENCE, V325, P1360, DOI 10.1126/science.1176627; Sachdev S., 1999, QUANTUM PHASE TRANSI; SOMMERFELD A, 1933, HDB PHYS 2, V24, P233	9	2	2	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1348	1349		10.1126/science.1179046	http://dx.doi.org/10.1126/science.1179046			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745139	Green Published			2022-12-28	WOS:000269699100022
J	Yang, GJ; Nagel, DH; Feschotte, C; Hancock, CN; Wessler, SR				Yang, Guojun; Nagel, Dawn Holligan; Feschotte, Cedric; Hancock, C. Nathan; Wessler, Susan R.			Tuned for Transposition: Molecular Determinants Underlying the Hyperactivity of a Stowaway MITE	SCIENCE			English	Article							TRANSPOSABLE ELEMENTS MITES; MARINER-LIKE TRANSPOSASES; RICE; EVOLUTION; GENOME; AMPLIFICATION; MOBILIZATION; COMPLEX; FAMILY	Miniature inverted repeat transposable elements (MITEs) are widespread in eukaryotic genomes, where they can attain high copy numbers despite a lack of coding capacity. However, little is known about how they originate and amplify. We performed a genome-wide screen of functional interactions between Stowaway MITEs and potential transposases in the rice genome and identified a transpositionally active MITE that possesses key properties that enhance transposition. Although not directly related to its autonomous element, the MITE has less affinity for the transposase than does the autonomous element but lacks a motif repressing transposition in the autonomous element. The MITE contains internal sequences that enhance transposition. These findings suggest that MITEs achieve high transposition activity by scavenging transposases encoded by distantly related and self-restrained autonomous elements.	[Yang, Guojun; Nagel, Dawn Holligan; Hancock, C. Nathan; Wessler, Susan R.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; [Yang, Guojun] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada; [Yang, Guojun] Univ Toronto, Toronto, ON M5S 3G5, Canada; [Feschotte, Cedric] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	University System of Georgia; University of Georgia; University of Toronto; University Toronto Mississauga; University of Toronto; University of Texas System; University of Texas Arlington	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	sue@plantbio.uga.edu	Hancock, Charles/AAA-5249-2020; Feschotte, Cedric/C-4048-2011	, Dawn/0000-0001-8996-3572	NIH; NSF; University of Georgia Research Foundation; University of Toronto	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); University of Georgia Research Foundation; University of Toronto(University of Toronto)	We thank C. F. Weil and D. J. Garfinkel for materials and technical assistance and J. Bennetzen, X. Zhang, and J. Leebens-Mack for discussion and insightful comments. This work was supported by NIH, the NSF Plant Genome Program, the University of Georgia Research Foundation, and the University of Toronto. Sequences for Osmar transposase coding sequences and their nonautonomous elements were deposited in GenBank (accession numbers GQ379705 to GQ379718 and GQ382183).	Auge-Gouillou C, 2005, MOL CELL BIOL, V25, P2861, DOI 10.1128/MCB.25.7.2861-2870.2005; Feschotte C, 2005, NUCLEIC ACIDS RES, V33, P2153, DOI 10.1093/nar/gki509; Feschotte C, 2003, GENETICS, V163, P747; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Hart DL, 1997, ANNU REV GENET, V31, P337, DOI 10.1146/annurev.genet.31.1.337; Jiang N, 2004, CURR OPIN PLANT BIOL, V7, P115, DOI 10.1016/j.pbi.2004.01.004; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kikuchi K, 2003, NATURE, V421, P167, DOI 10.1038/nature01218; Lampe DJ, 2001, MOL BIOL EVOL, V18, P954, DOI 10.1093/oxfordjournals.molbev.a003896; Menzel G, 2006, CHROMOSOME RES, V14, P831, DOI 10.1007/s10577-006-1090-1; Naito K, 2006, P NATL ACAD SCI USA, V103, P17620, DOI 10.1073/pnas.0605421103; Nakazaki T, 2003, NATURE, V421, P170, DOI 10.1038/nature01219; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Tosi LRO, 2000, NUCLEIC ACIDS RES, V28, P784, DOI 10.1093/nar/28.3.784; WAY JC, 1985, GENETICS, V111, P705; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528; Yang GJ, 2006, PLANT CELL, V18, P2469, DOI 10.1105/tpc.106.045906	19	110	116	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1391	1394		10.1126/science.1175688	http://dx.doi.org/10.1126/science.1175688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745152				2022-12-28	WOS:000269699100038
J	Ziegler, TR				Ziegler, Thomas R.			Parenteral Nutrition in the Critically Ill Patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE-UNIT; ENTERAL NUTRITION; GLUTAMINE DIPEPTIDE; INFECTIOUS COMPLICATIONS; ENERGY-EXPENDITURE; REFEEDING SYNDROME; CLINICAL-PRACTICE; CRITICAL ILLNESS; SEPTIC PATIENTS; CALORIC-INTAKE	A 67-year-old woman with type 2 diabetes mellitus undergoes extensive resection of the small bowel and right colon with a jejunostomy and colostomy because of mesenteric ischemia. In the surgical intensive care unit, severe systemic inflammatory response syndrome with possible sepsis develops. The patient is treated with volume resuscitation, vasopressor support, mechanical ventilation, broad-spectrum antibiotics, and intravenous insulin infusion. Low-dose tube feedings are initiated postoperatively through a nasogastric tube. However, these feedings are discontinued after the development of escalating vasopressor requirements, worsening abdominal distention, and increased gastric residual volume, along with an episode of emesis. The hospital nutritional-support service is consulted for feeding recommendations. A discussion with the patient's family reveals that during the previous 6 months, she lost approximately 15% of her usual body weight and decreased her food intake because of abdominal pain associated with eating. Her preoperative body weight was 51 kg (112 lb), or 90% of her ideal body weight. The physical examination reveals mild wasting of skeletal muscle and fat. Blood tests show hypomagnesemia, hypophosphatemia, and normal hepatic and renal function. Central venous parenteral nutrition is recommended.	[Ziegler, Thomas R.] Emory Univ, Atlanta Clin & Translat Sci Inst, Nutr & Metab Support Serv, Sch Med,Emory Univ Hosp, Atlanta, GA 30322 USA; [Ziegler, Thomas R.] Emory Univ, Dept Med, Div Endocrinol Metab & Lipids, Sch Med, Atlanta, GA 30322 USA	Emory University; Emory University	Ziegler, TR (corresponding author), Emory Univ, Atlanta Clin & Translat Sci Inst, Nutr & Metab Support Serv, Sch Med,Emory Univ Hosp, Room GG-23,1364 Clifton Rd, Atlanta, GA 30322 USA.	tzieg01@emory.edu			National Institutes of Health [U01-DK069322, K24-RR023356, UL1-RR025008]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR023356, UL1RR025008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK069322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants from the National Institutes of Health (U01-DK069322, K24-RR023356, and UL1-RR025008).	Anderegg BA, 2009, JPEN-PARENTER ENTER, V33, P168, DOI 10.1177/0148607108327192; *ASPEN BOARD DIR C, 2002, JPEN J PARENTER ENTE, V26, P144; ASPEN Board of Directors and the Clinical Guidelines Task Force, 2002, JPEN J Parenter Enteral Nutr, V26, p1SA; Battistella FD, 1997, J TRAUMA, V43, P52, DOI 10.1097/00005373-199707000-00013; Berger MM, 2007, CURR OPIN CRIT CARE, V13, P180, DOI 10.1097/MCC.0b013e3280895d47; Berger MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6981; Bistrian BR, 2006, CRIT CARE MED, V34, P1525, DOI 10.1097/01.CCM.0000216704.54446.FD; Bongers T, 2007, CRIT CARE MED, V35, pS545, DOI 10.1097/01.CCM.0000279193.23737.06; Braunschweig CL, 2001, AM J CLIN NUTR, V74, P534; Burnham EL, 2005, J NUTR, V135, p1818S, DOI 10.1093/jn/135.7.1818S; Cree MG, 2008, AM J PHYSIOL-ENDOC M, V294, pE1, DOI 10.1152/ajpendo.00562.2007; De Jonghe B, 2001, CRIT CARE MED, V29, P8, DOI 10.1097/00003246-200101000-00002; Dechelotte P, 2006, CRIT CARE MED, V34, P598, DOI 10.1097/01.CCM.0000201004.30750.D1; Doig GS, 2008, JAMA-J AM MED ASSOC, V300, P2731, DOI 10.1001/jama.2008.826; Doig GS, 2005, ANESTH ANALG, V100, P527, DOI 10.1213/01.ANE.0000141676.12552.D0; Elke G, 2008, CRIT CARE MED, V36, P1762, DOI 10.1097/CCM.0b013e318174dcf0; Estivariz CF, 2008, JPEN-PARENTER ENTER, V32, P389, DOI 10.1177/0148607108317880; Ferrando AA, 2006, CURR OPIN CLIN NUTR, V9, P410, DOI 10.1097/01.mco.0000232901.59168.e9; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Giner M, 1996, NUTRITION, V12, P23, DOI 10.1016/0899-9007(95)00015-1; Gramlich L, 2004, NUTRITION, V20, P843, DOI 10.1016/j.nut.2004.06.003; Grau T, 2007, CRIT CARE, V11, DOI 10.1186/cc5670; Griffiths RD, 2004, CURR OPIN CLIN NUTR, V7, P175, DOI 10.1097/00075197-200403000-00012; Heidegger CP, 2007, INTENS CARE MED, V33, P963, DOI 10.1007/s00134-007-0654-7; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Heyland DK, 1998, JAMA-J AM MED ASSOC, V280, P2013, DOI 10.1001/jama.280.23.2013; Jones NE, 2008, CURR OPIN GASTROEN, V24, P215, DOI 10.1097/MOG.0b013e3282f4cdd8; Kennedy JF, 2005, NUTRITION, V21, P1127, DOI 10.1016/j.nut.2005.08.002; Koletzko Berthold, 2005, J Pediatr Gastroenterol Nutr, V41 Suppl 2, pS1, DOI 10.1097/01.mpg.0000181841.07090.f4; Koretz RL, 2001, GASTROENTEROLOGY, V121, P970, DOI [10.1053/gast.2001.28031, 10.1016/S0016-5085(01)92000-1]; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Krishnan JA, 2003, CHEST, V124, P297, DOI 10.1378/chest.124.1.297; Luo MH, 2008, NUTRITION, V24, P37, DOI 10.1016/j.nut.2007.10.004; Marik PE, 2008, CRIT CARE MED, V36, P1964, DOI 10.1097/CCM.0b013e31817612d6; Martin CM, 2004, CAN MED ASSOC J, V170, P197, DOI 10.1503/cmaj.1040621; Mayer Konstantin, 2008, Curr Opin Clin Nutr Metab Care, V11, P121, DOI 10.1097/MCO.0b013e3282f4cdc6; McClave SA, 1998, JPEN-PARENTER ENTER, V22, P375, DOI 10.1177/0148607198022006375; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Mehta NM, 2009, JPEN-PARENTER ENTER, V33, P260, DOI 10.1177/0148607109333114; Mirtallo J, 2006, JPEN-PARENTER ENTER, V30, P177; MOORE FA, 1992, ANN SURG, V216, P172, DOI 10.1097/00000658-199208000-00008; Nardo P, 2008, CLIN NUTR, V27, P858, DOI 10.1016/j.clnu.2008.08.001; O'Brien JM, 2006, CRIT CARE MED, V34, P738, DOI 10.1097/01.CCM.0000202207.87891.FC; Pacelli F, 2001, ARCH SURG-CHICAGO, V136, P933, DOI 10.1001/archsurg.136.8.933; Peter JV, 2005, CRIT CARE MED, V33, P213, DOI 10.1097/01.CCM.0000150960.36228.C0; Plauth M, 2009, CLIN NUTR, V28, P436, DOI 10.1016/j.clnu.2009.04.019; QuinonesGalvan A, 1997, J NEPHROL, V10, P188; Reid CL, 2007, CLIN NUTR, V26, P649, DOI 10.1016/j.clnu.2007.02.003; Rhee P, 2007, J TRAUMA, V63, P1215, DOI 10.1097/TA.0b013e31815b83e9; Rubinson L, 2004, CRIT CARE MED, V32, P350, DOI 10.1097/01.CCM.0000089641.06306.68; Sala-Vila A, 2007, CURR OPIN CLIN NUTR, V10, P165, DOI 10.1097/MCO.0b013e32802bf787; SANDSTROM R, 1993, ANN SURG, V217, P185, DOI 10.1097/00000658-199302000-00013; Schneider SM, 2004, BRIT J NUTR, V92, P105, DOI 10.1079/BJN20041152; Sena MJ, 2008, J AM COLL SURGEONS, V207, P459, DOI 10.1016/j.jamcollsurg.2008.04.028; SHAW JHF, 1987, ANN SURG, V205, P288, DOI 10.1097/00000658-198703000-00012; Simpson F, 2005, INTENS CARE MED, V31, P12, DOI 10.1007/s00134-004-2511-2; Singer P, 2009, CLIN NUTR, V28, P387, DOI 10.1016/j.clnu.2009.04.024; SOLOMON SM, 1990, JPEN-PARENTER ENTER, V14, P90, DOI 10.1177/014860719001400190; Stanga Z, 2008, EUR J CLIN NUTR, V62, P687, DOI 10.1038/sj.ejcn.1602854; STREAT SJ, 1987, J TRAUMA, V27, P262, DOI 10.1097/00005373-198703000-00006; Trujillo EB, 1999, JPEN-PARENTER ENTER, V23, P109, DOI 10.1177/0148607199023002109; VANDENBERGHE G, 2009, J CLIN ENDOCRIN 0616; Villet S, 2005, CLIN NUTR, V24, P502, DOI 10.1016/j.clnu.2005.03.006; Vincent JL, 2008, CURR OPIN ANESTHESIO, V21, P148, DOI 10.1097/ACO.0b013e3282f49afe; Waitzberg DL, 2006, JPEN-PARENTER ENTER, V30, P351, DOI 10.1177/0148607106030004351; Wanten GJA, 2007, AM J CLIN NUTR, V85, P1171; Wernerman J, 2008, CURR OPIN CLIN NUTR, V11, P160, DOI 10.1097/MCO.0b013e3282f53370; WILMORE DW, 1991, NEW ENGL J MED, V325, P695, DOI 10.1056/NEJM199109053251005; Wischmeyer PE, 2008, CURR OPIN GASTROEN, V24, P190, DOI 10.1097/MOG.0b013e3282f4db94; Woodcock NP, 2001, NUTRITION, V17, P1, DOI 10.1016/S0899-9007(00)00576-1; Zaloga GP, 2006, LANCET, V367, P1101, DOI 10.1016/S0140-6736(06)68307-4; Ziegler TR, 2003, ANNU REV NUTR, V23, P229, DOI 10.1146/annurev.nutr.23.011702.073036	73	150	156	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1088	1097		10.1056/NEJMct0806956	http://dx.doi.org/10.1056/NEJMct0806956			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19741230	Green Accepted			2022-12-28	WOS:000269659400012
J	Bermejo, R; Capra, T; Gonzalez-Huici, V; Fachinetti, D; Cocito, A; Natoli, G; Katou, Y; Mori, H; Kurokawa, K; Shirahige, K; Foiani, M				Bermejo, Rodrigo; Capra, Thelma; Gonzalez-Huici, Victor; Fachinetti, Daniele; Cocito, Andrea; Natoli, Gioacchino; Katou, Yuki; Mori, Hiroshi; Kurokawa, Ken; Shirahige, Katsuhiko; Foiani, Marco			Genome-Organizing Factors Top2 and Hmo1 Prevent Chromosome Fragility at Sites of S phase Transcription	CELL			English	Article							DNA TOPOISOMERASE-II; RIBOSOMAL-PROTEIN GENES; SACCHAROMYCES-CEREVISIAE; REPLICATION FORKS; BOX PROTEIN; HMG-BOX; CHROMATIN; RNA; BINDING; PROGRESSION	Specialized topoisomerases solve the topological constraints arising when replication forks encounter transcription. We have investigated the contribution of Top2 in S phase transcription. Specifically in S phase, Top2 binds intergenic regions close to transcribed genes. The Top2-bound loci exhibit low nucleosome density and accumulate gamma H2A when Top2 is defective. These intergenic loci associate with the HMG protein Hmo1 throughout the cell cycle and are refractory to the histone variant Htz1. In top2 mutants, Hmo1 is deleterious and accumulates at pericentromeric regions in G2/M. Our data indicate that Top2 is dispensable for transcription and that Hmo1 and Top2 bind in the proximity of genes transcribed in S phase suppressing chromosome fragility at the M-G1 transition. We propose that an Hmo1-dependent epigenetic signature together with Top2 mediate an S phase architectural pathway to preserve genome integrity.	[Foiani, Marco] Univ Milan, DSBB, I-20122 Milan, Italy; [Natoli, Gioacchino] IFOM IEO Campus, European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Katou, Yuki; Mori, Hiroshi; Kurokawa, Ken; Shirahige, Katsuhiko] Tokyo Inst Technol, Lab Genome Struct & Funct, Div Gene Res, Ctr Biol Resources & Informat,Midori Ku, Yokohama, Kanagawa 2268501, Japan	University of Milan; IFOM - FIRC Institute of Molecular Oncology; IRCCS European Institute of Oncology (IEO); Tokyo Institute of Technology		marco.foiani@ifom-ieo-campus.it	Shingakujyutsu, Kurokawaken/G-1378-2011; Natoli, gioacchino/ABB-8679-2020; Capra, Thelma/AAN-4064-2020; Bermejo, Rodrigo/AAG-7830-2019; Natoli, gioacchino/J-2100-2018; Foiani, Marco/M-8234-2014; Bermejo, Rodrigo/S-2445-2019; Bermejo, Rodrigo/K-6613-2014; Gonzalez-Huici, Victor/ABB-4680-2020	Foiani, Marco/0000-0003-4795-834X; Bermejo, Rodrigo/0000-0002-2692-7045; Mori, Hiroshi/0000-0003-0806-7704; Gonzalez Huici, Victor/0000-0002-6977-1060; Natoli, Gioacchino/0000-0003-0711-2411; Shirahige, Katsuhiko/0000-0002-7862-1144; Fachinetti, Daniele/0000-0002-8795-6771	Italian Association for Cancer Research; Telethon-Italy, European Community (GENICA); Italian Ministry of Health; EMBO and Marie Curie fellowships; MEXT, Japan	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Telethon-Italy, European Community (GENICA)(European CommissionFondazione Telethon); Italian Ministry of Health(Ministry of Health, Italy); EMBO and Marie Curie fellowships(European Commission); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank A. Verreault for antibodies, D. Branzei, Y. Doksani, M. Bianchi (HSR), and all members of our laboratories for discussions. We thank R. Jossen, M. Saponaro, A. Colosio, and the COGENTECH microarray facility staff for technical advice and support. Work in M.F.'s laboratory is supported by grants from Italian Association for Cancer Research, Telethon-Italy, European Community (GENICA), and Italian Ministry of Health. V. G.-H. was supported by EMBO and Marie Curie fellowships. K. S. is supported by a grant of the Genome Network Project and Grant-in-Aid for Scientific Research (S) from the MEXT, Japan. Y. K. is a GCOE research associate.	Agresti A, 2003, CURR OPIN GENET DEV, V13, P170, DOI 10.1016/S0959-437X(03)00023-6; Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Baxter J, 2008, MOL CELL, V30, P790, DOI 10.1016/j.molcel.2008.04.019; Berger AB, 2007, MOL CELL BIOL, V27, P8015, DOI 10.1128/MCB.01102-07; Bermejo R, 2008, GENE DEV, V22, P2297, DOI 10.1101/gad.1719308; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BLASQUEZ VC, 1989, GENOME, V31, P503, DOI 10.1139/g89-098; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; BRILL SJ, 1988, CELL, V54, P403, DOI 10.1016/0092-8674(88)90203-6; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; Collins I, 2001, MOL CELL BIOL, V21, P8437, DOI 10.1128/MCB.21.24.8437-8451.2001; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Deshpande AM, 1996, SCIENCE, V272, P1030, DOI 10.1126/science.272.5264.1030; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DINARDO S, 1984, P NATL ACAD SCI-BIOL, V81, P2616, DOI 10.1073/pnas.81.9.2616; EARNSHAW WC, 1985, J CELL BIOL, V100, P1716, DOI 10.1083/jcb.100.5.1716; Elvazova ER, 2009, J MOL BIOL, V386, P929, DOI 10.1016/j.jmb.2008.12.022; Gadal O, 2002, EMBO J, V21, P5498, DOI 10.1093/emboj/cdf539; Gaillard Claire, 2000, BMC Biochemistry, V1, P1; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hall DB, 2006, MOL CELL BIOL, V26, P3672, DOI 10.1128/MCB.26.9.3672-3679.2006; HOLM C, 1989, MOL CELL BIOL, V9, P159, DOI 10.1128/MCB.9.1.159; HUGHES EN, 1992, J BIOL CHEM, V267, P13520; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kamau E, 2004, J BIOL CHEM, V279, P55234, DOI 10.1074/jbc.M409459200; Kasahara K, 2007, MOL CELL BIOL, V27, P6686, DOI 10.1128/MCB.00876-07; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Katou Y, 2006, METHOD ENZYMOL, V409, P389, DOI 10.1016/S0076-6879(05)09023-3; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Lemoine FJ, 2005, CELL, V120, P587, DOI 10.1016/j.cell.2004.12.039; Lengronne A, 2001, NUCLEIC ACIDS RES, V29, P1433, DOI 10.1093/nar/29.7.1433; Li TK, 1999, GENE DEV, V13, P1553, DOI 10.1101/gad.13.12.1553; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lopes M, 2003, MOL CELL, V12, P1499, DOI 10.1016/S1097-2765(03)00473-8; Lu J, 1996, J BIOL CHEM, V271, P33678, DOI 10.1074/jbc.271.52.33678; Lucas I, 2001, EMBO J, V20, P6509, DOI 10.1093/emboj/20.22.6509; Lydall D, 2005, DNA REPAIR, V4, P1195, DOI 10.1016/j.dnarep.2005.06.007; Mankouri HW, 2006, MOL BIOL CELL, V17, P4473, DOI 10.1091/mbc.E06-06-0516; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Myung K, 2002, P NATL ACAD SCI USA, V99, P4500, DOI 10.1073/pnas.062702199; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pellicioli A, 1999, EMBO J, V18, P6561, DOI 10.1093/emboj/18.22.6561; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Postow L, 2001, P NATL ACAD SCI USA, V98, P8219, DOI 10.1073/pnas.111006998; Prado F, 2005, EMBO J, V24, P1267, DOI 10.1038/sj.emboj.7600602; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Rocha EPC, 2004, MICROBIOL-SGM, V150, P1609, DOI 10.1099/mic.0.26974-0; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Schmidt KH, 2006, P NATL ACAD SCI USA, V103, P18196, DOI 10.1073/pnas.0608566103; Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607; Scholes DT, 2001, GENETICS, V159, P1449; Sikdar N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000290; Smith S, 2005, DNA REPAIR, V4, P606, DOI 10.1016/j.dnarep.2005.01.004; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SPELL RM, 1994, MOL CELL BIOL, V14, P1465, DOI 10.1128/MCB.14.2.1465; Stros M, 2007, CELL MOL LIFE SCI, V64, P2590, DOI 10.1007/s00018-007-7162-3; Stros M, 2000, J BIOL CHEM, V275, P35699, DOI 10.1074/jbc.M007167200; Stros M, 2007, NUCLEIC ACIDS RES, V35, P5001, DOI 10.1093/nar/gkm525; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; Thomas JO, 2001, TRENDS BIOCHEM SCI, V26, P167, DOI 10.1016/S0968-0004(01)01801-1; Torres JZ, 2004, GENE DEV, V18, P498, DOI 10.1101/gad.1154704; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang XD, 2008, GENE DEV, V22, P2426, DOI 10.1101/gad.487508; Warsi TH, 2008, MOL BIOL CELL, V19, P4421, DOI 10.1091/mbc.E08-05-0547; Yeh E, 2008, CURR BIOL, V18, P81, DOI 10.1016/j.cub.2007.12.019; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x; ZLATANOVA J S, 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P211; Zlatanova J, 2008, STRUCTURE, V16, P166, DOI 10.1016/j.str.2007.12.008	85	90	91	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					870	884		10.1016/j.cell.2009.06.022	http://dx.doi.org/10.1016/j.cell.2009.06.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737516	Bronze			2022-12-28	WOS:000269564600014
J	Chiang, SH; Bazuine, M; Lumeng, CN; Geletka, LM; Mowers, J; White, NM; Ma, JT; Zhou, J; Qi, N; Westcott, D; Delproposto, JB; Blackwell, TS; Yull, FE; Saltiel, AR				Chiang, Shian-Huey; Bazuine, Merlijn; Lumeng, Carey N.; Geletka, Lynn M.; Mowers, Jonathan; White, Nicole M.; Ma, Jing-Tyan; Zhou, Jie; Qi, Nathan; Westcott, Dan; Delproposto, Jennifer B.; Blackwell, Timothy S.; Yull, Fiona E.; Saltiel, Alan R.			The Protein Kinase IKK epsilon Regulates Energy Balance in Obese Mice	CELL			English	Article							ADIPOSE-TISSUE MACROPHAGES; INDUCED INSULIN-RESISTANCE; TUMOR-NECROSIS-FACTOR; KAPPA-B; PPAR-GAMMA; ADIPONECTIN RECEPTORS; CHRONIC INFLAMMATION; HEPATIC STEATOSIS; TNF-ALPHA; ACTIVATION	Obesity is associated with chronic low-grade inflammation that negatively impacts insulin sensitivity. Here, we show that high-fat diet can increase NF-kappa B activation in mice, which leads to a sustained elevation in level of I kappa B kinase epsilon (IKK epsilon) in liver, adipocytes, and adipose tissue macrophages. IKK epsilon knockout mice are protected from high-fat diet-induced obesity, chronic inflammation in liver and fat, hepatic steatosis, and whole-body insulin resistance. These mice show increased energy expenditure and thermogenesis via enhanced expression of the uncoupling protein UCP1. They maintain insulin sensitivity in liver and fat, without activation of the proinflammatory JNK pathway. Gene expression analyses indicate that IKK epsilon knockout reduces expression of inflammatory cytokines, and changes expression of certain regulatory proteins and enzymes involved in glucose and lipid metabolism. Thus, IKK epsilon may represent an attractive therapeutic target for obesity, insulin resistance, diabetes, and other complications associated with these disorders.	[Chiang, Shian-Huey; Bazuine, Merlijn; Lumeng, Carey N.; Geletka, Lynn M.; Mowers, Jonathan; White, Nicole M.; Ma, Jing-Tyan; Zhou, Jie; Westcott, Dan; Delproposto, Jennifer B.; Saltiel, Alan R.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lumeng, Carey N.; Mowers, Jonathan; Delproposto, Jennifer B.; Saltiel, Alan R.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Lumeng, Carey N.; Delproposto, Jennifer B.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Saltiel, Alan R.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Ma, Jing-Tyan] Fudan Univ, Inst Genet, Shanghai 200433, Peoples R China; [Blackwell, Timothy S.; Yull, Fiona E.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA; [Blackwell, Timothy S.; Yull, Fiona E.] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37232 USA; [Blackwell, Timothy S.; Yull, Fiona E.] Vanderbilt Univ, Sch Med, Dept Cell & Mol Biol, Nashville, TN 37232 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Fudan University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Saltiel, AR (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	saltiel@lsi.umich.edu	Saltiel, Alan/L-3632-2019	Saltiel, Alan/0000-0002-9726-9828; White, Nicole/0000-0003-3928-9502; Lumeng, Carey/0000-0003-0303-6204	American Diabetes Association [NIH RO1DK060591]; NIH [DK-078851, HD-028820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK078851, R01DK061618, R01DK060591] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Tom Maniatis for the IKK epsilon mice and constructs, and for helpful suggestions during the course of these studies. We also thank Drs. Benjamin Tenoever and Jiandie Lin for helpful discussions. We are grateful to Xiao-ling Peng for maintaining the mouse colony and genotyping. We thank Saltiel lab members for support and suggestions, and we especially thank Dr. Dave Bridges for help on statistical analyses. We also thank UM Microarray Core for their help on microarray data analyses and UM Phenotyping Core for CLAMS study. This research was funded by NIH RO1DK060591 to A. R. S. M. B. was supported by a Mentor-Based Postdoctoral Award from the American Diabetes Association. C. N. L. was supported by NIH DK-078851 and HD-028820.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Chen ZJ, 2008, ARTERIOSCL THROM VAS, V28, P1738, DOI 10.1161/ATVBAHA.108.171538; Eguchi J, 2008, CELL METAB, V7, P86, DOI 10.1016/j.cmet.2007.11.002; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kelly LJ, 1998, ENDOCRINOLOGY, V139, P4920, DOI 10.1210/en.139.12.4920; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Koh YK, 2008, J BIOL CHEM, V283, P34896, DOI 10.1074/jbc.M804007200; Laplante M, 2003, DIABETES, V52, P291, DOI 10.2337/diabetes.52.2.291; Lesniewski LA, 2007, NAT MED, V13, P455, DOI 10.1038/nm1550; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Min J, 1999, MOL CELL, V3, P751, DOI 10.1016/S1097-2765(01)80007-1; Moller DE, 2000, TRENDS ENDOCRIN MET, V11, P212, DOI 10.1016/S1043-2760(00)00272-1; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Okuno A, 1998, J CLIN INVEST, V101, P1354, DOI 10.1172/JCI1235; Otabe S, 2007, AM J PHYSIOL-ENDOC M, V293, pE210, DOI 10.1152/ajpendo.00645.2006; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Ribon V, 1998, P NATL ACAD SCI USA, V95, P14751, DOI 10.1073/pnas.95.25.14751; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Saltiel AR, 2001, CELL, V104, P517, DOI 10.1016/S0092-8674(01)00239-2; Sanyal AJ, 2005, NAT CLIN PRACT GASTR, V2, P46, DOI 10.1038/ncpgasthep0084; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Schwabe RF, 2006, AM J PHYSIOL-GASTR L, V290, pG583, DOI 10.1152/ajpgi.00422.2005; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Singh R, 2009, HEPATOLOGY, V49, P87, DOI 10.1002/hep.22578; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu J, 2006, DIABETES, V55, P3429, DOI 10.2337/db06-0260; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	53	265	286	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					961	975		10.1016/j.cell.2009.06.046	http://dx.doi.org/10.1016/j.cell.2009.06.046			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737522	Green Accepted, Bronze			2022-12-28	WOS:000269564600021
J	de Wit, H; Walter, AM; Milosevic, I; Gulyas-Kovacs, A; Riedel, D; Sorensen, JB; Verhage, M				de Wit, Heidi; Walter, Alexander M.; Milosevic, Ira; Gulyas-Kovacs, Attila; Riedel, Dietmar; Sorensen, Jakob B.; Verhage, Matthijs			Synaptotagmin-1 Docks Secretory Vesicles to Syntaxin-1/SNAP-25 Acceptor Complexes	CELL			English	Article							MEMBRANE-FUSION; SNARE COMPLEX; T-SNARE; NEUROTRANSMITTER RELEASE; CONFORMATIONAL SWITCH; REGULATED EXOCYTOSIS; SYNAPTIC VESICLES; CHROMAFFIN CELLS; PLASMA-MEMBRANE; C2B DOMAIN	Docking, the initial association of secretory vesicles with the plasma membrane, precedes formation of the SNARE complex, which drives membrane fusion. For many years, the molecular identity of the docked state, and especially the vesicular docking protein, has been unknown, as has the link to SNARE complex assembly. Here, using adrenal chromaffin cells, we identify the vesicular docking partner as synaptotagmin-1, the calcium sensor for exocytosis, and SNAP-25 as an essential plasma membrane docking factor, which, together with the previously known docking factors Munc18-1 and syntaxin, form the minimal docking machinery. Moreover, we show that the requirement for Munc18-1 in docking, but not fusion, can be overcome by stabilizing syntaxin/SNAP-25 acceptor complexes. These findings, together with cross-rescue, double-knockout, and electrophysiological data, lead us to propose that vesicles dock when synaptotagmin-1 binds to syntaxin/SNAP-25 acceptor complexes, whereas Munc18-1 is required for the downstream association of synaptobrevin to form fusogenic SNARE complexes.	[Walter, Alexander M.; Milosevic, Ira; Gulyas-Kovacs, Attila; Sorensen, Jakob B.] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; [Riedel, Dietmar] Max Planck Inst Biophys Chem, Electron Microscopy Lab, D-37077 Gottingen, Germany; [de Wit, Heidi; Verhage, Matthijs] Vrije Univ Amsterdam, Dept Funct Genom, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; [de Wit, Heidi; Verhage, Matthijs] VU Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Sorensen, Jakob B.] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark	Max Planck Society; Max Planck Society; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Copenhagen	Sorensen, JB (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany.	jakobbs@sund.ku.dk; matthijs.verhage@cncr.vu.nl	Walter, Alexander M/O-1824-2015; Cruz e Silva, Odete/AAH-5595-2020	Walter, Alexander M/0000-0001-5646-4750; Sorensen, Jakob/0000-0001-5465-3769; verhage, matthijs/0000-0002-6085-7503	Netherlands Organization for Scientific Research [GpD970-10-036, Pionier/VICI900-01-001, VENI 916-36-043]; NeuroBsik Mouse Phenomics Consortium [BSIK03053]; European Commission [LSHM-CT-2005-019055]; Deutsche Forschungsgemeinschaft [SFB523-B16]; Junior Group Leader Fellowship; Lundbeck Foundation; Lundbeck Foundation [R28-2008-1976] Funding Source: researchfish	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NeuroBsik Mouse Phenomics Consortium; European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Junior Group Leader Fellowship; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from Netherlands Organization for Scientific Research (GpD970-10-036 and Pionier/VICI900-01-001 to M. V., and VENI 916-36-043 to H. d. W.), the NeuroBsik Mouse Phenomics Consortium (BSIK03053), the European Commission (EU Synapse project, LSHM-CT-2005-019055), the Deutsche Forschungsgemeinschaft (SFB523-B16 to J. B. S.), and a Junior Group Leader Fellowship (to J. B. S.) from the Lundbeck Foundation.	Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chieregatti E, 2002, TRAFFIC, V3, P496, DOI 10.1034/j.1600-0854.2002.30706.x; Dai H, 2007, J MOL BIOL, V367, P848, DOI 10.1016/j.jmb.2007.01.040; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; FASSHAUER D, 1997, J BIOL CHEM, V242, P28036; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2006, BIOCHEM SOC T, V34, P691, DOI 10.1042/BST0340691; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Loewen CA, 2006, MOL BIOL CELL, V17, P5211, DOI 10.1091/mbc.E06-07-0622; Lynch KL, 2007, MOL BIOL CELL, V18, P4957, DOI 10.1091/mbc.E07-04-0368; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; NEHER E, 1994, NATURE, V372, P316, DOI 10.1038/372316a0; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Reist NE, 1998, J NEUROSCI, V18, P7662; Rickman C, 2004, J BIOL CHEM, V279, P12574, DOI 10.1074/jbc.M310710200; Rickman C, 2006, MOL BIOL CELL, V17, P283, DOI 10.1091/mbc.E05-07-0620; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Salem N, 1998, NAT NEUROSCI, V1, P551, DOI 10.1038/2787; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Schutz D, 2005, EUR J NEUROSCI, V21, P2419, DOI 10.1111/j.1460-9568.2005.04095.x; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Sorensen JB, 2003, CELL, V114, P75, DOI 10.1016/S0092-8674(03)00477-X; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Toonen RF, 2006, EMBO J, V25, P3725, DOI 10.1038/sj.emboj.7601256; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Weimer RM, 2005, CURR TOP DEV BIOL, V65, P83; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508; Zhang XD, 2002, NEURON, V34, P599, DOI 10.1016/S0896-6273(02)00671-2; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	58	197	200	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					935	946		10.1016/j.cell.2009.07.027	http://dx.doi.org/10.1016/j.cell.2009.07.027			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19716167	Bronze, Green Submitted			2022-12-28	WOS:000269564600019
J	Farrar, S; Yi, D; Sutton, M; Chalkley, M; Sussex, J; Scott, A				Farrar, Shelley; Yi, Deokhee; Sutton, Matt; Chalkley, Martin; Sussex, Jon; Scott, Anthony			Has payment by results affected the way that English hospitals provide care? Difference-in-differences analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINANCIAL FLOWS; QUALITY; NHS; SYSTEM	Objective To examine whether the introduction of payment by results (a fixed tariff case mix based payment system) was associated with changes in key outcome variables measuring volume, cost, and quality of care between 2003/4 and 2005/6. Setting Acute care hospitals in England. Design Difference-in-differences analysis (using a control group created from trusts in England and providers in Scotland not implementing payment by results in the relevant years); retrospective analysis of patient level secondary data with fixed effects models. Data sources English hospital episode statistics and Scottish morbidity records for 2002/3 to 2005/6. Main outcome measures Changes in length of stay and proportion of day case admissions as a proxy for unit cost; growth in number of spells to measure increases in output; and changes in in-hospital mortality, 30 day post-surgical mortality, and emergency readmission after treatment for hip fracture as measures of impact on quality of care. Results Length of stay fell more quickly and the proportion of day cases increased more quickly where payment by results was implemented, suggesting a reduction in the unit costs of care associated with payment by results. Some evidence of an association between the introduction of payment by results and growth in acute hospital activity was found. Little measurable change occurred in the quality of care indicators used in this study that can be attributed to the introduction of payment by results. Conclusion Reductions in unit costs may have been achieved without detrimental impact on the quality of care, at least in as far as these are measured by the proxy variables used in this study.	[Sutton, Matt] Univ Manchester, Hlth Methodol Res Grp, Manchester M13 9PL, Lancs, England; [Chalkley, Martin] Univ Dundee, Dept Econ Studies, Dundee DD1 4HN, Scotland; [Sussex, Jon] Off Hlth Econ, London SW1A 2DY, England	University of Manchester; University of Dundee		s.farrar@abdn.ac.uk	Yi, Deokhee/F-5913-2015; Sussex, Jon/J-5049-2014; Scott, Anthony/E-6636-2010	Yi, Deokhee/0000-0003-4894-1689; Sussex, Jon/0000-0001-8970-4546; Scott, Anthony/0000-0002-2851-5378; Chalkley, Martin/0000-0002-1091-8259; Sutton, Matt/0000-0002-6635-2127	Department of Health through the Policy Research Programme; Chief Scientist Office [HERU1] Funding Source: researchfish	Department of Health through the Policy Research Programme; Chief Scientist Office	This research was funded by the Department of Health through the Policy Research Programme. The researchers are independent of the funders. The views expressed in this paper are those of the authors and not the funding body.	APPLEBY J, 2004, NEW EC, V11, P195; *AUD COMM, 2005, EARL LESS PAYM RES; *AUD COMM, 2008, RIGHT RES PAYM RES 2; Blundell R., 2000, FISC STUD, V21, P427, DOI [DOI 10.1111/J.1475-5890.2000.TB00031.X, 10.1111/j.1475-5890.2000.tb00031.x]; Chalkley M, 2000, HANDB ECON, V17, P847; *DEP HLTH, 2005, IMPL PAYM RES TECHN; *DEP HLTH, 2004, IMPL PAYM RES TECHN; *DEP HLTH, 2004, NHS REF COSTS 2003 N; Department of Health, 2002, REF NHS FIN FLOWS IN; Dismuke CE, 2002, APPL ECON, V34, P1301, DOI 10.1080/00036840110095418; Dixon J, 2004, BMJ-BRIT MED J, V328, P969, DOI 10.1136/bmj.328.7446.969; France FHR, 2003, INT J MED INFORM, V70, P215, DOI 10.1016/S1386-5056(03)00044-3; Kjerstad Egil, 2003, Int J Health Care Finance Econ, V3, P231, DOI 10.1023/A:1026084304382; Ljunggren B, 2001, SCAND J CARING SCI, V15, P283, DOI 10.1046/j.1471-6712.2001.00046.x; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; MANNION R, 2006, 14 U YORK CTR HLTH E; Marini G, 2008, HEALTH ECON, V17, P751, DOI 10.1002/hec.1292; Marini G, 2007, HEALTH POLICY, V83, P17, DOI 10.1016/j.healthpol.2006.11.007; Mikkola H, 2002, HEALTH POLICY, V59, P37, DOI 10.1016/S0168-8510(01)00169-5; NEWHOUSE JP, 1988, J HEALTH ECON, V7, P413, DOI 10.1016/0167-6296(88)90023-9; Pitches DW, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-91; PROPPER C, 2007, CTR MARKET PUBLIC OR; Qin J, 2008, J ROY STAT SOC B, V70, P329, DOI 10.1111/j.1467-9868.2007.00638.x; Raftery J, 1996, HEALTH ECON, V5, P353, DOI 10.1002/(SICI)1099-1050(199607)5:4<353::AID-HEC215>3.3.CO;2-#; Rogers R, 2005, BMJ-BRIT MED J, V330, P563, DOI 10.1136/bmj.330.7491.563; Siciliani L, 2005, HEALTH POLICY, V72, P201, DOI 10.1016/j.healthpol.2004.07.003; Street A, 2004, PUBLIC MONEY MANAGE, V24, P301, DOI 10.1111/j.1467-9302.2004.00438.x; SUSSEX J, 2005, ACTIVITY BASED FINAN; Sussex J, 2009, EUR J HEALTH ECON, V10, P197, DOI 10.1007/s10198-008-0119-0	29	105	105	2	31	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2009	339								b3047	10.1136/bmj.b3047	http://dx.doi.org/10.1136/bmj.b3047			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489AY	19713233	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000269393100001
J	Keller, T; Zeller, T; Peetz, D; Tzikas, S; Roth, A; Czyz, E; Bickel, C; Baldus, S; Warnholtz, A; Frohlich, M; Sinning, CR; Eleftheriadis, MS; Wild, PS; Schnabel, RB; Lubos, E; Jachmann, N; Genth-Zotz, S; Post, F; Nicaud, V; Tiret, L; Lackner, KJ; Munzel, T; Blankenberg, S				Keller, Till; Zeller, Tanja; Peetz, Dirk; Tzikas, Stergios; Roth, Alexander; Czyz, Ewa; Bickel, Christoph; Baldus, Stephan; Warnholtz, Ascan; Froehlich, Meike; Sinning, Christoph R.; Eleftheriadis, Medea S.; Wild, Philipp S.; Schnabel, Renate B.; Lubos, Edith; Jachmann, Nicole; Genth-Zotz, Sabine; Post, Felix; Nicaud, Viviane; Tiret, Laurence; Lackner, Karl J.; Muenzel, Thomas; Blankenberg, Stefan			Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNIVERSAL DEFINITION; UNSTABLE ANGINA; ADVERSE EVENTS; ULTRA ASSAY; RISK; PERFORMANCE; ELEVATION; PREDICT	Background: Cardiac troponin testing is central to the diagnosis of acute myocardial infarction. We evaluated a sensitive troponin I assay for the early diagnosis and risk stratification of myocardial infarction. Methods: In a multicenter study, we determined levels of troponin I as assessed by a sensitive assay, troponin T, and traditional myocardial necrosis markers in 1818 consecutive patients with suspected acute myocardial infarction, on admission and 3 hours and 6 hours after admission. Results: For samples obtained on admission, the diagnostic accuracy was highest with the sensitive troponin I assay (area under the receiver-operating-characteristic curve [AUC], 0.96), as compared with the troponin T assay (AUC, 0.85) and traditional myocardial necrosis markers. With the use of the sensitive troponin I assay (cutoff value, 0.04 ng per milliliter) on admission, the clinical sensitivity was 90.7%, and the specificity was 90.2%. The diagnostic accuracy was virtually identical in baseline and serial samples, regardless of the time of chest-pain onset. In patients presenting within 3 hours after chest-pain onset, a single sensitive troponin I assay had a negative predictive value of 84.1% and a positive predictive value of 86.7%; these findings predicted a 30% rise in the troponin I level within 6 hours. A troponin I level of more than 0.04 ng per milliliter was independently associated with an increased risk of an adverse outcome at 30 days (hazard ratio, 1.96; 95% confidence interval, 1.27 to 3.05; P=0.003). Conclusions: The use of a sensitive assay for troponin I improves early diagnosis of acute myocardial infarction and risk stratification, regardless of the time of chest-pain onset. N Engl J Med 2009;361:868-77.	[Keller, Till; Zeller, Tanja; Tzikas, Stergios; Roth, Alexander; Czyz, Ewa; Warnholtz, Ascan; Sinning, Christoph R.; Eleftheriadis, Medea S.; Wild, Philipp S.; Schnabel, Renate B.; Lubos, Edith; Genth-Zotz, Sabine; Post, Felix; Muenzel, Thomas; Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, Mainz, Germany; [Peetz, Dirk; Jachmann, Nicole; Lackner, Karl J.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Clin Chem & Lab Med, Mainz, Germany; [Bickel, Christoph] Fed Armed Forces Hosp, Dept Internal Med, Koblenz, Germany; [Baldus, Stephan; Froehlich, Meike] Univ Hosp Hamburg Eppendorf, Ctr Heart, Dept Cardiol & Angiol, Hamburg, Germany; [Schnabel, Renate B.] Boston Univ, Sch Med, Framingham Heart Study, Framingham, MA USA; [Lubos, Edith] Harvard Univ, Sch Med, Boston, MA USA; [Lubos, Edith] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Nicaud, Viviane; Tiret, Laurence] Univ Paris 06, INSERM, U525, Paris, France	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; Boston University; Framingham Heart Study; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Blankenberg, S (corresponding author), Langenbeckstr 1, D-55101 Mainz, Germany.	blankenberg@2-med.klinik.uni-mainz.de	Tzikas, Stergios/AAW-2673-2020; Wild, Philipp S./M-2106-2019; Schnabel, Renate B/F-6527-2014; Tzikas, Stergios/A-2234-2010; Munzel, Thomas/A-2912-2014; Schnabel, Renate B/ABE-6668-2021	Tzikas, Stergios/0000-0002-7811-5620; Tzikas, Stergios/0000-0002-7811-5620; Munzel, Thomas/0000-0001-5503-4150; Schnabel, Renate B/0000-0001-7170-9509; Blankenberg, Stefan/0000-0001-6488-2362; Roth, Alexander/0000-0002-5975-0573; Wild, Philipp/0000-0003-4413-9752; Zeller, Tanja/0000-0003-3379-2641; Keller, Till/0000-0002-0895-6491	University Medical Center of the Johannes Gutenberg University of Mainz; BRAHMS Aktiengesellschaft	University Medical Center of the Johannes Gutenberg University of Mainz; BRAHMS Aktiengesellschaft	Supported by the University Medical Center of the Johannes Gutenberg University of Mainz and an unrestricted grant from BRAHMS Aktiengesellschaft.	AMBROSE JA, 1985, J AM COLL CARDIOL, V5, P609, DOI 10.1016/S0735-1097(85)80384-3; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Apple FS, 2008, CLIN CHEM, V54, P723, DOI 10.1373/clinchem.2007.097162; Apple FS, 2008, CLIN CHIM ACTA, V390, P72, DOI 10.1016/j.cca.2007.12.016; Apple FS, 2009, CLIN CHEM, V55, P930, DOI 10.1373/clinchem.2008.114728; Casals G, 2008, AM J CLIN PATHOL, V130, P964, DOI 10.1309/AJCP0CMZ6UJZHLKA; Eggers KM, 2009, CLIN CHEM, V55, P85, DOI 10.1373/clinchem.2007.101683; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; HOENIG MR, 2006, COCHRANE DB SYST REV, V3; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1763, DOI 10.1016/j.jacc.2006.08.006; MacRae AR, 2006, CLIN CHEM, V52, P812, DOI 10.1373/clinchem.2005.059550; Melanson SEF, 2007, AM J CLIN PATHOL, V128, P282, DOI 10.1309/Q9W5HJTT24GQCXXX; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Morrow DA, 2009, CLIN CHEM, V55, P5, DOI 10.1373/clinchem.2008.117218; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; Tate JR, 2008, CLIN CHEM LAB MED, V46, P1489, DOI 10.1515/CCLM.2008.292; Thygesen K, 2008, CURR OPIN CRIT CARE, V14, P543, DOI 10.1097/MCC.0b013e32830d34b9; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; van de Kerkhof D, 2008, ANN CLIN BIOCHEM, V45, P316, DOI 10.1258/acb.2007.007209; Venge P, 2009, CLIN CHEM, V55, P109, DOI 10.1373/clinchem.2008.106500; Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580	21	879	917	0	77	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					868	877		10.1056/NEJMoa0903515	http://dx.doi.org/10.1056/NEJMoa0903515			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XV	19710485				2022-12-28	WOS:000269312700007
J	Birleson, P				Birleson, Peter			Should youth mental health become a specialty in its own right? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDERS		Royal Childrens Hosp, Integrated Mental Hlth Program, Parkville, Vic 3052, Australia	Royal Children's Hospital Melbourne	Birleson, P (corresponding author), Royal Childrens Hosp, Integrated Mental Hlth Program, Parkville, Vic 3052, Australia.	peter.birleson@rch.org.au						*AM AC CHILD AD PS, 2007, J AM ACAD CHILD ADOL, V46, P184; Bierman KL, 2007, J AM ACAD CHILD PSY, V46, P1250, DOI 10.1097/chi.0b013e31813e5d39; Green J, 2007, J CHILD PSYCHOL PSYC, V48, P1259, DOI 10.1111/j.1469-7610.2007.01802.x; Kelvin Raphael G, 2005, Child Adolesc Ment Health, V10, P63, DOI 10.1111/j.1475-3588.2005.00120.x; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kim-Cohen J, 2003, ARCH GEN PSYCHIAT, V60, P709, DOI 10.1001/archpsyc.60.7.709; Lansford JE, 2008, J CHILD PSYCHOL PSYC, V49, P877, DOI 10.1111/j.1469-7610.2008.01915.x; March JS, 2007, J AM ACAD CHILD PSY, V46, P1098, DOI 10.1097/chi.0b013e318074eb48; McCarthy S, 2009, BRIT J PSYCHIAT, V194, P273, DOI 10.1192/bjp.bp.107.045245; McGorry PD, 2007, MED J AUSTRALIA, V187, pS53; *NAT HLTH ADV SERV, 1995, CHILD AD MENT HLTH S; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; STROUL BA, 1996, SYSTEM CARE CHILDREN; Vostanis P, 2005, CURR OPIN PSYCHIATR, V18, P449, DOI 10.1097/01.yco.0000172067.32014.91	14	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2009	339								b3371	10.1136/bmj.b3371	http://dx.doi.org/10.1136/bmj.b3371			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489AX	19710125				2022-12-28	WOS:000269393000004
J	Lynch, MF; Blanton, EM; Bulens, S; Polyak, C; Vojdani, J; Stevenson, J; Medalla, F; Barzilay, E; Joyce, K; Barrett, T; Mintz, ED				Lynch, Michael F.; Blanton, Elizabeth M.; Bulens, Sandra; Polyak, Christina; Vojdani, Jazmin; Stevenson, Jennifer; Medalla, Felicia; Barzilay, Ezra; Joyce, Kevin; Barrett, Timothy; Mintz, Eric Daniel			Typhoid Fever in the United States, 1999-2006	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT SALMONELLA-TYPHI; ENTERICA SEROTYPE TYPHI; ANTIMICROBIAL-RESISTANCE; DRUG-RESISTANCE; INFECTIONS; COUNTRIES; BURDEN; TRAVEL; INDIA	Context Typhoid fever in the United States has increasingly been due to infection with antimicrobial-resistant Salmonella ser Typhi. National surveillance for typhoid fever can inform prevention and treatment recommendations. Objective To assess trends in infections with antimicrobial-resistant S Typhi. Design Cross-sectional, laboratory-based surveillance study. Setting and Participants We reviewed data from 1999-2006 for 1902 persons with typhoid fever who had epidemiologic information submitted to the Centers for Disease Control and Prevention (CDC) and 2016 S Typhi isolates sent by participating public health laboratories to the National Antimicrobial Resistance Monitoring System Laboratory at the CDC for antimicrobial susceptibility testing. Main Outcome Measures Proportion of S Typhi isolates demonstrating resistance to 14 antimicrobial agents and patient risk factors for antimicrobial-resistant infections. Results Patient median age was 22 years (range, <1-90 years); 1295 (73%) were hospitalized and 3 (0.2%) died. Foreign travel within 30 days of illness was reported by 1439 (79%). Only 58 travelers (5%) had received typhoid vaccine. Two hundred seventy-two (13%) of 2016 isolates tested were resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole (multidrug-resistant S Typhi [MDRST]); 758 (38%) were resistant to nalidixic acid (nalidixic acid-resistant S Typhi [NARST]) and 734 NARST isolates (97%) had decreased susceptibility to ciprofloxacin. The proportion of NARST increased from 19% in 1999 to 54% in 2006. Five ciprofloxacin-resistant isolates were identified. Patients with resistant infections were more likely to report travel to the Indian subcontinent: 85% of patients infected with MDRST and 94% with NARST traveled to the Indian subcontinent, while 44% of those with susceptible infections did (MDRST odds ratio, 7.5; 95% confidence interval, 4.1-13.8; NARST odds ratio, 20.4; 95% confidence interval, 12.4-33.9). Conclusion Infection with antimicrobial-resistant S Typhi strains among US patients with typhoid fever is associated with travel to the Indian subcontinent, and an increasing proportion of these infections are due to S Typhi strains with decreased susceptibility to fluoroquinolones. JAMA. 2009; 302(8): 859-865	[Lynch, Michael F.; Blanton, Elizabeth M.; Bulens, Sandra; Polyak, Christina; Vojdani, Jazmin; Stevenson, Jennifer; Medalla, Felicia; Barzilay, Ezra; Mintz, Eric Daniel] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Enter Dis Epidemiol Branch, Atlanta, GA 30341 USA; [Joyce, Kevin; Barrett, Timothy] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Enter Dis Lab Branch, Atlanta, GA 30341 USA; [Barrett, Timothy] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Div Foodborne Bacterial & Mycot Dis, Atlanta, GA 30341 USA; [Barrett, Timothy] Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Off Chief Sci Officer, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lynch, MF (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Zoonot Vectorborne & Enter Dis, Enter Dis Epidemiol Branch, 4770 Buford Hwy,MS F-22, Atlanta, GA 30341 USA.	mlynch1@cdc.gov		Duque, Jazmin/0000-0003-3484-276X				Ackers ML, 2000, JAMA-J AM MED ASSOC, V283, P2668, DOI 10.1001/jama.283.20.2668; [Anonymous], REV CHILENA INFECTOL; Atkins BL, 1998, JAMA-J AM MED ASSOC, V279, P579, DOI 10.1001/jama.279.8.579; AVASIA S, 2004, 53 ANN EP INT SERV C; Baggett HC, 2009, J TRAVEL MED, V16, P112, DOI 10.1111/j.1708-8305.2008.00284.x; Bhutta ZA, 1996, ARCH DIS CHILD, V75, P214, DOI 10.1136/adc.75.3.214; BUTLER T, 1985, REV INFECT DIS, V7, P244; *CLSI, 2006, M100S16 CLSI S; Crump JA, 2008, EPIDEMIOL INFECT, V136, P436, DOI 10.1017/S0950268807009338; Crump JA, 2003, CLIN INFECT DIS, V37, P75, DOI 10.1086/375602; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2008, ANTIMICROB AGENTS CH, V52, P1278, DOI 10.1128/AAC.01509-07; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; Katz DJ, 2002, J INFECT DIS, V186, P234, DOI 10.1086/341208; McNabb Scott J N, 2008, MMWR Morb Mortal Wkly Rep, V55, P1; Mermin JH, 1998, ARCH INTERN MED, V158, P633, DOI 10.1001/archinte.158.6.633; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Rowe B, 1997, CLIN INFECT DIS, V24, pS106, DOI 10.1093/clinids/24.Supplement_1.S106; RYAN CA, 1989, REV INFECT DIS, V11, P1; Steinberg EB, 2004, CLIN INFECT DIS, V39, P186, DOI 10.1086/421945; THANAWALLA J. K., 1956, INDIAN JOUR PEDIATRICS, V23, P421; Threlfall EJ, 2008, EMERG INFECT DIS, V14, P860, DOI 10.3201/eid1405.071184; Threlfall EJ, 1999, LANCET, V353, P1590, DOI 10.1016/S0140-6736(99)01001-6; THRELFALL EJ, 1992, EUR J CLIN MICROBIOL, V11, P990, DOI 10.1007/BF01967788	25	126	134	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					859	865		10.1001/jama.2009.1229	http://dx.doi.org/10.1001/jama.2009.1229			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706859	Bronze			2022-12-28	WOS:000269260100019
J	Nanda, A; Chen, MH; Braccioforte, MH; Moran, BJ; D'Amico, AV				Nanda, Akash; Chen, Ming-Hui; Braccioforte, Michelle H.; Moran, Brian J.; D'Amico, Anthony V.			Hormonal Therapy Use for Prostate Cancer and Mortality in Men With Coronary Artery Disease-Induced Congestive Heart Failure or Myocardial Infarction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANDROGEN-DEPRIVATION THERAPY; EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; DEFINITIVE RADIOTHERAPY; CARDIOVASCULAR-DISEASE; BODY-COMPOSITION; SUPPRESSION; SURVIVAL; BRACHYTHERAPY; MANAGEMENT	Context Hormonal therapy (HT) when added to radiation therapy (RT) for treating unfavorable-risk prostate cancer leads to an increase in survival except possibly in men with moderate to severe comorbidity. However, it is unknown which comorbid conditions eliminate this survival benefit. Objective To assess whether neoadjuvant HT use affects the risk of all-cause mortality in men with prostate cancer and coronary artery disease (CAD)-induced congestive heart failure (CHF) or myocardial infarction (MI), CAD risk factors, or no comorbidity. Design, Setting, and Patients A total of 5077 men (median age, 69.5 years) with localized or locally advanced prostate cancer were consecutively treated with or without a median of 4 months of neoadjuvant HT followed by RT at a suburban cancer center between 1997 and 2006 and were followed up until July 1, 2008. Cox regression multivariable analyses were performed assessing whether neoadjuvant HT use affected the risk of all-cause mortality, adjusting for age, year and type of RT, treatment propensity score, and known prostate cancer prognostic factors in each comorbidity group. Main Outcome Measure Risk of all-cause mortality. Results Neoadjuvant HT use was not associated with an increased risk of all-cause mortality in men with no comorbidity (9.6% vs 6.7%, adjusted hazard ratio [HR], 0.97; 95% confidence interval [CI], 0.72-1.32; P=.86) or a single CAD risk factor (10.7% vs 7.0%, adjusted HR, 1.04; 95% CI, 0.75-1.43; P=.82) after median follow-ups of 5.0 and 4.4 years, respectively. However, for men with CAD-induced CHF or MI, after a median follow-up of 5.1 years, neoadjuvant HT use was significantly associated with an increased risk of all-cause mortality (26.3% vs 11.2%, adjusted HR, 1.96; 95% CI, 1.04-3.71; P=.04). Conclusion Neoadjuvant HT use is significantly associated with an increased risk of all-cause mortality among men with a history of CAD-induced CHF or MI but not among men with no comorbidity or a single CAD risk factor. JAMA. 2009; 302(8): 866-873	[Nanda, Akash] Brigham & Womens Hosp, Harvard Radiat Oncol Program, Dana Farber Canc Inst, Boston, MA 02115 USA; [D'Amico, Anthony V.] Brigham & Womens Hosp, Dept Radiat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Chen, Ming-Hui] Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; [Braccioforte, Michelle H.; Moran, Brian J.] Prostate Canc Fdn Chicago, Westmont, IL USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; University of Connecticut	Nanda, A (corresponding author), Brigham & Womens Hosp, Harvard Radiat Oncol Program, Dana Farber Canc Inst, 75 Francis St,ASB1 L2, Boston, MA 02115 USA.	ananda@partners.org						Agresti A., 2002, CATEGORICAL DATA ANA, V2nd ed; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; [Anonymous], 1979, Circulation, V59, P607; Ansell BJ, 1999, JAMA-J AM MED ASSOC, V282, P2051, DOI 10.1001/jama.282.21.2051; Beyer DC, 2005, INT J RADIAT ONCOL, V61, P1299, DOI 10.1016/j.ijrobp.2004.08.024; Bolla M, 2002, LANCET, V360, P103, DOI 10.1016/S0140-6736(02)09408-4; Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CUPPLES LA, 1995, STAT MED, V14, P1731, DOI 10.1002/sim.4780141603; D'Amico AV, 2008, JAMA-J AM MED ASSOC, V299, P289, DOI 10.1001/jama.299.3.289; D'Amico AV, 2007, J CLIN ONCOL, V25, P2420, DOI 10.1200/JCO.2006.09.3369; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Amico AV, 2004, JAMA-J AM MED ASSOC, V292, P821, DOI 10.1001/jama.292.7.821; Denham JW, 2005, LANCET ONCOL, V6, P841, DOI 10.1016/S1470-2045(05)70348-X; Gavin JR, 1997, DIABETES CARE, V20, P1183; Genuth S, 2003, DIABETES CARE, V26, P3160; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Hunt SA, 2005, CIRCULATION, V112, pE154, DOI 10.1161/CIRCULATIONAHA.105.167586; Hunt SA, 2001, CIRCULATION, V104, P2996, DOI 10.1161/hc4901.102568; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Keating NL, 2006, J CLIN ONCOL, V24, P4448, DOI 10.1200/JCO.2006.06.2497; Klein JP, 2003, SURVIVAL ANAL; Lee H, 2005, CANCER-AM CANCER SOC, V104, P1633, DOI 10.1002/cncr.21381; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Merrick GS, 2006, INT J RADIAT ONCOL, V65, P669, DOI 10.1016/j.ijrobp.2006.01.030; Nag S, 1999, INT J RADIAT ONCOL, V44, P789, DOI 10.1016/S0360-3016(99)00069-3; Newgard CD, 2004, ACAD EMERG MED, V11, P953, DOI 10.1197/j.aem.2004.02.530; Piccirillo JF, 2004, JAMA-J AM MED ASSOC, V291, P2441, DOI 10.1001/jama.291.20.2441; Pilepich MV, 2001, INT J RADIAT ONCOL, V50, P1243, DOI 10.1016/S0360-3016(01)01579-6; Pilepich MV, 2005, INT J RADIAT ONCOL, V61, P1285, DOI 10.1016/j.ijrobp.2004.08.047; Potters L, 2000, J CLIN ONCOL, V18, P1187, DOI 10.1200/JCO.2000.18.6.1187; Sesso HD, 2001, CIRCULATION, V104, P393, DOI 10.1161/hc2901.093115; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Smith MR, 2008, UROLOGY, V71, P318, DOI 10.1016/j.urology.2007.08.035; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Stock RG, 2006, INT J RADIAT ONCOL, V64, P810, DOI 10.1016/j.ijrobp.2005.09.005; Sylvester JE, 2007, INT J RADIAT ONCOL, V67, P57, DOI 10.1016/j.ijrobp.2006.07.1382; Tsai HK, 2007, J NATL CANCER I, V99, P1516, DOI 10.1093/jnci/djm168; Walsh PC, 2007, NEW ENGL J MED, V357, P2696, DOI 10.1056/NEJMcp0706784; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zelefsky MJ, 2008, BRACHYTHERAPY, V7, P1, DOI 10.1016/j.brachy.2007.12.002; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P65, DOI 10.1016/j.ijrobp.2006.08.030; 1997, ARCH INTERN MED, V157, P2413	46	219	227	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					866	873		10.1001/jama.2009.1137	http://dx.doi.org/10.1001/jama.2009.1137			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706860	Bronze			2022-12-28	WOS:000269260100020
J	Xia, QY; Guo, YR; Zhang, Z; Li, D; Xuan, ZL; Li, Z; Dai, FY; Li, YR; Cheng, DJ; Li, RQ; Cheng, TC; Jiang, T; Becquet, C; Xu, X; Liu, C; Zha, XF; Fan, W; Lin, Y; Shen, YH; Jiang, L; Jensen, J; Hellmann, I; Tang, S; Zhao, P; Xu, HF; Yu, C; Zhang, GJ; Li, J; Cao, JJ; Liu, SP; He, NJ; Zhou, Y; Liu, H; Zhao, J; Ye, C; Du, ZH; Pan, GQ; Zhao, AC; Shao, HJ; Zeng, W; Wu, P; Li, CF; Pan, MH; Li, JJ; Yin, XY; Li, DW; Wang, J; Zheng, HS; Wang, W; Zhang, XQ; Li, SG; Yang, HM; Lu, C; Nielsen, R; Zhou, ZY; Wang, J; Xiang, ZH; Wang, J				Xia, Qingyou; Guo, Yiran; Zhang, Ze; Li, Dong; Xuan, Zhaoling; Li, Zhuo; Dai, Fangyin; Li, Yingrui; Cheng, Daojun; Li, Ruiqiang; Cheng, Tingcai; Jiang, Tao; Becquet, Celine; Xu, Xun; Liu, Chun; Zha, Xingfu; Fan, Wei; Lin, Ying; Shen, Yihong; Jiang, Lan; Jensen, Jeffrey; Hellmann, Ines; Tang, Si; Zhao, Ping; Xu, Hanfu; Yu, Chang; Zhang, Guojie; Li, Jun; Cao, Jianjun; Liu, Shiping; He, Ningjia; Zhou, Yan; Liu, Hui; Zhao, Jing; Ye, Chen; Du, Zhouhe; Pan, Guoqing; Zhao, Aichun; Shao, Haojing; Zeng, Wei; Wu, Ping; Li, Chunfeng; Pan, Minhui; Li, Jingjing; Yin, Xuyang; Li, Dawei; Wang, Juan; Zheng, Huisong; Wang, Wen; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Lu, Cheng; Nielsen, Rasmus; Zhou, Zeyang; Wang, Jian; Xiang, Zhonghuai; Wang, Jun			Complete Resequencing of 40 Genomes Reveals Domestication Events and Genes in Silkworm (Bombyx)	SCIENCE			English	Article							FORK HEAD; EXPRESSION; SEQUENCE	A single-base pair resolution silkworm genetic variation map was constructed from 40 domesticated and wild silkworms, each sequenced to approximately threefold coverage, representing 99.88% of the genome. We identified similar to 16 million single-nucleotide polymorphisms, many indels, and structural variations. We find that the domesticated silkworms are clearly genetically differentiated from the wild ones, but they have maintained large levels of genetic variability, suggesting a short domestication event involving a large number of individuals. We also identified signals of selection at 354 candidate genes that may have been important during domestication, some of which have enriched expression in the silk gland, midgut, and testis. These data add to our understanding of the domestication processes and may have applications in devising pest control strategies and advancing the use of silkworms as efficient bioreactors.	[Xia, Qingyou; Zhang, Ze; Li, Dong; Dai, Fangyin; Cheng, Daojun; Cheng, Tingcai; Liu, Chun; Zha, Xingfu; Lin, Ying; Shen, Yihong; Zhao, Ping; Xu, Hanfu; Liu, Shiping; He, Ningjia; Du, Zhouhe; Pan, Guoqing; Zhao, Aichun; Li, Chunfeng; Pan, Minhui; Lu, Cheng; Zhou, Zeyang; Xiang, Zhonghuai] Southwest Univ, Coll Biotechnol, Key Sericultural Lab Agr Minist, Chongqing 400715, Peoples R China; [Xia, Qingyou; Zhang, Ze; Cheng, Tingcai] Chongqing Univ, Inst Agron & Life Sci, Chongqing 400044, Peoples R China; [Guo, Yiran; Li, Dong; Xuan, Zhaoling; Li, Zhuo; Li, Yingrui; Li, Ruiqiang; Jiang, Tao; Xu, Xun; Fan, Wei; Jiang, Lan; Yu, Chang; Zhang, Guojie; Li, Jun; Cao, Jianjun; Zhou, Yan; Liu, Hui; Zhao, Jing; Ye, Chen; Shao, Haojing; Zeng, Wei; Wu, Ping; Li, Jingjing; Yin, Xuyang; Li, Dawei; Wang, Juan; Zheng, Huisong; Wang, Wen; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Ruiqiang; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2100 Kbh O, Denmark; [Becquet, Celine; Jensen, Jeffrey; Hellmann, Ines; Tang, Si; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Becquet, Celine; Jensen, Jeffrey; Hellmann, Ines; Tang, Si; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Zhou, Zeyang] Chongqing Normal Univ, Chongqing 400047, Peoples R China; [Shao, Haojing] S China Univ Technol, Innovat Program Undergrad Students, Guangzhou 510006, Guangdong, Peoples R China	Southwest University - China; Chongqing University; Beijing Genomics Institute (BGI); University of Copenhagen; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Chongqing Normal University; South China University of Technology	Xiang, ZH (corresponding author), Southwest Univ, Coll Biotechnol, Key Sericultural Lab Agr Minist, Chongqing 400715, Peoples R China.	xbxzh@swu.edu.cn; wangj@genomics.org.cn	Wang, Jun/A-7261-2013; Guo, Yiran/H-4120-2011; Wang, Wen/AAP-9873-2020; Zhang, Guojie/B-6188-2014; Zhang, Guojie/J-7273-2019; Jiang, Lan/K-6869-2014; jiang, lan/T-3965-2019; Li, Yingrui/K-1064-2015; Yu, Chang/AAE-8538-2019; jiang, lan/C-1077-2009; Liu, Shiping/W-2577-2019; Tang, Si/D-6633-2018; Nielsen, Rasmus/D-4405-2009; Xu, Xun/AAI-6763-2020; Shao, Haojing/C-5429-2017; Zhao, Aichun/T-4308-2018; Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016; Jensen, Jeffrey/S-1084-2016	Zhang, Guojie/0000-0001-6860-1521; Zhang, Guojie/0000-0001-6860-1521; Jiang, Lan/0000-0003-2008-9631; jiang, lan/0000-0003-2008-9631; Liu, Shiping/0000-0002-2917-0172; Nielsen, Rasmus/0000-0003-0513-6591; Xu, Xun/0000-0002-5338-5173; Shao, Haojing/0000-0002-8806-197X; Zhao, Aichun/0000-0001-6140-0102; cheng, tingcai/0000-0002-3862-0817; Wang, Wen/0000-0002-7801-2066; Zha, Xingfu/0000-0003-2085-5260; Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931; LI, Dong/0000-0002-4536-9894; Li, Jun/0000-0001-7218-429X; Jensen, Jeffrey/0000-0002-4786-8064; Tang, Si/0000-0002-1050-8604; Xia, Qingyou/0000-0002-9263-2886	Ministry of Science and Technology of China [2005CB121000, 2007CB815700, 2006AA10A117, 2006AA10A118, 2006AA02Z177, 2006AA10A121]; Ministry of Education of China [IRT0750]; Chongqing Municipal Government [B07045]; National Natural Science Foundation of China [30725008, 30890032, 90608010]; International Science and Technology Cooperation Project [0806]; Chinese Academy of Science [GJHZ0701-6]; Danish Platform for Integrative Biology; Danish Natural Science Research Council; Solexa project [272-07-0196]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); Chongqing Municipal Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science and Technology Cooperation Project; Chinese Academy of Science(Chinese Academy of Sciences); Danish Platform for Integrative Biology; Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank two anonymous referees, L. Goodman, L. Bolund, and K. Kristiansen for providing valuable comments. This work was supported by the Ministry of Science and Technology of China (grants 2005CB121000, 2007CB815700, 2006AA10A117, 2006AA10A118, 2006AA02Z177, and 2006AA10A121), the Ministry of Education of China (Program for Changjiang Scholars and Innovative Research Team in University, grant IRT0750), Chongqing Municipal Government, the 111 Project (grant B07045), the National Natural Science Foundation of China (grants 30725008, 30890032, and 90608010), the International Science and Technology Cooperation Project (grant 0806), the Chinese Academy of Science (grant GJHZ0701-6), the Danish Platform for Integrative Biology, the Ole Romer grant from the Danish Natural Science Research Council, and the Solexa project (grant 272-07-0196). Raw genome data are deposited in the National Center for Biotechnology Information/Short Read archive database with accession number SRA009208; silkworm genetic variations, GROSS information, and microarray data can be found in http://silkworm.swu.edu.cn/silkdb/resequencing.html.	Abrams EW, 2006, DEVELOPMENT, V133, P3517, DOI 10.1242/dev.02525; Baba K, 1999, MOL CELL BIOL, V19, P4405; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Horard B, 1997, MOL CELL BIOL, V17, P1572, DOI 10.1128/MCB.17.3.1572; JIANG YL, 1987, AGR ARCHAEOL, V14, P316; Li MW, 2005, GENOME, V48, P802, DOI 10.1139/g05-053; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Liu HJ, 2005, P NATL ACAD SCI USA, V102, P10522, DOI 10.1073/pnas.0500945102; Lu Cheng, 2002, Agricultural Sciences in China, V1, P349; MACH V, 1995, J BIOL CHEM, V270, P9340, DOI 10.1074/jbc.270.16.9340; MAEDA S, 1989, ANNU REV ENTOMOL, V34, P351, DOI 10.1146/annurev.en.34.010189.002031; MAEDA S, 1985, NATURE, V315, P592, DOI 10.1038/315592a0; Marcillac F, 2005, P ROY SOC B-BIOL SCI, V272, P303, DOI 10.1098/rspb.2004.2971; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xia QY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r162; Xia Qingyou, 1998, Acta Entomologica Sinica, V41, P32; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; XIANG ZH, 2005, BIOL SERICULTURE; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yoshitake N., 1967, J SERICULT SCI JAPAN, V37, P83	26	262	350	17	194	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					433	436		10.1126/science.1176620	http://dx.doi.org/10.1126/science.1176620			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19713493	Green Accepted			2022-12-28	WOS:000270818600055
J	Levskaya, A; Weiner, OD; Lim, WA; Voigt, CA				Levskaya, Anselm; Weiner, Orion D.; Lim, Wendell A.; Voigt, Christopher A.			Spatiotemporal control of cell signalling using a light-switchable protein interaction	NATURE			English	Article							ACTIN POLYMERIZATION; NEURONAL-ACTIVITY; PHYTOCHROME-B; REMOTE; ACTIVATION; BACTERIA; RECEPTOR; PIF3	Genetically encodable optical reporters, such as green fluorescent protein, have revolutionized the observation and measurement of cellular states. However, the inverse challenge of using light to control precisely cellular behaviour has only recently begun to be addressed; semi-synthetic chromophore-tethered receptors(1) and naturally occurring channel rhodopsins have been used to perturb directly neuronal networks(2,3). The difficulty of engineering light-sensitive proteins remains a significant impediment to the optical control of most cell-biological processes. Here we demonstrate the use of a new genetically encoded light-control system based on an optimized, reversible protein-protein interaction from the phytochrome signalling network of Arabidopsis thaliana. Because protein-protein interactions are one of the most general currencies of cellular information, this system can, in principle, be generically used to control diverse functions. Here we show that this system can be used to translocate target proteins precisely and reversibly to the membrane with micrometre spatial resolution and at the second timescale. We show that light-gated translocation of the upstream activators of Rho-family GTPases, which control the actin cytoskeleton, can be used to precisely reshape and direct the cell morphology of mammalian cells. The light-gated protein-protein interaction that has been optimized here should be useful for the design of diverse light-programmable reagents, potentially enabling a new generation of perturbative, quantitative experiments in cell biology.	[Levskaya, Anselm; Weiner, Orion D.; Lim, Wendell A.; Voigt, Christopher A.] Univ Calif San Francisco, UCB NIH Nanomed Dev Ctr, Cell Prop Lab, San Francisco, CA 94158 USA; [Levskaya, Anselm] Univ Calif San Francisco, Grad Program Biophys, San Francisco, CA 94158 USA; [Levskaya, Anselm; Voigt, Christopher A.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Weiner, Orion D.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, UCB NIH Nanomed Dev Ctr, Cell Prop Lab, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu	Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543	NSFGR; NIH [R01 GM084040, GM55040, GM62583, EY016546, NIH AI067699, NSF BES-0547637]; Searles Scholar Award; Packard Fellowship; Howard Hughes Medical Institute; Pew Fellowship; Office of Naval Research; UC-Discovery; SynBERC NSF ERC; NATIONAL EYE INSTITUTE [PN1EY016546, PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067699, R56AI067699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084040, R01GM055040, R01GM062583] Funding Source: NIH RePORTER	NSFGR; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searles Scholar Award; Packard Fellowship(The David & Lucile Packard Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Pew Fellowship; Office of Naval Research(Office of Naval Research); UC-Discovery(University of California System); SynBERC NSF ERC; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. El-Sady, J. Tepperman, K. Thorn, G. Kapp and members of the Voigt, Weiner and Lim laboratories for assistance and discussion. We thank Molecular Devices and Photonics Instruments for the loan and customization of a Mosaic spatial light modulator. Data for this study were acquired at the Nikon Imaging Center at UCSF. This work was supported by a NSFGR fellowship (A. L.); NIH R01 GM084040 and Searles Scholar Award.(O. D. W.); Packard Fellowship, the Howard Hughes Medical Institute, and NIH grants GM55040, GM62583 and EY016546 (NIH Roadmap Nanomedicine Development Centers) (W. A. L.); Pew Fellowship, the Office of Naval Research, Packard Fellowship, NIH EY016546, NIH AI067699, NSF BES-0547637, UC-Discovery and the SynBERC NSF ERC (C. A. V.).	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Castellano F, 1999, CURR BIOL, V9, P351, DOI 10.1016/S0960-9822(99)80161-4; Chen M, 2005, CURR BIOL, V15, P637, DOI 10.1016/j.cub.2005.02.028; Gambetta GA, 2001, P NATL ACAD SCI USA, V98, P10566, DOI 10.1073/pnas.191375198; Genoud T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000143; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gorostiza P, 2008, SCIENCE, V322, P395, DOI 10.1126/science.1166022; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Leung DW, 2008, P NATL ACAD SCI USA, V105, P12797, DOI 10.1073/pnas.0801232105; Levskaya A, 2005, NATURE, V438, P441, DOI 10.1038/nature04405; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Shimizu-Sato S, 2002, NAT BIOTECHNOL, V20, P1041, DOI 10.1038/nbt734; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Tyszkiewicz AB, 2008, NAT METHODS, V5, P303, DOI [10.1038/nmeth.1189, 10.1038/NMETH.1189]; Wang S, 2007, NANO LETT, V7, P3859, DOI 10.1021/nl072783t	26	700	728	5	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 15	2009	461	7266					997	1001		10.1038/nature08446	http://dx.doi.org/10.1038/nature08446			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZF	19749742	Green Accepted, Green Submitted			2022-12-28	WOS:000270817700051
J	Amit, I; Garber, M; Chevrier, N; Leite, AP; Donner, Y; Eisenhaure, T; Guttman, M; Grenier, JK; Li, WB; Zuk, O; Schubert, LA; Birditt, B; Shay, T; Goren, A; Zhang, XL; Smith, Z; Deering, R; McDonald, RC; Cabili, M; Bernstein, BE; Rinn, JL; Meissner, A; Root, DE; Hacohen, N; Regev, A				Amit, Ido; Garber, Manuel; Chevrier, Nicolas; Leite, Ana Paula; Donner, Yoni; Eisenhaure, Thomas; Guttman, Mitchell; Grenier, Jennifer K.; Li, Weibo; Zuk, Or; Schubert, Lisa A.; Birditt, Brian; Shay, Tal; Goren, Alon; Zhang, Xiaolan; Smith, Zachary; Deering, Raquel; McDonald, Rebecca C.; Cabili, Moran; Bernstein, Bradley E.; Rinn, John L.; Meissner, Alex; Root, David E.; Hacohen, Nir; Regev, Aviv			Unbiased Reconstruction of a Mammalian Transcriptional Network Mediating Pathogen Responses	SCIENCE			English	Article							GENE-EXPRESSION; REGULATORS; INDUCTION; MODULE; RNA	Models of mammalian regulatory networks controlling gene expression have been inferred from genomic data but have largely not been validated. We present an unbiased strategy to systematically perturb candidate regulators and monitor cellular transcriptional responses. We applied this approach to derive regulatory networks that control the transcriptional response of mouse primary dendritic cells to pathogens. Our approach revealed the regulatory functions of 125 transcription factors, chromatin modifiers, and RNA binding proteins, which enabled the construction of a network model consisting of 24 core regulators and 76 fine-tuners that help to explain how pathogen-sensing pathways achieve specificity. This study establishes a broadly applicable, comprehensive, and unbiased approach to reveal the wiring and functions of a regulatory network controlling a major transcriptional response in primary mammalian cells.	[Amit, Ido; Garber, Manuel; Leite, Ana Paula; Donner, Yoni; Guttman, Mitchell; Grenier, Jennifer K.; Zuk, Or; Shay, Tal; Goren, Alon; Zhang, Xiaolan; Smith, Zachary; Cabili, Moran; Bernstein, Bradley E.; Rinn, John L.; Meissner, Alex; Root, David E.; Hacohen, Nir; Regev, Aviv] MIT, Broad Inst, Cambridge, MA 02142 USA; [Amit, Ido; Garber, Manuel; Leite, Ana Paula; Donner, Yoni; Guttman, Mitchell; Grenier, Jennifer K.; Zuk, Or; Shay, Tal; Goren, Alon; Zhang, Xiaolan; Smith, Zachary; Cabili, Moran; Bernstein, Bradley E.; Rinn, John L.; Meissner, Alex; Root, David E.; Hacohen, Nir; Regev, Aviv] Harvard Univ, Cambridge, MA 02142 USA; [Amit, Ido; Chevrier, Nicolas; Eisenhaure, Thomas; Li, Weibo; Deering, Raquel; McDonald, Rebecca C.; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Amit, Ido; Chevrier, Nicolas; Eisenhaure, Thomas; Li, Weibo; Deering, Raquel; McDonald, Rebecca C.; Bernstein, Bradley E.; Hacohen, Nir] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Amit, Ido; Guttman, Mitchell; Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02142 USA; [Leite, Ana Paula] MIT, Cambridge, MA 02139 USA; [Schubert, Lisa A.; Birditt, Brian] NanoString Technol, Seattle, WA 98109 USA; [Goren, Alon; Bernstein, Bradley E.] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Goren, Alon; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute	Hacohen, N (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	nhacohen@partners.org	Shay, Tal/J-4028-2016	Shay, Tal/0000-0003-0755-1350; Leite, Ana Paula/0000-0001-5773-3211; Goren, Alon/0000-0001-5669-9357; Rinn, John/0000-0002-7231-7539	American Physicians Fellowship for Medicine in Israel; NIH [R21 AI71060]; Burroughs Wellcome Fund; Sloan Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071060] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958, DP2OD002230] Funding Source: NIH RePORTER	American Physicians Fellowship for Medicine in Israel; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Sloan Foundation(Alfred P. Sloan Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Lander, I. Wapinski, D. Pe'er, N. Friedman, J. Kagan, A. Luster, V. Kuchroo, and A. Citri for discussions and comments; L. Gaffney for assistance with artwork; S. Gupta and the Broad Genetic Analysis Platform for microarray processing; and T. Mikkelsen and the Broad Sequencing Platform for help with the ChIP-seq experiments. Supported by the Human Frontier Science Program Organization and a Claire and Emanuel G. Rosenblatt Award from the American Physicians Fellowship for Medicine in Israel (I. A.); NIH grant R21 AI71060 and the NIH New Innovator Award (N. H.); and a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, an NIH Pioneer Award, and the Sloan Foundation (A. R.). A. R. is an Early Career Scientist of the Howard Hughes Medical Institute and an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. Complete microarray data sets are available at the Gene Expression Omnibus (accession no. GSE17721).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Capaldi AP, 2008, NAT GENET, V40, P1300, DOI 10.1038/ng.235; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Decker T, 2005, NAT REV IMMUNOL, V5, P675, DOI 10.1038/nri1684; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Erwin DH, 2009, NAT REV GENET, V10, P141, DOI 10.1038/nrg2499; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Li B, 2007, BIOCHEM J, V405, P369, DOI 10.1042/BJ20061873; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Pe'er Dana, 2002, Bioinformatics, V18 Suppl 1, pS258; Ramsey SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000021; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	28	374	392	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					257	263		10.1126/science.1179050	http://dx.doi.org/10.1126/science.1179050			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19729616	Green Accepted, Green Submitted			2022-12-28	WOS:000270599500035
J	Ranta, D; Bonmati, C				Ranta, Dana; Bonmati, Caroline			Acquired Melanonychia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ranta, Dana; Bonmati, Caroline] Ctr Hosp Univ Nancy Brabois, Vandoeuvre Les Nancy, France	CHU de Nancy	Ranta, D (corresponding author), Ctr Hosp Univ Nancy Brabois, Vandoeuvre Les Nancy, France.								0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1188	1188		10.1056/NEJMicm0804222	http://dx.doi.org/10.1056/NEJMicm0804222			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494QA	19759381				2022-12-28	WOS:000269828000010
J	Lipscombe, LL				Lipscombe, Lorraine L.			Review: Intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Lipscombe, LL (corresponding author), Univ Toronto, Womens Coll Hosp, Toronto, ON, Canada.			Lipscombe, Lorraine/0000-0001-7412-7993				Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Norris SL, 2008, ANN INTERN MED, V148, P855, DOI 10.7326/0003-4819-148-11-200806030-00008	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6							JC3-6	10.7326/0003-4819-151-6-200909150-02006	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755352				2022-12-28	WOS:000270390100023
J	Quill, TE; Lo, B; Brock, DW; Meisel, A				Quill, Timothy E.; Lo, Bernard; Brock, Dan W.; Meisel, Alan			Last-Resort Options for Palliative Sedation	ANNALS OF INTERNAL MEDICINE			English	Article							PHYSICIAN-ASSISTED SUICIDE; TERMINAL SEDATION; CARE; LIFE; REFUSAL; END	Despite receiving state-of-the-art palliative care, some patients still experience severe suffering toward the end of life. Palliative sedation is a potential way to respond to such suffering, but access is uneven and unpredictable, in part because of confusion about different kinds of sedation. Proportionate palliative sedation (PPS) uses the minimum amount of sedation necessary to relieve refractory physical symptoms at the very end of life. To relieve suffering may require progressive increases in sedation, sometimes to the point of unconsciousness, but consciousness is maintained if possible. Palliative sedation with the intended end point of unconsciousness (PSU) is a more controversial practice that may be considered for much fewer refractory cases. There is more ethical consensus about PPS than PSU. In this article, the authors explore the clinical, ethical, and legal issues associated with these practices. They recommend that palliative care and hospice programs develop clear policies about PPS and PSU, including mechanisms for training and ensuring competency for clinicians, and approaching situations where individuals or institutions may conscientiously object.	[Quill, Timothy E.] Univ Rochester, Ctr Eth Humanities & Palliat Care, Med Ctr, Rochester, NY 14642 USA; Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Pittsburgh, Ctr Bioeth & Hlth Law, Pittsburgh, PA USA	University of Rochester; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Quill, TE (corresponding author), Univ Rochester, Ctr Eth Humanities & Palliat Care, Med Ctr, Box 687,601 Elmwood Ave, Rochester, NY 14642 USA.				National Institutes of Health [MH062246]; Greenwall Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenwall Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr. Lo has received financial support from the National Institutes of Health (grant MH062246) and the Greenwall Foundation.	*AM MED ASS, 2008, SED UNC END OF LIF C; American Academy of Hospice and Palliative Medicine, 2006, POS STAT STAT PALL S; Brock DW, 2008, THEOR MED BIOETH, V29, P187, DOI 10.1007/s11017-008-9076-y; Burt RA, 1997, NEW ENGL J MED, V337, P1234, DOI 10.1056/NEJM199710233371712; Callahan D., 2000, TROUBLED DREAM LIFE; Cellarius V, 2008, J MED ETHICS, V34, P69, DOI 10.1136/jme.2006.019224; Chater S, 1998, PALLIATIVE MED, V12, P255, DOI 10.1191/026921698671831786; Claessens P, 2008, J PAIN SYMPTOM MANAG, V36, P310, DOI 10.1016/j.jpainsymman.2007.10.004; Curlin FA, 2008, AM J HOSP PALLIAT ME, V25, P112, DOI 10.1177/1049909107310141; Curlin FA, 2007, NEW ENGL J MED, V356, P593, DOI 10.1056/NEJMsa065316; Hospice and Palliative Nurses Association, 2008, HPNA POS STAT PALL S; Jansen LA, 2002, ANN INTERN MED, V136, P845, DOI 10.7326/0003-4819-136-11-200206040-00014; Lo B, 2005, JAMA-J AM MED ASSOC, V294, P1810, DOI 10.1001/jama.294.14.1810; Morrison RS, 2005, J PALLIAT MED, V8, P1127, DOI 10.1089/jpm.2005.8.1127; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; *NAT HOSP PALL CAR, TOT SED HOSP PALL CA; Quill TE, 1997, NEW ENGL J MED, V337, P1768, DOI 10.1056/NEJM199712113372413; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; QUILL TE, 1993, NEW ENGL J MED, V329, P1039, DOI 10.1056/NEJM199309303291414; Ventafridda V, 1990, J Palliat Care, V6, P7	21	89	92	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6					421	W134		10.7326/0003-4819-151-6-200909150-00007	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-00007			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755367				2022-12-28	WOS:000270390100007
J	Ivaz, S; Lloyd-Hughes, H; Oakeshott, P; Shah, S				Ivaz, Stella; Lloyd-Hughes, Hawys; Oakeshott, Pippa; Shah, Saima			10-Minute Consultation Malignant melanoma	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ivaz, Stella; Lloyd-Hughes, Hawys] Charing Cross Hosp, Imperial Coll NHS Trust, Dept Plast & Reconstruct Surg, London W6 8RF, England; [Oakeshott, Pippa] Univ London, London SW17 0RE, England	Imperial College London; University of London	Ivaz, S (corresponding author), Charing Cross Hosp, Imperial Coll NHS Trust, Dept Plast & Reconstruct Surg, London W6 8RF, England.	stellaivaz@hotmail.com	Ivaz, Stella L/G-1115-2015	Ivaz, Stella L/0000-0002-7211-9161; Oakeshott, Pippa/0000-0003-2568-8211					0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 4	2009	339								b3078	10.1136/bmj.b3078	http://dx.doi.org/10.1136/bmj.b3078			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CJ	19734194				2022-12-28	WOS:000269554200008
J	Tomasello, M; Kaminski, J				Tomasello, Michael; Kaminski, Juliane			Like Infant, Like Dog	SCIENCE			English	Editorial Material									[Tomasello, Michael; Kaminski, Juliane] Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany	Max Planck Society	Tomasello, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany.	tomas@eva.mpg.de		Kaminski, Juliane/0000-0002-3437-3484				Behne T, 2005, DEVELOPMENTAL SCI, V8, P492, DOI 10.1111/j.1467-7687.2005.00440.x; Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Hare B, 2005, TRENDS COGN SCI, V9, P439, DOI 10.1016/j.tics.2005.07.003; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Hare B., 1998, EVOL COMMUN, V2, P137; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 1998, Anim Cogn, V1, P113, DOI 10.1007/s100710050016; Piaget, 1954, CONSTR REALITY CHILD; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Wobber V, 2009, INTERACT STUD, V10, P206, DOI 10.1075/is.10.2.06wob	12	17	18	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1213	1214		10.1126/science.1179670	http://dx.doi.org/10.1126/science.1179670			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490RY	19729645				2022-12-28	WOS:000269523200025
J	Daniels, J; Gray, R; Hills, RK; Latthe, P; Buckley, L; Gupta, J; Selman, T; Adey, E; Xiong, TB; Champaneria, R; Lilford, R; Khan, KS				Daniels, Jane; Gray, Richard; Hills, Robert K.; Latthe, Pallavi; Buckley, Laura; Gupta, Janesh; Selman, Tara; Adey, Elizabeth; Xiong, Tengbin; Champaneria, Rita; Lilford, Richard; Khan, Khalid S.		LUNA Trial Collaboration	Laparoscopic Uterosacral Nerve Ablation for Alleviating Chronic Pelvic Pain A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARACERVICAL UTERINE DENERVATION; SURGICAL-TREATMENT; DOUBLE-BLIND; PREVALENCE; WOMEN; DYSMENORRHEA; RELIABILITY; RELIEF	Context Chronic pelvic pain is a common condition with a major effect on health-related quality of life, work productivity, and health care use. Operative interruption of nerve trunks in the uterosacral ligaments by laparoscopic uterosacral nerve ablation (LUNA) is a treatment option for patients with chronic pelvic pain. Objective To assess the effectiveness of LUNA in patients with chronic pelvic pain. Design, Setting, and Participants Randomized controlled trial of 487 women with chronic pelvic pain lasting longer than 6 months without or with minimal endometriosis, adhesions, or pelvic inflammatory disease, who were recruited to the study by consultant gynecological surgeons from 18 UK hospitals between February 1998 and December 2005. Follow-up was conducted by questionnaires mailed at 3 and 6 months and at 1, 2, 3, and 5 years. Intervention Bilateral LUNA or laparoscopy without pelvic denervation (no LUNA); participants were blinded to the treatment allocation. Main Outcome Measures The primary outcome was pain, which was assessed by a visual analogue scale. Data concerning the 3 types of pain (noncyclical pain, dysmenorrhea, and dyspareunia) were analyzed separately as was the worst pain level experienced from any of these 3 types of pain. The secondary outcome was health-related quality of life, which was measured using a generic instrument (EuroQoL EQ-5D and EQ-VAS). Results After a median follow-up of 69 months, there were no significant differences reported on the visual analogue pain scales for the worst pain (mean difference between the LUNA group and the no LUNA group, -0.04 cm [95% confidence interval {CI}, -0.33 to 0.25 cm]; P=.80), noncyclical pain (-0.11 cm [ 95% CI, -0.50 to 0.29 cm]; P=.60), dysmenorrhea (-0.09 cm [ 95% CI, -0.49 to 0.30 cm]; P=.60), or dyspareunia (0.18 cm [95% CI, -0.22 to 0.62 cm]; P=.40). No differences were observed between the LUNA group and the no LUNA group for quality of life. Conclusion Among women with chronic pelvic pain, LUNA did not result in improvements in pain, dysmenorrhea, dyspareunia, or quality of life compared with laparoscopy without pelvic denervation. Trial Registration controlled-trials.com Identifier: ISRCTN41196151 JAMA.2009;302(9):955-961 www.jama.com	[Daniels, Jane; Gupta, Janesh; Champaneria, Rita; Khan, Khalid S.] Univ Birmingham, Dept Obstet & Gynecol, Birmingham Womens Hosp, Birmingham B15 2TG, W Midlands, England; [Daniels, Jane; Gray, Richard] Univ Birmingham, Birmingham Clin Trials Unit, Robert Aitken Inst, Birmingham B15 2TG, W Midlands, England; [Buckley, Laura] Univ Birmingham, CRUK Clin Trials Unit, Birmingham B15 2TG, W Midlands, England; [Lilford, Richard] Univ Birmingham, Dept Publ Hlth, Birmingham B15 2TG, W Midlands, England; [Hills, Robert K.] Cardiff Univ, Sch Med, Dept Hematol, Cardiff, S Glam, Wales; [Adey, Elizabeth] Heart England NHS Fdn Trust, Birmingham, W Midlands, England; [Xiong, Tengbin] Univ E Anglia, Fac Hlth, Norwich NR4 7TJ, Norfolk, England	Birmingham Women's Hospital; University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; Cardiff University; Heart of England NHS Foundation Trust; University of East Anglia	Daniels, J (corresponding author), Univ Birmingham, Dept Obstet & Gynecol, Birmingham Womens Hosp, Metchley Pk Rd, Birmingham B15 2TG, W Midlands, England.	j.p.daniels@bham.ac.uk	Khan, Khalid S/AAT-8824-2020; Thornton, Jim/B-8336-2008	Khan, Khalid S/0000-0001-5084-7312; Thornton, Jim/0000-0001-9764-6876; Latthe, Pallavi/0000-0003-0529-0409; Gray, Richard/0000-0003-4440-574X; Hills, Robert/0000-0003-0166-0062; Macleod, Maureen/0000-0002-7536-8198	Wellbeing for Women charity [CT371]; Birmingham Women's Foundation NHS Trust Research and Development Committee; Birmingham Clinical Trials Unit; UK Department of Health; British Society of Gynaecological Endoscopy; MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: researchfish	Wellbeing for Women charity; Birmingham Women's Foundation NHS Trust Research and Development Committee; Birmingham Clinical Trials Unit; UK Department of Health; British Society of Gynaecological Endoscopy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Wellbeing for Women charity grant CT371 and Birmingham Women's Foundation NHS Trust Research and Development Committee, with additional support from the Birmingham Clinical Trials Unit, who are funded by the UK Department of Health. The LUNA trial was endorsed by the British Society of Gynaecological Endoscopy.	BAKER PN, 1992, AM J OBSTET GYNECOL, V166, P835, DOI 10.1016/0002-9378(92)91343-9; Bijlsma JWJ, 2005, ANN RHEUM DIS, V64, P1, DOI 10.1136/ard.2004.025072; CAMPBELL RM, 1950, AM J OBSTET GYNECOL, V59, P1; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Daniels J, 2000, GYNAECOL ENDOSC, V9, P157, DOI 10.1046/j.1365-2508.2000.00323.x; DOYLE JB, 1963, CLIN OBSTET GYNECOL, V6, P742, DOI 10.1097/00003081-196309000-00017; DOYLE JB, 1955, AM J OBSTET GYNECOL, V70, P1; Ghaly A. F. F., 1994, Journal of Obstetrics and Gynaecology (Abingdon), V14, P269, DOI 10.3109/01443619409027849; Goldstein H, 1995, MULTILEVEL STAT MODE, V2nd; Howard F M, 1993, Obstet Gynecol Surv, V48, P357, DOI 10.1097/00006254-199306000-00001; Howard FM, 2000, BEST PRACT RES CL OB, V14, P467, DOI 10.1053/beog.1999.0086; Jensen MP, 1999, PAIN, V83, P157, DOI 10.1016/S0304-3959(99)00101-3; Johnson AG, 1997, BRIT MED J, V314, P916, DOI 10.1136/bmj.314.7085.916; Johnson NP, 2004, BJOG-INT J OBSTET GY, V111, P950, DOI 10.1111/j.1471-0528.2004.00233.x; Khan KS, 1999, GYNAECOL ENDOSC, V8, P257, DOI 10.1046/j.1365-2508.1999.00269.x; Kind P., 1996, QUAL LIFE PHARMACOEC, V25, P3110, DOI [10.1097/00007632-200012150-00005, DOI 10.1097/00007632-200012150-00005]; LATARJET A, 1922, GYNECOL OBSTET, V6, P225; Latthe P, 2006, BMJ-BRIT MED J, V332, P749, DOI 10.1136/bmj.38748.697465.55; LATTHE P, 2003, BIOMED CENTRAL WOMEN, V8, P3; Latthe P M, 2004, J Obstet Gynaecol, V24, P547; Latthe P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-177; Latthe PM, 2005, BJOG-INT J OBSTET GY, V112, P243, DOI 10.1111/j.1471-0528.2004.00304.x; LICHTEN EM, 1987, J REPROD MED, V32, P37; Mathias SD, 1996, OBSTET GYNECOL, V87, P321, DOI 10.1016/0029-7844(95)00458-0; *NAT I HLTH CLIN E, 2007, INT PROC GUID NAT I, V234; Porpora MG, 1997, FERTIL STERIL, V68, P765, DOI 10.1016/S0015-0282(97)00192-1; Proctor ML, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001896.pub2; *RCOG GUID AUD COM, 2005, GUID RCOG, V41; REVILL SI, 1976, ANAESTHESIA, V31, P1191, DOI 10.1111/j.1365-2044.1976.tb11971.x; Rubin DB, 1987, MULTIPLE IMPUTATION; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; SUNDELL G, 1990, BRIT J OBSTET GYNAEC, V97, P588, DOI 10.1111/j.1471-0528.1990.tb02545.x; SUTTON C, 1993, ENDOSCOPIC SURG GYNA, P159; SUTTON CJG, 1994, FERTIL STERIL, V62, P696; Swank DJ, 2003, LANCET, V361, P1247, DOI 10.1016/S0140-6736(03)12979-0; Winkel CA, 1999, AM J MANAG CARE, V5, pS276; Zondervan KT, 1999, BRIT J OBSTET GYNAEC, V106, P1149, DOI 10.1111/j.1471-0528.1999.tb08140.x; Zullo F, 1996, J GYNECOL SURG, V12, P35, DOI 10.1089/gyn.1996.12.35	38	72	76	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					955	961		10.1001/jama.2009.1268	http://dx.doi.org/10.1001/jama.2009.1268			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724042	Bronze			2022-12-28	WOS:000269444900020
J	Brayard, A; Escarguel, G; Bucher, H; Monnet, C; Bruhwiler, T; Goudemand, N; Galfetti, T; Guex, J				Brayard, Arnaud; Escarguel, Gilles; Bucher, Hugo; Monnet, Claude; Bruehwiler, Thomas; Goudemand, Nicolas; Galfetti, Thomas; Guex, Jean			Good Genes and Good Luck: Ammonoid Diversity and the End-Permian Mass Extinction	SCIENCE			English	Article							FOSSIL RECORD; TAXONOMIC DIVERSITY; CARBON-CYCLE; RECOVERY; DYNAMICS; PERTURBATIONS; ORIGINATION; GRADIENTS; EVOLUTION; VOLCANISM	The end-Permian mass extinction removed more than 80% of marine genera. Ammonoid cephalopods were among the organisms most affected by this crisis. The analysis of a global diversity data set of ammonoid genera covering about 106 million years centered on the Permian-Triassic boundary (PTB) shows that Triassic ammonoids actually reached levels of diversity higher than in the Permian less than 2 million years after the PTB. The data favor a hierarchical rather than logistic model of diversification coupled with a niche incumbency hypothesis. This explosive and nondelayed diversification contrasts with the slow and delayed character of the Triassic biotic recovery as currently illustrated for other, mainly benthic groups such as bivalves and gastropods.	[Brayard, Arnaud] Univ Bourgogne, CNRS, UMR Biogeosci 5561, F-21000 Dijon, France; [Escarguel, Gilles] Univ Lyon 1, PEPS, CNRS, UMR 5125, F-69622 Villeurbanne, France; [Bucher, Hugo; Monnet, Claude; Bruehwiler, Thomas; Goudemand, Nicolas; Galfetti, Thomas] Univ Zurich, Palaontol Inst & Museum, CH-8006 Zurich, Switzerland; [Bucher, Hugo] ETH, Dept Earth Sci, Zurich, Switzerland; [Guex, Jean] Univ Lausanne, Dept Geol & Paleontol, Lausanne, Switzerland	Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Lausanne	Brayard, A (corresponding author), Univ Bourgogne, CNRS, UMR Biogeosci 5561, 6 Blvd Gabriel, F-21000 Dijon, France.	arnaud.brayard@u-bourgogne.fr; gilles.escarguel@univ-lyon1.fr	Monnet, Claude/F-8498-2010; Escarguel, Gilles/C-3297-2011; Brayard, Arnaud/E-4711-2011; Bucher, Hugo F.R./O-2212-2013; Brayard, Arnaud/AAH-3075-2020	Monnet, Claude/0000-0002-0899-8392; Bucher, Hugo F.R./0000-0001-9164-5258; Brayard, Arnaud/0000-0003-1304-6553; Escarguel, Gilles/0000-0003-0985-6369; Goudemand, Nicolas/0000-0002-2956-5852	Swiss NSF project [200020-113554]	Swiss NSF project	This article is a contribution from the team Forme, Evolution, Diversite of the UMR-CNRS 5561 Biogeosciences (A.B.), and from the team Adaptation, Morphologie, Environnement of the UMR-CNRS 5125 PEPS (G.E.). This work was supported by the Swiss NSF project 200020-113554 (H.B.). We thank R. Colwell (University of Connecticut, USA) and E. Fara (University of Burgundy, France) for discussion.	Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Alroy J, 2008, SCIENCE, V321, P97, DOI 10.1126/science.1156963; Brayard A, 2007, GEOBIOS-LYON, V40, P749, DOI 10.1016/j.geobios.2007.06.002; Brayard A, 2007, LETHAIA, V40, P175, DOI 10.1111/j.1502-3931.2007.00012.x; Brayard A, 2006, PALAEOGEOGR PALAEOCL, V239, P374, DOI 10.1016/j.palaeo.2006.02.003; BUCHER H, 1996, AMMONOID PALEOBIOLOG, P407; Embry AF, 1997, B CAN PETROL GEOL, V45, P415; Erwin DH, 2001, P NATL ACAD SCI USA, V98, P5399, DOI 10.1073/pnas.091092698; Escarguel G, 2008, CR GEOSCI, V340, P602, DOI 10.1016/j.crte.2007.11.005; Foote M, 2000, PALEOBIOLOGY, V26, P74, DOI 10.1666/0094-8373(2000)26[74:OAECOT]2.0.CO;2; Galfetti T, 2007, PALAEOGEOGR PALAEOCL, V243, P394, DOI 10.1016/j.palaeo.2006.08.014; Galfetti T, 2007, EARTH PLANET SC LETT, V258, P593, DOI 10.1016/j.epsl.2007.04.023; Galfetti T, 2007, GEOLOGY, V35, P291, DOI 10.1130/G23117A.1; Hautmann M, 2005, PALAEONTOLOGY, V48, P1131, DOI 10.1111/j.1475-4983.2005.00505.x; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; KULLMAN J, 2007, GONIAT VERSION 3 5; Lu PJ, 2006, P NATL ACAD SCI USA, V103, P2736, DOI 10.1073/pnas.0511083103; MAURER BA, 1989, PALEOBIOLOGY, V15, P133, DOI 10.1017/S0094837300009325; McGowan AJ, 2004, GEOLOGY, V32, P665, DOI 10.1130/G20462.1; McGowan AJ, 2007, PALAEONTOLOGY, V50, P573, DOI 10.1111/j.1475-4983.2007.00653.x; Orchard MJ, 2007, PALAEOGEOGR PALAEOCL, V252, P93, DOI 10.1016/j.palaeo.2006.11.037; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Payne JL, 2007, EARTH PLANET SC LETT, V256, P264, DOI 10.1016/j.epsl.2007.01.034; Saunders WB, 2008, PALEOBIOLOGY, V34, P128, DOI 10.1666/07053.1; Schaltegger U, 2008, EARTH PLANET SC LETT, V267, P266, DOI 10.1016/j.epsl.2007.11.031; SEPKOSKI JJ, 1978, PALEOBIOLOGY, V4, P223, DOI 10.1017/S0094837300005972; TOZER ET, 1982, GEOL RUNDSCH, V71, P1077, DOI 10.1007/BF01821119; Tozer ET, 1981, AMMONOIDEA, V18, P65; Villier L, 2004, SCIENCE, V306, P264, DOI 10.1126/science.1102127; WALKER TD, 1984, AM NAT, V124, P887, DOI 10.1086/284322; ZHOU Z., 1996, PERMOPHILES, V29, P52	31	220	229	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1118	1121		10.1126/science.1174638	http://dx.doi.org/10.1126/science.1174638			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713525				2022-12-28	WOS:000269382300038
J	Hamilton, W; Peters, TJ; Bankhead, C; Sharp, D				Hamilton, William; Peters, Tim J.; Bankhead, Clare; Sharp, Deborah			Risk of ovarian cancer in women with symptoms in primary care: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-FEATURES; DIAGNOSIS; BORDERLINE	Objective To identify and quantify symptoms of ovarian cancer in women in primary care. Design Case-control study, with coding of participants' primary care records for one year before diagnosis. Setting 39 general practices in Devon, England. Participants 212 women aged over 40 with a diagnosis of primary ovarian cancer, 2000-7; 1060 controls matched by age and general practice. Main outcome measures Odds ratios and positive predictive values for symptoms from conditional logistic regression analyses. Results Seven symptoms were associated with ovarian cancer in multivariable analysis. The univariable positive predictive values and multivariable odds ratios (with 95% confidence intervals) for these were 2.5% (1.2% to 5.9%) and 240 (46 to 1200) for abdominal distension; 0.5% (0.2% to 0.9%) and 24 (9.3 to 64) for postmenopausal bleeding; 0.6% (0.3% to 1.0%) and 17 (6.1 to 50) for loss of appetite; 0.2% (0.1% to 0.3%) and 16 (5.6 to 48) for increased urinary frequency; 0.3% (0.2% to 0.3%) and 12 (6.1 to 22) for abdominal pain; 0.2% (0.1% to 0.4%) and 7.6 (2.5 to 23) for rectal bleeding; and 0.3% (0.2% to 0.6%) and 5.3 (1.8 to 16) for abdominal bloating. In 181 (85%) cases and 164 (15%) controls at least one of these seven symptoms was reported to primary care before diagnosis. After exclusion of symptoms reported in the 180 days before diagnosis, abdominal distension, urinary frequency, and abdominal pain remained independently associated with a diagnosis of ovarian cancer. Conclusions Women with ovarian cancer usually have symptoms and report them to primary care, sometimes months before diagnosis. This study provides an evidence base for selection of patients for investigation, both for clinicians and for developers of guidelines.	[Hamilton, William; Peters, Tim J.; Bankhead, Clare; Sharp, Deborah] Univ Bristol, Dept Community Based Med, NIHR Sch Primary Care Res, Bristol BS8 2AA, Avon, England	University of Bristol	Hamilton, W (corresponding author), Univ Bristol, Dept Community Based Med, NIHR Sch Primary Care Res, Bristol BS8 2AA, Avon, England.	w.hamilton@bristol.ac.uk	Hamilton, Willie/G-8612-2014	Peters, Tim/0000-0003-2881-4180; sharp, deborah/0000-0003-3071-9860; Hamilton, William/0000-0003-1611-1373	Department of Health's NIHR School for Primary Care Research funding scheme; Department of Health's Research Practices scheme; University of Bristol; National Institute for Health Research [PDA/03/07/029] Funding Source: researchfish	Department of Health's NIHR School for Primary Care Research funding scheme; Department of Health's Research Practices scheme; University of Bristol; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Department of Health's NIHR School for Primary Care Research funding scheme. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health. Additionally, WH is funded through an NCCRCD postdoctoral fellowship, and his research practice in Exeter received funding from the Department of Health's Research Practices scheme. The study sponsor was the University of Bristol. The authors were independent from the funder and sponsor, who had no role in conduct, analysis or the decision to publish.	Bankhead CR, 2008, BJOG-INT J OBSTET GY, V115, P1008, DOI 10.1111/j.1471-0528.2008.01772.x; Bankhead CR, 2005, BJOG-INT J OBSTET GY, V112, P857, DOI 10.1111/j.1471-0528.2005.00572.x; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; *CANC RES UK, 2007, CANCERSTATS 2007; Chan YM, 2003, GYNECOL ONCOL, V90, P651, DOI 10.1016/S0090-8258(03)00394-9; Colombo N, 2006, CRIT REV ONCOL HEMAT, V60, P159, DOI 10.1016/j.critrevonc.2006.03.004; Ferrell B, 2003, J PAIN SYMPTOM MANAG, V25, P528, DOI 10.1016/S0885-3924(03)00148-9; Friedman GD, 2005, FAM PRACT, V22, P548, DOI 10.1093/fampra/cmi044; Goff BA, 2004, JAMA-J AM MED ASSOC, V291, P2705, DOI 10.1001/jama.291.22.2705; Goff BA, 2000, CANCER, V89, P2068, DOI 10.1002/1097-0142(20001115)89:10<2068::AID-CNCR6>3.0.CO;2-Z; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hamilton W, 2005, BRIT J CANCER, V93, P399, DOI 10.1038/sj.bjc.6602714; Lataifeh I, 2005, AUST NZ J OBSTET GYN, V45, P211, DOI 10.1111/j.1479-828X.2005.00391.x; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; *NICE, 2005, REF GUID SUSP CANC; *OFF NAT STAT, 2008, CANC STAT REG 2005 E; Olsen CM, 2007, EUR J GYNAECOL ONCOL, V28, P376; Olson SH, 2001, OBSTET GYNECOL, V98, P212, DOI 10.1016/S0029-7844(01)01457-0; Patel RR, 2005, INT J EPIDEMIOL, V34, P353, DOI 10.1093/ije/dyh401; Quaye L, 2008, CLIN CANCER RES, V14, P5833, DOI 10.1158/1078-0432.CCR-08-0819; Rufford BD, 2007, BJOG-INT J OBSTET GY, V114, P59, DOI 10.1111/j.1471-0528.2006.01153.x; Ryerson AB, 2007, OBSTET GYNECOL, V109, P1053, DOI 10.1097/01.AOG.0000260392.70365.5e; Smith LH, 2005, CANCER, V104, P1398, DOI 10.1002/cncr.21310; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Vine MF, 2003, GYNECOL ONCOL, V90, P75, DOI 10.1016/S0090-8258(03)00175-6; Vine MF, 2001, GYNECOL ONCOL, V83, P466, DOI 10.1006/gyno.2001.6411; Webb PM, 2004, GYNECOL ONCOL, V92, P232, DOI 10.1016/j.ygyno.2003.09.005; WONCA, 1998, ICPC 2 INT CLASS PRI	28	119	120	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2009	339								b2998	10.1136/bmj.b2998	http://dx.doi.org/10.1136/bmj.b2998			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AS	19706933	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000269392500003
J	Hancock, K; Veguilla, V; Lu, XH; Zhong, WM; Butler, EN; Sun, H; Liu, F; Dong, LB; DeVos, JR; Gargiullo, PM; Brammer, TL; Cox, NJ; Tumpey, TM; Katz, JM				Hancock, Kathy; Veguilla, Vic; Lu, Xiuhua; Zhong, Weimin; Butler, Ebonee N.; Sun, Hong; Liu, Feng; Dong, Libo; DeVos, Joshua R.; Gargiullo, Paul M.; Brammer, T. Lynnette; Cox, Nancy J.; Tumpey, Terrence M.; Katz, Jacqueline M.			Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEUTRALIZING ANTIBODIES; VACCINE; IMMUNITY; HUMANS; ORIGIN; H5N1; VOLUNTEERS; INFECTION; SERUM; AGE	Background: A new pandemic influenza A (H1N1) virus has emerged, causing illness globally, primarily in younger age groups. To assess the level of preexisting immunity in humans and to evaluate seasonal vaccine strategies, we measured the antibody response to the pandemic virus resulting from previous influenza infection or vaccination in different age groups. Methods: Using a microneutralization assay, we measured cross-reactive antibodies to pandemic H1N1 virus (2009 H1N1) in stored serum samples from persons who either donated blood or were vaccinated with recent seasonal or 1976 swine influenza vaccines. Results: A total of 4 of 107 persons (4%) who were born after 1980 had preexisting cross-reactive antibody titers of 40 or more against 2009 H1N1, whereas 39 of 115 persons (34%) born before 1950 had titers of 80 or more. Vaccination with seasonal trivalent inactivated influenza vaccines resulted in an increase in the level of cross-reactive antibody to 2009 H1N1 by a factor of four or more in none of 55 children between the ages of 6 months and 9 years, in 12 to 22% of 231 adults between the ages of 18 and 64 years, and in 5% or less of 113 adults 60 years of age or older. Seasonal vaccines that were formulated with adjuvant did not further enhance cross-reactive antibody responses. Vaccination with the A/New Jersey/1976 swine influenza vaccine substantially boosted cross-reactive antibodies to 2009 H1N1 in adults. Conclusions: Vaccination with recent seasonal nonadjuvanted or adjuvanted influenza vaccines induced little or no cross-reactive antibody response to 2009 H1N1 in any age group. Persons under the age of 30 years had little evidence of cross-reactive antibodies to the pandemic virus. However, a proportion of older adults had preexisting cross-reactive antibodies. N Engl J Med 2009;361:1945-52.	[DeVos, Joshua R.] Ctr Dis Control & Prevent, Div Global AIDS, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Hancock, Kathy; Veguilla, Vic; Lu, Xiuhua; Zhong, Weimin; Butler, Ebonee N.; Sun, Hong; Liu, Feng; Dong, Libo; Gargiullo, Paul M.; Brammer, T. Lynnette; Cox, Nancy J.; Tumpey, Terrence M.; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Katz, JM (corresponding author), CDC, Influenza Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd, Atlanta, GA 30333 USA.	jkatz@cdc.gov			GlaxoSmithKline; Juvaris BioTherapeutics	GlaxoSmithKline(GlaxoSmithKline); Juvaris BioTherapeutics	Dr. Hancock reports receiving research support from GlaxoSmithKline and Juvaris BioTherapeutics; Dr. Lu, research support from Juvaris BioTherapeutics; and Dr. Katz, research support from GlaxoSmithKline. No other conflict of interest relevant to this article was reported.	CUNEOCROVARI P, 1976, B I SIEROTER MILAN, V55, P463; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Dowdle Walter R., 1997, Journal of Infectious Diseases, V176, pS69, DOI 10.1086/514180; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kendal AP, 1982, CONCEPTS PROCEDURES; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; MARINE WM, 1973, POSTGRAD MED J, V49, P164, DOI 10.1136/pgmj.49.569.164; MASSICOT J, 1977, J INFECT DIS, V136, pS472, DOI 10.1093/infdis/136.Supplement_3.S472; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Newman AP, 2008, EMERG INFECT DIS, V14, P1470, DOI 10.3201/eid1409.080305; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sasaki S, 2007, J VIROL, V81, P215, DOI 10.1128/JVI.01957-06; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Shinde V, 2009, NEW ENGL J MED, V361, P102; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shope RE, 1936, J EXP MED, V63, P669, DOI 10.1084/jem.63.5.669; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Taubenberger JK, 2001, PHILOS T ROY SOC B, V356, P1829, DOI 10.1098/rstb.2001.1020; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; 2009, MMWR MORB MORTAL WKL, V58, P521	29	1009	1057	3	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 12	2009	361	20					1945	1952		10.1056/NEJMoa0906453	http://dx.doi.org/10.1056/NEJMoa0906453			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	518AI	19745214				2022-12-28	WOS:000271660500008
J	Brownell, KD; Farley, T; Willett, WC; Popkin, BM; Chaloupka, FJ; Thompson, JW; Ludwig, DS				Brownell, Kelly D.; Farley, Thomas; Willett, Walter C.; Popkin, Barry M.; Chaloupka, Frank J.; Thompson, Joseph W.; Ludwig, David S.			The Public Health and Economic Benefits of Taxing Sugar-Sweetened Beverages	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SOFT DRINK CONSUMPTION; ENERGY-INTAKE; WEIGHT-GAIN; FOOD-INTAKE; CHILDHOOD OBESITY; BODY-WEIGHT; ADOLESCENTS; TAXES; PREVENTION; APPETITE		[Brownell, Kelly D.] Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA; [Farley, Thomas] Dept Hlth & Mental Hyg, New York, NY USA; [Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Ludwig, David S.] Childrens Hosp, Optimal Weight Life Program, Boston, MA 02115 USA; [Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Popkin, Barry M.] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Popkin, Barry M.] Univ N Carolina, Interdisciplinary Obes Ctr, Chapel Hill, NC USA; [Chaloupka, Frank J.] Univ Illinois, Dept Econ, Chicago, IL 60680 USA; [Chaloupka, Frank J.] Univ Illinois, Ctr Hlth Policy, Chicago, IL 60680 USA; [Thompson, Joseph W.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; [Thompson, Joseph W.] Surgeon Generals Off, Little Rock, AR USA	Yale University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arkansas System; University of Arkansas Medical Sciences	Brownell, KD (corresponding author), Yale Univ, Rudd Ctr Food Policy & Obes, New Haven, CT 06520 USA.		Popkin, Barry/T-6633-2019	Ludwig, David/0000-0003-3307-8544; popkin, barry/0000-0001-9495-9324	NCI NIH HHS [R01 CA121152-05, R01 CA121152, R01-CA121152] Funding Source: Medline; NIDDK NIH HHS [P30 DK040561-14, P30 DK040561] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA121152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albala C, 2008, AM J CLIN NUTR, V88, P605, DOI 10.1093/ajcn/88.3.605; ANDREYEVA T, AM J PUBLIC IN PRESS; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163; Brownell K. D., 1994, NY TIMES, pA29; Brownell KD, 2005, J HEALTH POLIT POLIC, V30, P955, DOI 10.1215/03616878-30-5-955; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Cawley J, 2004, AM J PREV MED, V27, P117, DOI 10.1016/j.amepre.2004.06.012; CHALOUPKA FJ, CIGARETTE E IN PRESS; DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P1133, DOI 10.1016/0031-9384(93)90370-U; Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; Ebbeling CB, 2006, PEDIATRICS, V117, P673, DOI 10.1542/peds.2005-0983; Finkelstein EA, 2005, ANNU REV PUBL HEALTH, V26, P239, DOI 10.1146/annurev.publhealth.26.021304.144628; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Flood JE, 2006, J AM DIET ASSOC, V106, P1984, DOI 10.1016/j.jada.2006.09.005; Forshee RA, 2009, AM J CLIN NUTR, V89, P441, DOI 10.3945/ajcn.2008.27217; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; HAKIM D, 2009, NY TIMES        0301; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; Jacobson MF, 2000, AM J PUBLIC HEALTH, V90, P854, DOI 10.2105/AJPH.90.6.854; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; James J, 2004, BRIT MED J, V328, P1236; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2009, AM J CLIN NUTR, V89, P438, DOI 10.3945/ajcn.2008.26980; Mattes RD, 2009, AM J CLIN NUTR, V89, P1, DOI 10.3945/ajcn.2008.26792; Montonen J, 2007, J NUTR, V137, P1447, DOI 10.1093/jn/137.6.1447; Mourao DM, 2007, INT J OBESITY, V31, P1688, DOI 10.1038/sj.ijo.0803667; Palmer JR, 2008, ARCH INTERN MED, V168, P1487, DOI 10.1001/archinte.168.14.1487; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; *RUDD CTR FOOD POL, REV CALC SOFT DRINK; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sichieri R, 2009, PUBLIC HEALTH NUTR, V12, P197, DOI 10.1017/S1368980008002644; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Yoshida M, 2007, J NUTR, V137, P2121, DOI 10.1093/jn/137.9.2121	39	479	489	4	162	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 15	2009	361	16					1599	1605		10.1056/NEJMhpr0905723	http://dx.doi.org/10.1056/NEJMhpr0905723			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	506LT	19759377	Green Accepted, Green Published			2022-12-28	WOS:000270777000017
J	Mehran, R; Lansky, AJ; Witzenbichler, B; Guagliumi, G; Peruga, JZ; Brodie, BR; Dudek, D; Kornowski, R; Hartmann, F; Gersh, BJ; Pocock, SJ; Wong, SC; Nikolsky, E; Gambone, L; Vandertie, L; Parise, H; Dangas, GD; Stone, GW				Mehran, Roxana; Lansky, Alexandra J.; Witzenbichler, Bernhard; Guagliumi, Giulio; Peruga, Jan Z.; Brodie, Bruce R.; Dudek, Dariusz; Kornowski, Ran; Hartmann, Franz; Gersh, Bernard J.; Pocock, Stuart J.; Wong, S. Chiu; Nikolsky, Eugenia; Gambone, Louise; Vandertie, Lynn; Parise, Helen; Dangas, George D.; Stone, Gregg W.		HORIZONS-AMI Trial Investigators	Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial	LANCET			English	Article							ACUTE CORONARY SYNDROMES; GLYCOPROTEIN IIB/IIIA BLOCKADE; CLINICAL-OUTCOMES; BLOOD-TRANSFUSION; ACUITY TRIAL; ANTIPLATELET THERAPY; IMPACT; ABCIXIMAB; INTERVENTION; RISK	Background In the HORIZONS-AMI trial, patients with acute ST-segment elevation myocardial infarction (STEMI) undergoing percutaneous coronary intervention (PCI) who were treated with the thrombin inhibitor bivalirudin had substantially lower 30-day rates of major haemorrhagic complications and net adverse clinical events than did patients assigned to heparin plus a glycoprotein IIb/IIIa inhibitor (GPI). Here, we assess whether these initial benefits were maintained at 1 year of follow-up. Methods Patients aged 18 years or older were eligible for enrolment in this muldcentre, open-label, randomised controlled trial if they had STEMI, presented within 12 h after the onset of symptoms, and were undergoing primary PCI. 3602 eligible patients were randomly assigned by interactive voice response system in a 1:1 ratio to receive bivalirudin (0.75 mg/kg intravenous bolus followed by 1.75 mg/kg per h infusion; n=1800) or heparin plus a GPI (control; 60 IU/kg intravenous bolus followed by boluses with target activated clotting time 200-250 s; n=1802). The two primary trial endpoints were major bleeding and net adverse clinical events (NACE; consisting of major bleeding or composite major adverse cardiovascular events [MACE; death, reinfarction, target vessel revascularisation for ischaemia, or stroke]). This prespecified analysis reports data for the 1-year follow-up. Analysis was by intention to treat. Patients with missing data were censored at the time of withdrawal from the study or at last follow-up. This trial is registered with ClinicalTrials.gov, number NCT00433966. Findings 1-year data were available for 1696 patients in the bivalirudin group and 1702 patients in the control group. Reasons for participant dropout were loss to follow-up and withdrawal of consent. The rate of NACE was lower in the bivalirudin group than in the control group (15.6% vs 18.3%, hazard ratio [HR] 0.83, 95% CI 0.71-0.97, p=0.022), as a result of a lower rate of major bleeding in the bivalirudin group (5.8% vs 9.2%, HR 0.61, 0.48-0.78, p<0.0001). The rate of MACE was similar between groups (11.9% vs 11.9%, HR 1.00, 0.82-1.21, p=0.98). The 1-year rates of cardiac mortality (2.1% vs 3.8%, HR 0.57, 0.38-0.84, p=0.005) and all-cause mortality (3.5% vs 4.8%, HR 0.71, 0.51-0.98, p=0.037) were lower in the bivalirudin group than in the control group. Interpretation In patients with STEMI undergoing primary PCI, anticoagulation with bivalirudin reduced the rates of net adverse clinical events and major bleeding at 1 year compared with treatment with heparin plus a GPI. This finding has important clinical implications for the selection of optimum treatment strategies for patients with STEMI. Funding Cardiovascular Research Foundation, with unrestricted grant support from Boston Scientific Corporation and The Medicines Company.	[Mehran, Roxana; Lansky, Alexandra J.; Nikolsky, Eugenia; Gambone, Louise; Vandertie, Lynn; Parise, Helen; Dangas, George D.; Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY 10032 USA; [Mehran, Roxana; Lansky, Alexandra J.; Nikolsky, Eugenia; Gambone, Louise; Vandertie, Lynn; Parise, Helen; Dangas, George D.; Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Witzenbichler, Bernhard] Charite Campus Benjamin Franklin, Berlin, Germany; [Guagliumi, Giulio] Osped Riuniti Bergamo, I-24100 Bergamo, Italy; [Peruga, Jan Z.] Silesian Ctr Heart Dis, Lodz, Poland; [Brodie, Bruce R.] LeBauer Cardiovasc Res Fdn, Greensboro, NC USA; [Brodie, Bruce R.] Moses Cone Hosp, Greensboro, NC USA; [Dudek, Dariusz] Jagiellonian Univ, Krakow, Poland; [Kornowski, Ran] Rabin Med Ctr, Petah Tiqwa, Israel; [Hartmann, Franz] Univ Klinikum Schleswig Holstein, D-23538 Lubeck, Germany; [Gersh, Bernard J.] Mayo Clin, Rochester, MN USA; [Pocock, Stuart J.] London Sch Hyg & Trop Med, London WC1, England; [Wong, S. Chiu] New York Presbyterian Hosp, Weill Cornell Med Ctr, New York, NY USA	Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ospedali Riuniti di Bergamo; Silesian Center for Heart Diseases; LeBauer-Brodie Center for Cardiovascular Research & Education; Moses Cone Memorial Hospital; Jagiellonian University; Rabin Medical Center; University of Kiel; Schleswig Holstein University Hospital; Mayo Clinic; University of London; London School of Hygiene & Tropical Medicine; Cornell University; NewYork-Presbyterian Hospital	Mehran, R (corresponding author), Columbia Univ, Med Ctr, New York Presbyterian Hosp, 161 Ft Washington Ave,5th Floor, New York, NY 10032 USA.	rm2266@columbia.edu	Mehran, Roxana/ABF-4160-2021; Guagliumi, Giulio/K-8006-2016; Suryapranata, H./H-8095-2014; Witzenbichler, Bernhard/ABC-2525-2021	Banning, Adrian/0000-0002-2842-7861; Mendiz, Oscar/0000-0002-5268-0429; Witzenbichler, Bernhard/0000-0001-9322-1926; Parise, Helen/0000-0001-7761-4973	Cardiovascular Research Foundation; Boston Scientific Corporation; The Medicines Company	Cardiovascular Research Foundation; Boston Scientific Corporation(Boston Scientific); The Medicines Company	The trial was sponsored by the Cardiovascular Research Foundation, with unrestricted grant support from Boston Scientific Corporation and The Medicines Company.	Biedler AE, 2002, ANESTHESIOLOGY, V97, P1102, DOI 10.1097/00000542-200211000-00011; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Feit F, 2007, AM J CARDIOL, V100, P1364, DOI 10.1016/j.amjcard.2007.06.026; Ferrari E, 2005, J AM COLL CARDIOL, V45, P456, DOI 10.1016/j.jacc.2004.11.041; Fransen E, 1999, CHEST, V116, P1233, DOI 10.1378/chest.116.5.1233; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; KAHN RC, 1986, INTENS CARE MED, V12, P22, DOI 10.1007/BF00315364; Kandzari DE, 2004, AM HEART J, V147, P457, DOI 10.1016/j.ahj.2003.08.011; Kereiakes DJ, 2000, AM HEART J, V140, P74, DOI 10.1067/mhj.2000.106615; Kinnaird TD, 2003, AM J CARDIOL, V92, P930, DOI 10.1016/S0002-9149(03)00972-X; Kirtane AJ, 2006, J AM COLL CARDIOL, V47, P2374, DOI 10.1016/j.jacc.2005.09.080; Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Manoukian SV, 2007, J AM COLL CARDIOL, V49, P1362, DOI 10.1016/j.jacc.2007.02.027; Mehran R, 2008, AM HEART J, V156, P44, DOI 10.1016/j.ahj.2008.02.008; Mehran R, 2009, EUR HEART J, V30, P1457, DOI 10.1093/eurheartj/ehp110; Merlini PA, 2004, CIRCULATION, V109, P2203, DOI 10.1161/01.CIR.0000127867.41621.85; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Nikolsky E, 2005, AM J CARDIOL, V96, P474, DOI 10.1016/j.amjcard.2005.04.005; Nikolsky E, 2004, AM J CARDIOL, V94, P1023, DOI 10.1016/j.amjcard.2004.06.058; OHMAN EM, 1990, CIRCULATION, V82, P781, DOI 10.1161/01.CIR.82.3.781; Orn S, 2005, AM J MED, V118, P752, DOI 10.1016/j.amjmed.2005.02.010; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2007, JAMA-J AM MED ASSOC, V298, P2497, DOI 10.1001/jama.298.21.2497; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Stone GW, 2009, NEW ENGL J MED, V360, P1946, DOI 10.1056/NEJMoa0810116; Stone GW, 2002, NEW ENGL J MED, V346, P957, DOI 10.1056/NEJMoa013404; STONE GW, EUR HEART J IN PRESS; Tamhane UU, 2008, EXPERT OPIN DRUG SAF, V7, P809, DOI 10.1517/14740330802500353 ; Twomley KM, 2006, J THROMB THROMBOLYS, V21, P167, DOI 10.1007/s11239-006-5206-4; Wang TY, 2008, CIRCULATION, V118, P2139, DOI 10.1161/CIRCULATIONAHA.108.787143; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Zallen G, 2000, SHOCK, V13, P29, DOI 10.1097/00024382-200013010-00006	37	333	346	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1149	1159		10.1016/S0140-6736(09)61484-7	http://dx.doi.org/10.1016/S0140-6736(09)61484-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505IZ	19717185				2022-12-28	WOS:000270688200031
J	Mirouze, M; Reinders, J; Bucher, E; Nishimura, T; Schneeberger, K; Ossowski, S; Cao, J; Weigel, D; Paszkowski, J; Mathieu, O				Mirouze, Marie; Reinders, Jon; Bucher, Etienne; Nishimura, Taisuke; Schneeberger, Korbinian; Ossowski, Stephan; Cao, Jun; Weigel, Detlef; Paszkowski, Jerzy; Mathieu, Olivier			Selective epigenetic control of retrotransposition in Arabidopsis	NATURE			English	Article							DNA METHYLATION; TRANSPOSABLE ELEMENTS; CPG METHYLATION; GENOME-WIDE; RNA; METHYLTRANSFERASES; MAINTENANCE; STABILITY; EPIGENOME; LYSINE-9	Retrotransposons are mobile genetic elements that populate chromosomes, where the host largely controls their activities(1-3). In plants and mammals, retrotransposons are transcriptionally silenced by DNA methylation(1,4), which in Arabidopsis is propagated at CG dinucleotides by METHYLTRANSFERASE 1 (MET1)(5). In met1 mutants, however, mobilization of retrotransposons is not observed, despite their transcriptional activation(4-6). A post-transcriptional mechanism therefore seems to be preventing retrotransposition. Here we show that a copia-type retrotransposon (Evade, French for 'fugitive') evaded suppression of its movement during inbreeding of hybrid epigenomes consisting of met1-and wild-type-derived chromosomes. Evade (EVD) reinsertions caused a series of developmental mutations that allowed its identification. Genetic testing of host control of the EVD life cycle showed that transcriptional suppression occurred by CG methylation supported by RNA-directed DNA methylation. On transcriptional reactivation, subsequent steps of the EVD cycle were inhibited by plant-specific RNA polymerase IV/V-7,V-8 and the histone methyltransferase KRYPTONITE (KYP). Moreover, genome resequencing demonstrated retrotransposition of EVD but no other potentially active retroelements when this combination of epigenetic mechanisms was compromised. Our results demonstrate that epigenetic control of retrotransposons extends beyond transcriptional suppression and can be individualized for particular elements.	[Mirouze, Marie; Reinders, Jon; Bucher, Etienne; Nishimura, Taisuke; Paszkowski, Jerzy; Mathieu, Olivier] Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland; [Schneeberger, Korbinian; Ossowski, Stephan; Cao, Jun; Weigel, Detlef] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Mathieu, Olivier] Univ Clermont Ferrand 2, CNRS, INSERM, GReD,UMR 6247,U931, F-63177 Clermont Ferrand, France	University of Geneva; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Paszkowski, J (corresponding author), Univ Geneva, Dept Plant Biol, Sci III,30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	jerzy.paszkowski@unige.ch; olivier.mathieu@univ-bpclermont.fr	Weigel, Detlef/GSJ-0799-2022; Mirouze, Marie/AFL-9387-2022; Weigel, Detlef/AAR-3312-2021; Mathieu, Olivier/AAV-6593-2021; Cao, Jun/E-5422-2012; Weigel, Detlef/C-1418-2008; Mirouze, Marie/AAG-8128-2022; Mirouze, Marie/AFL-8165-2022; Schneeberger, Korbinian/U-6329-2019; Ossowski, Stephan/E-2139-2011; Bucher, Etienne/E-7681-2013	Weigel, Detlef/0000-0002-2114-7963; Mathieu, Olivier/0000-0001-5302-1102; Weigel, Detlef/0000-0002-2114-7963; Mirouze, Marie/0000-0002-0514-1270; Mirouze, Marie/0000-0002-0514-1270; Schneeberger, Korbinian/0000-0002-5512-0443; Ossowski, Stephan/0000-0002-7416-9568; Bucher, Etienne/0000-0002-3114-3763	Swiss National Science Foundation [3100A0-102107]; European Commission [LSHG-CT-2004- 503433]; Targeted Gene Integration in Plants (TAGIP) [018785]; Max Planck Society	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Targeted Gene Integration in Plants (TAGIP); Max Planck Society(Max Planck SocietyFoundation CELLEX)	We thank all members of the Paszkowski laboratory for discussion; L. Broger, M. Freyre, J. Nicolet, C. Megies and J. Lafleuriel for technical assistance; M. Dapp and X. Zhang for met1/ + drm1/ + drm2/ + cmt3/ + material; C. Lanz for help in preparing the Illumina libraries and running the instruments and P. King and E. Lacombe for critically reading the manuscript. This work was supported by grants from the Swiss National Science Foundation (3100A0-102107), the European Commission through The Epigenome (LSHG-CT-2004- 503433) and Targeted Gene Integration in Plants (TAGIP; 018785) and the Max Planck Society.	Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Chan SWL, 2006, PLOS GENET, V2, P791, DOI 10.1371/journal.pgen.0020083; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Ding Y, 2007, PLANT CELL, V19, P9, DOI 10.1105/tpc.106.048124; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Kanno T, 2008, NAT GENET, V40, P670, DOI 10.1038/ng.119; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Mathieu O, 2007, CELL, V130, P851, DOI 10.1016/j.cell.2007.07.007; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Reinders J, 2008, GENOME RES, V18, P469, DOI 10.1101/gr.7073008; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Wierzbicki AT, 2008, CELL, V135, P635, DOI 10.1016/j.cell.2008.09.035; Zhang X, 2006, COLD SPRING HARB SYM, V71, P439, DOI 10.1101/sqb.2006.71.047; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	31	235	246	1	53	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					427	U130		10.1038/nature08328	http://dx.doi.org/10.1038/nature08328			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19734882				2022-12-28	WOS:000269828100047
J	Organ, CL; Janes, DE; Meade, A; Pagel, M				Organ, Chris L.; Janes, Daniel E.; Meade, Andrew; Pagel, Mark			Genotypic sex determination enabled adaptive radiations of extinct marine reptiles	NATURE			English	Article							CORRELATED EVOLUTION; DISCRETE CHARACTERS; VIVIPAROUS REPTILE; LIVE BIRTH; LIZARDS; ICHTHYOSAURS; CONSTRAINTS; HISTORY	Adaptive radiations often follow the evolution of key traits, such as the origin of the amniotic egg and the subsequent radiation of terrestrial vertebrates. The mechanism by which a species determines the sex of its offspring has been linked to critical ecological and life-history traits(1-3) but not to major adaptive radiations, in part because sex-determining mechanisms do not fossilize. Here we establish a previously unknown coevolutionary relationship in 94 amniote species between sex-determining mechanism and whether a species bears live young or lays eggs. We use that relationship to predict the sex-determining mechanism in three independent lineages of extinct Mesozoic marine reptiles (mosasaurs, sauropterygians and ichthyosaurs), each of which is known from fossils to have evolved live birth(4-7). Our results indicate that each lineage evolved genotypic sex determination before acquiring live birth. This enabled their pelagic radiations, where the relatively stable temperatures of the open ocean constrain temperature-dependent sex determination in amniote species. Freed from the need to move and nest on land(4,5,8), extreme physical adaptations to a pelagic lifestyle evolved in each group, such as the fluked tails, dorsal fins and wing-shaped limbs of ichthyosaurs. With the inclusion of ichthyosaurs, mosasaurs and sauropterygians, genotypic sex determination is present in all known fully pelagic amniote groups (sea snakes, sirenians and cetaceans), suggesting that this mode of sex determination and the subsequent evolution of live birth are key traits required for marine adaptive radiations in amniote lineages.	[Organ, Chris L.; Janes, Daniel E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Meade, Andrew; Pagel, Mark] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England	Harvard University; University of Reading	Organ, CL (corresponding author), Harvard Univ, Museum Comparat Zool, 26 Oxford St, Cambridge, MA 02138 USA.	corgan@oeb.harvard.edu; m.pagel@reading.ac.uk			Museum of Comparative Zoology; National Institutes of Health [1 F32 GM075490-01, 5 F32 GM072494]; Natural Environment Research Council [NE/C51992X/1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM075490, F32GM072494] Funding Source: NIH RePORTER	Museum of Comparative Zoology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Everhart, R. Shine, M. Laurin, T. Quental, L. Cooper, S. Faul, M. Patten, N. Hobbs and C. Venditti for comments that improved the clarity of this paper. D. E. J. and C. L. O. thank S. V. Edwards for postdoctoral support. We thank the Department of Organismic and Evolutionary Biology and the Museum of Comparative Zoology at Harvard University for providing support that enabled this research, and the Centre for Advanced Computing and Emerging Technologies (ACET) at the University of Reading for making the ThamesBlue supercomputer available for our use. This research was supported in part by a travel grant from the Museum of Comparative Zoology at Harvard University, National Institutes of Health Postdoctoral Fellowships (1 F32 GM075490-01 to C. L. O., and 5 F32 GM072494 to D. E. J.), and Natural Environment Research Council grant NE/C51992X/1 to M. P.	Andrews RM, 2000, BIOSCIENCE, V50, P227, DOI 10.1641/0006-3568(2000)050[0227:NHORDC]2.3.CO;2; BELLOTGURLET L, 1996, INT ASS OBSIDIAN STU, V16, P3; BLACKBURN D G, 1985, Amphibia-Reptilia, V6, P259, DOI 10.1163/156853885X00290; BLACKBURN DG, 1984, P NATL ACAD SCI-BIOL, V81, P4860, DOI 10.1073/pnas.81.15.4860; Caldwell MW, 2001, P ROY SOC B-BIOL SCI, V268, P2397, DOI 10.1098/rspb.2001.1796; Cheng YN, 2004, NATURE, V432, P383, DOI 10.1038/nature03050; Clobert J, 1998, J EVOLUTION BIOL, V11, P329; Dal Sasso Cristiano, 1996, Paleontologia Lombarda, V4, P1; Everhart M. J., 2005, OCEANS KANSAS NATURA; Harrison R. J., 1969, P253; Hodges WL, 2004, J EVOLUTION BIOL, V17, P1230, DOI 10.1111/j.1420-9101.2004.00770.x; JANZEN DJ, 2004, TEMPERATURE DEPENDEN, P121; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Kennett R, 1998, CAN J ZOOL, V76, P1019, DOI 10.1139/cjz-76-6-1019; Lee MSY, 1998, EVOLUTION, V52, P1441, DOI 10.1111/j.1558-5646.1998.tb02025.x; Lee MSY, 1997, PHILOS T R SOC B, V352, P53, DOI 10.1098/rstb.1997.0005; MADDISION WP, 2008, MESQUITE MODULAR SYS; Maxwell EE, 2003, P ROY SOC B-BIOL SCI, V270, pS104, DOI 10.1098/rsbl.2003.0029; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Organ CL, 2008, INTEGR COMP BIOL, V48, P512, DOI 10.1093/icb/icn041; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Quinn AE, 2007, SCIENCE, V316, P411, DOI 10.1126/science.1135925; Robert KA, 2001, NATURE, V412, P698, DOI 10.1038/35089135; Shine R., 1985, Biology of Reptilia, V15, P605; Wapstra E, 2004, P ROY SOC B-BIOL SCI, V271, pS230, DOI 10.1098/rsbl.2003.0152; Warner DA, 2008, NATURE, V451, P566, DOI 10.1038/nature06519	28	49	51	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 17	2009	461	7262					389	392		10.1038/nature08350	http://dx.doi.org/10.1038/nature08350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19759619				2022-12-28	WOS:000269828100038
J	Sada, A; Suzuki, A; Suzuki, H; Saga, Y				Sada, Aiko; Suzuki, Atsushi; Suzuki, Hitomi; Saga, Yumiko			The RNA-Binding Protein NANOS2 Is Required to Maintain Murine Spermatogonial Stem Cells	SCIENCE			English	Article							SELF-RENEWAL; GERM-CELLS; DIFFERENTIATION; SPERMATOGENESIS; CONSERVATION; MAINTENANCE; PLZF	Stem cells give rise to differentiated cell types but also preserve their undifferentiated state through cell self-renewal. With the use of transgenic mice, we found that the RNA-binding protein NANOS2 is essential for maintaining spermatogonial stem cells. Lineage-tracing analyses revealed that undifferentiated spermatogonia expressing Nanos2 self-renew and generate the entire spermatogenic cell lineage. Conditional disruption of postnatal Nanos2 depleted spermatogonial stem cell reserves, whereas mouse testes in which Nanos2 had been overexpressed accumulated spermatogonia with undifferentiated, stem cell-like properties. Thus, NANOS2 is a key stem cell regulator that is expressed in self-renewing spermatogonial stem cells and maintains the stem cell state during murine spermatogenesis.	[Sada, Aiko; Saga, Yumiko] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Suzuki, Atsushi] Yokohama Natl Univ, Interdisciplinary Res Ctr, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan; [Suzuki, Hitomi; Saga, Yumiko] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Saga, Yumiko] Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 4118540, Japan	Graduate University for Advanced Studies - Japan; Yokohama National University; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Saga, Y (corresponding author), SOKENDAI, Dept Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	ysaga@lab.nig.ac.jp	Sada, Aiko/B-1176-2019	Sada, Aiko/0000-0002-0984-4280	Ministry of Education, Culture, Sports, Science and Technology of Japan; Research Fellowships of the Japan Society	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fellowships of the Japan Society	We thank Y. Nishimune for the TRA98 antibody; S. Chuma and N. Nakatsuji for the SCP3 antibody; S. Yoshida for the Ngn3-EGFP and Ngn3-Cre transgenic mice; S. Evans for the MER-Cre-MER construct; and T. Shinohara, R. Behringer, and Y. Hiromi for critical reading of the manuscript. This study was supported in part by the Genome Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists to A. S.	Atchison FW, 2003, BIOL REPROD, V69, P1989, DOI 10.1095/biolreprod.103.020859; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; De Rooij DG, 2000, J ANDROL, V21, P776; Draper BW, 2007, DEV BIOL, V305, P589, DOI 10.1016/j.ydbio.2007.03.007; Falender AE, 2005, GENE DEV, V19, P794, DOI 10.1101/gad.1290105; Jaruzelska J, 2003, DEV GENES EVOL, V213, P120, DOI 10.1007/s00427-003-0303-2; Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212; Mochizuki K, 2000, DEV GENES EVOL, V210, P591, DOI 10.1007/s004270000105; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Naughton CK, 2006, BIOL REPROD, V74, P314, DOI 10.1095/biolreprod.105.047365; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Wang Z, 2004, SCIENCE, V303, P2016, DOI 10.1126/science.1093983; YOSHIDA S, 2007, ANN N Y ACAD SCI, P73902	18	211	232	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1394	1398		10.1126/science.1172645	http://dx.doi.org/10.1126/science.1172645			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745153	Green Submitted			2022-12-28	WOS:000269699100039
J	Schadt, EE				Schadt, Eric E.			Molecular networks as sensors and drivers of common human diseases	NATURE			English	Review							INTEGRATIVE GENOMICS APPROACH; PROTEIN INTERACTION NETWORK; LARGE-SCALE REPLICATION; HUMAN GENE-EXPRESSION; MACULAR DEGENERATION; SUSCEPTIBILITY LOCI; RISK; ASSOCIATION; OBESITY; YEAST	The molecular biology revolution led to an intense focus on the study of interactions between DNA, RNA and protein biosynthesis in order to develop a more comprehensive understanding of the cell. One consequence of this focus was a reduced attention to whole-system physiology, making it difficult to link molecular biology to clinical medicine. Equipped with the tools emerging from the genomics revolution, we are now in a position to link molecular states to physiological ones through the reverse engineering of molecular networks that sense DNA and environmental perturbations and, as a result, drive variations in physiological states associated with disease.	Pacific Biosci, Menlo Pk, CA 94025 USA		Schadt, EE (corresponding author), Pacific Biosci, 1505 Adams Dr, Menlo Pk, CA 94025 USA.	eschadt@pacificbiosciences.com						Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; BOCK G, 2002, SILICO SIMULATION BI, P91; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Foss EJ, 2007, NAT GENET, V39, P1369, DOI 10.1038/ng.2007.22; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Ghazalpour A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r59; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Goldstein DB, 2008, PLOS BIOL, V6, P439, DOI 10.1371/journal.pbio.0060076; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Lum PY, 2009, PHARMACOGENOMICS, V10, P203, DOI 10.2217/14622416.10.2.203; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; McKusick V.A., 1998, MENDELIAN INHERITANC; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morgan TM, 2007, JAMA-J AM MED ASSOC, V297, P1551, DOI 10.1001/jama.297.14.1551; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHADT EE, 2005, SCI STKE, pPE40; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schadt EE, 2009, NAT REV DRUG DISCOV, V8, P286, DOI 10.1038/nrd2826; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Stolovitsky G., 2007, REVERSE ENG BIOL NET; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	54	555	567	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					218	223		10.1038/nature08454	http://dx.doi.org/10.1038/nature08454			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741703				2022-12-28	WOS:000269654600035
J	Zinner, DE; Campbell, EG				Zinner, Darren E.; Campbell, Eric G.			Life-Science Research Within US Academic Medical Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-RESEARCH; TRANSLATIONAL RESEARCH; BIOMEDICAL-RESEARCH; HEALTH CENTERS; CHALLENGES; INDUSTRY; NIH; FACULTY; MATTERS; CARE	Context Besides the generic "basic" vs "applied" labels, little information is known about the types of life-science research conducted within academic medical centers (AMCs). Objective To determine the relative proportion, characteristics, funding, and productivity of AMC faculty by the type of research they conduct. Design Mailed survey conducted in 2007 of 3080 life-science faculty at the 50 universities with medical schools that received the most funding from the National Institutes of Health in 2004. Response rate was 74%. Setting and Participants Research faculty affiliated with a medical school or teaching hospital, representing 77% of respondents (n=1663). Main Outcome Measures Type of research ( basic, translational, clinical trials, health services research/clinical epidemiology, multimode, other), total funding, industry funding, publications, professional activities, patenting behavior, and industry relationships. Results Among AMC research faculty, 33.6% exclusively conducted basic science research as principal investigators compared with translational researchers (9.1%), clinical trial investigators (7.1%), and health services researchers/clinical epidemiologists (9.0%). While principal investigators garnered a mean of $410 755 in total annual research funding, 22.1% of all AMC research faculty were unsponsored, a proportion that ranged from 11.5% for basic science researchers to 46.8% for health services researchers (P < .001). The average AMC faculty member received $33 417 in industry-sponsored funding, with most of this money concentrated among clinical trial ($110 869) and multimode ($59 916) principal investigators. Translational (61.3%), clinical trial (67.3%), and multimode (70.9%) researchers were significantly more likely than basic science researchers (41.9%) to report a relationship with industry and that these relationships contributed to their most important scientific work (P < .05 for all comparisons). Conclusion The research function of AMCs is active and diverse, incorporating a substantial proportion of faculty who are conducting research and publishing without sponsorship. JAMA. 2009;302(9):969-976 www.jama.com	[Zinner, Darren E.] Brandeis Univ, Heller Sch Social Policy & Management, Schneider Inst Hlth Policy, Waltham, MA 02454 USA; [Campbell, Eric G.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Inst Hlth Policy, Boston, MA USA	Brandeis University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Zinner, DE (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Schneider Inst Hlth Policy, 415 S St,MS 035, Waltham, MA 02454 USA.	dzinner@brandeis.edu			National Human Genome Research Institute of the National Institutes of Health [1R01GM074915-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074915] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grant 1R01GM074915-01 from the National Human Genome Research Institute of the National Institutes of Health ( E. G. C.).	[Anonymous], STAND DEF FIN DISP C; BEATY HN, 1986, ANN INTERN MED, V104, P90, DOI 10.7326/0003-4819-104-1-90; Blumenthal D, 1996, NEW ENGL J MED, V335, P1734, DOI 10.1056/NEJM199612053352305; Blumenthal D, 1996, ACAD MED, V71, P1291, DOI 10.1097/00001888-199612000-00010; BLUMENTHAL D, 1986, SCIENCE, V232, P1361, DOI 10.1126/science.3715452; Bonetta L, 2008, CELL, V135, P583, DOI 10.1016/j.cell.2008.10.038; Butler D, 2008, NATURE, V453, P840, DOI 10.1038/453840a; Campbell EG, 2004, HEALTH AFFAIR, V23, P64, DOI 10.1377/hlthaff.23.1.64; Campbell EG, 2001, JAMA-J AM MED ASSOC, V286, P800, DOI 10.1001/jama.286.7.800; Dickler HB, 2006, PLOS MED, V3, P1492, DOI 10.1371/journal.pmed.0030378; Dougherty D, 2008, JAMA-J AM MED ASSOC, V299, P2319, DOI 10.1001/jama.299.19.2319; Druss BG, 2005, BRIT MED J, V330, P360, DOI 10.1136/bmj.330.7487.360-b; DRUSS BG, 2005, BRIT MED J, V330, P363; Ehringhaus SH, 2008, JAMA-J AM MED ASSOC, V299, P665, DOI 10.1001/jama.299.6.665; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Heinig SJ, 2007, NEW ENGL J MED, V357, P1042, DOI 10.1056/NEJMsb071774; Hitt Greg, 2009, WALL ST J       0320, pAl; *I MED, 1998, SCI OPP PUBL NEEDS I; Mandel HG, 2004, J CLIN INVEST, V114, P872, DOI 10.1172/JCI200423245; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Moses H, 2005, JAMA-J AM MED ASSOC, V293, P1495, DOI 10.1001/jama.293.12.1495; Moskowitz J, 2001, ACAD MED, V76, P307, DOI 10.1097/00001888-200104000-00004; *NAT SCI BOARD, 2006, 0801A NSB, V2; *NAT SCI BOARD, 2006, 0801 NSB, V1; *NAT SCI BOARD, 0801A NSB, V2; *NAT SCI BOARD, 0801 NSB, V1; Nathan DG, 2003, NEW ENGL J MED, V349, P1860, DOI 10.1056/NEJMsb035066; Nathan DG, 2002, JAMA-J AM MED ASSOC, V287, P2424, DOI 10.1001/jama.287.18.2424; National Institutes of Health, NAT I HLTH RES PORTF; Sabroe I, 2007, NAT REV IMMUNOL, V7, P77, DOI 10.1038/nri1999; Slutsky JR, 2009, AM J MED QUAL, V24, P67, DOI 10.1177/1062860608328567; Sung NS, 2003, JAMA-J AM MED ASSOC, V289, P1278, DOI 10.1001/jama.289.10.1278; Tunis SR, 2007, HEALTH AFFAIR, V26, pW140, DOI 10.1377/hlthaff.26.2.w140; Weissman JS, 1999, JAMA-J AM MED ASSOC, V281, P1093, DOI 10.1001/jama.281.12.1093; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Zerhouni EA, 2006, SCIENCE, V314, P1088, DOI 10.1126/science.1136931	36	46	46	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					969	976		10.1001/jama.2009.1265	http://dx.doi.org/10.1001/jama.2009.1265			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724044	Bronze, Green Accepted			2022-12-28	WOS:000269444900022
J	Meehl, GA; Arblaster, JM; Matthes, K; Sassi, F; van Loon, H				Meehl, Gerald A.; Arblaster, Julie M.; Matthes, Katja; Sassi, Fabrizio; van Loon, Harry			Amplifying the Pacific Climate System Response to a Small 11-Year Solar Cycle Forcing	SCIENCE			English	Article							VARIABILITY; TEMPERATURE; IRRADIANCE; REGION; PEAKS	One of the mysteries regarding Earth's climate system response to variations in solar output is how the relatively small fluctuations of the 11-year solar cycle can produce the magnitude of the observed climate signals in the tropical Pacific associated with such solar variability. Two mechanisms, the top-down stratospheric response of ozone to fluctuations of shortwave solar forcing and the bottom-up coupled ocean-atmosphere surface response, are included in versions of three global climate models, with either mechanism acting alone or both acting together. We show that the two mechanisms act together to enhance the climatological off-equatorial tropical precipitation maxima in the Pacific, lower the eastern equatorial Pacific sea surface temperatures during peaks in the 11-year solar cycle, and reduce low-latitude clouds to amplify the solar forcing at the surface.	[Meehl, Gerald A.; Arblaster, Julie M.; van Loon, Harry] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Arblaster, Julie M.] Bur Meteorol, Ctr Australian Weather & Climate, Melbourne, Vic, Australia; [Matthes, Katja] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, Potsdam, Germany; [Matthes, Katja] Free Univ Berlin, Inst Meteorol, D-1000 Berlin, Germany; [Sassi, Fabrizio] USN, Res Lab, Washington, DC 20375 USA; [van Loon, Harry] Colorado Res Associates, Boulder, CO 80301 USA	National Center Atmospheric Research (NCAR) - USA; Bureau of Meteorology - Australia; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Free University of Berlin; United States Department of Defense; United States Navy; Naval Research Laboratory	Meehl, GA (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.	meehl@ncar.ucar.edu	Matthes, Katja/F-7361-2014; Arblaster, Julie/C-1342-2010	Matthes, Katja/0000-0003-1801-3072; Arblaster, Julie/0000-0002-4287-2363; Sassi, Fabrizio/0000-0002-9492-7434	Office of Science (BER), U.S. Department of Energy [DE-FC02-97ER62402]; NSF	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	Portions of this study were supported by the Office of Science (BER), U.S. Department of Energy, Cooperative Agreement No. DE-FC02-97ER62402, and the NSF. The National Center for Atmospheric Research is sponsored by the NSF.	Balachandran NK, 1999, J GEOPHYS RES-ATMOS, V104, P27321, DOI 10.1029/1999JD900924; Gleisner H, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017129; Haigh JD, 2005, J CLIMATE, V18, P3672, DOI 10.1175/JCLI3472.1; Haigh JD, 2003, PHILOS T ROY SOC A, V361, P95, DOI 10.1098/rsta.2002.1111; Haigh JD, 1996, SCIENCE, V272, P981, DOI 10.1126/science.272.5264.981; Kodera K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020928; Kodera K, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002224; Kodera K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026659; Lean J, 2005, SOL PHYS, V230, P27, DOI 10.1007/s11207-005-1527-2; Lean J, 2001, SCIENCE, V292, P234, DOI 10.1126/science.1060082; Matthes K, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006283; Meehl GA, 2006, CLIM DYNAM, V26, P549, DOI 10.1007/s00382-005-0098-0; Meehl GA, 2003, J CLIMATE, V16, P426, DOI [10.1175/1520-0442(2003)016<0426:SAGGFA>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;0426:SAGGFA&gt;2.0.CO;2]; Meehl GA, 2008, J CLIMATE, V21, P2883, DOI 10.1175/2007JCLI1776.1; Meehl GA, 2009, J CLIMATE, V22, P3647, DOI 10.1175/2009JCLI2619.1; Rind D, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010114; Rind D, 2002, SCIENCE, V296, P673, DOI 10.1126/science.1069562; Shindell D, 1999, SCIENCE, V284, P305, DOI 10.1126/science.284.5412.305; Shindell DT, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027468; Trenberth KE, 2001, CLIM DYNAM, V17, P259, DOI 10.1007/PL00007927; van Loon H, 2004, J ATMOS SOL-TERR PHY, V66, P1767, DOI 10.1016/j.jastp.2004.06.003; van Loon H., 1994, Meteorologische Zeitschrift, V3, P259; van Loon H, 2008, J ATMOS SOL-TERR PHY, V70, P1046, DOI 10.1016/j.jastp.2008.01.009; van Loon H, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007378; White WB, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002552; White WB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034831; White WB, 1998, J GEOPHYS RES-OCEANS, V103, P21355, DOI 10.1029/98JC01477; White WB, 1997, J GEOPHYS RES-OCEANS, V102, P3255, DOI 10.1029/96JC03549	28	298	316	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1114	1118		10.1126/science.1172872	http://dx.doi.org/10.1126/science.1172872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713524				2022-12-28	WOS:000269382300037
J	[Anonymous]				[Anonymous]			COPD-more than just tobacco smoke	LANCET			English	Editorial Material																			0	10	10	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					663	663						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716941				2022-12-28	WOS:000269422500001
J	Kiendler-Scharr, A; Wildt, J; Dal Maso, M; Hohaus, T; Kleist, E; Mentel, TF; Tillmann, R; Uerlings, R; Schurr, U; Wahner, A				Kiendler-Scharr, Astrid; Wildt, Juergen; Dal Maso, Miikka; Hohaus, Thorsten; Kleist, Einhard; Mentel, Thomas F.; Tillmann, Ralf; Uerlings, Ricarda; Schurr, Uli; Wahner, Andreas			New particle formation in forests inhibited by isoprene emissions	NATURE			English	Article							ORGANIC AEROSOL; NATURAL AEROSOL; SULFURIC-ACID; OXIDATION; IMPACT; RATES; MODEL	It has been suggested that volatile organic compounds (VOCs) are involved in organic aerosol formation, which in turn affects radiative forcing and climate(1). The most abundant VOCs emitted by terrestrial vegetation are isoprene and its derivatives, such as monoterpenes and sesquiterpenes(2). New particle formation in boreal regions is related to monoterpene emissions(3) and causes an estimated negative radiative forcing(4) of about -0.2 to -0.9 W m(-2). The annual variation in aerosol growth rates during particle nucleation events correlates with the seasonality of monoterpene emissions of the local vegetation, with a maximum during summer(5). The frequency of nucleation events peaks, however, in spring and autumn(5). Here we present evidence from simulation experiments conducted in a plant chamber that isoprene can significantly inhibit new particle formation. The process leading to the observed decrease in particle number concentration is linked to the high reactivity of isoprene with the hydroxyl radical (OH). The suppression is stronger with higher concentrations of isoprene, but with little dependence on the specific VOC mixture emitted by trees. A parameterization of the observed suppression factor as a function of isoprene concentration suggests that the number of new particles produced depends on the OH concentration and VOCs involved in the production of new particles undergo three to four steps of oxidation by OH. Our measurements simulate conditions that are typical for forested regions and may explain the observed seasonality in the frequency of aerosol nucleation events, with a lower number of nucleation events during summer compared to autumn and spring(5). Biogenic emissions of isoprene are controlled by temperature and light(2), and if the relative isoprene abundance of biogenic VOC emissions increases in response to climate change or land use change, the new particle formation potential may decrease, thus damping the aerosol negative radiative forcing effect.	[Kiendler-Scharr, Astrid; Dal Maso, Miikka; Hohaus, Thorsten; Mentel, Thomas F.; Tillmann, Ralf; Wahner, Andreas] Forschungszentrum Julich, Inst ICG 2, D-52425 Julich, Germany; [Wildt, Juergen; Kleist, Einhard; Uerlings, Ricarda; Schurr, Uli] Forschungszentrum Julich, Inst ICG 3, D-52425 Julich, Germany; [Dal Maso, Miikka] Univ Helsinki, Dept Phys, Helsinki 00014, Finland	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; University of Helsinki	Kiendler-Scharr, A (corresponding author), Forschungszentrum Julich, Inst ICG 2, Postfach 1913, D-52425 Julich, Germany.	a.kiendler-scharr@fz-juelich.de	Wahner, Andreas/J-4129-2012; Tillmann, Ralf/I-9203-2012; Hohaus, Thorsten/N-5507-2015; Mentel, Thomas F/A-3576-2011; Dal Maso, Miikka/A-7980-2008; Schurr, Ulrich/AAA-3158-2022; Tillmann, Ralf/AAM-5619-2021; Kiendler-Scharr, Astrid/E-8439-2011	Wahner, Andreas/0000-0001-8948-1928; Tillmann, Ralf/0000-0003-0648-6622; Hohaus, Thorsten/0000-0001-5722-6244; Mentel, Thomas F/0000-0003-0810-3541; Dal Maso, Miikka/0000-0003-3040-3612; Tillmann, Ralf/0000-0003-0648-6622; Kiendler-Scharr, Astrid/0000-0003-3166-2253	European Commission [036833-2]	European Commission(European CommissionEuropean Commission Joint Research Centre)	We gratefully acknowledge support by the European Commission (IP-EUCAARI, contract number 036833-2).	Berndt T, 2005, SCIENCE, V307, P698, DOI 10.1126/science.1104054; Bloss C, 2005, ATMOS CHEM PHYS, V5, P641, DOI 10.5194/acp-5-641-2005; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Greenberg JP, 1999, ATMOS ENVIRON, V33, P855, DOI 10.1016/S1352-2310(98)00302-1; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Guenther A, 2006, ATMOS CHEM PHYS, V6, P3181, DOI 10.5194/acp-6-3181-2006; Hakola H, 2003, ATMOS ENVIRON, V37, P1623, DOI 10.1016/S1352-2310(03)00014-1; Heiden AC, 2003, J ATMOS CHEM, V45, P143, DOI 10.1023/A:1024069605420; Kanakidou M, 2005, ATMOS CHEM PHYS, V5, P1053, DOI 10.5194/acp-5-1053-2005; KASHCHIEV D, 1982, J CHEM PHYS, V76, P5098, DOI 10.1063/1.442808; Kellomaki S, 2001, GLOBAL CHANGE BIOL, V7, P531, DOI 10.1046/j.1365-2486.2001.00414.x; Kerminen VM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023130; Kesselmeier J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000267; Kulmala M, 2004, ATMOS CHEM PHYS, V4, P557, DOI 10.5194/acp-4-557-2004; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Laaksonen A, 2008, ATMOS CHEM PHYS, V8, P2657, DOI 10.5194/acp-8-2657-2008; Lathiere J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024164; Lathiere J, 2006, ATMOS CHEM PHYS, V6, P2129, DOI 10.5194/acp-6-2129-2006; Lindfors V, 2000, ATMOS ENVIRON, V34, P4983, DOI 10.1016/S1352-2310(00)00223-5; Lindfors Virpi, 2000, Boreal Environment Research, V5, P95; Mentel TF, 2009, ATMOS CHEM PHYS, V9, P4387, DOI 10.5194/acp-9-4387-2009; Riipinen I, 2007, ATMOS CHEM PHYS, V7, P1899, DOI 10.5194/acp-7-1899-2007; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; Tsigaridis K, 2003, ATMOS CHEM PHYS, V3, P1849, DOI 10.5194/acp-3-1849-2003; Tunved P, 2008, TELLUS B, V60, P473, DOI [10.1111/j.1600-0889.2008.00363.x, 10.3402/tellusb.v60i4.16938]; Tunved P, 2006, SCIENCE, V312, P261, DOI 10.1126/science.1123052; Weber RJ, 1996, CHEM ENG COMMUN, V151, P53, DOI 10.1080/00986449608936541; WENT FW, 1960, NATURE, V187, P641, DOI 10.1038/187641a0; Wiedinmyer C, 2006, EARTH INTERACT, V10, DOI 10.1175/EI174.1	29	190	197	6	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					381	384		10.1038/nature08292	http://dx.doi.org/10.1038/nature08292			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19759617	Green Published			2022-12-28	WOS:000269828100036
J	Geffen, N				Geffen, Nathan			Beyond HAART: scientists and activists need to work together	LANCET			English	Editorial Material							SOUTH-AFRICA		Treatment Act Campaign, ZA-8000 Cape Town, Western Cape, South Africa		Geffen, N (corresponding author), Treatment Act Campaign, ZA-8000 Cape Town, Western Cape, South Africa.	nathangeffen@gmail.com						ABDOOLKARIM Q, 2001, BRED CONS STAT IMP E; *ACT SOC S AFR, 2003, ASSA2003; ADAM MA, S AFR MED J IN PRESS; Cameron Edwin, 2005, WITNESS AIDS; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; England R, 2007, BMJ-BRIT MED J, V334, P344, DOI 10.1136/bmj.39113.402361.94; Heywood M., 2004, PRICE DENIAL; Nattrass N, 2008, AFR AFFAIRS, V107, P157, DOI 10.1093/afraf/adm087; *TAC, 2008, HIV AIDS NAT STRAT P; *TAC, 2003, MOTH TO CHILD TRANSM; UNAIDS, 2005, HIV REL STIGM DISCR; ZONDI J, 2008, TREATMENT ACTION CAM	12	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 12	2009	374	9693					860	861		10.1016/S0140-6736(09)61260-5	http://dx.doi.org/10.1016/S0140-6736(09)61260-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19709727				2022-12-28	WOS:000269943100008
J	Mayosi, BM; Flisher, AJ; Lalloo, UG; Sitas, F; Tollman, SM; Bradshaw, D				Mayosi, Bongani M.; Flisher, Alan J.; Lalloo, Umesh G.; Sitas, Freddy; Tollman, Stephen M.; Bradshaw, Debbie			Health in South Africa 4 The burden of non-communicable diseases in South Africa	LANCET			English	Article							CORONARY HEART-DISEASE; HUMAN-IMMUNODEFICIENCY-VIRUS; RISK-FACTORS; MENTAL-HEALTH; BLACK-POPULATION; ANTIRETROVIRAL THERAPY; INDIGENOUS AFRICANS; BLOOD-PRESSURE; LOW-INCOME; ALMA-ATA	15 years after its first democratic election, South Africa is in the midst of a profound health transition that is characterised by a quadruple burden of communicable, non-communicable, perinatal and maternal, and injury-related disorders. Non-communicable diseases are emerging in both rural and urban areas, most prominently in poor people living in urban settings, and are resulting in increasing pressure on acute and chronic health-care services. Major factors include demographic change leading to a rise in the proportion of people older than 60 years, despite the negative effect of HIV/AIDS on life expectancy. The burden of these diseases will probably increase as the roll-out of antiretroviral therapy takes effect and reduces mortality from HIV/AIDS. The scale of the challenge posed by the combined and growing burden of HIV/AIDS and non-communicable diseases demands an extraordinary response that South Africa is well able to provide. Concerted action is needed to strengthen the district-based primary health-care system, to integrate the care of chronic diseases and management of risk factors, to develop a national surveillance system, and to apply interventions of proven cost-effectiveness in the primary and secondary prevention of such diseases within populations and health services. We urge the launching of a national initiative to establish sites of service excellence in urban and rural settings throughout South Africa to trial, assess, and implement integrated care interventions for chronic infectious and non-communicable diseases.	[Mayosi, Bongani M.] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Mayosi, Bongani M.; Flisher, Alan J.] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Flisher, Alan J.] Red Cross War Mem Childrens Hosp, Div Child & Adolescent Psychiat, Cape Town, South Africa; [Lalloo, Umesh G.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Durban, South Africa; [Lalloo, Umesh G.] Inkosi Albert Luthuli Cent Hosp, Dept Med, Durban, South Africa; [Sitas, Freddy] NSW Canc Council, Div Res, Kings Cross, NSW, Australia; [Tollman, Stephen M.] Univ Witwatersrand, MRC, Wits Rural Publ Hlth & Hlth Transit Res Unit Agin, Sch Publ Hlth, Johannesburg, South Africa; [Tollman, Stephen M.] Umea Univ, Ctr Global Hlth Res, Umea, Sweden; [Bradshaw, Debbie] Med Res Council S Africa, Burden Dis Res Unit, Tygerberg, South Africa	University of Cape Town; University of Cape Town; University of Kwazulu Natal; Cancer Council New South Wales; University of Witwatersrand; Umea University; South African Medical Research Council	Mayosi, BM (corresponding author), Groote Schuur Hosp, Dept Med, J Floor Old Main Bldg, ZA-7925 Cape Town, South Africa.	bongani.mayosi@uct.ac.za		Tollman, Stephen/0000-0003-0744-7588; Mayosi, Bongani/0000-0001-6641-8950; Sitas, Freddy/0000-0001-9679-1481	Medical Research Council and National Research Foundation, South Africa; Wellcome Trust, UK [085477/Z/08/Z, 069683/Z/02/Z]; Department for International Development (UK) [RPC RPC HD 6]; National Institutes of Health, USA; Lily & Ernst Hausmann Research Trust	Medical Research Council and National Research Foundation, South Africa; Wellcome Trust, UK(Wellcome Trust); Department for International Development (UK); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lily & Ernst Hausmann Research Trust	Kathleen Kahn and Berm Sartorius supported analyses of mortality data for the Agincourt subdistrict. The authors are funded in part by the Medical Research Council and National Research Foundation, South Africa; the Wellcome Trust, UK (grant numbers 085477/Z/08/Z and 069683/Z/02/Z); the Department for International Development (UK) (RPC RPC HD 6); the National Institutes of Health, USA: and the Lily & Ernst Hausmann Research Trust.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alberts M, 2005, EUR J CARDIOV PREV R, V12, P347, DOI 10.1097/01.hjr.0000174792.24188.8e; [Anonymous], 2003, NAT POL GUID CHILD A; [Anonymous], 1998, S AFR DEM HLTH SURV; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Bajaj Mandeep, 2004, Curr Diab Rep, V4, P213, DOI 10.1007/s11892-004-0026-4; Beaglehole R, 2003, LANCET, V362, P903, DOI 10.1016/S0140-6736(03)14335-8; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; BECKLAKE MR, 1989, AM REV RESPIR DIS, V140, pS85, DOI 10.1164/ajrccm/140.3_Pt_2.S85; Bourne LT, 2002, PUBLIC HEALTH NUTR, V5, P157, DOI 10.1079/PHN2001288; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Briggs CJ, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003318.PUB2; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; BURROUGHS S, 2008, CRIME VIOLENCE INJUR; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; CEGIELSKI JP, 1990, LANCET, V335, P209, DOI 10.1016/0140-6736(90)90288-G; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Collinson M., 2006, AFRICA MOVE AFRICAN, P194; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Coovadia H, 2008, LANCET, V372, P866, DOI 10.1016/S0140-6736(08)61373-2; Cullinan P, 1998, THORAX, V53, P909, DOI 10.1136/thx.53.11.909; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Denny L, 2008, S AFR J CHILD HEALTH, V2, P142; *DEP HLTH, 2006, NAT GUID NONC DIS ST; *DEP HLTH, 2001, NAT POL GUID YOUTH A; Department of Health, 1997, NAT HLTH POL GUID IM; Department of Health Medical Research Council OrcMacro, 2007, S AFR DEM HLTH SURV; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Donson H., 2008, PROFILE FATAL INJURI; EHRLICH R, 2006, CHRONIC DIS LIFESTYL, P112; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Esterhuizen TM, 2001, S AFR MED J, V91, P502; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Flisher AJ, 1999, J CHILD PSYCHOL PSYC, V40, P315; FLISHER AJ, 2006, S AFR MED J, V95, P630; Fowkes FGR, 2006, EUR J CARDIOV PREV R, V13, P964, DOI 10.1097/01.hjr.0000201511.28590.9f; Gaziano TA, 2007, LANCET, V370, P1939, DOI 10.1016/S0140-6736(07)61697-3; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Groenewald P, 2008, CAUSE DEATH PREMATUR; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; JHA P, 2002, REPORT WORKING GROUP; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Joubert J, 2006, CHRONIC DIS LIFESTYL, P204; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P8, DOI 10.1080/14034950701505031; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P26, DOI 10.1080/14034950701355668; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kitahata MM, 2002, BMJ-BRIT MED J, V325, P954, DOI 10.1136/bmj.325.7370.954; Kleintjes S, 2006, AFR J PSYCHIATRY, V9, P157, DOI DOI 10.4314/AJPSY.V9I3.30217; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; Leeder S, 2004, RACE TIME CHALLENGE; Levitt NS, 2005, DIABETOLOGIA, V48, P1118, DOI 10.1007/s00125-005-1748-9; Lund C, 2007, SAMJ S AFR MED J, V97, P352; LUND C, 2009, J CHILD PSYCHOL PSYC, DOI DOI 10.1111/J.14469-7610.2009.02078.X; Lund C, 2006, SOC PSYCH PSYCH EPID, V41, P587, DOI 10.1007/s00127-006-0057-z; Magula Nombulelo P, 2003, Cardiovasc J S Afr, V14, P231; Mayosi B, 2007, Cardiovasc J S Afr, V18, P4; Mayosi BM, 2008, SAMJ S AFR MED J, V98, P36; Mayosi BM, 2007, HEART, V93, P1176, DOI 10.1136/hrt.2007.127746; McIntyre D, 2008, B WORLD HEALTH ORGAN, V86, P871, DOI 10.2471/BLT.08.053413; *MED RES COUNC, 2007, S AFR DEM HLTH SURV; *MED RES COUNC, 1998, S AFR DEM HLTH SURV; Mensah GA, 2008, HEART, V94, P697, DOI 10.1136/hrt.2007.127753; Mensah GA, 2008, HEART, V94, P836, DOI 10.1136/hrt.2007.136523; MOLLENTZE WF, 1995, S AFR MED J, V85, P90; Mqoqi N, 2004, INCIDENCE HISTOLOGIC; Nair R, 2000, EUR J VASC ENDOVASC, V20, P235, DOI 10.1053/ejvs.2000.1169; Nair R, 2000, EUR J VASC ENDOVASC, V20, P353, DOI 10.1053/ejvs.2000.1195; Nair R, 2001, J VASC SURG, V33, P186, DOI 10.1067/mva.2001.108633; Norman R, 2007, SAMJ S AFR MED J, V97, P637; Ntsekhe M, 2009, NAT CLIN PRACT CARD, V6, P120, DOI 10.1038/ncpcardio1437; Oosthuizen W, 2002, SAMJ S AFR MED J, V92, P723; Opie LH, 2005, CIRCULATION, V112, P3536, DOI 10.1161/CIRCULATIONAHA.105.597765; Parkin DM, 2008, LANCET ONCOL, V9, P683, DOI 10.1016/S1470-2045(08)70175-X; PARKIN DM, 2003, IARC SCI PUBLICATION; Parry CDH, 2004, J ADOLESCENCE, V27, P429, DOI 10.1016/j.adolescence.2003.11.013; PATEL V, PRIORITY PU IN PRESS; Patel V, 2008, J CHILD PSYCHOL PSYC, V49, P313, DOI 10.1111/j.1469-7610.2007.01824.x; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Puoane T., 2008, S AFR HLTH REV, V1, P73; Qiao YL, 2008, LANCET ONCOL, V9, P929, DOI 10.1016/S1470-2045(08)70210-9; Reddy SP., 2003, UMTHENTHE UHLABA USA; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Schneider M, 2009, SCAND J PUBLIC HEALT, V37, P176, DOI 10.1177/1403494808100272; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Seedat S, 2008, SOC PSYCH PSYCH EPID, V43, P889, DOI 10.1007/s00127-008-0399-9; SEEDAT YK, 1993, J HUM HYPERTENS, V7, P529; Sitas F, 2004, TOB CONTROL, V13, P396, DOI 10.1136/tc.2004.007682; Sitas F, 2001, J Natl Cancer Inst Monogr, P1; Sitas F, 2008, LANCET ONCOL, V9, P786, DOI 10.1016/S1470-2045(08)70198-0; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Smith MA, 2008, INT J CANCER, V123, P1854, DOI 10.1002/ijc.23633; *STAT S A, 2008, P03093 STAT S AFR; Stevens D, 2007, LANCET, V370, P1901, DOI 10.1016/S0140-6736(07)61802-9; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; STEYN K, 1991, S AFR MED J, V79, P480; Steyn K, 1996, HUM GENET, V98, P479, DOI 10.1007/s004390050243; STEYN K, 2006, CHRONIC DIS LIFESTYL, P226; Steyn K, 2008, SAMJ S AFR MED J, V98, P618; Thorogood M, 2004, B WORLD HEALTH ORGAN, V82, P503; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Tipping B, 2007, J NEUROL NEUROSUR PS, V78, P1320, DOI 10.1136/jnnp.2007.116103; Tollman S, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1193; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Weinehall L, 2001, SCAND J PUBLIC HEALT, P59; WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9; Williams DR, 2008, PSYCHOL MED, V38, P211, DOI 10.1017/S0033291707001420; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5	115	648	668	2	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					934	947		10.1016/S0140-6736(09)61087-4	http://dx.doi.org/10.1016/S0140-6736(09)61087-4			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19709736				2022-12-28	WOS:000269943100032
J	Linda, H; von Heijne, A; Major, EO; Ryschkewitsch, C; Berg, J; Olsson, T; Martin, C				Linda, Hans; von Heijne, Anders; Major, Eugene O.; Ryschkewitsch, Caroline; Berg, Johan; Olsson, Tomas; Martin, Claes			Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							JC VIRUS-DNA; RELAPSING MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; CONTROLLED TRIAL; CROHNS-DISEASE; THERAPY; PCR	We describe progressive multifocal leukoencephalopathy (PML) caused by infection with human polyomavirus JC virus in a patient with multiple sclerosis who was treated with natalizumab. The first PML symptoms appeared after 14 monthly infusions of the drug. Magnetic resonance imaging (MRI) showed a presumed multiple sclerosis lesion, and JC virus DNA was not detected on polymerase-chain-reaction (PCR) assay of cerebrospinal fluid. The patient's symptoms worsened, and the diagnosis of PML was established with a more sensitive quantitative PCR assay after 16 infusions of natalizumab. Plasma exchange was used to accelerate clearance of natalizumab. Approximately 3 weeks after plasma exchange, an immune-reconstitution inflammatory syndrome appeared. JC virus DNA was no longer detectable on quantitative PCR assay, and the patient's symptoms improved.	[Linda, Hans; Berg, Johan; Martin, Claes] Danderyd Hosp, Karolinska Inst, Neurol Unit, Div Internal Med, SE-18288 Stockholm, Sweden; [von Heijne, Anders] Danderyd Hosp, Karolinska Inst, Dept Radiol, SE-18288 Stockholm, Sweden; [Olsson, Tomas] Danderyd Hosp, Karolinska Inst, Neuroimmunol Unit, Dept Clin Neurosci, SE-18288 Stockholm, Sweden; [Major, Eugene O.; Ryschkewitsch, Caroline] NINDS, Lab Mol Med & Neurosci, NIH, Bethesda, MD 20892 USA	Danderyds Hospital; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Linda, H (corresponding author), Danderyd Hosp, Dept Internal Med, Div Neurol, SE-18288 Stockholm, Sweden.	hans.linda@ki.se		Olsson, Tomas/0000-0002-2938-1877	Swedish Research Council; European Union's Sixth Framework Program [LSHM-CT-2005-018637]; Bibbi and Niels Jensens Foundation; Sderberg Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS001983, ZIANS001983, ZIANS003049] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union's Sixth Framework Program(European Commission); Bibbi and Niels Jensens Foundation; Sderberg Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants from the Swedish Research Council, the European Union's Sixth Framework Program (Neuropromise project, LSHM-CT-2005-018637), the Bibbi and Niels Jensens Foundation, and the Sderberg Foundation.	Aksamit AJ, 2008, CURR TREAT OPTION NE, V10, P178, DOI 10.1007/s11940-008-0019-8; Falco V, 2008, JAIDS-J ACQ IMM DEF, V49, P26, DOI 10.1097/QAI.0b013e31817bec64; Hamilton RS, 2000, J CLIN MICROBIOL, V38, P105; Hemmer B, 2006, CURR OPIN NEUROL, V19, P271, DOI 10.1097/01.wco.0000227037.70329.b0; Iacobaeus E, 2009, MULT SCLER J, V15, P28, DOI 10.1177/1352458508096870; Khatri BO, 2009, NEUROLOGY, V72, P402, DOI 10.1212/01.wnl.0000341766.59028.9d; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Koralnik IJ, 2004, CURR OPIN NEUROL, V17, P365, DOI 10.1097/00019052-200406000-00019; Landry ML, 2008, J CLIN VIROL, V43, P247, DOI 10.1016/j.jcv.2008.07.003; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Martin SI, 2006, CLIN INFECT DIS, V43, P16, DOI 10.1086/504811; Marzocchetti A, 2005, J CLIN MICROBIOL, V43, P4175, DOI 10.1128/JCM.43.8.4175-4177.2005; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Pelosini M, 2008, ANN HEMATOL, V87, P405, DOI 10.1007/s00277-007-0411-6; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Venkataramana A, 2006, NEUROLOGY, V67, P383, DOI 10.1212/01.wnl.0000227922.22293.93; YANG XD, 1994, P NATL ACAD SCI USA, V91, P12604, DOI 10.1073/pnas.91.26.12604; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693	22	176	179	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1081	1087		10.1056/NEJMoa0810316	http://dx.doi.org/10.1056/NEJMoa0810316			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19741229	Bronze			2022-12-28	WOS:000269659400011
J	Weintraub, NL				Weintraub, Neal L.			Understanding Abdominal Aortic Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OXIDATIVE STRESS		[Weintraub, Neal L.] Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45221 USA; [Weintraub, Neal L.] Univ Cincinnati, Coll Med, VA Med Ctr, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Weintraub, NL (corresponding author), Univ Cincinnati, Coll Med, Dept Internal Med, Cincinnati, OH 45221 USA.			Weintraub, Neal/0000-0002-5138-3705	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076684] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL076684] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Dobrin PB, 1996, ANN NY ACAD SCI, V800, P74, DOI 10.1111/j.1749-6632.1996.tb33300.x; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958	5	113	116	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1114	1116		10.1056/NEJMcibr0905244	http://dx.doi.org/10.1056/NEJMcibr0905244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19741234	Green Accepted			2022-12-28	WOS:000269659400019
J	Sackley, CM; van den Berg, ME; Lett, K; Patel, S; Hollands, K; Wright, CC; Hoppitt, TJ				Sackley, Catherine M.; van den Berg, Maayken E.; Lett, Karen; Patel, Smitaa; Hollands, Kristen; Wright, Christine C.; Hoppitt, Thomas J.			Effects of a physiotherapy and occupational therapy intervention on mobility and activity in care home residents: a cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL THERAPY; HEALTH-CARE; STROKE; REHABILITATION; EXERCISE; PERFORMANCE; CONTINENCE; DEPRESSION; RISK	Objective To compare the clinical effectiveness of a programme of physiotherapy and occupational therapy with standard care in care home residents who have mobility limitations and are dependent in performing activities of daily living. Design Cluster randomised controlled trial, with random allocation at the level of care home. Setting Care homes within the NHS South Birmingham primary care trust and the NHS Birmingham East and North primary care trust that had more than five beds and provided for people in the care categories "physical disability" and "older people." Participants Care home residents with mobility limitations, limitations in activities of daily living (as screened by the Barthel index), and not receiving end of life care were eligible to take part in the study. Intervention A targeted three month occupational therapy and physiotherapy programme. Main outcome measures Scores on the Barthel index and the Rivermead mobility index. Results 24 of 77 nursing and residential homes that catered for residents with mobility limitations and dependency for activities of daily living were selected for study: 12 were randomly allocated to the intervention arm (128 residents, mean age 86 years) and 12 to the control arm (121 residents, mean age 84 years). Participants were evaluated by independent assessors blind to study arm allocation before randomisation (0 months), three months after randomisation (at the end of the treatment period for patients who received the intervention), and again at six months after randomisation. After adjusting for home effect and baseline characteristics, no significant differences were found in mean Barthel index scores at six months post-randomisation between treatment arms (mean effect 0.08, 95% confidence interval -1.14 to 1.30; P=0.90), across assessments (-0.01, -0.63 to 0.60; P=0.96), or in the interaction between assessment and intervention (0.42, -0.48 to 1.32; P=0.36). Similarly, no significant differences were found in the mean Rivermead mobility index scores between treatment arms (0.62, -0.51 to 1.76; P=0.28), across assessments (-0.15, -0.65 to 0.35; P=0.55), or interaction (0.71, -0.02 to 1.44; P=0.06). Conclusions The three month occupational therapy and physiotherapy programme had no significant effect on mobility and independence. On the other hand, the variation in residents' functional ability, the prevalence of cognitive impairment, and the prevalence of depression were considerably higher in this sample than expected on the basis of previous work. Further research to clarify the efficacy of occupational therapy and physiotherapy is required if access to therapy services is to be recommended in this population.	[Sackley, Catherine M.; van den Berg, Maayken E.; Lett, Karen; Patel, Smitaa; Hollands, Kristen; Wright, Christine C.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham		t.j.hoppitt@bham.ac.uk	van den Berg, Maayken/D-1670-2011	van den Berg, Maayken/0000-0002-5878-7649; sackley, catherine/0000-0002-8580-6622	Health Foundation; NHS National Institute for Health Research	Health Foundation; NHS National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Health Foundation and the NHS National Institute for Health Research. The University of Birmingham acted as sponsors. The funders and sponsor had no involvement in the study design, data collection, analysis and interpretation, the writing of the report, or the decision to submit the paper for publication.	Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; Barodawala S, 2001, CLIN REHABIL, V15, P607, DOI 10.1191/0269215501cr454oa; Berg K, 1997, AGE AGEING, V26, P37, DOI 10.1093/ageing/26.suppl_2.37; BRILL PA, 1995, GERONTOLOGIST, V35, P263; Buchanan RJ, 2006, NEUROREHABILITATION, V21, P223; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; CHIODO LK, 1992, PHYS THER, V72, P168, DOI 10.1093/ptj/72.3.168; Collen F M, 1991, Int Disabil Stud, V13, P50; Collin C, 1988, Int Disabil Stud, V10, P61; De Boer ME, 2007, DISABIL REHABIL, V29, P665, DOI 10.1080/09638280600926561; Edwards Helen, 2003, Aust Health Rev, V26, P107; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Green J, 2001, DISABIL REHABIL, V23, P670, DOI 10.1080/09638280110045382; Helbostad Jorunn L, 2005, Tidsskr Nor Laegeforen, V125, P1195; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Kerse N, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1445; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Laird N M, 1992, Stat Methods Med Res, V1, P225, DOI 10.1177/096228029200100302; Leemrijse Chantal J, 2007, BMC Geriatr, V7, P7, DOI 10.1186/1471-2318-7-7; Legg L, 2007, BMJ-BRIT MED J, V335, P922, DOI 10.1136/bmj.39343.466863.55; Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3; Mozley CG, 2007, AGING MENT HEALTH, V11, P99, DOI 10.1080/13607860600637810; MULROW CD, 1994, JAMA-J AM MED ASSOC, V271, P519, DOI 10.1001/jama.271.7.519; Murray PK, 2005, ARCH PHYS MED REHAB, V86, P876, DOI 10.1016/j.apmr.2004.10.045; ONEIL MB, 1992, PHYS THER, V72, P596, DOI 10.1093/ptj/72.8.596; Ouslander Joseph G, 2005, J Am Med Dir Assoc, V6, P121, DOI 10.1016/j.jamda.2005.01.004; Paterson M., 2005, BRIT J OCCUP THER, V68, P409, DOI [10.1177/030802260506800905, DOI 10.1177/030802260506800905]; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Power, 2001, NURSING STANDARD, V16, P33, DOI [10.7748/ns.16.15.33.s53, DOI 10.7748/NS.16.15.33.S53]; Przybylski BR, 1996, ARCH PHYS MED REHAB, V77, P554, DOI 10.1016/S0003-9993(96)90294-4; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Rockwood K, 2007, AGE AGEING, V36, P225, DOI 10.1093/ageing/afl160; Rydwik E, 2004, AGE AGEING, V33, P13, DOI 10.1093/ageing/afh001; Sackley C, 2006, STROKE, V37, P2336, DOI 10.1161/01.STR.0000237124.20596.92; Sackley CM, 2008, CLIN REHABIL, V22, P714, DOI 10.1177/0269215508089058; Sackley CM, 2004, BRIT J OCCUPATIONAL, V67, P104, DOI DOI 10.1177/030802260406700302; Schnelle JF, 2003, J AM GERIATR SOC, V51, P161, DOI 10.1046/j.1532-5415.2003.51053.x; Schnelle JF, 2002, J AM GERIATR SOC, V50, P1476, DOI 10.1046/j.1532-5415.2002.50401.x; Schnelle JF, 1998, J AM GERIATR SOC, V46, P771, DOI 10.1111/j.1532-5415.1998.tb03815.x; Shaw C, 2000, J CLIN NURS, V9, P574, DOI 10.1046/j.1365-2702.2000.00414.x; Sutcliffe LM, 1998, CLIN REHABIL, V12, P506, DOI 10.1191/026921598672167702; van den Berg Maayken, 2006, Nurs Times, V102, P32; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	43	35	35	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2009	339								b3123	10.1136/bmj.b3123	http://dx.doi.org/10.1136/bmj.b3123			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	491CG	19723707	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000269553900004
J	Reichlin, T; Hochholzer, W; Bassetti, S; Steuer, S; Stelzig, C; Hartwiger, S; Biedert, S; Schaub, N; Buerge, C; Potocki, M; Noveanu, M; Breidthardt, T; Twerenbold, R; Winkler, K; Bingisser, R; Mueller, C				Reichlin, Tobias; Hochholzer, Willibald; Bassetti, Stefano; Steuer, Stephan; Stelzig, Claudia; Hartwiger, Sabine; Biedert, Stefan; Schaub, Nora; Buerge, Christine; Potocki, Mihael; Noveanu, Markus; Breidthardt, Tobias; Twerenbold, Raphael; Winkler, Katrin; Bingisser, Roland; Mueller, Christian			Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ST-SEGMENT ELEVATION; ACUTE CORONARY SYNDROMES; UNSTABLE ANGINA; NATRIURETIC PEPTIDE; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; CHEST-PAIN; TASK-FORCE; ASSOCIATION; DEFINITION	Background: The rapid and reliable diagnosis of acute myocardial infarction is a major unmet clinical need. Methods: We conducted a multicenter study to examine the diagnostic accuracy of new, sensitive cardiac troponin assays performed on blood samples obtained in the emergency department from 718 consecutive patients who presented with symptoms suggestive of acute myocardial infarction. Cardiac troponin levels were determined in a blinded fashion with the use of four sensitive assays (Abbott-Architect Troponin I, Roche High-Sensitive Troponin T, Roche Troponin I, and Siemens Troponin I Ultra) and a standard assay (Roche Troponin T). The final diagnosis was adjudicated by two independent cardiologists. Results: Acute myocardial infarction was the adjudicated final diagnosis in 123 patients (17%). The diagnostic accuracy of measurements obtained at presentation, as quantified by the area under the receiver-operating-characteristic curve (AUC), was significantly higher with the four sensitive cardiac troponin assays than with the standard assay (AUC for Abbott-Architect Troponin I, 0.96; 95% confidence interval [CI], 0.94 to 0.98; for Roche High-Sensitive Troponin T, 0.96; 95% CI, 0.94 to 0.98; for Roche Troponin I, 0.95; 95% CI, 0.92 to 0.97; and for Siemens Troponin I Ultra, 0.96; 95% CI, 0.94 to 0.98; vs. AUC for the standard assay, 0.90; 95% CI, 0.86 to 0.94). Among patients who presented within 3 hours after the onset of chest pain, the AUCs were 0.93 (95% CI, 0.88 to 0.99), 0.92 (95% CI, 0.87 to 0.97), 0.92 (95% CI, 0.86 to 0.99), and 0.94 (95% CI, 0.90 to 0.98) for the sensitive assays, respectively, and 0.76 (95% CI, 0.64 to 0.88) for the standard assay. We did not assess the effect of the sensitive troponin assays on clinical management. Conclusions: The diagnostic performance of sensitive cardiac troponin assays is excellent, and these assays can substantially improve the early diagnosis of acute myocardial infarction, particularly in patients with a recent onset of chest pain. (ClinicalTrials.gov number, NCT00470587.) N Engl J Med 2009;361:858-67.	[Reichlin, Tobias; Hochholzer, Willibald; Stelzig, Claudia; Hartwiger, Sabine; Biedert, Stefan; Schaub, Nora; Buerge, Christine; Potocki, Mihael; Noveanu, Markus; Breidthardt, Tobias; Twerenbold, Raphael; Bingisser, Roland; Mueller, Christian] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Bassetti, Stefano] Kantonsspital Olten, Olten, Switzerland; [Steuer, Stephan] Limmattalspital, Zurich, Switzerland; [Potocki, Mihael] Herz Zentrum Bad Krozingen, Bad Krozingen, Germany; [Winkler, Katrin] Hosp del Mar, Inst Municipal Invest Med, SC Serv Pneumol 111, Ctr Invest Red Enfermedades Resp, Barcelona, Spain	University of Basel; Kantonsspital Olten; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Mueller, C (corresponding author), Univ Basel Hosp, Dept Internal Med, Petersgraben 4, CH-4031 Basel, Switzerland.	chmueller@uhbs.ch	Müller, Christian/AAB-4783-2022	Müller, Christian/0000-0002-1120-6405; Breidthardt, Tobias/0000-0003-2671-6456; Twerenbold, Raphael/0000-0003-3814-6542; Bingisser, Roland/0000-0001-8223-9792	Swiss National Science Foundation [PP00B-102853]; Swiss Heart Foundation; Abbott; Roche; Siemens; Department of Internal Medicine, University Hospital Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; Abbott(Abbott Laboratories); Roche(Roche Holding); Siemens(Siemens AG); Department of Internal Medicine, University Hospital Basel	Supported by grants from the Swiss National Science Foundation (PP00B-102853), the Swiss Heart Foundation, Abbott, Roche, Siemens, and the .Department of Internal Medicine, University Hospital Basel	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Apple FS, 2008, CLIN CHEM, V54, P723, DOI 10.1373/clinchem.2007.097162; Apple Fred S, 2007, Circulation, V115, pe352; Apple FS, 2009, CLIN CHEM, V55, P93, DOI 10.1373/clinchem.2008.102905; Apple FS, 2002, AM HEART J, V144, P981, DOI 10.1067/mhj.2002.124048; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eggers KM, 2004, AM HEART J, V148, P574, DOI 10.1016/j.ahj.2004.04.030; Forberg JL, 2006, BMC EMERG MED, V6, DOI 10.1186/1471-227X-6-6; Hamm CW, 1999, NEW ENGL J MED, V341, P548; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Hochholzer W, 2008, AM J MED, V121, P399, DOI 10.1016/j.amjmed.2008.01.033; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1763, DOI 10.1016/j.jacc.2006.08.006; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Lindahl B, 2009, CLIN CHEM, V55, P9, DOI 10.1373/clinchem.2008.117572; MacRae AR, 2006, CLIN CHEM, V52, P812, DOI 10.1373/clinchem.2005.059550; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; McCann CJ, 2008, EUR HEART J, V29, P2843, DOI 10.1093/eurheartj/ehn363; Melanson SEF, 2007, AM J CLIN PATHOL, V128, P282, DOI 10.1309/Q9W5HJTT24GQCXXX; Mingels A, 2009, CLIN CHEM, V55, P101, DOI 10.1373/clinchem.2008.106427; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P2405, DOI 10.1001/jama.286.19.2405; Morrow DA, 2000, J AM COLL CARDIOL, V36, P1812, DOI 10.1016/S0735-1097(00)00942-6; Mueller C, 2004, AM J MED, V117, P897, DOI 10.1016/j.amjmed.2004.06.043; Mueller C, 2004, NEW ENGL J MED, V350, P647, DOI 10.1056/NEJMoa031681; NAWAR EW, 2007, ADV DATA VITAL HLTH, V386; Peacock WF, 2008, J AM COLL CARDIOL, V51, P2181, DOI 10.1016/j.jacc.2008.02.060; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580	29	1277	1339	0	108	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					858	867		10.1056/NEJMoa0900428	http://dx.doi.org/10.1056/NEJMoa0900428			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XV	19710484				2022-12-28	WOS:000269312700006
J	Mitchell, ARJ				Mitchell, Andrew R. J.			Is rate more important than rhythm in treating atrial fibrillation? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LEFT-VENTRICULAR FUNCTION; CONGESTIVE-HEART-FAILURE; QUALITY-OF-LIFE; SINUS RHYTHM; ELECTRICAL CARDIOVERSION; RANDOMIZED-TRIALS; CATHETER ABLATION; MANAGEMENT AFFIRM; MORTALITY; RACE		Gen Hosp, Jersey Heart & Lung Unit, St Helier JE1 3QS, Jersey, England	St Helier Hospital	Mitchell, ARJ (corresponding author), Gen Hosp, Jersey Heart & Lung Unit, St Helier JE1 3QS, Jersey, England.	mail@jerseycardiologist.com	Mitchell, Andrew/AFQ-7844-2022	Mitchell, Andrew/0000-0002-5386-9645				Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Bertaglia E, 2002, EUR HEART J, V23, P1522, DOI 10.1053/euhj.2002.3167; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Chung MK, 2005, J AM COLL CARDIOL, V46, P1891, DOI 10.1016/j.jacc.2005.07.040; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Deedwania PC, 1998, CIRCULATION, V98, P2574, DOI 10.1161/01.CIR.98.23.2574; Friberg L, 2009, HEART, V95, P1000, DOI 10.1136/hrt.2008.149237; Fuster V, 2006, EUR HEART J, V27, P1979, DOI 10.1093/eurheartj/ehl176; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hagens VE, 2005, AM HEART J, V149, P1106, DOI 10.1016/j.ahj.2004.11.030; Hagens VE, 2005, HEART RHYTHM, V2, P19, DOI 10.1016/j.hrthm.2004.09.028; Hallberg P, 2007, EUR J CLIN PHARMACOL, V63, P959, DOI 10.1007/s00228-007-0346-9; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Hsu LF, 2004, NEW ENGL J MED, V351, P2373, DOI 10.1056/NEJMoa041018; Mason PK, 2005, AM J CARDIOL, V95, P1248, DOI 10.1016/j.amjcard.2005.01.059; Morrison TB, 2009, NAT CLIN PRACT CARD, V6, P46, DOI 10.1038/ncpcardio1414; Nair GM, 2009, J CARDIOVASC ELECTR, V20, P138, DOI 10.1111/j.1540-8167.2008.01285.x; Opolski G, 2004, CHEST, V126, P476, DOI 10.1378/chest.126.2.476; Pappone C, 2003, J AM COLL CARDIOL, V42, P185, DOI 10.1016/S0735-1097(03)00577-1; Pedersen OD, 2001, CIRCULATION, V104, P292, DOI 10.1161/01.CIR.104.3.292; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Singh BN, 2005, NEW ENGL J MED, V352, P1861, DOI 10.1056/NEJMoa041705; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Weerasooriya R, 2005, HEART RHYTHM, V2, P619, DOI 10.1016/j.hrthm.2005.02.1037; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	25	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2009	339								b3174	10.1136/bmj.b3174	http://dx.doi.org/10.1136/bmj.b3174			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486SE	19700509				2022-12-28	WOS:000269217200008
J	Rutkove, SB				Rutkove, Seward B.			A 52-Year-Old Woman With Disabling Peripheral Neuropathy Review of Diabetic Polyneuropathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALPHA-LIPOIC ACID; CONTROLLED-RELEASE OXYCODONE; RANDOMIZED CONTROLLED-TRIAL; RESTLESS LEGS SYNDROME; DOUBLE-BLIND; DEGENERATIVE COMPLICATIONS; SENSORY NEUROPATHY; LIDOCAINE PATCH; PAIN; PLACEBO	Ms Q is a 52-year-old woman who has had progressive polyneuropathy in the setting of diabetes for the past 8 years. Ms Q's major disability is that of increasingly severe neuropathic pain and cramps that have been poorly responsive to a variety of therapies, including gabapentin and topiramate. The diagnosis of and differential diagnosis for diabetic polyneuropathy are reviewed herein. In general, treatment options for diabetic polyneuropathy remain primarily symptomatic. Improving the metabolic profile through weight loss, exercise, and if necessary, medications may help slow neuropathy progression. Many medications are effective in reducing pain, and newly developed ones, such as pregabalin and duloxetine, while specifically marketed for diabetic neuropathy, are likely to be no better and are considerably more expensive than older ones. alpha-Lipoic acid appears to be effective as well. JAMA. 2009; 302(13): 1451-1458	[Rutkove, Seward B.] Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neuromuscular Dis, Boston, MA 02215 USA; [Rutkove, Seward B.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Rutkove, SB (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, Div Neuromuscular Dis, 330 Brookline Ave,TCC 810, Boston, MA 02215 USA.	srutkove@bidmc.harvard.edu		Rutkove, Seward/0000-0002-6375-3312				Abuaisha BB, 1998, DIABETES RES CLIN PR, V39, P115, DOI 10.1016/S0168-8227(97)00123-X; Argoff CE, 2006, MAYO CLIN PROC, V81, pS12, DOI 10.1016/S0025-6196(11)61475-4; Backonja M, 1998, JAMA-J AM MED ASSOC, V280, P1831, DOI 10.1001/jama.280.21.1831; Barbano RL, 2004, ARCH NEUROL-CHICAGO, V61, P914, DOI 10.1001/archneur.61.6.914; Benatar M, 2004, J NEUROL SCI, V221, P47, DOI 10.1016/j.jns.2004.03.025; Berger A, 2004, J PAIN, V5, P143, DOI 10.1016/j.jpain.2003.12.004; Botez SA, 2009, MUSCLE NERVE, V39, P221, DOI 10.1002/mus.21143; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; BOULTON AJM, 1982, DIABETES CARE, V5, P386, DOI 10.2337/diacare.5.4.386; Bryans JS, 1999, MED RES REV, V19, P149, DOI 10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B; Calcutt NA, 2002, INT REV NEUROBIOL, V50, P205; Carlsson KC, 2004, ACTA ANAESTH SCAND, V48, P328, DOI 10.1111/j.0001-5172.2004.0325.x; Chaudhry V, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006152.pub2; COHEN KL, 1987, ARCH INTERN MED, V147, P1442, DOI 10.1001/archinte.147.8.1442; Collins SL, 2000, J PAIN SYMPTOM MANAG, V20, P449, DOI 10.1016/S0885-3924(00)00218-9; COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452; DAILEY GE, 1992, DIABETES CARE, V15, P159; Das Evcimen N, 2007, PHARMACOL RES, V55, P498, DOI 10.1016/j.phrs.2007.04.016; Diem P, 2003, EUR J CLIN INVEST, V33, P693, DOI 10.1046/j.1365-2362.2003.01195.x; Diener HC, 2002, INT J CLIN PRACT, V56, P243; DYCK PJ, 1993, NEUROLOGY, V43, P817, DOI 10.1212/WNL.43.4.817; Dyck PJB, 2002, MUSCLE NERVE, V25, P477, DOI 10.1002/mus.10080; Eisenberg E, 2001, NEUROLOGY, V57, P505, DOI 10.1212/WNL.57.3.505; England JD, 2009, NEUROLOGY, V72, P177, DOI 10.1212/01.wnl.0000336345.70511.0f; Fehrenbacher JC, 2003, PAIN, V105, P133, DOI 10.1016/S0304-3959(03)00173-8; Ferini-Strambi L, 2009, EXPERT OPIN PHARMACO, V10, P545, DOI [10.1517/14656560902793605 , 10.1517/14656560902793605]; Figueroa-Romero C, 2008, REV ENDOCR METAB DIS, V9, P301, DOI 10.1007/s11154-008-9104-2; Finnerup Nanna B, 2007, MedGenMed, V9, P36; Freeman R, 2008, DIABETES CARE, V31, P1448, DOI 10.2337/dc07-2105; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gemignani F, 2007, J PERIPHER NERV SYST, V12, P50, DOI 10.1111/j.1529-8027.2007.00116.x; Genuth S, 2003, DIABETES CARE, V26, P3160; Genuth Saul, 2006, Endocr Pract, V12 Suppl 1, P34; Gimbel JS, 2003, NEUROLOGY, V60, P927, DOI 10.1212/01.WNL.0000057720.36503.2C; Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x; GOLDMAN AL, 1972, CHEST, V62, P71, DOI 10.1378/chest.62.1.71; Goldstein DJ, 2005, PAIN, V116, P109, DOI 10.1016/j.pain.2005.03.029; Gorson KC, 2006, J NEUROL NEUROSUR PS, V77, P354, DOI 10.1136/innp.2005.075119; Harati Y, 1998, NEUROLOGY, V50, P1842, DOI 10.1212/WNL.50.6.1842; Hardy T, 2007, DIABETES CARE, V30, P21, DOI 10.2337/dc06-0947; Hersh EV, 2007, CLIN THER, V29, P2477, DOI 10.1016/j.clinthera.2007.12.003; Kajdasz DK, 2007, CLIN THER, V29, P2536, DOI 10.1016/j.clinthera.2007.12.002; Kumar D, 1997, DIABETES CARE, V20, P1702, DOI 10.2337/diacare.20.11.1702; Kwon OY, 2003, GAIT POSTURE, V18, P105, DOI 10.1016/S0966-6362(02)00166-2; Laughlin RS, 2009, NEUROLOGY, V73, P39, DOI 10.1212/WNL.0b013e3181aaea47; Lavery LA, 2008, DIABETES CARE, V31, P316, DOI 10.2337/dc07-1794; Law M, 2006, AM J CARDIOL, V97, p52C, DOI 10.1016/j.amjcard.2005.12.010; Liao K K, 1992, Zhonghua Yi Xue Za Zhi (Taipei), V50, P203; Mason L, 2004, BMJ-BRIT MED J, V328, P991, DOI 10.1136/bmj.38042.506748.EE; MAX MB, 1992, NEW ENGL J MED, V326, P1250, DOI 10.1056/NEJM199205073261904; MCQUAY H, 1995, BRIT MED J, V311, P1047, DOI 10.1136/bmj.311.7012.1047; Meier T, 2003, PAIN, V106, P151, DOI 10.1016/S0304-3959(03)00317-8; Miller TM, 2005, MUSCLE NERVE, V32, P431, DOI 10.1002/mus.20341; Morello CM, 1999, ARCH INTERN MED, V159, P1931, DOI 10.1001/archinte.159.16.1931; Neufeld SK, 2008, J AM ACAD ORTHOP SUR, V16, P338, DOI 10.5435/00124635-200806000-00006; Oates PJ, 2008, CURR DRUG TARGETS, V9, P14, DOI 10.2174/138945008783431781; Oh SJ, 1999, NEUROL CLIN, V17, P593, DOI 10.1016/S0733-8619(05)70154-7; Perkins BA, 2003, CLIN NEUROPHYSIOL, V114, P1167, DOI 10.1016/S1388-2457(03)00025-7; PIRART J, 1977, DIABETES METAB, V3, P97; PIRART J, 1977, DIABETES METAB, V3, P173; PIRART J, 1977, DIABETES METAB, V3, P245; Pirzada NA, 1997, POSTGRAD MED, V102, P249, DOI 10.3810/pgm.1997.10.344; Polydefkis M, 2001, Diabetes Technol Ther, V3, P23, DOI 10.1089/152091501750219994; Pop-Busui R, 2006, DIABETES-METAB RES, V22, P257, DOI 10.1002/dmrr.625; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; RAMCHANDREN S, CURR OPIN NEUROL, DOI DOI 10.1097/WCO.0B013E3282EF79E3; Raskin P, 2004, NEUROLOGY, V63, P865, DOI 10.1212/01.WNL.0000137341.89781.14; Richardson JK, 2002, ARCH PHYS MED REHAB, V83, P1553, DOI 10.1053/apmr.2002.35656; Rosenbaum R, 2001, MUSCLE NERVE, V24, P154, DOI 10.1002/1097-4598(200102)24:2<154::AID-MUS20>3.0.CO;2-3; Rowbotham MC, 2004, PAIN, V110, P697, DOI 10.1016/j.pain.2004.05.010; Ruhnau KJ, 1999, DIABETIC MED, V16, P1040, DOI 10.1046/j.1464-5491.1999.00190.x; Ruth A, 2005, CLIN NEUROL NEUROSUR, V107, P214, DOI 10.1016/j.clineuro.2004.08.004; Rutkove SB, 1996, MUSCLE NERVE, V19, P670, DOI 10.1002/(SICI)1097-4598(199605)19:5<670::AID-MUS20>3.0.CO;2-Q; RUTKOVE SB, 2000, J CLIN NEUROMUSC DIS, V2, P65; Sands ML, 1997, DIABETES CARE, V20, P322, DOI 10.2337/diacare.20.3.322; SCHAUMBURG H, 1983, NEW ENGL J MED, V309, P445, DOI 10.1056/NEJM198308253090801; Sheetz MJ, 2002, JAMA-J AM MED ASSOC, V288, P2579, DOI 10.1001/jama.288.20.2579; Sima AAF, 2005, DIABETES CARE, V28, P89, DOI 10.2337/diacare.28.1.89; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; Smith AG, 2006, J NEUROL SCI, V242, P9, DOI 10.1016/j.jns.2005.11.020; Stamboulis E, 2005, J NEUROL, V252, P448, DOI 10.1007/s00415-005-0672-8; Sumner CJ, 2003, NEUROLOGY, V60, P108, DOI 10.1212/WNL.60.1.108; TAHMOUSH AJ, 1991, NEUROLOGY, V41, P1021, DOI 10.1212/WNL.41.7.1021; Tang J, 2007, NEUROLOGIST, V13, P164, DOI 10.1097/01.nrl.0000263703.78318.2b; Tesfaye S, 1996, DIABETOLOGIA, V39, P1377, DOI 10.1007/s001250050586; Thienel U, 2004, ACTA NEUROL SCAND, V110, P221, DOI 10.1111/j.1600-0404.2004.00338.x; Thisted RA, 2006, CLIN THER, V28, P1607, DOI 10.1016/j.clinthera.2006.10.005; Watson CPN, 2003, PAIN, V105, P71, DOI 10.1016/S0304-3959(03)00160-X; Wernicke JF, 2006, NEUROLOGY, V67, P1411, DOI 10.1212/01.wnl.0000240225.04000.1a; WHITE NH, 1981, J PEDIATR-US, V99, P41, DOI 10.1016/S0022-3476(81)80954-7; Wilson RC, 1999, J AM PODIAT MED ASSN, V89, P468, DOI 10.7547/87507315-89-9-468; Wong MC, 2007, BMJ-BRIT MED J, V335, P87, DOI 10.1136/bmj.39213.565972.AE; Yuen KCJ, 2002, DIABETES CARE, V25, P1699, DOI 10.2337/diacare.25.10.1699; Ziegler D, 2004, DIABETIC MED, V21, P114, DOI 10.1111/j.1464-5491.2004.01109.x; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6	95	23	25	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 7	2009	302	13					1451	1458		10.1001/jama.2009.1377	http://dx.doi.org/10.1001/jama.2009.1377			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	503CL	19738078				2022-12-28	WOS:000270509600020
J	Kuppermann, N; Holmes, JF; Dayan, PS; Hoyle, JD; Atabaki, SM; Holubkov, R; Nadel, FM; Monroe, D; Stanley, RM; Borgialli, DA; Badawy, MK; Schunk, JE; Quayle, KS; Mahajan, P; Lichenstein, R; Lillis, KA; Tunik, MG; Jacobs, ES; Callahan, JM; Gorelick, MH; Glass, TF; Lee, LK; Bachman, MC; Cooper, A; Powell, EC; Gerardi, MJ; Melville, KA; Muizelaar, JP; Wisner, DH; Zuspan, SJ; Dean, JM; Wootton-Gorges, SL				Kuppermann, Nathan; Holmes, James F.; Dayan, Peter S.; Hoyle, John D., Jr.; Atabaki, Shireen M.; Holubkov, Richard; Nadel, Frances M.; Monroe, David; Stanley, Rachel M.; Borgialli, Dominic A.; Badawy, Mohamed K.; Schunk, Jeff E.; Quayle, Kimberly S.; Mahajan, Prashant; Lichenstein, Richard; Lillis, Kathleen A.; Tunik, Michael G.; Jacobs, Elizabeth S.; Callahan, James M.; Gorelick, Marc H.; Glass, Todd F.; Lee, Lois K.; Bachman, Michael C.; Cooper, Arthur; Powell, Elizabeth C.; Gerardi, Michael J.; Melville, Kraig A.; Muizelaar, J. Paul; Wisner, David H.; Zuspan, Sally Jo; Dean, J. Michael; Wootton-Gorges, Sandra L.		PECARN	Identification of children at very low risk of clinically-important brain injuries after head trauma: a prospective cohort study	LANCET			English	Article							COMPUTED-TOMOGRAPHY; INTRACRANIAL INJURY; DECISION RULE; EMERGENCY-DEPARTMENTS; PREDICTION RULES; SKULL FRACTURE; CONSCIOUSNESS; ABNORMALITIES; AGREEMENT; CT	Background CT imaging of head-injured children has risks of radiation-induced malignancy. Our aim was to identify children at very low risk of clinically-important traumatic brain injuries (ciTBI) for whom CT might be unnecessary. Methods We enrolled patients younger than 18 years presenting within 24 h of head trauma with Glasgow Coma Scale scores of 14-15 in 25 North American emergency departments. We derived and validated age-specific prediction rules for ciTBI (death from traumatic brain injury, neurosurgery, intubation >24 h, or hospital admission >= 2 nights). Findings We enrolled and analysed 42412 children (derivation and validation populations: 8502 and 2216 younger than 2 years, and 25 283 and 6411 aged 2 years and older). We obtained CT scans on 14969 (35.3%); ciTBIs occurred in 376 (0.9%), and 60 (0.1%) underwent neurosurgery. In the validation population, the prediction rule for children younger than 2 years (normal mental status, no scalp haematoma except frontal, no loss of consciousness or loss of consciousness for less than 5 s, non-severe injury mechanism, no palpable skull fracture, and acting normally according to the parents) had a negative predictive value for ciTBI of 1176/1176 (100.0%, 95% CI 99.7-100.0) and sensitivity of 25/25 (100%, 86.3-100.0). 167 (24.1%) of 694 CT imaged patients younger than 2 years were in this low-risk group. The prediction rule for children aged 2 years and older (normal mental status, no loss of consciousness, no vomiting, non-severe injury mechanism, no signs of basilar skull fracture, and no severe headache) had a negative predictive value of 3798/3800 (99.95%, 99.81-99.99) and sensitivity of 61/63 (96.8%, 89.0-99.6). 446 (20.1%) of 2223 CT imaged patients aged 2 years and older were in this low-risk group. Neither rule missed neurosurgery in validation populations. Interpretation These validated prediction rules identified children at very low risk of ciTBIs for whom CT can routinely be obviated. Funding The Emergency Medical Services for Children Programme of the Maternal and Child Health Bureau, and the Maternal and Child Health Bureau Research Programme, Health Resources and Services Administration, US Department of Health and Human Services.	[Kuppermann, Nathan; Holmes, James F.] Univ Calif Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA; [Muizelaar, J. Paul] Univ Calif Davis, Sch Med, Dept Neurol Surg, Davis, CA 95616 USA; [Wisner, David H.] Univ Calif Davis, Sch Med, Dept Surg, Davis, CA 95616 USA; [Wootton-Gorges, Sandra L.] Univ Calif Davis, Sch Med, Dept Radiol, Davis, CA 95616 USA; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Hoyle, John D., Jr.] Michigan State Univ, Sch Med, Helen DeVos Childrens Hosp, Div Emergency Med, Grand Rapids, MI USA; [Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA; [Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Emergency Med, Washington, DC USA; [Holubkov, Richard; Schunk, Jeff E.; Zuspan, Sally Jo; Dean, J. Michael] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Holubkov, Richard; Zuspan, Sally Jo; Dean, J. Michael] PECARN Cent Data Management & Coordinating Ctr, Salt Lake City, UT USA; [Nadel, Frances M.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Monroe, David] Howard Cty Gen Hosp, Dept Emergency Med, Columbia, MD USA; [Stanley, Rachel M.] Univ Michigan, Sch Med, Dept Emergency Med, Ann Arbor, MI USA; [Borgialli, Dominic A.] Univ Michigan, Sch Med, Dept Emergency Med, Flint, MI 48503 USA; [Borgialli, Dominic A.] Hudey Med Ctr, Flint, MI USA; [Badawy, Mohamed K.] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA; [Badawy, Mohamed K.] Univ Rochester, Sch Med & Dent, Dept Pediat, Rochester, NY 14642 USA; [Quayle, Kimberly S.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Mahajan, Prashant] Wayne State Univ, Sch Med, Dept Pediat, Detroit, MI 48201 USA; [Lichenstein, Richard] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Lillis, Kathleen A.] SUNY Buffalo, Dept Pediat & Emergency Med, Sch Med & Biomed Sci, Buffalo, NY 14260 USA; [Tunik, Michael G.] NYU, Sch Med, Dept Pediat, New York, NY USA; [Tunik, Michael G.] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Jacobs, Elizabeth S.] Holy Cross Hosp, Dept Pediat, Silver Spring, MD USA; [Callahan, James M.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY USA; [Callahan, James M.] SUNY Upstate Med Univ, Dept Emergency Med, Syracuse, NY USA; [Gorelick, Marc H.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Glass, Todd F.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Lee, Lois K.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Bachman, Michael C.] Newark Beth Israel Med Ctr, Dept Emergency Med, Newark, NJ USA; [Bachman, Michael C.] Newark Beth Israel Med Ctr, Dept Pediat, Newark, NJ USA; [Cooper, Arthur] Columbia Univ, Med Ctr, Harlem Hosp, Dept Surg, New York, NY USA; [Powell, Elizabeth C.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Gerardi, Michael J.] Morristown Mem Hosp, Dept Emergency Med, Morristown, NJ USA; [Melville, Kraig A.] Calvert Mem Hosp, Dept Emergency Med, Prince Frederick, MD USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Columbia University; Michigan State University; George Washington University; George Washington University; Utah System of Higher Education; University of Utah; University of Pennsylvania; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan Flint; University of Rochester; University of Rochester; Washington University (WUSTL); Wayne State University; University System of Maryland; University of Maryland Baltimore; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; New York University; New York University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Medical College of Wisconsin; University System of Ohio; University of Cincinnati; Harvard University; Harvard Medical School; Newark Beth Israel Medical Center; Newark Beth Israel Medical Center; Columbia University; Northwestern University; Feinberg School of Medicine; Atlantic Health System	Kuppermann, N (corresponding author), Univ Calif Davis, Med Ctr, Dept Emergency Med, 2315 Stockton Blvd,PSSB Suite 2100, Sacramento, CA 95817 USA.	nkuppermann@ucdavis.edu	Tsung, James W/I-6343-2019	Faul, Mark/0000-0002-7683-0348; Tsung, James/0000-0002-4718-8325; Tunik, Michael/0000-0002-2368-5933; Powell, Elizabeth/0000-0003-3147-9889	Emergency Medical Services for Children (EMSC) programme of the Maternal and Child Health Bureau [U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC00008]; Health Resources and Services Administration; US Department of Health and Human Services; Maternal and Child Health Bureau Research Programme [1 R40MC02461-01-00]	Emergency Medical Services for Children (EMSC) programme of the Maternal and Child Health Bureau; Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); US Department of Health and Human Services; Maternal and Child Health Bureau Research Programme	We thank Rene Enriquez and Li Dong at the PECARN Data Center (University of Utah) for their dedicated and diligent work; the research coordinators in PECARN, without whose dedication and hard work this study would not have been possible; all the clinicians around the PECARN network who enrolled children in this study; Mark Faul from the Centers for Disease Control and Prevention for analysing the NHAMCS databases for trends in CT usage over time. PECARN is supported by cooperative agreements U03MC00001, U03MC00003, U03MC00006, U03MC00007, and U03MC00008 from the Emergency Medical Services for Children (EMSC) programme of the Maternal and Child Health Bureau, Health Resources and Services Administration, US Department of Health and Human Services. This study was also supported by grant 1 R40MC02461-01-00 from the Maternal and Child Health Bureau Research Programme.	Abdel-Dayem HM, 1998, CLIN NUCL MED, V23, P309, DOI 10.1097/00003072-199805000-00009; Alexander D, 2003, PEDIATR EMERG CARE, V19, P185; Atabaki SM, 2008, ARCH PEDIAT ADOL MED, V162, P439, DOI 10.1001/archpedi.162.5.439; Bergman DA, 1999, PEDIATRICS, V104, P1407; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2002, PEDIATR RADIOL, V32, P228, DOI 10.1007/s00247-002-0671-1; Brieman L, 1984, CLASSIFICATION REGRE; Dayan PS, 2008, PEDIATR EMERG CARE, V24, P727; Dayan PS, 2008, ACAD EMERG MED, V15, pS175; DOEZEMA D, 1991, ANN EMERG MED, V20, P1281, DOI 10.1016/S0196-0644(05)81065-0; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; FAULKNER K, 1987, ACTA RADIOL, V28, P483; Frush DP, 2003, PEDIATRICS, V112, P951, DOI 10.1542/peds.112.4.951; Gausche-Hill M, 2007, PEDIATRICS, V120, P1229, DOI 10.1542/peds.2006-3780; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Homer CJ, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e78; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; Kuppermann N, 2008, ACAD EMERG MED, V15, pS82; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; Marr A. L., 2004, CENTRAL NERVOUS SYST; Mettler Fred A. Jr., 2000, Journal of Radiological Protection, V20, P353, DOI 10.1088/0952-4746/20/4/301; *NAT CTR HLTH STAT, 2005, PUBL US DAT FIL EM D; *NAT CTR HLTH STAT, 1995, PUBL US DAT FIL EM D; *NAT CTR INJ PREV, 2006, TRAUM BRAIN INJ US A; Oman JA, 2006, PEDIATRICS, V117, pE238, DOI 10.1542/peds.2005-1063; Palchak MJ, 2004, PEDIATRICS, V113, pE507, DOI 10.1542/peds.113.6.e507; Palchak MJ, 2003, ANN EMERG MED, V42, P492, DOI 10.1067/S0196-0644(03)00425-6; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Seidel JS, 1999, ANN EMERG MED, V33, P206, DOI 10.1016/S0196-0644(99)70395-1; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; TEASDALE G, 1974, LANCET, V2, P81	43	1001	1019	0	53	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1160	1170		10.1016/S0140-6736(09)61558-0	http://dx.doi.org/10.1016/S0140-6736(09)61558-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505IZ	19758692				2022-12-28	WOS:000270688200032
J	Chatterjee, S; Grosshans, H				Chatterjee, Saibal; Grosshans, Helge			Active turnover modulates mature microRNA activity in Caenorhabditis elegans	NATURE			English	Article							TARGET MESSENGER-RNA; C-ELEGANS; LET-7 MICRORNA; SACCHAROMYCES-CEREVISIAE; HUMAN-CELLS; INTERFERENCE; PURIFICATION; DEGRADATION; MATURATION; PROTEINS	MicroRNAs (miRNAs) constitute a large class of regulatory RNAs that repress target messenger RNAs to control various biological processes(1). Accordingly, miRNA biogenesis is highly regulated, controlled at both transcriptional and post-transcriptional levels(2), and overexpression and underexpression of miRNAs are linked to various human diseases, particularly cancers(1,3). As RNA concentrations are generally a function of biogenesis and turnover, active miRNA degradation might also modulate miRNA accumulation, and the plant 3'-> 5' exonuclease SDN1 has been implicated in miRNA turnover(4). Here we report that degradation of mature miRNAs in the nematode Caenorhabditis elegans, mediated by the 5'-> 3' exoribonuclease XRN-2, affects functional miRNA homeostasis in vivo. We recapitulate XRN-2-dependent miRNA turnover in larval lysates, where processing of precursor-miRNA (pre-miRNA) by Dicer, unannealing of the miRNA duplex and loading of the mature miRNA into the Argonaute protein of the miRNA-induced silencing complex (miRISC) are coupled processes that precede degradation of the mature miRNA. Although Argonaute: miRNA complexes are highly resistant to salt, larval lysate promotes efficient release of the miRNA, exposing it to degradation by XRN-2. Release and degradation can both be blocked by the addition of miRNA target RNA. Our results therefore suggest the presence of an additional layer of regulation of animal miRNA activity that might be important for rapid changes of miRNA expression profiles during developmental transitions and for the maintenance of steady-state concentrations of miRNAs. This pathway might represent a potential target for therapeutic intervention on miRNA expression.	[Chatterjee, Saibal; Grosshans, Helge] Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Grosshans, H (corresponding author), Friedrich Miescher Inst Biomed Res, POB 2543, CH-4002 Basel, Switzerland.	helge.grosshans@fmi.ch	Grosshans, Helge/W-8931-2019	Grosshans, Helge/0000-0002-8169-6905	Marie Curie; EMBO	Marie Curie(European Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank M. Buhler and W. Filipowicz for critical comments on the manuscript; W. Filipowicz for plasmids; C. Mello and F. Slack for C. elegans strains; and A. Esquela-Kerscher for sharing Starfire probes for pre-miRNA detection. S. C. was supported by Marie Curie and EMBO long-term postdoctoral fellowships.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2007, ANNU REV GENOM HUM G, V8, P215, DOI 10.1146/annurev.genom.8.080706.092351; Chatterjee S, 2006, J BIOL CHEM, V281, P25270, DOI 10.1074/jbc.M604126200; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; Ding XC, 2008, CELL CYCLE, V7, P3083, DOI 10.4161/cc.7.19.6778; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Ding XC, 2009, TRENDS BIOTECHNOL, V27, P27, DOI 10.1016/j.tibtech.2008.09.006; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Hutvagner G, 2004, PLOS BIOL, V2, P465, DOI 10.1371/journal.pbio.0020098; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kolb FA, 2005, METHOD ENZYMOL, V392, P316, DOI 10.1016/S0076-6879(04)92019-8; Lee MH, 2001, GENE DEV, V15, P2408, DOI 10.1101/gad.915901; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Pall GS, 2008, NAT PROTOC, V3, P1077, DOI 10.1038/nprot.2008.67; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; STEVENS A, 1987, NUCLEIC ACIDS RES, V15, P695, DOI 10.1093/nar/15.2.695; STEVENS A, 1995, J BIOL CHEM, V270, P16063, DOI 10.1074/jbc.270.27.16063; Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858	37	260	284	3	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					546	U120		10.1038/nature08349	http://dx.doi.org/10.1038/nature08349			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19734881				2022-12-28	WOS:000270082900045
J	Whellan, DJ; Ellis, SJ; Kraus, WE; Hawthorne, K; Pina, IL; Keteyian, SJ; Kitzman, DW; Cooper, L; Lee, K; O'Connor, CM				Whellan, David J.; Ellis, Stephen J.; Kraus, William E.; Hawthorne, Katie; Pina, Ileana L.; Keteyian, Steven J.; Kitzman, Dalane W.; Cooper, Lawton; Lee, Kerry; O'Connor, Christopher M.			Method for Establishing Authorship in a Multicenter Clinical Trial	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HEART-FAILURE; HF-ACTION; GUIDELINES; TIME	With the emergence of large multicenter trials over the past 20 years, the numbers of investigators involved and publications resulting from each study have grown exponentially. An efficient, fair, and effective way to establish authorship on study-related manuscripts could diminish conflict among the investigators and help ensure robust and timely dissemination of study results. This article describes a process developed by the investigators in the HF-ACTION (Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training) trial (ClinicalTrials. gov registration number: NCT00047437) to establish authorship of the manuscripts describing the baseline characteristics, study design, and trial outcomes in an equitable and transparent manner based on objective, quantifiable contributions to the study as a whole. The HF-ACTION investigators developed a scoring system that assigned points to investigators by using the criteria established for enrollment, adherence to the exercise program, data completion, committee service, and other trial efforts. The scoring system has been successfully implemented for baseline manuscripts and has allowed many investigators to participate in the HF-ACTION publication process.	Duke Univ, Med Ctr, Durham, NC USA; Duke Clin Res Inst, Durham, NC USA; Wake Forest Univ, Sch Med, Winston Salem, NC USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; Henry Ford Hosp, Detroit, MI 48202 USA; NHLBI, NIH, Bethesda, MD 20892 USA; [Whellan, David J.] Jefferson Med Coll, Dept Cardiol, Philadelphia, PA 19107 USA	Duke University; Duke University; Wake Forest University; Harvard University; Massachusetts General Hospital; Case Western Reserve University; Henry Ford Health System; Henry Ford Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Jefferson University	Whellan, DJ (corresponding author), Jefferson Med Coll, Dept Cardiol, 1015 Chestnut St,Suite 317, Philadelphia, PA 19107 USA.			Kudo, Mitsuhiro/0000-0002-9853-7476; Kraus, William E/0000-0003-1930-9684	National Heart, Lung, and Blood Institute, National Institutes of Health [NIH/NHLBI U01HL063747]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL063747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG018915] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Heart, Lung, and Blood Institute, National Institutes of Health, for the HF-ACTION trial (NIH/NHLBI U01HL063747).	Barker A, 1997, BRIT MED J, V314, P1046, DOI 10.1136/bmj.314.7086.1046; Bourbonniere MC, 2006, AM J OCCUP THER, V60, P111, DOI 10.5014/ajot.60.1.111; DIGIUSTO E, 1994, SOC SCI MED, V38, P55, DOI 10.1016/0277-9536(94)90299-2; Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457; Horton R, 1996, BRIT MED J, V312, P723; *INT COMM MED JOUR, 2008, BIOMEDICAL J UNPUB; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Smith R, 1996, BRIT MED J, V312, P789; Whellan DJ, 2007, AM HEART J, V153, P201, DOI 10.1016/j.ahj.2006.11.007	9	23	24	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6					414	W133		10.7326/0003-4819-151-6-200909150-00006	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	501OB	19755366	Green Accepted			2022-12-28	WOS:000270390100006
J	Blum, RW				Blum, Robert W.			Young people: not as healthy as they seem	LANCET			English	Editorial Material									Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Blum, RW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.	rblum@jhsph.edu						Diekstra RFW, 1987, SUICIDE ADOLESCENCE; Lloyd C. B., 2005, COMMITTEE POPULATION; NUGENT B, 2006, YOUTH GLOBAL WORLD; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; SUMMERS T, 2002, TIP ICEBERG GLOBAL I; Wasserman D., 2005, WORLD PSYCHIATRY, V4, P114; World Bank, 2006, WORLD DEV REP 2007 D	7	28	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					853	854		10.1016/S0140-6736(09)61607-X	http://dx.doi.org/10.1016/S0140-6736(09)61607-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19748383				2022-12-28	WOS:000269943100004
J	Gusarov, I; Shatalin, K; Starodubtseva, M; Nudler, E				Gusarov, Ivan; Shatalin, Konstantin; Starodubtseva, Marina; Nudler, Evgeny			Endogenous Nitric Oxide Protects Bacteria Against a Wide Spectrum of Antibiotics	SCIENCE			English	Article							BACILLUS-SUBTILIS; OXIDATIVE STRESS; MECHANISM; PYOCYANINE; SYNTHASES; VIRULENCE; CELLS	Bacterial nitric oxide synthases (bNOS) are present in many Gram-positive species and have been demonstrated to synthesize NO from arginine in vitro and in vivo. However, the physiological role of bNOS remains largely unknown. We show that NO generated by bNOS increases the resistance of bacteria to a broad spectrum of antibiotics, enabling the bacteria to survive and share habitats with antibiotic-producing microorganisms. NO-mediated resistance is achieved through both the chemical modification of toxic compounds and the alleviation of the oxidative stress imposed by many antibiotics. Our results suggest that the inhibition of NOS activity may increase the effectiveness of antimicrobial therapy.	[Gusarov, Ivan; Shatalin, Konstantin; Starodubtseva, Marina; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem, 550 1st Ave, New York, NY 10016 USA.	evgeny.nudler@nyumc.org	Gusarov, Ivan/AAJ-6282-2020	Nudler, Evgeny/0000-0002-8811-3071	NIH; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000799] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the NIH Director's Pioneer Award to E. N.	ASAD NR, 1991, J BACTERIOL, V173, P2562, DOI 10.1128/jb.173.8.2562-2568.1991; BARON SS, 1981, ANTIMICROB AGENTS CH, V20, P814, DOI 10.1128/AAC.20.6.814; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; FISHER SH, 1991, ANNU REV MICROBIOL, V45, P107, DOI 10.1146/annurev.mi.45.100191.000543; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; HASSAN HM, 1980, J BACTERIOL, V141, P156, DOI 10.1128/JB.141.1.156-163.1980; Inaoka T, 1998, J BACTERIOL, V180, P3697, DOI 10.1128/JB.180.14.3697-3703.1998; Inaoka T, 1999, J BACTERIOL, V181, P1939, DOI 10.1128/JB.181.6.1939-1943.1999; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lim MH, 2006, NAT CHEM BIOL, V2, P375, DOI 10.1038/nchembio794; MONCADA S, 1991, PHARMACOL REV, V43, P109; Moore CM, 2004, J BACTERIOL, V186, P4655, DOI 10.1128/JB.186.14.4655-4664.2004; Nedospasov A, 2000, P NATL ACAD SCI USA, V97, P13543, DOI 10.1073/pnas.250398197; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Shatalin K, 2008, P NATL ACAD SCI USA, V105, P1009, DOI 10.1073/pnas.0710950105; STAMLER JS, 1992, SCIENCE, V258, P1898, DOI 10.1126/science.1281928; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Vukomanovic DV, 1997, BIOCHEM J, V322, P25, DOI 10.1042/bj3220025; Wainwright M, 2001, J ANTIMICROB CHEMOTH, V47, P1, DOI 10.1093/jac/47.1.1	24	271	290	6	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1380	1384		10.1126/science.1175439	http://dx.doi.org/10.1126/science.1175439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745150	Green Accepted			2022-12-28	WOS:000269699100035
J	Gevers, W				Gevers, Wieland			Clinical research in South Africa: a core asset under pressure	LANCET			English	Editorial Material									ASSAf, ZA-0040 Pretoria, Gauteng Prov, South Africa		Gevers, W (corresponding author), ASSAf, ZA-0040 Pretoria, Gauteng Prov, South Africa.	wieland.gevers@uct.ac.za						Benatar SR, 2008, S AFR J SCI, V104, P439; CLERY D, 1995, SCIENCE, V268, P1282, DOI 10.1126/science.268.5215.1282; GEVERS W, 2006, STRATEGIC APPROACH R; Marais AD, 2008, SAMJ S AFR MED J, V98, P91; Paraje G, 2005, SCIENCE, V308, P959, DOI 10.1126/science.1108705; Pienaar ED, 2002, SAMJ S AFR MED J, V92, P901; Pouris A, 2003, S AFR J SCI, V99, P425; *S AFR DEP HLTH, 2001, HLTH RES POL S AFR; *S AFR DEP SCI TEC, 10 YEAR INN PLAN; *S AFR MED RES COU, SHORT GEN HIST MRC; Tijssen RJW, 2007, SCIENTOMETRICS, V71, P303, DOI 10.1007/s11192-007-1658-3; van Niekerk JPD, 2007, SAMJ S AFR MED J, V97, P797	12	13	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					760	762		10.1016/S0140-6736(09)61119-3	http://dx.doi.org/10.1016/S0140-6736(09)61119-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492QU	19709733				2022-12-28	WOS:000269675000005
J	Fishbein, TM				Fishbein, Thomas M.			Current Concepts: Intestinal Transplantation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SHORT-BOWEL SYNDROME; HOME PARENTERAL-NUTRITION; QUALITY-OF-LIFE; ISOLATED LIVER-TRANSPLANTATION; ALLOGRAFT-REJECTION; MULTIVISCERAL TRANSPLANTATION; BACTERIAL TRANSLOCATION; MACROPHAGE DEPLETION; UNITED-STATES; FAILURE		Georgetown Univ Hosp, Georgetown Transplant Inst, Washington, DC 20007 USA	Georgetown University	Fishbein, TM (corresponding author), Georgetown Univ Hosp, Georgetown Transplant Inst, 2 Main,3800 Reservoir Rd NW, Washington, DC 20007 USA.							Andres AM, 2008, TRANSPLANTATION, V85, P1294, DOI 10.1097/TP.0b013e31817268ca; Atkison P, 1997, Pediatr Transplant, V1, P111; Beath S, 2008, TRANSPLANTATION, V85, P1378, DOI 10.1097/TP.0b013e31816dd513; Botha JF, 2006, LIVER TRANSPLANT, V12, P1062, DOI 10.1002/lt.20763; Buchman AL, 2006, HEPATOLOGY, V43, P9, DOI 10.1002/hep.20997; Buchman AL, 2003, GASTROENTEROLOGY, V124, P1111, DOI 10.1053/gast.2003.50139; Bueno J, 1997, CLIN INFECT DIS, V25, P1078, DOI 10.1086/516113; Carbonnel F, 1996, JPEN-PARENTER ENTER, V20, P275, DOI 10.1177/0148607196020004275; Casey L, 2008, NUTR CLIN PRACT, V23, P436, DOI 10.1177/0884533608321213; Cavicchi M, 2000, ANN INTERN MED, V132, P525, DOI 10.7326/0003-4819-132-7-200004040-00003; Chan S, 1999, SURGERY, V126, P28, DOI 10.1067/msy.1999.98925; Chaney Michael, 2004, Prog Transplant, V14, P312; Chung Chuhan, 2002, Clin Liver Dis, V6, P1067, DOI 10.1016/S1089-3261(02)00057-0; Diamond IR, 2006, J PEDIATR SURG, V41, P955, DOI 10.1016/j.jpedsurg.2006.01.016; DiMartini A, 1998, JPEN-PARENTER ENTER, V22, P357, DOI 10.1177/0148607198022006357; Fecteau A, 2001, J PEDIATR SURG, V36, P681, DOI 10.1053/jpsu.2001.22936; Fiel MI, 2008, CLIN GASTROENTEROL H, V6, P926, DOI 10.1016/j.cgh.2008.04.011; Fishbein T, 2008, GUT, V57, DOI 10.1136/gut.2007.133322; Fishbein TM, 2006, GASTROENTEROLOGY, V130, pS147, DOI 10.1053/j.gastro.2005.12.004; Fishbein TM, 2003, TRANSPLANTATION, V76, P636, DOI 10.1097/01.TP.0000083042.03188.6C; Fishbein TM, 2002, J GASTROINTEST SURG, V6, P554, DOI 10.1016/S1091-255X(01)00026-9; Fishbein TM, 2002, TRANSPLANTATION, V73, P1538, DOI 10.1097/00007890-200205270-00004; FLEMING CR, 1994, DIGEST DIS, V12, P191; Florescu DF, 2008, PEDIATR TRANSPLANT, V12, P372, DOI 10.1111/j.1399-3046.2007.00875.x; Florman SS, 2002, TRANSPLANTATION, V74, P406, DOI 10.1097/00007890-200208150-00019; Fryer J, 2003, LIVER TRANSPLANT, V9, P748, DOI 10.1053/jlts.2003.50151; Fryer J, 1996, TRANSPLANT P, V28, P2660; Fryer J, 1996, TRANSPLANTATION, V62, P553, DOI 10.1097/00007890-199609150-00002; Grant D, 2005, ANN SURG, V241, P607, DOI 10.1097/01.sla.0000157265.85388.a1; Guaraldi G, 2005, TRANSPLANTATION, V80, P1742, DOI 10.1097/01.tp.0000185622.91708.57; Gura KM, 2006, PEDIATRICS, V118, pE197, DOI 10.1542/peds.2005-2662; Hanto DW, 2005, AM J TRANSPLANT, V5, P916, DOI 10.1111/j.1600-6135.2005.00839.x; Howard L, 2006, GASTROENTEROLOGY, V130, pS52, DOI 10.1053/j.gastro.2005.09.065; Howard L, 1996, TRANSPLANT P, V28, P2691; HOWARD L, 1995, GASTROENTEROLOGY, V109, P355, DOI 10.1016/0016-5085(95)90321-6; IWAKI Y, 1991, LANCET, V337, P818, DOI 10.1016/0140-6736(91)92517-6; Iyer K, 2002, J PEDIATR SURG, V37, P464, DOI 10.1053/jpsu.2002.30864; Kaila B, 2004, AM J GASTROENTEROL, V99, P158, DOI 10.1046/j.1572-0241.2003.04004.x; Kato T, 2003, J PEDIATR SURG, V38, P145, DOI 10.1053/jpsu.2003.50033; Kato T, 2008, TRANSPLANTATION, V86, P293, DOI 10.1097/TP.0b013e31817ef01c; Kaufman SS, 2002, TRANSPLANT P, V34, P943, DOI 10.1016/S0041-1345(02)02683-0; Kellersmann R, 2002, TRANSPLANTATION, V74, P1327, DOI 10.1097/00007890-200211150-00022; Kiyochi H, 2000, TRANSPLANT P, V32, P964, DOI 10.1016/S0041-1345(00)01063-0; Lopushinsky SR, 2007, ANN SURG, V246, P1092, DOI 10.1097/SLA.0b013e3181571029; Matsumoto CS, 2007, TRANSPLANTATION, V83, P234, DOI 10.1097/01.tp.0000248885.76183.1b; Mayer L, 2000, J PEDIATR GASTR NUTR, V30, pS4, DOI 10.1097/00005176-200001001-00002; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; Newell KA, 2003, AM J TRANSPLANT, V3, P1, DOI 10.1034/j.1600-6143.2003.30101.x; Nucci AM, 2002, J PEDIATR SURG, V37, P460, DOI 10.1053/jpsu.2002.30863; O'Keefe SJD, 2007, AM J GASTROENTEROL, V102, P1093, DOI 10.1111/j.1572-0241.2007.01125.x; Ozcay N, 1997, TRANSPLANTATION, V63, P1220, DOI 10.1097/00007890-199705150-00006; Porubsky M, 2006, PEDIATR TRANSPLANT, V10, P701, DOI 10.1111/j.1399-3046.2006.00520.x; Quan D, 1996, TRANSPLANT P, V28, P2460; Quiros-Tejeira RE, 2004, J PEDIATR-US, V145, P157, DOI 10.1016/j.jpeds.2004.02.030; Reyes J, 2002, PEDIATR TRANSPLANT, V6, P193, DOI 10.1034/j.1399-3046.2002.02003.x; Ricour C, 1989, Nutrition, V5, P345; Rovera GM, 1998, TRANSPLANTATION, V66, P1141, DOI 10.1097/00007890-199811150-00005; Ruiz P, 2004, TRANSPLANT P, V36, P335, DOI 10.1016/j.transproceed.2004.01.079; Salvia G, 2008, J PEDIATR-US, V153, P674, DOI 10.1016/j.jpeds.2008.05.017; Sarkar S, 2006, PEDIATR TRANSPLANT, V10, P162, DOI 10.1111/j.1399-3046.2005.00437.x; Scolapio JS, 1999, MAYO CLIN PROC, V74, P217, DOI 10.4065/74.3.217; Sigalet D L, 2001, Semin Pediatr Surg, V10, P49, DOI 10.1053/spsu.2001.22382; Sondheimer JM, 1998, J PEDIATR GASTR NUTR, V27, P131, DOI 10.1097/00005176-199808000-00001; STARZL TE, 1962, AM J SURG, V103, P219, DOI 10.1016/0002-9610(62)90491-9; Sudan D, 2006, GASTROENTEROLOGY, V130, pS158, DOI 10.1053/j.gastro.2005.09.066; Sudan D, 2005, J GASTROINTEST SURG, V9, P165, DOI 10.1016/j.gassur.2004.10.014; Sudan D, 2004, AM J TRANSPLANT, V4, P407, DOI 10.1111/j.1600-6143.2004.00330.x; Sudan D, 2002, TRANSPLANT P, V34, P938, DOI 10.1016/S0041-1345(02)02680-5; Sudan D, 2007, ANN SURG, V246, P593, DOI 10.1097/SLA.0b013e318155aa0c; Sudan DL, 2002, TRANSPLANT P, V34, P940, DOI 10.1016/S0041-1345(02)02681-7; Sudan DL, 2001, TRANSPLANTATION, V72, P1846, DOI 10.1097/00007890-200112150-00025; Sudan DL, 2000, AM J GASTROENTEROL, V95, P1506; Takahashi H, 2007, TRANSPLANTATION, V84, P689, DOI 10.1097/01.tp.0000280541.83994.93; Thakur A, 2002, AM SURGEON, V68, P75; TODO S, 1994, TRANSPLANTATION, V57, P840, DOI 10.1097/00007890-199403270-00012; TODO S, 1992, ANN SURG, V216, P223, DOI 10.1097/00000658-199209000-00002; Torres C, 2007, J PEDIATR GASTR NUTR, V45, P204, DOI 10.1097/MPG.0b013e31805905f9; Turner D, 2006, AM J TRANSPLANT, V6, P236, DOI 10.1111/j.1600-6143.2005.01149.x; Tzakis AG, 2003, TRANSPLANTATION, V75, P1227, DOI 10.1097/01.TP.0000065192.53065.50; Ueno T, 2006, TRANSPLANT P, V38, P1702, DOI 10.1016/j.transproceed.2006.05.025; Van Gossum A, 2001, CLIN NUTR, V20, P205, DOI 10.1054/clnu.2000.0380; VARGAS JH, 1987, J PEDIATR GASTR NUTR, V6, P24, DOI 10.1097/00005176-198701000-00006; Vincenti F, 2005, NEW ENGL J MED, V353, P770, DOI 10.1056/NEJMoa050085; Wilmore DW, 1997, ANN SURG, V226, P288, DOI 10.1097/00000658-199709000-00008; Zhang Z, 1996, TRANSPLANTATION, V62, P1267, DOI 10.1097/00007890-199611150-00016; Zhang Z, 1996, TRANSPLANT P, V28, P2487	86	268	276	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					998	1008		10.1056/NEJMra0804605	http://dx.doi.org/10.1056/NEJMra0804605			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19726774				2022-12-28	WOS:000269480400009
J	Kempers, MJE; Lenders, JWM; van Outheusden, L; van der Wilt, GJ; Kool, LJS; Hermus, ARMM; Deinum, J				Kempers, Marlies J. E.; Lenders, Jacques W. M.; van Outheusden, Lieke; van der Wilt, Gert Jan; Kool, Leo J. Schultze; Hermus, Ad R. M. M.; Deinum, Jaap			Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism	ANNALS OF INTERNAL MEDICINE			English	Review							PRIMARY HYPERALDOSTERONISM; COMPUTED-TOMOGRAPHY; PREOPERATIVE LOCALIZATION; HYPER-ALDOSTERONISM; ADENOMA; MANAGEMENT; CT; HYPERTENSION; PREVALENCE; ACCURACY	Background: Computed tomography (CT), magnetic resonance imaging (MRI), and adrenal vein sampling (AVS) are used to distinguish unilateral from bilateral increased aldosterone secretion as a cause of primary aldosteronism. This distinction is crucial because unilateral primary aldosteronism can be treated surgically, whereas bilateral primary aldosteronism should be treated medically. Purpose: To determine the proportion of patients with primary aldosteronism whose CT or MRI results with regard to unilateral or bilateral adrenal abnormality agreed or did not agree with those of AVS. Data Sources: PubMed, MEDLINE, EMBASE, and Cochrane Library, 1977 to April 2009. Study Selection: Studies describing adults with primary aldosteronism who underwent CT/MRI and AVS were included. Of 472 initially identified studies, 38 met the selection criteria; extractable data were available for 950 patients. Data Extraction: The CT/MRI result was considered accurate when AVS showed unilaterally increased aldosterone secretion on the same side as the abnormality seen on CT/MRI or when AVS showed symmetric aldosterone secretion and CT/MRI revealed bilateral or no unilateral abnormality. Data Synthesis: In 37.8% of patients ( 359 of 950), CT/MRI results did not agree with AVS results. If only CT/MRI results had been used to determine lateralization of an adrenal abnormality, inappropriate adrenalectomy would have occurred in 14.6% of patients ( where AVS showed a bilateral problem), inappropriate exclusion from adrenalectomy would have occurred in 19.1% ( where AVS showed unilateral secretion), and adrenalectomy on the wrong side would have occurred in 3.9% ( where AVS showed aldosterone secretion on the opposite side). Limitation: The lack of follow-up data in the included articles made it impossible to confirm that adrenalectomies were performed appropriately. Conclusion: When AVS is used as the criterion standard test for diagnosing laterality of aldosterone secretion in patients with primary aldosteronism, CT/MRI misdiagnosed the cause of primary aldosteronism in 37.8% of patients. Relying only on CT/MRI may lead to inappropriate treatment of patients with primary aldosteronism.	[Kempers, Marlies J. E.; Lenders, Jacques W. M.; van Outheusden, Lieke; van der Wilt, Gert Jan; Kool, Leo J. Schultze; Hermus, Ad R. M. M.; Deinum, Jaap] Radboud Univ Nijmegen, Med Ctr, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Deinum, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.deinum@aig.umcn.nl	Hermus, A.R.M.M./H-8043-2014; Lenders, J.W.M./L-4487-2015; Deinum, J./L-4261-2015; van der Wilt, G.J./H-8120-2014; Kool, L.J. Schultze/H-8088-2014	Hermus, A.R.M.M./0000-0003-1075-2655; Lenders, J.W.M./0000-0002-7658-4466; Deinum, J./0000-0003-2465-1986; van der Wilt, G.J./0000-0002-5856-762X; 				Bernini G, 2002, EUR J ENDOCRINOL, V146, P523, DOI 10.1530/eje.0.1460523; BLUMENFELD JD, 1994, ANN INTERN MED, V121, P877, DOI 10.7326/0003-4819-121-11-199412010-00010; Carr CE, 2004, J VASC INTERV RADIOL, V15, P1245, DOI 10.1097/01.RVI.0000134495.26900.6A; Castro OL, 2002, HYPERTENSION, V39, P935, DOI 10.1161/01.HYP.0000014324.68506.CA; Doppman JL, 1996, RADIOLOGY, V198, P309, DOI 10.1148/radiology.198.2.8596821; DOPPMAN JL, 1992, RADIOLOGY, V184, P677, DOI 10.1148/radiology.184.3.1509049; Douma S, 2008, LANCET, V371, P1921, DOI 10.1016/S0140-6736(08)60834-X; Duh QY, 2008, SURGERY, V144, P933; DUNNICK NR, 1993, AM J ROENTGENOL, V160, P321, DOI 10.2214/ajr.160.2.8424342; DUNNICK NR, 1982, RADIOLOGY, V142, P429, DOI 10.1148/radiology.142.2.7054832; Espiner EA, 2003, J CLIN ENDOCR METAB, V88, P3637, DOI 10.1210/jc.2002-022051; Fardella CE, 2000, J CLIN ENDOCR METAB, V85, P1863, DOI 10.1210/jc.85.5.1863; Freriks K, 2007, Ned Tijdschr Geneeskd, V151, P1029; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; GEISINGER MA, 1983, AM J ROENTGENOL, V141, P299, DOI 10.2214/ajr.141.2.299; GLEASON PE, 1993, J UROLOGY, V150, P1365, DOI 10.1016/S0022-5347(17)35781-6; Glodny B, 2000, ENDOCR J, V47, P657, DOI 10.1507/endocrj.47.657; GORDON RD, 1993, CLIN EXP PHARMACOL P, V20, P296, DOI 10.1111/j.1440-1681.1993.tb01687.x; HAMBLING C, 1993, Q J MED, V86, P383; Harper R, 1999, QJM-MON J ASSOC PHYS, V92, P643, DOI 10.1093/qjmed/92.11.643; Harvey A, 2006, SURGERY, V140, P847, DOI 10.1016/j.surg.2006.07.026; Ishibashi T, 2007, ABDOM IMAGING, V32, P504, DOI 10.1007/s00261-006-9151-7; Kline G, 2008, INT UROL NEPHROL, V40, P1035, DOI 10.1007/s11255-008-9441-9; LINDE R, 1979, J CLIN ENDOCR METAB, V49, P642, DOI 10.1210/jcem-49-4-642; Lo CY, 1996, ANN SURG, V224, P125, DOI 10.1097/00000658-199608000-00003; MA JTC, 1986, Q J MED, V61, P1021; Magill SB, 2001, J CLIN ENDOCR METAB, V86, P1066, DOI 10.1210/jc.86.3.1066; McAlister FA, 1998, CAN J SURG, V41, P299; MCAREAVEY D, 1981, CLIN ENDOCRINOL, V15, P593, DOI 10.1111/j.1365-2265.1981.tb00706.x; MELBY JC, 1967, NEW ENGL J MED, V277, P1050, DOI 10.1056/NEJM196711162772002; Minami I, 2008, ENDOCR J, V55, P839, DOI 10.1507/endocrj.K07E-164; Mosso L, 2003, HYPERTENSION, V42, P161, DOI 10.1161/01.HYP.0000079505.25750.11; Mulatero P, 2004, J CLIN ENDOCR METAB, V89, P1045, DOI 10.1210/jc.2003-031337; Mulatero P, 2008, J CLIN ENDOCR METAB, V93, P1366, DOI 10.1210/jc.2007-2055; NARUSE K, 1994, HYPERTENSION, V23, pI102, DOI 10.1161/01.HYP.23.1_Suppl.I102; Nocaudie-Calzada M, 1999, EUR J NUCL MED, V26, P1326, DOI 10.1007/s002590050590; Nwariaku FE, 2006, ARCH SURG-CHICAGO, V141, P497, DOI 10.1001/archsurg.141.5.497; Omura M, 2006, HYPERTENS RES, V29, P883, DOI 10.1291/hypres.29.883; RAO A, 1995, J CLIN ENDOCR METAB, V80, P1677, DOI 10.1210/jc.80.5.1677; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Rossi GP, 2006, BEST PRACT RES CL EN, V20, P385, DOI 10.1016/j.beem.2006.07.003; Rossi GP, 2006, J HYPERTENS, V24, P371, DOI 10.1097/01.hjh.0000202818.10459.96; Satoh F, 2007, HYPERTENS RES, V30, P1083, DOI 10.1291/hypres.30.1083; Schwab CW, 2008, J ENDOUROL, V22, P1247, DOI 10.1089/end.2008.0007; Schwartz GL, 2005, CLIN CHEM, V51, P386, DOI 10.1373/clinchem.2004.041780; Sheaves R, 1996, EUR J ENDOCRINOL, V134, P308, DOI 10.1530/eje.0.1340308; Stowasser M, 2004, MOL CELL ENDOCRINOL, V217, P33, DOI 10.1016/j.mce.2003.10.006; TAKASAKI I, 1987, J HUM HYPERTENS, V1, P95; Toniato A, 2006, WORLD J SURG, V30, P624, DOI 10.1007/s00268-005-0482-2; Volpe C, 2008, SCAND J SURG, V97, P248, DOI 10.1177/145749690809700308; Wang J H, 2000, Zhonghua Yi Xue Za Zhi (Taipei), V63, P475; White ML, 2008, SURGERY, V144, P926, DOI 10.1016/j.surg.2008.07.025; WITZGALL H, 1983, KLIN WOCHENSCHR, V61, P35, DOI 10.1007/BF01484437; Wu C, 2008, QJM-INT J MED, V101, P13, DOI 10.1093/qjmed/hcm101; Wu KD, 2001, J FORMOS MED ASSOC, V100, P598; Young WF, 2004, SURGERY, V136, P1227, DOI 10.1016/j.surg.2004.06.051; Young WF, 2003, ENDOCRINOLOGY, V144, P2208, DOI 10.1210/en.2003-0279	57	288	315	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					329	U60		10.7326/0003-4819-151-5-200909010-00007	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00007			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492KB	19721021				2022-12-28	WOS:000269653100005
J	Lee, J; Fujita, K; Schmidt, AR; Kim, CK; Eisaki, H; Uchida, S; Davis, JC				Lee, Jhinhwan; Fujita, K.; Schmidt, A. R.; Kim, Chung Koo; Eisaki, H.; Uchida, S.; Davis, J. C.			Spectroscopic Fingerprint of Phase-Incoherent Superconductivity in the Underdoped Bi2Sr2CaCu2O8+delta	SCIENCE			English	Article							QUASI-PARTICLE INTERFERENCE; T-C SUPERCONDUCTOR; SUPERFLUID DENSITY; PSEUDOGAP STATE; FLUCTUATIONS; COHERENCE; GAP	A possible explanation for the existence of the cuprate "pseudogap" state is that it is a d-wave superconductor without quantum phase rigidity. Transport and thermodynamic studies provide compelling evidence that supports this proposal, but few spectroscopic explorations of it have been made. One spectroscopic signature of d-wave superconductivity is the particle-hole symmetric " octet" of dispersive Bogoliubov quasiparticle interference modulations. Here we report on this octet's evolution from low temperatures to well into the underdoped pseudogap regime. No pronounced changes occur in the octet phenomenology at the superconductor's critical temperature T-c, and it survives up to at least temperature T similar to 1.5 T-c. In this pseudogap regime, we observe the detailed phenomenology that was theoretically predicted for quasiparticle interference in a phase-incoherent d-wave superconductor. Thus, our results not only provide spectroscopic evidence to confirm and extend the transport and thermodynamics studies, but they also open the way for spectroscopic explorations of phase fluctuation rates, their effects on the Fermi arc, and the fundamental source of the phase fluctuations that suppress superconductivity in underdoped cuprates.	[Lee, Jhinhwan; Fujita, K.; Schmidt, A. R.; Kim, Chung Koo; Davis, J. C.] Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Fujita, K.; Uchida, S.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Eisaki, H.] Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Davis, J. C.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA	Cornell University; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); United States Department of Energy (DOE); Brookhaven National Laboratory	Davis, JC (corresponding author), Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	jcdavis@cornell.edu	Lee, Jhinhwan/C-2074-2011; Eisaki, Hiroshi/F-6317-2018; Lee, Jhinhwan/I-3727-2012	Eisaki, Hiroshi/0000-0002-8299-6416; Lee, Jhinhwan/0000-0001-7159-6305; KIM, CHUNG KOO/0000-0002-2463-197X	Brookhaven National Laboratory; U.S. Department of Energy; U.S. Office of Naval Research; Ministry of Science and Education (Japan) [Grant-in-Aid for Scientific Research]; Global Centers of Excellence Program for Japan Society for the Promotion of Science; U.S. Army Research Office	Brookhaven National Laboratory(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Office of Naval Research(Office of Naval Research); Ministry of Science and Education (Japan); Global Centers of Excellence Program for Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); U.S. Army Research Office	We acknowledge and thank J. C. Campuzano, T. Hanaguri, M. Franz, P. J. Hirschfeld, D.H. Lee, S. Kivelson, Y. Kohsaka, E.A. Kim, M. Lawler, J. Lee, K. Levin, D. Morr, M. Norman, N. P. Ong, J. Orenstein, M. Randeria, S. Sachdev, H. Takagi, and A. Tsvelik for helpful discussions and communications. These studies are supported by Brookhaven National Laboratory, the U.S. Department of Energy, the U.S. Office of Naval Research, by Grant-in-Aid for Scientific Research from the Ministry of Science and Education (Japan), and by the Global Centers of Excellence Program for Japan Society for the Promotion of Science. A.S. acknowledges support from the U.S. Army Research Office.	Berg E, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.247001; Bergeal N, 2008, NAT PHYS, V4, P608, DOI 10.1038/nphys1017; Carlson EW, 1999, PHYS REV LETT, V83, P612, DOI 10.1103/PhysRevLett.83.612; Chubukov AV, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.180501; Corson J, 1999, NATURE, V398, P221, DOI 10.1038/18402; Cyr-Choiniere O, 2009, NATURE, V458, P743, DOI 10.1038/nature07931; Franz M, 1998, PHYS REV B, V58, P14572, DOI 10.1103/PhysRevB.58.14572; Franz M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.257003; Grilli M, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125111; Haas S, 1997, PHYS REV B, V56, P5108, DOI 10.1103/PhysRevB.56.5108; Hanaguri T, 2007, NAT PHYS, V3, P865, DOI 10.1038/nphys753; Hanaguri T, 2009, SCIENCE, V323, P923, DOI 10.1126/science.1166138; Herbut IF, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.047006; Hermele M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.104404; Hetel I, 2007, NAT PHYS, V3, P700, DOI 10.1038/nphys707; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; Kim EA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184514; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Kwon HJ, 2001, PHYS REV LETT, V86, P3875, DOI 10.1103/PhysRevLett.86.3875; Li L, 2005, EUROPHYS LETT, V72, P451, DOI 10.1209/epl/i2005-10254-4; McElroy K, 2003, NATURE, V422, P592, DOI 10.1038/nature01496; Misra S, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.220503; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Pelissetto A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.027005; Pereg-Barnea T, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.180506; RANDERIA M, 1992, PHYS REV LETT, V69, P2001, DOI 10.1103/PhysRevLett.69.2001; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Wang YY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.247002; WULIN D, 2009, CONDENS MATT; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016	34	108	109	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1099	1103		10.1126/science.1176369	http://dx.doi.org/10.1126/science.1176369			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713522	Green Submitted			2022-12-28	WOS:000269382300033
J	Restuccia, DF; Hemmings, BA				Restuccia, David F.; Hemmings, Brian A.			Blocking Akt-ivity	SCIENCE			English	Editorial Material							PLECKSTRIN HOMOLOGY DOMAIN; CANCER; TRANSLOCATION; PATHWAY		[Restuccia, David F.; Hemmings, Brian A.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Restuccia, DF (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	hemmings@fmi.ch	Restuccia, David/D-7114-2012	Restuccia, David/0000-0001-7131-8065				Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Klein S, 2009, CURR OPIN CELL BIOL, V21, P185, DOI 10.1016/j.ceb.2008.12.006; Lakshmanan M, 2008, EXPERT OPIN THER TAR, V12, P855, DOI 10.1517/14728222.12.7.855 ; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	10	18	20	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1083	1084		10.1126/science.1179972	http://dx.doi.org/10.1126/science.1179972			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713516				2022-12-28	WOS:000269382300027
J	Terasawa, T; Dvorak, T; Ip, S; Raman, G; Lau, J; Trikalinos, TA				Terasawa, Teruhiko; Dvorak, Tomas; Ip, Stanley; Raman, Gowri; Lau, Joseph; Trikalinos, Thomas A.			Systematic Review: Charged-Particle Radiation Therapy for Cancer	ANNALS OF INTERNAL MEDICINE			English	Review							PROTON-BEAM THERAPY; RANDOMIZED CONTROLLED-TRIAL; HIGH-DOSE IRRADIATION; UVEAL MELANOMA; COST-EFFECTIVENESS; CHOROIDAL MELANOMA; LOCAL RECURRENCE; PROPENSITY SCORE; CLINICAL-TRIALS; SURVIVAL RATES	Background: Radiation therapy with charged particles can potentially deliver maximum doses while minimizing irradiation of surrounding tissues, and it may be more effective or less harmful than other forms of radiation therapy. Purpose: To review evidence about the benefits and harms of charged-particle radiation therapy for patients with cancer. Data Sources: MEDLINE (inception to 11 July 2009) was searched for publications in English, German, French, Italian, and Japanese. Web sites of manufacturers, treatment centers, and professional organizations were searched for relevant information. Study Selection: Four reviewers identified studies of any design that described clinical outcomes or adverse events in 10 or more patients with cancer treated with charged-particle radiation therapy. Data Extraction: The 4 reviewers extracted study, patient, and treatment characteristics; clinical outcomes; and adverse events for nonoverlapping sets of articles. A fifth reviewer verified data on comparative studies. Data Synthesis: Currently, 7 centers in the United States have facilities for particle (proton)-beam irradiation, and at least 4 are under construction, each costing between $100 and $225 million. In 243 eligible articles, charged- particle radiation therapy was used alone or in combination with other interventions for common (for example, lung, prostate, or breast) or uncommon (for example, skull-base tumors or uveal melanomas) types of cancer. Of 243 articles, 185 were single-group retrospective studies. Eight randomized and 9 nonrandomized clinical trials compared treatments with or without charged particles. No comparative study reported statistically significant or important differences in overall or cancer-specific survival or in total serious adverse events. Limitation: Few studies directly compared treatments with or without particle irradiation. Conclusion: Evidence on the comparative effectiveness and safety of charged-particle radiation therapy in cancer is needed to assess the benefits, risks, and costs of treatment alternatives.	[Terasawa, Teruhiko; Dvorak, Tomas; Ip, Stanley; Raman, Gowri; Lau, Joseph; Trikalinos, Thomas A.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA	Tufts Medical Center	Terasawa, T (corresponding author), Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Box 63,800 Washington St, Boston, MA 02111 USA.	tterasawa@tuftsmedicalcenter.org			Agency for Healthcare Research and Quality [HHSA-290-2007-10055-1-EPC3]; U.S. Department of Health and Human Services	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services	By contract HHSA-290-2007-10055-1-EPC3 from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.	[Anonymous], 2009, COMMON TERMINOLOGY C; Behera Madhusmita, 2007, Cancer Control, V14, P160; BENK VA, 1993, INT J RADIAT ONCOL, V26, P551, DOI 10.1016/0360-3016(93)90978-5; Brada M, 2007, J CLIN ONCOL, V25, P965, DOI 10.1200/JCO.2006.10.0131; *CANC, 2004, RAD THER CANC QUEST; Castro JR, 1997, INT J RADIAT ONCOL, V38, P257, DOI 10.1016/S0360-3016(97)00039-4; Char DH, 2003, AM J OPHTHALMOL, V136, P180, DOI 10.1016/S0002-9394(02)02292-4; CHAR DH, 1993, OPHTHALMOLOGY, V100, P1547; CHAR DH, 1989, OPHTHALMOLOGY, V96, P1708; Char DH, 1996, BRIT J OPHTHALMOL, V80, P117, DOI 10.1136/bjo.80.2.117; CHUI G, 2008, SYMMETRY, V5, P24; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Desjardins L, 2006, OPHTHAL RES, V38, P255, DOI 10.1159/000094834; Desjardins L, 2003, J FR OPHTALMOL, V26, P269; DUTTENHAVER JR, 1983, CANCER, V51, P1599, DOI 10.1002/1097-0142(19830501)51:9<1599::AID-CNCR2820510908>3.0.CO;2-O; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Galbraith M E, 2001, Oncol Nurs Forum, V28, P551; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; GERWECK L, 2007, PROTON CHARGED PARTI, P8; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Glatstein E, 2008, J CLIN ONCOL, V26, P2438, DOI 10.1200/JCO.2008.17.1843; Glimelius B, 2005, ACTA ONCOL, V44, P836, DOI 10.1080/02841860500361049; Goitein M, 2003, CLIN ONCOL-UK, V15, pS37, DOI 10.1053/clon.2002.0174; Goitein M, 2008, J CLIN ONCOL, V26, P175, DOI 10.1200/JCO.2007.14.4329; Gragoudas ES, 2000, ARCH OPHTHALMOL-CHIC, V118, P773, DOI 10.1001/archopht.118.6.773; Halperin EC, 2006, LANCET ONCOL, V7, P676, DOI 10.1016/S1470-2045(06)70795-1; Harbour JW, 1997, OPHTHALMOLOGY, V104, P1785, DOI 10.1016/S0161-6420(97)30025-6; HERRMANN T, 1987, Radiobiologia Radiotherapia, V28, P519; HUYBRECHTS M, 2007, KCE REPORTS, V67; JANJAN NA, 1994, ANN SURG ONCOL, V1, P415, DOI 10.1007/BF02303815; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; JERMANN M, 2008, HADRON THERAPY PATIE; Johannesen TB, 2002, RADIOTHER ONCOL, V62, P227, DOI 10.1016/S0167-8140(01)00495-9; Konski A, 2007, J CLIN ONCOL, V25, P3603, DOI 10.1200/JCO.2006.09.0811; Levin WP, 2005, BRIT J CANCER, V93, P849, DOI 10.1038/sj.bjc.6602754; LINSTADT D, 1988, RADIOLOGY, V168, P261, DOI 10.1148/radiology.168.1.3132732; Lodge M, 2007, RADIOTHER ONCOL, V83, P110, DOI 10.1016/j.radonc.2007.04.007; Lomax AJ, 2001, MED PHYS, V28, P317, DOI 10.1118/1.1350587; Lundkvist J, 2005, ACTA ONCOL, V44, P850, DOI 10.1080/02841860500341157; Mell LK, 2005, CANCER-AM CANCER SOC, V104, P1296, DOI 10.1002/cncr.21284; Nakano T, 2006, CLIN CANCER RES, V12, P2185, DOI 10.1158/1078-0432.CCR-05-1907; *NAT ASS PROT THER, 2009, VOIC PROT COMM; *NAT CANC I PDQ AD, 2002, LEV EV HUM STUD CANC; Olsen DR, 2007, RADIOTHER ONCOL, V83, P123, DOI 10.1016/j.radonc.2007.03.001; *PART THER COOP GR, 2009, PART THER FAC OP; Patel RR, 2006, HEMATOL ONCOL CLIN N, V20, P97, DOI 10.1016/j.hoc.2006.01.008; Pijls-Johannesma M, 2008, RADIOTHER ONCOL, V89, P127, DOI 10.1016/j.radonc.2008.07.015; RUBIN P, 1995, RADIOTHER ONCOL, V35, P11; Santoni R, 1998, INT J RADIAT ONCOL, V41, P59, DOI 10.1016/S0360-3016(98)00031-5; SCHOENTHALER R, 1994, ANN SURG, V219, P267, DOI 10.1097/00000658-199403000-00006; SCHOENTHALER R, 1993, INT J RADIAT ONCOL, V27, P75, DOI 10.1016/0360-3016(93)90423-S; Schulz-Ertner D, 2005, CANCER-AM CANCER SOC, V104, P338, DOI 10.1002/cncr.21158; Schulz-Ertner D, 2004, INT J RADIAT ONCOL, V58, P631, DOI 10.1016/j.ijrobp.2003.09.041; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; SEDDON JM, 1990, OPHTHALMOLOGY, V97, P769; SEDDON JM, 1985, AM J OPHTHALMOL, V99, P282, DOI 10.1016/0002-9394(85)90357-5; SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5; Skandarajah AR, 2009, ANN SURG ONCOL, V16, P735, DOI 10.1245/s10434-008-0287-2; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; SUIT H, 2008, NO RADIOTHER ONCOL, V86, P148; Timmerman RD, 2007, J CLIN ONCOL, V25, P947, DOI 10.1200/JCO.2006.09.7469; TRIKALINOS TA, 2008, PARTICLE BEAM RAD TH; Veldeman L, 2008, LANCET ONCOL, V9, P367, DOI 10.1016/S1470-2045(08)70098-6; Willett CG, 2007, J CLIN ONCOL, V25, P971, DOI 10.1200/JCO.2006.10.0255; Wilson MW, 1999, OPHTHALMOLOGY, V106, P1579, DOI 10.1016/S0161-6420(99)90456-6; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233	66	77	77	0	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 20	2009	151	8					556	U75		10.7326/0003-4819-151-8-200910200-00145	http://dx.doi.org/10.7326/0003-4819-151-8-200910200-00145			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	514HY	19755348				2022-12-28	WOS:000271386200005
J	Gimnig, JE; Slutsker, L				Gimnig, John E.; Slutsker, Laurence			House screening for malaria control	LANCET			English	Editorial Material							LARGE-SCALE		[Gimnig, John E.; Slutsker, Laurence] Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Slutsker, L (corresponding author), Ctr Dis Control & Prevent, Div Parasit Dis, Atlanta, GA 30341 USA.	laurence.slutsker@cdc.hhs.gov						Atieli H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-108; BOYD MARK F., 1926, AMER JOUR TROP MED, V6, P157; Brentlinger PE, 2003, LANCET INFECT DIS, V3, P467, DOI 10.1016/s1473-3099(03)00717-5; Curtis C, 2003, LANCET INFECT DIS, V3, P304, DOI 10.1016/S1473-3099(03)00612-1; De Zulueta J., 1994, Parassitologia (Rome), V36, P7; Geissbuhler Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005107; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Watson RB, 1941, AM J HYG, V34, P86, DOI 10.1093/oxfordjournals.aje.a118764; WILLIAMS LL, 1963, AM J PUBLIC HEALTH N, V53, P17, DOI 10.2105/AJPH.53.1.17; Yukich JO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-258	11	12	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					954	955		10.1016/S0140-6736(09)61078-3	http://dx.doi.org/10.1016/S0140-6736(09)61078-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PK	19732948				2022-12-28	WOS:000270154100006
J	Von Hoff, DD; LoRusso, PM; Rudin, CM; Reddy, JC; Yauch, RL; Tibes, R; Weiss, GJ; Borad, MJ; Hann, CL; Brahmer, JR; Mackey, HM; Lum, BL; Darbonne, WC; Marsters, JC; de Sauvage, FJ; Low, JA				Von Hoff, Daniel D.; LoRusso, Patricia M.; Rudin, Charles M.; Reddy, Josina C.; Yauch, Robert L.; Tibes, Raoul; Weiss, Glen J.; Borad, Mitesh J.; Hann, Christine L.; Brahmer, Julie R.; Mackey, Howard M.; Lum, Bertram L.; Darbonne, Walter C.; Marsters, James C., Jr.; de Sauvage, Frederic J.; Low, Jennifer A.			Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN HOMOLOG; CANCER; MUTATIONS; RISK	Background: Mutations in hedgehog pathway genes, primarily genes encoding patched homologue 1 (PTCH1) and smoothened homologue (SMO), occur in basal-cell carcinoma. In a phase 1 clinical trial, we assessed the safety and pharmacokinetics of GDC-0449, a small-molecule inhibitor of SMO, and responses of metastatic or locally advanced basal-cell carcinoma to the drug. Methods: We selected 33 patients with metastatic or locally advanced basal-cell carcinoma to receive oral GDC-0449 at one of three doses; 17 patients received 150 mg per day, 15 patients received 270 mg per day, and 1 patient received 540 mg per day. We assessed tumor responses with the use of Response Evaluation Criteria in Solid Tumors (RECIST), physical examination, or both. Molecular aspects of the tumors were examined. Results: The median duration of the study treatment was 9.8 months. Of the 33 patients, 18 had an objective response to GDC-0449, according to assessment on imaging (7 patients), physical examination (10 patients), or both (1 patient). Of the patients who had a response, 2 had a complete response and 16 had a partial response. The other 15 patients had either stable disease (11 patients) or progressive disease (4 patients). Eight grade 3 adverse events that were deemed to be possibly related to the study drug were reported in six patients, including four with fatigue, two with hyponatremia, one with muscle spasm, and one with atrial fibrillation. One grade 4 event, asymptomatic hyponatremia, was judged to be unrelated to GDC-0449. One patient withdrew from the study because of adverse events. We found evidence of hedgehog signaling in tumors that responded to the treatment. Conclusions: GDC-0449, an orally active small molecule that targets the hedgehog pathway, appears to have antitumor activity in locally advanced or metastatic basal-cell carcinoma. (ClinicalTrials.gov number, NCT00607724.) N Engl J Med 2009;361:1164-72.	[Reddy, Josina C.; Yauch, Robert L.; Mackey, Howard M.; Lum, Bertram L.; Darbonne, Walter C.; Marsters, James C., Jr.; de Sauvage, Frederic J.; Low, Jennifer A.] Genentech Inc, San Francisco, CA 94080 USA; [Rudin, Charles M.; Hann, Christine L.; Brahmer, Julie R.] Johns Hopkins Univ, Baltimore, MD USA; [Von Hoff, Daniel D.; Tibes, Raoul; Weiss, Glen J.; Borad, Mitesh J.] Translat Genom Res Inst, Scottsdale, AZ USA; [Von Hoff, Daniel D.; Tibes, Raoul; Weiss, Glen J.; Borad, Mitesh J.] Scottsdale Healthcare, Scottsdale, AZ USA; [LoRusso, Patricia M.] Karmanos Canc Inst, Detroit, MI USA	Roche Holding; Genentech; Johns Hopkins University; Translational Genomics Research Institute; Scottsdale Healthcare Osborn; Barbara Ann Karmanos Cancer Institute	Low, JA (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	low.jennifer@gene.com	Tibes, Raoul/AAV-1683-2020; de Sauvage, Frederic/ABE-8400-2020; Rudin, Charles/R-2530-2019	de Sauvage, Frederic/0000-0002-5275-2584; Rudin, Charles/0000-0001-5204-3465; Tibes, Raoul/0000-0002-1372-8733	Genentech	Genentech(Roche HoldingGenentech)	Supported by Genentech.	BINNS W, 1963, AM J VET RES, V24, P1164; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; GALLAGHER RP, 1995, ARCH DERMATOL, V131, P157, DOI 10.1001/archderm.131.2.157; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kovarik CL, 2005, J AM ACAD DERMATOL, V52, P149, DOI 10.1016/j.jaad.2004.08.014; Lear JT, 1997, J ROY SOC MED, V90, P371, DOI 10.1177/014107689709000704; PFEIFFER P, 1990, EUR J CANCER, V26, P73, DOI 10.1016/0277-5379(90)90262-R; RASZEWSKI RL, 1990, ANN PLAS SURG, V24, P170, DOI 10.1097/00000637-199002000-00012; Rubin AI, 2005, NEW ENGL J MED, V353, P2262, DOI 10.1056/NEJMra044151; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; *SEER, CANC FACTS FIG; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wadhera Akhil, 2006, Dermatol Online J, V12, P7; Walling HW, 2004, CANCER METAST REV, V23, P389, DOI 10.1023/B:CANC.0000031775.04618.30; Williams JA, 2003, DRUG NEWS PERSPECT, V16, P657, DOI 10.1358/dnp.2003.16.10.829296; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	21	830	861	4	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1164	1172		10.1056/NEJMoa0905360	http://dx.doi.org/10.1056/NEJMoa0905360			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494QA	19726763	Bronze			2022-12-28	WOS:000269828000007
J	Ludvigsson, JF; Montgomery, SM; Ekbom, A; Brandt, L; Granath, F				Ludvigsson, Jonas F.; Montgomery, Scott M.; Ekbom, Anders; Brandt, Lena; Granath, Fredrik			Small-Intestinal Histopathology and Mortality Risk in Celiac Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POPULATION-BASED COHORT; C-REACTIVE PROTEIN; TISSUE TRANSGLUTAMINASE; GLUTEN SENSITIVITY; INFLAMMATION; DIAGNOSIS; INDIVIDUALS; MALIGNANCY; SMOKING; PEOPLE	Context Studies of mortality in celiac disease have not taken small-intestinal pathology into account. Objective To examine mortality in celiac disease according to small-intestinal histopathology. Design, Setting, and Patients Retrospective cohort study. We collected data from duodenal/jejunal biopsies taken between July 1969 and February 2008 on celiac disease (Marsh stage 3: villous atrophy; n=29 096 individuals) and inflammation (Marsh stage 1-2; n=13 306) from all 28 pathology departments in Sweden. A third cohort consisted of individuals with latent celiac disease from 8 university hospitals (n=3719). Latent celiac disease was defined as positive celiac disease serology in individuals with normal mucosa (Marsh stage 0). Through linkage with the Swedish Total Population Register, we estimated the risk of death through August 31, 2008, compared with age-and sex-matched controls from the general population. Main Outcome Measure All-cause mortality. Results There were 3049 deaths among patients with celiac disease, 2967 with inflammation, and 183 with latent celiac disease. We found an increased hazard ratio (HR) for death in celiac disease (HR, 1.39; 95% confidence interval [CI], 1.33-1.45; median follow-up, 8.8 years), inflammation (HR, 1.72; 95% CI, 1.64-1.79; median follow-up, 7.2 years), and latent celiac disease (HR, 1.35; 95% CI, 1.14-1.58; median follow-up, 6.7 years). The absolute mortality rate was 10.4 (95% CI, 10.0-10.8) per 1000 person-years in celiac disease, 25.9 (95% CI, 25.0-26.8) in inflammation, and 6.7 (95% CI, 5.7-7.6) in latent celiac disease. Excess mortality was 2.9 per 1000 person-years in celiac disease, 10.8 in inflammation, and 1.7 in latent celiac disease. This risk increase was also seen in children. Excluding the first year of follow-up, HRs decreased somewhat. Conclusion Risk of death among patients with celiac disease, inflammation, or latent celiac disease is modestly increased. JAMA. 2009; 302(11): 1171-1178	[Ludvigsson, Jonas F.] Orebro Univ Hosp, Dept Pediat, S-70185 Orebro, Sweden; [Montgomery, Scott M.] Orebro Univ Hosp, Clin Res Ctr, S-70185 Orebro, Sweden; [Ludvigsson, Jonas F.; Montgomery, Scott M.; Ekbom, Anders; Brandt, Lena; Granath, Fredrik] Karolinska Inst, Clin Epidemiol Unit, Dept Med, Stockholm, Sweden; [Montgomery, Scott M.] Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, Charing Cross Hosp, London, England	Orebro University; Orebro University; Karolinska Institutet; Imperial College London	Ludvigsson, JF (corresponding author), Orebro Univ Hosp, Dept Pediat, S-70185 Orebro, Sweden.	jonasludvigsson@yahoo.com	Ludvigsson, Jonas F/A-8560-2012; Montgomery, Scott/AAN-2546-2020	Ludvigsson, Jonas F/0000-0003-1024-5602; Montgomery, Scott/0000-0001-6328-5494	Orebro University Hospital; Swedish Society of Medicine; Swedish Research Council; Sven Jerring Foundation; Orebro Society of Medicine; Karolinska Institutet; Clas Groschinsky Foundation; Juhlin Foundation; Majblomman Foundation; Uppsala-Orebro Regional Research Council; Swedish Celiac Society	Orebro University Hospital; Swedish Society of Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Sven Jerring Foundation; Orebro Society of Medicine; Karolinska Institutet(Karolinska Institutet); Clas Groschinsky Foundation; Juhlin Foundation; Majblomman Foundation; Uppsala-Orebro Regional Research Council; Swedish Celiac Society	Funding/Support: Dr Ludvigsson was supported by a grant from the Orebro University Hospital. This project was supported by a grant from the Swedish Society of Medicine, the Swedish Research Council, the Sven Jerring Foundation, the Orebro Society of Medicine, the Karolinska Institutet, the Clas Groschinsky Foundation, the Juhlin Foundation, the Majblomman Foundation, Uppsala-Orebro Regional Research Council, and the Swedish Celiac Society.	Anderson LA, 2007, WORLD J GASTROENTERO, V13, P146, DOI 10.3748/wjg.v13.i1.146; [Anonymous], 2005, GASTROENTEROLOGY, V128, pS1, DOI 10.1053/j.gastro.2005.02.007; BURGINWOLFF A, 1991, ARCH DIS CHILD, V66, P941, DOI 10.1136/adc.66.8.941; COLLIN P, 1994, GUT, V35, P1215, DOI 10.1136/gut.35.9.1215; Corrao G, 2001, LANCET, V358, P356, DOI 10.1016/S0140-6736(01)05554-4; Cottone M, 1999, DIGEST DIS SCI, V44, P2538, DOI 10.1023/A:1026655609906; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Dickson BC, 2006, J CLIN PATHOL, V59, P1008, DOI 10.1136/jcp.2005.035345; Dieterich W, 1998, GASTROENTEROLOGY, V115, P1317, DOI 10.1016/S0016-5085(98)70007-1; Erlinger TP, 2004, JAMA-J AM MED ASSOC, V291, P585, DOI 10.1001/jama.291.5.585; Hill PG, 2008, ALIMENT PHARM THER, V27, P572, DOI 10.1111/j.1365-2036.2008.03609.x; Johannesson I, 2002, TOTAL POPULATION REG; Lee SK, 2003, GASTROINTEST ENDOSC, V57, P187, DOI 10.1067/mge.2003.54; LOGAN RFA, 1989, GASTROENTEROLOGY, V97, P265, DOI 10.1016/0016-5085(89)90060-7; Ludvigsson JF, 2005, CLIN GASTROENTEROL H, V3, P869, DOI 10.1016/S1542-3565(05)00414-3; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-57; Ludvigsson JF, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-19; Mahadeva S, 2002, J CLIN PATHOL, V55, P424, DOI 10.1136/jcp.55.6.424; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Metzger MH, 2006, EUR J EPIDEMIOL, V21, P359, DOI 10.1007/s10654-006-9002-4; NIELSEN OH, 1985, SCAND J GASTROENTERO, V20, P13, DOI 10.3109/00365528509089626; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Peters U, 2003, ARCH INTERN MED, V163, P1566, DOI 10.1001/archinte.163.13.1566; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Snook JA, 1996, GUT, V39, P60, DOI 10.1136/gut.39.1.60; Solaymani-Dodaran M, 2007, AM J GASTROENTEROL, V102, P864, DOI 10.1111/j.1572-0241.2007.01111.x; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Viljamaa M, 2006, DIGEST LIVER DIS, V38, P374, DOI 10.1016/j.dld.2006.03.002; WALKERSMITH JA, 1990, ARCH DIS CHILD, V65, P909, DOI 10.1136/adc.65.8.909; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C; West J, 2003, GUT, V52, P960, DOI 10.1136/gut.52.7.960; Westin M, 2004, HEALTH POLICY, V68, P333, DOI 10.1016/j.healthpol.2003.10.008	34	277	279	1	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1171	1178		10.1001/jama.2009.1320	http://dx.doi.org/10.1001/jama.2009.1320			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755695				2022-12-28	WOS:000269797600026
J	Schofield, PN; Bubela, T; Weaver, T; Brown, SD; Hancock, JM; Einhorn, D; Tocchini-Valentini, G; de Angelis, MH; Rosenthal, N				Schofield, Paul N.; Bubela, Tania; Weaver, Thomas; Brown, Stephen D.; Hancock, John M.; Einhorn, David; Tocchini-Valentini, Glauco; de Angelis, Martin Hrabe; Rosenthal, Nadia		Casimir Rome Meeting Participants	Post-publication sharing of data and tools	NATURE			English	Editorial Material									[Schofield, Paul N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Bubela, Tania] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6G 2V2, Canada; [Weaver, Thomas] NIH, Natl Ctr Res Resources, Bethesda, MD 20892 USA; [Brown, Stephen D.; Hancock, John M.] MRC Harwell, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England; [Einhorn, David] Jackson Lab, Bar Harbor, ME 04609 USA; [Tocchini-Valentini, Glauco] Ist Biol Cellulare, I-00015 Rome, Italy; [de Angelis, Martin Hrabe] Inst Expt Genet, Munich, Germany; [Rosenthal, Nadia] EMBL Monterotondo, I-00015 Rome, Italy	University of Cambridge; University of Alberta; National Institutes of Health (NIH) - USA; MRC Harwell; Jackson Laboratory; European Molecular Biology Laboratory (EMBL)	Schofield, PN (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England.	PS@mole.bio.cam.ac.uk	Hancock, John/A-2442-2009; Schofield, Paul/AAA-9414-2020; Hubbard, Tim J/C-2567-2008; de Angelis, Martin Hrabe/F-5531-2012; Rosenthal, Nadia/O-7009-2015; Bubela, Tania/F-4860-2014; Hubbard, Tim J.P./AAT-4571-2020	Hancock, John/0000-0003-2991-2217; Schofield, Paul/0000-0002-5111-7263; Hubbard, Tim J/0000-0002-1767-9318; de Angelis, Martin Hrabe/0000-0002-7898-2353; Bubela, Tania/0000-0002-0807-2899; Hubbard, Tim J.P./0000-0002-1767-9318; MATTEONI, RAFAELE/0000-0002-0314-5948; McKerlie, Colin/0000-0002-2232-0967; Rosenthal, Nadia/0000-0002-7599-7365; Quackenbush, John/0000-0002-2702-5879; Gkoutos, Georgios/0000-0002-2061-091X	Medical Research Council [MC_U142684171] Funding Source: Medline; NHLBI NIH HHS [R01 HL111759] Funding Source: Medline; NLM NIH HHS [R01 LM010129, R01 LM008795] Funding Source: Medline; Wellcome Trust [077198, 062023] Funding Source: Medline; MRC [MC_U142684171] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson NR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-260; Cohen CB, 2008, AM J BIOETHICS, V8, P30, DOI 10.1080/15265160802248237; HUGO, 1996, 1 INT STRAT M HUM GE; National Institutes of Health (NIH), 2003, FIN NIH STAT SHAR RE; Natl. Res. Counc. Comm. Responsib. Authorship Biol. Sci, 2003, SHAR PUBL REL DAT MA; Nelson RR, 2004, RES POLICY, V33, P455, DOI 10.1016/j.respol.2003.09.008; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; Walsh JP, 2007, RES POLICY, V36, P1184, DOI 10.1016/j.respol.2007.04.006; Wellcome Trust, 2003, SHAR DAT LARG SCAL B; 2009, NATURE BIOTECHNOL, V27, P579; 1999, FED REG, V64, P72090	11	101	105	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					171	173		10.1038/461171a	http://dx.doi.org/10.1038/461171a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	492KN	19741686	Green Accepted, hybrid			2022-12-28	WOS:000269654600018
J	Francois, P; Vonica, A; Brivanlou, AH; Siggia, ED				Francois, Paul; Vonica, Alin; Brivanlou, Ali H.; Siggia, Eric D.			Scaling of BMP gradients in Xenopus embryos	NATURE			English	Letter							ORGANIZER; PATTERNS; AXIS		[Francois, Paul; Siggia, Eric D.] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Vonica, Alin; Brivanlou, Ali H.] Rockefeller Univ, Lab Mol Vertebrate Embryol, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Francois, P (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, 1230 York Ave, New York, NY 10065 USA.	siggiae@rockefeller.edu	Francois, Paul/G-5673-2010	Francois, Paul/0000-0002-2223-839X				Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; COOKE J, 1981, NATURE, V290, P775, DOI 10.1038/290775a0; Faure S, 2000, DEVELOPMENT, V127, P2917; Gerhart J, 2002, DEV DYNAM, V225, P380, DOI 10.1002/dvdy.10198; KAGEURA H, 1984, DEV BIOL, V101, P410, DOI 10.1016/0012-1606(84)90155-6; Kinoshita T, 2006, DEV DYNAM, V235, P3189, DOI 10.1002/dvdy.20963; Marom K, 2005, DEV BIOL, V282, P442, DOI 10.1016/j.ydbio.2005.03.024; Meinhardt H, 2001, INT J DEV BIOL, V45, P177; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; Schohl A, 2002, DEVELOPMENT, V129, P37; Solnica-Krezel L, 2003, CURR BIOL, V13, pR7, DOI 10.1016/S0960-9822(02)01378-7; Tucker JA, 2008, DEV CELL, V14, P108, DOI 10.1016/j.devcel.2007.11.004; Williams PH, 2004, CURR BIOL, V14, P1916, DOI 10.1016/j.cub.2004.10.020	15	18	18	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 3	2009	461	7260					E1	E1		10.1038/nature08305	http://dx.doi.org/10.1038/nature08305			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19736667	Bronze			2022-12-28	WOS:000269478800027
J	Kadhiravan, T; Sharma, SK				Kadhiravan, Tamilarasu; Sharma, Surendra K.			Giant Congenital Nevus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kadhiravan, Tamilarasu; Sharma, Surendra K.] All India Inst Med Sci, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Kadhiravan, T (corresponding author), All India Inst Med Sci, New Delhi, India.	sksharma@aiims.ac.in	Kadhiravan, Tamilarasu/AAU-8104-2020	Kadhiravan, Tamilarasu/0000-0002-4676-743X					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					E15	E15		10.1056/NEJMicm0802078	http://dx.doi.org/10.1056/NEJMicm0802078			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19726769				2022-12-28	WOS:000269480400011
J	Huybers, P				Huybers, Peter			Antarctica's Orbital Beat	SCIENCE			English	Editorial Material							TEMPERATURE		Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Harvard University	Huybers, P (corresponding author), Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA.	phuybers@fas.harvard.edu		Huybers, Peter/0000-0002-3734-8145				HUTTERLI M, 2009, GEOPH RES ABSTR, V11; Huybers P, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017875; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Imbrie J, 1992, PALEOCEANOGRAPHY, V7, P701, DOI 10.1029/92PA02253; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kaiser J, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001146; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; LAEPPLE T, 2009, GEOPH RES ABSTR, V11; Lee JE, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009859; LORIUS C, 1990, NATURE, V347, P139, DOI 10.1038/347139a0; Mercer J.H., 1984, CLIM PROCESS CLIM SE, V29, P307, DOI DOI 10.1029/GM029P0307; Milankovitch M., 1941, KANON ERDBESTRAHLUNG; Rubincam DP, 2004, THEOR APPL CLIMATOL, V79, P111, DOI 10.1007/s00704-004-0056-5; Timmermann A, 2009, J CLIMATE, V22, P1626, DOI 10.1175/2008JCLI2161.1	14	21	22	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1085	1086		10.1126/science.1176186	http://dx.doi.org/10.1126/science.1176186			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713518				2022-12-28	WOS:000269382300029
J	Sokol, DK				Sokol, Daniel K.			Observations Ethics Man Informed consent is more than a patient's signature	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, London WC1E 7HU, England	University of London	Sokol, DK (corresponding author), Univ London, London WC1E 7HU, England.	daniel.sokol@talk21.com						Jones M A, 1999, Med Law Rev, V7, P103, DOI 10.1093/medlaw/7.2.103; MANSON Neil, 2007, RETHINKING INFORM CO; Sokol DK, 2008, J ROY SOC MED, V101, P443, DOI 10.1258/jrsm.2008.080133	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2009	339								b3224	10.1136/bmj.b3224	http://dx.doi.org/10.1136/bmj.b3224			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489AY	19713231				2022-12-28	WOS:000269393100004
J	Weinfurt, KP; Hall, MA; King, NMP; Friedman, JY; Schulman, KA; Sugarman, J				Weinfurt, Kevin P.; Hall, Mark A.; King, Nancy M. P.; Friedman, Joelle Y.; Schulman, Kevin A.; Sugarman, Jeremy			Disclosure of Financial Relationships to Participants in Clinical Research.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CONFLICTS-OF-INTEREST; POTENTIAL RESEARCH PARTICIPANTS; INFORMED-CONSENT; VIEWS; INVESTIGATOR; PHYSICIANS; INTERESTS; POLICIES; TRUST		[Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA; [Sugarman, Jeremy] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Weinfurt, Kevin P.; Friedman, Joelle Y.; Schulman, Kevin A.] Duke Univ, Sch Med, Ctr Clin & Genet Econ, Duke Clin Res Inst, Durham, NC USA; [Weinfurt, Kevin P.] Duke Univ, Sch Med, Dept Psychiat & Behav Sci, Durham, NC USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC USA; [Hall, Mark A.; King, Nancy M. P.] Wake Forest Univ, Sch Med, Ctr Bioeth Hlth & Soc, Winston Salem, NC 27109 USA; [Hall, Mark A.; King, Nancy M. P.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Dept Social Sci & Hlth Policy, Winston Salem, NC 27109 USA	Johns Hopkins University; Johns Hopkins University; Duke University; Duke University; Duke University; Wake Forest University; Wake Forest University	Sugarman, J (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Hampton House 351,624 N Broadway, Baltimore, MD 21205 USA.	jsugarm1@jhmi.edu		Sugarman, Jeremy/0000-0001-7022-8332; Hall, Mark A./0000-0001-6277-144X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075538] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL075538, R01 HL075538-03, R01 HL075538-02, R01 HL075538-04, R01 HL075538-01, R01HL075538, R01 HL075538-05] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		APPELBAUM PS, 1982, INT J LAW PSYCHIAT, V5, P319, DOI 10.1016/0160-2527(82)90026-7; APPELBAUM PS, 1987, HASTINGS CENT REP, V17, P20, DOI 10.2307/3562038; Association of American Medical Colleges, 2008, PROT PAT PRES INT AD; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Boyd EA, 2004, HEALTH AFFAIR, V23, P206, DOI 10.1377/hlthaff.23.2.206; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; CAPRON AM, 1974, U PENN LAW REV, V123, P340, DOI 10.2307/3311492; Coleman C.H., 2005, VANDERBILT LAW REV, V58, P387; Dana J, 2003, JAMA-J AM MED ASSOC, V290, P252, DOI 10.1001/jama.290.2.252; Danforth W, 2003, ACAD MED, V78, P237; DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2009, DHHS PUBL, V2009-119; Dresser R, 2002, SOC PHILOS POLICY, V19, P271, DOI 10.1017/S0265052502192119; Ehringhaus SH, 2008, JAMA-J AM MED ASSOC, V299, P665, DOI 10.1001/jama.299.6.665; Faden R., 1986, HIST THEORY INFORM C; FADEN RR, 1980, SOC INDIC RES, V7, P313, DOI 10.1007/BF00305604; Fisher MA, 2007, PERSPECT BIOL MED, V50, P1, DOI 10.1353/pbm.2007.0003; Friedman JY, 2007, CLIN TRIALS, V4, P272, DOI 10.1177/1740774507079239; Grady C, 2006, J LAW MED ETHICS, V34, P592, DOI 10.1111/j.1748-720X.2006.00073.x; Hall MA, 2001, MILBANK Q, V79, P613, DOI 10.1111/1468-0009.00223; Hall MA, 1998, ANN INTERN MED, V128, P395, DOI 10.7326/0003-4819-128-5-199803010-00009; Hall MA, 2002, HEALTH AFFAIR, V21, P197, DOI 10.1377/hlthaff.21.2.197; HALL MA, 2007, HLTH CARE LAW ETHICS; Hampson LA, 2006, NEW ENGL J MED, V355, P2330, DOI 10.1056/NEJMsa064160; Institute of Medicine, 2009, CONFL INT MED RES ED; Kass NE, 1996, HASTINGS CENT REP, V26, P25, DOI 10.2307/3528467; Kim SYH, 2004, J MED ETHICS, V30, P73, DOI 10.1136/jme.2002.001461; Krimsky Sheldon, 2004, Account Res, V11, P79, DOI 10.1080/03050620490512214; Lavori PW, 1999, CONTROL CLIN TRIALS, V20, P187, DOI 10.1016/S0197-2456(98)00064-6; Lipton Shira, 2004, Account Res, V11, P83, DOI 10.1080/03050620490512241; Medicare Payment Advisory Commission, 2021, REP C MED PAYM POL; MEDPAC, 2008, REP C REF DEL SYST; Morin K, 2002, JAMA-J AM MED ASSOC, V287, P78, DOI 10.1001/jama.287.1.78; Morreim EH, 2005, J LAW MED ETHICS, V33, P586, DOI 10.1111/j.1748-720X.2005.tb00521.x; Resnik David B, 2004, Account Res, V11, P141, DOI 10.1080/03050620490512322; Sage WM, 2007, TEX LAW REV, V85, P1413; Stossel TP, 2005, NEW ENGL J MED, V353, P1060, DOI 10.1056/NEJMsb051758; Weinfurt KP, 2008, AM HEART J, V156, P689, DOI 10.1016/j.ahj.2008.06.001; Weinfurt KP, 2008, J GEN INTERN MED, V23, P860, DOI 10.1007/s11606-008-0590-4; Weinfurt KP, 2006, J LAW MED ETHICS, V34, P581, DOI 10.1111/j.1748-720X.2006.00072.x; Weinfurt KP, 2006, J GEN INTERN MED, V21, P901, DOI 10.1111/j.1525-1497.2006.00502.x; Weinfurt KP, 2006, ACAD MED, V81, P113, DOI 10.1097/00001888-200602000-00003; Weissman JS, 2008, J EMPIR RES HUM RES, V3, P3, DOI 10.1525/jer.2008.3.1.3; WILSON RF, 2009, MONEY PRESTIGE CONFL	43	26	27	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					916	921		10.1056/NEJMsb0902598	http://dx.doi.org/10.1056/NEJMsb0902598			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	487XV	19710491	Green Accepted			2022-12-28	WOS:000269312700014
J	Cole, BL; Harris, RW				Cole, Barry L.; Harris, Ross W.			Caution: coloured medication and the colour blind	LANCET			English	Editorial Material							VISION		[Cole, Barry L.; Harris, Ross W.] Univ Melbourne, Victorian Coll Optometry, Melbourne, Vic 3053, Australia	University of Melbourne	Cole, BL (corresponding author), Univ Melbourne, Victorian Coll Optometry, Corner Cardigan & Keppel St, Melbourne, Vic 3053, Australia.	bcole@vco.org.au		Mishra, Arun Kumar/0000-0001-6096-8097				Cole BL, 2006, OPTOMETRY VISION SCI, V83, P879, DOI 10.1097/01.opx.0000249974.22205.2a; STEWARD JM, 1989, OPTOMETRY VISION SCI, V66, P288, DOI 10.1097/00006324-198905000-00006	2	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2009	374	9691					720	720		10.1016/S0140-6736(09)60313-5	http://dx.doi.org/10.1016/S0140-6736(09)60313-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489LV	19716964				2022-12-28	WOS:000269422500028
J	Welte, T				Welte, Tobias			Inhaled corticosteroids in COPD and the risk of pneumonia	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; COMMUNITY-ACQUIRED PNEUMONIA; SALMETEROL/FLUTICASONE PROPIONATE; EXACERBATIONS; SALMETEROL; CAPNETZ; PATIENT		Hannover Med Sch, Dept Resp Med, D-30659 Hannover, Germany	Hannover Medical School	Welte, T (corresponding author), Hannover Med Sch, Dept Resp Med, D-30659 Hannover, Germany.	welte.tobias@mh-hannover.de						Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Garcia-Vidal C, 2007, EUR RESPIR J, V30, P951, DOI 10.1183/09031936.00027607; Kardos P, 2007, AM J RESP CRIT CARE, V175, P144, DOI 10.1164/rccm.200602-244OC; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; Restrepo MI, 2006, EUR RESPIR J, V28, P346, DOI 10.1183/09031936.06.00131905; Sin DD, 2009, LANCET, V374, P712, DOI 10.1016/S0140-6736(09)61250-2; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; von Baum H, 2010, EUR RESPIR J, V35, P598, DOI 10.1183/09031936.00091809; von Baum H, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-62; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Welte T, 2004, INFECTION, V32, P234, DOI 10.1007/s15010-004-3107-z; Welte T, 2009, INT J CLIN PRACT, V63, P1136, DOI 10.1111/j.1742-1241.2009.02139.x; Welte T, 2009, SEMIN RESP CRIT CARE, V30, P127, DOI 10.1055/s-0029-1202941	16	15	16	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					668	670		10.1016/S0140-6736(09)61540-3	http://dx.doi.org/10.1016/S0140-6736(09)61540-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716946				2022-12-28	WOS:000269422500006
J	Puschnig, P; Berkebile, S; Fleming, AJ; Koller, G; Emtsev, K; Seyller, T; Riley, JD; Ambrosch-Draxl, C; Netzer, FP; Ramsey, MG				Puschnig, Peter; Berkebile, Stephen; Fleming, Alexander J.; Koller, Georg; Emtsev, Konstantin; Seyller, Thomas; Riley, John D.; Ambrosch-Draxl, Claudia; Netzer, Falko P.; Ramsey, Michael G.			Reconstruction of Molecular Orbital Densities from Photoemission Data	SCIENCE			English	Article							ANGLE-RESOLVED PHOTOEMISSION; PHOTOELECTRON-SPECTROSCOPY; ANGULAR-DISTRIBUTIONS; LEAD PHTHALOCYANINE; ORIENTED FILMS; THIN-FILMS; SURFACE; ORIENTATION; APPROXIMATION; SEXIPHENYL	Photoemission spectroscopy is commonly applied to study the band structure of solids by measuring the kinetic energy versus angular distribution of the photoemitted electrons. Here, we apply this experimental technique to characterize discrete orbitals of large pi-conjugated molecules. By measuring the photoemission intensity from a constant initial-state energy over a hemispherical region, we generate reciprocal space maps of the emitting orbital density. We demonstrate that the real-space electron distribution of molecular orbitals in both a crystalline pentacene film and a chemisorbed p-sexiphenyl monolayer can be obtained from a simple Fourier transform of the measurement data. The results are in good agreement with density functional calculations.	[Puschnig, Peter; Ambrosch-Draxl, Claudia] Univ Leoben, Chair Atomist Modelling & Design Mat, A-8700 Leoben, Austria; [Berkebile, Stephen; Fleming, Alexander J.; Koller, Georg; Netzer, Falko P.; Ramsey, Michael G.] Karl Franzens Univ Graz, Inst Phys, A-8010 Graz, Austria; [Emtsev, Konstantin; Seyller, Thomas] Univ Erlangen Nurnberg, Lehrstuhl Tech Phys, D-91058 Erlangen, Germany; [Riley, John D.] La Trobe Univ, Dept Phys, Bundoora, Vic 3086, Australia	University of Leoben; University of Graz; University of Erlangen Nuremberg; La Trobe University	Puschnig, P (corresponding author), Univ Leoben, Chair Atomist Modelling & Design Mat, A-8700 Leoben, Austria.	peter.puschnig@unileoben.ac.at	Puschnig, Peter/C-9203-2011; Seyller, Thomas K/F-8410-2011; Draxl, Claudia/O-6189-2016	Puschnig, Peter/0000-0002-8057-7795; Seyller, Thomas K/0000-0002-4953-2142; Draxl, Claudia/0000-0003-3523-6657				Berkebile S, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115312; Brion CE, 2001, CHEM PHYS, V270, P13, DOI 10.1016/S0301-0104(01)00385-8; Broekman L, 2005, J ELECTRON SPECTROSC, V144, P1001, DOI 10.1016/j.elspec.2005.01.022; Damascelli A, 2004, PHYS SCRIPTA, VT109, P61, DOI 10.1238/Physica.Topical.109a00061; FEIBELMAN PJ, 1974, PHYS REV B, V10, P4932, DOI 10.1103/PhysRevB.10.4932; GADZUK JW, 1974, PHYS REV B, V10, P5030, DOI 10.1103/PhysRevB.10.5030; GOLDBERG SM, 1978, SOLID STATE COMMUN, V28, P459, DOI 10.1016/0038-1098(78)90838-4; Gonze X, 2002, COMP MATER SCI, V25, P478, DOI 10.1016/S0927-0256(02)00325-7; GROBMAN WD, 1978, PHYS REV B, V17, P4573, DOI 10.1103/PhysRevB.17.4573; HASEGAWA S, 1993, PHYS REV B, V48, P2596, DOI 10.1103/PhysRevB.48.2596; Hummer K, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205205; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Kakuta H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.247601; Kera S, 2006, CHEM PHYS, V325, P113, DOI 10.1016/j.chemphys.2005.10.023; Koch N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.156803; Koini M, 2008, THIN SOLID FILMS, V517, P483, DOI 10.1016/j.tsf.2008.06.053; Koller G, 2007, SCIENCE, V317, P351, DOI 10.1126/science.1143239; Nabok D, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.235322; Oehzelt M, 2007, CHEMPHYSCHEM, V8, P1707, DOI 10.1002/cphc.200700357; PERMIEN T, 1983, CHEM PHYS LETT, V98, P527, DOI 10.1016/0009-2614(83)80234-6; RAMSEY MG, 1994, EUROPHYS LETT, V28, P85, DOI 10.1209/0295-5075/28/2/002; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; RICHARDSON NV, 1983, CHEM PHYS LETT, V102, P390, DOI 10.1016/0009-2614(83)87062-6; Schwarz WHE, 2006, ANGEW CHEM INT EDIT, V45, P1508, DOI 10.1002/anie.200501333; SHIRLEY EL, 1995, PHYS REV B, V51, P13614, DOI 10.1103/PhysRevB.51.13614; Temirov R, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/5/053012; Tiago ML, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.115212; Ueno N, 1997, J CHEM PHYS, V107, P2079, DOI 10.1063/1.474558	28	216	216	0	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 30	2009	326	5953					702	706		10.1126/science.1176105	http://dx.doi.org/10.1126/science.1176105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19745118				2022-12-28	WOS:000271233200030
J	Bramanti, B; Thomas, MG; Haak, W; Unterlaender, M; Jores, P; Tambets, K; Antanaitis-Jacobs, I; Haidle, MN; Jankauskas, R; Kind, CJ; Lueth, F; Terberger, T; Hiller, J; Matsumura, S; Forster, P; Burger, J				Bramanti, B.; Thomas, M. G.; Haak, W.; Unterlaender, M.; Jores, P.; Tambets, K.; Antanaitis-Jacobs, I.; Haidle, M. N.; Jankauskas, R.; Kind, C. -J.; Lueth, F.; Terberger, T.; Hiller, J.; Matsumura, S.; Forster, P.; Burger, J.			Genetic Discontinuity Between Local Hunter-Gatherers and Central Europe's First Farmers	SCIENCE			English	Article								After the domestication of animals and crops in the Near East some 11,000 years ago, farming had reached much of central Europe by 7500 years before the present. The extent to which these early European farmers were immigrants or descendants of resident hunter-gatherers who had adopted farming has been widely debated. We compared new mitochondrial DNA ( mtDNA) sequences from late European hunter-gatherer skeletons with those from early farmers and from modern Europeans. We find large genetic differences between all three groups that cannot be explained by population continuity alone. Most (82%) of the ancient hunter-gatherers share mtDNA types that are relatively rare in central Europeans today. Together, these analyses provide persuasive evidence that the first farmers were not the descendants of local hunter-gatherers but immigrated into central Europe at the onset of the Neolithic.	[Bramanti, B.; Haak, W.; Unterlaender, M.; Jores, P.; Burger, J.] Johannes Gutenberg Univ Mainz, Inst Anthropol, Mainz, Germany; [Thomas, M. G.] UCL, Res Dept Genet Evolut & Environm, London WC1E 6BT, England; [Thomas, M. G.] UCL, Arts & Humanities Res Council, Ctr Evolut Cultural Divers, London WC1E 6BT, England; [Tambets, K.] Univ Tartu, Dept Evolutionary Biol, Inst Mol & Cell Biol, EE-50090 Tartu, Estonia; [Tambets, K.] Estonian Bioctr, Tartu, Estonia; [Antanaitis-Jacobs, I.; Jankauskas, R.] Univ Vilnius, Dept Anat Histol & Anthropol, Vilnius, Lithuania; [Haidle, M. N.] Heidelberg Acad Sci & Humanities, Senckenberg Res Inst, Res Ctr Role Culture Early Expans Humans, Frankfurt, Germany; [Kind, C. -J.] Regierungsprasidium Stuttgart, Landesamt, Germany; [Lueth, F.] RGK, Frankfurt, Germany; [Terberger, T.] Ernst Moritz Arndt Univ Greifswald, Lehrstuhl Ur & Fruhgeschichte, D-17487 Greifswald, Germany; [Hiller, J.] Cardiff Univ, Cardiff Sch Optometry & Vis Sci, Biophys Grp, Cardiff, Wales; [Matsumura, S.] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Matsumura, S.] Leibniz Inst Freshwater Ecol & Inland Fisheries, Berlin, Germany; [Forster, P.] Cambridge Soc Applicat Res, Cambridge, England	Johannes Gutenberg University of Mainz; University of London; University College London; UK Research & Innovation (UKRI); Arts & Humanities Research Council (AHRC); University of London; University College London; University of Tartu; Estonian Biocentre; Vilnius University; Senckenberg Gesellschaft fur Naturforschung (SGN); Ernst Moritz Arndt Universitat Greifswald; Cardiff University; International Institute for Applied Systems Analysis (IIASA); Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB)	Bramanti, B (corresponding author), Johannes Gutenberg Univ Mainz, Inst Anthropol, Mainz, Germany.	bramanti@uni-mainz.de	Thomas, Mark G/A-2219-2012; Matsumura, Shuichi/C-7986-2013; Haak, Wolfgang/Z-4947-2019; Bramanti, Barbara/AAF-8542-2019; Jankauskas, Rimantas/Q-7689-2017; Haak, Wolfgang/C-2362-2014; Tambets, Kristiina/M-2568-2019; Bramanti, Barbara/A-9112-2015	Thomas, Mark G/0000-0002-2452-981X; Matsumura, Shuichi/0000-0002-0368-006X; Haak, Wolfgang/0000-0003-2475-2007; Bramanti, Barbara/0000-0002-5433-663X; Jankauskas, Rimantas/0000-0001-7611-2576; Haak, Wolfgang/0000-0003-2475-2007; Tambets, Kristiina/0000-0002-8173-6380; Bramanti, Barbara/0000-0002-5433-663X; Bardsley, Jennifer/0000-0001-8714-942X; Terberger, Dr. Thomas/0000-0001-9802-5553	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft; Estonian Science Foundation [6040]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Estonian Science Foundation	The authors are grateful to W. Guminski ( Institute of Archeology and Ethnology, Polish Academy of Sciences, Warsaw, Poland), J. Siemaszko ( Suwalki Province Museum, Suwalki, Poland), A. Khokhlov ( Institute of Cell Biophysics, Russian Academy of Sciences, Pushchino, Moscow oblast, Russia), H. Meller and M. Porr (Landesamt fur Arch ologie Sachsen-Anhalt, Halle/Saale, Germany), and L. P. Louwe Kooijmans and L. Smits ( Faculty of Archeology, Leiden University, Leiden, Netherlands) for providing them with the archaeological samples. The authors are indebted to R. Villems, A. Zimmermann, and J. Luning for comments and to D. Kasperaviciute for Lithuanian sequences. We also thank M. Forster for editorial comments. Research grants were provided by the Bundesministerium fur Bildung und Forschung, the Deutsche Forschungsgemeinschaft, and the Estonian Science Foundation ( grant no. 6040 to K. T).	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; [Anonymous], 2013, INS PESTS POT GLOB, DOI DOI 10.1016/B978-0-12-386895-4.00005-3; Childe V.G., 1925, DAWN EUROPEAN CIVILI; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; DANGEGLOCKE U, 2007, CALPAL ONLINE; DEMORTILLET G, 1897, FORMATION NATION FRA; Eberhards G, 2002, JUT ARCH SOC PUBL, V39, P85; Eriksen BV, 2002, JUT ARCH SOC PUBL, V39, P25; GRONEBORN D, 1997, UNIVERSITATSFORSCHUN, V37; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; HAAK W, 2006, THESIS MAINZ U MAINZ; HARVATI K, 2007, HDB PALEOANTHROPOLOG, V3, P1717; MATEICIUCOVA I., 2003, ARCH INF, V26, P299; Mellars P, 2004, NATURE, V432, P461, DOI 10.1038/nature03103; PAVUK J, 2005, BANDKERAMIK, V21, P17; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rohl A, 2001, INT J LEGAL MED, V115, P29, DOI 10.1007/s004140100217; Terberger T, 2002, ANTIQUITY, V76, P691, DOI 10.1017/S0003598X00091134; Zimmermann A., 2004, BERICHT ROMISCH GERM, V85, P37; Zvelebil M., 1998, HARVESTING SEA FARMI, P9	21	327	331	1	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					137	140		10.1126/science.1176869	http://dx.doi.org/10.1126/science.1176869			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19729620				2022-12-28	WOS:000270355600054
J	Uraguchi, D; Ueki, Y; Ooi, T				Uraguchi, Daisuke; Ueki, Yusuke; Ooi, Takashi			Chiral Organic Ion Pair Catalysts Assembled Through a Hydrogen-Bonding Network	SCIENCE			English	Article							ORGANOCATALYSTS; ACIDS	Research to develop structurally discrete, chiral supramolecular catalysts for asymmetric organic transformations has met with limited success. Here, we report that a chiral tetraaminophosphonium cation, two phenols, and a phenoxide anion appear to self-assemble into a catalytically active supramolecular architecture through intermolecular hydrogen bonding. The structure of the resulting molecular assembly was determined in the solid state by means of x-ray diffraction analysis. Furthermore, in solution the complex promotes a highly stereoselective conjugate addition of acyl anion equivalents to alpha,beta-unsaturated ester surrogates with a broad substrate scope. All structural components of the catalyst cooperatively participate in the stereocontrolling event.	[Uraguchi, Daisuke; Ueki, Yusuke; Ooi, Takashi] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Nagoya University	Ooi, T (corresponding author), Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.	tooi@apchem.nagoya-u.ac.jp	Uraguchi, Daisuke/I-6592-2014; Ooi, Takashi/AAD-2730-2022; Ooi, Takashi/E-2364-2012	Uraguchi, Daisuke/0000-0002-6584-797X; Ooi, Takashi/0000-0003-2332-0472; Ooi, Takashi/0000-0003-2332-0472	Ministry of Education, Culture, Sports, Science and Technology, Japan; Global Centers of Excellence Program in Chemistry of Nagoya University; Japan Society for the Promotion of Science for Scientific Research; Kurata Memorial Hitachi Science and Technology Foundation	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Centers of Excellence Program in Chemistry of Nagoya University; Japan Society for the Promotion of Science for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kurata Memorial Hitachi Science and Technology Foundation	Financial support was provided by a Grant-in-Aid for Scientific Research on Priority Areas "Chemistry of Concerto Catalysis" from the Ministry of Education, Culture, Sports, Science and Technology, Japan, the Global Centers of Excellence Program in Chemistry of Nagoya University, Grants of Japan Society for the Promotion of Science for Scientific Research, and the Kurata Memorial Hitachi Science and Technology Foundation. We gratefully acknowledge S. Hiroto and H. Shinokubo ( Nagoya University) for kindly allowing us access to high-resolution mass spectroscopy facilities. Structural parameters for 1a center dot(OPh)<INF>3</INF>H<INF>2</INF> are available free of charge from the Cambridge Crystallographic Data Centre under reference number CCDC 741902.	Barco A, 1996, TETRAHEDRON, V52, P4719, DOI 10.1016/0040-4020(96)00143-3; Breit B, 2008, PURE APPL CHEM, V80, P855, DOI 10.1351/pac200880050855; Breuil PAR, 2009, ANGEW CHEM INT EDIT, V48, P2162, DOI 10.1002/anie.200806177; Clarke ML, 2007, ANGEW CHEM INT EDIT, V46, P930, DOI 10.1002/anie.200602912; Katritzky AR, 2003, SYNTHESIS-STUTTGART, P2795, DOI 10.1055/s-2003-42462; Meot-Ner M, 2005, CHEM REV, V105, P213, DOI 10.1021/cr9411785; Park J, 2008, J AM CHEM SOC, V130, P16484, DOI 10.1021/ja807221s; Tozawa T, 2007, CHEM-ASIAN J, V2, P123, DOI 10.1002/asia.200600228; Uraguchi D, 2008, J AM CHEM SOC, V130, P14088, DOI 10.1021/ja806311e; Uraguchi D, 2007, J AM CHEM SOC, V129, P12392, DOI 10.1021/ja075152+; vanLeeuwen P.W.N.M., 2008, SUPRAMOLECULAR CATAL; Yamamoto H, 2005, ANGEW CHEM INT EDIT, V44, P1924, DOI 10.1002/anie.200460394	12	188	188	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					120	123		10.1126/science.1176758	http://dx.doi.org/10.1126/science.1176758			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	501CA	19713492				2022-12-28	WOS:000270355600048
J	Seedat, M; Van Niekerk, A; Jewkes, R; Suffla, S; Ratele, K				Seedat, Mohamed; Van Niekerk, Ashley; Jewkes, Rachel; Suffla, Shahnaaz; Ratele, Kopano			Health in South Africa 5 Violence and injuries in South Africa: prioritising an agenda for prevention	LANCET			English	Article							ATTENDING ANTENATAL CLINICS; INTIMATE-PARTNER VIOLENCE; GENDER-BASED VIOLENCE; RISK-FACTORS; WESTERN CAPE; BURN INJURY; HIV; WOMEN; RAPE; CHILDHOOD	Violence and injuries are the second leading cause of death and lost disability-adjusted life years in South Africa. The overall injury death rate of 157.8 per 100 000 population is nearly twice the global average, and the-rate of homicide of women by intimate partners is six times the global average. With a focus on homicide, and violence against women and children, we review the magnitude, contexts of occurrence, and patterns of violence, and refer to traffic-related and other unintentional injuries. The social dynamics that support violence are widespread poverty, unemployment, and income inequality; patriarchal notions of masculinity that valourise toughness, risk-taking, and defence of honour; exposure to abuse in childhood and weak parenting; access to firearms; widespread alcohol misuse; and weaknesses in the mechanisms of law enforcement. Although there have been advances in development of services for victims of violence, innovation from non-governmental organisations, and evidence from research, there has been a conspicuous absence of government stewardship and leadership. Successful prevention of violence and injury is contingent on identification by the government of violence as a strategic priority and development of an intersectoral plan based on empirically driven programmes and policies.	[Seedat, Mohamed; Ratele, Kopano] Univ S Africa, Inst Social & Hlth Sci, Johannesburg, South Africa; [Seedat, Mohamed; Van Niekerk, Ashley; Suffla, Shahnaaz; Ratele, Kopano] Univ S Africa, Crime Violence & Injury Lead Programme, MRC, Cape Town, South Africa; [Jewkes, Rachel] MRC, Gender & Hlth Res Unit, Pretoria, South Africa	University of South Africa; University of South Africa	Van Niekerk, A (corresponding author), POB 19070, ZA-7505 Tygerberg, South Africa.	ashley.vanniekerk@mrc.ac.za	Ratele, Kopano/R-6624-2019	Ratele, Kopano/0000-0002-1688-5136; Seedat, Mohamed/0000-0001-9018-3370; Jewkes, Rachel/0000-0002-4330-6267; van Niekerk, Ashley/0000-0003-2900-8519				Abrahams N, 2006, TROP MED INT HEALTH, V11, P751, DOI 10.1111/j.1365-3156.2006.01600.x; Abrahams N, 2005, AM J PUBLIC HEALTH, V95, P1811, DOI 10.2105/AJPH.2003.035006; Abrahams N, 2004, B WORLD HEALTH ORGAN, V82, P330; ABRAHAMS N, VIOLENCE VI IN PRESS; Abrahams N, 2008, FORENSIC SCI INT, V178, P132, DOI 10.1016/j.forsciint.2008.03.006; Alpers P, 2002, INJ PREV, V8, P262, DOI 10.1136/ip.8.4.262; Altbeker A, 2008, CRIME VIOLENCE INJUR, P122; Altbeker A., 2007, COUNTRY WAR ITSELF; BHAILIA M, 2007, THESIS U WITWATERSRA; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P643; BURGER D, 2006, S AFRICA YB 2005 200; Christofides NJ, 2005, B WORLD HEALTH ORGAN, V83, P495; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; DENSON H, 2008, PROFILE FATAL INJURI; *DEP MIN EN REP S, MIN HLTH SAF; DEPARTMENT OF SOCIAL DEVELOPMENT, 2007, NAT DRUG MAST PLAN 2; Dunkle KL, 2004, AM J EPIDEMIOL, V160, P230, DOI 10.1093/aje/kwh194; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; Forjuoh S., 2008, WORLD REPORT CHILD I, P79; Gawryszewski VP, 2005, REV SAUDE PUBL, V39, P191, DOI 10.1590/S0034-89102005000200008; Groenewald P, 2008, CAUSE DEATH PREMATUR; Hearn J., 2007, BOYS MEN SOCIAL CONS, P12; Hotaling G T, 1986, Violence Vict, V1, P101; Human Rights Watch, 2001, SCAR SCH SEX VIOL GI; HUMAN RIGHTS WATCH, 1995, VIOL WOM S AFR STAT; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1461, DOI 10.1093/ije/dyl218; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1455, DOI 10.1093/ije/dyl217; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; Jewkes R, 2002, LANCET, V359, P319, DOI 10.1016/S0140-6736(02)07530-X; Jewkes R, 2000, INT CLIN PSYCHOPHARM, V15, pS37; Jewkes R, 2001, SOC SCI MED, V52, P733, DOI 10.1016/S0277-9536(00)00177-5; JEWKES R, 2002, SOC SCI MED, V55, P153; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Jina R., 2008, PARTICIPANTS MANUAL; Kaminer D, 2008, SOC SCI MED, V67, P1589, DOI 10.1016/j.socscimed.2008.07.023; KEEGAN M, 2004, CRIME VIOLENCE INJUR, P65; KIRSTEN A, 2004, ROLE SOCIAL MOVEMENT; KOSS MP, 1989, J CONSULT CLIN PSYCH, V57, P242, DOI 10.1037/0022-006X.57.2.242; Krug E. G., 2002, WORLD HLTH REPORT VI; Krug EG, 1998, INT J EPIDEMIOL, V27, P214, DOI 10.1093/ije/27.2.214; LUYT R, 2005, SEXUALITY AFRICA MAG, V2, P11; MAFELA N, 2009, SUNDAY TIMES JO 0322; Mathews S, 2008, B WORLD HEALTH ORGAN, V86, P552, DOI 10.2471/BLT.07.043786; Mathews S, 2009, J STUD ALCOHOL DRUGS, V70, P321, DOI 10.15288/jsad.2009.70.321; Matzopoulos R, 2008, SAMJ S AFR MED J, V98, P692; MATZOPOULOS R, 2008, CRIME VIOLENCE INJUR, P10; Matzopoulos R, 2004, CRIME VIOLENCE INJUR, P9; Matzopoulos Richard G, 2006, Int J Inj Contr Saf Promot, V13, P49, DOI 10.1080/15660970500036382; *MIN TRANSP REP S, ROAD SAF 2001 2005; Morrell R, 1998, J S AFR STUD, V24, P605, DOI 10.1080/03057079808708593; MYERS B, 2003, REPORT AUDIT SUBSTAN; *NAT I OCC SAF HLT, DEP HHS NIOSH PUBL; Norman R., 2006, REVISED BURDEN DIS E; Norman R, 2007, SAMJ S AFR MED J, V97, P637; Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI 10.2471/BLT.06.037184; Parry CDH, 2004, AM J DRUG ALCOHOL AB, V30, P167, DOI 10.1081/ADA-120029872; Parry CDH., 2005, AFR J PSYCHIATRY, V8, P20, DOI [10.4314/ajpsy.v8i1.30180, DOI 10.4314/AJPSY.V8I1.30180]; Parry Charles D H, 2005, World Psychiatry, V4, P34; PEDEN M, 1999, S AFRICAN HLTH REV, P331; Peden M, 2002, INJURY CHART BOOK GR; Pluddemann Andreas, 2004, Inj Control Saf Promot, V11, P265, DOI 10.1080/156609704/233/289599; *PRES, 2008, DEV IND 2008; Prinsloo M., 2004, CRIME VIOLENCE INJUR, P114; PRINSLOO M, 2007, 7 NIMSS MRCUNISA CRI; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Ratele K., 2008, AFRICAN SAFETY PROMO, V6, P22; Ratele K, 2009, NIGHTLIFE CRIME SOCI, P277; Ratelle K, 2008, AFR ASIAN STUD, V7, P515, DOI 10.1163/156921008X359641; REDPATH J, 2009, MASCULINITIES PUBLIC; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Ribbens H., 2008, CRIME VIOLENCE INJUR; Rosenberg ML, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P755; *RTMC, 2008, ROAD TRAFF REP; *S AFR GOV, 365 DAY NAT ACT PLAN; *S AFR POL SERV, CRIM STAT 2005 2006; Schlebusch L., 2008, CRIME VIOLENCE INJUR, P173; Sethi D., 2004, HDB DOCUMENTATION IN; Sikweyiya Y, 2009, CULT HEALTH SEX, V11, P529, DOI 10.1080/13691050902912783; Smit W., 2006, INT TRENDS GOOD PRAC; South African Police Service, 2008, CRIM STAT CRIM SIT S; *STAT S AFR, 2003, STAT S AFR ANN REP 2; *STAT S AFR, 2008, STAT S AFR ANN REP 2; STEINBERG J, 2008, THIN BLUE LINE; STEVENS G, 2003, HLTH HUM RIGHTS, V6, P168; SUKHAI A, 2008, CRIME VIOLENCE INJUR, P70; van As AB, 2003, SAMJ S AFR MED J, V93, P828; Van Niekerk A, 2007, CHILD CARE HLTH DEV, V33, P236, DOI 10.1111/j.1365-2214.2006.00724.x; Van Niekerk A, 2006, PUBLIC HEALTH, V120, P115, DOI 10.1016/j.puhe.2005.08.015; Van Niekerk A, 2004, BURNS, V30, P341, DOI 10.1016/j.burns.2003.12.014; Vetten L, 2008, TRACKING JUSTICE ATT; WATKINS B, 1992, J CHILD PSYCHOL PSYC, V33, P197, DOI 10.1111/j.1469-7610.1992.tb00862.x; WELBOURN A, 1995, STEPPING STONES TRAI; *WHO, 2000, WHO WORLD REP DAT; Wilkinson RG, 1998, SOCIOL HEALTH ILL, V20, P578, DOI 10.1111/1467-9566.00120; Wood A., 2006, ATTACKING ROOT CAUSE; Wood K, 2005, CULT HEALTH SEX, V7, P303, DOI 10.1080/13691050500100724; Wood K., 2001, CHANGING MEN SO AFRI, P317; Wood K, 2008, MED ANTHROPOL, V27, P43, DOI 10.1080/01459740701831427	100	397	409	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					1011	1022		10.1016/S0140-6736(09)60948-X	http://dx.doi.org/10.1016/S0140-6736(09)60948-X			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	498PK	19709732				2022-12-28	WOS:000270154100032
J	Ellis, O				Ellis, Oliver			Patient Safety Putting safety on the curriculum	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL-STUDENTS; EDUCATION		BMJ, London WC1H 9JR, England		Ellis, O (corresponding author), BMJ, London WC1H 9JR, England.	oellis@bmj.com						Kohn KT, 2000, ERR IS HUMAN BUILDIN; Lockwood JH, 2004, MED EDUC, V38, P234, DOI 10.1111/j.1365-2923.2004.01760.x; Sandars J, 2007, MED TEACH, V29, P60, DOI 10.1080/01421590601087546; Walton MM, 2006, QUAL SAF HEALTH CARE, V15, P437, DOI 10.1136/qshc.2006.019216; World Health Organization, 2009, WHO PAT SAF CURR GUI	5	13	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2009	339								b3725	10.1136/bmj.b3725	http://dx.doi.org/10.1136/bmj.b3725			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RR	19755556				2022-12-28	WOS:000269994600017
J	Matulonis, U				Matulonis, Ursula			Review: Erythropoiesis-stimulating agents increase mortality in patients with cancer	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Matulonis, U (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.							Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; *FDA, PROCR EP ALF INJ EP; FDA, AR DARB ALF INJ; Rodgers George M 3rd, 2008, J Natl Compr Canc Netw, V6, P536	4	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6							JC3-7	10.7326/0003-4819-151-6-200909150-02007	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755353				2022-12-28	WOS:000270390100024
J	Alifrangis, C; Harcourt, JP; Gojis, O; Palmieri, C				Alifrangis, Constantine; Harcourt, Jonny P.; Gojis, Ondrej; Palmieri, Carlo			Poor reception?	LANCET			English	Editorial Material									[Alifrangis, Constantine; Gojis, Ondrej; Palmieri, Carlo] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Med Oncol, London W6 8RF, England; [Harcourt, Jonny P.] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Ear Nose & Throat, London W6 8RF, England	Imperial College London; Imperial College London	Palmieri, C (corresponding author), Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Med Oncol, London W6 8RF, England.	c.palmieri@imperial.ac.uk						Cvorovic L, 2008, OTOL NEUROTOL, V29, P464, DOI 10.1097/MAO.0b013e31816fdcb4; Merchant SN, 2008, ORL-J OTO-RHIN-LARYN, V70, P52, DOI 10.1159/000111048; Rauch SD, 2008, NEW ENGL J MED, V359, P833, DOI 10.1056/NEJMcp0802129; Wei BP, 2006, COCHRANE DB SYST REV; WILSON WR, 1980, ARCH OTOLARYNGOL, V106, P772	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					948	948		10.1016/S0140-6736(09)61120-X	http://dx.doi.org/10.1016/S0140-6736(09)61120-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496BN	19748400				2022-12-28	WOS:000269943100033
J	Bennett, CL				Bennett, Charles L.			Cosmology at a Crossroads	SCIENCE			English	Editorial Material							SPECTRUM; COBE		Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA	Johns Hopkins University	Bennett, CL (corresponding author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.	cbennett@jhu.edu						Brandenberger R, 2008, PHYS TODAY, V61, P44, DOI 10.1063/1.2897949; Eisenstein DJ, 2008, PHYS TODAY, V61, P44, DOI 10.1063/1.2911177; Fixsen DJ, 2002, ASTROPHYS J, V581, P817, DOI 10.1086/344402; Freedman WL, 2001, ASTROPHYS J, V553, P47, DOI 10.1086/320638; Guth AH, 2005, SCIENCE, V307, P884, DOI 10.1126/science.1107483; Hubble E, 1929, P NATL ACAD SCI USA, V15, P168, DOI 10.1073/pnas.15.3.168; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; MATHER JC, 1990, ASTROPHYS J, V354, pL37, DOI 10.1086/185717; Miller AD, 1999, ASTROPHYS J, V524, pL1, DOI 10.1086/312293; Munshi D, 2008, PHYS REP, V462, P67, DOI 10.1016/j.physrep.2008.02.003; Percival WJ, 2007, MON NOT R ASTRON SOC, V381, P1053, DOI 10.1111/j.1365-2966.2007.12268.x; Riess AG, 2007, ASTROPHYS J, V659, P98, DOI 10.1086/510378; Zwicky F., 1933, HELV PHYS ACTA, V6, P110, DOI [DOI 10.1007/S10714-008-0707-4, 10.1007/s10714-008-0707-4]; GROUND CMB EXPT INCL	15	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1347	1348		10.1126/science.1172427	http://dx.doi.org/10.1126/science.1172427			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745138				2022-12-28	WOS:000269699100021
J	Kvavadze, E; Bar-Yosef, O; Belfer-Cohen, A; Boaretto, E; Jakeli, N; Matskevich, Z; Meshveliani, T				Kvavadze, Eliso; Bar-Yosef, Ofer; Belfer-Cohen, Anna; Boaretto, Elisabetta; Jakeli, Nino; Matskevich, Zinovi; Meshveliani, Tengiz			30,000-Year-Old Wild Flax Fibers	SCIENCE			English	Article									[Bar-Yosef, Ofer; Matskevich, Zinovi] Harvard Univ, Peabody Museum, Dept Anthropol, Cambridge, MA 02138 USA; [Kvavadze, Eliso] Natl Museum Georgia, Inst Paleobiol, GE-380007 Tbilisi, Georgia; [Belfer-Cohen, Anna] Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel; [Boaretto, Elisabetta] Weizmann Inst Sci, Kimmel Ctr Archaeol Sci, Radiocarbon Dating & Cosmogen Isotopes Lab, IL-76100 Rehovot, Israel; [Boaretto, Elisabetta] Bar Ilan Univ, Dept Land Israel Studies & Archaeol, IL-59100 Ramat Gan, Israel; [Jakeli, Nino; Meshveliani, Tengiz] Georgian State Museum, Dept Prehist, GE-380105 Tbilisi, Georgia	Harvard University; Hebrew University of Jerusalem; Weizmann Institute of Science; Bar Ilan University	Bar-Yosef, O (corresponding author), Harvard Univ, Peabody Museum, Dept Anthropol, Cambridge, MA 02138 USA.	obaryos@fas.harvard.edu			The American School of Prehistoric Research, Peabody Museum, Harvard University	The American School of Prehistoric Research, Peabody Museum, Harvard University	The American School of Prehistoric Research, Peabody Museum, Harvard University, funded this project; J. P. Wild helped in the identification of flax, cotton, and wool fibers; D. Lordkipanidze, I. Koridze, and G. Bar-Oz provided assistance; and D. Pilbeam, C. Brezine, and anonymous reviewers provided valuable comments.	ADOVASIO JM, 2001, ARCHAEOL ETHNOL ANTH, P48; Grossgeim AA, 1946, RASTITELNYE RESURSY; Meshveliani T, 2004, EARLY UPPER PALEOLITHIC BEYOND WESTERN EUROPE, P129; NADEL D, 1994, CURR ANTHROPOL, V35, P451, DOI 10.1086/204303; van Geel B, 2006, NOVA HEDWIGIA, V82, P313, DOI 10.1127/0029-5035/2006/0082-0313	5	188	194	2	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1359	1359		10.1126/science.1175404	http://dx.doi.org/10.1126/science.1175404			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745144	Green Submitted			2022-12-28	WOS:000269699100028
J	Bakewell, C; Dugowson, C				Bakewell, Catherine; Dugowson, Carin			Baker's Cyst in a Patient with Rheumatoid Arthritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bakewell, Catherine; Dugowson, Carin] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bakewell, C (corresponding author), Univ Washington, Seattle, WA 98195 USA.	bakewell@u.washington.edu							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1098	1098		10.1056/NEJMicm0709049	http://dx.doi.org/10.1056/NEJMicm0709049			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19741231				2022-12-28	WOS:000269659400013
J	Choi, M; Na, K; Kim, J; Sakamoto, Y; Terasaki, O; Ryoo, R				Choi, Minkee; Na, Kyungsu; Kim, Jeongnam; Sakamoto, Yasuhiro; Terasaki, Osamu; Ryoo, Ryong			Stable single-unit-cell nanosheets of zeolite MFI as active and long-lived catalysts	NATURE			English	Article							COKE FORMATION	Zeolites-microporous crystalline aluminosilicates-are widely used in petrochemistry and fine-chemical synthesis(1-3) because strong acid sites within their uniform micropores enable size- and shape-selective catalysis. But the very presence of the micropores, with aperture diameters below 1 nm, often goes hand-in-hand with diffusion limitations(3-5) that adversely affect catalytic activity. The problem can be overcome by reducing the thickness of the zeolite crystals, which reduces diffusion path lengths and thus improves molecular diffusion(4,5). This has been realized by synthesizing zeolite nanocrystals(6), by exfoliating layered zeolites(7-9), and by introducing mesopores in the microporous material through templating strategies(10-17) or demetallation processes(18-22). But except for the exfoliation, none of these strategies has produced 'ultrathin' zeolites with thicknesses below 5 nm. Here we show that appropriately designed bifunctional surfactants can direct the formation of zeolite structures on themesoporous and microporous length scales simultaneously and thus yield MFI (ZSM-5, one of the most important catalysts in the petrochemical industry) zeolite nanosheets that are only 2 nm thick, which corresponds to the b-axis dimension of a single MFI unit cell. The large number of acid sites on the external surface of these zeolites renders them highly active for the catalytic conversion of large organic molecules, and the reduced crystal thickness facilitates diffusion and thereby dramatically suppresses catalyst deactivation through coke deposition during methanol-to-gasoline conversion. We expect that our synthesis approach could be applied to other zeolites to improve their performance in a range of important catalytic applications.	[Choi, Minkee; Na, Kyungsu; Kim, Jeongnam; Ryoo, Ryong] Korea Adv Inst Sci & Technol, Dept Chem, Ctr Funct Nanomat, Taejon 305701, South Korea; [Kim, Jeongnam; Ryoo, Ryong] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea; [Ryoo, Ryong] Korea Adv Inst Sci & Technol, Inst NanoCentury, Taejon 305701, South Korea; [Terasaki, Osamu] Korea Adv Inst Sci & Technol, Grad Sch EEWS WCU, Taejon 305701, South Korea; [Sakamoto, Yasuhiro] Stockholm Univ, Arrhenius Lab, S-10691 Stockholm, Sweden; [Sakamoto, Yasuhiro; Terasaki, Osamu] Osaka Prefecture Univ, Nanosci & Nanotechnol Res Ctr, Sakai, Osaka 5998570, Japan	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Stockholm University; Osaka Metropolitan University	Ryoo, R (corresponding author), Korea Adv Inst Sci & Technol, Dept Chem, Ctr Funct Nanomat, Taejon 305701, South Korea.	rryoo@kaist.ac.kr	Na, Kyungsu/AAQ-7708-2020; Terasaki, Osamu/A-4912-2010; Ryoo, Ryong/B-1090-2009; Terasaki, Osamu/Y-1137-2018; Sakamoto, Yasuhiro/G-8289-2012; Choi, Minkee/C-1839-2011; Na, Kyungsu/C-6210-2009	Terasaki, Osamu/0000-0001-5803-0817; Ryoo, Ryong/0000-0003-0047-3329	National Honor Scientist Program of the Ministry of Education, Science and Technology in Korea; Knut and Alice Wallenberg Foundation; Swedish Research Council (VR); Japan Science and Technology Agency (JST)	National Honor Scientist Program of the Ministry of Education, Science and Technology in Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council (VR)(Swedish Research Council); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This work was mainly supported by the National Honor Scientist Program of the Ministry of Education, Science and Technology in Korea. Electron microscopic studies were performed with help from the measurement and analysis team at the National NanoFab Center, from the research supporting team at KAIST, and also at the Electron Microscopy Center (EMC) at Stockholm University with support from the Knut and Alice Wallenberg Foundation. Y. S. and O. T. thank the Swedish Research Council (VR) and the Japan Science and Technology Agency (JST), respectively.	BECK JS, 1994, CHEM MATER, V6, P1816, DOI 10.1021/cm00046a040; BIBBY DM, 1992, APPL CATAL A-GEN, V93, P1, DOI 10.1016/0926-860X(92)80291-J; BIBBY DM, 1986, J CATAL, V97, P493, DOI 10.1016/0021-9517(86)90020-5; Choi M, 2006, NAT MATER, V5, P718, DOI 10.1038/nmat1705; Corma A, 2003, J CATAL, V216, P298, DOI 10.1016/S0021-9517(02)00132-X; Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n; Corma A, 1999, J CATAL, V186, P57, DOI 10.1006/jcat.1999.2503; Corma A, 1998, NATURE, V396, P353, DOI 10.1038/24592; Corma A, 2000, J AM CHEM SOC, V122, P2804, DOI 10.1021/ja9938130; Cundy CS, 2003, CHEM REV, V103, P663, DOI 10.1021/cr020060i; Egeblad K, 2008, CHEM MATER, V20, P946, DOI 10.1021/cm702224p; Fan W, 2008, NAT MATER, V7, P984, DOI 10.1038/nmat2302; Gao Y., 2004, MICROPOR MESOPOR MAT, V70, P93; Groen JC, 2005, J AM CHEM SOC, V127, P10792, DOI 10.1021/ja052592x; Groen JC, 2007, J AM CHEM SOC, V129, P355, DOI 10.1021/ja065737o; Holland BT, 1999, J AM CHEM SOC, V121, P4308, DOI 10.1021/ja990425p; Jacobsen CJH, 2000, J AM CHEM SOC, V122, P7116, DOI 10.1021/ja000744c; KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0; Pavel CC, 2006, CHEM COMMUN, P882, DOI 10.1039/b515720j; Serrano DP, 2006, CHEM MATER, V18, P2462, DOI 10.1021/cm060080r; Shetti VN, 2008, J CATAL, V254, P296, DOI 10.1016/j.jcat.2008.01.006; Srivastava R, 2006, CHEM COMMUN, P4489, DOI 10.1039/b612116k; Tao YS, 2006, CHEM REV, V106, P896, DOI 10.1021/cr040204o; Tao YS, 2003, J AM CHEM SOC, V125, P6044, DOI 10.1021/ja0299405; Tosheva L, 2005, CHEM MATER, V17, P2494, DOI 10.1021/cm047908z; van Donk S, 2003, CATAL REV, V45, P297, DOI 10.1081/CR-120023908; Wang H, 2006, ANGEW CHEM INT EDIT, V45, P7603, DOI 10.1002/anie.200602595; Xiao FS, 2006, ANGEW CHEM INT EDIT, V45, P3090, DOI 10.1002/anie.200600241	28	1659	1742	66	1946	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					246	U120		10.1038/nature08288	http://dx.doi.org/10.1038/nature08288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	492KN	19741706				2022-12-28	WOS:000269654600040
J	Cooper, RA				Cooper, Richard A.			Regional Variation and the Affluence-Poverty Nexus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY HEALTH-CARE; STATES; MEDICARE		Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA	University of Pennsylvania	Cooper, RA (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, 3641 Locust Walk, Philadelphia, PA 19104 USA.	cooperra@wharton.upenn.edu						Chen AY, 2004, MED CARE, V42, P38, DOI 10.1097/01.mlr.0000103526.13935.b5; Cooper RA, 2004, ANN INTERN MED, V141, P705, DOI 10.7326/0003-4819-141-9-200411020-00012; Cooper RA, 2003, HEALTH SERV RES, V38, P675, DOI 10.1111/1475-6773.00139; Cooper RA, 2009, HEALTH AFFAIR, V28, pW103, DOI 10.1377/hlthaff.28.1.w103; Cooper RA, 2009, HEALTH AFFAIR, V28, pW91, DOI 10.1377/hlthaff.28.1.w91; Doyle J., 2007, 13301 NAT BUR EC RES; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Goodman DC, 2006, HEALTH AFFAIR, V25, P521, DOI 10.1377/hlthaff.25.2.521; Pauly MV, 2007, HEALTH AFFAIR, V26, P1304, DOI 10.1377/hlthaff.26.5.1304; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P1166, DOI 10.1001/jama.2009.320	10	9	9	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1113	1114		10.1001/jama.2009.1222	http://dx.doi.org/10.1001/jama.2009.1222			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	491XH	19738099				2022-12-28	WOS:000269616200033
J	Kulkarni, AV; Aziz, B; Shams, I; Busse, JW				Kulkarni, Abhaya V.; Aziz, Brittany; Shams, Iffat; Busse, Jason W.			Comparisons of Citations in Web of Science, Scopus, and Google Scholar for Articles Published in General Medical Journals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-SCIENCE; IMPACT	Context Until recently, Web of Science was the only database available to track citation counts for published articles. Other databases are now available, but their relative performance has not been established. Objective To compare the citation count profiles of articles published in general medical journals among the citation databases of Web of Science, Scopus, and Google Scholar. Design Cohort study of 328 articles published in JAMA, Lancet, or the New England Journal of Medicine between October 1, 1999, and March 31, 2000. Total citation counts for each article up to June 2008 were retrieved from Web of Science, Scopus, and Google Scholar. Article characteristics were analyzed in linear regression models to determine interaction with the databases. Main Outcome Measures Number of citations received by an article since publication and article characteristics associated with citation in databases. Results Google Scholar and Scopus retrieved more citations per article with a median of 160 (interquartile range [IQR], 83 to 324) and 149 ( IQR, 78 to 289), respectively, than Web of Science ( median, 122; IQR, 66 to 241) (P<.001 for both comparisons). Compared with Web of Science, Scopus retrieved more citations from non-English-language sources ( median, 10.2% vs 4.1%) and reviews (30.8% vs 18.2%), and fewer citations from articles (57.2% vs 70.5%), editorials (2.1% vs 5.9%), and letters (0.8% vs 2.6%) (all P<.001). On a log(10)-transformed scale, fewer citations were found in Google Scholar to articles with declared industry funding ( nonstandardized regression coefficient, -0.09; 95% confidence interval [CI], -0.15 to -0.03), reporting a study of a drug or medical device (-0.05; 95% CI, -0.11 to 0.01), or with group authorship (-0.29; 95% CI, -0.35 to -0.23). In multivariable analysis, group authorship was the only characteristic that differed among the databases; Google Scholar had significantly fewer citations to group-authored articles (-0.30; 95% CI, -0.36 to -0.23) compared with Web of Science. Conclusion Web of Science, Scopus, and Google Scholar produced quantitatively and qualitatively different citation counts for articles published in 3 general medical journals. JAMA. 2009;302(10):1092-1096 www.jama.com	[Kulkarni, Abhaya V.; Aziz, Brittany; Shams, Iffat] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Busse, Jason W.] Inst Work & Hlth, Toronto, ON, Canada; [Busse, Jason W.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Institute for Work & Health; McMaster University	Kulkarni, AV (corresponding author), Hosp Sick Children, Room 1503,555 Univ Ave, Toronto, ON M5G 1X8, Canada.	abhaya.kulkarni@sickkids.ca	Busse, Jason/CAH-3696-2022	Busse, Jason/0000-0002-0178-8712	Canadian Institutes of Health Research; Canadian Chiropractic Research Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Chiropractic Research Foundation	Dr Busse is funded by a New Investigator Award from the Canadian Institutes of Health Research and the Canadian Chiropractic Research Foundation.	[Anonymous], THOMSON REUTERS J SE; Bakkalbasi Nisa, 2006, Biomed Digit Libr, V3, P7, DOI 10.1186/1742-5581-3-7; Burnham Judy F, 2006, Biomed Digit Libr, V3, P1; Callaham M, 2002, JAMA-J AM MED ASSOC, V287, P2847, DOI 10.1001/jama.287.21.2847; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Gami AS, 2004, CAN MED ASSOC J, V170, P1925, DOI 10.1503/cmaj.1031879; Giustini D, 2005, BRIT MED J, V331, P1487, DOI 10.1136/bmj.331.7531.1487; *GOOGL, LIB CENTR; *GOOGL, SUPP SCHOL PUBL; Harzing A.W., 2008, ETHICS SCI ENV POLIT, V8, P61, DOI DOI 10.3354/ESEP00076; Hull D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000204; Jacso P, 2005, CURR SCI INDIA, V89, P1537; KLEINBAUM DG, 1988, COLLINEARITY CONCEPT, P209; Kousha K, 2008, SCIENTOMETRICS, V74, P273, DOI 10.1007/s11192-008-0217-x; Kulkarni AV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000403; Meho LI, 2007, J AM SOC INF SCI TEC, V58, P2105, DOI 10.1002/asi.20677; Meho LI, 2007, PHYS WORLD, V20, P32; Noruzi A, 2005, LIBRI, V55, P170, DOI 10.1515/LIBR.2005.170; Patsopoulos NA, 2005, JAMA-J AM MED ASSOC, V293, P2362, DOI 10.1001/jama.293.19.2362; Patsopoulos NA, 2006, BMJ-BRIT MED J, V332, P1061, DOI 10.1136/bmj.38768.420139.80; *THOMS REUT, WEB SCI OV; SCOPUS DETAIL FACTS; CONTENT COVERAGE	23	445	454	4	123	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1092	1096		10.1001/jama.2009.1307	http://dx.doi.org/10.1001/jama.2009.1307			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738094	Bronze			2022-12-28	WOS:000269616200027
J	Chopra, M; Daviaud, E; Pattinson, R; Fonn, S; Lawn, JE				Chopra, Mickey; Daviaud, Emmanuelle; Pattinson, Robert; Fonn, Sharon; Lawn, Joy E.			Health in South Africa 2 Saving the lives of South Africa's mothers, babies, and children: can the health system deliver?	LANCET			English	Article							ASSISTANT MEDICAL OFFICERS; TRANSMISSION; PREVENTION; WORKERS; NEVIRAPINE; SURVIVAL; PROGRAM; CARE; HIV; INTERVENTIONS	South Africa is one of only 12 countries in which mortality rates for children have increased since the baseline for the Millennium Development Goals (MDGs) in 1990. Continuing poverty and the HIV/AIDS epidemic are important factors. Additionally, suboptimum implementation of high-impact interventions limits programme effectiveness; between a quarter and half of maternal, neonatal, and child deaths in national audits have an avoidable health-system factor contributing to the death. Using the LiST model, we estimate that 11500 infants' lives could be saved by effective implementation of basic neonatal care at 95% coverage. Similar coverage of dual-therapy prevention of mother-to-child transmission with appropriate feeding choices could save 37 200 children's lives in South Africa per year in 2015 compared with 2008. These interventions would also avert many maternal deaths and stillbirths. The total cost of such a target package is US$1.5 billion per year, 24% of the public-sector health expenditure; the incremental cost is $220 million per year. Such progress would put South Africa squarely on track to meet MDG 4 and probably also MDG 5. The costs are affordable and the key gap is leadership and effective implementation at every level of the health system, including national and local accountability for-service provision.	[Chopra, Mickey; Daviaud, Emmanuelle; Lawn, Joy E.] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Chopra, Mickey] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Pattinson, Robert] Univ Pretoria, MRC, Maternal & Infant Heath Care Strategies Res Unit, ZA-0002 Pretoria, South Africa; [Fonn, Sharon] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England	University of the Western Cape; University of Pretoria; University of Witwatersrand; University of London; University College London	Chopra, M (corresponding author), MRC, Hlth Syst Res Unit, Van Zyl Dr, ZA-7535 Parow, Western Cape, South Africa.	mickeychopra28@gmail.com	Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443; Fonn, Sharon/0000-0001-6115-8707	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	We thank Neff Walker and Ingrid Friberg of Johns Hopkins University and John Stover of Futures Institute for assistance with the LIST modelling; Nigel Rollins, WHO CAH, who reviewed an earlier draft; and the many clinicians and colleagues in South Africa who reviewed the assumptions for the economic modelling or provided data. Lesley Bamford, National Department of Health and School of Health Systems and Public Health, University of Pretoria, coordinated the inputs for the costing model and reviewed and made comments on the report. JL is supported by a grant from the Bill & Melinda Gates Foundation to the Saving Newborn Lives program of Save the Children-US.	ANDERSSON N, 1988, SOC SCI MED, V27, P667, DOI 10.1016/0277-9536(87)90327-3; BAMFORD L, 2008, EVERY DEATH COUNTS S; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Case A, 2007, SCAND J PUBLIC HEALT, V35, P157, DOI 10.1080/14034950701355445; *CHILDR PROJ, 2008, UPD CHILD SUPP GRANT; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Coetzee D, 2005, B WORLD HEALTH ORGAN, V83, P489; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; COTTINGHAM J, 2001, TRANSFORMING HLTH SY; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; DOHERTY T, 2003, EVALUATION PMTCT INI; Doherty Tanya M, 2005, Afr Health Sci, V5, P213; Fonn S, 2003, WOMEN HEALTH, V37, P105, DOI 10.1300/J013v37n04_08; Fonn S, 2001, HEALTH POLICY PLANN, V16, P13, DOI 10.1093/heapol/16.suppl_1.13; Gray GE, 2005, AIDS, V19, P1289, DOI 10.1097/01.aids.0000180100.42770.a7; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haffejee I E, 1995, Glob Child Health New Rev, V3, P18; JACKSON D, 2007, CAUSES MATERNAL MORT; Jackson DJ, 2007, AIDS, V21, P509, DOI 10.1097/QAD.0b013e32801424d2; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Jewkes R, 2002, BRIT MED J, V324, P1252, DOI 10.1136/bmj.324.7348.1252; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Kruk ME, 2007, BJOG-INT J OBSTET GY, V114, P1253, DOI 10.1111/j.1471-0528.2007.01443.x; LABADARIOS D, 2008, NATL FOOD CONSUMPTIO, P533; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Li XF, 1996, INT J GYNECOL OBSTET, V54, P1, DOI 10.1016/0020-7292(96)02667-7; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McCoy D, 1996, FREE HLTH CARE PREGN; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; *NAT COMM CONF ENQ, 4 NAT DEP HLTH NAT C; *NAT DEP HLTH SA, 2008, DISTR HLTH INF SYST; *NAT DEP HLTH SA, 2009, 6 NAT DEP HLTH SA; *NAT DEP HLTH SA, 2007, SAV NEWB REP S AFR 2; Onyanga-Ouma W, 2001, HEALTH POLICY PLANN, V16, P33, DOI 10.1093/heapol/16.suppl_1.33; Onyango-Ouma W, 2001, HEALTH POLICY PLANN, V16, P24, DOI 10.1093/heapol/16.suppl_1.24; OSKOWITZ B, 1997, TAKING CARE QUALITY; PATRICK M, 2007, SAVING CHILDREN 2005; PATTINSON R, 2008, REPORT UNICEF SCALIN; PENNKEKANA L, 2004, HLTH POLICY PLANNING, V19, P71; Pereira C, 2007, BJOG-INT J OBSTET GY, V114, P1530, DOI 10.1111/j.1471-0528.2007.01489.x; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; Rosenfield A, 2001, AM J PUBLIC HEALTH, V91, P703, DOI 10.2105/AJPH.91.5.703; Rowe AK, 2005, LANCET, V366, P1026, DOI 10.1016/S0140-6736(05)67028-6; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Thomas LS, 2007, REPROD HEALTH MATTER, V15, P38, DOI 10.1016/S0968-8080(07)30314-5; TINT KS, 1996, N W REPROD HLTH TRAN; *UNAIDS, 2008, UNAIDS PROGR REP 200; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; WIGTON A, 2008, HLTH SYSTEMS AUDITS; World Health Organization, 2005, WORLD HLTH REP 2005	58	155	160	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					835	846		10.1016/S0140-6736(09)61123-5	http://dx.doi.org/10.1016/S0140-6736(09)61123-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492QU	19709729				2022-12-28	WOS:000269675000031
J	Brose, N; Neher, E				Brose, Nils; Neher, Erwin			Flowers for Synaptic Endocytosis	CELL			English	Editorial Material							VESICLE; SYNAPSES; RELEASE; MODES; CALYX	Exocytosis and endocytosis of synaptic vesicles are tightly coordinated to maintain a steady supply of new vesicles during periods of extended neuronal stimulation. Yao et al. (2009) now report that a synaptic vesicle membrane protein named Flower promotes endocytosis at neuromuscular junctions in the fruit fly Drosophila.	[Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; [Neher, Erwin] Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Brose, N (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.	brose@em.mpg.de; eneher@gwdg.de	Neher, Erwin/A-2109-2013					de Lange RPJ, 2003, J NEUROSCI, V23, P10164; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Jung N, 2007, TRAFFIC, V8, P1129, DOI 10.1111/j.1600-0854.2007.00595.x; Kuromi H, 2004, NEURON, V41, P101, DOI 10.1016/S0896-6273(03)00815-8; Shupliakov O, 2009, NEUROSCIENCE, V158, P204, DOI 10.1016/j.neuroscience.2008.03.035; Wu LG, 2007, J NEUROSCI, V27, P11793, DOI 10.1523/JNEUROSCI.3471-07.2007	7	3	3	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 4	2009	138	5					836	837		10.1016/j.cell.2009.08.023	http://dx.doi.org/10.1016/j.cell.2009.08.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737513	Bronze, Green Published			2022-12-28	WOS:000269564600011
J	Hait, NC; Allegood, J; Maceyka, M; Strub, GM; Harikumar, KB; Singh, SK; Luo, C; Marmorstein, R; Kordula, T; Milstien, S; Spiegel, S				Hait, Nitai C.; Allegood, Jeremy; Maceyka, Michael; Strub, Graham M.; Harikumar, Kuzhuvelil B.; Singh, Sandeep K.; Luo, Cheng; Marmorstein, Ronen; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah			Regulation of Histone Acetylation in the Nucleus by Sphingosine-1-Phosphate	SCIENCE			English	Article							MEDIATED PHOSPHORYLATION; DEACETYLASE INHIBITORS; SPHINGOSINE-KINASE-2; ACTIVATION; FAMILY	The pleiotropic lipid mediator sphingosine-1-phosphate (S1P) can act intracellularly independently of its cell surface receptors through unknown mechanisms. Sphingosine kinase 2 (SphK2), one of the isoenzymes that generates S1P, was associated with histone H3 and produced S1P that regulated histone acetylation. S1P specifically bound to the histone deacetylases HDAC1 and HDAC2 and inhibited their enzymatic activity, preventing the removal of acetyl groups from lysine residues within histone tails. SphK2 associated with HDAC1 and HDAC2 in repressor complexes and was selectively enriched at the promoters of the genes encoding the cyclin-dependent kinase inhibitor p21 or the transcriptional regulator c-fos, where it enhanced local histone H3 acetylation and transcription. Thus, HDACs are direct intracellular targets of S1P and link nuclear S1P to epigenetic regulation of gene expression.	[Hait, Nitai C.; Allegood, Jeremy; Maceyka, Michael; Strub, Graham M.; Harikumar, Kuzhuvelil B.; Singh, Sandeep K.; Kordula, Tomasz; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Hait, Nitai C.; Allegood, Jeremy; Maceyka, Michael; Strub, Graham M.; Harikumar, Kuzhuvelil B.; Singh, Sandeep K.; Kordula, Tomasz; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA; [Luo, Cheng; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Luo, Cheng; Marmorstein, Ronen] Univ Penn, Wistar Inst, Philadelphia, PA 19104 USA; [Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Milstien, Sheldon] NIMH, NIH, Bethesda, MD 20892 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Pennsylvania; The Wistar Institute; University of Pennsylvania; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Maceyka, Michael/B-9277-2008; Harikumar, Kuzhuvelil/AAC-2407-2020	Harikumar, Kuzhuvelil/0000-0002-1763-4179	NIH [R37GM043880, R01CA61774]; National Research Service Award [F30NSO58008]; NIMH Intramural Research Program; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880, R01GM060293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS058008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH R37GM043880 and R01CA61774 (S. S.). G. S. was supported by National Research Service Award F30NSO58008. S. M. was supported by the NIMH Intramural Research Program.	Albi E, 2008, BIOCHEM J, V410, P381, DOI 10.1042/BJ20070758; Chun J, 2006, CURR PHARM DESIGN, V12, P161, DOI 10.2174/138161206775193109; Clayton AL, 2006, MOL CELL, V23, P289, DOI 10.1016/j.molcel.2006.06.017; COCCO L, 1980, BIOCHEM BIOPH RES CO, V96, P890, DOI 10.1016/0006-291X(80)91439-4; Ding G, 2007, J BIOL CHEM, V282, P27493, DOI 10.1074/jbc.M701641200; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gui CY, 2004, P NATL ACAD SCI USA, V101, P1241, DOI 10.1073/pnas.0307708100; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Mitra P, 2007, METHOD ENZYMOL, V434, P257, DOI 10.1016/S0076-6879(07)34014-7; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Spiegel S, 2007, J BIOL CHEM, V282, P2125, DOI 10.1074/jbc.R600028200; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	21	695	728	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1254	1257		10.1126/science.1176709	http://dx.doi.org/10.1126/science.1176709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729656	Green Accepted			2022-12-28	WOS:000269523200040
J	Kellermann, V; van Heerwaarden, B; Sgro, CM; Hoffmann, AA				Kellermann, Vanessa; van Heerwaarden, Belinda; Sgro, Carla M.; Hoffmann, Ary A.			Fundamental Evolutionary Limits in Ecological Traits Drive Drosophila Species Distributions	SCIENCE			English	Article							RAIN-FOREST DROSOPHILA; ADDITIVE GENETIC VARIANCE; NATURAL-POPULATIONS; STRESS RESISTANCE; TOLERANCE; DESICCATION; ADAPTATION; VARIABILITY; STARVATION; SELECTION	Species that are habitat specialists make up much of biodiversity, but the evolutionary factors that limit their distributions have rarely been considered. We show that in Drosophila, narrow and wide ranges of desiccation and cold resistance are closely associated with the distributions of specialist and generalist species, respectively. Furthermore, our data show that narrowly distributed tropical species consistently have low means and low genetic variation for these traits as compared with those of widely distributed species after phylogenetic correction. These results are unrelated to levels of neutral variation. Thus, specialist species may simply lack genetic variation in key traits, limiting their ability to adapt to conditions beyond their current range. We predict that such species are likely to be constrained in their evolutionary responses to future climate changes.	[van Heerwaarden, Belinda; Sgro, Carla M.] Monash Univ, Sch Biol Sci, Ctr Environm Stress & Adaptat Res, Melbourne, Vic 3800, Australia; [Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Dept Zool, Melbourne, Vic 3010, Australia	Monash University; University of Melbourne	Kellermann, V (corresponding author), Univ Melbourne, Dept Genet, Ctr Environm Stress & Adaptat Res, Dept Zool, Melbourne, Vic 3010, Australia.	vanessa.kellermann@biology.au.dk	Sgro, Carla/A-2495-2010; Hoffmann, Ary/C-2961-2011; Hoffmann, Ary/R-2972-2019; van Heerwaarden, Belinda/A-4515-2012; Sgro, Carla M/G-5166-2010; Kellermann, Vanessa/C-3908-2011	Hoffmann, Ary/0000-0001-9497-7645; Kellermann, Vanessa/0000-0002-9859-9642; van Heerwaarden, Belinda/0000-0003-2435-2900	Australian Research Council; Commonwealth Environmental Research Fund	Australian Research Council(Australian Research Council); Commonwealth Environmental Research Fund	We thank the Australian Research Council and the Commonwealth Environmental Research Fund for financial support. We also thank M. Blacket for molecular work; A. Miller for assistance with the phylogenetic analysis; K. Mitchell, C. Doig, T. Kristensen, J. Overgaard, L. Carrington, K. Lein, and X. Du for technical support; and reviewers for constructive comments.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; BLOWS MW, 1993, EVOLUTION, V47, P1255, DOI 10.1111/j.1558-5646.1993.tb02151.x; BRADSHAW AD, 1991, PHILOS T R SOC B, V333, P289, DOI 10.1098/rstb.1991.0079; Chown SL, 2002, COMP BIOCHEM PHYS B, V131, P587, DOI 10.1016/S1096-4959(02)00017-9; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; FUTUYMA DJ, 1995, EVOLUTION, V49, P797, DOI 10.1111/j.1558-5646.1995.tb02316.x; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Gibert P, 2001, EVOLUTION, V55, P1063, DOI 10.1554/0014-3820(2001)055[1063:CCTAMC]2.0.CO;2; Gomez-Valero L, 2007, GENOME RES, V17, P1178, DOI 10.1101/gr.6360207; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; HOFFMANN AA, 1993, J EVOLUTION BIOL, V6, P643, DOI 10.1046/j.1420-9101.1993.6050643.x; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; Kellermann VM, 2006, EVOLUTION, V60, P1104, DOI 10.1554/05-710.1; KIMURA MT, 1994, J NAT HIST, V28, P401, DOI 10.1080/00222939400770181; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Kruuk LEB, 2004, PHILOS T R SOC B, V359, P873, DOI 10.1098/rstb.2003.1437; LANDE R, 1975, GENET RES, V26, P221, DOI 10.1017/S0016672300016037; Matzkin LM, 2009, FUNCT ECOL, V23, P521, DOI 10.1111/j.1365-2435.2008.01533.x; Merila J, 2001, GENETICA, V112, P199, DOI 10.1023/A:1013391806317; PARSONS PA, 1982, EVOL BIOL, V14, P297; van Heerwaarden B, 2008, GENETICS, V179, P2135, DOI 10.1534/genetics.107.082768; van Heerwaarden B, 2009, P ROY SOC B-BIOL SCI, V276, P1517, DOI 10.1098/rspb.2008.1288; vanHerrewege J, 1997, ECOSCIENCE, V4, P151, DOI 10.1080/11956860.1997.11682389	27	321	324	3	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1244	1246		10.1126/science.1175443	http://dx.doi.org/10.1126/science.1175443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729654				2022-12-28	WOS:000269523200037
J	Ip, D; Syed, H; Cohen, M				Ip, Dorothy; Syed, Hafiz; Cohen, Maurice			Lesson of the Week Digoxin specific antibody fragments (Digibind) in digoxin toxicity	BRITISH MEDICAL JOURNAL			English	Article									[Ip, Dorothy; Syed, Hafiz; Cohen, Maurice] N Middlesex Hosp, London N18 1QX, England		Ip, D (corresponding author), N Middlesex Hosp, London N18 1QX, England.	dorothyip@doctors.org.uk						*GLAXOSMITHKLINE, 2003, DIG PRESCR INF; National Institute for Health and Clinical Excellence, 2006, ATR FIBR NAT CLIN GU	2	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 3	2009	339								b2884	10.1136/bmj.b2884	http://dx.doi.org/10.1136/bmj.b2884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CI	19729422				2022-12-28	WOS:000269554100004
J	de Almeida, JR; Al Khabori, M; Guyatt, GH; Witterick, IJ; Lin, VYW; Nedzelski, JM; Chen, JM				de Almeida, John R.; Al Khabori, Murtadha; Guyatt, Gordon H.; Witterick, Ian J.; Lin, Vincent Y. W.; Nedzelski, Julian M.; Chen, Joseph M.			Combined Corticosteroid and Antiviral Treatment for Bell Palsy A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							VARICELLA-ZOSTER-VIRUS; HERPES-SIMPLEX-VIRUS; POLYMERASE-CHAIN-REACTION; FACIAL-NERVE PARALYSIS; DOUBLE-BLIND; PREDNISOLONE; ACYCLOVIR; PLACEBO; DNA; VALACYCLOVIR	Context New evidence has emerged regarding the use of corticosteroids and antiviral agents in Bell palsy. Objective To estimate the association of corticosteroids and antiviral agents with the risk of unsatisfactory facial recovery in patients with Bell palsy. Data Sources The search included MEDLINE, EMBASE, CENTRAL, PsychInfo, CINAHL, Web of Science, PAPERSFIRST, PROCEEDINGSFIRST, and PROQUEST to identify studies up to March 1, 2009. Study Selection and Data Extraction Eligible studies were randomized controlled trials comparing treatment with either corticosteroids or antiviral agents with a control and measuring at least 1 of the following outcomes: unsatisfactory facial recovery (>= 4 months), unsatisfactory short-term recovery (6 weeks to < 4 months), synkinesis and autonomic dysfunction, or adverse effects. Two reviewers extracted data on study characteristics, methods, and outcomes. Disagreement was resolved by consensus. Results Eighteen trials involving 2786 patients were eligible. Regression analysis identified a synergistic effect when corticosteroids and antiviral agents were administered in combination compared with alone (odds ratio for interaction term, 0.54 [95% confidence interval {CI}, 0.35-0.83]; P=.004). Meta-analysis using a random-effects model showed corticosteroids alone were associated with a reduced risk of unsatisfactory recovery (relative risk [RR], 0.69 [95% CI, 0.55-0.87]; P=.001) (number needed to treat to benefit 1 person, 11 [95% CI, 8-25]), a reduced risk of synkinesis and autonomic dysfunction (RR, 0.48 [95% CI, 0.36-0.65]; P < .001) (number needed to treat to benefit 1 person, 7 [95% CI, 6-10]), and no increase in adverse effects. Antiviral agents alone were not associated with a reduced risk of unsatisfactory recovery (RR, 1.14[95% CI, 0.80-1.62]; P=.48). When combined with antiviral agents, corticosteroids were associated with greater benefit (RR, 0.48 [95% CI, 0.29-0.79]; P=.004) than antiviral agents alone. When combined with corticosteroids, antiviral agents were associated with greater risk reduction of borderline significance compared with corticosteroids alone (RR, 0.75 [95% CI, 0.56-1.00]; P=.05). Conclusions In Bell palsy, corticosteroids are associated with a reduced risk of unsatisfactory recovery. Antiviral agents, when administered with corticosteroids, may be associated with additional benefit. JAMA .2009;302(9):985-993 www.jama.com	[Guyatt, Gordon H.] McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; [Guyatt, Gordon H.] McMaster Univ, CLARITY Res Grp, Hamilton, ON L8N 3Z5, Canada; [de Almeida, John R.; Lin, Vincent Y. W.; Nedzelski, Julian M.; Chen, Joseph M.] Univ Toronto, Sunnybrook Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada; [Al Khabori, Murtadha] Univ Toronto, Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON, Canada; [Witterick, Ian J.] Univ Toronto, Mt Sinai Hosp, Dept Otolaryngol Head & Neck Surg, Toronto, ON M5G 1X5, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Guyatt, GH (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, 2C12,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	guyatt@mcmaster.ca	Witterick, Ian/ABH-9001-2020; Al-Khabori, Murtadha/I-4774-2019	Witterick, Ian/0000-0001-5612-481X; Al-Khabori, Murtadha/0000-0002-2937-8838	Albert and Temmy Latner Family Foundation	Albert and Temmy Latner Family Foundation	Dr de Almeida is supported by an educational grant for graduate studies from the Albert and Temmy Latner Family Foundation in conjunction with Dr Jeremy Freeman and the Samuel Lunenfeld Research Institute at Mount Sinai Hospital, Toronto, Ontario, Canada.	ADOUR K K, 1971, Transactions of the American Academy of Ophthalmology and Oto-Laryngology, V75, P1284; ADOUR KK, 1975, JAMA-J AM MED ASSOC, V233, P527, DOI 10.1001/jama.233.6.527; Adour KK, 1996, ANN OTO RHINOL LARYN, V105, P371, DOI 10.1177/000348949610500508; Allen D, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001869.PUB2; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; ANTUNES ML, 2000, ACTA AWHO, V19, P68; AUSTIN JR, 1993, LARYNGOSCOPE, V103, P1326; Bento RF, 1991, REV BRAS OTORRINOLAR, V57, P196; Berg T, 2004, OTOL NEUROTOL, V25, P1020, DOI 10.1097/00129492-200411000-00027; CAWTHORNE T, 1963, ARCHIV OTOLARYNGOL, V78, P429, DOI 10.1001/archotol.78.3.40; Vazquez MC, 2008, REV MED URUG, V24, P167; Deeks JJ., 2020, COCHRANE HDB SYSTEMA, V1; Engstrom M, 2008, LANCET NEUROL, V7, P993, DOI 10.1016/S1474-4422(08)70221-7; FISCH U, 1972, ARCHIV OTOLARYNGOL, V95, P335; Furuta Y, 1997, J MED VIROL, V52, P316, DOI 10.1002/(SICI)1096-9071(199707)52:3&lt;316::AID-JMV13&gt;3.0.CO;2-G; Furuta Y, 2001, J CLIN MICROBIOL, V39, P2856, DOI 10.1128/JCM.39.8.2856-2859.2001; Grogan PM, 2001, NEUROLOGY, V56, P830, DOI 10.1212/WNL.56.7.830; GUYATT G, 2008, USERS GUIDES MED LIT, P537; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hato N, 2008, LANCET, V371, P1818, DOI 10.1016/S0140-6736(08)60776-X; Hato N, 2007, OTOL NEUROTOL, V28, P408, DOI 10.1097/01.mao.0000265190.29969.12; HAUSER WA, 1971, MAYO CLIN PROC, V46, P258; Hernandez RA, 2009, FAM PRACT, V26, P137, DOI 10.1093/fampra/cmn107; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Holland NJ, 2004, BMJ-BRIT MED J, V329, P553, DOI 10.1136/bmj.329.7465.553; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; INANLI S, 2001, TURKISH ARCH OTOLARY, V39, P19; Kawaguchi K, 2007, LARYNGOSCOPE, V117, P147, DOI 10.1097/01.mlg.0000248737.65607.9e; Lagalla G, 2002, NEUROL SCI, V23, P107, DOI 10.1007/s100720200035; Madhok V, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b255; MARTINEZ C, 1988, B HOSP SAN JUAN DIOS, V35, P273; MARTINEZ GC, 1990, B HOSP SAN JUAN DIOS, V37, P13; MAY M, 1976, LARYNGOSCOPE, V86, P1111, DOI 10.1288/00005537-197608000-00003; Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005; PEITERSEN E, 1982, AM J OTOL, V4, P107; Ramsey MJ, 2000, LARYNGOSCOPE, V110, P335, DOI 10.1097/00005537-200003000-00001; Ross BG, 1996, OTOLARYNG HEAD NECK, V114, P380, DOI 10.1016/S0194-5998(96)70206-1; Rowlands S, 2002, EUR J NEUROL, V9, P63, DOI 10.1046/j.1468-1331.2002.00343.x; Roy A, 2005, J NEUROL SCI, V238, pS207; SALINAS RA, 2004, COCHRANE DATABASE SY, V0004; Stjernquist-Desatnik A, 2006, ANN OTO RHINOL LARYN, V115, P306, DOI 10.1177/000348940611500410; Sullivan F, 2008, NEW ENGL J MED, V358, P307; Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006; Sweeney CJ, 2001, J NEUROL NEUROSUR PS, V71, P149, DOI 10.1136/jnnp.71.2.149; TEKLEHAIMANOT R, 1987, ETHIOPIAN MED J, V25, P23; Theil D, 2001, BRAIN PATHOL, V11, P408, DOI 10.1111/j.1750-3639.2001.tb00408.x; Unuvar E, 1999, PEDIATR NEUROL, V21, P814, DOI 10.1016/S0887-8994(99)00099-5; WOLF SM, 1978, NEUROLOGY, V28, P158, DOI 10.1212/WNL.28.2.158; YANAGIHARA N, 2003, ACOUSTIC NEUROMA CON; Yeo SG, 2008, AM J OTOLARYNG, V29, P163, DOI 10.1016/j.amjoto.2007.05.001	51	94	96	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					985	993		10.1001/jama.2009.1243	http://dx.doi.org/10.1001/jama.2009.1243			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724046				2022-12-28	WOS:000269444900024
J	Marshall, CR; Jacobs, DK				Marshall, Charles R.; Jacobs, David K.			Flourishing After the End-Permian Mass Extinction	SCIENCE			English	Editorial Material							HISTORY		[Marshall, Charles R.] Harvard Univ, Museum Comparat Zool, Dept Invertebrate Paleontol, Cambridge, MA 02138 USA; [Jacobs, David K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA	Harvard University; University of California System; University of California Los Angeles	Marshall, CR (corresponding author), Harvard Univ, Museum Comparat Zool, Dept Invertebrate Paleontol, Cambridge, MA 02138 USA.	cmarshall@oeb.harvard.edu; djacobs@ucla.edu						Brayard A, 2009, SCIENCE, V325, P1118, DOI 10.1126/science.1174638; Erwin D. H., 2006, EXTINCTION LIFE EART; Fischer Alfred G., 1995, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V195, P133; JACOBS DK, 1993, LETHAIA, V26, P101, DOI 10.1111/j.1502-3931.1993.tb01799.x; Knoll AH, 2007, EARTH PLANET SC LETT, V256, P295, DOI 10.1016/j.epsl.2007.02.018; Kump LR, 2005, GEOLOGY, V33, P397, DOI 10.1130/G21295.1; Meyer KM, 2008, ANNU REV EARTH PL SC, V36, P251, DOI 10.1146/annurev.earth.36.031207.124256; Payne JL, 2004, SCIENCE, V305, P506, DOI 10.1126/science.1097023; Payne JL, 2007, EARTH PLANET SC LETT, V256, P264, DOI 10.1016/j.epsl.2007.01.034; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6	10	11	11	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1079	1080		10.1126/science.1178325	http://dx.doi.org/10.1126/science.1178325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713513				2022-12-28	WOS:000269382300024
J	Pronovost, PJ; Faden, RR				Pronovost, Peter J.; Faden, Ruth R.			Setting Priorities for Patient Safety Ethics, Accountability, and Public Engagement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Faden, Ruth R.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Pronovost, PJ (corresponding author), 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Fleck Leonard M., 2009, JUST CARING HLTH CAR; Harris J, 2005, J MED ETHICS, V31, P373, DOI 10.1136/jme.2005.012906; Kohn KT, 1999, ERR IS HUMAN BUILDIN; Lipscomb J, 2009, VALUE HEALTH, V12, pS18, DOI 10.1111/j.1524-4733.2009.00518.x; Orlikoff James E, 2006, Healthc Exec, V21, P54; Powers M, 2006, SOCIAL JUSTICE MORAL; Pronovost PJ, 2009, HEALTH AFFAIR, V28, pW479, DOI 10.1377/hlthaff.28.3.w479; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224	8	12	13	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					890	891		10.1001/jama.2009.1177	http://dx.doi.org/10.1001/jama.2009.1177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706863				2022-12-28	WOS:000269260100023
J	Tollefson, J				Tollefson, Jeff			US joins China in climate talks	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 6	2009	460	7256					670	670		10.1038/460670a	http://dx.doi.org/10.1038/460670a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	479OO	19746520	Bronze			2022-12-28	WOS:000268670300003
J	Lieberman, DA				Lieberman, David A.			Screening for Colorectal Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FECAL-OCCULT-BLOOD; SERVICES-TASK-FORCE; COMPUTED TOMOGRAPHIC COLONOGRAPHY; RANDOMIZED CONTROLLED-TRIAL; CONTRAST BARIUM ENEMA; ASYMPTOMATIC ADULTS; OUTPATIENT COLONOSCOPY; VIRTUAL COLONOSCOPY; CLINICAL-PRACTICE; AMERICAN-COLLEGE		Oregon Hlth & Sci Univ, Dept Med, Div Gastroenterol & Hepatol, Portland, OR 97239 USA	Oregon Health & Science University	Lieberman, DA (corresponding author), Oregon Hlth & Sci Univ, Dept Med, Div Gastroenterol & Hepatol, Mail Code L461,3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lieberma@ohsu.edu						Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150; Arora G, 2009, GASTROINTEST ENDOSC, V69, P654, DOI 10.1016/j.gie.2008.09.008; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Collins JF, 2005, ANN INTERN MED, V142, P81, DOI 10.7326/0003-4819-142-2-200501180-00006; Cotton PB, 2004, JAMA-J AM MED ASSOC, V291, P1713, DOI 10.1001/jama.291.14.1713; Gatto NM, 2003, J NATL CANCER I, V95, P230, DOI 10.1093/jnci/95.3.230; Hawk ET, 2004, GASTROENTEROLOGY, V126, P1423, DOI 10.1053/j.gastro.2004.03.002; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; Imperiale TF, 2008, NEW ENGL J MED, V359, P1218, DOI 10.1056/NEJMoa0803597; Itzkowitz SH, 2007, CLIN GASTROENTEROL H, V5, P111, DOI 10.1016/j.cgh.2006.10.006; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson CD, 2008, NEW ENGL J MED, V359, P2853; Korman LY, 2003, GASTROINTEST ENDOSC, V58, P554, DOI 10.1067/S0016-5107(03)01890-X; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Lieberman DA, 2005, CLIN GASTROENTEROL H, V3, P798, DOI 10.1016/S1542-3565(05)00405-2; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman D, 2008, GASTROENTEROLOGY, V135, P1100, DOI 10.1053/j.gastro.2008.06.083; Lieberman D, 2007, GASTROINTEST ENDOSC, V65, P757, DOI 10.1016/j.gie.2006.12.055; Lieberman DA, 2008, JAMA-J AM MED ASSOC, V300, P1417, DOI 10.1001/jama.300.12.1417; Lieberman DA, 2007, GASTROENTEROLOGY, V133, P1077, DOI 10.1053/j.gastro.2007.07.006; Lin OS, 2006, JAMA-J AM MED ASSOC, V295, P2357, DOI 10.1001/jama.295.20.2357; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MANDEL JS, 1993, NEW ENGL J MED, V329, P672; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nadel MR, 2005, ANN INTERN MED, V142, P86, DOI 10.7326/0003-4819-142-2-200501180-00007; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Pignone M, 2005, EC MODELS COLORECTAL; Rabeneck L, 2008, GASTROENTEROLOGY, V135, P1899, DOI 10.1053/j.gastro.2008.08.058; Rathgaber SW, 2006, GASTROINTEST ENDOSC, V64, P556, DOI 10.1016/j.gie.2006.03.014; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2009, AM J GASTROENTEROL, V104, P1612, DOI 10.1038/ajg.2009.265; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Rockey DC, 2005, LANCET, V365, P305; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Singh H, 2009, GASTROINTEST ENDOSC, V69, P665, DOI 10.1016/j.gie.2008.09.046; Soetikno RM, 2008, JAMA-J AM MED ASSOC, V299, P1027, DOI 10.1001/jama.299.9.1027; Warren JL, 2009, ANN INTERN MED, V150, P849, DOI 10.7326/0003-4819-150-12-200906160-00008; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Winawer SJ, 2000, NEW ENGL J MED, V342, P1766, DOI 10.1056/NEJM200006153422401	57	191	204	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1179	1187		10.1056/NEJMcp0902176	http://dx.doi.org/10.1056/NEJMcp0902176			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494QA	19759380				2022-12-28	WOS:000269828000009
J	Ristenpart, WD; Bird, JC; Belmonte, A; Dollar, F; Stone, HA				Ristenpart, W. D.; Bird, J. C.; Belmonte, A.; Dollar, F.; Stone, H. A.			Non-coalescence of oppositely charged drops	NATURE			English	Article							IN-OIL EMULSIONS; WATER DROPS; ELECTRIC FIELD; LIQUID-DROPS; DROPLETS; PARTICLES; STABILITY; MOTIONS; DEVICES; FLUID	Electric fields induce motion in many fluid systems, including polymer melts(1), surfactant micelles(2) and colloidal suspensions(3). Likewise, electric fields can be used to move liquid drops(4). Electrically induced droplet motion manifests itself in processes as diverse as storm cloud formation(5), commercial ink-jet printing(6), petroleum and vegetable oil dehydration(7), electrospray ionization for use in mass spectrometry(8), electrowetting(9) and lab-on-a-chip manipulations(10). An important issue in practical applications is the tendency for adjacent drops to coalesce, and oppositely charged drops have long been assumed to experience an attractive force that favours their coalescence(11-13). Here we report the existence of a critical field strength above which oppositely charged drops do not coalesce. We observe that appropriately positioned and oppositely charged drops migrate towards one another in an applied electric field; but whereas the drops coalesce as expected at low field strengths, they are repelled from one another after contact at higher field strengths. Qualitatively, the drops appear to 'bounce' off one another. We directly image the transient formation of a meniscus bridge between the bouncing drops, and propose that this temporary bridge is unstable with respect to capillary pressure when it forms in an electric field exceeding a critical strength. The observation of oppositely charged drops bouncing rather than coalescing in strong electric fields should affect our understanding of any process involving charged liquid drops, including de-emulsification, electrospray ionization and atmospheric conduction.	[Ristenpart, W. D.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA; [Ristenpart, W. D.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Bird, J. C.; Dollar, F.; Stone, H. A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Belmonte, A.] Penn State Univ, Dept Math, WG Pritchard Labs, University Pk, PA 16802 USA	University of California System; University of California Davis; University of California System; University of California Davis; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ristenpart, WD (corresponding author), Univ Calif Davis, Dept Chem Engn & Mat Sci, 1 Shields Dr, Davis, CA 95616 USA.	wdristenpart@ucdavis.edu	Han, Kyuhee/B-6201-2009; Ristenpart, William/AAG-4462-2021; Dollar, Franklin/C-9214-2013	Dollar, Franklin/0000-0003-3346-5763	Harvard University's MRSEC	Harvard University's MRSEC(National Science Foundation (NSF))	We thank M. Poitzsch and M. Sullivan at the Schlumberger-Doll Research Center for supplying samples of crude oil, C. Holtze, T. Schneider and D. A. Weitz for feedback and the Harvard Nanoscale Science and Engineering Center for support. A. B. acknowledges support from Harvard University's MRSEC.	ALLAN RS, 1962, J COLL SCI IMP U TOK, V17, P383, DOI 10.1016/0095-8522(62)90016-8; ALLAN RS, 1961, T FARADAY SOC, V57, P2027, DOI 10.1039/tf9615702027; Baret JC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016106; BAYGENTS JC, 1991, J CHEM SOC FARADAY T, V87, P1883, DOI 10.1039/ft9918701883; BIBETTE J, 1992, PHYS REV LETT, V69, P2439, DOI 10.1103/PhysRevLett.69.2439; Binks BP, 2001, LANGMUIR, V17, P4540, DOI 10.1021/la0103822; BRAZIERSMITH PR, 1972, PROC R SOC LON SER-A, V326, P393, DOI 10.1098/rspa.1972.0016; BRAZIERSMITH PR, 1971, PHYS FLUIDS, V14, P1, DOI 10.1063/1.1693258; BRAZIERSMITH PR, 1971, PROC R SOC LON SER-A, V325, P363, DOI 10.1098/rspa.1971.0174; Calvert P, 2001, CHEM MATER, V13, P3299, DOI 10.1021/cm0101632; Chabert M, 2005, ELECTROPHORESIS, V26, P3706, DOI 10.1002/elps.200500109; de la Mora JF, 2007, ANNU REV FLUID MECH, V39, P217, DOI 10.1146/annurev.fluid.39.050905.110159; Eow JS, 2001, CHEM ENG J, V84, P173, DOI 10.1016/S1385-8947(00)00386-7; FENN JB, 1989, SCIENCE, V246, P64, DOI 10.1126/science.2675315; Hase M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.046301; JAYARATNE OW, 1964, PROC R SOC LON SER-A, V280, P545, DOI 10.1098/rspa.1964.0161; Jung YM, 2008, J COLLOID INTERF SCI, V322, P617, DOI 10.1016/j.jcis.2008.04.019; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Link DR, 2006, ANGEW CHEM INT EDIT, V45, P2556, DOI 10.1002/anie.200503540; MOCHIZUKI T, 1990, AICHE J, V36, P1039, DOI 10.1002/aic.690360710; OCHS HT, 1987, NATURE, V327, P606, DOI 10.1038/327606a0; Pohl H., 1978, DIELECTROPHORESIS; RAYLEIGH, 1879, P R SOC LOND, V28, P405; SADEK SE, 1974, IND ENG CHEM FUND, V13, P139, DOI 10.1021/i160050a009; SARTOR D, 1954, J METEOROL, V11, P91, DOI 10.1175/1520-0469(1954)011<0091:ALIOCE>2.0.CO;2; Schaffer E, 2000, NATURE, V403, P874, DOI 10.1038/35002540; TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151; Taylor SE, 1996, CHEM ENG RES DES, V74, P526; Trau M, 1997, NATURE, V390, P674, DOI 10.1038/37764; Urdahl O, 1996, CHEM ENG RES DES, V74, P158	30	217	225	6	263	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					377	380		10.1038/nature08294	http://dx.doi.org/10.1038/nature08294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19759616	Green Submitted			2022-12-28	WOS:000269828100035
J	Shores, NJ; Bloomfeld, RS				Shores, Nathan Joseph; Bloomfeld, Richard Seth			Uvular Necrosis after Endoscopy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Shores, Nathan Joseph; Bloomfeld, Richard Seth] Wake Forest Univ Hlth Sci, Winston Salem, NC 27106 USA	Wake Forest University; Wake Forest University School of Medicine	Shores, NJ (corresponding author), Wake Forest Univ Hlth Sci, Winston Salem, NC 27106 USA.	nshores@wfubmc.edu							0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					E20	E20		10.1056/NEJMicm0803418	http://dx.doi.org/10.1056/NEJMicm0803418			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494QA	19759379				2022-12-28	WOS:000269828000011
J	Mistry, D; Atkinson, H				Mistry, Dipan; Atkinson, Helen			Picture quiz An itchy ear that became painful	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE OTITIS-EXTERNA		[Mistry, Dipan; Atkinson, Helen] Hull Royal Infirm, Dept Ear Nose & Throat, Kingston Upon Hull HU3 2JZ, N Humberside, England	University of Hull	Mistry, D (corresponding author), Hull Royal Infirm, Dept Ear Nose & Throat, Kingston Upon Hull HU3 2JZ, N Humberside, England.	dipanmistry@hotmail.com						*NHS CLIN KNOWL SU, OT EXT; Ninkovic G, 2008, AURIS NASUS LARYNX, V35, P480, DOI 10.1016/j.anl.2007.09.013; Rosenfeld RM, 2006, OTOLARYNG HEAD NECK, V134, pS4, DOI [10.1177/0194599813517083, 10.1016/j.otohns.2006.02.014]; Rosenfeld RM, 2006, OTOLARYNG HEAD NECK, V134, pS24, DOI 10.1016/j.otohns.2006.02.013; Rowlands S, 2001, BRIT J GEN PRACT, V51, P533	5	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2009	339								b3632	10.1136/bmj.b3632	http://dx.doi.org/10.1136/bmj.b3632			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RT	19759090				2022-12-28	WOS:000269994800003
J	Belknap, SM				Belknap, Steven M.			A ward-based pharmacist intervention reduced emergency department visits and drug-related readmissions in elderly patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PROGRAM		Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Belknap, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA.			Belknap, Steven/0000-0002-3670-7409				Belknap SM, 2008, CLIN PHARMACOL THER, V84, P385, DOI 10.1038/clpt.2008.24; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Schnipper JL, 2006, ARCH INTERN MED, V166, P565, DOI 10.1001/archinte.166.5.565	4	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6							JC3-14	10.7326/0003-4819-151-6-200909150-02014	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-02014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755360				2022-12-28	WOS:000270390100030
J	Wenning, W; Haghikia, A; Laubenberger, J; Clifford, DB; Behrens, PF; Chan, A; Gold, R				Wenning, Werner; Haghikia, Aiden; Laubenberger, Joerg; Clifford, David B.; Behrens, Peter F.; Chan, Andrew; Gold, Ralf			Treatment of Progressive Multifocal Leukoencephalopathy Associated with Natalizumab	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-SCLEROSIS; JC VIRUS; THERAPY; CELLS; HIV	We describe the clinical and therapeutic course of a 52-year-old patient with multiple sclerosis in whom progressive multifocal leukoencephalopathy (PML) developed after 12 months of therapy with natalizumab. The patient was hospitalized 2 months after the onset of neurologic and psychiatric symptoms and was treated with plasma exchange and immunoadsorption to eliminate natalizumab. After a brief improvement, he became critically ill with an apparent episode of immune reconstitution inflammatory syndrome. Steroid-pulse therapy led to stabilization of the patient's condition and clinically significant recovery. This case illustrates that prompt diagnosis and treatment may improve the outcome in patients with severe PML associated with natalizumab therapy.	[Haghikia, Aiden; Chan, Andrew; Gold, Ralf] Ruhr Univ Bochum, Dept Neurol, St Josef Hosp, D-44791 Bochum, Germany; [Wenning, Werner; Behrens, Peter F.] Ortenau Klinikum, Neurol Clin, Offenburg, Germany; [Laubenberger, Joerg] Ortenau Klinikum, Radiol Clin, Offenburg, Germany; [Clifford, David B.] Washington Univ, St Louis, MO 63130 USA	Ruhr University Bochum; Washington University (WUSTL)	Gold, R (corresponding author), Ruhr Univ Bochum, Dept Neurol, St Josef Hosp, Gudrunstr 56, D-44791 Bochum, Germany.	ralf.gold@rub.de		Chan, Andrew/0000-0003-3434-7283	Biogen [111 JC 101]; Biogen Idec; Bayer-Schering; Merck Serono; Teva-Sanofi-Aventis	Biogen(Biogen); Biogen Idec(Biogen); Bayer-Schering(Bayer AG); Merck Serono(Merck & Company); Teva-Sanofi-Aventis(Sanofi-Aventis)	Dr. Wenning reports receiving lecture fees from Biogen Idec; Dr. Clifford, consulting fees from Biogen Idec and Elan and grant support from Biogen (Protocol 111 JC 101) as per-patient reimbursement for costs; Dr. Chan, lecture fees from Biogen Idec, Bayer-Schering, Merck Serono, and Teva-Sanofi-Aventis and grant support from Biogen Idec; and Dr. Gold, lecture and consulting fees from Biogen Idec, Bayer-Schering, Merck Serono, and Teva-Sanofi-Aventis and grant support from Biogen Idec and Teva. No other potential conflict of interest relevant to this article was reported.	Brickelmaier M, 2008, MULT SCLER, V14, pS44; De Luca A, 2008, AIDS, V22, P1759, DOI 10.1097/QAD.0b013e32830a5043; Delbue S, 2008, NEUROL SCI, V29, pS283, DOI 10.1007/s10072-008-0965-7; Gonzalez-Duarte A, 2009, NEUROLOGY, V72, P289, DOI 10.1212/01.wnl.0000339488.32588.0f; Gray F, 2003, J NEUROPATH EXP NEUR, V62, P429, DOI 10.1093/jnen/62.5.429; Kappos L, 2007, LANCET NEUROL, V6, P431, DOI 10.1016/S1474-4422(07)70078-9; Khatri BO, 2009, NEUROLOGY, V72, P402, DOI 10.1212/01.wnl.0000341766.59028.9d; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Linda H, 2009, NEW ENGL J MED, V361, P1081, DOI 10.1056/NEJMoa0810316; Martin MD, 2008, ARCH NEUROL-CHICAGO, V65, P1596, DOI 10.1001/archneur.65.12.noc80051; O'Hara BA, 2008, VIRUS RES, V132, P97, DOI 10.1016/j.virusres.2007.11.002; Perez-Liz G, 2008, ANN NEUROL, V64, P379, DOI 10.1002/ana.21443; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Steinman L, 2005, NAT REV DRUG DISCOV, V4, P510, DOI 10.1038/nrd1752; Stuve O, 2006, ANN NEUROL, V59, P743, DOI 10.1002/ana.20858; Stuve O, 2006, ARCH NEUROL-CHICAGO, V63, P1383, DOI 10.1001/archneur.63.10.1383; Thurnher MM, 2001, AM J NEURORADIOL, V22, P977; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Verma S, 2007, J INFECT DIS, V196, P709, DOI 10.1086/520514; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693	22	141	146	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1075	1080		10.1056/NEJMoa0810257	http://dx.doi.org/10.1056/NEJMoa0810257			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19741228				2022-12-28	WOS:000269659400010
J	Bartlett, JR; Friedman, KJ; Ling, SC; Pace, RG; Bell, SC; Bourke, B; Castaldo, G; Castellani, C; Cipolli, M; Colombo, C; Colombo, JL; Debray, D; Fernandez, A; Lacaille, F; Macek, M; Rowland, M; Salvatore, F; Taylor, CJ; Wainwright, C; Wilschanski, M; Zemkova, D; Hannah, WB; Phillips, MJ; Corey, M; Zielenski, J; Dorfman, R; Wang, YF; Zou, F; Silverman, LM; Drumm, ML; Wright, FA; Lange, EM; Durie, PR; Knowles, MR; Clancy, J; Sindel, LJ; Roberts, D; Roberts, V; Radford, P; Argel, N; Morgan, W; Douthit, J; Schellhase, D; Anderson, P; Taggart, A; Morrissey, B; Platzker, A; Woo, M; Fukushima, L; Hsu, E; Shay, G; Hardy, K; Moss, R; Dunn, CE; Pian, M; Wojtczak, H; Burns, L; Henig, N; Nielson, D; Landon, C; Thompson, A; Accurso, F; Nick, J; Jones, M; Lapin, C; Drapeau, V; Egan, M; Padman, R; Winnie, G; George, C; Olson, E; Light, M; Geller, D; Gondor, M; Flanary, J; Stecenko, A; Guill, M; McColley, S; Potter, E; Chung, Y; Garvey, M; Howenstine, M; Sannuti, A; Yeley, J; Sloven, D; Ahrens, R; Teresi, M; Riva, C; Davis, S; Quiniones-Ellis, B; Gabor, C; Lever, T; Welch, R; Cairns, A; Corrigan, M; Zeitlin, P; Brass, L; Dorkin, H; Levy, H; Huntington, I; O'Sullivan, B; Simon, R; Nasr, S; Lumeng, C; Ball, M; Toder, D; Honicky, R; Fitch, S; Contreras, L; Regelmann, W; Phillips, J; McNamara, J; Johnson, M; Ruiz, F; Adcock, K				Bartlett, Jaclyn R.; Friedman, Kenneth J.; Ling, Simon C.; Pace, Rhonda G.; Bell, Scott C.; Bourke, Billy; Castaldo, Giuseppe; Castellani, Carlo; Cipolli, Marco; Colombo, Carla; Colombo, John L.; Debray, Dominique; Fernandez, Adriana; Lacaille, Florence; Macek, Milan, Jr.; Rowland, Marion; Salvatore, Francesco; Taylor, Christopher J.; Wainwright, Claire; Wilschanski, Michael; Zemkova, Dana; Hannah, William B.; Phillips, M. James; Corey, Mary; Zielenski, Julian; Dorfman, Ruslan; Wang, Yunfei; Zou, Fei; Silverman, Lawrence M.; Drumm, Mitchell L.; Wright, Fred A.; Lange, Ethan M.; Durie, Peter R.; Knowles, Michael R.; Clancy, J. P.; Sindel, L. J.; Roberts, D. M.; Roberts, V.; Radford, P. J.; Argel, N.; Morgan, W. J.; Douthit, J. L.; Schellhase, D. E.; Anderson, P.; Taggart, A.; Morrissey, B.; Platzker, A. C. G.; Woo, M. S.; Fukushima, L.; Hsu, E.; Shay, G. F.; Hardy, K. A.; Moss, R. B.; Dunn, C. E.; Pian, M. S.; Wojtczak, H. A.; Burns, L.; Henig, N. R.; Nielson, D. W.; Landon, C.; Thompson, A.; Accurso, F. J.; Nick, J. A.; Jones, M.; Lapin, C.; Drapeau, V. M.; Egan, M. E.; Padman, R.; Winnie, G. B.; George, C.; Olson, E. L.; Light, M. J.; Geller, D. E.; Gondor, M.; Flanary, J.; Stecenko, A. A.; Guill, M. F.; McColley, S. A.; Potter, E. M.; Chung, Y.; Garvey, M.; Howenstine, M. S.; Sannuti, A.; Yeley, J.; Sloven, D. G.; Ahrens, R. C.; Teresi, M.; Riva, C. M.; Davis, S.; Quiniones-Ellis, B.; Gabor, C.; Lever, T. F.; Welch, R.; Cairns, A.; Corrigan, M.; Zeitlin, P. L.; Brass, L.; Dorkin, H.; Levy, H.; Huntington, I.; O'Sullivan, B. P.; Simon, R. H.; Nasr, S. Z.; Lumeng, C. N.; Ball, M. E.; Toder, D. S.; Honicky, R. E.; Fitch, S.; Contreras, L.; Regelmann, W. E.; Phillips, J. R.; McNamara, J.; Johnson, M.; Ruiz, F. E.; Adcock, K. G.		Gene Modifier Study Grp	Genetic Modifiers of Liver Disease in Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ALPHA-1-ANTITRYPSIN DEFICIENCY; LUNG-DISEASE; RISK-FACTORS; ALPHA(1)-ANTITRYPSIN DEFICIENCY; SEVERITY; EPIDEMIOLOGY; ASSOCIATION; EXPRESSION; CIRRHOSIS	Context A subset (approximate to 3%-5%) of patients with cystic fibrosis (CF) develops severe liver disease with portal hypertension. Objective To assess whether any of 9 polymorphisms in 5 candidate genes (alpha(1)-antitrypsin or alpha(1)-antiprotease [SERPINA1], angiotensin-converting enzyme [ACE], glutathione S-transferase [GSTP1], mannose-binding lectin 2 [MBL2], and transforming growth factor beta 1 [TGFB1]) are associated with severe liver disease in patients with CF. Design, Setting, and Participants Two-stage case-control study enrolling patients with CF and severe liver disease with portal hypertension (CFLD) from 63 CF centers in the United States as well as 32 in Canada and 18 outside of North America, with the University of North Carolina at Chapel Hill as the coordinating site. In the initial study, 124 patients with CFLD (enrolled January 1999-December 2004) and 843 control patients without CFLD were studied by genotyping 9 polymorphisms in 5 genes previously studied as modifiers of liver disease in CF. In the second stage, the SERPINA1 Z allele and TGFB1 codon 10 genotype were tested in an additional 136 patients with CFLD (enrolled January 2005-February 2007) and 1088 with no CFLD. Main Outcome Measures Differences in distribution of genotypes in patients with CFLD vs patients without CFLD. Results The initial study showed CFLD to be associated with the SERPINA1 Z allele (odds ratio [OR], 4.72; 95% confidence interval [CI], 2.31-9.61; P = 3.3 x 10(-6)) and with TGFB1 codon 10 CC genotype (OR, 1.53; 95% CI, 1.16-2.03; P = 2.8 x 10(-3)). In the replication study, CFLD was associated with the SERPINA1 Z allele (OR, 3.42; 95% CI, 1.54-7.59; P = 1.4 x 10(-3)) but not with TGFB1 codon 10. A combined analysis of the initial and replication studies by logistic regression showed CFLD to be associated with SERPINA1 Z allele (OR, 5.04; 95% CI, 2.88-8.83; P = 1.5 x 10(-8)). Conclusions The SERPINA1 Z allele is a risk factor for liver disease in CF. Patients who carry the Z allele are at greater risk (OR, approximate to 5) of developing severe liver disease with portal hypertension. JAMA. 2009;302(10):1076-1083	[Bartlett, Jaclyn R.; Pace, Rhonda G.; Hannah, William B.; Knowles, Michael R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 7019 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA; [Wang, Yunfei; Lange, Ethan M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Wang, Yunfei; Zou, Fei; Wright, Fred A.; Lange, Ethan M.] Univ N Carolina, Sch Med, Chapel Hill, NC 27599 USA; [Wang, Yunfei; Zou, Fei; Wright, Fred A.; Lange, Ethan M.] Univ N Carolina, Sch Publ Hlth, Dept Biostat, Chapel Hill, NC 27599 USA; [Friedman, Kenneth J.] Lab Corp Amer, Ctr Mol Biol & Pathol, Res Triangle Pk, NC USA; [Ling, Simon C.; Durie, Peter R.] Hosp Sick Children, Div Gastroenterol Hepatol & Nutr, Toronto, ON M5G 1X8, Canada; [Ling, Simon C.; Corey, Mary; Durie, Peter R.] Univ Toronto, Toronto, ON, Canada; [Bell, Scott C.] Prince Charles Hosp, Adult Cyst Fibrosis Ctr, Chermside, Qld, Australia; [Bourke, Billy; Rowland, Marion] Our Ladys Childrens Hosp, Childrens Res Ctr, Crumlin, Ireland; [Rowland, Marion] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Castaldo, Giuseppe; Salvatore, Francesco] Univ Naples Federico II, CEINGE Adv Biotechnol, Naples, Italy; [Castaldo, Giuseppe; Salvatore, Francesco] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy; [Castellani, Carlo; Cipolli, Marco] Azienda Osped Verona, Cyst Fibrosis Ctr, Verona, Italy; [Colombo, Carla] Univ Milan, CF Ctr, Fdn IRCCS Osped Maggiore Policlin, Milan, Italy; [Colombo, John L.] Univ Nebraska Med Ctr, Dept Pediat, Pulm Sect, Omaha, NE USA; [Debray, Dominique] Ctr Hosp Univ Bicetre, Serv Hepatol Pediat, Le Kremlin Bicetre, France; [Fernandez, Adriana] La Plata Childrens Hosp, Cyst Fibrosis Ctr, Buenos Aires, DF, Argentina; [Lacaille, Florence] Hop Necker Enfants Malad, Pediat Hepatogastroenterol Nutr Unit, Paris, France; [Macek, Milan, Jr.] Charles Univ Prague, Dept Biol, Prague, Czech Republic; [Macek, Milan, Jr.] Charles Univ Prague, Dept Med Genet, Prague, Czech Republic; [Zemkova, Dana] Charles Univ Prague, Dept Pediat, Prague, Czech Republic; Univ Hosp Motol, Prague, Czech Republic; [Taylor, Christopher J.] Univ Sheffield, Acad Unit Child Hlth, Dept Paediat Gastroenterol, Sheffield, S Yorkshire, England; [Wainwright, Claire] Royal Childrens Hosp, Queensland Childrens Resp Ctr, Brisbane, Qld, Australia; [Wilschanski, Michael] Hadassah Med Org, Dept Pediat Gastroenterol, Jerusalem, Israel; [Silverman, Lawrence M.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Drumm, Mitchell L.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Prince Charles Hospital; National Children's Research Centre (NCRC); University College Dublin; CEINGE Biotecnologie Avanzate; University of Naples Federico II; University of Naples Federico II; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Nebraska System; University of Nebraska Medical Center; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Charles University Prague; Charles University Prague; Charles University Prague; Motol University Hospital; University of Sheffield; Royal Children's Hospital Brisbane; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Virginia; Case Western Reserve University; Case Western Reserve University	Knowles, MR (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 7019 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	knowles@med.unc.edu	Bell, Scott C/A-7241-2011; Moss, Richard B./S-9218-2019; Lewindon, Peter/E-9196-2014; Castellani, Carlo/AAB-3847-2019; Repetto, Gabriela/C-7833-2012; Wainwright, Claire E/G-4218-2013; Van Biervliet, stephanie/M-6386-2019; Bell, Scott/AAJ-4298-2020; Castaldo, Giuseppe/AAC-6782-2022; Kumar, Vinod/ABC-4866-2020; Cipolli, Marco/AAL-1419-2020; rowland, marion/AAL-2446-2020; Salvatore, Francesco/A-1966-2011	Bell, Scott C/0000-0001-8651-7139; Moss, Richard B./0000-0003-3611-4221; Lewindon, Peter/0000-0002-9502-3090; Repetto, Gabriela/0000-0003-0120-5684; Wainwright, Claire E/0000-0001-8389-3809; Van Biervliet, stephanie/0000-0001-5609-3726; Bell, Scott/0000-0001-8651-7139; Castaldo, Giuseppe/0000-0002-4036-0874; Kumar, Vinod/0000-0002-2775-6049; Cipolli, Marco/0000-0001-5652-7248; Pace, Rhonda/0000-0001-8606-0327; Milavetz, Mary/0000-0001-9989-3010; Salvatore, Francesco/0000-0002-2346-3564; Rowland, Marion/0000-0003-2701-830X; Ling, Simon/0000-0002-4223-4601; Rovitelli, Amy MK/0000-0002-8587-4502; Dorfman, Ruslan/0000-0002-3421-5582	Cystic Fibrosis Foundation [SILVER0Z00, KNOWLE00A0, DRUMM04P0, DRUMM0A00]; National Institutes of Health [NIH R01GM074175, NIH/NIDDK DK066368, CTRC RR00046, CTSA UL1RR025747]; Prince Charles Hospital Foundation; OWHC/CIHR Fellowship; Czech Ministry of Health [VZFNM00064203, NS9488/3]; MIUR, Rome, Italy; Regione Campania, Italy; Health Research Board Grant [RFRD-05-07]; Genome Canada through the Ontario Genomics Institute [2004-OGI-3-05]; Lloyd Carr-Harris Foundation; Canadian Cystic Fibrosis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000046, UL1RR025747] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068890, R21HL079093] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074175] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prince Charles Hospital Foundation; OWHC/CIHR Fellowship(Canadian Institutes of Health Research (CIHR)); Czech Ministry of Health(Ministry of Health, Czech Republic); MIUR, Rome, Italy(Ministry of Education, Universities and Research (MIUR)); Regione Campania, Italy(Regione Campania); Health Research Board Grant; Genome Canada through the Ontario Genomics Institute(Genome Canada); Lloyd Carr-Harris Foundation; Canadian Cystic Fibrosis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the Cystic Fibrosis Foundation (SILVER0Z00, KNOWLE00A0, DRUMM04P0, DRUMM0A00); the National Institutes of Health (NIH R01GM074175, NIH/NIDDK DK066368, CTRC RR00046, CTSA UL1RR025747); the Prince Charles Hospital Foundation; the OWHC/CIHR Fellowship; the Czech Ministry of Health (VZFNM00064203, NS9488/3); MIUR, Rome, Italy, and Regione Campania, Italy; a Fellowship in Rare Diseases from The Health Research Board Grant (RFRD-05-07); Genome Canada through the Ontario Genomics Institute (2004-OGI-3-05); the Lloyd Carr-Harris Foundation; and the Canadian Cystic Fibrosis Foundation.	Arkwright PD, 2003, AM J RESP CRIT CARE, V167, P384, DOI 10.1164/rccm.200204-364OC; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Bremer LA, 2008, HUM MOL GENET, V17, P2228, DOI 10.1093/hmg/ddn123; Castaldo G, 2001, AM J MED GENET, V98, P294, DOI 10.1002/1096-8628(20010201)98:4<294::AID-AJMG1097>3.0.CO;2-K; COHN JA, 1993, GASTROENTEROLOGY, V105, P1857, DOI 10.1016/0016-5085(93)91085-V; COLOMBO C, 1994, J PEDIATR-US, V124, P393, DOI 10.1016/S0022-3476(94)70361-2; Colombo C, 2002, HEPATOLOGY, V36, P1374, DOI 10.1053/jhep.2002.37136; Colombo C, 2007, CURR OPIN PULM MED, V13, P529, DOI 10.1097/MCP.0b013e3282f10a16; Corbett K, 2004, J PEDIATR-US, V145, P327, DOI 10.1016/j.jpeds.2004.05.051; de Serres F J, 2007, Monaldi Arch Chest Dis, V67, P184; de Serres FJ, 2003, CLIN GENET, V64, P382, DOI 10.1034/j.1399-0004.2003.00143.x; Debray D, 1999, J HEPATOL, V31, P77, DOI 10.1016/S0168-8278(99)80166-4; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Drumm ML, 2005, NEW ENGL J MED, V353, P1443, DOI 10.1056/NEJMoa051469; Eigenbrodt ML, 1997, AM J GASTROENTEROL, V92, P602; Feranchak Andrew P, 2004, Curr Gastroenterol Rep, V6, P231, DOI 10.1007/s11894-004-0013-6; Feranchak AP, 2001, SEMIN LIVER DIS, V21, P471, DOI 10.1055/s-2001-19030; Fischer HP, 2000, J HEPATOL, V33, P883, DOI 10.1016/S0168-8278(00)80119-1; Frangolias DD, 2003, AM J RESP CELL MOL, V29, P390, DOI 10.1165/rcmb.2002-0271OC; Gabolde M, 2001, J MED GENET, V38, P310, DOI 10.1136/jmg.38.5.310; Graziadei IW, 1998, HEPATOLOGY, V28, P1058, DOI 10.1002/hep.510280421; Henrion-Caude A, 2002, HEPATOLOGY, V36, P913, DOI 10.1053/jhep.2002.35534; Kinnman N, 2000, HEPATOLOGY, V32, P334, DOI 10.1053/jhep.2000.9111; Lamireau T, 2004, J HEPATOL, V41, P920, DOI 10.1016/j.jhep.2004.08.006; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; LEVIN ML, 1978, AM J EPIDEMIOL, V108, P78; Mekus F, 2000, Twin Res, V3, P277, DOI 10.1375/twin.3.4.277; Mencin A, 2007, HEPATOLOGY, V46, P1443, DOI 10.1002/hep.21832; Perlmutter DH, 2006, PEDIATR RES, V60, P233, DOI 10.1203/01.pdr.0000228350.61496.90; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Regev A, 2006, J PEDIATR GASTR NUTR, V43, pS30, DOI 10.1097/01.mpg.0000226387.56612.1e; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Slieker MG, 2003, HEPATOLOGY, V38, P775, DOI 10.1053/jhep.2003.50403; Sontag Marci K, 2004, Adv Pediatr, V51, P5; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wilschanski M, 1999, PEDIATRICS, V103, P52, DOI 10.1542/peds.103.1.52; Yang QH, 2003, EPIDEMIOLOGY, V14, P161, DOI 10.1097/00001648-200303000-00009	41	196	202	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1076	1083		10.1001/jama.2009.1295	http://dx.doi.org/10.1001/jama.2009.1295			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738092	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000269616200025
J	Milne, F; Redman, C; Walker, J; Baker, P; Black, R; Blincowe, J; Cooper, C; Fletcher, G; Jokinen, M; Moran, PA; Nelson-Piercy, C; Robson, S; Shennan, A; Tuffnell, A; Waugh, J				Milne, Fiona; Redman, Chris; Walker, James; Baker, Phil; Black, Rebecca; Blincowe, Jill; Cooper, Carol; Fletcher, Gillian; Jokinen, Mervi; Moran, Paul A.; Nelson-Piercy, Catherine; Robson, Stephen; Shennan, Andrew; Tuffnell, Angela; Waugh, Jason			Guidelines Assessing the onset of pre-eclampsia in the hospital day unit: summary of the pre-eclampsia guideline (PRECOG II)	BRITISH MEDICAL JOURNAL			English	Editorial Material							NORMAL-PREGNANCY; GESTATIONAL HYPERTENSION		[Milne, Fiona; Fletcher, Gillian] Act Preeclampsia, Syston LE7 1LD, England; [Redman, Chris] John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; [Walker, James; Tuffnell, Angela] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Baker, Phil] Univ Manchester, St Marys Hosp, NIHR Biomed Res Ctr, Manchester M13 0JH, Lancs, England; [Blincowe, Jill] Horton Matern Hosp, Banbury OX16 9AL, England; [Jokinen, Mervi] Royal Coll Midw, London W1G 9NH, England; [Moran, Paul A.] Worcestershire Royal Hosp, Worcester WR5 1DD, England; [Nelson-Piercy, Catherine] St Thomas Hosp, London SE1 7EH, England; [Robson, Stephen] Univ Newcastle, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Shennan, Andrew] Kings Coll London, St Thomas Hosp, London SE1 7EH, England; [Waugh, Jason] Royal Victoria Hosp, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	University of Oxford; Saint James's University Hospital; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Milne, F (corresponding author), Act Preeclampsia, 2c Halfcroft, Syston LE7 1LD, England.	fionamilne@talk21.com		Walker, James/0000-0002-8922-083X; Shennan, Andrew/0000-0001-5273-3132	Department of Health and various foundations; Bayer; GlaxoSmithKline's corporate department	Department of Health and various foundations; Bayer(Bayer AG); GlaxoSmithKline's corporate department(GlaxoSmithKline)	Action on Pre-eclampsia is a self funded charity that provides information and support to women and healthcare professionals about pre-eclampsia. Funds are raised from donations and subscriptions, individual grants from the Department of Health and various foundations, and income from study and other education days, primarily for midwives. We received a grant from GlaxoSmithKline's corporate department to support the development of this guideline. We also received some initial funding via Bayer for organization of the first guideline development meeting in 2002. No member of the group was paid for their contribution, except for travel expenses to attend the various meetings. Neither funder had any involvement in the content or development of the guideline.	*AG HEALTHCARE POL, 1993, AHCPR PUBL; ANUMBA DOC, HYPERTENS P IN PRESS; Bailey DJ, 2005, AUST NZ J OBSTET GYN, V45, P144, DOI 10.1111/j.1479-828X.2005.00382.x; Girling JC, 1997, BRIT J OBSTET GYNAEC, V104, P246, DOI 10.1111/j.1471-0528.1997.tb11054.x; Girling Joanna C., 2000, Journal of Obstetrics and Gynaecology (Abingdon), V20, P128; LIND T, 1984, BRIT J OBSTET GYNAEC, V91, P128, DOI 10.1111/j.1471-0528.1984.tb05895.x; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; *NAT I CLIN EXC SC, 2004, 6 NAT I CLIN EXC SCO; *NAT I CLIN EXC SC, 2007, 7 NAT I CLIN EXC SCO; National Institute for Clinical Excellence, 2003, ANT CAR ROUT CAR HLT; *PRECOG DEV GROUP, 2004, PREECL COMM GUID PRE; Price CP, 2005, CLIN CHEM, V51, P1577, DOI 10.1373/clinchem.2005.049742; Saudan P, 1998, BRIT J OBSTET GYNAEC, V105, P1177, DOI 10.1111/j.1471-0528.1998.tb09971.x; TWADDLE S, 1992, BRIT J OBSTET GYNAEC, V99, P459, DOI 10.1111/j.1471-0528.1992.tb13781.x; TYGART SG, 1986, AM J OBSTET GYNECOL, V154, P883, DOI 10.1016/0002-9378(86)90476-X	15	34	35	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 9	2009	339								b3129	10.1136/bmj.b3129	http://dx.doi.org/10.1136/bmj.b3129			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	493RD	19740933				2022-12-28	WOS:000269754700001
J	Quant, EC; Jeste, SS; Muni, RH; Cape, AV; Bhussar, MK; Peleg, AY				Quant, Eudocia C.; Jeste, Shafali S.; Muni, Rajeev H.; Cape, Alison V.; Bhussar, Manveen K.; Peleg, Anton Y.			The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SIMPLEX-VIRUS TYPE-1; DOUBLE-BLIND; ACYCLOVIR; PREDNISOLONE; EFFICACY; QUALITY; VALACYCLOVIR; REACTIVATION; MULTICENTER; SURGERY	Objective To determine whether steroids plus antivirals provide a better degree of facial muscle recovery in patients with Bell's palsy than steroids alone. Design Meta-analysis. Data sources PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials were searched for studies published in all languages from 1984 to January 2009. Additional studies were identified from cited references. Selection criteria Randomised controlled trials that compared steroids with the combination of steroids and antivirals for the treatment of Bell's palsy were included in this study. At least one month of follow-up and a primary end point of at least partial facial muscle recovery, as defined by a House-Brackmann grade of at least 2 (complete palsy is designated a grade of 6) or an equivalent score on an alternative recognised scoring system, were required. Review methods Two authors independently reviewed studies for methodological quality, treatment regimens, duration of symptoms before treatment, length of follow-up, and outcomes. Odds ratios with 95% confidence intervals were calculated and pooled using a random effects model. Results Six trials were included, a total of 1145 patients; 574 patients received steroids alone and 571 patients received steroids and antivirals. The pooled odds ratio for facial muscle recovery showed no benefit of steroids plus antivirals compared with steroids alone (odds ratio 1.50, 95% confidence interval 0.83 to 2.69; P=0.18). A one study removed analysis showed that the highest quality studies had the greatest effect on the lack of difference between study arms shown by the odds ratio. Subgroup analyses assessing causes of heterogeneity defined a priori (time from symptom onset to treatment, length of follow-up, and type of antiviral studied) showed no benefit of antivirals in addition to that provided by steroids. Conclusions Antivirals did not provide an added benefit in achieving at least partial facial muscle recovery compared with steroids alone in patients with Bell's palsy. This study does not, therefore, support the routine use of antivirals in Bell's palsy. Future studies should use improved herpes virus diagnostics and newer antivirals to assess whether combination therapy benefits patients with more severe facial paralysis at study entry.	[Jeste, Shafali S.; Peleg, Anton Y.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jeste, Shafali S.] Childrens Hosp Boston, Div Neurol, Boston, MA 02115 USA; [Muni, Rajeev H.] Univ Toronto, St Michaels Hosp, Dept Ophthalmol & Vis Sci, Toronto, ON M5B 1W8, Canada; [Bhussar, Manveen K.; Peleg, Anton Y.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Peleg, Anton Y.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital	Peleg, AY (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	apeleg@bidmc.harvard.edu	Jeste, Shafali S/N-2350-2017	Jeste, Shafali S/0000-0003-2955-6902; Peleg, Anton/0000-0002-2296-2126	American National Cancer Institute Paul Calabresi Award for Clinical Oncology [K12CA090354]; American Academy of Neurology Clinical Research Training fellowship; Canadian National Institute for the Blind; University of Queensland; NATIONAL CANCER INSTITUTE [K12CA090354] Funding Source: NIH RePORTER	American National Cancer Institute Paul Calabresi Award for Clinical Oncology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Academy of Neurology Clinical Research Training fellowship; Canadian National Institute for the Blind; University of Queensland(University of Queensland); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	No specific funding was received for this study. However, ECQ was funded by an American National Cancer Institute Paul Calabresi Award for Clinical Oncology (K12CA090354), SSJ was funded by an American Academy of Neurology Clinical Research Training fellowship, RHM by an EA Baker Fellowship from the Canadian National Institute for the Blind, and AYP by a University of Queensland postgraduate fellowship. All researchers are independent of the funding body.	ADOUR KK, 1974, NEUROLOGY, V24, P1112, DOI 10.1212/WNL.24.12.1112; Adour KK, 1996, ANN OTO RHINOL LARYN, V105, P371, DOI 10.1177/000348949610500508; Ahangar AA, 2006, NEUROSCIENCES, V11, P256; Alberton DL, 2006, ANN PHARMACOTHER, V40, P1838, DOI 10.1345/aph.1H077; Allen C, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004753.pub2; Anpalahan V, 2000, AUST J OTOLARYNGOL, V3, P476; ANTUNES ML, 2000, ACTA AWHO, V19, P68; CAWTHORNE T, 1950, P ROY SOC MED, V43, P491, DOI 10.1177/003591575004300701; Davenport RJ, 2008, LANCET, V372, P1219, DOI 10.1016/S0140-6736(08)61515-9; De Diego-Sastre JI, 2005, REV NEUROLOGIA, V41, P287, DOI 10.33588/rn.4105.2004593; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engstrom M, 2008, LANCET NEUROL, V7, P993, DOI 10.1016/S1474-4422(08)70221-7; Furuta Y, 2001, AURIS NASUS LARYNX, V28, pS13, DOI 10.1016/S0385-8146(00)00105-X; Gilden DH, 2004, NEW ENGL J MED, V351, P1323, DOI 10.1056/NEJMcp041120; Grogan PM, 2001, NEUROLOGY, V56, P830, DOI 10.1212/WNL.56.7.830; Hato N, 2003, OTOL NEUROTOL, V24, P948, DOI 10.1097/00129492-200311000-00022; Hato N, 2008, LANCET, V371, P1818, DOI 10.1016/S0140-6736(08)60776-X; Hato N, 2007, OTOL NEUROTOL, V28, P408, DOI 10.1097/01.mao.0000265190.29969.12; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kawaguchi K, 2007, LARYNGOSCOPE, V117, P147, DOI 10.1097/01.mlg.0000248737.65607.9e; Kim IS, 2007, YONSEI MED J, V48, P963, DOI 10.3349/ymj.2007.48.6.963; MACIAS AR, 1992, ACTA OTORRINOLARINGO, V43, P117; Minnerop M, 2008, J NEUROL, V255, P1726, DOI 10.1007/s00415-008-0008-6; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MURAKAMI S, 1996, ANN INTERN MED, P12427; Roy A, 2005, J NEUROL SCI, V238, pS207; Salinas RA, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001942.PUB2; Sullivan FM, 2007, NEW ENGL J MED, V357, P1598, DOI 10.1056/NEJMoa072006; Yeo SG, 2008, AM J OTOLARYNG, V29, P163, DOI 10.1016/j.amjoto.2007.05.001	30	70	71	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2009	339								b3354	10.1136/bmj.b3354	http://dx.doi.org/10.1136/bmj.b3354			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	493RB	19736282	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000269754500002
J	Haller, E; Gustavsson, M; Mark, MJ; Danzl, JG; Hart, R; Pupillo, G; Nagerl, HC				Haller, Elmar; Gustavsson, Mattias; Mark, Manfred J.; Danzl, Johann G.; Hart, Russell; Pupillo, Guido; Naegerl, Hanns-Christoph			Realization of an Excited, Strongly Correlated Quantum Gas Phase	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATION; FERMIONS	Ultracold atomic physics offers myriad possibilities to study strongly correlated many-body systems in lower dimensions. Typically, only ground-state phases are accessible. Using a tunable quantum gas of bosonic cesium atoms, we realized and controlled in one-dimensional geometry a highly excited quantum phase that is stabilized in the presence of attractive interactions by maintaining and strengthening quantum correlations across a confinement-induced resonance. We diagnosed the crossover from repulsive to attractive interactions in terms of the stiffness and energy of the system. Our results open up the experimental study of metastable, excited, many-body phases with strong correlations and their dynamical properties.	[Haller, Elmar; Gustavsson, Mattias; Mark, Manfred J.; Danzl, Johann G.; Hart, Russell; Naegerl, Hanns-Christoph] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Haller, Elmar; Gustavsson, Mattias; Mark, Manfred J.; Danzl, Johann G.; Hart, Russell; Naegerl, Hanns-Christoph] Univ Innsbruck, Zentrum Quantenphys, A-6020 Innsbruck, Austria; [Pupillo, Guido] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Pupillo, Guido] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; University of Innsbruck; Austrian Academy of Sciences	Nagerl, HC (corresponding author), Univ Innsbruck, Inst Expt Phys, Tech Str 25, A-6020 Innsbruck, Austria.	christoph.naegerl@uibk.ac.at	Naegerl, Hanns-Christoph/E-7329-2010; Haller, Elmar/E-8916-2010; Gustavsson, Mattias/A-3397-2009; Mark, Manfred J/E-4286-2010; Danzl, Johann Georg/AGX-2475-2022; Danzl, Johann/N-9987-2015	Naegerl, Hanns-Christoph/0000-0002-7789-4431; Haller, Elmar/0000-0002-7951-1721; Mark, Manfred J/0000-0001-8157-4716; Danzl, Johann Georg/0000-0001-8559-3973; Danzl, Johann/0000-0001-8559-3973; Pupillo, Guido/0000-0002-1549-0386	Austrian Ministry of Science and Research (Bundesministerium fur Wissenschaft und Forschung); Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung); European Union [FP7-ICT-2007-C]; European Community	Austrian Ministry of Science and Research (Bundesministerium fur Wissenschaft und Forschung); Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung)(Austrian Science Fund (FWF)); European Union(European Commission); European Community(European Commission)	We thank S. Giorgini and C. Menotti for helpful discussions and for providing the theory curves shown in Fig. 3A. We are indebted to R. Grimm for generous support and to H. Haffner and his group for the loan of a charge-coupled device camera. We gratefully acknowledge funding by the Austrian Ministry of Science and Research (Bundesministerium fur Wissenschaft und Forschung) and the Austrian Science Fund (Fonds zur Forderung der wissenschaftlichen Forschung) in the form of a START prize grant and by the European Union through the Specific Targeted Research Project FP7-ICT-2007-C project NAME-QUAM (Nanodesigning of Atomic and Molecular Quantum Matter) and within the framework of the EuroQUASAR collective research project Quantum-Degenerate Gases for Precision Measurements. R. H. is supported by a Marie Curie International Incoming Fellowship within the 7th European Community Framework Programme.	Alet F, 2006, PHYSICA A, V369, P122, DOI 10.1016/j.physa.2006.04.003; Astrakharchik GE, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190407; Astrakharchik GE, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.030402; Batchelor MT, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/L10001; Bergeman T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.163201; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bockrath M, 1999, NATURE, V397, P598, DOI 10.1038/17569; GIRARDEAU M, 1960, J MATH PHYS, V1, P516, DOI 10.1063/1.1703687; Inouye S, 1998, NATURE, V392, P151, DOI 10.1038/32354; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; Lange AD, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.013622; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; MCGUIRE JB, 1965, J MATH PHYS, V6, P432, DOI 10.1063/1.1704291; Menotti C, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043610; Moritz H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250402; Olshanii M, 1998, PHYS REV LETT, V81, P938, DOI 10.1103/PhysRevLett.81.938; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Petrov DS, 2000, PHYS REV LETT, V85, P3745, DOI 10.1103/PhysRevLett.85.3745; Petrov DS, 2004, J PHYS IV, V116, P5, DOI 10.1051/jp4:2004116001; Petrov DS, 2000, PHYS REV LETT, V84, P2551, DOI 10.1103/PhysRevLett.84.2551; Steinberg H, 2008, NAT PHYS, V4, P116, DOI 10.1038/nphys810; Syassen N, 2008, SCIENCE, V320, P1329, DOI 10.1126/science.1155309; Tempfli E, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/10/103021; Tolra BL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190401; Weber T, 2003, SCIENCE, V299, P232, DOI 10.1126/science.1079699	27	391	391	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1224	1227		10.1126/science.1175850	http://dx.doi.org/10.1126/science.1175850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729651	Green Submitted			2022-12-28	WOS:000269523200031
J	Vanacore, R; Ham, AJL; Voehler, M; Sanders, CR; Conrads, TP; Veenstra, TD; Sharpless, KB; Dawson, PE; Hudson, BG				Vanacore, Roberto; Ham, Amy-Joan L.; Voehler, Markus; Sanders, Charles R.; Conrads, Thomas P.; Veenstra, Timothy D.; Sharpless, K. Barry; Dawson, Philip E.; Hudson, Billy G.			A Sulfilimine Bond Identified in Collagen IV	SCIENCE			English	Article							BASEMENT-MEMBRANE COLLAGEN; COVALENT CROSS-LINK; CRYSTAL-STRUCTURE; IMMUNE PRIVILEGE; STRUCTURAL BASIS; METHIONINE; DOMAIN; STABILIZATION; AUTOANTIGEN; INTEGRINS	Collagen IV networks are ancient proteins of basement membranes that underlie epithelia in metazoa from sponge to human. The networks provide structural integrity to tissues and serve as ligands for integrin cell-surface receptors. They are assembled by oligomerization of triple-helical protomers and are covalently crosslinked, a key reinforcement that stabilizes networks. We used Fourier-transform ion cyclotron resonance mass spectrometry and nuclear magnetic resonance spectroscopy to show that a sulfilimine bond (-S=N-) crosslinks hydroxylysine-211 and methionine-93 of adjoining protomers, a bond not previously found in biomolecules. This bond, the nitrogen analog of a sulfoxide, appears to have arisen at the divergence of sponge and cnidaria, an adaptation of the extracellular matrix in response to mechanical stress in metazoan evolution.	[Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA; [Vanacore, Roberto; Hudson, Billy G.] Vanderbilt Univ, Ctr Matrix Biol, Nashville, TN 37232 USA; [Ham, Amy-Joan L.; Sanders, Charles R.; Hudson, Billy G.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Voehler, Markus] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA; [Hudson, Billy G.] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA; [Conrads, Thomas P.; Veenstra, Timothy D.] NCI, Lab Prote & Analyt Technol, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21702 USA; [Sharpless, K. Barry; Dawson, Philip E.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Sharpless, K. Barry; Dawson, Philip E.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Dawson, Philip E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Vanacore, R (corresponding author), Vanderbilt Univ, Dept Med, Div Nephrol, Nashville, TN 37232 USA.	roberto.vanacore@vanderbilt.edu; billy.hudson@vanderbilt.edu	Vanacore, Roberto/AAD-6399-2020; Vanacore, Roberto/C-9763-2012	Vanacore, Roberto/0000-0002-2886-0606; Vanacore, Roberto/0000-0002-2886-0606; Hudson, Billy/0000-0002-5420-4100	NIH [DK065123, DK18381, DC007416, GM059380]; W. M. Keck Foundation; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018381, P01DK065123, R37DK018381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007416] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Liebler for facilitating the initial contact with T. D. Veenstra from SAIC-Frederick, Incorporated, and C. Bolm (Aachen University, Germany) for helpful discussions. The technical assistance of P. Todd and M. Rafi is greatly appreciated. We would also like to thank S. Hill and H. McDonald, from the Proteomics Laboratory at the Mass Spectrometry Research Center of Vanderbilt University, for their assistance with the Orbitrap-LTQ (Therme Electron, San Jose, CA) instrument. This work was supported in part by NIH grants DK065123 and DK18381 (to B. G. H.), DC007416 (C. R. S.), and GM059380 (P. E. D.); the W. M. Keck Foundation (K. B. S.); and the Skaggs Institute for Chemical Biology (K. B. S.). R. V. and B. G. H. have filed a provisional patent (1 June 2009) on the potential enzyme system that catalyses the sulfilimine bond formation and that may be involved in pathophysiological processes.	Aouacheria A, 2006, MOL BIOL EVOL, V23, P2288, DOI 10.1093/molbev/msl100; Borza DB, 2005, J BIOL CHEM, V280, P27147, DOI 10.1074/jbc.M504050200; COPE AC, 1949, J AM CHEM SOC, V71, P3929, DOI 10.1021/ja01180a014; GILCHRIST TL, 1977, CHEM REV, V77, P409, DOI 10.1021/cr60307a005; GLASS RS, 1976, J AM CHEM SOC, V98, P965, DOI 10.1021/ja00420a016; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2006, NEW ENGL J MED, V354, P1489, DOI 10.1056/NEJMoa053727; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; JOHNSON CR, 1972, TETRAHEDRON LETT, V6, P501; Khoshnoodi J, 2006, J BIOL CHEM, V281, P6058, DOI 10.1074/jbc.M506555200; Khoshnoodi J, 2008, MICROSC RES TECHNIQ, V71, P357, DOI 10.1002/jemt.20564; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; KOVAL IV, 1990, USP KHIM+, V59, P1409; Lagerwerf FM, 1996, RAPID COMMUN MASS SP, V10, P1905, DOI 10.1002/(SICI)1097-0231(199612)10:15<1905::AID-RCM755>3.0.CO;2-9; LAMBETH DO, 1979, J ORG CHEM, V44, P263; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Reid GE, 2004, J PROTEOME RES, V3, P751, DOI 10.1021/pr0499646; SIEBOLD B, 1988, EUR J BIOCHEM, V176, P617, DOI 10.1111/j.1432-1033.1988.tb14321.x; Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200; Than ME, 2005, BIOL CHEM, V386, P759, DOI 10.1515/BC.2005.089; Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499; Thorner PS, 1996, J BIOL CHEM, V271, P13821, DOI 10.1074/jbc.271.23.13821; Vanacore RM, 2005, J BIOL CHEM, V280, P29300, DOI 10.1074/jbc.M502752200; Vanacore RM, 2004, J BIOL CHEM, V279, P44723, DOI 10.1074/jbc.M406344200; Vanacore RM, 2008, J BIOL CHEM, V283, P22737, DOI 10.1074/jbc.M803451200; Wang XM, 2008, NATURE, V455, P72, DOI 10.1038/nature07214; WEBER S, 1984, EUR J BIOCHEM, V139, P401, DOI 10.1111/j.1432-1033.1984.tb08019.x; YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040	30	150	154	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1230	1234		10.1126/science.1176811	http://dx.doi.org/10.1126/science.1176811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729652	Green Accepted			2022-12-28	WOS:000269523200033
J	Schouten, O; Boersma, E; Hoeks, SE; Benner, R; van Urk, H; van Sambeek, MRHM; Verhagen, HJM; Khan, NA; Dunkelgrun, M; Bax, JJ; Poldermans, D				Schouten, Olaf; Boersma, Eric; Hoeks, Sanne E.; Benner, Robbert; van Urk, Hero; van Sambeek, Marc R. H. M.; Verhagen, Hence J. M.; Khan, Nisar A.; Dunkelgrun, Martin; Bax, Jeroen J.; Poldermans, Don		Dutch Echocardiographic Cardiac Ri	Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Annual Congress of the European-Society-of-Cardiology	AUG 30-SEP 03, 2008	Munich, GERMANY	European Soc Cardiol			RISK-ASSESSMENT STRATEGIES; ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; VULNERABLE PATIENT; STATINS; DEFINITIONS; REDUCTION; MORTALITY; OUTCOMES; THERAPY	Background: Adverse cardiac events are common after vascular surgery. We hypothesized that perioperative statin therapy would improve postoperative outcomes. Methods: In this double-blind, placebo-controlled trial, we randomly assigned patients who had not previously been treated with a statin to receive, in addition to a beta-blocker, either 80 mg of extended-release fluvastatin or placebo once daily before undergoing vascular surgery. Lipid, interleukin-6, and C-reactive protein levels were measured at the time of randomization and before surgery. The primary end point was the occurrence of myocardial ischemia, defined as transient electrocardiographic abnormalities, release of troponin T, or both, within 30 days after surgery. The secondary end point was the composite of death from cardiovascular causes and myocardial infarction. Results: A total of 250 patients were assigned to fluvastatin, and 247 to placebo, a median of 37 days before vascular surgery. Levels of total cholesterol, low-density lipoprotein cholesterol, interleukin-6, and C-reactive protein were significantly decreased in the fluvastatin group but were unchanged in the placebo group. Postoperative myocardial ischemia occurred in 27 patients (10.8%) in the fluvastatin group and in 47 (19.0%) in the placebo group (hazard ratio, 0.55; 95% confidence interval [CI], 0.34 to 0.88; P=0.01). Death from cardiovascular causes or myocardial infarction occurred in 12 patients (4.8%) in the fluvastatin group and 25 patients (10.1%) in the placebo group (hazard ratio, 0.47; 95% CI, 0.24 to 0.94; P=0.03). Fluvastatin therapy was not associated with a significant increase in the rate of adverse events. Conclusions: In patients undergoing vascular surgery, perioperative fluvastatin therapy was associated with an improvement in postoperative cardiac outcome. (Current Controlled Trials number, ISRCTN83738615.) N Engl J Med 2009;361:980-9.	[Poldermans, Don] Erasmus MC, Dept Anesthesiol, NL-3015 CE Rotterdam, Netherlands; [Schouten, Olaf; van Urk, Hero; van Sambeek, Marc R. H. M.; Verhagen, Hence J. M.; Dunkelgrun, Martin] Erasmus MC, Dept Surg, NL-3015 CE Rotterdam, Netherlands; [Boersma, Eric; Hoeks, Sanne E.] Erasmus MC, Dept Cardiol, NL-3015 CE Rotterdam, Netherlands; [Benner, Robbert; Khan, Nisar A.] Erasmus MC, Dept Immunol, NL-3015 CE Rotterdam, Netherlands; [van Sambeek, Marc R. H. M.] Catharina Hosp, Dept Surg, Eindhoven, Netherlands; [Bax, Jeroen J.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Catharina Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Poldermans, D (corresponding author), Erasmus MC, Dept Anesthesiol, Gravendijkwal 230,Rm H-805, NL-3015 CE Rotterdam, Netherlands.	d.poldermans@erasmusmc.nl	Hoeks, Sanne/AAM-3313-2020; van Sambeek, marc/CAF-1289-2022					Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Cohen MC, 1999, CARDIOVASC PATHOL, V8, P133, DOI 10.1016/S1054-8807(98)00032-5; Dawood MM, 1996, INT J CARDIOL, V57, P37, DOI 10.1016/S0167-5273(96)02769-6; Durazzo AES, 2004, J VASC SURG, V39, P967, DOI 10.1016/j.jvs.2004.01.004; Halcox JPJ, 2004, CIRCULATION, V109, P42, DOI 10.1161/01.CIR.0000129500.29229.92; Heeschen C, 2002, CIRCULATION, V105, P1446, DOI 10.1161/01.CIR.0000012530.68333.C8; HERTZER NR, 1984, ANN SURG, V199, P223, DOI 10.1097/00000658-198402000-00016; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Kertai MD, 2004, EUR J VASC ENDOVASC, V28, P343, DOI 10.1016/j.ejvs.2004.07.008; Landesberg G, 2003, J AM COLL CARDIOL, V42, P1547, DOI 10.1016/j.jacc.2003.05.001; Lindenauer PK, 2004, JAMA-J AM MED ASSOC, V291, P2092, DOI 10.1001/jama.291.17.2092; MANGANO DT, 1990, ANESTHESIOLOGY, V72, P153, DOI 10.1097/00000542-199001000-00025; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; O'Neil-Callahan K, 2005, J AM COLL CARDIOL, V45, P336, DOI 10.1016/j.jacc.2004.10.048; Pasternak RC, 2002, J AM COLL CARDIOL, V40, P567, DOI 10.1016/S0735-1097(02)02030-2; Poldermans D, 2003, CIRCULATION, V107, P1848, DOI 10.1161/01.CIR.0000066286.15621.98; Poldermans D, 2006, J AM COLL CARDIOL, V48, P964, DOI 10.1016/j.jacc.2006.03.059; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Schouten O, 2006, J VASC SURG, V44, P419, DOI 10.1016/j.jvs.2006.04.039; Spencer FA, 2004, ANN INTERN MED, V140, P857, DOI 10.7326/0003-4819-140-11-200406010-00006; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38	25	264	270	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					980	989		10.1056/NEJMoa0808207	http://dx.doi.org/10.1056/NEJMoa0808207			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	490EI	19726772	Bronze			2022-12-28	WOS:000269480400007
J	Kiblbock, C; Schutzenberger, W; Kammler, J; Demmer, J; Leisch, F				Kiblboeck, Christoph; Schuetzenberger, Wilhelm; Kammler, Juergen; Demmer, Johannes; Leisch, Franz			Case report Transient loss of consciousness and a heart murmur	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LEFT ATRIAL-MYXOMA; CARDIAC MYXOMAS; IMMUNOLOGICAL FEATURES; MYOCARDIAL-INFARCTION; CLINICAL PRESENTATION; INTERLEUKIN-6; EXPRESSION; TUMORS		[Kiblboeck, Christoph; Schuetzenberger, Wilhelm; Kammler, Juergen; Leisch, Franz] Acad Teaching & Gen Hosp Linz, Div Cardiovasc, Dept Internal Med 1, A-4020 Linz, Austria; [Demmer, Johannes] Acad Teaching & Gen Hosp Linz, Dept Cardiovasc & Thorac Surg, A-4020 Linz, Austria	Kepler University Hospital; Kepler University Hospital	Kiblbock, C (corresponding author), Acad Teaching & Gen Hosp Linz, Div Cardiovasc, Dept Internal Med 1, A-4020 Linz, Austria.	christoph.kiblboeck@akh.linz.at						Aggarwal S, 2007, AM HEART J, V154, P1102, DOI 10.1016/j.ahj.2007.07.032; Braun S, 2005, INT J CARDIOL, V101, P115, DOI 10.1016/j.ijcard.2004.08.047; Brignole M, 2004, EUROPACE, V6, P467, DOI 10.1016/j.eupc.2004.08.008; Ekinci EI, 2004, INTERN MED J, V34, P243, DOI 10.1111/j.1444-0903.2004.00563.x; ElBardissi AW, 2008, CIRCULATION, V118, pS7, DOI 10.1161/CIRCULATIONAHA.107.783126; Mendoza CE, 2001, TEX HEART I J, V28, P3; Ozaydin M, 2005, ANGIOLOGY, V56, P767, DOI 10.1177/000331970505600615; Parissis JT, 1996, J INTERF CYTOK RES, V16, P589, DOI 10.1089/jir.1996.16.589; Pinede L, 2001, MEDICINE, V80, P159, DOI 10.1097/00005792-200105000-00002; Rahmanian Parwis B, 2007, Interact Cardiovasc Thorac Surg, V6, P479; REYNEN K, 1995, NEW ENGL J MED, V333, P1610, DOI 10.1056/NEJM199512143332407; Sato H, 2008, J FORENSIC LEG MED, V15, P454, DOI 10.1016/j.jflm.2008.02.013; Schmidt D, 2005, EUR J MED RES, V10, P296; SEINO Y, 1993, BRIT HEART J, V69, P565; Stratakis CA, 2001, J CLIN ENDOCR METAB, V86, P4041, DOI 10.1210/jc.86.9.4041; Yokomuro H, 2007, SURG TODAY, V37, P750, DOI 10.1007/s00595-006-3448-6; Yoo Minwook, 2008, Cases J, V1, P96, DOI 10.1186/1757-1626-1-96	17	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2009	339								b3323	10.1136/bmj.b3323	http://dx.doi.org/10.1136/bmj.b3323			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CH	19726483				2022-12-28	WOS:000269554000015
J	Morehouse, NI; Rutowski, RL				Morehouse, Nathan I.; Rutowski, Ronald L.			Comment on "Floral Iridescence, Produced by Diffractive Optics, Acts As a Cue for Animal Pollinators"	SCIENCE			English	Editorial Material							LIGHT	Whitney et al. (Reports, 2 January 2009, p. 130) investigated the mechanism of iridescence in hibiscus and tulip flowers and suggested that bumblebees are able to use this iridescence as a pollination cue. However, their study failed to isolate iridescence from other coincident visual cues, leaving open questions regarding the importance of iridescent stimuli in foraging-based associative learning in bumblebees.	[Morehouse, Nathan I.; Rutowski, Ronald L.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Morehouse, NI (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	nmorehouse@asu.edu		Morehouse, Nathan/0000-0001-6449-7106				Douglas JM, 2007, J EXP BIOL, V210, P788, DOI 10.1242/jeb.02713; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Sweeney A, 2003, NATURE, V423, P31, DOI 10.1038/423031a; Vukusic P, 2001, NATURE, V410, P36, DOI 10.1038/35065161; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256	5	7	7	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944								10.1126/science.1173324	http://dx.doi.org/10.1126/science.1173324			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713509	Bronze			2022-12-28	WOS:000269382300019
J	Sprague, BL; Trentham-Dietz, A				Sprague, Brian L.; Trentham-Dietz, Amy			Prevalence of Breast Carcinoma In Situ in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							CANCER; RISK		[Sprague, Brian L.; Trentham-Dietz, Amy] Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sprague, BL (corresponding author), Univ Wisconsin, Dept Populat Hlth Sci, Madison, WI 53706 USA.	bsprague@wisc.edu			NATIONAL CANCER INSTITUTE [R01CA067264] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA067264-12, R01 CA067264, CA67264] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Capocaccia R, 1997, STAT MED, V16, P425, DOI 10.1002/(SICI)1097-0258(19970228)16:4<425::AID-SIM414>3.0.CO;2-Z; Gail MH, 1999, BIOMETRICS, V55, P1137, DOI 10.1111/j.0006-341X.1999.01137.x; Rakovitch E, 2003, BREAST CANCER RES TR, V77, P285, DOI 10.1023/A:1021853302033; Ries L, 1975, SEER CANC STAT REV; SEER, SEER STAT DAT; Warnberg F, 2000, LANCET, V355, P724, DOI 10.1016/S0140-6736(99)03703-4	6	17	17	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					846	848						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706857	Green Accepted			2022-12-28	WOS:000269260100017
J	Ma, WZ; Trusina, A; El-Samad, H; Lim, WA; Tang, C				Ma, Wenzhe; Trusina, Ala; El-Samad, Hana; Lim, Wendell A.; Tang, Chao			Defining Network Topologies that Can Achieve Biochemical Adaptation	CELL			English	Article							BACTERIAL CHEMOTAXIS; POSITIVE FEEDBACK; ESCHERICHIA-COLI; ROBUSTNESS; MOTIFS; CELLS; TRANSDUCTION; SENSITIVITY; CALCIUM; DESIGN	Many signaling systems show adaptation-the ability to reset themselves after responding to a stimulus. We computationally searched all possible three-node enzyme network topologies to identify those that could perform adaptation. Only two major core topologies emerge as robust solutions: a negative feedback loop with a buffering node and an incoherent feedforward loop with a proportioner node. Minimal circuits containing these topologies are, within proper regions of parameter space, sufficient to achieve adaptation. Morecomplex circuits that robustly perform adaptation all contain at least one of these topologies at their core. This analysis yields a design table highlighting a finite set of adaptive circuits. Despite the diversity of possible biochemical networks, it may be common to find that only a finite set of core topologies can execute a particular function. These design rules provide a framework for functionally classifying complex natural networks and a manual for engineering networks. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Ma, Wenzhe; Trusina, Ala; El-Samad, Hana; Lim, Wendell A.; Tang, Chao] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Ma, Wenzhe; Tang, Chao] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Ma, Wenzhe; Trusina, Ala; Tang, Chao] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [El-Samad, Hana; Tang, Chao] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Lim, Wendell A.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Peking University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA.	lim@cmp.ucsf.edu; chao.tang@ucsf.edu	Trusina, Ala/L-6069-2013; Ma, Wenzhe/N-3320-2017; trusina, ala/H-7312-2012	Trusina, Ala/0000-0003-1945-454X; Tang, Chao/0000-0003-1474-3705	National Science Foundation [DMR-0804183]; Ministry of Science and Technology of China; National Natural Science Foundation of China; Howard Hughes Medical Institute; Packard Foundation; NIH; NIH Nano-medicine Development Centers; NATIONAL EYE INSTITUTE [PN2EY016546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055040] Funding Source: NIH RePORTER; Division Of Materials Research [0804183] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Packard Foundation(The David & Lucile Packard Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Nano-medicine Development Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank Caleb Bashor, Noah Helman, Morten Kloster, Ilya Nemenman, and Eduardo Sontag for helpful discussions, Angi Chau, Kai-Yeung Lau, Thomas Shimizu, and David Burkhardt for critical reading of the manuscript.W.M. acknowledges the support from the Li Foundation.A.T.acknowledges the support from the Sandler Family Supporting Foundation.This work was supported in part by the National Science Foundation (DMR-0804183) (C.T.), Ministry of Science and Technology of China (C.T.), the National Natural Science Foundation of China (C.T.), the Howard Hughes Medical Institute (W.A.L.), the Packard Foundation (W.A.L.), the NIH (W.A.L.), and the NIH Nano-medicine Development Centers (W.A.L.).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Behar M, 2007, BIOPHYS J, V93, P806, DOI 10.1529/biophysj.107.107516; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; El-Samad H, 2002, J THEOR BIOL, V214, P17, DOI 10.1006/jtbi.2001.2422; Endres RG, 2006, P NATL ACAD SCI USA, V103, P13040, DOI 10.1073/pnas.0603101103; Francois P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026009; GOLDBETER A, 1984, J BIOL CHEM, V259, P14441; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; IMAN RL, 1980, LATIN HYPERCUBE SAMP, P77; KIRSCH ML, 1993, J BIOL CHEM, V268, P18610; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Mello BA, 2003, P NATL ACAD SCI USA, V100, P8223, DOI 10.1073/pnas.1330839100; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Rao CV, 2004, PLOS BIOL, V2, P239, DOI 10.1371/journal.pbio.0020049; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Wagner A, 2005, P NATL ACAD SCI USA, V102, P11775, DOI 10.1073/pnas.0501094102; Yang L, 2006, SYST CONTROL LETT, V55, P329, DOI 10.1016/j.sysconle.2005.08.009; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	28	588	610	8	138	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					760	773		10.1016/j.cell.2009.06.013	http://dx.doi.org/10.1016/j.cell.2009.06.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703401	Green Accepted, Bronze			2022-12-28	WOS:000269156100017
J	Drinnenberg, IA; Weinberg, DE; Xie, KT; Mower, JP; Wolfe, KH; Fink, GR; Bartel, DP				Drinnenberg, Ines A.; Weinberg, David E.; Xie, Kathleen T.; Mower, Jeffrey P.; Wolfe, Kenneth H.; Fink, Gerald R.; Bartel, David P.			RNAi in Budding Yeast	SCIENCE			English	Article							RESOLUTION; EVOLUTION; RIBONUCLEASE; INITIATION; ELEMENTS	RNA interference (RNAi), a gene-silencing pathway triggered by double-stranded RNA, is conserved in diverse eukaryotic species but has been lost in the model budding yeast Saccharomyces cerevisiae. Here, we show that RNAi is present in other budding yeast species, including Saccharomyces castellii and Candida albicans. These species use noncanonical Dicer proteins to generate small interfering RNAs, which mostly correspond to transposable elements and Y' subtelomeric repeats. In S. castellii, RNAi mutants are viable but have excess Y' messenger RNA levels. In S. cerevisiae, introducing Dicer and Argonaute of S. castellii restores RNAi, and the reconstituted pathway silences endogenous retrotransposons. These results identify a previously unknown class of Dicer proteins, bring the tool of RNAi to the study of budding yeasts, and bring the tools of budding yeast to the study of RNAi.	[Drinnenberg, Ines A.; Weinberg, David E.; Xie, Kathleen T.; Fink, Gerald R.; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Drinnenberg, Ines A.; Weinberg, David E.; Xie, Kathleen T.; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Weinberg, David E.; Xie, Kathleen T.; Fink, Gerald R.; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Mower, Jeffrey P.; Wolfe, Kenneth H.] Univ Dublin Trinity Coll, Smurfit Inst Genet, Dublin 2, Ireland	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Trinity College Dublin	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Mower, Jeff/B-7875-2008; Mower, Jeff/P-5893-2019	Mower, Jeff/0000-0002-1501-5809; Mower, Jeff/0000-0002-1501-5809; Xie, Kathleen/0000-0002-3178-8959; Wolfe, Kenneth/0000-0003-4992-4979	Science Foundation Ireland; Irish Research Council for Science, Engineering, and Technology; NIH [GM040266, GM0305010, GM067031]; NSF graduate research fellowship; Boehringer-Ingelheim Fonds predoctoral fellowship; Howard Hughes Medical Institute;  [GSE17872]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031, R01GM040266] Funding Source: NIH RePORTER	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Irish Research Council for Science, Engineering, and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF graduate research fellowship(National Science Foundation (NSF)); Boehringer-Ingelheim Fonds predoctoral fellowship(Boehringer Ingelheim); Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Hochwagen, G. Ruby, and H. Guo for helpful discussions; V. Agarwal for protein homology modeling; D. Garfinkel for Ty1-VLP antiserum and other reagents; M. Cohn and A. Regev for yeast strains; W. Johnston and the Whitehead Genome Technology Core for high-throughput sequencing; and S. P bo for academic advising. Supported by Science Foundation Ireland and the Irish Research Council for Science, Engineering, and Technology ( K. H. W.), NIH grants GM040266 ( G. R. F.), GM0305010 ( G. R. F.), and GM067031 ( D. P. B.), an NSF graduate research fellowship ( D. E. W.), and a Boehringer-Ingelheim Fonds predoctoral fellowship ( I. A. D.). D. P. B. is an Investigator of the Howard Hughes Medical Institute. The Gene Expression Omnibus accession number for all the mRNA-Seq and small-RNA cloning data is GSE17872.	Astromskas E, 2007, YEAST, V24, P499, DOI 10.1002/yea.1488; Axelson-Fisk M, 2006, TOP CURR GENET, V15, P1, DOI 10.1007/4735_111; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; GARFINKEL DJ, 1988, GENETICS, V120, P95; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; KAWAKAMI K, 1993, GENETICS, V135, P309; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Lamontagne B, 2001, Curr Issues Mol Biol, V3, P71; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Laurie JD, 2008, CURR GENET, V53, P49, DOI 10.1007/s00294-007-0165-7; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; LOUIS EJ, 1992, GENETICS, V131, P559; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nakayashiki H, 2006, J MOL EVOL, V63, P127, DOI 10.1007/s00239-005-0257-2; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vazquez F, 2004, CURR BIOL, V14, P346, DOI 10.1016/j.cub.2004.01.035; Wickner RB, 1996, MICROBIOL REV, V60, P250, DOI 10.1128/MMBR.60.1.250-265.1996; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	35	364	387	6	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					544	550		10.1126/science.1176945	http://dx.doi.org/10.1126/science.1176945			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19745116	Green Submitted, Green Accepted			2022-12-28	WOS:000271019400033
J	Thomas, DL; Thio, CL; Martin, MP; Qi, Y; Ge, D; O'hUigin, C; Kidd, J; Kidd, K; Khakoo, SI; Alexander, G; Goedert, JJ; Kirk, GD; Donfield, SM; Rosen, HR; Tobler, LH; Busch, MP; McHutchison, JG; Goldstein, DB; Carrington, M				Thomas, David L.; Thio, Chloe L.; Martin, Maureen P.; Qi, Ying; Ge, Dongliang; O'hUigin, Colm; Kidd, Judith; Kidd, Kenneth; Khakoo, Salim I.; Alexander, Graeme; Goedert, James J.; Kirk, Gregory D.; Donfield, Sharyne M.; Rosen, Hugo R.; Tobler, Leslie H.; Busch, Michael P.; McHutchison, John G.; Goldstein, David B.; Carrington, Mary			Genetic variation in IL28B and spontaneous clearance of hepatitis C virus	NATURE			English	Article							NATURAL-HISTORY; INFECTION; ALPHA-2A; HOST	Hepatitis C virus (HCV) infection is the most common bloodborne infection in the United States, with estimates of 4 million HCV-infected individuals in the United States and 170 million worldwide(1). Most (70-80%) HCV infections persist and about 30% of individuals with persistent infection develop chronic liver disease, including cirrhosis and hepatocellular carcinoma(2). Epidemiological, viral and host factors have been associated with the differences in HCV clearance or persistence, and studies have demonstrated that a strong host immune response against HCV favours viral clearance(3,4). Thus, variation in genes involved in the immune response may contribute to the ability to clear the virus. In a recent genome-wide association study, a single nucleotide polymorphism (rs12979860) 3 kilobases upstream of the IL28B gene, which encodes the type III interferon IFN-lambda 3, was shown to associate strongly with more than a twofold difference in response to HCV drug treatment(5). To determine the potential effect of rs12979860 variation on outcome to HCV infection in a natural history setting, we genotyped this variant in HCV cohorts comprised of individuals who spontaneously cleared the virus (n = 388) or had persistent infection (n = 620). We show that the C/C genotype strongly enhances resolution of HCV infection among individuals of both European and African ancestry. To our knowledge, this is the strongest and most significant genetic effect associated with natural clearance of HCV, and these results implicate a primary role for IL28B in resolution of HCV infection.	[Martin, Maureen P.; Qi, Ying; O'hUigin, Colm; Carrington, Mary] NCI Frederick, SAIC Frederick Inc, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA; [Thomas, David L.; Thio, Chloe L.] Johns Hopkins Univ, Div Infect Dis, Baltimore, MD 21205 USA; [Martin, Maureen P.; Qi, Ying; O'hUigin, Colm; Carrington, Mary] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02114 USA; [Martin, Maureen P.; Qi, Ying; O'hUigin, Colm; Carrington, Mary] Harvard Univ, Boston, MA 02114 USA; [Ge, Dongliang; Goldstein, David B.] Duke Univ, Inst Genome Sci & Policy, Ctr Human Genome Variat, Durham, NC 27708 USA; [Kidd, Judith; Kidd, Kenneth] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Alexander, Graeme] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Khakoo, Salim I.] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1NY, England; [Goedert, James J.] NCI, Infect & Immunoepidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; [Kirk, Gregory D.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Donfield, Sharyne M.] Rho Inc, Chapel Hill, NC 27517 USA; [Rosen, Hugo R.] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol & Hepatol, Aurora, CO 80045 USA; [Tobler, Leslie H.] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Busch, Michael P.] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [McHutchison, John G.] Duke Univ, Sch Med, Div Gastroenterol, Durham, NC 27705 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Duke University; Yale University; University of Cambridge; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rho; University of Colorado System; University of Colorado Anschutz Medical Campus; Vitalant; Vitalant Research Institute; Duke University; Duke University	Carrington, M (corresponding author), NCI Frederick, SAIC Frederick Inc, Expt Immunol Lab, Canc & Inflammat Program, Frederick, MD 21702 USA.	carringm@mail.nih.gov	Goldstein, David/AAY-8125-2020; Ge, Dongliang/A-2073-2010	Ge, David/0000-0002-9732-8170; Khakoo, Salim/0000-0002-4057-9091	National Cancer Institute; National Institutes of Health [HHSN261200800001E, R01DA013324, R01DA004334, R01HL076902, R01DK60590, R01HD41224]; Wellcome Trust Senior Clinical Fellow; NATIONAL CANCER INSTITUTE [ZIABC010791, ZICBC011237, ZIACP010214] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Senior Clinical Fellow(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract number HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This Research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This research was supported by NIH grants R01DA013324 ( D. L. T.), R01DA004334 ( G. D. K.), R01HL076902 ( M. P. B.), R01DK60590 ( H. R. R.) and R01HD41224 ( S. M. D.). S. I. K. is a Wellcome Trust Senior Clinical Fellow.	[Anonymous], 1998, MMWR Recomm Rep, V47, P1; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; Dellgren C, 2009, GENES IMMUN, V10, P125, DOI 10.1038/gene.2008.87; Donnelly RP, 2004, J LEUKOCYTE BIOL, V76, P314, DOI 10.1189/jlb.0204117; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; HILGARTNER MW, 1993, AM J PEDIAT HEMATOL, V15, P208; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371; Marcello T, 2006, GASTROENTEROLOGY, V131, P1887, DOI 10.1053/j.gastro.2006.09.052; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; Osier MV, 2002, AM J PHYS ANTHROPOL, V119, P77, DOI 10.1002/ajpa.10094; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Thio CL, 2008, CLIN LIVER DIS, V12, P713, DOI 10.1016/j.cld.2008.03.002; Thio CL, 2000, HEPATOLOGY, V31, P819, DOI 10.1053/he.2000.4316; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Vlahov D, 1991, NIDA Res Monogr, V109, P75; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301	24	1675	1772	0	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					798	U52		10.1038/nature08463	http://dx.doi.org/10.1038/nature08463			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19759533	Green Accepted			2022-12-28	WOS:000270547500037
J	Antiel, RM; Curlin, FA; James, KM; Tilburt, JC				Antiel, Ryan M.; Curlin, Farr A.; James, Katherine M.; Tilburt, Jon C.			Physicians' Beliefs and US Health Care Reform -- A National Survey.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICARE		[Antiel, Ryan M.] Mayo Clin, Mayo Med Sch, Rochester, MN 55905 USA; [Antiel, Ryan M.; James, Katherine M.; Tilburt, Jon C.] Mayo Clin, Program Professionalism & Bioeth, Rochester, MN USA; [James, Katherine M.] Mayo Clin, Mayo Knowledge & Encounter Res Unit, Rochester, MN USA; [Tilburt, Jon C.] Mayo Clin, Div Gen Internal Med, Rochester, MN USA; [Curlin, Farr A.] Univ Chicago, Gen Internal Med Sect, Chicago, IL 60637 USA; [Curlin, Farr A.] Univ Chicago, MacLean Ctr Clin Med Eth, Chicago, IL 60637 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Chicago; University of Chicago	Antiel, RM (corresponding author), Mayo Clin, Mayo Med Sch, Rochester, MN 55905 USA.				NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [K23AT002749] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024151] Funding Source: NIH RePORTER; NCCIH NIH HHS [K23 AT002749] Funding Source: Medline; NCRR NIH HHS [KL2 RR024151] Funding Source: Medline	NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Avorn J, 2009, NEW ENGL J MED, V360, P1927, DOI 10.1056/NEJMp0902427; Cortese DA, 2006, MAYO CLIN PROC, V81, P492, DOI 10.4065/81.4.492; Fisher ES, 2009, NEW ENGL J MED, V360, P2495, DOI 10.1056/NEJMp0903923; Neumann PJ, 2005, NEW ENGL J MED, V353, P1516, DOI 10.1056/NEJMsb050564; Tunis SR, 2004, NEW ENGL J MED, V350, P2196, DOI 10.1056/NEJMe048091	5	28	28	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14								10.1056/NEJMp0907876	http://dx.doi.org/10.1056/NEJMp0907876			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500KZ	19752464	Green Accepted			2022-12-28	WOS:000270300000004
J	Sutherland, JM; Fisher, ES; Skinner, JS				Sutherland, Jason M.; Fisher, Elliott S.; Skinner, Jonathan S.			Getting Past Denial - The High Cost of Health Care in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sutherland, Jason M.; Skinner, Jonathan S.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Fisher, Elliott S.] Dartmouth Med Sch, Lebanon, NH USA; [Skinner, Jonathan S.] Dartmouth Coll, Hanover, NH 03755 USA	Dartmouth College; Dartmouth College; Dartmouth College	Sutherland, JM (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA.							Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fowler FJ, 2008, JAMA-J AM MED ASSOC, V299, P2406, DOI 10.1001/jama.299.20.2406; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; WENNBERG JE, 1999, QUALITY MED CARE US, P80	5	105	105	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 24	2009	361	13					1227	1230		10.1056/NEJMp0907172	http://dx.doi.org/10.1056/NEJMp0907172			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	497RN	19741220				2022-12-28	WOS:000270078700002
J	Ignagni, K				Ignagni, Karen			Health Insurers at the Table -- Industry Proposals for Regulation and Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Amer Hlth Insurance Plans, Washington, DC USA		Ignagni, K (corresponding author), Amer Hlth Insurance Plans, Washington, DC USA.								0	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1133	1134		10.1056/NEJMp0907376	http://dx.doi.org/10.1056/NEJMp0907376			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	494QA	19726760				2022-12-28	WOS:000269828000003
J	Nosrati, MS				Nosrati, Mordechai Saeid			Steroid avoidance or withdrawal does not increase mortality or graft loss in kidney transplant patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Nosrati, MS (corresponding author), Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA.							Doxiadis IIN, 2007, TRANSPLANTATION, V83, P1207, DOI 10.1097/01.tp.0000261108.27421.bc; OPELZ G, 1985, TRANSPLANTATION, V40, P240, DOI 10.1097/00007890-198509000-00003	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6							JC3-11	10.7326/0003-4819-151-6-200909150-02011	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755357				2022-12-28	WOS:000270390100027
J	O'Brien, KL; Wolfson, LJ; Watt, JP; Henkle, E; Deloria-Knoll, M; McCall, N; Lee, E; Mulholland, K; Levine, OS; Cherian, T				O'Brien, Katherine L.; Wolfson, Lara J.; Watt, James P.; Henkle, Emily; Deloria-Knoll, Maria; McCall, Natalie; Lee, Ellen; Mulholland, Kim; Levine, Orin S.; Cherian, Thomas		Hib Pneumococcal Global Burden Dis	Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates	LANCET			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; STANDARDIZED INTERPRETATION; DOUBLE-BLIND; MENINGITIS; DEATHS; AGE; PREVENTION; EFFICACY	Background Streptococcus pneumoniae is a leading cause of bacterial pneumonia, meningitis, and sepsis in children worldwide. However, many countries lack national estimates of disease burden. Effective interventions are available, including pneumococcal conjugate vaccine and case management. To support local and global policy decisions on pneumococcal disease prevention and treatment, we estimated country-specific incidence of serious cases and deaths in children younger than 5 years. Methods We measured the burden of pneumococcal pneumonia by applying the proportion of pneumonia cases caused by S pneumoniae derived from efficacy estimates from vaccine trials to WHO country-specific estimates of all-cause pneumonia cases and deaths. We also estimated burden of meningitis and non-pneumonia, non-meningitis invasive disease using disease incidence and case-fatality data from a systematic literature review. When high-quality data were available from a country, these were used for national estimates. Otherwise, estimates were based on data from neighbouring countries with similar child mortality. Estimates were adjusted for HIV prevalence and access to care and, when applicable, use of vaccine against Haemophilus influenzae type b. Findings In 2000, about 14.5 million episodes of serious pneumococcal disease (uncertainty range 11.1-18.0 million) were estimated to occur. Pneumococcal disease caused about 826 000 deaths (582 000-926 000) in children aged 1-59 months, of which 91 000 (63 000-102 000) were in HIV-positive and 735000 (519 000-825 000) in HIV-negative children. Of the deaths in HIV-negative children, over 61% (449 000 [316 000-501 000]) occurred in ten African and Asian countries. Interpretation S pneumoniae causes around 11% (8-12%) of all deaths in children aged 1-59 months (excluding pneumococcal deaths in HIV-positive children). Achievement of the UN Millennium Development Goal 4 for child mortality reduction can be accelerated by prevention and treatment of pneumococcal disease, especially in regions of the world with the greatest burden.	[O'Brien, Katherine L.; Henkle, Emily; Deloria-Knoll, Maria; McCall, Natalie; Lee, Ellen; Levine, Orin S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, GAVIs PneumoADIP, Baltimore, MD USA; [Wolfson, Lara J.; Cherian, Thomas] WHO, CH-1211 Geneva, Switzerland; [Watt, James P.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Hib Initiat, Baltimore, MD USA; [Mulholland, Kim] London Sch Hyg & Trop Med, London WC1, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine	O'Brien, KL (corresponding author), Johns Hopkins Ctr Amer Indian Hlth, 621 N Washington St, Baltimore, MD 21205 USA.	klobrien@jhsph.edu	Wolfson, Lara/AAC-1400-2019; McCall, Natalie/ABA-3767-2021	Wolfson, Lara/0000-0002-6454-3368; McCall, Natalie/0000-0001-9387-4521; Mangtani, Punam/0000-0001-7074-2999; Deloria Knoll, Maria/0000-0001-9041-2671; O'Brien, Katherine/0000-0002-0164-4030	GAVI Alliance; Vaccine Fund	GAVI Alliance; Vaccine Fund	Funding GAVI Alliance and the Vaccine Fund.	[Anonymous], 2003, Weekly Epidemiological Record, V78, P110; Anonymous, 2008, Morbidity and Mortality Weekly Report, V57, P1148; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; BERNARDBONNIN AC, 1985, ANN SOC BELG MED TR, V65, P59; Black SB, 2002, PEDIATR INFECT DIS J, V21, P810, DOI 10.1097/00006454-200209000-00005; Bliss SJ, 2008, LANCET INFECT DIS, V8, P67, DOI 10.1016/S1473-3099(07)70242-6; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cherian T, 1998, J CLIN MICROBIOL, V36, P3605, DOI 10.1128/JCM.36.12.3605-3608.1998; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Constenla D, 2007, BURDEN PNEUMOCOCCAL; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; DELORIAKNOLL M, GLOBAL LIT REV HAEMO; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Levine OS, 2006, LANCET, V367, P1880, DOI 10.1016/S0140-6736(06)68703-5; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; MOISI JC, 2008, 6 INT S PNEUM PNEUM; Morris SS, 2003, INT J EPIDEMIOL, V32, P1041, DOI 10.1093/ije/dyg241; Mulholland K, 1999, VACCINE, V17, pS79, DOI 10.1016/S0264-410X(99)00112-7; Mulholland K, 1999, PEDIATR INFECT DIS J, V18, pS17; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Shibuya K, 2005, B WORLD HEALTH ORGAN, V83, P722; TALL FR, 1992, MED MALADIES INFECT, V22, P1173, DOI 10.1016/S0399-077X(05)81433-7; *UNICEF, PERC 5 SUSP PNEUM TA; United Nations, 2001, SECR GEN REP GEN ASS; United Nations Population Division, WORLD POP PROSP; WATT J, 2004, WPICPEPI52001XZ04200; *WHO, VIT REG DAT REP WHO; *WHO, 1999, WHOVB0114; *WHO UNICEF, EST NAT IMM COV; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93; World Health Organization, 2006, WORLD HLTH STAT 2006; World Health Organization, WORLD HLTH REP 2005; World Health Organization, 2004, GLOB BURD DIS 2004 U	40	1694	1803	4	174	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					893	902		10.1016/S0140-6736(09)61204-6	http://dx.doi.org/10.1016/S0140-6736(09)61204-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496BN	19748398				2022-12-28	WOS:000269943100028
J	Walker, B; Barrett, S; Polasky, S; Galaz, V; Folke, C; Engstrom, G; Ackerman, F; Arrow, K; Carpenter, S; Chopra, K; Daily, G; Ehrlich, P; Hughes, T; Kautsky, N; Levin, S; Maler, KG; Shogren, J; Vincent, J; Xepapadeas, T; de Zeeuw, A				Walker, Brian; Barrett, Scott; Polasky, Stephen; Galaz, Victor; Folke, Carl; Engstrom, Gustav; Ackerman, Frank; Arrow, Ken; Carpenter, Stephen; Chopra, Kanchan; Daily, Gretchen; Ehrlich, Paul; Hughes, Terry; Kautsky, Nils; Levin, Simon; Maler, Karl-Goran; Shogren, Jason; Vincent, Jeff; Xepapadeas, Tasos; de Zeeuw, Aart			Looming Global-Scale Failures and Missing Institutions	SCIENCE			English	Editorial Material									[Walker, Brian] CSIRO, Canberra, ACT 2601, Australia; [Walker, Brian; Galaz, Victor; Folke, Carl; Maler, Karl-Goran] Stockholm Univ, Stockholm Resilience Ctr, SE-10691 Stockholm, Sweden; [Barrett, Scott] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Barrett, Scott] Columbia Univ, Sch Int & Publ Affairs, New York, NY 10027 USA; [Polasky, Stephen; Folke, Carl; Engstrom, Gustav; Maler, Karl-Goran; de Zeeuw, Aart] Royal Swedish Acad Sci, Beijer Inst Ecol Econ, SE-10405 Stockholm, Sweden; [Polasky, Stephen] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Ackerman, Frank] Stockholm Environm Inst, SE-10691 Stockholm, Sweden; [Engstrom, Gustav] Lund Univ, Dept Econ, SE-22180 Lund, Sweden; [Ackerman, Frank] Tufts Univ, Medford, MA 02155 USA; [Arrow, Ken] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Carpenter, Stephen] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Chopra, Kanchan] Inst Econ Growth, Delhi 110007, India; [Daily, Gretchen; Ehrlich, Paul] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hughes, Terry] James Cook Univ, Ctr Excellence Coral Reef Studies, ARC, Townsville, Qld 4811, Australia; [Kautsky, Nils] Stockholm Univ, Dept Syst Ecol, SE-10691 Stockholm, Sweden; [Levin, Simon] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Shogren, Jason] Univ Wyoming, Dept Econ & Finance, Laramie, WY 82071 USA; [Vincent, Jeff] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Xepapadeas, Tasos] Athens Univ Econ & Business, Dept Int & European Econ Studies, GR-10434 Athens, Greece; [de Zeeuw, Aart] Tilburg Univ, NL-5000 LE Tilburg, Netherlands	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Stockholm University; Columbia University; Columbia University; Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics; University of Minnesota System; University of Minnesota Twin Cities; Stockholm Environment Institute; Lund University; Tufts University; Stanford University; University of Wisconsin System; University of Wisconsin Madison; Stanford University; James Cook University; Stockholm University; Princeton University; University of Wyoming; Duke University; Athens University of Economics & Business; Tilburg University	Walker, B (corresponding author), CSIRO, Canberra, ACT 2601, Australia.	brian.walker@csiro.au	Hughes, Terry P/L-4721-2013; Polasky, Stephen/AAC-5341-2019; Shogren, Jason/B-9771-2017; Levin, Simon A/J-1218-2014; Shogren, Jason/N-8193-2019; Walker, Brian H/F-2386-2011; Folke, Carl/Z-1545-2019; Carpenter, Stephen/AAQ-6404-2020; Xepapadeas, Anastasios/ABH-3240-2020	Hughes, Terry P/0000-0002-5257-5063; Shogren, Jason/0000-0003-3757-959X; Levin, Simon A/0000-0002-8216-5639; Shogren, Jason/0000-0003-3757-959X; Folke, Carl/0000-0002-4050-3281; Galaz, Victor/0000-0002-7303-8849				Barrett S, 2007, WHY COOPERATE INCENT; BASU K, 2008, CONTESTED COMMONS CO, P229; Cash DW, 2003, P NATL ACAD SCI USA, V100, P8086, DOI 10.1073/pnas.1231332100; DeSombre Elizabeth R., 2000, DOMESTIC SOURCES INT; Ehrlich PR, 2005, SCIENCE, V309, P562, DOI 10.1126/science.1113028; Evans G, 2002, FOREIGN AFF, V81, P99, DOI 10.2307/20033347; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Gehring T, 2008, INSTITUTIONS AND ENVIRONMENTAL CHANGE: PRINCIPAL FINDINGS, APPLICATIONS, AND RESEARCH FRONTIERS, P187; Inomata Tadanori, 2008, MANAGEMENT REV ENV G; Institute of Medicine (US) Committee on the Economics of Antimalarial Drugs, 2004, SAVING LIVES BUYING; LAWRENCE RZ, 2003, CRIMES PUNISHMENTS R; PATTERSON E, 2003, ASIL INSIGHT; Sandler T., 2004, GLOBAL COLLECTIVE AC; Thaler RH., 2021, NUDGE FINAL EDITION	14	242	255	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1345	1346		10.1126/science.1175325	http://dx.doi.org/10.1126/science.1175325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	492YO	19745137				2022-12-28	WOS:000269699100020
J	Fuda, NJ; Ardehali, MB; Lis, JT				Fuda, Nicholas J.; Ardehali, M. Behfar; Lis, John T.			Defining mechanisms that regulate RNA polymerase II transcription in vivo	NATURE			English	Review							HEAT-SHOCK GENES; HISTONE CHAPERONE ASF1; P-TEFB KINASE; PHO5 PROMOTER; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; NUCLEOSOME DISRUPTION; PREINITIATION COMPLEX; ELONGATION RATE; YEAST PHO5	In the eukaryotic genome, the thousands of genes that encode messenger RNA are transcribed by a molecular machine called RNA polymerase II. Analysing the distribution and status of RNA polymerase II across a genome has provided crucial insights into the long-standing mysteries of transcription and its regulation. These studies identify points in the transcription cycle where RNA polymerase II accumulates after encountering a rate-limiting step. When coupled with genome-wide mapping of transcription factors, these approaches identify key regulatory steps and factors and, importantly, provide an understanding of the mechanistic generalities, as well as the rich diversities, of gene regulation.	[Fuda, Nicholas J.; Ardehali, M. Behfar; Lis, John T.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Lis, JT (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	jtl10@cornell.edu		Ardehali, Behfar/0000-0002-4648-275X	US National Institutes of Health [GM25232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025232, R01GM025232] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Lis laboratory for discussions and critical reading of the manuscript. Work in our laboratory is supported by US National Institutes of Health grant GM25232.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Barbaric S, 1998, MOL CELL BIOL, V18, P2629, DOI 10.1128/MCB.18.5.2629; Barbaric S, 2007, J BIOL CHEM, V282, P27610, DOI 10.1074/jbc.M700623200; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Blau J, 1996, MOL CELL BIOL, V16, P2044; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; HERSCHLAG D, 1993, GENE DEV, V7, P173, DOI 10.1101/gad.7.2.173; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Lis JT, 2000, GENE DEV, V14, P792; Liu Y, 2004, MOL CELL BIOL, V24, P1721, DOI 10.1128/MCB.24.4.1721-1735.2004; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; MIRKOVITCH J, 1992, MOL BIOL CELL, V3, P1085, DOI 10.1091/mbc.3.10.1085; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Ni ZY, 2008, MOL CELL BIOL, V28, P1161, DOI 10.1128/MCB.01859-07; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Patterson GH, 2004, METHODS, V32, P445, DOI 10.1016/j.ymeth.2003.10.006; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Peterson CL, 2000, CURR OPIN GENET DEV, V10, P187, DOI 10.1016/S0959-437X(00)00068-X; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Sakurai H, 2000, J BIOL CHEM, V275, P37251, DOI 10.1074/jbc.M004364200; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schwartz BE, 2003, MOL CELL BIOL, V23, P6876, DOI 10.1128/MCB.23.19.6876-6886.2003; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shi H, 1999, P NATL ACAD SCI USA, V96, P10033, DOI 10.1073/pnas.96.18.10033; Spilianakis C, 2003, EMBO J, V22, P5125, DOI 10.1093/emboj/cdg496; Stargell LA, 1996, TRENDS GENET, V12, P311, DOI 10.1016/0168-9525(96)10028-7; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; SVAREN J, 1994, EMBO J, V13, P4856, DOI 10.1002/j.1460-2075.1994.tb06812.x; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; TSUKIYAMA T, 1994, NATURE, V367, P525, DOI 10.1038/367525a0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang YV, 2005, MOL CELL BIOL, V25, P3543, DOI 10.1128/MCB.25.9.3543-3552.2005; Wittmann BM, 2005, ONCOGENE, V24, P5576, DOI 10.1038/sj.onc.1208728; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Wu CH, 2005, NUCLEIC ACIDS RES, V33, P1269, DOI 10.1093/nar/gki274; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; WUARIN J, 1994, MOL CELL BIOL, V14, P7219, DOI 10.1128/MCB.14.11.7219; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	75	375	383	1	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					186	192		10.1038/nature08449	http://dx.doi.org/10.1038/nature08449			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741698	Green Accepted			2022-12-28	WOS:000269654600030
J	Hu, WQ; Sweet, TJ; Chamnongpol, S; Baker, KE; Coller, J				Hu, Wenqian; Sweet, Thomas J.; Chamnongpol, Sangpen; Baker, Kristian E.; Coller, Jeff			Co-translational mRNA decay in Saccharomyces cerevisiae	NATURE			English	Article							P-BODY FORMATION; CELLS; DEGRADATION; PATHWAYS; TURNOVER; BODIES	The rates of RNA decay and transcription determine the steady-state levels of allmessenger RNA and both can be subject to regulation. Although the details of transcriptional regulation are becoming increasingly understood, the mechanism(s) controlling mRNA decay remain unclear. In yeast, a major pathway of mRNA decay begins with deadenylation followed by decapping and 5'-3' exonuclease digestion. Importantly, it is hypothesized that ribosomes must be removed from mRNA before transcripts are destroyed. Contrary to this prediction, here we show that decay takes place while mRNAs are associated with actively translating ribosomes. The data indicate that dissociation of ribosomes from mRNA is not a prerequisite for decay and we suggest that the 5'-3' polarity of mRNA degradation has evolved to ensure that the last translocating ribosome can complete translation.	[Hu, Wenqian; Sweet, Thomas J.; Baker, Kristian E.; Coller, Jeff] Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA; [Chamnongpol, Sangpen] Affymetrix Inc, Cleveland, OH 44128 USA	Case Western Reserve University; Affymetrix	Coller, J (corresponding author), Case Western Reserve Univ, Ctr RNA Mol Biol, Cleveland, OH 44106 USA.	jmc71@case.edu	Hu, Wenqian/H-6094-2019	Hu, Wenqian/0000-0003-3577-3604; Coller, Jeff/0000-0001-5662-8110	American Heart Association; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080465] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Maroney and T. Nilsen for sharing unpublished data about the poly( A) tailing assay. We also thank T. Nilsen for his insight, suggestions and evaluation of the manuscript. We also thank R. Parker, A. van Hoof and M. Wickens for reagents and advice. Funding was provided by the American Heart Association and the National Institutes of Health.	Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; BEELMAN CA, 1994, J BIOL CHEM, V269, P9687; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Couttet P, 1997, P NATL ACAD SCI USA, V94, P5628, DOI 10.1073/pnas.94.11.5628; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; He F, 2001, MOL CELL BIOL, V21, P1515, DOI 10.1128/MCB.21.5.1515-1530.2001; HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826; Inada T, 2002, RNA, V8, P948, DOI 10.1017/S1355838202026018; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Mangus DA, 1999, METHODS, V17, P28, DOI 10.1006/meth.1998.0704; Moore MJ, 2000, METHOD ENZYMOL, V317, P109; MUHLRAD D, 1995, MOL CELL BIOL, V15, P2145; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; SMITH DW, 1971, SCIENCE, V971, P577; Stevens A, 2001, METHOD ENZYMOL, V342, P251, DOI 10.1016/S0076-6879(01)42549-3; Sweet TJ, 2007, RNA, V13, P493, DOI 10.1261/rna.355807; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599	23	225	226	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					225	U96		10.1038/nature08265	http://dx.doi.org/10.1038/nature08265			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19701183	Green Accepted			2022-12-28	WOS:000269654600036
J	Coovadia, H; Jewkes, R; Barron, P; Sanders, D; McIntyre, D				Coovadia, Hoosen; Jewkes, Rachel; Barron, Peter; Sanders, David; McIntyre, Diane			Health in South Africa 1 The health and health system of South Africa: historical roots of current public health challenges	LANCET			English	Article							CARE; VIOLENCE; GENDER; MASCULINITY; REFLECTIONS; PREGNANCY; DISEASE; NURSES; RISK; MEN	The roots of a dysfunctional health system and the collision of the epidemics of communicable and non-communicable diseases in South Africa can be found in policies from periods of the country's history, from colonial subjugation, apartheid dispossession, to the post-apartheid period. Racial and gender discrimination, the migrant labour system, the destruction of family life, vast income inequalities, and extreme violence have all formed part of South Africa's troubled past, and all have inexorably affected health and health services. in 1994, when apartheid ended, the health system faced massive challenges, many of which still persist. Macroeconomic policies, fostering growth rather than redistribution, contributed to the persistence of economic disparities between races despite a large expansion in social grants. The public health system has been transformed into an integrated, comprehensive national service, but failures in leadership and stewardship and weak management have led to inadequate implementation of what are often good policies. Pivotal facets of primary health care are not in place and there is a substantial human resources crisis facing the health sector. The HIV epidemic has contributed to and accelerated these challenges. All of these factors need to be addressed by the new government if health is to be improved and the Millennium Development Goals achieved in South Africa.	[Coovadia, Hoosen] Univ KwaZulu Natal, Nelson Mandela Sch Med, Durban, South Africa; [Coovadia, Hoosen] Univ Witwatersrand, HIV Management Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Jewkes, Rachel] Univ Witwatersrand, Gender & Hlth Res Unit, MRC, Johannesburg, South Africa; [Jewkes, Rachel; Barron, Peter] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Sanders, David] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [McIntyre, Diane] Univ Cape Town, Sch Publ Hlth & Family Med, Hlth Econ Unit, ZA-7925 Cape Town, South Africa	University of Kwazulu Natal; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; University of the Western Cape; University of Cape Town	Coovadia, H (corresponding author), Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Westridge Med Ctr, 3rd Floor,95 Jan Smuts Highway, ZA-4091 Durban, South Africa.	hcoovadia@rhru.co.za		McIntyre, Diane/0000-0001-6319-4111; Sanders, David/0000-0003-1094-7655; Jewkes, Rachel/0000-0002-4330-6267				ABRAHAMS N, VIOLENCE VI IN PRESS; *AFR NAT C, NAT HLTH PLAN S AFR; Barron P, 2007, DISTRICT HLTH BAROME; BERRY B, MAP 18 BANTUSTANS S; BRADSHAW D, 2007, S AFRICAN NATL BURDE; Bradshaw D, 2004, S AFRICAN HLTH REV 2; Breckenridge K, 1998, J S AFR STUD, V24, P669, DOI 10.1080/03057079808708596; BRUIJN IDR, 1994, SOC HIST MED, V7, P359, DOI 10.1093/shm/7.3.359; Buchmann E, 2008, INT J GYNECOL OBSTET, V101, P191, DOI 10.1016/j.ijgo.2007.10.017; CARTON B, 2007, WERKSTATTGESCHICHTE, V44, P65; Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Cole Ernest, 1967, HOUSE BONDAGE; COOVADIA H, 2007, HOT TOPICS INFECT IM, V4; Day C., 2009, DISTRICT HLTH BAROME; DAY C, 1998, S AFRICAN HLTH REV 1, P203; Day C, 2007, S AFR HLTH REV, P213; DEACON H, 2004, WELLCOME SERIES HIST; Delius P., 2002, African Studies, V61, P1, DOI 10.1080/00020180220140046; Dennison CR, 2007, ETHNIC DIS, V17, P484; Department for Health, 2007, 2003 S AFR DEM HLTH; Department of Finance, 1996, GROWTH EMPL RED MACR; Department of Health, 2006, NAT HUM RES PLAN HLT; Department of Health, 2005, NAT HIV SYPH ANT SER; DIGBY A, 2006, MISSIONARY MED DIVER; DUGARD J, 2008, SUBMISSION PARLIAMEN; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; EDELSTEIN G, 1998, ASSESSMENT EXIT COMP; Gevisser Mark, 2007, DREAM DEFERRED; GIESE S, 2002, RAPID APPRAISAL PRIM; GLUCKMAN H, 1944, PROVISION ORGANIZED; Groenewald P, 2008, CAUSE DEATH PREMATUR; Guy J, 1990, WOMEN GENDER SO AFRI; HELLMAN E, 1948, SOCIOLOGICAL SURVEY; HOUGHTON DH, 1976, S AFRICAN EC; Hunter M, 2005, CULT HEALTH SEX, V7, P209, DOI 10.1080/13691050412331293458; *INT DEF AID FUND, 1983, AP FACTS; JANSEN J, 2007, TRACING EXLAINING CH; Jeeves Alan H., 1985, MIGRANT LABOUR S AFR; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Jewkes R, 2005, SOC SCI MED, V61, P1809, DOI 10.1016/j.socscimed.2005.03.022; JEWKES R, CULT HLTH S IN PRESS; Jewkes R, 2006, SOC SCI MED, V63, P2949, DOI 10.1016/j.socscimed.2006.07.027; Jewkes R, 2009, HIV/AIDS IN SOUTH AFRICA 25 YEARS ON: PSYCHOSOCIAL PERSPECTIVES, P27, DOI 10.1007/978-1-4419-0306-8_3; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; KENYON C, 2001, S AFRICAN HLTH REV 2; KHUMALO F, 2006, S AFRICAN HLTH REV 2; KOLBEN P, 1738, PRESENT STATE CAPE G; Lehmann U., 2008, S AFRICAN HLTH REV 2; Lurie MN, 2003, AIDS, V17, P2245, DOI 10.1097/00002030-200310170-00013; Mager A, 1999, GENDER MAKING S AFRI; MARKS S, 1987, J S AFR STUD, V13, P177, DOI 10.1080/03057078708708140; Marks Shula, 1994, DIVIDED SISTERHOOD C; Mayer P., 1970, SOCIALISATION APPROA; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McCoy D, 2002, INTERIM FINDINGS NAT; MCCOY D, 1998, EVALUATION S AFRICAS; Mcintyre D, 2007, CRITICAL ANAL CURREN; McIntyre D., 1995, HLTH EXPENDITURE FIN; MCINTYRE D, 1990, 1 U CAP TOWN HLTH EC; MCINTYRE D, 2007, S AFRICAN HLTH REV 2; MCINTYRE DE, 1990, S AFR MED J, V78, P125; Morrell R, 1998, J S AFR STUD, V24, P605, DOI 10.1080/03057079808708593; Morrell R., 2001, BOYS GENTLEMEN SETTL; NAYLOR CD, 1988, SOC SCI MED, V27, P1153, DOI 10.1016/0277-9536(88)90345-0; NIEHAUS I, 2002, AFRICAN STUDIES, V61, P77, DOI DOI 10.1080/00020180220140082; Norman R, 2006, S AFRICAN NATL BURDE; Norman R, 2007, SAMJ S AFR MED J, V97, P637; PACKARD R, 1989, PREINDUSTRIAL S AFRI; PENNKEKANA L, 2004, HLTH POLICY PLANNING, V19, P71; PHILLIPS H, 2004, WELLCOME SERIES HIST; Pick W, 1995, S AFRICAN HLTH REV 1; *PRES REP S AFR, 2008, DEV IND 2008; Puoane T, 2008, HEALTH POLICY PLANN, V23, P428, DOI 10.1093/heapol/czn036; REAGON G, 2004, NATL PHC FACILITIES; Reid SJ, 2003, S AFRICAN HLTH REV 2; RESHA M, 1992, MY LIFE STRUGGLE; Richter L, 2006, BABA FATHERS FATHERH; Rispel L, 1992, HLTH INDICATORS POLI; RISPEL L, 2007, S AFRICAN HLTH REV 2; *S AFR GOV, 2008, MIN SOC DEV ZOL SKWE; *S AFR MED SCH TRU, 1981, S AFR MED SCH TRUST; *S AFR NURS COUNC, 2007, STAT 2007; *S AFR POL SERV, CRIM STAT 2005; *S AFR RES BANK, ONL STAT QUER DAT; *SAHO, S AFR HIST TIM; Sanders D, 2006, AM J PUBLIC HEALTH, V96, P73, DOI 10.2105/AJPH.2005.062679; Schapera I, 1933, AFRICA, V6, P59, DOI 10.2307/1155702; SCHAPIRO K, 1981, DELIVERY HLTH CARE R; Schneider H, 2005, SAMJ S AFR MED J, V95, P782; Schneider H., 2007, STATE NATION S AFRIC; Schneider M, 2007, SAMJ S AFR MED J, V97, P664; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; SEGALL M, 2003, REV PUBLIC HLTH SERV; SHISANA O, 2005, S AFRICAN NATL HIV P; South Sudan Ministry of Health, 2007, STRAT PLAN HUM RES H; *STAT S AFR, 1996, S AFR CENS 1996; Statistics South Africa, 2008, INC EXP HOUS 2005 20; Statistics South Africa, 2002, EARN SPEND S AFR SEL; SWART R, 1998, EVALUATING PRIMARY S; Terreblanche Sampie, 2002, HIST INEQUALITY S AF; *UN GOV, 1948, REP NAT LAWS COMM; VANRENSBURG D, 1999, S AFRICAN HLTH REV 1; VANRENSBURG H, 1982, PROFILE DIS HLTH CAR; Victora CG, 2007, LANCET, V370, P1113, DOI 10.1016/S0140-6736(07)61492-5; WHO, 1983, AP HLTH; WILDEMAN R, 2005, REV 10 YEARS SCH NUT; Wood K, 1998, SOC SCI MED, V47, P233, DOI 10.1016/S0277-9536(98)00057-4; Wood K., 2001, CHANGING MEN SO AFRI, P317; Wood K, 2006, REPROD HEALTH MATTER, V14, P109, DOI 10.1016/S0968-8080(06)27231-8; *WORK GROUP PRIV D, 1986, PRIV DER HLTH CAR S; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE	112	714	753	4	105	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					817	834		10.1016/S0140-6736(09)60951-X	http://dx.doi.org/10.1016/S0140-6736(09)60951-X			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492QU	19709728				2022-12-28	WOS:000269675000030
J	Calarco, JA; Superina, S; O'Hanlon, D; Gabut, M; Raj, B; Pan, Q; Skalska, U; Clarke, L; Gelinas, D; van der Kooy, D; Zhen, M; Ciruna, B; Blencowe, BJ				Calarco, John A.; Superina, Simone; O'Hanlon, Dave; Gabut, Mathieu; Raj, Bushra; Pan, Qun; Skalska, Ursula; Clarke, Laura; Gelinas, Danielle; van der Kooy, Derek; Zhen, Mei; Ciruna, Brian; Blencowe, Benjamin J.			Regulation of Vertebrate Nervous System Alternative Splicing and Development by an SR-Related Protein	CELL			English	Article							TRACT-BINDING-PROTEIN; STEM-CELLS; SWITCH; INSIGHTS; FAMILY; SHAPE; NOVA; CODE; PTB	Alternative splicing is a key process underlying the evolution of increased proteomic and functional complexity and is especially prevalent in the mammalian nervous system. However, the factors and mechanisms governing nervous system-specific alternative splicing are not well understood. Through a genome-wide computational and expression profiling strategy, we have identified a tissue- and verte-brate-restricted Ser/Arg (SR) repeat splicing factor, the neural-specific SR-related protein of 100 kDa (nSR100). We show that nSR100 regulates an extensive network of brain-specific alternative exons enriched in genes that function in neural cell differentiation. nSR100 acts by increasing the levels of the neural/brain-enriched polypyrimidine tract binding protein and by interacting with its target transcripts. Disruption of nSR100 prevents neural cell differentiation in cell culture and in the developing zebrafish. Our results thus reveal a critical neural-specific alternative splicing regulator, the evolution of which has contributed to increased complexity in the vertebrate nervous system.	[Calarco, John A.; O'Hanlon, Dave; Gabut, Mathieu; Raj, Bushra; Pan, Qun; Skalska, Ursula; van der Kooy, Derek; Blencowe, Benjamin J.] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Calarco, John A.; Superina, Simone; Raj, Bushra; Clarke, Laura; van der Kooy, Derek; Zhen, Mei; Ciruna, Brian; Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Superina, Simone; Gelinas, Danielle; Ciruna, Brian] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Zhen, Mei] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Blencowe, Benjamin J.] Kings Coll London, Ctr Bioinformat, London WC2R 2LS, England	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of London; King's College London	Blencowe, BJ (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca	GABUT, Mathieu/M-7624-2017; Zhen, Mei/A-4967-2012	GABUT, Mathieu/0000-0001-7343-5361; Zhen, Mei/0000-0003-0086-9622; Raj, Bushra/0000-0002-5833-0251	Canada Research Chairs Program; Terry Fox Foundation [018165]; Canadian Institutes of Health Research [MOP-14609]; Ontario Research Fund; Ontario Genomics Institute	Canada Research Chairs Program(Canada Research Chairs); Terry Fox Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund; Ontario Genomics Institute	We are grateful to Leo Lee, Yoseph Barash, Valentina Slobodeniuc, and Xinyi Tang for assistance. We thank many colleagues for providing reagents ( Supplemental Data) and to Donny Licatalosi and Robert Darnell for sharing unpublished information and for critical reading of the manuscript. Jim Ingles, Christos Ouzounis, Duncan Odom, Nuno Barbosa-Morais, Arneet Saltzman, Joanna Ip, Jonathan Ellis, and Cori Hanson are also thanked for helpful comments on the manuscript. This work was supported in part by the Canada Research Chairs Program and a grant from the Terry Fox Foundation (# 018165) to B. C. Research funding to B. J. B. was provided by a Canadian Institutes of Health Research operating grant (MOP-14609), the Ontario Research Fund, and a grant from Genome Canada through the Ontario Genomics Institute. M. Z. is the recipient of an EJLB scholarship and J.A.C is the recipient of an Alexander Graham Bell Canada graduate scholarship.	Ashiya M, 1997, RNA, V3, P996; Barbosa-Morais NL, 2006, GENOME RES, V16, P66, DOI 10.1101/gr.3936206; Behrends U, 2003, INT J CANCER, V106, P244, DOI 10.1002/ijc.11208; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Boutz PL, 2007, GENE DEV, V21, P1636, DOI 10.1101/gad.1558107; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hanamura A, 1998, RNA, V4, P430; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin SR, 2007, ADV EXP MED BIOL, V623, P107, DOI 10.1007/978-0-387-77374-2_7; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Markovtsov V, 2000, MOL CELL BIOL, V20, P7463, DOI 10.1128/MCB.20.20.7463-7479.2000; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Matusek T, 2008, J NEUROSCI, V28, P13310, DOI 10.1523/JNEUROSCI.2727-08.2008; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Polydorides AD, 2000, P NATL ACAD SCI USA, V97, P6350, DOI 10.1073/pnas.110128397; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048; Shen HH, 2004, MOL CELL, V13, P367, DOI 10.1016/S1097-2765(04)00025-5; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108	36	142	148	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					898	910		10.1016/j.cell.2009.06.012	http://dx.doi.org/10.1016/j.cell.2009.06.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737518	Bronze			2022-12-28	WOS:000269564600016
J	Osama, A; Najam, A; Kassim-Lakha, S; Gilani, SZ; King, C				Osama, Athar; Najam, Adil; Kassim-Lakha, Shamsh; Gilani, Syed Zulfiqar; King, Christopher			Pakistan's reform experiment	NATURE			English	Editorial Material									[Najam, Adil] Boston Univ, Pardee Ctr Study Long Range Future, Boston, MA 02215 USA; [Gilani, Syed Zulfiqar] Univ Peshawar, Inst Educ & Res, Peshawar, Pakistan; [King, Christopher] Thomson Reuters, Philadelphia, PA 19104 USA	Boston University; University of Peshawar; Clarivate		athar@atharosama.com						*HIGH ED COMM, 2008, HIGH ED COMM REP 200; *THOMS REUT, 2008, RIS STAR RANK; *USAID, 2008, REE107050005300 USAI; World Bank, 2006, 37247 WORLD BANK; *WORLD BANK UNESCO, 2002, HIGH ED DEV COUNTR P	5	13	13	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 3	2009	461	7260					38	39		10.1038/461038a	http://dx.doi.org/10.1038/461038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490DT	19727184				2022-12-28	WOS:000269478800015
J	Unger, EF				Unger, Ellis F.			Weighing Benefits and Risks -- The FDA's Review of Prasugrel.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ACUTE CORONARY SYNDROMES		US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Unger, EF (corresponding author), US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Food and Drug Administration, FDA APPR DRUG PROD; *FOOD DRUG ADM CTR, PRAS RED CARD EV PAT; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	4	74	75	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					942	945		10.1056/NEJMp0907122	http://dx.doi.org/10.1056/NEJMp0907122			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19726770				2022-12-28	WOS:000269480400003
J	Mehrotra, A; Liu, HS; Adams, JL; Wang, MC; Lave, JR; Thygeson, NM; Solberg, LI; McGlynn, EA				Mehrotra, Ateev; Liu, Hangsheng; Adams, John L.; Wang, Margaret C.; Lave, Judith R.; Thygeson, N. Marcus; Solberg, Leif I.; McGlynn, Elizabeth A.			Comparing Costs and Quality of Care at Retail Clinics With That of Other Medical Settings for 3 Common Illnesses	ANNALS OF INTERNAL MEDICINE			English	Article							NURSE-PRACTITIONERS; GUIDELINES; PHYSICIANS; PHARYNGITIS; MANAGEMENT; CHILDREN; ADULTS; PAY	Background: Retail clinics are an increasingly popular source for medical care. Concerns have been raised about the effect of these clinics on the cost, quality, and delivery of preventive care. Objective: To compare the care received at retail clinics for 3 acute conditions with that received at other care settings. Design: Claims data from 2005 and 2006 from the health plan were aggregated into care episodes ( units that included initial and follow-up visits, pharmaceuticals, and ancillary tests). After 2100 episodes ( 700 each) were identified in which otitis media, pharyngitis, and urinary tract infection ( UTI) were treated first in retail clinics, these episodes were matched with other episodes in which these illnesses were treated first in physician offices, urgent care centers, or emergency departments. Setting: Enrollees of a large Minnesota health plan. Patients: Enrollees who received care for otitis media, pharyngitis, or UTI. Measurements: Costs per episode, performance on 14 quality indicators, and receipt of 7 preventive care services at the initial appointment or subsequent 3 months. Results: Overall costs of care for episodes initiated at retail clinics were substantially lower than those of matched episodes initiated at physician offices, urgent care centers, and emergency departments ($110 vs. $166, $156, and $570, respectively; P < 0.001 for each comparison). Prescription costs were similar in retail clinics, physician offices, and urgent care centers ($21, $21, and $22), as were aggregate quality scores (63.6%, 61.0%, and 62.6%) and patient's receipt of preventive care (14.5%, 14.2%, and 13.7%) ( P > 0.05 vs. retail clinics). In emergency departments, average prescription costs were higher and aggregate quality scores were significantly lower than in other settings. Limitations: A limited number of quality measures and preventive care services were studied. Despite matching, patients at different care sites might differ in their severity of illness. Conclusion: Retail clinics provide less costly treatment than physician offices or urgent care centers for 3 common illnesses, with no apparent adverse effect on quality of care or delivery of preventive care.	[Mehrotra, Ateev] Univ Pittsburgh, Sch Med, Div Gen Internal Med, Pittsburgh, PA 15213 USA; RAND Hlth, Santa Monica, CA USA; RAND Hlth, Pittsburgh, PA USA; HealthPartners Res Fdn, Minneapolis, MN 55440 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; RAND Corporation; RAND Corporation; HealthPartners Institute for Education & Research	Mehrotra, A (corresponding author), Univ Pittsburgh, Sch Med, Div Gen Internal Med, 230 McKee Pl,Suite 600, Pittsburgh, PA 15213 USA.	mehrotra@rand.org	Adams, John/ABE-6170-2021; Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582	California HealthCare Foundation; National Center for Research Resources [KL2-RR024154-03]; National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER	California HealthCare Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Primary Funding Source: California HealthCare Foundation.; By the California Health Care Foundation and a career development award (KL2-RR024154-03) from the National Center for Research Resources, a component of the National Institutes of Health.	*AM AC FAM PHYS, 2007, POL STAT AM AC FAM P; Bach PB, 2004, NEW ENGL J MED, V351, P575, DOI 10.1056/NEJMsa040609; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Bohmer R, 2007, NEW ENGL J MED, V356, P765, DOI 10.1056/NEJMp068289; Brown H., 1999, APPL MIXED MODELS ME; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; Corwin RM, 2006, PEDIATRICS, V118, P2561, DOI 10.1542/peds.2006-2681; *CTR MED MED SERV, 2008, BER TYP SERV BETOS C; Dang D K, 1996, Med Interface, V9, P118; DAVIS MM, 2007, MORE CHILDREN EXPECT; Hansen-Turton T, 2007, DIS MANAGE, V10, P61, DOI 10.1089/dis.2006.636; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; JAPSEN B, 2007, CHICAGO TRIBUNE 0625; KANTOR A, 2007, AHIP COVER, V48, P30; KANTOR A, 2007, AHIP COVER, V48, P32; Kantor Aileen, 2007, AHIP Cover, V48, P26; Kerr EA, 2000, QUALITY CARE CARDIOP; KERR EA, 2000, QUALITY CARE GEN MED; Lieberthal AS, 2004, PEDIATRICS, V113, P1451, DOI 10.1542/peds.113.5.1451; Mangione-Smith R, 2007, NEW ENGL J MED, V357, P1515, DOI 10.1056/NEJMsa064637; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; MCGLYNN EAD, 2007, QUALITY CARE CHILDRE; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; Mehrotra A, 2008, HEALTH AFFAIR, V27, P1272, DOI 10.1377/hlthaff.27.5.1272; Melnlck GA, 2008, HEALTH AFFAIR, V27, pW116, DOI 10.1377/hlthaff.27.2.w116; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; OKEEFE L, 2006, AAP NEWS, V1, P9; Pham HH, 2007, NEW ENGL J MED, V356, P1130, DOI 10.1056/NEJMsa063979; REINBERG S, 2007, HEALTHDAY       0626; ROSENBLUTH H, 2006, PITTSBURGH POST 1107; Rudavsky R, 2009, ANN INTERN MED, V151, P315, DOI 10.7326/0003-4819-151-5-200909010-00005; Scott MK, 2006, HLTH CARE EXPRESS LA; Smith HL, 1997, SOCIOL METHODOL, V27, P325, DOI 10.1111/1467-9531.271030; STARZ TW, 2006, PITTSBURGH POST 1101; STEENHUYSEN J, 2007, AMA SEEK PROBE RETAI; Thygeson M, 2008, HEALTH AFFAIR, V27, P1283, DOI 10.1377/hlthaff.27.5.1283; Wielawski I, 2000, HEALTH AFFAIR, V19, P180, DOI 10.1377/hlthaff.19.5.180; Woodburn JA, 2007, AM J MED QUAL, V22, P457, DOI 10.1177/1062860607309626; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	40	179	179	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					321	U50		10.7326/0003-4819-151-5-200909010-00006	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00006			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492KB	19721020	Green Accepted			2022-12-28	WOS:000269653100004
J	Berger, JS; Elliott, L; Gallup, D; Roe, M; Granger, CB; Armstrong, PW; Simes, RJ; White, HD; Van de Werf, F; Topol, EJ; Hochman, JS; Newby, LK; Harrington, RA; Califf, RM; Becker, RC; Douglas, PS				Berger, Jeffrey S.; Elliott, Laine; Gallup, Dianne; Roe, Matthew; Granger, Christopher B.; Armstrong, Paul W.; Simes, R. John; White, Harvey D.; Van de Werf, Frans; Topol, Eric J.; Hochman, Judith S.; Newby, L. Kristin; Harrington, Robert A.; Califf, Robert M.; Becker, Richard C.; Douglas, Pamela S.			Sex Differences in Mortality Following Acute Coronary Syndromes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CLINICAL PRESENTATION; INTERNATIONAL TRIAL; GENDER-DIFFERENCES; DIABETES-MELLITUS; 30-DAY MORTALITY; PLAQUE EROSION; RISK-FACTORS; WOMEN; MEN	Context Conflicting information exists about whether sex differences modulate short-term mortality following acute coronary syndromes (ACS). Objectives To investigate the relationship between sex and 30-day mortality in ACS, and to determine whether this relationship was modified by clinical syndrome or coronary anatomy using a large database across the spectrum of ACS and adjusting for potentially confounding clinical covariates. Design, Setting, and Participants A convenience sample of patients pooled from 11 independent, international, randomized ACS clinical trials between 1993 and 2006 whose databases are maintained at the Duke Clinical Research Institute, Durham, North Carolina. Of 136 247 patients, 38 048 (28%) were women; 102 004 (26% women) with ST-segment elevation myocardial infarction (STEMI), 14 466 (29% women) with non-STEMI (NSTEMI), and 19 777 (40% women) with unstable angina. Main Outcome Measure Thirty-day mortality following ACS. Results Thirty-day mortality was 9.6% in women and 5.3% in men (odds ratio [OR], 1.91; 95% confidence interval [CI], 1.83-2.00). After multivariable adjustment, mortality was not significantly different between women and men (adjusted OR, 1.06; 95% CI, 0.99-1.15). A significant sex by type of ACS interaction was demonstrated (P<.001). In STEMI, 30-day mortality was higher among women (adjusted OR, 1.15; 95% CI, 1.06-1.24), whereas in NSTEMI (adjusted OR, 0.77; 95% CI, 0.63-0.95) and unstable angina, mortality was lower among women (adjusted OR, 0.55; 95% CI, 0.43-0.70). In a cohort of 35 128 patients with angiographic data, women more often had nonobstructive (15% vs 8%) and less often had 2-vessel (25% vs 28%) and 3-vessel (23% vs 26%) coronary disease, regardless of ACS type. After additional adjustment for angiographic disease severity, 30-day mortality among women was not significantly different than men, regardless of ACS type. The relationship between sex and 30-day mortality was similar across the levels of angiographic disease severity (P for interaction=.70). Conclusions Sex-based differences existed in 30-day mortality among patients with ACS and vary depending on clinical presentation. However, these differences appear to be largely explained by clinical differences at presentation and severity of angiographically documented disease. JAMA. 2009; 302(8): 874-882	[Berger, Jeffrey S.] NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med, New York, NY 10016 USA; [Elliott, Laine; Gallup, Dianne] Duke Clin Res Inst, Dept Biostat & Bioinformat, Durham, NC USA; [Califf, Robert M.] Duke Translat Med Inst, Durham, NC USA; [Armstrong, Paul W.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Simes, R. John] Univ Sydney, Sydney, NSW 2006, Australia; [White, Harvey D.] Auckland City Hosp, Auckland, New Zealand; [Van de Werf, Frans] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium; [Topol, Eric J.] Scripps Translat Res Inst, La Jolla, CA USA; [Topol, Eric J.] Scripps Clin, La Jolla, CA 92037 USA	New York University; Duke University; Duke University; University of Alberta; University of Sydney; Auckland City Hospital; KU Leuven; University Hospital Leuven; Scripps Research Institute	Berger, JS (corresponding author), NYU, Sch Med, Leon H Charney Div Cardiol, Dept Med, 530 1st Ave,Skirball 9R, New York, NY 10016 USA.	jeffrey.berger@nyumc.org	Granger, Christopher B/D-3458-2014; Simes, Robert John/P-1497-2014	Granger, Christopher B/0000-0002-0045-3291; Douglas, Pamela/0000-0001-9876-4049; Topol, Eric/0000-0002-1478-4729; Hochman, Judith/0000-0002-5889-5981; Armstrong, Paul/0000-0002-0460-3445; Berger, Jeffrey/0000-0001-8216-4647; Van de Werf, Frans/0000-0001-9479-7767	American Heart Association [0775074N]; Duke Clinical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079896] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Duke Clinical Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding/Support: This study was partly funded by an American Heart Association Fellow to Faculty Award 0775074N (Dr Berger). The statistical portion of the manuscript was funded by the Duke Clinical Research Institute.	ABBOTT RD, 1988, JAMA-J AM MED ASSOC, V260, P3456, DOI 10.1001/jama.260.23.3456; Arbustini E, 1999, HEART, V82, P269, DOI 10.1136/hrt.82.3.269; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; Boersma E, 2000, CIRCULATION, V101, P2557, DOI 10.1161/01.CIR.101.22.2557; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Burke AP, 1998, CIRCULATION, V97, P2110, DOI 10.1161/01.CIR.97.21.2110; CALIFF RM, 1989, JAMA-J AM MED ASSOC, V261, P2077, DOI 10.1001/jama.261.14.2077; Chang WC, 2003, ARCH INTERN MED, V163, P2476, DOI 10.1001/archinte.163.20.2476; CHARNEY R, 1993, AM HEART J, V126, P937, DOI 10.1016/0002-8703(93)90710-Q; Chua TP, 2000, INT J CARDIOL, V72, P281, DOI 10.1016/S0167-5273(99)00204-1; DEUTSCH E, 1990, CIRCULATION, V82, P2044, DOI 10.1161/01.CIR.82.6.2044; DONAHUE RP, 1993, J CLIN EPIDEMIOL, V46, P245, DOI 10.1016/0895-4356(93)90072-9; Dotevall A, 2005, DIABETIC MED, V22, P1542, DOI 10.1111/j.1464-5491.2005.01696.x; FARB A, 1995, CIRCULATION, V92, P1701, DOI 10.1161/01.CIR.92.7.1701; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; FUSTER V, 1995, AM J CARDIOL, V76, pC24, DOI 10.1016/S0002-9149(99)80467-6; Gan SC, 2000, NEW ENGL J MED, V343, P8, DOI 10.1056/NEJM200007063430102; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; Gottlieb S, 2000, CIRCULATION, V102, P2484, DOI 10.1161/01.CIR.102.20.2484; HLATKY MA, 1988, J AM COLL CARDIOL, V11, P237, DOI 10.1016/0735-1097(88)90086-1; Hochman JS, 1999, NEW ENGL J MED, V341, P226, DOI 10.1056/NEJM199907223410402; Hochman JS, 1997, J AM COLL CARDIOL, V30, P141, DOI 10.1016/S0735-1097(97)00107-1; JOHANSSON S, 1984, EUR HEART J, V5, P374, DOI 10.1093/oxfordjournals.eurheartj.a061671; Kleiman NS, 2000, CIRCULATION, V101, P751, DOI 10.1161/01.CIR.101.7.751; KOSTIS JB, 1994, CIRCULATION, V90, P1715, DOI 10.1161/01.CIR.90.4.1715; KRUMHOLZ HM, 1992, ANN INTERN MED, V116, P785, DOI 10.7326/0003-4819-116-10-785; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; MAYNARD C, 1992, ARCH INTERN MED, V152, P972, DOI 10.1001/archinte.152.5.972; Moliterno DJ, 2000, AM HEART J, V139, P563, DOI 10.1016/S0002-8703(00)90031-0; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Naslund U, 1999, EUR HEART J, V20, P771, DOI 10.1053/euhj.1998.1351; Nicholls SJ, 2006, J AM COLL CARDIOL, V47, P1967, DOI 10.1016/j.jacc.2005.12.058; NICOL D, 2004, ACM T MODEL COMPUT S, V14, P1; Oe K, 2002, CIRC J, V66, P435, DOI 10.1253/circj.66.435; Reynolds HR, 2007, ARCH INTERN MED, V167, P2054, DOI 10.1001/archinte.167.19.2054; Roger VL, 2000, JAMA-J AM MED ASSOC, V283, P646, DOI 10.1001/jama.283.5.646; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Rosengren A, 2004, EUR HEART J, V25, P663, DOI 10.1016/j.ehj.2004.02.023; Simoons ML, 2001, LANCET, V357, P1915; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Topol E, 1998, CIRCULATION, V97, P2386; Topol EJ, 1996, NEW ENGL J MED, V335, P775; Vaccarino V, 2000, AM J EPIDEMIOL, V152, P965, DOI 10.1093/aje/152.10.965; Vaccarino V, 1996, J AM GERIATR SOC, V44, P1174, DOI 10.1111/j.1532-5415.1996.tb01366.x; VACCARINO V, 1995, CIRCULATION, V91, P1861, DOI 10.1161/01.CIR.91.6.1861; Vaccarino V, 1999, NEW ENGL J MED, V341, P217, DOI 10.1056/NEJM199907223410401; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Van de Werf F, 2001, LANCET, V358, P605; Wallentin L, 2003, CIRCULATION, V108, P135, DOI 10.1161/01.CIR.0000081659.72985.A8; Weaver WD, 1996, JAMA-J AM MED ASSOC, V275, P777, DOI 10.1001/jama.275.10.777; White HD, 2001, LANCET, V358, P1855; Woodfield SL, 1997, J AM COLL CARDIOL, V29, P35, DOI 10.1016/S0735-1097(96)00449-4; Yellon DM, 2000, CIRC RES, V87, P543, DOI 10.1161/01.RES.87.7.543	54	364	374	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					874	882		10.1001/jama.2009.1227	http://dx.doi.org/10.1001/jama.2009.1227			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706861	Green Accepted			2022-12-28	WOS:000269260100021
J	Chandler, M				Chandler, Mick			Clamping down on Transposon Targeting	CELL			English	Editorial Material							DNA-POLYMERASE-III; SLIDING CLAMP; TN7	The sliding beta clamp subunit of the DNA replication machinery in the bacterium Escherichia coli coordinates multiple functions in the cell beyond genome duplication. In this issue, Parks et al. (2009) find that the beta clamp interacts with the transposition protein TnsE to target the Tn7 transposon to discontinuously replicating DNA at the replication fork.	CNRS, Lab Microbiol & Genet Mol, UMR 5100, F-31062 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Chandler, M (corresponding author), CNRS, Lab Microbiol & Genet Mol, UMR 5100, F-31062 Toulouse, France.	mike@ibcg.biotoul.fr		Chandler, Michael/0000-0002-0292-6662				Craig Nancy L., 2002, P423; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; HANIFORD DB, 1989, CELL, V59, P385, DOI 10.1016/0092-8674(89)90299-7; Hu WY, 1998, J BACTERIOL, V180, P3039, DOI 10.1128/JB.180.12.3039-3048.1998; Kongsuwan K, 2006, J BACTERIOL, V188, P5501, DOI 10.1128/JB.00231-06; LANE D, 1994, J MOL BIOL, V242, P339, DOI 10.1006/jmbi.1994.1585; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; Wijffels G, 2004, BIOCHEMISTRY-US, V43, P5661, DOI 10.1021/bi036229j	9	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					621	623		10.1016/j.cell.2009.08.003	http://dx.doi.org/10.1016/j.cell.2009.08.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703389	Bronze			2022-12-28	WOS:000269156100004
J	Kramer, MS; Martin, RM; Sterne, JAC; Shapiro, S; Dahhou, M; Platt, RW				Kramer, Michael S.; Martin, Richard M.; Sterne, Jonathan A. C.; Shapiro, Stanley; Dahhou, Mourad; Platt, Robert W.			The double jeopardy of clustered measurement and cluster randomisation	BMJ-BRITISH MEDICAL JOURNAL			English	Article									[Kramer, Michael S.; Dahhou, Mourad; Platt, Robert W.] McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; [Kramer, Michael S.; Shapiro, Stanley; Platt, Robert W.] McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Martin, Richard M.; Sterne, Jonathan A. C.] Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England; [Martin, Richard M.] Univ Bristol, MRC Ctr Causal Anal, Bristol BS8 1TH, Avon, England	McGill University; McGill University; University of Bristol; University of Bristol	Kramer, MS (corresponding author), Montreal Childrens Hosp, 2300 Tupper St Les Tourelles, Montreal, PQ H3H 1P3, Canada.	michael.kramer@mcgill.ca	Sterne, Jonathan/Z-3106-2019	Sterne, Jonathan/0000-0001-8496-6053; Martin, Richard/0000-0002-7992-7719; Platt, Robert/0000-0002-5981-8443	ESRC [ES/G007543/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Kirkwood BR, 2003, ESSENTIAL MED STAT; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Kramer MS, 2007, CARIES RES, V41, P484, DOI 10.1159/000108596; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kramer MS, 2007, BMJ-BRIT MED J, V335, P815, DOI 10.1136/bmj.39304.464016.AE; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Lee KJ, 2005, BRIT MED J, V330, P142, DOI 10.1136/bmj.330.7483.142; Ukoumunne OC, 1999, HLTH TECHNOLOGY ASSE, V3, piii, DOI [DOI 10.3310/HTA3050, DOI 10.3310/hta3050]	11	19	19	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2009	339								b2900	10.1136/bmj.b2900	http://dx.doi.org/10.1136/bmj.b2900			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486SE	19700507	Green Published, hybrid			2022-12-28	WOS:000269217200012
J	Mayr, C; Bartel, DP				Mayr, Christine; Bartel, David P.			Widespread Shortening of 3 ' UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells	CELL			English	Article							MESSENGER-RNA POLYADENYLATION; 3' UNTRANSLATED REGIONS; BINDING PROTEIN; TRANSGENIC MICE; POSTTRANSCRIPTIONAL REGULATION; MICRORNA TARGETS; GENE-EXPRESSION; SITE SELECTION; RICH ELEMENTS; CYCLIN D2	In cancer cells, genetic alterations can activate proto-oncogenes, thereby contributing to tumorigenesis. However, the protein products of oncogenes are sometimes overexpressed without alteration of the proto-oncogene. Helping to explain this phenomenon, we found that when compared to similarly proliferating nontransformed cell lines, cancer cell lines often expressed substantial amounts of mRNA isoforms with shorter 30 untranslated regions (UTRs). These shorter isoforms usually resulted from alternative cleavage and polyadenylation (APA). The APA had functional consequences, with the shorter mRNA isoforms exhibiting increased stability and typically producing ten-fold more protein, in part through the loss of microRNA-mediated repression. Moreover, expression of the shorter mRNA isoform of the proto-oncogene IGF2BP1/IMP-1 led to far more oncogenic transformation than did expression of the full-length, annotated mRNA. The high incidence of APA in cancer cells, with consequent loss of 3'UTR repressive elements, suggests a pervasive role for APA in oncogene activation without genetic alteration.	[Mayr, Christine; Bartel, David P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Mayr, Christine; Bartel, David P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Mayr, Christine; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Mayr, C (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	mayrc@mskcc.org; dbartel@wi.mit.edu			Deutsche Forschungsgemeinschaft; National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Calvin Jan (C.J.) and Andrew Grimson (A.G.) for very helpful advice throughout the project; Wendy Johnston for preparing the small RNA libraries for the cell lines; Gina Lafkas for help with the soft-agar assay; A. G. and Rosaria Chang for analyzing the Solexa reads; and Olivia Rissland, A. G., C.J., and Alena Shkumatava for helpful comments on the manuscript. Supported by grants from the Deutsche Forschungsgemeinschaft (C.M.) and the National Institutes of Health (D.B.). D.B. is a Howard Hughes Medical Institute Investigator.	Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; COLEMAN MS, 1974, NATURE, V248, P407, DOI 10.1038/248407a0; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; DERYNCK R, 1995, CURR OPIN CELL BIOL, V7, P843, DOI 10.1016/0955-0674(95)80068-9; Doyle GAR, 1998, NUCLEIC ACIDS RES, V26, P5036, DOI 10.1093/nar/26.22.5036; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Evron E, 2001, CANCER RES, V61, P2782; Fedele M, 2002, ONCOGENE, V21, P3190, DOI 10.1038/sj.onc.1205428; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HAUSER H, 1978, EXP CELL RES, V111, P175, DOI 10.1016/0014-4827(78)90247-1; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He XY, 2007, CANCER RES, V67, P11099, DOI 10.1158/0008-5472.CAN-07-2672; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014; LEBWOHL DE, 1994, ONCOGENE, V9, P1925; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LUKAS J, 1995, ONCOGENE, V10, P2125; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Martincic K, 1998, P NATL ACAD SCI USA, V95, P11095, DOI 10.1073/pnas.95.19.11095; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Miyamoto S, 1996, BIOCHEM J, V315, P791, DOI 10.1042/bj3150791; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nielsen J, 1999, MOL CELL BIOL, V19, P1262; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Primrose Sandy, 2006, PRINCIPLES GENE MANI; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; Rosenwald A, 2003, CANCER CELL, V3, P185, DOI 10.1016/S1535-6108(03)00028-X; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Rowley JD, 2001, NAT REV CANCER, V1, P245, DOI 10.1038/35106108; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; SAMBROOK J, 2006, SEPARATION RNA ACCOR; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tessier CR, 2004, CANCER RES, V64, P209, DOI 10.1158/0008-5472.CAN-03-2927; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Veraldi KL, 2001, MOL CELL BIOL, V21, P1228, DOI 10.1128/MCB.21.4.1228-1238.2001; Vlasova IA, 2008, MOL CELL, V29, P263, DOI 10.1016/j.molcel.2007.11.024; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wiestner A, 2007, BLOOD, V109, P4599, DOI 10.1182/blood-2006-08-039859; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	54	1081	1105	5	63	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					673	684		10.1016/j.cell.2009.06.016	http://dx.doi.org/10.1016/j.cell.2009.06.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703394	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000269156100010
J	Wang, Y; Zhang, H; Chen, YP; Sun, YM; Yang, F; Yu, WH; Liang, J; Sun, LY; Yang, XH; Shi, L; Li, RF; Li, YY; Zhang, Y; Li, Q; Yi, X; Shang, YF				Wang, Yan; Zhang, Hua; Chen, Yupeng; Sun, Yimin; Yang, Fen; Yu, Wenhua; Liang, Jing; Sun, Luyang; Yang, Xiaohan; Shi, Lei; Li, Ruifang; Li, Yanyan; Zhang, Yu; Li, Qian; Yi, Xia; Shang, Yongfeng			LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer	CELL			English	Article							RECEPTOR-REGULATED TRANSCRIPTION; HISTONE LYSINE DEMETHYLASES; TGF-BETA; ENDOMETRIAL CARCINOGENESIS; MESENCHYMAL TRANSITIONS; MOLECULAR-MECHANISMS; MI-2/NURD COMPLEX; GENE-REGULATION; EMERGING ROLES; ESTROGEN	Lysine-specific demethylase 1 (LSD1) exerts pathway-specific activity in animal development and has been linked to several high-risk cancers. Here, we report that LSD1 is an integral component of the Mi-2/nucleosome remodeling and deacetylase (NuRD) complex. Transcriptional target analysis revealed that the LSD1/NuRD complexes regulate several cellular signaling pathways including TGF beta 1 signaling pathway that are critically involved in cell proliferation, survival, and epithelial-to-mesenchymal transition. We demonstrated that LSD1 inhibits the invasion of breast cancer cells in vitro and suppresses breast cancer metastatic potential in vivo. We found that LSD1 is downregulated in breast carcinomas and that its level of expression is negatively correlated with that of TGFb1. Our data provide a molecular basis for the interplay of histone demethylation and deacetylation in chromatin remodeling. By enlisting LSD1, the NuRD complex expands its chromatin remodeling capacity to include ATPase, histone deacetylase, and histone demethylase.	[Wang, Yan; Zhang, Hua; Chen, Yupeng; Sun, Yimin; Yang, Fen; Yu, Wenhua; Liang, Jing; Sun, Luyang; Yang, Xiaohan; Shi, Lei; Li, Ruifang; Li, Yanyan; Zhang, Yu; Li, Qian; Yi, Xia; Shang, Yongfeng] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China	Peking University	Shang, YF (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100191, Peoples R China.	yshang@hsc.pku.edu.cn	Chen, Yupeng/T-5275-2019	Chen, Yupeng/0000-0001-8887-9547; Li, Qian/0000-0003-0359-5604	National Natural Science Foundation of China [30830032, 30621002, 30470912]; Ministry of Science and Technology of China [2006AA02Z466, 2005CB522404, 2007CB914503]; NATIONAL INSTITUTE ON AGING [Z01AG000650] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Joanne Balmer Green (Penn State University) for editorial assistance. This work was supported by grants (30830032, 30621002 and 30470912, to Y.S.) from the National Natural Science Foundation of China and grants (863 Program: 2006AA02Z466 and 973 Program: 2005CB522404 and 2007CB914503, to Y.S.) from the Ministry of Science and Technology of China.	Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Di Stefano L, 2007, CURR BIOL, V17, P808, DOI 10.1016/j.cub.2007.03.068; Dumont N, 2003, CANCER CELL, V3, P531, DOI 10.1016/S1535-6108(03)00135-1; Forneris F, 2008, TRENDS BIOCHEM SCI, V33, P181, DOI 10.1016/j.tibs.2008.01.003; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lee MG, 2006, MOL CELL BIOL, V26, P6395, DOI 10.1128/MCB.00723-06; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Mukherjee Shibaji, 2005, Journal of Bioinformatics and Computational Biology, V3, P491, DOI 10.1142/S0219720005001077; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Sasai N, 2008, CELL, V133, P878, DOI 10.1016/j.cell.2008.03.035; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shang YF, 2006, NAT REV CANCER, V6, P360, DOI 10.1038/nrc1879; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wang JX, 2007, NATURE, V446, P882, DOI 10.1038/nature05671; WELCH DR, 1990, P NATL ACAD SCI USA, V87, P7678, DOI 10.1073/pnas.87.19.7678; Wu HJ, 2005, NATURE, V438, P981, DOI 10.1038/nature04225; Yamazaki K, 2006, BIOCHEM BIOPH RES CO, V346, P802, DOI 10.1016/j.bbrc.2006.05.178; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Ye Zhaohui, 2008, V430, P243, DOI 10.1007/978-1-59745-182-6_17; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zhang H, 2006, EMBO J, V25, P4223, DOI 10.1038/sj.emboj.7601306; Zhang Y, 2007, EMBO J, V26, P2645, DOI 10.1038/sj.emboj.7601710	44	498	543	9	95	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					660	672		10.1016/j.cell.2009.05.050	http://dx.doi.org/10.1016/j.cell.2009.05.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703393	Bronze			2022-12-28	WOS:000269156100009
J	Puhan, MA; Garcia-Aymerich, J; Frey, M; ter Riet, G; Anto, JM; Agusti, AG; Gomez, FP; Rodriguez-Roisin, R; Moons, KGM; Kessels, AG; Held, U				Puhan, Milo A.; Garcia-Aymerich, Judith; Frey, Martin; ter Riet, Gerben; Anto, Josep M.; Agusti, Alvar G.; Gomez, Federico P.; Rodriguez-Roisin, Roberto; Moons, Karel G. M.; Kessels, Alphons G.; Held, Ulrike			Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index	LANCET			English	Article							EXTERNAL VALIDATION; EXERCISE CAPACITY; WALK DISTANCE; RISK SCORE; MORTALITY; COPD; SURVIVAL; PREDICTION; MODELS; DYSPNEA	Background The BODE index (including body-mass index, airflow obstruction, dyspnoea, and exercise capacity) was an important contribution to the prognostic assessment of patients with chronic obstructive pulmonary disease (COPD). However, no study has assessed whether the risk of mortality predicted by the BODE index matches the observed mortality in different populations. We assessed the calibration of the BODE index, updated it to improve its calibration, and developed and validated a simplified index for use in primary-care settings. Methods We included 232 patients from the Swiss Barmelweid cohort with longstanding and severe COPD and 342 patients from the Spanish Phenotype and Course of COPD cohort study who had had their first hospital admission due to moderate-to-severe COPD. In both cohorts we compared the observed 3-year risk of all-cause mortality with the risk predicted by the BODE index. We then updated the BODE index and developed a simplified ADO index (including age, dyspnoea, and airflow obstruction) from the Swiss cohort, and validated both in the Spanish cohort. Findings Calibration of the BODE index was poor, with relative underprediction of 3-year risk of mortality by 36% in the Swiss cohort (median predicted risk 21.7% [IQR 12.7-31.7] vs 34.1% observed risk; p=0.013) and relative overprediction by 39% in the Spanish cohort (16.7% [12.7-31.7] vs 12.0%; p=0.035). The 3-year risk of mortality predicted by both the updated BODE (median 10.7% [8.1-13.8]) and ADO indices (11.8% [9.1-14.3]) matched the observed mortality in the Spanish cohort well (p=0.99 and p=0.98, respectively). Interpretation Both the updated BODE and ADO indices could lend support to the prognostic assessment of patients with COPD in specialised and primary-care settings. Such assessment enhances the targeting of treatments to individual patients.	[Puhan, Milo A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Puhan, Milo A.; Held, Ulrike] Univ Zurich, Horten Ctr Patient Oriented Res, Zurich, Switzerland; [Garcia-Aymerich, Judith; Anto, Josep M.] Ctr Res Environm Epidemiol CREAL, Barcelona, Spain; [Garcia-Aymerich, Judith; Anto, Josep M.] Hosp del Mar, IMIM, Municipal Inst Med Res, Barcelona, Spain; [Garcia-Aymerich, Judith; Anto, Josep M.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Barcelona, Spain; [Frey, Martin] Klin Barmelweid, Barmelweid, Switzerland; [ter Riet, Gerben] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, NL-1105 AZ Amsterdam, Netherlands; [Agusti, Alvar G.; Rodriguez-Roisin, Roberto] IDIBAPS, Hosp Clin, Dept Pneumol, Inst Torax, Barcelona, Spain; [Agusti, Alvar G.; Rodriguez-Roisin, Roberto] CIBERES, Barcelona, Spain; [Gomez, Federico P.] IDIBAPS, FCRB, Barcelona, Spain; [Moons, Karel G. M.] Univ Med Ctr, Julius Ctr Hlth Sci & Gen Practice, Utrecht, Netherlands; [Kessels, Alphons G.] Univ Hosp Maastricht, Maastricht, Netherlands	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Zurich; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Amsterdam; Academic Medical Center Amsterdam; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC)	Puhan, MA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St,Mail Room 5010, Baltimore, MD 21205 USA.	mpuhan@jhsph.edu	Garcia-Navarro, Alvar Agusti/F-4474-2015; Puhan, Milo/ABE-6298-2020; J, Garcia-Aymerich/G-6867-2014; Riet, Gerben ter/A-6943-2011; Held, Ulrike/D-3666-2013; Anto, J M/H-2676-2014; Held, Ulrike/O-8328-2019	Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Puhan, Milo/0000-0003-4721-1879; J, Garcia-Aymerich/0000-0002-7097-4586; Riet, Gerben ter/0000-0002-2231-7637; Anto, J M/0000-0002-4736-8529; Held, Ulrike/0000-0003-3105-5840	Swiss National Science Foundation [3233130-115216]; Klinik Barmelweid; Fondo de Investigacion Sanitaria [FIS P1020541, PI052486, PI052302]; Ministry of Health, Spain; Agencia d'Avaluacio de Tecnologia i Recerca Wediques [AATRM 035/20/02]; Catalonia Government; Spanish Society of Pneumology and Thoracic Surgery [SEPAR 2002/137]; Catalan Foundation of Pneumology; Red RESPIRA [RTIC C03/11]; Red RCESP [RTIC C03/09]; Fundacio La Marato de TV3 [041110]; Novartis Fannaceutica, Spain; Instituto de Salud Carlos III, Ministry of Health, Spain; Instituto de Salud Carlos III [CP05/00118]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Klinik Barmelweid; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Ministry of Health, Spain(Spanish Government); Agencia d'Avaluacio de Tecnologia i Recerca Wediques; Catalonia Government; Spanish Society of Pneumology and Thoracic Surgery; Catalan Foundation of Pneumology; Red RESPIRA; Red RCESP; Fundacio La Marato de TV3; Novartis Fannaceutica, Spain; Instituto de Salud Carlos III, Ministry of Health, Spain(Instituto de Salud Carlos IIISpanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	The Swiss Barmelweid cohort study was funded by the Swiss National Science Foundation (grant number 3233130-115216) and by the Klinik Barmelweid. The PAC-COPD study is funded by grants from Fondo de Investigacion Sanitaria (FIS P1020541), Ministry of Health, Spain; Agencia d'Avaluacio de Tecnologia i Recerca Wediques (AATRM 035/20/02), Catalonia Government; Spanish Society of Pneumology and Thoracic Surgery (SEPAR 2002/137); Catalan Foundation of Pneumology (FUCAP 2003 Beca Maria Rava); Red RESPIRA (RTIC C03/11); Red RCESP (RTIC C03/09); Fondo de Investigacion Sanitaria (PI052486); Fondo de Investigacion Sanitaria (PI052302); Fundacio La Marato de TV3 (number 041110); and Novartis Fannaceutica, Spain. CIBERESP and CIBERES are funded by the Instituto de Salud Carlos III, Ministry of Health, Spain. JG-A has a researcher contract from the Instituto de Salud Carlos III (CP05/00118), Ministry of Health, Spain.	Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Balcells E, 2009, RESP MED, V103, P1293, DOI 10.1016/j.rmed.2009.04.001; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Copas J B, 1997, Stat Methods Med Res, V6, P167, DOI 10.1191/096228097667367976; Cote CG, 2008, EUR RESPIR J, V32, P1269, DOI 10.1183/09031936.00138507; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Torres JP, 2008, CHEST, V133, P1336, DOI 10.1378/chest.07-2433; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Duiverman ML, 2008, EUR RESPIR J, V32, P379, DOI 10.1183/09031936.00163607; Eichler K, 2007, AM HEART J, V153, P722, DOI 10.1016/j.ahj.2007.02.027; Eltayara L, 1996, AM J RESP CRIT CARE, V154, P1726, DOI 10.1164/ajrccm.154.6.8970362; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Garcia-Aymerich J, 2009, ARCH BRONCONEUMOL, V45, P4, DOI 10.1016/j.arbres.2008.03.001; Imfeld S, 2006, CHEST, V129, P873, DOI 10.1378/chest.129.4.873; Janssen KJM, 2008, J CLIN EPIDEMIOL, V61, P76, DOI 10.1016/j.jclinepi.2007.04.018; Man SFP, 2008, EUR RESPIR J, V32, P1451, DOI 10.1183/09031936.00153207; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; Martinez FJ, 2008, AM J RESP CRIT CARE, V178, P491, DOI 10.1164/rccm.200709-1383OC; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Oga T, 2003, AM J RESP CRIT CARE, V167, P544, DOI 10.1164/rccm.200206-583OC; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; Puhan MA, 2008, EUR RESPIR J, V32, P637, DOI 10.1183/09031936.00140507; Puhan MA, 2008, LANCET, V371, P27, DOI 10.1016/S0140-6736(08)60064-1; Puhan MA, 2006, ANN INTERN MED, V145, P816, DOI 10.7326/0003-4819-145-11-200612050-00006; Puhan Milo A, 2004, Health Qual Life Outcomes, V2, P1; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Royston P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b604; Sauerbrei W, 2007, STAT MED, V26, P5512, DOI 10.1002/sim.3148; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; van Houwelingen HC, 2000, STAT MED, V19, P3401, DOI 10.1002/1097-0258(20001230)19:24<3401::AID-SIM554>3.0.CO;2-2; Wood D, 2005, HEART, V91, P1, DOI 10.1136/hrt.2005.079988; Yang XL, 2008, ARCH INTERN MED, V168, P451, DOI 10.1001/archinte.168.5.451	40	358	371	2	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					704	711		10.1016/S0140-6736(09)61301-5	http://dx.doi.org/10.1016/S0140-6736(09)61301-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716962				2022-12-28	WOS:000269422500026
J	Davies, L; Calverley, PMA				Davies, Lisa; Calverley, Peter M. A.			UPLIFTing care for chronic obstructive pulmonary disease	LANCET			English	Editorial Material							SALMETEROL/FLUTICASONE PROPIONATE; LUNG-FUNCTION; EXACERBATIONS; TIOTROPIUM; TRIAL; FLUTICASONE; PREVENTION; SALMETEROL; DECLINE; TORCH		[Calverley, Peter M. A.] Univ Liverpool, Sch Clin Sci, Liverpool L9 7AL, Merseyside, England; [Davies, Lisa] Aintree Univ Hosp NHS Fdn Trust, Aintree Chest Ctr, Liverpool L9 7AL, Merseyside, England	University of Liverpool; Aintree University Hospitals NHS Foundation Trust	Calverley, PMA (corresponding author), Univ Liverpool, Sch Clin Sci, Liverpool L9 7AL, Merseyside, England.	pmacal@liverpool.ac.uk						Bridevaux PO, 2008, THORAX, V63, P768, DOI 10.1136/thx.2007.093724; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Celli BR, 2008, AM J RESP CRIT CARE, V178, P332, DOI 10.1164/rccm.200712-1869OC; Decramer M, 2009, LANCET, V374, P1171, DOI 10.1016/S0140-6736(09)61298-8; Donohue James F, 2005, COPD, V2, P111; Jenkins CR, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-59; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Spencer S, 2004, EUR RESPIR J, V23, P698, DOI 10.1183/09031936.04.00121404; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC	12	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 3	2009	374	9696					1129	1130		10.1016/S0140-6736(09)61518-X	http://dx.doi.org/10.1016/S0140-6736(09)61518-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505IZ	19716599				2022-12-28	WOS:000270688200009
J	Kidd, IM; Down, J; Nastouli, E; Shulman, R; Grant, PR; Howell, DCJ; Singer, M				Kidd, I. Michael; Down, Jim; Nastouli, Eleni; Shulman, Rob; Grant, Paul R.; Howell, David C. J.; Singer, Mervyn			H1N1 pneumonitis treated with intravenous zanamivir	LANCET			English	Editorial Material									[Kidd, I. Michael; Nastouli, Eleni; Grant, Paul R.] Univ Coll London Hosp NHS Fdn Trust, Dept Virol, London NW1 2BU, England; [Down, Jim; Shulman, Rob; Howell, David C. J.; Singer, Mervyn] Univ Coll London Hosp NHS Fdn Trust, Dept Crit Care, London NW1 2BU, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Kidd, IM (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Dept Virol, 235 Euston Rd, London NW1 2BU, England.	Michael.Kidd@uclh.nhs.uk	Singer, Mervyn/J-4425-2012; Kidd, Ian Michael/CAH-4551-2022; Singer, Mervyn/Q-6142-2019	Singer, Mervyn/0000-0002-1042-6350; Kidd, Ian Michael/0000-0002-5264-9712; Singer, Mervyn/0000-0002-1042-6350	Department of Health Funding Source: Medline	Department of Health		Calfee DP, 1999, ANTIMICROB AGENTS CH, V43, P1616, DOI 10.1128/AAC.43.7.1616; *CDC, 2009, INT GUID ANT REC PAT; GSK, 2009, GUID DOC ZAN AQ SOL; Tang BMP, 2009, CRIT CARE MED, V37, P1594, DOI 10.1097/CCM.0b013e31819fb507	4	72	75	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 19	2009	374	9694					1036	1036		10.1016/S0140-6736(09)61528-2	http://dx.doi.org/10.1016/S0140-6736(09)61528-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PK	19733390				2022-12-28	WOS:000270154100035
J	Stern, AM; Markel, H				Stern, Alexandra Minna; Markel, Howard			What Mexico Taught the World About Pandemic Influenza Preparedness and Community Mitigation Strategies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							US CITIES; INTERVENTIONS		[Markel, Howard] Univ Michigan, Sch Med, Ctr Hist Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markel, H (corresponding author), Univ Michigan, Sch Med, Ctr Hist Med, 102 Observ 0725,100 SMI, Ann Arbor, MI 48109 USA.	howard@umich.edu						BOOTH W, 2009, WASHINGTON POST 0511; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Kelso JK, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-117; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; MASSIEU JFR, 1989, AM HLTH ORG SCI PUBL, V509, P372; *PRES CALD IN REUN, 2009, LECC APR INFL A H1N1; ZUCKERMANN L, 2009, NEXOS, V31, P24	9	26	27	3	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1221	1222		10.1001/jama.2009.1367	http://dx.doi.org/10.1001/jama.2009.1367			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755702				2022-12-28	WOS:000269797600033
J	Hirsch, C				Hirsch, Calvin			Cholinesterase inhibitors were associated with increased risk for syncope and its consequences in older persons with dementia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PREVALENCE		Calif State Univ Sacramento, Davis Med Ctr, Sacramento, CA 95819 USA	California State University System; California State University Sacramento	Hirsch, C (corresponding author), Calif State Univ Sacramento, Davis Med Ctr, Sacramento, CA 95819 USA.							Allan L, 2006, DEMENT GERIATR COGN, V22, P230, DOI 10.1159/000094971; Ballard C, 1998, NEUROLOGY, V51, P1760, DOI 10.1212/WNL.51.6.1760	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6							JC3-13	10.7326/0003-4819-151-6-200909150-02013	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755359				2022-12-28	WOS:000270390100029
J	McGeechan, K; Liew, G; Macaskill, P; Irwig, L; Klein, R; Klein, BEK; Wang, JJ; Mitchell, P; Vingerling, JR; Dejong, PTVM; Witteman, JCM; Breteler, MMB; Shaw, J; Zimmet, P; Wong, TY				McGeechan, Kevin; Liew, Gerald; Macaskill, Petra; Irwig, Les; Klein, Ronald; Klein, Barbara E. K.; Wang, Jie Jin; Mitchell, Paul; Vingerling, Johannes R.; deJong, Paulus T. V. M.; Witteman, Jacqueline C. M.; Breteler, Monique M. B.; Shaw, Jonathan; Zimmet, Paul; Wong, Tien Y.			Meta-analysis: Retinal Vessel Caliber and Risk for Coronary Heart Disease	ANNALS OF INTERNAL MEDICINE			English	Review							ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; VASCULAR CALIBER; DIABETIC-RETINOPATHY; ATHEROSCLEROSIS RISK; MICROVASCULAR ABNORMALITIES; BLOOD-PRESSURE; GENDER-DIFFERENCES; OLDER PERSONS; LIFE-STYLE	Background: Retinal vessel caliber may be a novel marker of coronary heart disease (CHD) risk. However, the sex-specific effect, magnitude of association, and effect independent of traditional CHD disease risk factors remain unclear. Purpose: To determine the association between retinal vessel caliber and risk for CHD. Data Sources: Relevant studies in any language identified through MEDLINE (1950 to June 2009) and EMBASE (1950 to June 2009) databases. Study Selection: Studies were included if they examined a general population, measured retinal vessel caliber from retinal photographs, and documented CHD risk factors and incident CHD events. Data Extraction: 6 population-based prospective cohort studies provided data for individual participant meta-analysis. Data Synthesis: Proportional hazards models, adjusted for traditional CHD risk factors, were constructed for retinal vessel caliber and incident CHD in women and men. Among 22 159 participants who were free of CHD and followed for 5 to 14 years, 2219 (10.0%) incident CHD events occurred. Retinal vessel caliber changes (wider venules and narrower arterioles) were each associated with an increased risk for CHD in women (pooled multivariable-adjusted hazard ratios, 1.16 [95% CI, 1.06 to 1.26] per 20-mu m increase in venular caliber and 1.17 [CI, 1.07 to 1.28] per 20-mu m decrease in arteriolar caliber) but not in men (1.02 [CI, 0.94 to 1.10] per 20-mu m increase in venular caliber and 1.02 [CI, 0.95 to 1.10] per 20-mu m decrease in arteriolar caliber). Women without hypertension or diabetes had higher hazard ratios. Limitation: Error in the measurement of retinal vessel caliber and Framingham variables was not taken into account. Conclusion: Retinal vessel caliber changes were independently associated with an increased risk for CHD events in women.	[Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 168751, Singapore; Univ Sydney, Sydney, NSW 2006, Australia; Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; Erasmus MC, Rotterdam, Netherlands; Univ Melbourne, Melbourne, Vic, Australia; Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; Royal Netherlands Acad Arts & Sci, Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	National University of Singapore; Singapore National Eye Center; University of Sydney; University of Wisconsin System; University of Wisconsin Madison; Erasmus University Rotterdam; Erasmus MC; University of Melbourne; Baker Heart and Diabetes Institute; University of Amsterdam; Academic Medical Center Amsterdam	Wong, TY (corresponding author), Natl Univ Singapore, Singapore Eye Res Inst, 11 3rd Hosp Ave, Singapore 168751, Singapore.	ophwty@nus.edu.sg	Zimmet, Paul/O-8486-2019; Wong, Tien Yin/AAC-9724-2020; Wang, Jie Jin/P-1499-2014; wang, jie/GRS-0942-2022; Mitchell, Paul/P-1498-2014; Liew, Gerald/AAB-6870-2022; Shaw, Jonathan/E-7388-2010; Breteler, Monique M.B./J-5058-2014	Zimmet, Paul/0000-0003-0627-0776; Wong, Tien Yin/0000-0002-8448-1264; Wang, Jie Jin/0000-0001-9491-4898; Shaw, Jonathan/0000-0002-6187-2203; Breteler, Monique M.B./0000-0002-0626-9305; McGeechan, Kevin/0000-0002-9679-9827; Macaskill, Petra/0000-0001-5879-6193; Klein, Ronald/0000-0002-4428-6237	Australian National Health and Medical Research Council [402764, 358395]; National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC- 75150, N01-HC-45133, U01 HL080295, N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; National Institute of Neurological Disorders and Stroke; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC085079, N01HC075150, N01HC055222, N01HC055015, N01HC045133, N01HC055021, N01HC055020, N01HC055018, N01HC055019, N01HC085086, N01HC035129, N01HC055022, N01HC055016] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL055018, R41HL055019, U01HL080295, R41HL055018] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the Australian National Health and Medical Research Council (program grants 402764 and 358395) and the National Heart, Lung, and Blood Institute (contracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC- 75150, and N01-HC-45133 and grant U01 HL080295), with additional contributions from the National Institute of Neurological Disorders and Stroke. The ARIC Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022.	Agardh CD, 1996, DIABETES RES CLIN PR, V32, P35, DOI 10.1016/0168-8227(96)01218-1; Anderson RD, 2007, CIRCULATION, V115, P823, DOI 10.1161/CIRCULATIONAHA.106.685859; Barr ELM, 2007, CIRCULATION, V116, P151, DOI 10.1161/CIRCULATIONAHA.106.685628; Bennett DA, 2003, STAT METHODS MED RES, V12, P297, DOI 10.1191/0962280203sm319ra; Buchthal SD, 2000, NEW ENGL J MED, V342, P829, DOI 10.1056/NEJM200003233421201; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Camici PG, 2007, NEW ENGL J MED, V356, P830, DOI 10.1056/NEJMra061889; Cheung N, 2007, HYPERTENSION, V50, P617, DOI 10.1161/HYPERTENSIONAHA.107.091926; Cheung N, 2007, ANN NEUROL, V62, P618, DOI 10.1002/ana.21236; Cordero A, 2006, HEART, V92, P145, DOI 10.1136/hrt.2005.069187; Couper DJ, 2002, AM J OPHTHALMOL, V133, P78, DOI 10.1016/S0002-9394(01)01315-0; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Egger M, 2001, BMJ; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hubbard LD, 1999, OPHTHALMOLOGY, V106, P2269, DOI 10.1016/S0161-6420(99)90525-0; Hughes AD, 2008, J HYPERTENS, V26, P1703, DOI 10.1097/HJH.0b013e328304b072; Ikram MK, 2006, NEUROLOGY, V66, P1339, DOI 10.1212/01.wnl.0000210533.24338.ea; Ikram MK, 2006, HYPERTENSION, V47, P189, DOI 10.1161/01.HYP.0000199104.61945.33; Ikram MK, 2004, INVEST OPHTH VIS SCI, V45, P2129, DOI 10.1167/iovs.03-1390; Klein BEK, 2004, ARCH INTERN MED, V164, P1917, DOI 10.1001/archinte.164.17.1917; Klein BEK, 2002, DIABETES CARE, V25, P1790, DOI 10.2337/diacare.25.10.1790; Knudtson MD, 2003, CURR EYE RES, V27, P143, DOI 10.1076/ceyr.27.3.143.16049; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Leske MC, 1999, OPHTHALMOLOGY, V106, P1893, DOI 10.1016/S0161-6420(99)90398-6; Leung H, 2003, INVEST OPHTH VIS SCI, V44, P2900, DOI 10.1167/iovs.02-1114; Liew G, 2008, ARCH OPHTHALMOL-CHIC, V126, P1404, DOI 10.1001/archopht.126.10.1404; Liew G, 2007, INVEST OPHTH VIS SCI, V48, P52, DOI 10.1167/iovs.06-0672; Liew G, 2008, CIRC-CARDIOVASC IMAG, V1, P156, DOI 10.1161/CIRCIMAGING.108.784876; Ling R, 2002, EYE, V16, P140, DOI 10.1038/sj/EYE/6700081; Looker HC, 2003, DIABETES CARE, V26, P320, DOI 10.2337/diacare.26.2.320; Matthews DR, 2004, ARCH OPHTHALMOL-CHIC, V122, P1631; McCarty DJ, 2003, CLIN EXP OPHTHALMOL, V31, P397, DOI 10.1046/j.1442-9071.2003.00685.x; McGeechan K, 2008, AM J CARDIOL, V102, P58, DOI 10.1016/j.amjcard.2008.02.094; MERZ CNB, 2006, J AM COLL CARDIOL, V47, pS21, DOI [DOI 10.1016/J.JACC.2004.12.084, 10.1016/j.jacc.2004.12.084]; Meyer MR, 2006, HYPERTENSION, V47, P1019, DOI 10.1161/01.HYP.0000223064.62762.0b; Miller RG, 2009, AM J OPHTHALMOL, V147, P653, DOI 10.1016/j.ajo.2008.10.004; Mitchell P, 2005, NEUROLOGY, V65, P1005, DOI 10.1212/01.wnl.0000179177.15900.ca; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Pepine CJ, 2006, J AM COLL CARDIOL, V47, p30S, DOI 10.1016/j.jacc.2005.09.023; Qiu CX, 2008, DIABETES, V57, P1645, DOI 10.2337/db07-1455; Roy MS, 2007, DIABETIC MED, V24, P1361, DOI 10.1111/j.1464-5491.2007.02293.x; Sauerbrei W, 2006, COMPUT STAT DATA AN, V50, P3464, DOI 10.1016/j.csda.2005.07.015; Sherry LM, 2002, CLIN EXP OPHTHALMOL, V30, P179, DOI 10.1046/j.1442-9071.2002.00520.x; Stolk RP, 2007, CONTEMP CLIN TRIALS, V28, P6, DOI 10.1016/j.cct.2006.08.011; Sun C, 2009, SURV OPHTHALMOL, V54, P74, DOI 10.1016/j.survophthal.2008.10.003; TANAKA M, 1987, CIRCULATION, V75, P1130, DOI 10.1161/01.CIR.75.6.1130; Tikellis G, 2007, DIABETOLOGIA, V50, P2263, DOI 10.1007/s00125-007-0822-x; Tillin T, 2008, DIABETOLOGIA, V51, P1719, DOI 10.1007/s00125-008-1096-7; TSO MOM, 1991, RETINAL AND CHOROIDAL MANIFESTATIONS OF SYSTEMIC DISEASE, P79; van den Born BJH, 2005, BMJ-BRIT MED J, V331, P73, DOI 10.1136/bmj.331.7508.73; van Hecke MV, 2005, DIABETES CARE, V28, P1383, DOI 10.2337/diacare.28.6.1383; van Hecke MV, 2003, DIABETES CARE, V26, P2958, DOI 10.2337/diacare.26.10.2958; Voutilainen-Kaunisto RM, 2001, J DIABETES COMPLICAT, V15, P24, DOI 10.1016/S1056-8727(00)00126-4; Wang JJ, 2006, HEART, V92, P1583, DOI 10.1136/hrt.2006.090522; Wang JJ, 2007, EUR HEART J, V28, P1984, DOI 10.1093/eurheartj/ehm221; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong TY, 2006, ARCH INTERN MED, V166, P2388, DOI 10.1001/archinte.166.21.2388; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2004, OPHTHALMOLOGY, V111, P1183, DOI 10.1016/j.ophtha.2003.09.039; Wong TY, 2003, OPHTHALMOLOGY, V110, P933, DOI 10.1016/S0161-6420(03)00084-8; Wong TY, 2003, OPHTHALMOLOGY, V110, P658, DOI 10.1016/S0161-6420(02)01931-0; Wong TY, 2002, JAMA-J AM MED ASSOC, V287, P1153, DOI 10.1001/jama.287.9.1153; Xu L, 2008, GRAEF ARCH CLIN EXP, V246, P923, DOI 10.1007/s00417-008-0773-z; YANKO L, 1983, BRIT J OPHTHALMOL, V67, P759, DOI 10.1136/bjo.67.11.759	67	233	235	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6					404	131		10.7326/0003-4819-151-6-200909150-00005	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755365	Green Accepted			2022-12-28	WOS:000270390100005
J	Wang, LG; Sigworth, FJ				Wang, Liguo; Sigworth, Fred J.			Structure of the BK potassium channel in a lipid membrane from electron cryomicroscopy	NATURE			English	Article							DEPENDENT K+ CHANNEL; HIGH-CONDUCTANCE; VOLTAGE SENSOR; CRYO-EM; STREPTAVIDIN; ENVIRONMENT; REFINEMENT; ACTIVATION; MECHANISM; PROTEINS	A long-sought goal in structural biology has been the imaging of membrane proteins in their membrane environments. This goal has been achieved with electron crystallography(1) in those special cases where a protein forms highly ordered arrays in lipid bilayers. It has also been achieved by NMR methods(1) in proteins up to 50 kilodaltons (kDa) in size, although milligram quantities of protein and isotopic labelling are required. For structural analysis of large soluble proteins in microgram quantities, an increasingly powerful method that does not require crystallization is single-particle reconstruction from electron microscopy of cryogenically cooled samples (electron cryomicroscopy (cryo-EM))(2). Here we report the first single-particle cryo-EM study of a membrane protein, the human large-conductance calcium-and voltage-activated potassium channel(3) (BK), in a lipid environment. The new method is called random spherically constrained (RSC) single-particle reconstruction. BK channels, members of the six-transmembrane segment (6TM) ion channel family, were reconstituted at low density into lipid vesicles (liposomes), and their function was verified by a potassium flux assay. Vesicles were also frozen in vitreous ice and imaged in an electron microscope. From images of 8,400 individual protein particles, a three-dimensional (3D) reconstruction of the BK channel and its membrane environment was obtained at a resolution of 1.7-2.0 nm. Not requiring the formation of crystals, the RSC approach promises to be useful in the structural study of many other membrane proteins as well.	[Wang, Liguo; Sigworth, Fred J.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Sigworth, FJ (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	fred.sigworth@yale.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR014739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM062580] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021501] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR014739-01, S10 RR014739-018020] Funding Source: Medline; NIGMS NIH HHS [P01 GM062580, P01 GM062580-080007, P01 GM062580-06A10007, P01 GM062580-070007] Funding Source: Medline; NINDS NIH HHS [R01 NS021501-19, R01 NS021501-19S1, R01 NS021501-22, R01 NS021501, R01 NS021501-23, R01 NS021501-24, R01 NS021501-21, R01 NS021501-20] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bingham JP, 2006, BIOCONJUGATE CHEM, V17, P689, DOI 10.1021/bc060002u; Chanda B, 1999, BBA-BIOMEMBRANES, V1416, P92, DOI 10.1016/S0005-2736(98)00217-X; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Fodor AA, 2006, J GEN PHYSIOL, V127, P755, DOI 10.1085/jgp.200509419; Fodor AA, 2009, ANNU REV PHYSIOL, V71, P19, DOI 10.1146/annurev.physiol.010908.163124; Frank J, 2006, 3 DIMENSIONAL ELECT; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GRIGORIEFF N, 1995, J MOL BIOL, V254, P404, DOI 10.1006/jmbi.1995.0627; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Jiang QX, 2001, J STRUCT BIOL, V133, P119, DOI 10.1006/jsbi.2001.4376; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Liu G, 2008, J GEN PHYSIOL, V131, P537, DOI 10.1085/jgp.200809968; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MILLER C, 1987, J GEN PHYSIOL, V90, P427, DOI 10.1085/jgp.90.3.427; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raunser S, 2009, ANNU REV BIOPHYS, V38, P89, DOI 10.1146/annurev.biophys.050708.133649; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Stewart A, 2004, ULTRAMICROSCOPY, V102, P67, DOI 10.1016/j.ultramic.2004.08.008; Wang LG, 2008, J STRUCT BIOL, V164, P190, DOI 10.1016/j.jsb.2008.07.008; Wang LG, 2006, P NATL ACAD SCI USA, V103, P18528, DOI 10.1073/pnas.0608714103; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Zhang Z, 2006, J NEUROSCI, V26, P11833, DOI 10.1523/JNEUROSCI.3812-06.2006	30	148	153	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					292	U177		10.1038/nature08291	http://dx.doi.org/10.1038/nature08291			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19718020	Green Accepted			2022-12-28	WOS:000269654600050
J	Sittig, DF; Singh, H				Sittig, Dean F.; Singh, Hardeep			Eight Rights of Safe Electronic Health Record Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNEXPECTED INCREASED MORTALITY; IMPLEMENTATION		[Sittig, Dean F.] UT Mem Hermann Ctr Healthcare Qual & Safety, Houston, TX 77030 USA; [Sittig, Dean F.] Univ Texas Houston, Sch Hlth Informat Sci, Houston, TX USA; [Singh, Hardeep] Baylor Coll Med, Dept Med, Sect Hlth Serv Res, Houston, TX 77030 USA; [Singh, Hardeep] Baylor Coll Med, Michael E DeBakey Vet Affairs Med Ctr, Ctr Inquiry Improve Outpatient Safety Effect Elec, Houston, TX 77030 USA; [Singh, Hardeep] Baylor Coll Med, Houston VA Hlth Serv, Res & Dev Ctr Excellence, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Baylor College of Medicine	Sittig, DF (corresponding author), UT Mem Hermann Ctr Healthcare Qual & Safety, 6410 Fannin St,UTPB 1100-43, Houston, TX 77030 USA.	dean.f.sittig@uth.tmc.edu	Sittig, Dean F./D-2471-2009	Sittig, Dean F./0000-0001-5811-8915	NCI NIH HHS [K23CA125585] Funding Source: Medline; NLM NIH HHS [R01-LM006942] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K23CA125585] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM006942] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		[Anonymous], SAF IMPL HLTH INF CO; Campbell EM, 2009, J GEN INTERN MED, V24, P21, DOI 10.1007/s11606-008-0857-9; Carayon P, 2006, QUAL SAF HEALTH CARE, V15, pI50, DOI 10.1136/qshc.2005.015842; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Miller RA, 1997, J AM MED INFORM ASSN, V4, P442, DOI 10.1136/jamia.1997.0040442; Singh H, 2007, J AM MED INFORM ASSN, V14, P459, DOI 10.1197/jamia.M2280; Sittig DF, 2006, PEDIATRICS, V118, P797, DOI 10.1542/peds.2005-3132; SITTIG DF, CLIN INFORM IN PRESS	10	54	54	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1111	1113		10.1001/jama.2009.1311	http://dx.doi.org/10.1001/jama.2009.1311			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	491XH	19738098				2022-12-28	WOS:000269616200032
J	McKnight, SL				McKnight, Steven L.			Unconventional Wisdom	CELL			English	Editorial Material								Science is an "endless frontier," and opportunities for transformative discovery abound. The young scientist will profit by paying mind to two forms of balance: the contrast between depth and breadth in training, and the contrast between hypothesis-driven research and random inquiry into the unknown.	Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu						Ayala FJ, 2009, P NATL ACAD SCI USA, V106, P10033, DOI 10.1073/pnas.0901404106; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; Darwin F., 1903, MORE LETT C DARWIN; Stent G., 1963, MOL BIOL BACTERIAL V; STENT GS, 1968, SCIENCE, V160, P390, DOI 10.1126/science.160.3826.390; YANOFSKY C, 1991, CELL, V65, P199, DOI 10.1016/0092-8674(91)90152-O	6	6	6	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 4	2009	138	5					817	819		10.1016/j.cell.2009.08.016	http://dx.doi.org/10.1016/j.cell.2009.08.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737508	Bronze			2022-12-28	WOS:000269564600006
J	Mereghetti, S; Tiengo, A; Esposito, P; La Palombara, N; Israel, GL; Stella, L				Mereghetti, S.; Tiengo, A.; Esposito, P.; La Palombara, N.; Israel, G. L.; Stella, L.			An Ultramassive, Fast-Spinning White Dwarf in a Peculiar Binary System	SCIENCE			English	Article							RAY PULSATING COMPANION; PHOTON IMAGING CAMERA; XMM-NEWTON; STARS; EVOLUTION	White dwarfs typically have masses in a narrow range centered at about 0.6 solar mass (M-circle dot). Only a few ultramassive white dwarfs (mass > 1.2 M-circle dot) are known. Those in binary systems are of particular interest, because a small amount of accreted mass could drive them above the Chandrasekhar limit, beyond which they become gravitationally unstable. Using data from the x-ray multimirror mission (XMM)-Newton satellite, we show that the x-ray pulsator RX J0648.0-4418 is a white dwarf with mass > 1.2 M-circle dot, based on dynamical measurements only. This ultramassive white dwarf in a post-common envelope binary with a hot subdwarf can reach the Chandrasekhar limit, and possibly explode as a type Ia supernova, when its helium-rich companion will transfer mass at an increased rate through Roche lobe overflow.	[Mereghetti, S.; Tiengo, A.; Esposito, P.; La Palombara, N.] Ist Astrofis Spaziale & Fis Cosm Milano, Ist Nazl Astrofis, I-20133 Milan, Italy; [Esposito, P.] Ist Nazl Fis Nucl, Sez Pavia, I-27100 Pavia, Italy; [Israel, G. L.; Stella, L.] Osserv Astron Roma, Ist Nazl Astrofis, I-00040 Monte Porzio Catone, Italy	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale Astrofisica (INAF)	Mereghetti, S (corresponding author), Ist Astrofis Spaziale & Fis Cosm Milano, Ist Nazl Astrofis, Via E Bassini 15, I-20133 Milan, Italy.	sandro@iasf-milano.inaf.it	Esposito, Paolo/ABE-6389-2020	Esposito, Paolo/0000-0003-4849-5092; MEREGHETTI, SANDRO/0000-0003-3259-7801; Israel, GianLuca/0000-0001-5480-6438; Tiengo, Andrea/0000-0002-6038-1090; La Palombara, Nicola/0000-0001-7015-6359; Stella, Luigi/0000-0002-0018-1687	ESA Member States; NASA; Italian Space Agency (ASI/INAF) [I/088/06/0]	ESA Member States(European Space Agency); NASA(National Aeronautics & Space Administration (NASA)); Italian Space Agency (ASI/INAF)(Istituto Nazionale Astrofisica (INAF)Agenzia Spaziale Italiana (ASI))	This work was based on observations obtained with XMM-Newton, a European Space Agency (ESA) science mission with instruments and contributions directly funded by ESA Member States and NASA. We thank E. Bozzo for interesting discussions. We acknowledge partial support from the Italian Space Agency (ASI/INAF contract I/088/06/0).	Althaus LG, 2007, ASTRON ASTROPHYS, V465, P249, DOI 10.1051/0004-6361:20066059; Althaus LG, 2005, ASTRON ASTROPHYS, V441, P689, DOI 10.1051/0004-6361:20052996; Archibald AM, 2009, SCIENCE, V324, P1411, DOI 10.1126/science.1172740; BHATTACHARYA D, 1991, PHYS REP, V203, P1, DOI 10.1016/0370-1573(91)90064-S; Bisscheroux BC, 1997, ASTRON ASTROPHYS, V317, P815; Bozzo E, 2008, ASTROPHYS J, V683, P1031, DOI 10.1086/589990; Dahn CC, 2004, ASTROPHYS J, V605, P400, DOI 10.1086/382208; Dupuis J, 2003, ASTROPHYS J, V598, P486, DOI 10.1086/378719; Ferrario L, 1997, MON NOT R ASTRON SOC, V292, P205, DOI 10.1093/mnras/292.2.205; Frank J., 2002, ACCRETION POWER ASTR, V3rd; HAMADA T, 1961, ASTROPHYS J, V134, P683, DOI 10.1086/147195; HAMANN WR, 1981, ASTRON ASTROPHYS, V104, P249; IBEN I, 1993, ASTROPHYS J, V418, P343, DOI 10.1086/173395; IBEN I, 1994, ASTROPHYS J, V431, P264, DOI 10.1086/174484; Israel GL, 1997, ASTROPHYS J, V474, pL53, DOI 10.1086/310418; KING AR, 1985, MON NOT R ASTRON SOC, V217, P23; Koester D, 2002, ASTRON ASTROPHYS REV, V11, P33, DOI 10.1007/s001590100015; KUDRITZKI RP, 1978, ASTRON ASTROPHYS, V70, P653; Perryman MAC, 1997, ASTRON ASTROPHYS, V323, pL49; RAO GCM, 1987, ASTROPHYS J, V319, P188, DOI 10.1086/165444; STICKLAND DJ, 1994, OBSERVATORY, V114, P41; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; THACKERAY A, 1970, MON NOT R ASTRON SOC, V150, P211; Tiengo A, 2004, NUCL PHYS B-PROC SUP, V132, P705, DOI 10.1016/j.nuclphysbps.2004.04.126; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087; van Kerkwijk MH, 1999, ASTROPHYS J, V516, pL25, DOI 10.1086/311991; Vennes S, 2008, MON NOT R ASTRON SOC, V389, P1367, DOI 10.1111/j.1365-2966.2008.13652.x	27	81	81	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1222	1223		10.1126/science.1176252	http://dx.doi.org/10.1126/science.1176252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729650	Green Submitted			2022-12-28	WOS:000269523200030
J	Shackleton, M; Quintana, E; Fearon, ER; Morrison, SJ				Shackleton, Mark; Quintana, Elsa; Fearon, Eric R.; Morrison, Sean J.			Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution	CELL			English	Article							ACUTE MYELOID-LEUKEMIA; TUMOR-INITIATING CELLS; BREAST-CANCER; MOUSE MODEL; IDENTIFICATION; PROGENITOR; RESISTANCE; MICE; DIFFERENTIATION; TRANSPLANTATION	The identification and characterization of cancer stem cells might lead to more effective treatments for some cancers by focusing therapy on the most malignant cells. To achieve this goal it will be necessary to determine which cancers follow a cancer stem cell model and which do not, to address technical issues related to tumorigenesis assays, and to test the extent to which cancer cell heterogeneity arises from genetic versus epigenetic differences.	[Shackleton, Mark; Quintana, Elsa; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Fearon, Eric R.; Morrison, Sean J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021; damiani, chiara/R-4256-2016	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Deshpande AJ, 2006, CANCER CELL, V10, P363, DOI 10.1016/j.ccr.2006.08.023; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; FEARON ER, 1986, NEW ENGL J MED, V315, P15, DOI 10.1056/NEJM198607033150103; Feuring-Buske M, 2003, LEUKEMIA, V17, P760, DOI 10.1038/sj.leu.2402882; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Oravecz-Wilson KI, 2009, CANCER CELL, V16, P137, DOI 10.1016/j.ccr.2009.06.007; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shah NP, 2007, J CLIN INVEST, V117, P2562, DOI 10.1172/JCI30890; SIKIC BI, 2008, MOL BASIS CANC, P583; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	39	816	841	2	114	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 4	2009	138	5					822	829		10.1016/j.cell.2009.08.017	http://dx.doi.org/10.1016/j.cell.2009.08.017			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737509	Bronze			2022-12-28	WOS:000269564600007
J	Zhang, J; Fonovic, M; Suyama, K; Bogyo, M; Scott, MP				Zhang, Jun; Fonovic, Marko; Suyama, Kaye; Bogyo, Matthew; Scott, Matthew P.			Rab35 Controls Actin Bundling by Recruiting Fascin as an Effector Protein	SCIENCE			English	Article							DROSOPHILA BRISTLES; SHORT FILAMENTS; CYTOKINESIS; EXPRESSION; SHAPE	Actin filaments are key components of the eukaryotic cytoskeleton that provide mechanical structure and generate forces during cell shape changes, growth, and migration. Actin filaments are dynamically assembled into higher-order structures at specified locations to regulate diverse functions. The Rab family of small guanosine triphosphatases is evolutionarily conserved and mediates intracellular vesicle trafficking. We found that Rab35 regulates the assembly of actin filaments during bristle development in Drosophila and filopodia formation in cultured cells. These effects were mediated by the actin-bundling protein fascin, which directly associated with active Rab35. Targeting Rab35 to the outer mitochondrial membrane triggered actin recruitment, demonstrating a role for an intracellular trafficking protein in localized actin assembly.	[Zhang, Jun; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Zhang, Jun; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Zhang, Jun; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Dept Biol Engn, Sch Med, Stanford, CA 94305 USA; [Zhang, Jun; Suyama, Kaye; Scott, Matthew P.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Fonovic, Marko; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Fonovic, Marko; Bogyo, Matthew] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Fonovic, Marko] Jozef Stefan Inst, Dept Biochem Mol & Struct Biol, Ljubljana 1000, Slovenia	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Scott, MP (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	mscott@stanford.edu	Fonović, Marko/X-9957-2019	Fonovic, Marko/0000-0002-8375-6713; Bogyo, Matthew/0000-0003-3753-4412	Jane Coffin Childs Memorial Fund for Medical Research fellowship; NIH National Technology Center for Networks and NIH Pathway [U54 RR020843]; Howard Hughes Medical Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research fellowship; NIH National Technology Center for Networks and NIH Pathway; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank M. Fish for DNA injections; X. Huang, E. Bustamante, and C. Gauthier for help with initial experiments; Scott lab members for valuable discussion and comments; the Stanford Cell Sciences Imaging Facility for assistance with scanning electron microscopy studies; and S. Pfeffer, A. Ghabrial, and R. Rohatgi for critical reading and comments on the manuscript. Supported by a Jane Coffin Childs Memorial Fund for Medical Research fellowship (J. Z.) and by the NIH National Technology Center for Networks and NIH Pathway grant U54 RR020843 (M.F. and M.B.). The research reported here was supported by the Howard Hughes Medical Institute. M. P. S. is an Investigator of the HHMI.	Adams JC, 1999, MOL BIOL CELL, V10, P4177, DOI 10.1091/mbc.10.12.4177; Bakshi NA, 2007, ARCH PATHOL LAB MED, V131, P742; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; CANT K, 1994, J CELL BIOL, V125, P369, DOI 10.1083/jcb.125.2.369; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; Christoforidis S, 2001, METHOD ENZYMOL, V329, P120; De Arcangelis A, 2004, GENE EXPR PATTERNS, V4, P637, DOI 10.1016/j.modgep.2004.04.012; Faix J, 2006, CURR OPIN CELL BIOL, V18, P18, DOI 10.1016/j.ceb.2005.11.002; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Guild GM, 2003, J CELL BIOL, V162, P1069, DOI 10.1083/jcb.200305143; Kostopoulou E, 2008, HISTOL HISTOPATHOL, V23, P935, DOI 10.14670/HH-23.935; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; MOOSEKER MS, 1983, CELL, V35, P11, DOI 10.1016/0092-8674(83)90202-7; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Pfeffer S, 2005, BIOCHEM SOC T, V33, P627, DOI 10.1042/BST0330627; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Tilney LG, 2003, MOL BIOL CELL, V14, P3953, DOI 10.1091/mbc.E03-03-0158; Tilney LG, 1996, J CELL BIOL, V135, P1291, DOI 10.1083/jcb.135.5.1291; TILNEY LG, 1995, J CELL BIOL, V130, P629, DOI 10.1083/jcb.130.3.629; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Zhang H, 2006, J CLIN PATHOL, V59, P958, DOI 10.1136/jcp.2005.032730; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	25	103	107	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1250	1254		10.1126/science.1174921	http://dx.doi.org/10.1126/science.1174921			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729655				2022-12-28	WOS:000269523200039
J	Bonow, RO				Bonow, Robert O.			Should Coronary Calcium Screening Be Used in Cardiovascular Prevention Strategies?.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BEAM COMPUTED-TOMOGRAPHY; ARTERY CALCIUM; RISK-FACTORS; HEART-DISEASE; MYOCARDIAL-INFARCTION; PROGNOSTIC VALUE; CARDIAC EVENTS; CALCIFICATION; PREDICTION; RADIATION		[Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Dept Med, Ctr Cardiovasc Qual & Outcomes Res, Chicago, IL 60611 USA; [Bonow, Robert O.] NW Mem Hosp, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital	Bonow, RO (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, Ctr Cardiovasc Qual & Outcomes Res, 676 N St Clair St,Suite 600, Chicago, IL 60611 USA.	r-bonow@northwestern.edu						AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Arad Y, 2005, J AM COLL CARDIOL, V46, P158, DOI 10.1016/j.jacc.2005.02.088; Becker A, 2008, AM HEART J, V155, P154, DOI 10.1016/j.ahj.2007.08.024; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Budoff MJ, 2007, J AM COLL CARDIOL, V49, P1860, DOI 10.1016/j.jacc.2006.10.079; Budoff MJ, 2006, CIRCULATION, V114, P1761, DOI 10.1161/CIRCULATIONAHA.106.178458; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Church TS, 2007, ATHEROSCLEROSIS, V190, P224, DOI 10.1016/j.atherosclerosis.2006.02.005; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Detrano RC, 2005, RADIOLOGY, V236, P477, DOI 10.1148/radiol.2362040513; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; EPSTEIN SE, 1988, NEW ENGL J MED, V318, P1038, DOI 10.1056/NEJM198804213181606; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Greenland P, 2003, JAMA-J AM MED ASSOC, V290, P891, DOI 10.1001/jama.290.7.891; Greenland P, 2000, CIRCULATION, V101, P723; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Greenland P, 2008, CIRCULATION, V117, P1627, DOI 10.1161/CIRCULATIONAHA.108.767665; Greenland P, 2007, CIRCULATION, V115, P402, DOI 10.1161/CIRCULATIONAHA..107.181425; Grundy, 2004, CIRCULATION, V110, P763, DOI 10.1161/01.CIR.0000140446.06098.6B; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; He ZX, 2000, CIRCULATION, V101, P244, DOI 10.1161/01.CIR.101.3.244; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Hlatky, 2009, CIRCULATION, V119, pE606, DOI 10.1161/CIRCULATIONAHA.109.192590; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Kondos GT, 2003, CIRCULATION, V107, P2571, DOI 10.1161/01.CIR.0000068341.61180.55; Lakoski SG, 2007, ARCH INTERN MED, V167, P2437, DOI 10.1001/archinte.167.22.2437; Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735; Lloyd-Jones, 2009, CIRCULATION, V119, pE182, DOI 10.1161/CIRCULATIONAHA.108.191898; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; McClelland RL, 2006, CIRCULATION, V113, P30, DOI 10.1161/CIRCULATIONAHA.105.580696; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nasir K, 2007, J AM COLL CARDIOL, V50, P953, DOI 10.1016/j.jacc.2007.03.066; *NAT HEART LUNG BL, 2007, MORB MORT 2007 CHART; O'Malley PG, 2003, JAMA-J AM MED ASSOC, V289, P2215, DOI 10.1001/jama.289.17.2215; *PREV SERV TASK FO, SCREEN COR HEART DIS; Preventive Services Task Force, GUID CLIN PREV SERV; Raggi P, 2000, CIRCULATION, V101, P850, DOI 10.1161/01.CIR.101.8.850; RUMBERGER JA, 1995, CIRCULATION, V92, P2157, DOI 10.1161/01.CIR.92.8.2157; Shareghi Shahrzad, 2007, J Cardiovasc Comput Tomogr, V1, P155, DOI 10.1016/j.jcct.2007.10.001; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Smith S C Jr, 2000, Circulation, V101, P111; Stamler J, 1999, JAMA-J AM MED ASSOC, V282, P2012, DOI 10.1001/jama.282.21.2012; Taylor AJ, 2005, J AM COLL CARDIOL, V46, P807, DOI 10.1016/j.jacc.2005.05.049; Taylor AJ, 2008, J AM COLL CARDIOL, V51, P1337, DOI 10.1016/j.jacc.2007.11.069; Vliegenthart R, 2005, CIRCULATION, V112, P572, DOI 10.1161/CIRCULATIONAHA.104.488916; Wong ND, 1996, AM J CARDIOL, V78, P1220, DOI 10.1016/S0002-9149(96)00599-1; Wong ND, 2000, AM J CARDIOL, V86, P495, DOI 10.1016/S0002-9149(00)01000-6	54	60	62	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					990	997		10.1056/NEJMcp0902177	http://dx.doi.org/10.1056/NEJMcp0902177			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19726773				2022-12-28	WOS:000269480400008
J	Vogl, U; Weitz, M				Vogl, Ulrich; Weitz, Martin			Laser cooling by collisional redistribution of radiation	NATURE			English	Article							PHOTOTHERMAL DEFLECTION SPECTROSCOPY; FLUORESCENCE; POLARITONS; SCATTERING; GASES; ATOMS; WATER	The general idea that optical radiation may cool matter was put forward 80 years ago(1). Doppler cooling of dilute atomic gases is an extremely successful application of this concept(2,3). More recently, anti-Stokes cooling in multilevel systems has been explored(4,5), culminating in the optical refrigeration of solids(6-9). Collisional redistribution of radiation has been proposed(10) as a different cooling mechanism for atomic two-level systems, although experimental investigations using moderate-density gases have not reached the cooling regime(11). Here we experimentally demonstrate laser cooling of an atomic gas based on collisional redistribution of radiation, using rubidium atoms in argon buffer gas at a pressure of 230 bar. The frequent collisions in the ultradense gas transiently shift a highly red-detuned laser beam(that is, one detuned to a much lower frequency) into resonance, whereas spontaneous decay occurs close to the unperturbed atomic resonance frequency. During each excitation cycle, kinetic energy of order k(B)T-that is, the thermal energy (k(B), Boltzmann's constant; T, temperature)-is extracted from the dense atomic sample. In a proof-of-principle experiment with a thermally non-isolated sample, we demonstrate relative cooling by 66 K. The cooled gas has a density more than ten orders of magnitude greater than the typical values used in Doppler-cooling experiments, and the cooling power reaches 87 mW. Future applications of the technique may include supercooling beyond the homogeneous nucleation temperature(12,13) and optical chillers(9).	[Vogl, Ulrich; Weitz, Martin] Univ Bonn, Inst Angew Phys, D-53115 Bonn, Germany	University of Bonn	Weitz, M (corresponding author), Univ Bonn, Inst Angew Phys, Wegelerstr 8, D-53115 Bonn, Germany.	martin.weitz@uni-bonn.de	Vogl, Ulrich/G-4624-2014	Vogl, Ulrich/0000-0003-2399-2797; Weitz, Martin/0000-0002-4236-318X	Deutsche Forschungsgemeinschaft [FOR557]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank J. Nipper for experimental contributions during the early phase of this project. Financial support from the Deutsche Forschungsgemeinschaft within the focused research unit FOR557 is acknowledged.	Adams CS, 1997, PROG QUANT ELECTRON, V21, P1, DOI 10.1016/S0079-6727(96)00006-7; BERMAN PR, 1978, OPT COMMUN, V24, P155, DOI 10.1016/0030-4018(78)90107-4; Bolkart C, 2005, LASER PHYS, V15, P3; BORN M, 1999, PRINCIPLES OPTICS, P89; Chu S, 1998, REV MOD PHYS, V70, P685, DOI 10.1103/RevModPhys.70.685; COHENTANNOUDJI C, 1992, ATOM PHOTON INTERACT, P490; Debenedetti PG, 2003, PHYS TODAY, V56, P40, DOI 10.1063/1.1595053; Deng H, 2002, SCIENCE, V298, P199, DOI 10.1126/science.1074464; DJEU N, 1981, PHYS REV LETT, V46, P236, DOI 10.1103/PhysRevLett.46.236; Eastham PR, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.235101; EPSTEIN RI, 1995, NATURE, V377, P500, DOI 10.1038/377500a0; GIACOBINO E, 1983, PHYS REV A, V28, P2555, DOI 10.1103/PhysRevA.28.2555; HANSCH TW, 1975, OPT COMMUN, V13, P68, DOI 10.1016/0030-4018(75)90159-5; HEDGES REM, 1972, PHYS REV A-GEN PHYS, V6, P1519, DOI 10.1103/PhysRevA.6.1519; Hoyt CW, 2003, J OPT SOC AM B, V20, P1066, DOI 10.1364/JOSAB.20.001066; JACKSON WB, 1981, APPL OPTICS, V20, P1333, DOI 10.1364/AO.20.001333; Koop T, 2000, NATURE, V406, P611, DOI 10.1038/35020537; PASCALE J, 1974, J CHEM PHYS, V60, P2278, DOI 10.1063/1.1681360; Pringsheim P, 1929, Z PHYS, V57, P739, DOI 10.1007/BF01340652; ROSENBAU.BM, 1966, J CHEM PHYS, V44, P2831, DOI 10.1063/1.1727141; Schuller F., 1974, Physics Reports. Physics Letters Section C, V12C, P273, DOI 10.1016/0370-1573(74)90018-0; Sheik-Bahae M, 2007, NAT PHOTONICS, V1, P693, DOI 10.1038/nphoton.2007.244; SPEAR JD, 1990, APPL OPTICS, V29, P4225, DOI 10.1364/AO.29.004225; SPELLER E, 1979, Z PHYS A-HADRON NUCL, V291, P311, DOI 10.1007/BF01408379; Thiede J, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1900951; Tournier JMP, 2008, ENERG CONVERS MANAGE, V49, P469, DOI 10.1016/j.enconman.2007.06.050; Vogl U, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.011401; WHINNERY JR, 1974, ACCOUNTS CHEM RES, V7, P225, DOI 10.1021/ar50079a003; YEH S, 1979, PHYS REV A, V19, P1106, DOI 10.1103/PhysRevA.19.1106; Zander C., 1995, ADV PHOTOCHEM, P59, DOI DOI 10.1002/9780470133514.CH2/SUMMARY	30	48	48	3	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					70	73		10.1038/nature08203	http://dx.doi.org/10.1038/nature08203			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19727195	Green Submitted			2022-12-28	WOS:000269478800031
J	Singer, DE; Chang, YC; Fang, MC; Borowsky, LH; Pomernacki, NK; Udaltsova, N; Go, AS				Singer, Daniel E.; Chang, Yuchiao; Fang, Margaret C.; Borowsky, Leila H.; Pomernacki, Niela K.; Udaltsova, Natalla; Go, Alan S.			The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation	ANNALS OF INTERNAL MEDICINE			English	Article							CLOPIDOGREL PLUS ASPIRIN; ORAL ANTICOAGULATION; VASCULAR EVENTS; RISK STRATIFICATION; STROKE PREVENTION; THERAPY; THROMBOEMBOLISM; IRBESARTAN; INTENSITY; SCHEMES	Background: Guidelines recommend warfarin use in patients with atrial fibrillation solely on the basis of risk for ischemic stroke without antithrombotic therapy. These guidelines rely on ischemic stroke rates observed in older trials and do not explicitly account for increased risk for hemorrhage. Objective: To quantify the net clinical benefit of warfarin therapy in a cohort of patients with atrial fibrillation. Design: Mixed retrospective and prospective cohort study of patients with atrial fibrillation between 1996 and 2003. Setting: An integrated health care delivery system. Patients: 13 559 adults with nonvalvular atrial fibrillation. Measurements: Warfarin exposure, patient characteristics, CHADS(2) score ( 1 point for each of congestive heart failure, hypertension, age, and diabetes and 2 points for stroke), and outcome events were ascertained from health plan records and databases. Net clinical benefit was defined as the annual rate of ischemic strokes and systemic emboli prevented by warfarin minus intracranial hemorrhages attributable to warfarin, multiplied by an impact weight. The base-case impact weight was 1.5, reflecting the greater clinical impact of intracranial hemorrhage versus thromboembolism. Results: Patients accumulated more than 66 000 person-years of follow-up. The adjusted net clinical benefit of warfarin for the cohort overall was 0.68% per year (95% CI, 0.34% to 0.87%). Adjusted net clinical benefit was greatest for patients with a history of ischemic stroke (2.48% per year [ CI, 0.75% to 4.22%]) and for those 85 years or older (2.34% per year [ CI, 1.29% to 3.30%]). The net clinical benefit of warfarin increased from essentially zero in CHADS(2) stroke risk categories 0 and 1 to 2.22% per year ( CI, 0.58% to 3.75%) in CHADS(2) categories 4 to 6. The patterns of results were preserved when weighting factors for intracranial hemorrhage of 1.0 and 2.0 were used. Limitations: Residual confounding is a possibility. Some outcome events were probably missed by the screening algorithm or when medical records were unavailable. Conclusion: Expected net clinical benefit of warfarin therapy is highest among patients with the highest untreated risk for stroke, which includes the oldest age category. Risk assessment that incorporates both risk for thromboembolism and risk for intracranial hemorrhage provides a more quantitatively informed basis for the decision on antithrombotic therapy in patients with atrial fibrillation.	[Singer, Daniel E.] Massachusetts Gen Hosp, Clin Epidemiol Unit, Boston, MA 02114 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; Kaiser Permanente No Calif, Oakland, CA 94612 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California San Francisco; Kaiser Permanente	Singer, DE (corresponding author), Massachusetts Gen Hosp, Clin Epidemiol Unit, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	dsinger@partners.org	White, Howard D/A-7034-2009; Go, Alan S./AAE-7745-2019		National Institute on Aging [R01 AG15478, K23 AG28978]; National Heart, Lung, and Blood Institute [U19 HL091179]; Massachusetts General Hospital; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U19HL091179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015478, K23AG028978] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Massachusetts General Hospital(General Electric); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging; National Heart, Lung, and Blood Institute; and Massachusetts General Hospital.; By the National Institute on Aging (R01 AG15478); the National Heart, Lung, and Blood Institute (U19 HL091179); and the Eliot B. and Edith C. Shoolman fund of the Massachusetts General Hospital. Dr. Fang's efforts were also partially supported by the National Institute on Aging (K23 AG28978).	Albers GW, 2003, LANCET, V362, P1691; Arima H, 2005, STROKE, V36, P2164, DOI 10.1161/01.STR.0000181115.59173.42; Bousser MG, 2008, LANCET, V371, P315, DOI 10.1016/S0140-6736(08)60168-3; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Efron B., 1994, MONOGRAPHS STAT APPL; Fang MC, 2008, J AM COLL CARDIOL, V51, P810, DOI 10.1016/j.jacc.2007.09.065; Fang MC, 2007, AM J MED, V120, P700, DOI 10.1016/j.amjmed.2006.07.034; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Fuster V, 2006, EUROPACE, V8, P651, DOI 10.1093/europace/eul097; Gage BF, 2004, CIRCULATION, V110, P2287, DOI 10.1161/01.CIR.0000145172.55640.93; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; HART RG, 2009, STROKE; Healey JS, 2008, STROKE, V39, P1482, DOI 10.1161/STROKEAHA.107.500199; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Korn EL., 1999, ANAL HLTH SURVEYS; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Miettinen O S, 1983, Stat Med, V2, P267, DOI 10.1002/sim.4780020222; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Stokes ME, 2000, CATEGORICAL DATA ANA; van Walraven C, 2002, JAMA-J AM MED ASSOC, V288, P2441, DOI 10.1001/jama.288.19.2441; Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8	28	496	508	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					297	U16		10.7326/0003-4819-151-5-200909010-00003	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492KB	19721017	Green Accepted			2022-12-28	WOS:000269653100001
J	Kinnamon, SC; Reynolds, SD				Kinnamon, Sue C.; Reynolds, Susan D.			Using Taste to Clear the Air(ways)	SCIENCE			English	Editorial Material							CILIARY BEAT FREQUENCY; PROTEOMIC ANALYSIS; AIRWAY; CELLS; BITTER; LACTONES		[Kinnamon, Sue C.] Univ Colorado Denver, Dept Otolaryngol, Aurora, CO 80045 USA; [Kinnamon, Sue C.] Univ Colorado Denver, Rocky Mt Taste & Smell Ctr, Aurora, CO 80045 USA; [Reynolds, Susan D.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Kinnamon, SC (corresponding author), Univ Colorado Denver, Dept Otolaryngol, 12700 E 19th Ave, Aurora, CO 80045 USA.	sue.kinnamon@ucdenver.edu						Behrens M, 2006, CELL MOL LIFE SCI, V63, P1501, DOI 10.1007/s00018-006-6113-8; Brockhoff A, 2007, J AGR FOOD CHEM, V55, P6236, DOI 10.1021/jf070503p; Delmotte P, 2006, AM J RESP CELL MOL, V35, P110, DOI 10.1165/rcmb.2005-0417OC; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Gulbransen BD, 2008, J NEUROPHYSIOL, V99, P2929, DOI 10.1152/jn.00066.2008; Hayashi T, 2005, EXP PHYSIOL, V90, P535, DOI 10.1113/expphysiol.2004.028746; Merigo F, 2005, CELL TISSUE RES, V319, P211, DOI 10.1007/s00441-004-1007-2; Merigo F, 2007, CELL TISSUE RES, V327, P231, DOI 10.1007/s00441-006-0280-7; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Salathe M, 1999, J PHYSIOL-LONDON, V520, P851, DOI 10.1111/j.1469-7793.1999.00851.x; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; SANDERSON MJ, 1989, AM REV RESPIR DIS, V139, P432, DOI 10.1164/ajrccm/139.2.432; Sbarbati A, 2006, CELLS TISSUES ORGANS, V183, P206, DOI 10.1159/000096511; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Sternini C, 2008, CURR OPIN ENDOCRINOL, V15, P73, DOI 10.1097/MED.0b013e3282f43a73	17	13	13	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1081	1082		10.1126/science.1179180	http://dx.doi.org/10.1126/science.1179180			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713515				2022-12-28	WOS:000269382300026
J	Forde, I; Zeuner, D				Forde, Ian; Zeuner, Dagmar			Financial incentives to promote social mobility	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONDITIONAL CASH TRANSFERS; COUNTRIES		[Zeuner, Dagmar] Hammersmith & Fulham NHS & Council, London W6 9DL, England			i.forde@ucl.ac.uk			Medical Research Council [G0701333] Funding Source: Medline; MRC [G0701333] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adato, 2000, IMPACT PROGRESA COMM; Adato M., 2000, IMPACT PROGRESA WOME; Attanasio O, 2005, 54 IFS BRIEF; Behrman JR, 2006, ANN AM ACAD POLIT SS, V606, P244, DOI 10.1177/0002716206288956; Boyle PJ, 2009, SOC SCI MED, V68, P1835, DOI 10.1016/j.socscimed.2009.02.051; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; Forde I, 2008, LANCET, V372, P1694, DOI 10.1016/S0140-6736(08)61695-5; *H M GOV, 2009, NEW OPP FAIR CHANC F; JONES N, 2007, SOCIAL PROTECTION IN; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Levy D., 2007, EVALUATION JAMAICAS; Maluccio J., 2004, IMPACT EVALUATION CO; Morris SS, 2004, J NUTR, V134, P2336, DOI 10.1093/jn/134.9.2336; Nigenda Gustavo, 2005, LESSONS OFFERED LATI; Palma J., 2005, ANTIPOVERTY POLICIES; Popay Jennie, 2008, BMJ, V337, pa594, DOI 10.1136/bmj.a594; Schubert B, 2006, DEV POLICY REV, V24, P571, DOI 10.1111/j.1467-7679.2006.00348.x; Skoufias E, 2005, PROGRESA ITS IMPACTS; Skoufias E., 1999, TARGETING POOR MEXIC; Soares S., 2007, CONDITIONAL CASH TRA; STECKLOV G, DEMOGRAPHIC EXTERNAL	21	7	7	1	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 25	2009	339								b3219	10.1136/bmj.b3219	http://dx.doi.org/10.1136/bmj.b3219			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489AS	19706934	Green Submitted			2022-12-28	WOS:000269392500005
J	Sin, DD; Tashkin, D; Zhang, XK; Radner, F; Sjobring, U; Thoren, A; Calverley, PMA; Rennard, SI				Sin, Don D.; Tashkin, Donald; Zhang, Xuekui; Radner, Finn; Sjobring, Ulf; Thoren, Anders; Calverley, Peter M. A.; Rennard, Stephen I.			Budesonide and the risk of pneumonia: a meta-analysis of individual patient data	LANCET			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; METERED-DOSE INHALER; FLUTICASONE PROPIONATE; SAFETY; CORTICOSTEROIDS; FORMOTEROL; EFFICACY; MODERATE; MILD; BUDESONIDE/FORMOTEROL	Background Concern is continuing about increased risk of pneumonia in patients with chronic obstructive pulmonary disease (COPD) who use inhaled corticosteroids. We aimed to establish the effects of inhaled budesonide on the risk of pneumonia in such patients. Methods We pooled patient data from seven large clinical trials of inhaled budesonide (320-1280 mu g/day), with or without formoterol, versus control regimen (placebo or formoterol alone) in patients with stable COPD and at least 6 months of follow-up. The primary analysis compared treatment groups for the risk of pneumonia as an adverse event or serious adverse event during the trial or within 15 days of the trial end. Cox proportional hazards regression was used to analyse the data on an intention-to-treat basis. Data were adjusted for patients' age, sex, smoking status, body-mass index, and postbronchodilator percent of predicted forced expiratory volume in 1 s (FEV1). Findings We analysed data from 7042 patients, of whom 3801 were on inhaled budesonide and 3241 were on control treatment, with 5212 patient-years of exposure to treatment. We recorded no significant difference between treatment groups for the occurrence of pneumonia as an adverse event (3% [n=122 patients] vs 3% [n=103]; adjusted hazard ratio 1.05, 95% CI 0.81-1.37) or a serious adverse event (1% [n=53] vs 2% [n=50]; 0.92, 0.62-1.35), or for time to pneumonia as an adverse event (log-rank test 0.94) or a serious adverse event (0.61). Increasing age and decreasing percent of predicted FEV1 were the only two variables that were significantly associated with occurrence of pneumonia as an adverse event or a serious adverse event. Interpretation Budesonide treatment for 12 months does not increase the risk of pneumonia in patients with COPD during that time and therefore is safe for clinical use in such patients.	[Sin, Don D.; Zhang, Xuekui] St Pauls Hosp, Providence Heart & Lung Inst, iCAPTURE Ctr, Vancouver, BC V6Z 1Y6, Canada; [Sin, Don D.; Zhang, Xuekui] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada; [Tashkin, Donald] Univ Calif Los Angeles, David Geffen Sch Med, Div Pulm & Crit Care Med, Los Angeles, CA 90095 USA; [Radner, Finn; Sjobring, Ulf; Thoren, Anders] AstraZeneca R&D, Lund, Sweden; [Calverley, Peter M. A.] Univ Liverpool, Sch Clin Sci, Liverpool L69 3BX, Merseyside, England; [Rennard, Stephen I.] Nebraska Med Ctr, Internal Med Sect Pulm & Crit Care, Omaha, NE USA	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; AstraZeneca; University of Liverpool; University of Nebraska System; University of Nebraska Medical Center	Sin, DD (corresponding author), St Pauls Hosp, Providence Heart & Lung Inst, iCAPTURE Ctr, 1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	dsin@mrl.ubc.ca	Sin, Don/AAC-2219-2021; Zhang, Xuekui/C-5105-2015	Zhang, Xuekui/0000-0003-4728-2343	Michael Smith Foundation for Health Research (MSFHR)	Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	We thank Steven Kesten for providing the UPLIFT study data. This study was supported by a team grant from the Michael Smith Foundation for Health Research (MSFHR) (to DDS). DDS is supported by a Canada Research Chair in COPD and a Senior Scholar Award from MSFHR. The original data were provided by AstraZeneca, but no funding was supplied by AstraZeneca.	Basi SK, 2004, AM J MED, V117, P305, DOI 10.1016/j.amjmed.2004.03.029; Bourbeau J, 1998, THORAX, V53, P477, DOI 10.1136/thx.53.6.477; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Calverley PMA, 2003, CHEST, V124, P1350, DOI 10.1378/chest.124.4.1350; Drummond MB, 2008, JAMA-J AM MED ASSOC, V300, P2407, DOI 10.1001/jama.2008.717; Ek A, 1999, ALLERGY, V54, P691, DOI 10.1034/j.1398-9995.1999.00087.x; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Esmailpour N, 2000, INT ARCH ALLERGY IMM, V122, P151, DOI 10.1159/000024371; Estborn L, 2008, DRUG SAFETY, V31, P627, DOI 10.2165/00002018-200831070-00008; Feagan BG, 2000, CAN MED ASSOC J, V162, P1415; Ferguson GT, 2008, RESP MED, V102, P1099, DOI 10.1016/j.rmed.2008.04.019; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; *GLAXOSMITHKLINE, PROT SUMM SCO100250; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Minogue MF, 1998, ANN EMERG MED, V31, P376, DOI 10.1016/S0196-0644(98)70350-6; Mortimer KJ, 2007, BRIT J CLIN PHARMACO, V64, P439, DOI 10.1111/j.1365-2125.2007.02856.x; Nannini LJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829; Pauwels RA, 2003, EUR RESPIR J, V22, P787, DOI 10.1183/09031936.03.00055803; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rennard SI, 2009, DRUGS, V69, P549, DOI 10.2165/00003495-200969050-00004; Rosell A, 2005, ARCH INTERN MED, V165, P891, DOI 10.1001/archinte.165.8.891; Sheffer AL, 2005, ANN ALLERG ASTHMA IM, V94, P48, DOI 10.1016/S1081-1206(10)61285-9; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin DP, 2008, DRUGS, V68, P1975, DOI 10.2165/00003495-200868140-00004; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Vestbo J, 1999, LANCET, V353, P1819, DOI 10.1016/S0140-6736(98)10019-3; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC	31	151	152	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					712	719		10.1016/S0140-6736(09)61250-2	http://dx.doi.org/10.1016/S0140-6736(09)61250-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716963				2022-12-28	WOS:000269422500027
J	Greenberg, ME; Lai, MH; Hartel, GF; Wichems, CH; Gittleson, C; Bennet, J; Dawson, G; Hu, W; Leggio, C; Washington, D; Basser, RL				Greenberg, Michael E.; Lai, Michael H.; Hartel, Gunter F.; Wichems, Christine H.; Gittleson, Charmaine; Bennet, Jillian; Dawson, Gail; Hu, Wilson; Leggio, Connie; Washington, Diane; Basser, Russell L.			Response to a Monovalent 2009 Influenza A (H1N1) Vaccine.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMMUNOGENICITY; VIRUS; IMMUNIZATION; ANTIBODY; SAFETY	Background: A novel 2009 influenza A (H1N1) virus is responsible for the first influenza pandemic in 41 years. A safe and effective vaccine is needed. A randomized, observer-blind, parallel-group trial evaluating two doses of an inactivated, split-virus 2009 H1N1 vaccine in healthy adults between the ages of 18 and 64 years is ongoing at a single site in Australia. Methods: We evaluated the immunogenicity and safety of the vaccine after each of two scheduled doses, administered 21 days apart. A total of 240 subjects, equally divided into two age groups (<50 years and greater/equal 50 years), were enrolled and underwent randomization to receive either 15 microg or 30 microg of hemagglutinin antigen by intramuscular injection. We measured antibody titers using hemagglutination-inhibition and microneutralization assays at baseline and 21 days after vaccination. The coprimary immunogenicity end points were the proportion of subjects with antibody titers of 1:40 or more on hemagglutination-inhibition assay, the proportion of subjects with either seroconversion or a significant increase in antibody titer, and the factor increase in the geometric mean titer. Results: By day 21 after the first dose, antibody titers of 1:40 or more were observed in 114 of 120 subjects (95.0%) who received the 15-microg dose and in 106 of 119 subjects (89.1%) who received the 30-microg dose. A similar result was observed after the second dose of vaccine. No deaths, serious adverse events, or adverse events of special interest were reported. Local discomfort (e.g., injection-site tenderness or pain) was reported by 56.3% of subjects, and systemic symptoms (e.g., headache) by 53.8% of subjects after each dose. Nearly all events were mild to moderate in intensity. Conclusions: A single 15-microg dose of 2009 H1N1 vaccine was immunogenic in adults, with mild-to-moderate vaccine-associated reactions. (ClinicalTrials.gov number, NCT00938639.) N Engl J Med 2009;361:2405-13.	[Greenberg, Michael E.; Lai, Michael H.; Hartel, Gunter F.; Wichems, Christine H.; Gittleson, Charmaine; Bennet, Jillian; Dawson, Gail; Hu, Wilson; Leggio, Connie; Washington, Diane; Basser, Russell L.] CSL, Clin Res & Dev, Parkville, Vic 3052, Australia	CSL	Greenberg, ME (corresponding author), CSL, Clin Res & Dev, 45 Poplar Rd, Parkville, Vic 3052, Australia.	michael.greenberg@csl.com.au	Greenberg, Michael E/AGZ-9651-2022; Hartel, Gunter/J-7790-2017	Hartel, Gunter/0000-0002-5454-6450; Greenberg, Michael/0000-0002-4085-4348; Lai, Michael/0000-0003-4983-7146	Department of Health and Aging of the Australian government	Department of Health and Aging of the Australian government(Australian GovernmentDepartment of Health & Ageing)	Supported by CSL with funding from the Department of Health and Aging of the Australian government.	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P341; *AUSTR GOV DEP HLT, 2009, AUSTR INFL SURV REP; *COMM PROP MED PRO, 1996, COMM PROP MED PROD P; Cox, 2009, MMWR RECOMM REP, V58, P896; Department of health and human services. Food and drug administration. Center for biologics evaluation and research, 2007, GUID IND CLIN DAT NE; Englund JA, 2006, PEDIATRICS, V118, pE579, DOI 10.1542/peds.2006-0201; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Henderson DA, 2009, BIOSECUR BIOTERROR, V7, P265, DOI 10.1089/bsp.2009.0729; Kendal AP, 1982, CONCEPTS PROCEDURES; KUEHN BM, 2009, JAMA, V302, P375; NEERGAARD L, 2009, FACTORY LOGJAM COULD; Neuzil KM, 2006, J INFECT DIS, V194, P1032, DOI 10.1086/507309; PARKMAN PD, 1977, J INFECT DIS, V136, pS722, DOI 10.1093/infdis/136.Supplement_3.S722; President's Council of Advisors on Science and Technology, 2009, REP PRES US PREP 200; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Talbot HK, 2008, VACCINE, V26, P4057, DOI 10.1016/j.vaccine.2008.05.024; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; *WHO, 2009, I00705 CDC WHO; *WHO, 2009, SUMM AV CAND VACC VI; *WHO, 2009, DG STAT FOLL M EM CO; World Health Organization, 2009, PAND H1N1 2009 UPD 6; World Health Organization, 2009, AV CAND REASS VACC V; Zimmer SM, 2009, NEW ENGL J MED, V361, P279, DOI 10.1056/NEJMra0904322	26	407	426	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2405	2413		10.1056/NEJMoa0907413	http://dx.doi.org/10.1056/NEJMoa0907413			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533CE	19745216	Bronze			2022-12-28	WOS:000272798900005
J	Yauch, RL; Dijkgraaf, GJP; Alicke, B; Januario, T; Ahn, CP; Holcomb, T; Pujara, K; Stinson, J; Callahan, CA; Tang, T; Bazan, JF; Kan, Z; Seshagiri, S; Hann, CL; Gould, SE; Low, JA; Rudin, CM; de Sauvage, FJ				Yauch, Robert L.; Dijkgraaf, Gerrit J. P.; Alicke, Bruno; Januario, Thomas; Ahn, Christina P.; Holcomb, Thomas; Pujara, Kanan; Stinson, Jeremy; Callahan, Christopher A.; Tang, Tracy; Bazan, J. Fernando; Kan, Zhengyan; Seshagiri, Somasekar; Hann, Christine L.; Gould, Stephen E.; Low, Jennifer A.; Rudin, Charles M.; de Sauvage, Frederic J.			Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; CYCLOPAMINE; CANCER	The Hedgehog (Hh) signaling pathway is inappropriately activated in certain human cancers, including medulloblastoma, an aggressive brain tumor. GDC-0449, a drug that inhibits Hh signaling by targeting the serpentine receptor Smoothened (SMO), has produced promising anti-tumor responses in early clinical studies of cancers driven by mutations in this pathway. To evaluate the mechanism of resistance in a medulloblastoma patient who had relapsed after an initial response to GDC-0449, we determined the mutational status of Hh signaling genes in the tumor after disease progression. We identified an amino acid substitution at a conserved aspartic acid residue of SMO that had no effect on Hh signaling but disrupted the ability of GDC-0449 to bind SMO and suppress this pathway. A mutation altering the same amino acid also arose in a GDC-0449-resistant mouse model of medulloblastoma. These findings show that acquired mutations in a serpentine receptor with features of a G protein-coupled receptor can serve as a mechanism of drug resistance in human cancer.	[Yauch, Robert L.; Dijkgraaf, Gerrit J. P.; Alicke, Bruno; Januario, Thomas; Ahn, Christina P.; Holcomb, Thomas; Pujara, Kanan; Stinson, Jeremy; Callahan, Christopher A.; Tang, Tracy; Bazan, J. Fernando; Kan, Zhengyan; Seshagiri, Somasekar; Gould, Stephen E.; Low, Jennifer A.; de Sauvage, Frederic J.] Genentech Inc, San Francisco, CA 94080 USA; [Hann, Christine L.; Rudin, Charles M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA	Roche Holding; Genentech; Johns Hopkins University; Johns Hopkins Medicine	de Sauvage, FJ (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	sauvage@gene.com	Bazan, J. Fernando/B-4562-2010; Rudin, Charles/R-2530-2019; de Sauvage, Frederic/ABE-8400-2020	Rudin, Charles/0000-0001-5204-3465; de Sauvage, Frederic/0000-0002-5275-2584; Seshagiri, Somasekar/0000-0003-4272-6443	Genentech [GDC-0449]; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Fu, H. Tian, Z. Zhang, K. Toy, Z. Modrusan, L. Li, S. Scales, and T. Wu for their contributions to this manuscript. Patient-informed consent was obtained for the research performed in this study. C. M. R. received research funding from Genentech for a GDC-0449 phase I trial and received a BioOncology Grant Program Award from Genentech. All authors, except C. M. R. and C. L. H., are employees of Genentech. F. J. S. holds patents related to hedgehog signaling.	Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Dellovade T, 2006, ANNU REV NEUROSCI, V29, P539, DOI 10.1146/annurev.neuro.29.051605.112858; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Goudet C., 2004, DRUG DISCOV TODAY TH, V1, P125, DOI DOI 10.1016/J.DDSTR.2004.08.017; Hyman JM, 2009, P NATL ACAD SCI USA, V106, P14132, DOI 10.1073/pnas.0907134106; Molckovsky A, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-20; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Rudin CM, 2009, NEW ENGL J MED, V361, P1173, DOI 10.1056/NEJMoa0902903; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; VONHOFF DD, 2009, NEW ENGL J MED, V164, P1164; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	16	666	710	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					572	574		10.1126/science.1179386	http://dx.doi.org/10.1126/science.1179386			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509LN	19726788	Green Accepted			2022-12-28	WOS:000271019400041
J	Snijder, B; Sacher, R; Ramo, P; Damm, EM; Liberali, P; Pelkmans, L				Snijder, Berend; Sacher, Raphael; Raemoe, Pauli; Damm, Eva-Maria; Liberali, Prisca; Pelkmans, Lucas			Population context determines cell-to-cell variability in endocytosis and virus infection	NATURE			English	Article							STOCHASTIC GENE-EXPRESSION; MEDIATED ENDOCYTOSIS; GM1 GANGLIOSIDE; SINGLE-CELL; SYSTEMS; ENTRY; KINASES	Single-cell heterogeneity in cell populations arises from a combination of intrinsic and extrinsic factors(1-3). This heterogeneity has been measured for gene transcription, phosphorylation, cell morphology and drug perturbations, and used to explain various aspects of cellular physiology(4-6). In all cases, however, the causes of heterogeneity were not studied. Here we analyse, for the first time, the heterogeneous patterns of related cellular activities, namely virus infection, endocytosis and membrane lipid composition in adherent human cells. We reveal correlations with specific cellular states that are defined by the population context of a cell, and we derive probabilistic models that can explain and predict most cellular heterogeneity of these activities, solely on the basis of each cell's population context. We find that accounting for population-determined heterogeneity is essential for interpreting differences between the activity levels of cell populations. Finally, we reveal that synergy between two molecular components, focal adhesion kinase and the sphingolipid GM1, enhances the population-determined pattern of simian virus 40 (SV40) infection. Our findings provide an explanation for the origin of heterogeneity patterns of cellular activities in adherent cell populations.	[Snijder, Berend; Sacher, Raphael; Raemoe, Pauli; Damm, Eva-Maria; Liberali, Prisca; Pelkmans, Lucas] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Snijder, Berend; Sacher, Raphael] Zurich PhD Program Mol Life Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Pelkmans, L (corresponding author), Swiss Fed Inst Technol, Swiss Fed Inst Technol, Inst Mol Syst Biol, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	pelkmans@imsb.biol.ethz.ch	Snijder, Berend/O-9206-2019; Snijder, Berend/M-2998-2017	Snijder, Berend/0000-0003-3386-6583; Liberali, Prisca/0000-0003-0695-6081; Pelkmans, Lucas/0000-0002-6754-9730	European Molecular Biology Organisation; Human Frontiers Science Program; Oncosuisse; Federation of European Biochemical Societies; ETH Zurich; SystemsX.ch; Swiss National Science Foundation; European Union	European Molecular Biology Organisation; Human Frontiers Science Program(Human Frontier Science Program); Oncosuisse; Federation of European Biochemical Societies; ETH Zurich(ETH Zurich); SystemsX.ch; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission)	We acknowledge H. Verheije and L. Burleigh for providing images of MHV and dengue virus infection, G. Jurisic for providing primary cells and help with experiments, and all members of the laboratory for comments on the manuscript. P. R. is supported by the European Molecular Biology Organisation and the Human Frontiers Science Program, E.- M. D. by Oncosuisse and P. L. by the Federation of European Biochemical Societies. L. P. is supported by the ETH Zurich, SystemsX.ch, the Swiss National Science Foundation and the European Union.	Ben-Jacob E, 1998, ANNU REV MICROBIOL, V52, P779, DOI 10.1146/annurev.micro.52.1.779; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CASTOR LN, 1970, J CELL PHYSIOL, V75, P57, DOI 10.1002/jcp.1040750107; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Eifart P, 2007, J VIROL, V81, P10758, DOI 10.1128/JVI.00725-07; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; HOLMGREN J, 1973, INFECT IMMUN, V8, P208, DOI 10.1128/IAI.8.2.208-214.1973; Iwabuchi K, 2000, J BIOL CHEM, V275, P15174, DOI 10.1074/jbc.275.20.15174; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Liberali P, 2008, ANNU REV CELL DEV BI, V24, P501, DOI 10.1146/annurev.cellbio.041008.145637; Lopez S, 2004, TRENDS MICROBIOL, V12, P271, DOI 10.1016/j.tim.2004.04.003; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Neu U, 2008, P NATL ACAD SCI USA, V105, P5219, DOI 10.1073/pnas.0710301105; Neumann AK, 2008, J CELL SCI, V121, P634, DOI 10.1242/jcs.022418; Newman JRS, 2006, NATURE, V444, P561, DOI 10.1038/nature05407; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Pelkmans L, 2005, BBA-MOL CELL RES, V1746, P295, DOI 10.1016/j.bbamcr.2005.06.009; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Sacher R, 2008, CURR OPIN CELL BIOL, V20, P483, DOI 10.1016/j.ceb.2008.06.002; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Slacka MD, 2008, P NATL ACAD SCI USA, V105, P19306, DOI 10.1073/pnas.0807038105; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509	29	297	300	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					520	523		10.1038/nature08282	http://dx.doi.org/10.1038/nature08282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19710653				2022-12-28	WOS:000270082900039
J	Ramnarace, R; Ricketts, J; Dalton, H				Ramnarace, Rene; Ricketts, James; Dalton, Harry			Case Report Persistent diarrhoea in a young woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ALOSETRON; WOMEN		[Ramnarace, Rene; Ricketts, James; Dalton, Harry] Royal Cornwall Hosp, Div Gastroenterol, Dept Med, Truro TR1 3LJ, Cornwall, England	Royal Cornwall Hospital	Ramnarace, R (corresponding author), Royal Cornwall Hosp, Div Gastroenterol, Dept Med, Truro TR1 3LJ, Cornwall, England.	rene_ramnarace@yahoo.co.uk		Dalton, Harry/0000-0001-7786-5457				Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; Chey WD, 2004, AM J GASTROENTEROL, V99, P2195, DOI 10.1111/j.1572-0241.2004.30509.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Gershon MD, 2005, J CLIN GASTROENTEROL, V39, pS184, DOI 10.1097/01.mcg.0000156403.37240.30; Johanson JF, 2004, CLIN GASTROENTEROL H, V2, P796, DOI 10.1016/S1542-3565(04)00356-8; Jones R, 2000, GUT, V46, P7, DOI 10.1136/gut.46.1.7; Lembo T, 2001, AM J GASTROENTEROL, V96, P2662; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; MANNING AP, 1978, BRIT MED J, V2, P653, DOI 10.1136/bmj.2.6138.653; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V61; Orr KK, 2006, FORMULARY, V41, P118; Sanders DS, 2003, EUR J GASTROEN HEPAT, V15, P407, DOI 10.1097/00042737-200304000-00012; 2009, AM J GASTROENTERO S1, V104, pS1	14	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2009	339								b3369	10.1136/bmj.b3369	http://dx.doi.org/10.1136/bmj.b3369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RT	19759088				2022-12-28	WOS:000269994800009
J	Ferguson, ND				Ferguson, Niall D.			Low-dose corticosteroids improve outcomes in acute lung injury and the acute respiratory distress syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ferguson, Niall D.] Mt Sinai Hosp, Univ Hlth Network, Toronto, ON M5G 1X5, Canada; [Ferguson, Niall D.] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto; University of Toronto	Ferguson, ND (corresponding author), Mt Sinai Hosp, Univ Hlth Network, Toronto, ON M5G 1X5, Canada.		Ferguson, Niall/D-7619-2019	Ferguson, Niall/0000-0002-6213-5264				Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203	1	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6							JC3-12	10.7326/0003-4819-151-6-200909150-02012	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755358				2022-12-28	WOS:000270390100028
J	Jones, DA; MacKellar, C				Jones, David A.; MacKellar, Callum			Consent for biobank tissue in somatic-cell nuclear transfer	LANCET			English	Editorial Material									[Jones, David A.] St Marys Univ Coll, Ctr Bioeth & Emerging Technol, Twickenham TW1 4SX, Middx, England; [MacKellar, Callum] Scottish Council Human Bioeth, Edinburgh, Midlothian, Scotland		Jones, DA (corresponding author), St Marys Univ Coll, Ctr Bioeth & Emerging Technol, Twickenham TW1 4SX, Middx, England.	jonesd@smuc.ac.uk						Barbour V, 2003, LANCET, V361, P1734, DOI 10.1016/S0140-6736(03)13377-6; European Commission, 2007, ETH ISS EU RES PROP; *GEN SCOTL, SAMPL INF CONF FAQS; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Jones DA, 2009, J MED ETHICS, V35, P168, DOI 10.1136/jme.2008.026336; *NIH, 2009, NAT I HLTH GUID HUM; *OFF PUBL SECT INF, HUM FERT EMBR ACT 20; Redfern Michael, 2001, ROYAL LIVERPOOL CHIL; Salvaterra E, 2008, EMBO REP, V9, P307, DOI 10.1038/embor.2008.41; *UK BIOB, UK BIOB WHAT IS IT	10	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 12	2009	374	9693					861	863		10.1016/S0140-6736(09)61609-3	http://dx.doi.org/10.1016/S0140-6736(09)61609-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19748385	Green Accepted			2022-12-28	WOS:000269943100009
J	Gabor, NM; Zhong, ZH; Bosnick, K; Park, J; McEuen, PL				Gabor, Nathaniel M.; Zhong, Zhaohui; Bosnick, Ken; Park, Jiwoong; McEuen, Paul L.			Extremely Efficient Multiple Electron-Hole Pair Generation in Carbon Nanotube Photodiodes	SCIENCE			English	Article							SILICON NANOWIRES; SOLAR-CELLS; EMISSION; EXCITONS	We observed highly efficient generation of electron-hole pairs due to impact excitation in single-walled carbon nanotube p-n junction photodiodes. Optical excitation into the second electronic subband E-22 leads to striking photocurrent steps in the device I-V-SD characteristics that occur at voltage intervals of the band-gap energy E-GAP/e. Spatially and spectrally resolved photocurrent combined with temperature-dependent studies suggest that these steps result from efficient generation of multiple electron-hole pairs from a single hot E-22 carrier. This process is both of fundamental interest and relevant for applications in future ultra-efficient photovoltaic devices.	[Gabor, Nathaniel M.; McEuen, Paul L.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Zhong, Zhaohui; McEuen, Paul L.] Cornell Univ, Ctr Nanoscale Syst, Ithaca, NY 14853 USA; [Park, Jiwoong] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14853 USA; [Bosnick, Ken] Natl Res Council Canada, Natl Inst Nanotechnol, Edmonton, AB T6G 2M9, Canada	Cornell University; Cornell University; Cornell University; National Research Council Canada	Gabor, NM (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	nmg32@cornell.edu	Park, Jiwoong/C-2327-2013	Gabor, Nathaniel/0000-0002-0351-2787; Bosnick, Kenneth/0000-0002-4928-0264	NSF through the Center for Nanoscale Systems; Microelectronics Advanced Research Corporation Focused Research Center on Materials, Structures, and Devices	NSF through the Center for Nanoscale Systems; Microelectronics Advanced Research Corporation Focused Research Center on Materials, Structures, and Devices	We thank R. Ilic and J. Kinder for useful discussions. This work was supported by the NSF through the Center for Nanoscale Systems and by the Microelectronics Advanced Research Corporation Focused Research Center on Materials, Structures, and Devices. Sample fabrication was performed at the Cornell Nanoscale Science and Technology Facility, a National Nanotechnology Infrastructure Network node, funded by NSF.	Avouris P, 2007, NAT NANOTECHNOL, V2, P605, DOI 10.1038/nnano.2007.300; Bosnick K, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2360895; Chen J, 2005, SCIENCE, V310, P1171, DOI 10.1126/science.1119177; Ellingson RJ, 2005, NANO LETT, V5, P865, DOI 10.1021/nl0502672; Hayden O, 2006, NAT MATER, V5, P352, DOI 10.1038/nmat1635; KIM J, 2008, APPL PHYS LETT, V92; Lee JU, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2010598; Lee JU, 2004, APPL PHYS LETT, V85, P145, DOI 10.1063/1.1769595; Liao A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.256804; Manzoni C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.207401; Marty L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.136803; Misewich JA, 2003, SCIENCE, V300, P783, DOI 10.1126/science.1081294; Park JY, 2004, NANO LETT, V4, P517, DOI 10.1021/nl035258c; Perebeinos V, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.121410; Pop E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.155505; Saito R, 1998, PHYS PROPERTIES CARB; Schaller RD, 2005, NAT PHYS, V1, P189, DOI 10.1038/nphys151; Schaller RD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.186601; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Sze S., 1981, PHYS SEMICONDUCTOR D, V2nd ed., P85; Tian BZ, 2007, NATURE, V449, P885, DOI 10.1038/nature06181; Yang C, 2006, NANO LETT, V6, P2929, DOI 10.1021/nl062314b; Yao Z, 2000, PHYS REV LETT, V84, P2941, DOI 10.1103/PhysRevLett.84.2941	23	379	389	2	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1367	1371		10.1126/science.1176112	http://dx.doi.org/10.1126/science.1176112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745146				2022-12-28	WOS:000269699100031
J	Chung, A; Goel, A				Chung, Augustine; Goel, Amitabh			De Garengeot's Hernia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chung, Augustine; Goel, Amitabh] Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University	Chung, A (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	amitabh.goel@uhhospitals.org							0	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					E18	E18		10.1056/NEJMicm0802611	http://dx.doi.org/10.1056/NEJMicm0802611			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19741225				2022-12-28	WOS:000269659400014
J	Sharon, I; Alperovitch, A; Rohwer, F; Haynes, M; Glaser, F; Atamna-Ismaeel, N; Pinter, RY; Partensky, F; Koonin, EV; Wolf, YI; Nelson, N; Beja, O				Sharon, Itai; Alperovitch, Ariella; Rohwer, Forest; Haynes, Matthew; Glaser, Fabian; Atamna-Ismaeel, Nof; Pinter, Ron Y.; Partensky, Frederic; Koonin, Eugene V.; Wolf, Yuri I.; Nelson, Nathan; Beja, Oded			Photosystem I gene cassettes are present in marine virus genomes	NATURE			English	Article							CYANOBACTERIUM SYNECHOCYSTIS SP; PHOTOSYNTHESIS GENES; TARGETED INACTIVATION; ELECTRON FLOW; PROCHLOROCOCCUS; ORGANIZATION; PROKARYOTE	Cyanobacteria of the Synechococcus and Prochlorococcus genera are important contributors to photosynthetic productivity in the open oceans(1-3). Recently, core photosystem II (PSII) genes were identified in cyanophages and proposed to function in photosynthesis and in increasing viral fitness by supplementing the host production of these proteins(4-7). Here we show evidence for the presence of photosystem I (PSI) genes in the genomes of viruses that infect these marine cyanobacteria, using pre-existing meta-genomic data from the global ocean sampling expedition(8) as well as from viral biomes(9). The seven cyanobacterial core PSI genes identified in this study, psaA, B, C, D, E, K and a unique J and F fusion, form a cluster in cyanophage genomes, suggestive of selection for a distinct function in the virus life cycle. The existence of this PSI cluster was confirmed with overlapping and long polymerase chain reaction on environmental DNA from the Northern Line Islands. Potentially, the seven proteins encoded by the viral genes are sufficient to form an intact monomeric PSI complex. Projection of viral predicted peptides on the cyanobacterial PSI crystal structure(10) suggested that the viral-PSI components might provide a unique way of funnelling reducing power from respiratory and other electron transfer chains to the PSI.	[Sharon, Itai; Alperovitch, Ariella; Atamna-Ismaeel, Nof; Beja, Oded] Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel; [Sharon, Itai; Pinter, Ron Y.] Technion Israel Inst Technol, Fac Comp Sci, IL-32000 Haifa, Israel; [Glaser, Fabian] Technion Israel Inst Technol, Bioinformat Knowledge Unit, Lorry I Lokey Interdisciplinary Ctr Life Sci & En, IL-32000 Haifa, Israel; [Rohwer, Forest; Haynes, Matthew] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Rohwer, Forest] San Diego State Univ, Ctr Microbial Sci, San Diego, CA 92182 USA; [Partensky, Frederic] CNRS, F-29682 Roscoff, France; [Partensky, Frederic] UPMC, Biol Stn, UMR 7144, F-29682 Roscoff, France; [Koonin, Eugene V.; Wolf, Yuri I.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Nelson, Nathan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, Daniella Rich Inst Struct Biol, IL-69978 Tel Aviv, Israel	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Technion Israel Institute of Technology; California State University System; San Diego State University; California State University System; San Diego State University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Tel Aviv University	Beja, O (corresponding author), Technion Israel Inst Technol, Fac Biol, IL-32000 Haifa, Israel.	beja@tx.technion.ac.il	Sharon, Itai/M-4472-2019; Rohwer, Forest/AAC-5315-2019; Partensky, Frédéric/B-9194-2018; Partensky, Frédéric/AAH-1170-2021	Sharon, Itai/0000-0003-0705-2316; Partensky, Frédéric/0000-0003-1274-4050; Partensky, Frédéric/0000-0003-1274-4050; Rohwer, Forest/0000-0003-1548-5429; Nelson, Nathan/0000-0003-3588-7265; Wolf, Yuri/0000-0002-0247-8708	Israel Science Foundation [1203/06, 356/06]; Henry Taub Award for Academic Excellence; Technion V. P. R. Fund-Henri Gutwirth Promotion of Research Fund	Israel Science Foundation(Israel Science Foundation); Henry Taub Award for Academic Excellence; Technion V. P. R. Fund-Henri Gutwirth Promotion of Research Fund	We would like to thank M. Rosenberg for technical support, D. Rusch, J. Zehr and S. Bench for sharing genomic data, D. Lindell and R. Sorek for encouragement and discussions, and U. Pick for the comments on cyclic photosynthesis. This work was supported in part by grants 1203/06 ( O. B.) and 356/06 ( N. N.) from the Israel Science Foundation, by the Henry Taub Award for Academic Excellence, and by the Technion V. P. R. Fund-Henri Gutwirth Promotion of Research Fund ( O. B.).	Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; BOEKEMA EJ, 1987, FEBS LETT, V217, P283, DOI 10.1016/0014-5793(87)80679-8; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Dammeyer T, 2008, CURR BIOL, V18, P442, DOI 10.1016/j.cub.2008.02.067; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dinsdale EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001584; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kerfeld CA, 1998, ANNU REV PLANT PHYS, V49, P397, DOI 10.1146/annurev.arplant.49.1.397; Kouril R, 2005, PHOTOCH PHOTOBIO SCI, V4, P1091, DOI 10.1039/b505519a; LI WKW, 1993, MAR ECOL PROG SER, V102, P79, DOI 10.3354/meps102079; Lindell D, 2005, NATURE, V438, P86, DOI 10.1038/nature04111; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Liu HB, 1997, AQUAT MICROB ECOL, V12, P39, DOI 10.3354/ame012039; Mann NH, 2003, NATURE, V424, P741, DOI 10.1038/424741a; Merchant S, 2005, PLANT CELL, V17, P648, DOI 10.1105/tpc.105.030676; Millard A, 2004, P NATL ACAD SCI USA, V101, P11007, DOI 10.1073/pnas.0401478101; Naithani S, 2000, PHOTOSYNTH RES, V63, P225, DOI 10.1023/A:1006463932538; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Partensky F, 1997, PHOTOSYNTH RES, V51, P209, DOI 10.1023/A:1005807408161; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Rumeau D, 2007, PLANT CELL ENVIRON, V30, P1041, DOI 10.1111/j.1365-3040.2007.01675.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sharon I, 2007, ISME J, V1, P492, DOI 10.1038/ismej.2007.67; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; XU Q, 1995, J BIOL CHEM, V270, P16243, DOI 10.1074/jbc.270.27.16243	30	145	158	1	70	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					258	262		10.1038/nature08284	http://dx.doi.org/10.1038/nature08284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19710652	Green Accepted			2022-12-28	WOS:000269654600043
J	D'Avolio, LW				D'Avolio, Leonard W.			Electronic Medical Records at a Crossroads Impetus for Change or Missed Opportunity?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE-SYSTEM; QUALITY-OF-CARE		[D'Avolio, Leonard W.] Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Cooperat Studies Program Coordinating Ctr, Jamaica Plain, MA 02130 USA; [D'Avolio, Leonard W.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital	D'Avolio, LW (corresponding author), Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr 15, 150 S Huntington Ave, Jamaica Plain, MA 02130 USA.	leonard.davolio@va.gov						Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; *CTR MED MED SERV, 2005, MED PAY FOR PERF P4P; Jha AK, 2003, NEW ENGL J MED, V348, P2218, DOI 10.1056/NEJMsa021899; Kerr EA, 2004, ANN INTERN MED, V141, P272, DOI 10.7326/0003-4819-141-4-200408170-00007; Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483; US Department of Health and Human Services Office of Disease Prevention and Health Promotion, HLTH PEOPL	6	19	21	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1109	1111		10.1001/jama.2009.1319	http://dx.doi.org/10.1001/jama.2009.1319			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738097				2022-12-28	WOS:000269616200031
J	Westert, GP; Burgers, JS; Verkleij, H				Westert, Gert P.; Burgers, Jako S.; Verkleij, Harry			Looking to Europe The Netherlands: regulated competition behind the dykes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGED-COMPETITION; HEALTH		[Westert, Gert P.] Tilburg Univ, NL-5000 LE Tilburg, Netherlands; [Burgers, Jako S.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare, Nijmegen, Netherlands; [Westert, Gert P.; Verkleij, Harry] Natl Inst Publ Hlth & Environm RIVM, NL-3720 BA Bilthoven, Netherlands	Tilburg University; Radboud University Nijmegen; Netherlands National Institute for Public Health & the Environment	Westert, GP (corresponding author), Tilburg Univ, POB 90153, NL-5000 LE Tilburg, Netherlands.	gert.westert@rivm.nl	Westert, G.P./H-8115-2014	Westert, G.P./0000-0003-3744-8207				*CENTR KLANT ZORG, CQ IND ZORG ZORG 200; DEKKER W, 1987, BEREIDHEID VERNADERI; Enthoven AC, 2007, NEW ENGL J MED, V357, P2421, DOI 10.1056/NEJMp078199; Leu R. E., 2009, SWISS DUTCH HLTH INS; Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129; *OECD, 2007, HLTH GLANC OECD IND; Okma KGH, 2008, J HEALTH POLIT POLIC, V33, P1057, DOI 10.1215/03616878-2008-036; Schoen C, 2007, HEALTH AFFAIR, V26, pW717, DOI 10.1377/hlthaff.26.6.w717; Seddon N, 2008, LANCET, V372, P103, DOI 10.1016/S0140-6736(08)61016-8; van de Ven WPMM, 2009, HEALTH ECON, V18, P253, DOI 10.1002/hec.1446; WESTERT GP, DUTCH HLTH CARE PERF; WESTERT GP, 2005, MORBIDITY PERFORMANC; Westert GP, 2006, DUTCH HLTH CARE PERF; *WHO, 2007, WHO MORT DAT	14	14	14	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2009	339								b3397	10.1136/bmj.b3397	http://dx.doi.org/10.1136/bmj.b3397			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	493RB	19736283	Green Submitted			2022-12-28	WOS:000269754500003
J	Ogundare, O; Jumma, O; Turnbull, DM; Woywodt, A				Ogundare, Olumide; Jumma, Odai; Turnbull, Douglass M.; Woywodt, Alexander			Searching for the needle in the Haystacks	LANCET			English	Editorial Material							ACYL-COA DEHYDROGENASE; DEFICIENCY; DISEASE		[Woywodt, Alexander] Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Renal Unit, Preston PR2 9HT, Lancs, England; [Jumma, Odai] Lancashire Teaching Hosp NHS Fdn Trust, Dept Neurol, Preston PR2 9HT, Lancs, England; [Turnbull, Douglass M.] Univ Newcastle, Mitochondrial Res Grp, Newcastle Upon Tyne, Tyne & Wear, England	Royal Preston Hospital; Newcastle University - UK	Woywodt, A (corresponding author), Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Renal Unit, Sharoe Green Lane, Preston PR2 9HT, Lancs, England.	alex.woywodt@lthtr.nhs.uk	Woywodt, Alexander/ABD-2711-2020	Woywodt, Alexander/0000-0002-3825-6955	Medical Research Council [G0800674] Funding Source: Medline; Wellcome Trust [074454] Funding Source: Medline; Medical Research Council [G0601943B] Funding Source: researchfish; MRC [G0800674] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; OGILVIE I, 1994, NEUROLOGY, V44, P467, DOI 10.1212/WNL.44.3_Part_1.467; WAINWRIGHT A, 2007, 12 FAVOURITE MOUNTAI, P153	5	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					850	850		10.1016/S0140-6736(09)61032-1	http://dx.doi.org/10.1016/S0140-6736(09)61032-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492QU	19733782				2022-12-28	WOS:000269675000033
J	Pizzorusso, T				Pizzorusso, Tommaso			Erasing Fear Memories	SCIENCE			English	Editorial Material							VISUAL-CORTEX; EXTINCTION; PLASTICITY		[Pizzorusso, Tommaso] CNR, Ist Neurosci, I-56100 Pisa, Italy; [Pizzorusso, Tommaso] Univ Florence, Dip Psicol, I-50135 Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Florence	Pizzorusso, T (corresponding author), CNR, Ist Neurosci, Via Moruzzi 1, I-56100 Pisa, Italy.	tommaso.pizzorusso@in.cnr.it	Pizzorusso, Tommaso/D-1399-2013	Pizzorusso, Tommaso/0000-0001-5614-0668				Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Gogolla N, 2009, SCIENCE, V325, P1258, DOI 10.1126/science.1174146; Huang ZJ, 2008, NEURON, V59, P355, DOI 10.1016/j.neuron.2008.07.029; Kim JH, 2008, J NEUROSCI, V28, P1282, DOI 10.1523/JNEUROSCI.4736-07.2008; Myers KM, 2002, NEURON, V36, P567, DOI 10.1016/S0896-6273(02)01064-4; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699	7	15	15	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1214	1215		10.1126/science.1179697	http://dx.doi.org/10.1126/science.1179697			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490RY	19729646				2022-12-28	WOS:000269523200026
J	Topal, J; Gergely, G; Erdohegyi, A; Csibra, G; Miklosi, A				Topal, Jozsef; Gergely, Gyoergy; Erdohegyi, Agnes; Csibra, Gergely; Miklosi, Adam			Differential Sensitivity to Human Communication in Dogs, Wolves, and Human Infants	SCIENCE			English	Article							CANIS-FAMILIARIS; SOCIAL COGNITION; REARED WOLVES; TASK; ATTENTION; CHOICE; LUPUS; LOGIC; FOOD	Ten-month-old infants persistently search for a hidden object at its initial hiding place even after observing it being hidden at another location. Recent evidence suggests that communicative cues from the experimenter contribute to the emergence of this perseverative search error. We replicated these results with dogs (Canis familiaris), who also commit more search errors in ostensive-communicative (in 75% of the total trials) than in noncommunicative (39%) or nonsocial (17%) hiding contexts. However, comparative investigations suggest that communicative signals serve different functions for dogs and infants, whereas human-reared wolves (Canis lupus) do not show doglike context-dependent differences of search errors. We propose that shared sensitivity to human communicative signals stems from convergent social evolution of the Homo and the Canis genera.	[Topal, Jozsef] Hungarian Acad Sci, Res Inst Psychol, H-1132 Budapest, Hungary; [Gergely, Gyoergy; Csibra, Gergely] Cent European Univ, Dept Philosophy, H-1051 Budapest, Hungary; [Erdohegyi, Agnes; Miklosi, Adam] Eotvos Lorand Univ, Dept Ethol, H-1117 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Central European University; Eotvos Lorand University	Topal, J (corresponding author), Hungarian Acad Sci, Res Inst Psychol, H-1132 Budapest, Hungary.	topaljozsef@gmail.com	Csibra, Gergely/C-4345-2008; Miklosi, Adam/N-5147-2017	Csibra, Gergely/0000-0002-7044-3056; Gergely, Gyorgy/0000-0002-2094-4258; Miklosi, Adam/0000-0003-4831-8985	Orszagos Tudomanyos Kutatasi Alap [T049615]; Bolyai Foundation of the Hungarian Academy of Sciences; MRC [G9715587] Funding Source: UKRI; Medical Research Council [G9715587] Funding Source: researchfish	Orszagos Tudomanyos Kutatasi Alap(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Bolyai Foundation of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Z. Sumegi, B. Belenyi, D. Ujvary, M. Toth, and A. Kovacs for their assistance in data collection. Funded by the Orszagos Tudomanyos Kutatasi Alap (grant T049615) and the Bolyai Foundation of the Hungarian Academy of Sciences.	Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; Erdohegyi A, 2007, ANIM BEHAV, V74, P725, DOI 10.1016/j.anbehav.2007.03.004; Gacsi M, 2005, DEV PSYCHOBIOL, V47, P111, DOI 10.1002/dev.20082; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Gergely G, 2007, DEVELOPMENTAL SCI, V10, P139, DOI 10.1111/j.1467-7687.2007.00576.x; Grossmann T, 2008, P ROY SOC B-BIOL SCI, V275, P2803, DOI 10.1098/rspb.2008.0986; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Miklosi A, 2003, CURR BIOL, V13, P763, DOI 10.1016/S0960-9822(03)00263-X; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Moll H, 2008, INFANCY, V13, P90, DOI 10.1080/15250000701779402; Pongracz P, 2004, J COMP PSYCHOL, V118, P375, DOI 10.1037/0735-7036.118.4.375; Prato-Previde E, 2008, ANIM COGN, V11, P167, DOI 10.1007/s10071-007-0102-7; Riedel J, 2008, ANIM BEHAV, V75, P1003, DOI 10.1016/j.anbehav.2007.08.010; Senju A, 2008, CURR BIOL, V18, P668, DOI 10.1016/j.cub.2008.03.059; Smith LB, 1999, PSYCHOL REV, V106, P235, DOI 10.1037/0033-295X.106.2.235; Tomasello M, 2003, DEV PSYCHOL, V39, P906, DOI 10.1037/0012-1649.39.5.906; Tomasello M, 2008, JEAN NICOD LECT, P1; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Topal J, 2009, ADV STUD BEHAV, V39, P71, DOI 10.1016/S0065-3454(09)39003-8; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Viranyi Z, 2008, ANIM COGN, V11, P373, DOI 10.1007/s10071-007-0127-y; Warneken F, 2007, INFANCY, V11, P271, DOI 10.1111/j.1532-7078.2007.tb00227.x; Watson JS, 2001, J COMP PSYCHOL, V115, P219, DOI 10.1037//0735-7036.115.3.219; WELLMAN HM, 1986, MONOGRAPH SOC RES CH, V51, P214; Yoon JMD, 2008, P NATL ACAD SCI USA, V105, P13690, DOI 10.1073/pnas.0804388105	28	183	182	2	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1269	1272		10.1126/science.1176960	http://dx.doi.org/10.1126/science.1176960			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490RY	19729660				2022-12-28	WOS:000269523200044
J	Ward, BB; Devol, AH; Rich, JJ; Chang, BX; Bulow, SE; Naik, H; Pratihary, A; Jayakumar, A				Ward, B. B.; Devol, A. H.; Rich, J. J.; Chang, B. X.; Bulow, S. E.; Naik, Hema; Pratihary, Anil; Jayakumar, A.			Denitrification as the dominant nitrogen loss process in the Arabian Sea	NATURE			English	Article							ANAEROBIC AMMONIUM OXIDATION; WATER COLUMN; ANAMMOX; BACTERIA; OXIDE; N-2; NIRS	Primary production in over half of the world's oceans is limited by fixed nitrogen availability. The main loss term from the fixed nitrogen inventory is the production of dinitrogen gas (N-2) by heterotrophic denitrification or the more recently discovered autotrophic process, anaerobic ammonia oxidation (anammox). Oceanic oxygen minimum zones (OMZ) are responsible for about 35% of oceanic N-2 production and up to half of that occurs in the Arabian Sea(1). Although denitrification was long thought to be the only loss term, it has recently been argued that anammox alone is responsible for fixed nitrogen loss in the OMZs(2-4). Here we measure denitrification and anammox rates and quantify the abundance of denitrifying and anammox bacteria in the OMZ regions of the Eastern Tropical South Pacific and the Arabian Sea. We find that denitrification rather than anammox dominates the N-2 loss term in the Arabian Sea, the largest and most intense OMZ in the world ocean. In seven of eight experiments in the Arabian Sea denitrification is responsible for 87-99% of the total N-2 production. The dominance of denitrification is reproducible using two independent isotope incubation methods. In contrast, anammox is dominant in the Eastern Tropical South Pacific OMZ, as detected using one of the isotope incubation methods, as previously reported(3,5). The abundance of denitrifying bacteria always exceeded that of anammox bacteria by up to 7- and 19-fold in the Eastern Tropical South Pacific and Arabian Sea, respectively. Geographic and temporal variability in carbon supply may be responsible for the different contributions of denitrification and anammox in these two OMZs. The large contribution of denitrification to N-2 loss in the Arabian Sea indicates the global significance of denitrification to the oceanic nitrogen budget.	[Ward, B. B.; Bulow, S. E.; Jayakumar, A.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Devol, A. H.; Chang, B. X.] Univ Washington, Dept Oceanog, Seattle, WA 98195 USA; [Rich, J. J.] Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA; [Naik, Hema; Pratihary, Anil] Natl Inst Oceanog, Panaji 403004, Goa, India	Princeton University; University of Washington; University of Washington Seattle; Brown University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Institute of Oceanography (NIO)	Ward, BB (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	bbw@princeton.edu	黄, 宝同/E-6579-2010; Newell, Silvia E/M-4336-2014; Jayakumar, Amal/AAM-1748-2020	Newell, Silvia E/0000-0002-0684-3100; Jayakumar, Amal/0000-0002-3568-1403	NSF	NSF(National Science Foundation (NSF))	W. Naqvi helped make it possible to schedule the RV Roger Revelle to work in the Arabian Sea in 2007. We thank the master and crews of the RV Knorr and RV Roger Revelle, and J. Moffett who was chief scientist on the Knorr. This work was supported by NSF grants to B. B. W., A. H. D. and A. J.	Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; CASTROGONZALEZ M, 2005, ENVIRON MICROBIOL, DOI DOI 10.1111/J.1462-2920; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; Dalsgaard T, 2005, RES MICROBIOL, V156, P457, DOI 10.1016/j.resmic.2005.01.011; Devol AH, 2006, DEEP-SEA RES PT I, V53, P1533, DOI 10.1016/j.dsr.2006.07.005; Ducklow HW, 2001, DEEP-SEA RES PT II, V48, P1303, DOI 10.1016/S0967-0645(00)00140-5; Emerson S, 1999, MAR CHEM, V64, P337, DOI 10.1016/S0304-4203(98)00090-5; Farias L, 2009, LIMNOL OCEANOGR, V54, P132, DOI 10.4319/lo.2009.54.1.0132; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Jayakumar A, 2009, MICROB ECOL, V58, P350, DOI 10.1007/s00248-009-9487-y; JAYAKUMAR A, GEOPHYS MON IN PRESS; Jayakumar DA, 2004, AQUAT MICROB ECOL, V34, P69, DOI 10.3354/ame034069; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Nicholls JC, 2007, LIMNOL OCEANOGR, V52, P156, DOI 10.4319/lo.2007.52.1.0156; NIELSEN LP, 1992, FEMS MICROBIOL ECOL, V86, P357, DOI 10.1016/0378-1097(92)90800-4; Schmid M, 2003, SYST APPL MICROBIOL, V26, P529, DOI 10.1078/072320203770865837; Schmid MC, 2007, ENVIRON MICROBIOL, V9, P1476, DOI 10.1111/j.1462-2920.2007.01266.x; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Ward BB, 2005, AQUAT MICROB ECOL, V38, P295, DOI 10.3354/ame038295; Ward BB, 2008, DEEP-SEA RES PT I, V55, P1672, DOI 10.1016/j.dsr.2008.07.005; Woebken D, 2008, ENVIRON MICROBIOL, V10, P3106, DOI 10.1111/j.1462-2920.2008.01640.x; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	27	360	386	7	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					78	U77		10.1038/nature08276	http://dx.doi.org/10.1038/nature08276			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19727197				2022-12-28	WOS:000269478800033
J	Oppo, DW; Rosenthal, Y; Linsley, BK				Oppo, Delia W.; Rosenthal, Yair; Linsley, Braddock K.			2,000-year-long temperature and hydrology reconstructions from the Indo-Pacific warm pool	NATURE			English	Article							INTERTROPICAL CONVERGENCE ZONE; SURFACE-TEMPERATURE; CLIMATE; MONSOON; OCEAN	Northern Hemisphere surface temperature reconstructions suggest that the late twentieth century was warmer than any other time during the past 500 years and possibly any time during the past 1,300 years (refs 1, 2). These temperature reconstructions are based largely on terrestrial records from extra-tropical or high-elevation sites; however, global average surface temperature changes closely follow those of the global tropics(3), which are 75% ocean. In particular, the tropical Indo-Pacific warm pool (IPWP) represents a major heat reservoir that both influences global atmospheric circulation(4) and responds to remote northern high-latitude forcings(5,6). Here we present a decadally resolved continuous sea surface temperature (SST) reconstruction from the IPWP that spans the past two millennia and overlaps the instrumental record, enabling both a direct comparison of proxy data to the instrumental record and an evaluation of past changes in the context of twentieth century trends. Our record from the Makassar Strait, Indonesia, exhibits trends that are similar to a recent Northern Hemisphere temperature reconstruction(2). Reconstructed SST was, however, within error of modern values from about AD 1000 to AD 1250, towards the end of the Medieval Warm Period. SSTs during the Little Ice Age ( approximately AD 1550-1850) were variable, and similar to 0.5 to 1 degrees C colder than modern values during the coldest intervals. A companion reconstruction of delta O-18 of sea water-a sea surface salinity and hydrology indicator-indicates a tight coupling with the East Asian monsoon system and remote control of IPWP hydrology on centennial-millennial timescales, rather than a dominant influence from local SST variation.	[Oppo, Delia W.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Rosenthal, Yair] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Rosenthal, Yair] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08901 USA; [Linsley, Braddock K.] SUNY Albany, Dept Atmospher & Environm Sci, Albany, NY 12222 USA	Woods Hole Oceanographic Institution; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Oppo, DW (corresponding author), Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA.	doppo@whoi.edu		Linsley, Braddock/0000-0003-2085-0662	US NSF; Ocean Climate Change Institute of WHOI	US NSF(National Science Foundation (NSF)); Ocean Climate Change Institute of WHOI	We thank the following people and institutions for their support: Y. S. Djajadihardja, F. Syamsudin, the captain and crew of our 2003 RV Baruna Jaya VIII cruise, the Indonesian Agency for Assessment and Application of Technology (BPPT), and the Center of Research and Development for Oceanography (LIPI) of Indonesia. This work was financially supported by the US NSF and the Ocean Climate Change Institute of WHOI. We thank L. Zou, D. Ostermann, K. Rose, S. Pike and M. Chong for technical assistance, W. Martin, O. Marchal, C. Saenger and K. Dahl for discussions, and the NOSAMS and Radioanalytical facilities at WHOI for radiocarbon and <SUP>210</SUP>Pb analyses, respectively.	Aldrian E, 2003, INT J CLIMATOL, V23, P1435, DOI 10.1002/joc.950; Anand P, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000846; Barsugli JJ, 2002, J CLIMATE, V15, P3427, DOI 10.1175/1520-0442(2002)015<3427:GASTTS>2.0.CO;2; Broccoli AJ, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024546; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Gordon AL, 2003, NATURE, V425, P824, DOI 10.1038/nature02038; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; *INT AT ENAG WORLD, 2006, GNIP PROGR RES; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Kawahata H, 2002, DEEP-SEA RES PT II, V49, P2783, DOI 10.1016/S0967-0645(02)00058-9; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; LOCARNINI RA, 2006, NOAA ATLAS NESDIS, V61; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Mohtadi M, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001636; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; National Research Council, 2006, SURF TEMP REC LAST 2; Newton A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027234; Qu T., 2005, OCEANOGRAPHY, V18, P50, DOI [DOI 10.5670/OCEANOG.2005.05, 10.5670/oceanog.2005.05]; Rosenthal Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016612; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; SONTAKKE NA, 1993, J CLIMATE, V6, P1807, DOI 10.1175/1520-0442(1993)006<1807:COAISM>2.0.CO;2; Stott L, 2004, NATURE, V431, P56, DOI 10.1038/nature02903; THUNELL RC, 1984, MICROPALEONTOLOGY, V30, P243, DOI 10.2307/1485688; Vuille M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006022; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; Xie PP, 1996, J CLIMATE, V9, P840, DOI 10.1175/1520-0442(1996)009<0840:AOGMPU>2.0.CO;2; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965	29	221	240	2	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1113	1116		10.1038/nature08233	http://dx.doi.org/10.1038/nature08233			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19713927	Green Submitted			2022-12-28	WOS:000269314000035
J	Delamothe, T				Delamothe, Tony			Observations On the Contrary Assisted dying: what's disability got to do with it?	BRITISH MEDICAL JOURNAL			English	Editorial Material												tdelamothe@bmj.com						2009, LANCET, V373, P1840; 2006, BRIT MED J, V332, P1169; 2009, BRIT MED J, V339	3	3	3	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 26	2009	339								b3446	10.1136/bmj.b3446	http://dx.doi.org/10.1136/bmj.b3446			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489AX	19710127				2022-12-28	WOS:000269393000007
J	Rousseau, P				Rousseau, Paul			The Other Person	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												palliativedoctor@aol.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					832	832		10.1001/jama.2009.1263	http://dx.doi.org/10.1001/jama.2009.1263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706850				2022-12-28	WOS:000269260100001
J	Hankins, J; Ware, RE				Hankins, Jane; Ware, Russell E.			Sickle-cell disease: an ounce of prevention, a pound of cure	LANCET			English	Editorial Material							DISORDERS; CHILDREN		[Hankins, Jane; Ware, Russell E.] St Jude Childrens Hosp, Dept Hematol, Memphis, TN 38015 USA	St Jude Children's Research Hospital	Ware, RE (corresponding author), St Jude Childrens Hosp, Dept Hematol, Memphis, TN 38015 USA.	russell.ware@stjude.org						Adamkiewicz TV, 2008, PEDIATRICS, V121, P562, DOI 10.1542/peds.2007-0018; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Kafando E, 2005, J MED SCREEN, V12, P112, DOI 10.1258/0969141054855300; Lerner NB, 2009, J PEDIATR-US, V154, P121, DOI 10.1016/j.jpeds.2008.06.039; Lobo Clarisse Lopes de Castro, 2003, Rev Panam Salud Publica, V13, P154, DOI 10.1590/S1020-49892003000200018; Michlitsch J, 2009, PEDIATR BLOOD CANCER, V52, P486, DOI 10.1002/pbc.21883; MOTULSKY AG, 1973, NEW ENGL J MED, V288, P31, DOI 10.1056/NEJM197301042880108; Rahimy MC, 2009, J CLIN PATHOL, V62, P46, DOI 10.1136/jcp.2008.059113; Silva Wellington dos Santos, 2006, Cad. Saúde Pública, V22, P2561, DOI 10.1590/S0102-311X2006001200006; Tshilolo L, 2008, PUBLIC HEALTH, V122, P933, DOI 10.1016/j.puhe.2007.12.005; VICHINSKY E, 1988, PEDIATRICS, V81, P749; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X	12	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 17	2009	374	9698					1308	1310		10.1016/S0140-6736(09)61602-0	http://dx.doi.org/10.1016/S0140-6736(09)61602-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	512MW	19747720				2022-12-28	WOS:000271254600007
J	Rudan, I; Campbell, H				Rudan, Igor; Campbell, Harry			The deadly toll of S pneumoniae and H influenzae type b	LANCET			English	Editorial Material							CHILDREN; INFECTIONS; PRIORITIES; MORTALITY		[Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split 21000, Croatia; [Rudan, Igor; Campbell, Harry] Univ Edinburgh, Sch Med, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland	University of Split; University of Edinburgh	Rudan, I (corresponding author), Univ Split, Sch Med, Croatian Ctr Global Hlth, Split 21000, Croatia.	irudan@hotmail.com	Rudan, Igor/I-1467-2012; Campbell, Harry/E-2959-2010	Rudan, Igor/0000-0001-6993-6884; Campbell, Harry/0000-0002-6169-6262				Bahl R, 2009, PEDIATR INFECT DIS J, V28, pS43, DOI 10.1097/INF.0b013e31819588d7; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; Enserink M, 2009, SCIENCE, V323, P700, DOI 10.1126/science.323.5915.700; G8 Leaders Declaration, 2009, RESP LEAD SUST FUT; Lanata CF, 2004, INT J EPIDEMIOL, V33, P1362, DOI 10.1093/ije/dyh229; Laxminarayan R., 2006, ACUTE RESP INFECT CH; Madhi SA, 2008, B WORLD HEALTH ORGAN, V86, P365, DOI 10.2471/BLT.07.044503; Moran M, 2009, PLOS MED, V6, P137, DOI 10.1371/journal.pmed.1000030; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rudan I, 2005, LANCET, V365, P2031, DOI 10.1016/S0140-6736(05)66697-4; Rudan I, 2007, LANCET INFECT DIS, V7, P56, DOI 10.1016/S1473-3099(06)70687-9; Watt JP, 2009, LANCET, V374, P903, DOI 10.1016/S0140-6736(09)61203-4	14	4	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 12	2009	374	9693					854	856		10.1016/S0140-6736(09)61608-1	http://dx.doi.org/10.1016/S0140-6736(09)61608-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19748384				2022-12-28	WOS:000269943100005
J	Lyons, TW; Reinhard, CT				Lyons, Timothy W.; Reinhard, Christopher T.			EARLY EARTH Oxygen for heavy-metal fans	NATURE			English	Editorial Material							PROTEROZOIC OCEAN CHEMISTRY; ATMOSPHERIC OXYGEN; EVOLUTION; RISE; EUKARYOTES; APPEARANCE		[Lyons, Timothy W.; Reinhard, Christopher T.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Lyons, TW (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	timothy.lyons@ucr.edu	Reinhard, Christopher/A-1736-2011					Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; Johnston DT, 2006, GEOCHIM COSMOCHIM AC, V70, P5723, DOI 10.1016/j.gca.2006.08.001; Kopp RE, 2005, P NATL ACAD SCI USA, V102, P11131, DOI 10.1073/pnas.0504878102; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Lyons TW, 2009, ANNU REV EARTH PL SC, V37, P507, DOI 10.1146/annurev.earth.36.031207.124233; Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381	16	33	35	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					179	181		10.1038/461179a	http://dx.doi.org/10.1038/461179a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741692				2022-12-28	WOS:000269654600025
J	Schnuelle, P; Gottmann, U; Hoeger, S; Boesebeck, D; Lauchart, W; Weiss, C; Fischereder, M; Jauch, KW; Heemann, U; Zeier, M; Hugo, C; Pisarski, P; Kramer, BK; Lopau, K; Rahmel, A; Benck, U; Birck, R; Yard, BA				Schnuelle, Peter; Gottmann, Uwe; Hoeger, Simone; Boesebeck, Detlef; Lauchart, Werner; Weiss, Christel; Fischereder, Michael; Jauch, Karl-Walter; Heemann, Uwe; Zeier, Martin; Hugo, Christian; Pisarski, Przemyslaw; Kraemer, Bernhard K.; Lopau, Kai; Rahmel, Axel; Benck, Urs; Birck, Rainer; Yard, Benito Antonio			Effects of Donor Pretreatment With Dopamine on Graft Function After Kidney Transplantation A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-DOSE DOPAMINE; COLD-PRESERVATION; PROTOCOL BIOPSIES; SUBCLINICAL REJECTION; RENAL DYSFUNCTION; BRAIN-DEATH; INJURY; SURVIVAL; CATECHOLAMINES; CLEARANCE	Context Kidney graft function after transplantation can be improved through pharmacological donor pretreatment to limit organ injury from cold preservation. Objective To determine whether pretreatment of brain-dead donors with low-dose dopamine improves early graft function in human renal transplant recipients. Design, Setting, and Patients Randomized, open-label, multicenter, parallel-group trial of 264 deceased heart-beating donors and 487 subsequent renal transplants performed at 60 European centers between March 2004 and August 2007 (final follow-up, December 31, 2008). Eligible donors were stable under low-dose norepinephrine with a normal serum creatinine concentration on admission. Interventions Donors were randomized to receive low-dose dopamine (4 mu g/kg/min). Main Outcome Measures Dialysis requirement during first week after transplantation. Results Dopamine was infused for a median of 344 minutes (IQR, 215 minutes). Dialysis was significantly reduced in recipients of a dopamine-treated graft. Fewer recipients in the treatment group needed multiple dialyses (56/227; 24.7%; 95% CI, 19.0%-30.3%; vs 92/260; 35.4%; 95% CI, 29.5%-41.2%; P = .01). The need for multiple dialyses posttransplant was associated with allograft failure after 3 years (HR, 3.61; 95% CI, 2.39-5.45; P < .001), whereas a single dialysis was not (HR, 0.67; 95% CI, 0.21-2.18; P = .51). Besides donor dopamine (OR, 0.54; 95% CI, 0.35-0.83; P = .005), cold ischemic time (OR, 1.07; 95% CI, 1.02-1.11 per hour; P = .001), donor age (OR, 1.03; 95% CI, 1.01-1.05 per year; P < .001), and recipient body weight (OR, 1.02; 95% CI, 1.01-1.04 per kg; P = .009) were independent explanatory variables in a multiple logistic regression model. Dopamine resulted in significant but clinically meaningless increases in the donor's systolic blood pressure (3.8 mm Hg; 95% CI, 0.7-6.9 mm Hg; P = .02) and urine production before surgical recovery of the kidneys (29 mL; 95% CI, 7-51 mL; P = .009) but had no influence on outcome. Conclusion Donor pretreatment with low-dose dopamine reduces the need for dialysis after kidney transplantation. Trial Registration clinicaltrials.gov Identifier: NCT00115115 JAMA. 2009;302(10):1067-1075	[Schnuelle, Peter; Gottmann, Uwe; Hoeger, Simone; Benck, Urs; Birck, Rainer; Yard, Benito Antonio] Univ Med Ctr Mannheim, Dept Med 5, D-68167 Mannheim, Germany; [Boesebeck, Detlef] Organ Procurement Org Bavaria, Munich, Germany; [Lauchart, Werner] Organ Procurement Org Baden Wurttemberg, Stuttgart, Germany; [Weiss, Christel] Dept Biomath & Med Stat, Mannheim, Germany; [Fischereder, Michael] Univ Munich, Klinikum Innenstadt, D-8000 Munich, Germany; [Jauch, Karl-Walter] Univ Munich, Klinikum Grosshadern, Dept Surg, D-8000 Munich, Germany; [Heemann, Uwe] Tech Univ Munich, Klinikum Rechts Isar, D-8000 Munich, Germany; [Zeier, Martin] Univ Heidelberg Hosp, Heidelberg, Germany; [Hugo, Christian] Univ Hosp Erlangen, Erlangen, Germany; [Pisarski, Przemyslaw] Univ Hosp Freiburg, Freiburg, Germany; [Kraemer, Bernhard K.] Univ Hosp Bochum, Marienhosp Herne, Bochum, Germany; [Lopau, Kai] Univ Hosp Wurzburg, Wurzburg, Germany; [Rahmel, Axel] Eurotransplant Int Fdn, Leiden, Netherlands	Ruprecht Karls University Heidelberg; University of Munich; University of Munich; Technical University of Munich; Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; University of Freiburg; Ruhr University Bochum; University of Wurzburg	Schnuelle, P (corresponding author), Univ Med Ctr Mannheim, Dept Med 5, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany.	peter.schnuelle@med5.ma.uni-heidelberg.de			Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	The study was an investigator-driven clinical trial conducted by the University Medical Centre of Mannheim, Germany. It was partially supported by a medical school grant from Novartis Pharmaceuticals released in November 2002, before the study started recruiting eligible donors.	Bellomo R, 2000, LANCET, V356, P2139; Brinkkoetter PT, 2008, CELL PHYSIOL BIOCHEM, V22, P195, DOI 10.1159/000149797; Brinkkoetter PT, 2006, TRANSPLANTATION, V82, P534, DOI 10.1097/01.tp.0000229396.34362.e2; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Desschans B, 2008, ACTA CHIR BELG, V108, P31, DOI 10.1080/00015458.2008.11680171; Dragun D, 2001, KIDNEY INT, V60, P1173, DOI 10.1046/j.1523-1755.2001.0600031173.x; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Gottmann U, 2006, KIDNEY INT, V70, P321, DOI 10.1038/sj.ki.5001501; Gottmann U, 2005, TRANSPLANTATION, V79, P1344, DOI 10.1097/01.TP.0000159030.86574.6C; Halloran PF, 2001, AM J TRANSPLANT, V1, P1, DOI 10.1034/j.1600-6143.2001.010101.x; Hoeger S, 2009, TRANSPLANTATION, V87, P52, DOI 10.1097/TP.0b013e318191b2ca; Juste RN, 1998, INTENS CARE MED, V24, P1217, DOI 10.1007/s001340050747; Kouwenhoven EA, 2001, KIDNEY INT, V59, P1142; Liu ZZ, 2007, TRANSPLANTATION, V83, P297, DOI 10.1097/01.tp.0000251809.90609.e0; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; Mengel M, 2007, AM J TRANSPLANT, V7, P512, DOI 10.1111/j.1600-6143.2006.01677.x; Moreso F, 2006, AM J TRANSPLANT, V6, P747, DOI 10.1111/j.1600-6143.2005.01230.x; Nankivell BJ, 2004, TRANSPLANTATION, V78, P242, DOI 10.1097/01.tp.0000128167.60172.cc; Nankivell BJ, 2001, TRANSPLANTATION, V71, P515, DOI 10.1097/00007890-200102270-00006; Novitzky D, 2006, TRANSPLANTATION, V82, P1396, DOI 10.1097/01.tp.0000237195.12342.f1; Opelz G, 2007, TRANSPLANTATION, V83, P247, DOI 10.1097/01.tp.0000251781.36117.27; Perico N, 2004, LANCET, V364, P1814, DOI 10.1016/S0140-6736(04)17406-0; Pratschke J, 1999, TRANSPLANTATION, V67, P343, DOI 10.1097/00007890-199902150-00001; Qureshi F, 2002, TRANSPLANTATION, V74, P1400, DOI 10.1097/00007890-200211270-00010; Schnuelle P, 2004, AM J TRANSPLANT, V4, P419, DOI 10.1111/j.1600-6143.2004.00331.x; Schnuelle P, 1999, KIDNEY INT, V56, P738, DOI 10.1046/j.1523-1755.1999.00567.x; Schnuelle P, 2001, TRANSPLANTATION, V72, P455, DOI 10.1097/00007890-200108150-00017; Shapiro R, 2001, AM J TRANSPLANT, V1, P47, DOI 10.1034/j.1600-6143.2001.010109.x; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; TERASAKI PI, 1995, NEW ENGL J MED, V333, P333, DOI 10.1056/NEJM199508103330601; van der Hoeven JAB, 2003, KIDNEY INT, V64, P1874, DOI 10.1046/j.1523-1755.2003.00272.x; Wood KE, 2004, NEW ENGL J MED, V351, P2730, DOI 10.1056/NEJMra013103; Yard B, 2004, AM J TRANSPLANT, V4, P22, DOI 10.1046/j.1600-6143.2003.00268.x	33	178	187	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1067	1075		10.1001/jama.2009.1310	http://dx.doi.org/10.1001/jama.2009.1310			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738091				2022-12-28	WOS:000269616200024
J	Fine, B; Hodakoski, C; Koujak, S; Su, T; Saal, LH; Maurer, M; Hopkins, B; Keniry, M; Sulis, ML; Mense, S; Hibshoosh, H; Parsons, R				Fine, Barry; Hodakoski, Cindy; Koujak, Susan; Su, Tao; Saal, Lao H.; Maurer, Matthew; Hopkins, Benjamin; Keniry, Megan; Sulis, Maria Luisa; Mense, Sarah; Hibshoosh, Hanina; Parsons, Ramon			Activation of the PI3K Pathway in Cancer Through Inhibition of PTEN by Exchange Factor P-REX2a	SCIENCE			English	Article							BREAST-CANCER; GENETIC ALTERATIONS; TUMOR-SUPPRESSOR; PROSTATE-CANCER; RAC; CELLS; PHOSPHATASE; MUTATIONS	PTEN (phosphatase and tensin homolog on chromosome 10) is a tumor suppressor whose cellular regulation remains incompletely understood. We identified phosphatidylinositol 3,4,5-trisphosphate RAC exchanger 2a (P-REX2a) as a PTEN-interacting protein. P-REX2a mRNA was more abundant in human cancer cells and significantly increased in tumors with wild-type PTEN that expressed an activated mutant of PIK3CA encoding the p110 subunit of phosphoinositide 3-kinase subunit alpha (PI3K alpha). P-REX2a inhibited PTEN lipid phosphatase activity and stimulated the PI3K pathway only in the presence of PTEN. P-REX2a stimulated cell growth and cooperated with a PIK3CA mutant to promote growth factor-independent proliferation and transformation. Depletion of P-REX2a reduced amounts of phosphorylated AKT and growth in human cell lines with intact PTEN. Thus, P-REX2a is a component of the PI3K pathway that can antagonize PTEN in cancer cells.	[Fine, Barry; Hodakoski, Cindy; Koujak, Susan; Su, Tao; Saal, Lao H.; Maurer, Matthew; Hopkins, Benjamin; Keniry, Megan; Sulis, Maria Luisa; Mense, Sarah; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Fine, Barry; Hodakoski, Cindy; Koujak, Susan; Su, Tao; Saal, Lao H.; Maurer, Matthew; Hopkins, Benjamin; Keniry, Megan; Sulis, Maria Luisa; Mense, Sarah; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Sulis, Maria Luisa] Columbia Univ, Med Ctr, Div Pediat Oncol, New York, NY 10032 USA; [Maurer, Matthew; Parsons, Ramon] Columbia Univ, Med Ctr, Dept Med, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University	Parsons, R (corresponding author), Columbia Univ, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	rep15@columbia.edu	Saal, Lao H/A-2919-2011; Su, Tao/T-4411-2019; Califano, Andrea/F-7239-2012	Saal, Lao H/0000-0002-0815-1896; Su, Tao/0000-0002-9148-6127; Parsons, Ramon/0000-0002-6656-3514	NIH Medical Scientist Training Program; NCI [CA097403]; Avon Foundation; Octoberwoman Foundation; Adele Meyer Fund; NATIONAL CANCER INSTITUTE [P01CA097403, R01CA082783] Funding Source: NIH RePORTER	NIH Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Avon Foundation; Octoberwoman Foundation; Adele Meyer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. Zhang and the Herbert Irving Comprehensive Cancer Center Proteomics Shared Resource, M. Li, W. Gu, V. Seshan, S. Voronov, G. DiPaolo, R. Baer, J. Settleman, K. Kinzler, A. Hall, N. Leslie, C. P. Downes, and the members of the Parsons laboratory for technical assistance or critical reading. B. F. is supported by the NIH Medical Scientist Training Program. Supported by NCI CA097403, the Avon Foundation, Octoberwoman Foundation, and the Adele Meyer Fund.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; BIECHE I, 1995, GENE CHROMOSOME CANC, V14, P227, DOI 10.1002/gcc.2870140402; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Courtois-Cox S, 2006, CANCER CELL, V10, P459, DOI 10.1016/j.ccr.2006.10.003; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Donald S, 2004, FEBS LETT, V572, P172, DOI 10.1016/j.febslet.2004.06.096; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fejzo MS, 1998, GENE CHROMOSOME CANC, V22, P105; Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Rosenfeldt H, 2004, FEBS LETT, V572, P167, DOI 10.1016/j.febslet.2004.06.097; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Yu ZB, 2002, J BIOL CHEM, V277, P40247, DOI 10.1074/jbc.M207608200	23	162	167	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1261	1265		10.1126/science.1173569	http://dx.doi.org/10.1126/science.1173569			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729658	Green Accepted			2022-12-28	WOS:000269523200042
J	Kurokawa, M; Kornbluth, S				Kurokawa, Manabu; Kornbluth, Sally			Caspases and Kinases in a Death Grip	CELL			English	Review							NF-KAPPA-B; FOCAL ADHESION KINASE; ICE-LIKE PROTEASE; ALPHA-DEPENDENT APOPTOSIS; INDUCED CELL-DEATH; C-DELTA; PROTEOLYTIC ACTIVATION; MEDIATED ACTIVATION; TNF-ALPHA; PKC-DELTA	The complex process of apoptosis is orchestrated by caspases, a family of cysteine proteases with unique substrate specificities. Accumulating evidence suggests that cell death pathways are finely tuned by multiple signaling events, including direct phosphorylation of caspases, whereas kinases are often substrates of active caspases. Importantly, caspase-mediated cleavage of kinases can terminate prosurvival signaling or generate proapoptotic peptide fragments that help to execute the death program and facilitate packaging of the dying cells. Here, we review caspases as kinase substrates and kinases as caspase substrates and discuss how the balance between cell survival and cell death can be shifted through crosstalk between these two enzyme families.	[Kurokawa, Manabu; Kornbluth, Sally] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Kornbluth, S (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kornb001@mc.duke.edu		Kurokawa, Manabu/0000-0002-4138-5934	NIH [RO1s CA102707GM61919]; Cancer Research Institute; NATIONAL CANCER INSTITUTE [R01CA102707, K99CA140948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061919] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank members of the Kornbluth lab for stimulating discussions and critical reading of the manuscript. This work is supported by NIH RO1s CA102707GM61919 (to S. K.) and by the Irvington Institute Fellowship of the Cancer Research Institute (to M. K.).	Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Allan LA, 2007, MOL CELL, V26, P301, DOI 10.1016/j.molcel.2007.03.019; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Alvarado-Kristensson M, 2005, J BIOL CHEM, V280, P6238, DOI 10.1074/jbc.M409718200; Arnold R, 2007, CELL DEATH DIFFER, V14, P568, DOI 10.1038/sj.cdd.4402042; Arnold R, 2001, J BIOL CHEM, V276, P14675, DOI 10.1074/jbc.M008343200; Bachelder RE, 2001, J BIOL CHEM, V276, P34702, DOI 10.1074/jbc.M102806200; Bae SS, 2000, FASEB J, V14, P1083, DOI 10.1096/fasebj.14.9.1083; Barbero S, 2008, J BIOL CHEM, V283, P13031, DOI 10.1074/jbc.M800549200; Barila D, 2003, MOL CELL BIOL, V23, P2790, DOI 10.1128/MCB.23.8.2790-2799.2003; Barkett M, 1997, J BIOL CHEM, V272, P29419, DOI 10.1074/jbc.272.47.29419; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Brenner D, 2005, EMBO J, V24, P4279, DOI 10.1038/sj.emboj.7600894; Brenner D, 2007, BLOOD, V110, P3968, DOI 10.1182/blood-2007-01-071167; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Cardone MH, 1997, CELL, V90, P315, DOI 10.1016/S0092-8674(00)80339-6; CASCIOLAROSEN LA, 1995, J EXP MED, V182, P1625, DOI 10.1084/jem.182.6.1625; Ch'en IL, 2008, P NATL ACAD SCI USA, V105, P17463, DOI 10.1073/pnas.0808043105; Cha H, 2004, J CELL SCI, V117, P751, DOI 10.1242/jcs.00897; Chen D, 2004, P NATL ACAD SCI USA, V101, P1235, DOI 10.1073/pnas.0308050100; Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chew TL, 1998, J MUSCLE RES CELL M, V19, P839, DOI 10.1023/A:1005417926585; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Clarke PR, 2009, TRENDS CELL BIOL, V19, P89, DOI 10.1016/j.tcb.2008.12.003; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; Crouch DH, 1996, ONCOGENE, V12, P2689; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; D'Costa AM, 2005, CELL DEATH DIFFER, V12, P224, DOI 10.1038/sj.cdd.4401558; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Deak JC, 1998, P NATL ACAD SCI USA, V95, P5595, DOI 10.1073/pnas.95.10.5595; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Deheuninck J, 2008, BIOCHEM BIOPH RES CO, V367, P573, DOI 10.1016/j.bbrc.2007.12.177; Desagher S, 2001, MOL CELL, V8, P601, DOI 10.1016/S1097-2765(01)00335-5; Dessauge F, 2006, J IMMUNOL, V177, P2441, DOI 10.4049/jimmunol.177.4.2441; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Eymin B, 1999, ONCOGENE, V18, P4839, DOI 10.1038/sj.onc.1202860; Feng SS, 2007, CELL SIGNAL, V19, P2056, DOI 10.1016/j.cellsig.2007.05.016; Finkielstein CV, 2002, J BIOL CHEM, V277, P38476, DOI 10.1074/jbc.M206184200; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; Foveau B, 2007, CELL DEATH DIFFER, V14, P752, DOI 10.1038/sj.cdd.4402080; Frelin C, 2008, CELL DEATH DIFFER, V15, P152, DOI 10.1038/sj.cdd.4402240; Fujita E, 1999, BIOCHEM BIOPH RES CO, V264, P550, DOI 10.1006/bbrc.1999.1387; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hamaguchi A, 2003, J BIOL CHEM, V278, P41557, DOI 10.1074/jbc.M305294200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Helfer B, 2006, CANCER RES, V66, P4273, DOI 10.1158/0008-5472.CAN-05-4183; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Huang HS, 2008, J BIOL CHEM, V283, P18135, DOI 10.1074/jbc.M709735200; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Jakobi R, 2003, J BIOL CHEM, V278, P38675, DOI 10.1074/jbc.M306494200; Jakobi R, 2001, J BIOL CHEM, V276, P16624, DOI 10.1074/jbc.M007753200; Jang SW, 2007, J BIOL CHEM, V282, P30836, DOI 10.1074/jbc.M704542200; Janicke RU, 1996, EMBO J, V15, P6969, DOI 10.1002/j.1460-2075.1996.tb01089.x; Jia SH, 2008, J BIOL CHEM, V283, P5402, DOI 10.1074/jbc.M706462200; Kim JW, 2000, ONCOGENE, V19, P4491, DOI 10.1038/sj.onc.1203796; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lee N, 1997, P NATL ACAD SCI USA, V94, P13642, DOI 10.1073/pnas.94.25.13642; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Leitges M, 2001, J CLIN INVEST, V108, P1505; Levkau B, 1998, J EXP MED, V187, P579, DOI 10.1084/jem.187.4.579; Levkau B, 1999, NAT CELL BIOL, V1, P227, DOI 10.1038/12050; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Lu CR, 2006, MOL CELL, V23, P121, DOI 10.1016/j.molcel.2006.05.023; Lu ML, 1996, P NATL ACAD SCI USA, V93, P8977, DOI 10.1073/pnas.93.17.8977; Lu W, 2007, CELL SIGNAL, V19, P2165, DOI 10.1016/j.cellsig.2007.06.015; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; Matsuura K, 2008, J BIOL CHEM, V283, P25485, DOI 10.1074/jbc.M803111200; Mazars A, 2009, CELL DEATH DIFFER, V16, P208, DOI 10.1038/cdd.2008.142; Mazumder S, 2002, MOL CELL BIOL, V22, P2398, DOI 10.1128/MCB.22.7.2398-2409.2002; Mazumder S, 2007, MOL CELL BIOL, V27, P3511, DOI 10.1128/MCB.01448-06; McDonnell MA, 2008, J BIOL CHEM, V283, P20149, DOI 10.1074/jbc.M802846200; Morita A, 2000, BIOCHEM BIOPH RES CO, V278, P627, DOI 10.1006/bbrc.2000.3860; Naresh A, 2006, CANCER RES, V66, P6412, DOI 10.1158/0008-5472.CAN-05-2368; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; NUTT LK, 2009, CELL, V16, P856; Panaretakis T, 2005, MOL BIOL CELL, V16, P3821, DOI 10.1091/mbc.E04-10-0862; Raina D, 2005, J BIOL CHEM, V280, P11147, DOI 10.1074/jbc.M413787200; Reuther JY, 1999, J BIOL CHEM, V274, P20664, DOI 10.1074/jbc.274.29.20664; Rudel T, 1997, SCIENCE, V276, P1571, DOI 10.1126/science.276.5318.1571; Santoro MF, 1998, J BIOL CHEM, V273, P13119, DOI 10.1074/jbc.273.21.13119; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Schulze-Luehrmann J, 2002, BLOOD, V100, P954, DOI 10.1182/blood-2002-01-0089; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Seifert A, 2009, CELL SIGNAL, V21, P1626, DOI 10.1016/j.cellsig.2009.06.009; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Senft J, 2007, CANCER RES, V67, P11505, DOI 10.1158/0008-5472.CAN-07-5755; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Song JJ, 2008, CELL SIGNAL, V20, P892, DOI 10.1016/j.cellsig.2008.01.001; Song QZ, 1996, EMBO J, V15, P3238, DOI 10.1002/j.1460-2075.1996.tb00688.x; Strohecker AM, 2008, J BIOL CHEM, V283, P18269, DOI 10.1074/jbc.M802156200; Torres J, 2003, J BIOL CHEM, V278, P30652, DOI 10.1074/jbc.M212610200; Tulasne D, 2004, MOL CELL BIOL, V24, P10328, DOI 10.1128/MCB.24.23.10328-10339.2004; Ura S, 2001, P NATL ACAD SCI USA, V98, P10148, DOI 10.1073/pnas.181161698; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vilas GL, 2006, P NATL ACAD SCI USA, V103, P6542, DOI 10.1073/pnas.0600824103; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Voss OH, 2005, J BIOL CHEM, V280, P17371, DOI 10.1074/jbc.M412449200; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Wong CH, 2009, NAT CELL BIOL, V11, P36, DOI 10.1038/ncb1810; Xu J, 2002, J BIOL CHEM, V277, P35561, DOI 10.1074/jbc.M203805200; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785	138	324	350	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					838	854		10.1016/j.cell.2009.08.021	http://dx.doi.org/10.1016/j.cell.2009.08.021			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737514	Green Accepted, Bronze			2022-12-28	WOS:000269564600012
J	Hone, J; Deshpande, VV				Hone, James; Deshpande, Vikram V.			Coupling Strongly, Discretely	SCIENCE			English	Editorial Material							CARBON NANOTUBES		[Hone, James] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Deshpande, Vikram V.] Columbia Univ, Dept Phys, New York, NY 10027 USA	Columbia University; Columbia University	Hone, J (corresponding author), Columbia Univ, Dept Mech Engn, 500 W 120th St, New York, NY 10027 USA.	jh2228@columbia.edu; vdesh@phys.columbia.edu	Hone, James C/E-1879-2011	Hone, James C/0000-0002-8084-3301				Cao J, 2005, NAT MATER, V4, P745, DOI 10.1038/nmat1478; Chiu HY, 2008, NANO LETT, V8, P4342, DOI 10.1021/nl802181c; Deshpande VV, 2008, NAT PHYS, V4, P314, DOI 10.1038/nphys895; Deshpande VV, 2009, SCIENCE, V323, P106, DOI 10.1126/science.1165799; Hanson R, 2007, REV MOD PHYS, V79, P1217, DOI 10.1103/RevModPhys.79.1217; Kuemmeth F, 2008, NATURE, V452, P448, DOI 10.1038/nature06822; Lassagne B, 2009, SCIENCE, V325, P1107, DOI 10.1126/science.1174290; Peng HB, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087203; Sazonova V, 2004, NATURE, V431, P284, DOI 10.1038/nature02905; Schwab KC, 2005, PHYS TODAY, V58, P36, DOI 10.1063/1.2012461; Steele GA, 2009, SCIENCE, V325, P1103, DOI 10.1126/science.1176076; Witkamp B, 2006, NANO LETT, V6, P2904, DOI 10.1021/nl062206p	12	6	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1084	1085		10.1126/science.1178574	http://dx.doi.org/10.1126/science.1178574			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713517				2022-12-28	WOS:000269382300028
J	Sommer, MOA; Dantas, G; Church, GM				Sommer, Morten O. A.; Dantas, Gautam; Church, George M.			Functional Characterization of the Antibiotic Resistance Reservoir in the Human Microflora	SCIENCE			English	Article							BETA-LACTAMASE NOMENCLATURE; MOLECULAR-MECHANISMS; GUT MICROBIOME; GENE-TRANSFER; BACTERIA; DIVERSITY; DISEASE	To understand the process by which antibiotic resistance genes are acquired by human pathogens, we functionally characterized the resistance reservoir in the microbial flora of healthy individuals. Most of the resistance genes we identified using culture-independent sampling have not been previously identified and are evolutionarily distant from known resistance genes. By contrast, nearly half of the resistance genes we identified in cultured aerobic gut isolates (a small subset of the gut microbiome) are identical to resistance genes harbored by major pathogens. The immense diversity of resistance genes in the human microbiome could contribute to future emergence of antibiotic resistance in human pathogens.	[Sommer, Morten O. A.; Dantas, Gautam; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sommer, MOA (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	sommer@genetics.med.harvard.edu; dantas@wustl.edu		Dantas, Gautam/0000-0003-0455-8370; Sommer, Morten Otto Alexander/0000-0003-4005-5674; church, george/0000-0001-6232-9969	National Human Genome Research Institute Centers of Excellence in Genomic Science; Personal Genome Project; Bill and Melinda Gates Foundation; Harvard Biophysics Program; Hartmann Foundation; Det Kongelige Danske Videnskabernes Selskab; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003170] Funding Source: NIH RePORTER	National Human Genome Research Institute Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Personal Genome Project; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Harvard Biophysics Program; Hartmann Foundation; Det Kongelige Danske Videnskabernes Selskab; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge J. Davies, J. Aach, and M. Strong for helpful discussions regarding this manuscript; and the expert assistance of G. Jacoby and K. Bush for beta-lactamase enzyme family nomenclature, L. Kraal and G. Rockwell for sequence manipulations and similarity computations, and S. Caliri, A. Ellison, and T. Ellison for microbial culturing and DNA processing. We acknowledge National Human Genome Research Institute Centers of Excellence in Genomic Science, Personal Genome Project, Bill and Melinda Gates Foundation, Harvard Biophysics Program, Hartmann Foundation, and Det Kongelige Danske Videnskabernes Selskab for funding. GenBank accession numbers GQ342978 to GQ343187 are listed in Table 1 and tables S3, S4, and S7. M.O.A.S. and G.M.C. advise many companies, listed in (24); none is working within fields related to the subject of the manuscript.	Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Florez AB, 2006, APPL ENVIRON MICROB, V72, P7377, DOI 10.1128/AEM.00486-06; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; *CDC, 2006, CTR DIS CONTR PREV A; *CDC, 2008, CTR DIS CONTR PREV H, V18; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; Dantas G, 2008, SCIENCE, V320, P100, DOI 10.1126/science.1155157; DAVIES J, 1994, SCIENCE, V264, P375, DOI 10.1126/science.8153624; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jacoby GA, 2006, ANTIMICROB AGENTS CH, V50, P1123, DOI 10.1128/AAC.50.4.1123-1129.2006; Jacoby GA, 2005, J CLIN MICROBIOL, V43, P6220, DOI 10.1128/JCM.43.12.6220.2005; Jacoby GA, 2009, AMINO ACID SEQUENCES; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Marshall B., 2009, MICROBE WASH 600, V4, P231, DOI [DOI 10.1128/MICROBE.4.231.1, 10.1128/microbe.4.231.1]; McHardy AC, 2007, NAT METHODS, V4, P63, DOI 10.1038/NMETH976; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ready D, 2004, ANTIMICROB AGENTS CH, V48, P2883, DOI 10.1128/AAC.48.8.2883-2887.2004; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004	32	569	597	6	229	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1128	1131		10.1126/science.1176950	http://dx.doi.org/10.1126/science.1176950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713526	Green Accepted			2022-12-28	WOS:000269382300041
J	Willingale-Theune, J; Manaia, A; Gebhardt, P; De Lorenzi, R; Haury, M				Willingale-Theune, Julia; Manaia, Alexandra; Gebhardt, Philipp; De Lorenzi, Rossana; Haury, Matthias			Introducing Modern Science into Schools	SCIENCE			English	Editorial Material									[Willingale-Theune, Julia; Manaia, Alexandra; Gebhardt, Philipp; De Lorenzi, Rossana; Haury, Matthias] European Mol Biol Lab, EMBL Int Ctr Adv Training, European Learning Lab Life Sci ELLS, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Willingale-Theune, J (corresponding author), European Mol Biol Lab, EMBL Int Ctr Adv Training, European Learning Lab Life Sci ELLS, Meyerhofstr 1, D-69117 Heidelberg, Germany.	Julia.willingale@embl.de		Haury, Matthias/0000-0002-1796-1479; Gebhardt, Philipp/0000-0001-5879-2512				Brill Gilat, 2003, Cell Biol Educ, V2, P266, DOI 10.1187/cbe.02-12-0062; Cooper P., 1996, EFFECTIVE TEACHING L; *EUR, 2006, SCI TEACH SCH EUR PO; European Commission, 2004, EUR NEEDS MOR SCI RE; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; MOORE A, 2007, 6 EMBO INT WORKSH NE; OECD-PISA, 2003, LEARN TOM WORLD 1 RE; Osborne J., 2008, SCI ED EUROPE CRITIC; Rocard M., 2007, SCI ED NOW RENEWED P; Schreiner C., 2005, ASIA PACIFIC FORUM S, V6, P1; *SET ROUT, SAS6CT2006036715 SET; VIRTUAL DNA MICROARR	12	10	11	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1077	1078		10.1126/science.1171989	http://dx.doi.org/10.1126/science.1171989			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	488WZ	19713512				2022-12-28	WOS:000269382300023
J	Lurie, N				Lurie, Nicole			H1N1 Influenza, Public Health Preparedness, and Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lurie, Nicole] RAND Hlth, Arlington, VA USA	RAND Corporation	Lurie, N (corresponding author), RAND Hlth, Arlington, VA USA.							Keim M., 2006, DISASTER MED, P164; Kessler RC, 2007, J GEN INTERN MED, V22, P1225, DOI 10.1007/s11606-007-0294-1; LACEY M, 2009, NY TIMES        0430; Oster A, 2003, MED CARE, V41, P198, DOI 10.1097/00005650-200302000-00002	4	21	22	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					843	845		10.1056/NEJMp0905330	http://dx.doi.org/10.1056/NEJMp0905330			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	487XV	19710481				2022-12-28	WOS:000269312700002
J	Wu, G; Park, MY; Conway, SR; Wang, JW; Weigel, D; Poethig, RS				Wu, Gang; Park, Mee Yeon; Conway, Susan R.; Wang, Jia-Wei; Weigel, Detlef; Poethig, R. Scott			The Sequential Action of miR156 and miR172 Regulates Developmental Timing in Arabidopsis	CELL			English	Article							EPIDERMAL-CELL IDENTITY; BOX GENE SPL3; PHASE-CHANGE; MICRORNA ACTIVITY; SHOOT DEVELOPMENT; TARGET GENES; THALIANA; MAIZE; GLOSSY15; ELEGANS	The transition from the juvenile to the adult phase of shoot development in plants is accompanied by changes in vegetative morphology and an increase in reproductive potential. Here, we describe the regulatory mechanism of this transition. We show that miR156 is necessary and sufficient for the expression of the juvenile phase, and regulates the timing of the juvenile-to-adult transition by coordinating the expression of several pathways that control different aspects of this process. miR156 acts by repressing the expression of functionally distinct SPL transcription factors. miR172 acts downstream of miR156 to promote adult epidermal identity. miR156 regulates the expression of miR172 via SPL9 which, redundantly with SPL10, directly promotes the transcription of miR172b. Thus, like the larval-to-adult transition in Caenorhabditis elegans, the juvenile-to-adult transition in Arabidopsis is mediated by sequentially operating miRNAs. miR156 and miR172 are positively regulated by the transcription factors they target, suggesting that negative feedback loops contribute to the stability of the juvenile and adult phases.	[Wu, Gang; Park, Mee Yeon; Conway, Susan R.; Poethig, R. Scott] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Wang, Jia-Wei; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	University of Pennsylvania; Max Planck Society	Poethig, RS (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	spoethig@sas.upenn.edu	Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Poethig, R. Scott/J-7009-2015; Weigel, Detlef/GSJ-0799-2022	Weigel, Detlef/0000-0002-2114-7963; Poethig, R. Scott/0000-0001-6592-5862; Weigel, Detlef/0000-0002-2114-7963; Wang, Jia-Wei/0000-0003-3885-6296	NIH [R01 GM051893]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM051893, R01GM051893] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Poethig laboratory for comments on this manuscript and helpful discussions throughout the course of these experiments. We are also grateful to Milo Aukerman for supplying seeds of toe1 toe2. This research was supported by a grant from NIH (R01 GM051893).	Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chuck G, 2005, CURR OPIN PLANT BIOL, V8, P67, DOI 10.1016/j.pbi.2004.11.002; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Daxinger L, 2008, TRENDS PLANT SCI, V13, P4, DOI 10.1016/j.tplants.2007.10.007; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; EVANS MMS, 1994, DEVELOPMENT, V120, P1971; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gould S. J., 1977, ONTOGENY PHYLOGENY; Guo AY, 2008, GENE, V418, P1, DOI 10.1016/j.gene.2008.03.016; Hackett W. P., 1997, Biotechnology of ornamental plants., P73; Hackett W. P., 1985, Horticultural Reviews, V7, P109, DOI 10.1002/9781118060735.ch3; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Jung JH, 2007, PLANT CELL, V19, P2736, DOI 10.1105/tpc.107.054528; Kerstetter RA, 1998, ANNU REV CELL DEV BI, V14, P373, DOI 10.1146/annurev.cellbio.14.1.373; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Parcy F, 2005, INT J DEV BIOL, V49, P585, DOI 10.1387/ijdb.041930fp; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rougvie AE, 2005, DEVELOPMENT, V132, P3787, DOI 10.1242/dev.01972; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Smith MR, 2009, P NATL ACAD SCI USA, V106, P5424, DOI 10.1073/pnas.0812729106; Telfer A, 1997, DEVELOPMENT, V124, P645; Tsukaya H, 2000, PLANTA, V210, P536, DOI 10.1007/s004250050042; Usami T, 2009, DEVELOPMENT, V136, P955, DOI 10.1242/dev.028613; Varghese J, 2007, GENE DEV, V21, P2277, DOI 10.1101/gad.439807; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; William DA, 2004, P NATL ACAD SCI USA, V101, P1775, DOI 10.1073/pnas.0307842100; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Zhao L, 2007, PLANT J, V51, P840, DOI 10.1111/j.1365-313X.2007.03181.x; ZIMMERMAN RH, 1985, ENCY PLANT PHYSL, V11, P79	47	1070	1183	34	313	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					750	759		10.1016/j.cell.2009.06.031	http://dx.doi.org/10.1016/j.cell.2009.06.031			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703400	Green Accepted, Bronze			2022-12-28	WOS:000269156100016
J	Oulton, RF; Sorger, VJ; Zentgraf, T; Ma, RM; Gladden, C; Dai, L; Bartal, G; Zhang, X				Oulton, Rupert F.; Sorger, Volker J.; Zentgraf, Thomas; Ma, Ren-Min; Gladden, Christopher; Dai, Lun; Bartal, Guy; Zhang, Xiang			Plasmon lasers at deep subwavelength scale	NATURE			English	Article							WAVE-GUIDE	Laser science has been successful in producing increasingly high-powered, faster and smaller coherent light sources(1-9). Examples of recent advances are microscopic lasers that can reach the diffraction limit, based on photonic crystals(3), metal-clad cavities(4) and nanowires(5-7). However, such lasers are restricted, both in optical mode size and physical device dimension, to being larger than half the wavelength of the optical field, and it remains a key fundamental challenge to realize ultracompact lasers that can directly generate coherent optical fields at the nanometre scale, far beyond the diffraction limit(10,11). A way of addressing this issue is to make use of surface plasmons(12,13), which are capable of tightly localizing light, but so far ohmic losses at optical frequencies have inhibited the realization of truly nanometre-scale lasers based on such approaches(14,15). A recent theoretical work predicted that such losses could be significantly reduced while maintaining ultrasmall modes in a hybrid plasmonic waveguide(16). Here we report the experimental demonstration of nanometre-scale plasmonic lasers, generating optical modes a hundred times smaller than the diffraction limit. We realize such lasers using a hybrid plasmonic waveguide consisting of a high-gain cadmium sulphide semiconductor nanowire, separated from a silver surface by a 5-nm thick insulating gap. Direct measurements of the emission lifetime reveal a broad-band enhancement of the nanowire's exciton spontaneous emission rate by up to six times owing to the strong mode confinement(17) and the signature of apparently threshold-less lasing. Because plasmonic modes have no cutoff, we are able to demonstrate downscaling of the lateral dimensions of both the device and the optical mode. Plasmonic lasers thus offer the possibility of exploring extreme interactions between light and matter, opening up new avenues in the fields of active photonic circuits(18), bio-sensing(19) and quantum information technology(20).	[Oulton, Rupert F.; Sorger, Volker J.; Zentgraf, Thomas; Gladden, Christopher; Bartal, Guy; Zhang, Xiang] Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Ma, Ren-Min; Dai, Lun] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Ma, Ren-Min; Dai, Lun] Peking Univ, State Key Lab Mesoscop Phys, Beijing 100871, Peoples R China	National Science Foundation (NSF); University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Peking University; Peking University	Zhang, X (corresponding author), Univ Calif Berkeley, NSF Nanoscale Sci & Engn Ctr, 3112 Etcheverry Hall, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Zentgraf, Thomas/G-8848-2013; Zhang, Xiang/F-6905-2011; oulton, rupert/AAA-8186-2021; Plekhanov, Alexander I/C-5971-2014; Ma, Ren-Min/H-9621-2012	Zentgraf, Thomas/0000-0002-8662-1101; Plekhanov, Alexander I/0000-0002-4073-0636; Zhang, Xiang/0000-0002-3272-894X	US Air Force Office of Scientific Research (AFOSR) MURI programme [FA9550-04-1-0434]; National Science Foundation Nano-scale Science and Engineering Center (NSF-NSEC) [CMMI-0751621]; Alexander von Humboldt Foundation; Intel Corporation; National Natural Science Foundation of China [60576037, 10774007]; National Basic Research Program of China [2006CB921607, 2007CB613402]	US Air Force Office of Scientific Research (AFOSR) MURI programme(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Science Foundation Nano-scale Science and Engineering Center (NSF-NSEC)(National Science Foundation (NSF)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Intel Corporation(Intel Corporation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	We thank M. Ambati and D. Genov for discussions and the Lawrence Berkeley National Laboratory's Molecular Foundry for technical support. We acknowledge financial support from the US Air Force Office of Scientific Research (AFOSR) MURI programme under grant number FA9550-04-1-0434 and from the National Science Foundation Nano-scale Science and Engineering Center (NSF-NSEC) under award number CMMI-0751621. T. Z. acknowledges a fellowship from the Alexander von Humboldt Foundation. V. J. S. acknowledges a fellowship from the Intel Corporation. L. D. and R.-M. M. acknowledge the National Natural Science Foundation of China ( award numbers 60576037 and 10774007) and the National Basic Research Program of China ( grant numbers 2006CB921607 and 2007CB613402).	Akimov AV, 2007, NATURE, V450, P402, DOI 10.1038/nature06230; Altug H, 2006, NAT PHYS, V2, P484, DOI 10.1038/nphys343; Ambati M, 2008, NANO LETT, V8, P3998, DOI 10.1021/nl802603r; Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Astafiev O, 2007, NATURE, V449, P588, DOI 10.1038/nature06141; Bergman DJ, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.027402; BJORK G, 1991, IEEE J QUANTUM ELECT, V27, P2386, DOI 10.1109/3.100877; Bozhevolnyi SI, 2006, NATURE, V440, P508, DOI 10.1038/nature04594; CASPERSON LW, 1975, J APPL PHYS, V12, P5194; Drescher M, 2001, SCIENCE, V291, P1923, DOI 10.1126/science.1058561; Duan XF, 2003, NATURE, V421, P241, DOI 10.1038/nature01353; FORD GW, 1984, PHYS REP, V113, P195, DOI 10.1016/0370-1573(84)90098-X; GORDON JP, 1955, PHYS REV, V99, P1264, DOI 10.1103/PhysRev.99.1264; Hill MT, 2007, NAT PHOTONICS, V1, P589, DOI 10.1038/nphoton.2007.171; Johnson JC, 2002, NAT MATER, V1, P106, DOI 10.1038/nmat728; Liu YM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.153901; Ma RM, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2710004; Maier SA, 2003, NAT MATER, V2, P229, DOI 10.1038/nmat852; Noginov MA, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.226806; Oulton RF, 2008, NAT PHOTONICS, V2, P496, DOI 10.1038/nphoton.2008.131; Oulton RF, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/10/105018; Pile DFP, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1991990; PURCELL EM, 1946, PHYS REV, V69, P681; Scalari G, 2009, LASER PHOTONICS REV, V3, P45, DOI 10.1002/lpor.200810030; Siegman A. E., 1986, LASERS, P466; Stockman MI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.137404; THOMAS GD, 1962, PHYS REV, V128, P2135; WEBER C, 1988, Z PHYS B CON MAT, V72, P379, DOI 10.1007/BF01312825; Zheludev NI, 2008, NAT PHOTONICS, V2, P351, DOI 10.1038/nphoton.2008.82; Zimmler MA, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2965797	30	2015	2062	36	1457	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					629	632		10.1038/nature08364	http://dx.doi.org/10.1038/nature08364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19718019	Green Submitted			2022-12-28	WOS:000270302600035
J	Owusu-Ansah, E; Banerjee, U				Owusu-Ansah, Edward; Banerjee, Utpal			Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation	NATURE			English	Article							OXIDATIVE STRESS; FEEDBACK-REGULATION; SIGNALING CENTER; CELL; JNK; INSULIN; GROWTH; BLOOD; FOXO; ACTIVATION	Reactive oxygen species (ROS), produced during various electron transfer reactions in vivo, are generally considered to be deleterious to cells(1). In the mammalian haematopoietic system, haematopoietic stem cells contain low levels of ROS. However, unexpectedly, the common myeloid progenitors (CMPs) produce significantly increased levels of ROS2. The functional significance of this difference in ROS level in the two progenitor types remains unresolved(2,3). Here we show that Drosophila multipotent haematopoietic progenitors, which are largely akin to the mammalian myeloid progenitors(4), display increased levels of ROS under in vivo physiological conditions, which are downregulated on differentiation. Scavenging the ROS from these haematopoietic progenitors by using in vivo genetic tools retards their differentiation into mature blood cells. Conversely, increasing the haematopoietic progenitor ROS beyond their basal level triggers precocious differentiation into all three mature blood cell types found in Drosophila, through a signalling pathway that involves JNK and FoxO activation as well as Polycomb downregulation. We conclude that the developmentally regulated, moderately high ROS level in the progenitor population sensitizes them to differentiation, and establishes a signalling role for ROS in the regulation of haematopoietic cell fate. Our results lead to a model that could be extended to reveal a probable signalling role for ROS in the differentiation of CMPs in mammalian haematopoietic development and oxidative stress response.	[Owusu-Ansah, Edward; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu			US National Institutes of Health [R01HL067395]; T32 institutional postdoctoral fellowship [T32-HL069766]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067395, T32HL069766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR057291] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T32 institutional postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank I. Ando and H. Muller for antibodies, and E. Hafen, A. Martinez- Arias, F. Missirlis, S. Noselli, R. Paro, S Sinenko, the National Institute of Genetics Fly Stock Center ( Japan) and the Bloomington Stock Center for fly stocks. We acknowledge M. Kulkarni and C. Pitsouli of the Perrimon laboratory for technical assistance. Owing to space limitations, we apologize to our colleagues whose work is not referenced. This study was supported by US National Institutes of Health grant R01HL067395 to U. B. and a T32 institutional postdoctoral fellowship T32-HL069766 to E. O.-A.	BRAND AH, 1993, DEVELOPMENT, V118, P401; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Coffer PJ, 2007, NAT CELL BIOL, V9, P251, DOI 10.1038/ncb0307-251; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Harvey KF, 2008, J CELL BIOL, V180, P691, DOI 10.1083/jcb.200710100; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Owusu-Ansah E., 2008, NATURE PROTOCOLS, DOI [10.1038/nprot.2008.23, DOI 10.1038/NPROT.2008.23]; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wood W, 2007, NAT REV MOL CELL BIO, V8, P542, DOI 10.1038/nrm2202	26	540	563	5	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					537	U109		10.1038/nature08313	http://dx.doi.org/10.1038/nature08313			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19727075	Green Submitted, Green Accepted			2022-12-28	WOS:000270082900043
J	Kirby, MJ; Ameh, D; Bottomley, C; Green, C; Jawara, M; Milligan, PJ; Snell, PC; Conway, DJ; Lindsay, SW				Kirby, Matthew J.; Ameh, David; Bottomley, Christian; Green, Clare; Jawara, Musa; Milligan, Paul J.; Snell, Paul C.; Conway, David J.; Lindsay, Steve W.			Effect of two different house screening interventions on exposure to malaria vectors and on anaemia in children in The Gambia: a randomised controlled trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM INFECTION; ANOPHELES-GAMBIAE; REDUCE EXPOSURE; RISK-FACTORS; BURDEN; IDENTIFICATION; TRANSMISSION; RESISTANCE; BEDNETS; AFRICA	Background House screening should protect people against malaria. We assessed whether two types of house screening-full screening of windows, doors, and closing eaves, or installation of screened ceilings-could reduce house entry of malaria vectors and frequency of anaemia in children in an area of seasonal malaria transmission. Methods During 2006 and 2007, 500 occupied houses in and near Farafenni town in The Gambia, an area with low use of insecticide-treated bednets, were randomly assigned to receive full screening, screened ceilings, or no screening (control). Randomisation was done by computer-generated list, in permuted blocks of five houses in the ratio 2:2:1. Screening was not treated with insecticide. Exposure to mosquitoes indoors was assessed by fortnightly light trap collections during the transmission season. Primary endpoints included the number of female Anopheles gambiae sensu lato mosquitoes collected per trap per night. Secondary endpoints included frequency of anaemia (haemoglobin concentration <80 g/L) and parasitaemia at the end of the transmission season in children (aged 6 months to 10 years) who were living in the study houses. Analysis was by modified intention to treat (ITT), including all randomised houses for which there were some outcome data and all children from those houses who were sampled for haemoglobin and parasitaemia. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN51184253. Findings 462 houses were included in the modified ITT analysis (full screening, n=188; screened ceilings, n=178; control, n=96). The mean number of A gambiae caught in houses without screening was 37.5 per trap per night (95% CI 31.6-43-3), compared with 15.2 (12.9-17-4) in houses with full screening (ratio of means 0.41, 95% CI 0.31-0.54; p<0.0001) and 19.1 (16.1-22.1) in houses with screened ceilings (ratio 0.53, 0.40-0.70; p<0.0001). 755 children completed the study, of whom 731 had complete clinical and covariate data and were used in the analysis of clinical outcomes. 30 (19%) of 158 children from control houses had anaemia, compared with 38 (12%) of 309 from houses with full screening (adjusted odds ratio [OR] 0.53, 95% CI 0.9-0.97; p=0.04), and 31 (12%) of 264 from houses with screened ceilings (OR 0.51, 0.27-0.96; p=0.04). Frequency of parasitaemia did not differ between intervention and control groups. Interpretation House screening substantially reduced the number of mosquitoes inside houses and could contribute to prevention of anaemia in children. Funding Medical Research Council.	[Kirby, Matthew J.; Green, Clare; Lindsay, Steve W.] Univ Durham, Sci Labs, Durham DH1 3LE, England; [Ameh, David; Jawara, Musa; Milligan, Paul J.; Snell, Paul C.; Conway, David J.] MRC Labs, Banjul, Gambia; [Snell, Paul C.] Univ Bristol, Dept Social Med, Bristol, Avon, England	Durham University; MRC Laboratory Molecular Biology; University of Bristol	Lindsay, SW (corresponding author), Univ London London Sch Hyg & Trop Med, Dis Control & Vector Biol Unit, Keppel St, London WC1E 7HT, England.	Steve.Lindsay@lshtm.ac.uk	Milligan, Paul/D-8985-2017	Milligan, Paul/0000-0003-3430-3395; Bottomley, Christian/0000-0002-5241-8412; Kirby, Matt/0000-0001-5470-1433; Lindsay, Steve/0000-0002-3461-9050; Conway, David/0000-0002-8711-3037	Medical Research Council, UK; MRC [G0700837, G0400031] Funding Source: UKRI; Medical Research Council [G0400031, G0700837] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful for the helpful comments made by the reviewers. We thank Paul Emerson and Amy Ratcliffe for their help in designing an early version of the study. We are grateful for the donations of netting from the Vestergaard-Frandsen group and in particular the efforts of the director of development, Torben Frandsen, and associates in transporting the netting to The Gambia. We thank Rob Hutchinson who helped develop methods for erecting the screening and the carpentry team that installed it; M RC and Durham University associates of the STOPMAL trial and other support staff at M RC Farafenni and MRC Fajara, in particular Chloe Day, Erin Dilger, Margaret Pinder, Pateh Bah, Ensa Touray, Pa Chebou Same, Manikumba Sanneh, and Roger Conteh; Momodou Jasseh and Sarah Crozier as members ofthe data monitoring and ethics committee, and the late Chris Curtis, chairman of the TSC and the other committee members Robin Bailey and Peter Billingsley; and Ann Kelly and Caroline Jones of the London School of Hygiene and Tropical Medicine for help with the acceptability studies. We also thank the study children and their parents for their continuous support for this work. This study was funded by the Medical Research Council, UK.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bodker R, 2006, AM J TROP MED HYG, V74, P716; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Breman JG, 2004, AM J TROP MED HYG, V71, P1; BREWSTER DR, 1993, ANN TROP PAEDIATR, V13, P133, DOI 10.1080/02724936.1993.11747637; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; BUTRAPORN P, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P386; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Celli A., 1901, COLLECTED PAPERS MAL, V1899-1912, P1; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; CLARKE SE, 2001, THESIS U COPENHAGEN; Curtis CF, 1998, TROP MED INT HEALTH, V3, P619, DOI 10.1046/j.1365-3156.1998.00281.x; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Goodman CA, 2001, TROP MED INT HEALTH, V6, P280, DOI 10.1046/j.1365-3156.2001.00700.x; GREENWOOD BM, 1989, T ROY SOC TROP MED H, V83, P182, DOI 10.1016/0035-9203(89)90635-4; Jambou R, 2005, LANCET, V366, P1960, DOI 10.1016/S0140-6736(05)67787-2; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Kerah-Hinzoumbe C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-192; Kilian AHD, 2000, TROP MED INT HEALTH, V5, P3, DOI 10.1046/j.1365-3156.2000.00509.x; Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3; Kirby MJ, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-33; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; LINDSAY SW, 1995, MED VET ENTOMOL, V9, P50, DOI 10.1111/j.1365-2915.1995.tb00116.x; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; Lindsay SW, 2002, TRENDS PARASITOL, V18, P510, DOI 10.1016/S1471-4922(02)02382-6; *REP GAMB, 2001, NAT SURV PREV VIT A; *ROLL BACK MAL, KEY MAL FACTS; Rowland M, 2000, TROP MED INT HEALTH, V5, P472, DOI 10.1046/j.1365-3156.2000.00581.x; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024; Smith T, 1998, AM J TROP MED HYG, V59, P252, DOI 10.4269/ajtmh.1998.59.252; SPIELMAN A, 2001, NATURAL HIST OUR MOS; TAKKEN W, 1990, WAGENINGEN AGR U PAP; WHO, 1982, WHO OFFS PUBL, V66; WHO, 2004, WHOCDSCPEPVC200410; WHO, 2008, WORLD HLTH REPORT 20	41	173	173	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					998	1009		10.1016/S0140-6736(09)60871-0	http://dx.doi.org/10.1016/S0140-6736(09)60871-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PK	19732949	Green Accepted			2022-12-28	WOS:000270154100030
J	Post, E; Forchhammer, MC; Bret-Harte, MS; Callaghan, TV; Christensen, TR; Elberling, B; Fox, AD; Gilg, O; Hik, DS; Hoye, TT; Ims, RA; Jeppesen, E; Klein, DR; Madsen, J; McGuire, AD; Rysgaard, S; Schindler, DE; Stirling, I; Tamstorf, MP; Tyler, NJC; van der Wal, R; Welker, J; Wookey, PA; Schmidt, NM; Aastrup, P				Post, Eric; Forchhammer, Mads C.; Bret-Harte, M. Syndonia; Callaghan, Terry V.; Christensen, Torben R.; Elberling, Bo; Fox, Anthony D.; Gilg, Olivier; Hik, David S.; Hoye, Toke T.; Ims, Rolf A.; Jeppesen, Erik; Klein, David R.; Madsen, Jesper; McGuire, A. David; Rysgaard, Soren; Schindler, Daniel E.; Stirling, Ian; Tamstorf, Mikkel P.; Tyler, Nicholas J. C.; van der Wal, Rene; Welker, Jeffrey; Wookey, Philip A.; Schmidt, Niels Martin; Aastrup, Peter			Ecological Dynamics Across the Arctic Associated with Recent Climate Change	SCIENCE			English	Review							PLANT COMMUNITY RESPONSES; NORTHERN ALASKA; TUNDRA; CARBON; POPULATION; ECOSYSTEMS; VEGETATION; FEEDBACKS; IMPACTS; TEMPERATURES	At the close of the Fourth International Polar Year, we take stock of the ecological consequences of recent climate change in the Arctic, focusing on effects at population, community, and ecosystem scales. Despite the buffering effect of landscape heterogeneity, Arctic ecosystems and the trophic relationships that structure them have been severely perturbed. These rapid changes may be a bellwether of changes to come at lower latitudes and have the potential to affect ecosystem services related to natural resources, food production, climate regulation, and cultural integrity. We highlight areas of ecological research that deserve priority as the Arctic continues to warm.	[Post, Eric] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Post, Eric; Forchhammer, Mads C.; Madsen, Jesper; Tamstorf, Mikkel P.; Schmidt, Niels Martin; Aastrup, Peter] Aarhus Univ, NERI, Dept Arctic Environm, DK-4000 Roskilde, Denmark; [Bret-Harte, M. Syndonia; Klein, David R.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Callaghan, Terry V.] Abisko Sci Res Stn, SE-98107 Abisko, Sweden; [Callaghan, Terry V.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Christensen, Torben R.] Lund Univ, GeoBiosphere Sci Ctr, Dept Phys Geog & Ecosyst Anal, S-22100 Lund, Sweden; [Elberling, Bo] Univ Copenhagen, Dept Geog & Geol, DK-1350 Copenhagen, Denmark; [Elberling, Bo] Univ Ctr Svalbard, Longyearbyen, Norway; [Fox, Anthony D.; Hoye, Toke T.] Aarhus Univ, NERI, Dept Wildlife Ecol & Biodivers, DK-8410 Ronde, Denmark; [Gilg, Olivier] Univ Helsinki, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [Gilg, Olivier] Arctic Ecol Res Grp GREA, FR-21440 Francheville, France; [Hik, David S.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Ims, Rolf A.] Univ Tromso, Dept Biol, NO-9037 Tromso, Norway; [Jeppesen, Erik] Aarhus Univ, NERI, Dept Freshwater Ecol, DK-8600 Silkeborg, Denmark; [McGuire, A. David] Univ Alaska Fairbanks, Alaska Cooperat Fish andWildlife Res Unit, US Geol Survey, Fairbanks, AK 99775 USA; [Rysgaard, Soren] Greenland Inst Nat Resources, Nuuk 3900, Greenland; [Schindler, Daniel E.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Stirling, Ian] Canadian Wildlife Serv, Environm Canada, Edmonton, AB T6H 3S5, Canada; [Tyler, Nicholas J. C.] Univ Tromso, Ctr Saami Studies, N-9037 Tromso, Norway; [van der Wal, Rene] Univ Aberdeen, Sch Biol Sci, Aberdeen Ctr Environm Sustainabil, Aberdeen AB24 3UU, Scotland; [Welker, Jeffrey] Univ Alaska Anchorage, Environm & Nat Resources Inst, Anchorage, AK 99501 USA; [Wookey, Philip A.] Univ Stirling, Sch Biol & Environm Sci, Stirling FK9 4LA, Scotland	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Aarhus University; University of Alaska System; University of Alaska Fairbanks; University of Sheffield; Lund University; University of Copenhagen; University Centre Svalbard (UNIS); Aarhus University; University of Helsinki; University of Alberta; UiT The Arctic University of Tromso; Aarhus University; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; Greenland Institute of Natural Resources; University of Washington; University of Washington Seattle; Environment & Climate Change Canada; Canadian Wildlife Service; UiT The Arctic University of Tromso; University of Aberdeen; University of Alaska System; University of Alaska Anchorage; University of Stirling	Post, E (corresponding author), Penn State Univ, Dept Biol, 208 Mueller Lab, University Pk, PA 16802 USA.	esp10@psu.edu	Rysgaard, Søren/K-6689-2013; Tamstorf, Mikkel/ACU-7592-2022; Hoye, Toke T./ABF-7808-2020; Høye, Toke Thomas/A-7701-2008; Hik, David S/B-3462-2009; Callaghan, Terens V./N-7640-2014; Jeppesen, Erik/O-2667-2019; Wookey, Philip/AAA-6271-2020; Madsen, Jesper/J-7853-2013; Jeppesen, Erik/A-4463-2012; GILG, Olivier/C-2588-2008; Fox, Anthony D/I-7465-2013; Welker, Jeffrey/C-9493-2013; Elberling, Bo/M-4000-2014; Tamstorf, Mikkel/I-7101-2013; Tamstorf, Mikkel/AAB-6627-2020; Schmidt, Niels Martin/G-3843-2011; van der Wal, Rene/F-3177-2010; Forchhammer, Mads/I-7474-2013	Hoye, Toke T./0000-0001-5387-3284; Høye, Toke Thomas/0000-0001-5387-3284; Hik, David S/0000-0002-8994-9305; Wookey, Philip/0000-0001-5957-6424; Madsen, Jesper/0000-0003-3246-0215; Jeppesen, Erik/0000-0002-0542-369X; GILG, Olivier/0000-0002-9083-4492; Elberling, Bo/0000-0002-6023-885X; Tamstorf, Mikkel/0000-0002-2811-331X; Tamstorf, Mikkel/0000-0002-2811-331X; Schmidt, Niels Martin/0000-0002-4166-6218; Rysgaard, Soren/0000-0003-1726-2958; Aastrup, Peter/0000-0003-4258-3358	The Danish Polar Center; U. S. National Science Foundation; NERC [NE/D005833/1] Funding Source: UKRI; Natural Environment Research Council [NE/D005833/1] Funding Source: researchfish	The Danish Polar Center; U. S. National Science Foundation(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. E. Mann, M. O. Recowbell, and two anonymous referees for helpful comments and Aarhus University, The Danish Polar Center, and the U. S. National Science Foundation for financial support.	[Anonymous], SPECIES COMMUNITIES; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Bennike O, 2008, ADV ECOL RES, V40, P45, DOI 10.1016/S0065-2504(07)00003-7; Bokhorst SF, 2009, J ECOL, V97, P1408, DOI 10.1111/j.1365-2745.2009.01554.x; Bret-Harte MS, 2001, ECOLOGY, V82, P18, DOI 10.1890/0012-9658(2001)082[0018:DPABNT]2.0.CO;2; Callaghan TV, 2004, AMBIO, V33, P436, DOI 10.1639/0044-7447(2004)033[0436:EOTSOA]2.0.CO;2; Chapin FS, 2008, FRONT ECOL ENVIRON, V6, P313, DOI 10.1890/080005; Christensen TR, 2007, PHILOS T R SOC A, V365, P1643, DOI 10.1098/rsta.2007.2035; Christoffersen KS, 2008, ADV ECOL RES, V40, P371, DOI 10.1016/S0065-2504(07)00016-5; Danby RK, 2007, J ECOL, V95, P352, DOI 10.1111/j.1365-2745.2006.01200.x; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Forchhammer MC, 2008, ADV ECOL RES, V40, P499, DOI 10.1016/S0065-2504(07)00021-9; Forchhammer MC, 2008, ADV ECOL RES, V40, P391, DOI 10.1016/S0065-2504(08)00017-7; Frenot Y, 2005, BIOL REV, V80, P45, DOI 10.1017/S1464793104006542; Friberg N, 2009, FRESHWATER BIOL, V54, P2051, DOI 10.1111/j.1365-2427.2009.02234.x; Gilg O, 2009, GLOBAL CHANGE BIOL, V15, P2634, DOI 10.1111/j.1365-2486.2009.01927.x; Guthrie RD, 2006, NATURE, V441, P207, DOI 10.1038/nature04604; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Hoye TT, 2007, CURR BIOL, V17, pR449, DOI 10.1016/j.cub.2007.04.047; Ims RA, 2008, TRENDS ECOL EVOL, V23, P79, DOI 10.1016/j.tree.2007.10.010; Jeppesen E, 2003, ECOSYSTEMS, V6, P313, DOI 10.1007/PL00021503; Jepsen JU, 2008, J ANIM ECOL, V77, P257, DOI 10.1111/j.1365-2656.2007.01339.x; Killengreen ST, 2007, BIOL CONSERV, V135, P459, DOI 10.1016/j.biocon.2006.10.039; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Mastepanov M, 2008, NATURE, V456, P628, DOI 10.1038/nature07464; McGuire AD, 2006, ANNU REV ENV RESOUR, V31, P61, DOI 10.1146/annurev.energy.31.020105.100253; Moore GWK, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027764; Overpeck J, 1996, NATURE, V384, P447, DOI 10.1038/384447a0; Parker BF, 2006, RENAISSANCE QUART, V59, P261, DOI 10.1353/ren.2008.0201; Parkinson CL, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004558; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; Post E, 2009, BIOSCIENCE, V59, P489, DOI 10.1525/bio.2009.59.6.7; Quayle WC, 2002, SCIENCE, V295, P645, DOI 10.1126/science.1064074; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Rysgaard S, 2003, ARCT ANTARCT ALP RES, V35, P301, DOI 10.1657/1523-0430(2003)035[0301:PCCTAC]2.0.CO;2; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Smol JP, 2007, FRONT ECOL ENVIRON, V5, P466, DOI 10.1890/060162; Stirling I, 2004, ARCTIC, V57, P59; Strom L, 2007, SOIL BIOL BIOCHEM, V39, P1689, DOI 10.1016/j.soilbio.2007.01.019; Sturm M, 2005, BIOSCIENCE, V55, P17, DOI 10.1641/0006-3568(2005)055[0017:WBPCHC]2.0.CO;2; Sullivan PF, 2008, ECOSYSTEMS, V11, P61, DOI 10.1007/s10021-007-9107-y; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Tyler NJC, 2008, ECOLOGY, V89, P1675, DOI 10.1890/07-0416.1; van der Wal R, 2007, GLOBAL CHANGE BIOL, V13, P539, DOI 10.1111/j.1365-2486.2006.01310.x; van der Wal R, 2006, OIKOS, V114, P177, DOI 10.1111/j.2006.0030-1299.14264.x; Van Geest GJ, 2007, OECOLOGIA, V153, P653, DOI 10.1007/s00442-007-0770-7; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Walker DA, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2008JG000740; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Welker JM, 2000, CLIMATIC CHANGE, V44, P139, DOI 10.1023/A:1005555012742; Welker JM, 2004, GLOBAL CHANGE BIOL, V10, P1981, DOI 10.1111/j.1365-2486.2004.00857.x; Wookey PA, 2009, GLOBAL CHANGE BIOL, V15, P1153, DOI 10.1111/j.1365-2486.2008.01801.x; Wrona Frederick J., 2005, P353	60	832	865	16	874	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1355	1358		10.1126/science.1173113	http://dx.doi.org/10.1126/science.1173113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745143				2022-12-28	WOS:000269699100027
J	Hosseini, M; Sparkes, BM; Hetet, G; Longdell, JJ; Lam, PK; Buchler, BC				Hosseini, Mahdi; Sparkes, Ben M.; Hetet, Gabriel; Longdell, Jevon J.; Lam, Ping Koy; Buchler, Ben C.			Coherent optical pulse sequencer for quantum applications	NATURE			English	Article							ELECTROMAGNETICALLY INDUCED TRANSPARENCY; COMMUNICATION; PROPAGATION; PHOTONS; STORAGE	The bandwidth and versatility of optical devices have revolutionized information technology systems and communication networks. Precise and arbitrary control of anoptical field that preserves optical coherence is an important requisite for many proposed photonic technologies. For quantum information applications(1,2), a device that allows storage and on-demand retrieval of arbitrary quantum states of light would form an ideal quantum optical memory. Recently, significant progress has been made in implementing atomic quantum memories using electromagnetically induced transparency, photon echo spectroscopy, off-resonance Raman spectroscopy and other atom-light interaction processes. Single-photon(3,4) and bright-optical-field(5,6) storage with quantum states have both been successfully demonstrated. Here we present a coherent optical memory based on photon echoes induced through controlled reversible inhomogeneous broadening. Our scheme allows storage of multiple pulses of light within a chosen frequency bandwidth, and stored pulses can be recalled in arbitrary order with any chosen delay between each recalled pulse. Furthermore, pulses can be time-compressed, time-stretched or split into multiple smaller pulses and recalled in several pieces at chosen times. Although our experimental results are so far limited to classical light pulses, our technique should enable the construction of an optical random-access memory for time-bin quantum information, and have potential applications in quantum information processing.	[Hosseini, Mahdi; Sparkes, Ben M.; Hetet, Gabriel; Longdell, Jevon J.; Lam, Ping Koy; Buchler, Ben C.] Australian Natl Univ, Dept Quantum Sci, ARC Ctr Excellence Quantum Atom Opt, Canberra, ACT 0200, Australia; [Longdell, Jevon J.] Univ Otago, Dept Phys, Dunedin 9016, New Zealand	Australian National University; University of Western Australia; University of Otago	Buchler, BC (corresponding author), Australian Natl Univ, Dept Quantum Sci, ARC Ctr Excellence Quantum Atom Opt, GPO Box 4, Canberra, ACT 0200, Australia.	ben.buchler@anu.edu.au	Hosseini, Mahdi/A-5430-2013; Lam, Ping Koy/A-5276-2008; Buchler, Ben C/D-4581-2009; Sparkes, Benjamin M/I-3216-2014	Hosseini, Mahdi/0000-0002-2539-1664; Lam, Ping Koy/0000-0002-4421-601X; Buchler, Ben C/0000-0002-2852-7483; Sparkes, Benjamin M/0000-0002-9370-2006; Hetet, Gabriel/0000-0002-4759-0939	Australian Research Council	Australian Research Council(Australian Research Council)	We thank S. Bell for the solenoid design code and J. Close, C. Savage and P. Drummond for suggestions. This work was supported by the Australian Research Council.	Alexander AL, 2007, J LUMIN, V127, P94, DOI 10.1016/j.jlumin.2007.02.034; Alexander AL, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.043602; Appel J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093602; Brendel J, 1999, PHYS REV LETT, V82, P2594, DOI 10.1103/PhysRevLett.82.2594; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; de Riedmatten H, 2008, NATURE, V456, P773, DOI 10.1038/nature07607; DRUMMOND PD, 1991, PHYS REV A, V44, P2072, DOI 10.1103/PhysRevA.44.2072; Duan LM, 2001, NATURE, V414, P413, DOI 10.1038/35106500; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Fraval E, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.030506; Gisin N, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.014302; Gorshkov AV, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.033804; Hetet G, 2008, OPT LETT, V33, P2323, DOI 10.1364/OL.33.002323; Hetet G, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.012323; Hetet G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.023601; Hetet G, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203601; Honda K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093601; Longdell JJ, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.032337; Nilsson M, 2005, OPT COMMUN, V247, P393, DOI 10.1016/j.optcom.2004.11.077; Novikova I, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.021802; RAYMER MG, 1981, PHYS REV A, V24, P1980, DOI 10.1103/PhysRevA.24.1980; Sangouard N, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032327; Simon C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.190503; Zoller P, 2005, EUR PHYS J D, V36, P203, DOI 10.1140/epjd/e2005-00251-1	25	135	137	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					241	245		10.1038/nature08325	http://dx.doi.org/10.1038/nature08325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741705				2022-12-28	WOS:000269654600039
J	[Anonymous]				[Anonymous]			A step too far?	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					145	146		10.1038/461145b	http://dx.doi.org/10.1038/461145b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	492KN	19741658	Bronze			2022-12-28	WOS:000269654600002
J	Kleinert, S; Horton, R				Kleinert, Sabine; Horton, Richard			South Africa's health: departing for a better future?	LANCET			English	Editorial Material									[Kleinert, Sabine; Horton, Richard] The Lancet, London NW1 7BY, England		Kleinert, S (corresponding author), The Lancet, London NW1 7BY, England.							[Anonymous], 2008 WORLD DEV IND; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Geffen N, 2009, LANCET, V374, P860, DOI 10.1016/S0140-6736(09)61260-5; Gevers W, 2009, LANCET, V374, P760, DOI 10.1016/S0140-6736(09)61119-3; Jewkes R., 2009, UNDERSTANDING MENS H; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mooney G, 2009, LANCET, V374, P858, DOI 10.1016/S0140-6736(09)61125-9; MOTSOALEDI A, 2009, COMMUNICATION   0630; Peltzer K, 2009, LANCET, V374, P956, DOI 10.1016/S0140-6736(09)61261-7; Pottinger Brian, 2008, MBEKI LEGACY; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; Sewankambo NK, 2009, LANCET, V374, P957, DOI 10.1016/S0140-6736(09)61244-7	16	24	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					759	760		10.1016/S0140-6736(09)61306-4	http://dx.doi.org/10.1016/S0140-6736(09)61306-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492QU	19709726				2022-12-28	WOS:000269675000004
J	Duncan, M				Duncan, Martin			Re-viewing an Old Comet Reservoir	SCIENCE			English	Editorial Material							OORT CLOUD; CLUSTERS; OBJECTS		Queens Univ, Dept Phys Engn Phys & Astron, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Duncan, M (corresponding author), Queens Univ, Dept Phys Engn Phys & Astron, Kingston, ON K7L 3N6, Canada.	duncan@astro.queensu.ca						BAILEY ME, 1976, NATURE, V259, P290, DOI 10.1038/259290a0; Brasser R, 2006, ICARUS, V184, P59, DOI 10.1016/j.icarus.2006.04.010; Brown ME, 2004, ASTROPHYS J, V617, P645, DOI 10.1086/422095; Duncan M. J., 2008, SOLAR SYSTEM NEPTUNE, P315; Fernandez JA, 2000, ICARUS, V145, P580, DOI 10.1006/icar.2000.6348; HEISLER J, 1986, ICARUS, V65, P13, DOI 10.1016/0019-1035(86)90060-6; Kaib NA, 2009, SCIENCE, V325, P1234, DOI 10.1126/science.1172676; Kaiser N, 2002, P SOC PHOTO-OPT INS, V4836, P154, DOI 10.1117/12.457365; Lada CJ, 2003, ANNU REV ASTRON ASTR, V41, P57, DOI 10.1146/annurev.astro.41.011802.094844; Lehner MJ, 2009, PUBL ASTRON SOC PAC, V121, P138, DOI 10.1086/597516; Levison HF, 2006, ICARUS, V184, P619, DOI 10.1016/j.icarus.2006.05.008; Nihei TC, 2007, ASTRON J, V134, P1596, DOI 10.1086/521396; Oort J. H., 1950, B ASTRON I NETH, V11, P91	14	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1211	1212		10.1126/science.1177312	http://dx.doi.org/10.1126/science.1177312			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729643				2022-12-28	WOS:000269523200023
J	Olefsky, JM				Olefsky, Jerrold M.			IKK epsilon: A Bridge between Obesity and Inflammation	CELL			English	Editorial Material							INSULIN-RESISTANCE	Obesity leads to tissue inflammation and insulin resistance, which are features of metabolic diseases such as type 2 diabetes. Chiang et al. (2009) now show that the I kappa B kinase IKK epsilon is an important link between obesity and inflammation and may be a new therapeutic target for treating obesity-related metabolic diseases.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303, U54HD012303] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD012303, P50 HD012303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; OLEFSKY JM, 2005, DEGROOT TXB ENDOCRIN, P1093; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	9	33	35	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 4	2009	138	5					834	836		10.1016/j.cell.2009.08.018	http://dx.doi.org/10.1016/j.cell.2009.08.018			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737512	Bronze			2022-12-28	WOS:000269564600010
J	McConnachie, AW; Irwin, MJ; Ibata, RA; Dubinski, J; Widrow, LM; Martin, NF; Cote, P; Dotter, AL; Navarro, JF; Ferguson, AMN; Puzia, TH; Lewis, GF; Babul, A; Barmby, P; Bienayme, O; Chapman, SC; Cockcroft, R; Collins, MLM; Fardal, MA; Harris, WE; Huxor, A; Mackey, AD; Penarrubia, J; Rich, RM; Richer, HB; Siebert, A; Tanvir, N; Valls-Gabaud, D; Venn, KA				McConnachie, Alan W.; Irwin, Michael J.; Ibata, Rodrigo A.; Dubinski, John; Widrow, Lawrence M.; Martin, Nicolas F.; Cote, Patrick; Dotter, Aaron L.; Navarro, Julio F.; Ferguson, Annette M. N.; Puzia, Thomas H.; Lewis, Geraint F.; Babul, Arif; Barmby, Pauline; Bienayme, Olivier; Chapman, Scott C.; Cockcroft, Robert; Collins, Michelle L. M.; Fardal, Mark A.; Harris, William E.; Huxor, Avon; Mackey, A. Dougal; Penarrubia, Jorge; Rich, R. Michael; Richer, Harvey B.; Siebert, Arnaud; Tanvir, Nial; Valls-Gabaud, David; Venn, Kimberly A.			The remnants of galaxy formation from a panoramic survey of the region around M31	NATURE			English	Article							LOCAL GROUP GALAXIES; ANDROMEDA GALAXY; GALACTIC SATELLITES; PROPER MOTION; HALO; SUBSTRUCTURE; ORIGIN; STARS; DISK; SAGITTARIUS	In hierarchical cosmological models(1), galaxies grow in mass through the continual accretion of smaller ones. The tidal disruption of these systems is expected to result in loosely bound stars surrounding the galaxy, at distances that reach 10-100 times the radius of the central disk(2,3). The number, luminosity and morphology of the relics of this process provide significant clues to galaxy formation history(4), but obtaining a comprehensive survey of these components is difficult because of their intrinsic faintness and vast extent. Here we report a panoramic survey of the Andromeda galaxy (M31). We detect stars and coherent structures that are almost certainly remnants of dwarf galaxies destroyed by the tidal field of M31. An improved census of their surviving counterparts implies that three-quarters of M31's satellites brighter than M(v) =-6 await discovery. The brightest companion, Triangulum (M33), is surrounded by a stellar structure that provides persuasive evidence for a recent encounter with M31. This panorama of galaxy structure directly confirms the basic tenets of the hierarchical galaxy formation model and reveals the shared history of M31 and M33 in the unceasing build-up of galaxies.	[McConnachie, Alan W.; Cote, Patrick; Puzia, Thomas H.] NRC Herzberg Inst Astrophys, Victoria, BC V9E 2E7, Canada; [Irwin, Michael J.; Chapman, Scott C.; Collins, Michelle L. M.; Penarrubia, Jorge] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Ibata, Rodrigo A.; Bienayme, Olivier; Siebert, Arnaud] Observ Strasbourg, F-67000 Strasbourg, France; [Dubinski, John] Univ Toronto, Dept Astron & Astrophys, Toronto, ON M5S 3H4, Canada; [Widrow, Lawrence M.] Queens Univ, Dept Phys Engn Phys & Astron, Kingston, ON K7L 3N6, Canada; [Martin, Nicolas F.] Max Planck Inst Astron, D-69117 Heidelberg, Germany; [Dotter, Aaron L.; Navarro, Julio F.; Babul, Arif; Venn, Kimberly A.] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada; [Ferguson, Annette M. N.; Mackey, A. Dougal] Univ Edinburgh, Inst Astron, Edinburgh EH9 3HJ, Midlothian, Scotland; [Lewis, Geraint F.] Univ Sydney, Sch Phys, Sydney Inst Astron, Sydney, NSW 2006, Australia; [Barmby, Pauline] Univ Western Ontario, Dept Phys & Astron, London, ON N6A 3K7, Canada; [Cockcroft, Robert; Harris, William E.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Fardal, Mark A.] Univ Massachusetts, Dept Astron, Amherst, MA 01003 USA; [Huxor, Avon] Univ Bristol, HH Wills Phys Lab, Dept Phys, Astrophys Grp, Bristol BS8 1TL, Avon, England; [Rich, R. Michael] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Richer, Harvey B.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Tanvir, Nial] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Valls-Gabaud, David] Observ Paris, CNRS, UMR 8111, Lab Galaxies & Etoiles Phys & Instrumentat, F-92195 Meudon, France	National Research Council Canada; University of Cambridge; University of Toronto; Queens University - Canada; Max Planck Society; University of Victoria; University of Edinburgh; University of Sydney; Western University (University of Western Ontario); McMaster University; University of Massachusetts System; University of Massachusetts Amherst; University of Bristol; University of California System; University of California Los Angeles; University of British Columbia; University of Leicester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite	McConnachie, AW (corresponding author), NRC Herzberg Inst Astrophys, 5071 W Saanich Rd, Victoria, BC V9E 2E7, Canada.	alan.mcconnachie@nrc-cnrc.gc.ca	Lewis, Geraint/F-9069-2015; Babul, Arif/E-2730-2010; Barmby, Pauline/I-7194-2016; Puzia, Thomas H./E-6108-2010; Puzia, Thomas H./AAV-2520-2020	Lewis, Geraint/0000-0003-3081-9319; Babul, Arif/0000-0003-1746-9529; Barmby, Pauline/0000-0003-2767-0090; Puzia, Thomas H./0000-0003-0350-7061; Dubinski, John/0000-0001-5337-0732; Arnaud, Siebert/0000-0001-8059-2840; Huxor, Avon/0000-0001-5467-5730; Navarro, Julio/0000-0003-3862-5076; McConnachie, Alan/0000-0003-4666-6564; Ibata, Rodrigo/0000-0002-3292-9709; Mackey, Dougal/0000-0002-6529-8093; Venn, Kim/0000-0003-4134-2042	European Commission [MCEXT-CT-2005-025869]; Australian Nuclear Science and Technology Organisation (ANSTO); National Science Foundation [AST-0709479]; Space Telescope Science Institute [GO-9453, GO-10265, GO-10816]; Science and Technology Facilities Council [PP/E00105X/1, ST/H004157/1, ST/H004165/1, ST/F001967/1, PP/C002229/1] Funding Source: researchfish; STFC [ST/F001967/1, ST/H004157/1, ST/H004165/1, PP/E00105X/1, PP/C002229/1] Funding Source: UKRI	European Commission(European CommissionEuropean Commission Joint Research Centre); Australian Nuclear Science and Technology Organisation (ANSTO); National Science Foundation(National Science Foundation (NSF)); Space Telescope Science Institute(Space Telescope Science Institute); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the entire staff at the Canada-France-Hawaii Telescope for taking the data, for initial processing with Elixir and for their continuing support throughout this project. A. M. N. F. and A. D. M. are supported by a Marie Curie Excellence Grant from the European Commission under contract MCEXT-CT-2005-025869. G. F. L. thanks the Australian Nuclear Science and Technology Organisation (ANSTO) for supporting his involvement in PAndAS through its Access to Major Research Facilities Program (AMRFP). R. M. R. acknowledges grant AST-0709479 from the National Science Foundation, and grants GO-9453, GO-10265 and GO-10816 from the Space Telescope Science Institute. The image of M33 overlaid in Fig. 1 is reproduced by courtesy of T. A. Rector and M. Hanna.	Abadi MG, 2006, MON NOT R ASTRON SOC, V365, P747, DOI 10.1111/j.1365-2966.2005.09789.x; Belokurov V, 2006, ASTROPHYS J, V642, pL137, DOI 10.1086/504797; Brunthaler A, 2005, SCIENCE, V307, P1440, DOI 10.1126/science.1108342; Bullock JS, 2000, ASTROPHYS J, V539, P517, DOI 10.1086/309279; Bullock JS, 2005, ASTROPHYS J, V635, P931, DOI 10.1086/497422; Corbelli E, 1997, ASTROPHYS J, V479, P244, DOI 10.1086/303849; Dotter A, 2008, ASTROPHYS J SUPPL S, V178, P89, DOI 10.1086/589654; Dubinski J., 1996, New Astronomy, V1, P133, DOI 10.1016/S1384-1076(96)00009-7; EGGEN OJ, 1962, ASTROPHYS J, V136, P748, DOI 10.1086/147433; Ferguson AMN, 2002, ASTRON J, V124, P1452, DOI 10.1086/342019; Ibata R, 2007, ASTROPHYS J, V671, P1591, DOI 10.1086/522574; Ibata R, 2001, NATURE, V412, P49, DOI 10.1038/35083506; Ibata R, 2005, ASTROPHYS J, V634, P287, DOI 10.1086/491727; IBATA RA, 1994, NATURE, V370, P194, DOI 10.1038/370194a0; Johnston KV, 2008, ASTROPHYS J, V689, P936, DOI 10.1086/592228; Johnston KV, 1996, ASTROPHYS J, V465, P278, DOI 10.1086/177418; Klypin A, 1999, ASTROPHYS J, V522, P82, DOI 10.1086/307643; Kravtsov AV, 2004, ASTROPHYS J, V609, P482, DOI 10.1086/421322; Loeb A, 2005, ASTROPHYS J, V633, P894, DOI 10.1086/491644; Martin NF, 2006, MON NOT R ASTRON SOC, V371, P1983, DOI 10.1111/j.1365-2966.2006.10823.x; McConnachie AW, 2008, ASTROPHYS J, V688, P1009, DOI 10.1086/591313; McConnachie AW, 2005, MON NOT R ASTRON SOC, V356, P979, DOI 10.1111/j.1365-2966.2004.08514.x; Moore B, 1999, ASTROPHYS J, V524, pL19, DOI 10.1086/312287; Richardson JC, 2008, ASTRON J, V135, P1998, DOI 10.1088/0004-6256/135/6/1998; ROGSTAD DH, 1976, ASTROPHYS J, V204, P703, DOI 10.1086/154219; SCHECHTER P, 1976, ASTROPHYS J, V203, P297, DOI 10.1086/154079; SEARLE L, 1978, ASTROPHYS J, V225, P357, DOI 10.1086/156499; Thilker DA, 2004, ASTROPHYS J, V601, pL39, DOI 10.1086/381703; Widrow LM, 2008, ASTROPHYS J, V679, P1239, DOI 10.1086/587636	30	468	471	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 3	2009	461	7260					66	69		10.1038/nature08327	http://dx.doi.org/10.1038/nature08327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19727194	Green Submitted			2022-12-28	WOS:000269478800030
J	Scott, GR; Gibert, L				Scott, Gary R.; Gibert, Luis			The oldest hand-axes in Europe	NATURE			English	Article							BAZA BASIN; SE SPAIN; ORCE; AGE; CHRONOLOGIES; 40AR/39AR; BOUNDARY; AFRICA; RECORD	Stone tools are durable reminders of the activities, skills and customs of early humans, and have distinctive morphologies that reflect the development of technological skills during the Pleistocene epoch. In Africa, large cutting tools (hand-axes and bifacial chopping tools) became part of Palaeolithic technology during the Early Pleistocene (similar to 1.5 Myr ago)(1-3). However, in Europe this change had not been documented until the Middle Pleistocene (<0.5 Myr ago)(4,5). Here we report dates for two western Mediterranean hand-axe sites that are nearly twice the age of the supposed earliest Acheulian in western Europe. Palaeomagnetic analysis of these two sites in southeastern Spain found reverse polarity magnetozones, showing that hand-axes were already in Europe as early as 0.9 Myr ago. This expanded antiquity for European hand-axe culture supports a wide geographic distribution of Palaeolithic bifacial technology outside of Africa during the Early Pleistocene.	[Scott, Gary R.; Gibert, Luis] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA	Berkeley Geochronolgy Center	Gibert, L (corresponding author), Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA.	lgibert@bgc.org	Gibert, Luís/L-1941-2019	Gibert, Luis/0000-0002-4207-3465	Fullbright Scholar Program; Fundacion Espanola para la Ciencia y la Tecnologia; Fundacion Seneca [05584/ARQ/07]; Direccion General de Investigacion [CGL2005-05337BTE]; Earthwatch Institute	Fullbright Scholar Program; Fundacion Espanola para la Ciencia y la Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Seneca(Fundacion Seneca); Direccion General de Investigacion(Spanish Government); Earthwatch Institute	Partial funding and support was from the Fullbright Scholar Program (L. G.), Fundacion Espanola para la Ciencia y la Tecnologia (L. G.), project 05584/ARQ/07 of the Fundacion Seneca (M. Walker), project CGL2005-05337BTE of the Direccion General de Investigacion (L. Rosell), and the Earthwatch Institute (L. G.). For discussions, laboratory, and field assistance we thank J. Gibert, M. Walker, R. Martin, C. Ferrandez, J. Butterworth, L. Hinton, M. Leria, A. Lopez-Jimenez, M. Lopez-Martinez, S. Matson, J. Ortega, F. Ribot, A. Ruiz-Bustos and L. Smeenk. We also thank the Museo Arqueologico de Velez Rubio (Almeria) for access to their collection from Solana del Zamborino, R. Gomez Torres for access to the Solana del Zamborino site, and M. Walker for access to fossils/artefacts and sampling at Estrecho del Quipar. We acknowledge the late J. Gibert Clols for encouraging the development of this research and providing the large mammal fauna identifications.	Aguirre Emiliano, 2008, HOMO HISPANICO; [Anonymous], 2006, EURASIAN PREHISTORY; Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; BARYOSEF O, 1993, MONOGR I ARCHAEOL QE, V34; Borja C, 1997, AM J PHYS ANTHROPOL, V103, P433, DOI 10.1002/(SICI)1096-8644(199708)103:4<433::AID-AJPA1>3.0.CO;2-O; Botella M.C., 1975, CUAD PREHIST U GRANA, V1, P1; BUSTOS AR, 1995, HOMINIDOS ENTORNO PL, P153; Chazan M, 2008, J HUM EVOL, V55, P1, DOI 10.1016/j.jhevol.2008.01.004; Ciaranfi N, 2005, QUATERN INT, V131, P1, DOI 10.1016/j.quaint.2004.10.017; Coe RS, 2004, EARTH PLANET SC LETT, V222, P667, DOI 10.1016/j.epsl.2004.03.003; Coltorti M, 2005, QUATERN INT, V131, P11, DOI 10.1016/j.quaint.2004.07.004; De Castro JMB, 2004, EVOL ANTHROPOL, V13, P25, DOI 10.1002/evan.10130; Dennell R, 2003, J HUM EVOL, V45, P421, DOI 10.1016/j.jhevol.2003.09.006; Gibert J., 2004, HOMBRE ORCE HOMINIDO; GIBERT J, 2006, ARQUEOLOGIA REGION M, V14, P37; GIBERT J, 2007, HUMAN EVOLUTION SOUR, P327; Gibert L, 2007, QUATERNARY SCI REV, V26, P2067, DOI 10.1016/j.quascirev.2007.06.012; Gibert L, 2006, QUATERNARY SCI REV, V25, P507, DOI 10.1016/j.quascirev.2005.03.006; Gibert L, 2007, SEDIMENT GEOL, V200, P89, DOI 10.1016/j.sedgeo.2007.03.003; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hou YM, 2000, SCIENCE, V287, P1622, DOI 10.1126/science.287.5458.1622; ISAACS GL, 1974, NATURE, V249, P624, DOI 10.1038/249624a0; Monnier GF, 2006, CURR ANTHROPOL, V47, P709, DOI 10.1086/506280; Parfitt SA, 2005, NATURE, V438, P1008, DOI 10.1038/nature04227; Santonja M., 2006, AXE AGE ACHEULIAN TO, P429; Scott GR, 2007, QUATERNARY SCI REV, V26, P415, DOI 10.1016/j.quascirev.2006.09.007; Walker MJ., 2001, VERY REMOTE PERIOD I, P153	29	128	129	0	34	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					82	85		10.1038/nature08214	http://dx.doi.org/10.1038/nature08214			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490DT	19727198				2022-12-28	WOS:000269478800034
J	Hartung, T; Rovida, C				Hartung, Thomas; Rovida, Costanza			Chemical regulators have overreached	NATURE			English	Editorial Material									[Hartung, Thomas] Johns Hopkins Univ Bloomberg, Sch Publ Hlth, Baltimore, MD 21205 USA; [Hartung, Thomas] Univ Konstanz, D-7750 Constance, Germany	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Konstanz	Hartung, T (corresponding author), Johns Hopkins Univ Bloomberg, Sch Publ Hlth, Baltimore, MD 21205 USA.	thartung@jhsph.edu						Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a; Janer G, 2007, REPROD TOXICOL, V24, P97, DOI 10.1016/j.reprotox.2007.04.068; PEDERSEN F, 2003, 20863 EUR JOINT RES; ROVIDA C, 2009, REEVALUATION ANIMAL; Van der Jagt K., 2004, 21405 JRC EUR EN	5	205	211	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1080	1081		10.1038/4601080a	http://dx.doi.org/10.1038/4601080a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	487YE	19713914				2022-12-28	WOS:000269314000016
J	Ridd, M; Purdy, S				Ridd, Matthew; Purdy, Sarah			10-Minute Consultation Exacerbation of atopic eczema in children	BRITISH MEDICAL JOURNAL			English	Editorial Material							GUIDELINES		[Ridd, Matthew] Univ Bristol, Acad Unit Primary Hlth Care, Natl Inst Hlth Res, Bristol BS8 2AA, Avon, England; [Purdy, Sarah] Univ Bristol, Acad Unit Primary Hlth Care, MRC, Bristol BS8 2AA, Avon, England	University of Bristol; University of Bristol	Ridd, M (corresponding author), Univ Bristol, Acad Unit Primary Hlth Care, Natl Inst Hlth Res, Bristol BS8 2AA, Avon, England.	m.ridd@bristol.ac.uk	Ridd, Matthew/E-5656-2016	Ridd, Matthew/0000-0002-7954-8823; Purdy, Sarah/0000-0002-3445-986X	MRC [G0501936] Funding Source: UKRI; Medical Research Council [G0501936] Funding Source: Medline; National Institute for Health Research [CL-2008-25-004] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))		Bath-Hextall F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005203.pub2; Hanifin JM, 2004, J AM ACAD DERMATOL, V50, P391, DOI 10.1016/j.jaad.2003.08.003; Lewis-Jones S, 2007, BRIT MED J, V335, P1263, DOI 10.1136/bmj.39405.503773.AD; *NAT COLL CTR WOM, 2007, AT ECZ CHILDR MAN AT; *NAT I CLIN EXC, 2007, CG57 AT ECZ CHILDR Q; *NAT I CLIN EXC, 2007, CG57 AT ECZ CHILDR U	6	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 25	2009	339								b2997	10.1136/bmj.b2997	http://dx.doi.org/10.1136/bmj.b2997			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AS	19706651				2022-12-28	WOS:000269392500002
J	Seto, WK; Mak, CM; But, D; Hung, I; Lam, CW; Tam, S; Yuen, MF; Lai, CL				Seto, Wai Kay; Mak, Chloe Miu; But, David; Hung, Ivun; Lam, Ching Wan; Tam, Sidney; Yuen, Man Fung; Lai, Ching Lung			Mutational analysis for Wilson's disease	LANCET			English	Editorial Material									[Seto, Wai Kay; But, David; Yuen, Man Fung; Lai, Ching Lung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lam, Ching Wan; Tam, Sidney] Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Mak, Chloe Miu] Princess Margaret Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lai, CL (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, 102 Pok Fu Lam Rd, Hong Kong, Hong Kong, Peoples R China.	hrmelcl@hkucc.hku.hk	Hung, Ivan FN/ABD-5916-2021; SETO, Wai-Kay/H-4452-2012; Lai, Ching Lung/C-4298-2009	Hung, Ivan FN/0000-0002-1556-2538; SETO, Wai-Kay/0000-0002-9012-313X; Lai, Ching-Lung/0000-0002-5927-2436				Ferenci P, 2005, CLIN GASTROENTEROL H, V3, P811, DOI 10.1016/S1542-3565(05)00181-3; Hahn SH, 2002, MOL GENET METAB, V76, P133, DOI 10.1016/S1096-7192(02)00026-4; Mak CM, 2008, J HUM GENET, V53, P55, DOI 10.1007/s10038-007-0218-2; Prashanth LK, 2004, J NEUROL NEUROSUR PS, V75, P907, DOI 10.1136/jnnp.2003.026310; [No title captured]	5	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 22	2009	374	9690					662	662		10.1016/S0140-6736(09)60915-6	http://dx.doi.org/10.1016/S0140-6736(09)60915-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486TU	19700008	Green Submitted			2022-12-28	WOS:000269222600027
J	Halabi, N; Rivoire, O; Leibler, S; Ranganathan, R				Halabi, Najeeb; Rivoire, Olivier; Leibler, Stanislas; Ranganathan, Rama			Protein Sectors: Evolutionary Units of Three-Dimensional Structure	CELL			English	Article							AMINO-ACID SUBSTITUTIONS; SUBSTRATE-SPECIFICITY; CORRELATED MUTATIONS; ALLOSTERIC COMMUNICATION; SIGNAL-TRANSDUCTION; SERINE PROTEASES; PEPTIDE RECOGNITION; CONTACT PREDICTION; SEQUENCE ALIGNMENT; ENZYME CATALYSIS	Proteins display a hierarchy of structural features at primary, secondary, tertiary, and higher-order levels, an organization that guides our current understanding of their biological properties and evolutionary origins. Here, we reveal a structural organization distinct from this traditional hierarchy by statistical analysis of correlated evolution between amino acids. Applied to the S1A serine proteases, the analysis indicates a decomposition of the protein into three quasi-independent groups of correlated amino acids that we term "protein sectors.'' Each sector is physically connected in the tertiary structure, has a distinct functional role, and constitutes an independent mode of sequence divergence in the protein family. Functionally relevant sectors are evident in other protein families as well, suggesting that they may be general features of proteins. We propose that sectors represent a structural organization of proteins that reflects their evolutionary histories.	[Halabi, Najeeb; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Halabi, Najeeb; Ranganathan, Rama] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Rivoire, Olivier; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10065 USA; [Leibler, Stanislas] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA; [Leibler, Stanislas] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Rockefeller University; Rockefeller University; Institute for Advanced Study - USA; Institute for Advanced Study - USA	Ranganathan, R (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	rama.ranganathan@utsouthwestern.edu	Halabi, Najeeb/AAX-8250-2020	Halabi, Najeeb/0000-0002-9345-6132	Robert A. Welch foundation; UT Southwestern Medical Center; NATIONAL EYE INSTITUTE [R01EY018720] Funding Source: NIH RePORTER	Robert A. Welch foundation(The Welch Foundation); UT Southwestern Medical Center; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank members of the Ranganathan and Leibler laboratories for discussion and critical review of the manuscript, L. Hedstrom for materials and protocols, and A. Poole and W. Russ for the SH domain alignments. This study was supported by the Robert A. Welch foundation (R.R.) and the Green Center for Systems Biology at UT Southwestern Medical Center. O.R. is a fellow of the Human Frontier Science Program.	Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Baird TT, 2006, PROTEIN SCI, V15, P1229, DOI 10.1110/ps.062179006; Bell JK, 2003, NAT STRUCT BIOL, V10, P527, DOI 10.1038/nsb944; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Bittar ER, 2003, BRAZ J MED BIOL RES, V36, P1621, DOI 10.1590/S0100-879X2003001200003; Bodi A, 2001, EUR J BIOCHEM, V268, P6238, DOI 10.1046/j.0014-2956.2001.02578.x; Bouchaud J.-P., 2000, THEORY FINANCIAL RIS; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Brumano MHN, 2000, ARCH BIOCHEM BIOPHYS, V382, P57; Buck MJ, 2005, MOL BIOL EVOL, V22, P1627, DOI 10.1093/molbev/msi157; Bush-Pelc LA, 2007, J BIOL CHEM, V282, P27165, DOI 10.1074/jbc.M703202200; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; CHOTHIA C, 1982, J MOL BIOL, V160, P309, DOI 10.1016/0022-2836(82)90178-4; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CRAIK CS, 1985, SCIENCE, V228, P291, DOI 10.1126/science.3838593; DARROCH JN, 1972, ANN MATH STAT, V43, P1470, DOI 10.1214/aoms/1177692379; Datta D, 2008, J MOL BIOL, V381, P1157, DOI 10.1016/j.jmb.2008.06.040; DOOLITTLE RF, 1996, COMPUTER METHODS MAC, V266; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Ferguson AD, 2007, P NATL ACAD SCI USA, V104, P513, DOI 10.1073/pnas.0609887104; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Hamilton N, 2004, PROTEINS, V56, P679, DOI 10.1002/prot.20160; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; HEDSTROM L, 1994, BIOCHEMISTRY-US, V33, P8757, DOI 10.1021/bi00195a017; Hedstrom L, 1996, BIOL CHEM, V377, P465; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Huntington JA, 2003, STRUCTURE, V11, P469, DOI 10.1016/S0969-2126(03)00049-2; John DM, 2000, PROTEIN SCI, V9, P1416, DOI 10.1110/ps.9.7.1416; Kam CM, 2000, BBA-PROTEIN STRUCT M, V1477, P307, DOI 10.1016/S0167-4838(99)00282-4; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Kullback S., 1997, INFORM THEORY STAT; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lapedes A. S., 1999, STAT MOL BIOL GENETI, P236; Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146; Lee J, 2008, SCIENCE, V322, P438, DOI 10.1126/science.1159052; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Lee WS, 2004, J BIOCHEM, V135, P93, DOI 10.1093/jb/mvh011; LESK AM, 1982, J MOL BIOL, V160, P325, DOI 10.1016/0022-2836(82)90179-6; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; MCGRATH ME, 1992, BIOCHEMISTRY-US, V31, P3059, DOI 10.1021/bi00127a005; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Naganathan AN, 2008, BIOCHEMISTRY-US, V47, P6752, DOI 10.1021/bi800336x; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6; Olsson AY, 2004, GENOMICS, V84, P147, DOI 10.1016/j.ygeno.2004.01.009; Orengo CA, 2005, ANNU REV BIOCHEM, V74, P867, DOI 10.1146/annurev.biochem.74.082803.133029; Ortiz AR, 1999, PROTEINS, P177; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Pasternak A, 1999, PROTEIN SCI, V8, P253; PERONA JJ, 1995, BIOCHEMISTRY-US, V34, P1489, DOI 10.1021/bi00005a004; PERONA JJ, 1993, SCIENCE, V261, P620, DOI 10.1126/science.8342029; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; Rugles SW, 2004, J BIOL CHEM, V279, P30751, DOI 10.1074/jbc.M400949200; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; SHINDYALOV IN, 1994, PROTEIN ENG, V7, P349, DOI 10.1093/protein/7.3.349; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Thomas DJ, 1996, PROTEIN ENG, V9, P941, DOI 10.1093/protein/9.11.941; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thornton JM, 1999, J MOL BIOL, V293, P333, DOI 10.1006/jmbi.1999.3054; Wang ECW, 1997, PROTEIN ENG, V10, P405, DOI 10.1093/protein/10.4.405; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; WIGNER EP, 1967, SIAM REV, V9, P1, DOI 10.1137/1009001; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; ZVELEBIL MJ, 1987, J MOL BIOL, V195, P957, DOI 10.1016/0022-2836(87)90501-8	87	484	493	2	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					774	786		10.1016/j.cell.2009.07.038	http://dx.doi.org/10.1016/j.cell.2009.07.038			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703402	Green Accepted, Bronze			2022-12-28	WOS:000269156100018
J	Keyhani, S; Federman, A				Keyhani, Salomeh; Federman, Alex			Doctors on Coverage -- Physicians' Views on a New Public Insurance Option and Medicare Expansion.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Keyhani, Salomeh] James J Peters Vet Adm Med Ctr, Bronx, NY USA; [Keyhani, Salomeh] Mt Sinai Sch Med, Dept Hlth Policy, New York, NY USA; [Keyhani, Salomeh; Federman, Alex] Mt Sinai Sch Med, Div Gen Internal Med, New York, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Keyhani, S (corresponding author), James J Peters Vet Adm Med Ctr, Bronx, NY USA.							*AM MED ASS, 2008, AMA HLTH CAR REF PRO; Blendon RJ, 2009, NEW ENGL J MED, V361, pE13, DOI 10.1056/NEJMp0906392; Starr P, 1982, SOCIAL TRANSFORMATIO	3	21	21	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14								10.1056/NEJMp0908239	http://dx.doi.org/10.1056/NEJMp0908239			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500KZ	19752465				2022-12-28	WOS:000270300000005
J	Moss, AJ; Hall, WJ; Cannom, DS; Klein, H; Brown, MW; Daubert, JP; Estes, NAM; Foster, E; Greenberg, H; Higgins, SL; Pfeffer, MA; Solomon, SD; Wilber, D; Zareba, W				Moss, Arthur J.; Hall, W. Jackson; Cannom, David S.; Klein, Helmut; Brown, Mary W.; Daubert, James P.; Estes, N. A. Mark, III; Foster, Elyse; Greenberg, Henry; Higgins, Steven L.; Pfeffer, Marc A.; Solomon, Scott D.; Wilber, David; Zareba, Wojciech		MADIT-CRT Trial Investigators	Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROPHYLACTIC IMPLANTATION; DEFIBRILLATOR; TRIAL; GUIDELINES; COMMITTEE; CHAMBER	Background: This trial was designed to determine whether cardiac-resynchronization therapy (CRT) with biventricular pacing would reduce the risk of death or heart-failure events in patients with mild cardiac symptoms, a reduced ejection fraction, and a wide QRS complex. Methods: During a 4.5-year period, we enrolled and followed 1820 patients with ischemic or nonischemic cardiomyopathy, an ejection fraction of 30% or less, a QRS duration of 130 msec or more, and New York Heart Association class I or II symptoms. Patients were randomly assigned in a 3:2 ratio to receive CRT plus an implantable cardioverter-defibrillator (ICD) (1089 patients) or an ICD alone (731 patients). The primary end point was death from any cause or a nonfatal heart-failure event (whichever came first). Heart-failure events were diagnosed by physicians who were aware of the treatment assignments, but they were adjudicated by a committee that was unaware of assignments. Results: During an average follow-up of 2.4 years, the primary end point occurred in 187 of 1089 patients in the CRT-ICD group (17.2%) and 185 of 731 patients in the ICD-only group (25.3%) (hazard ratio in the CRT-ICD group, 0.66; 95% confidence interval [CI], 0.52 to 0.84; P=0.001). The benefit did not differ significantly between patients with ischemic cardiomyopathy and those with nonischemic cardiomyopathy. The superiority of CRT was driven by a 41% reduction in the risk of heart-failure events, a finding that was evident primarily in a prespecified subgroup of patients with a QRS duration of 150 msec or more. CRT was associated with a significant reduction in left ventricular volumes and improvement in the ejection fraction. There was no significant difference between the two groups in the overall risk of death, with a 3% annual mortality rate in each treatment group. Serious adverse events were infrequent in the two groups. Conclusions: CRT combined with ICD decreased the risk of heart-failure events in relatively asymptomatic patients with a low ejection fraction and wide QRS complex. (ClinicalTrials.gov number, NCT00180271.) N Engl J Med 2009;361:1329-38.	[Moss, Arthur J.] Univ Rochester, Med Ctr, Heart Res Follow Up Program, Dept Med, Rochester, NY 14642 USA; [Hall, W. Jackson] Univ Rochester, Med Ctr, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Cannom, David S.] Hosp Good Samaritan, Div Cardiol, Los Angeles, CA 90017 USA; [Daubert, James P.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Estes, N. A. Mark, III] Tufts Univ New England Med Ctr, New England Cardiac Arrhythmia Ctr, Boston, MA USA; [Foster, Elyse] Univ Calif San Francisco, Cardiol Unit, San Francisco, CA 94143 USA; [Greenberg, Henry] St Lukes Roosevelt Hosp, Cardiol Unit, New York, NY 10025 USA; [Higgins, Steven L.] Scripps Mem Hosp, Dept Cardiol, La Jolla, CA USA; [Pfeffer, Marc A.; Solomon, Scott D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA; [Wilber, David] Loyola Univ, Med Ctr, Cardiovasc Inst, Chicago, IL 60611 USA	University of Rochester; University of Rochester; Duke University; Tufts Medical Center; University of California System; University of California San Francisco; Mount Sinai St. Luke's; Mount Sinai West; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Loyola University Chicago	Moss, AJ (corresponding author), Univ Rochester, Med Ctr, Heart Res Follow Up Program, Dept Med, Box 653, Rochester, NY 14642 USA.	heartajm@heart.rochester.edu	Daubert, James P./ABC-1476-2021; Zhang, Hui/E-8112-2010; Solomon, Scott/I-5789-2013	Sharma, Arjun/0000-0002-6484-1250; Katz, Amos/0000-0003-0422-934X; Zhang, Hui/0000-0001-6825-5649; Duru, Firat/0000-0002-4748-0158	Boston Scientific to the University of Rochester	Boston Scientific to the University of Rochester	Supported by a research grant from Boston Scientific to the University of Rochester, with funds distributed to the coordination and data center, enrolling centers, core laboratories, committees, and boards under subcontracts from the University of Rochester.	Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; COX DR, 1972, J R STAT SOC B, V187, P220; Curtis AB, 2009, CIRCULATION, V120, P921, DOI 10.1161/CIRCULATIONAHA.109.890335; Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741; Goldenberg I, 2006, CIRCULATION, V113, P2810, DOI 10.1161/CIRCULATIONAHA.105.577262; Hall WJ, 2002, BIOMETRIKA, V89, P699, DOI 10.1093/biomet/89.3.699; HEALY B, 1989, NEW ENGL J MED, V320, P949, DOI 10.1056/NEJM198904063201432; Kalbfleisch J.D., 2002, STAT ANAL FAILURE TI; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Moss AJ, 2005, ANN NONINVAS ELECTRO, V10, P34, DOI 10.1111/j.1542-474X.2005.00073.x; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Sharma AD, 2005, HEART RHYTHM, V2, P830, DOI 10.1016/j.hrthm.2005.05.015; Skali H, 2006, CIRCULATION, V114, P2298, DOI 10.1161/CIRCULATIONAHA.106.620039; WANG SK, 1987, BIOMETRICS, V43, P193, DOI 10.2307/2531959; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115	19	1993	2067	2	66	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14					1329	1338		10.1056/NEJMoa0906431	http://dx.doi.org/10.1056/NEJMoa0906431			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	500KZ	19723701	Bronze			2022-12-28	WOS:000270300000007
J	Haas, BJ; Kamoun, S; Zody, MC; Jiang, RHY; Handsaker, RE; Cano, LM; Grabherr, M; Kodira, CD; Raffaele, S; Torto-Alalibo, T; Bozkurt, TO; Ah-Fong, AMV; Alvarado, L; Anderson, VL; Armstrong, MR; Avrova, A; Baxter, L; Beynon, J; Boevink, PC; Bollmann, SR; Bos, JIB; Bulone, V; Cai, GH; Cakir, C; Carrington, JC; Chawner, M; Conti, L; Costanzo, S; Ewan, R; Fahlgren, N; Fischbach, MA; Fugelstad, J; Gilroy, EM; Gnerre, S; Green, PJ; Grenville-Briggs, LJ; Griffith, J; Grunwald, NJ; Horn, K; Horner, NR; Hu, CH; Huitema, E; Jeong, DH; Jones, AME; Jones, JDG; Jones, RW; Karlsson, EK; Kunjeti, SG; Lamour, K; Liu, ZY; Ma, LJ; MacLean, D; Chibucos, MC; McDonald, H; McWalters, J; Meijer, HJG; Morgan, W; Morris, PF; Munro, CA; O'Neill, K; Ospina-Giraldo, M; Pinzon, A; Pritchard, L; Ramsahoye, B; Ren, QH; Restrepo, S; Roy, S; Sadanandom, A; Savidor, A; Schornack, S; Schwartz, DC; Schumann, UD; Schwessinger, B; Seyer, L; Sharpe, T; Silvar, C; Song, J; Studholme, DJ; Sykes, S; Thines, M; van de Vondervoort, PJI; Phuntumart, V; Wawra, S; Weide, R; Win, J; Young, C; Zhou, SG; Fry, W; Meyers, BC; van West, P; Ristaino, J; Govers, F; Birch, PRJ; Whisson, SC; Judelson, HS; Nusbaum, C				Haas, Brian J.; Kamoun, Sophien; Zody, Michael C.; Jiang, Rays H. Y.; Handsaker, Robert E.; Cano, Liliana M.; Grabherr, Manfred; Kodira, Chinnappa D.; Raffaele, Sylvain; Torto-Alalibo, Trudy; Bozkurt, Tolga O.; Ah-Fong, Audrey M. V.; Alvarado, Lucia; Anderson, Vicky L.; Armstrong, Miles R.; Avrova, Anna; Baxter, Laura; Beynon, Jim; Boevink, Petra C.; Bollmann, Stephanie R.; Bos, Jorunn I. B.; Bulone, Vincent; Cai, Guohong; Cakir, Cahid; Carrington, James C.; Chawner, Megan; Conti, Lucio; Costanzo, Stefano; Ewan, Richard; Fahlgren, Noah; Fischbach, Michael A.; Fugelstad, Johanna; Gilroy, Eleanor M.; Gnerre, Sante; Green, Pamela J.; Grenville-Briggs, Laura J.; Griffith, John; Gruenwald, Niklaus J.; Horn, Karolyn; Horner, Neil R.; Hu, Chia-Hui; Huitema, Edgar; Jeong, Dong-Hoon; Jones, Alexandra M. E.; Jones, Jonathan D. G.; Jones, Richard W.; Karlsson, Elinor K.; Kunjeti, Sridhara G.; Lamour, Kurt; Liu, Zhenyu; Ma, LiJun; MacLean, Daniel; Chibucos, Marcus C.; McDonald, Hayes; McWalters, Jessica; Meijer, Harold J. G.; Morgan, William; Morris, Paul F.; Munro, Carol A.; O'Neill, Keith; Ospina-Giraldo, Manuel; Pinzon, Andres; Pritchard, Leighton; Ramsahoye, Bernard; Ren, Qinghu; Restrepo, Silvia; Roy, Sourav; Sadanandom, Ari; Savidor, Alon; Schornack, Sebastian; Schwartz, David C.; Schumann, Ulrike D.; Schwessinger, Ben; Seyer, Lauren; Sharpe, Ted; Silvar, Cristina; Song, Jing; Studholme, David J.; Sykes, Sean; Thines, Marco; van de Vondervoort, Peter J. I.; Phuntumart, Vipaporn; Wawra, Stephan; Weide, Rob; Win, Joe; Young, Carolyn; Zhou, Shiguo; Fry, William; Meyers, Blake C.; van West, Pieter; Ristaino, Jean; Govers, Francine; Birch, Paul R. J.; Whisson, Stephen C.; Judelson, Howard S.; Nusbaum, Chad			Genome sequence and analysis of the Irish potato famine pathogen Phytophthora infestans	NATURE			English	Article							EFFECTOR PROTEINS; RXLR EFFECTORS; CELL-DEATH; PLANT; AVIRULENCE; AVR3A; RESISTANCE; INFECTION; GENES	Phytophthora infestans is the most destructive pathogen of potato and a model organism for the oomycetes, a distinct lineage of fungus-like eukaryotes that are related to organisms such as brown algae and diatoms. As the agent of the Irish potato famine in the mid-nineteenth century, P. infestans has had a tremendous effect on human history, resulting in famine and population displacement(1). To this day, it affects world agriculture by causing the most destructive disease of potato, the fourth largest food crop and a critical alternative to the major cereal crops for feeding the world's population(1). Current annual worldwide potato crop losses due to late blight are conservatively estimated at $6.7 billion(2). Management of this devastating pathogen is challenged by its remarkable speed of adaptation to control strategies such as genetically resistant cultivars(3,4). Here we report the sequence of the P. infestans genome, which at similar to 240 megabases (Mb) is by far the largest and most complex genome sequenced so far in the chromalveolates. Its expansion results from a proliferation of repetitive DNA accounting for similar to 74% of the genome. Comparison with two other Phytophthora genomes showed rapid turnover and extensive expansion of specific families of secreted disease effector proteins, including many genes that are induced during infection or are predicted to have activities that alter host physiology. These fast-evolving effector genes are localized to highly dynamic and expanded regions of the P. infestans genome. This probably plays a crucial part in the rapid adaptability of the pathogen to host plants and underpins its evolutionary potential.	[Kamoun, Sophien; Cano, Liliana M.; Raffaele, Sylvain; Bozkurt, Tolga O.; Jones, Alexandra M. E.; Jones, Jonathan D. G.; MacLean, Daniel; Schornack, Sebastian; Schwessinger, Ben; Silvar, Cristina; Studholme, David J.; Thines, Marco; Win, Joe] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Haas, Brian J.; Zody, Michael C.; Handsaker, Robert E.; Grabherr, Manfred; Kodira, Chinnappa D.; Alvarado, Lucia; Gnerre, Sante; Karlsson, Elinor K.; Ma, LiJun; O'Neill, Keith; Sharpe, Ted; Sykes, Sean; Nusbaum, Chad] Broad Inst MIT & Harvard, Cambridge, MA 02141 USA; [Kamoun, Sophien; Torto-Alalibo, Trudy; Bos, Jorunn I. B.; Cakir, Cahid; Huitema, Edgar; Liu, Zhenyu; Song, Jing; Young, Carolyn] Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Plant Pathol, Wooster, OH 44691 USA; [Zody, Michael C.] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; [Jiang, Rays H. Y.; Meijer, Harold J. G.; van de Vondervoort, Peter J. I.; Weide, Rob; Govers, Francine] Univ Wageningen & Res Ctr, Phytopathol Lab, NL-6708 PB Wageningen, Netherlands; [Ah-Fong, Audrey M. V.; Roy, Sourav; Judelson, Howard S.] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Anderson, Vicky L.; Grenville-Briggs, Laura J.; Horner, Neil R.; Schumann, Ulrike D.; Wawra, Stephan; van West, Pieter] Univ Aberdeen, Aberdeen Oomycete Lab, Coll Life Sci & Med, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Armstrong, Miles R.; Avrova, Anna; Boevink, Petra C.; Gilroy, Eleanor M.; Pritchard, Leighton; Whisson, Stephen C.] Scottish Crop Res Inst, Plant Pathol Programme, Dundee DD2 5DA, Scotland; [Baxter, Laura; Beynon, Jim] Univ Warwick, Warwick CV35 9EF, England; [Bollmann, Stephanie R.; Gruenwald, Niklaus J.] ARS, USDA, Hort Crops Res Lab, Corvallis, OR 97330 USA; [Bulone, Vincent; Fugelstad, Johanna] AlbaNova Univ Ctr, Sch Biotechnol, Royal Inst Technol KTH, SE-10691 Stockholm, Sweden; [Cai, Guohong; Fry, William] Cornell Univ, Dept Plant Pathol & Plant Microbe Biol, Ithaca, NY 14853 USA; [Carrington, James C.; Fahlgren, Noah] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Carrington, James C.; Fahlgren, Noah] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Chawner, Megan; Griffith, John; Horn, Karolyn; McWalters, Jessica; Ospina-Giraldo, Manuel; Seyer, Lauren] Lafayette Coll, Dept Biol, Easton, PA 18042 USA; [Conti, Lucio; Ewan, Richard; Sadanandom, Ari] Univ Glasgow, Plant Mol Sci Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Costanzo, Stefano] ARS, USDA, Dale Bumpers Natl Rice Res Ctr, Stuttgart, AR 72160 USA; [Fischbach, Michael A.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Green, Pamela J.; Jeong, Dong-Hoon; Meyers, Blake C.] Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19711 USA; [Hu, Chia-Hui; Ristaino, Jean] N Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Jones, Richard W.] ARS, USDA, Beltsville, MD 20705 USA; [Kunjeti, Sridhara G.] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19716 USA; [Lamour, Kurt] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA; [Chibucos, Marcus C.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [McDonald, Hayes] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Morgan, William] Coll Wooster, Dept Biol, Wooster, OH 44691 USA; [Morris, Paul F.; Phuntumart, Vipaporn] Bowling Green State Univ, Dept Biol Sci, Bowling Green, OH 43403 USA; [Munro, Carol A.] Univ Aberdeen, Sch Med Sci, Coll Life Sci & Med, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Pinzon, Andres; Restrepo, Silvia] Univ Los Andes, Mycol & Phytopathol Lab, Bogota, Colombia; [Ramsahoye, Bernard] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Canc Res Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Schwartz, David C.; Zhou, Shiguo] Univ Wisconsin, Dept Chem, Genet Lab, Ctr Biotechnol,Lab Mol & Computat Genom, Madison, WI 53706 USA; [Thines, Marco] Univ Hohenheim, Inst Bot 210, D-70593 Stuttgart, Germany; [Birch, Paul R. J.] Univ Dundee, SCRI, Coll Life Sci, Div Plant Sci, Dundee DD2 5DA, Scotland; [Ren, Qinghu] J Craig Venter Inst, Rockville, MD 20850 USA; [Savidor, Alon] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Ohio; Ohio State University; Uppsala University; Wageningen University & Research; University of California System; University of California Riverside; University of Aberdeen; James Hutton Institute; University of Warwick; United States Department of Agriculture (USDA); Royal Institute of Technology; Cornell University; Oregon State University; Oregon State University; Lafayette College; University of Glasgow; United States Department of Agriculture (USDA); Harvard University; Massachusetts General Hospital; University of Delaware; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Delaware; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University System of Maryland; University of Maryland Baltimore; Vanderbilt University; College of Wooster; University System of Ohio; Bowling Green State University; University of Aberdeen; Universidad de los Andes (Colombia); University of Edinburgh; University of Wisconsin System; University of Wisconsin Madison; University Hohenheim; James Hutton Institute; University of Dundee; J. Craig Venter Institute; Tel Aviv University	Kamoun, S (corresponding author), Sainsbury Lab, Norwich NR4 7UH, Norfolk, England.	sophien.kamoun@tsl.ac.uk; chad@broad.mit.edu	Handsaker, Bob/AAX-9095-2021; Kamoun, Sophien/B-3529-2009; Govers, Francine/A-5616-2009; Jones, Alexandra/B-5227-2009; Grunwald, Niklaus` J/K-6041-2013; Bozkurt, Tolga O/C-9764-2014; Cano, Liliana M/O-7041-2016; Thines, Marco/H-1685-2011; Bulone, Vincent/C-8492-2019; Carrington, James C/A-4656-2012; Meijer, Harold/S-3891-2019; Schwessinger, Benjamin/R-5869-2018; Liu, Zhenyu/C-9814-2012; Meijer, HJG/AFN-5216-2022; Young, Carolyn Anne/Q-2963-2019; Liu, Zhenyu/O-2337-2018; Cai, Guohong/N-1274-2013; Schornack, Sebastian/AAE-4897-2020; Boevink, Petra/AAO-6498-2021; Meyers, Blake/B-6535-2012; Bozkurt, Tolga Osman/AAA-8014-2019; Liu, Zhenyu/C-1369-2014; Grenville-Briggs, Laura/B-3386-2013; Restrepo, Silvia/G-1297-2010; Schornack, Sebastian/A-3650-2011; Bos, Jorunn IB/E-4703-2011; Kunjeti, Sridhara/AFU-0653-2022; Win, Joe/H-2557-2014; Silvar, Cristina/G-5141-2010; Baxter, laura/GWD-1304-2022; Schumann, Ulrike D/F-3987-2011; Raffaele, Sylvain/F-7187-2012; Bulone, Vincent/D-7469-2013; Song, Jing/F-7567-2014; Munro, Carol A/A-5175-2011; Zhou, Shiguo/B-3832-2011; Fahlgren, Noah/D-4404-2011; Studholme, David/H-6790-2019; Raffaele, Sylvain/K-6673-2019; Grenville-Briggs, Laura J/C-3419-2014; MacLean, Dan/C-7046-2013; Meijer, Harold/G-5703-2012; Chibucos, Marcus/B-1506-2015; Roy, Sourav/A-5330-2013; Wawra, Stephan/D-2781-2013; Conti, Lucio/M-7982-2013; Huitema, Edgar/G-3760-2011; Ristaino, Jean Beagle/N-3616-2018; Birch, Paul/F-7681-2012; Ma, Li-Jun/AAG-2359-2020; Pritchard, Leighton/A-7331-2008	Handsaker, Bob/0000-0002-3128-3547; Kamoun, Sophien/0000-0002-0290-0315; Govers, Francine/0000-0001-5311-929X; Jones, Alexandra/0000-0003-2571-8708; Grunwald, Niklaus` J/0000-0003-1656-7602; Bozkurt, Tolga O/0000-0003-0507-6875; Cano, Liliana M/0000-0002-7996-4181; Bulone, Vincent/0000-0003-2809-4160; Carrington, James C/0000-0003-3572-129X; Meijer, Harold/0000-0002-0883-219X; Schwessinger, Benjamin/0000-0002-7194-2922; Meijer, HJG/0000-0002-0883-219X; Young, Carolyn Anne/0000-0003-0406-8398; Liu, Zhenyu/0000-0002-8320-7845; Cai, Guohong/0000-0002-7700-6019; Schornack, Sebastian/0000-0002-7836-5881; Boevink, Petra/0000-0002-7021-9097; Meyers, Blake/0000-0003-3436-6097; Bozkurt, Tolga Osman/0000-0003-0507-6875; Schornack, Sebastian/0000-0002-7836-5881; Bos, Jorunn IB/0000-0003-3222-8643; Win, Joe/0000-0002-9851-2404; Silvar, Cristina/0000-0002-1782-8045; Schumann, Ulrike D/0000-0002-2379-1226; Raffaele, Sylvain/0000-0002-2442-9632; Zhou, Shiguo/0000-0001-7421-2506; Fahlgren, Noah/0000-0002-5597-4537; Studholme, David/0000-0002-3010-6637; Raffaele, Sylvain/0000-0002-2442-9632; Grenville-Briggs, Laura J/0000-0001-5910-3651; MacLean, Dan/0000-0003-1032-0887; Chibucos, Marcus/0000-0001-9586-0780; Roy, Sourav/0000-0002-0359-994X; Wawra, Stephan/0000-0001-8555-1618; Conti, Lucio/0000-0002-7837-4227; Huitema, Edgar/0000-0002-5766-0830; Ristaino, Jean Beagle/0000-0002-9458-0514; Pritchard, Leighton/0000-0002-8392-2822; Horner, Neil/0000-0002-0550-4537; van West, Pieter/0000-0002-0767-6017; Karlsson, Elinor/0000-0002-4343-3776; Fischbach, Michael/0000-0003-3079-8247; Ma, Li-Jun/0000-0002-2733-3708; Sykes, Sean/0000-0001-8344-5176; Pinzon, Andres/0000-0002-4133-810X; Morgan, William/0000-0001-7995-8067; Restrepo, Silvia/0000-0001-9016-1040; Birch, Paul/0000-0002-6559-3746; Munro, Carol/0000-0003-0761-1755; Grabherr, Manfred/0000-0001-8792-6508; Kunjeti, Sridhara/0000-0002-6326-2644; Morris, Paul/0000-0002-2989-041X	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2004-35600-15024, 2006-35600-16623]; National Science Foundation [EF-0333274, EF-0523670]; Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council [BB/E006795/1, BB/E007120/1, BB/C509123/1, BBS/B/07152, BB/G015244/1] Funding Source: researchfish; Medical Research Council [G0400284] Funding Source: researchfish; Natural Environment Research Council [NE/F012578/1] Funding Source: researchfish; BBSRC [BB/G015244/1, BB/E007120/1, BB/E006795/1] Funding Source: UKRI; MRC [G0400284] Funding Source: UKRI; NERC [NE/F012578/1] Funding Source: UKRI	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation(National Science Foundation (NSF)); Gatsby Charitable Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Acknowledgements We thank L. Gaffney for help with figures and tables, E. Blanco and R. Guigo for training the GeneID gene prediction software, J. Crabtree for providing a Sybil (http://sybil.sf.net) software component used to render genome comparison illustrations, the Broad Institute Genome Sequencing Platform for sequence data generation, and C. Cuomo and D. Neafsey for comments on the manuscript. The project was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, grant numbers 2004-35600-15024 and 2006-35600-16623, and the National Science Foundation grants EF-0333274 and EF-0523670, and the Gatsby Charitable Foundation.	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Blair JE, 2008, FUNGAL GENET BIOL, V45, P266, DOI 10.1016/j.fgb.2007.10.010; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Enright AJ, 2003, NUCLEIC ACIDS RES, V31, P4632, DOI 10.1093/nar/gkg495; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Grenville-Briggs LJ, 2005, FUNGAL GENET BIOL, V42, P244, DOI 10.1016/j.fgb.2004.11.009; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Haverkort AJ, 2008, POTATO RES, V51, P47, DOI 10.1007/s11540-008-9089-y; Jiang RHY, 2008, P NATL ACAD SCI USA, V105, P4874, DOI 10.1073/pnas.0709303105; Kamoun S, 1997, MOL PLANT MICROBE IN, V10, P13, DOI 10.1094/MPMI.1997.10.1.13; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Morgan W, 2007, CURR OPIN MICROBIOL, V10, P332, DOI 10.1016/j.mib.2007.04.005; Qutob D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005066; Reader J., 2009, POTATO HIST PROPITIO; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; van Poppel PMJA, 2008, MOL PLANT MICROBE IN, V21, P1460, DOI 10.1094/MPMI-21-11-1460; Vleeshouwers VGAA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002875; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Yuan YN, 2002, GENOME RES, V12, P1345, DOI 10.1101/gr.185902	24	977	1150	15	427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					393	398		10.1038/nature08358	http://dx.doi.org/10.1038/nature08358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19741609	hybrid, Green Published			2022-12-28	WOS:000269828100039
J	Worster, A				Worster, Andrew			3 prediction rules, particularly ABCD, identify ED patients who can be discharged with low risk for stroke after TIA	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Worster, A (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Cucchiara BL, 2006, STROKE, V37, P1710, DOI 10.1161/01.STR.0000227195.46336.93	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6							JC3-15	10.7326/0003-4819-151-6-200909150-02015	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-02015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755361				2022-12-28	WOS:000270390100031
J	Nabelek, J; Hetenyi, G; Vergne, J; Sapkota, S; Kafle, B; Jiang, M; Su, HP; Chen, J; Huang, BS				Nabelek, John; Hetenyi, Gyoergy; Vergne, Jerome; Sapkota, Soma; Kafle, Basant; Jiang, Mei; Su, Heping; Chen, John; Huang, Bor-Shouh		Hi-CLIMB Team	Underplating in the Himalaya-Tibet Collision Zone Revealed by the Hi-CLIMB Experiment	SCIENCE			English	Article							INDIAN LITHOSPHERE BENEATH; SOUTHERN TIBET; GRAVITY-ANOMALIES; MIDDLE CRUST; PLATEAU; MANTLE; SUBDUCTION; NEPAL; VELOCITIES; WAVES	We studied the formation of the Himalayan mountain range and the Tibetan Plateau by investigating their lithospheric structure. Using an 800-kilometer-long, densely spaced seismic array, we have constructed an image of the crust and upper mantle beneath the Himalayas and the southern Tibetan Plateau. The image reveals in a continuous fashion the Main Himalayan thrust fault as it extends from a shallow depth under Nepal to the mid-crust under southern Tibet. Indian crust can be traced to 31 degrees N. The crust/mantle interface beneath Tibet is anisotropic, indicating shearing during its formation. The dipping mantle fabric suggests that the Indian mantle is subducting in a diffuse fashion along several evolving subparallel structures.	[Nabelek, John] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Hetenyi, Gyoergy; Vergne, Jerome] Ecole Normale Super, CNRS, Geol Lab, UMR 8538, F-75005 Paris, France; [Sapkota, Soma; Kafle, Basant] Natl Seismol Ctr, Dept Mines & Geol, Kathmandu, Nepal; [Jiang, Mei; Su, Heping] Chinese Acad Geol Sci, Inst Geol, Beijing, Peoples R China; [Chen, John] Peking Univ, Inst Theoret & Appl Geophys, Beijing 100871, Peoples R China; [Huang, Bor-Shouh] Acad Sinica, Inst Earth Sci, Taipei 115, Taiwan	Oregon State University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Chinese Academy of Geological Sciences; Peking University; Academia Sinica - Taiwan	Nabelek, J (corresponding author), Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	nabelek@coas.oregonstate.edu	Hetenyi, Gyorgy/A-9120-2013; Huang, B.S./N-3371-2013; Vergne, Jérôme/F-8592-2014; Mitchell, Logan/A-5481-2011	Hetenyi, Gyorgy/0000-0001-9036-4761; Vergne, Jérôme/0000-0003-1731-9360; Huang, Bor-Shouh/0000-0003-4905-1960; Mitchell, Logan/0000-0002-8749-954X; Nabelek, John/0000-0001-6433-207X; liang, xiao feng/0000-0002-0600-0461; TSENG, TAI-LIN/0000-0003-4918-6662	U. S. NSF; Continental Dynamics Program [EAR 9909609]; Department of Mines and Geology, Nepal; Chinese Academy of Geological Sciences and Peking University; Institute of Earth Sciences, Academia Sinica, Taiwan; French program DyETI	U. S. NSF(National Science Foundation (NSF)); Continental Dynamics Program; Department of Mines and Geology, Nepal; Chinese Academy of Geological Sciences and Peking University; Institute of Earth Sciences, Academia Sinica, Taiwan(Academia Sinica - Taiwan); French program DyETI	The Hi-CLIMB team was supported by the U. S. NSF, Continental Dynamics Program, grant EAR 9909609. The fieldwork was also supported in part by the Department of Mines and Geology, Nepal; the Chinese Academy of Geological Sciences and Peking University; and the Institute of Earth Sciences, Academia Sinica, Taiwan. G. H.'s thesis (http://tel.archives-ouvertes.fr/tel-00194619/en/) was supported by the French program DyETI. We acknowledge W.-P. Chen for the contribution to the planning of the experiment.	Alsdorf D, 1996, J GEOPHYS RES-SOL EA, V101, P25305, DOI 10.1029/96JB02120; BABUSKA V, 1982, GEOPHYS J ROY ASTRON, V76, P113; BARAZANGI M, 1982, GEOLOGY, V10, P179, DOI 10.1130/0091-7613(1982)10<179:VAPCOP>2.0.CO;2; Beaumont C, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002809; Bollinger L, 2006, EARTH PLANET SC LETT, V244, P58, DOI 10.1016/j.epsl.2006.01.045; Chen WP, 1998, GEOPHYS J INT, V135, P93, DOI 10.1046/j.1365-246X.1998.00611.x; Chen WP, 2004, SCIENCE, V304, P1949, DOI 10.1126/science.1097324; DeCelles PG, 2001, TECTONICS, V20, P487, DOI 10.1029/2000TC001226; Guillot S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000484; Hetenyi G, 2007, EARTH PLANET SC LETT, V264, P226, DOI 10.1016/j.epsl.2007.09.036; Hetenyi G, 2006, GEOPHYS J INT, V167, P1106, DOI 10.1111/j.1365-246X.2006.03198.x; HIRN A, 1984, NATURE, V307, P25, DOI 10.1038/307025a0; Kind R, 2002, SCIENCE, V298, P1219, DOI 10.1126/science.1078115; Kong XG, 1999, CHINESE SCI BULL, V44, P2022, DOI 10.1007/BF02884914; LANGSTON CA, 1979, J GEOPHYS RES, V84, P4749, DOI 10.1029/JB084iB09p04749; Lemonnier C, 1999, GEOPHYS RES LETT, V26, P3261, DOI 10.1029/1999GL008363; Li C, 2008, EARTH PLANET SC LETT, V274, P157, DOI 10.1016/j.epsl.2008.07.016; Makovsky Y, 1999, J GEOPHYS RES-SOL EA, V104, P10795, DOI 10.1029/1998JB900074; Monsalve G, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004062; NABELEK J, 1994, EOS S, V75, P628; Nelson KD, 1996, SCIENCE, V274, P1684, DOI 10.1126/science.274.5293.1684; Patro PK, 2009, PHYS EARTH PLANET IN, V173, P171, DOI 10.1016/j.pepi.2008.10.011; Rodgers ATJ, 1997, GEOPHYS RES LETT, V24, P9, DOI 10.1029/96GL03774; Schulte-Pelkum V, 2005, NATURE, V435, P1222, DOI 10.1038/nature03678; Shi D, 2004, GEOLOGY, V32, P209, DOI 10.1130/G19814.1; Tilmann F, 2003, SCIENCE, V300, P1424, DOI 10.1126/science.1082777; Unsworth MJ, 2005, NATURE, V438, P78, DOI 10.1038/nature04154; VERGNE J, 2005, EOS S, V86; Wittlinger G, 2004, EARTH PLANET SC LETT, V221, P117, DOI 10.1016/S0012-821X(03)00723-4	29	554	601	14	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1371	1374		10.1126/science.1167719	http://dx.doi.org/10.1126/science.1167719			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745147				2022-12-28	WOS:000269699100032
J	Gowri, V; Jain, R				Gowri, Vaidyanathan; Jain, Rajeev			Case Report Investigating infertility	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TUMOR-MARKER; OVARIAN-CANCER; DOPPLER; COLOR; METFORMIN		[Gowri, Vaidyanathan; Jain, Rajeev] Sultan Qaboos Univ, Muscat 123, Oman	Sultan Qaboos University	Gowri, V (corresponding author), Sultan Qaboos Univ, POB 35, Muscat 123, Oman.	gowrie61@hotmail.com		Gowri, vaidyanatahn/0000-0002-7055-336X				ALCZAR JL, 1999, INT J GYNECOL OBSTET, V66, P255; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bon GG, 1996, AM J OBSTET GYNECOL, V174, P107, DOI 10.1016/S0002-9378(96)70381-2; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Eltabbakh GH, 1998, J REPROD MED, V43, P636; Gadducci A, 1996, GYNECOL ONCOL, V60, P197, DOI 10.1006/gyno.1996.0025; Guerriero S, 2005, AM J OBSTET GYNECOL, V192, P401, DOI 10.1016/j.ajog.2004.09.002; KOONINGS PP, 1989, OBSTET GYNECOL, V74, P921; KURJAK A, 1992, J ULTRAS MED, V11, P631; Kurtz AB, 1999, RADIOLOGY, V212, P19, DOI 10.1148/radiology.212.1.r99jl3619; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Lord JM, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003053; Moll E, 2006, BRIT MED J, V332, P1485, DOI 10.1136/bmj.38867.631551.55; Paramasivam S, 2005, J CLIN ONCOL, V23, P5938, DOI 10.1200/JCO.2005.08.151; Predanic M, 1996, OBSTET GYNECOL, V88, P283, DOI 10.1016/0029-7844(96)00152-4; PRESSLEY RH, 1992, GYNECOL ONCOL, V44, P281, DOI 10.1016/0090-8258(92)90058-Q; REYNOL K, 2004, OBSTET GYNECOLOGY EV, P38; *ROYAL COLL OBST G, 2007, LONG TERM CONS POL O; SOUTTER P, 2003, AM J OBSTET GYNECOL, P665; Tuxen MK, 2001, J TUMOR MARKER ONCOL, V16, P49; Van Calster B, 2007, JNCI-J NATL CANCER I, V99, P1706, DOI 10.1093/jnci/djm199	21	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2009	339								b3390	10.1136/bmj.b3390	http://dx.doi.org/10.1136/bmj.b3390			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	493RD	19740916				2022-12-28	WOS:000269754700002
J	Sing, A; Pannell, D; Karaiskakis, A; Sturgeon, K; Djabali, M; Ellis, J; Lipshitz, HD; Cordes, SP				Sing, Angela; Pannell, Dylan; Karaiskakis, Angelo; Sturgeon, Kendra; Djabali, Malek; Ellis, James; Lipshitz, Howard D.; Cordes, Sabine P.			A Vertebrate Polycomb Response Element Governs Segmentation of the Posterior Hindbrain	CELL			English	Article							EMBRYONIC STEM-CELLS; H3 LYSINE-27 METHYLATION; DNA-BINDING PROTEIN; DROSOPHILA-MELANOGASTER; TARGET GENES; METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; TRANSCRIPTION FACTOR; BITHORAX COMPLEX; UBX GENE	Chromatin remodeling by Polycomb group (PcG) and trithorax group (trxG) proteins regulates gene expression in all metazoans. Two major complexes, Polycomb repressive complexes 1 and 2 (PRC1 and PRC2), are thought to mediate PcG-dependent repression in flies and mammals. In Drosophila, PcG/trxG protein complexes are recruited by PcG/trxG response elements (PREs). However, it has been unclear how PcG/trxG are recuited in vertebrates. Here we have identified a vertebrate PRE, PRE-kr, that regulates expression of the mouse MafB/Kreisler gene. PRE-kr recruits PcG proteins in flies and mouse F9 cells and represses gene expression in a PcG/trxG-dependent manner. PRC1 and 2 bind to a minimal PRE-kr region, which can recruit stable PRC1 binding but only weak PRC2 binding when introduced ectopically, suggesting that PRC1 and 2 have different binding requirements. Thus, we provide evidence that similar to invertebrates, PREs act as entry sites for PcG/trxG chromatin remodeling in vertebrates.	[Sing, Angela; Sturgeon, Kendra; Cordes, Sabine P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Pannell, Dylan; Karaiskakis, Angelo; Ellis, James; Lipshitz, Howard D.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Sing, Angela; Pannell, Dylan; Karaiskakis, Angelo; Sturgeon, Kendra; Ellis, James; Lipshitz, Howard D.; Cordes, Sabine P.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada; [Djabali, Malek] CNRS, INSERM, Ctr Immunol, F-13288 Marseille 9, France	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Cordes, SP (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	cordes@lunenfeld.ca	Ellis, James/F-4789-2011; Cordes, Sabine P/A-5423-2012	Ellis, James/0000-0002-4400-0091; Lipshitz, Howard/0000-0002-7372-4419	CIHR [14312]	CIHR(Canadian Institutes of Health Research (CIHR))	We thank Renato Paro for PC and PH antibodies, G. Cavalli for the immuno-FISH protocol, Sandra Tondat and the Samuel Lunenfeld Research Institute Transgenic facility for transgenic mice, and Eddy Rubin for help with sequence analysis. We would also like to thank Dragana Vukasovic and Lori Nelson for administrative assistance. This work was funded by CIHR grant # 14312 to S. P. C.	ARTZT K, 1973, P NATL ACAD SCI USA, V70, P2988, DOI 10.1073/pnas.70.10.2988; Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Beisel C, 2007, P NATL ACAD SCI USA, V104, P16615, DOI 10.1073/pnas.0701538104; Bel-Vialar S, 2000, DEV BIOL, V224, P238, DOI 10.1006/dbio.2000.9791; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Courel M, 2008, DEV DYNAM, V237, P1232, DOI 10.1002/dvdy.21516; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Eden E, 2007, PLOS COMPUT BIOL, V3, P508, DOI 10.1371/journal.pcbi.0030039; FROHMAN MA, 1993, DEVELOPMENT, V117, P925; Gavalas A, 1998, DEVELOPMENT, V125, P1123; Gee H, 2008, NATURE, V453, P999, DOI 10.1038/453999a; Gellon G, 1997, DEVELOPMENT, V124, P3321; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Giudicelli F, 2003, DEV BIOL, V253, P150, DOI 10.1006/dbio.2002.0864; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; GUTHRIE S, 1991, DEVELOPMENT, V112, P221; Hauenschild A, 2008, PLOS BIOL, V6, P2130, DOI 10.1371/journal.pbio.0060261; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Huang DH, 2002, MOL CELL BIOL, V22, P6261, DOI 10.1128/MCB.22.17.6261-6271.2002; John RM, 2001, DEV BIOL, V236, P387, DOI 10.1006/dbio.2001.0327; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Karakuzu O, 2009, DEVELOPMENT, V136, P943, DOI 10.1242/dev.029363; Kim FA, 2005, MECH DEVELOP, V122, P1300, DOI 10.1016/j.mod.2005.08.001; King IFG, 2002, MOL CELL BIOL, V22, P7919, DOI 10.1128/MCB.22.22.7919-7928.2002; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Lavrov S, 2004, METH MOL B, V247, P289; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Lyko F, 1997, NAT GENET, V16, P171, DOI 10.1038/ng0697-171; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Puschendorf M, 2008, NAT GENET, V40, P411, DOI 10.1038/ng.99; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Rivkin E, 2008, GENESIS, V46, P119, DOI 10.1002/dvg.20371; Rusch DB, 2000, GENETICS, V156, P183; Sadl VS, 2003, DEV DYNAM, V227, P134, DOI 10.1002/dvdy.10279; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Swaminathan J, 2005, GENE DEV, V19, P65, DOI 10.1101/gad.1259105; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; WIJNHOLDS J, 1995, DEV BIOL, V171, P73, DOI 10.1006/dbio.1995.1261; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021	71	188	200	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					885	897		10.1016/j.cell.2009.08.020	http://dx.doi.org/10.1016/j.cell.2009.08.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737517	Bronze			2022-12-28	WOS:000269564600015
J	Yan, D; Wu, ZL; Chisholm, AD; Jin, YS				Yan, Dong; Wu, Zilu; Chisholm, Andrew D.; Jin, Yishi			The DLK-1 Kinase Promotes mRNA Stability and Local Translation in C. elegans Synapses and Axon Regeneration	CELL			English	Article							ZIPPER-BEARING KINASE; TRANSCRIPTION FACTOR; PROTEIN-SYNTHESIS; GENE-EXPRESSION; LOCALIZATION; RPM-1; IDENTIFICATION; GROWTH; C/EBP; TRANSPORT	Growth cone guidance and synaptic plasticity involve dynamic local changes in proteins at axons and dendrites. The Dual-Leucine zipper Kinase MAPKKK (DLK) has been previously implicated in synaptogenesis and axon outgrowth in C. elegans and other animals. Here we show that in C. elegans DLK-1 regulates not only proper synapse formation and axon morphology but also axon regeneration by influencing mRNA stability. DLK-1 kinase signals via a MAPKAP kinase, MAK-2, to stabilize the mRNA encoding CEBP-1, a bZip protein related to CCAAT/enhancer-binding proteins, via its 3'UTR. Inappropriate upregulation of cebp-1 in adult neurons disrupts synapses and axon morphology. CEBP-1 and the DLK-1 pathway are essential for axon regeneration after laser axotomy in adult neurons, and axotomy induces translation of CEBP-1 in axons. Our findings identify the DLK-1 pathway as a regulator of mRNA stability in synapse formation and maintenance and also in adult axon regeneration.	[Yan, Dong; Wu, Zilu; Chisholm, Andrew D.; Jin, Yishi] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Chisholm, Andrew D.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Jin, Yishi] Univ Calif San Diego, Dept Cellular & Mol Med, Sch Med, La Jolla, CA 92093 USA; [Yan, Dong; Wu, Zilu; Jin, Yishi] Howard Hughes Med Inst, Chevy Chase, MD USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute	Jin, YS (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	yijin@ucsd.edu		Chisholm, Andrew/0000-0001-5091-0537; Jin, Yishi/0000-0002-9371-9860	NIH [NS35546, NS57317]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057317, R01NS035546, R56NS057317] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 awards NS35546 to Y. J. and NS57317 to A. D. C. D. Y. and Z.W. are associates and Y. J. is an Investigator of the Howard Hughes Medical Institute.	Abrams B, 2008, DEV DYNAM, V237, P630, DOI 10.1002/dvdy.21446; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; BERNARDI A, 1972, P NATL ACAD SCI USA, V69, P3033, DOI 10.1073/pnas.69.10.3033; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; BRENNER S, 1974, GENETICS, V77, P71; Brittis PA, 2002, CELL, V110, P223, DOI 10.1016/S0092-8674(02)00813-9; Brunet I, 2005, NATURE, V438, P94, DOI 10.1038/nature04110; Ch'ng' Q, 2003, GENETICS, V164, P1355; Chalfie M, 1995, PROG BRAIN RES, V105, P179; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Di Giovanni S, 2004, FASEB J, V18, P153, DOI 10.1096/fj.04-2694fje; FIRE A, 1990, GENE, V93, P189, DOI 10.1016/0378-1119(90)90224-F; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Giuditta A, 2002, TRENDS NEUROSCI, V25, P400, DOI 10.1016/S0166-2236(02)02188-4; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; Hammarlund M, 2009, SCIENCE, V323, P802, DOI 10.1126/science.1165527; Harris KD, 2008, TRENDS NEUROSCI, V31, P130, DOI 10.1016/j.tins.2007.12.002; Herdegen T, 1997, TRENDS NEUROSCI, V20, P227, DOI 10.1016/S0166-2236(96)01000-4; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Hu JY, 2004, J NEUROSCI, V24, P9933, DOI 10.1523/JNEUROSCI.3329-04.2004; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; KIM J, 1993, P NATL ACAD SCI USA, V90, P4513, DOI 10.1073/pnas.90.10.4513; Korneev Sergei, 1997, Invertebrate Neuroscience, V3, P185, DOI 10.1007/BF02480373; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Leung KM, 2006, NAT NEUROSCI, V9, P1247, DOI 10.1038/nn1775; Lewcock JW, 2007, NEURON, V56, P604, DOI 10.1016/j.neuron.2007.09.009; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lyles V, 2006, NEURON, V49, P349, DOI 10.1016/j.neuron.2005.12.029; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; Nedelec S, 2004, P NATL ACAD SCI USA, V101, P10815, DOI 10.1073/pnas.0403824101; Piper M, 2004, ANNU REV CELL DEV BI, V20, P505, DOI 10.1146/annurev.cellbio.20.010403.111746; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Raivich G, 2004, NEURON, V43, P57, DOI 10.1016/j.neuron.2004.06.005; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Roche FK, 2009, J NEUROSCI, V29, P638, DOI 10.1523/JNEUROSCI.3845-08.2009; SANFORD T, 1983, J BIOL CHEM, V258, P2804; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; STEWARD O, 1982, J NEUROSCI, V2, P284; Sung YJ, 2001, J NEUROBIOL, V47, P67, DOI 10.1002/neu.1016; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Wang DO, 2009, SCIENCE, V324, P1536, DOI 10.1126/science.1173205; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Willis DE, 2007, J CELL BIOL, V178, P965, DOI 10.1083/jcb.200703209; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wu Z, 2007, P NATL ACAD SCI USA, V104, P15132, DOI 10.1073/pnas.0707001104; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yudin D, 2008, NEURON, V59, P241, DOI 10.1016/j.neuron.2008.05.029; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	61	252	267	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					1005	1018		10.1016/j.cell.2009.06.023	http://dx.doi.org/10.1016/j.cell.2009.06.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737525	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000269564600024
J	Yao, CK; Lin, YQ; Ly, CV; Ohyama, T; Haueter, CM; Moiseenkova-Bell, VY; Wensel, TG; Bellen, HJ				Yao, Chi-Kuang; Lin, Yong Qi; Ly, Cindy V.; Ohyama, Tomoko; Haueter, Claire M.; Moiseenkova-Bell, Vera Y.; Wensel, Theodore G.; Bellen, Hugo J.			A Synaptic Vesicle-Associated Ca2+ Channel Promotes Endocytosis and Couples Exocytosis to Endocytosis	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; CALCIUM-DEPENDENCE; ENDOPHILIN; MEMBRANE; RELEASE; SYNAPTOJANIN; SELECTIVITY; PERMEATION; SUPPRESSOR; MUTATIONS	Synaptic vesicle (SV) exo- and endocytosis are tightly coupled to sustain neurotransmission in presynaptic terminals, and both are regulated by Ca2+. Ca2+ influx triggered by voltage-gated Ca2+ channels is necessary for SV fusion. However, extracellular Ca2+ has also been shown to be required for endocytosis. The intracellular Ca2+ levels (<1 mu M) that trigger endocytosis are typically much lower than those (>10 mu M) needed to induce exocytosis, and endocytosis is inhibited when the Ca2+ level exceeds 1 mu M. Here, we identify and characterize a transmembrane protein associated with SVs that, upon SV fusion, localizes at periactive zones. Loss of Flower results in impaired intracellular resting Ca2+ levels and impaired endocytosis. Flower multimerizes and is able to form a channel to control Ca2+ influx. We propose that Flower functions as a Ca2+ channel to regulate synaptic endocytosis and hence couples exo- with endocytosis.	[Yao, Chi-Kuang; Lin, Yong Qi; Haueter, Claire M.; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Ly, Cindy V.; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ohyama, Tomoko; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Moiseenkova-Bell, Vera Y.; Wensel, Theodore G.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.	hbellen@bcm.tmc.edu	Yao, Chi-Kuang/Y-9325-2019	Yao, Chi-Kuang/0000-0003-0977-4347; Bellen, Hugo/0000-0001-5992-5989; Ohyama, Tomoko/0000-0003-1697-1138; Wensel, Theodore/0000-0003-3518-9352	National Institute of Neurological Disease [F30NS056520]; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS056520] Funding Source: NIH RePORTER	National Institute of Neurological Disease; Baylor College of Medicine Intellectual and Developmental Disabilities Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Yuchun He, Hongling Pan, Yu Cao, and Zhihua Wang for technical assistance. We thank Ben Tobe, Julie Vargas, and Frank T. Horrigan for helping with the 45 Ca<SUP>2+</SUP> experiments. We thank Karen L. Schulze, Christian Rosenmund, Huda Zoghbi, Patrik Verstreken, Robin Hiesinger, Paul Pfaffinger, Ellen Lumpkin, Mingshan Xue, and Nikos Giagtzoglou for comments and discussions, and the Bloomington Stock Center and the Developmental Studies Hybridoma Bank for reagents. C. V. L. was supported by a National Research Service Award from the National Institute of Neurological Disease (F30NS056520). Confocal microscopy was supported by the Baylor College of Medicine Intellectual and Developmental Disabilities Research Center. H. J. B. is an investigator of the Howard Hughes Medical Institute.	ADLER EM, 1991, J NEUROSCI, V11, P1496; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Catterall WA, 2008, NEURON, V59, P882, DOI 10.1016/j.neuron.2008.09.005; Cousin MA, 1998, NEUROSCI LETT, V253, P1, DOI 10.1016/S0304-3940(98)00610-7; Cousin MA, 2000, J NEUROSCI, V20, P949, DOI 10.1523/JNEUROSCI.20-03-00949.2000; Cousin MA, 2000, MOL NEUROBIOL, V22, P115, DOI 10.1385/MN:22:1-3:115; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dickman DK, 2006, CURR BIOL, V16, P591, DOI 10.1016/j.cub.2006.02.058; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Fabian-Fine R, 2003, J NEUROSCI, V23, P10732; Farkas R, 1998, IN VITRO CELL DEV-AN, V34, P813; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Guatimosim C, 1998, J NEUROCHEM, V70, P2477; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HENKEL AW, 1995, NEUROPHARMACOLOGY, V34, P1397, DOI 10.1016/0028-3908(95)00126-Q; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Kuromi H, 2004, NEURON, V41, P101, DOI 10.1016/S0896-6273(03)00815-8; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lisman JE, 2007, NAT REV NEUROSCI, V8, P597, DOI 10.1038/nrn2191; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Macleod GT, 2004, J NEUROSCI, V24, P2496, DOI 10.1523/JNEUROSCI.5372-03.2004; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Marks B, 1998, CURR BIOL, V8, P740, DOI 10.1016/S0960-9822(98)70297-0; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Ohkura M, 2005, ANAL CHEM, V77, P5861, DOI 10.1021/ac0506837; Ohyama T, 2007, J CELL BIOL, V179, P1481, DOI 10.1083/jcb.200710061; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; PETROVICH TZ, 1993, GENETICS, V133, P955; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sather WA, 2003, ANNU REV PHYSIOL, V65, P133, DOI 10.1146/annurev.physiol.65.092101.142345; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Stowers RS, 1999, GENETICS, V152, P1631; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Xiong J, 2002, J NEUROSCI, V22, P10761; Zefirov AL, 2006, NEUROSCIENCE, V143, P905, DOI 10.1016/j.neuroscience.2006.08.025; Zhai RG, 2003, P NATL ACAD SCI USA, V100, P10860, DOI 10.1073/pnas.1832753100; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	59	102	104	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					947	960		10.1016/j.cell.2009.06.033	http://dx.doi.org/10.1016/j.cell.2009.06.033			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737521	Green Accepted, Bronze			2022-12-28	WOS:000269564600020
J	Mallen, CD; Chesterton, LS; Hay, EM				Mallen, Christian David; Chesterton, Linda S.; Hay, Elaine M.			10-Minute Consultation Tennis elbow	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mallen, Christian David; Chesterton, Linda S.; Hay, Elaine M.] Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele ST5 5BG, Staffs, England	Keele University	Mallen, CD (corresponding author), Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele ST5 5BG, Staffs, England.	c.d.mallen@cphc.keele.ac.uk		Mallen, Christian/0000-0002-2677-1028	Arthritis Research UK Funding Source: Medline; Department of Health [PB-PG-0407-13189] Funding Source: Medline; National Institute for Health Research [PB-PG-0407-13189] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))			0	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 2	2009	339								b3180	10.1136/bmj.b3180	http://dx.doi.org/10.1136/bmj.b3180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CH	19726459				2022-12-28	WOS:000269554000013
J	Montalescot, G; Cayla, G; Collet, JP; Elhadad, S; Beygui, F; Le Breton, H; Choussat, R; Leclercq, F; Silvain, J; Duclos, F; Aout, M; Dubois-Rande, JL; Barthelemy, O; Ducrocq, G; Bellemain-Appaix, A; Payot, L; Steg, PG; Henry, P; Spaulding, C; Vicaut, E				Montalescot, Gilles; Cayla, Guillaume; Collet, Jean-Philippe; Elhadad, Simon; Beygui, Farzin; Le Breton, Herve; Choussat, Remi; Leclercq, Florence; Silvain, Johanne; Duclos, Francois; Aout, Mounir; Dubois-Rande, Jean-Luc; Barthelemy, Olivier; Ducrocq, Gregory; Bellemain-Appaix, Anne; Payot, Laurent; Steg, Philippe-Gabriel; Henry, Patrick; Spaulding, Christian; Vicaut, Eric		ABOARD Investigators	Immediate vs Delayed Intervention for Acute Coronary Syndromes A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELEVATION MYOCARDIAL-INFARCTION; HIGH-RISK PATIENTS; UNSTABLE ANGINA; UNFRACTIONATED HEPARIN; INVASIVE MANAGEMENT; GLOBAL REGISTRY; TASK-FORCE; STRATEGIES; OUTCOMES; METAANALYSIS	Context International guidelines recommend an early invasive strategy for patients with high-risk acute coronary syndromes without ST-segment elevation, but the optimal timing of intervention is uncertain. Objective To determine whether immediate intervention on admission can result in a reduction of myocardial infarction compared with a delayed intervention. Design, Setting, and Patients The Angioplasty to Blunt the Rise of Troponin in Acute Coronary Syndromes Randomized for an Immediate or Delayed Intervention (ABOARD) study, a randomized clinical trial that assigned, from August 2006 through September 2008 at 13 centers in France, 352 patients with acute coronary syndromes without ST-segment elevation and a Thrombolysis in Myocardial Infarction (TIMI) score of 3 or more to receive intervention either immediately or on the next working day (between 8 and 60 hours after enrollment). Main Outcome Measures The primary end point was the peak troponin value during hospitalization; the key secondary end point was the composite of death, myocardial infarction, or urgent revascularization at 1-month follow-up. Results Time from randomization to sheath insertion was 70 minutes with immediate intervention vs 21 hours with delayed intervention. The primary end point did not differ between the 2 strategies ( median [interquartile range] troponin I value, 2.1 [0.3-7.1] ng/mL vs 1.7 [0.3-7.2] ng/mL in the immediate and delayed intervention groups, respectively; P=.70). The key secondary end point was observed in 13.7% (95% confidence interval, 8.6%-18.8%) of the group assigned to receive immediate intervention and 10.2% ( 95% confidence interval, 5.7%-14.6%) of the group assigned to receive delayed intervention (P=.31). The other end points, as well as major bleeding, did not differ between the 2 strategies. Conclusion In patients with acute coronary syndromes without ST-segment elevation, a strategy of immediate intervention compared with a strategy of intervention deferred to the next working day ( mean, 21 hours) did not result in a difference in myocardial infarction as defined by peak troponin level. Trial Registration clinicaltrials.gov Identifier: NCT00442949 JAMA.2009;302(9):947-954 www.jama.com	[Montalescot, Gilles] Univ Paris 06, INSERM, CHU Pitie Salpetriere, AP HP,Inst Cardiol,Bur 2 236,CMR 937, 47 Blvd Hop, F-75013 Paris, France; [Cayla, Guillaume] Ctr Hosp Univ Caremeau, Serv Cardiol, Nimes, France; [Elhadad, Simon] Ctr Hosp Lagny Marne La Vallee, Serv Cardiol, Lagny Sur Marne, France; [Le Breton, Herve] Univ Rennes 1, INSERM, Serv Cardiol & Malad Vasc, Ctr Hosp Univ Rennes,U642, Rennes, France; [Leclercq, Florence] Ctr Hosp Univ Arnaud Villeneuve, Serv Cardiol, Montpellier, France; [Duclos, Francois] Ctr Hosp V Dupouy, Serv Cardiol, Argenteuil, France; [Aout, Mounir; Vicaut, Eric] Univ Paris, Ctr Hosp Univ Lariboisiere, AP HP, Unite Rech Clin, F-75252 Paris, France; [Henry, Patrick] Univ Paris, Ctr Hosp Univ Lariboisiere, AP HP, Serv Cardiol, F-75252 Paris, France; [Aout, Mounir; Dubois-Rande, Jean-Luc; Vicaut, Eric] CHU Henri Mondor, AP HP, Serv Cardiol, F-94010 Creteil, France; [Ducrocq, Gregory; Steg, Philippe-Gabriel] Ctr Hosp Univ Bichat Claude Bernard, AP HP, INSERM, U698, Paris, France; [Duclos, Francois; Steg, Philippe-Gabriel] Ctr Hosp Univ Bichat Claude Bernard, AP HP, Serv Cardiol, Paris, France; [Payot, Laurent] Ctr Hosp Intercommunal A Gregoire, Serv Cardiol, Montreuil, France; [Spaulding, Christian] Univ Paris 05, INSERM, Ctr Hosp Cochin, AP HP,Serv Cardiol,INSERM,U909, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; CHU de Nimes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Montalescot, G (corresponding author), Univ Paris 06, INSERM, CHU Pitie Salpetriere, AP HP,Inst Cardiol,Bur 2 236,CMR 937, 47 Blvd Hop, F-75013 Paris, France.	gilles.montalescot@psl.aphp.fr	STEG, Philippe Gabriel/Z-1567-2019; Le Breton, Herve/ABD-8171-2020; SILVAIN, Johanne/C-7521-2016	SILVAIN, Johanne/0000-0002-1901-2808; STEG, Philippe Gabriel/0000-0001-6896-2941	Programme Hospitalier de Recherche Clinique (French Ministry of Health); Assistance Publique-Hopitaux de Paris (AP-HP); A. C. T. I. O. N. group (Academic Research Organization); Eli Lilly	Programme Hospitalier de Recherche Clinique (French Ministry of Health); Assistance Publique-Hopitaux de Paris (AP-HP); A. C. T. I. O. N. group (Academic Research Organization); Eli Lilly(Eli Lilly)	This study was primarily funded by the Programme Hospitalier de Recherche Clinique (French Ministry of Health); sponsored by Assistance Publique-Hopitaux de Paris (AP-HP); led by the A. C. T. I. O. N. group (Academic Research Organization); Coordinating Center: Pitie-Salpetriere University Hospital; Data Management and Statistics: Unite de Recherche Clinique, Lariboisiere University Hospital. Eli Lilly provided an unrestricted research grant as well as the abciximab used for the study.	Akkerhuis KM, 2002, CIRCULATION, V105, P554, DOI 10.1161/hc0502.104278; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Bavry AA, 2006, J AM COLL CARDIOL, V48, P1319, DOI 10.1016/j.jacc.2006.06.050; Bertrand ME, 2002, EUR HEART J, V23, P1809, DOI 10.1053/euhj.2002.3385; BEYGUI F, 2008, TXB INTERVENTIONAL C, P527; Bhatt DL, 2004, JAMA-J AM MED ASSOC, V292, P2096, DOI 10.1001/jama.292.17.2096; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; de Winter RJ, 2005, NEW ENGL J MED, V353, P1095, DOI 10.1056/NEJMoa044259; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Fox KAA, 2002, LANCET, V360, P743, DOI 10.1016/S0140-6736(02)09894-X; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Jolly SS, 2009, AM HEART J, V157, P132, DOI 10.1016/j.ahj.2008.08.023; Kastrati A, 2006, JAMA-J AM MED ASSOC, V295, P1531, DOI 10.1001/jama.295.13.joc60034; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Michalis LK, 2000, EUR HEART J, V21, P1954, DOI 10.1053/euhj.2000.2397; Montalescot G, 2005, AM J CARDIOL, V95, P1397, DOI 10.1016/j.amjcard.2005.02.004; Montalescot G, 2006, NEW ENGL J MED, V355, P1006, DOI 10.1056/NEJMoa052711; Neumann FJ, 2003, JAMA-J AM MED ASSOC, V290, P1593, DOI 10.1001/jama.290.12.1593; Nienhuis MB, 2008, CATHETER CARDIO INTE, V71, P318, DOI 10.1002/ccd.21345; Riezebos RK, 2009, HEART, V95, P807, DOI 10.1136/hrt.2008.154815; Roe MT, 2004, EUR HEART J, V25, P313, DOI 10.1016/j.ehj.2003.12.009; Spacek R, 2002, EUR HEART J, V23, P230, DOI 10.1053/euhj.2001.2735; Swanson N, 2009, HEART, V95, P211, DOI 10.1136/hrt.2008.149922; Thygesen K, 2007, J AM COLL CARDIOL, V50, P2173, DOI 10.1016/j.jacc.2007.09.011; van't Hof AWJ, 2003, EUR HEART J, V24, P1401, DOI 10.1016/S0195-668X(03)00259-8; Wallentin L, 1999, LANCET, V354, P708; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012	30	218	225	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					947	954		10.1001/jama.2009.1267	http://dx.doi.org/10.1001/jama.2009.1267			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724041	Bronze			2022-12-28	WOS:000269444900019
J	Linnen, CR; Kingsley, EP; Jensen, JD; Hoekstra, HE				Linnen, Catherine R.; Kingsley, Evan P.; Jensen, Jeffrey D.; Hoekstra, Hopi E.			On the Origin and Spread of an Adaptive Allele in Deer Mice	SCIENCE			English	Article							STANDING GENETIC-VARIATION; MULTILOCUS GENOTYPE DATA; MOUSE AGOUTI LOCUS; POSITIVE SELECTION; COAT COLOR; PIGMENTATION; POLYMORPHISM; MUTATIONS; EVOLUTION; PEROMYSCUS	Adaptation is a central focus of biology, although it can be difficult to identify both the strength and agent of selection and the underlying molecular mechanisms causing change. We studied cryptically colored deer mice living on the Nebraska Sand Hills and show that their light coloration stems from a novel banding pattern on individual hairs produced by an increase in Agouti expression caused by a cis-acting mutation (or mutations), which either is or is closely linked to a single amino acid deletion in Agouti that appears to be under selection. Furthermore, our data suggest that this derived Agouti allele arose de novo after the formation of the Sand Hills. These findings reveal one means by which genetic, developmental, and evolutionary mechanisms can drive rapid adaptation under ecological pressure.	[Linnen, Catherine R.; Kingsley, Evan P.; Hoekstra, Hopi E.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Linnen, Catherine R.; Kingsley, Evan P.; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Jensen, Jeffrey D.] Univ Calif Berkeley, Ctr Theoret Evolutionary Genom, Dept Integrat Biol, Berkeley, CA 94720 USA	Harvard University; Harvard University; University of California System; University of California Berkeley	Linnen, CR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, 26 Oxford St, Cambridge, MA 02138 USA.	clinnen@oeb.harvard.edu	Linnen, Catherine/F-2492-2011; Hoekstra, Hopi E/I-6690-2012; Jensen, Jeffrey/S-1084-2016	Hoekstra, Hopi E/0000-0003-1431-1769; Linnen, Catherine/0000-0001-5715-456X; Kingsley, Evan/0000-0002-4351-2300; Jensen, Jeffrey/0000-0002-4786-8064	NIH [Ruth Kirschstein National Research Service Award]; NSF [Biological Informatics Postdoctoral Fellowship]; Museum of Comparative Zoology at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083073] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Museum of Comparative Zoology at Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Crossland and M. Dewey for assistance with crosses; W. Dawson for his advice; M. Chin, B. Hehli, and K. Hogan for laboratory assistance; J. Chupasko, E. Kay, M. Manceau, and J. Weber for field assistance; J. Demboski and the Denver Museum of Nature and Science for logistical support; J. Losos and B. Payseur for comments; and G. Barsh for ongoing discussion about Agouti. C.R.L. was supported by a Ruth Kirschstein National Research Service Award from NIH; J.D.J. was supported by a NSF Biological Informatics Postdoctoral Fellowship. Laboratory and fieldwork was funded by NSF and the Museum of Comparative Zoology at Harvard University. P. maniculatus were collected under the Nebraska Game and Parks Commission Scientific and Educational Permit 901, and voucher specimens were deposited in the Mammal Department at the Museum of Comparative Zoology. Sequence data were deposited in GenBank (accession numbers GQ337976 to GQ337987 and GQ340804 to GQ340896).	AHLBRANDT TS, 1981, RECENT ANCIENT NONMA, P293; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; BULTMAN SJ, 1994, GENE DEV, V8, P481, DOI 10.1101/gad.8.4.481; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; CLARKE B, 1962, HEREDITY, V17, P445, DOI 10.1038/hdy.1962.47; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; CREED ER, 1975, PROC R SOC SER B-BIO, V190, P135, DOI 10.1098/rspb.1975.0083; Dice L. R., 1941, Contributions from the Laboratory of Vertebrate Genetics University of Michigan, Vno. 15, P1; Dice Lee R., 1947, CONIR LAB VERTEBRATE BIOL UNIV MICHIGAN, V34, P1; DODSON KM, 1982, THESIS U S CAROLINA; Falush D, 2003, GENETICS, V164, P1567; Feder JL, 2003, P NATL ACAD SCI USA, V100, P10314, DOI 10.1073/pnas.1730757100; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2004, EVOLUTION, V58, P1329; HORNER BE, 1980, J HERED, V71, P49, DOI 10.1093/oxfordjournals.jhered.a109310; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; Jackson PJ, 2006, CHEM BIOL, V13, P1297, DOI 10.1016/j.chembiol.2006.10.006; Jensen JD, 2005, GENETICS, V170, P1401, DOI 10.1534/genetics.104.038224; Jensen JD, 2008, MOL BIOL EVOL, V25, P438, DOI 10.1093/molbev/msm273; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; Kim Y, 2002, GENETICS, V160, P765; Kingsley EP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006435; Laurie CC, 2007, PLOS GENET, V3, P1487, DOI 10.1371/journal.pgen.0030144; LEWIS DT, 1989, ATLAS SANDHILLS, P57; Loope D.B., 2000, GREAT PLAINS RES, V10, P5; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; McIntosh W. B., 1956, Contributions from the Laboratory of Vertebrate Biology of the University of Michigan, VNo. 73, P1; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; Miltenberger RJ, 2002, GENETICS, V160, P659; Mullen LM, 2008, EVOLUTION, V62, P1555, DOI 10.1111/j.1558-5646.2008.00425.x; Pritchard JK, 2000, GENETICS, V155, P945; Przeworski M, 2005, EVOLUTION, V59, P2312, DOI 10.1554/05-273.1; Przeworski M, 2003, GENETICS, V164, P1667; STEPHAN W, 1992, THEOR POPUL BIOL, V41, P237, DOI 10.1016/0040-5809(92)90045-U; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Swinehart J.B., 1989, ATLAS SAND HILLS, P43; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698	39	181	189	0	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1095	1098		10.1126/science.1175826	http://dx.doi.org/10.1126/science.1175826			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713521	Green Accepted			2022-12-28	WOS:000269382300032
J	Miossec, P; Korn, T; Kuchroo, VK				Miossec, Pierre; Korn, Thomas; Kuchroo, Vijay K.			Mechanisms of Disease: Interleukin-17 and Type 17 Helper T Cells.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GROWTH-FACTOR-BETA; ROR-GAMMA-T; CENTRAL-NERVOUS-SYSTEM; TGF-BETA; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; TH17 CELLS; AUTOIMMUNE INFLAMMATION; TRANSCRIPTION FACTOR; MULTIPLE-SCLEROSIS		[Miossec, Pierre] Univ Lyon, Hop Edouard Herriot, Dept Immunol & Rheumatol, Clin Immunol Unit, F-69003 Lyon, France; [Korn, Thomas] Tech Univ Munich, Dept Neurol, Munich, Germany; [Kuchroo, Vijay K.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	CHU Lyon; Technical University of Munich; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Miossec, P (corresponding author), Univ Lyon, Hop Edouard Herriot, Dept Immunol & Rheumatol, Clin Immunol Unit, 5 Pl Arsonval, F-69003 Lyon, France.	miossec@univ-lyon1.fr	Korn, Thomas/AAE-6960-2019	Korn, Thomas/0000-0002-3633-0955	Deutsche Forschungsgemeinschaft [KO2964/2-1]; National Institutes of Health (NIH); National Multiple Sclerosis Society; Juvenile Diabetes Research Foundation Center at Harvard Medical School	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Juvenile Diabetes Research Foundation Center at Harvard Medical School(Juvenile Diabetes Research Foundation)	Supported by grants from the Deutsche Forschungsgemeinschaft (KO2964/2-1, to Dr. Korn) and from the National Institutes of Health ( NIH), the National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation Center at Harvard Medical School ( all to Dr. Kuchroo), and by a Javits Neuroscience Investigator Award from the NIH ( to Dr. Kuchroo).	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2008, INT IMMUNOL, V20, P1361, DOI 10.1093/intimm/dxn106; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Barczyk A, 2003, RESP MED, V97, P726, DOI 10.1053/rmed.2003.1507; Batten M, 2006, NAT IMMUNOL, V7, P929, DOI 10.1038/ni1375; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chabaud M, 1998, J IMMUNOL, V161, P409; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Feldmann M, 2005, J AUTOIMMUN, V25, P26, DOI 10.1016/j.jaut.2005.09.006; Fitzgerald DC, 2008, NAT IMMUNOL, V9, P105, DOI 10.1038/ni0108-105d; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Glimcher LH, 2000, GENE DEV, V14, P1693; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Infante-Duarte C, 2000, J IMMUNOL, V165, P6107, DOI 10.4049/jimmunol.165.11.6107; Ishizu T, 2005, BRAIN, V128, P988, DOI 10.1093/brain/awh453; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Kleinschek MA, 2007, J EXP MED, V204, P161, DOI 10.1084/jem.20061738; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kotenko SV, 2001, J BIOL CHEM, V276, P2725, DOI 10.1074/jbc.M007837200; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leonard WJ, 2005, NAT REV IMMUNOL, V5, P688, DOI 10.1038/nri1688; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Li MO, 2006, ANNU REV IMMUNOL, V24, P99, DOI 10.1146/annurev.immunol.24.021605.090737; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Nurieva R, 2007, NATURE, V448, P480, DOI 10.1038/nature05969; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Page G, 2005, ARTHRITIS RHEUM-US, V52, P2307, DOI 10.1002/art.21211; Page G, 2004, AM J PATHOL, V164, P409, DOI 10.1016/S0002-9440(10)63131-8; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Parrish-Novak J, 2000, NATURE, V408, P57, DOI 10.1038/35040504; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Sato W, 2007, J IMMUNOL, V178, P7525, DOI 10.4049/jimmunol.178.12.7525; Serada S, 2008, P NATL ACAD SCI USA, V105, P9041, DOI 10.1073/pnas.0802218105; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Vaknin-Dembinsky AK, 2006, J IMMUNOL, V177, P2025, DOI 10.4049/jimmunol.177.3.2025-b; Vaknin-Dembinsky A, 2006, J IMMUNOL, V176, P7768, DOI 10.4049/jimmunol.176.12.7768; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yokota S, 2005, ARTHRITIS RHEUM, V52, P818, DOI 10.1002/art.20944; Young DA, 2007, ARTHRITIS RHEUM, V56, P1152, DOI 10.1002/art.22452; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang FP, 2009, NAT IMMUNOL, V10, P223, DOI 10.1038/ni0209-223a; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	94	1051	1166	1	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					888	898		10.1056/NEJMra0707449	http://dx.doi.org/10.1056/NEJMra0707449			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XV	19710487				2022-12-28	WOS:000269312700009
J	Houghton, FJ; Chew, PL; Lodeho, S; Goud, B; Gleeson, PA				Houghton, Fiona J.; Chew, Pau Ling; Lodeho, Sylvain; Goud, Bruno; Gleeson, Paul A.			The Localization of the Golgin GCC185 Is Independent of Rab6A/A ' and Arl1	CELL			English	Article							COILED-COIL PROTEINS; GRIP-DOMAIN PROTEINS; TRANS-GOLGI; MOLECULAR CHARACTERIZATION; EARLY/RECYCLING ENDOSOMES; MEMBRANE TRAFFICKING; RETROGRADE TRANSPORT; STRUCTURAL BASIS; NETWORK GOLGIN; BINDING-SITES	Mammalian golgins of the trans-Golgi network (TGN) are small G protein effectors that are required for membrane transport and contain a Golgi targeting C-terminal GRIP domain. The localization of two TGN golgins, p230/golgin-245 and golgin-97, is mediated by the small GTPase Arl1, whereas recruitment of the TGN golgin GCC185 is controversial. Recently, GCC185 was proposed to localize to the Golgi by the co-operation of two small GTPases, Rab6A/A' and Arl1 (Burguete et al., 2008), a model based predominantly on in vitro interactions. Here we demonstrate that Golgi recruitment of endogenous GCC185 does not involve Rab6A/A' and Arl1. We find minimal colocalization between Rab6A/A' and endogenous GCC185 on Golgi membranes and failed to detect an interaction between Rab6A/A' and C-terminal domains of GCC185 by yeast two-hybrid analyses. Moreover, depletion of both Rab6A/A' and Arl1 also had no effect on the localization of endogenous GCC185 or the isolated GRIP domain of GCC185.	[Houghton, Fiona J.; Chew, Pau Ling; Gleeson, Paul A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Houghton, Fiona J.; Chew, Pau Ling; Gleeson, Paul A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Lodeho, Sylvain; Goud, Bruno] CNRS, Inst Curie, UMR144, F-75005 Paris, France	University of Melbourne; University of Melbourne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Gleeson, PA (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia.	pgleeson@unimelb.edu.au	Goud, Bruno/GWC-4807-2022	HOUGHTON, FIONA/0000-0002-4420-2953; Gleeson, Paul/0000-0002-5336-6503	Australian Research Council	Australian Research Council(Australian Research Council)	We gratefully thank Florence Jollivet, Institut Curie, for expert technical support. This work was supported by funding from the Australian Research Council.	Barr FA, 1999, CURR BIOL, V9, P381, DOI 10.1016/S0960-9822(99)80167-5; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Del Nery E, 2006, TRAFFIC, V7, P394, DOI 10.1111/j.1600-0854.2006.00395.x; Derby MC, 2004, J CELL SCI, V117, P5865, DOI 10.1242/jcs.01497; Derby MC, 2007, INT REV CYTOL, V261, P47, DOI 10.1016/S0074-7696(07)61002-X; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Erlich R, 1996, J BIOL CHEM, V271, P8328, DOI 10.1074/jbc.271.14.8328; Fritzler MJ, 1995, J BIOL CHEM, V270, P31262, DOI 10.1074/jbc.270.52.31262; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gleeson PA, 2004, TRAFFIC, V5, P315, DOI 10.1111/j.1398-9219.2004.00182.x; Gleeson PA, 1996, J CELL SCI, V109, P2811; Griffith KJ, 1997, ARTHRITIS RHEUM, V40, P1693, DOI 10.1002/art.1780400920; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Janoueix-Lerosey I, 2000, METHODS, V20, P399, DOI 10.1006/meth.2000.0952; Kjer-Nielsen L, 1999, CURR BIOL, V9, P385, DOI 10.1016/S0960-9822(99)80168-7; Kjer-Nielsen L, 1999, J CELL SCI, V112, P1645; KOOY J, 1992, J BIOL CHEM, V267, P20255; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lieu ZZ, 2007, MOL BIOL CELL, V18, P4979, DOI 10.1091/mbc.E07-06-0622; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Luke MR, 2005, BIOCHEM J, V388, P835, DOI 10.1042/BJ20041810; Luke MR, 2003, J BIOL CHEM, V278, P4216, DOI 10.1074/jbc.M210387200; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Munro S, 1999, CURR BIOL, V9, P377, DOI 10.1016/S0960-9822(99)80166-3; Opdam FJM, 2000, J CELL SCI, V113, P2725; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Panic B, 2003, CURR BIOL, V13, P405, DOI 10.1016/S0960-9822(03)00091-5; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Reddy JV, 2006, MOL BIOL CELL, V17, P4353, DOI 10.1091/mbc.E06-02-0153; Setty SRG, 2003, CURR BIOL, V13, P401, DOI 10.1016/S0960-9822(03)00089-7; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Wu MS, 2004, NAT STRUCT MOL BIOL, V11, P86, DOI 10.1038/nsmb714	38	33	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					787	794		10.1016/j.cell.2009.05.048	http://dx.doi.org/10.1016/j.cell.2009.05.048			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703403	Bronze			2022-12-28	WOS:000269156100019
J	Parks, AR; Li, ZP; Shi, QJ; Owens, RM; Jin, MM; Peters, JE				Parks, Adam R.; Li, Zaoping; Shi, Qiaojuan; Owens, Roisin M.; Jin, Moonsoo M.; Peters, Joseph E.			Transposition into Replicating DNA Occurs through Interaction with the Processivity Factor	CELL			English	Article							BETA-SLIDING-CLAMP; POLYMERASE-III HOLOENZYME; TN7 TRANSPOSITION; MISMATCH-REPAIR; DELTA-SUBUNIT; PROTEIN; RECOGNITION; COMPLEX; BINDING; MOTIF	The bacterial transposon Tn7 directs transposition into actively replicating DNA by a mechanism involving the transposon-encoded protein TnsE. Here we show that TnsE physically and functionally interacts with the processivity factor of the DNA replication machinery in vivo and in vitro. Our work establishes an in vitro TnsABC+E transposition reaction reconstituted from purified proteins and target DNA structures. Using the in vitro reaction we confirm that the processivity factor specifically reorders TnsE-mediated transposition events on target DNAs in a way that matches the bias with active DNA replication in vivo. The TnsE interaction with an essential and conserved component of the replication machinery, and a DNA structure reveals a mechanism by which Tn7, and probably other elements, selects target sites associated with DNA replication.	[Parks, Adam R.; Li, Zaoping; Shi, Qiaojuan; Peters, Joseph E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Owens, Roisin M.; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University	Peters, JE (corresponding author), NCI, Ctr Canc Res, Frederick, MD 21702 USA.	jep48@cornell.edu	Peters, Joseph/P-7130-2019; Jin, Moonsoo/D-6128-2011; Owens, Roisin/O-4371-2019	Peters, Joseph/0000-0001-8309-3297; Owens, Roisin/0000-0001-7856-2108	National Institutes of Health [R01 GM069508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant R01 GM069508. We thank Mark Sutton and Bik Tye for strains and plasmids and helpful discussions. We also thank Eric Alani, Bik Tye, Jeff Roberts, and the members of the Peters laboratory for comments on the manuscript.	AMBERG DC, 2006, COLD SPRING HARBOR P, DOI DOI 10.1101/PDB.PROT4158; BAINTON RJ, 1993, CELL, V72, P931, DOI 10.1016/0092-8674(93)90581-A; Beuning PJ, 2006, MOL MICROBIOL, V59, P460, DOI 10.1111/j.1365-2958.2005.04959.x; BIACORE I, 1997, BIAEVALUATION SOFTWA; Biery MC, 2000, NUCLEIC ACIDS RES, V28, P1067, DOI 10.1093/nar/28.5.1067; Bordi C, 2008, APPL ENVIRON MICROB, V74, P3419, DOI 10.1128/AEM.00476-08; Bunting KA, 2003, EMBO J, V22, P5883, DOI 10.1093/emboj/cdg568; CHEN J, 1992, GENETICS, V130, P665; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Craig Nancy L., 2002, P423; CRAIG NL, 2002, MOBILE DNA, V2; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; Dalrymple BP, 2001, P NATL ACAD SCI USA, V98, P11627, DOI 10.1073/pnas.191384398; de Saro FJL, 2001, P NATL ACAD SCI USA, V98, P8376, DOI 10.1073/pnas.121009498; de Saro FL, 2004, PHILOS T R SOC B, V359, P25, DOI 10.1098/rstb.2003.1361; Einarson Margret B, 2007, CSH Protoc, V2007, DOI [10.1101/pdb.prot4759, 10.1101/pdb.prot4757]; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Flores MJ, 2005, MOL MICROBIOL, V57, P1664, DOI 10.1111/j.1365-2958.2005.04753.x; Garsin DA, 2004, J BACTERIOL, V186, P7280, DOI 10.1128/JB.186.21.7280-7289.2004; Georgescu RE, 2008, CELL, V132, P43, DOI 10.1016/j.cell.2007.11.045; Golemis E.A., 2002, PROTEIN PROTEIN INTE; Jeruzalmi D, 2001, CELL, V106, P429, DOI 10.1016/S0092-8674(01)00463-9; Jeruzalmi D, 2001, CELL, V106, P417, DOI 10.1016/S0092-8674(01)00462-7; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; KELMAN Z, 1995, GENE, V166, P177, DOI 10.1016/0378-1119(95)00556-7; Kelman Z, 1995, METHOD ENZYMOL, V262, P430; Kuduvalli PN, 2001, EMBO J, V20, P924, DOI 10.1093/emboj/20.4.924; KUZMINOV A, 1995, BIOESSAYS, V17, P733, DOI 10.1002/bies.950170810; Laurence TA, 2008, J BIOL CHEM, V283, P22895, DOI 10.1074/jbc.M800174200; Leu FP, 2000, J BIOL CHEM, V275, P34609, DOI 10.1074/jbc.M005495200; Leu FP, 2001, J BIOL CHEM, V276, P47185, DOI 10.1074/jbc.M106780200; Liachko I, 2005, GENETICS, V171, P503, DOI 10.1534/genetics.105.042333; de Saro FJL, 2006, J BIOL CHEM, V281, P14340, DOI 10.1074/jbc.M601264200; Maul RW, 2007, MOL MICROBIOL, V65, P811, DOI 10.1111/j.1365-2958.2007.05828.x; MCKOWN RL, 1988, J BACTERIOL, V170, P352, DOI 10.1128/jb.170.1.352-358.1988; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Parks AR, 2007, J BACTERIOL, V189, P2170, DOI 10.1128/JB.01536-06; Parks AR, 2009, PLASMID, V61, P1, DOI 10.1016/j.plasmid.2008.09.008; Peters J.E., 2007, METHODS GEN MOL MICR, P735; Peters JE, 2001, GENE DEV, V15, P737, DOI 10.1101/gad.870201; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; Peters JE, 2000, MOL CELL, V6, P573, DOI 10.1016/S1097-2765(00)00056-3; Rao JE, 2000, P NATL ACAD SCI USA, V97, P3936, DOI 10.1073/pnas.080061497; Rao JE, 2001, J MOL BIOL, V307, P1161, DOI 10.1006/jmbi.2001.4553; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Seringhaus M, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl184; SHAFFERMAN A, 1982, J MOL BIOL, V161, P57, DOI 10.1016/0022-2836(82)90278-9; Sharp PL, 1998, EMBO J, V17, P5822, DOI 10.1093/emboj/17.19.5822; Shi QJ, 2008, GENETICS, V179, P1237, DOI 10.1534/genetics.108.088161; Simmons LA, 2008, MOL CELL, V29, P291, DOI 10.1016/j.molcel.2007.10.036; Stellwagen AE, 1997, GENETICS, V145, P573; Stellwagen AE, 1998, TRENDS BIOCHEM SCI, V23, P486, DOI 10.1016/S0968-0004(98)01325-5; Stellwagen AE, 2001, J MOL BIOL, V305, P633, DOI 10.1006/jmbi.2000.4317; Sutton MD, 2004, J BACTERIOL, V186, P6738, DOI 10.1128/JB.186.20.6738-6748.2004; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang HX, 2001, MOL BIOTECHNOL, V19, P133, DOI 10.1385/MB:19:2:133; Warbrick E, 1998, NUCLEIC ACIDS RES, V26, P3925, DOI 10.1093/nar/26.17.3925; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Wijffels G, 2004, BIOCHEMISTRY-US, V43, P5661, DOI 10.1021/bi036229j; Wilkins B, 1993, BACTERIAL CONJUGATIO, P105; Wolkow CA, 1996, GENE DEV, V10, P2145, DOI 10.1101/gad.10.17.2145	62	45	46	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					685	695		10.1016/j.cell.2009.06.011	http://dx.doi.org/10.1016/j.cell.2009.06.011			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703395	Green Accepted, Bronze			2022-12-28	WOS:000269156100011
J	Yu, SR; Burkhardt, M; Nowak, M; Ries, J; Petrasek, Z; Scholpp, S; Schwille, P; Brand, M				Yu, Shuizi Rachel; Burkhardt, Markus; Nowak, Matthias; Ries, Jonas; Petrasek, Zdenek; Scholpp, Steffen; Schwille, Petra; Brand, Michael			Fgf8 morphogen gradient forms by a source-sink mechanism with freely diffusing molecules	NATURE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; EARLY XENOPUS EMBRYO; CROSS-CORRELATION; ZEBRAFISH; DIFFERENTIATION; ENDOCYTOSIS; TRANSPORT; DYNAMICS; PATTERN; RANGE	It is widely accepted that tissue differentiation and morphogenesis in multicellular organisms are regulated by tightly controlled concentration gradients of morphogens(1,2). How exactly these gradients are formed, however, remains unclear(3-12). Here we show that Fgf8 morphogen gradients in living zebrafish embryos are established andmaintained by two essential factors: fast, free diffusion of single molecules away from the source through extracellular space, and a sink function of the receiving cells, regulated by receptor-mediated endocytosis. Evidence is provided by directly examining single molecules of Fgf8 in living tissue by fluorescence correlation spectroscopy, quantifying their local mobility and concentration with high precision. By changing the degree of uptake of Fgf8 into its target cells, we are able to alter the shape of the Fgf8 gradient. Our results demonstrate that a freely diffusing morphogen can set up concentration gradients in a complex multicellular tissue by a simple source-sink mechanism.	[Yu, Shuizi Rachel; Burkhardt, Markus; Nowak, Matthias; Ries, Jonas; Petrasek, Zdenek; Scholpp, Steffen; Schwille, Petra; Brand, Michael] TUD, Ctr Biotechnol, D-01307 Dresden, Germany; [Yu, Shuizi Rachel; Burkhardt, Markus; Nowak, Matthias; Ries, Jonas; Petrasek, Zdenek; Schwille, Petra; Brand, Michael] TUD, Ctr Regenerat Therapies, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden	Schwille, P (corresponding author), TUD, Ctr Biotechnol, Tatzberg 47-49, D-01307 Dresden, Germany.	petra.schwille@biotec.tu-dresden.de; michael.brand@biotec.tu-dresden.de	Ries, Jonas/Q-5157-2019; Scholpp, Steffen/E-4472-2018; Brand, Michael/A-5509-2010; Schwille, Petra/A-4983-2010; Scholpp, Steffen/H-2060-2013; , q/P-3251-2015; Ries, Jonas/P-3027-2014	Scholpp, Steffen/0000-0002-4903-9657; Brand, Michael/0000-0001-5711-6512; Scholpp, Steffen/0000-0002-4903-9657; , q/0000-0002-4930-1635; Ries, Jonas/0000-0002-6640-9250	HFSP network grant [050503-50]; EU [050503-52]	HFSP network grant; EU(European Commission)	We thank members of the Brand and Schwille laboratories for discussions; A. Picker and K. Heinze for help with initial FCS measurements; B. Lutz for discussions; A. Oates, C. Boekel, A. Picker and P. Scott for comments on the manuscript; M. Fischer and K. Sipple for fish care; and A. Machate and B. Borgonov for technical assistance. This work was supported by an HFSP network grant (050503-50) to M. Br. and P. S., and by the EU Endotrack grant (050503-52) to M.	AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Brinkmeier M, 1999, ANAL CHEM, V71, P609, DOI 10.1021/ac980820i; Burkhardt M, 2006, OPT EXPRESS, V14, P5013, DOI 10.1364/OE.14.005013; CRICK F, 1970, NATURE, V225, P420, DOI 10.1038/225420a0; Dertinger T, 2007, CHEMPHYSCHEM, V8, P433, DOI 10.1002/cphc.200600638; DESAI UR, 1993, ARCH BIOCHEM BIOPHYS, V306, P461, DOI 10.1006/abbi.1993.1538; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Goldfarb Mitchell, 1996, Cytokine and Growth Factor Reviews, V7, P311, DOI 10.1016/S1359-6101(96)00039-1; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Hou S, 2007, DEV CELL, V13, P226, DOI 10.1016/j.devcel.2007.07.001; Kerszberg M, 1998, J THEOR BIOL, V191, P103, DOI 10.1006/jtbi.1997.0575; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; McDowell N, 2001, INT J DEV BIOL, V45, P199; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Petrov EP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258101; Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7; Reifers F, 1998, DEVELOPMENT, V125, P2381; Reifers F, 2000, DEVELOPMENT, V127, P225; Ries J, 2009, NAT METHODS, V6, P643, DOI [10.1038/NMETH.1355, 10.1038/nmeth.1355]; RIGLER R, 1993, EUR BIOPHYS J BIOPHY, V22, P169, DOI 10.1007/BF00185777; Robinson MS, 1996, CELL, V84, P13, DOI 10.1016/S0092-8674(00)80988-5; Scholpp S, 2004, CURR BIOL, V14, P1834, DOI 10.1016/j.cub.2004.09.084; Strigini M, 2000, CURR BIOL, V10, P293, DOI 10.1016/S0960-9822(00)00378-X; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0	32	275	277	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					533	U100		10.1038/nature08391	http://dx.doi.org/10.1038/nature08391			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19741606				2022-12-28	WOS:000270082900042
J	O'Donoghue, ML; Braunwald, E; Antman, EM; Murphy, SA; Bates, ER; Rozenman, Y; Michelson, AD; Hautvast, RW; Lee, PNV; Close, SL; Shen, L; Mega, JL; Sabatine, MS; Wiviott, SD				O'Donoghue, Michelle L.; Braunwald, Eugene; Antman, Elliott M.; Murphy, Sabina A.; Bates, Eric R.; Rozenman, Yoseph; Michelson, Alan D.; Hautvast, Raymond W.; Lee, Peter N. Ver; Close, Sandra L.; Shen, Lei; Mega, Jessica L.; Sabatine, Marc S.; Wiviott, Stephen D.			Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials	LANCET			English	Article							OF-FUNCTION POLYMORPHISM; ACUTE CORONARY SYNDROMES; PLATELET-AGGREGATION; ANTIPLATELET ACTION; ATORVASTATIN; THROMBOLYSIS; OMEPRAZOLE; OUTCOMES; THERAPY	Background Proton-pump inhibitors (PPIs) are often prescribed in combination with thienopyridines. Conflicting data exist as to whether PPIs diminish the efficacy of clopiclogrel. We assessed the association between PPI use, measures of platelet function, and clinical outcomes for patients treated with clopidogrel or prasugrel. Methods In the PRINCIPLE-TIMI 44 trial, the primary outcome was inhibition of platelet aggregation at 6 h assessed by light-transmission aggregometry. In the TRITON-TIMI 38 trial, the primary endpoint was the composite of cardiovascular death, myocardial infarction, or stroke. In both studies, PPI use was at physician's discretion. We used a multivariable Cox model with propensity score to assess the association of PPI use with clinical outcomes. Findings In the PRINCIPLE-TIMI 44 trial, 201 patients undergoing elective percutaneous coronary intervention were randomly assigned to prasugrel (n=102) or high-dose clopidogrel (n=99). Mean inhibition of platelet aggregation was significantly lower for patients on a PPI than for those not on a PPI at 6 h after a 600 mg clopiclogrel loading dose (23.2 +/- 19.5% vs 35.2 +/- 20.9%, p=0.02), whereas a more modest difference was seen with and without a PPI after a 60 mg loading dose of prasugrel (69.6 +/- 13.5% vs 76.7 +/- 12.4%, p=0.054). In the TRITON-TIMI 38 trial, 13 608 patients with an acute coronary syndrome were randomly assigned to prasugrel (n=6813) or clopidogrel (n=6795). In this study, 33% (n=4529) of patients were on a PPI at randomisation. No association existed between PPI use and risk of the primary endpoint for patients treated with clopiclogrel (adjusted hazard ratio [HR] 0.94, 95% CI 0.80-1.11) or prasugrel (1.00, 0.84-1.20). Interpretation The current findings do not support the need to avoid concomitant use of PPIs, when clinically indicated, in patients receiving clopidogrel or prasugrel. Funding Daiichi Sankyo Company Limited and Eli Lilly and Company sponsored the trials. This analysis had no funding.	[O'Donoghue, Michelle L.] Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA; [Bates, Eric R.] Univ Michigan, Ann Arbor, MI 48109 USA; [Rozenman, Yoseph] Tel Aviv Univ, Edith Wolfson Med Ctr, Holon, Israel; [Michelson, Alan D.] Childrens Hosp, Boston, MA 02115 USA; [Hautvast, Raymond W.] Med Ctr Alkmaar, Alkmaar, Netherlands; [Lee, Peter N. Ver] NE Cardiol Associates, Bangor, ME USA; [Close, Sandra L.; Shen, Lei] Eli Lilly Res Labs, Indianapolis, IN USA	Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; Tel Aviv University; Harvard University; Boston Children's Hospital; Medical Center Of Alkmaar; Eli Lilly	O'Donoghue, ML (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, 350 Longwood Ave, Boston, MA 02115 USA.	modonoghue@partners.org	Wiviott, Stephen/HIK-2534-2022; Sabatine, Marc/AAJ-6751-2020; Michelson, Alan/ABE-8487-2021	Sabatine, Marc/0000-0002-0691-3359; Michelson, Alan/0000-0002-1746-4819	Eli Lilly; Daiichi Sankyo; Sanofi Aventis; Johnson Johnson; Bayer Healthcare; Astra Zeneca; Bristol-Myers Squibb; Schering Plough	Eli Lilly(Eli Lilly); Daiichi Sankyo(Daiichi Sankyo Company Limited); Sanofi Aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Astra Zeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Schering Plough(Merck & CompanySchering Plough Corporation)	EB received research grants and honoraria from Eli Lilly and Daiichi Sankyo. EMA received research grants from Eli Lilly, Daiichi Sankyo, and Sanofi Aventis; and consulting fees or paid advisory board fees from Sanofi Aventis and lecture fees from Eli Lilly and Sanofi Aventis. SAM received research grants front Eli Lilly and Daiichi Sankyo, and consulting fees from Eli Lilly. ERB received honoraria from Eli Lilly, Daiichi Sankyo, Sanofi Aventis, and Bristol-Myers Squibb. YR received consulting or lecture fees from Eli Lilly, Sanofi Aventis, Medtronic, Boston Scientific, Pfizer, and Schering-Plough. ADM is a consultant to Eli Lilly, Daiichi Sankyo, Sanofi Aventis, and Bristol-Myers Squibb. S LC and LS are employees and stockholders of Eli Lilly. JLM received research grants from Eli Lilly, Daiichi Sankyo, and Johnson & Johnson, and honoraria from Bayer Healthcare. MSS received research grants from Sanofi Aventis and Astra Zeneca, and honoraria and/or consulting fees from Sanofi Aventis, Bristol-Myers Squibb, Astra Zeneca, and Eli Lilly. SDW received research grants from Eli Lilly, Daiichi Sankyo, Sanofi Aventis, and Schering Plough; consulting fees or paid advisory fees from Astra Zeneca, and Sanofi Aventis; and honoraria from Eli Lilly, Daiichi Sankyo, Astra Zeneca, and Schering Plough. MO'D, RWH, PVL declare that they have no conflicts of interest.	Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Dunn SP, 2008, CIRCULATION, V118, pS815; *E LILL CO, EFF LAB INF; *EUR MED AG, PUBL STAT POSS INT C; Food and Drug Administration, 2009, EARL COMM ONG SAF RE; Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; Gorchakova O, 2004, EUR HEART J, V25, P1898, DOI 10.1016/j.ehj.2003.10.039; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Lau WC, 2003, CIRCULATION, V107, P32, DOI 10.1161/01.CIR.0000047060.60595.CC; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mega JL, 2009, CIRCULATION, V119, P2553, DOI 10.1161/CIRCULATIONAHA.109.851949; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Saw J, 2003, CIRCULATION, V108, P921, DOI 10.1161/01.CIR.0000088780.57432.43; Sibbing D, 2009, THROMB HAEMOSTASIS, V101, P714, DOI 10.1160/TH08-12-0808; Sibbing D, 2009, EUR HEART J, V30, P916, DOI 10.1093/eurheartj/ehp041; Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; STANEK EJ, 2009, SCAI 32 ANN SCI SESS; Wienbergen H, 2003, AM J CARDIOL, V92, P285, DOI 10.1016/S0002-9149(03)00626-X; Wiviott SD, 2007, CIRCULATION, V116, P2923, DOI 10.1161/CIRCULATIONAHA.107.740324; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wiviott SD, 2006, AM HEART J, V152, P627, DOI 10.1016/j.ahj.2006.04.012	28	559	600	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					989	997		10.1016/S0140-6736(09)61525-7	http://dx.doi.org/10.1016/S0140-6736(09)61525-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PK	19726078				2022-12-28	WOS:000270154100029
J	Wyart, C; Del Bene, F; Warp, E; Scott, EK; Trauner, D; Baier, H; Isacoff, EY				Wyart, Claire; Del Bene, Filippo; Warp, Erica; Scott, Ethan K.; Trauner, Dirk; Baier, Herwig; Isacoff, Ehud Y.			Optogenetic dissection of a behavioural module in the vertebrate spinal cord	NATURE			English	Article							FLUID-CONTACTING NEURONS; IONOTROPIC GLUTAMATE-RECEPTOR; LARVAL ZEBRAFISH; IN-VIVO; GENETIC DISSECTION; LOCOMOTOR NETWORK; NEURAL CIRCUITS; CELLS; LIGHT; INTERNEURONS	Locomotion relies on neural networks called central pattern generators (CPGs) that generate periodic motor commands for rhythmic movements(1). In vertebrates, the excitatory synaptic drive for inducing the spinal CPG can originate from either supraspinal glutamatergic inputs or from within the spinal cord(2,3). Here we identify a spinal input to the CPG that drives spontaneous locomotion using a combination of intersectional gene expression and optogenetics(4) in zebrafish larvae. The photo-stimulation of one specific cell type was sufficient to induce a symmetrical tail beating sequence that mimics spontaneous slow forward swimming. This neuron is the Kolmer-Agduhr cell(5), which extends cilia into the central cerebrospinal-fluid-containing canal of the spinal cord and has an ipsilateral ascending axon that terminates in a series of consecutive segments(6). Genetically silencing Kolmer-Agduhr cells reduced the frequency of spontaneous free swimming, indicating that activity of Kolmer-Agduhr cells provides necessary tone for spontaneous forward swimming. Kolmer-Agduhr cells have been known for over 75 years, but their function has been mysterious. Our results reveal that during early development in zebrafish these cells provide a positive drive to the spinal CPG for spontaneous locomotion.	[Wyart, Claire; Warp, Erica; Isacoff, Ehud Y.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Wyart, Claire; Warp, Erica; Isacoff, Ehud Y.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Del Bene, Filippo; Scott, Ethan K.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; [Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Isacoff, Ehud Y.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of Munich; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Isacoff, EY (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	herwig.baier@ucsf.edu; ehud@berkeley.edu	del bene, filippo/D-1245-2010; Wyart, Claire/AAB-4603-2020; Wyart, Claire/H-3783-2016; isacoff, ehud/AAP-1459-2020	del bene, filippo/0000-0001-8551-2846; Wyart, Claire/0000-0002-1668-4975; Wyart, Claire/0000-0002-1668-4975; Scott, Ethan/0000-0003-3150-9216; Isacoff, Ehud Y./0000-0003-4775-9359	Marie Curie Outgoing International Fellowship [CNRS-UMR5020]; Human Frontier Science Program Long-term Postdoctoral Fellowship; National Institutes of Health Nanomedicine Development Center [5PN2EY018241]; Human Frontiers Science Program [RGP23-2005]; Lawrence Berkeley National Laboratory Directed Research and Development Program [R01 NS053358]; Sandler Opportunity Award; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035549, R01NS053358] Funding Source: NIH RePORTER	Marie Curie Outgoing International Fellowship(European Commission); Human Frontier Science Program Long-term Postdoctoral Fellowship(Human Frontier Science Program); National Institutes of Health Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Lawrence Berkeley National Laboratory Directed Research and Development Program; Sandler Opportunity Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M.Volgraf for MAG-1 synthesis, K.Kawakami for the UAS: TeTxLC-CFP line, B.Appel for the Olig2-DsRed line, W.Staub for animal care, D.Li for help with screening BGUG larvae, B.Vigh, C.Girit, E.Brustein, P.Drapeau and S.Hugel for discussions, P.G.de Gennes and Noam Sobel for support and O.Wyart for aesthetic input.We are grateful to K.Best, P.Tavormina, H.Aaron, R.Ayer, B.Nowak and M.Ulbrich for advice on the design of the photostimulation setup.Support for the work was from the Marie Curie Outgoing International Fellowship (with the CNRS-UMR5020 'Neurosciences Sensorielles, Comportement Cognition' laboratory, Lyon, France) (C.W.), the Human Frontier Science Program Long-term Postdoctoral Fellowship (F.D.B.), the National Institutes of Health Nanomedicine Development Center for the Optical Control of Biological Function (5PN2EY018241) (E.Y.I., D.T.and H.B.), the Human Frontiers Science Program (RGP23-2005) (E.Y.I.and D.T.), the Lawrence Berkeley National Laboratory Directed Research and Development Program (E.Y.I.and D.T.), R01 NS053358 (H.B.) and a Sandler Opportunity Award (H.B.).	AGDUHR E, 1932, CYTOLOGY CELLULAR PA, V2, P535; ALFORD S, 1990, BRAIN RES, V506, P303, DOI 10.1016/0006-8993(90)91267-K; Asakawa K, 2008, P NATL ACAD SCI USA, V105, P1255, DOI 10.1073/pnas.0704963105; Brustein E, 2005, J NEUROSCI, V25, P10607, DOI 10.1523/JNEUROSCI.2017-05.2005; Budick SA, 2000, J EXP BIOL, V203, P2565; DALE N, 1987, PROC R SOC SER B-BIO, V232, P193, DOI 10.1098/rspb.1987.0068; DOUGLAS JR, 1993, J NEUROSCI, V13, P990; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; FENAUX F, 1991, EXP BRAIN RES, V86, P393; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Furusho M, 2006, DEV BIOL, V293, P348, DOI 10.1016/j.ydbio.2006.01.031; Gorostiza P, 2007, P NATL ACAD SCI USA, V104, P10865, DOI 10.1073/pnas.0701274104; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Kiehn O, 2008, BRAIN RES REV, V57, P56, DOI 10.1016/j.brainresrev.2007.07.002; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Liao JC, 2008, J NEUROSCI, V28, P12982, DOI 10.1523/JNEUROSCI.3330-08.2008; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Stoeckel ME, 2003, J COMP NEUROL, V457, P159, DOI 10.1002/cne.10565; Szobota S, 2007, NEURON, V54, P535, DOI 10.1016/j.neuron.2007.05.010; Vigh B, 1998, MICROSC RES TECHNIQ, V41, P57, DOI 10.1002/(SICI)1097-0029(19980401)41:1<57::AID-JEMT6>3.0.CO;2-R; Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756; Xiao T, 2007, NAT NEUROSCI, V10, P1529, DOI 10.1038/nn2002	31	290	302	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					407	U105		10.1038/nature08323	http://dx.doi.org/10.1038/nature08323			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19759620	Green Accepted			2022-12-28	WOS:000269828100042
J	Bleichert, F; Gagnon, KT; Brown, BA; Maxwell, ES; Leschziner, AE; Unger, VM; Baserga, SJ				Bleichert, Franziska; Gagnon, Keith T.; Brown, Bernard A., II; Maxwell, E. Stuart; Leschziner, Andres E.; Unger, Vinzenz M.; Baserga, Susan J.			A Dimeric Structure for Archaeal Box C/D Small Ribonucleoproteins	SCIENCE			English	Article							SMALL NUCLEOLAR RNAS; HUMAN TELOMERASE; RIBOSE METHYLATION; CORE PROTEIN; COMPLEX; HOMOLOGS; BINDING; DOMAIN; RNPS	Methylation of ribosomal RNA ( rRNA) is required for optimal protein synthesis. Multiple 2'-O-ribose methylations are carried out by box C/D guide ribonucleoproteins [small ribonucleoproteins (sRNPs) and small nucleolar ribonucleoproteins (snoRNPs)], which are conserved from archaea to eukaryotes. Methylation is dictated by base pairing between the specific guide RNA component of the sRNP or snoRNP and the target rRNA. We determined the structure of a reconstituted and catalytically active box C/D sRNP from the archaeon Methanocaldococcus jannaschii by single-particle electron microscopy. We found that archaeal box C/D sRNPs unexpectedly formed a dimeric structure with an alternative organization of their RNA and protein components that challenges the conventional view of their architecture. Mutational analysis demonstrated that this di-sRNP structure was relevant for the enzymatic function of archaeal box C/D sRNPs.	[Bleichert, Franziska; Baserga, Susan J.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; [Gagnon, Keith T.; Brown, Bernard A., II; Maxwell, E. Stuart] N Carolina State Univ, Dept Biol Mol & Struct, Raleigh, NC 27695 USA; [Leschziner, Andres E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Unger, Vinzenz M.; Baserga, Susan J.] Yale Univ, Dept Mol Biophys & Biochem, Sch Med, New Haven, CT 06520 USA; [Baserga, Susan J.] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University; University of North Carolina; North Carolina State University; Harvard University; Yale University; Yale University	Baserga, SJ (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06520 USA.	susan.baserga@yale.edu		Leschziner, Andres/0000-0002-7732-7023	NIH [RR19895, R01GM69699, R01GM52581]; Boehringer Ingelheim Fonds Ph. D. scholarship; NSF [MCB0543741]; EMDB [EMD-1636]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069699, R01GM052581] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds Ph. D. scholarship(Boehringer Ingelheim); NSF(National Science Foundation (NSF)); EMDB; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Golas, P. Moore, K. Reinisch, J. Steitz, T. Steitz, H. Wang, and S. Wolin for helpful discussion and/or critical reading of the manuscript, and the Yale University Biomedical High Performance Computing Center ( supported by NIH grant RR19895). This work was supported by a Boehringer Ingelheim Fonds Ph. D. scholarship ( F. B.), NIH grants R01GM69699 ( B. A. B.) and R01GM52581 ( S. J. B.), and NSF grant MCB0543741 ( E. S. M.). The EM map has been deposited into EMDB ( accession code EMD-1636).	Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; Beattie TL, 2001, MOL CELL BIOL, V21, P6151, DOI 10.1128/MCB.21.18.6151-6160.2001; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Fouche N, 2006, BIOCHEMISTRY-US, V45, P9624, DOI 10.1021/bi060313s; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; HODNETT JL, 1968, J BIOL CHEM, V243, P6334; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Oruganti S, 2007, J MOL BIOL, V371, P1141, DOI 10.1016/j.jmb.2007.06.029; Prescott J, 1997, GENE DEV, V11, P2790, DOI 10.1101/gad.11.21.2790; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Rashid R, 2003, J MOL BIOL, V333, P295, DOI 10.1016/j.jmb.2003.08.012; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Stark H, 2006, ANNU REV BIOPH BIOM, V35, P435, DOI 10.1146/annurev.biophys.35.040405.101953; Suryadi J, 2005, BIOCHEMISTRY-US, V44, P9657, DOI 10.1021/bi050568q; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; Wenz C, 2001, EMBO J, V20, P3526, DOI 10.1093/emboj/20.13.3526; Zhang XX, 2006, RNA, V12, P1092, DOI 10.1261/rna.2230106	24	47	47	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1384	1387		10.1126/science.1176099	http://dx.doi.org/10.1126/science.1176099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745151	Green Accepted			2022-12-28	WOS:000269699100036
J							Toronto Int Data Release Workshop	Prepublication data sharing	NATURE			English	Editorial Material							RELEASE						Scherer, Stephen W./B-3785-2013; Sensen, Christoph W./C-1798-2013; Hubbard, Tim J/C-2567-2008; Tsunoda, Tatsuhiko/K-2061-2014; Weinstock, George M/C-6314-2013; Ecker, Joseph R/B-9144-2008; Guarner, Francisco/ABF-1192-2020; Ouellette, Francis/G-1684-2010; Hubbard, Tim J.P./AAT-4571-2020; Durbin, Richard/AAE-7178-2019; Chisholm, Rex L/B-3418-2009; McPherson, John/D-2633-2017	Scherer, Stephen W./0000-0002-8326-1999; Sensen, Christoph W./0000-0001-9604-8962; Hubbard, Tim J/0000-0002-1767-9318; Tsunoda, Tatsuhiko/0000-0002-5439-7918; Weinstock, George M/0000-0002-2997-4592; Ecker, Joseph R/0000-0001-5799-5895; Guarner, Francisco/0000-0002-4051-0836; Hubbard, Tim J.P./0000-0002-1767-9318; Durbin, Richard/0000-0002-9130-1006; Chisholm, Rex L/0000-0002-5638-3990; Thornton, Janet/0000-0003-0824-4096; jackson, scott/0000-0002-3172-1607; Eddy, Sean/0000-0001-6676-4706; wu, jia yan/0000-0001-6048-405X; Rawlings, Christopher/0000-0003-3702-1633; Birney, Ewan/0000-0001-8314-8497; Apweiler, Rolf/0000-0001-7078-200X; Worley, Kim/0000-0002-0282-1000; McPherson, John/0000-0001-8049-9347; Walker, Neil/0000-0001-9796-7688; Ouellette, B. F. Francis/0000-0003-4676-675X	Biotechnology and Biological Sciences Research Council Funding Source: Medline; NHGRI NIH HHS [U54 HG003273-05S2, U54 HG003273-05S1, U54 HG003273-04S1, U54 HG003273-05, U54 HG003273, U54 HG003273-08, U54 HG003273-04, U54 HG003273-06S1, U54 HG003273-07, U54 HG003273-06S2, U54 HG003273-06] Funding Source: Medline; Wellcome Trust [077198, 062023] Funding Source: Medline; Division Of Integrative Organismal Sys [0938589] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); Division Of Integrative Organismal Sys(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Guyer M, 1998, GENOME RES, V8, P413; *HUGO, 1997, 2 INT STRAT M HUM GE; HUGO, 1996, 1 INT STRAT M HUM GE; Kaye J, 2009, NAT REV GENET, V10, P331, DOI 10.1038/nrg2573; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Natl. Res. Counc. Comm. Responsib. Authorship Biol. Sci, 2003, SHAR PUBL REL DAT MA; Rodriguez H, 2009, J PROTEOME RES, V8, P3689, DOI 10.1021/pr900023z; Wellcome Trust, 2003, SHAR DAT LARG SCAL B; 2009, NATURE BIOTECHNOL, V27, P579	9	126	128	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					168	170		10.1038/461168a	http://dx.doi.org/10.1038/461168a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	492KN	19741685	Bronze, Green Accepted			2022-12-28	WOS:000269654600017
J	Koshiba-Takeuchi, K; Mori, AD; Kaynak, BL; Cebra-Thomas, J; Sukonnik, T; Georges, RO; Latham, S; Beck, L; Henkelman, RM; Black, BL; Olson, EN; Wade, J; Takeuchi, JK; Nemer, M; Gilbert, SF; Bruneau, BG				Koshiba-Takeuchi, Kazuko; Mori, Alessandro D.; Kaynak, Bogac L.; Cebra-Thomas, Judith; Sukonnik, Tatyana; Georges, Romain O.; Latham, Stephany; Beck, Laural; Henkelman, R. Mark; Black, Brian L.; Olson, Eric N.; Wade, Juli; Takeuchi, Jun K.; Nemer, Mona; Gilbert, Scott F.; Bruneau, Benoit G.			Reptilian heart development and the molecular basis of cardiac chamber evolution	NATURE			English	Article							VENTRICULAR SEPTUM; TBX5; EXPRESSION; PHYLOGENY; TURTLE; GROWTH; ROLES	The emergence of terrestrial life witnessed the need for more sophisticated circulatory systems. This has evolved in birds, mammals and crocodilians into complete septation of the heart into left and right sides, allowing separate pulmonary and systemic circulatory systems, a key requirement for the evolution of endothermy(1-3). However, the evolution of the amniote heart is poorly understood. Reptilian hearts have been the subject of debate in the context of the evolution of cardiac septation: do they possess a single ventricular chamber or two incompletely septated ventricles(4-7)? Here we examine heart development in the red-eared slider turtle, Trachemys scripta elegans (a chelonian), and the green anole, Anolis carolinensis (a squamate), focusing on gene expression in the developing ventricles. Both reptiles initially form a ventricular chamber that homogenously expresses the T-box transcription factor gene Tbx5. In contrast, in birds and mammals, Tbx5 is restricted to left ventricle precursors(8,9). In later stages, Tbx5 expression in the turtle (but not anole) heart is gradually restricted to a distinct left ventricle, forming a left-right gradient. This suggests that Tbx5 expression was refined during evolution to pattern the ventricles. In support of this hypothesis, we show that loss of Tbx5 in the mouse ventricle results in a single chamber lacking distinct identity, indicating a requirement for Tbx5 in septation. Importantly, misexpression of Tbx5 throughout the developing myocardium to mimic the reptilian expression pattern also results in a single mispatterned ventricular chamber lacking septation. Thus ventricular septation is established by a steep and correctly positioned Tbx5 gradient. Our findings provide a molecular mechanism for the evolution of the amniote ventricle, and support the concept that altered expression of developmental regulators is a key mechanism of vertebrate evolution.	[Koshiba-Takeuchi, Kazuko; Mori, Alessandro D.; Kaynak, Bogac L.; Sukonnik, Tatyana; Bruneau, Benoit G.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Koshiba-Takeuchi, Kazuko; Mori, Alessandro D.; Kaynak, Bogac L.; Sukonnik, Tatyana; Black, Brian L.; Bruneau, Benoit G.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Koshiba-Takeuchi, Kazuko; Mori, Alessandro D.; Kaynak, Bogac L.; Sukonnik, Tatyana; Bruneau, Benoit G.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Koshiba-Takeuchi, Kazuko; Takeuchi, Jun K.] Tokyo Inst Technol, Div Cardiovasc Res, Global Edge Inst, Yokohama, Kanagawa 2268503, Japan; [Mori, Alessandro D.; Bruneau, Benoit G.] Hosp Sick Children, Program Stem Cell & Dev Biol, Toronto, ON M5G 1X8, Canada; [Mori, Alessandro D.; Bruneau, Benoit G.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Cebra-Thomas, Judith] Millersville Univ Pennsylvania, Dept Biol, Millersville, PA 17551 USA; [Georges, Romain O.; Nemer, Mona] Univ Montreal, Programme Biol Mol, Inst Rech Clin Montreal, Montreal, PQ H3C 3J7, Canada; [Latham, Stephany; Beck, Laural; Wade, Juli] Michigan State Univ, Dept Psychol, E Lansing, MI 48824 USA; [Latham, Stephany; Beck, Laural; Wade, Juli] Michigan State Univ, Program Neurosci, E Lansing, MI 48824 USA; [Henkelman, R. Mark] Hosp Sick Children, Mouse Imaging Ctr, Toronto, ON M5G 1X8, Canada; [Henkelman, R. Mark] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Black, Brian L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Nemer, Mona] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Gilbert, Scott F.] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Tokyo Institute of Technology; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Pennsylvania State System of Higher Education (PASSHE); Millersville University of Pennsylvania; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Michigan State University; Michigan State University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Ottawa; Swarthmore College	Bruneau, BG (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	bbruneau@gladstone.ucsf.edu	wade, juli/F-4993-2012; HENKELMAN, MARK/W-6847-2019	Kaynak, Bogac/0000-0002-6946-9603; Bruneau, Benoit/0000-0002-0804-7597; Black, Brian/0000-0002-6664-8913	March of Dimes Birth Defects Foundation; J. David Gladstone Institutes; William H. Younger; National Institutes of Health [P01HL089707]; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Richard Lewar Centre for Excellence; University of Toronto; Ontario Graduate Scholarship; Fumi Yamamura Memorial Foundation; MEXT; Sumitomo Foundation and Nakajima Foundation; Canada Research Chair in Imaging; Heart and Stroke foundation of Canada and the Canadian Institutes for Health Research; National Science Foundation [RUI-0748508, IOS-0742833]; National Institutes of Health/National Center for Research Resources [C06 RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089707, R01HL064658] Funding Source: NIH RePORTER	March of Dimes Birth Defects Foundation(March of Dimes); J. David Gladstone Institutes(University of California System); William H. Younger; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Richard Lewar Centre for Excellence; University of Toronto(University of Toronto); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Fumi Yamamura Memorial Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation and Nakajima Foundation; Canada Research Chair in Imaging(Canada Research Chairs); Heart and Stroke foundation of Canada and the Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Acknowledgements We thank J. N. Wylie and L. Davidson for technical assistance, M. Harris and J. Fallon for alligator embryos, T. Sanger and J. Gibson-Brown for unpublished data on Anolis staging, T. Ogura for chick Tbx5 and Tbx20 probes, and G. Howard and S. Ordway for editorial assistance. This work was funded in part by the March of Dimes Birth Defects Foundation (B. G. B.), the J. David Gladstone Institutes (B. G. B.), William H. Younger Jr (B. G. B.); a National Institutes of Health program project grant (P01HL089707 to B. G. B., B. L. B.); scholarships from the Natural Sciences and Engineering Research Council of Canada, the Heart and Stroke Richard Lewar Centre for Excellence, University of Toronto, and Ontario Graduate Scholarship (A. D. M.); the Fumi Yamamura Memorial Foundation for Female Natural Scientists and Grants-in-Aid for Scientific Research (C) (K. K.-T.), MEXT's program for young independent researchers (K. K.-T., J. K. T.), Sumitomo Foundation and Nakajima Foundation (J. K. T.), a Canada Research Chair in Imaging (R. M. H.), the Heart and Stroke foundation of Canada and the Canadian Institutes for Health Research (M. N.), and grants from the National Science Foundation (RUI-0748508 to S. F. G., J. C.-T. and IOS-0742833 to J. W.). Funding for the J. David Gladstone Institutes from a National Institutes of Health/National Center for Research Resources grant (C06 RR018928) is also acknowledged.	Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; Farmer CG, 1999, ANNU REV PHYSIOL, V61, P573, DOI 10.1146/annurev.physiol.61.1.573; Farrel A.P., 1998, BIOL REPTILIA, V19, P375; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; Greenbaum E, 2002, J MORPHOL, V254, P272, DOI 10.1002/jmor.10036; Greil A., 1903, MORPH JB, V31, P123; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Hicks JW, 2002, NEWS PHYSIOL SCI, V17, P241, DOI 10.1152/nips.01397.2002; Hillenius WJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1019, DOI 10.1086/425185; HOLMES EB, 1975, J MORPHOL, V147, P209, DOI 10.1002/jmor.1051470207; Horb ME, 1999, DEVELOPMENT, V126, P1739; Koshiba-Takeuchi K, 2006, NAT GENET, V38, P175, DOI 10.1038/ng1707; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lyson T, 2009, EVOL DEV, V11, P133, DOI 10.1111/j.1525-142X.2009.00325.x; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Rieppel O, 1999, SCIENCE, V283, P945, DOI 10.1126/science.283.5404.945; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Seymour RS, 2004, PHYSIOL BIOCHEM ZOOL, V77, P1051, DOI 10.1086/422766; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Takeuchi JK, 2003, DEVELOPMENT, V130, P5953, DOI 10.1242/dev.00797; Trajanovska S, 2008, GEN COMP ENDOCR, V156, P339, DOI 10.1016/j.ygcen.2008.01.013; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; WEBB GJW, 1979, J MORPHOL, V161, P221, DOI 10.1002/jmor.1051610209	30	98	99	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					95	U99		10.1038/nature08324	http://dx.doi.org/10.1038/nature08324			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19727199	Green Accepted, Green Submitted			2022-12-28	WOS:000269478800037
J	Laraque, D				Laraque, Danielle			A Moral Imperative for Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Laraque, D (corresponding author), Mt Sinai Sch Med, 1 Gustave L Levy Pl,Box 1198, New York, NY 10029 USA.	danielle.laraque@mssm.edu						*1 FOC, 2008, BIG ID CHILDR INV OU, P53; Becker G. S., 1987, HUMAN CAPITAL THEORE, DOI DOI 10.7208/CHICAGO/9780226041223.001.0001; Cooper JL, 2008, UNCLAIMED CHILDREN R, DOI [10.7916/D8BR91XN, DOI 10.7916/D8BR91XN]; CUNHA F, 2008, AM ECON REV, V97, P42; DeAngelis CD, 2009, JAMA-J AM MED ASSOC, V301, P1929, DOI 10.1001/jama.2009.642; Knitzer J., 1982, UNCLAIMED CHILDREN F; *UN CHILDR FUND, 2007, CHILD POV PERSP OV C; Vladeck B, 2003, AM J PUBLIC HEALTH, V93, P16, DOI 10.2105/AJPH.93.1.16	8	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					892	893		10.1001/jama.2009.1260	http://dx.doi.org/10.1001/jama.2009.1260			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	487GN	19706864				2022-12-28	WOS:000269260100024
J	Khan, AA; Kelly, RJ; Carrim, ZI				Khan, Ashraf A.; Kelly, Ross J.; Carrim, Zia I.			10-Minute Consultation Acute anterior uveitis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Carrim, Zia I.] St James Univ Hosp, Dept Ophthalmol, Leeds LS9 7TF, W Yorkshire, England; [Khan, Ashraf A.] No Gen Hosp, Dept Med, Sheffield S5 7AU, S Yorkshire, England	Saint James's University Hospital; Northern General Hospital	Carrim, ZI (corresponding author), St James Univ Hosp, Dept Ophthalmol, Leeds LS9 7TF, W Yorkshire, England.	zia.carrim@doctors.org.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2009	339								b2986	10.1136/bmj.b2986	http://dx.doi.org/10.1136/bmj.b2986			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AS	19706650				2022-12-28	WOS:000269392500001
J	Steer, PJ; Modi, N				Steer, Philip J.; Modi, Neena			Elective caesarean sections-risks to the infant	LANCET			English	Editorial Material							DELIVERY; METAANALYSIS		[Steer, Philip J.] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London SW10 9NH, England; [Modi, Neena] Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Acad Dept Neonatol, London SW10 9NH, England	Imperial College London; Imperial College London	Steer, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Chelsea & Westminster Hosp, Acad Dept Obstet & Gynaecol, London SW10 9NH, England.	p.steer@imperial.ac.uk						Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Hyde MJ, 2010, CLIN SCI, V118, P47, DOI 10.1042/CS20090169; Kamath BD, 2009, OBSTET GYNECOL, V113, P1231, DOI 10.1097/AOG.0b013e3181a66d57; Koplin J, 2008, PEDIAT ALLERG IMM-UK, V19, P682, DOI 10.1111/j.1399-3038.2008.00731.x; Miller NM, 2005, BJOG-INT J OBSTET GY, V112, P921, DOI 10.1111/j.1471-0528.2005.00620.x; MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x; *NIH, 2006, NIH STAT OF THE SCI; Saisto T, 2003, ACTA OBSTET GYN SCAN, V82, P201, DOI 10.1034/j.1600-0412.2003.00114.x; Stutchfield P, 2005, BMJ-BRIT MED J, V331, P662, DOI 10.1136/bmj.38547.416493.06; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; UTZ RL, 2008, POLICY PERSPECTIVES	12	32	37	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					675	676		10.1016/S0140-6736(09)61544-0	http://dx.doi.org/10.1016/S0140-6736(09)61544-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489LV	19716950				2022-12-28	WOS:000269422500010
J	Weber, MA; Black, H; Bakris, G; Krum, H; Linas, S; Weiss, R; Linseman, JV; Wiens, BL; Warren, MS; Lindholm, LH				Weber, Michael A.; Black, Henry; Bakris, George; Krum, Henry; Linas, Stuart; Weiss, Robert; Linseman, Jennifer V.; Wiens, Brian L.; Warren, Marshelle S.; Lindholm, Lars H.			A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							SPIRONOLACTONE; DIAGNOSIS; EFFICACY	Background Hypertension cannot always be adequately controlled with available drugs. We investigated the blood-pressure-lowering effects of the new vasodilatory, selective endothelin type A antagonist, darusentan, in patients with treatment-resistant hypertension. Methods This randomised, double-blind study was undertaken in 117 sites in North and South America, Europe, New Zealand, and Australia. 379 patients with systolic blood pressure of 140 mm Hg or more (>= 130 mm Hg if patient had diabetes or chronic kidney disease) who were receiving at least three blood-pressure-lowering drugs, including a diuretic, at full or maximum tolerated doses were randomly assigned to 14 weeks' treatment with placebo (n=132) or darusentan 50 mg (n=81), 100 ring (n=81), or 300 ring (n=85) taken once daily. Randomisation was made centrally via an automated telephone system, and patients and all investigators were masked to treatment assignments. The primary endpoints were changes in sitting systolic and diastolic blood pressures. Analysis was by intention to treat. The study is registered with ClinicalTrials.gov, number NCT00330369. Findings All randomly assigned participants were analysed. The mean reductions in clinic systolic and diastolic blood pressures were 9/5 mm Hg (SD 14/8) with placebo, 17/10 mm Hg (15/9) with darusentan 50 mg, 18/10 mm Hg (16/9) with darusentan 100 mg, and 18/11 mm, Hg (18/10) with darusentan 300 mg (p<0.0001 for all effects). The main adverse effects were related to fluid accumulation. Oedema or fluid retention occurred in 67 (27%) patients given darusentan compared with 19 (14%) given placebo. One patient in the placebo group died (sudden cardiac death), and five patients in the three darusentan dose groups combined had cardiac-related serious adverse events. Interpretation Darusentan provides additional reduction in blood pressure in patients who have not attained their treatment goals with three or more antihypertensive drugs. As with other vasodilatory drugs, fluid management with effective diuretic therapy might be needed. Funding Gilead Sciences.	[Weber, Michael A.] SUNY, Downstate Coll Med, Brooklyn, NY 11203 USA; [Black, Henry] NYU, New York, NY USA; [Bakris, George] Univ Chicago, Chicago, IL 60637 USA; [Krum, Henry] Monash Univ, Clayton, Vic, Australia; [Linas, Stuart] Denver Hlth Med Ctr, Denver, CO USA; [Weiss, Robert] Maine Res Associates, Auburn, ME USA; [Linseman, Jennifer V.; Wiens, Brian L.; Warren, Marshelle S.] Gilead Sci Inc, Foster City, CA 94404 USA; [Lindholm, Lars H.] Umea Univ Hosp, S-90185 Umea, Sweden	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; SUNY Maritime College; New York University; University of Chicago; Monash University; Denver Health Medical Center; Gilead Sciences; Umea University	Weber, MA (corresponding author), SUNY, Downstate Coll Med, 450 Clarkson Ave,Box 97, Brooklyn, NY 11203 USA.	michaelwebermd@cs.com		Wiens, Brian/0000-0003-2321-8259	Gilead Sciences	Gilead Sciences(Gilead Sciences)	We thank the study participants and Philip Sager for his critical scientific review and input into the report. This study was funded by Gilead Sciences.	Black Henry R, 2007, J Clin Hypertens (Greenwich), V9, P760, DOI 10.1111/j.1524-6175.2007.07244.x; Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Einhorn PT, 2007, AM HEART J, V153, P42, DOI 10.1016/j.ahj.2006.10.012; HAAK T, 1992, AM J HYPERTENS, V5, P161, DOI 10.1093/ajh/5.3.161; KNEPPER MA, 2005, HYPERTENSION, P638; Krum H, 1998, NEW ENGL J MED, V338, P784, DOI 10.1056/NEJM199803193381202; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; McGill JB, 2001, CLIN THER, V23, P833, DOI 10.1016/S0149-2918(01)80072-2; Nakov R, 2002, AM J HYPERTENS, V15, P583, DOI 10.1016/S0895-7061(02)02933-3; Nishizaka MK, 2003, AM J HYPERTENS, V16, P925, DOI 10.1016/S0895-7061(03)01032-X; Ouzan J, 2002, AM J HYPERTENS, V15, P333, DOI 10.1016/S0895-7061(01)02342-1; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Saha C, 2005, HYPERTENSION, V46, P481, DOI 10.1161/01.HYP.0000179582.42830.1d; SAITO Y, 1990, NEW ENGL J MED, V322, P205; Schneider LG, 2002, AM J HYPERTENS, V15, P967; SICA D, 2005, HYPERTENSION COMPANI, P669; Weber Michael A, 2006, J Clin Hypertens (Greenwich), V8, P840, DOI 10.1111/j.1524-6175.2006.05696.x; Weir MR, 2001, AM J HYPERTENS, V14, P567, DOI 10.1016/S0895-7061(00)01304-2; Wiens BL, 2003, PHARM STAT, V2, P211, DOI 10.1002/pst.64; Wiens BL, 2005, J BIOPHARM STAT, V15, P929, DOI 10.1080/10543400500265660; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1	22	228	244	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1423	1431		10.1016/S0140-6736(09)61500-2	http://dx.doi.org/10.1016/S0140-6736(09)61500-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MZ	19748665				2022-12-28	WOS:000271255000031
J	Lin, G; Li, DY; de Carvalho, LPS; Deng, HT; Tao, H; Vogt, G; Wu, KY; Schneider, J; Chidawanyika, T; Warren, JD; Li, HL; Nathan, C				Lin, Gang; Li, Dongyang; de Carvalho, Luiz Pedro Sorio; Deng, Haiteng; Tao, Hui; Vogt, Guillaume; Wu, Kangyun; Schneider, Jean; Chidawanyika, Tamutenda; Warren, J. David; Li, Huilin; Nathan, Carl			Inhibitors selective for mycobacterial versus human proteasomes	NATURE			English	Article							UBIQUITIN-LIKE PROTEIN; TUBERCULOSIS PROTEASOME; NITRIC-OXIDE; SOFTWARE; IDENTIFICATION; TOOLS	Many anti-infectives inhibit the synthesis of bacterial proteins, but none selectively inhibits their degradation. Most anti-infectives kill replicating pathogens, but few preferentially kill pathogens that have been forced into a non-replicating state by conditions in the host. To explore these alternative approaches we sought selective inhibitors of the proteasome of Mycobacterium tuberculosis. Given that the proteasome structure is extensively conserved, it is not surprising that inhibitors of all chemical classes tested have blocked both eukaryotic and prokaryotic proteasomes, and no inhibitor has proved substantially more potent on proteasomes of pathogens than of their hosts. Here we show that certain oxathiazol-2-one compounds kill non-replicating M. tuberculosis and act as selective suicide-substrate inhibitors of the M. tuberculosis proteasome by cyclocarbonylating its active site threonine. Major conformational changes protect the inhibitor-enzyme intermediate from hydrolysis, allowing formation of an oxazolidin-2-one and preventing regeneration of active protease. Residues outside the active site whose hydrogen bonds stabilize the critical loop before and after it moves are extensively non-conserved. This may account for the ability of oxathiazol-2-one compounds to inhibit the mycobacterial proteasome potently and irreversibly while largely sparing the human homologue.	[Lin, Gang; de Carvalho, Luiz Pedro Sorio; Vogt, Guillaume; Wu, Kangyun; Schneider, Jean; Chidawanyika, Tamutenda; Nathan, Carl] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA; [Tao, Hui; Warren, J. David] Weill Cornell Med Coll, Milstein Chem Core Facil, New York, NY 10065 USA; [Tao, Hui; Warren, J. David] Weill Cornell Med Coll, Dept Biochem & Struct Biol, New York, NY 10065 USA; [Li, Dongyang; Li, Huilin] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Deng, Haiteng] Rockefeller Univ, Prote Resource Ctr, New York, NY 10065 USA; [Li, Huilin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	Cornell University; Cornell University; Cornell University; United States Department of Energy (DOE); Brookhaven National Laboratory; Rockefeller University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Nathan, C (corresponding author), Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA.	gal2005@med.cornell.edu; hli@bnl.gov; cnathan@med.cornell.edu	Warren, J David/B-5625-2008; Vogt, Guillaume/L-6046-2015	Warren, J David/0000-0002-2833-2248; Vogt, Guillaume/0000-0001-8192-1247; Sorio de Carvalho, Luiz Pedro/0000-0003-2875-4552; Wu, Kangyun/0000-0002-8093-094X; Deng, Haiteng/0000-0001-9496-1280; Li, Huilin/0000-0001-8085-8928	NIH [PO1-AI056293, R01AI070285]; Milstein Program in Chemical Biology of Infectious Diseases; US DOE; William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070285, P01AI056293] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Milstein Program in Chemical Biology of Infectious Diseases; US DOE(United States Department of Energy (DOE)); William Randolph Hearst Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	S. Eswaramoorthy helped with crystallography software, C. Lipinski, C. Walsh and M. Fischbach proposed reaction mechanisms, and C. Karan assisted with screening. S. Ehrt and S. Gandotra performed some bactericidal assays, C. Tsu and L. Dick donated a fluorimeter and J. Blanchard provided BlaC. Supported by NIH PO1-AI056293, NIH R01AI070285 and the Milstein Program in Chemical Biology of Infectious Diseases. X-ray diffraction data were collected at beamline X6A, X25 and X29 in the National Synchrotron Light Source, a facility supported by the US DOE and NIH. The Department of Microbiology and Immunology is supported by the William Randolph Hearst Foundation.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bryk R, 2008, CELL HOST MICROBE, V3, P137, DOI 10.1016/j.chom.2008.02.003; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Copeland R.A., 2000, ENZYMES PRACTICAL IN, P305; COPP LJ, 2003, ENZYME KINETICS MODE, P158; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Glenn RJ, 2004, INT J ANTIMICROB AG, V24, P286, DOI 10.1016/j.ijantimicag.2004.02.023; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Hu YM, 1998, FEMS MICROBIOL LETT, V158, P139; Huth JR, 2007, CHEM RES TOXICOL, V20, P1752, DOI 10.1021/tx700319t; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Kropff M, 2007, BRIT J HAEMATOL, V138, P330, DOI 10.1111/j.1365-2141.2007.06656.x; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Lin G, 2008, J BIOL CHEM, V283, P34423, DOI 10.1074/jbc.M805324200; Lu LQ, 2008, J AM CHEM SOC, V130, P6946, DOI 10.1021/ja800746q; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; RAJCA A, 1983, SYNTHESIS-STUTTGART, P1032; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; Restrepo BI, 2007, CLIN INFECT DIS, V45, P436, DOI 10.1086/519939; Russo A, 2008, J PROTEOME RES, V7, P4178, DOI 10.1021/pr800224v; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727	30	169	180	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					621	U63		10.1038/nature08357	http://dx.doi.org/10.1038/nature08357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	500LH	19759536	Green Accepted			2022-12-28	WOS:000270302600033
J	Kaplan, F				Kaplan, Fred			An alien concept	NATURE			English	Editorial Material												war_stories@hotmail.com							0	1	1	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					345	346		10.1038/461345a	http://dx.doi.org/10.1038/461345a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	494QB	19759602				2022-12-28	WOS:000269828100020
J	Coombes, R				Coombes, Rebecca			Climate Change Population: the forgotten priority	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Coombes, R (corresponding author), BMJ, London WC1H 9JR, England.	rcoombes@bmjgroup.com						*UN DEP EC SOC AFF, 2008, WORLD CONTR US 2007; United Nations Population Fund, 2008, STAT WORLD POP 2008	2	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2009	339								b3750	10.1136/bmj.b3750	http://dx.doi.org/10.1136/bmj.b3750			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RT	19759080				2022-12-28	WOS:000269994800010
J	Watt, JP; Wolfson, LJ; O'Brien, KL; Henkle, E; Deloria-Knoll, M; McCall, N; Lee, E; Levine, OS; Hajjeh, R; Mulholland, K; Cherian, T				Watt, James P.; Wolfson, Lara J.; O'Brien, Katherine L.; Henkle, Emily; Deloria-Knoll, Maria; McCall, Natalie; Lee, Ellen; Levine, Orin S.; Hajjeh, Rana; Mulholland, Kim; Cherian, Thomas		Hib Pneumococcol Global Burden Dis	Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates	LANCET			English	Article							CONJUGATE VACCINE; HIB DISEASE; PNEUMONIA; IMMUNIZATION; MENINGITIS; PREVENTION; EPIDEMIOLOGY; ELIMINATION; SURVIVAL; DEATHS	Background Haemophilus influenzae type b (Hib) is a leading cause of childhood bacterial meningitis, pneumonia, and other serious infections. Hib disease can be almost completely eliminated through routine vaccination. We assessed the global burden of disease to help national policy makers and international donors set priorities. Methods We did a comprehensive literature search of studies of Hib disease incidence, case-fatality ratios, age distribution, syndrome distribution, and effect of Hib vaccine. We used vaccine trial data to estimate the proportion of pneumonia cases and pneumonia deaths caused by Hib. We applied these proportions to WHO country-specific estimates of pneumonia cases and deaths to estimate Hib pneumonia burden. We used data from surveillance studies to develop estimates of incidence and mortality of Hib meningitis and serious non-pneumonia, non-meningitis disease. if available, high-quality data were used for national estimates of Hib meningitis and non-pneumonia, non-meningitis disease burden. Otherwise, estimates were based on data from other countries matched as closely as possible for geographic region and child mortality. Estimates were adjusted for HIV prevalence and access to care. Disease burden was estimated for the year 2000 in children younger than 5 years. Findings We calculated that Hib caused about 8.13 million serious illnesses worldwide in 2000 (uncertainty range 7.33-13.2 million). We estimated that Hib caused 371 000 deaths (247 000-527 000) in children aged 1-59 months, of which 8100 (5600-10 000) were in HIV-positive and 363 000 (242 000-517 000) in HIV-negative children. Interpretation Global burden of Hib disease is substantial and almost entirely vaccine preventable. Expanded use of Hib vaccine could reduce childhood pneumonia and meningitis, and decrease child mortality.	[Watt, James P.; Hajjeh, Rana] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Hib Initiat, Baltimore, MD USA; [O'Brien, Katherine L.; Henkle, Emily; Deloria-Knoll, Maria; McCall, Natalie; Lee, Ellen; Levine, Orin S.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, GAVIs PneumoADIP, Baltimore, MD USA; [Wolfson, Lara J.; Cherian, Thomas] WHO, CH-1211 Geneva, Switzerland; [Mulholland, Kim] London Sch Hyg & Trop Med, London WC1, England	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Watt, JP (corresponding author), Johns Hopkins Ctr Amer Indian Hlth, 621 N Washington St, Baltimore, MD 21205 USA.	jwatt@jhsph.edu	McCall, Natalie/ABA-3767-2021; Wolfson, Lara/AAC-1400-2019	McCall, Natalie/0000-0001-9387-4521; Wolfson, Lara/0000-0002-6454-3368; Deloria Knoll, Maria/0000-0001-9041-2671; Mangtani, Punam/0000-0001-7074-2999; O'Brien, Katherine/0000-0002-0164-4030	GAVI Alliance; Vaccine Fund	GAVI Alliance; Vaccine Fund	Funding GAVI Alliance and the Vaccine Fund.	Adegbola RA, 1998, J INFECT DIS, V177, P1758, DOI 10.1086/517440; Adegbola RA, 2005, LANCET, V366, P144, DOI 10.1016/S0140-6736(05)66788-8; Adegbola RA, 1999, LANCET, V354, P1091, DOI 10.1016/S0140-6736(99)03010-X; Baqui AH, 2007, PEDIATR INFECT DIS J, V26, P565, DOI 10.1097/INF.0b013e31806166a0; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Dagan R, 1999, VACCINE, V17, P134, DOI 10.1016/S0264-410X(98)00165-0; de Andrade ALSS, 2004, INT J EPIDEMIOL, V33, P173, DOI 10.1093/ije/dyh025; de la Hoz F, 2004, VACCINE, V23, P36, DOI 10.1016/j.vaccine.2004.05.017; Feikin DR, 2004, EMERG INFECT DIS, V10, P1270, DOI 10.3201/eid1007.030737; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; KNOLL MD, GLOBAL LIT REV HAEMO; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Levine OS, 1999, PEDIATR INFECT DIS J, V18, P1060, DOI 10.1097/00006454-199912000-00006; Lewis RF, 2008, B WORLD HEALTH ORGAN, V86, P292, DOI 10.2471/BLT.07.045336; Mendsaikhan J, 2009, CLIN INFECT DIS, V48, pS141, DOI 10.1086/596493; Moisi JC, 2006, PEDIATR INFECT DIS J, V25, P960, DOI 10.1097/01.inf.0000235748.52411.a9; Moulton LH, 2000, INT J EPIDEMIOL, V29, P753, DOI 10.1093/ije/29.4.753; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Mulholland K, 1999, EPIDEMIOL REV, V21, P43, DOI 10.1093/oxfordjournals.epirev.a017987; MURPHY TV, 1993, JAMA-J AM MED ASSOC, V269, P246, DOI 10.1001/jama.269.2.246; MURPHY TV, 1993, J PEDIATR-US, V122, P517, DOI 10.1016/S0022-3476(05)83529-2; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rossi IA, 2007, VACCINE, V25, P7075, DOI 10.1016/j.vaccine.2007.07.058; Rudan I, 2008, B WORLD HEALTH ORGAN, V86, P408, DOI 10.2471/BLT.07.048769; Shibuya K, 2005, B WORLD HEALTH ORGAN, V83, P722; *UNICEF, 2009, PERC 5 SUSP PNEUM TA; United Nations Population Division, WORLD POP PROSP; Watt JP, 2003, J PEDIATR-US, V143, pS163, DOI 10.1067/S0022-3476(03)00576-6; Wenger JD, 1998, PEDIATR INFECT DIS J, V17, pS132, DOI 10.1097/00006454-199809001-00008; Wenger JD, 1999, VACCINE, V18, P736, DOI 10.1016/S0264-410X(99)00269-8; *WHO, 1996, GEN PROT POP BAS SUR; WHO, 2006, WORLD HLTH REP 2005; *WHO, 2008, WKLY EPIDEMIOL REC, V83, P61; *WHO, 2009, WHO UNICEF EST NAT I; *WHO, 2004, WKLY EPIDEMIOL REC, V79, P173; *WHO, 2001, EST LOC BURD HAEM IN; Williams BG, 2002, LANCET INFECT DIS, V2, P25, DOI 10.1016/S1473-3099(01)00170-0; Wilson N, 2003, VACCINE, V21, P1907, DOI 10.1016/S0264-410X(02)00825-3; World Health Organization, 2006, Wkly Epidemiol Rec, V81, P445; World Health Organization, 2008, GLOB BURD DIS 2004 U	42	352	368	1	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					903	911		10.1016/S0140-6736(09)61203-4	http://dx.doi.org/10.1016/S0140-6736(09)61203-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496BN	19748399				2022-12-28	WOS:000269943100029
J	McElroy, MB; Lu, X; Nielsen, CP; Wang, YX				McElroy, Michael B.; Lu, Xi; Nielsen, Chris P.; Wang, Yuxuan			Potential for Wind-Generated Electricity in China	SCIENCE			English	Article								Wind offers an important alternative to coal as a source of energy for generation of electricity in China with the potential for substantial savings in carbon dioxide emissions. Wind fields derived from assimilated meteorological data are used to assess the potential for wind-generated electricity in China subject to the existing government-approved bidding process for new wind farms. Assuming a guaranteed price of 0.516 RMB (7.6 U. S. cents) per kilowatt-hour for delivery of electricity to the grid over an agreed initial average period of 10 years, it is concluded that wind could accommodate all of the demand for electricity projected for 2030, about twice current consumption. Electricity available at a concession price as low as 0.4 RMB per kilowatt-hour would be sufficient to displace 23% of electricity generated from coal.	[McElroy, Michael B.; Lu, Xi; Nielsen, Chris P.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [McElroy, Michael B.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Nielsen, Chris P.] Harvard Univ, Harvard China Project, Cambridge, MA 02138 USA; [Wang, Yuxuan] Tsinghua Univ, Dept Environm Sci & Engn, Beijing 100084, Peoples R China	Harvard University; Harvard University; Harvard University; Tsinghua University	McElroy, MB (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	mbm@seas.harvard.edu	Lu, Xi/B-1262-2016; Wang, Yuxuan/C-6902-2014; 欧阳, 冰洁/G-2925-2011	Lu, Xi/0000-0002-5063-3776; Wang, Yuxuan/0000-0002-1649-6974; 	NSF [ATM-0635548]	NSF(National Science Foundation (NSF))	The GEOS-5 data were provided by NASA-GMAO ( Global Modeling and Assimilation Office). We thank Y. Li for research assistance and R. M. O'Connell and J. Cao for advice. This research was supported by NSF grant ATM-0635548.	Barbour W., 2000, CARBON DIOXIDE EMISS; *CARB DIOX INF AN, 2008, PREL 2006 2007 GLOB; Cyranoski D, 2009, NATURE, V457, P372, DOI 10.1038/457372a; *GEO, 2009, GE 1 5 MW SER WIND T; Ho M.S., 2007, CLEARING AIR HLTH EC; Hsu, 2008, BRIEF DESCRIPTION SM; *INT EN AG, 2009, WORLD EN OUTL 2008; Kempton W, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028016; Li J., 2008, CHINA WIND POWER REP; Lu X, 2009, P NATL ACAD SCI USA, V106, P10933, DOI 10.1073/pnas.0904101106; *NAT DEV REF COMM, 2006, REL PROV ADM GEN EL; NI CC, 2008, CHINAS WIND POWER GE; RIENECKER MM, 2007, NASA PUBLICATION, V27; Wiser R., 2008, US DOE PUBLICATION	14	133	141	18	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1378	1380		10.1126/science.1175706	http://dx.doi.org/10.1126/science.1175706			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745149	Green Submitted			2022-12-28	WOS:000269699100034
J	Ohtake, M; Matsunaga, T; Haruyama, J; Yokota, Y; Morota, T; Honda, C; Ogawa, Y; Torii, M; Miyamoto, H; Arai, T; Hirata, N; Iwasaki, A; Nakamura, R; Hiroi, T; Sugihara, T; Takeda, H; Otake, H; Pieters, CM; Saiki, K; Kitazato, K; Abe, M; Asada, N; Demura, H; Yamaguchi, Y; Sasaki, S; Kodama, S; Terazono, J; Shirao, M; Yamaji, A; Minami, S; Akiyama, H; Josset, JL				Ohtake, Makiko; Matsunaga, Tsuneo; Haruyama, Junichi; Yokota, Yasuhiro; Morota, Tomokatsu; Honda, Chikatoshi; Ogawa, Yoshiko; Torii, Masaya; Miyamoto, Hideaki; Arai, Tomoko; Hirata, Naru; Iwasaki, Akira; Nakamura, Ryosuke; Hiroi, Takahiro; Sugihara, Takamitsu; Takeda, Hiroshi; Otake, Hisashi; Pieters, Carle M.; Saiki, Kazuto; Kitazato, Kohei; Abe, Masanao; Asada, Noriaki; Demura, Hirohide; Yamaguchi, Yasushi; Sasaki, Sho; Kodama, Shinsuke; Terazono, Junya; Shirao, Motomaro; Yamaji, Atsushi; Minami, Shigeyuki; Akiyama, Hiroaki; Josset, Jean-Luc			The global distribution of pure anorthosite on the Moon	NATURE			English	Article							LUNAR-SURFACE; CRUST; PLAGIOCLASE; OLIVINE; SELENE	It has been thought that the lunar highland crust was formed by the crystallization and floatation of plagioclase from a global magma ocean(1,2), although the actual generation mechanisms are still debated(2,3). The composition of the lunar highland crust is therefore important for understanding the formation of such a magma ocean and the subsequent evolution of the Moon. The Multiband Imager(4) on the Selenological and Engineering Explorer (SELENE)(5) has a high spatial resolution of optimized spectral coverage, which should allow a clear view of the composition of the lunar crust. Here we report the global distribution of rocks of high plagioclase abundance ( approaching 100 vol.%), using an unambiguous plagioclase absorption band recorded by the SELENE Multiband Imager. If the upper crust indeed consists of nearly 100 vol.% plagioclase, this is significantly higher than previous estimates of 82-92 vol.% (refs 2, 6, 7), providing a valuable constraint on models of lunar magma ocean evolution.	[Ohtake, Makiko; Haruyama, Junichi; Yokota, Yasuhiro; Morota, Tomokatsu; Abe, Masanao] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Matsunaga, Tsuneo] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Torii, Masaya] Fujitsu Ltd, Mihama Ku, Chiba 2618588, Japan; [Honda, Chikatoshi; Ogawa, Yoshiko; Hirata, Naru; Kitazato, Kohei; Asada, Noriaki; Demura, Hirohide; Terazono, Junya] Univ Aizu, Fukushima 9658580, Japan; [Miyamoto, Hideaki] Univ Tokyo, Univ Museum, Bunkyo Ku, Tokyo 1130033, Japan; [Arai, Tomoko] Chiba Inst Technol, Planetary Explorat Res Ctr, Chiba 2750016, Japan; [Iwasaki, Akira] Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; [Nakamura, Ryosuke; Kodama, Shinsuke] Natl Inst Adv Ind Sci & Technol, Informat Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Hiroi, Takahiro; Pieters, Carle M.] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Sugihara, Takamitsu] Japan Agcy Marine Earth Sci & Technol, Ctr Deep Earth Explorat, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Takeda, Hiroshi] Chiba Inst Technol, Frontier Plasma Res Ctr, Chiba 2750016, Japan; [Otake, Hisashi] Japan Aerosp Explorat Agcy, Lunar & Planetary Explorat Program Grp, Tsukuba, Ibaraki 3058505, Japan; [Saiki, Kazuto] Osaka Univ, Dept Earth & Space Sci, Osaka 5600043, Japan; [Yamaguchi, Yasushi] Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Environm Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Sasaki, Sho] Natl Inst Nat Sci, Natl Astron Observ Japan, RISE Project Off, Mizusawa, Oshu 0230861, Japan; [Yamaji, Atsushi] Kyoto Univ, Grad Sch Sci, Div Earth & Planetary Sci, Sakyo Ku, Kyoto 6068502, Japan; [Minami, Shigeyuki] Osaka City Univ, Dept Elect Engn, Sumiyoshi Ku, Osaka 5588585, Japan; [Akiyama, Hiroaki] Wakayama Univ, Wakayama 6408510, Japan; [Josset, Jean-Luc] Space Explorat Inst CP 774, CH-2002 Neuchatel, Switzerland	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); National Institute for Environmental Studies - Japan; Fujitsu Ltd; University of Aizu; University of Tokyo; Chiba Institute of Technology; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); Brown University; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Chiba Institute of Technology; Japan Aerospace Exploration Agency (JAXA); Osaka University; Nagoya University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Kyoto University; Osaka Metropolitan University; Wakayama University	Ohtake, M (corresponding author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, 3-1-1 Yoshino Dai, Sagamihara, Kanagawa 2298510, Japan.	ohtake.makiko@jaxa.jp	Matsunaga, Tsuneo/H-3040-2018; Yamaji, Atsushi/ABB-2815-2021; Miyamoto, Hideaki/E-3381-2012; Kodama, Shinsuke/L-7117-2018; Miyamoto, Hideaki/B-9666-2008	Matsunaga, Tsuneo/0000-0002-3380-5230; Yamaji, Atsushi/0000-0001-8074-543X; Miyamoto, Hideaki/0000-0001-8013-6124; Hirata, Naru/0000-0002-2435-604X; Yamaguchi, Yasushi/0000-0002-2554-1060				Adams J.B., 1978, PLAGIOCLASE FELDSPAR, V9, P2901; Cintala MJ, 1998, METEORIT PLANET SCI, V33, P889, DOI 10.1111/j.1945-5100.1998.tb01695.x; CLARK PE, 1978, P LUN PLAN SCI C, V9, P3029; Denevi BW, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002802; Grier JA, 2001, J GEOPHYS RES-PLANET, V106, P32847, DOI 10.1029/1999JE001160; Hawke BR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001890; HAWKE BR, 1986, LUNAR PLANET SCI, V17, P999; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Kato M, 2008, ADV SPACE RES, V42, P294, DOI 10.1016/j.asr.2007.03.049; Korotev RL, 2003, GEOCHIM COSMOCHIM AC, V67, P4895, DOI 10.1016/j.gca.2003.08.001; Lafrance B, 1996, CONTRIB MINERAL PETR, V122, P431, DOI 10.1007/s004100050139; Lawrence DJ, 2000, J GEOPHYS RES-PLANET, V105, P20307, DOI 10.1029/1999JE001177; Longhi J, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001941; LONGHI J, 1995, LUNAR PLANET SCI, V26, P859; Lucey P, 2006, REV MINERAL GEOCHEM, V60, P83, DOI 10.2138/rmg.2006.60.2; Lucey PG, 2000, J GEOPHYS RES-PLANET, V105, P20297, DOI 10.1029/1999JE001117; Lucey PG, 1998, J GEOPHYS RES-PLANET, V103, P1703, DOI 10.1029/97JE03145; Lucey PG, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014655; Matsunaga T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035868; McEwen A., 1998, LUNAR PLANET SCI, V29, P1466; MCEWEN AS, 1994, SCIENCE, V266, P1858, DOI 10.1126/science.266.5192.1858; MOUELIC SL, 1999, GEOPHYS RES LETT, V26, P1195; Ohtake M, 2008, EARTH PLANETS SPACE, V60, P257, DOI 10.1186/BF03352789; PHINNEY WC, 1990, GEOCHIM COSMOCHIM AC, V54, P1639, DOI 10.1016/0016-7037(90)90397-4; Pieters C. M, 1999, WORKSH NEW VIEWS MOO, VII, P8025; SPUDIS PD, 1984, J GEOPHYS RES, V89, pC197, DOI 10.1029/JB089iS01p0C197; Sunshine JM, 1998, J GEOPHYS RES-PLANET, V103, P13675, DOI 10.1029/98JE01217; Takeda H, 2006, EARTH PLANET SC LETT, V247, P171, DOI 10.1016/j.epsl.2006.04.004; Taylor S. R., 1982, PLANETARY SCI LUNAR; Tompkins S, 1999, METEORIT PLANET SCI, V34, P25, DOI 10.1111/j.1945-5100.1999.tb01729.x; WARREN PH, 1990, AM MINERAL, V75, P46; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3	32	211	220	1	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					236	U110		10.1038/nature08317	http://dx.doi.org/10.1038/nature08317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741704				2022-12-28	WOS:000269654600038
J	Schuetz, P; Christ-Crain, M; Thomann, R; Falconnier, C; Wolbers, M; Widmer, I; Neidert, S; Fricker, T; Blum, C; Schild, U; Regez, K; Schoenenberger, R; Henzen, C; Bregenzer, T; Hoess, C; Krause, M; Bucher, HC; Zimmerli, W; Mueller, B				Schuetz, Philipp; Christ-Crain, Mirjam; Thomann, Robert; Falconnier, Claudine; Wolbers, Marcel; Widmer, Isabelle; Neidert, Stefanie; Fricker, Thomas; Blum, Claudine; Schild, Ursula; Regez, Katharina; Schoenenberger, Ronald; Henzen, Christoph; Bregenzer, Thomas; Hoess, Claus; Krause, Martin; Bucher, Heiner C.; Zimmerli, Werner; Mueller, Beat		ProHOSP Study Grp	Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections The ProHOSP Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; DIAGNOSTIC-VALUE; THERAPY; MANAGEMENT; EXACERBATIONS; EQUIVALENCE; ADHERENCE; GUIDANCE; ADULTS	Context In previous smaller trials, a procalcitonin (PCT) algorithm reduced antibiotic use in patients with lower respiratory tract infections (LRTIs). Objective To examine whether a PCT algorithm can reduce antibiotic exposure without increasing the risk for serious adverse outcomes. Design, Setting, and Patients A multicenter, noninferiority, randomized controlled trial in emergency departments of 6 tertiary care hospitals in Switzerland with an open intervention of 1359 patients with mostly severe LRTIs randomized between October 2006 and March 2008. Intervention Patients were randomized to administration of antibiotics based on a PCT algorithm with predefined cutoff ranges for initiating or stopping antibiotics (PCT group) or according to standard guidelines (control group). Serum PCT was measured locally in each hospital and instructions were Web-based. Main Outcome Measures Noninferiority of the composite adverse outcomes of death, intensive care unit admission, disease-specific complications, or recurrent infection requiring antibiotic treatment within 30 days, with a predefined noninferiority boundary of 7.5%; and antibiotic exposure and adverse effects from antibiotics. Results The rate of overall adverse outcomes was similar in the PCT and control groups (15.4% [n = 103] vs 18.9% [n = 130]; difference, -3.5%; 95% CI, -7.6% to 0.4%). The mean duration of antibiotics exposure in the PCT vs control groups was lower in all patients (5.7 vs 8.7 days; relative change, -34.8%; 95% CI, -40.3% to -28.7%) and in the subgroups of patients with community-acquired pneumonia (n = 925, 7.2 vs 10.7 days; -32.4%; 95% CI, -37.6% to -26.9%), exacerbation of chronic obstructive pulmonary disease (n = 228, 2.5 vs 5.1 days; -50.4%; 95% CI, -64.0% to -34.0%), and acute bronchitis (n = 151, 1.0 vs 2.8 days; -65.0%; 95% CI, -84.7% to -37.5%). Antibiotic-associated adverse effects were less frequent in the PCT group (19.8% [n = 133] vs 28.1% [n = 193]; difference, -8.2%; 95% CI, -12.7% to -3.7%). Conclusion In patients with LRTIs, a strategy of PCT guidance compared with standard guidelines resulted in similar rates of adverse outcomes, as well as lower rates of antibiotic exposure and antibiotic-associated adverse effects. Trial Registration isrctn.org Identifier: ISRCTN95122877 JAMA. 2009;302(10):1059-1066	[Schuetz, Philipp; Christ-Crain, Mirjam; Schild, Ursula; Regez, Katharina; Bregenzer, Thomas; Mueller, Beat] Kantonsspital Aarau, Dept Internal Med, CH-5001 Aarau, Switzerland; [Schuetz, Philipp; Christ-Crain, Mirjam; Thomann, Robert; Falconnier, Claudine; Blum, Claudine; Schild, Ursula; Regez, Katharina; Mueller, Beat] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Schuetz, Philipp; Wolbers, Marcel; Bucher, Heiner C.] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Thomann, Robert; Schoenenberger, Ronald] Buergerspital, Dept Internal Med, Solothurn, Switzerland; [Falconnier, Claudine; Zimmerli, Werner] Kantonsspital Liestal, Dept Internal Med, CH-4410 Liestal, Switzerland; [Widmer, Isabelle; Neidert, Stefanie; Henzen, Christoph] Kantonsspital, Dept Internal Med, Luzern, Switzerland; [Fricker, Thomas; Hoess, Claus; Krause, Martin] Kantonsspital, Dept Internal Med, Muensterlingen, Switzerland	Kantonsspital Aarau AG (KSA); University of Basel; University of Basel; Kantonsspital Baselland; Kantonsspital Aarau AG (KSA); Lucerne Cantonal Hospital; Kantonsspital Aarau AG (KSA)	Mueller, B (corresponding author), Kantonsspital Aarau, Dept Internal Med, Tellstr, CH-5001 Aarau, Switzerland.	happy.mueller@unibas.ch	Blum, Claudine Angela A/G-8467-2016; schuetz, philipp/C-8475-2013; Franzeck, Fabian C/B-5055-2011; Mueller, Beat/G-2662-2012	Blum, Claudine Angela A/0000-0003-0487-5587; schuetz, philipp/0000-0001-6400-4949; Bingisser, Roland/0000-0001-8223-9792; Christ-Crain, Mirjam/0000-0002-6336-0965	Swiss National Science Foundation [SNF 3200BO-116177/1]; Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation; University Hospital Basel; Medical University Clinic Liestal; Medical Clinic Buergerspital Solothurn; Cantonal Hospitals Muensterlingen; Aarau; Lucerne; Swiss Society for Internal Medicine; Department of Endocrinology, Diabetology, and Clinical Nutrition; BRAHMS Inc	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation; University Hospital Basel; Medical University Clinic Liestal; Medical Clinic Buergerspital Solothurn; Cantonal Hospitals Muensterlingen; Aarau; Lucerne; Swiss Society for Internal Medicine; Department of Endocrinology, Diabetology, and Clinical Nutrition; BRAHMS Inc	This work was supported in part by grant SNF 3200BO-116177/1 from the Swiss National Science Foundation and contributions from Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation, the University Hospital Basel, the Medical University Clinic Liestal, the Medical Clinic Buergerspital Solothurn, the Cantonal Hospitals Muensterlingen, Aarau, and Lucerne, respectively, the Swiss Society for Internal Medicine, and the Department of Endocrinology, Diabetology, and Clinical Nutrition, University Hospital Basel. BRAHMS Inc, the major manufacturer of the procalcitonin assay, provided all assay-related material, Kryptor machines if not already available onsite, and kits and maintenance required for 10 000 measurements related to the study.	Agresti A, 2000, AM STAT, V54, P280, DOI 10.2307/2685779; ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P655, DOI 10.1164/rccm.2506009; Briel M, 2008, ARCH INTERN MED, V168, P2000, DOI 10.1001/archinte.168.18.2000; Briel Matthias, 2005, BMC Fam Pract, V6, P34, DOI 10.1186/1471-2296-6-34; Calverley PMA, 2003, LANCET, V362, P1053, DOI 10.1016/S0140-6736(03)14416-9; Christ-Crain M, 2004, LANCET, V363, P600, DOI 10.1016/S0140-6736(04)15591-8; Christ-Crain M, 2006, AM J RESP CRIT CARE, V174, P84, DOI 10.1164/rccm.200512-1922OC; Filippini M, 2006, HEALTH POLICY, V78, P77, DOI 10.1016/j.healthpol.2005.09.009; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; GOLD, GLOB IN CHRON OBSTR; Gonzales R, 2000, ANN INTERN MED, V133, P981, DOI 10.7326/0003-4819-133-12-200012190-00014; Harbarth S, 2001, AM J RESP CRIT CARE, V164, P396, DOI 10.1164/ajrccm.164.3.2009052; Macfarlane J, 1997, RESP MED, V91, P427, DOI 10.1016/S0954-6111(97)90258-4; Menendez R, 2005, AM J RESP CRIT CARE, V172, P757, DOI 10.1164/rccm.200411-1444OC; Mizgerd JP, 2008, NEW ENGL J MED, V358, P716, DOI 10.1056/NEJMra074111; Muller B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-10; Muller B, 2000, CRIT CARE MED, V28, P977, DOI 10.1097/00003246-200004000-00011; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; R Development Core Team, 2008, LANG ENV STAT COMP; Scalera NM, 2007, CURR OPIN INFECT DIS, V20, P177, DOI 10.1097/QCO.0b013e3280555072; Schouten JA, 2005, J ANTIMICROB CHEMOTH, V56, P575, DOI 10.1093/jac/dki275; Schuetz P, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-102; Shehab N, 2008, CLIN INFECT DIS, V47, P735, DOI 10.1086/591126; Song JX, 2003, CONTROL CLIN TRIALS, V24, P378, DOI 10.1016/S0197-2456(03)00026-6; Stolz D, 2007, CHEST, V131, P9, DOI 10.1378/chest.06-1500; Stolz D, 2006, SWISS MED WKLY, V136, P434; van Buuren S, 2000, MULTIVARIATE IMPUTAT; Wenzel RP, 2004, NEW ENGL J MED, V351, P523, DOI 10.1056/NEJMp048093; Whitney CG, 2000, NEW ENGL J MED, V343, P1917, DOI 10.1056/NEJM200012283432603; Wipf JE, 1999, ARCH INTERN MED, V159, P1082, DOI 10.1001/archinte.159.10.1082; Woodhead M, 2005, EUR RESPIR J, V26, P1138, DOI 10.1183/09031936.05.00055705	34	670	729	1	47	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1059	1066		10.1001/jama.2009.1297	http://dx.doi.org/10.1001/jama.2009.1297			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738090	Bronze			2022-12-28	WOS:000269616200023
J	Heitmann, BL; Frederiksen, P				Heitmann, Berit L.; Frederiksen, Peder			Thigh circumference and risk of heart disease and premature death: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; BODY-MASS INDEX; FAT-FREE MASS; FOLLOW-UP; DANISH POPULATION; HIP CIRCUMFERENCE; PHYSICAL-ACTIVITY; STRENGTH; MUSCLE; ASSOCIATIONS	Objective To examine associations between thigh circumference and incident cardiovascular disease and coronary heart disease and total mortality. Design Prospective observational cohort study with Cox proportional hazards model and restricted cubic splines. Setting Random subset of adults in Denmark. Participants 1436 men and 1380 women participating in the Danish MONICA project, examined in 1987-8 for height, weight, and thigh, hip, and waist circumference, and body composition by impedance. Main outcome measures 10 year incidence of cardiovascular and coronary heart disease and 12.5 years of follow-up for total death. Results A small thigh circumference was associated with an increased risk of cardiovascular and coronary heart diseases and total mortality in both men and women. A threshold effect for thigh circumference was evident, with greatly increased risk of premature death below around 60 cm. Above the threshold there seemed to be no additional benefit of having larger thighs in either sex. These findings were independent of abdominal and general obesity, lifestyle, and cardiovascular risk factors such as blood pressure and lipid concentration. Conclusion A low thigh circumference seems to be associated with an increased risk of developing heart disease or premature death. The adverse effects of small thighs might be related to too little muscle mass in the region. The measure of thigh circumference might be a relevant anthropometric measure to help general practitioners in early identification of individuals at an increased risk of premature morbidity and mortality.	[Heitmann, Berit L.; Frederiksen, Peder] Copenhagen Univ Hosp, Inst Prevent Med, Res Unit Dietary Studies, DK-1357 Copenhagen K, Denmark; [Heitmann, Berit L.] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark	University of Copenhagen; University of Copenhagen	Heitmann, BL (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Res Unit Dietary Studies, Ostre Sogade 20, DK-1357 Copenhagen K, Denmark.	blh@ipm.regionh.dk		Heitmann, Berit Lilienthal/0000-0002-6809-4504	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Danish Medical Research Council. Both researchers were independent of the funding agency.	Andersen LB, 2000, ARCH INTERN MED, V160, P1621, DOI 10.1001/archinte.160.11.1621; Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Brotman DJ, 2003, CIRCULATION, V108, pE61, DOI 10.1161/01.CIR.0000086784.14560.C3; Evans WJ, 1996, GERIATRICS, V51, P46; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; GRIMBY G, 1979, MUSCLE METABOLISM EX, P469; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; HEITMANN BL, 1991, INT J OBESITY, V15, P535; HEITMANN BL, 1990, INT J OBESITY, V14, P789; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; Hippe M, 1999, J EPIDEMIOL COMMUN H, V53, P269, DOI 10.1136/jech.53.5.269; JENSEN KH, 1991, GASTROENTEROLOGY, V100, P790, DOI 10.1016/0016-5085(91)80027-7; Korn EL, 1997, AM J EPIDEMIOL, V145, P72; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; MCCARTNEY N, 1995, J GERONTOL A-BIOL, V50, pB97, DOI 10.1093/gerona/50A.2.B97; McCarty MF, 2003, MED HYPOTHESES, V61, P173, DOI 10.1016/S0306-9877(02)00238-4; MILLER JP, 1994, J APPL PHYSIOL, V77, P1122, DOI 10.1152/jappl.1994.77.3.1122; Olsen DB, 2005, J PHYSIOL-LONDON, V565, P555, DOI 10.1113/jphysiol.2004.081356; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Sacchetti M, 2005, DIABETOLOGIA, V48, P938, DOI 10.1007/s00125-005-1727-1; Snijder MB, 2004, DIABETES CARE, V27, P372, DOI 10.2337/diacare.27.2.372; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Tanko LB, 2004, CIRCULATION, V110, P2246, DOI 10.1161/01.CIR.0000144470.55149.E5; Therneau TM, 2000, MODELING SURVIVAL DA; WAALER HT, 1988, ACTA MED SCAND, V713, P17; World Health Organization, 1989, 123 EURICPNUT WHO; Zhu SK, 2003, ANN EPIDEMIOL, V13, P286, DOI 10.1016/S1047-2797(02)00417-9	28	119	120	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2009	339								b3292	10.1136/bmj.b3292	http://dx.doi.org/10.1136/bmj.b3292			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CI	19729416	Green Published, hybrid			2022-12-28	WOS:000269554100002
J	Downward, J				Downward, Julian			Finding the Weakness in Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ONCOGENE; THERAPY		Canc Res UK London Res Inst, London, England	Cancer Research UK	Downward, J (corresponding author), Canc Res UK London Res Inst, London, England.		Downward, Julian/A-3251-2012	Downward, Julian/0000-0002-2331-4729				Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017	4	5	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					922	924		10.1056/NEJMcibr0905242	http://dx.doi.org/10.1056/NEJMcibr0905242			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XV	19710492				2022-12-28	WOS:000269312700015
J	Lloyd, RC; Goldmann, DA				Lloyd, Robert C.; Goldmann, Donald A.			A Matter of Time	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROFECOXIB; TRIAL		[Lloyd, Robert C.; Goldmann, Donald A.] Inst Healthcare Improvement, Cambridge, MA 02138 USA; [Goldmann, Donald A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Goldmann, Donald A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Institute for Healthcare Improvement; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Goldmann, DA (corresponding author), Inst Healthcare Improvement, 20 Univ Rd,7th Floor, Cambridge, MA 02138 USA.	dgoldmann@ihi.org						Baron JA, 2008, LANCET, V372, P1756, DOI 10.1016/S0140-6736(08)61490-7; Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Batalden PB, 2007, QUAL SAF HEALTH CARE, V16, P2, DOI 10.1136/qshc.2006.022046; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Campbell D. T., 1966, EXPT QUASIEXPERIMENT; Kern S, 2000, ANN INTERN MED, V132, P3, DOI 10.7326/0003-4819-132-1-200001040-00002; Murray TJ, 2000, ANN INTERN MED, V132, P58, DOI 10.7326/0003-4819-132-1-200001040-00010; Scannell KA, 2000, ANN INTERN MED, V132, P55, DOI 10.7326/0003-4819-132-1-200001040-00009; Scherkenbach WW, 1991, DEMINGS ROAD CONTINU	9	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					894	895		10.1001/jama.2009.1251	http://dx.doi.org/10.1001/jama.2009.1251			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706865				2022-12-28	WOS:000269260100025
J	McGorry, P				McGorry, Patrick			Should youth mental health become a specialty in its own right? Yes	BRITISH MEDICAL JOURNAL			English	Editorial Material							TRANSITION; ADULTHOOD; FUTURE; CHILD; CARE		Univ Melbourne, Orygen Youth Hlth Res Ctr, Melbourne, Vic, Australia	Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne	McGorry, P (corresponding author), Univ Melbourne, Orygen Youth Hlth Res Ctr, Melbourne, Vic, Australia.	pmcgorry@unimelb.edu.au	McGorry, Patrick/O-4115-2019					[Anonymous], 1995, PSYCHOSOCIAL DISORDE; Arnett J., 2004, EMERGING ADULTHOOD W; Australian Bureau of Statistics [ABS], 2008, NAT SURV MENT HLTH W; Bates T., 2009, SOMEWHERE TURN SOMEO; Collishaw S, 2004, J CHILD PSYCHOL PSYC, V45, P1350, DOI 10.1111/j.1469-7610.2004.00335.x; Davis M, 2005, J BEHAV HEALTH SER R, V32, P27, DOI 10.1007/BF02287326; Eckersley Richard M, 2007, Int J Adolesc Med Health, V19, P217; Graham P., 2004, END ADOLESCENCE; Horton R, 2007, LANCET, V370, P806, DOI 10.1016/S0140-6736(07)61243-4; Insel TR, 2005, ARCH GEN PSYCHIAT, V62, P590, DOI 10.1001/archpsyc.62.6.590; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kutcher S, 2007, CAN MED ASSOC J, V176, P417, DOI 10.1503/cmaj.061694; Masten AS, 2004, DEV PSYCHOPATHOL, V16, P1071, DOI 10.1017/S0954579404040143; McGorry PD, 2008, WORLD PSYCHIATRY, V7, P148; McGorry PD, 2007, MED J AUSTRALIA, V187, pS53; McGorry PD, 2007, MED J AUSTRALIA, V187, pS5; MIHALOPOULOS C, 2009, SCHIZOPHR B     0609; PARRYJONES WL, 1995, BRIT J PSYCHIAT, V166, P299, DOI 10.1192/bjp.166.3.299; Pottick KJ, 2008, J BEHAV HEALTH SER R, V35, P373, DOI 10.1007/s11414-007-9080-4; Rickwood DJ, 2007, MED J AUSTRALIA, V187, pS35, DOI 10.5694/j.1326-5377.2007.tb01334.x; Singh SP, 2009, CURR OPIN PSYCHIATR, V22, P386, DOI 10.1097/YCO.0b013e32832c9221; Tonin V, 2007, LANCET, V369, P1239, DOI 10.1016/S0140-6736(07)60375-4; *VICT GOV HLTH INF, MENT HLTH MATT VICT	23	17	17	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 26	2009	339								b3373	10.1136/bmj.b3373	http://dx.doi.org/10.1136/bmj.b3373			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489AX	19710126				2022-12-28	WOS:000269393000005
J	Silva, J; Nichols, J; Theunissen, TW; Guo, G; van Oosten, AL; Barrandon, O; Wray, J; Yamanaka, S; Chambers, I; Smith, A				Silva, Jose; Nichols, Jennifer; Theunissen, Thorold W.; Guo, Ge; van Oosten, Anouk L.; Barrandon, Ornella; Wray, Jason; Yamanaka, Shinya; Chambers, Ian; Smith, Austin			Nanog Is the Gateway to the Pluripotent Ground State	CELL			English	Article							EMBRYONIC STEM-CELLS; X-INACTIVATION; TRANSCRIPTIONAL NETWORK; REGULATORY CIRCUITRY; MOUSE EPIBLAST; SOMATIC-CELLS; TERATOCARCINOMA; DIFFERENTIATION; ESTABLISHMENT; FIBROBLASTS	Pluripotency is generated naturally during mammalian development through formation of the epiblast, founder tissue of the embryo proper. Pluripotency can be recreated by somatic cell reprogramming. Here we present evidence that the homeodomain protein Nanog mediates acquisition of both embryonic and induced pluripotency. Production of pluripotent hybrids by cell fusion is promoted by and dependent on Nanog. In transcription factor-induced molecular reprogramming, Nanog is initially dispensable but becomes essential for dedifferentiated intermediates to transit to ground state pluripotency. In the embryo, Nanog specifically demarcates the nascent epiblast, coincident with the domain of X chromosome reprogramming. Without Nanog, pluripotency does not develop, and the inner cell mass is trapped in a pre-pluripotent, indeterminate state that is ultimately nonviable. These findings suggest that Nanog choreographs synthesis of the naive epiblast ground state in the embryo and that this function is recapitulated in the culmination of somatic cell reprogramming.	[Silva, Jose; Nichols, Jennifer; Theunissen, Thorold W.; Guo, Ge; van Oosten, Anouk L.; Barrandon, Ornella; Wray, Jason; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Silva, Jose; Theunissen, Thorold W.; Guo, Ge; van Oosten, Anouk L.; Barrandon, Ornella; Wray, Jason; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England; [Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; [Chambers, Ian] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, MRC,Ctr Regenerat Med, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of Cambridge; Kyoto University; University of Edinburgh	Silva, J (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	jcs64@cscr.cam.ac.uk; austin.smith@cscr.cam.ac.uk	Silva, Jose C R/X-5140-2019; Chambers, Ian/H-5416-2011; Silva, Jose/G-1920-2014	Silva, Jose C R/0000-0001-5487-1117; Chambers, Ian/0000-0003-2605-1597; Silva, Jose/0000-0001-5487-1117; Nichols, Jennifer/0000-0002-8650-1388; Smith, Austin/0000-0002-3029-4682; Theunissen, Thorold/0000-0001-6943-7858	The Wellcome Trust; Biotechnology and Biological Sciences Research Council; Medical Research Council; EC Framework 7; MRC [G0700665, G9806702] Funding Source: UKRI; Medical Research Council [G9806702, G0300723B, G0700665, G0700711B] Funding Source: researchfish	The Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC Framework 7(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Sameera Patel for genotyping, Rachel Walker for flow cytometry, Peter Humphreys for imaging, Bill Mansfield for chimera generation, and Sam Jameson and staff for mouse husbandry. This research was supported by The Wellcome Trust, the Biotechnology and Biological Sciences Research Council, the Medical Research Council, and the EC Framework 7 project Euro-SyStem. A.S. is a Medical Research Council Professor.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; GARDNER RL, 1988, J CELL SCI, P11; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MILLER RA, 1976, CELL, V9, P45, DOI 10.1016/0092-8674(76)90051-9; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Navarro P, 2009, FEBS LETT, V583, P1721, DOI 10.1016/j.febslet.2009.03.043; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; NICHOLS J, 1984, J EMBRYOL EXP MORPH, V80, P225; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Selwood L, 2006, BIOESSAYS, V28, P128, DOI 10.1002/bies.20360; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TAKAGI N, 1983, CELL, V34, P1053, DOI 10.1016/0092-8674(83)90563-9; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	58	728	797	4	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					722	737		10.1016/j.cell.2009.07.039	http://dx.doi.org/10.1016/j.cell.2009.07.039			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703398	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000269156100014
J	Calverley, PMA; Rabe, KF; Goehring, UM; Kristiansen, S; Fabbri, LM; Martinez, FJ				Calverley, Peter M. A.; Rabe, Klaus F.; Goehring, Udo-Michael; Kristiansen, Soren; Fabbri, Leonardo M.; Martinez, Fernando J.		M2-124 Study Grp; M2-125 Study Grp	Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials	LANCET			English	Article							PDE4 INHIBITOR ROFLUMILAST; FLUTICASONE PROPIONATE; STATISTICAL-ANALYSIS; COPD EXACERBATIONS; HEALTH-STATUS; SALMETEROL; TIOTROPIUM; INFLAMMATION; PREVENTION; SPUTUM	Background The phosphodiesterase-4 inhibitor roflumilast can improve lung function and prevent exacerbations in certain patients with chronic obstructive pulmonary disease (COPD). We therefore investigated whether roflumilast would reduce the frequency of exacerbations requiring corticosteroids in patients with COPD. Methods In two placebo-controlled, double-blind, multicentre trials (M2-124 and M2-125) with identical design that were done in two different populations in an outpatient setting, patients with COPD older than 40 years, with severe airflow limitation, bronchitic symptoms, and a history of exacerbations were randomly assigned to oral roflumilast (500 mu g once per day) or placebo for 52 weeks. Primary endpoints were change in prebronchodilator forced expiratory volume in 1 s (FEV1) and the rate of exacerbations that were moderate (glucocorticosteroid-treated) or severe. Analysis was by intention to treat. The trials are registered with ClinicalTrials.gov, number NCT00297102 for M2-124, and NCT00297115 for M2-125. Findings Patients were assigned to treatment, stratified according to smoking status and treatment with longacting beta(2) agonists, and given roflumilast (n=1537) or placebo (n=1554). In both studies, the prespecified primary endpoints were achieved and were similar in magnitude. In a pooled analysis, prebronchodilator FEV1 increased by 48 mL with roflumilast compared with placebo (p<0.0001). The rate of exacerbations that were moderate or severe per patient per year was 1.14 with roflumilast and 1.37 with placebo (reduction 17% [95% Cl 8-25], p<0.0003). Adverse events were more common with roflumilast (1040 [67%]) than with placebo (963 [62%]); 219 (14%) patients in the roflumilast group and 177 (12%) in the placebo group discontinued because of adverse events. In the pooled analysis, the difference in weight change during the study between the roflumilast and placebo groups was -2.17 kg. Interpretation Since different subsets of patients exist within the broad spectrum of COPD, targeted specific therapies could improve disease management. This possibility should be explored further in prospective studies.	[Calverley, Peter M. A.] Sch Clin Sci, Liverpool, Merseyside, England; [Martinez, Fernando J.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Fabbri, Leonardo M.] Univ Modena & Reggio Emilia, Modena, Italy; [Rabe, Klaus F.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Goehring, Udo-Michael; Kristiansen, Soren] Nycomed, Constance, Germany	University of Liverpool; University of Michigan System; University of Michigan; Universita di Modena e Reggio Emilia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Nycomed GmbH	Calverley, PMA (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Div Infect & Immun, Ctr Clin Sci, Lower Lane, Liverpool L9 7AL, Merseyside, England.	pmacal@liverpool.ac.uk	Ishina, Tatiana/AAO-7286-2021; Fabbri, Leonardo M/I-4055-2012; Cukier, Alberto/C-6101-2012; Aisanov, Zaurbek/Q-2685-2017; Lapa e Silva, Jose R./AAS-4793-2020; Rabe, Klaus F./AAW-6296-2021	Ishina, Tatiana/0000-0001-7720-0770; Fabbri, Leonardo M/0000-0001-8894-1689; Cukier, Alberto/0000-0002-7217-9498; Aisanov, Zaurbek/0000-0002-4044-674X; Lapa e Silva, Jose R./0000-0003-3116-0253; Rabe, Klaus F./0000-0002-7020-1401; Knox, Alan/0000-0002-5906-4143; , Sandhya/0000-0002-3167-1152; Peters, Matthew/0000-0002-9649-8741; chanez, pascal/0000-0003-4059-0917; Kuschner, Ware/0000-0002-9732-1366	Nycomed, Konstanz, Germany	Nycomed, Konstanz, Germany	These studies were supported by Nycomed, Konstanz, Germany. We thank Dirk Bredenbroker (Limburg an der Lahn, Germany), Frank Cerasoli Jr (New York, NY, USA), and Tushar Shah, (Sellersville, PA, USA) for their substantial contribution to the development of the protocols of the two studies reported here; all of the investigators who recruited and treated patients at the 246 centres involved in the M2-124 trial and the 221 centres in the M2-125 trial; Jane Davies, Christine Groves, and Paul Wilmott of Caudex Medical, Oxford, UK (supported by Nycomed) for editorial assistance with the preparation of the report.	Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Bundschuh DS, 2001, J PHARMACOL EXP THER, V297, P280; Burge PS, 2000, BMJ-BRIT MED J, V320, P1297, DOI 10.1136/bmj.320.7245.1297; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2007, AM J RESP CRIT CARE, V176, P154, DOI 10.1164/rccm.200610-1563OC; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-73; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Calverley PMA, 2003, LANCET, V362, P1053, DOI 10.1016/S0140-6736(03)14416-9; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Keene ON, 2008, EUR RESPIR J, V32, P1421, DOI 10.1183/09031936.00123408; Keene ON, 2008, EUR RESPIR J, V32, P17, DOI 10.1183/09031936.00161507; Kessler R, 2006, CHEST, V130, P133, DOI 10.1378/chest.130.1.133; Lanes SF, 2008, AM J RESP CRIT CARE, V178, P543, DOI 10.1164/ajrccm.178.5.543; MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Sin DD, 2006, THORAX, V61, P1, DOI 10.1136/thx.2005.044941; Snoeck-Stroband JB, 2008, EUR RESPIR J, V31, P70, DOI 10.1183/09031936.00137006; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Spencer S, 2001, AM J RESP CRIT CARE, V163, P122, DOI 10.1164/ajrccm.163.1.2005009; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; Stockley RA, 2006, THORAX, V61, P122, DOI 10.1136/thx.2004.033266; Suissa S, 2008, EUR RESPIR J, V32, P1117, DOI 10.1183/09031936.00108308; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; VERBEKE G, 2000, SERIES STAT; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC	33	555	583	1	77	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					685	694		10.1016/S0140-6736(09)61255-1	http://dx.doi.org/10.1016/S0140-6736(09)61255-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716960				2022-12-28	WOS:000269422500024
J	Salvi, SS; Barnes, PJ				Salvi, Sundeep S.; Barnes, Peter J.			Chronic obstructive pulmonary disease in non-smokers	LANCET			English	Review							INDOOR AIR-POLLUTION; CHRONIC-BRONCHITIS; LUNG-FUNCTION; RESPIRATORY SYMPTOMS; BIOMASS FUELS; OCCUPATIONAL EXPOSURES; SOCIOECONOMIC-STATUS; VENTILATORY FUNCTION; DEVELOPING-COUNTRIES; AIRWAYS OBSTRUCTION	Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. Tobacco smoking is established as a major risk factor, but emerging evidence suggests that other risk factors are important, especially in developing countries. An estimated 25-45% of patients with COPD have never smoked; the burden of non-smoking COPD is therefore much higher than previously believed. About 3 billion people, half the worldwide population, are exposed to smoke from biomass fuel compared with 1.01 billion people who smoke tobacco, which suggests that exposure to biomass smoke might be the biggest risk factor for COPD globally. We review the evidence for the association of COPD with biomass fuel, occupational exposure to dusts and gases, history of pulmonary tuberculosis, chronic asthma, respiratory-tract infections during childhood, outdoor air pollution, and poor socioeconomic status.	[Salvi, Sundeep S.] Chest Res Fdn, Pune 411014, Maharashtra, India; [Barnes, Peter J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Imperial College London	Salvi, SS (corresponding author), Chest Res Fdn, Pune 411014, Maharashtra, India.	ssalvi@crfindia.com		Barnes, Peter/0000-0002-5122-4018	AstraZeneca; Boehringer Ingelheim; Chiesi Farmaceutici; GlaxoSmithKline; Novartis; Pfizer; Teva; Union Chimique Belge	AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc); GlaxoSmithKline(GlaxoSmithKline); Novartis(Novartis); Pfizer(Pfizer); Teva(Teva Pharmaceutical Industries); Union Chimique Belge	PJB has received research funding and been a member of scientific advisory boards for AstraZeneca, Boehringer Ingelheim, Chiesi Farmaceutici, GlaxoSmithKline, Novartis, Pfizer, Teva, and Union Chimique Belge, some of which are marketing and developing treatments for COPD. SSS declares that he has no conflicts of interest.	ABHYANKAR A, 2008, PREVALENCE COPD REVE; Akhtar T, 2007, CHEST, V132, P1472, DOI 10.1378/chest.06-2529; ANDERSON DO, 1962, NEW ENGL J MED, V267, P787, DOI 10.1056/NEJM196210182671601; ANDERSON HR, 1979, THORAX, V34, P647, DOI 10.1136/thx.34.5.647; Arbex MA, 2009, J EPIDEMIOL COMMUN H, V63, P777, DOI 10.1136/jech.2008.078360; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Barnes D. F., 1994, WHAT MAKES PEOPLE CO; Barnes PJ, 2006, AM J RESP CRIT CARE, V174, P240, DOI 10.1164/rccm.2604008; BECKLAKE MR, 1989, AM REV RESPIR DIS, V140, pS85, DOI 10.1164/ajrccm/140.3_Pt_2.S85; BEHERA D, 1994, RESPIRATION, V61, P89; Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Bergdahl IA, 2004, EUR RESPIR J, V23, P402, DOI 10.1183/09031936.04.00034304; BIRATH G, 1966, SCAND J RESPIR DIS, V47, P27; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Blanc RD, 2007, INT J TUBERC LUNG D, V11, P251; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Brashier B, 2007, EUR RESP SOC ANN C S; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; BURROWS B, 1968, ARCH ENVIRON HEALTH, V16, P406, DOI 10.1080/00039896.1968.10665079; Caballero A, 2008, CHEST, V133, P343, DOI 10.1378/chest.07-1361; Cerveri I, 2001, EUR RESPIR J, V18, P85, DOI 10.1183/09031936.01.00087101; CHESTER EH, 1969, AM REV RESPIR DIS, V99, P365; de Marco R, 2004, THORAX, V59, P120, DOI 10.1136/thorax.2003.011163; Dennis RJ, 1996, CHEST, V109, P115, DOI 10.1378/chest.109.1.115; DOSSING M, 1994, RESP MED, V88, P519, DOI 10.1016/S0954-6111(05)80334-8; Dutt D, 1996, NATL MED J INDIA, V9, P113; Eduard W, 2009, CHEST, V136, P716, DOI 10.1378/chest.08-2192; Ehrlich RI, 2004, INT J TUBERC LUNG D, V8, P369; Ekici A, 2005, ENVIRON RES, V99, P93, DOI 10.1016/j.envres.2005.01.004; Ezzati M, 2002, ENVIRON HEALTH PERSP, V110, P1057, DOI 10.1289/ehp.021101057; FAIRBAIRN A S, 1958, Br J Prev Soc Med, V12, P94; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Fullerton DG, 2008, T ROY SOC TROP MED H, V102, P843, DOI 10.1016/j.trstmh.2008.05.028; Gunen H, 2008, EUR J INTERN MED, V19, P499, DOI 10.1016/j.ejim.2007.06.028; HAHN DL, 2002, 20 COMMON PROBLEMS R, P141; Hancox RJ, 2009, THORAX, V64, P228, DOI 10.1136/thx.2008.103978; Hardie JA, 2005, RESP MED, V99, P186, DOI 10.1016/j.rmed.2004.06.006; Hegewald MJ, 2007, CHEST, V132, P1608, DOI 10.1378/chest.07-1405; Hnizdo E, 2002, AM J EPIDEMIOL, V156, P738, DOI 10.1093/aje/kwf105; HOLLAND WW, 1965, LANCET, V1, P445; HUCHON G, 1997, REV MAL RESP, V14; HUHTI E, 1982, EUR J RESPIR DIS, V63, P35; HUSMAN K, 1987, EUR J RESPIR DIS, V71, P57; Kan HD, 2007, THORAX, V62, P873, DOI 10.1136/thx.2006.073015; Kara M, 2003, EUR RADIOL, V13, P2372, DOI 10.1007/s00330-003-1925-5; Kim DS, 2005, AM J RESP CRIT CARE, V172, P842, DOI 10.1164/rccm.200502-259OC; Kiraz K, 2003, CLIN INVEST MED, V26, P243; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; LAMBERT PM, 1970, LANCET, V1, P853; Lamprecht B, 2007, AM J IND MED, V50, P421, DOI 10.1002/ajim.20470; Lamprecht B, 2008, RESP MED, V102, P1833, DOI 10.1016/j.rmed.2008.07.007; LANCASTER JF, 1963, AM REV RESPIR DIS, V87, P435, DOI 10.1164/arrd.1963.87.3P1.435; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lindberg A, 2005, RESPIRATION, V72, P471, DOI 10.1159/000087670; Lindstrom M, 2001, CHEST, V119, P852, DOI 10.1378/chest.119.3.852; Liu SM, 2007, THORAX, V62, P889, DOI 10.1136/thx.2006.061457; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Moran-Mendoza O, 2008, INT J TUBERC LUNG D, V12, P1092; Murray C. J. L., 1996, GLOBAL BURDEN DIS; NORBOO T, 1991, INT J EPIDEMIOL, V20, P749, DOI 10.1093/ije/20.3.749; O'Byrne PM, 2006, CHEST, V129, P1478, DOI 10.1378/chest.129.6.1478; Orie NGM, 1961, BRONCHITIS INT S; OSWALD NC, 1955, LANCET, V2, P843; Ozbay B, 2001, Respirology, V6, P255, DOI 10.1046/j.1440-1843.2001.00339.x; PANDEY MR, 1984, THORAX, V39, P337, DOI 10.1136/thx.39.5.337; Pena VS, 2000, CHEST, V118, P981, DOI 10.1378/chest.118.4.981; PerezPadilla R, 1996, AM J RESP CRIT CARE, V154, P701, DOI 10.1164/ajrccm.154.3.8810608; PHILLIPS A. M., 1963, JOUR OCCUP MED, V5, P468; Plit ML, 1998, EUR RESPIR J, V12, P351, DOI 10.1183/09031936.98.12020351; Po JYT, 2009, AM J RESP CRIT CARE, V179; Prescott E, 1999, THORAX, V54, P737, DOI 10.1136/thx.54.8.737; Ramirez-Venegas A, 2006, AM J RESP CRIT CARE, V173, P393, DOI 10.1164/rccm.200504-568OC; Ran Pi-xin, 2006, Zhonghua Nei Ke Za Zhi, V45, P974; Reddy AKN, 1996, ENERGY RIO PROSPECTS; Regalado J, 2006, AM J RESP CRIT CARE, V174, P901, DOI 10.1164/rccm.200503-479OC; Rushton Lesley, 2007, Reviews on Environmental Health, V22, P255; Sezer H, 2006, ANN EPIDEMIOL, V16, P59, DOI 10.1016/j.annepidem.2004.12.014; Shahab L, 2006, THORAX, V61, P1043, DOI 10.1136/thx.2006.064410; Shavelle Robert M, 2009, Int J Chron Obstruct Pulmon Dis, V4, P137; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; Smith KR, 2002, INDOOR AIR, V12, P198, DOI 10.1034/j.1600-0668.2002.01137.x; SNIDER GL, 1971, AM REV RESPIR DIS, V103, P625; Sood A, 2009, AM J RESP CRIT CARE, V179; SUNGU YS, 2001, TURKISH RESP J, V2, P26; Sunyer J, 2006, OCCUP ENVIRON MED, V63, P836, DOI 10.1136/oem.2006.027995; Sunyer J, 2001, EUR RESPIR J, V17, P1024, DOI 10.1183/09031936.01.17510240; Tan WC, 2003, RESPIROLOGY, V8, P192; Torres-Duque Carlos, 2008, Proc Am Thorac Soc, V5, P577, DOI 10.1513/pats.200707-100RP; Trupin L, 2003, EUR RESPIR J, V22, P462, DOI 10.1183/09031936.03.00094203; Tzanakis N, 2004, CHEST, V125, P892, DOI 10.1378/chest.125.3.892; ULRIK CS, 1994, AM J RESP CRIT CARE, V150, P629, DOI 10.1164/ajrccm.150.3.8087330; Ulvestad B, 2001, OCCUP ENVIRON MED, V58, P663, DOI 10.1136/oem.58.10.663; Viegi G, 2000, CHEST, V117, p339S, DOI 10.1378/chest.117.5_suppl_2.339S; Vignola AM, 2000, J ALLERGY CLIN IMMUN, V105, P1041, DOI 10.1067/mai.2000.107195; von Hertzen L, 2000, RESP MED, V94, P356, DOI 10.1053/rmed.1999.0715; Weinmann S, 2008, J OCCUP ENVIRON MED, V50, P561, DOI 10.1097/JOM.0b013e3181651556; WHITTEMORE AS, 1995, AM J PUBLIC HEALTH, V85, P702, DOI 10.2105/AJPH.85.5.702; *WHO, PROGR REP 2000 01 WH; *WHO, CHILDR ENV HLTH 2; *WHO, WHO STOP TB PARTN TU; WILLCOX PA, 1989, RESP MED, V83, P195, DOI 10.1016/S0954-6111(89)80031-9; Zhou Y, 2009, EUR RESPIR J, V33, P509, DOI 10.1183/09031936.00084408	107	832	860	1	120	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					733	743		10.1016/S0140-6736(09)61303-9	http://dx.doi.org/10.1016/S0140-6736(09)61303-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716966				2022-12-28	WOS:000269422500030
J	Clark, TW; Pareek, M; Hoschler, K; Dillon, H; Nicholson, KG; Groth, N; Stephenson, I				Clark, Tristan W.; Pareek, Manish; Hoschler, Katja; Dillon, Helen; Nicholson, Karl G.; Groth, Nicola; Stephenson, Iain			Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							A/DUCK/SINGAPORE/97 H5N3 VACCINE; MAMMALIAN-CELL CULTURE; RANDOMIZED-TRIAL; WHOLE VIRUS; SAFETY; IMMUNOGENICITY; ANTIBODY; ANTIGENICITY; SERUM	Background: The 2009 pandemic influenza A (H1N1) virus has emerged to cause the first pandemic of the 21st century. Development of effective vaccines is a public health priority. Methods: We conducted a single-center study, involving 176 adults, 18 to 50 years of age, to test the monovalent influenza A/California/2009 (H1N1) surface-antigen vaccine, in both MF59-adjuvanted and nonadjuvanted forms. Subjects were randomly assigned to receive two intramuscular injections of vaccine containing 7.5 microg of hemagglutinin on day 0 in each arm or one injection on day 0 and the other on day 7, 14, or 21; or two 3.75-microg doses of MF59-adjuvanted vaccine, or 7.5 or 15 microg of nonadjuvanted vaccine, administered 21 days apart. Antibody responses were measured by means of hemagglutination-inhibition assay and a microneutralization assay on days 0, 14, 21, and 42 after injection of the first dose. Results: The most frequent local and systemic reactions were pain at the injection site and muscle aches, noted in 70% and 42% of subjects, respectively; reactions were more common with the MF59-adjuvanted vaccine than with nonadjuvanted vaccine. Three subjects reported fever, with a temperature of 38 degreesC or higher, after either dose. Antibody titers, expressed as geometric means, were higher at day 21 among subjects who had received one dose of MF59-adjuvanted vaccine than among those who had received one dose of nonadjuvanted vaccine (P<0.001 by the microneutralization assay). By day 21, hemagglutination-inhibition and microneutralization antibody titers of 1:40 or more were seen in 77 to 96% and 92 to 100% of subjects receiving MF59-adjuvanted vaccine, respectively, and in 63 to 72% and 67 to 76% of those receiving nonadjuvanted vaccine, respectively. By day 42, after two doses of vaccine, hemagglutination-inhibition and microneutralization antibody titers of 1:40 or more were seen in 92 to 100% and 100% of recipients of MF59-adjuvanted vaccine, respectively, and in 74 to 79% and 78 to 83% of recipients of nonadjuvanted vaccine, respectively. Conclusions: Monovalent 2009 influenza A (H1N1) MF59-adjuvanted vaccine generates antibody responses likely to be associated with protection after a single dose is administered. (ClinicalTrials.gov number, NCT00943358.) N Engl J Med 2009;361:2424-35.	[Stephenson, Iain] Univ Leicester, Leicester Royal Infirm, Infect Dis Unit, Univ Hosp Leicester, Leicester, Leics, England; [Clark, Tristan W.; Pareek, Manish; Dillon, Helen; Nicholson, Karl G.; Stephenson, Iain] Univ Leicester, Dept Inflammat Infect & Immun, Leicester, Leics, England; [Hoschler, Katja] Hlth Protect Agcy, Resp Virus Lab, London, England; [Groth, Nicola] Novartis Vaccines & Diagnost, Siena, Italy	University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester; Health Protection Agency; Novartis	Stephenson, I (corresponding author), Univ Leicester, Leicester Royal Infirm, Infect Dis Unit, Univ Hosp Leicester, Level 6,Windsor Bldg, Leicester, Leics, England.	iain.stephenson@uhl-tr.nhs.uk		Pareek, Manish/0000-0003-1521-9964	University Hospitals Leicester; Novartis Vaccines and Diagnostics; MRC [G0700846] Funding Source: UKRI; Medical Research Council [G0700846] Funding Source: researchfish	University Hospitals Leicester; Novartis Vaccines and Diagnostics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from University Hospitals Leicester and Novartis Vaccines and Diagnostics.	[Anonymous], 2009, GLOB AL RESP PAND H1; Atmar RL, 2006, CLIN INFECT DIS, V43, P1135, DOI 10.1086/508174; Audsley JM, 2008, DRUGS, V68, P1483, DOI 10.2165/00003495-200868110-00002; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Doroshenko A, 2009, EXPERT REV VACCINES, V8, P679, DOI 10.1586/ERV.09.31; Ellis JS, 1997, EUR J EPIDEMIOL, V13, P369, DOI 10.1023/A:1007391222905; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; KELLY H, INTERIM ANAL PANDEMI; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; MADER R, 1993, J RHEUMATOL, V20, P1429; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; NICHOLSON KG, 1979, J BIOL STAND, V7, P123, DOI 10.1016/S0092-1157(79)80044-X; Oxford JS, 2005, VACCINE, V23, P5440, DOI 10.1016/j.vaccine.2004.10.053; PARKMAN PD, 1977, J INFECT DIS, V136, pS722, DOI 10.1093/infdis/136.Supplement_3.S722; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Schultze V, 2008, VACCINE, V26, P3209, DOI 10.1016/j.vaccine.2008.03.093; Stephenson I, 2003, J MED VIROL, V70, P391, DOI 10.1002/jmv.10408; Stephenson I, 2005, J INFECT DIS, V191, P1210, DOI 10.1086/428948; Stephenson I, 2003, LANCET, V362, P1959, DOI 10.1016/S0140-6736(03)15014-3; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Szymczakiewicz-Multanowska A, 2009, J INFECT DIS, V200, P841, DOI 10.1086/605505; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; WISELKA MJ, 1998, TXB INFLUENZA, P346; World Health Organization, 2009, GLOB AL RESP WHO REC	28	374	384	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2424	2435		10.1056/NEJMoa0907650	http://dx.doi.org/10.1056/NEJMoa0907650			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533CE	19745215	Bronze, Green Accepted			2022-12-28	WOS:000272798900007
J	Sibbing, D; Kastrati, A				Sibbing, Dirk; Kastrati, Adnan			Risk of combining PPIs with thienopyridines: fact or fiction?	LANCET			English	Editorial Material							PROTON PUMP INHIBITORS; CLOPIDOGREL		[Sibbing, Dirk] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany; Tech Univ Munich, Med Klin Rechts Isar 1, D-80636 Munich, Germany	German Heart Centre Munich; Technical University of Munich; Technical University of Munich	Sibbing, D (corresponding author), Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany.	dirk@sibbing.net	, Kastrati/Y-2389-2019					Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Dunn SP, 2008, CIRCULATION, V118, pS815; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Sibbing D, 2009, THROMB HAEMOSTASIS, V101, P714, DOI 10.1160/TH08-12-0808; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017; STANEK EJ, 2009, SOC CARD ANG INT 32; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	12	32	34	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					952	954		10.1016/S0140-6736(09)61562-2	http://dx.doi.org/10.1016/S0140-6736(09)61562-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	498PK	19726077				2022-12-28	WOS:000270154100005
J	Eggleston, KN; Shah, ND; Smith, SA; Wagie, AE; Williams, AR; Grossman, JH; Berndt, ER; Long, KH; Banerjee, R; Newhouse, JP				Eggleston, Karen N.; Shah, Nilay D.; Smith, Steven A.; Wagie, Amy E.; Williams, Arthur R.; Grossman, Jerome H.; Berndt, Ernst R.; Long, Kirsten Hall; Banerjee, Ritesh; Newhouse, Joseph P.			The Net Value of Health Care for Patients With Type 2 Diabetes, 1997 to 2005	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; UKPDS RISK ENGINE; GLYCEMIC CONTROL; COSTS; ILLNESSES; MELLITUS; IMPACT; MODEL; LIFE	Background: The net economic value of increased health care spending remains unclear, especially for chronic diseases. Objective: To assess the net value of health care for patients with type 2 diabetes. Design: Economic analysis of observational cohort data. Setting: Mayo Clinic, Rochester, Minnesota, a not-for-profit integrated health care delivery system. Patients: 613 patients with type 2 diabetes. Measurements: Changes in inflation-adjusted annual health care spending and in health status between 1997 and 2005 (with health status defined as 10-year cardiovascular risk), holding age and diabetes duration constant across the observation period ("modifiable risk"), and simulated outcomes for all diabetes complications based on the UKPDS (United Kingdom Perspective Diabetes Study) Outcomes Model. Net value was estimated as the present discounted monetary value of improved survival and avoided treatment spending for coronary heart disease minus the increase in annual spending per patient. Results: Assuming that 1 life-year is worth $200 000 and accounting for changes in modifiable cardiovascular risk, the net value of changes in health care for patients with type 2 diabetes was $10 911 per patient (95% CI, -$8480 to $33 402) between 1997 and 2005, a positive dollar value that suggests the value of health care has improved despite increased spending. A second approach based on diabetes complications yielded a net value of $6931 per patient (CI, -$186 901 to $211 980). Limitation: The patient population was homogeneous and small, and the wide CIs of the estimates are compatible with a decrease as well as an increase in value. Conclusion: The economic value of improvements in health status for patients with type 2 diabetes seems to exceed or equal increases in health care spending, suggesting that those increases were worth the extra cost. However, the possibility that society is getting less value for its money could not be statistically excluded, and there is opportunity to improve the value of diabetes-related health care.	Harvard Univ, Dept Hlth Care Policy, Sch Med, Boston, MA 02115 USA; Stanford Univ, Shorenstein Asia Pacific Res Ctr, Stanford, CA 94305 USA; Mayo Clin, Rochester, MN USA; Childrens Mercy Hosp & Clin, Kansas City, MO USA; Univ Missouri, Sch Med, Kansas City, MO 64108 USA; Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Stanford University; Mayo Clinic; Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health	Newhouse, JP (corresponding author), Harvard Univ, Dept Hlth Care Policy, Sch Med, 180 Longwood Ave, Boston, MA 02115 USA.	newhouse@hcp.med.harvard.edu	Newhouse, Joseph/AAD-9763-2019; Smith, Steven/HDM-9496-2022; Newhouse, Joseph/AGJ-5632-2022					Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; Beaulieu N, 2006, FORUM HLTH EC POLICY, V9, P1, DOI [DOI 10.2202/1558-9544.1072], 10.2202/1558-9544.1072, DOI 10.2202/1558-9544.1072]; Berndt ER, 2002, J HEALTH ECON, V21, P373, DOI 10.1016/S0167-6296(01)00132-1; Berndt ER, 2000, HANDB ECON, V17, P119; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Brown JB, 1999, DIABETES CARE, V22, P1116, DOI 10.2337/diacare.22.7.1116; Christensen C, 2009, INNOVATORS PRESCRIPT; Clarke PM, 2004, DIABETOLOGIA, V47, P1747, DOI 10.1007/s00125-004-1527-z; Cutler DM, 1998, Q J ECON, V113, P991, DOI 10.1162/003355398555801; Fireman B, 2004, HEALTH AFFAIR, V23, P63, DOI 10.1377/hlthaff.23.6.63; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gold MR, 1996, COST EFFECTIVENESS H; Gorman CA, 2000, COMPUT METH PROG BIO, V62, P127, DOI 10.1016/S0169-2607(99)00054-1; HAHN RA, 1992, JAMA-J AM MED ASSOC, V267, P268, DOI 10.1001/jama.267.2.268; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2007, HEALTH SERV RES, V42, P2174, DOI 10.1111/j.1475-6773.2007.00734.x; HUANG ES, 2007, HEALTH SERV RES, V42, P2294; Kupersmith J, 2007, HEALTH AFFAIR, V26, pW156, DOI 10.1377/hlthaff.26.2.w156; Lee JD, 2004, CURR MED RES OPIN, V20, P765, DOI 10.1185/030079904125003539; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; Montori VM, 2002, DIABETES CARE, V25, P1952, DOI 10.2337/diacare.25.11.1952; Nathan DM, 2007, NEW ENGL J MED, V356, P437, DOI 10.1056/NEJMp068294; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Petersen M, 2003, DIABETES CARE, V26, P917; Rosen AB, 2007, HEALTH AFFAIR, V26, P111, DOI 10.1377/hlthaff.26.1.111; Rubin RJ, 1998, J CLIN ENDOCR METAB, V83, P2635, DOI 10.1210/jc.83.8.2635; SCITOVSKY AA, 1985, MED CARE, V23, P1345, DOI 10.1097/00005650-198512000-00004; Scitovsky AA, 1967, AM ECON REV, V57, P1182; Shapiro I, 2001, STUD INCOME, V62, P411; Song SH, 2004, DIABETIC MED, V21, P238, DOI 10.1111/j.1464-5491.2004.01116.x; Stevens RJ, 2001, CLIN SCI, V101, P671, DOI 10.1042/CS20000335; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Viscusi WK, 2003, J RISK UNCERTAINTY, V27, P5, DOI 10.1023/A:1025598106257; Wagner EH, 2001, JAMA-J AM MED ASSOC, V285, P182, DOI 10.1001/jama.285.2.182; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	37	23	23	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6					386	W127		10.7326/0003-4819-151-6-200909150-00003	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-00003			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	501OB	19755364				2022-12-28	WOS:000270390100003
J	Fortuna, RJ; Robbins, BW; Halterman, JS				Fortuna, Robert J.; Robbins, Brett W.; Halterman, Jill S.			Ambulatory Care Among Young Adults in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							CONTROLLED-TRIAL; MEDICAL-CARE; HEALTH; ADOLESCENTS; SERVICES; UNINSURANCE; DELIVERY; BEHAVIOR; VISITS; RISK	Background: Young adults are the most likely age group to be uninsured and have the highest prevalence of substance abuse, motor vehicle accidents, and sexually transmitted diseases, yet little is known about their use of ambulatory care. Objective: To characterize ambulatory care of young adults. Design: Cross-sectional data from the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey. Setting: Community and hospital-based clinics. Patients: Nonpregnant young adults age 20 to 29 years. Measurements: Ambulatory care utilization, types of visits, and preventive care. Results: Insured young adults had more visits (2.16 [95% CI, 2.14 to 2.19] annual visits per capita) than those without insurance (0.59 [CI, 0.54 to 0.67] annual visits per capita). Young men utilized ambulatory medical care less than adolescents age 15 to 19 years or older adults age 30 to 39 years (1.10, 1.65, and 1.73 annual visits per capita, respectively) and had lower rates of utilization than young women (1.10 vs. 2.31 annual visits per capita). Young black and Hispanic men had considerably fewer annual visits per capita (0.75 and 0.65, respectively) than did young white men (1.21). Young men had nearly one half the preventive care visits compared with male adolescents or older men (0.11, 0.24, and 0.19 annual visits per capita, respectively) and less than one quarter the visits compared with young women (0.11 vs. 0.48 annual visits per capita). Only 30.6% of visits by young adults included any preventive counseling, and few encounters included counseling directed toward injury prevention (2.4%), mental health (4.1%), or sexually transmitted diseases (2.7%). Limitation: School-based clinics were not included, and counseling may be underreported. Conclusion: Young adults use less ambulatory medical care relative to other groups and infrequently receive preventive care directed at the greatest threats to their health. Efforts to ensure appropriate preventive care are needed.	[Fortuna, Robert J.] Univ Rochester, Sch Med & Dent, Ctr Primary Care, Rochester, NY 14609 USA; Univ Rochester, Sch Med & Dent, Strong Childrens Res Ctr, Rochester, NY 14609 USA	University of Rochester; University of Rochester	Fortuna, RJ (corresponding author), Univ Rochester, Sch Med & Dent, Ctr Primary Care, 913 Culver Rd, Rochester, NY 14609 USA.	Robert_Fortuna@urmc.rochester.edu			Center for Primary Care	Center for Primary Care	The authors thank the Center for Primary Care at the University of Rochester School of Medicine and Dentistry for support of this project.	American Academy of Pediatrics, 2008, BRIGHT FUT GUID HLTH; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; BIEN TH, 1993, ADDICTION, V88, P315, DOI 10.1111/j.1360-0443.1993.tb00820.x; Callahan ST, 2005, PEDIATRICS, V116, P88, DOI 10.1542/peds.2004-1449; Callahan ST, 2004, PEDIATRICS, V113, P291, DOI 10.1542/peds.113.2.291; *CDCP, 2008, SEX TRANSM DIS SURV; ELSTER A, 2004, GUIDELINES ADOLESCEN; Gilchrist VJ, 2004, MED CARE, V42, P276, DOI 10.1097/01.mlr.0000114916.95639.af; HIBBARD JH, 1986, WOMEN HEALTH, V11, P21, DOI 10.1300/J013v11n02_03; *I CLIN SYST IMPR, PREV SERV CHILDR AD; Johnston BD, 2002, PEDIATRICS, V110, P267, DOI 10.1542/peds.110.2.267; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Klein JD, 2001, ARCH PEDIAT ADOL MED, V155, P597, DOI 10.1001/archpedi.155.5.597; Kriss Jennifer L, 2008, Issue Brief (Commonw Fund), V38, P1; Ma J, 2005, J ADOLESCENT HEALTH, V37, P434, DOI 10.1016/j.jadohealth.2005.07.012; Marcell AV, 2002, J ADOLESCENT HEALTH, V30, P35, DOI 10.1016/S1054-139X(01)00319-6; *NAT CTR HLTH STAT, US ULT CLUST MOD NAM; *NAT CTR HLTH STAT, PROT 2003 05 NAT AMB; National Center for Health Statistics, NCHS PUBL US DAT FIL; Ortega-Sanchez R, 2004, PREV MED, V38, P219, DOI 10.1016/j.ypmed.2003.09.042; Ozer E, 2003, J ADOLESCENT HEALTH, V32, P132, DOI 10.1016/S1054-139X(02)00638-9; Park MJ, 2008, J ADOLESCENT HEALTH, V42, P329, DOI 10.1016/j.jadohealth.2008.01.008; Park MJ, 2006, J ADOLESCENT HEALTH, V39, P305, DOI 10.1016/j.jadohealth.2006.04.017; Rand CM, 2005, J ADOLESCENT HEALTH, V37, P87, DOI 10.1016/j.jadohealth.2005.02.008; Rand CM, 2007, ARCH PEDIAT ADOL MED, V161, P252, DOI 10.1001/archpedi.161.3.252; *ROCH COMM WID CLI, 2007, PREV CAR AD AG 19 YE; Stein RJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.5.e66; *SUBST AB MENT HLT, 2008, NSDUH REP TREATM YEA; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2008, NSDUH SERIES H; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; *US BUR CENS POP D, MONTHL POP EST US; *US BUR CENS POP D, CENS 2000 BRIEFS SPE; VERBRUGGE LM, 1982, PUBLIC HEALTH REP, V97, P417; Ziv A, 1999, PEDIATRICS, V104, P35, DOI 10.1542/peds.104.1.35	34	89	89	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6					379	W119		10.7326/0003-4819-151-6-200909150-00002	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	501OB	19755363				2022-12-28	WOS:000270390100002
J	Yang, J; Zhang, ZG; Roe, SM; Marshall, CJ; Barford, D				Yang, Jing; Zhang, Ziguo; Roe, S. Mark; Marshall, Christopher J.; Barford, David			Activation of Rho GTPases by DOCK Exchange Factors Is Mediated by a Nucleotide Sensor	SCIENCE			English	Article							STRUCTURAL BASIS; CDC42; PROTEINS; GEF; BINDING; DOMAIN; RAC; MEMBRANE; ZIZIMIN1; CRYSTAL	Activation of Rho guanosine triphosphatases (GTPases) to the guanine triphosphate (GTP)-bound state is a critical event in their regulation of the cytoskeleton and cell signaling. Members of the DOCK family of guanine nucleotide exchange factors (GEFs) are important activators of Rho GTPases, but the mechanism of activation by their catalytic DHR2 domain is unknown. Through structural analysis of DOCK9-Cdc42 complexes, we identify a nucleotide sensor within the alpha 10 helix of the DHR2 domain that contributes to release of guanine diphosphate (GDP) and then to discharge of the activated GTP-bound Cdc42. Magnesium exclusion, a critical factor in promoting GDP release, is mediated by a conserved valine residue within this sensor, whereas binding of GTP-Mg2+ to the nucleotide-free complex results in magnesium-inducing displacement of the sensor to stimulate discharge of Cdc42-GTP. These studies identify an unusual mechanism of GDP release and define the complete GEF catalytic cycle from GDP dissociation followed by GTP binding and discharge of the activated GTPase.	[Yang, Jing; Zhang, Ziguo; Roe, S. Mark; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Marshall, Christopher J.] Inst Canc Res, Chester Beatty Labs, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	David.Barford@icr.ac.uk		Zhang, Ziguo/0000-0002-7268-9631; Roe, Mark/0000-0002-7371-9855	Cancer Research-UK; Gibb Life Fellow of Cancer Resesarch-UK; Diamond Light Source	Cancer Research-UK(Cancer Research UK); Gibb Life Fellow of Cancer Resesarch-UK; Diamond Light Source	This work was funded by grants from Cancer Research-UK to D. B. and C. J. M. C. J. M. is a Gibb Life Fellow of Cancer Resesarch-UK, and work was carried out with the support of the Diamond Light Source. We thank staff at the European Synchrotron Radiation Facility for help with data collection, T. Bunney for advice and reagents, and D. Komander for discussions. Accession numbers for coordinates and structure factors are 2wm9, 2wm9sf, 2wmn, 2wmnsf, 2wmo, and 2wmosf for the DOCK9DHR2-Cdc42 complex and -GDP and -GTP complexes, respectively.	Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kobayashi S, 2001, BIOCHEM J, V354, P73, DOI 10.1042/0264-6021:3540073; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Meller N, 2004, J BIOL CHEM, V279, P37470, DOI 10.1074/jbc.M404535200; Miyamoto Y, 2007, EXP CELL RES, V313, P791, DOI 10.1016/j.yexcr.2006.11.017; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Phillips MJ, 2008, J BIOL CHEM, V283, P14153, DOI 10.1074/jbc.M706271200; REINSTEIN J, 1991, J BIOL CHEM, V266, P17700; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Rossman KL, 2002, J BIOL CHEM, V277, P50893, DOI 10.1074/jbc.M208580200; Rudolph MG, 1999, PROTEIN SCI, V8, P778; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014	28	91	94	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1398	1402		10.1126/science.1174468	http://dx.doi.org/10.1126/science.1174468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745154				2022-12-28	WOS:000269699100040
J	Iglehart, JK				Iglehart, John K.			Setbacks and Fissions - Reconsidering the Scope and Timing of Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Balz D., 2009, WASHINGTON POST 1202, pA1; BELKIN D, 2009, WALL STREET J   0825, pA4; Kessler DP, 2009, HEALTH AFFAIR, V28, pW917, DOI 10.1377/hlthaff.28.5.w917; PEAR R, 2009, NY TIMES        0818, pA1; STEELE MS, 2009, WASHINGTON POST 0824, pA15	5	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11								10.1056/NEJMp0906676	http://dx.doi.org/10.1056/NEJMp0906676			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492LP	19741224				2022-12-28	WOS:000269659400006
J	Aggarwal, A; Bhatt, M				Aggarwal, Annu; Bhatt, Mohit			Picture quiz Eye sign in an 18 year old man with psychosis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							WILSONS-DISEASE; DIAGNOSIS		[Bhatt, Mohit] Jaslok Hosp & Res Ctr, Dept Neurol, Mumbai 400053, Maharashtra, India; [Bhatt, Mohit] Kokilaben Dhirubhai Ambani Hosp, Mumbai 400053, Maharashtra, India; [Bhatt, Mohit] Med Res Inst, Mumbai 400053, Maharashtra, India; [Aggarwal, Annu] Univ Adelaide, Univ Dept Med, Adelaide, SA 5000, Australia; [Aggarwal, Annu] Royal Adelaide Hosp, Dept Neurol, Adelaide, SA 5000, Australia	University of Adelaide; Royal Adelaide Hospital	Bhatt, M (corresponding author), Jaslok Hosp & Res Ctr, Dept Neurol, Mumbai 400053, Maharashtra, India.	drmbhatt@gmail.com		Aggarwal, Annu/0000-0003-3096-3206; Bhatt, Mohit/0000-0002-5233-3371				Aggarwal A, 2009, MOVEMENT DISORD, V24, P509, DOI 10.1002/mds.22231; Brewer GJ, 2006, J INORG BIOCHEM, V100, P927, DOI 10.1016/j.jinorgbio.2005.10.007; Brewer GJ, 1998, J LAB CLIN MED, V132, P264, DOI 10.1016/S0022-2143(98)90039-7; Compston A., 1912, BRAIN, V34, P295, DOI DOI 10.1093/BRAIN/34.4.295; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; JackJr CR, 2002, MAGNETIC RESONANCE I, P1177; Leinweber B, 2008, MOVEMENT DISORD, V23, P54, DOI 10.1002/mds.21761; Prashanth LK, 2004, J NEUROL NEUROSUR PS, V75, P907, DOI 10.1136/jnnp.2003.026310; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Scheinberg I. H., 1984, MAJOR PROBLEMS INTER, P1; vanWassenaervanHall HN, 1996, RADIOLOGY, V198, P531, DOI 10.1148/radiology.198.2.8596862; WALSHE JM, 1986, LANCET, V1, P845; Walshe JM, 2007, MOVEMENT DISORD, V22, P2216, DOI 10.1002/mds.21693	13	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2009	339								b3494	10.1136/bmj.b3494	http://dx.doi.org/10.1136/bmj.b3494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	493RD	19740917	Green Submitted			2022-12-28	WOS:000269754700003
J	Kuehn, BM				Kuehn, Bridget M.			CDC Links Data on Health and Environment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1049	1049		10.1001/jama.2009.1261	http://dx.doi.org/10.1001/jama.2009.1261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738084				2022-12-28	WOS:000269616200005
J	Coulombe, F; Behr, MA				Coulombe, Francois; Behr, Marcel A.			Crohn's disease as an immune deficiency?	LANCET			English	Editorial Material									[Coulombe, Francois; Behr, Marcel A.] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3G 1A4, Canada	McGill University	Behr, MA (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3G 1A4, Canada.	marcel.behr@mcgill.ca						Behr MA, 2006, INFLAMM BOWEL DIS, V12, P1000, DOI 10.1097/01.mib.0000228183.70197.dd; Coulombe F, 2009, J EXP MED, V206, P1709, DOI 10.1084/jem.20081779; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Park JH, 2007, CYTOKINE, V39, P32, DOI 10.1016/j.cyto.2007.07.123; SEGAL AW, 1976, LANCET, V2, P219; Smith AM, 2009, J EXP MED, V206, P1883, DOI 10.1084/jem.20091233	8	20	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					769	770		10.1016/S0140-6736(09)61576-2	http://dx.doi.org/10.1016/S0140-6736(09)61576-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492QU	19733770				2022-12-28	WOS:000269675000010
J	Gogolla, N; Caroni, P; Luthi, A; Herry, C				Gogolla, Nadine; Caroni, Pico; Luethi, Andreas; Herry, Cyril			Perineuronal Nets Protect Fear Memories from Erasure	SCIENCE			English	Article							CHONDROITIN-SULFATE PROTEOGLYCANS; CONDITIONED FEAR; DEVELOPMENTAL DISSOCIATION; AMYGDALA DEPOTENTIATION; BASOLATERAL AMYGDALA; EXTRACELLULAR-MATRIX; EXTINGUISHED FEAR; VISUAL-CORTEX; EXTINCTION; PLASTICITY	In adult animals, fear conditioning induces a permanent memory that is resilient to erasure by extinction. In contrast, during early postnatal development, extinction of conditioned fear leads to memory erasure, suggesting that fear memories are actively protected in adults. We show here that this protection is conferred by extracellular matrix chondroitin sulfate proteoglycans (CSPGs) in the amygdala. The organization of CSPGs into perineuronal nets (PNNs) coincided with the developmental switch in fear memory resilience. In adults, degradation of PNNs by chondroitinase ABC specifically rendered subsequently acquired fear memories susceptible to erasure. This result indicates that intact PNNs mediate the formation of erasure-resistant fear memories and identifies a molecular mechanism closing a postnatal critical period during which traumatic memories can be erased by extinction.	[Gogolla, Nadine; Caroni, Pico; Luethi, Andreas; Herry, Cyril] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research	Luthi, A (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	andreas.luthi@fmi.ch; cyril.herry@inserm.fr	Herry, Cyril/AAP-9902-2020	Herry, Cyril/0000-0003-2973-0843	Austrian Science Fund (FWF); Swiss National Science Foundation; Novartis Research Foundation	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Research Foundation	This work was supported by the Austrian Science Fund (FWF), Swiss National Science Foundation, and Novartis Research Foundation. We thank G. Cassasus for electrophysiological characterization of ChABC-injected animals and K. Scheffler for help with programming. We thank R. F. Westbrook and all members of the Luthi lab for discussions and critical comments on the manuscript. The manuscript was prepared by N.G., P.C., A.L., and C.H. The authors declare that they have no competing financial interest.	Anglada-Figueroa D, 2005, J NEUROSCI, V25, P9680, DOI 10.1523/JNEUROSCI.2600-05.2005; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; Bouwmeester H, 2002, J COMP NEUROL, V450, P241, DOI 10.1002/cne.10321; Bruckner G, 1998, EXP BRAIN RES, V121, P300, DOI 10.1007/s002210050463; Bukalo O, 2001, NEUROSCIENCE, V104, P359, DOI 10.1016/S0306-4522(01)00082-3; Cunningham MG, 2002, J COMP NEUROL, V453, P116, DOI 10.1002/cne.10376; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Gale GD, 2004, J NEUROSCI, V24, P3810, DOI 10.1523/JNEUROSCI.4100-03.2004; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Harris JA, 2000, J EXP PSYCHOL-ANIM B, V26, P174, DOI 10.1037//0097-7403.26.2.174; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Kim JH, 2008, J NEUROSCI, V28, P1282, DOI 10.1523/JNEUROSCI.4736-07.2008; Kim JH, 2007, BEHAV NEUROSCI, V121, P131, DOI 10.1037/0735-7044.121.1.131; Kim JH, 2007, NEUROBIOL LEARN MEM, V88, P48, DOI 10.1016/j.nlm.2007.03.004; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lin CH, 2003, MOL PHARMACOL, V63, P44, DOI 10.1124/mol.63.1.44; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010; Rodriguez BI, 1999, BEHAV RES THER, V37, P845, DOI 10.1016/S0005-7967(98)00106-5; Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732	28	478	490	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1258	1261		10.1126/science.1174146	http://dx.doi.org/10.1126/science.1174146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490RY	19729657				2022-12-28	WOS:000269523200041
J	Kaufman, DS; Schneider, DP; McKay, NP; Ammann, CM; Bradley, RS; Briffa, KR; Miller, GH; Otto-Bliesner, BL; Overpeck, JT; Vinther, BM				Kaufman, Darrell S.; Schneider, David P.; McKay, Nicholas P.; Ammann, Caspar M.; Bradley, Raymond S.; Briffa, Keith R.; Miller, Gifford H.; Otto-Bliesner, Bette L.; Overpeck, Jonathan T.; Vinther, Bo M.		Arctic Lakes 2k Project Members	Recent Warming Reverses Long-Term Arctic Cooling	SCIENCE			English	Article							CLIMATE-CHANGE; LOW-RESOLUTION; HOLOCENE	The temperature history of the first millennium C. E. is sparsely documented, especially in the Arctic. We present a synthesis of decadally resolved proxy temperature records from poleward of 60 degrees N covering the past 2000 years, which indicates that a pervasive cooling in progress 2000 years ago continued through the Middle Ages and into the Little Ice Age. A 2000-year transient climate simulation with the Community Climate System Model shows the same temperature sensitivity to changes in insolation as does our proxy reconstruction, supporting the inference that this long-term trend was caused by the steady orbitally driven reduction in summer insolation. The cooling trend was reversed during the 20th century, with four of the five warmest decades of our 2000-year-long reconstruction occurring between 1950 and 2000.	[Kaufman, Darrell S.] No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA; [Schneider, David P.; Ammann, Caspar M.; Otto-Bliesner, Bette L.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA; [McKay, Nicholas P.; Overpeck, Jonathan T.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Bradley, Raymond S.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Briffa, Keith R.] Univ E Anglia, Climat Res Unit, Norwich NR4 7TJ, Norfolk, England; [Miller, Gifford H.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Vinther, Bo M.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark	Northern Arizona University; National Center Atmospheric Research (NCAR) - USA; University of Arizona; University of Massachusetts System; University of Massachusetts Amherst; University of East Anglia; University of Colorado System; University of Colorado Boulder; University of Copenhagen; Niels Bohr Institute	Kaufman, DS (corresponding author), No Arizona Univ, Sch Earth Sci & Environm Sustainabil, Flagstaff, AZ 86011 USA.	darrell.kaufman@nau.edu	Axford, Yarrow/N-4151-2014; Ammann, Caspar M/A-4899-2011; Briffa, Keith/C-8834-2009; Francus, Pierre/H-3713-2019; Kaufman, Darrell/A-2471-2008; Schneider, David/E-2726-2010; Birks, John B/C-3103-2008; Bradley, Raymond S/P-9358-2015; Otto-Bliesner, Bette/AAY-7691-2020; Geirsdóttir, Áslaug/L-3267-2015	Axford, Yarrow/0000-0002-8033-358X; Francus, Pierre/0000-0001-5465-1966; Kaufman, Darrell/0000-0002-7572-1414; Schneider, David/0000-0001-5308-1834; Birks, John B/0000-0002-5891-9859; Bradley, Raymond S/0000-0002-4032-9519; Geirsdóttir, Áslaug/0000-0003-3125-0195; Cook, Timothy/0000-0002-4982-6415; Vinther, Bo/0000-0002-6078-771X; McKay, Nicholas/0000-0003-3598-5113; Seppa, Heikki/0000-0003-2494-7955; Loso, Michael/0000-0001-8414-2310; Bjune, Anne Elisabeth/0000-0002-4509-0148; Briffa, Keith/0000-0003-3323-3639; Porinchu, David/0000-0002-0495-3082	NSF [ARC-0455043, 0454959, 0455025, 0450938, 0454930]	NSF(National Science Foundation (NSF))	Supported by the Arctic System Science Program of NSF [grants ARC-0455043 (D.S.K.), 0454959 (R.S.B.), 0455025 (G.H.M.), 0450938 (J.T.O.), and 0454930 (B.L.O.-B.)].NCAR is funded by NSF.We thank our collaborators on the ARCSS 2k Project (www.arcus.org/synthesis2k) for their contributions, and M.Hughes, K.Kreutz, and reviewers for their input. NOAA Paleoclimatology assisted with data management.	Ammann CM, 2007, P NATL ACAD SCI USA, V104, P3713, DOI 10.1073/pnas.0605064103; [Anonymous], 2005, ARCTIC CLIMATE IMPAC; Bengtsson L, 2004, J CLIMATE, V17, P4045, DOI 10.1175/1520-0442(2004)017<4045:TETWIT>2.0.CO;2; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Briffa KR, 2008, PHILOS T R SOC B, V363, P2271, DOI 10.1098/rstb.2007.2199; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Crowley TJ, 2000, SCIENCE, V289, P270, DOI 10.1126/science.289.5477.270; England JH, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034470; FISHER DA, 1995, HOLOCENE, V5, P19, DOI 10.1177/095968369500500103; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; Hegerl GC, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P663; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; JONES PD, 1995, CLIMATIC VARIATIONS, P625; Jouzel J, 1997, J GEOPHYS RES-OCEANS, V102, P26471, DOI 10.1029/97JC01283; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P529, DOI 10.1016/j.quascirev.2003.09.007; Kerwin MW, 1999, PALEOCEANOGRAPHY, V14, P200, DOI 10.1029/1998PA900011; Lamb H.H., 1995, CLIMATE HIST MODERN, P211; Lee TCK, 2008, CLIM DYNAM, V31, P263, DOI 10.1007/s00382-007-0351-9; MacDonald GM, 2000, QUATERNARY RES, V53, P302, DOI 10.1006/qres.1999.2123; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Mckay NP, 2009, J PALEOLIMNOL, V41, P143, DOI 10.1007/s10933-008-9260-0; MILLER GH, 2009, CLIMATE VARIABILITY, pCH4; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Osborn TJ, 2006, SCIENCE, V311, P841, DOI 10.1126/science.1120514; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2567, DOI 10.1175/JCLI3754.1; Overpeck J, 1997, SCIENCE, V278, P1251, DOI 10.1126/science.278.5341.1251; Seppa H, 2002, QUATERNARY RES, V57, P191, DOI 10.1006/qres.2001.2313; Serreze MC, 2009, CRYOSPHERE, V3, P11, DOI 10.5194/tc-3-11-2009; Serreze MC, 2006, CLIMATIC CHANGE, V76, P241, DOI 10.1007/s10584-005-9017-y; Smol JP, 2005, P NATL ACAD SCI USA, V102, P4397, DOI 10.1073/pnas.0500245102; Wanner H, 2008, QUATERNARY SCI REV, V27, P1791, DOI 10.1016/j.quascirev.2008.06.013	31	508	526	6	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1236	1239		10.1126/science.1173983	http://dx.doi.org/10.1126/science.1173983			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729653	Green Published			2022-12-28	WOS:000269523200035
J	Logsdail, S				Logsdail, Steve			A Patient's Journey Synaesthesia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Chiltern Hosp, Great Missenden HP16 0EN, Bucks, England		Logsdail, S (corresponding author), Chiltern Hosp, Great Missenden HP16 0EN, Bucks, England.	sjlogs@yahoo.co.uk							0	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2009	339								b3191	10.1136/bmj.b3191	http://dx.doi.org/10.1136/bmj.b3191			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CJ	19734195				2022-12-28	WOS:000269554200011
J	Magurran, AE				Magurran, Anne E.			Threats to Freshwater Fish	SCIENCE			English	Editorial Material							EXTINCTION RISK; CICHLID FISH; ZOOGONETICUS; DIVERSITY		Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 8LB, Fife, Scotland	University of St Andrews	Magurran, AE (corresponding author), Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 8LB, Fife, Scotland.	aem1@st-andrews.ac.uk	Magurran, Anne E/D-7463-2013	Magurran, Anne/0000-0002-0036-2795				Bailey NW, 2007, HEREDITY, V98, P360, DOI 10.1038/sj.hdy.6800947; Chu C, 2005, DIVERS DISTRIB, V11, P299, DOI 10.1111/j.1366-9516.2005.00153.x; De La Vega-Salazar MY, 2003, ENVIRON BIOL FISH, V68, P14, DOI 10.1023/A:1026040727808; De La Vega-Salazar MY, 2003, BIODIVERS CONSERV, V12, P2043, DOI 10.1023/A:1024155731112; Duncan JR, 2001, BIOL CONSERV, V102, P97, DOI 10.1016/S0006-3207(01)00077-5; Fagan WE, 2005, ECOLOGY, V86, P34, DOI 10.1890/04-0491; GASTON KJ, 1990, J FISH BIOL, V37, P97, DOI 10.1111/j.1095-8649.1990.tb05025.x; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; HORN MH, 1972, FISH B-NOAA, V70, P1295; Jelks HL, 2008, FISHERIES, V33, P372, DOI 10.1577/1548-8446-33.8.372; Langerhans RB, 2007, EVOLUTION, V61, P2056, DOI 10.1111/j.1558-5646.2007.00171.x; MAGURRAN AE, 2005, EVOLUTIONARY ECOLOGY; MAITLAND PS, 1995, BIOL CONSERV, V72, P259, DOI 10.1016/0006-3207(94)00088-8; Nelson JS, 2006, FISHES WORLD, DOI DOI 10.1002/9781119174844; Rabinowitz D., 1981, BIOL ASPECTS RARE PL, P205, DOI DOI 10.1177/004728702237415; Reynolds JD, 2005, CAN J FISH AQUAT SCI, V62, P854, DOI 10.1139/F05-066; Richter BD, 1997, CONSERV BIOL, V11, P1081, DOI 10.1046/j.1523-1739.1997.96236.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Van Oppen MJH, 1997, P ROY SOC B-BIOL SCI, V264, P1803, DOI 10.1098/rspb.1997.0248; Verzijden MN, 2007, BIOL LETTERS, V3, P134, DOI 10.1098/rsbl.2006.0601	20	48	51	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1215	1216		10.1126/science.1177215	http://dx.doi.org/10.1126/science.1177215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729647				2022-12-28	WOS:000269523200027
J	Rand, DG; Dreber, A; Ellingsen, T; Fudenberg, D; Nowak, MA				Rand, David G.; Dreber, Anna; Ellingsen, Tore; Fudenberg, Drew; Nowak, Martin A.			Positive Interactions Promote Public Cooperation	SCIENCE			English	Article							REPEATED GAMES; ALTRUISTIC PUNISHMENT; INDIRECT RECIPROCITY; COSTLY PUNISHMENT; SANCTIONS; EVOLUTION; GOODS; PROVISION; REWARDS; ORGANIZATIONS	The public goods game is the classic laboratory paradigm for studying collective action problems. Each participant chooses how much to contribute to a common pool that returns benefits to all participants equally. The ideal outcome occurs if everybody contributes the maximum amount, but the self-interested strategy is not to contribute anything. Most previous studies have found punishment to be more effective than reward for maintaining cooperation in public goods games. The typical design of these studies, however, represses future consequences for today's actions. In an experimental setting, we compare public goods games followed by punishment, reward, or both in the setting of truly repeated games, in which player identities persist from round to round. We show that reward is as effective as punishment for maintaining public cooperation and leads to higher total earnings. Moreover, when both options are available, reward leads to increased contributions and payoff, whereas punishment has no effect on contributions and leads to lower payoff. We conclude that reward outperforms punishment in repeated public goods games and that human cooperation in such repeated settings is best supported by positive interactions with others.	[Rand, David G.; Dreber, Anna; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Rand, David G.] Harvard Univ, Berkman Ctr Internet & Soc, Cambridge, MA 02138 USA; [Fudenberg, Drew] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Math, Cambridge, MA 02138 USA; [Nowak, Martin A.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Dreber, Anna; Ellingsen, Tore] Stockholm Sch Econ, Dept Econ, S-11358 Stockholm, Sweden	Harvard University; Harvard University; Harvard University; Harvard University; Harvard University; Stockholm School of Economics	Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Nowak, Martin A/A-6977-2008; Rand, David G./B-3716-2009; Ellingsen, Tore/E-9356-2011; Dreber, Anna/D-8709-2010	Rand, David G./0000-0002-2821-468X; Ellingsen, Tore/0000-0001-9501-0137; Rand, David/0000-0001-8975-2783	John Templeton Foundation; National Science Foundation-National Institutes of Health; Torsten and Ragnar Soderberg Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078986] Funding Source: NIH RePORTER	John Templeton Foundation; National Science Foundation-National Institutes of Health(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Torsten and Ragnar Soderberg Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Racimo and J. Paci for assistance in performing the experiments. Support from the John Templeton Foundation, the National Science Foundation-National Institutes of Health joint program in mathematical biology, and J. Epstein, as well as the Jan Wallander and Tom Hedelius Foundation (A. D.) and the Torsten and Ragnar Soderberg Foundation (T. E.), is gratefully acknowledged.	Alexander R., 1987, BIOL MORAL SYSTEMS; Andreoni J, 2003, AM ECON REV, V93, P893, DOI 10.1257/000282803322157142; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; Boehm C., 1999, HIERARCHY FOREST EVO; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Cinyabuguma M, 2005, J PUBLIC ECON, V89, P1421, DOI 10.1016/j.jpubeco.2004.05.011; Cohen-Charash Y, 2001, ORGAN BEHAV HUM DEC, V86, P278, DOI 10.1006/obhd.2001.2958; Coleman JS., 1990, FDN SOCIAL THEORY; Dal Bo P, 2005, AM ECON REV, V95, P1591; Denant-Boemont L, 2007, ECON THEOR, V33, P145, DOI 10.1007/s00199-007-0212-0; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Ellingsen T, 2008, EVOL HUM BEHAV, V29, P100, DOI 10.1016/j.evolhumbehav.2007.11.001; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Houser D, 2008, GAME ECON BEHAV, V62, P509, DOI 10.1016/j.geb.2007.05.001; Lowe KB, 1996, LEADERSHIP QUART, V7, P385, DOI 10.1016/S1048-9843(96)90027-2; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Nikiforakis N, 2008, J PUBLIC ECON, V92, P91, DOI 10.1016/j.jpubeco.2007.04.008; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; OSTROM E, 1992, AM POLIT SCI REV, V86, P404, DOI 10.2307/1964229; Podsakoff PM, 2006, ORGAN BEHAV HUM DEC, V99, P113, DOI 10.1016/j.obhdp.2005.09.002; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Sefton M, 2007, ECON INQ, V45, P671, DOI 10.1111/j.1465-7295.2007.00051.x; Stajkovic AD, 2003, PERS PSYCHOL, V56, P155, DOI 10.1111/j.1744-6570.2003.tb00147.x; Sutter M., 2006, 5497 CEPR; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Walker JM, 2004, EXP ECON, V7, P235, DOI 10.1023/B:EXEC.0000040559.08652.51; Wiessner P, 2005, HUM NATURE-INT BIOS, V16, P115, DOI 10.1007/s12110-005-1000-9; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	39	435	448	11	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1272	1275		10.1126/science.1177418	http://dx.doi.org/10.1126/science.1177418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490RY	19729661	Green Accepted, Green Submitted			2022-12-28	WOS:000269523200045
J	Tajunisah, I; Patel, DK				Tajunisah, Iqbal; Patel, Dinesh Kumar			Retinal Detachment in Malignant Hypertension.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tajunisah, Iqbal; Patel, Dinesh Kumar] Univ Malaya, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Tajunisah, I (corresponding author), Univ Malaya, Kuala Lumpur 50603, Malaysia.		iqbal, tajunisah/U-8032-2017	iqbal, tajunisah/0000-0001-7474-7770					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					899	899		10.1056/NEJMicm0802683	http://dx.doi.org/10.1056/NEJMicm0802683			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	487XV	19710488				2022-12-28	WOS:000269312700010
J	Leslie, WD; O'Donnell, S; Jean, S; Lagace, C; Walsh, P; Bancej, C; Morin, S; Hanley, DA; Papaioannou, A				Leslie, William D.; O'Donnell, Siobhan; Jean, Sonia; Lagace, Claudia; Walsh, Peter; Bancej, Christina; Morin, Suzanne; Hanley, David A.; Papaioannou, Alexandra		Osteoporosis Surveillance Expert W	Trends in Hip Fracture Rates in Canada	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OSTEOPOROSIS CARE GAP; QUALITY-OF-LIFE; UNITED-STATES; FRAGILITY FRACTURES; RISK-FACTORS; OLDER MEN; WOMEN; METAANALYSIS; COMMUNITY; MORTALITY	Context Hip fractures are a public health concern because they are associated with significant morbidity, excess mortality, and the majority of the costs directly attributable to osteoporosis. Objective To examine trends in hip fracture rates in Canada. Design, Setting, and Patients Ecologic trend study using nationwide hospitalization data for 1985 to 2005 from a database at the Canadian Institute for Health Information. Data for all patients with a hospitalization for which the primary reason was a hip fracture (570 872 hospitalizations) were analyzed. Main Outcome Measures Age-specific and age-standardized hip fracture rates. Results There was a decrease in age-specific hip fracture rates (all P for trend <.001). Over the 21-year period of the study, age-adjusted hip fracture rates decreased by 31.8% in females (from 118.6 to 80.9 fractures per 100 000 person-years) and by 25.0% in males (from 68.2 to 51.1 fractures per 100 000 person-years). Joinpoint regression analysis identified a change in the linear slope around 1996. For the overall population, the average age-adjusted annual percentage decrease in hip fracture rates was 1.2% (95% confidence interval, 1.0%-1.3%) per year from 1985 to 1996 and 2.4% (95% confidence interval, 2.1%-2.6%) per year from 1996 to 2005 (P<.001 for difference in slopes). Similar changes were seen in both females and males with greater slope reductions after 1996 (P<.001 for difference in slopes for each sex). Conclusions Age-standardized rates of hip fracture have steadily declined in Canada since 1985 and more rapidly during the later study period. The factors primarily responsible for the earlier reduction in hip fractures are unknown. JAMA. 2009; 302(8): 883-889	[Leslie, William D.] Univ Manitoba, Dept Med, Winnipeg, MB R2H 2A6, Canada; [O'Donnell, Siobhan; Lagace, Claudia; Walsh, Peter; Bancej, Christina] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Jean, Sonia] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Morin, Suzanne] McGill Univ, Montreal, PQ, Canada; [Hanley, David A.] Univ Calgary, Calgary, AB, Canada; [Papaioannou, Alexandra] McMaster Univ, Hamilton, ON, Canada	University of Manitoba; Public Health Agency of Canada; Institut national de sante publique du Quebec (INSPQ); McGill University; University of Calgary; McMaster University	Leslie, WD (corresponding author), Univ Manitoba, Dept Med C5121, 409 Tache Ave, Winnipeg, MB R2H 2A6, Canada.	bleslie@sbgh.mb.ca		Leslie, William/0000-0002-1056-1691; Morin, Suzanne/0000-0002-4317-492X; Kendler, David/0000-0001-7679-3965				Adachi JD, 2001, OSTEOPOROSIS INT, V12, P903, DOI 10.1007/s001980170017; Berry SD, 2007, ARCH INTERN MED, V167, P1971, DOI 10.1001/archinte.167.18.1971; Briefel RR, 2004, ANNU REV NUTR, V24, P401, DOI 10.1146/annurev.nutr.23.011702.073349; Browner WS, 1996, ARCH INTERN MED, V156, P1521, DOI 10.1001/archinte.156.14.1521; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chapurlat RD, 2003, OSTEOPOROSIS INT, V14, P130, DOI 10.1007/s00198-002-1327-6; CHENG N, 2008, CAN FAM PHYSICIAN, V54, pE1; Cheng N, 2008, CAN FAM PHYSICIAN, V54, P1140; Chevalley T, 2007, BONE, V40, P1284, DOI 10.1016/j.bone.2006.12.063; Couris CM, 2007, BONE, V41, P896, DOI 10.1016/j.bone.2007.06.020; Feldstein AC, 2005, OSTEOPOROSIS INT, V16, P953, DOI 10.1007/s00198-005-1950-0; Gates S, 2008, BRIT MED J, V336, P130, DOI 10.1136/bmj.39412.525243.BE; Gehlbach SH, 2007, OSTEOPOROSIS INT, V18, P585, DOI 10.1007/s00198-006-0281-0; Giangregorio L, 2006, SEMIN ARTHRITIS RHEU, V35, P293, DOI 10.1016/j.semarthrit.2005.11.001; GILMORE J, 82F0077XIE STAT CAN; Hagenau T, 2009, OSTEOPOROSIS INT, V20, P133, DOI 10.1007/s00198-008-0626-y; Hallberg I, 2004, OSTEOPOROSIS INT, V15, P834, DOI 10.1007/s00198-004-1622-5; Hannan EL, 2001, JAMA-J AM MED ASSOC, V285, P2736, DOI 10.1001/jama.285.21.2736; Icks A, 2008, OSTEOPOROSIS INT, V19, P1139, DOI 10.1007/s00198-007-0534-6; Jaglal SB, 2005, J BONE MINER RES, V20, P898, DOI 10.1359/JBMR.041231; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P155, DOI 10.1007/s00198-004-1640-3; Kannus P, 2006, J BONE MINER RES, V21, P1836, DOI 10.1359/JBMR.060815; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Lippuner K, 2005, OSTEOPOROSIS INT, V16, pS8, DOI 10.1007/s00198-004-1696-0; Melton LJ, 2007, J BONE MINER RES, V22, P1096, DOI 10.1359/JBMR.070323; Melton LJ, 1996, PUBLIC HEALTH REP, V111, P146; Melton LJ, 2003, ENDOCRIN METAB CLIN, V32, P1, DOI 10.1016/S0889-8529(02)00061-0; Nichols HB, 2006, AM J EPIDEMIOL, V164, P1003, DOI 10.1093/aje/kwj282; Papaioannou A, 2008, OSTEOPOROSIS INT, V19, P581, DOI 10.1007/s00198-007-0483-0; RICHARDS J, 1989, SOC SCI MED, V28, P175; Ryg P, 2009, J BONE MINER RES, V24, P1299, DOI [10.1359/JBMR.090207, 10.1359/jbmr.090207]; Stone KL, 2003, J BONE MINER RES, V18, P1947, DOI 10.1359/jbmr.2003.18.11.1947; Zingmond DS, 2004, OSTEOPOROSIS INT, V15, P603, DOI 10.1007/s00198-004-1592-7	35	248	256	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					883	889		10.1001/jama.2009.1231	http://dx.doi.org/10.1001/jama.2009.1231			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706862	Bronze			2022-12-28	WOS:000269260100022
J	Betts, TR				Betts, Timothy R.			Is rate more important than rhythm in treating atrial fibrillation? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ELECTRICAL CARDIOVERSION RACE; QUALITY-OF-LIFE; MANAGEMENT AFFIRM; RANDOMIZED-TRIAL; STRATEGIES; AMIODARONE; ABLATION		John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England	University of Oxford	Betts, TR (corresponding author), John Radcliffe Hosp, Dept Cardiol, Oxford OX3 9DU, England.	EP.doctors@orh.nhs.uk	Mitchell, Andrew/AFQ-7844-2022	Mitchell, Andrew/0000-0002-5386-9645				Betts TR, 2008, EUROPACE, V10, P425, DOI 10.1093/europace/eun063; Carlsson J, 2003, J AM COLL CARDIOL, V41, P1690, DOI 10.1016/S0735-1097(03)00332-2; Corley SD, 2004, CIRCULATION, V109, P1509, DOI 10.1161/01.CIR.0000121736.16643.11; Curtis AB, 2005, AM HEART J, V149, P645, DOI 10.1016/j.ahj.2004.09.038; Fetsch T, 2004, EUR HEART J, V25, P1385, DOI 10.1016/j.ehj.2004.04.015; Gronefeld GC, 2003, EUR HEART J, V24, P1430, DOI 10.1016/S0195-668X(03)00261-6; Hagens VE, 2004, EUR HEART J, V25, P1542, DOI 10.1016/j.ehj.2004.06.020; Hagens VE, 2004, J AM COLL CARDIOL, V43, P241, DOI 10.1016/j.jacc.2003.08.037; Hohnloser SH, 2000, LANCET, V356, P1789, DOI 10.1016/S0140-6736(00)03230-X; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Kumana CR, 2005, BRIT J CLIN PHARMACO, V60, P347, DOI 10.1111/j.1365-2125.2005.02449.x; Lubitz SA, 2008, BMJ-BRIT MED J, V336, P819, DOI 10.1136/bmj.39513.555150.BE; Marshall DA, 2004, ANN INTERN MED, V141, P653, DOI 10.7326/0003-4819-141-9-200411020-00005; Opolski G, 2004, CHEST, V126, P476, DOI 10.1378/chest.126.2.476; Roy D, 2000, NEW ENGL J MED, V342, P913, DOI 10.1056/NEJM200003303421302; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Van Gelder IC, 2002, NEW ENGL J MED, V347, P1834, DOI 10.1056/NEJMoa021375; Vorperian VR, 1997, J AM COLL CARDIOL, V30, P791, DOI 10.1016/S0735-1097(97)00220-9; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	19	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2009	339								b3173	10.1136/bmj.b3173	http://dx.doi.org/10.1136/bmj.b3173			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	486SE	19700508				2022-12-28	WOS:000269217200007
J	Hansel, TT; Barnes, PJ				Hansel, Trevor T.; Barnes, Peter J.			New drugs for exacerbations of chronic obstructive pulmonary disease	LANCET			English	Review							RESPIRATORY SYNCYTIAL VIRUS; TOLL-LIKE RECEPTORS; AIRWAY INFLAMMATION; EPITHELIAL-CELLS; INNATE IMMUNITY; DOUBLE-BLIND; BACTERIAL-COLONIZATION; COPD EXACERBATIONS; NATURAL-HISTORY; LUNG-FUNCTION	Tobacco smoking is the dominant risk factor for chronic obstructive pulmonary disease (COPD), but viral and bacterial infections are the major causes of exacerbations in later stages of disease. Reactive oxygen species (ROS), pathogen-associated molecular patterns (PAMPs), and damage-associated molecular patterns (DAMPs) activate families of pattern recognition receptors (PRRs) that include the toll-like receptors (TLRs). This understanding has led to the hypothesis that COPD is an archetypal disease of innate immunity. COPD is characterised by abnormal response to injury, with altered barrier function of the respiratory tract, an acute phase reaction, and excessive activation of macrophages, neutrophils, and fibroblasts in the lung. The activated non-specific immune system then mediates the processes of inflammation and repair, fibrosis, and proteolysis. COPD is also associated with corticosteroid resistance, abnormal macrophage and T-cell populations in the airway, autoinflammation and autoimmunity, aberrant fibrosis, accelerated ageing, systemic and concomitant disease, and defective regeneration. Such concepts have been used to generate a range of molecular targets, and clinical trials are taking place to identify effective drugs for the prevention and treatment of COPD exacerbations.	[Hansel, Trevor T.; Barnes, Peter J.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	Imperial College London	Hansel, TT (corresponding author), St Marys Hosp, Imperial Clin Resp Res Unit, Mint Wing,Praed St, London W2 1NY, England.	t.hansel@imperial.ac.uk		Barnes, Peter/0000-0002-5122-4018				Adcock IM, 2008, CHEST, V134, P394, DOI 10.1378/chest.08-0440; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; Barcelo B, 2008, EUR RESPIR J, V31, P555, DOI 10.1183/09031936.00010407; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2007, AM J RESP CRIT CARE, V175, P866, DOI 10.1164/rccm.200702-253ED; Baumgartner RA, 2007, CLIN THER, V29, P261, DOI 10.1016/j.clinthera.2007.02.009; Beeh KM, 2003, CHEST, V123, P1240, DOI 10.1378/chest.123.4.1240; Berclaz PY, 2007, AM J RESP CELL MOL, V36, P114, DOI 10.1165/rcmb.2006-0174OC; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Birrell MA, 2006, MOL PHARMACOL, V69, P1791, DOI 10.1124/mol.105.019521; Black PN, 2009, POSTGRAD MED J, V85, P141, DOI 10.1136/pgmj.2008.072439; Blamoun AI, 2008, INT J CLIN PRACT, V62, P1373, DOI 10.1111/j.1742-1241.2008.01731.x; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Bozinovski S, 2008, AM J RESP CRIT CARE, V177, P269, DOI 10.1164/rccm.200705-678OC; Brownlee JW, 2008, CURR OPIN PEDIATR, V20, P67, DOI 10.1097/MOP.0b013e3282f41cb6; Calverley PMA, 2007, AM J RESP CRIT CARE, V176, P154, DOI 10.1164/rccm.200610-1563OC; Carrera M, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2008.08.007; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Cazzola M, 2009, CURR OPIN INVEST DR, V10, P482; Celli BR, 2007, EUR RESPIR J, V29, P1224, DOI 10.1183/09031936.00109906; Celli BR, 2008, CHEST, V133, P1451, DOI 10.1378/chest.07-2061; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chaudhuri N, 2007, CHEST, V131, P1550, DOI 10.1378/chest.06-2869; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Compton CH, 2001, LANCET, V358, P265, DOI 10.1016/S0140-6736(01)05481-2; Cookson William O C, 2006, Proc Am Thorac Soc, V3, P473, DOI 10.1513/pats.200603-036MS; Cosio BG, 2009, THORAX, V64, P424, DOI 10.1136/thx.2008.103432; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Currie GP, 2008, BRIT J CLIN PHARMACO, V65, P803, DOI 10.1111/j.1365-2125.2008.03155.x; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong YP, 2007, CHEST, V132, P1741, DOI 10.1378/chest.07-0208; Decramer M, 2005, LANCET, V365, P1552, DOI 10.1016/S0140-6736(05)66456-2; Decrarner M, 2008, RESP MED, V102, pS3, DOI 10.1016/S0954-6111(08)70003-9; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Doz E, 2008, J IMMUNOL, V180, P1169, DOI 10.4049/jimmunol.180.2.1169; Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003; Feghali-Bostwick CA, 2008, AM J RESP CRIT CARE, V177, P156, DOI 10.1164/rccm.200701-014OC; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; Foreman MG, 2008, EUR RESPIR J, V32, P938, DOI 10.1183/09031936.00040208; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Gaestel M, 2009, NAT REV DRUG DISCOV, V8, P480, DOI 10.1038/nrd2829; Giembycz MA, 2008, BRIT J PHARMACOL, V155, P288, DOI 10.1038/bjp.2008.297; Glezen WP, 2008, NEW ENGL J MED, V359, P2579, DOI 10.1056/NEJMcp0807498; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hanania Nicola A, 2007, Proc Am Thorac Soc, V4, P526, DOI 10.1513/pats.200701-016FM; Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.04.006; Harrison OJ, 2008, IMMUNOL LETT, V121, P13, DOI 10.1016/j.imlet.2008.07.011; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Heltzer ML, 2009, J LEUKOCYTE BIOL, V85, P1036, DOI 10.1189/jlb.1108710; Hersh Craig P, 2008, Proc Am Thorac Soc, V5, P486, DOI 10.1513/pats.200706-078ET; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hoogerwerf JJ, 2008, AM J RESP CRIT CARE, V178, P34, DOI 10.1164/rccm.200708-1261OC; Hudson TJ, 1996, ANN PHARMACOTHER, V30, P674, DOI 10.1177/106002809603000616; Hunninghake Donald B, 2005, Proc Am Thorac Soc, V2, P44, DOI 10.1513/pats.200410-050SF; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; IVANOV S, 2009, NEW DRUGS TARGETS RE; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Janda S, 2009, CHEST, V136, P734, DOI 10.1378/chest.09-0194; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Kanner RE, 2001, AM J RESP CRIT CARE, V164, P358, DOI 10.1164/ajrccm.164.3.2010017; Kelsen SG, 2009, AM J RESP CRIT CARE, V179, P799, DOI 10.1164/rccm.200807-1089OC; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; KIRKHAM P, 2009, NEW DRUGS TARGETS RE; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kovacic P, 2009, REV ENVIRON CONTAM T, V201, P41, DOI 10.1007/978-1-4419-0032-6_2; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Laan M, 2004, J IMMUNOL, V173, P4164, DOI 10.4049/jimmunol.173.6.4164; Lagente V, 2009, EXPERT OPIN THER TAR, V13, P287, DOI [10.1517/14728220902751632, 10.1517/14728220902751632 ]; Laurent Geoffrey J, 2008, Proc Am Thorac Soc, V5, P311, DOI 10.1513/pats.200710-159DR; Lee SH, 2007, NAT MED, V13, P567, DOI 10.1038/nm1583; Leff Alan R, 2007, Proc Am Thorac Soc, V4, P659, DOI 10.1513/pats.200707-103TH; Li L, 2009, FREE RADICAL BIO MED, V47, P103, DOI 10.1016/j.freeradbiomed.2009.04.014; Li YJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-16; Ling Sean H, 2009, Int J Chron Obstruct Pulmon Dis, V4, P233; Louten J, 2009, J ALLERGY CLIN IMMUN, V123, P1004, DOI 10.1016/j.jaci.2009.04.003; Mak JCW, 2008, INT J TUBERC LUNG D, V12, P368; Makris D, 2008, CHEST, V134, P483, DOI 10.1378/chest.07-2626; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Marciniak SJ, 2009, THORAX, V64, P359, DOI 10.1136/thx.2008.099408; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; Matzinger P, 2007, NAT IMMUNOL, V8, P11, DOI 10.1038/ni0107-11; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murawski MR, 2009, J VIROL, V83, P1492, DOI 10.1128/JVI.00671-08; Muroski ME, 2008, CURR PHARM BIOTECHNO, V9, P34; Murphy TF, 2006, CURR OPIN INFECT DIS, V19, P225, DOI 10.1097/01.qco.0000224815.89363.15; Nseir S, 2008, CURR OPIN PULM MED, V14, P95, DOI 10.1097/MCP.0b013e3282f37a11; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; OCONNOR BJ, 2007, EUR RESP J S51, V30, P1294; Olszewska W, 2009, EXPERT OPIN EMERG DR, V14, P207, DOI 10.1517/14728210902946399; Owen Caroline A, 2008, Int J Chron Obstruct Pulmon Dis, V3, P253; Papi A, 2007, CURR OPIN PHARMACOL, V7, P259, DOI 10.1016/j.coph.2006.11.015; Patel IS, 2003, EUR RESPIR J, V22, P94, DOI 10.1183/09031936.03.00093703; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Paul-Clark MJ, 2009, AM J RESP CRIT CARE, V179, P299, DOI 10.1164/rccm.200707-1019OC; Paul-Pletzer K, 2006, DRUG TODAY, V42, P559, DOI 10.1358/dot.2006.42.9.1025692; Prause O, 2009, PULM PHARMACOL THER, V22, P199, DOI 10.1016/j.pupt.2008.12.005; Presicce P, 2009, J LEUKOCYTE BIOL, V86, P941, DOI 10.1189/jlb.0708412; Quon BS, 2008, CHEST, V133, P756, DOI 10.1378/chest.07-1207; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Ramaswamy M, 2009, COPD, V6, P64, DOI 10.1080/15412550902724024; Raymond Tracy, 2007, Proc Am Thorac Soc, V4, P635, DOI 10.1513/pats.200706-067TH; Rennard SI, 2006, CHEST, V129, P56, DOI 10.1378/chest.129.1.56; Rennard SI, 2007, AM J RESP CRIT CARE, V175, P926, DOI 10.1164/rccm.200607-995OC; Rogers DF, 2007, RESP CARE, V52, P1176; Rohde Gernot, 2009, Infectious Disorders - Drug Targets, V9, P126; Roth MD, 2006, CHEST, V130, P1334, DOI 10.1378/chest.130.5.1334; Sarir H, 2008, EUR J PHARMACOL, V585, P346, DOI 10.1016/j.ejphar.2008.03.009; Scotton CJ, 2007, CHEST, V132, P1311, DOI 10.1378/chest.06-2568; Seemungal TAR, 2009, COPD, V6, P79, DOI 10.1080/15412550902806011; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Sethi S, 2006, AM J RESP CRIT CARE, V173, P991, DOI 10.1164/rccm.200509-1525OC; Sikkel MB, 2008, PEDIATR INFECT DIS J, V27, pS63, DOI 10.1097/INF.0b013e3181684d67; Silverman Edwin K, 2007, Proc Am Thorac Soc, V4, P586, DOI 10.1513/pats.200706-068TH; Soyseth V, 2007, EUR RESPIR J, V29, P279, DOI 10.1183/09031936.00106406; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; Sykes Annemarie, 2007, Proc Am Thorac Soc, V4, P642, DOI 10.1513/pats.200707-101TH; Tamaoki J, 2004, AM J MED, V117, P5, DOI 10.1016/j.amjmed.2004.07.023; Taraseviciene-Stewart L, 2008, J CLIN INVEST, V118, P394, DOI 10.1172/JCI31811; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), GUID IND CHRON OBSTR; van der Strate BWA, 2006, AM J RESP CRIT CARE, V173, P751, DOI 10.1164/rccm.200504-594OC; van Gestel YRBM, 2008, AM J CARDIOL, V102, P192, DOI 10.1016/j.amjcard.2008.03.038; Varkey JB, 2008, CURR OPIN PULM MED, V14, P89, DOI 10.1097/MCP.0b013e3282f4a99f; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wenzel SE, 2009, AM J RESP CRIT CARE, V179, P549, DOI 10.1164/rccm.200809-1512OC; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007; Wilson MS, 2009, MUCOSAL IMMUNOL, V2, P103, DOI 10.1038/mi.2008.85; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC; Xie XH, 2009, PEDIATR RES, V65, P156, DOI 10.1203/PDR.0b013e318191f5c6; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang IA, 2003, GENES IMMUN, V4, P269, DOI 10.1038/sj.gene.6363961; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR; Zheng JP, 2008, LANCET, V371, P2013, DOI 10.1016/S0140-6736(08)60869-7; Zhu L, 2009, AM J RESP CELL MOL, V40, P610, DOI 10.1165/rcmb.2008-0223OC	146	74	80	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					744	755		10.1016/S0140-6736(09)61342-8	http://dx.doi.org/10.1016/S0140-6736(09)61342-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716967				2022-12-28	WOS:000269422500031
J	Angelo, G; Van Gilst, MR				Angelo, Giana; Van Gilst, Marc R.			Starvation Protects Germline Stem Cells and Extends Reproductive Longevity in C-elegans	SCIENCE			English	Article							LIFE-SPAN EXTENSION; CAENORHABDITIS-ELEGANS; EMBRYONIC DIAPAUSE; RECEPTOR NHR-49; DROSOPHILA; RESTRICTION; GENETICS; HYPOXIA; DEATH	The study of starvation-resistant biological programs has elucidated numerous mechanisms influencing aging. Here we present the discovery and characterization of starvation-induced adult reproductive diapause (ARD) in Caenorhabditis elegans. ARD differs from the C. elegans dauer diapause in that it enables sexually mature adults to delay reproductive onset 15-fold and extend total adult life span at least threefold. The effectiveness of ARD requires apoptotic death of the entire germ line, except for a small population of protected germline stem cells (GSCs). When feeding is resumed, surviving GSCs regenerate a new germ line capable of offspring production near the level of nonstarved animals. The starvation-sensing nuclear receptor NHR-49 is required for ARD entry and recovery. Our findings establish mechanisms for preserving stem cell potency and reproductive potential during prolonged starvation.	[Angelo, Giana; Van Gilst, Marc R.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Van Gilst, MR (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	vangilst@fhcrc.org			NIH [GM080895-02, RDK079273A]; American Diabetes Association Junior Investigator Award [1-07-JF-72]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080895] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Junior Investigator Award(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Priess and B. Edgar for critical reading of the manuscript; J. Kimble and L. Jones for helpful suggestions; the Priess lab for materials and equipment; and the Van Gilst, Priess, and Roth laboratories for helpful discussions and feedback. G. A. is funded by a Ruth Kirchstein postdoctoral fellowship from NIH (GM080895-02). This work was also funded by an American Diabetes Association Junior Investigator Award ( ADA 1-07-JF-72)and by a grant from NIH (RDK079273A).	Aballay A, 2001, P NATL ACAD SCI USA, V98, P2735, DOI 10.1073/pnas.041613098; Chen JJ, 2004, J NEMATOL, V36, P107; Crittenden SL, 2006, MOL BIOL CELL, V17, P3051, DOI 10.1091/mbc.E06-03-0170; Cypser JR, 2006, EXP GERONTOL, V41, P935, DOI 10.1016/j.exger.2006.09.004; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; HUANG HFS, 1979, BIOL REPROD, V21, P891, DOI 10.1095/biolreprod21.4.891; JOHNSON TE, 1984, MECH AGEING DEV, V28, P23, DOI 10.1016/0047-6374(84)90150-7; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Mair W, 2008, ANNU REV BIOCHEM, V77, P727, DOI 10.1146/annurev.biochem.77.061206.171059; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Renfree MB, 2000, ANNU REV PHYSIOL, V62, P353, DOI 10.1146/annurev.physiol.62.1.353; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Riddle DL, 1997, C ELEGANS, P739; Salinas LS, 2006, CELL DEATH DIFFER, V13, P2129, DOI 10.1038/sj.cdd.4401976; Selesniemi K, 2008, AGING CELL, V7, P622, DOI 10.1111/j.1474-9726.2008.00409.x; Tatar M, 2001, EXP GERONTOL, V36, P723, DOI 10.1016/S0531-5565(00)00238-2; Tavaluc RT, 2007, CELL CYCLE, V6, P2554, DOI 10.4161/cc.6.20.4911; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011	27	185	192	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 13	2009	326	5955					954	958		10.1126/science.1178343	http://dx.doi.org/10.1126/science.1178343			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	518SB	19713489				2022-12-28	WOS:000271712300027
J	Parkin, PC; Maguire, JL				Parkin, Patricia C.; Maguire, Jonathon L.			Clinically important head injuries after head trauma in children	LANCET			English	Editorial Material							PREDICTION RULES; METHODOLOGICAL STANDARDS; DECISION RULES; MEDICINE		[Parkin, Patricia C.; Maguire, Jonathon L.] Hosp Sick Children, Div Pediat Med, Toronto, ON M5G 1X8, Canada; [Parkin, Patricia C.; Maguire, Jonathon L.] Hosp Sick Children, Pediat Outcomes Res Team, Toronto, ON M5G 1X8, Canada; [Parkin, Patricia C.; Maguire, Jonathon L.] Dept Pediat, Toronto, ON, Canada; [Parkin, Patricia C.] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Parkin, Patricia C.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Maguire, Jonathon L.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Parkin, PC (corresponding author), Hosp Sick Children, Div Pediat Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	patricia.parkin@sickkids.ca						Gill CJ, 2005, BRIT MED J, V330, P1080, DOI 10.1136/bmj.330.7499.1080; Guyatt G, 2004, BRIT MED J, V329, P990, DOI 10.1136/bmj.329.7473.990; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Maguire JL, 2009, PEDIATRICS, V124, pE145, DOI 10.1542/peds.2009-0075; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; O'Connor AM, 2003, BMJ-BRIT MED J, V327, P736, DOI 10.1136/bmj.327.7417.736; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Stiell IG, 1999, ANN EMERG MED, V33, P437, DOI 10.1016/S0196-0644(99)70309-4; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306	10	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 3	2009	374	9696					1127	1129		10.1016/S0140-6736(09)61634-2	http://dx.doi.org/10.1016/S0140-6736(09)61634-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505IZ	19758693				2022-12-28	WOS:000270688200008
J	Rajakulendran, T; Sahmi, M; Lefrancois, M; Sicheri, F; Therrien, M				Rajakulendran, Thanashan; Sahmi, Malha; Lefrancois, Martin; Sicheri, Frank; Therrien, Marc			A dimerization-dependent mechanism drives RAF catalytic activation	NATURE			English	Article							B-RAF; SIGNALING PATHWAY; ONCOGENIC BRAF; HUMAN CANCER; KINASE; PROTEIN; HETERODIMERIZATION; DOMAIN; INHIBITORS; DROSOPHILA	The ERK (extracellular signal-regulated kinase) pathway is an evolutionarily conserved signal transduction module that controls cellular growth, differentiation and survival(1). Activation of receptor tyrosine kinases (RTKs) by the binding of growth factors initiates GTP loading of RAS, which triggers the initial steps in the activation of the ERK pathway by modulating RAF family kinase function. Once activated, RAF participates in a sequential cascade of phosphorylation events that activate MEK, and in turn ERK. Unbridled signalling through the ERK pathway caused by activating mutations in RTKs, RAS or RAF has been linked to several human cancers(2). Of note, one member of the RAF family, BRAF, is the most frequently mutated oncogene in the kinase superfamily(3). Not surprisingly, there has been a colossal effort to understand the underlying regulation of this family of kinases. In particular, the process by which the RAF kinase domain becomes activated towards its substrate MEK remains of topical interest. Here, using Drosophila Schneider S2 cells, we demonstrate that RAF catalytic function is regulated in response to a specific mode of dimerization of its kinase domain, which we term the side-to-side dimer. Moreover, we find that the RAF-related pseudo-kinase KSR ( kinase suppressor of Ras) also participates in forming side-to-side heterodimers with RAF and can thereby trigger RAF activation. This mechanism provides an elegant explanation for the longstanding conundrumabout RAF catalytic activation, and also provides an explanation for the capacity of KSR, despite lacking catalytic function, to directly mediate RAF activation. We also show that RAF side-to-side dimer formation is essential for aberrant signalling by oncogenic BRAF mutants, and identify an oncogenic mutation that acts specifically by promoting side-to-side dimerization. Together, our data identify the side-to-side dimer interface of RAF as a potential therapeutic target for intervention in BRAF-dependent tumorigenesis.	[Rajakulendran, Thanashan; Sicheri, Frank] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Rajakulendran, Thanashan; Sicheri, Frank] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Sahmi, Malha; Lefrancois, Martin; Therrien, Marc] Univ Montreal, Inst Res Immunol & Canc, Lab Intracellular Signaling, Montreal, PQ H3C 3J7, Canada; [Therrien, Marc] Univ Montreal, Dept Pathol & Biol Cellular, Montreal, PQ H3C 3J7, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Universite de Montreal; Universite de Montreal	Sicheri, F (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	sicheri@lunenfeld.ca; marc.therrien@umontreal.ca	Sicheri, Frank/F-8856-2013		Canadian Institutes for Health Research [MOP-36399]; Canadian Cancer Society [018046]; Research Fellow of The Terry Fox Foundation [019684]; National Cancer Institute of Canada Scientist award; Canada Research Chair	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Research Fellow of The Terry Fox Foundation; National Cancer Institute of Canada Scientist award; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	We thank members of the F. S. and M. T. laboratories for advice and discussions. We are also grateful to R. Lambert and IRIC genomic platform for conducting qPCR reactions. This work was supported by grants from the Canadian Institutes for Health Research to F. S. (MOP-36399) and from the Canadian Cancer Society to M. T. ( Award 018046). T. R. is a Research Fellow of The Terry Fox Foundation ( Award 019684). F. S. is a recipient of a National Cancer Institute of Canada Scientist award, and M. T. is a Canada Research Chair ( Tier II) in Intracellular Signaling.	Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Douziech M, 2006, GENE DEV, V20, P807, DOI 10.1101/gad.1390406; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Halilovic E, 2008, CURR OPIN PHARMACOL, V8, P419, DOI 10.1016/j.coph.2008.06.014; Hansen JD, 2008, BIOORG MED CHEM LETT, V18, P4692, DOI 10.1016/j.bmcl.2008.07.002; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Muthuswamy SK, 1999, MOL CELL BIOL, V19, P6845; Ritt DA, 2007, CURR BIOL, V17, P179, DOI 10.1016/j.cub.2006.11.061; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roignant JY, 2006, GENE DEV, V20, P795, DOI 10.1101/gad.1390506; Roy F, 2002, GENE DEV, V16, P427, DOI 10.1101/gad.962902; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	25	328	335	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					542	U114		10.1038/nature08314	http://dx.doi.org/10.1038/nature08314			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19727074				2022-12-28	WOS:000270082900044
J	Patton, GC; Coffey, C; Sawyer, SM; Viner, RM; Haller, DM; Bose, K; Vos, T; Ferguson, J; Mathers, CD				Patton, George C.; Coffey, Carolyn; Sawyer, Susan M.; Viner, Russell M.; Haller, Dagmar M.; Bose, Krishna; Vos, Theo; Ferguson, Jane; Mathers, Colin D.			Global patterns of mortality in young people: a systematic analysis of population health data	LANCET			English	Article							ADOLESCENT HEALTH; ADULT MORTALITY; TRENDS; HOMICIDE; BURDEN; DEATHS; COUNTS; FATALITIES; SUICIDES; ALCOHOL	Background Pronounced changes in patterns of health take place in adolescence and young adulthood, but the effects on mortality patterns worldwide have not been reported. We analysed worldwide rates and patterns of mortality between early adolescence and young adulthood. Methods We obtained data from the 2004 Global Burden of Disease Study, and used all-cause mortality estimates developed for the 2006 World Health Report, with adjustments for revisions in death from HIV/AIDS and from war and natural disasters. Data for cause of death were derived from national vital registration when available; for other countries we used sample registration data, verbal autopsy, and disease surveillance data to model causes of death. Worldwide rates and patterns of mortality were investigated by WHO region, income status, and cause in age-groups of 10-14 years, 15-19 years, and 20-24 years. Findings 2.6 million deaths occurred in people aged 10-24 years in 2004. 2.56 million (97%) of these deaths were in low-income and middle-income countries, and almost two thirds (1.67 million) were in sub-Saharan Africa and southeast Asia. Pronounced rises in mortality rates were recorded from early adolescence (10-14 years) to young adulthood (20-24 years), but reasons varied by region and sex. Maternal conditions were a leading cause of female deaths at 15%. HIV/AIDS and tuberculosis contributed to 11% of deaths. Traffic accidents were the largest cause and accounted for 14% of male and 5% of female deaths. Other prominent causes included violence (12% of male deaths) and suicide (6% of all deaths). Interpretation Present global priorities for adolescent health policy, which focus on HIV/AIDS and maternal mortality, are an important but insufficient response to prevent mortality in an age-group in which more than two in five deaths are due to intentional and unintentional injuries.	[Patton, George C.; Coffey, Carolyn; Sawyer, Susan M.] Royal Childrens Hosp, Ctr Adolescent Hlth, Parkville, Vic 3052, Australia; [Patton, George C.; Coffey, Carolyn; Sawyer, Susan M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Patton, George C.; Sawyer, Susan M.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Viner, Russell M.] UCL, Inst Child Hlth, London, England; [Haller, Dagmar M.] Univ Geneva, Dept Community Med & Primary Care, Geneva, Switzerland; [Bose, Krishna; Ferguson, Jane] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland; [Vos, Theo] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Mathers, Colin D.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of London; University College London; University of Geneva; University of Geneva; World Health Organization; University of Queensland; World Health Organization	Patton, GC (corresponding author), Royal Childrens Hosp, Ctr Adolescent Hlth, 2 Gatehouse St, Parkville, Vic 3052, Australia.	george.patton@rch.org.au	Vos, Theo/F-3324-2010; Haller, Dagmar M./AAA-5078-2021; Patton, George C/B-5246-2013; Ribeiro, Ana Cristina/HHN-7466-2022; Viner, Russell/A-1441-2009	Patton, George C/0000-0001-5039-8326; Ribeiro, Ana Cristina/0000-0002-0493-8376; Haller, Dagmar/0000-0003-1781-3318; Viner, Russell/0000-0003-3047-2247; Mathers, Colin/0000-0002-0617-6731	WHO; National Health and Medical Research Council	WHO(World Health Organization); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The age disaggregation of the Global Burden of Disease data was supported with funds from WHO. GCP is supported by a Senior Principal Research Fellowship from the National Health and Medical Research Council. We thank Professor John Carlin for his comments on an early version of the analysis.	Aaron R, 2004, LANCET, V363, P1117, DOI 10.1016/S0140-6736(04)15896-0; AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Ahmed N, 2000, PUBLIC HEALTH, V114, P416, DOI 10.1016/S0033-3506(00)00376-0; Ambade VN, 2006, BURNS, V32, P902, DOI 10.1016/j.burns.2006.03.001; [Anonymous], POPULATION STUDIES; Banister J, 2004, POP STUD-J DEMOG, V58, P55, DOI 10.1080/0032472032000183753; Batra AK, 2003, BURNS, V29, P270, DOI 10.1016/S0305-4179(02)00306-6; Beaglehole Robert, 2004, PUBLIC HLTH CROSSROA; Bearinger LH, 2007, LANCET, V369, P1220, DOI 10.1016/S0140-6736(07)60367-5; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Blum RW, 2004, J ADOLESCENT HEALTH, V35, P402, DOI [10.1016/j.jadohealth.2003.10.007, 10.1016/S1054-139X(03)00537-8]; BOERMA JT, 1994, DHS METHODOLOGICAL R, P145; Borrell C, 2001, J EPIDEMIOL COMMUN H, V55, P577, DOI 10.1136/jech.55.8.577; Branche C., 2008, WORLD REPORT CHILD I; Briceno-Leon R, 2008, INT J EPIDEMIOL, V37, P751, DOI 10.1093/ije/dyn153; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Bye EK, 2008, HOMICIDE STUD, V12, P7, DOI 10.1177/1088767907310851; Caldwell JC, 2001, B WORLD HEALTH ORGAN, V79, P159; Chandramohan D, 2008, PLOS MED, V5, P169, DOI 10.1371/journal.pmed.0050057; Chapman G, 2006, TROP MED INT HEALTH, V11, P660, DOI 10.1111/j.1365-3156.2006.01601.x; Duke L, 2002, J INVERTEBR PATHOL, V80, P1, DOI 10.1016/S0022-2011(02)00040-X; Falbo GH, 2001, B WORLD HEALTH ORGAN, V79, P2; Gluckman PD, 2006, TRENDS ENDOCRIN MET, V17, P7, DOI 10.1016/j.tem.2005.11.006; GOODBURN EA, 2008, HLTH POLICY PLAN, V15, P137; Hill K, 2007, LANCET, V370, P1726, DOI 10.1016/S0140-6736(07)61309-9; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Kanchan Tanuj, 2008, J Forensic Leg Med, V15, P7, DOI 10.1016/j.jflm.2007.05.006; Karkhaneh M, 2006, INJURY PREV, V12, P76, DOI 10.1136/ip.2005.010942; Kleinert S, 2007, LANCET, V369, P1057, DOI 10.1016/S0140-6736(07)60374-2; Kopits E, 2005, ACCIDENT ANAL PREV, V37, P169, DOI 10.1016/j.aap.2004.04.006; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Lopez A, 2008, LANCET, V372, P1525, DOI 10.1016/S0140-6736(08)61632-3; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P399; McKee M, 2001, BRIT MED J, V323, P1051, DOI 10.1136/bmj.323.7320.1051; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nemtsov A, 2003, DRUG ALCOHOL DEPEN, V71, P161, DOI 10.1016/S0376-8716(03)00094-2; Pan SY, 2007, J ADOLESCENT HEALTH, V41, P84, DOI 10.1016/j.jadohealth.2007.02.011; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Patton GC, 2007, LANCET, V369, P1130, DOI 10.1016/S0140-6736(07)60366-3; Pridemore WA, 2007, BRIT J CRIMINOL, V47, P331, DOI 10.1093/bjc/azl029; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Schlueter V, 2004, EUR J EPIDEMIOL, V19, P291, DOI 10.1023/B:EJEP.0000024673.93494.2e; Sedgh G, 2007, LANCET, V370, P1338, DOI 10.1016/S0140-6736(07)61575-X; Sells CW, 1996, AM J PUBLIC HEALTH, V86, P513, DOI 10.2105/AJPH.86.4.513; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Singh GK, 1996, AM J PUBLIC HEALTH, V86, P560, DOI 10.2105/AJPH.86.4.560; Stuckler D, 2008, LANCET, V372, P1563, DOI 10.1016/S0140-6736(08)61656-6; Wang SY, 2008, LANCET, V372, P1765, DOI 10.1016/S0140-6736(08)61367-7; *WORLD BANK, 2006, WORLD DEV REP 2004 E; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Yang Gonghuan, 2005, Popul Health Metr, V3, P3, DOI 10.1186/1478-7954-3-3; Yang L, 2007, INJURY PREV, V13, P178, DOI 10.1136/ip.2006.013409	56	696	721	4	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					881	892		10.1016/S0140-6736(09)60741-8	http://dx.doi.org/10.1016/S0140-6736(09)60741-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19748397				2022-12-28	WOS:000269943100027
J	Gonzalez, J; Petrov, D				Gonzalez, Josefa; Petrov, Dmitri			MITEs-The Ultimate Parasites	SCIENCE			English	Editorial Material							ELEMENTS		[Gonzalez, Josefa; Petrov, Dmitri] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Gonzalez, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.			/0000-0001-9824-027X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077368] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 077368] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashburner M., 2004, DROSOPHILA LAB HDB; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; DEMORGAN A, 1915, BUDGET PARADOXES, V2; Feschotte C, 2003, GENETICS, V163, P747; Feschotte C, 2002, MOBILE DNA-UK, P1147, DOI DOI 10.1128/9781555817954.CH50; Hart DL, 1997, ANNU REV GENET, V31, P337, DOI 10.1146/annurev.genet.31.1.337; LEVIS RW, 1993, CELL, V75, P1083, DOI 10.1016/0092-8674(93)90318-K; Yang GJ, 2006, PLANT CELL, V18, P2469, DOI 10.1105/tpc.106.045906; Yang GJ, 2009, SCIENCE, V325, P1391, DOI 10.1126/science.1175688	9	16	16	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1352	1353		10.1126/science.1179556	http://dx.doi.org/10.1126/science.1179556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745141				2022-12-28	WOS:000269699100025
J	Moglia, A; Pietrabissa, A; Cuschieri, A				Moglia, Andrea; Pietrabissa, Andrea; Cuschieri, Alfred			Science, medicine, and the future Capsule endoscopy	BRITISH MEDICAL JOURNAL			English	Review							PILLCAM COLON CAPSULE; DIAGNOSTIC MODALITIES; COLORECTAL-CANCER; CELIAC-DISEASE; METAANALYSIS; YIELD; ENTEROSCOPY; PATHOLOGY; TRIAL		[Moglia, Andrea; Pietrabissa, Andrea] Univ Pisa, Ctr Comp Assisted Surg, EndoCAS, I-56124 Pisa, Italy; [Pietrabissa, Andrea] Univ Pisa, Dept Oncol Transplantat & New Technol Med, I-56124 Pisa, Italy; [Cuschieri, Alfred] Univ Dundee, Inst Med Sci & Technol, Dundee DD2 1FD, Scotland; [Cuschieri, Alfred] Scuola Super St Anna Studi Univ, I-56127 Pisa, Italy	University of Pisa; University of Pisa; University of Dundee; Scuola Superiore Sant'Anna	Moglia, A (corresponding author), Univ Pisa, Ctr Comp Assisted Surg, EndoCAS, I-56124 Pisa, Italy.	andrea.moglia@endocas.org	Pietrabissa, Andrea/AAC-9894-2019; Moglia, Andrea/Y-5433-2018	Pietrabissa, Andrea/0000-0001-9703-7587; Moglia, Andrea/0000-0002-3365-580X				Appleyard M, 2001, NEW ENGL J MED, V344, P232, DOI 10.1056/NEJM200101183440316; Bang S, 2009, GASTROINTEST ENDOSC, V69, P253, DOI 10.1016/j.gie.2008.04.033; Culliford A, 2005, GASTROINTEST ENDOSC, V62, P55, DOI 10.1016/S0016-5107(05)01566-X; Daum S, 2007, ENDOSCOPY, V39, P455, DOI 10.1055/s-2007-966239; Eliakim R, 2006, ENDOSCOPY, V38, P963, DOI 10.1055/s-2006-944832; ELMATARY W, 2009, J LAPAROENDOSC  0430; Galmiche JP, 2008, GUT, V57, P695, DOI 10.1136/gut.2007.127852; GETTMAN MT, 2009, EUR UROL        0205; Hassan C, 2008, ENDOSCOPY, V40, P414, DOI 10.1055/s-2007-995565; Iddan Gavriel J, 2004, Gastrointest Endosc Clin N Am, V14, P1, DOI 10.1016/j.giec.2003.10.022; Liao Z, 2009, GASTROINTEST ENDOSC, V69, P418, DOI 10.1016/j.gie.2008.06.051; Lu Y, 2009, WORLD J GASTROENTERO, V15, P1254, DOI 10.3748/wjg.15.1254; Mishkin DS, 2006, GASTROINTEST ENDOSC, V63, P539, DOI 10.1016/j.gie.2006.01.014; Moglia Andrea, 2008, Recent Patents on Biomedical Engineering, V1, P24, DOI 10.2174/1874764710801010024; Moglia A, 2007, LANCET, V370, P114, DOI 10.1016/S0140-6736(07)61066-6; *NIH CLIN EXC, 2004, WIR CAPS END INV SMA; Pasha SF, 2008, CLIN GASTROENTEROL H, V6, P671, DOI 10.1016/j.cgh.2008.01.005; Pennazio M, 2006, DIGEST LIVER DIS, V38, P867, DOI 10.1016/j.dld.2006.09.007; Rey JF, 2004, ENDOSCOPY, V36, P656, DOI 10.1055/s-2004-814557; Rondonotti E, 2005, GASTROINTEST ENDOSC, V62, P712, DOI 10.1016/j.gie.2005.05.002; Rubenstein JH, 2007, CLIN GASTROENTEROL H, V5, P312, DOI 10.1016/j.cgh.2006.12.008; Scapa E, 2002, AM J GASTROENTEROL, V97, P2776, DOI 10.1111/j.1572-0241.2002.07021.x; Schoofs N, 2006, ENDOSCOPY, V38, P971, DOI 10.1055/s-2006-944835; Sidhu R, 2008, GUT, V57, P125, DOI 10.1136/gut.2007.129999; Sieg A, 2009, AM J GASTROENTEROL, V104, P848, DOI 10.1038/ajg.2008.163; Somsouk V, 2008, CLIN GASTROENTEROL H, V6, P661, DOI 10.1016/j.cgh.2008.02.033; Swain P, 2008, WORLD J GASTROENTERO, V14, P4142, DOI 10.3748/wjg.14.4142; Triester SL, 2005, AM J GASTROENTEROL, V100, P2407, DOI 10.1111/j.1572-0241.2005.00274.x; Triester SL, 2006, AM J GASTROENTEROL, V101, P954, DOI 10.1111/j.1572-0241.2006.00506.x	29	6	6	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 11	2009	339								b3420	10.1136/bmj.b3420	http://dx.doi.org/10.1136/bmj.b3420			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	493RG	19748970				2022-12-28	WOS:000269755000001
J	Chen, YP; Bord, E; Tompkins, T; Miller, J; Tan, CS; Kinkel, RP; Stein, MC; Viscidi, RP; Ngo, LH; Koralnik, IJ				Chen, Yiping; Bord, Evelyn; Tompkins, Troy; Miller, Janice; Tan, Chen S.; Kinkel, R. Philip; Stein, Marion C.; Viscidi, Raphael P.; Ngo, Long H.; Koralnik, Igor J.			Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; CYTOTOXIC T-LYMPHOCYTES; BK-VIRUS; MULTIPLE-SCLEROSIS; REGULATORY REGION; PERIPHERAL-BLOOD; VIRAL LATENCY; DNA; EPITOPE; ASSOCIATION	BACKGROUND Progressive multifocal leukoencephalopathy (PML) occurs in a fraction of patients with multiple sclerosis who were treated with natalizumab. Most adults who are infected with the JC virus, the etiologic agent in PML, do not have symptoms. We sought to determine whether exposure to natalizumab causes subclinical reactivation and neurotropic transformation of JC virus. METHODS We followed 19 consecutive patients with multiple sclerosis who were treated with natalizumab over an 18-month period, performing quantitative polymerase-chainreaction assays in blood and urine for JC virus reactivation; BK virus, a JC virus-related polyomavirus, was used as a control. We determined JC virus-specific T-cell responses by means of an enzyme-linked immunospot assay and antibody responses by means of an enzyme-linked immunosorbent assay and analyzed JC virus regulatory-region sequences. RESULTS After 12 months of natalizumab therapy, the prevalence of JC virus in the urine of the 19 patients increased from a baseline value of 19% to 63% (P = 0.02). After 18 months of treatment, JC virus was detectable in 3 of 15 available plasma samples (20%) and in 9 of 15 available samples of peripheral-blood mononuclear cells (60%) (P = 0.02). JC virus regulatory-region sequences in blood samples and in most of the urine samples were similar to those usually found in PML. Conversely, BK virus remained stable in urine and was undetectable in blood. The JC virus-specific cellular immune response dropped significantly between 6 and 12 months of treatment, and variations in the cellular immune response over time tended to be greater in patients in whom JC viremia developed. None of the patients had clinical or radiologic signs of PML. CONCLUSIONS Subclinical reactivation of JC virus occurs frequently in natalizumab-treated patients with multiple sclerosis. Viral shedding is associated with a transient drop in the JC virus-specific cellular immune response.	[Chen, Yiping; Bord, Evelyn; Tompkins, Troy; Miller, Janice; Tan, Chen S.; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Tan, Chen S.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Kinkel, R. Philip; Stein, Marion C.; Koralnik, Igor J.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; [Ngo, Long H.] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; [Viscidi, Raphael P.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Johns Hopkins University	Koralnik, IJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, E-CLS 1005,330 Brookline Ave, Boston, MA 02215 USA.	ikoralni@bidmc.harvard.edu		Viscidi, Raphael/0000-0002-7906-8002	National Institutes of Health [R01 NS 041198, R01 NS 047029, K24 NS 060950]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047029, K08NS064215, K24NS060950, R01NS041198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by grants from the National Institutes of Health (R01 NS 041198 and R01 NS 047029, and K24 NS 060950 [to Dr. Koralnik]).	ARTHUR RR, 1989, J CLIN MICROBIOL, V27, P1174, DOI 10.1128/JCM.27.6.1174-1179.1989; Berger JR, 2005, NEW ENGL J MED, V353, P414, DOI 10.1056/NEJMe058122; Chen YP, 2006, J VIROL, V80, P3495, DOI 10.1128/JVI.80.7.3495-3505.2006; Du Pasquier RA, 2004, BRAIN, V127, P1970, DOI 10.1093/brain/awh215; Du Pasquier RA, 2003, J VIROL, V77, P11918, DOI 10.1128/JVI.77.22.11918-11926.2003; Du Pasquier RA, 2006, J NEUROIMMUNOL, V176, P181, DOI 10.1016/j.jneuroim.2006.04.003; Dubois V, 1997, J CLIN MICROBIOL, V35, P2288, DOI 10.1128/JCM.35.9.2288-2292.1997; *FDA MEDWATCH, 2008, TYS NAT 2 NEW CAS PR; FOX M, 2008, MS DRUG TYSABRI MAY; Gasnault J, 2003, AIDS, V17, P1443, DOI 10.1097/00002030-200307040-00004; JEFFREY S, 2008, NEW CASE PML NATALIZ; Jensen PN, 2001, J NEUROVIROL, V7, P280; KITAMURA T, 1990, J INFECT DIS, V161, P1128, DOI 10.1093/infdis/161.6.1128; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Koralnik IJ, 2002, J IMMUNOL, V168, P499, DOI 10.4049/jimmunol.168.1.499; Koralnik IJ, 1999, NEUROLOGY, V52, P253, DOI 10.1212/WNL.52.2.253; Krymskaya L, 2005, J VIROL, V79, P11170, DOI 10.1128/JVI.79.17.11170-11178.2005; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Letvin NL, 2007, J VIROL, V81, P12368, DOI 10.1128/JVI.00822-07; Lima MA, 2007, J VIROL, V81, P3361, DOI 10.1128/JVI.01809-06; MARKOWITZ RB, 1993, J INFECT DIS, V167, P13, DOI 10.1093/infdis/167.1.13; Monaco MCG, 1996, J VIROL, V70, P7004, DOI 10.1128/JVI.70.10.7004-7012.1996; Monao MCG, 1998, J VIROL, V72, P9918, DOI 10.1128/JVI.72.12.9918-9923.1998; Pfister LA, 2001, J VIROL, V75, P5672, DOI 10.1128/JVI.75.12.5672-5676.2001; PUCCIO L, 2008, 60 ANN M AM AC NEUR, P2; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Ransohoff RM, 2005, NAT NEUROSCI, V8, P1275, DOI 10.1038/nn1005-1275; Rollison DE, 2006, CANCER EPIDEM BIOMAR, V15, P543, DOI 10.1158/1055-9965.EPI-05-0728; Ryschkewitsch C, 2004, J VIROL METHODS, V121, P217, DOI 10.1016/j.jviromet.2004.06.021; SAS Institute, 2003, SAS STAT SOFTW VERS; Tan CS, 2009, J INFECT DIS, V199, P881, DOI 10.1086/597117; TORNATORE C, 1992, ANN NEUROL, V31, P454, DOI 10.1002/ana.410310426; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Viscidi RP, 2003, CLIN DIAGN LAB IMMUN, V10, P278, DOI 10.1128/CDLI.10.2.278-285.2003; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693; TYSABRI UPDATE	36	171	175	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1067	1074		10.1056/NEJMoa0904267	http://dx.doi.org/10.1056/NEJMoa0904267			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19741227	Green Accepted, Bronze			2022-12-28	WOS:000269659400009
J	Hand, E				Hand, Eric			Cash crisis could ground NASA rocket	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					153	153		10.1038/461153a	http://dx.doi.org/10.1038/461153a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741672	Bronze			2022-12-28	WOS:000269654600004
J	Synolakis, C; Foteinis, S				Synolakis, Costas; Foteinis, Spyros			Choking on carbon emissions from Greek academic paperwork	NATURE			English	Letter									[Synolakis, Costas] Univ So Calif, Viterbi Sch Engn, Los Angeles, CA 90089 USA; [Foteinis, Spyros] Tech Univ Crete, Lab Nat Hazards, Khania, Greece	University of Southern California; Technical University of Crete	Synolakis, C (corresponding author), Univ So Calif, Viterbi Sch Engn, Los Angeles, CA 90089 USA.	costas@usc.edu	Foteinis, Spyros/O-9203-2017; Synolakis, Costas E/B-3197-2008; Foteinis, Spyros/P-5713-2019	Foteinis, Spyros/0000-0003-1471-578X; Synolakis, Costas E/0000-0003-0140-5379; Foteinis, Spyros/0000-0003-1471-578X					0	3	3	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					167	167		10.1038/461167a	http://dx.doi.org/10.1038/461167a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741684	Bronze			2022-12-28	WOS:000269654600013
J	Turner, SL; Ray, A				Turner, Stephanie Lynn; Ray, Anandasankar			Modification of CO2 avoidance behaviour in Drosophila by inhibitory odorants	NATURE			English	Article							CARBON-DIOXIDE; RECEPTORS; BANANA; ETHYLENE; ANTENNA; FLIGHT; AROMA; LIFE	The fruitfly Drosophila melanogaster exhibits a robust and innate olfactory-based avoidance behaviour to CO2, a component of odour emitted from stressed flies(1). Specialized neurons in the antenna and a dedicated neuronal circuit in the higher olfactory system mediate CO2 detection and avoidance(1,2). However, fruitflies need to overcome this avoidance response in some environments that contain CO2 such as ripening fruits and fermenting yeast, which are essential food sources. Very little is known about the molecular and neuronal basis of this unique, context-dependent modification of innate olfactory avoidance behaviour. Here we identify a new class of odorants present in food that directly inhibit CO2-sensitive neurons in the antenna. Using an in vivo expression system we establish that the odorants act on the Gr21a/Gr63a CO2 receptor(3). The presence of these odorants significantly and specifically reduces CO2-mediated avoidance behaviour, as well as avoidance mediated by 'Drosophila stress odour'. We propose a model in which behavioural avoidance to CO2 is directly influenced by inhibitory interactions of the novel odours with CO2 receptors. Furthermore, we observe differences in the temporal dynamics of inhibition: the effect of one of these odorants lasts several minutes beyond the initial exposure. Notably, animals that have been briefly pre-exposed to this odorant do not respond to the CO2 avoidance cue even after the odorant is no longer present. We also show that related odorants are effective inhibitors of the CO2 response in Culex mosquitoes that transmit West Nile fever and filariasis. Our findings have broader implications in highlighting the important role of inhibitory odorants in olfactory coding, and in their potential to disrupt CO2-mediated host-seeking behaviour in disease-carrying insects like mosquitoes.	[Ray, Anandasankar] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Turner, Stephanie Lynn] Univ Calif Riverside, Cellular Mol & Dev Biol Program, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Ray, A (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	anand.ray@ucr.edu	Chen, Stephanie/G-3888-2010	Ray, Anandasankar/0000-0003-4133-2581				Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Carde RT, 1996, CIBA F SYMP, V200, P54; CARDE RT, 1996, CIBA F SYMP, V200, P66; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Cooperband MF, 2006, MED VET ENTOMOL, V20, P11, DOI 10.1111/j.1365-2915.2006.00613.x; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Faucher C, 2006, J EXP BIOL, V209, P2739, DOI 10.1242/jeb.02297; Fischler W, 2007, NATURE, V448, P1054, DOI 10.1038/nature06101; GALLIARD T, 1977, J SCI FOOD AGR, V28, P863, DOI 10.1002/jsfa.2740280915; Golding JB, 1998, POSTHARVEST BIOL TEC, V14, P87, DOI 10.1016/S0925-5214(98)00032-5; Golding JB, 1999, J AGR FOOD CHEM, V47, P1646, DOI 10.1021/jf980906c; Guerenstein PG, 2008, ANNU REV ENTOMOL, V53, P161, DOI 10.1146/annurev.ento.53.103106.093402; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2008, P NATL ACAD SCI USA, V105, P8038, DOI 10.1073/pnas.0707469105; Hughes P. S., 2001, BEER QUALITY SAFETY, P40; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Katz DB, 2008, J NEUROSCI, V28, P11802, DOI 10.1523/JNEUROSCI.3613-08.2008; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; MARTINEAU B, 1995, AM J ENOL VITICULT, V46, P385; Mayr D, 2003, INT J MASS SPECTROM, V223, P743, DOI 10.1016/S1387-3806(02)00967-3; NYKANEN L, 1991, VOLATILE COMPOUNDS F, P548; ROBERTSON HM, 2009, J INSECT SCI, V19, P1; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Suh GSB, 2007, CURR BIOL, V17, P905, DOI 10.1016/j.cub.2007.04.046; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	29	136	145	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					277	U159		10.1038/nature08295	http://dx.doi.org/10.1038/nature08295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19710651				2022-12-28	WOS:000269654600047
J	Wallentin, L; Becker, RC; Budaj, A; Cannon, CP; Emanuelsson, H; Held, C; Horrow, J; Husted, S; James, S; Katus, H; Mahaffey, KW; Scirica, BM; Skene, A; Steg, PG; Storey, RF; Harrington, RA				Wallentin, Lars; Becker, Richard C.; Budaj, Andrzej; Cannon, Christopher P.; Emanuelsson, Hakan; Held, Claes; Horrow, Jay; Husted, Steen; James, Stefan; Katus, Hugo; Mahaffey, Kenneth W.; Scirica, Benjamin M.; Skene, Allan; Steg, Philippe Gabriel; Storey, Robert F.; Harrington, Robert A.		PLATO Investigators	Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; P2Y(12) RECEPTOR ANTAGONIST; PRASUGREL ACHIEVES GREATER; ASPIRIN-TREATED PATIENTS; PLATELET-AGGREGATION; EUROPEAN-SOCIETY; TASK-FORCE; LONG-TERM; INHIBITION; THERAPY	BACKGROUND Ticagrelor is an oral, reversible, direct-acting inhibitor of the adenosine diphosphate receptor P2Y12 that has a more rapid onset and more pronounced platelet inhibition than clopidogrel. METHODS In this multicenter, double-blind, randomized trial, we compared ticagrelor (180-mg loading dose, 90 mg twice daily thereafter) and clopidogrel (300-to-600-mg loading dose, 75 mg daily thereafter) for the prevention of cardiovascular events in 18,624 patients admitted to the hospital with an acute coronary syndrome, with or without ST-segment elevation. RESULTS At 12 months, the primary end point - a composite of death from vascular causes, myocardial infarction, or stroke - had occurred in 9.8% of patients receiving ticagrelor as compared with 11.7% of those receiving clopidogrel (hazard ratio, 0.84; 95% confidence interval [CI], 0.77 to 0.92; P<0.001). Predefined hierarchical testing of secondary end points showed significant differences in the rates of other composite end points, as well as myocardial infarction alone (5.8% in the ticagrelor group vs. 6.9% in the clopidogrel group, P = 0.005) and death from vascular causes (4.0% vs. 5.1%, P = 0.001) but not stroke alone (1.5% vs. 1.3%, P = 0.22). The rate of death from any cause was also reduced with ticagrelor (4.5%, vs. 5.9% with clopidogrel; P<0.001). No significant difference in the rates of major bleeding was found between the ticagrelor and clopidogrel groups (11.6% and 11.2%, respectively; P = 0.43), but ticagrelor was associated with a higher rate of major bleeding not related to coronary-artery bypass grafting (4.5% vs. 3.8%, P = 0.03), including more instances of fatal intracranial bleeding and fewer of fatal bleeding of other types. CONCLUSIONS In patients who have an acute coronary syndrome with or without ST-segment elevation, treatment with ticagrelor as compared with clopidogrel significantly reduced the rate of death from vascular causes, myocardial infarction, or stroke without an increase in the rate of overall major bleeding but with an increase in the rate of non-procedure-related bleeding. (ClinicalTrials.gov number, NCT00391872.)	[Wallentin, Lars] Univ Uppsala Hosp, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden; [Becker, Richard C.; Mahaffey, Kenneth W.; Harrington, Robert A.] Duke Clin Res Inst, Durham, NC USA; [Budaj, Andrzej] Grochowski Hosp, Warsaw, Poland; [Cannon, Christopher P.; Scirica, Benjamin M.] Brigham & Womens Hosp, Thrombolysis Myocardial Infarct Study Grp, Boston, MA 02115 USA; [Emanuelsson, Hakan] AstraZeneca Res & Dev, Molndal, Sweden; [Horrow, Jay] AstraZeneca Res & Dev, Wilmington, DE USA; [Husted, Steen] Arhus Univ Hosp, Aarhus, Denmark; [Katus, Hugo] Univ Klinikum Heidelberg, Heidelberg, Germany; [Skene, Allan] Worldwide Clin Trials UK, Nottingham, England; [Steg, Philippe Gabriel] APHP, INSERM, U698, Paris, France; [Steg, Philippe Gabriel] Univ Paris 07, Paris, France; [Storey, Robert F.] Univ Sheffield, Sheffield, S Yorkshire, England	Uppsala University; Uppsala University Hospital; Duke University; Centre of Postgraduate Medical Education - Poland; Harvard University; Brigham & Women's Hospital; AstraZeneca; AstraZeneca; Aarhus University; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Sheffield	Wallentin, L (corresponding author), Univ Uppsala Hosp, Uppsala Clin Res Ctr, S-75185 Uppsala, Sweden.	lars.wallentin@ucr.uu.se	STEG, Philippe Gabriel/Z-1567-2019; De+Servi, Stefano/AAT-2631-2021; James, Stefan K/J-4554-2014; Held, Claes/AAA-3973-2021; WORNER, FERNANDO/A-6821-2010; Zateyshchikov, Dmitry A/D-6575-2012; Manolis, Antonis/F-5003-2014; Cannon, Christopher P/AAY-7644-2020; Motovska, Zuzana/J-1122-2016; Blas, Juan Ramón Rey/AAB-4064-2021; Walters, Darren/A-7069-2011; Storey, Robert/AAA-6853-2019; Lotufo, Paulo/A-9843-2008; Boldueva, Svetlana/AAH-3862-2019; Georgescu, Catalina Arsenescu/R-5709-2017; Arkhipov, Mikhail V/Q-2316-2015; Marchev, Sotir/AAH-6529-2020; Kubica, Jacek/D-6906-2014; Sinkiewicz, Wladyslaw/G-5169-2014; Waltenberger, Johannes/I-1813-2013	Held, Claes/0000-0001-9402-7404; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Manolis, Antonis/0000-0002-0336-4745; Cannon, Christopher P/0000-0003-4596-2791; Motovska, Zuzana/0000-0002-5319-473X; Blas, Juan Ramón Rey/0000-0002-4749-7451; Lotufo, Paulo/0000-0002-4856-8450; Boldueva, Svetlana/0000-0002-1898-084X; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Arkhipov, Mikhail V/0000-0002-7924-7668; Marchev, Sotir/0000-0001-9250-510X; Kubica, Jacek/0000-0001-8250-754X; Storey, Robert/0000-0002-6677-6229; Welsh, Robert/0000-0003-2613-9142; Varenhorst, Christoph/0000-0002-8378-3869; Airaksinen, Juhani/0000-0002-0193-568X; Fox, Keith/0000-0002-0140-2752; STEG, Philippe Gabriel/0000-0001-6896-2941; Volpe, Massimo/0000-0002-9642-8380; Brilakis, Emmanouil/0000-0001-9416-9701; Gotberg, Matthias/0000-0002-0912-7927; Van de Werf, Frans/0000-0001-9479-7767; Maurer, Gerald/0000-0002-9043-7657; Waltenberger, Johannes/0000-0002-2417-9880	AstraZeneca	AstraZeneca(AstraZeneca)	Supported by AstraZeneca.	Adams RJ, 2004, CIRCULATION, V110, P2512, DOI 10.1161/01.CIR.0000134791.68010.FA; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Anderson SD, 2008, CIRCULATION, V117, pE174, DOI 10.1161/CIRCULATIONAHA.107.737551; [Anonymous], 1988, LANCET, V2, P349; Antithrombotic Trialists' Collaboration, 2002, BMJ-BRIT MED J, V324, P141, DOI DOI 10.1136/BMJ.324.7330.141; Antman EM, 2005, CIRCULATION, V111, P2013; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Boersma E, 2002, LANCET, V359, P2120; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Bonello L, 2009, AM J CARDIOL, V103, P5, DOI 10.1016/j.amjcard.2008.08.048; Cannon CP, 2007, J AM COLL CARDIOL, V50, P2196, DOI 10.1016/j.jacc.2007.11.001; Cannon CP, 2007, J AM COLL CARDIOL, V50, P1844, DOI 10.1016/j.jacc.2007.07.053; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collet JP, 2008, CIRCULATION, V118, P1225, DOI [10.1161/CIRCULATIONAHA.108.776757, 10.1161/CIRCULATIONAHA.108.191108]; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Fox KAA, 2004, CIRCULATION, V110, P1202, DOI 10.1161/01.CIR.0000140675.85342.1B; Husted S, 2006, EUR HEART J, V27, P1038, DOI 10.1093/eurheartj/ehi754; James S, 2009, AM HEART J, V157, P599, DOI 10.1016/j.ahj.2009.01.003; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Kuliczkowski W, 2009, EUR HEART J, V30, P426, DOI 10.1093/eurheartj/ehn562; Lotrionte M, 2007, AM J CARDIOL, V100, P1199, DOI 10.1016/j.amjcard.2007.05.048; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Montalescot G, 2006, J AM COLL CARDIOL, V48, P931, DOI 10.1016/j.jacc.2006.04.090; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sabatine MS, 2005, JAMA-J AM MED ASSOC, V294, P1224, DOI 10.1001/jama.294.10.1224; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Storey RF, 2007, J AM COLL CARDIOL, V50, P1852, DOI 10.1016/j.jacc.2007.07.058; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2003, CIRCULATION, V107, P966, DOI 10.1161/01.CIR.0000051362.96946.15; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Yusuf S, 2001, NEW ENGL J MED, V345, P1716; [No title captured]	38	4893	5176	12	305	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1045	1057		10.1056/NEJMoa0904327	http://dx.doi.org/10.1056/NEJMoa0904327			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19717846				2022-12-28	WOS:000269659400007
J	Dempsey, OJ; Paterson, EW; Kerr, KM; Denison, AR				Dempsey, Owen J.; Paterson, Edward W.; Kerr, Keith M.; Denison, Alan R.			Sarcoidosis	BMJ-BRITISH MEDICAL JOURNAL			English	Review									[Dempsey, Owen J.; Paterson, Edward W.] Aberdeen Royal Infirm, Dept Resp Med, Aberdeen AB25 2ZN, Scotland; [Kerr, Keith M.] Univ Aberdeen, Sch Med, Aberdeen AB25 2ZD, Scotland; [Denison, Alan R.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Royal Infirm, Aberdeen AB25 2ZD, Scotland	University of Aberdeen; University of Aberdeen; Royal Infirmary of Edinburgh; University of Aberdeen	Dempsey, OJ (corresponding author), Aberdeen Royal Infirm, Dept Resp Med, Foresterhill, Aberdeen AB25 2ZN, Scotland.	owen.dempsey@nhs.net						[Anonymous], 1999, Am J Respir Crit Care Med, V160, P736; Baughman RP, 2008, SARCOIDOSIS VASC DIF, V25, P76; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Cox CE, 2004, CHEST, V125, P997, DOI 10.1378/chest.125.3.997; Drent M, 1999, EUR RESPIR J, V13, P718, DOI 10.1034/j.1399-3003.1999.13d03.x; Du Bois R, 2005, EUR RESP MON, V32, P64, DOI DOI 10.1183/1025448X.00032005; Gribbin J, 2006, THORAX, V61, P980, DOI 10.1136/thx.2006.062836; Gupta D, 2007, EUR RESPIR J, V30, P508, DOI 10.1183/09031936.00002607; Hutchinson J., 1877, ILLUSTRATIONS CLIN S; MACFARLANE JT, 1984, BRIT MED J, V288, P1557, DOI 10.1136/bmj.288.6430.1557; McGrath DS, 2000, THORAX, V55, P751, DOI 10.1136/thorax.55.9.751; Miyara M, 2006, J EXP MED, V203, P359, DOI 10.1084/jem.20050648; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Newman LS, 2005, EUR RESP MON, V10, P23, DOI [10.1183/1025448x.00032003, DOI 10.1183/1025448X.00032003]; PARAMOTHAYAN NS, 2000, COCHRANE DB SYST REV; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; Sverrild A, 2008, THORAX, V63, P894, DOI 10.1136/thx.2007.094060; Taylor AN, 2004, AM J RESP CRIT CARE, V170, P1268, DOI 10.1164/rccm.2409006; Walters EH, 2003, COCHRANE DB SYST REV; Wells AU, 2008, THORAX, V63, DOI 10.1136/thx.2008.101691	21	71	74	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2009	339								b3206	10.1136/bmj.b3206	http://dx.doi.org/10.1136/bmj.b3206			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AZ	19717499				2022-12-28	WOS:000269393200002
J	Bryan, CS; Podolsky, SH				Bryan, Charles S.; Podolsky, Scott H.			Medical History: Dr. Holmes at 200-- The Spirit of Skepticism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bryan, Charles S.] Providence Hosp, Columbia, SC 29203 USA; [Bryan, Charles S.] Univ S Carolina, Columbia, SC 29208 USA; [Podolsky, Scott H.] Harvard Univ, Sch Med, Boston, MA USA; [Podolsky, Scott H.] Ctr Hist Med, Francis A Countway Lib Med, Boston, MA USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Harvard University; Harvard Medical School	Bryan, CS (corresponding author), Providence Hosp, Columbia, SC 29203 USA.							Dowling William C, 2006, OW HOLMES PARIS MED; Gibian P., 2001, OW HOLMES CULTURE CO, DOI [10.1017/CBO9780511485503, DOI 10.1017/CBO9780511485503]; Warner John Harley, 1998, SPIRIT SYSTEM FRENCH; Whorton James C., 1980, HIST ANTIBIOTICS, P125; 1879, LECT 1 YEAR CL UNPUB	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					846	847		10.1056/NEJMp0905310	http://dx.doi.org/10.1056/NEJMp0905310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	487XV	19710482				2022-12-28	WOS:000269312700003
J	Heo, I; Joo, C; Kim, YK; Ha, M; Yoon, MJ; Cho, J; Yeom, KH; Han, J; Kim, VN				Heo, Inha; Joo, Chirlmin; Kim, Young-Kook; Ha, Minju; Yoon, Mi-Jeong; Cho, Jun; Yeom, Kyu-Hyeon; Han, Jinju; Kim, V. Narry			TUT4 in Concert with Lin28 Suppresses MicroRNA Biogenesis through Pre-MicroRNA Uridylation	CELL			English	Article							EMBRYONIC STEM-CELLS; RNA-INTERFERENCE; POLY(A) POLYMERASE; NUCLEAR EXPORT; POSTTRANSCRIPTIONAL REGULATION; BINDING PROTEIN; LET-7 MICRORNA; MESSENGER-RNA; LIN-28; IDENTIFICATION	As key regulators in cellular functions, microRNAs (miRNAs) themselves need to be tightly controlled. Lin28, a pluripotency factor, was reported to downregulate let-7 miRNA by inducing uridylation of let-7 precursor (pre-let-7). But the enzyme responsible for the uridylation remained unknown. Here we identify a noncanonical poly (A) polymerase, TUTase4 (TUT4), as the uridylyl transferase for pre-let-7. Lin28 recruits TUT4 to pre-let-7 by recognizing a tetra-nucleotide sequence motif (GGAG) in the terminal loop. TUT4 in turn adds an oligouridine tail to the pre-let-7, which blocks Dicer processing. Other miRNAs with the same sequence motif (miR-107, -143, and -200c) are regulated through the same mechanism. Knockdown of TUT4 and Lin28 reduces the level of stem cell markers, suggesting that they are required for stem cell maintenance. This study uncovers the role of TUT4 and Lin28 as specific suppressors of miRNA biogenesis, which has implications for stem cell research and cancer biology.	[Heo, Inha; Joo, Chirlmin; Kim, Young-Kook; Ha, Minju; Yoon, Mi-Jeong; Cho, Jun; Yeom, Kyu-Hyeon; Han, Jinju; Kim, V. Narry] Seoul Natl Univ, Creat Res Ctr, Seoul 151742, South Korea; [Heo, Inha; Joo, Chirlmin; Kim, Young-Kook] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, VN (corresponding author), Seoul Natl Univ, Creat Res Ctr, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Han, Jinju/D-9091-2017; Joo, Chirlmin/B-9294-2008; Kim, Young-Kook/AAE-8306-2020; Ha, Minju/G-3559-2017	Joo, Chirlmin/0000-0003-2803-0335; Kim, Young-Kook/0000-0001-6434-2235; Ha, Minju/0000-0003-2328-415X; Kim, Young Kook/0000-0002-6037-8449; HAN, Jinju/0000-0003-1844-2301	National Research Foundation of Korea [20090063603]; Ministry of Education, Science and Technology of Korea	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We are grateful to the members of our laboratory, particularly Hyeshik Chang for helpful discussion and Ahyoung Cho and Je-Keun Rhee for technical help. We also thank Yong Joon Huh and Dr. Dong-Wook Kim for the gift of mES cells (R1) and their advice on stem cell culture; Kyung Hoon Kim and Dr. Se Won Seo for their advice on protein purification; and Drs. Guhung Jung and Seung Hwan Hong for the gift of cell lines. This work was supported by the Creative Research Initiatives Program (20090063603) through the National Research Foundation of Korea (NRF) and the BK21 Research Fellowships (I. H., C.J., Y.-K.K., J.C., K.-H.Y., and J.H.) from the Ministry of Education, Science and Technology of Korea.	Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grosshans H, 2005, DEV CELL, V8, P321, DOI 10.1016/j.devcel.2004.12.019; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; MENEELY PM, 1979, GENETICS, V92, P99; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nakanishi T, 2006, DEV BIOL, V289, P115, DOI 10.1016/j.ydbio.2005.10.017; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Pappalardo L, 1998, J MOL BIOL, V282, P801, DOI 10.1006/jmbi.1998.2046; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06; Rouhana L, 2005, RNA, V11, P1117, DOI 10.1261/rna.2630205; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Trippe R, 2003, EUR J BIOCHEM, V270, P971, DOI 10.1046/j.1432-1033.2003.03466.x; Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; Wang X., 2008, J VIS EXP, V17; Wickens M, 2008, SCIENCE, V319, P1344, DOI 10.1126/science.1154946; Wilusz CJ, 2008, GENE DEV, V22, P1, DOI 10.1101/gad.1634508; Wulczyn FG, 2007, FASEB J, V21, P415, DOI 10.1096/fj.06-6130com; Yang DH, 2003, GENE EXPR PATTERNS, V3, P719, DOI 10.1016/S1567-133X(03)00140-6; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	65	592	620	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					696	708		10.1016/j.cell.2009.08.002	http://dx.doi.org/10.1016/j.cell.2009.08.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703396	Bronze			2022-12-28	WOS:000269156100012
J	Beasley, R; Weatherall, M; Travers, J; Shirtcliffe, P				Beasley, Richard; Weatherall, Mark; Travers, Justin; Shirtcliffe, Philippa			Time to define the disorders of the syndrome of COPD	LANCET			English	Editorial Material									[Beasley, Richard; Travers, Justin; Shirtcliffe, Philippa] Med Res Inst New Zealand, Wellington 6143, New Zealand; [Beasley, Richard; Weatherall, Mark; Shirtcliffe, Philippa] Capital & Coast Dist Hlth Board, Wellington, New Zealand; [Weatherall, Mark] Univ Otago, Wellington, New Zealand	Medical Research Institute Of New Zealand; University of Otago	Beasley, R (corresponding author), Med Res Inst New Zealand, Wellington 6143, New Zealand.	Richard.Beasley@mrinz.ac.nz	Weatherall, Mark/Y-6824-2019; Beasley, Richard/AAH-3908-2019	Weatherall, Mark/0000-0002-0051-9107; Beasley, Richard/0000-0003-0337-406X; Travers, Justin/0000-0002-5992-7682				[Anonymous], 2006, LANCET, V368, P705; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Calverley PMA, 2007, LANCET, V370, P774, DOI 10.1016/S0140-6736(07)61381-6; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Fishman A, 2003, NEW ENGL J MED, V348, P2059; *GLOB IN ASTHM, 2008, GLOB STRAT ASTHM MAN; Global Strategy for the Diagnosis Management and Prevention of COPD, 2008, GLOB STRAT DIAGN MAN; Lapperre TS, 2004, AM J RESP CRIT CARE, V170, P499, DOI 10.1164/rccm.200401-112OC; Marsh SE, 2008, THORAX, V63, P761, DOI 10.1136/thx.2007.089193; Travers J, 2007, TREATING INDIVIDUALS, P131; Vonk JM, 2003, THORAX, V58, P322, DOI 10.1136/thorax.58.4.322; Wardlaw AJ, 2005, CLIN EXP ALLERGY, V35, P1254, DOI 10.1111/j.1365-2222.2005.02344.x; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408	14	42	43	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					670	672		10.1016/S0140-6736(09)61541-5	http://dx.doi.org/10.1016/S0140-6736(09)61541-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716947				2022-12-28	WOS:000269422500007
J	Pearson, GAH; Eckford, SD; Trinder, J; Levy, A				Pearson, Greg A. H.; Eckford, Seumas D.; Trinder, Jo; Levy, Andrew			A reason to panic in pregnancy	LANCET			English	Editorial Material									[Pearson, Greg A. H.; Eckford, Seumas D.] N Devon Dist Hosp, Dept Obstet & Gynaecol, Barnstaple EX31 4JB, Devon, England; [Trinder, Jo] St Michaels Hosp, Dept Obstet & Gynaecol, Bristol, Avon, England; [Levy, Andrew] Univ Bristol, Dept Res Endocrinol, Bristol, Avon, England	University of Bristol	Pearson, GAH (corresponding author), N Devon Dist Hosp, Dept Obstet & Gynaecol, Barnstaple EX31 4JB, Devon, England.	greg.pearson@doctors.org.uk						Ahlawat S K, 1999, Obstet Gynecol Surv, V54, P728, DOI 10.1097/00006254-199911000-00025; Lenders JWM, 2002, JAMA-J AM MED ASSOC, V287, P1427, DOI 10.1001/jama.287.11.1427; Mannelli M, 2002, J ENDOCRINOL INVEST, V25, P567, DOI 10.1007/BF03345503; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943	5	7	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					756	756		10.1016/S0140-6736(09)61035-7	http://dx.doi.org/10.1016/S0140-6736(09)61035-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716968				2022-12-28	WOS:000269422500032
J	Soriano, JB; Zielinski, J; Price, D				Soriano, Joan B.; Zielinski, Jan; Price, David			Screening for and early detection of chronic obstructive pulmonary disease	LANCET			English	Review							AIR-FLOW OBSTRUCTION; 3RD NATIONAL-HEALTH; NUTRITION EXAMINATION SURVEY; RESTRICTIVE LUNG-DISEASE; UNITED-STATES; SMOKING-CESSATION; GLOBAL BURDEN; HIGH-RISK; RESPIRATORY-DISEASES; OFFICE SPIROMETRY	Chronic obstructive pulmonary disease (COPD) is a substantially underdiagnosed disorder, with the diagnosis typically missed or delayed until the condition is advanced. Spirometry is the most frequently used pulmonary function test and enables health professionals to make an objective measurement of airflow obstruction and assess the degree to which it is reversible. As a diagnostic test for COPD, spirometry is a reliable, simple, non-invasive, safe, and non-expensive procedure. Early diagnosis of COPD should provide support for smoking cessation initiatives and lead to reduction of the societal burden of the disease, but definitive confirmation of both proves elusive. Despite substantial effort and investment, implementation of quality spirometry is deficient because of several hurdles and limitations, described in this Review. All in all, spirometry is recognised as the essential test for diagnosis and monitoring of COPD.	[Soriano, Joan B.] Recinte Hosp Joan March, Int Ctr Adv Resp Med, CIMERA, Bunyola, Spain; [Zielinski, Jan] Natl Res Inst TB & Lung Dis, Warsaw, Poland; [Zielinski, Jan] Warsaw Med Univ, Warsaw, Poland; [Price, David] Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland	Medical University of Warsaw; University of Aberdeen	Soriano, JB (corresponding author), Recinte Hosp Joan March, Program Epidemiol & Clin Res, CIMERA, Carretera Soller Km 12, Mallorca 07110, Illes Balears, Spain.	jbsoriano@caubet-cimera.es	Soriano, Joan B/O-1215-2017; Price, David/H-2837-2019	Soriano, Joan B/0000-0001-9740-2994; Price, David/0000-0002-9728-9992				Aldington S, 2007, THORAX, V62, P1058, DOI 10.1136/thx.2006.077081; [Anonymous], EPIDEMIOLOGY BASIS D; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; Barr RG, 2009, AM J MED, V122, P348, DOI 10.1016/j.amjmed.2008.09.042; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bednarek M, 2008, THORAX, V63, P402, DOI 10.1136/thx.2007.085456; Berry CE, 2009, CLIN REV ALLERG IMMU, V37, P173, DOI 10.1007/s12016-009-8123-4; BIZE R, 2009, COCHRANE DB SYST REV, V2; Blanc PD, 2009, EUR RESPIR J, V33, P298, DOI 10.1183/09031936.00118808; Bolton CE, 2005, RESP MED, V99, P493, DOI 10.1016/j.rmed.2004.09.015; Bridevaux PO, 2008, THORAX, V63, P768, DOI 10.1136/thx.2007.093724; Buffels J, 2004, CHEST, V125, P1394, DOI 10.1378/chest.125.4.1394; Buist AS, 2008, INT J TUBERC LUNG D, V12, P703; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Castillo D, 2009, RESP MED, V103, P839, DOI 10.1016/j.rmed.2008.12.022; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cornwell Jocelyn, 1984, HARD EARNED LIVES AC; Coultas DB, 2001, AM J RESP CRIT CARE, V164, P372, DOI 10.1164/ajrccm.164.3.2004029; Damarla M, 2006, RESP CARE, V51, P1120; Derom E, 2008, EUR RESPIR J, V31, P197, DOI 10.1183/09031936.00066607; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Ferguson GT, 2000, CHEST, V117, P1146, DOI 10.1378/chest.117.4.1146; Fiore MC, 2008, RESP CARE, V53, P1217; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Halpin D, 2004, THORAX, V59, P181, DOI 10.1136/thx.2004.021113; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; Joo MJ, 2008, CHEST, V134, P38, DOI 10.1378/chest.08-0013; Kanner RE, 1999, AM J MED, V106, P410, DOI 10.1016/S0002-9343(99)00056-X; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Lange P, 1998, NEW ENGL J MED, V339, P1194, DOI 10.1056/NEJM199810223391703; Lin K, 2008, ANN INTERN MED, V148, P535, DOI 10.7326/0003-4819-148-7-200804010-00213; Lindberg Anne, 2007, COPD, V4, P5, DOI 10.1080/15412550601168358; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Lundback B, 2003, RESP MED, V97, P115, DOI 10.1053/rmed.2003.1446; Maleki-Yazdi M Reza, 2007, COPD, V4, P313, DOI 10.1080/15412550701595740; Mannino DM, 2003, J INTERN MED, V254, P540, DOI 10.1111/j.1365-2796.2003.01211.x; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; Mannino DM, 2003, AM J MED, V114, P758, DOI 10.1016/S0002-9343(03)00185-2; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Morris JN, 1975, USES OF EPIDEMIOLOGY; Murray CJL, 2007, LANCET, V370, P109, DOI 10.1016/S0140-6736(07)61064-2; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray RP, 1998, J CLIN EPIDEMIOL, V51, P1317, DOI 10.1016/S0895-4356(98)00120-6; NHS website, CHRON OBSTR PULM DIS; Ofir D, 2008, AM J RESP CRIT CARE, V177, P622, DOI 10.1164/rccm.200707-1064OC; Parkes G, 2008, BMJ-BRIT MED J, V336, P598, DOI 10.1136/bmj.39503.582396.25; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Peces-Barba G, 2008, ARCH BRONCONEUMOL, V44, P271, DOI 10.1016/S1579-2129(08)60043-9; Pena VS, 2000, CHEST, V118, P981, DOI 10.1378/chest.118.4.981; Perez-Padilla R, 2009, INT J TUBERC LUNG D, V13, P387; Perez-Padilla R, 2008, RESP CARE, V53, P1019; PETO R, 1983, AM REV RESPIR DIS, V128, P491, DOI 10.1164/arrd.1983.128.3.491; Petty Thomas L, 2004, Respir Care, V49, P678; Pietinalho A, 2007, RESP MED, V101, P1419, DOI 10.1016/j.rmed.2007.01.022; Pratt P C, 1970, Hum Pathol, V1, P443; PRICE D, 2002, PRIM CARE RESP J S1, V11, pS12; Price David, 2009, Prim Care Respir J, V18, P216, DOI 10.4104/pcrj.2009.00055; Qaseem A, 2007, ANN INTERN MED, V147, P633, DOI 10.7326/0003-4819-147-9-200711060-00008; Quanjer PH, 2008, AM J RESP CRIT CARE, V178, P1262, DOI 10.1164/rccm.200805-700OC; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rennard Stephen I, 2008, Proc Am Thorac Soc, V5, P878, DOI 10.1513/pats.200804-035QC; Roche N, 2008, EUR RESPIR J, V31, P1227, DOI 10.1183/09031936.00089607; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Scanlon PD, 2000, AM J RESP CRIT CARE, V161, P381, DOI 10.1164/ajrccm.161.2.9901044; Smith-Sivertsen T, 2004, SCAND J PRIM HEALTH, V22, P196, DOI 10.1080/02813430410006657; Soriano JB, 2008, EUR RESPIR J, V31, P695, DOI 10.1183/09031936.00017008; Soriano JB, 2003, CHEST, V124, P474, DOI 10.1378/chest.124.2.474; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; STEAD LF, 2008, COCHRANE DB SYST REV, V1; Stoller JK, 2005, LANCET, V365, P2225, DOI 10.1016/S0140-6736(05)66781-5; Tashkin D P, 2005, Monaldi Arch Chest Dis, V63, P93; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Tinkelman David G, 2007, Prim Care Respir J, V16, P41, DOI 10.3132/pcrj.2007.00009; Tinkelman DG, 2006, J ASTHMA, V43, P75, DOI 10.1080/02770900500448738; Tonnesen P, 2007, EUR RESPIR J, V29, P390, DOI 10.1183/09031936.00060806; Torres-Duque Carlos, 2008, Proc Am Thorac Soc, V5, P577, DOI 10.1513/pats.200707-100RP; TUOMISTO L, 2008, PRIM CARE RESP J, V17, P238; *US DEP HHS, 1989, DHHS PUBL; US Preventive Serv Task Force, 2008, ANN INTERN MED, V148, P529, DOI 10.7326/0003-4819-148-7-200804010-00212; van den Berg J W K, 2007, Ned Tijdschr Geneeskd, V151, P1557; van Schayck CP, 2002, BMJ-BRIT MED J, V324, P1370, DOI 10.1136/bmj.324.7350.1370; Vestbo J, 2002, AM J RESP CRIT CARE, V166, P329, DOI 10.1164/rccm.2112048; Walker PP, 2006, EUR RESPIR J, V28, P945, DOI 10.1183/09031936.06.00019306; Zielinski J, 2006, EUR RESPIR J, V27, P833, DOI 10.1183/09031936.06.00025905; Zielinski J, 2001, CHEST, V119, P731, DOI 10.1378/chest.119.3.731	97	242	247	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					721	732		10.1016/S0140-6736(09)61290-3	http://dx.doi.org/10.1016/S0140-6736(09)61290-3			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716965				2022-12-28	WOS:000269422500029
J	Sewankambo, NK; Katamba, A				Sewankambo, Nelson K.; Katamba, Achilles			Health systems in Africa: learning from South Africa	LANCET			English	Editorial Material									[Sewankambo, Nelson K.; Katamba, Achilles] Makerere Univ, Coll Hlth Sci, Makere, Uganda	Makerere University	Sewankambo, NK (corresponding author), Makerere Univ, Coll Hlth Sci, Makere, Uganda.	sewankam@infocom.co.ug		Sewankambo, Nelson/0000-0001-9362-053X				Chopra M, 2009, LANCET, V374, P1023, DOI 10.1016/S0140-6736(09)61122-3; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; Hughes D, 2007, HEALTH AFFAIR, V26, P999, DOI 10.1377/hlthaff.26.4.999; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; KING N. M. P, 1999, REGULATIONS ETHICS H; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; MICHAEL AJ, 2008, LANCET, V371, P1895; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X	11	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					957	959		10.1016/S0140-6736(09)61244-7	http://dx.doi.org/10.1016/S0140-6736(09)61244-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	498PK	19709730				2022-12-28	WOS:000270154100008
J	Fitzgerald, E; Mathieu, S; Ball, A				Fitzgerald, Emma; Mathieu, Stephen; Ball, Andrew			Lesson of the Week Metformin associated lactic acidosis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							THERAPY		[Fitzgerald, Emma; Mathieu, Stephen; Ball, Andrew] Dorset Cty Hosp, Dorchester DT1 2JY, Dorset, England		Fitzgerald, E (corresponding author), Dorset Cty Hosp, Dorchester DT1 2JY, Dorset, England.	zcharm6@hotmail.com						Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Brown JB, 1998, DIABETES CARE, V21, P1659, DOI 10.2337/diacare.21.10.1659; Bruijstens LA, 2008, NETH J MED, V66, P185; Chang CT, 2002, J NEPHROL, V15, P398; Gudmundsdottir H, 2006, CLIN NEPHROL, V66, P380; Jones GC, 2003, BMJ-BRIT MED J, V326, P4, DOI 10.1136/bmj.326.7379.4; *NAT I HLTH CLIN E, 2008, CLIN GUID NAT I HLTH, V66; Price G, 2003, BRIT J ANAESTH, V91, P909, DOI 10.1093/bja/aeg255; Silvestre Joana, 2007, J Med Case Rep, V1, P126, DOI 10.1186/1752-1947-1-126; Stades AME, 2004, J INTERN MED, V255, P179, DOI 10.1046/j.1365-2796.2003.01271.x; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8	11	21	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 16	2009	339								b3660	10.1136/bmj.b3660	http://dx.doi.org/10.1136/bmj.b3660			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RT	19759079				2022-12-28	WOS:000269994800006
J	Johnstone, RE				Johnstone, Robert E.			Driving Thoughts	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												johnstoner@rcbhsc.wvu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1154	1154		10.1001/jama.2009.1164	http://dx.doi.org/10.1001/jama.2009.1164			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755686				2022-12-28	WOS:000269797600001
J	Alle, H; Roth, A; Geiger, JRP				Alle, Henrik; Roth, Arnd; Geiger, Joerg R. P.			Energy-Efficient Action Potentials in Hippocampal Mossy Fibers	SCIENCE			English	Article							CHANNELS; BOUTONS; SIGNALS; BUDGET; MATTER; BRAIN	Action potentials in nonmyelinated axons are considered to contribute substantially to activity-dependent brain metabolism. Here we show that fast Na(+) current decay and delayed K(+) current onset during action potentials in nonmyelinated mossy fibers of the rat hippocampus minimize the overlap of their respective ion fluxes. This results in total Na(+) influx and associated energy demand per action potential of only 1.3 times the theoretical minimum, in contrast to the factor of 4 used in previous energy budget calculations for neural activity. Analysis of ionic conductance parameters revealed that the properties of Na(+) and K(+) channels are matched to make axonal action potentials energy-efficient, minimizing their contribution to activity-dependent metabolism.	[Alle, Henrik; Geiger, Joerg R. P.] Max Planck Inst Brain Res, Independent Hertie Res Grp, D-60528 Frankfurt, Germany; [Roth, Arnd] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England	Max Planck Society; University of London; University College London	Alle, H (corresponding author), Max Planck Inst Brain Res, Independent Hertie Res Grp, D-60528 Frankfurt, Germany.	henrik.alle@charite.de		Roth, Arnd/0000-0003-0325-4287	Max Planck Society; Hertie Foundation; Deutsche Forschungsgemeinschaft [AL 1193/2-1]; Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish	Max Planck Society(Max Planck SocietyFoundation CELLEX); Hertie Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. Lampert and C. Schmidt- Hieber for discussion on sodium conductances and M. H usser for comments on the manuscript. This work was supported by the Max Planck Society, the Hertie Foundation, the Deutsche Forschungsgemeinschaft ( AL 1193/2-1), and the Engineering and Physical Sciences Research Council.	Acsady L, 1998, J NEUROSCI, V18, P3386; Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Faisal AA, 2007, PLOS COMPUT BIOL, V3, P783, DOI 10.1371/journal.pcbi.0030079; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; HODGKIN A, 1975, PHILOS T ROY SOC B, V270, P297, DOI 10.1098/rstb.1975.0010; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Mangia S, 2009, J CEREBR BLOOD F MET, V29, P441, DOI 10.1038/jcbfm.2008.134; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Nawroth JC, 2007, J NEUROSCI, V27, P9790, DOI 10.1523/JNEUROSCI.1415-07.2007; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Ritchie J M, 1973, Prog Biophys Mol Biol, V26, P147; Wang SSH, 2008, J NEUROSCI, V28, P4047, DOI 10.1523/JNEUROSCI.5559-05.2008; Yu YG, 2008, J NEUROSCI, V28, P7260, DOI 10.1523/JNEUROSCI.1613-08.2008	23	273	276	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1405	1408		10.1126/science.1174331	http://dx.doi.org/10.1126/science.1174331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745156				2022-12-28	WOS:000269699100042
J	Frankenberg, C; Yoshimura, K; Warneke, T; Aben, I; Butz, A; Deutscher, N; Griffith, D; Hase, F; Notholt, J; Schneider, M; Schrijver, H; Rockmann, T				Frankenberg, Christian; Yoshimura, Kei; Warneke, Thorsten; Aben, Ilse; Butz, Andre; Deutscher, Nicholas; Griffith, David; Hase, Frank; Notholt, Justus; Schneider, Matthias; Schrijver, Hans; Rockmann, Thomas			Dynamic Processes Governing Lower-Tropospheric HDO/H2O Ratios as Observed from Space and Ground	SCIENCE			English	Article							ATMOSPHERIC WATER-VAPOR; GENERAL-CIRCULATION; CLIMATE-CHANGE; ICE CORES; PRECIPITATION; ISOTOPES; VARIABILITY; MODELS; CYCLE	The hydrological cycle and its response to environmental variability such as temperature changes is of prime importance for climate reconstruction and prediction. We retrieved deuterated water/water (HDO/H2O) abundances using spaceborne absorption spectroscopy, providing an almost global perspective on the near-surface distribution of water vapor isotopologs. We observed an unexpectedly high HDO/H2O seasonality in the inner Sahel region, pointing to a strong isotopic depletion in the subsiding branch of the Hadley circulation and its misrepresentation in general circulation models. An extension of the analysis at high latitudes using ground-based observations of (delta D) over bar and a model study shows that dynamic processes can entirely compensate for temperature effects on the isotopic composition of precipitation.	[Frankenberg, Christian; Aben, Ilse; Butz, Andre; Schrijver, Hans] SRON Netherlands Inst Space Res, NL-3584 CA Utrecht, Netherlands; [Yoshimura, Kei] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Warneke, Thorsten] Inst Environm Phys, D-28359 Bremen, Germany; [Deutscher, Nicholas; Griffith, David] Univ Wollongong, Sch Chem, Wollongong, NSW, Australia; [Hase, Frank; Schneider, Matthias] IMK ASF Karlsruhe, Inst Meteorol & Climate Res, Karlsruhe, Germany; [Rockmann, Thomas] Inst Marine & Atmospher Res Utrecht, NL-3584 CC Utrecht, Netherlands	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Bremen; University of Wollongong; Utrecht University	Frankenberg, C (corresponding author), SRON Netherlands Inst Space Res, Sorbonnelaan 2, NL-3584 CA Utrecht, Netherlands.	C.Frankenberg@sron.nl	Hase, Frank/A-7497-2013; Yoshimura, Kei/F-2041-2010; Röckmann, Thomas/F-4479-2015; Warneke, Thorsten/K-1884-2012; Butz, Andre/A-7024-2013; Schneider, Matthias/B-1441-2013; Frankenberg, Christian/A-2944-2013; Deutscher, Nicholas M/E-3683-2015; Notholt, Justus/P-4520-2016	Yoshimura, Kei/0000-0002-5761-1561; Röckmann, Thomas/0000-0002-6688-8968; Butz, Andre/0000-0003-0593-1608; Frankenberg, Christian/0000-0002-0546-5857; Deutscher, Nicholas M/0000-0002-2906-2577; Notholt, Justus/0000-0002-3324-885X; aben, ilse/0000-0003-2198-0768	Deutsche Forschungsgemeinschaft through project RISOTO; Dutch science foundation NWO	Deutsche Forschungsgemeinschaft through project RISOTO(German Research Foundation (DFG)); Dutch science foundation NWO(Netherlands Organization for Scientific Research (NWO))	We thank all the scientists and engineers involved in the ESA's ENVISAT/SCIAMACHY mission, especially J. P. Burrows and H. Bovensmann from the University of Bremen, and, apart from the ESA, the national space agencies of Germany [ German Aerospace Center (DLR)], Netherlands [ Netherlands Space Office (NSO)], and Belgium [ Belgian User Support and Operations Center (BUSOC)]. The ground-based FTS activities at Kiruna and Iza a were supported by the Deutsche Forschungsgemeinschaft through project RISOTO. We are grateful to the Alfred Wegener Institute for providing the FTIR instrument and logistical support in Ny Alesund. Financial support from the European Union project GEOMON for the FTS stations is acknowledged. We thank H. Sodemann for a valuable discussion on an earlier manuscript draft; R. Snel, R. van Hees, and P. van der Meer for their work on instrument calibration; and A. de Lange and P. Tol for proofreading and image creation, respectively. C. F. was supported by a VENI fellowship from the Dutch science foundation NWO.	Bovensmann H, 1999, J ATMOS SCI, V56, P127, DOI 10.1175/1520-0469(1999)056<0127:SMOAMM>2.0.CO;2; Caballero R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035084; Chen JY, 2002, SCIENCE, V295, P838, DOI 10.1126/science.1065835; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; DANSGAARD W, 1964, TELLUS, V16, P436; Ehhalt DH, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005569; Galewsky J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031330; Gat JR, 1996, ANNU REV EARTH PL SC, V24, P225, DOI 10.1146/annurev.earth.24.1.225; Hendricks MB, 2000, GLOBAL BIOGEOCHEM CY, V14, P851, DOI 10.1029/1999GB001198; Hoffmann G, 2000, HYDROL PROCESS, V14, P1385, DOI [10.1002/1099-1085(20000615)14:8<1385::AID-HYP989>3.0.CO;2-1, 10.1002/1099-1085(20000615)14:8&lt;1385::AID-HYP989&gt;3.0.CO;2-1]; *INT AT EN AG WORL, 2004, GLOB NETW IS PREC GN; JACOB H, 1991, TELLUS B, V43, P291, DOI 10.1034/j.1600-0889.1991.t01-2-00003.x; JOUSSAUME S, 1984, NATURE, V311, P24, DOI 10.1038/311024a0; Jouzel J, 1997, J GEOPHYS RES-OCEANS, V102, P26471, DOI 10.1029/97JC01283; Koster RD, 2004, SCIENCE, V305, P1138, DOI 10.1126/science.1100217; Noone D, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008892; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; RAVAL A, 1989, NATURE, V342, P758, DOI 10.1038/342758a0; RIND D, 1991, NATURE, V349, P500, DOI 10.1038/349500a0; Schneider M, 2006, ATMOS CHEM PHYS, V6, P4705, DOI 10.5194/acp-6-4705-2006; Seneviratne SI, 2006, NATURE, V443, P205, DOI 10.1038/nature05095; Sodemann H, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009416; Soden BJ, 2005, SCIENCE, V310, P841, DOI 10.1126/science.1115602; Steffensen JP, 2008, SCIENCE, V321, P680, DOI 10.1126/science.1157707; Trenberth KE, 2005, CLIM DYNAM, V24, P741, DOI 10.1007/s00382-005-0017-4; Webster CR, 2003, SCIENCE, V302, P1742, DOI 10.1126/science.1089496; Wielicki BA, 2002, SCIENCE, V295, P841, DOI 10.1126/science.1065837; Worden J, 2007, NATURE, V445, P528, DOI 10.1038/nature05508; Yoshimura K, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010074; Zakharov VI, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019433	30	144	152	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1374	1377		10.1126/science.1173791	http://dx.doi.org/10.1126/science.1173791			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745148				2022-12-28	WOS:000269699100033
J	Doshi, P				Doshi, Peter			Calibrated response to emerging infections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									MIT, Program Hist Anthropol & Sci, Technol & Society, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Doshi, P (corresponding author), MIT, Program Hist Anthropol & Sci, Technol & Society, 77 Massachusetts Avenue, Cambridge, MA 02139 USA.	pnd@mit.edu						[Anonymous], 2009, Wkly Epidemiol Rec, V84, P197; BARRY JM, 2005, TIME; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M., 2009, INFLUENZA A H1N1; CHAN M, 2009, TRANS STATEMENT; CHAN M, 2009, WORLD BETTER PREPARE; COHEN E, 2009, WHEN PANDEMIC ISNT; Doshi P, 2008, AM J PUBLIC HEALTH, V98, P939, DOI 10.2105/AJPH.2007.119933; Fineberg HV, 2009, SCIENCE, V324, P987, DOI 10.1126/science.1176297; FOLLIN P, 2009, VARIETY RESP VIR; *GOV CANADA, H1N1 FLU VIRUS; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068; PARK M, 2009, WALKING WELL FLOOD; *PUB HLTH AGCY CAN, 2006, HIGHLIGHTS CANADIAN; *US CDCP, 2009, FLUVIEW; *US CDCP, EMERG INFECT INFL; *US DHHS, 2009, HHS DECLARES PUBL; *US DHHS, 2005, INFL PAND HOW THEY; *US DHHS, 2007, PANDEMIC FLU BASICS; *US DHHS, 2009, H1N1 FLU UPDATE; *WHO, 2009, TRANS PRESS CONF; *WHO, PADEMIC PREPARED; *WHO, 2005, TEN THINGS NEED KNOW; *WHO, 2005, WHO GLOB PREPARE	26	16	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2009	339								b3471	10.1136/bmj.b3471	http://dx.doi.org/10.1136/bmj.b3471			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	493RE	19729419	Green Submitted, Green Published			2022-12-28	WOS:000269754800004
J	Gingeras, TR				Gingeras, Thomas R.			Implications of chimaeric non-co-linear transcripts	NATURE			English	Review							LONG NONCODING RNAS; HUMAN GENOME; SPLICED LEADER; MESSENGER-RNAS; FUNCTIONAL ELEMENTS; PROSTATE-CANCER; GENE FUSION; SEQUENCE; SITES; IDENTIFICATION	Deep sequencing of 'transcriptomes' - the collection of all RNA transcripts produced at a given time - from worms to humans reveals that some transcripts are composed of sequence segments that are not co-linear, with pieces of sequence coming from distant regions of DNA, even different chromosomes. Some of these 'chimaeric' transcripts are formed by genetic rearrangements, but others arise during post-transcriptional events. The 'trans-splicing' process in lower eukaryotes is well understood, but events in higher eukaryotes are not. The existence of such chimaeric RNAs has far-reaching implications for the potential information content of genomes and the way it is arranged.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Gingeras, TR (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	gingeras@cshl.edu		Gingeras, Thomas/0000-0001-9106-3573	National Human Genome Research Institute [U54 HG004557, U01 HG004271]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004557, U01HG004271] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Work in my laboratory is supported by the National Human Genome Research Institute ( grants U54 HG004557 and U01 HG004271). I thank P. Kapranov for discussions and long-term collaboration, H. Sussman for helpful discussions and editing of the manuscript, and A. Dobin for help deriving the computational expressions to determine the co-linear and non-co-linear permutations, and for the plot shown in Fig. 4c.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Ashe A, 2007, TRENDS GENET, V23, P8, DOI 10.1016/j.tig.2006.11.008; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; BRUZIK JP, 1992, NATURE, V360, P692, DOI 10.1038/360692a0; BRUZIK JP, 1995, P NATL ACAD SCI USA, V92, P7056, DOI 10.1073/pnas.92.15.7056; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DAVIS RE, 1994, J BIOL CHEM, V269, P20026; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; Djebali S, 2008, NAT METHODS, V5, P629, DOI 10.1038/nmeth.1216; Dostie J., 2007, CURR PROTOC MOL BIOL; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Hastings KEM, 2005, TRENDS GENET, V21, P240, DOI 10.1016/j.tig.2005.02.005; Hert DG, 2008, ELECTROPHORESIS, V29, P4618, DOI 10.1002/elps.200800456; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Janz S, 2003, GENE CHROMOSOME CANC, V36, P211, DOI 10.1002/gcc.10178; Jones PA, 2008, NATURE, V454, P711, DOI 10.1038/454711a; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Margulies EH, 2003, COLD SPRING HARB SYM, V68, P255, DOI 10.1101/sqb.2003.68.255; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; Mattick JS, 2009, BIOESSAYS, V31, P51, DOI 10.1002/bies.080099; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Pombo A, 1998, EMBO J, V17, P1768, DOI 10.1093/emboj/17.6.1768; Pombo A, 1996, EXP CELL RES, V229, P201, DOI 10.1006/excr.1996.0360; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; RAJKOVIC A, 1990, P NATL ACAD SCI USA, V87, P8879, DOI 10.1073/pnas.87.22.8879; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; Rickman DS, 2009, CANCER RES, V69, P2734, DOI 10.1158/0008-5472.CAN-08-4926; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; TESSIER LH, 1991, EMBO J, V10, P2621, DOI 10.1002/j.1460-2075.1991.tb07804.x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	48	152	157	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					206	211		10.1038/nature08452	http://dx.doi.org/10.1038/nature08452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741701	Green Accepted			2022-12-28	WOS:000269654600033
J	Gnecco, E				Gnecco, Enrico			NANOTECHNOLOGY A gentle jackhammer	NATURE			English	Editorial Material									Univ Basel, Dept Phys, Natl Ctr Competence Res Nanoscale Sci, CH-4056 Basel, Switzerland	University of Basel	Gnecco, E (corresponding author), Univ Basel, Dept Phys, Natl Ctr Competence Res Nanoscale Sci, Klingelbergstr 82, CH-4056 Basel, Switzerland.	enrico.gnecco@unibas.ch	Gnecco, Enrico/H-5419-2013	Gnecco, Enrico/0000-0002-3053-923X				Erdemir A., 2007, SUPERLUBRICITY; Gnecco E, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/2/025501; Knoll A, 2006, MICROELECTRON ENG, V83, P1692, DOI 10.1016/j.mee.2006.01.206; LANTZ MA, 2009, NATURE; Schirmeisen A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.245403; Socoliuc A, 2006, SCIENCE, V313, P207, DOI 10.1126/science.1125874	6	4	4	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					178	179		10.1038/461178a	http://dx.doi.org/10.1038/461178a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741691				2022-12-28	WOS:000269654600024
J	Weinberger, S				Weinberger, Sharon			Export-control laws worry academics	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					156	156		10.1038/461156a	http://dx.doi.org/10.1038/461156a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741674	Bronze			2022-12-28	WOS:000269654600006
J	Sabatine, MS; Antman, EM; Widimsky, P; Ebrahim, IO; Kiss, RG; Saaiman, A; Polasek, R; Contant, CF; McCabe, CH; Braunwald, E				Sabatine, Marc S.; Antman, Elliott M.; Widimsky, Petr; Ebrahim, Iftikhar O.; Kiss, Robert G.; Saaiman, Andre; Polasek, Rostislav; Contant, Charles F.; McCabe, Carolyn H.; Braunwald, Eugene			Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial	LANCET			English	Article							FACTOR-XA INHIBITOR; MYOCARDIAL-INFARCTION; UNFRACTIONATED HEPARIN; RECEPTOR ANTAGONIST; TASK-FORCE; ENOXAPARIN; EFFICACY; SAFETY; MODEL; INTERVENTION	Background Otamixaban is an intravenous direct factor Xa inhibitor. We aimed to assess its efficacy and safety in non-ST-elevation acute coronary syndromes and to identify the optimum dose range for further assessment in a phase 3 study. Methods In this double-blind, phase 2 trial undertaken in 196 sites in 36 countries, 3241 patients with non-ST-elevation acute coronary syndromes were randomly assigned via a central, telephone-based interactive voice response system to one of five doses of otamixaban (0.08 mg/kg bolus followed by infusions of 0.035 [n=125], 0.070 [676], 0.105 [662], 0.140 [658], or 0.175 [671] mg/kg/h) or to a control of unfractionated heparin (60 IU/kg intravenous bolus followed by an infusion of 12 IU/kg/h) plus eptifibatide (180 mu g/kg intravenous bolus followed by an infusion of 1.0-2.0 mu g/kg/min [n=449]). Both investigators and patients were unaware of treatment allocation. Enrolment into the lowest dose group was stopped early at the recommendation of the Data Monitoring Committee. The primary efficacy endpoint was a composite of death, myocardial infarction, urgent revascularisation, or bailout glycoprotein IIb/IIIa inhibitor use up to 7 days. The primary safety endpoint was TIMI major or minor bleeding not related to coronary-artery bypass grafting. Efficacy analyses were by intention to treat; safety analyses were in treated patients. This study is registered with Clinical.Trials.gov, number NCT00317395. Findings Rates of the primary efficacy endpoint in the five otamixaban doses were 7.2% (nine of 125) with 0.035 mg/kg/h, 4.6% (31/676) with 0.070 mg/kg/h, 3.8% (25/662) with 0.105 mg/kg/h, 3.6% (24/658) with 0.140 mg/kg/h, and 4.3% (29/671) with 0.175 mg/kg/h (p=0.34 for trend). In the control group, the rate was 6.2% (28/449), yielding relative risks for the five otamixaban doses of 1.16 (95% CI 0.56-2.38), 0.74 (0.45-1.21), 0.61 (0.36-1.02), 0.58 (0.34-1.00), and 0.69 (0.42-1.15), respectively. Rates of the primary safety endpoint in the five otamixaban doses were 1.6% (two of 122), 1.6% (11/669), 3.1% (20/651), 3.4% (22/651), and 5.4% (36/664), respectively (p=0.0001 for trend); the rate in the control group was 2.7% (12/448). Interpretation In patients with non-ST-elevation acute coronary syndromes, otamixaban infusions of 0.100-0.140 mg/kg/h might reduce ischaemic events and have a safety profile similar to unfractionated heparin plus eptifibatide. Further testing in a phase 3 trial is warranted.	[Sabatine, Marc S.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, TIMI Study Grp, Boston, MA 02115 USA; [Sabatine, Marc S.; Antman, Elliott M.; Contant, Charles F.; McCabe, Carolyn H.; Braunwald, Eugene] Harvard Univ, Sch Med, Boston, MA USA; [Widimsky, Petr] Charles Univ Prague, Cardioctr, Fac Med 3, Prague, Czech Republic; [Ebrahim, Iftikhar O.] Unitas Hosp, Pretoria, South Africa; [Kiss, Robert G.] Semmelweis Univ, Hungarian Acad Sci, Res Grp Inflammat Biol & Immunogenom, Dept Cardiol,State Hlth Ctr, H-1085 Budapest, Hungary; [Saaiman, Andre] Kuils River Heart Unit, Cape Town, South Africa; [Polasek, Rostislav] Dist Hosp Liberec, Dept Cardiol, Liberec, Czech Republic	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Charles University Prague; Hungarian Academy of Sciences; Semmelweis University	Sabatine, MS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, TIMI Study Grp, 7S Francis St, Boston, MA 02115 USA.	msabatine@partners.org	Sabatine, Marc/AAJ-6751-2020; Widimsky, Petr/P-8088-2016	Sabatine, Marc/0000-0002-0691-3359; Widimsky, Petr/0000-0001-5686-7752	Sanofi-Aventis; Johnson Johnson; Bayer Healthcare AG; Daiichi Sankyo	Sanofi-Aventis(Sanofi-Aventis); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Bayer Healthcare AG(Bayer AGBayer Healthcare Pharmaceuticals); Daiichi Sankyo(Daiichi Sankyo Company Limited)	The TIMI Study Group receives research grant support from Sanofi-Aventis, Johnson & Johnson, Bayer Healthcare AG, and Daiichi Sankyo. Additionally, MSS reports receiving honoraria and consultant fees from Sanofi-Aventis and honoraria from Bristol-Myers Squibb. EMA reports receiving research grants from Sanofi-Aventis and Daaichi-Sankyo. RCK reports receiving honoraria from Sanofi-Aventis and Bayer AG. EB reports receiving grant support from Johnson & Johnson and honoraria and consultant fees from Sanofi-Aventis. All other authors declare that they have no conflicts of interest.	Alexander JH, 2009, CIRCULATION, V119, P2877, DOI 10.1161/CIRCULATIONAHA.108.832139; Andersen H, 1999, P NATL ACAD SCI USA, V96, P11189, DOI 10.1073/pnas.96.20.11189; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Blazing MA, 2004, JAMA-J AM MED ASSOC, V292, P55, DOI 10.1001/jama.292.1.55; Cannon CP, 2007, J AM COLL CARDIOL, V50, P1844, DOI 10.1016/j.jacc.2007.07.053; Chu V, 2001, THROMB RES, V103, P309, DOI 10.1016/S0049-3848(01)00328-0; Cohen M, 2007, CIRCULATION, V115, P2642, DOI 10.1161/CIRCULATIONAHA.106.653428; Ferguson JJ, 2004, JAMA-J AM MED ASSOC, V292, P45; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Hinder M, 2006, CLIN PHARMACOL THER, V80, P691, DOI 10.1016/j.clpt.2006.09.002; Hirsh J, 2004, CHEST, V126, p188S, DOI 10.1378/chest.126.3_suppl.188S; James S, 2009, AM HEART J, V157, P599, DOI 10.1016/j.ahj.2009.01.003; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Mehta SR, 2007, J AM COLL CARDIOL, V50, P1742, DOI 10.1016/j.jacc.2007.07.042; Oler A, 1996, JAMA-J AM MED ASSOC, V276, P811, DOI 10.1001/jama.276.10.811; Paccaly A, 2006, J CLIN PHARMACOL, V46, P37, DOI 10.1177/0091270005281817; Rebello SS, 2001, J CARDIOVASC PHARM, V38, P288, DOI 10.1097/00005344-200108000-00015; Rebello SS, 2001, BRIT J PHARMACOL, V133, P1190, DOI 10.1038/sj.bjp.0704182; Sabatine MS, 2005, AM HEART J, V149, P227, DOI 10.1016/j.ahj.2004.11.006; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	26	107	116	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					787	795		10.1016/S0140-6736(09)61454-9	http://dx.doi.org/10.1016/S0140-6736(09)61454-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492QU	19717184				2022-12-28	WOS:000269675000027
J	Lange, J; Skaletsky, H; van Daalen, SKM; Embry, SL; Korver, CM; Brown, LG; Oates, RD; Silber, S; Repping, S; Page, DC				Lange, Julian; Skaletsky, Helen; van Daalen, Saskia K. M.; Embry, Stephanie L.; Korver, Cindy M.; Brown, Laura G.; Oates, Robert D.; Silber, Sherman; Repping, Sjoerd; Page, David C.			Isodicentric Y Chromosomes and Sex Disorders as Byproducts of Homologous Recombination that Maintains Palindromes	CELL			English	Article							NATURALLY-OCCURRING DELETIONS; TESTIS-DETERMINING GENE; ROBERTSONIAN TRANSLOCATIONS; MATERNAL AGE; INTRACHROMOSOMAL RECOMBINATION; FUNCTIONAL CENTROMERES; DICENTRIC CHROMOSOMES; TURNER-SYNDROME; SERTOLI-CELLS; X-CHROMOSOMES	Massive palindromes in the human Y chromosome harbor mirror-image gene pairs essential for spermatogenesis. During evolution, these gene pairs have been maintained by intrapalindrome, arm-to-arm recombination. The mechanism of intrapalindrome recombination and risk of harmful effects are unknown. We report 51 patients with isodicentric Y (idicY) chromosomes formed by homologous crossing over between opposing arms of palindromes on sister chromatids. These ectopic recombination events occur at nearly all Y-linked palindromes. Based on our findings, we propose that intrapalindrome sequence identity is maintained via noncrossover pathways of homologous recombination. DNA double-strand breaks that initiate these pathways can be alternatively resolved by crossing over between sister chromatids to form idicY chromosomes, with clinical consequences ranging from spermatogenic failure to sex reversal and Turner syndrome. Our observations imply that crossover and noncrossover pathways are active in nearly all Y-linked palindromes, exposing an Achilles' heel in the mechanism that preserves palindrome-borne genes.	[Lange, Julian; Skaletsky, Helen; Brown, Laura G.; Page, David C.] MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; [Lange, Julian; Skaletsky, Helen; Brown, Laura G.; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [van Daalen, Saskia K. M.; Korver, Cindy M.; Repping, Sjoerd] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, Ctr Reprod Med, NL-1012 WX Amsterdam, Netherlands; [Embry, Stephanie L.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Oates, Robert D.] Boston Univ, Dept Urol, Med Ctr, Boston, MA 02118 USA; [Silber, Sherman] St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO 63107 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); University of Amsterdam; Academic Medical Center Amsterdam; Duke University; Boston University; Saint Luke's Hospital - Missouri	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu		Repping, Sjoerd/0000-0002-6959-149X; Oates, Robert/0000-0003-2330-6697	National Institutes of Health; Howard Hughes Medical Institute; Netherlands Organization for Scientific Research; Academic Medical Center of the University of Amsterdam; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Academic Medical Center of the University of Amsterdam; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health, the Howard Hughes Medical Institute, the Netherlands Organization for Scientific Research, and the Academic Medical Center of the University of Amsterdam. J. L. received a Boehringer Ingelheim fellowship.	BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; BURGOYNE PS, 1988, DEVELOPMENT, V102, P443; CAMARGO M, 1984, HUM GENET, V67, P37, DOI 10.1007/BF00270556; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; DANIEL A, 1976, J MED GENET, V13, P381, DOI 10.1136/jmg.13.5.381; Darlington CD, 1939, J GENET, V37, P341, DOI 10.1007/BF02982733; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Guillon H, 2005, MOL CELL, V20, P563, DOI 10.1016/j.molcel.2005.09.021; HAIR JB, 1953, HEREDITY S, V6, P215; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD T, 1988, AM J HUM GENET, V42, P534; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD T, 1980, ANN HUM GENET, V44, P29, DOI 10.1111/j.1469-1809.1980.tb00943.x; HSU LYF, 1994, AM J MED GENET, V53, P108, DOI 10.1002/ajmg.1320530204; HSU TC, 1975, CYTOGENET CELL GENET, V15, P41, DOI 10.1159/000130497; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; Hurles ME, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r55; Jacobs P, 1997, ANN HUM GENET, V61, P471, DOI 10.1017/S0003480097006507; JACOBS PA, 1966, NATURE, V210, P352, DOI 10.1038/210352a0; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; JOHN B, 1975, CHROMOSOMA, V52, P123, DOI 10.1007/BF00326262; Kamp C, 2000, HUM MOL GENET, V9, P2563, DOI 10.1093/hmg/9.17.2563; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kirsch S, 2005, GENOME RES, V15, P195, DOI 10.1101/gr.3302705; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOSHLAND D, 1987, CELL, V48, P801, DOI 10.1016/0092-8674(87)90077-8; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lange J, 2008, NUCLEIC ACIDS RES, V36, pD809, DOI 10.1093/nar/gkm849; MOHANDAS TK, 1992, AM J HUM GENET, V51, P526; NIEBUHR E, 1972, HUMANGENETIK, V15, P96, DOI 10.1007/BF00273440; Page SL, 1998, CHROMOSOME RES, V6, P115, DOI 10.1023/A:1009286929145; PAGE SL, 1995, HUM MOL GENET, V4, P289, DOI 10.1093/hmg/4.2.289; PALMER SJ, 1991, DEVELOPMENT, V112, P265; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Sullivan BA, 1998, NAT GENET, V20, P227, DOI 10.1038/3024; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; THERMAN E, 1986, HUM GENET, V72, P191, DOI 10.1007/BF00291876; THERMAN E, 1974, AM J HUM GENET, V26, P83; Tilford CA, 2001, NATURE, V409, P943, DOI 10.1038/35057170; Uematsu A, 2002, AM J MED GENET, V111, P134, DOI 10.1002/ajmg.10506; VERGNAUD G, 1986, AM J HUM GENET, V38, P109; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; VOLLRATH D, 1992, SCIENCE, V258, P52, DOI 10.1126/science.1439769; WANDALL A, 1989, HUM GENET, V82, P137, DOI 10.1007/BF00284046; WARBURTON D, 1980, LANCET, V1, P167	56	163	172	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					855	869		10.1016/j.cell.2009.07.042	http://dx.doi.org/10.1016/j.cell.2009.07.042			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737515	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000269564600013
J	Yadav, VK; Oury, F; Suda, N; Liu, ZW; Gao, XB; Confavreux, C; Klemenhagen, KC; Tanaka, KF; Gingrich, JA; Guo, XE; Tecott, LH; Mann, JJ; Hen, R; Horvath, TL; Karsenty, G				Yadav, Vijay K.; Oury, Franck; Suda, Nina; Liu, Zhong-Wu; Gao, Xiao-Bing; Confavreux, Cyrille; Klemenhagen, Kristen C.; Tanaka, Kenji F.; Gingrich, Jay A.; Guo, X. Edward; Tecott, Laurence H.; Mann, J. John; Hen, Rene; Horvath, Tamas L.; Karsenty, Gerard			A Serotonin-Dependent Mechanism Explains the Leptin Regulation of Bone Mass, Appetite, and Energy Expenditure	CELL			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; BODY-WEIGHT; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; 5-HT1A RECEPTOR; ARCUATE NUCLEUS; MICE LACKING; NEURONS; ACTIVATION; OBESITY	Leptin inhibition of bone mass accrual requires the integrity of specific hypothalamic neurons but not expression of its receptor on these neurons. The same is true for its regulation of appetite and energy expenditure. This suggests that leptin acts elsewhere in the brain to achieve these three functions. We show here that brainstem-derived serotonin (BDS) favors bone mass accrual following its binding to Htr2c receptors on ventromedial hypothalamic neurons and appetite via Htr1a and 2b receptors on arcuate neurons. Leptin inhibits these functions and increases energy expenditure because it reduces serotonin synthesis and firing of serotonergic neurons. Accordingly, while abrogating BDS synthesis corrects the bone, appetite and energy expenditure phenotypes caused by leptin deficiency, inactivation of the leptin receptor in serotonergic neurons recapitulates them fully. This study modifies the map of leptin signaling in the brain and identifies a molecular basis for the common regulation of bone and energy metabolisms. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Yadav, Vijay K.; Oury, Franck; Suda, Nina; Confavreux, Cyrille; Karsenty, Gerard] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; [Liu, Zhong-Wu; Gao, Xiao-Bing; Horvath, Tamas L.] Yale Univ, Comparat Med Sect, Sch Med, New Haven, CT 06510 USA; [Klemenhagen, Kristen C.; Tanaka, Kenji F.; Hen, Rene] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Tanaka, Kenji F.] Natl Inst Physiol Sci, Okazaki, Aichi 4448585, Japan; [Gingrich, Jay A.] Columbia Univ, Dept Psychiat Dev Psychobiol, New York, NY 10032 USA; [Guo, X. Edward] Columbia Univ, Dept Biomed Engn, Bone Bioengn Lab, New York, NY 10027 USA; [Tecott, Laurence H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Mann, J. John] Columbia Univ, Dept Psychiat, New York, NY 10032 USA	Columbia University; Yale University; Columbia University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Columbia University; Columbia University; University of California System; University of California San Francisco; Columbia University	Karsenty, G (corresponding author), Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA.	gk2172@columbia.edu	Bruix, Marta/H-4161-2011; Liu, Zhong-Wu/C-2794-2011; Martinez-del-Pozo, Alvaro/L-8556-2014; Gao, Xiao-Bing/C-3121-2011; yadav, VIJAY k/Q-2540-2016	Bruix, Marta/0000-0002-0096-3558; Martinez-del-Pozo, Alvaro/0000-0003-0043-5939; Gao, Xiao-Bing/0000-0002-2035-4936; yadav, VIJAY k/0000-0003-2345-2846; Tanaka, Kenji/0000-0003-2511-0057; OURY, FRANCK/0000-0003-0562-9900	NIH; IBMS; HFSP; FRM; foundation Bettencourt Schueller; Philippe foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058883, R01DK067936] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IBMS; HFSP(Human Frontier Science Program); FRM(Fondation pour la Recherche Medicale); foundation Bettencourt Schueller; Philippe foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (G. K.), a Gideon and Sevgi Rodan fellowship from IBMS (V. K. Y.), HFSP (F. O.), FRM (F. O.), foundation Bettencourt Schueller (F. O. and C. C.), and the Philippe foundation (F. O. and C. C.). G. K. is the founder of Escoublac.	ASTONJONES G, 1991, J NEUROSCI, V11, P760; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Coppari R, 2005, CELL METAB, V1, P63, DOI 10.1016/j.cmet.2004.12.004; de Wall EV, 2008, ENDOCRINOLOGY, V149, P1773, DOI 10.1210/en.2007-1132; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 2000, FRONT HORM RES, V26, P21; EYRE DR, 1988, BIOCHEM J, V252, P495, DOI 10.1042/bj2520495; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GILBERT F, 1988, PSYCHONEUROENDOCRINO, V13, P471, DOI 10.1016/0306-4530(88)90032-7; HEATH MJS, 1995, CURR BIOL, V5, P997, DOI 10.1016/S0960-9822(95)00199-0; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Hinoi E, 2008, J CELL BIOL, V183, P1235, DOI 10.1083/jcb.200809113; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jensen P, 2008, NAT NEUROSCI, V11, P417, DOI 10.1038/nn2050; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Klemenhagen KC, 2006, NEUROPSYCHOPHARMACOL, V31, P101, DOI 10.1038/sj.npp.1300774; Lam DD, 2008, ENDOCRINOLOGY, V149, P1323, DOI 10.1210/en.2007-1321; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Liu RJ, 2002, J NEUROSCI, V22, P9453; MANN JJ, 1992, ARCH GEN PSYCHIAT, V49, P442; NEILL JC, 1988, EUR J PHARMACOL, V151, P329, DOI 10.1016/0014-2999(88)90818-7; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; Oury F, 2006, SCIENCE, V313, P1408, DOI 10.1126/science.1130042; Pasqualetti M, 1998, ANN NY ACAD SCI, V861, P245, DOI 10.1111/j.1749-6632.1998.tb10202.x; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Pogoda P, 2006, J BONE MINER RES, V21, P1591, DOI 10.1359/JBMR.060709; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; Richards JB, 2007, ARCH INTERN MED, V167, P188, DOI 10.1001/archinte.167.2.188; Shi Y, 2008, P NATL ACAD SCI USA, V105, P20529, DOI 10.1073/pnas.0808701106; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952; Waddington SN, 2007, CURR OPIN MOL THER, V9, P432; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Xu Y, 2008, NEURON, V60, P582, DOI 10.1016/j.neuron.2008.09.033; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	48	462	486	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					976	989		10.1016/j.cell.2009.06.051	http://dx.doi.org/10.1016/j.cell.2009.06.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737523	Bronze, Green Accepted			2022-12-28	WOS:000269564600022
J	de Andrade, M				de Andrade, Marisa			Research Ethics In clear sight	BRITISH MEDICAL JOURNAL			English	Editorial Material												marisa.de-andrade@strath.ac.uk						*BEATT COMM, 2009, FULL SERV HEALTHC PR; *CLIN TRIALS GOV, 2007, STAND CAR VERS CEL O; *CLIN TRIALS GOV, 2008, PROT DAT EL DEF; *ED CLIN TRIALS UN, 2009, SCOT STAND CAR VERS; *EUR MED EV AG, 2005, HUM MED REF; *INT COMM MED J AU, 2008, UN REQ MAN SUBM BIOM; Smyth RL, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2473; 2007, HERALD          1217; 2007, BBC NEWS        1217; 2007, PHARM MARKETLET 1219; 2007, DAILY MAIL      1217	11	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 2	2009	339								b3443	10.1136/bmj.b3443	http://dx.doi.org/10.1136/bmj.b3443			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CH	19726462	Green Submitted			2022-12-28	WOS:000269554000010
J	Rosenbaum, JT				Rosenbaum, James T.			Howard	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rosenbaj@ohsu.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					929	930		10.1001/jama.2009.1170	http://dx.doi.org/10.1001/jama.2009.1170			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724031				2022-12-28	WOS:000269444900001
J	Quill, TE; Arnold, R; Back, AL				Quill, Timothy E.; Arnold, Robert; Back, Anthony L.			Discussing Treatment Preferences With Patients Who Want "Everything"	ANNALS OF INTERNAL MEDICINE			English	Article							NOT-RESUSCITATE ORDERS; SERIOUSLY ILL PATIENTS; ADVANCED CANCER; CARDIOPULMONARY-RESUSCITATION; PALLIATIVE CARE; LIFE; PHYSICIANS; END; COMMUNICATION; FAMILIES	When asked about setting limits on medical treatment in the face of severe illness, patients and their families often respond that they want "everything." Clinicians should not take this request at face value, but should instead use it as the basis for a broader discussion about what "doing everything" means to the patient. The discussion might include questions about what balances of treatment burden and benefit the patient can tolerate and about emotional, cognitive, spiritual, and family factors that underlie the request. After this initial exploration, the clinician can propose a philosophy of treatment and make recommendations that capture the patient's values and preferences in light of the medical condition. Clinicians should respond to emotional reactions, directly negotiate disagreements, and use harm-reduction strategies for the relatively infrequent instances in which patients continue to request burdensome therapy that is unlikely to help. By using this approach, patients, families, and clinicians will be better able to understand each other and join together to develop a treatment approach that best respects patient and family values in light of what is medically achievable.	[Quill, Timothy E.] Univ Rochester, Med Ctr, Ctr Eth Humanities & Palliat Care, Rochester, NY 14642 USA; Univ Pittsburgh, Pittsburgh, PA 15213 USA; Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA	University of Rochester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Ctr Eth Humanities & Palliat Care, Box 687,601 Elmwood Ave, Rochester, NY 14642 USA.	timothy_quill@urmc.rochester.edu						Back AL, 2009, MASTERING COMMUNICAT; Back AL, 2008, CANCER-AM CANCER SOC, V113, P1897, DOI 10.1002/cncr.23653; Beach MC, 2002, J AM GERIATR SOC, V50, P2057, DOI 10.1046/j.1532-5415.2002.50620.x; COHENCOLE SA, 2000, MEDICAL INTERVIEW 3; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Curtis JR, 2007, CHEST, V132, P754, DOI 10.1378/chest.07-1331; Cwrtis JR, 2007, CHEST, V132, P748, DOI 10.1378/chest.07-0745; Doig C, 2006, CRIT CARE, V10, DOI 10.1186/cc5016; Fisher R., 2011, GETTING YES NEGOTIAT; Gazelle G, 1998, NEW ENGL J MED, V338, P467, DOI 10.1056/NEJM199802123380712; Gillis J, 2008, ARCH DIS CHILD, V93, P192, DOI 10.1136/adc.2007.120568; Goold SD, 2000, JAMA-J AM MED ASSOC, V283, P909, DOI 10.1001/jama.283.7.909; King DA, 2006, J PALLIAT MED, V9, P704, DOI 10.1089/jpm.2006.9.704; Kubler-Ross E., 1969, DEATH DYING; Lamont EB, 2003, JAMA-J AM MED ASSOC, V290, P98, DOI 10.1001/jama.290.1.98; Manthous CA, 2007, CHEST, V132, P751, DOI 10.1378/chest.07-0912; MILLER DL, 1993, ARCH INTERN MED, V153, P1999, DOI 10.1001/archinte.153.17.1999; MURPHY DJ, 1989, ANN INTERN MED, V111, P199, DOI 10.7326/0003-4819-111-3-199; Olver I, 2008, PSYCHO-ONCOL, V17, P347, DOI 10.1002/pon.1246; Pantilat SZ, 2009, JAMA-J AM MED ASSOC, V301, P1279, DOI 10.1001/jama.2009.396; Phelps AC, 2009, JAMA-J AM MED ASSOC, V301, P1140, DOI 10.1001/jama.2009.341; Pisetsky DS, 1998, ANN INTERN MED, V128, P869, DOI 10.7326/0003-4819-128-10-199805150-00013; Prigerson HG, 2001, JAMA-J AM MED ASSOC, V286, P1369, DOI 10.1001/jama.286.11.1369; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Quill T, 2006, J PALLIAT MED, V9, P382, DOI 10.1089/jpm.2006.9.382; Reinke LF, 2008, J PALLIAT MED, V11, P601, DOI 10.1089/jpm.2007.0236; ROTER DL, 1995, ARCH INTERN MED, V155, P1877, DOI 10.1001/archinte.155.17.1877; TOMLINSON T, 1988, NEW ENGL J MED, V318, P43, DOI 10.1056/NEJM198801073180109; TULSKY JA, 1995, J GEN INTERN MED, V10, P436, DOI 10.1007/BF02599915	30	92	92	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					345	U75		10.7326/0003-4819-151-5-200909010-00010	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492KB	19721022				2022-12-28	WOS:000269653100008
J	Rudavsky, R; Pollack, CE; Mehrotra, A				Rudavsky, Rena; Pollack, Craig Evan; Mehrotra, Ateev			The Geographic Distribution, Ownership, Prices, and Scope of Practice at Retail Clinics	ANNALS OF INTERNAL MEDICINE			English	Article							HEALTH-CARE; VISITS	Background: Retail clinics are clinics within a retail store that provide simple acute and preventive care services for a fixed price without an appointment. Objective: To describe characteristics of retail clinics, including their location, scope of practice, prices, acceptance of insurance, and ownership, and to estimate the proportion of the U. S. population that lives within a short driving distance of such a clinic. Design: Cross-sectional descriptive study. Setting: United States. Participants: All 982 retail clinics operating as of August 2008. Measurements: Population living within a 5- and 10-minute driving distance of a retail clinic. Results: In August 2008, 42 operators ran 982 clinics in 33 states; 88.4% were located in urban areas. Nearly half (44%) of all clinics were located in 5 states ( Florida, California, Texas, Minnesota, and Illinois). All offered sore throat treatment ( average price, $78) and more than 95% offered treatment of skin conditions, immunizations, pregnancy testing, and lipid or diabetes screening. Almost all (97%) accepted private insurance and Medicare fee-for-service (93%). Among 42 clinic operators, 25 are existing health care companies that operate 11% of the clinics, and 3 are for-profit retail chains that operate 73% of the clinics. An estimated 10.6% of the total U. S. and 13.4% of the urban U. S. population lives within a 5- minute driving distance of a retail clinic, whereas 28.7% ( total) and 35.8% ( urban) live within a 10-minute driving distance. Limitation: Our inventory of clinics stopped in August 2008 and estimates of proximity are based on 2000 census data. Conclusion: Retail clinics are positioned to provide immunizations and care for simple acute conditions for a substantial segment of the urban U. S. population.	[Mehrotra, Ateev] RAND Hlth, Pittsburgh, PA 15213 USA; RAND Hlth, Washington, DC USA; Univ Penn, Philadelphia, PA 19104 USA; Vet Affairs Med Ctr, Philadelphia, PA USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	RAND Corporation; RAND Corporation; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Philadelphia Veterans Affairs Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mehrotra, A (corresponding author), RAND Hlth, 4570 5th Ave,Suite 600, Pittsburgh, PA 15213 USA.	mehrotra@rand.org	Mehrotra, Ateev/AAO-8454-2021	Mehrotra, Ateev/0000-0003-2223-1582	California Healthcare Foundation; National Center for Research Resources [KL2 RR024154-03]; National Institutes of Health; Department of Veterans Affairs; Robert Wood Johnson Foundation Clinical Scholars Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER	California Healthcare Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Robert Wood Johnson Foundation Clinical Scholars Program(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Primary Funding Source: California Healthcare Foundation.; By the California Healthcare Foundation; a career development award (KL2 RR024154-03) from the National Center for Research Resources, a component of the National Institutes of Health (Dr. Mehrotra); and the Department of Veterans Affairs and the Robert Wood Johnson Foundation Clinical Scholars Program ( Dr. Pollack).	*AM AC FAM PHYS, 2007, POL STAT AM AC FAM P; *AM COLL EM PHYS, 2008, ANN EMERG MED, V52, P190; Anderson Howard J, 2008, Health Data Manag, V16, P50; [Anonymous], 2009, AM MED NEWS; Bachman John, 2006, Fam Pract Manag, V13, P19; Bohmer R, 2007, NEW ENGL J MED, V356, P765, DOI 10.1056/NEJMp068289; Corwin RM, 2006, PEDIATRICS, V118, P2561, DOI 10.1542/peds.2006-2681; Costello D, 2008, HEALTH AFFAIR, V27, P1299, DOI 10.1377/hlthaff.27.5.1299; Dunkley B, 2004, J PLAN EDUC RES, V23, P387, DOI 10.1177/0739456X04264890; Hansen-Turton T, 2007, DIS MANAGE, V10, P61, DOI 10.1089/dis.2006.636; JAPSEN B, 2007, CHICAGO TRIBUNE 0625; Kolar Ray, 2008, Healthc Financ Manage, V62, P46; Laws M, 2008, HEALTH AFFAIR, V27, P1293, DOI 10.1377/hlthaff.27.5.1293; Mehrotra A, 2008, HEALTH AFFAIR, V27, P1272, DOI 10.1377/hlthaff.27.5.1272; OKEEFE L, 2006, AAP NEWS, V1, P9; Robertson JA, 2007, HASTINGS CENT REP, V37, P26, DOI 10.1353/hcr.2007.0060; Rohrer JE, 2008, J AM BOARD FAM MED, V21, P475, DOI 10.3122/jabfm.2008.05.080072; Rohrer James E, 2009, Qual Manag Health Care, V18, P19, DOI 10.1097/01.QMH.0000344590.61971.97; SCOTT M, 2007, HLTH CARE EXPRESS LA; Scott MK, 2006, HLTH CARE EXPRESS LA; SCOTT MK, 2008, ADAPTING RETAIL CLIN; STARZ TW, 2006, PITTSBURGH POST 1101; STEENHUYSEN J, 2007, AMA SEEK PROBE RETAI; TAKACH M, 2009, ANAL STATE REGULATIO; Thygeson M, 2008, HEALTH AFFAIR, V27, P1283, DOI 10.1377/hlthaff.27.5.1283; Tu H. T., 2008, CHECKING RETAIL BASE; U. S. Bureau of the Census, 2002, CENS 2000 URB RUR CL; Williams Brenda, 2008, Tenn Med, V101, P21; Woodburn JA, 2007, AM J MED QUAL, V22, P457, DOI 10.1177/1062860607309626; 2007, GOVERNOR RENDELLS PR; 2008, REMARKS J MCCAIN HLT	31	59	59	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					315	U41		10.7326/0003-4819-151-5-200909010-00005	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00005			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492KB	19721019	Green Accepted			2022-12-28	WOS:000269653100003
J	Abramson, JS; Digumarthy, S; Ferry, JA				Abramson, Jeremy S.; Digumarthy, Subba; Ferry, Judith A.			A Woman with Fever, Rash, and Lymphadenopathy Angioimmunoblastic T-cell lymphoma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-HODGKINS-LYMPHOMA; CLINICAL-FEATURES; KIKUCHIS-DISEASE; COMPLETE REMISSION; NATURAL-HISTORY; TRANSPLANTATION; CHEMOTHERAPY; THERAPY; LYMPHADENITIS; EXPRESSION		[Abramson, Jeremy S.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Digumarthy, Subba] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ferry, Judith A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Abramson, Jeremy S.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Digumarthy, Subba] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Ferry, Judith A.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Abramson, JS (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.		Abramson, Jeremy/N-5178-2019					Abramson JS, 2006, ONCOLOGIST, V11, P384, DOI 10.1634/theoncologist.11-4-384; Armitage JO, 1998, J CLIN ONCOL, V16, P2780, DOI 10.1200/JCO.1998.16.8.2780; Attygalle A, 2002, BLOOD, V99, P627, DOI 10.1182/blood.V99.2.627; Attygalle AD, 2007, AM J SURG PATHOL, V31, P1077, DOI 10.1097/PAS.0b013e31802d68e9; Atwater AR, 2008, J AM ACAD DERMATOL, V59, P130, DOI 10.1016/j.jaad.2008.03.012; Bruns I, 2005, LEUKEMIA, V19, P1993, DOI 10.1038/sj.leu.2403936; Bujanda DA, 2008, ANN ONCOL, V19, P396, DOI 10.1093/annonc/mdm579; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Corradini P, 2004, J CLIN ONCOL, V22, P2172, DOI 10.1200/JCO.2004.12.050; Crispin JC, 2005, MEDICINE, V84, P331, DOI 10.1097/01.md.0000188009.47085.76; Dang NH, 2007, BRIT J HAEMATOL, V136, P439, DOI 10.1111/j.1365-2141.2006.06457.x; deShazo RD, 2004, AM J MED, V116, P843, DOI 10.1016/j.amjmed.2004.02.026; DOGAN A, 2008, WHO CLASSIFICATION T, P309; Dorfman DM, 2006, AM J SURG PATHOL, V30, P802, DOI 10.1097/01.pas.0000209855.28282.ce; Enblad G, 2004, BLOOD, V103, P2920, DOI 10.1182/blood-2003-10-3389; FELLER AC, 1988, AM J PATHOL, V133, P549; Ferry JA, 2002, ADV ANAT PATHOL, V9, P273, DOI 10.1097/00125480-200209000-00001; Freeman TM, 2004, NEW ENGL J MED, V351, P1978, DOI 10.1056/NEJMcp042013; FRIZZERA G, 1974, LANCET, V1, P1070; Gaig P, 1999, J INVEST ALLERG CLIN, V9, P190; Grogg KL, 2006, MODERN PATHOL, V19, P1101, DOI 10.1038/modpathol.3800625; Halene S, 2006, NAT CLIN PRACT ONCOL, V3, P165, DOI 10.1038/ncponc0430; Hurt C, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.12.011; KANEKO Y, 1988, BLOOD, V72, P413; KELLY CA, 1987, ANN RHEUM DIS, V46, P224, DOI 10.1136/ard.46.3.224; KUO TT, 1995, AM J SURG PATHOL, V19, P798, DOI 10.1097/00000478-199507000-00008; Kyriakou C, 2008, J CLIN ONCOL, V26, P218, DOI 10.1200/JCO.2007.12.6219; Lachenal F, 2007, MEDICINE, V86, P282, DOI 10.1097/MD.0b013e3181573059; Lazoglu AH, 1995, ANN ALLERG ASTHMA IM, V75, P522; Le Gouill S, 2008, J CLIN ONCOL, V26, P2264, DOI 10.1200/JCO.2007.14.1366; LIGHT WC, 1977, J ALLERGY CLIN IMMUN, V59, P391, DOI 10.1016/0091-6749(77)90024-0; Lin HC, 2003, OTOLARYNG HEAD NECK, V128, P650, DOI 10.1016/S0194-5998(02)23291-X; LUKES RJ, 1975, NEW ENGL J MED, V292, P1, DOI 10.1056/NEJM197501022920101; Mourad N, 2008, BLOOD, V111, P4463, DOI 10.1182/blood-2007-08-105759; Nguyen SA, 2005, ANN ALLERG ASTHMA IM, V94, P387, DOI 10.1016/S1081-1206(10)60992-1; Oksenhendler E, 1996, AIDS, V10, P61, DOI 10.1097/00002030-199601000-00009; Park BB, 2007, LEUKEMIA LYMPHOMA, V48, P716, DOI 10.1080/10428190601123989; Pautier P, 1999, LEUKEMIA LYMPHOMA, V32, P545, DOI 10.3109/10428199909058412; Reiser M, 2002, LEUKEMIA LYMPHOMA, V43, P805, DOI 10.1080/10428190290016926; Rodriguez J, 2007, EUR J HAEMATOL, V78, P290, DOI 10.1111/j.1600-0609.2007.00815.x; Roncador G, 2007, HAEMATOLOGICA, V92, P1059, DOI 10.3324/haematol.10864; Rudiger T, 2002, ANN ONCOL, V13, P140, DOI 10.1093/annonc/mdf033; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; SEGAL GH, 1993, SEMIN ONCOL, V20, P611; SIEGERT W, 1992, ANN INTERN MED, V117, P364, DOI 10.7326/0003-4819-117-5-364; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; TSANG WYW, 1994, AM J SURG PATHOL, V18, P219, DOI 10.1097/00000478-199403000-00001; Vose JM, 2008, J CLIN ONCOL, V26, P4124, DOI 10.1200/JCO.2008.16.4558; WEISS LM, 1986, AM J PATHOL, V122, P392; Willenbrock K, 2007, BRIT J HAEMATOL, V138, P733, DOI 10.1111/j.1365-2141.2007.06725.x	50	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					900	911		10.1056/NEJMcpc0902223	http://dx.doi.org/10.1056/NEJMcpc0902223			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XV	19710489				2022-12-28	WOS:000269312700012
J	Beug, H				Beug, Hartmut			Breast Cancer Stem Cells: Eradication by Differentiation Therapy?	CELL			English	Editorial Material							EPITHELIAL-MESENCHYMAL TRANSITION	During metastasis, migrating breast cancer stem cells undergo a loss of polarity leading to an epithelial-to-mesenchymal transition (EMT). Gupta et al. (2009) use this attribute of cancer stem cells to develop a high-throughput screen, which successfully identifies small molecules that specifically inhibit cancer stem cell proliferation through the induction of differentiation.	Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Beug, H (corresponding author), Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	beug@imp.ac.at						Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Jean-Yves L, 2007, RECENT PAT ANTI-CANC, V2, P189, DOI 10.2174/157489207782497244; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; LE G, 2007, ANTICANCER DRUG DISC, V2, P189; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; MITANI M, 1975, BIOCHEM BIOPH RES CO, V66, P1231, DOI 10.1016/0006-291X(75)90490-8; Peters TL, 2002, AVIAN DIS, V46, P75, DOI 10.1637/0005-2086(2002)046[0075:EOAOIV]2.0.CO;2; Tanos B, 2008, ONCOGENE, V27, P6939, DOI 10.1038/onc.2008.345; Zhang Lei, 2009, Shengli Xuebao, V61, P15	10	36	43	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					623	625		10.1016/j.cell.2009.08.007	http://dx.doi.org/10.1016/j.cell.2009.08.007			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703390	Bronze			2022-12-28	WOS:000269156100005
J	O'Byrne, PM; Gauvreau, G				O'Byrne, Paul M.; Gauvreau, Gail			Phosphodiesterase-4 inhibition in COPD	LANCET			English	Editorial Material							OBSTRUCTIVE PULMONARY-DISEASE; ROFLUMILAST; NEUTROPHIL; CILOMILAST; TRIAL		[O'Byrne, Paul M.] McMaster Univ, Med Ctr, Firestone Inst Resp Hlth, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Med Ctr, Dept Med, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University	O'Byrne, PM (corresponding author), McMaster Univ, Med Ctr, Firestone Inst Resp Hlth, Hamilton, ON L8N 3Z5, Canada.	obyrnep@mcmaster.ca		O'Byrne, Paul/0000-0003-0979-281X				Aversa A, 2006, CURR PHARM DESIGN, V12, P3467, DOI 10.2174/138161206778343046; Boswell-Smith V, 2006, BRIT J PHARMACOL, V147, pS252, DOI 10.1038/sj.bjp.0706495; Calverley PMA, 2007, AM J RESP CRIT CARE, V176, P154, DOI 10.1164/rccm.200610-1563OC; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Compton CH, 2001, LANCET, V358, P265, DOI 10.1016/S0140-6736(01)05481-2; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Fabbri LM, 2009, LANCET, V374, P695, DOI 10.1016/S0140-6736(09)61252-6; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Hidi R, 2000, EUR RESPIR J, V15, P342, DOI 10.1034/j.1399-3003.2000.15b21.x; Jones NA, 2005, PULM PHARMACOL THER, V18, P93, DOI 10.1016/j.pupt.2004.10.001; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rennard SI, 2006, CHEST, V129, P56, DOI 10.1378/chest.129.1.56; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800	15	17	18	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2009	374	9691					665	667		10.1016/S0140-6736(09)61538-5	http://dx.doi.org/10.1016/S0140-6736(09)61538-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716944				2022-12-28	WOS:000269422500004
J	Yang, Y; Sugimoto, JD; Halloran, ME; Basta, NE; Chao, DL; Matrajt, L; Potter, G; Kenah, E; Longini, IM				Yang, Yang; Sugimoto, Jonathan D.; Halloran, M. Elizabeth; Basta, Nicole E.; Chao, Dennis L.; Matrajt, Laura; Potter, Gail; Kenah, Eben; Longini, Ira M., Jr.			The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus	SCIENCE			English	Article							MITIGATION STRATEGIES; UNITED-STATES; COMMUNITY; MODEL; PARAMETERS; HOUSEHOLD	Pandemic influenza A (H1N1) 2009 (pandemic H1N1) is spreading throughout the planet. It has become the dominant strain in the Southern Hemisphere, where the influenza season has now ended. Here, on the basis of reported case clusters in the United States, we estimated the household secondary attack rate for pandemic H1N1 to be 27.3% [95% confidence interval (CI) from 12.2% to 50.5%]. From a school outbreak, we estimated that a typical schoolchild infects 2.4 (95% CI from 1.8 to 3.2) other children within the school. We estimated the basic reproductive number, R-0, to range from 1.3 to 1.7 and the generation interval to range from 2.6 to 3.2 days. We used a simulation model to evaluate the effectiveness of vaccination strategies in the United States for fall 2009. If a vaccine were available soon enough, vaccination of children, followed by adults, reaching 70% overall coverage, in addition to high-risk and essential workforce groups, could mitigate a severe epidemic.	[Yang, Yang; Sugimoto, Jonathan D.; Halloran, M. Elizabeth; Basta, Nicole E.; Chao, Dennis L.; Kenah, Eben; Longini, Ira M., Jr.] Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Seattle, WA 98109 USA; [Yang, Yang; Sugimoto, Jonathan D.; Halloran, M. Elizabeth; Basta, Nicole E.; Chao, Dennis L.; Kenah, Eben; Longini, Ira M., Jr.] Univ Washington, Seattle, WA 98109 USA; [Sugimoto, Jonathan D.; Basta, Nicole E.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Halloran, M. Elizabeth; Kenah, Eben; Longini, Ira M., Jr.] Univ Washington, Dept Biostat, Sch Publ Hlth, Seattle, WA 98195 USA; [Matrajt, Laura] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Potter, Gail] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Kenah, Eben] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Longini, IM (corresponding author), Fred Hutchinson Canc Res Ctr, Ctr Stat & Quantitat Infect Dis, Seattle, WA 98109 USA.	longini@scharp.org	Basta, Nicole/B-4157-2013; Matrajt, Laura/AAV-5216-2020	Chao, Dennis/0000-0002-8253-6321; Sugimoto, Jonathan/0000-0002-1761-328X; Yang, Yang/0000-0003-0428-5480	National Institute of General Medical Sciences MIDAS [U01-GM070749]; National Institute of Allergy and Infectious Diseases [R01-AI32042]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institute of General Medical Sciences MIDAS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the National Institute of General Medical Sciences MIDAS grant U01-GM070749 and the National Institute of Allergy and Infectious Diseases grant R01-AI32042.	Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Basta NE, 2008, AM J EPIDEMIOL, V168, P1343, DOI 10.1093/aje/kwn259; BRIAND S, 2009, WHO STRAT ADV GROUP; *CDCP, 2009, FLUVIEW 2008 2009 IN; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P435, DOI DOI 10.1007/S00134-010-2021-3; Chan M., 2009, WORLD NOW START 2009; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Chowell G, 2007, MATH BIOSCI ENG, V4, P457, DOI 10.3934/mbe.2007.4.457; DUNN FL, 1959, AM J HYG, V70, P351, DOI 10.1093/oxfordjournals.aje.a120083; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; GLEZEN WP, 1982, AM J EPIDEMIOL, V116, P589, DOI 10.1093/oxfordjournals.aje.a113441; Grais R F, 2004, Health Care Manag Sci, V7, P127, DOI 10.1023/B:HCMS.0000020652.38181.da; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Halloran ME, 2006, SCIENCE, V311, P615, DOI 10.1126/science.1122143; *KS DEP HLTH ENV, 2009, SWIN INFL NEWS C 29; *KS DEP HLTH ENV, 2009, KDHE REP 2 CAS SWIN; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; LONGINI IM, 1978, MATH BIOSCI, V38, P141, DOI 10.1016/0025-5564(78)90023-8; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; LONGINI IM, 1986, MATH BIOSCI, V82, P19, DOI 10.1016/0025-5564(86)90003-9; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; *NAT I ALL INF DIS, 2009, CLIN TRIALS 2009 H1N; *NY CIT DEP HLTH M, 2009, ST FRANC PREP UPD SW; ROBINSON R, 2009, ADV COMM IMM PRACT A; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; *WHO, 2009, NOV INFL A H1N1 UPD; *WORLD HLTH ORG, 2009, PROD AV PAND INFL H1; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111; Yang Y, 2007, COMPUT STAT DATA AN, V51, P6582, DOI 10.1016/j.csda.2007.03.007	35	398	420	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 30	2009	326	5953					729	733		10.1126/science.1177373	http://dx.doi.org/10.1126/science.1177373			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512GB	19745114	Green Accepted			2022-12-28	WOS:000271233200038
J	Williams, B				Williams, Bryan			Resistant hypertension: an unmet treatment need	LANCET			English	Editorial Material							BLOOD-PRESSURE; SPIRONOLACTONE; MANAGEMENT		[Williams, Bryan] Univ Leicester, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England; [Williams, Bryan] Univ Leicester, NIHR, Cardiovasc Biomed Res Unit, Leicester LE2 7LX, Leics, England	University of Leicester; University of Leicester	Williams, B (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester LE2 7LX, Leics, England.	bw17@le.acuk		Williams, Bryan/0000-0002-8094-1841				Calhoun DA, 2008, HYPERTENSION, V51, P1403, DOI 10.1161/HYPERTENSIONAHA.108.189141; Chapman N, 2007, HYPERTENSION, V49, P839, DOI 10.1161/01.HYP.0000259805.18468.8c; Higgins B, 2007, CLIN MED, V7, P612, DOI 10.7861/clinmedicine.7-6-612; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lane DA, 2007, J HYPERTENS, V25, P891, DOI 10.1097/HJH.0b013e328014954d; Weber MA, 2009, LANCET, V374, P1423, DOI 10.1016/S0140-6736(09)61500-2; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1	7	23	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 24	2009	374	9699					1396	1398		10.1016/S0140-6736(09)61600-7	http://dx.doi.org/10.1016/S0140-6736(09)61600-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MZ	19748666				2022-12-28	WOS:000271255000005
J	Klattenhoff, C; Xi, HL; Li, CJ; Lee, S; Xu, J; Khurana, JS; Zhang, F; Schultz, N; Koppetsch, BS; Nowosielska, A; Seitz, H; Zamore, PD; Weng, ZP; Theurkauf, WE				Klattenhoff, Carla; Xi, Hualin; Li, Chengjian; Lee, Soohyun; Xu, Jia; Khurana, Jaspreet S.; Zhang, Fan; Schultz, Nadine; Koppetsch, Birgit S.; Nowosielska, Anetta; Seitz, Herve; Zamore, Phillip D.; Weng, Zhiping; Theurkauf, William E.			The Drosophila HP1 Homolog Rhino Is Required for Transposon Silencing and piRNA Production by Dual-Strand Clusters	CELL			English	Article							EMBRYONIC AXIS SPECIFICATION; SELFISH GENETIC ELEMENTS; FLAMENCO GENE; DNA-DAMAGE; GERM-LINE; MELANOGASTER; HETEROCHROMATIN; GYPSY; PIWI; PROTEIN	Piwi-interacting RNAs (piRNAs) silence transposons and maintain genome integrity during germline development. In Drosophila, transposon-rich heterochromatic clusters encode piRNAs either on both genomic strands (dual-strand clusters) or predominantly one genomic strand (uni-strand clusters). Primary piRNAs derived from these clusters are proposed to drive a ping-pong amplification cycle catalyzed by proteins that localize to the perinuclear nuage. We show that the HP1 homolog Rhino is required for nuage organization, transposon silencing, and ping-pong amplification of piRNAs. rhi mutations virtually eliminate piRNAs from the dual-strand clusters and block production of putative precursor RNAs from both strands of the major 42AB dual-strand cluster, but not of transcripts or piRNAs from the uni-strand clusters. Furthermore, Rhino protein associates with the 42AB dual-strand cluster, but does not bind to uni-strand cluster 2 or flamenco. Rhino thus appears to promote transcription of dual-strand clusters, leading to production of piRNAs that drive the ping-pong amplification cycle.	[Li, Chengjian; Seitz, Herve; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; [Li, Chengjian; Seitz, Herve; Zamore, Phillip D.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; [Klattenhoff, Carla; Khurana, Jaspreet S.; Zhang, Fan; Schultz, Nadine; Koppetsch, Birgit S.; Nowosielska, Anetta; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Klattenhoff, Carla; Khurana, Jaspreet S.; Zhang, Fan; Schultz, Nadine; Koppetsch, Birgit S.; Nowosielska, Anetta; Theurkauf, William E.] Univ Massachusetts, Sch Med, Program Cell Dynam, Worcester, MA 01605 USA; [Xi, Hualin; Lee, Soohyun; Xu, Jia; Weng, Zhiping] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01605 USA; [Seitz, Herve] Univ Toulouse 3, Univ Toulouse, Lab Biol Mol Eucaryote, F-31000 Toulouse, France; [Seitz, Herve] CNRS, Lab Biol Mol Eucaryote, F-31000 Toulouse, France; [Xu, Jia] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Xi, Hualin; Lee, Soohyun] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Xi, Hualin] Pfizer Inc, Computat Sci Ctr Emphasis, Cambridge, MA 02139 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Boston University; Boston University; Pfizer	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.	phillip.zamore@umassmed.edu; zhiping.weng@umassmed.edu; william.theurkauf@umassmed.edu	Zamore, Phillip D/A-8941-2013; Xu, Jia/F-7750-2012; Seitz, Hervé/AAE-6487-2019	Seitz, Hervé/0000-0001-8172-5393; Zamore, Phillip/0000-0002-4505-9618; Theurkauf, William/0000-0001-7342-1912; Xu, Jia/0000-0003-3921-018X; Lee, Soohyun/0000-0002-3594-6213	Diabetes and Endocrinology research Center [DK032502]; National Institutes of Health [HD049116, GM62862, GM65236]; Pfizer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD049116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM062862, R01GM065236, R01GM062862] Funding Source: NIH RePORTER	Diabetes and Endocrinology research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pfizer(Pfizer); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Celeste Berg for rhi mutant stocks, Maria Zapp and Ellie Kittler in the UMass Deep Sequencing Core and Phyllis Spartick in the UMass Genomics core for expert assistance with small RNA sequencing and tiling array analyses, and members of the Zamore, Weng, and Theurkauf labs for critical discussions during the course of these studies. The Genomics Core was supported by the Diabetes and Endocrinology research Center grant DK032502. This work was supported in part by grants from the National Institutes of Health to W. E. T. (HD049116) and P. D. Z. (GM62862 and GM65236). H. X. was supported in part by Pfizer.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; BOZZETTI MP, 1995, P NATL ACAD SCI USA, V92, P6067, DOI 10.1073/pnas.92.13.6067; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brower-Toland B, 2007, GENE DEV, V21, P2300, DOI 10.1101/gad.1564307; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; Chambeyron S, 2008, P NATL ACAD SCI USA, V105, P14964, DOI 10.1073/pnas.0805943105; Chen Y, 2007, CURR BIOL, V17, P637, DOI 10.1016/j.cub.2007.02.027; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Desset S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001526; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elgin SCR, 2003, CURR BIOL, V13, pR895, DOI 10.1016/j.cub.2003.11.006; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Girton JR, 2008, ADV GENET, V61, P1, DOI 10.1016/S0065-2660(07)00001-6; Gong WJ, 2005, PLOS GENET, V1, P589, DOI 10.1371/journal.pgen.0010067; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HAWLEY RS, 1983, GENETICS, V104, P63; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Jang JK, 2003, J CELL SCI, V116, P3069, DOI 10.1242/jcs.00614; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIANG L, 1994, DEVELOPMENT, V120, P1201; Lim AK, 2007, P NATL ACAD SCI USA, V104, P6714, DOI 10.1073/pnas.0701920104; Lin HF, 2007, SCIENCE, V316, P397, DOI 10.1126/science.1137543; LIVAK KJ, 1990, GENETICS, V124, P303; LIVAK KJ, 1984, GENETICS, V107, P611; McKim KS, 1998, GENE DEV, V12, P2932, DOI 10.1101/gad.12.18.2932; Mevel-Ninio M, 2007, GENETICS, V175, P1615, DOI 10.1534/genetics.106.068106; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; O'Donnell KA, 2007, CELL, V129, P37, DOI 10.1016/j.cell.2007.03.028; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; PALUMBO G, 1994, GENETICS, V138, P1181; Pane A, 2007, DEV CELL, V12, P851, DOI 10.1016/j.devcel.2007.03.022; PELISSON A, 1994, EMBO J, V13, P4401, DOI 10.1002/j.1460-2075.1994.tb06760.x; Pelisson A, 2007, MOL BIOL EVOL, V24, P498, DOI 10.1093/molbev/msl176; PRUDHOMME N, 1995, GENETICS, V139, P697; Redon C, 2002, CURR OPIN GENET DEV, V12, P162, DOI 10.1016/S0959-437X(02)00282-4; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; THEURKAUF WE, 1994, METHOD CELL BIOL, V44, P489, DOI 10.1016/S0091-679X(08)60928-0; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Vermaak D, 2005, PLOS GENET, V1, P96, DOI 10.1371/journal.pgen.0010009; Volpe AM, 2001, GENETICS, V159, P1117; Wang XQ, 2006, J CELL PHYSIOL, V208, P613, DOI 10.1002/jcp.20700	59	282	294	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1137	1149		10.1016/j.cell.2009.07.014	http://dx.doi.org/10.1016/j.cell.2009.07.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19732946	Green Accepted, Bronze			2022-12-28	WOS:000269923200014
J	Connolly, SJ; Ezekowitz, MD; Yusuf, S; Eikelboom, J; Oldgren, J; Parekh, A; Pogue, J; Reilly, PA; Themeles, E; Varrone, J; Wang, S; Alings, M; Xavier, D; Zhu, J; Diaz, R; Lewis, BS; Darius, H; Diener, HC; Joyner, CD; Wallentin, L				Connolly, Stuart J.; Ezekowitz, Michael D.; Yusuf, Salim; Eikelboom, John; Oldgren, Jonas; Parekh, Amit; Pogue, Janice; Reilly, Paul A.; Themeles, Ellison; Varrone, Jeanne; Wang, Susan; Alings, Marco; Xavier, Denis; Zhu, Jun; Diaz, Rafael; Lewis, Basil S.; Darius, Harald; Diener, Hans-Christoph; Joyner, Campbell D.; Wallentin, Lars		RE-LY Steering Comm & Investigator	Dabigatran versus Warfarin in Patients with Atrial Fibrillation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-INFERIORITY TRIAL; ANTITHROMBOTIC THERAPY; ANTICOAGULANT-THERAPY; ORAL ANTICOAGULANT; PREVENT STROKE; ASPIRIN; THROMBOEMBOLISM; METAANALYSIS; CLOPIDOGREL; ETEXILATE	Background: Warfarin reduces the risk of stroke in patients with atrial fibrillation but increases the risk of hemorrhage and is difficult to use. Dabigatran is a new oral direct thrombin inhibitor. Methods: In this noninferiority trial, we randomly assigned 18,113 patients who had atrial fibrillation and a risk of stroke to receive, in a blinded fashion, fixed doses of dabigatran -- 110 mg or 150 mg twice daily -- or, in an unblinded fashion, adjusted-dose warfarin. The median duration of the follow-up period was 2.0 years. The primary outcome was stroke or systemic embolism. Results: Rates of the primary outcome were 1.69% per year in the warfarin group, as compared with 1.53% per year in the group that received 110 mg of dabigatran (relative risk with dabigatran, 0.91; 95% confidence interval [CI], 0.74 to 1.11; P<0.001 for noninferiority) and 1.11% per year in the group that received 150 mg of dabigatran (relative risk, 0.66; 95% CI, 0.53 to 0.82; P<0.001 for superiority). The rate of major bleeding was 3.36% per year in the warfarin group, as compared with 2.71% per year in the group receiving 110 mg of dabigatran (P=0.003) and 3.11% per year in the group receiving 150 mg of dabigatran (P=0.31). The rate of hemorrhagic stroke was 0.38% per year in the warfarin group, as compared with 0.12% per year with 110 mg of dabigatran (P<0.001) and 0.10% per year with 150 mg of dabigatran (P<0.001). The mortality rate was 4.13% per year in the warfarin group, as compared with 3.75% per year with 110 mg of dabigatran (P=0.13) and 3.64% per year with 150 mg of dabigatran (P=0.051). Conclusions: In patients with atrial fibrillation, dabigatran given at a dose of 110 mg was associated with rates of stroke and systemic embolism that were similar to those associated with warfarin, as well as lower rates of major hemorrhage. Dabigatran administered at a dose of 150 mg, as compared with warfarin, was associated with lower rates of stroke and systemic embolism but similar rates of major hemorrhage. (ClinicalTrials.gov number, NCT00262600.) N Engl J Med 2009;361:1139-51.	[Connolly, Stuart J.; Yusuf, Salim; Eikelboom, John; Pogue, Janice; Themeles, Ellison] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Connolly, Stuart J.; Yusuf, Salim; Eikelboom, John; Pogue, Janice; Themeles, Ellison] Hamilton Hlth Sci, Hamilton, ON, Canada; [Ezekowitz, Michael D.; Parekh, Amit] Lankenau Inst Med Res, Wynnewood, PA USA; [Ezekowitz, Michael D.; Parekh, Amit] Ctr Heart, Wynnewood, PA USA; [Oldgren, Jonas; Wallentin, Lars] Uppsala Clin Res Ctr, Uppsala, Sweden; [Reilly, Paul A.; Varrone, Jeanne; Wang, Susan] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Alings, Marco] Working Grp Cardiovasc Res Netherlands, Utrecht, Netherlands; [Xavier, Denis] St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India; [Zhu, Jun] FuWai Hosp, Beijing, Peoples R China; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina; [Lewis, Basil S.] Lady Davies Carmel Med Ctr, Haifa, Israel; [Darius, Harald] Vivantes Klinikum Neukolln, Berlin, Germany; [Diener, Hans-Christoph] Univ Duisburg Essen, Essen, Germany; [Joyner, Campbell D.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada	McMaster University; Population Health Research Institute; McMaster University; Lankenau Medical Center; Lankenau Institute for Medical Research; Uppsala University; Boehringer Ingelheim; St. John's National Academy of Health Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Clalit Health Services; Carmel Medical Center; VIivantes Klinikum Neukolln; University of Duisburg Essen; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Connolly, SJ (corresponding author), McMaster Univ, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	connostu@phri.ca	Kokorin, Valentin Alexandrovich/ABG-9667-2021; Manolis, Antonis/F-5003-2014; Vanhooren, Geert/H-4433-2011; Schulman, Sam/I-7559-2019; Ramshev, Konstantin/GYU-1641-2022; Tanne, David/F-2560-2010; Ručka, David/O-6785-2017; Hankey, Graeme J/H-4968-2014; Turazza, Fabio/AAB-8736-2020; Diener, Hans-Christoph/AAF-7275-2019; Villacastín, Julián P/F-8469-2016; Eikelboom, John/AAG-6117-2019; Ezekowitz, Michael/AAJ-2543-2021	Kokorin, Valentin Alexandrovich/0000-0001-8614-6542; Manolis, Antonis/0000-0002-0336-4745; Vanhooren, Geert/0000-0001-6818-9346; Schulman, Sam/0000-0002-8512-9043; Ramshev, Konstantin/0000-0002-6978-6641; Tanne, David/0000-0002-6699-2220; Ručka, David/0000-0002-3564-9788; Hankey, Graeme J/0000-0002-6044-7328; Turazza, Fabio/0000-0002-2348-5309; Villacastín, Julián P/0000-0002-4867-3912; Eikelboom, John/0000-0003-4126-1285; Yusuf, Salim/0000-0003-4776-5601; Tomek, Ales/0000-0002-7468-499X; Alonso, Joaquin J/0000-0003-4360-5897; Fengsrud, Espen/0000-0002-2654-9427; Harenberg, Job/0000-0003-4590-4225; Andersen, Grethe/0000-0001-6807-2500; McEneaney, David/0000-0002-1734-0736; Engelter, Stefan/0000-0003-3855-6234; Kostov, Kosta/0000-0001-5516-2208; Talajic, Mario/0000-0001-8469-4748; Pasco, Paul Matthew/0000-0002-1533-2214; Adragao, Pedro/0000-0003-3729-3137; Zafeiridis, Tilemachos/0000-0001-5020-312X; Cunha, Luis/0000-0002-0828-3485	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Supported by a grant from Boehringer Ingelheim.	Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Bousser MG, 2008, LANCET, V371, P315, DOI 10.1016/S0140-6736(08)60168-3; Bousser MG, 2008, LANCET, V372, P2022; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Connolly SJ, 2008, CIRCULATION, V118, P2029, DOI 10.1161/CIRCULATIONAHA.107.750000; Diener HC, 2006, CEREBROVASC DIS, V21, P279, DOI 10.1159/000091265; Eriksson BI, 2007, LANCET, V370, P2004; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Ezekowitz MD, 2007, AM J CARDIOL, V100, P1419, DOI 10.1016/j.amjcard.2007.06.034; Ezekowitz MD, 2009, AM HEART J, V157, P805, DOI 10.1016/j.ahj.2009.02.005; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Hylek EM, 2007, CIRCULATION, V115, P2689, DOI 10.1161/CIRCULATIONAHA.106.653048; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Stangier J, 2008, CLIN PHARMACOKINET, V47, P285, DOI 10.2165/00003088-200847050-00001	19	7693	7995	7	737	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1139	1151		10.1056/NEJMoa0905561	http://dx.doi.org/10.1056/NEJMoa0905561			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494QA	19717844	Green Published			2022-12-28	WOS:000269828000005
J	Wald, R; Quinn, RR; Luo, J; Li, P; Scales, DC; Mamdani, MM; Ray, JG				Wald, Ron; Quinn, Robert R.; Luo, Jin; Li, Ping; Scales, Damon C.; Mamdani, Muhammad M.; Ray, Joel G.		Univ Toronto Acute Kidney Injury R	Chronic Dialysis and Death Among Survivors of Acute Kidney Injury Requiring Dialysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; REPLACEMENT THERAPY; HOSPITALIZED-PATIENTS; ELDERLY-PATIENTS; RECOVERY; OUTCOMES; RISK; EPIDEMIOLOGY	Context Severe acute kidney injury among hospitalized patients often necessitates initiation of short-term dialysis. Little is known about the long-term outcome of those who survive to hospital discharge. Objective To assess the risk of chronic dialysis and all-cause mortality in individuals who experience an episode of acute kidney injury requiring dialysis. Design, Setting, and Participants We conducted a population-based cohort study of all adult patients in Ontario, Canada, with acute kidney injury who required in-hospital dialysis and survived free of dialysis for at least 30 days after discharge between July 1, 1996, and December 31, 2006. These individuals were matched with patients without acute kidney injury or dialysis during their index hospitalization. Matching was by age plus or minus 5 years, sex, history of chronic kidney disease, receipt of mechanical ventilation during the index hospitalization, and a propensity score for developing acute kidney injury requiring dialysis. Patients were followed up until March 31, 2007. Main Outcome Measures The primary end point was the need for chronic dialysis and the secondary outcome was all-cause mortality. Results We identified 3769 adults with acute kidney injury requiring in-hospital dialysis and 13 598 matched controls. The mean age was 62 years and median follow-up was 3 years. The incidence rate of chronic dialysis was 2.63 per 100 personyears among individuals with acute kidney injury requiring dialysis, and 0.91 per 100 person-years among control participants (adjusted hazard ratio, 3.23; 95% confidence interval, 2.70-3.86). All-cause mortality rates were 10.10 and 10.85 per 100 person-years, respectively (adjusted hazard ratio, 0.95; 95% confidence interval, 0.891.02). Conclusions Acute kidney injury necessitating in-hospital dialysis was associated with an increased risk of chronic dialysis but not all-cause mortality. JAMA. 2009; 302(11): 1179-1185	[Wald, Ron] St Michaels Hosp, Div Nephrol, Toronto, ON M5C 2T2, Canada; [Ray, Joel G.] St Michaels Hosp, Div Gen Internal Med, Toronto, ON M5C 2T2, Canada; [Wald, Ron; Mamdani, Muhammad M.; Ray, Joel G.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Wald, Ron; Scales, Damon C.; Mamdani, Muhammad M.; Ray, Joel G.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Quinn, Robert R.] Sunnybrook Hlth Sci Ctr, Div Nephrol, Toronto, ON M4N 3M5, Canada; [Scales, Damon C.] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada; [Luo, Jin; Li, Ping; Scales, Damon C.; Mamdani, Muhammad M.; Ray, Joel G.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Mamdani, Muhammad M.] King Saud Univ, Fac Med, Riyadh, Saudi Arabia	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; King Saud University	Wald, R (corresponding author), St Michaels Hosp, Div Nephrol, 61 Queen St E,9-140, Toronto, ON M5C 2T2, Canada.	waldr@smh.toronto.on.ca	Li, Ping/GYV-4914-2022; Lapinsky, Stephen/C-4624-2015; Quinn, Robert R/E-7017-2011	Lapinsky, Stephen/0000-0002-6930-0306; Friedrich, Jan/0000-0001-7248-2350	Ontario Ministry of Health and Long-Term Care; University of Toronto Faculty of Medicine; Canadian Institutes of Health Research New Investigator Award; Canadian Institutes of Health Research; Amgen; Canadian Institutes of Health Research Institute of Health Services and Policy Research Fellowship	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); University of Toronto Faculty of Medicine(University of Toronto); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Amgen(Amgen); Canadian Institutes of Health Research Institute of Health Services and Policy Research Fellowship(Canadian Institutes of Health Research (CIHR))	Funding/Support: This study was supported by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care; and a New Staff Dean's Grant from the University of Toronto Faculty of Medicine. Dr Scales reports support from a Canadian Institutes of Health Research New Investigator Award. Dr Wald reports receipt of an RCT Mentoring Program Award from the Canadian Institutes of Health Research and an unrestricted grant from Amgen. Dr Quinn reports support from a Canadian Institutes of Health Research Institute of Health Services and Policy Research Fellowship. Dr Ray reports support from a Canadian Institutes of Health Research New Investigator Award.	Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6; Bagshaw SM, 2005, CRIT CARE, V9, pR700, DOI 10.1186/cc3879; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Brivet FG, 1996, CRIT CARE MED, V24, P192, DOI 10.1097/00003246-199602000-00003; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; de Mendonca A, 2000, INTENS CARE MED, V26, P915, DOI 10.1007/s001340051281; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Liangos O, 2006, CLIN J AM SOC NEPHRO, V1, P43, DOI 10.2215/CJN.00220605; McCarthy JT, 1996, MAYO CLIN PROC, V71, P117, DOI 10.4065/71.2.117; Mehta RL, 2004, KIDNEY INT, V66, P1613, DOI 10.1111/j.1523-1755.2004.00927.x; Metnitz PGH, 2002, CRIT CARE MED, V30, P2051, DOI 10.1097/00003246-200209000-00016; Morgera S, 2002, AM J KIDNEY DIS, V40, P275, DOI 10.1053/ajkd.2002.34505; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Redelmeier DA, 2005, BRIT MED J, V331, P932, DOI 10.1136/bmj.38603.746944.3A; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Scales DC, 2006, J CLIN EPIDEMIOL, V59, P802, DOI 10.1016/j.jclinepi.2005.11.015; Schiffl H, 2006, NEPHROL DIAL TRANSPL, V21, P1248, DOI 10.1093/ndt/gfk069; Schiffl H, 2008, NEPHROL DIAL TRANSPL, V23, P2235, DOI 10.1093/ndt/gfn182; Silvester W, 2001, CRIT CARE MED, V29, P1910, DOI 10.1097/00003246-200110000-00010; Spurgeon KR, 2005, AM J PHYSIOL-RENAL, V288, pF568, DOI 10.1152/ajprenal.00330.2004; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	25	519	540	1	19	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1179	1185		10.1001/jama.2009.1322	http://dx.doi.org/10.1001/jama.2009.1322			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755696	Bronze			2022-12-28	WOS:000269797600027
J	Meijer, D				Meijer, Dies			Went Fishing, Caught a Snake	SCIENCE			English	Editorial Material							TRANSCRIPTION FACTOR; SCHWANN-CELLS; DIFFERENTIATION; GROWTH; INHIBITION; CAMP; SCIP		ErasmusMC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Meijer, D (corresponding author), ErasmusMC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands.	d.meijer@erasmusmc.nl						Birchmeier C, 2008, GLIA, V56, P1491, DOI 10.1002/glia.20753; Howe DG, 2000, J NEUROSCI, V20, P3513, DOI 10.1523/JNEUROSCI.20-10-03513.2000; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; Mandemakers W, 2000, EMBO J, V19, P2992, DOI 10.1093/emboj/19.12.2992; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MORGAN L, 1991, J CELL BIOL, V112, P457, DOI 10.1083/jcb.112.3.457; Nickols JC, 2003, NAT NEUROSCI, V6, P161, DOI 10.1038/nn995; SCHERER SS, 1994, J NEUROSCI, V14, P1930; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005	13	3	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1353	1354		10.1126/science.1180103	http://dx.doi.org/10.1126/science.1180103			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745142				2022-12-28	WOS:000269699100026
J	Monk, KR; Naylor, SG; Glenn, TD; Mercurio, S; Perlin, JR; Dominguez, C; Moens, CB; Talbot, WS				Monk, Kelly R.; Naylor, Stephen G.; Glenn, Thomas D.; Mercurio, Sara; Perlin, Julie R.; Dominguez, Claudia; Moens, Cecilia B.; Talbot, William S.			A G Protein-Coupled Receptor Is Essential for Schwann Cells to Initiate Myelination	SCIENCE			English	Article							ADHESION FAMILY; TRANSCRIPTION; ENSHEATHMENT; EXPRESSION; ZEBRAFISH; GENES; OCT-6; AXONS; ERBB2; SCIP	The myelin sheath allows axons to conduct action potentials rapidly in the vertebrate nervous system. Axonal signals activate expression of specific transcription factors, including Oct6 and Krox20, that initiate myelination in Schwann cells. Elevation of cyclic adenosine monophosphate ( cAMP) can mimic axonal contact in vitro, but the mechanisms that regulate cAMP levels in vivo are unknown. Using mutational analysis in zebrafish, we found that the G protein-coupled receptor Gpr126 is required autonomously in Schwann cells for myelination. In gpr126 mutants, Schwann cells failed to express oct6 and krox20 and were arrested at the promyelinating stage. Elevation of cAMP in gpr126 mutants, but not krox20 mutants, could restore myelination. We propose that Gpr126 drives the differentiation of promyelinating Schwann cells by elevating cAMP levels, thereby triggering Oct6 expression and myelination.	[Monk, Kelly R.; Naylor, Stephen G.; Glenn, Thomas D.; Mercurio, Sara; Perlin, Julie R.; Dominguez, Claudia; Talbot, William S.] Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA; [Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Stanford University; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center	Talbot, WS (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.	william.talbot@stanford.edu	mercurio, sara/ABH-2793-2021; Moens, Cecilia/AAN-1536-2020	mercurio, sara/0000-0003-3469-8323; , William/0000-0002-2048-7472; Moens, Cecilia/0000-0002-1099-0728	NIH [HG002995, R01 NS050223]; National Multiple Sclerosis Society [FG 1719-A-1]; Telethon Italy fellowship [GFP03011]; Stanford Gabilan fellowship; Muscular Dystrophy Association [92233]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050223, R56NS050223] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Telethon Italy fellowship(Fondazione Telethon); Stanford Gabilan fellowship; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Talbot laboratory for helpful discussions and suggestions, T. Reyes and C. Hill for fish facility support, J. Perrino and J. Buchanan for electron microscopy advice, and E. Wolf-Saxon and T. Donn for identifying the krox20<SUP>fh227</SUP> mutation with the support of NIH grant HG002995 ( C. B. M.). This work was also supported by National Multiple Sclerosis Society postdoctoral award FG 1719-A-1 ( K. R. M.), a Stanford NIH training grant ( T. D. G.), Telethon Italy fellowship GFP03011 ( S. M.), a Stanford Gabilan fellowship ( J. R. P.), and NIH grant R01 NS050223 and Muscular Dystrophy Association grant 92233 ( W. S. T.). The GenBank accession number for zebrafish gpr126 is GQ202546.	Bermingham JR, 1996, GENE DEV, V10, P1751, DOI 10.1101/gad.10.14.1751; Bjarnadottir TK, 2004, GENOMICS, V84, P23, DOI 10.1016/j.ygeno.2003.12.004; Chen S, 2006, J NEUROSCI, V26, P3079, DOI 10.1523/JNEUROSCI.3785-05.2006; Fredriksson R, 2003, BIOCHEM BIOPH RES CO, V301, P725, DOI 10.1016/S0006-291X(03)00026-3; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Jaegle M, 1996, SCIENCE, V273, P507, DOI 10.1126/science.273.5274.507; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Levavasseur F, 1998, MECH DEVELOP, V74, P89, DOI 10.1016/S0925-4773(98)00067-7; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862; Moens Cecilia B., 2008, Briefings in Functional Genomics & Proteomics, V7, P454, DOI 10.1093/bfgp/eln046; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Pogoda HM, 2006, DEV BIOL, V298, P118, DOI 10.1016/j.ydbio.2006.06.021; SCHERER SS, 1994, J NEUROSCI, V14, P1930; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Stehlik C, 2004, FEBS LETT, V569, P149, DOI 10.1016/j.febslet.2004.05.038; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Zorick TS, 1999, DEVELOPMENT, V126, P1397	22	237	246	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1402	1405		10.1126/science.1173474	http://dx.doi.org/10.1126/science.1173474			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745155	Green Accepted			2022-12-28	WOS:000269699100041
J	Gregory, IN				Gregory, Ian N.			Comparisons between geographies of mortality and deprivation from the 1900s and 2001: spatial analysis of census and mortality statistics	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENGLAND; HEALTH; WALES	Objectives To examine the geographical relation between mortality and deprivation in England and Wales at the start of the 20th and 21st centuries. To explore the evidence for a strengthening or weakening of this relation over the century and test for relations between the mortality and deprivation patterns of a century ago and modern mortality and causes of death. Design Census and mortality data for 634 districts from the 1900s directly compared with interpolated ward level data from 2001. Setting Census data and national statistics for England and Wales in the 1900s and 2001. Population Entire population in both periods. Main outcome measures Standardised mortality ratios for all districts for both periods with additional cause specific ratios calculated for 2001. Deprivation (Carstairs) scores for each district in 2001, with comparable measure created for the 1900s. Correlations and partial correlations between deprivation scores and standardised mortality ratios in the 1900s and 2001 for the 614 districts for which all data were available. Results The was no evidence of a significant change in the strength of the relation between deprivation and mortality between the start and end of the 20th century. Modern patterns of mortality and deprivation remain closely related to the patterns of a century ago. Even after adjustment for modern deprivation, standardised mortality ratios from the 1900s show a significant correlation with modern mortality and most modern causes of death. Conversely, however, there was no significant relation between deprivation in the 1900s and modern mortality for most causes of death after adjustment for modern deprivation. Conclusions Despite all the medical, public health, social, economic, and political changes over the 20th century, patterns of poverty and mortality and the relations between them remain firmly entrenched. There is a strong relation between the mortality levels of a century ago and those of today. This goes beyond what would have been expected from the continuing relation between deprivation and mortality and holds true for most major modern causes of death.	Univ Lancaster, Furness Coll, Fac Arts & Social Sci, Lancaster LA1 4YG, England	Lancaster University	Gregory, IN (corresponding author), Univ Lancaster, Furness Coll, Fac Arts & Social Sci, Lancaster LA1 4YG, England.	I.Gregory@lancaster.ac.uk			Leverhulme Trust [ECF/40115]	Leverhulme Trust(Leverhulme Trust)	This study was funded by the Leverhulme Trust under their early career fellowship scheme (ECF/40115).	Barker D. J. P., 1994, MOTHERS BABIES DIS L; Barker DJP, 1992, FETAL INFANT ORIGINS; Dorling D, 2000, BRIT MED J, V321, P1547, DOI 10.1136/bmj.321.7276.1547; Gordon-Watson M., 2000, HDB RIDING, V5; Gregory IN, 2005, J R STAT SOC A STAT, V168, P419, DOI 10.1111/j.1467-985X.2005.00356.x; Gregory IN, 2002, CARTOGR J, V39, P37, DOI 10.1179/caj.2002.39.1.37; Gregory IN, 2001, AREA, V33, P297, DOI 10.1111/1475-4762.00033; KINSELLA KG, 1992, AM J CLIN NUTR, V55, P1196; Morgan Oliver, 2006, Health Stat Q, P28; MORRIS R, 1991, J PUBLIC HEALTH MED, V13, P318; Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008; NORMAN P, 2007, RES163250012; *OFF NAT STAT, CENS STAND AR STAT E; *OFF NAT STAT, 2002, VIT STAT ENGL WAL 20; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Rasulo Domenica, 2007, Health Stat Q, P35; ROWNTREE BS, 1901, POVERTY STUDY TOWN L, P86; Shaw M, 2008, GRIM REAPERS ROAD MA; Shelton NJ, 2006, HEALTH PLACE, V12, P557, DOI 10.1016/j.healthplace.2005.08.012; Smith GD, 2002, J EPIDEMIOL COMMUN H, V56, P434; Townsend P., 1993, INT ANAL POVERTY	21	27	27	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 10	2009	339								b3454	10.1136/bmj.b3454	http://dx.doi.org/10.1136/bmj.b3454			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	493RE	19744974	Green Published, hybrid			2022-12-28	WOS:000269754800001
J	Alston, JM; Beddow, JM; Pardey, PG				Alston, Julian M.; Beddow, Jason M.; Pardey, Philip G.			Agricultural Research, Productivity, and Food Prices in the Long Run	SCIENCE			English	Editorial Material									[Beddow, Jason M.; Pardey, Philip G.] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Beddow, Jason M.; Pardey, Philip G.] Univ Minnesota, InSTePP Ctr, St Paul, MN 55108 USA; [Alston, Julian M.] Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA; [Alston, Julian M.] Univ Calif Davis, Robert Mondavi Inst Ctr Wine Econ, Davis, CA 95616 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of California System; University of California Davis	Pardey, PG (corresponding author), Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA.	ppardey@umn.edu						Alston J.M., 2000, META ANAL RATES RETU; EVENSON RE, 1979, SCIENCE, V205, P1101, DOI 10.1126/science.205.4411.1101; EVENSON RE, 2002, HDB AGR EC A, V1, pCH11; Fan SG, 1997, J DEV ECON, V53, P115, DOI 10.1016/S0304-3878(97)00005-9; *FAO, 2008, HUNG RIS SOAR PRIC 7; *FAO, FAOSTAT PROD IND; Food and Agricultural Organisation of the United Nations (FAO), FAOSTAT DAT; JAMES JS, 2008, 0801 INSTEPP; Macours K, 2002, ECON DEV CULT CHANGE, V50, P365, DOI 10.1086/322883; Pardey P.G., 2006, AGR R D DEV WORLD TO; Ruttan V.W., 1982, AGR RES POLICY; *USDA, MAN CLASS AGR FOR RE; *USDA, CRIS DAT FIL; *USDA, INV AGR RES	14	229	233	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1209	1210		10.1126/science.1170451	http://dx.doi.org/10.1126/science.1170451			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490RY	19729642				2022-12-28	WOS:000269523200022
J	Goldston, D				Goldston, David			Budget instructions	NATURE			English	Editorial Material									Nat Resources Def Council, Govt Affairs, Washington, DC USA		Goldston, D (corresponding author), Nat Resources Def Council, Govt Affairs, Washington, DC USA.	partyofonecolumn@gmail.com							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					25	25		10.1038/461025a	http://dx.doi.org/10.1038/461025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	490DT	19727178	Bronze			2022-12-28	WOS:000269478800009
J	Fazel, R; Krumholz, HM; Wang, YF; Ross, JS; Chen, J; Ting, HH; Shah, ND; Nasir, K; Einstein, AJ; Nallamothu, BK				Fazel, Reza; Krumholz, Harlan M.; Wang, Yongfei; Ross, Joseph S.; Chen, Jersey; Ting, Henry H.; Shah, Nilay D.; Nasir, Khurram; Einstein, Andrew J.; Nallamothu, Brahmajee K.			Exposure to Low-Dose Ionizing Radiation from Medical Imaging Procedures.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPUTED-TOMOGRAPHY; UNITED-STATES; PATIENT; RISKS; ANGIOGRAPHY; PROTECTION; RADIOLOGY; CANCER; PHYSICIAN; AWARENESS	Background: The growing use of imaging procedures in the United States has raised concerns about exposure to low-dose ionizing radiation in the general population. Methods: We identified 952,420 nonelderly adults (between 18 and 64 years of age) in five health care markets across the United States between January 1, 2005, and December 31, 2007. Utilization data were used to estimate cumulative effective doses of radiation from imaging procedures and to calculate population-based rates of exposure, with annual effective doses defined as low (lessthan/equal 3 mSv), moderate (>3 to 20 mSv), high (>20 to 50 mSv), or very high (>50 mSv). Results: During the study period, 655,613 enrollees (68.8%) underwent at least one imaging procedure associated with radiation exposure. The mean (+/-SD) cumulative effective dose from imaging procedures was 2.4+/-6.0 mSv per enrollee per year; however, a wide distribution was noted, with a median effective dose of 0.1 mSv per enrollee per year (interquartile range, 0.0 to 1.7). Overall, moderate effective doses of radiation were incurred in 193.8 enrollees per 1000 per year, whereas high and very high doses were incurred in 18.6 and 1.9 enrollees per 1000 per year, respectively. In general, cumulative effective doses of radiation from imaging procedures increased with advancing age and were higher in women than in men. Computed tomographic and nuclear imaging accounted for 75.4% of the cumulative effective dose, with 81.8% of the total administered in outpatient settings. Conclusions: Imaging procedures are an important source of exposure to ionizing radiation in the United States and can result in high cumulative effective doses of radiation. N Engl J Med 2009;361:849-57.	[Fazel, Reza] Emory Univ, Div Cardiol, Sch Med, Dept Med, Atlanta, GA 30306 USA; [Krumholz, Harlan M.; Wang, Yongfei; Chen, Jersey] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, Dept Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sch Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Ross, Joseph S.] Columbia Univ, Med Ctr, Mt Sinai Sch Med, New York, NY USA; [Ross, Joseph S.] Columbia Univ, Med Ctr, James J Peters Vet Affairs Med Ctr, New York, NY USA; Columbia Univ, Med Ctr, Dept Med, Div Cardiol, New York, NY USA; Columbia Univ, Med Ctr, Dept Radiol, New York, NY USA; [Einstein, Andrew J.] New York Presbyterian Hosp, New York, NY USA; [Ting, Henry H.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Shah, Nilay D.] Hlth Care Policy & Res, Rochester, MN USA; [Nasir, Khurram] Johns Hopkins Ciccarone Prevent Cardiol Ctr, Baltimore, MD USA; [Nasir, Khurram] Boston Med Ctr, Dept Internal Med, Boston, MA USA; [Nallamothu, Brahmajee K.] Vet Affairs Ann Arbor Hlth Serv Res & Dev Ctr Exc, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA	Emory University; Yale University; Yale University; Yale University; Yale University; Columbia University; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Boston Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Fazel, R (corresponding author), Emory Univ, Div Cardiol, Sch Med, Dept Med, Bldg A,Suite 1-N,1256 Briarcliff Rd NE, Atlanta, GA 30306 USA.	rfazel@emory.edu	, Harlan/AAI-2875-2020; Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Fazel, Reza/0000-0002-9102-6155; Ross, Joseph/0000-0002-9218-3320	NCRR NIH HHS [5 KL2 RR024157, KL2 RR024157] Funding Source: Medline; NIA NIH HHS [K08 AG032886, K08 AG032886-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Administration of Radioactive Substances Advisory Committee, 2014, ARSAC NOT GUID GOOD; [Anonymous], 2007, Ann ICRP, V37, P1, DOI 10.1016/j.icrp.2008.08.001; BEEBE MDJ, 2006, CPT 2007 STANDARD ED; Bhargavan M, 2005, RADIOLOGY, V234, P824, DOI 10.1148/radiol.2343031536; Brenner DJ, 2008, BRIT J RADIOL, V81, P521, DOI 10.1259/bjr/22942198; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Brenner DJ, 2004, RADIOLOGY, V231, P440, DOI 10.1148/radiol.2312030880; Buls N, 2003, HEALTH PHYS, V85, P165, DOI 10.1097/00004032-200308000-00005; Dietze G, 2009, BRIT J RADIOL, V82, P348, DOI 10.1259/bjr/91937653; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Einstein AJ, 2009, JAMA-J AM MED ASSOC, V301, P545, DOI 10.1001/jama.2009.53; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Goske Marilyn J, 2008, J Am Coll Radiol, V5, P1200, DOI 10.1016/j.jacr.2008.06.007; Hausleiter J, 2009, JAMA-J AM MED ASSOC, V301, P500, DOI 10.1001/jama.2009.54; Henzlova MJ, 2009, J NUCL CARDIOL, V16, P331, DOI DOI 10.1007/S12350-009-9062-4; ICRP, 1996, ANN ICRP, V26, P1; *IMV MED INF DIV, 2005, IMV 2005 NUCL MED CE; Jacob K, 2004, CLIN RADIOL, V59, P928, DOI 10.1016/j.crad.2004.04.020; Kailasnath P, 2001, Cardiol Rev, V9, P160, DOI 10.1097/00045415-200105000-00009; Lee CI, 2004, RADIOLOGY, V231, P393, DOI 10.1148/radiol.2312030767; Martin CJ, 2007, BRIT J RADIOL, V80, P639, DOI 10.1259/bjr/25922439; Martin CJ, 2008, RADIAT PROT DOSIM, V128, P1, DOI 10.1093/rpd/ncm425; McCollough CH, 2008, HEALTH PHYS, V95, P508, DOI 10.1097/01.HP.0000326343.35884.03; Menzel H. G, 2009, BRIT J RADIOL, V81, p[521, 976]; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; National Research Council, 2006, HLTH RISKS EXP LOW L, P141; NCRP, 2009, J RADIOLOGICAL PROTE, V29; *NEXT, 2007, CRCPD PUBL E, V72; Perisinakis K, 2005, J AM COLL CARDIOL, V46, P2335, DOI 10.1016/j.jacc.2005.01.070; Perisinakis K, 2001, CIRCULATION, V104, P58, DOI 10.1161/hc2601.091710; Prasad KN, 2004, BRIT J RADIOL, V77, P97, DOI 10.1259/bjr/88081058; Quinn AD, 1997, BRIT J RADIOL, V70, P102, DOI 10.1259/bjr.70.829.9059306; Shiralkar S, 2003, BRIT MED J, V327, P371, DOI 10.1136/bmj.327.7411.371; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; United Nations, 2000, SOURC EFF ION RAD, V1; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607; Wrixon AD, 2008, J RADIOL PROT, V28, P161, DOI 10.1088/0952-4746/28/2/R02; 1996, ANN ICRP, V27, P61	41	980	1007	1	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					849	857		10.1056/NEJMoa0901249	http://dx.doi.org/10.1056/NEJMoa0901249			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XV	19710483	Green Accepted			2022-12-28	WOS:000269312700005
J	Hellier, C; Anderson, DR; Cameron, AC; Gillon, M; Hebb, L; Maxted, PFL; Queloz, D; Smalley, B; Triaud, AHMJ; West, RG; Wilson, DM; Bentley, SJ; Enoch, B; Horne, K; Irwin, J; Lister, TA; Mayor, M; Parley, N; Pepe, F; Pollacco, DL; Segransan, D; Udry, S; Wheatley, PJ				Hellier, Coel; Anderson, D. R.; Cameron, A. Collier; Gillon, M.; Hebb, L.; Maxted, P. F. L.; Queloz, D.; Smalley, B.; Triaud, A. H. M. J.; West, R. G.; Wilson, D. M.; Bentley, S. J.; Enoch, B.; Horne, K.; Irwin, J.; Lister, T. A.; Mayor, M.; Parley, N.; Pepe, F.; Pollacco, D. L.; Segransan, D.; Udry, S.; Wheatley, P. J.			An orbital period of 0.94 days for the hot-Jupiter planet WASP-18b	NATURE			English	Article							IN EXTRASOLAR PLANETS; TRANSITING PLANET; EVOLUTION; ATMOSPHERE; CANDIDATES; MIGRATION; SYSTEMS; CLUSTER; STARS	The 'hot Jupiters' that abound in lists of known extrasolar planets are thought to have formed far from their host stars, but migrate inwards through interactions with the proto-planetary disk from which they were born(1,2), or by an alternative mechanism such as planet-planet scattering(3). The hot Jupiters closest to their parent stars, at orbital distances of only similar to 0.02 astronomical units, have strong tidal interactions(4,5), and systems such as OGLE-TR-56 have been suggested as tests of tidal dissipation theory(6,7). Here we report the discovery of planet WASP-18b with an orbital period of 0.94 days and a mass of ten Jupiter masses (10 M-Jup), resulting in a tidal interaction an order of magnitude stronger than that of planet OGLE-TR-56b. Under the assumption that the tidal-dissipation parameter Q of the host star is of the order of 10 6, as measured for Solar System bodies and binary stars and as often applied to extrasolar planets, WASP-18b will be spiralling inwards on a timescale less than a thousandth that of the lifetime of its host star. Therefore either WASP-18 is in a rare, exceptionally short-lived state, or the tidal dissipation in this system (and possibly other hot-Jupiter systems) must be much weaker than in the Solar System.	[Hellier, Coel; Anderson, D. R.; Maxted, P. F. L.; Smalley, B.; Wilson, D. M.; Bentley, S. J.] Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England; [Anderson, D. R.; Hebb, L.; Enoch, B.; Horne, K.; Parley, N.] Univ St Andrews, Sch Phys & Astron, Haugh KY16 9SS, Fife, Scotland; [Gillon, M.; Queloz, D.; Triaud, A. H. M. J.; Mayor, M.; Pepe, F.; Segransan, D.; Udry, S.] Univ Geneva, Observ Geneve, CH-1290 Sauverny, Switzerland; [Gillon, M.] Univ Liege, Inst Astrophys & Geophys, Liege 1, Belgium; [West, R. G.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Irwin, J.] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA; [Lister, T. A.] Las Cumbres Observ, Santa Barbara, CA 93117 USA; [Pollacco, D. L.] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Wheatley, P. J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	Keele University; University of St Andrews; University of Geneva; University of Liege; University of Leicester; Harvard University; Queens University Belfast; University of Warwick	Hellier, C (corresponding author), Keele Univ, Astrophys Grp, Keele ST5 5BG, Staffs, England.	ch@astro.keele.ac.uk	Anderson, David/ADM-7446-2022; Triaud, Amaury/AAT-5603-2021	Anderson, David/0000-0001-7416-7522; Triaud, Amaury/0000-0002-5510-8751; West, Richard/0000-0001-6604-5533; Cameron, Andrew/0000-0002-8863-7828; Lister, Tim/0000-0002-3818-7769; udry, Stephane/0000-0001-7576-6236; Gillon, Michael/0000-0003-1462-7739; Pepe, Francesco/0000-0002-9815-773X; Wheatley, Peter/0000-0003-1452-2240	UK's Science and Technology Facilities Council; STFC [PP/D000955/1, PP/D000890/1, ST/G001987/1, PP/F000057/1, ST/G002355/1, PP/F000081/1, ST/F002599/1, ST/J000035/1, ST/F002270/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/D000890/1, PP/F000057/1, PP/F000081/1, ST/G002355/1, ST/F002270/1, PP/D000955/1, ST/F002599/1, ST/G001987/1] Funding Source: researchfish	UK's Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank the South African Astronomical Observatory for hosting WASP-South and the UK's Science and Technology Facilities Council for funding.	Baraffe I, 1998, ASTRON ASTROPHYS, V337, P403; BOESGAARD AM, 1986, ASTROPHYS J, V302, pL49, DOI 10.1086/184635; Cameron AC, 2007, MON NOT R ASTRON SOC, V375, P951, DOI 10.1111/j.1365-2966.2006.11350.x; Dobbs-Dixon I, 2004, ASTROPHYS J, V610, P464, DOI 10.1086/421510; Eggleton PP, 1998, ASTROPHYS J, V499, P853, DOI 10.1086/305670; Gillon M, 2009, ASTRON ASTROPHYS, V496, P259, DOI 10.1051/0004-6361:200810929; GOLDREICH P, 1966, ICARUS, V5, P375, DOI 10.1016/0019-1035(66)90051-0; Hebb L, 2009, ASTROPHYS J, V693, P1920, DOI 10.1088/0004-637X/693/2/1920; HUT P, 1981, ASTRON ASTROPHYS, V99, P126; Israelian G, 2001, NATURE, V411, P163, DOI 10.1038/35075512; Jackson B, 2008, ASTROPHYS J, V681, P1631, DOI 10.1086/587641; Laughlin G, 2009, NATURE, V457, P562, DOI 10.1038/nature07649; Levrard B, 2009, ASTROPHYS J LETT, V692, pL9, DOI 10.1088/0004-637X/692/1/L9; Lin DNC, 1996, NATURE, V380, P606, DOI 10.1038/380606a0; Meibom S, 2005, ASTROPHYS J, V620, P970, DOI 10.1086/427082; Ogilvie GI, 2007, ASTROPHYS J, V661, P1180, DOI 10.1086/515435; Patzold M, 2004, ASTRON ASTROPHYS, V427, P1075, DOI 10.1051/0004-6361:20040258; Patzold M, 2002, ASTROPHYS J, V568, pL117, DOI 10.1086/339794; Peale SJ, 1999, ANNU REV ASTRON ASTR, V37, P533, DOI 10.1146/annurev.astro.37.1.533; Pollacco DL, 2006, PUBL ASTRON SOC PAC, V118, P1407, DOI 10.1086/508556; Pont F, 2008, ASTRON ASTROPHYS, V487, P749, DOI 10.1051/0004-6361:20078949; Rasio FA, 1996, SCIENCE, V274, P954, DOI 10.1126/science.274.5289.954; Sahu KC, 2006, NATURE, V443, P534, DOI 10.1038/nature05158; Sasselov DD, 2003, ASTROPHYS J, V596, P1327, DOI 10.1086/378145; Tanaka H, 2002, ASTROPHYS J, V565, P1257, DOI 10.1086/324713; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357	27	176	176	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1098	1100		10.1038/nature08245	http://dx.doi.org/10.1038/nature08245			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19713926	Green Published			2022-12-28	WOS:000269314000031
J	Shuldiner, AR; O'Connell, JR; Bliden, KP; Gandhi, A; Ryan, K; Horenstein, RB; Damcott, CM; Pakyz, R; Tantry, US; Gibson, Q; Pollin, TI; Post, W; Parsa, A; Mitchell, BD; Faraday, N; Herzog, W; Gurbel, PA				Shuldiner, Alan R.; O'Connell, Jeffrey R.; Bliden, Kevin P.; Gandhi, Amish; Ryan, Kathleen; Horenstein, Richard B.; Damcott, Coleen M.; Pakyz, Ruth; Tantry, Udaya S.; Gibson, Quince; Pollin, Toni I.; Post, Wendy; Parsa, Afshin; Mitchell, Braxton D.; Faraday, Nauder; Herzog, William; Gurbel, Paul A.			Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; ACTIVE METABOLITE; HEALTHY-SUBJECTS; CYP2C19 POLYMORPHISM; STENT THROMBOSIS; PHARMACOKINETICS; PHARMACODYNAMICS; RESISTANCE; PRASUGREL	Context Clopidogrel therapy improves cardiovascular outcomes in patients with acute coronary syndromes and following percutaneous coronary intervention by inhibiting adenosine diphosphate (ADP)-dependent platelet activation. However, nonresponsiveness is widely recognized and is related to recurrent ischemic events. Objective To identify gene variants that influence clopidogrel response. Design, Setting, and Participants In the Pharmacogenomics of Antiplatelet Intervention (PAPI) Study (2006-2008), we administered clopidogrel for 7 days to 429 healthy Amish persons and measured response by ex vivo platelet aggregometry. A genome-wide association study was performed followed by genotyping the loss-of-function cytochrome P450 (CYP) 2C19*2 variant (rs4244285). Findings in the PAPI Study were extended by examining the relation of CYP2C19*2 genotype to platelet function and cardiovascular outcomes in an independent sample of 227 patients undergoing percutaneous coronary intervention. Main Outcome Measure ADP-stimulated platelet aggregation in response to clopidogrel treatment and cardiovascular events. Results Platelet response to clopidogrel was highly heritable (h(2)=0.73; P<.001). Thirteen single-nucleotide polymorphisms on chromosome 10q24 within the CYP2C18-CYP2C19-CYP2C9-CYP2C8 cluster were associated with diminished clopidogrel response, with a high degree of statistical significance (P=1.5 x 10(-13) for rs12777823, additive model). The rs12777823 polymorphism was in strong linkage disequilibrium with the CYP2C19*2 variant, and was associated with diminished clopidogrel response, accounting for 12% of the variation in platelet aggregation to ADP (P=4.3 x 10(-11)). The relation between CYP2C19*2 genotype and platelet aggregation was replicated in clopidogrel-treated patients undergoing coronary intervention (P=.02). Furthermore, patients with the CYP2C19*2 variant were more likely (20.9% vs 10.0%) to have a cardiovascular ischemic event or death during 1 year of follow-up (hazard ratio, 2.42; 95% confidence interval, 1.18-4.99; P=.02). Conclusion CYP2C19*2 genotype was associated with diminished platelet response to clopidogrel treatment and poorer cardiovascular outcomes. JAMA. 2009; 302(8): 849-858	[Shuldiner, Alan R.; O'Connell, Jeffrey R.; Gandhi, Amish; Ryan, Kathleen; Horenstein, Richard B.; Damcott, Coleen M.; Pakyz, Ruth; Gibson, Quince; Pollin, Toni I.; Mitchell, Braxton D.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Dept Med, Baltimore, MD 21201 USA; [Parsa, Afshin] Univ Maryland, Sch Med, Div Nephrol, Dept Med, Baltimore, MD 21201 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Ctr Geriatr Res Educ & Clin, Baltimore, MD 21218 USA; [Bliden, Kevin P.; Tantry, Udaya S.; Herzog, William; Gurbel, Paul A.] Sinai Hosp, Sinai Ctr Thrombosis Res, Baltimore, MD 21215 USA; [Post, Wendy; Herzog, William] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; [Faraday, Nauder] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Sinai Center Thrombosis Research; Sinai Hospital of Baltimore; Johns Hopkins University; Johns Hopkins University	Shuldiner, AR (corresponding author), Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Dept Med, 660 W Redwood St,Room 494, Baltimore, MD 21201 USA.	ashuldin@medicine.umaryland.edu	Mitchell, Braxton/CAF-0876-2022	Mitchell, Braxton/0000-0003-4920-4744; Shuldiner, Alan/0000-0001-9921-4305	National Institutes of Health [NIH U01 GM074518, U01 HL084756]; Clinical Nutrition Research Unit of Maryland [P30 DK072488]; University of Maryland General Clinical Research Center [M01 RR 16500]; Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Sinai Hospital of Baltimore; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488, P30DK079637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Nutrition Research Unit of Maryland; University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Baltimore Veterans Administration Geriatric Research and Education Clinical Center; Sinai Hospital of Baltimore; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding/Support: This study was supported by National Institutes of Health grants NIH U01 GM074518 and U01 HL084756, the Clinical Nutrition Research Unit of Maryland (P30 DK072488), the University of Maryland General Clinical Research Center (M01 RR 16500), the Baltimore Veterans Administration Geriatric Research and Education Clinical Center, and Sinai Hospital of Baltimore.	Agarwala R, 1998, GENOME RES, V8, P211, DOI 10.1101/gr.8.3.211; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Angiolillo DJ, 2007, THROMB HAEMOSTASIS, V98, P707, DOI 10.1160/TH07-08-0518; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Antman EM, 2008, J AM COLL CARDIOL, V51, P2028, DOI [10.1016/j.jacc.2008.04.002, 10.1016/j.jacc.2007.10.001]; Applegate RJ, 2008, AM J CARDIOL, V102, P683, DOI 10.1016/j.amjcard.2008.04.050; Bliden KP, 2007, J AM COLL CARDIOL, V49, P657, DOI 10.1016/j.jacc.2006.10.050; Brandt JT, 2007, J THROMB HAEMOST, V5, P2429, DOI 10.1111/j.1538-7836.2007.02775.x; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Buonamici P, 2007, J AM COLL CARDIOL, V49, P2312, DOI 10.1016/j.jacc.2007.01.094; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Farid NA, 2008, PHARMACOTHERAPY, V28, P1483, DOI 10.1592/phco.28.12.1483; Fontana P, 2007, J THROMB HAEMOST, V5, P2153, DOI 10.1111/j.1538-7836.2007.02722.x; Frere C, 2008, AM J CARDIOL, V101, P1088, DOI 10.1016/j.amjcard.2007.11.065; Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x; Gurbel PA, 2005, J AM COLL CARDIOL, V46, P1820, DOI 10.1016/j.jacc.2005.07.041; Gurbel PA, 2003, CIRCULATION, V107, P2908, DOI 10.1161/01.CIR.0000072771.11429.83; Gurbel PA, 2008, J AM COLL CARDIOL, V51, P261, DOI 10.1016/j.jacc.2007.07.090; Gurbel PA, 2007, THROMB RES, V120, P311, DOI 10.1016/j.thromres.2006.08.012; Gurbel PA, 2006, NAT CLIN PRACT CARD, V3, P387, DOI 10.1038/ncpcardio0602; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; Kim KA, 2008, CLIN PHARMACOL THER, V84, P236, DOI 10.1038/clpt.2008.20; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Lau WC, 2004, CIRCULATION, V109, P166, DOI 10.1161/01.CIR.0000112378.09325.F9; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Luo HR, 2006, CLIN PHARMACOL THER, V80, P33, DOI 10.1016/j.clpt.2006.03.003; Malek LA, 2008, CIRC J, V72, P1165, DOI 10.1253/circj.72.1165; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; Siller-Matula JM, 2008, J AM COLL CARDIOL, V52, P1557, DOI 10.1016/j.jacc.2008.07.055; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Small DS, 2008, CURR MED RES OPIN, V24, P2251, DOI 10.1185/03007990802205985; Takahashi M, 2008, J PHARMACEUT BIOMED, V48, P1219, DOI 10.1016/j.jpba.2008.08.020; Takakubo F, 1996, PHARMACOGENETICS, V6, P265, DOI 10.1097/00008571-199606000-00011; Tcheng JE, 2000, LANCET, V356, P2037; Trenk D, 2008, J AM COLL CARDIOL, V51, P1925, DOI 10.1016/j.jacc.2007.12.056; Umemura K, 2008, J THROMB HAEMOST, V6, P1439, DOI 10.1111/j.1538-7836.2008.03050.x; Wallentin L, 2008, EUR HEART J, V29, P21, DOI 10.1093/eurheartj/ehm545; Xiao ZS, 1997, J PHARMACOL EXP THER, V281, P604	41	1090	1166	6	96	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 26	2009	302	8					849	858		10.1001/jama.2009.1232	http://dx.doi.org/10.1001/jama.2009.1232			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487GN	19706858	Green Accepted			2022-12-28	WOS:000269260100018
J	Fox, R				Fox, Robin			Commentary: Diagnosing ovarian cancer-more problems than answers	BRITISH MEDICAL JOURNAL			English	Editorial Material									Ctr Hlth, Bicester OX26 6AT, Oxon, England		Fox, R (corresponding author), Ctr Hlth, Bicester OX26 6AT, Oxon, England.	Robin.Fox@gp-K84052.nhs.uk						Department of Health, 2009, OV CANC KEY MESS HLT; *EV APP OV, 2008, OV CANC UK CONS STAT; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Menon U, 2009, LANCET ONCOL, V10, P327, DOI 10.1016/S1470-2045(09)70026-9; Moss EL, 2005, J CLIN PATHOL, V58, P308, DOI 10.1136/jcp.2004.018077; *NICE, 2005, REF GUID SUSP CANC; *SIGN, 2003, SIGN PUBL, V75; Troiano RN, 1997, AM J ROENTGENOL, V168, P1587, DOI 10.2214/ajr.168.6.9168732	8	0	0	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	AUG 25	2009	339								b3233	10.1136/bmj.b3233	http://dx.doi.org/10.1136/bmj.b3233			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489AS	19706935	Green Published, hybrid			2022-12-28	WOS:000269392500006
J	Chacinska, A; Koehler, CM; Milenkovic, D; Lithgow, T; Pfanner, N				Chacinska, Agnieszka; Koehler, Carla M.; Milenkovic, Dusanka; Lithgow, Trevor; Pfanner, Nikolaus			Importing Mitochondrial Proteins: Machineries and Mechanisms	CELL			English	Review							DISULFIDE RELAY SYSTEM; OUTER-MEMBRANE BIOGENESIS; TWIN-PORE TRANSLOCASE; BETA-BARREL PROTEINS; SPACE RECEPTOR MIA40; M-AAA PROTEASE; INTERMEMBRANE SPACE; INNER MEMBRANE; PRESEQUENCE TRANSLOCASE; PREPROTEIN TRANSLOCASE	Most mitochondrial proteins are synthesized on cytosolic ribosomes and must be imported across one or both mitochondrial membranes. There is an amazingly versatile set of machineries and mechanisms, and at least four different pathways, for the importing and sorting of mitochondrial precursor proteins. The translocases that catalyze these processes are highly dynamic machines driven by the membrane potential, ATP, or redox reactions, and they cooperate with molecular chaperones and assembly complexes to direct mitochondrial proteins to their correct destinations. Here, we discuss recent insights into the importing and sorting of mitochondrial proteins and their contributions to mitochondrial biogenesis.	[Chacinska, Agnieszka; Milenkovic, Dusanka; Pfanner, Nikolaus] Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Chacinska, Agnieszka; Milenkovic, Dusanka; Pfanner, Nikolaus] Univ Freiburg, Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Koehler, Carla M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	University of Freiburg; University of Freiburg; University of California System; University of California Los Angeles; Monash University	Pfanner, N (corresponding author), Univ Freiburg, ZBMZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de	Lithgow, Trevor J/H-5925-2017; Pfanner, Nikolaus/AAV-7878-2021	Lithgow, Trevor J/0000-0002-0102-7884; Chacinska, Agnieszka/0000-0002-2832-2568	Deutsche Forschungsgemeinschaft; Sonderforschungsbereich [746]; Excellence Initiative of the German Federal and State Governments [EXC 294]; Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061721] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Gottfried Wilhelm Leibniz Program; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are supported by the Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 746, Excellence Initiative of the German Federal and State Governments (EXC 294), Gottfried Wilhelm Leibniz Program, and Fonds der Chemischen Industrie.	Ahting U, 2005, J BIOL CHEM, V280, P48, DOI 10.1074/jbc.M410905200; Ahting U, 2001, J CELL BIOL, V153, P1151, DOI 10.1083/jcb.153.6.1151; Alder NN, 2008, CELL, V134, P439, DOI 10.1016/j.cell.2008.06.007; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Becker T, 2008, J BIOL CHEM, V283, P120, DOI 10.1074/jbc.M706997200; Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200; Bihlmaier K, 2007, J CELL BIOL, V179, P389, DOI 10.1083/jcb.200707123; Boldogh IR, 2003, MOL BIOL CELL, V14, P4618, DOI 10.1091/mbc.E03-04-0225; Brandner K, 2005, J BIOL CHEM, V280, P6215, DOI 10.1074/jbc.M412269200; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chacinska A, 2008, J BIOL CHEM, V283, P29723, DOI 10.1074/jbc.M805356200; Chan NC, 2008, MOL BIOL CELL, V19, P126, DOI 10.1091/mbc.E07-08-0796; Chauwin JF, 1998, BIOPHYS J, V74, P1732, DOI 10.1016/S0006-3495(98)77884-1; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Curran SP, 2004, J BIOL CHEM, V279, P43744, DOI 10.1074/jbc.M404878200; Curran SP, 2002, J CELL BIOL, V158, P1017, DOI 10.1083/jcb.200205124; Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942; D'Silva PR, 2008, MOL BIOL CELL, V19, P424, DOI 10.1091/mbc.E07-08-0748; Dabir DV, 2007, EMBO J, V26, P4801, DOI 10.1038/sj.emboj.7601909; Davis AJ, 2007, MOL BIOL CELL, V18, P475, DOI 10.1091/mbc.E06-06-0546; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Dienhart MK, 2008, MOL BIOL CELL, V19, P3934, DOI 10.1091/mbc.E08-04-0402; Dietmeier K, 1997, NATURE, V388, P195, DOI 10.1038/40663; Duvezin-Caubet S, 2007, MOL BIOL CELL, V18, P3582, DOI 10.1091/mbc.E07-02-0164; Esaki M, 2004, J BIOL CHEM, V279, P45701, DOI 10.1074/jbc.M404591200; Esaki M, 2003, NAT STRUCT BIOL, V10, P988, DOI 10.1038/nsb1008; Farrell SR, 2005, BIOCHEMISTRY-US, V44, P1532, DOI 10.1021/bi0479555; Fiumera HL, 2007, MOL CELL BIOL, V27, P4664, DOI 10.1128/MCB.01955-06; Gabriel K, 2001, TRENDS BIOCHEM SCI, V26, P36, DOI 10.1016/S0968-0004(00)01684-4; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gerber J, 2001, J BIOL CHEM, V276, P23486, DOI 10.1074/jbc.M100134200; GLICK BS, 1992, CELL, V69, P809, DOI 10.1016/0092-8674(92)90292-K; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Grumbt B, 2007, J BIOL CHEM, V282, P37461, DOI 10.1074/jbc.M707439200; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hofmann S, 2005, J MOL BIOL, V353, P517, DOI 10.1016/j.jmb.2005.08.064; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Hulett JM, 2008, J MOL BIOL, V376, P694, DOI 10.1016/j.jmb.2007.12.021; Hutu DP, 2008, MOL BIOL CELL, V19, P2642, DOI 10.1091/mbc.E07-12-1226; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Jan PS, 2000, MOL GEN GENET, V263, P483, DOI 10.1007/s004380051192; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kanamori T, 1999, P NATL ACAD SCI USA, V96, P3634, DOI 10.1073/pnas.96.7.3634; Karniely S, 2006, J MOL BIOL, V358, P396, DOI 10.1016/j.jmb.2006.02.023; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Kozany C, 2004, NAT STRUCT MOL BIOL, V11, P234, DOI 10.1038/nsmb734; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Krayl M, 2007, MOL CELL BIOL, V27, P411, DOI 10.1128/MCB.01391-06; KUHLBRANDT W, 2003, SCIENCE, V299, P1747; Kurz M, 1999, MOL BIOL CELL, V10, P2461, DOI 10.1091/mbc.10.7.2461; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Liu QL, 2003, SCIENCE, V300, P139, DOI 10.1126/science.1083379; Lu H, 2004, J BIOL CHEM, V279, P18952, DOI 10.1074/jbc.M313045200; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2007, EMBO J, V26, P2229, DOI 10.1038/sj.emboj.7601673; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Mesecke N, 2008, EMBO REP, V9, P1107, DOI 10.1038/embor.2008.173; Milenkovic D, 2007, J BIOL CHEM, V282, P22472, DOI 10.1074/jbc.M703294200; Milenkovic D, 2009, MOL BIOL CELL, V20, P2530, DOI 10.1091/mbc.E08-11-1108; Moberg P, 2004, J MOL BIOL, V336, P1129, DOI 10.1016/j.jmb.2004.01.006; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Model K, 2008, J MOL BIOL, V383, P1049, DOI 10.1016/j.jmb.2008.07.087; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Mokranjac D, 2009, MOL BIOL CELL, V20, P1400, DOI 10.1091/mbc.E08-09-0934; Morgan B, 2009, J BIOL CHEM, V284, P6818, DOI 10.1074/jbc.M808691200; Muller JM, 2008, MOL BIOL CELL, V19, P226, DOI 10.1091/mbc.E07-08-0814; Naoe M, 2004, J BIOL CHEM, V279, P47815, DOI 10.1074/jbc.M410272200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Okamoto K, 2002, EMBO J, V21, P3659, DOI 10.1093/emboj/cdf358; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Peixoto PMV, 2007, J BIOL CHEM, V282, P18694, DOI 10.1074/jbc.M700775200; Perocchi F, 2006, PLOS GENET, V2, P1612, DOI 10.1371/journal.pgen.0020170; Popov-Celeketic D, 2008, EMBO J, V27, P1469, DOI 10.1038/emboj.2008.79; Popov-Celeketic J, 2008, J MOL BIOL, V376, P671, DOI 10.1016/j.jmb.2007.12.006; Preuss M, 2005, J BIOL CHEM, V280, P13004, DOI 10.1074/jbc.M414093200; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Rainey RN, 2006, MOL CELL BIOL, V26, P8488, DOI 10.1128/MCB.01006-06; Roesch K, 2002, HUM MOL GENET, V11, P477, DOI 10.1093/hmg/11.5.477; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Setoguchi K, 2006, EMBO J, V25, P5635, DOI 10.1038/sj.emboj.7601438; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; Shariff K, 2004, BIOPHYS J, V86, P3647, DOI 10.1529/biophysj.104.040865; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Slutsky-Leiderman O, 2007, J BIOL CHEM, V282, P33935, DOI 10.1074/jbc.M704435200; Stojanovski D, 2008, J CELL BIOL, V183, P195, DOI 10.1083/jcb.200804095; Stojanovski D, 2007, J CELL BIOL, V179, P881, DOI 10.1083/jcb.200706043; Tamm LK, 2004, BBA-BIOMEMBRANES, V1666, P250, DOI 10.1016/j.bbamem.2004.06.011; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Taylor AB, 2001, STRUCTURE, V9, P615, DOI 10.1016/S0969-2126(01)00621-9; Terziyska N, 2009, J BIOL CHEM, V284, P1353, DOI 10.1074/jbc.M805035200; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; van der Laan M, 2006, CURR BIOL, V16, P2271, DOI 10.1016/j.cub.2006.10.025; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Wagner K, 2008, MOL CELL BIOL, V28, P4251, DOI 10.1128/MCB.02216-07; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Webb CT, 2006, MOL CELL, V21, P123, DOI 10.1016/j.molcel.2005.11.010; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Wiedemann N, 2007, J CELL BIOL, V179, P1115, DOI 10.1083/jcb.200709087; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106; Yamano K, 2008, J BIOL CHEM, V283, P27325, DOI 10.1074/jbc.M805249200; Yamano K, 2008, J BIOL CHEM, V283, P3799, DOI 10.1074/jbc.M708339200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zara V, 2009, BIOCHEM J, V419, P369, DOI 10.1042/BJ20082270	130	950	966	4	155	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					628	644		10.1016/j.cell.2009.08.005	http://dx.doi.org/10.1016/j.cell.2009.08.005			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703392	Bronze, Green Accepted			2022-12-28	WOS:000269156100007
J	Neogi, T; Felson, D; Niu, JB; Nevitt, M; Lewis, CE; Aliabadi, P; Sack, B; Torner, J; Bradley, L; Zhang, YQ				Neogi, Tuhina; Felson, David; Niu, Jingbo; Nevitt, Michael; Lewis, Cora E.; Aliabadi, Piran; Sack, Burt; Torner, James; Bradley, Lawrence; Zhang, Yuqing			Association between radiographic features of knee osteoarthritis and pain: results from two cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OSTEO-ARTHRITIS; JOINT SPACE; PLACEBO ANALGESIA; PREVALENCE; VARIABLES; HIP; SENSITIVITY; LIMITATIONS; EXPERIENCE; SYMPTOMS	Objective To examine the relation of radiographic features of osteoarthritis to knee pain in people with knees discordant for knee pain in two cohorts. Design Within person, knee matched, case-control study. Setting and participants Participants in the Multicenter Osteoarthritis (MOST) and Framingham Osteoarthritis studies who had knee radiographs and assessments of knee pain. Main outcome measures Association of each pain measure (frequency, consistency, and severity) with radiographic osteoarthritis, as assessed by Kellgren and Lawrence grade (0-4) and osteophyte and joint space narrowing grades (0-3) among matched sets of two knees within individual participants whose knees were discordant for pain status. Results 696 people from MOST and 336 people from Framingham were included. Kellgren and Lawrence grades were strongly associated with frequent knee pain - for example, for Kellgren and Lawrence grade 4 v grade 0 the odds ratio for pain was 151 (95% confidence interval 43 to 526) in MOST and 73 (16 to 331) in Framingham (both P<0.001 for trend). Similar results were also seen for the relation of Kellgren and Lawrence scores to consistency and severity of knee pain. Joint space narrowing was more strongly associated with each pain measure than were osteophytes. Conclusions Using a method that minimises between person confounding, this study found that radiographic osteoarthritis and individual radiographic features of osteoarthritis were strongly associated with knee pain.	[Neogi, Tuhina; Felson, David; Niu, Jingbo; Sack, Burt; Zhang, Yuqing] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Nevitt, Michael] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Lewis, Cora E.; Bradley, Lawrence] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL 35205 USA; [Aliabadi, Piran] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Torner, James] Univ Iowa, Coll Publ Hlth, Gen Hosp E107, Iowa City, IA 52242 USA	Boston University; University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; University of Iowa	Neogi, T (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, 650 Albany St, Boston, MA 02118 USA.	tneogi@bu.edu	Neogi, Tuhina/AAM-1110-2020	Sack, Burton/0000-0002-8458-1062; Zhang, Yuqing/0000-0001-7954-1149; Bradley, Laurence/0000-0002-1206-2263; Felson, David/0000-0002-2668-2447; Niu, Jingbo/0000-0002-6170-1965; Neogi, Tuhina/0000-0002-9515-1711	NIH [U01 AG18820, U01 AG18832, U01 AG18947, U01 AG19069, AR47785, AG18393]; NHLBI, Framingham Heart Study [N01-HC-25195]; NIAMS [K23 AR055127]; Arthritis Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR055127, P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG018947, U01AG018820, R01AG018393, U01AG019069, U01AG018832] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	MOST was funded by NIH U01 AG18820, U01 AG18832, U01 AG18947, and U01 AG19069. Framingham was funded by NIH AR47785 and AG18393 and NHLBI, Framingham Heart Study contract N01-HC-25195. TN was supported by NIAMS K23 AR055127, an Arthritis Foundation arthritis investigator award, and a Boston OAIC Claude Pepper research career development core grant. The study sponsors had no role in the study design; collection, analysis, and interpretation of data; writing of the article; or the decision to submit it for publication. The researchers work independently of their funders.	BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bradley LA, 2004, J RHEUMATOL, V31, P54; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Creamer P, 1999, J RHEUMATOL, V26, P1785; CREAMER P, 2004, NOVART FDN SYMP, V260, P74; Creamer P., 2004, NOVART FDN SYMP, V260, P100; Creamer P., 2004, NOVART FDN SYMP, V260, P277; Creamer Paul, 2004, Novartis Found Symp, V260, P64; DAVIS MA, 1992, J RHEUMATOL, V19, P1943; DESHIELDS TL, 1995, CLIN J PAIN, V11, P189, DOI 10.1097/00002508-199509000-00005; Dieppe PA, 2004, J RHEUMATOL, V31, P50; Duncan R, 2007, ANN RHEUM DIS, V66, P86, DOI 10.1136/ard.2006.052548; Englund M, 2008, NEW ENGL J MED, V359, P1108, DOI 10.1056/NEJMoa0800777; Felson DT, 2008, J RHEUMATOL, V35, P2047; Felson DT, 2007, ANN INTERN MED, V147, P534, DOI 10.7326/0003-4819-147-8-200710160-00005; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P2986, DOI 10.1002/art.22851; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Fields HL, 2000, PROG BRAIN RES, V122, P245; GAMSA A, 1990, PAIN, V42, P183, DOI 10.1016/0304-3959(90)91161-B; Giardino ND, 2003, PAIN, V106, P19, DOI 10.1016/S0304-3959(03)00226-4; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; HADLER NM, 1992, ANN INTERN MED, V116, P598, DOI 10.7326/0003-4819-116-7-598; Hannan MT, 2000, J RHEUMATOL, V27, P1513; Hawker GA, 2008, OSTEOARTHR CARTILAGE, V16, P415, DOI 10.1016/j.joca.2007.12.017; HOCHBERG MC, 1989, SEMIN ARTHRITIS RHEU, V18, P4, DOI 10.1016/0049-0172(89)90008-5; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Janes H, 2008, AM J EPIDEMIOL, V168, P89, DOI 10.1093/aje/kwn099; Karlson Elizabeth W., 1995, Annals of Epidemiology, V5, P297, DOI 10.1016/1047-2797(94)00096-C; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; LaValley MP, 2005, ARTHRITIS RHEUM-US, V52, P3542, DOI 10.1002/art.21374; LAWRENCE JS, 1966, ANN RHEUM DIS, V25, P1; Lethbridge-Cejku M, 1995, Arthritis Care Res, V8, P182; Mogil JS, 1999, P NATL ACAD SCI USA, V96, P7744, DOI 10.1073/pnas.96.14.7744; OReilly SC, 1996, ANN RHEUM DIS, V55, P931, DOI 10.1136/ard.55.12.931; Rothman KJ, 2002, EPIDEMIOLOGY INTRO; SALAFFI F, 1991, J RHEUMATOL, V18, P1581; SPECTOR TD, 1993, ANN RHEUM DIS, V52, P790, DOI 10.1136/ard.52.11.790; STOKES ME, 2000, CATEGORICAL DATA ANA, P271; SUMMERS MN, 1988, ARTHRITIS RHEUM, V31, P204, DOI 10.1002/art.1780310208; Vase L, 2002, PAIN, V99, P443, DOI 10.1016/S0304-3959(02)00205-1; Villemure C, 2003, PAIN, V106, P101, DOI 10.1016/S0304-3959(03)00297-5; Wager TD, 2005, PAIN, V115, P225, DOI 10.1016/j.pain.2005.03.018; Zubieta JK, 2001, SCIENCE, V293, P311, DOI 10.1126/science.1060952	43	290	294	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2009	339								b2844	10.1136/bmj.b2844	http://dx.doi.org/10.1136/bmj.b2844			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486SE	19700505	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000269217200003
J	Ramalho-Santos, M				Ramalho-Santos, Miguel			iPS Cells: Insights into Basic Biology	CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; GENERATION	The discovery that adult somatic cells can be induced to become pluripotent by overexpression of a few key transcription factors provides an exciting new window into the basic biology of pluripotency and differentiation.	[Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Ob Gyn, San Francisco, CA 94143 USA; [Ramalho-Santos, Miguel] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ramalho-Santos, M (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Ob Gyn, San Francisco, CA 94143 USA.	mrsantos@diabetes.ucsf.edu	Ramalho-Santos, Miguel/L-9092-2018	Ramalho-Santos, Miguel/0000-0003-0177-5556	NIH; California Institute; Juvenile Diabetes Research Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004698] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank the Santos lab, R. Blelloch, J. Ramalho-Santos, M. Conti, B. Bruneau, J. Reiter, and S. Fisher for helpful comments and M. Grskovic for help with the figure. M. R.-S. is funded by an NIH Director's New Innovator Award, the California Institute for Regenerative Medicine, and the Juvenile Diabetes Research Foundation.	Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; GURDON JB, 1962, J EMBRYOL EXP MORPH, V10, P622; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	15	20	22	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					616	618		10.1016/j.cell.2009.08.012	http://dx.doi.org/10.1016/j.cell.2009.08.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703387	Green Accepted, Bronze			2022-12-28	WOS:000269156100002
J	McKinstry, B; Pinnock, H; Sheikh, A				McKinstry, Brian; Pinnock, Hilary; Sheikh, Aziz			Telemedicine for management of patients with COPD?	LANCET			English	Editorial Material							EXACERBATIONS		[McKinstry, Brian] Univ Edinburgh, Gen Practice Sect, Edinburgh EH8 9DR, Midlothian, Scotland; [Pinnock, Hilary; Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Hlth Grp E, Edinburgh EH8 9DR, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	McKinstry, B (corresponding author), Univ Edinburgh, Gen Practice Sect, Edinburgh EH8 9DR, Midlothian, Scotland.	brian.mckinstry@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; McKinstry, Brian/0000-0001-9581-0468	Chief Scientist Office [ARPG/07/03, PCRCA/08/01] Funding Source: Medline	Chief Scientist Office		CAR J, 2008, IMPACT EHEALTH QUALI; Casas A, 2006, EUR RESPIR J, V28, P123, DOI 10.1183/09031936.06.00063205; CHEUNG K, 2003, USER GUIDE BASIC INF; Clark RA, 2007, BMJ-BRIT MED J, V334, P942, DOI 10.1136/bmj.39156.536968.55; Commission of the European Communities, 2008, COMM COMM EUR PARL C; Darzi A., 2008, HIGH QUALITY CARE AL; Halbert RJ, 2003, CHEST, V123, P1684, DOI 10.1378/chest.123.5.1684; Jennett P, 2003, J TELEMED TELECARE, V9, pS27, DOI 10.1258/135763303322596183; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; McKinstry B, 2009, BRIT J GEN PRACT, V59, P433, DOI 10.3399/bjgp09X420941; Wilkinson TMA, 2004, AM J RESP CRIT CARE, V169, P1298, DOI 10.1164/rccm.200310-1443OC	11	41	41	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					672	673		10.1016/S0140-6736(09)61542-7	http://dx.doi.org/10.1016/S0140-6736(09)61542-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489LV	19716948				2022-12-28	WOS:000269422500008
J	Walker, LM; Phogat, SK; Chan-Hui, PY; Wagner, D; Phung, P; Goss, JL; Wrin, T; Simek, MD; Fling, S; Mitcham, JL; Lehrman, JK; Priddy, FH; Olsen, OA; Frey, SM; Hammond, PW; Kaminsky, S; Zamb, T; Moyle, M; Koff, WC; Poignard, P; Burton, DR				Walker, Laura M.; Phogat, Sanjay K.; Chan-Hui, Po-Ying; Wagner, Denise; Phung, Pham; Goss, Julie L.; Wrin, Terri; Simek, Melissa D.; Fling, Steven; Mitcham, Jennifer L.; Lehrman, Jennifer K.; Priddy, Frances H.; Olsen, Ole A.; Frey, Steven M.; Hammond, Phillip W.; Kaminsky, Stephen; Zamb, Timothy; Moyle, Matthew; Koff, Wayne C.; Poignard, Pascal; Burton, Dennis R.		Protocol G Principal Investigators	Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target	SCIENCE			English	Article							SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; MONOCLONAL-ANTIBODIES; PASSIVE TRANSFER; V2 DOMAIN; GP120; ENVELOPE; PROTECTION; MACAQUES; EPITOPE; DESIGN	Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1-infected individuals, define critical epitopes for HIV vaccine design. Using a systematic approach, we have examined neutralization breadth in the sera of about 1800 HIV-1-infected individuals, primarily infected with non-clade B viruses, and have selected donors for monoclonal antibody (mAb) generation. We then used a high-throughput neutralization screen of antibody-containing culture supernatants from about 30,000 activated memory B cells from a clade A-infected African donor to isolate two potent mAbs that target a broadly neutralizing epitope. This epitope is preferentially expressed on trimeric Envelope protein and spans conserved regions of variable loops of the gp120 subunit. The results provide a framework for the design of new vaccine candidates for the elicitation of bNAb responses.	[Phogat, Sanjay K.; Wagner, Denise; Kaminsky, Stephen; Zamb, Timothy] Int AIDS Vaccine Initiat, AIDS Vaccine Design & Dev Lab, New York, NY 11220 USA; [Walker, Laura M.; Fling, Steven; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Walker, Laura M.; Fling, Steven; Poignard, Pascal; Burton, Dennis R.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Chan-Hui, Po-Ying; Mitcham, Jennifer L.; Olsen, Ole A.; Frey, Steven M.; Hammond, Phillip W.; Moyle, Matthew] Theraclone Sci, Seattle, WA 98104 USA; [Phung, Pham; Goss, Julie L.; Wrin, Terri] Monogram Biosci Inc, San Francisco, CA 94080 USA; [Simek, Melissa D.; Lehrman, Jennifer K.; Priddy, Frances H.; Koff, Wayne C.] Int AIDS Vaccine Initiat, New York, NY 10038 USA; [Burton, Dennis R.] Massachusetts Gen Hosp, MIT, Ragon Inst, Boston, MA 02114 USA; [Burton, Dennis R.] Harvard Univ, Boston, MA 02114 USA	International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; International AIDS Vaccine Initiative; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University	Phogat, SK (corresponding author), Int AIDS Vaccine Initiat, AIDS Vaccine Design & Dev Lab, New York, NY 11220 USA.	SPhogat@iavi.org; burton@scripps.edu	poignard, pascal/N-6678-2013; Kaminsky, Stephen/J-5141-2016; poignard, pascal/AAB-4613-2020	Kaminsky, Stephen/0000-0003-1869-834X; Poignard, Pascal/0000-0002-0021-7192; DeHovitz, Jack/0000-0001-7307-0614	International AIDS Vaccine Initiative (IAVI); U. S. Agency for International Development (USAID); National Institute of Allergy and Infectious Diseases; NIH [AI33292]; MRC [MC_U950097145] Funding Source: UKRI; Medical Research Council [MC_U950097145] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033292, R37AI033292] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI); U. S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Aguilar-Sino for technical assistance at The Scripps Research Institute; C. Ward, W. Cieplak, and M. Branum for technical assistance at Theraclone Sciences; R. Pejchal for assistance in structural modeling; S. M. Eagol and C. Williams for assistance with figures; E. Anton from Monogram R & D and the Monogram Clinical Reference Laboratory staff; all the study participants and research staff at each of the Protocol G clinical centers; and Protocol G project team members for all of the support that they have provided for this study (individuals and affiliations are listed in the supporting online material text as notes). We also thank A. Pinter for supplying the antibodies 10/76b and c108 g, W. Olson and J. Moore for providing the KNH1144 SOSIP trimer, and R. Wyatt for providing the YU2gp140foldon trimer. This work was supported by the International AIDS Vaccine Initiative (IAVI) through the contributions of a number of government and private donors who are listed on the Web site www. iavi. org, as well as IAVI's Innovation Fund (which is cofunded by the Bill & Melinda Gates Foundation); the U. S. Agency for International Development (USAID); and the National Institute of Allergy and Infectious Diseases, NIH, AI33292 (D. R. B.). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the U. S. government. The authors declare competing financial interests. Protocol G Principal Investigators: G. Miiro, J. Serwanga, A. Pozniak, D. McPhee, O. Manigart, L. Mwananyanda, E. Karita, A. Inwoley, W. Jaoko, J. DeHovitz, L. G. Bekker, P. Pitisuttithum, R. Paris, and S. Allen.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; Darbha R, 2004, BIOCHEMISTRY-US, V43, P1410, DOI 10.1021/bi035323x; Gorny MK, 2005, J VIROL, V79, P5232, DOI 10.1128/JVI.79.8.5232-5237.2005; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Honnen WJ, 2007, J VIROL, V81, P1424, DOI 10.1128/JVI.02054-06; ICHIYOSHI Y, 1994, J EXP MED, V180, P885, DOI 10.1084/jem.180.3.885; Johnston MI, 2007, NEW ENGL J MED, V356, P2073, DOI 10.1056/NEJMra066267; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Pantophlet R, 2009, J VIROL, V83, P1649, DOI 10.1128/JVI.02046-08; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Phogat S, 2007, CURR PHARM DESIGN, V13, P213, DOI 10.2174/138161207779313632; Pinter A, 2005, J VIROL, V79, P6909, DOI 10.1128/JVI.79.11.6909-6917.2005; Scanlan CN, 2007, NATURE, V446, P1038, DOI 10.1038/nature05818; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker BD, 2008, SCIENCE, V320, P760, DOI 10.1126/science.1152622	23	1344	1438	2	149	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 9	2009	326	5950					285	289		10.1126/science.1178746	http://dx.doi.org/10.1126/science.1178746			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504EX	19729618	Green Accepted			2022-12-28	WOS:000270599500042
J	Iglehart, JK				Iglehart, John K.			Obama's Vision and the Prospects for Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Iglehart JK, 2009, NEW ENGL J MED, V361, P229, DOI 10.1056/NEJMp0904854; Mello MM, 2009, NEW ENGL J MED, V361, P1, DOI 10.1056/NEJMp0903765	2	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 1	2009	361	14								10.1056/NEJMp0908476	http://dx.doi.org/10.1056/NEJMp0908476			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	500KZ	19752463				2022-12-28	WOS:000270300000006
J	Strong, A; Chisholm, S; Miller, C; Cullen, J				Strong, Aaron; Chisholm, Sallie; Miller, Charles; Cullen, John			Ocean fertilization: time to move on	NATURE			English	Editorial Material									[Strong, Aaron; Chisholm, Sallie] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Strong, Aaron] Tufts Univ, Fletcher Sch Law & Diplomacy, Medford, MA 02155 USA; [Miller, Charles] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Cullen, John] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Massachusetts Institute of Technology (MIT); Tufts University; Oregon State University; Dalhousie University	Strong, A (corresponding author), MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	chisholm@mit.edu	Cuillen, John/AAE-1371-2019; Cullen, John J/B-6105-2008	Cuillen, John/0000-0002-7740-0999; Cullen, John J/0000-0002-7740-0999; Chisholm, Sallie/0000-0003-1480-2445					0	58	58	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					347	348		10.1038/461347a	http://dx.doi.org/10.1038/461347a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	494QB	19759603				2022-12-28	WOS:000269828100021
J	Chan, PS; Nichol, G; Krumholz, HM; Spertus, JA; Jones, PG; Peterson, ED; Rathore, SS; Nallamothu, BK				Chan, Paul S.; Nichol, Graham; Krumholz, Harlan M.; Spertus, John A.; Jones, Philip G.; Peterson, Eric D.; Rathore, Saif S.; Nallamothu, Brahmajee K.		Amer Heart Assoc NRCPR Investigato	Racial Differences in Survival After In-Hospital Cardiac Arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; EUROPEAN RESUSCITATION COUNCIL; HEALTH-CARE PROFESSIONALS; INTERNATIONAL LIAISON COMMITTEE; ADVANCED LIFE-SUPPORT; RECOMMENDED GUIDELINES; STROKE FOUNDATION; CARDIOPULMONARY-RESUSCITATION; UTSTEIN STYLE; TASK-FORCE	Context Racial differences in survival have not been previously studied after in-hospital cardiac arrest, an event for which access to care is not likely to influence treatment. Objectives To estimate racial differences in survival for patients with in-hospital cardiac arrests and examine the association of sociodemographic and clinical factors and the admitting hospital with racial differences in survival. Design, Setting, and Patients Cohort study of 10 011 patients with cardiac arrests due to ventricular fibrillation or pulseless ventricular tachycardia enrolled between January 1, 2000, and February 29, 2008, at 274 hospitals within the National Registry of Cardiopulmonary Resuscitation. Main Outcome Measures Survival to hospital discharge; successful resuscitation from initial arrest and postresuscitation survival (secondary outcome measures). Results Included were 1883 black patients (18.8%) and 8128 white patients (81.2%). Rates of survival to discharge were lower for black patients (25.2%) than for white patients (37.4%) (unadjusted relative rate [RR], 0.73; 95% confidence interval [CI], 0.67-0.79). Unadjusted racial differences narrowed after adjusting for patient characteristics (adjusted RR, 0.81 [95% CI, 0.75-0.88]; P<.001) and diminished further after additional adjustment for hospital site (adjusted RR, 0.89 [95% CI, 0.82-0.96]; P=.002). Lower rates of survival to discharge for blacks reflected lower rates of both successful resuscitation (55.8% vs 67.4% for whites; unadjusted RR, 0.84 [95% CI, 0.81-0.88]) and postresuscitation survival (45.2% vs 55.5% for whites; unadjusted RR, 0.85 [95% CI, 0.79-0.91]). Adjustment for the hospital site at which patients received care explained a substantial portion of the racial differences in successful resuscitation (adjusted RR, 0.92 [95% CI, 0.88-0.96]; P<.001) and eliminated the racial differences in postresuscitation survival (adjusted RR, 0.99 [95% CI, 0.92-1.06]; P=.68). Conclusions Black patients with in-hospital cardiac arrest were significantly less likely to survive to discharge than white patients, with lower rates of survival during both the immediate resuscitation and postresuscitation periods. Much of the racial difference was associated with the hospital center in which black patients received care. JAMA. 2009; 302(11): 1195-1201	[Chan, Paul S.; Spertus, John A.; Jones, Philip G.] St Lukes Mid Amer Heart Inst, Kansas City, MO 64111 USA; [Nichol, Graham] Univ Washington, Dept Med, Clin Trial Ctr, Seattle, WA USA; [Nichol, Graham] Univ Washington, Dept Biostat, Clin Trial Ctr, Seattle, WA 98195 USA; [Nichol, Graham] Harborview Ctr Prehosp Emergency Care, Seattle, WA USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Krumholz, Harlan M.; Rathore, Saif S.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.; Rathore, Saif S.] Yale Univ, Sch Med, Sect Hlth Policy & Adm, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Nallamothu, Brahmajee K.] Univ Michigan, Div Cardiovasc Med, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] VA Ann Arbor Hlth Serv, Res & Develop Ctr Excellence, Ann Arbor, MI USA	Saint Luke's Mid America Heart Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; Yale University; Yale University; Yale University; Yale University; Yale University; Duke University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Chan, PS (corresponding author), St Lukes Mid Amer Heart Inst, 5th Floor,4401 Wornall Rd, Kansas City, MO 64111 USA.	pchan@cc-pc.com	, Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021; Peterson, Eric David/ABF-5033-2021; Nichol, Graham/Z-4996-2019		American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding/Support: The American Heart Association provided funding for the collection and management of the data and reviewed and approved the final manuscript.	Barnato AE, 2008, AM J RESP CRIT CARE, V177, P279, DOI 10.1164/rccm.200703-480OC; Barnato AE, 2006, HEALTH SERV RES, V41, P2219, DOI 10.1111/j.1475-6773.2006.00598.x; Carr BG, 2009, RESUSCITATION, V80, P30, DOI 10.1016/j.resuscitation.2008.09.001; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Cummins RO, 1997, ANN EMERG MED, V29, P647, DOI 10.1016/S0196-0644(97)70255-5; Cummins RO, 1997, CIRCULATION, V95, P2213, DOI 10.1161/01.CIR.95.8.2213; Degenholtz HB, 2002, J AM GERIATR SOC, V50, P378, DOI 10.1046/j.1532-5415.2002.50073.x; Epstein AM, 2000, NEW ENGL J MED, V343, P1537, DOI 10.1056/NEJM200011233432106; ESCARCE JJ, 1993, AM J PUBLIC HEALTH, V83, P948, DOI 10.2105/AJPH.83.7.948; Ewy GA, 2000, J AM COLL CARDIOL, V35, P830; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hernandez AF, 2007, JAMA-J AM MED ASSOC, V298, P1525, DOI 10.1001/jama.298.13.1525; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; *R DEV COR TEAM, R FDN STAT COMP V R; Rathore SS, 2004, ANN INTERN MED, V141, P635, DOI 10.7326/0003-4819-141-8-200410190-00011; Schneider EC, 2001, ANN INTERN MED, V135, P328, DOI 10.7326/0003-4819-135-5-200109040-00009; Shepardson LB, 1999, J GEN INTERN MED, V14, P15, DOI 10.1046/j.1525-1497.1999.00275.x; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; WENGER NS, 1995, ARCH INTERN MED, V155, P2056, DOI 10.1001/archinte.155.19.2056; ZARITSKY A, 1995, RESUSCITATION, V30, P95, DOI 10.1016/0300-9572(95)00884-V; ZARITSKY A, 1995, CIRCULATION, V92, P2006, DOI 10.1161/01.CIR.92.7.2006; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	31	121	122	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1195	1201		10.1001/jama.2009.1340	http://dx.doi.org/10.1001/jama.2009.1340			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	494FR	19755698	Bronze, Green Accepted			2022-12-28	WOS:000269797600029
J	Frei, R; Gaucher, C; Poulton, SW; Canfield, DE				Frei, Robert; Gaucher, Claudio; Poulton, Simon W.; Canfield, Don E.			Fluctuations in Precambrian atmospheric oxygenation recorded by chromium isotopes	NATURE			English	Article							HEXAVALENT CHROMIUM; RISE; REDUCTION; EDIACARAN; EVOLUTION; OXIDATION; RATIOS; EARTH	Geochemical data(1-4) suggest that oxygenation of the Earth's atmosphere occurred in two broad steps. The first rise in atmospheric oxygen is thought to have occurred between similar to 2.45 and 2.2 Gyr ago(1,5), leading to a significant increase in atmospheric oxygen concentrations and concomitant oxygenation of the shallow surface ocean. The second increase in atmospheric oxygen appears to have taken place in distinct stages during the late Neoproterozoic era (similar to 800-542 Myr ago)(3,4), ultimately leading to oxygenation of the deep ocean similar to 580 Myr ago(3), but details of the evolution of atmospheric oxygenation remain uncertain. Here we use chromium (Cr) stable isotopes from banded iron formations (BIFs) to track the presence of Cr(VI) in Precambrian oceans, providing a time-resolved picture of the oxygenation history of the Earth's atmosphere-hydrosphere system. The geochemical behaviour of Cr is highly sensitive to the redox state of the surface environment because oxidative weathering processes produce the oxidized hexavalent [Cr(VI)] form. Oxidation of reduced trivalent [Cr(III)] chromium on land is accompanied by an isotopic fractionation, leading to enrichment of the mobile hexavalent form in the heavier isotope. Our fractionated Cr isotope data indicate the accumulation of Cr(VI) in ocean surface waters similar to 2.8 to 2.6 Gyr ago and a likely transient elevation in atmospheric and surface ocean oxygenation before the first great rise of oxygen 2.45-2.2 Gyr ago ( the Great Oxidation Event)(1,5). In similar to 1.88-Gyr-old BIFs we find that Cr isotopes are not fractionated, indicating a decline in atmospheric oxygen. Our findings suggest that the Great Oxidation Event did not lead to a unidirectional stepwise increase in atmospheric oxygen. In the late Neoproterozoic, we observe strong positive fractionations in Cr isotopes (delta(53) Cr up to +4.9 parts per thousand), providing independent support for increased surface oxygenation at that time, which may have stimulated rapid evolution of macroscopic multicellular life(3,4,6).	[Frei, Robert; Gaucher, Claudio] Univ Copenhagen, Inst Geog & Geol, DK-1350 Copenhagen, Denmark; [Frei, Robert; Gaucher, Claudio] Univ Copenhagen, Nord Ctr Earth Evolut, DK-1350 Copenhagen, Denmark; [Gaucher, Claudio] Fac Ciencias, Dept Geol, Montevideo 11400, Uruguay; [Poulton, Simon W.] Univ Newcastle, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Canfield, Don E.] Univ So Denmark, Inst Biol, DK-5230 Odense, Denmark; [Canfield, Don E.] Nord Ctr Earth Evolut, DK-5230 Odense, Denmark	University of Copenhagen; University of Copenhagen; Universidad de la Republica, Uruguay; Newcastle University - UK; University of Southern Denmark	Frei, R (corresponding author), Univ Copenhagen, Inst Geog & Geol, Oster Voldgade 10, DK-1350 Copenhagen, Denmark.	robertf@geo.ku.dk	Frei, Robert/N-6798-2014; Canfield, Don/C-1735-2012	Frei, Robert/0000-0001-7708-9881; Canfield, Don/0000-0001-7602-8366; Poulton, Simon/0000-0001-7621-189X	Danish Agency for Science, Technology and Innovation; Danish National Research Foundation	Danish Agency for Science, Technology and Innovation; Danish National Research Foundation(Danmarks Grundforskningsfond)	This study was funded by the Danish Agency for Science, Technology and Innovation and by the Danish National Research Foundation (Danmarks Grundforskningsfond). We thank R. Schoenberg for sharing his Cr double spike with us and for contributions during many thematic and analytical discussions. To add to our own collection, critical samples were provided by C. Klein, A. Polat, P. S. Dahl, S. K. Mondal, H.-J. Hansen and E. F. Duke. Help with the clean-laboratory chemical separation procedures by T. Larsen is acknowledged. T. Leeper helped with the mass spectrometry and kept the mass spectrometer in excellent condition.	Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; Ball JW, 2000, CHEM GEOL, V168, P123, DOI 10.1016/S0009-2541(00)00189-3; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bekker A, 2007, EARTH PLANET SC LETT, V258, P486, DOI 10.1016/j.epsl.2007.04.009; CAMPBELL JA, 1981, EARTH PLANET SC LETT, V53, P427, DOI 10.1016/0012-821X(81)90047-9; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Connelly JN, 2006, CHEM GEOL, V233, P126, DOI 10.1016/j.chemgeo.2006.02.020; EARY LE, 1989, AM J SCI, V289, P180, DOI 10.2475/ajs.289.2.180; EARY LE, 1988, ENVIRON SCI TECHNOL, V22, P972, DOI 10.1021/es00173a018; Ellis AS, 2004, ENVIRON SCI TECHNOL, V38, P3604, DOI 10.1021/es0352294; Ellis AS, 2002, SCIENCE, V295, P2060, DOI 10.1126/science.1068368; Farquhar J, 2003, EARTH PLANET SC LETT, V213, P1, DOI 10.1016/S0012-821X(03)00296-6; FENDORF SE, 1995, GEODERMA, V67, P55, DOI 10.1016/0016-7061(94)00062-F; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Frei R, 2005, EARTH PLANET SC LETT, V236, P28, DOI 10.1016/j.epsl.2005.05.024; Gaucher C, 2008, GONDWANA RES, V13, P488, DOI 10.1016/j.gr.2007.05.008; Isley AE, 1999, J GEOPHYS RES-SOL EA, V104, P15461, DOI 10.1029/1999JB900066; Izbicki JA, 2008, APPL GEOCHEM, V23, P1325, DOI 10.1016/j.apgeochem.2007.11.015; Johnston DT, 2006, GEOCHIM COSMOCHIM AC, V70, P5723, DOI 10.1016/j.gca.2006.08.001; Kalsbeek F, 2006, CONTRIB MINERAL PETR, V152, P89, DOI 10.1007/s00410-006-0096-1; Kamber BS, 2007, GEOBIOLOGY, V5, P5, DOI 10.1111/j.1472-4669.2006.00091.x; Kaufman AJ, 2007, SCIENCE, V317, P1900, DOI 10.1126/science.1138700; Oze C, 2007, P NATL ACAD SCI USA, V104, P6544, DOI 10.1073/pnas.0701085104; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Rouxel OJ, 2005, SCIENCE, V307, P1088, DOI 10.1126/science.1105692; SASS BM, 1987, INORG CHEM, V26, P2228, DOI 10.1021/ic00261a013; Schauble E, 2004, CHEM GEOL, V205, P99, DOI 10.1016/j.chemgeo.2003.12.015; Schoenberg R, 2008, CHEM GEOL, V249, P294, DOI 10.1016/j.chemgeo.2008.01.009; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; SHIELDS WR, 1966, J RES NBS A PHYS CH, VA 70, P193, DOI 10.6028/jres.070A.016; Sikora ER, 2008, GEOCHIM COSMOCHIM AC, V72, P3631, DOI 10.1016/j.gca.2008.05.051; Wille M, 2007, GEOCHIM COSMOCHIM AC, V71, P2417, DOI 10.1016/j.gca.2007.02.019	35	435	465	10	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					250	U125		10.1038/nature08266	http://dx.doi.org/10.1038/nature08266			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741707				2022-12-28	WOS:000269654600041
J	Price, LC				Price, Laura Claire			Personal View Should I have an H1N1 flu vaccination after Guillain-Barre syndrome?	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFLUENZA VACCINATION; UNITED-KINGDOM; IMMUNIZATION; ASSOCIATION; VACCINES; ADULTS; STATES					lauracprice@hotmail.com						Evans D, 2009, J INFECT DIS, V200, P321, DOI 10.1086/603560; Geier MR, 2003, CLIN IMMUNOL, V107, P116, DOI 10.1016/S1521-6616(03)00046-9; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Hughes RA, 2006, ARCH INTERN MED, V166, P1301, DOI 10.1001/archinte.166.12.1301; HURWITZ ES, 1981, NEW ENGL J MED, V304, P1557, DOI 10.1056/NEJM198106253042601; Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110; Juurlink DN, 2006, ARCH INTERN MED, V166, P2217, DOI 10.1001/archinte.166.20.2217; KAPLAN JE, 1982, JAMA-J AM MED ASSOC, V248, P698, DOI 10.1001/jama.248.6.698; Kuitwaard K, 2009, J PERIPHER NERV SYST, V14, P81; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Marwick Charles, 2003, BMJ, V326, P620; Pritchard J, 2002, J NEUROL NEUROSUR PS, V73, P348, DOI 10.1136/jnnp.73.3.348; ROSCELLI JD, 1991, AM J EPIDEMIOL, V133, P952, DOI 10.1093/oxfordjournals.aje.a115974; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; Sivadon-Tardy V, 2009, CLIN INFECT DIS, V48, P48, DOI 10.1086/594124; Stowe J, 2009, AM J EPIDEMIOL, V169, P382, DOI 10.1093/aje/kwn310; Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344; Vellozzi C, 2009, VACCINE, V27, P2114, DOI 10.1016/j.vaccine.2009.01.125	20	6	6	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	SEP 9	2009	339								b3577	10.1136/bmj.b3577	http://dx.doi.org/10.1136/bmj.b3577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	493RD	19740925				2022-12-28	WOS:000269754700004
J	van Heijst, JWJ; Gerlach, C; Swart, E; Sie, D; Nunes-Alves, C; Kerkhoven, RM; Arens, R; Correia-Neves, M; Schepers, K; Schumacher, TNM				van Heijst, Jeroen W. J.; Gerlach, Carmen; Swart, Erwin; Sie, Daoud; Nunes-Alves, Claudio; Kerkhoven, Ron M.; Arens, Ramon; Correia-Neves, Margarida; Schepers, Koen; Schumacher, Ton N. M.			Recruitment of Antigen-Specific CD8(+) T Cells in Response to Infection Is Markedly Efficient	SCIENCE			English	Article							REPERTOIRE; AFFINITY; BINDING; MAGNITUDE	The magnitude of antigen-specific CD8(+) T cell responses is not fixed but correlates with the severity of infection. Although by definition T cell response size is the product of both the capacity to recruit naive T cells (clonal selection) and their subsequent proliferation (clonal expansion), it remains undefined how these two factors regulate antigen-specific T cell responses. We determined the relative contribution of recruitment and expansion by labeling naive T cells with unique genetic tags and transferring them into mice. Under disparate infection conditions with different pathogens and doses, recruitment of antigen-specific T cells was near constant and close to complete. Thus, naive T cell recruitment is highly efficient, and the magnitude of antigen-specific CD8(+) T cell responses is primarily controlled by clonal expansion.	[van Heijst, Jeroen W. J.; Gerlach, Carmen; Swart, Erwin; Arens, Ramon; Schepers, Koen; Schumacher, Ton N. M.] Netherlands Canc Inst, Dept Immunol, NL-1066 CX Amsterdam, Netherlands; [Sie, Daoud; Kerkhoven, Ron M.] Netherlands Canc Inst, Cent Microarray Facil, NL-066 CX Amsterdam, Netherlands; [Nunes-Alves, Claudio; Correia-Neves, Margarida] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, P-4710057 Braga, Portugal	Netherlands Cancer Institute; Netherlands Cancer Institute; Universidade do Minho	Schumacher, TNM (corresponding author), Netherlands Canc Inst, Dept Immunol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	t.schumacher@nki.nl	Correia-Neves, Margarida/AAH-4636-2020; Schepers, Koen/H-7108-2013; Arens, Ramon/V-4010-2018; Correia-Neves, Margarida/C-9122-2009; Schumacher, Ton/Y-2432-2019	Correia-Neves, Margarida/0000-0002-2202-5431; Schepers, Koen/0000-0003-2442-242X; Arens, Ramon/0000-0001-5058-4110; Correia-Neves, Margarida/0000-0002-2202-5431; Schumacher, Ton/0000-0003-0517-8804; Sie, Daoud/0000-0001-6762-2582; Nunes-Alves, Claudio/0000-0001-9639-0477; Gerlach, Carmen/0000-0001-7889-2393				Alam SM, 1999, IMMUNITY, V10, P227, DOI 10.1016/S1074-7613(00)80023-0; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	15	108	110	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1265	1269		10.1126/science.1175455	http://dx.doi.org/10.1126/science.1175455			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729659				2022-12-28	WOS:000269523200043
J	Scheffer, M; Bascompte, J; Brock, WA; Brovkin, V; Carpenter, SR; Dakos, V; Held, H; van Nes, EH; Rietkerk, M; Sugihara, G				Scheffer, Marten; Bascompte, Jordi; Brock, William A.; Brovkin, Victor; Carpenter, Stephen R.; Dakos, Vasilis; Held, Hermann; van Nes, Egbert H.; Rietkerk, Max; Sugihara, George			Early-warning signals for critical transitions	NATURE			English	Review							CATASTROPHIC REGIME SHIFTS; SELF-ORGANIZED PATCHINESS; CRITICAL SLOWING-DOWN; THERMOHALINE CIRCULATION; EPILEPTIC SEIZURES; TIME-SERIES; CLIMATE; PREDICTION; THRESHOLDS; VOLATILITY	Complex dynamical systems, ranging from ecosystems to financial markets and the climate, can have tipping points at which a sudden shift to a contrasting dynamical regime may occur. Although predicting such critical points before they are reached is extremely difficult, work in different scientific fields is now suggesting the existence of generic early-warning signals that may indicate for a wide class of systems if a critical threshold is approaching.	[Scheffer, Marten; Dakos, Vasilis; van Nes, Egbert H.] Wageningen Univ, Dept Environm Sci, NL-6700 AA Wageningen, Netherlands; [Bascompte, Jordi] CSIC, Integrat Ecol Grp, Estac Biol Donana, E-41092 Seville, Spain; [Brock, William A.] Univ Wisconsin, Dept Econ, Madison, WI 53706 USA; [Carpenter, Stephen R.] Univ Wisconsin, Ctr Limnol, Madison, WI 53706 USA; [Brovkin, Victor] Max Planck Inst Meteorol, D-20146 Hamburg, Germany; [Held, Hermann] Potsdam Inst Climate Impact Res, D-14412 Potsdam, Germany; [Rietkerk, Max] Univ Utrecht, Fac Geosci, Dept Environm Sci, Copernicus Inst, NL-3508 TC Utrecht, Netherlands; [Sugihara, George] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Max Planck Society; Potsdam Institut fur Klimafolgenforschung; Utrecht University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Scheffer, M (corresponding author), Wageningen Univ, Dept Environm Sci, POB 47, NL-6700 AA Wageningen, Netherlands.	marten.scheffer@wur.nl	Rietkerk, Max/H-6235-2011; Brovkin, Victor/C-2803-2016; van Nes, Egbert H/F-2681-2011; Carpenter, Stephen/AAQ-6404-2020; Brovkin, Victor/I-7450-2012; Bascompte, Jordi/B-7596-2008; Scheffer, Marten/C-1852-2012; Dakos, Vasilis/D-6488-2012	Brovkin, Victor/0000-0001-6420-3198; Bascompte, Jordi/0000-0002-0108-6411; Rietkerk, Max/0000-0002-2698-3848; van Nes, Egbert/0000-0002-6345-104X; Dakos, Vasilis/0000-0001-8862-718X	US National Science Foundation; European Heads of Research Councils; European Science Foundation and the European Commission Sixth Framework Programme through a European Young Investigator Award; Deutsche Bank Jameson Complexity Studies Fund; NSF/NOAA CAMEO [NA08OAR4320894]	US National Science Foundation(National Science Foundation (NSF)); European Heads of Research Councils; European Science Foundation and the European Commission Sixth Framework Programme through a European Young Investigator Award; Deutsche Bank Jameson Complexity Studies Fund; NSF/NOAA CAMEO	Our work was supported by the Institute Para Limes and by the South American Institute for Resilience and Sustainability Studies. The work of S. R. C. is also supported by the US National Science Foundation. The research of M. R. and V. D. is supported by the Netherlands Organisation of Scientific Research, Earth and Life Sciences, in the case of M. R. through a Vidi grant. The work of J. B. is supported by the European Heads of Research Councils, the European Science Foundation and the European Commission Sixth Framework Programme through a European Young Investigator Award. G. S. was supported by Deutsche Bank Jameson Complexity Studies Fund, and by an NSF/NOAA CAMEO Grant NA08OAR4320894.	Alley RB, 2003, SCIENCE, V299, P2005, DOI 10.1126/science.1081056; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 1991, FRACTALS CHAOS POWER; ARVEDLUND E, 2002, BARRONS         0128; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; Bakke J, 2009, NAT GEOSCI, V2, P202, DOI 10.1038/NGEO439; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; BATES DS, 1991, J FINANC, V46, P1009, DOI 10.2307/2328552; Bates DS, 1996, REV FINANC STUD, V9, P69, DOI 10.1093/rfs/9.1.69; BENCE JR, 1995, ECOLOGY, V76, P628, DOI 10.2307/1941218; Berglund N., 2002, STOCH DYNAM, V2, P327, DOI DOI 10.1142/S0219493702000455; Berglund N., 2006, PROB APPL S, DOI 10.1007/1-84628-186-5; Biggs R, 2009, P NATL ACAD SCI USA, V106, P826, DOI 10.1073/pnas.0811729106; Box GEP., 2008, TIME SERIES ANAL, DOI [10.1002/9781118619193, DOI 10.1002/9781118619193]; BROCK W, 1992, J FINANC, V47, P1731, DOI 10.2307/2328994; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Chisholm RA, 2009, J THEOR BIOL, V257, P142, DOI 10.1016/j.jtbi.2008.11.008; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Crowley TJ, 2008, NATURE, V456, P226, DOI 10.1038/nature07365; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Elger CE, 1998, EUR J NEUROSCI, V10, P786, DOI 10.1046/j.1460-9568.1998.00090.x; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Guttal V, 2009, THEOR ECOL-NETH, V2, P3, DOI 10.1007/s12080-008-0033-1; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Held H, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020972; Hens T, 2009, HANDB FINANC, P1; Holyst JA, 2001, ANN REV COMP PHYS, V9, P253; Hong H, 2003, REV FINANC STUD, V16, P487, DOI 10.1093/rfs/hhg006; Horsthemke W., 1984, NOISE INDUCED TRANSI; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Kambhu J., 2007, NEW DIRECTIONS UNDER; Kefi S, 2007, NATURE, V449, P213, DOI 10.1038/nature06111; Kleinen T., 2003, OCEAN DYNAM, V53, P53, DOI DOI 10.1007/S10236-002-0023-6; Kump LR, 2005, NATURE, V436, P333, DOI 10.1038/436333a; Kuznetsov Y.A., 1997, ELEMENTS APPL BIFURC; LEBARON B, 1992, J BUS, V65, P199, DOI 10.1086/296565; Lebaron B., 2000, DERIV USE TRADING RE, V5, P324; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2009, PHILOS T R SOC A, V367, P871, DOI 10.1098/rsta.2008.0171; Leung HK, 2000, PHYSICA A, V281, P311, DOI 10.1016/S0378-4371(00)00041-8; Litt B, 2001, NEURON, V30, P51, DOI 10.1016/S0896-6273(01)00262-8; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Livina VN, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028672; Lo AW, 2000, J FINANC, V55, P1705, DOI 10.1111/0022-1082.00265; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; MATSUMOTO G, 1978, J PHYS SOC JPN, V44, P1047, DOI 10.1143/JPSJ.44.1047; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; McSharry PE, 2003, NAT MED, V9, P241, DOI 10.1038/nm0303-241; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Ovaskainen O, 2002, THEOR POPUL BIOL, V61, P285, DOI 10.1006/tpbi.2002.1586; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Rinaldi S, 2000, ECOSYSTEMS, V3, P507, DOI 10.1007/s100210000045; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M, 2003, ECOSYSTEMS, V6, P493, DOI 10.1007/s10021-002-0146-0; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2007, HYDROBIOLOGIA, V584, P455, DOI 10.1007/s10750-007-0616-7; Sole R. V., 1995, Complexity, V1, P13; STROGATZ SH, 1994, NONLINEAR DYNAMICS C, P248; Tredicce JR, 2004, AM J PHYS, V72, P799, DOI 10.1119/1.1688783; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; van Nes EH, 2005, ECOLOGY, V86, P1797, DOI 10.1890/04-0550; Vandermeer J, 2001, CHAOS SOLITON FRACT, V12, P265, DOI 10.1016/S0960-0779(00)00111-9; Vandermeer J, 1999, ECOLOGY, V80, P1817, DOI 10.1890/0012-9658(1999)080[1817:BBCAAM]2.0.CO;2; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Whaley R. E., 1993, J DERIV, V1, P71, DOI [DOI 10.3905/JOD.1993.407868, 10.3905/jod.1993.407868]; Whaley RE, 2000, J PORTFOLIO MANAGE, V26, P12, DOI 10.3905/jpm.2000.319728; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470; ZAHLER RS, 1977, NATURE, V269, P759, DOI 10.1038/269759a0	77	2369	2443	51	1235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					53	59		10.1038/nature08227	http://dx.doi.org/10.1038/nature08227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19727193				2022-12-28	WOS:000269478800026
J	Wake, M; Baur, LA; Gerner, B; Gibbons, K; Gold, L; Gunn, J; Levickis, P; McCallum, Z; Naughton, G; Sanci, L; Ukoumunne, OC				Wake, Melissa; Baur, Louise A.; Gerner, Bibi; Gibbons, Kay; Gold, Lisa; Gunn, Jane; Levickis, Penny; McCallum, Zoe; Naughton, Geraldine; Sanci, Lena; Ukoumunne, Obioha C.			Outcomes and costs of primary care surveillance and intervention for overweight or obese children: the LEAP 2 randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WEIGHT-MANAGEMENT PROGRAM; CHILDHOOD OVERWEIGHT; WORLDWIDE; EFFICACY; LIVE; EAT	Objective To determine whether ascertainment of childhood obesity by surveillance followed by structured secondary prevention in primary care improved outcomes in overweight or mildly obese children. Design Randomised controlled trial nested within a baseline cross sectional survey of body mass index (BMI). Randomisation and outcomes measurement, but not participants, were blinded to group assignment. Setting 45 family practices (66 general practitioners) in Melbourne, Australia. Participants 3958 children visiting their general practitioner in May 2005-July 2006 were surveyed for BMI. Of these, 258 children aged 5 years 0 months up to their 10th birthday who were overweight or obese by International Obesity Taskforce criteria were randomised to intervention (n=139) or control (n=119) groups. Children who were very obese (UK BMI z score >= 3.0) were excluded. Intervention Four standard consultations over 12 weeks targeting change in nutrition, physical activity, and sedentary behaviour, supported by purpose designed family materials. Main outcomes measures Primary measure was BMI at 6 and 12 months after randomisation. Secondary measures were mean activity count/min by 7-day accelerometry, nutrition score from 4-day abbreviated food frequency diary, and child health related quality of life. Differences were adjusted for socioeconomic status, age, sex, and baseline BMI. Results Of 781 eligible children, 258 (33%) entered the trial; attrition was 3.1% at 6 months and 6.2% at 12 months. Adjusted mean differences (intervention control) at 6 and 12 months were, for BMI, -0.12 (95% CI -0.40 to 0.15, P=0.4) and -0.11 (-0.45 to 0.22, P=0.5); for physical activity in counts/min, 24 (-4 to 52, P=0.09) and 11 (-26 to 49, P=0.6); and, for nutrition score, 0.2 (-0.03 to 0.4, P=0.1) and 0.1 (-0.1 to 0.4, P=0.2). There was no evidence of harm to the child. Costs to the healthcare system were significantly higher in the intervention arm. Conclusions Primary care screening followed by brief counselling did not improve BMI, physical activity, or nutrition in overweight or mildly obese 5-10 year olds, and it would be very costly if universally implemented. These findings are at odds with national policies in countries including the US, UK, and Australia.	[Wake, Melissa] Royal Childrens Hosp, Ctr Community Child Hlth, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Gunn, Jane] Univ Melbourne, Dept Gen Practice, Parkville, Vic 3052, Australia; [Baur, Louise A.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2145, Australia; [Baur, Louise A.] Childrens Hosp Westmead, Sydney, NSW 2145, Australia; [Gold, Lisa] Deakin Univ, Sch Hlth & Social Dev, Hlth Econ Unit, Burwood, Vic 3125, Australia; [Naughton, Geraldine] Australian Catholic Univ, Sch Exercise Sci, Ctr Phys Act Lifespan, Strathfield, NSW 2135, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Sydney; University of Sydney; Deakin University; Australian Catholic University	Wake, M (corresponding author), Royal Childrens Hosp, Ctr Community Child Hlth, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	melissa.wake@rch.org.au	Levickis, Penny/M-3579-2019; Levickis, Penny/N-9394-2018; Levickis, Penny/K-8968-2019; Naughton, Geraldine/M-4094-2017; Baur, Louise/AAE-3413-2021; Wake, Melissa/J-1396-2012	Levickis, Penny/0000-0003-0534-733X; Levickis, Penny/0000-0003-0534-733X; Naughton, Geraldine/0000-0002-0534-1627; Wake, Melissa/0000-0001-7501-9257; Baur, Louise/0000-0002-4521-9482; Gold, Lisa/0000-0002-2733-900X; Gibbons, Kay/0000-0002-1428-3166; Gunn, Jane/0000-0001-8836-7525	Australian National Health and Medical Research Council (NHMRC) [334309]; NH&MRC Career Development Award [284556]; NH&MRC Capacity Building Grant [425855, 436914]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NH&MRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NH&MRC Capacity Building Grant(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the Australian National Health and Medical Research Council (NH&MRC) Project Grant 334309. MW is supported by NH&MRC Career Development Award 284556; LG by NH&MRC Capacity Building Grant 425855; and OCU by NH&MRC Capacity Building Grant 436914. The researchers were independent of the funders.	*AUSTR GOV DEP HLT, 2006, MED BEN SCHED BOOK 2; Australian Bureau of Statistics, 2003, 2001 CENS POP HOUS S; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cole TJ, 1997, ARCH DIS CHILD, V76, P47, DOI 10.1136/adc.76.1.47; COLLINS ME, 1991, INT J EAT DISORDER, V10, P199, DOI 10.1002/1098-108X(199103)10:2&lt;199::AID-EAT2260100209&gt;3.0.CO;2-D; Davidson A.C., 1997, BOOTSTRAP METHODS TH; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Gerner B, 2006, J PAEDIATR CHILD H, V42, P206, DOI 10.1111/j.1440-1754.2006.00831.x; Goldstein H, 1995, MULTILEVEL STAT MODE, DOI 10.1002/9780470973394; Golley RK, 2007, PEDIATRICS, V119, P517, DOI 10.1542/peds.2006-1746; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; Greenberg G, 2001, CAN FAM PHYSICIAN, V47, P2289; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hughes AR, 2008, PEDIATRICS, V121, pE539, DOI 10.1542/peds.2007-1786; Kalavainen MP, 2007, INT J OBESITY, V31, P1500, DOI 10.1038/sj.ijo.0803628; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; Lobstein T., 2004, OBES REV S1, V5, P4, DOI [https://doi.org/10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; McCallum Z, 2007, INT J OBESITY, V31, P630, DOI 10.1038/sj.ijo.0803509; McCallum Z, 2005, J PAEDIATR CHILD H, V41, P488, DOI 10.1111/j.1440-1754.2005.00689.x; Moyer VA, 2004, PEDIATRICS, V114, P1511, DOI 10.1542/peds.2004-1076; National Health Medical Research Council (Australia), 2003, CLIN PRACT GUID MAN; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Prochaska J O, 1992, Prog Behav Modif, V28, P183; Savoye M, 2007, JAMA-J AM MED ASSOC, V297, P2697, DOI 10.1001/jama.297.24.2697; Schwartz RP, 2007, ARCH PEDIAT ADOL MED, V161, P495, DOI 10.1001/archpedi.161.5.495; *STAT CORP, 2005, STAT STAT SOFTW REL; Turnell A, 1994, CASE STUDIES BRIEF F, V8, P39; *UK DEP HLTH, OB CAR PATHW YOUR WE; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; WATERS E, 2000, MED J AUSTRALIA, V173, P98; Westwood M, 2007, ARCH DIS CHILD, V92, P416, DOI 10.1136/adc.2006.113589; Whitlock EP, 2005, PEDIATRICS, V116, pE125, DOI 10.1542/peds.2005-0242; Wilfley DE, 2007, JAMA-J AM MED ASSOC, V298, P1661, DOI 10.1001/jama.298.14.1661	35	121	121	0	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2009	339								b3308	10.1136/bmj.b3308	http://dx.doi.org/10.1136/bmj.b3308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CI	19729418	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-28	WOS:000269554100003
J	Brook, RH				Brook, Robert H.			Assessing the Appropriateness of Care-Its Time Has Come	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CRITERIA; VALIDITY		[Brook, Robert H.] RAND Corp, Santa Monica, CA USA; [Brook, Robert H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Brook, Robert H.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA	RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Brook, RH (corresponding author), RAND Hlth, 1776 Main St,POB 2138, Santa Monica, CA 90407 USA.	brook@rand.org	Young, Alexander/A-1523-2009	Young, Alexander/0000-0002-9367-9213				Brook R H, 1986, Int J Technol Assess Health Care, V2, P53; CHASSIN MR, 1987, JAMA-J AM MED ASSOC, V258, P2533, DOI 10.1001/jama.258.18.2533; Fitch K, 2001, MR1269DG12RE126 RAND; Froehlich F, 1997, GASTROINTEST ENDOSC, V45, P13, DOI 10.1016/S0016-5107(97)70330-4; Gonzalez N, 2009, GAC SANIT, V23, P232, DOI 10.1016/j.gaceta.2007.06.001; Hemingway H, 2008, ANN INTERN MED, V149, P221, DOI 10.7326/0003-4819-149-4-200808190-00003; KLEINMAN LC, 1994, JAMA-J AM MED ASSOC, V271, P1250, DOI 10.1001/jama.271.16.1250; KRAVITZ RL, 1995, JAMA-J AM MED ASSOC, V274, P632, DOI 10.1001/jama.274.8.632; Pilpel Dina, 1992, Public Health Reviews, V20, P61; WINSLOW CM, 1988, NEW ENGL J MED, V318, P721, DOI 10.1056/NEJM198803243181201	10	38	38	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					997	998		10.1001/jama.2009.1279	http://dx.doi.org/10.1001/jama.2009.1279			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724048				2022-12-28	WOS:000269444900026
J	Federoff, HJ; Gostin, LO				Federoff, Howard J.; Gostin, Lawrence O.			Evolving From Reductionism to Holism Is There a Future for Systems Medicine?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENOMEWIDE ASSOCIATION; DISEASE; BIOLOGY		[Federoff, Howard J.] Georgetown Univ, Med Ctr, Washington, DC 20057 USA; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global & Hlth Law, Washington, DC USA	Georgetown University; Georgetown University	Federoff, HJ (corresponding author), Georgetown Univ, Med Ctr, Bldg D,4000 Reservoir Rd NW, Washington, DC 20057 USA.	hjf8@georgetown.edu						Burja AM, 2003, TRENDS BIOTECHNOL, V21, P504, DOI 10.1016/j.tibtech.2003.08.008; Clayton EW, 2003, NEW ENGL J MED, V349, P562, DOI 10.1056/NEJMra012577; Flexner A., 1910, MEDICAL ED US CANADA; Gostin LO, 2009, JAMA-J AM MED ASSOC, V301, P1373, DOI 10.1001/jama.2009.424; GOTTLIEB S, 2000, BRIT MED J, V321, pD1040; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Pollard HB, 2000, ANAT REC, V259; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Yuan JS, 2008, TRENDS PLANT SCI, V13, P165, DOI 10.1016/j.tplants.2008.02.003	10	58	61	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					994	996		10.1001/jama.2009.1264	http://dx.doi.org/10.1001/jama.2009.1264			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724047				2022-12-28	WOS:000269444900025
J	Porco, TC; Gebre, T; Ayele, B; House, J; Keenan, J; Zhou, ZX; Hong, KC; Stoller, N; Ray, KJ; Emerson, P; Gaynor, BD; Lietman, TM				Porco, Travis C.; Gebre, Teshome; Ayele, Berhan; House, Jenafir; Keenan, Jeremy; Zhou, Zhaoxia; Hong, Kevin Cyrus; Stoller, Nicole; Ray, Kathryn J.; Emerson, Paul; Gaynor, Bruce D.; Lietman, Thomas M.			Effect of Mass Distribution of Azithromycin for Trachoma Control on Overall Mortality in Ethiopian Children A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OCULAR CHLAMYDIA-TRACHOMATIS; PLASMODIUM-VIVAX MALARIA; SINGLE-DOSE AZITHROMYCIN; INFECTIOUS TRACHOMA; STREPTOCOCCUS-PNEUMONIAE; CHILDHOOD MORTALITY; ORAL AZITHROMYCIN; GAMBIAN CHILDREN; DOUBLE-BLIND; ADDIS-ABABA	Context Mass oral azithromycin distribution to affected communities is a cornerstone of the World Health Organization's trachoma elimination program. Antibiotics are provided to target the ocular strains of chlamydia that cause trachoma, but may also be efficacious against respiratory disease, diarrhea, and malaria-frequent causes of childhood mortality in trachoma-endemic areas. Objective To compare mortality rates of participants aged 1 to 9 years in treated communities with those in untreated communities. Design, Setting, and Participants We conducted a cluster-randomized clinical trial of mass azithromycin administration for trachoma control. Forty-eight communities (known as subkebeles) were randomized into 1 of 3 treatment schedules (annual treatment of all residents [15 902 participants], biannual treatment of all residents [17 288 participants], or quarterly treatment of children only [14 716 participants]) or into 1 group for which treatment was delayed by 1 year (control, 18 498 participants). Twelve subkebeles were randomized to each of the 4 schedules with all children in each of the 3 communities being eligible for treatment. The trial was conducted in a field setting in rural Ethiopia, May 2006 to May 2007. Interventions A single dose of oral azithromycin (adults, 1 g; children, 20 mg/kg) was administered for treatment of ocular Chlamydia trachomatis infection. Antibiotic coverage levels for children aged 1 to 9 years exceeded 80% at all visits. Main Outcome Measure The main outcome measure was the community-specific mortality risk for children aged 1 to 9 years over the course of 1 year. Mortality was measured by enumerative census at baseline and again after 1 year. Comparison of the risk of mortality was a prespecified outcome for the clinical trial. Results The odds ratio for childhood mortality in the intervention communities was 0.51 (95% confidence interval, 0.29-0.90; P=.02; clustered logistic regression) compared with the control group. In the treated communities, the estimated overall mortality rate during this period for children aged 1 to 9 years in the untreated group was 8.3 per 1000 person-years (95% confidence interval, 5.3-13.1), while among the treated communities, the estimated overall mortality rate was 4.1 per 1000 person-years (95% confidence interval, 3.0-5.7) for children aged 1 to 9 years. Conclusion In a trachoma-endemic area, mass distribution of oral azithromycin was associated with reduced mortality in children. Trial Registration clinicaltrials.gov Identifier: NCT00322972 JAMA. 2009;302(9):962-968 www.jama.com	[Lietman, Thomas M.] Univ Calif San Francisco, Inst Global Hlth, San Francisco, CA 94143 USA; [Porco, Travis C.; House, Jenafir; Keenan, Jeremy; Zhou, Zhaoxia; Hong, Kevin Cyrus; Stoller, Nicole; Ray, Kathryn J.; Gaynor, Bruce D.; Lietman, Thomas M.] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Porco, Travis C.; Keenan, Jeremy; Zhou, Zhaoxia; Gaynor, Bruce D.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA; [Porco, Travis C.; Lietman, Thomas M.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lietman, TM (corresponding author), Univ Calif San Francisco, Inst Global Hlth, 513 Parnassus Ave,Room S309 Med Sci, San Francisco, CA 94143 USA.	tom.lietman@ucsf.edu	Gebre, Teshome/F-2973-2011; Keenan, Jeremy David/AAO-5882-2020	Gebre, Teshome/0000-0002-9884-0344; Keenan, Jeremy David/0000-0002-7118-1457; Emerson, Paul/0000-0002-6478-8816	The National Eye Institute of the National Institutes of Health [U10 EY016214]; Pfizer International (New York, New York); Bernard Osher Foundation; That Man May See; Peierls Foundation; Bodri Foundation; Harper Inglis Trust; South Asia Research Fund; Research to Prevent Blindness; Clinical & Translational Science Institute-Strategic Opportunities; NATIONAL EYE INSTITUTE [U10EY016214] Funding Source: NIH RePORTER	The National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Pfizer International (New York, New York); Bernard Osher Foundation; That Man May See; Peierls Foundation; Bodri Foundation; Harper Inglis Trust; South Asia Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Clinical & Translational Science Institute-Strategic Opportunities; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The National Eye Institute of the National Institutes of Health (the TANA study, U10 EY016214) was the primary supporter of this trial. Pfizer International (New York, New York) and the International Trachoma Initiative provided the azithromycin. Donations were also provided by the Bernard Osher Foundation, That Man May See, the Peierls Foundation, the Bodri Foundation, the Harper Inglis Trust, the South Asia Research Fund, and Research to Prevent Blindness. Dr Lietman gratefully acknowledges support from the Clinical & Translational Science Institute-Strategic Opportunities Support program sabbatical grant.	ADEGBOLA RA, 1995, PEDIATR INFECT DIS J, V14, P335, DOI 10.1097/00006454-199504000-00024; Ali M, 2005, B WORLD HEALTH ORGAN, V83, P27; Atik B, 2006, JAMA-J AM MED ASSOC, V296, P1488, DOI 10.1001/jama.296.12.1488; BAILEY RL, 1993, LANCET, V342, P453, DOI 10.1016/0140-6736(93)91591-9; Batt SL, 2003, ANTIMICROB AGENTS CH, V47, P2765, DOI 10.1128/AAC.47.9.2765-2769.2003; Chidambaram JD, 2006, JAMA-J AM MED ASSOC, V295, P1142, DOI 10.1001/jama.295.10.1142; Dunne MW, 2005, AM J TROP MED HYG, V73, P1108; Eisenberg JNS, 2003, EPIDEMIOLOGY, V14, P442, DOI 10.1097/01.ede.0000071411.19255.4c; Fleiss JL., 2003, STAT METHODS RATES P; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; Gill DA, 2008, CLIN INFECT DIS, V46, P564, DOI 10.1086/526777; Guchev IA, 2004, CLIN INFECT DIS, V38, P1095, DOI 10.1086/382879; Heppner DG, 2005, AM J TROP MED HYG, V73, P842; House JI, 2009, LANCET, V373, P1111, DOI 10.1016/S0140-6736(09)60323-8; Leach AJ, 1997, CLIN INFECT DIS, V24, P356, DOI 10.1093/clinids/24.3.356; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; Maher MJ, 1996, ACCIDENT ANAL PREV, V28, P281, DOI 10.1016/0001-4575(95)00059-3; Mariotti SP, 2004, NEW ENGL J MED, V351, P2004, DOI 10.1056/NEJMe048205; Melese M, 2004, JAMA-J AM MED ASSOC, V292, P721, DOI 10.1001/jama.292.6.721; Melese M, 2008, JAMA-J AM MED ASSOC, V299, P778, DOI 10.1001/jama.299.7.778; MENON A, 1990, T ROY SOC TROP MED H, V84, P768, DOI 10.1016/0035-9203(90)90071-L; Mohammed E, 2000, ETHIOPIAN MED J, V38, P165; SADIQ ST, 1995, LANCET, V346, P881, DOI 10.1016/S0140-6736(95)92712-3; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; SNOW RW, 1992, LANCET, V340, P351, DOI 10.1016/0140-6736(92)91414-4; Solomon AW, 2005, ANTIMICROB AGENTS CH, V49, P4804, DOI 10.1128/AAC.49.11.4804-4806.2005; Solomon AW, 2004, NEW ENGL J MED, V351, P1962, DOI 10.1056/NEJMoa040979; SOMMER A, 1986, LANCET, V1, P1169; Taye A, 2007, ANN TROP MED PARASIT, V101, P441, DOI 10.1179/136485907X176544; THOREN A, 1982, J TROP PEDIATRICS, V28, P127, DOI 10.1093/tropej/28.3.127; Whitty CJM, 1999, PEDIATR INFECT DIS J, V18, P955, DOI 10.1097/00006454-199911000-00003; *WHO, 2004, NAT CHILD SURV C APR	33	137	137	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					962	968		10.1001/jama.2009.1266	http://dx.doi.org/10.1001/jama.2009.1266			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724043	Bronze			2022-12-28	WOS:000269444900021
J	Chu, Y; Lee, J				Chu, Yueng-Hsiang; Lee, Jih-Chin			Unilateral Epistaxis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chu, Yueng-Hsiang; Lee, Jih-Chin] Tri Serv Gen Hosp, Taipei 114, Taiwan	Tri-Service General Hospital	Chu, Y (corresponding author), Tri Serv Gen Hosp, Taipei 114, Taiwan.	doc30450@yahoo.com		Chu, Yueng Hsiang/0000-0002-2587-958X					0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					E14	E14		10.1056/NEJMicm0807268	http://dx.doi.org/10.1056/NEJMicm0807268			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	487XV	19710479				2022-12-28	WOS:000269312700011
J	You, D; Wardlaw, T; Salama, P; Jones, G				You, Danzhen; Wardlaw, Tessa; Salama, Peter; Jones, Gareth			Levels and trends in under-5 mortality, 1990-2008	LANCET			English	Editorial Material									[You, Danzhen; Wardlaw, Tessa; Salama, Peter; Jones, Gareth] UNICEF, New York, NY 10017 USA	UNICEF	You, D (corresponding author), UNICEF, New York, NY 10017 USA.	dyou@unicef.org						Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; *UNICEF, 2009, MAL CHILDR PROGR INT; *UNICEF, CHILD MORT DAT CME I; UNICEF the World Health Organization (WHO) World Bank and United Nation Population Division (UNPD), 2007, LEV TRENDS CHILD MOR; UNICEF World Health Organization, 2011, IMM SUMM STAT REF CO; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE	7	101	101	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 9	2010	375	9709					100	103		10.1016/S0140-6736(09)61601-9	http://dx.doi.org/10.1016/S0140-6736(09)61601-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	19748116				2022-12-28	WOS:000273664500007
J	Kim, JB; Greber, B; Arauzo-Bravo, MJ; Meyer, J; Park, KI; Zaehres, H; Scholer, HR				Kim, Jeong Beom; Greber, Boris; Arauzo-Bravo, Marcos J.; Meyer, Johann; Park, Kook In; Zaehres, Holm; Schoeler, Hans R.			Direct reprogramming of human neural stem cells by OCT4	NATURE			English	Article							HUMAN FIBROBLASTS; GENERATION; MOUSE; PLURIPOTENCY; INDUCTION; MYC	Induced pluripotent stem (iPS) cells have been generated from mouse and human somatic cells by ectopic expression of four transcription factors (OCT4 (also called POU5F1), SOX2, c-Myc and KLF4)(1-7). We previously reported that Oct4 alone is sufficient to reprogram directly adult mouse neural stem cells to iPS cells(8). Here we report the generation of one-factor human iPS cells from human fetal neural stem cells (one-factor (1F) human NiPS cells) by ectopic expression of OCT4 alone. One-factor human NiPS cells resemble human embryonic stem cells in global gene expression profiles, epigenetic status, as well as pluripotency in vitro and in vivo. These findings demonstrate that the transcription factor OCT4 is sufficient to reprogram human neural stem cells to pluripotency. One-factor iPS cell generation will advance the field further towards understanding reprogramming and generating patient-specific pluripotent stem cells.	[Kim, Jeong Beom; Greber, Boris; Arauzo-Bravo, Marcos J.; Zaehres, Holm; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, NRW, Germany; [Meyer, Johann] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany; [Park, Kook In] Yonsei Univ, Coll Med, Dept Pediat, Project Med Sci BK21, Seoul 120752, South Korea	Max Planck Society; Hannover Medical School; Yonsei University; Yonsei University Health System	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, NRW, Germany.	office@mpi-muenster.mpg.de	, HS/AAB-4434-2019; Marcos, Arauzo-Bravo/A-1706-2011	, HS/0000-0003-2643-5136; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Kim, Jeong Beom/0000-0001-6230-8826; Greber, Boris/0000-0002-9404-7293	German Federal Ministry of Education and Research BMBF [01GN0811]; Deutsche Forschungsgemeinschaft DFG [SCHO 340/4-1]	German Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	We thank B. Schafer for histology, T. Kitamura for the pMX retroviral vector and A. Malapetsas and S. Kolsch for editing. This work has been supported, in part, by a grant from the German Federal Ministry of Education and Research BMBF 01GN0811 and in part by a grant by the Deutsche Forschungsgemeinschaft DFG SCHO 340/4-1.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim YT, 2006, EXP NEUROL, V199, P222, DOI 10.1016/j.expneurol.2006.03.015; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Widera D, 2009, STEM CELLS, V27, P1899, DOI 10.1002/stem.104; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zaehres H, 2006, METHOD ENZYMOL, V420, P49, DOI 10.1016/S0076-6879(06)20004-1	25	506	565	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					649	U93		10.1038/nature08436	http://dx.doi.org/10.1038/nature08436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19718018				2022-12-28	WOS:000270302600040
J	Wang, X; Kruithof-de Julio, M; Economides, KD; Walker, D; Yu, HL; Halili, MV; Hu, YP; Price, SM; Abate-Shen, C; Shen, MM				Wang, Xi; Kruithof-de Julio, Marianna; Economides, Kyriakos D.; Walker, David; Yu, Hailong; Halili, M. Vivienne; Hu, Ya-Ping; Price, Sandy M.; Abate-Shen, Cory; Shen, Michael M.			A luminal epithelial stem cell that is a cell of origin for prostate cancer	NATURE			English	Article							ANDROGEN-INDUCED REGENERATION; BASAL-CELLS; RECOMBINASE ACTIVITY; TUMOR INITIATION; MOUSE PROSTATE; HOMEOBOX GENE; MUTANT MICE; IN-VIVO; NKX3.1; EXPRESSION	In epithelial tissues, the lineage relationship between normal progenitor cells and cell type(s) of origin for cancer has been poorly understood. Here we show that a known regulator of prostate epithelial differentiation, the homeobox gene Nkx3-1, marks a stem cell population that functions during prostate regeneration. Genetic lineage-marking demonstrates that rare luminal cells that express Nkx3-1 in the absence of testicular androgens (castration-resistant Nkx3-1-expressing cells, CARNs) are bipotential and can self-renew in vivo, and single-cell transplantation assays show that CARNs can reconstitute prostate ducts in renal grafts. Functional assays of Nkx3-1 mutant mice in serial prostate regeneration suggest that Nkx3-1 is required for stem cell maintenance. Furthermore, targeted deletion of the Pten tumour suppressor gene in CARNs results in rapid carcinoma formation after androgen-mediated regeneration. These observations indicate that CARNs represent a new luminal stem cell population that is an efficient target for oncogenic transformation in prostate cancer.	[Wang, Xi; Kruithof-de Julio, Marianna; Shen, Michael M.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Wang, Xi; Kruithof-de Julio, Marianna; Shen, Michael M.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ Coll Phys & Surg, Dept Urol, New York, NY 10032 USA; [Abate-Shen, Cory] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Wang, Xi; Economides, Kyriakos D.; Walker, David; Yu, Hailong; Halili, M. Vivienne; Hu, Ya-Ping; Price, Sandy M.; Abate-Shen, Cory; Shen, Michael M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Wang, Xi; Walker, David; Yu, Hailong; Halili, M. Vivienne; Hu, Ya-Ping; Price, Sandy M.; Shen, Michael M.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Piscataway, NJ 08854 USA; [Economides, Kyriakos D.; Abate-Shen, Cory] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA	Columbia University; Columbia University; Columbia University; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Shen, MM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA.	mshen@columbia.edu	yu, hailong/F-7716-2011; Abate-Shen, Cory/O-2520-2014; Thomson, Axel/A-7893-2013; Shen, Michael M/C-7546-2009	Abate-Shen, Cory/0000-0002-5021-0570; Shen, Michael M/0000-0002-4042-1657; Kruithof-de Julio, Marianna/0000-0002-6085-7706; Walker, David/0000-0002-8783-0562	NIH; DOD Prostate Cancer Research Program; NCI Mouse Models of Human Cancer Consortium; NATIONAL CANCER INSTITUTE [U01CA084294, P01CA154293] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076602] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD Prostate Cancer Research Program; NCI Mouse Models of Human Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Kim for her initial observations on Nkx3-1 expression in the regressed prostate, and C. Cordon-Cardo, E. Gelmann, C. Mendelsohn and B. Reizis for comments on the manuscript. Weare also grateful to C. Bieberich, M. Capecchi, P. Chambon and F. Costantini for providing mice and reagents. This work was supported by grants from the NIH (C.A.-S. and M. M. S.), DOD Prostate Cancer Research Program ( K. D. E., C. A.-S. and M. M. S.), and the NCI Mouse Models of Human Cancer Consortium.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Abate-Shen C, 2008, DIFFERENTIATION, V76, P717, DOI 10.1111/j.1432-0436.2008.00292.x; Abdulkadir SA, 2002, MOL CELL BIOL, V22, P1495, DOI 10.1128/MCB.22.5.1495-1503.2002; Banach-Petrosky W, 2007, CANCER RES, V67, P9089, DOI 10.1158/0008-5472.CAN-07-2887; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; BICKENBACH JR, 1987, J INVEST DERMATOL, V88, P42, DOI 10.1111/1523-1747.ep12464857; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Chen H, 2005, DEV DYNAM, V234, P961, DOI 10.1002/dvdy.20596; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; CUNHA GR, 1984, STAIN TECHNOL, V59, P7, DOI 10.3109/10520298409113823; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Gao H, 2006, CANCER RES, V66, P7929, DOI 10.1158/0008-5472.CAN-06-1637; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Grisanzio C, 2008, J CELL BIOCHEM, V103, P1354, DOI 10.1002/jcb.21555; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Humphrey PA, 2007, J CLIN PATHOL, V60, P35, DOI 10.1136/jcp.2005.036442; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Isaacs JT, 1985, BENIGN PROSTATIC HYP, P85; Kasper S, 2008, J CELL PHYSIOL, V216, P332, DOI 10.1002/jcp.21489; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim MJ, 2002, CANCER RES, V62, P2999; Kurita T, 2004, DEVELOPMENT, V131, P4955, DOI 10.1242/dev.01384; Lawson DA, 2007, J CLIN INVEST, V117, P2044, DOI 10.1172/JCI32810; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Ouyang X, 2005, CANCER RES, V65, P6773, DOI 10.1158/0008-5472.CAN-05-1948; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SUGIMURA Y, 1986, BIOL REPROD, V34, P973, DOI 10.1095/biolreprod34.5.973; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	50	515	533	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 24	2009	461	7263					495	U61		10.1038/nature08361	http://dx.doi.org/10.1038/nature08361			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19741607	Green Accepted			2022-12-28	WOS:000270082900033
J	Lu-Yao, GL; Albertsen, PC; Moore, DF; Shih, WC; Lin, Y; DiPaola, RS; Barry, MJ; Zietman, A; O'Leary, M; Walker-Corkery, E; Yao, SL				Lu-Yao, Grace L.; Albertsen, Peter C.; Moore, Dirk F.; Shih, Weichung; Lin, Yong; DiPaola, Robert S.; Barry, Michael J.; Zietman, Anthony; O'Leary, Michael; Walker-Corkery, Elizabeth; Yao, Siu-Long			Outcomes of Localized Prostate Cancer Following Conservative Management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACTIVE SURVEILLANCE; RADICAL PROSTATECTOMY; ANDROGEN-DEPRIVATION; SURVIVAL; MEN; TRENDS; RISK; INTERVENTION; DEATH	Context Most newly diagnosed prostate cancers are clinically localized, and major treatment options include surgery, radiation, or conservative management. Although conservative management can be a reasonable choice, there is little contemporary prostate-specific antigen (PSA)-era data on outcomes with this approach. Objective To evaluate the outcomes of clinically localized prostate cancer managed without initial attempted curative therapy in the PSA era. Design, Setting, and Participants A population-based cohort study of men aged 65 years or older when they were diagnosed (1992-2002) with stage T1 or T2 prostate cancer and whose cases were managed without surgery or radiation for 6 months after diagnosis. Living in areas covered by the Surveillance, Epidemiology, and End Results (SEER) program, the men were followed up for a median of 8.3 years (through December 31, 2007). Competing risk analyses were performed to assess outcomes. Main Outcome Measures Ten-year overall survival, cancer-specific survival, and major cancer related interventions. Results Among men who were a median age of 78 years at cancer diagnosis, 10-year prostate cancer-specific mortality was 8.3%(95% confidence interval [CI], 4.2%-12.8%) formen with well-differentiated tumors; 9.1%(95% CI, 8.3%-10.1%) for those with moderately differentiated tumors, and 25.6% (95% CI, 23.7%-28.3%) for those with poorly differentiated tumors. The corresponding 10-year risks of dying of competing causes were 59.8%(95% CI, 53.2%-67.8%), 57.2%(95% CI, 52.6%-63.9%), and 56.5%(95% CI, 53.6%-58.8%), respectively. Ten-year disease-specific mortality for men aged 66 to 74 years diagnosed with moderately differentiated disease was 60% to 74% lower than earlier studies: 6%(95% CI, 4%-8%) in the contemporary PSA era (1992-2002) compared with results of previous studies(15%-23%) in earlier eras (1949-1992). Improved survival was also observed in poorly differentiated disease. The use of chemotherapy (1.6%) or major interventions for spinal cord compression (0.9%) was uncommon. Conclusions Results following conservative management of clinically localized prostate cancer diagnosed from 1992 through 2002 are better than outcomes among patients diagnosed in the 1970s and 1980s. This may be due, in part, to additional lead time, overdiagnosis related to PSA testing, grade migration, or advances in medical care. JAMA. 2009; 302(11): 1202-1209	[Lu-Yao, Grace L.; Moore, Dirk F.; Shih, Weichung; Lin, Yong; DiPaola, Robert S.; Yao, Siu-Long] Univ Med & Dent New Jersey, Canc Inst New Jersey, Piscataway, NJ 08854 USA; [Lu-Yao, Grace L.; DiPaola, Robert S.; Yao, Siu-Long] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA; [Moore, Dirk F.; Shih, Weichung; Lin, Yong] Univ Med & Dent New Jersey, Sch Publ Hlth, Dept Biostat, Piscataway, NJ 08854 USA; [Albertsen, Peter C.] Univ Connecticut, Dept Surg Oncol, Farmington, CT USA; [Lu-Yao, Grace L.; DiPaola, Robert S.] Massachusetts Gen Hosp, Dean & Betty Gallo Prostate Canc Ctr, Boston, MA 02114 USA; [Barry, Michael J.; Walker-Corkery, Elizabeth] Massachusetts Gen Hosp, Med Practices Evaluat Ctr, Boston, MA 02114 USA; [Zietman, Anthony] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [O'Leary, Michael] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Yao, Siu-Long] Schering Plough Res Inst, Kenilworth, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Connecticut; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Merck & Company; Schering-Plough Research Institute	Lu-Yao, GL (corresponding author), 195 Little Albany St,Room 5534, New Brunswick, NJ USA.	luyaogr@umdnj.edu		Lu-Yao, Grace/0000-0002-6017-9175	US Army Medical Research Acquisition Activity, Fort Detrick, MD [DAMD17-01-10755]; Department of Defense award [W81XWG-05-1-0235]; Ohl Foundation [R01 CA116399]; National Cancer Institute [CA-72720-10]; NATIONAL CANCER INSTITUTE [P30CA072720, R01CA116399] Funding Source: NIH RePORTER	US Army Medical Research Acquisition Activity, Fort Detrick, MD; Department of Defense award(United States Department of Defense); Ohl Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: The study was supported by the following grants and awards: award DAMD17-01-10755 from the US Army Medical Research Acquisition Activity, Fort Detrick, MD, Department of Defense award W81XWG-05-1-0235, Ohl Foundation, and grants R01 CA116399 and CINJ core grant CA-72720-10 from the National Cancer Institute.	ADOLFSSON J, 1993, CANCER-AM CANCER SOC, V72, P310, DOI 10.1002/1097-0142(19930715)72:2<310::AID-CNCR2820720203>3.0.CO;2-T; ADOLFSSON J, 1992, BRIT J UROL, V69, P183, DOI 10.1111/j.1464-410X.1992.tb15493.x; Albertsen PC, 2005, J NATL CANCER I, V97, P1248, DOI 10.1093/jnci/dji248; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Albertsen PC, 2000, J UROLOGY, V163, P519, DOI 10.1016/S0022-5347(05)67915-3; Bill-Axelson A, 2005, NEW ENGL J MED, V352, P1977, DOI 10.1056/NEJMoa043739; Carter HB, 2007, J UROLOGY, V178, P2359, DOI 10.1016/j.juro.2007.08.039; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; Cooperberg MR, 2007, J UROLOGY, V178, pS14, DOI 10.1016/j.juro.2007.03.135; Cooperberg MR, 2003, J NATL CANCER I, V95, P981, DOI 10.1093/jnci/95.13.981; Cooperberg MR, 2004, J UROLOGY, V171, P1393, DOI 10.1097/01.ju.0000107247.81471.06; Dall'Era MA, 2008, CANCER-AM CANCER SOC, V112, P1650, DOI 10.1002/cncr.23373; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Efron B., 1994, INTRO BOOTSTRAP; Hardie C, 2005, BJU INT, V95, P956, DOI 10.1111/j.1464-410X.2005.05446.x; Jani AB, 2008, AM J CLIN ONCOL-CANC, V31, P375, DOI 10.1097/COC.0b013e3181637384; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JOHANSSON JE, 1992, JAMA-J AM MED ASSOC, V267, P2191, DOI 10.1001/jama.267.16.2191; Johansson JE, 1997, JAMA-J AM MED ASSOC, V277, P467, DOI 10.1001/jama.277.6.467; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Kattan MW, 2008, CANCER, V112, P69, DOI 10.1002/cncr.23106; Kawakami J, 2006, CANCER, V106, P1708, DOI 10.1002/cncr.21799; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Klotz L, 2008, SEMIN RADIAT ONCOL, V18, P2, DOI 10.1016/j.semradonc.2007.09.001; LuYao GL, 1997, LANCET, V349, P906, DOI 10.1016/S0140-6736(96)09380-4; MULLER HG, 1994, BIOMETRICS, V50, P61, DOI 10.2307/2533197; OLEYNICK JU, 2006, AM SOC CLIN ONC ANN; Patel MI, 2004, J UROLOGY, V171, P1520, DOI 10.1097/01.ju.0000118224.54949.78; Penson DF, 2001, J NATL CANCER I, V93, P1822, DOI 10.1093/jnci/93.23.1822; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Ries LAG, 2007, SEER CANC STAT REV 1; Shahinian VB, 2005, NEW ENGL J MED, V352, P154, DOI 10.1056/NEJMoa041943; Virnig BA, 2002, MED CARE, V40, P49; Walsh PC, 2007, NEW ENGL J MED, V357, P2696, DOI 10.1056/NEJMcp0706784; Warlick C, 2006, JNCI-J NATL CANCER I, V98, P355, DOI 10.1093/jnci/djj072; Warren JL, 2002, MED CARE, V40, P3; Warren JL, 2002, MED CARE, V40, P55; Wilt TJ, 2008, ANN INTERN MED, V148, P888, DOI 10.7326/0003-4819-148-11-200806030-00023; Wilt TJ, 2008, ANN INTERN MED, V148, P435, DOI 10.7326/0003-4819-148-6-200803180-00209; Wilt TJ, 2009, CONTEMP CLIN TRIALS, V30, P81, DOI 10.1016/j.cct.2008.08.002	40	291	302	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1202	1209		10.1001/jama.2009.1348	http://dx.doi.org/10.1001/jama.2009.1348			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755699	Green Accepted			2022-12-28	WOS:000269797600030
J	Corsi, P				Corsi, Pietro			Evolution pioneers: Lamarck's reputation saved by his zoology	NATURE			English	Letter									Univ Oxford, Hist Fac, Old Boys High Sch, Oxford OX1 2RL, England	University of Oxford	Corsi, P (corresponding author), Univ Oxford, Hist Fac, Old Boys High Sch, George St, Oxford OX1 2RL, England.	pietro.corsi@history.ox.ac.uk							0	2	2	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					167	167		10.1038/461167c	http://dx.doi.org/10.1038/461167c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741682	Bronze			2022-12-28	WOS:000269654600015
J	Dey, BR; Spitzer, TR; Hasserjian, RP				Dey, Bimalangshu R.; Spitzer, Thomas R.; Hasserjian, Robert P.			A Man with Fatigue, Cough, and Peripheral-Blood Monocytosis Acute myeloid leukemia, not otherwise specified (acute monocytic leukemia), with FLT3-ITD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Clinicopathological Conference 2009	MAR 26, 2009	MA	Gen Hosp Canc Ctr Grand Rounds			STEM-CELL TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; HOST DISEASE; OLDER; INDUCTION; GRAFT; NUCLEOPHOSMIN; CHEMOTHERAPY; OUTCOMES; ADULTS		[Dey, Bimalangshu R.; Spitzer, Thomas R.] Massachusetts Gen Hosp, Hematol Oncol Unit, Boston, MA 02114 USA; [Hasserjian, Robert P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Dey, Bimalangshu R.; Spitzer, Thomas R.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Hasserjian, Robert P.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Dey, BR (corresponding author), Massachusetts Gen Hosp, Hematol Oncol Unit, Boston, MA 02114 USA.		Spitzer, Thomas/AAR-7652-2020					Appelbaum FR, 2006, BLOOD, V107, P3481, DOI 10.1182/blood-2005-09-3724; Blau IW, 2000, BONE MARROW TRANSPL, V25, P41, DOI 10.1038/sj.bmt.1702101; Eapen M, 2004, BONE MARROW TRANSPL, V34, P721, DOI 10.1038/sj.bmt.1704645; Erba HP, 2008, BLOOD, V112, P209; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Goldstone AH, 2001, BLOOD, V98, P1302, DOI 10.1182/blood.V98.5.1302; Hegenbart U, 2006, J CLIN ONCOL, V24, P444, DOI 10.1200/JCO.2005.03.1765; HOROWITZ MM, 1990, BLOOD, V75, P555; Kroger N, 2006, BONE MARROW TRANSPL, V37, P339, DOI 10.1038/sj.bmt.1705259; Kroger Nicolaus, 2008, Hematology Am Soc Hematol Educ Program, P60, DOI 10.1182/asheducation-2008.1.60; Loren AW, 2008, BONE MARROW TRANSPL, V41, P483, DOI 10.1038/sj.bmt.1705898; Lowenberg B, 1998, J CLIN ONCOL, V16, P872; Menzin J, 2002, ARCH INTERN MED, V162, P1597, DOI 10.1001/archinte.162.14.1597; Mrozek K, 2007, BLOOD, V109, P431, DOI 10.1182/blood-2006-06-001149; Plimack ER, 2007, LEUKEMIA LYMPHOMA, V48, P1472, DOI 10.1080/10428190701471981; PORTER DL, 1994, NEW ENGL J MED, V330, P100, DOI 10.1056/NEJM199401133300204; Schmid C, 2007, J CLIN ONCOL, V25, P4938, DOI 10.1200/JCO.2007.11.6053; Scholl S, 2008, EUR J HAEMATOL, V80, P208, DOI 10.1111/j.1600-0609.2007.01019.x; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Vardiman JW, 2008, WHO CLASSIFICATION T, P18; Wallen H, 2005, J CLIN ONCOL, V23, P3439, DOI 10.1200/JCO.2005.05.694; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902	22	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1099	1106		10.1056/NEJMcpc0900641	http://dx.doi.org/10.1056/NEJMcpc0900641			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	492LP	19741232				2022-12-28	WOS:000269659400015
J	Levine, RA				Levine, Robert A.			Fiscal Responsibility and Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							WASTE		Norwalk Hosp, Norwalk, CT 06856 USA		Levine, RA (corresponding author), Norwalk Hosp, Norwalk, CT 06856 USA.							Himmelstein DU, 2004, INT J HEALTH SERV, V34, P79, DOI 10.2190/D2BL-HUXY-RLF8-ULXA; Iglehart JK, 2009, NEW ENGL J MED, V361, P229, DOI 10.1056/NEJMp0904854; LEVINE RA, 2009, SHOCK THERAPY AM HLT; Orszag P. R., 2008, OPPORTUNITIES INCREA	4	3	3	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11								10.1056/NEJMp0906503	http://dx.doi.org/10.1056/NEJMp0906503			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492LP	19741223				2022-12-28	WOS:000269659400005
J	Visel, A; Rubin, EM; Pennacchio, LA				Visel, Axel; Rubin, Edward M.; Pennacchio, Len A.			Genomic views of distant-acting enhancers	NATURE			English	Review							BETA-GLOBIN GENE; BINDING-SITES; ULTRACONSERVED ELEMENTS; HISTONE MODIFICATIONS; REGULATORY ELEMENTS; EXPRESSION; CHROMATIN; MOUSE; IDENTIFICATION; LIMB	In contrast to protein-coding sequences, the significance of variation in non-coding DNA in human disease has been minimally explored. A great number of recent genome-wide association studies suggest that non-coding variation is a significant risk factor for common disorders, but the mechanisms by which this variation contributes to disease remain largely obscure. Distant-acting transcriptional enhancers - a major category of functional non-coding DNA - are involved in many developmental and disease-relevant processes. Genome-wide approaches to their discovery and functional characterization are now available and provide a growing knowledge base for the systematic exploration of their role in human biology and disease susceptibility.	[Visel, Axel; Rubin, Edward M.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Visel, Axel; Rubin, Edward M.; Pennacchio, Len A.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Pennacchio, LA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	lapennacchio@lbl.gov	Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; Pennacchio, Len/0000-0002-8748-3732	US National Heart, Lung, and Blood Institute; Director, Office of Science, Office of Basic Energy Sciences; US Department of Energy [DE-AC02-05CH11231]; US National Human Genome Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681, R21HL098940] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER	US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Director, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE)); US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. Blow, S. Deutsch and A. Sczyrba for help with computational analysis of GWAS data and C. Attanasio for comments. L. A. P. and E. M. R. were supported by the Berkeley Program for Genomic Applications ( funded by the US National Heart, Lung, and Blood Institute), and the Director, Office of Science, Office of Basic Energy Sciences, US Department of Energy, under contract number DE-AC02-05CH11231. L. A. P. was also supported by the US National Human Genome Research Institute.	Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; APARICIO S, 1995, P NATL ACAD SCI USA, V92, P1684, DOI 10.1073/pnas.92.5.1684; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Barski A, 2009, J CELL BIOCHEM, V107, P11, DOI 10.1002/jcb.22077; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Clark RM, 2000, GENOMICS, V67, P19, DOI 10.1006/geno.2000.6225; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2008, GENOME RES, V18, P201, DOI 10.1101/gr.7205808; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fullwood MJ, 2009, GENOME RES, V19, P521, DOI 10.1101/gr.074906.107; Furniss D, 2008, HUM MOL GENET, V17, P2417, DOI 10.1093/hmg/ddn141; Gabriel SB, 2002, NAT GENET, V31, P89, DOI 10.1038/ng868; Gao N, 2008, GENE DEV, V22, P3435, DOI 10.1101/gad.1752608; Grice EA, 2005, HUM MOL GENET, V14, P3837, DOI 10.1093/hmg/ddi408; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; HINDORFF LA, 2009, OPG CATALOG PUBLISHE; Horak CE, 2002, P NATL ACAD SCI USA, V99, P2924, DOI 10.1073/pnas.052706999; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; KAN YW, 1975, NATURE, V255, P255, DOI 10.1038/255255a0; KIOUSSIS D, 1983, NATURE, V306, P662, DOI 10.1038/306662a0; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2002, P NATL ACAD SCI USA, V99, P7548, DOI 10.1073/pnas.112212199; Lettice LA, 2008, HUM MOL GENET, V17, P978, DOI 10.1093/hmg/ddm370; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Masuya H, 2007, GENOMICS, V89, P207, DOI 10.1016/j.ygeno.2006.09.005; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Panne D, 2008, CURR OPIN STRUC BIOL, V18, P236, DOI 10.1016/j.sbi.2007.12.002; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; SEMENZA GL, 1984, CELL, V39, P123, DOI 10.1016/0092-8674(84)90197-1; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; VANLENTE F, 1975, CELL, V5, P45, DOI 10.1016/0092-8674(75)90090-2; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2007, SEMIN CELL DEV BIOL, V18, P140, DOI 10.1016/j.semcdb.2006.12.014; Visel A, 2009, GENOMICS, V93, P509, DOI 10.1016/j.ygeno.2009.02.002; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	76	432	454	3	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					199	205		10.1038/nature08451	http://dx.doi.org/10.1038/nature08451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741700	Green Submitted, Green Accepted			2022-12-28	WOS:000269654600032
J	Ulbrich, C; Diepholz, M; Bassler, J; Kressler, D; Pertschy, B; Galani, K; Bottcher, B; Hurt, E				Ulbrich, Cornelia; Diepholz, Meikel; Bassler, Jochen; Kressler, Dieter; Pertschy, Brigitte; Galani, Kyriaki; Boettcher, Bettina; Hurt, Ed			Mechanochemical Removal of Ribosome Biogenesis Factors from Nascent 60S Ribosomal Subunits	CELL			English	Article							NUCLEAR EXPORT; STRUCTURAL BASIS; PRE-RIBOSOME; AAA-ATPASE; RNA; BINDING; PROTEIN; NUCLEOLUS; DYNEIN; MATURATION	The dynein-related AAA ATPase Rea1 is a preribosomal factor that triggers an unknown maturation step in 60S subunit biogenesis. Using electron microscopy, we show that Rea1's motor domain is docked to the pre-60S particle and its tail-like structure, harboring a metal ion-dependent adhesion site (MIDAS), protrudes from the preribosome. Typically, integrins utilize a MIDAS to bind extracellular ligands, an interaction that is strengthened under applied tensile force. Likewise, the Rea1 MIDAS binds the preribosomal factor Rsa4, which is located on the pre-60S subunit at a site that is contacted by the flexible Rea1 tail. The MIDAS-Rsa4 interaction is essential for ATP-dependent dissociation of a group of non-ribosomal factors from the pre-60S particle. Thus, Rea1 aligns with its interacting partners on the preribosome to effect a necessary step on the path to the export-competent 60S subunit.	[Diepholz, Meikel; Galani, Kyriaki; Boettcher, Bettina] EMBL, D-69117 Heidelberg, Germany; [Ulbrich, Cornelia; Bassler, Jochen; Kressler, Dieter; Pertschy, Brigitte; Galani, Kyriaki; Hurt, Ed] Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; [Boettcher, Bettina] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; University of Edinburgh	Bottcher, B (corresponding author), EMBL, Meyerhofstr 1, D-69117 Heidelberg, Germany.	bettina.boettcher@ed.ac.uk; ed.hurt@bzh.uni-heidelberg.de	Ed Hurt, Dr./AAE-8874-2019; Kressler, Dieter/C-2218-2012; Bottcher, Bettina/E-9397-2010; Baßler, Jochen/AAC-5336-2021	Ed Hurt, Dr./0000-0002-4535-8255; Bottcher, Bettina/0000-0002-7962-4849; Baßler, Jochen/0000-0002-7441-7867; Pertschy, Brigitte/0000-0003-3558-0191; Kressler, Dieter/0000-0003-4855-3563	Welcome Trust [WT 087658]; FP6 Marie Curie Action for Early-Stage-Training [MEST-CT-2004-504640]; Deutsche Forschungsgemeinschaft [Hu363/9-2]; Fonds der Chemischen Industrie;  [LSHG-CT-2005-512028]	Welcome Trust(Wellcome Trust); FP6 Marie Curie Action for Early-Stage-Training(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); 	The excellent technical help of Martina Kallas and Claire Batisse is gratefully acknowledged. We thank Drs. M. Remacha, H. Tschochner, M. FromontRacine, A. W. Johnson, M. Seedorf, B. Stillman, and J. Warner for antibodies. B. B. was supported by the EU-grant '3D repertoire (LSHG-CT-2005-512028) and by the Welcome Trust (WT 087658). M. D. was supported by an E-STAR project (FP6 Marie Curie Action for Early-Stage-Training, MEST-CT-2004-504640). E. H. and J. B. are recipients of grants from the Deutsche Forschungsgemeinschaft (Hu363/9-2) and Fonds der Chemischen Industrie.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2006, J BIOL CHEM, V281, P24737, DOI 10.1074/jbc.M604261200; Carter AP, 2008, SCIENCE, V322, P1691, DOI 10.1126/science.1164424; Chantha SC, 2007, PLANTA, V225, P1107, DOI 10.1007/s00425-006-0420-z; Craig D, 2004, STRUCTURE, V12, P2049, DOI 10.1016/j.str.2004.09.009; Diepholz M, 2008, STRUCTURE, V16, P1789, DOI 10.1016/j.str.2008.09.010; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gadal O, 2002, J CELL BIOL, V157, P941, DOI 10.1083/jcb.200111039; Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Garbarino JE, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-18; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200; Nissan TA, 2004, MOL CELL, V15, P295, DOI 10.1016/j.molcel.2004.06.033; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Pertschy B, 2007, MOL CELL BIOL, V27, P6581, DOI 10.1128/MCB.00668-07; Puig O, 1998, YEAST, V14, P1139; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Vale RD, 2000, J CELL BIOL, V150, pF13, DOI 10.1083/jcb.150.1.F13; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	36	115	119	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					911	922		10.1016/j.cell.2009.06.045	http://dx.doi.org/10.1016/j.cell.2009.06.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737519	Green Submitted, Bronze			2022-12-28	WOS:000269564600017
J	Liu, ZF; Gandhi, CS; Rees, DC				Liu, Zhenfeng; Gandhi, Chris S.; Rees, Douglas C.			Structure of a tetrameric MscL in an expanded intermediate state	NATURE			English	Article							MECHANOSENSITIVE ION-CHANNEL; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; GATING MECHANISM; PROGRAM; MODELS; MAPS	The ability of cells to sense and respond to mechanical force underlies diverse processes such as touch and hearing in animals, gravitropism in plants, and bacterial osmoregulation(1,2). In bacteria, mechanosensation is mediated by the mechanosensitive channels of large (MscL), small (MscS), potassium-dependent (MscK) and mini (MscM) conductances. These channels act as 'emergency relief valves' protecting bacteria from lysis upon acute osmotic down-shock(3). Among them, MscL has been intensively studied since the original identification and characterization 15 years ago(4). MscL is reversibly and directly gated by changes in membrane tension. In the open state, MscL forms a non-selective 3 nS conductance channel which gates at tensions close to the lytic limit of the bacterial membrane. An earlier crystal structure at 3.5 angstrom resolution of a pentameric MscL from Mycobacterium tuberculosis represents a closed-state or non-conducting conformation(5,6). MscL has a complex gating behaviour; it exhibits several intermediates between the closed and open states, including one putative non-conductive expanded state and at least three sub-conducting states(7). Although our understanding of the closed(5,6) and open(8-10) states of MscL has been increasing, little is known about the structures of the intermediate states despite their importance in elucidating the complete gating process of MscL. Here we present the crystal structure of a carboxy-terminal truncation mutant (Delta 95-120) of MscL from Staphylococcus aureus (SaMscL(C Delta 26)) at 3.8 angstrom resolution. Notably, SaMscL(C Delta 26) forms a tetrameric channel with both transmembrane helices tilted away from the membrane normal at angles close to that inferred for the open state(9), probably corresponding to a non-conductive but partially expanded intermediate state.	[Liu, Zhenfeng; Gandhi, Chris S.; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Liu, Zhenfeng; Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Rees, DC (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	dcrees@caltech.edu		liu, zhen feng/0000-0001-5502-9474	Howard Hughes Medical Institute; National Institutes of Health [GM084211]; Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084211] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Shih for early cloning work, T. Walton for biochemical analysis, A. Lee for initial efforts on the MscL project, J. Choe for expression and purification protocols, O. Lewinson for manuscript reading, Y. Poon and J. Lai for treating MJF465 with lDE3 and the osmotic down-shock assay protocol, J. Kaiser for suggestions on structure refinement, R. Phillips, E. Haswell and P. Pal for discussions, P. Blount for the MJF465 strain, and the staff at SSRL, the Advanced Light Source (ALS) and the Advanced Photon Source (APS) for technical support with crystal screening and data collection. We would like to acknowledge the Gordon and Betty Moore Foundation for support of the Molecular Observatory at Caltech. Operations at SSRL, ALS and APS are supported by the US Department of Energy and NIH. This work was supported in part by grants from the Howard Hughes Medical Institute and the National Institutes of Health (GM084211). C. S. G. was supported in part by postdoctoral fellowships from the National Institutes of Health and the Beckman Foundation. D. C. R. is an Investigator in the Howard Hughes Medical Institute.	Ajouz B, 1998, J BIOL CHEM, V273, P26670, DOI 10.1074/jbc.273.41.26670; Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Anishkin A, 2009, J BIOL CHEM, V284, P19153, DOI 10.1074/jbc.R109.009357; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckstein O, 2004, PHYS BIOL, V1, P42, DOI 10.1088/1478-3967/1/1/005; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Booth IR, 2007, NAT REV MICROBIOL, V5, P431, DOI 10.1038/nrmicro1659; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Cogdell RJ, 1997, PROG BIOPHYS MOL BIO, V68, P1, DOI 10.1016/S0079-6107(97)00010-2; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Cruickshank CC, 1997, BIOPHYS J, V73, P1925, DOI 10.1016/S0006-3495(97)78223-7; DeLano WL, 2002, PYMOL USERS MANUAL; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HASE CC, 1995, J BIOL CHEM, V270, P18329, DOI 10.1074/jbc.270.31.18329; Hase CC, 1997, J MEMBRANE BIOL, V157, P17, DOI 10.1007/s002329900212; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Lusty CJ, 1999, J APPL CRYSTALLOGR, V32, P106, DOI 10.1107/S002188989801053X; Maurer JA, 2000, J BIOL CHEM, V275, P22238, DOI 10.1074/jbc.M003056200; Moe PC, 1998, MOL MICROBIOL, V28, P583, DOI 10.1046/j.1365-2958.1998.00821.x; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Spencer RH, 2002, ANNU REV BIOPH BIOM, V31, P207, DOI 10.1146/annurev.biophys.31.082901.134329; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Strop P, 2005, PROTEIN SCI, V14, P2207, DOI 10.1110/ps.051543805; Strop P, 2003, ADV PROTEIN CHEM, V63, P177; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; SUKHAREV SI, 1993, BIOPHYS J, V65, P177, DOI 10.1016/S0006-3495(93)81044-0; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; SUKHAREV SI, 2004, SCI STKE, P1; Tsai IJ, 2005, EUR BIOPHYS J BIOPHY, V34, P403, DOI 10.1007/s00249-005-0476-x; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Yoshimura K, 2008, P NATL ACAD SCI USA, V105, P4033, DOI 10.1073/pnas.0709436105	46	96	100	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					120	U132		10.1038/nature08277	http://dx.doi.org/10.1038/nature08277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19701184	Green Accepted			2022-12-28	WOS:000269478800042
J	Down, C; Chappell, A				Down, Chantelle; Chappell, Anna			A Patient's Journey Childhood asthma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												apldj@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 1	2009	339								b2889	10.1136/bmj.b2889	http://dx.doi.org/10.1136/bmj.b2889			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	491CG	19723712				2022-12-28	WOS:000269553900006
J	Gross, L; Mohn, F; Moll, N; Liljeroth, P; Meyer, G				Gross, Leo; Mohn, Fabian; Moll, Nikolaj; Liljeroth, Peter; Meyer, Gerhard			The Chemical Structure of a Molecule Resolved by Atomic Force Microscopy	SCIENCE			English	Article							BOND FORMATION; MANIPULATION; RESOLUTION	Resolving individual atoms has always been the ultimate goal of surface microscopy. The scanning tunneling microscope images atomic-scale features on surfaces, but resolving single atoms within an adsorbed molecule remains a great challenge because the tunneling current is primarily sensitive to the local electron density of states close to the Fermi level. We demonstrate imaging of molecules with unprecedented atomic resolution by probing the short-range chemical forces with use of noncontact atomic force microscopy. The key step is functionalizing the microscope's tip apex with suitable, atomically well-defined terminations, such as CO molecules. Our experimental findings are corroborated by ab initio density functional theory calculations. Comparison with theory shows that Pauli repulsion is the source of the atomic resolution, whereas van der Waals and electrostatic forces only add a diffuse attractive background.	[Gross, Leo; Mohn, Fabian; Moll, Nikolaj; Liljeroth, Peter; Meyer, Gerhard] IBM Res Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland; [Liljeroth, Peter] Univ Utrecht, Debye Inst Nanomat Sci, NL-3508 TA Utrecht, Netherlands	International Business Machines (IBM); Utrecht University	Gross, L (corresponding author), IBM Res Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.	lgr@zurich.ibm.com	Moll, Nikolaj/C-5674-2013; Liljeroth, Peter/A-5594-2009; Gross, Leo/M-8564-2019; Gross, Leo/E-1789-2011	Moll, Nikolaj/0000-0001-5645-4667; Liljeroth, Peter/0000-0003-1253-8097; Gross, Leo/0000-0002-5337-4159; Gross, Leo/0000-0002-5337-4159	Swiss National Center of Competence in Research (NCCR); European Communitys Seventh Framework Programme [214954]; Nederlandse Organisatie voor Wetenschappelijk Onderzoek [700.56.423]	Swiss National Center of Competence in Research (NCCR)(Swiss National Science Foundation (SNSF)); European Communitys Seventh Framework Programme(European Commission); Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	We thank A. Curioni, J. Repp, and R. Allenspach for valuable discussions and comments and M. Heyde and F. J. Giessibl for fruitful discussions on instrumental issues. The research leading to these results has received funding from the Swiss National Center of Competence in Research (NCCR) "Nanoscale Science" and from the European Communitys Seventh Framework Programme under grant agreement no. 214954 (HERODOT). P.L. gratefully acknowledges funding by the Nederlandse Organisatie voor Wetenschappelijk Onderzoek (Chemical Sciences, Vidi-grant 700.56.423).	Albers BJ, 2009, NAT NANOTECHNOL, V4, P307, DOI [10.1038/nnano.2009.57, 10.1038/NNANO.2009.57]; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Ashino M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.136101; Ashino M, 2008, NAT NANOTECHNOL, V3, P337, DOI 10.1038/nnano.2008.126; Bartels L, 1998, PHYS REV LETT, V80, P2004, DOI 10.1103/PhysRevLett.80.2004; *CPMD, IBM CORP MPI FESTK; Giessibl FJ, 2000, APPL PHYS LETT, V76, P1470, DOI 10.1063/1.126067; Giessibl FJ, 2003, REV MOD PHYS, V75, P949, DOI 10.1103/RevModPhys.75.949; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; HAMANN DR, 1989, PHYS REV B, V40, P2980, DOI 10.1103/PhysRevB.40.2980; Heyde M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2012523; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRevB.7.1912; Holscher H, 2002, APPL PHYS LETT, V81, P4428, DOI 10.1063/1.1525056; Kaiser U, 2007, NATURE, V446, P522, DOI 10.1038/nature05617; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; Lagoute J, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.245415; Lee HJ, 1999, SCIENCE, V286, P1719, DOI 10.1126/science.286.5445.1719; Loppacher C, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.066107; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; Repp J, 2006, SCIENCE, V312, P1196, DOI 10.1126/science.1126073; Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267; Sugimoto Y, 2005, NAT MATER, V4, P156, DOI 10.1038/nmat1297; Sugimoto Y, 2008, SCIENCE, V322, P413, DOI 10.1126/science.1160601; Ternes M, 2008, SCIENCE, V319, P1066, DOI 10.1126/science.1150288	25	1157	1177	43	770	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1110	1114		10.1126/science.1176210	http://dx.doi.org/10.1126/science.1176210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713523				2022-12-28	WOS:000269382300036
J	Fornara, F; Coupland, G				Fornara, Fabio; Coupland, George			Plant Phase Transitions Make a SPLash	CELL			English	Editorial Material								During post-embryonic development, plants undergo a series of phase transitions, from juvenile to adult and from the vegetative to the reproductive phase. Recent findings reported in Cell (Wang et al., 2009; Wu et al., 2009) and Developmental Cell (Yamaguchi et al., 2009) reveal how microRNAs and their transcription factor targets coordinate these phase transitions.	[Fornara, Fabio; Coupland, George] Max Planck Inst Plant Breeding, D-50829 Cologne, Germany	Max Planck Society	Coupland, G (corresponding author), Max Planck Inst Plant Breeding, D-50829 Cologne, Germany.	coupland@mpiz-koeln.mpg.de	Coupland, George/AAP-8609-2020; Fornara, Fabio/AAL-3306-2020; Fornara, Fabio/B-9978-2012	Coupland, George/0000-0001-6988-4172; Fornara, Fabio/0000-0002-1050-0477; Fornara, Fabio/0000-0002-1050-0477				Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Mathieu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000148; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yamaguchi A, 2009, DEV CELL, V17, P268, DOI 10.1016/j.devcel.2009.06.007	7	64	71	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					625	627		10.1016/j.cell.2009.08.011	http://dx.doi.org/10.1016/j.cell.2009.08.011			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703391	Bronze			2022-12-28	WOS:000269156100006
J	Morris, DJP; Tennant, DA; Grigera, SA; Klemke, B; Castelnovo, C; Moessner, R; Czternasty, C; Meissner, M; Rule, KC; Hoffmann, JU; Kiefer, K; Gerischer, S; Slobinsky, D; Perry, RS				Morris, D. J. P.; Tennant, D. A.; Grigera, S. A.; Klemke, B.; Castelnovo, C.; Moessner, R.; Czternasty, C.; Meissner, M.; Rule, K. C.; Hoffmann, J. -U.; Kiefer, K.; Gerischer, S.; Slobinsky, D.; Perry, R. S.			Dirac Strings and Magnetic Monopoles in the Spin Ice Dy2Ti2O7	SCIENCE			English	Article							ENTROPY	Sources of magnetic fields-magnetic monopoles-have so far proven elusive as elementary particles. Condensed-matter physicists have recently proposed several scenarios of emergent quasiparticles resembling monopoles. A particularly simple proposition pertains to spin ice on the highly frustrated pyrochlore lattice. The spin-ice state is argued to be well described by networks of aligned dipoles resembling solenoidal tubes-classical, and observable, versions of a Dirac string. Where these tubes end, the resulting defects look like magnetic monopoles. We demonstrated, by diffuse neutron scattering, the presence of such strings in the spin ice dysprosium titanate (Dy2Ti2O7). This is achieved by applying a symmetry-breaking magnetic field with which we can manipulate the density and orientation of the strings. In turn, heat capacity is described by a gas of magnetic monopoles interacting via a magnetic Coulomb interaction.	[Morris, D. J. P.; Tennant, D. A.; Klemke, B.; Czternasty, C.; Meissner, M.; Rule, K. C.; Hoffmann, J. -U.; Kiefer, K.; Gerischer, S.; Perry, R. S.] Helmholtz Zentrum Berlin Mat & Energie, D-14109 Berlin, Germany; [Tennant, D. A.; Klemke, B.] Tech Univ Berlin, Inst Festkorperphys, D-10623 Berlin, Germany; [Grigera, S. A.; Slobinsky, D.] Sch Phys & Astron, St Andrews KY15 9SS, Fife, Scotland; [Grigera, S. A.] UNLP, CONICET, Inst Fis Liquidos & Sistemas Biol, La Plata, Buenos Aires, Argentina; [Castelnovo, C.] Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England; [Moessner, R.] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Perry, R. S.] Univ Edinburgh, Sch Phys, Edinburgh EH9 3JZ, Midlothian, Scotland	Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); Technical University of Berlin; University of St Andrews; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; University of Oxford; Max Planck Society; University of Edinburgh	Morris, DJP (corresponding author), Helmholtz Zentrum Berlin Mat & Energie, Glienicker Str 100, D-14109 Berlin, Germany.	jonathan.morris@helmholtz-berlin.de; tennant@helmholtz-berlin.de; sag@iflysib.unlp.edu.ar	grigera, santiago a/A-4932-2010; Tennant, David A/Q-2497-2015; Hoffmann, Jens-Uwe/J-6035-2013; Hoffmann, Jens-Uwe/U-9858-2019; Klemke, Bastian/J-4746-2013; Morris, David Jonathan Pryce/D-9183-2011; Kiefer, Klaus/J-3544-2013	Tennant, David A/0000-0002-9575-3368; Hoffmann, Jens-Uwe/0000-0002-3651-958X; Hoffmann, Jens-Uwe/0000-0002-3651-958X; Klemke, Bastian/0000-0003-4560-6025; Morris, David Jonathan Pryce/0000-0002-4785-7541; Kiefer, Klaus/0000-0002-5178-0495; Grigera, Santiago/0000-0002-1343-5885	Royal Society; Engineering and Physical Sciences Research Council (UK) [GR/R83712/01]; EPSRC [EP/G007357/1, EP/G049394/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G049394/1, EP/G007357/1] Funding Source: researchfish	Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. L. Sondhi for help and encouragement, J. T. Chalker for insights into the expected behavior in field of the correlation functions, K. Siemensmeyer for help with sample cutting and preparation, and J. Heinrich for help with the COMSOL Multiphysics computer package used for the demagnetization calculations. Supported by the Royal Society ( S. A. G.) and by Engineering and Physical Sciences Research Council (UK) grant GR/R83712/01 (C. Ca.).	Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Bramwell ST, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047205; Canals B, 2001, CAN J PHYS, V79, P1323, DOI 10.1139/cjp-79-11/12-1323; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Cozzi M, 2007, PHYS ATOM NUCL+, V70, P118, DOI 10.1134/S1063778807010127; Dirac PAM, 1931, P R SOC LOND A-CONTA, V133, P60, DOI 10.1098/rspa.1931.0130; Fennell T, 2007, NAT PHYS, V3, P566, DOI 10.1038/nphys632; Fennell T, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.134408; Fennell T, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.224411; Isakov SV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.167204; Jaubert LDC, 2009, J PHYS CONF SER, V145, DOI 10.1088/1742-6596/145/1/012024; Jaubert LDC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.067207; Jaubert LDC, 2009, NAT PHYS, V5, P258, DOI 10.1038/NPHYS1227; Levin Y, 2002, REP PROG PHYS, V65, P1577, DOI 10.1088/0034-4885/65/11/201; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; Preskill J, 1984, ANNU REV NUCL PART S, V34, P461, DOI 10.1146/annurev.ns.34.120184.002333; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Snyder J, 2001, NATURE, V413, P48, DOI 10.1038/35092516; Yavors'kii T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037204	19	439	444	3	166	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					411	414		10.1126/science.1178868	http://dx.doi.org/10.1126/science.1178868			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19729617	Green Submitted			2022-12-28	WOS:000270818600049
J	Cadieu, E; Neff, MW; Quignon, P; Walsh, K; Chase, K; Parker, HG; VonHoldt, BM; Rhue, A; Boyko, A; Byers, A; Wong, A; Mosher, DS; Elkahloun, AG; Spady, TC; Andre, C; Lark, KG; Cargill, M; Bustamante, CD; Wayne, RK; Ostrander, EA				Cadieu, Edouard; Neff, Mark W.; Quignon, Pascale; Walsh, Kari; Chase, Kevin; Parker, Heidi G.; VonHoldt, Bridgett M.; Rhue, Alison; Boyko, Adam; Byers, Alexandra; Wong, Aaron; Mosher, Dana S.; Elkahloun, Abdel G.; Spady, Tyrone C.; Andre, Catherine; Lark, K. Gordon; Cargill, Michelle; Bustamante, Carlos D.; Wayne, Robert K.; Ostrander, Elaine A.			Coat Variation in the Domestic Dog Is Governed by Variants in Three Genes	SCIENCE			English	Article							MAJOR DETERMINANT; HAIR FOLLICLE; MUTATIONS; GENOME; FGF5; MULTIPLE; SEQUENCE; CATENIN; TRAITS; CYCLE	Coat color and type are essential characteristics of domestic dog breeds. Although the genetic basis of coat color has been well characterized, relatively little is known about the genes influencing coat growth pattern, length, and curl. We performed genome-wide association studies of more than 1000 dogs from 80 domestic breeds to identify genes associated with canine fur phenotypes. Taking advantage of both inter- and intrabreed variability, we identified distinct mutations in three genes, RSPO2, FGF5, and KRT71 (encoding R-spondin-2, fibroblast growth factor-5, and keratin-71, respectively), that together account for most coat phenotypes in purebred dogs in the United States. Thus, an array of varied and seemingly complex phenotypes can be reduced to the combinatorial effects of only a few genes.	[Cadieu, Edouard; Quignon, Pascale; Parker, Heidi G.; Byers, Alexandra; Mosher, Dana S.; Elkahloun, Abdel G.; Spady, Tyrone C.; Ostrander, Elaine A.] NHGRI, NIH, Bethesda, MD 20892 USA; [Neff, Mark W.; Walsh, Kari; Rhue, Alison; Wong, Aaron] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA; [Chase, Kevin; Lark, K. Gordon] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [VonHoldt, Bridgett M.; Wayne, Robert K.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Boyko, Adam; Bustamante, Carlos D.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Cargill, Michelle] Affymetrix Corp, Santa Clara, CA 95051 USA; [Andre, Catherine] Univ Rennes 1, CNRS, Fac Med, UMR 6061, Rennes, France	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of California System; University of California Davis; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles; Cornell University; Affymetrix; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Ostrander, EA (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov	Fiumefreddo, Andrea/T-2977-2019	Bustamante, Carlos D./0000-0002-4187-7920; Ostrander, Elaine/0000-0001-6075-9738; Wong, Aaron/0000-0002-7294-0646; Parker, Heidi G./0000-0002-9707-6380	NSF [0733033, 516310]; NIH [1RO1GM83606, GM063056]; Nestle Purina company; AKC Canine Health Foundation; University of California-Davis Veterinary Genetics Laboratory; Intramural Program of the National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325, ZICHG200365, T32HG002536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063056, R01GM083606] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nestle Purina company(Nestle SA); AKC Canine Health Foundation; University of California-Davis Veterinary Genetics Laboratory; Intramural Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge support from NSF grants 0733033 ( R. K. W.) and 516310 ( C. D. B.), NIH grants 1RO1GM83606 ( C. D. B.) and GM063056 ( K. G. L. and K. C.), the Nestle Purina company, the AKC Canine Health Foundation, the University of California-Davis Veterinary Genetics Laboratory, and the Intramural Program of the National Human Genome Research Institute. We thank L. Warren and S. Stafford for providing pictures. Finally, we thank the many dog owners who generously provided us with samples from their pets.	American Kennel Club, 1998, COMPL DOG BOOK, V19th; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; ASH EC, 1927, DOGS THEIR HIST DEV; Chan EF, 1999, NAT GENET, V21, P410, DOI 10.1038/7747; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Drogemuller C, 2007, ANIM GENET, V38, P218, DOI 10.1111/j.1365-2052.2007.01590.x; Drogemuller C, 2008, SCIENCE, V321, P1462, DOI 10.1126/science.1162525; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Housley DJE, 2006, ANIM GENET, V37, P309, DOI 10.1111/j.1365-2052.2006.01448.x; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Martin J, 2004, TRENDS BIOCHEM SCI, V29, P455, DOI 10.1016/j.tibs.2004.07.004; Meuten D.J., 2020, TUMORS DOMESTIC ANIM; Mou C, 2008, HUM MUTAT, V29, P1405, DOI 10.1002/humu.20795; Runkel F, 2006, MAMM GENOME, V17, P1172, DOI 10.1007/s00335-006-0084-9; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA; Sundberg JP, 1997, VET PATHOL, V34, P171, DOI 10.1177/030098589703400301; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; Wayne RK, 2007, TRENDS GENET, V23, P557, DOI 10.1016/j.tig.2007.08.013; Wong AK, 2009, ANIM GENET, V40, P569, DOI 10.1111/j.1365-2052.2009.01875.x	25	225	236	6	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					150	153		10.1126/science.1177808	http://dx.doi.org/10.1126/science.1177808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19713490	Green Accepted			2022-12-28	WOS:000270355600058
J	Guo, JH; Cheng, P; Yuan, HY; Liu, Y				Guo, Jinhu; Cheng, Ping; Yuan, Haiyan; Liu, Yi			The Exosome Regulates Circadian Gene Expression in a Posttranscriptional Negative Feedback Loop	CELL			English	Article							RNA-BINDING PROTEIN; CLOCK-CONTROLLED GENES; MESSENGER-RNA; NEUROSPORA-CRASSA; MULTIPLE OSCILLATORS; LIGHT RESPONSES; PHOSPHORYLATION; FREQUENCY; TRANSCRIPTION; RHYTHMS	The eukaryotic circadian oscillators consist of autoregulatory negative feedback loops. However, little is known about the role of posttranscriptional regulation of RNA in circadian oscillators. In the Neurospora circadian negative feedback loop, FRQ and FRH form the FFC complex that represses frq transcription. Here, we show that FFC also binds frq RNA and interacts with the exosome to regulate frq RNA decay. Consequently, frq RNA is robustly rhythmic as it is more stable when FRQ levels are low. Silencing of RRP44, the catalytic subunit of the exosome, elevates frq RNA levels and impairs clock function. In addition, rrp44 is a clock-controlled gene and a direct target of the WHITE COLLAR complex, and RRP44 controls the circadian expression of some ccgs. Taken together, these results suggest that FFC and the exosome are part of a posttranscriptional negative feedback loop that regulates frq transcript levels and the circadian output pathway.	[Guo, Jinhu; Cheng, Ping; Yuan, Haiyan; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	yi.liu@utsouthwestern.edu			National Institutes of Health; Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Guocun Huang for technical assistance and Chi-Tai Tang for critical comments. We thank Jay Dunlap for providing the luciferase-containing plasmid. This research was supported by grants from National Institutes of Health and Welch Foundation to Y. L.	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; BellPedersen D, 1996, P NATL ACAD SCI USA, V93, P13096, DOI 10.1073/pnas.93.23.13096; BellPedersen D, 1996, MOL CELL BIOL, V16, P513; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Buttner K, 2006, MOL MICROBIOL, V61, P1372, DOI 10.1111/j.1365-2958.2006.05331.x; Cha J, 2008, EMBO J, V27, P3246, DOI 10.1038/emboj.2008.245; Cheng P, 2005, GENE DEV, V19, P234, DOI 10.1101/gad.1266805; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cheng P, 2001, EMBO J, V20, P101, DOI 10.1093/emboj/20.1.101; Correa A, 2003, P NATL ACAD SCI USA, V100, P13597, DOI 10.1073/pnas.2233734100; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003; de Paula RM, 2007, COLD SPRING HARB SYM, V72, P345, DOI 10.1101/sqb.2007.72.002; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Garbarino-Pico E, 2007, COLD SH Q B, V72, P145, DOI 10.1101/sqb.2007.72.022; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; Heintzen C, 1997, P NATL ACAD SCI USA, V94, P8515, DOI 10.1073/pnas.94.16.8515; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang GC, 2007, GENE DEV, V21, P3283, DOI 10.1101/gad.1610207; Kojima S, 2007, P NATL ACAD SCI USA, V104, P1859, DOI 10.1073/pnas.0607567104; Kwak E, 2006, J BIOL CHEM, V281, P19100, DOI 10.1074/jbc.M511927200; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lewis ZA, 2002, MOL MICROBIOL, V45, P917, DOI 10.1046/j.1365-2958.2002.03074.x; Lidder P, 2005, PLANT PHYSIOL, V138, P2374, DOI 10.1104/pp.105.060368; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Lorentzen E, 2006, CELL, V125, P651, DOI 10.1016/j.cell.2006.05.002; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Newby LM, 1996, J NEUROBIOL, V31, P117, DOI 10.1002/(SICI)1097-4695(199609)31:1<117::AID-NEU10>3.0.CO;2-I; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Nowrousian M, 2003, GENETICS, V164, P923; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Sehgal A, 2004, MOL BIOL CIRCADIAN R; Shinohara ML, 1998, J BIOL CHEM, V273, P446, DOI 10.1074/jbc.273.1.446; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Staiger D, 2003, PLANT J, V33, P361, DOI 10.1046/j.1365-313X.2003.01629.x; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	54	78	82	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 18	2009	138	6					1236	1246		10.1016/j.cell.2009.06.043	http://dx.doi.org/10.1016/j.cell.2009.06.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	495VM	19747717	Bronze, Green Accepted			2022-12-28	WOS:000269923200022
J	Annas, GJ				Annas, George J.			Good Law from Tragic Facts -- Congress, the FDA, and Preemption.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SAFETY		Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Committee on the Assessment of the US Drug Safety System, 2007, FUT DRUG SAF PROM PR; Curfman GD, 2008, NEW ENGL J MED, V359, P1, DOI 10.1056/NEJMp0804448; Curfman GD, 2009, NEW ENGL J MED, V360, P1550, DOI 10.1056/NEJMe0902377; Gilhooley M, 2008, AM J LAW MED, V34, P539, DOI 10.1177/009885880803400403; Glantz LH, 2008, NEW ENGL J MED, V358, P1883, DOI 10.1056/NEJMp0802108; Kennedy D, 2008, SCIENCE, V320, P585, DOI 10.1126/science.1159568; Obama B., 2009, MEMORANDUM HEADS EXE; Psaty BM, 2006, NEW ENGL J MED, V355, P1753, DOI 10.1056/NEJMp068228; ROSEN J, 2008, NY TIMES MAGAZI 0316; 2009, WALL STREET J   0305, pA16; 2008, NATURE, V452, P254; 2009, NY TIMES        0305	12	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1206	1211		10.1056/NEJMhle0902889	http://dx.doi.org/10.1056/NEJMhle0902889			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	494QA	19759383				2022-12-28	WOS:000269828000015
J	Oberlander, J; White, J				Oberlander, Jonathan; White, Joseph			Systemwide Cost Control -- The Missing Link in Health Care Reform.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC 27515 USA; [White, Joseph] Case Western Reserve Univ, Cleveland, OH 44106 USA	University of North Carolina; University of North Carolina Chapel Hill; Case Western Reserve University	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.							Congressional Budget Office, 2008, BUDG OPT, V1; Hacker Jacob S., 2008, CASE PUBLIC PLAN CHO; Marmor T, 2009, ANN INTERN MED, V150, P485, DOI 10.7326/0003-4819-150-7-200904070-00114; Reinhardt UE, 2006, HEALTH AFFAIR, V25, P57, DOI 10.1377/hlthaff.25.1.57; WHITE J, 2009, COST CONTROL HLTH CA	5	9	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1131	1133		10.1056/NEJMp0907487	http://dx.doi.org/10.1056/NEJMp0907487			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	494QA	19726762				2022-12-28	WOS:000269828000002
J	Shortell, SM				Shortell, Stephen M.			Bending the Cost Curve A Critical Component of Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE		Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, 417E Univ Hall, Berkeley, CA 94720 USA.	shortell@berkelev.edu						*COMM FUND, 2008, BEND CURV OPT ACH SA; *CONGR BUDG OFF, 2008, HEALTHC, V1; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; ORSZAG P, 2008, EVIDENCE BASED MED C; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; Russell LB, 2009, HEALTH AFFAIR, V28, P42, DOI 10.1377/hlthaff.28.1.42; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Trust for America's Health, 2008, PREV HEALTH AM INV D; *UN HLTH CTR HLTH, 2009, 1 UN HLTH CTR HLTH R; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P536, DOI 10.1001/jama.2009.51	10	16	16	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1223	1224		10.1001/jama.2009.1373	http://dx.doi.org/10.1001/jama.2009.1373			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755703				2022-12-28	WOS:000269797600034
J	Levi, M				Levi, Marcel			Rosuvastatin reduced venous thromboembolism in healthy older adults with elevated C-reactive protein levels	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Amsterdam, Amsterdam, Netherlands	University of Amsterdam	Levi, M (corresponding author), Univ Amsterdam, Amsterdam, Netherlands.		Levi, Marcel/AAZ-8559-2020						0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6							JC3-10	10.7326/0003-4819-151-6-200909150-02010	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755356				2022-12-28	WOS:000270390100026
J	Alvarado, D; Klein, DE; Lemmon, MA				Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.			ErbB2 resembles an autoinhibited invertebrate epidermal growth factor receptor	NATURE			English	Article							EXTRACELLULAR DOMAIN; CRYSTAL-STRUCTURE; REGION; REVEALS; SYSTEM; HER2; CONFORMATION; ACTIVATION; HERCEPTIN; COMPLEX	The orphan receptor tyrosine kinase ErbB2 ( also known as HER2 or Neu) transforms cells when overexpressed(1), and it is an important therapeutic target in human cancer(2,3). Structural studies(4,5) have suggested that the oncogenic (and ligand-independent) signalling properties of ErbB2 result from the absence of a key intramolecular 'tether' in the extracellular region that autoinhibits other human ErbB receptors, including the epidermal growth factor (EGF) receptor(6). Although ErbB2 is unique among the four human ErbB receptors(6,7), here we show that it is the closest structural relative of the single EGF receptor family member in Drosophila melanogaster (dEGFR). Genetic and biochemical data show that dEGFR is tightly regulated by growth factor ligands(8), yet a crystal structure shows that it, too, lacks the intramolecular tether seen in human EGFR, ErbB3 and ErbB4. Instead, a distinct set of autoinhibitory interdomain interactions hold unliganded dEGFR in an inactive state. All of these interactions are maintained (and even extended) in ErbB2, arguing against the suggestion that ErbB2 lacks autoinhibition. We therefore suggest that normal and pathogenic ErbB2 signalling may be regulated by ligands in the same way as dEGFR. Our findings have important implications for ErbB2 regulation in human cancer, and for developing therapeutic approaches that target novel aspects of this orphan receptor.	[Alvarado, Diego; Klein, Daryl E.; Lemmon, Mark A.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, 809C Stellar Chance Labs,422 Curie Blvd, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Garzon-Alvarado, Diego/AAD-6607-2019	Lemmon, Mark/0000-0002-3379-5319; Klein, Daryl/0000-0002-7188-0450	National Cancer Institute; National Institute of General Medical Science; NIH; US Army Breast Cancer Research Program; Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA079992, R01CA125432] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Breast Cancer Research Program(United States Department of Defense); Damon Runyon Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Lemmon and Ferguson laboratories, K. Ferguson, G. Van Duyne, C. Abrams and J. Shorter for advice and comments on the manuscript; Z. Bu for assistance with collecting SAXS data; and R. Gillilan of MacCHESS for help with SAXS data collection and processing at CHESS beamline G1. Crystallographic results were obtained in research conducted at the GM/CA Collaborative Access Team at the Advanced Photon Source ( APS), supported with funds from the National Cancer Institute and National Institute of General Medical Science. This study was supported by grants from the NIH ( to M. A. L.). D. E. K. was supported by a Predoctoral fellowship from the US Army Breast Cancer Research Program. D. A. was supported by an NIH Postdoctoral Training Grant and a Postdoctoral Fellowship from the Damon Runyon Cancer Research Foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berger MB, 2004, FEBS LETT, V569, P332, DOI 10.1016/j.febslet.2004.06.014; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Brennan PJ, 2000, ONCOGENE, V19, P6093, DOI 10.1038/sj.onc.1203967; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; CLIFFORD R, 1994, GENETICS, V137, P531; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; DeLano W.L, PYMOL MOL GRAPHICS S; DIFIORE PP, 1987, SCIENCE, V237, P178, DOI 10.1126/science.2885917; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HORAN T, 1995, J BIOL CHEM, V270, P24604, DOI 10.1074/jbc.270.41.24604; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Klein DE, 2008, NATURE, V453, P1271, DOI 10.1038/nature06978; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lemmon MA, 2009, EXP CELL RES, V315, P638, DOI 10.1016/j.yexcr.2008.10.024; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Miura GI, 2006, DEV CELL, V10, P167, DOI 10.1016/j.devcel.2005.11.017; Moasser MM, 2007, ONCOGENE, V26, P6577, DOI 10.1038/sj.onc.1210478; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penuel E, 2002, J BIOL CHEM, V277, P28468, DOI 10.1074/jbc.M202510200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shilo BZ, 2005, DEVELOPMENT, V132, P4017, DOI 10.1242/dev.02006; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wriggers W, 2001, J STRUCT BIOL, V133, P193, DOI 10.1006/jsbi.2000.4350	43	63	66	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					287	U172		10.1038/nature08297	http://dx.doi.org/10.1038/nature08297			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19718021	Green Accepted			2022-12-28	WOS:000269654600049
J	Corma, A				Corma, Avelino			MATERIALS CHEMISTRY Catalysts made thinner	NATURE			English	Editorial Material							ZEOLITE		Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Valencia 46022, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Corma, A (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Ave Los Naranjos, Valencia 46022, Spain.	acorma@itq.upv.es	CANOS, AVELINO CORMA/A-3040-2013	CANOS, AVELINO CORMA/0000-0002-2232-3527				BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020; Cheetham A. K., 2001, STUD SURF SCI CATAL, V135, P788; Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288; Corma A, 2004, CHEM COMMUN, P2008, DOI 10.1039/b406303a; Corma A, 2001, ANGEW CHEM INT EDIT, V40, P2277, DOI 10.1002/1521-3773(20010618)40:12<2277::AID-ANIE2277>3.0.CO;2-O; Corma A, 1998, NATURE, V396, P353, DOI 10.1038/24592; Corma A, 2006, NATURE, V443, P842, DOI 10.1038/nature05238; Corma A, 2008, CHEM COMMUN, P6218, DOI 10.1039/b810310k; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Lee JS, 2003, SCIENCE, V301, P818, DOI 10.1126/science.1086441; LOVALLO MC, 1996, ADV CATALYSTS NANOST, P307; Sun JL, 2009, NATURE, V458, P1154, DOI 10.1038/nature07957	12	25	26	1	66	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					182	183		10.1038/461182a	http://dx.doi.org/10.1038/461182a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741695				2022-12-28	WOS:000269654600027
J	Elliott, MR; Chekeni, FB; Trampont, PC; Lazarowski, ER; Kadl, A; Walk, SF; Park, D; Woodson, RI; Ostankovich, M; Sharma, P; Lysiak, JJ; Harden, TK; Leitinger, N; Ravichandran, KS				Elliott, Michael R.; Chekeni, Faraaz B.; Trampont, Paul C.; Lazarowski, Eduardo R.; Kadl, Alexandra; Walk, Scott F.; Park, Daeho; Woodson, Robin I.; Ostankovich, Marina; Sharma, Poonam; Lysiak, Jeffrey J.; Harden, T. Kendall; Leitinger, Norbert; Ravichandran, Kodi S.			Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance	NATURE			English	Article							EXTRACELLULAR NUCLEOTIDES; RECEPTOR SUBTYPES; EPITHELIAL-CELLS; INFLAMMATION; CHEMOTAXIS; ENGULFMENT; ELEGANS; THYMUS; DEATH; UTP	Phagocytic removal of apoptotic cells occurs efficiently in vivo such that even in tissues with significant apoptosis, very few apoptotic cells are detectable(1). This is thought to be due to the release of 'find-me' signals by apoptotic cells that recruit motile phagocytes such as monocytes, macrophages and dendritic cells, leading to the prompt clearance of the dying cells(2). However, the identity and in vivo relevance of such find-me signals are not well understood. Here, through several lines of evidence, we identify extracellular nucleotides as a critical apoptotic cell find-me signal. We demonstrate the caspase-dependent release of ATP and UTP (in equimolar quantities) during the early stages of apoptosis by primary thymocytes and cell lines. Purified nucleotides at these concentrations were sufficient to induce monocyte recruitment comparable to that of apoptotic cell supernatants. Enzymatic removal of ATP and UTP (by apyrase or the expression of ectopic CD39) abrogated the ability of apoptotic cell supernatants to recruit monocytes in vitro and in vivo. We then identified the ATP/UTP receptor P2Y(2) as a critical sensor of nucleotides released by apoptotic cells using RNA interference-mediated depletion studies in monocytes, and macrophages from P2Y(2)-null mice(3). The relevance of nucleotides in apoptotic cell clearance in vivo was revealed by two approaches. First, in a murine air-pouch model, apoptotic cell supernatants induced a threefold greater recruitment of monocytes and macrophages than supernatants from healthy cells did; this recruitment was abolished by depletion of nucleotides and was significantly decreased in P2Y(2)(-/-) ( also known as P2ry(2)(-/-)) mice. Second, clearance of apoptotic thymocytes was significantly impaired by either depletion of nucleotides or interference with P2Y receptor function ( by pharmacological inhibition or in P2Y(2)(-/-) mice). These results identify nucleotides as a critical find-me cue released by apoptotic cells to promote P2Y(2)-dependent recruitment of phagocytes, and provide evidence for a clear relationship between a find-me signal and efficient corpse clearance in vivo.	[Elliott, Michael R.; Chekeni, Faraaz B.; Trampont, Paul C.; Walk, Scott F.; Park, Daeho; Ravichandran, Kodi S.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA; [Elliott, Michael R.; Trampont, Paul C.; Walk, Scott F.; Park, Daeho; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Chekeni, Faraaz B.; Leitinger, Norbert] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Kadl, Alexandra; Ostankovich, Marina; Sharma, Poonam; Leitinger, Norbert] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Woodson, Robin I.; Lysiak, Jeffrey J.] Univ Virginia, Dept Urol, Charlottesville, VA 22908 USA; [Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Lazarowski, Eduardo R.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Harden, T. Kendall] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ravichandran, KS (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	ravi@virginia.edu	Kadl, Alexandra/AAV-3395-2021	Ravichandran, Kodi/0000-0001-9049-1410; Ostankovitch, Marina/0000-0001-8467-6486; Elliott, Michael/0000-0002-0642-482X; Trampont, Paul/0000-0002-3643-8472	National Institutes of Health; American Cancer Society; University of Virginia Farrow Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267, R01GM069998, R01GM064709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of Virginia Farrow Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Rock, C. Borowski and members of the Ravichandran laboratory for helpful suggestions; I. Juncadella for lung epithelial cells; K. Lauber and S. Wesselborg for providing MCF-7/caspase-3 cells; and R. Tacke for assistance with primary monocyte experiments. This work was supported by Public Health Service grants from the National Institutes of Health ( to K. S. R. and N. L.), the American Cancer Society ( to M. R. E.) and the University of Virginia Farrow Fellowship ( to M. R. E.).	Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Burnstock G, 2004, INT REV CYTOL, V240, P31, DOI 10.1016/S0074-7696(04)40002-3; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Homolya L, 1999, J BIOL CHEM, V274, P26454, DOI 10.1074/jbc.274.37.26454; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI11638; Idzko M, 2004, J CELL PHYSIOL, V201, P286, DOI 10.1002/jcp.20070; Kadl A, 2009, ARTHRITIS RHEUM-US, V60, P1362, DOI 10.1002/art.24448; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lazarowski ER, 1997, J BIOL CHEM, V272, P24348, DOI 10.1074/jbc.272.39.24348; Lysiak JJ, 2000, BIOL REPROD, V63, P1465, DOI 10.1095/biolreprod63.5.1465; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Moore DJ, 2001, BBA-GENE STRUCT EXPR, V1521, P107, DOI 10.1016/S0167-4781(01)00291-3; Myrtek D, 2007, PURINERG SIGNAL, V3, P5, DOI 10.1007/s11302-006-9032-0; Ravichandran KS, 2007, NAT REV IMMUNOL, V7, P964, DOI 10.1038/nri2214; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Truman LA, 2008, BLOOD, V112, P5026, DOI 10.1182/blood-2008-06-162404	30	1022	1060	7	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					282	U165		10.1038/nature08296	http://dx.doi.org/10.1038/nature08296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741708	Green Accepted, Green Submitted			2022-12-28	WOS:000269654600048
J	Decock, S; McGee, P; Hirschfield, GM				Decock, Sofie; McGee, Phyllis; Hirschfield, Gideon M.			Autoimmune liver disease for the non-specialist	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PRIMARY SCLEROSING CHOLANGITIS; PRIMARY BILIARY-CIRRHOSIS; DOSE URSODEOXYCHOLIC ACID; NATURAL-HISTORY; ANTIMITOCHONDRIAL ANTIBODIES; BIOCHEMICAL RESPONSE; TREATMENT WITHDRAWAL; ULCERATIVE-COLITIS; CONTROLLED-TRIAL; INCREASED RISK		[McGee, Phyllis; Hirschfield, Gideon M.] Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Hirschfield, GM (corresponding author), Toronto Western Hosp, Ctr Liver, 399 Bathurst St,6B Fell Pavil, Toronto, ON M5T 2S8, Canada.	gideon.hirschfield@uhn.on.ca	Hirschfield, Gideon M/M-2143-2015	Hirschfield, Gideon M/0000-0002-6736-2255				Al-Chalabi T, 2008, CLIN GASTROENTEROL H, V6, P1389, DOI 10.1016/j.cgh.2008.08.018; Alabraba E, 2009, LIVER TRANSPLANT, V15, P330, DOI 10.1002/lt.21679; Bhat M, 2009, GUT, V58, P152, DOI 10.1136/gut.2008.163220; Bjornsson E, 2008, GASTROENTEROLOGY, V134, P975, DOI 10.1053/j.gastro.2008.01.042; Boberg KM, 2002, SCAND J GASTROENTERO, V37, P1205, DOI 10.1080/003655202760373434; Bressler B, 2005, GUT, V54, P407, DOI 10.1136/gut.2004.040832; Broome U, 2006, SEMIN LIVER DIS, V26, P31, DOI 10.1055/s-2006-933561; BUNGAY HK, 2008, DDW, pW1847; Card TR, 2008, J HEPATOL, V48, P939, DOI 10.1016/j.jhep.2008.02.017; Charatcharoenwitthaya P, 2008, HEPATOLOGY, V48, P1106, DOI 10.1002/hep.22441; CHEN W, 2004, COCHRANE DB SYST REV; Collier J, 2007, HEPATOLOGY, V46, P1271, DOI 10.1002/hep.21852; COOK GC, 1971, Q J MED, V40, P159, DOI 10.1093/oxfordjournals.qjmed.a067264; Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428; Czaja AJ, 2002, HEPATOLOGY, V36, P479, DOI 10.1053/jhep.2002.34944; DEGROOTE J, 1978, GUT, V19, P510, DOI 10.1136/gut.19.6.510; Feld JJ, 2005, HEPATOLOGY, V42, P53, DOI 10.1002/hep.20732; Fickert P, 2006, GASTROENTEROLOGY, V130, P465, DOI 10.1053/j.gastro.2005.10.018; Gong Y, 2008, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000551.PUB2; HEGARTY JE, 1983, HEPATOLOGY, V3, P685; Heneghan MA, 2001, GUT, V48, P97, DOI 10.1136/gut.48.1.97; Hennes EM, 2008, HEPATOLOGY, V48, P169, DOI 10.1002/hep.22322; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; James OFW, 1999, HEPATOLOGY, V30, P390, DOI 10.1002/hep.510300213; JOHNSON PJ, 1995, NEW ENGL J MED, V333, P958, DOI 10.1056/NEJM199510123331502; Kandiel A, 2005, GUT, V54, P1121, DOI 10.1136/gut.2004.049460; Kanzler S, 2001, J HEPATOL, V34, P354, DOI 10.1016/S0168-8278(00)00095-7; LaRusso NF, 2006, HEPATOLOGY, V44, P746, DOI 10.1002/hep.21337; Lee J, 2007, CLIN GASTROENTEROL H, V5, P1313, DOI 10.1016/j.cgh.2007.07.015; Lindor KD, 2009, HEPATOLOGY, V50, P808, DOI 10.1002/hep.23082; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Luth S, 2008, J CLIN GASTROENTEROL, V42, P926, DOI 10.1097/MCG.0b013e318154af74; Manns MP, 2008, J HEPATOL, V48, pS369, DOI 10.1016/S0168-8278(08)60991-5; Mendes FD, 2008, HEPATOLOGY, V47, P1241, DOI 10.1002/hep.22178; Mitchell SA, 2001, GASTROENTEROLOGY, V121, P900, DOI 10.1053/gast.2001.27965; Montano-Loza AJ, 2007, LIVER INT, V27, P507, DOI 10.1111/j.1478-3231.2007.01444.x; MURRAYLYON IM, 1973, LANCET, V1, P735; Oertelt S, 2007, HEPATOLOGY, V45, P659, DOI 10.1002/hep.21583; Olsson R, 2005, GASTROENTEROLOGY, V129, P1464, DOI 10.1053/j.gastro.2005.08.017; Pardi DS, 2003, GASTROENTEROLOGY, V124, P889, DOI 10.1053/gast.2003.50156; Pares A, 2006, GASTROENTEROLOGY, V130, P715, DOI 10.1053/j.gastro.2005.12.029; Pla X, 2007, EUR J GASTROEN HEPAT, V19, P859, DOI 10.1097/MEG.0b013e328277594a; Poupon RE, 1997, GASTROENTEROLOGY, V113, P884, DOI 10.1016/S0016-5085(97)70183-5; SCHALM SW, 1977, AM J DIG DIS, V22, P973, DOI 10.1007/BF01076196; Shi J, 2006, AM J GASTROENTEROL, V101, P1529, DOI 10.1111/j.1572-0241.2006.00634.x; Soetikno RM, 2002, GASTROINTEST ENDOSC, V56, P48, DOI 10.1067/mge.2002.125367; SOLOWAY RD, 1972, GASTROENTEROLOGY, V63, P820; STELLON AJ, 1985, LANCET, V1, P668; SUMMERSKILL WHJ, 1975, GUT, V16, P876, DOI 10.1136/gut.16.11.876; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Verma S, 2007, HEPATOLOGY, V46, P1828, DOI 10.1002/hep.21884; Werner M, 2008, SCAND J GASTROENTERO, V43, P1232, DOI 10.1080/00365520802130183; Zein CO, 2003, CLIN GASTROENTEROL H, V1, P89, DOI 10.1053/cgh.2003.50014	53	6	6	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 8	2009	339								b3305	10.1136/bmj.b3305	http://dx.doi.org/10.1136/bmj.b3305			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	493RC	19737821				2022-12-28	WOS:000269754600001
J	Politi, A; Matthews, JCF; O'Brien, JL				Politi, Alberto; Matthews, Jonathan C. F.; O'Brien, Jeremy L.			Shor's Quantum Factoring Algorithm on a Photonic Chip	SCIENCE			English	Article							CIRCUITS		[O'Brien, Jeremy L.] Univ Bristol, HH Wills Phys Lab, Ctr Quantum Photon, Bristol BS8 1UB, Avon, England; Univ Bristol, Dept Elect & Elect Engn, Bristol BS8 1UB, Avon, England	University of Bristol; University of Bristol	O'Brien, JL (corresponding author), Univ Bristol, HH Wills Phys Lab, Ctr Quantum Photon, Merchant Venturers Bldg,Woodland Rd, Bristol BS8 1UB, Avon, England.	Jeremy.OBrien@bristol.ac.uk	O'Brien, Jeremy L/A-6290-2008; Politi, Alberto/D-7134-2011; Matthews, Jonathan/D-7129-2011	Politi, Alberto/0000-0002-3668-9474; Matthews, Jonathan/0000-0001-6184-1813; O'Brien, Jeremy/0000-0002-3576-8285	Engineering and Physical Sciences Research Council; Quantum Information Processing Interdisciplinary Research Collaboration; Intelligence Advanced Research Projects Activity; Leverhulme Trust; Royal Society [Wolfson Merit Award]; Engineering and Physical Sciences Research Council [EP/F008023/1, EP/F010524/1] Funding Source: researchfish; EPSRC [EP/F008023/1, EP/F010524/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Quantum Information Processing Interdisciplinary Research Collaboration; Intelligence Advanced Research Projects Activity; Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank R. Jozsa, A. Laing, A. Montanaro, S. Takeuchi, M. G. Thompson, and X.-Q. Zhou for helpful discussions. This work was supported by Engineering and Physical Sciences Research Council, Quantum Information Processing Interdisciplinary Research Collaboration, Intelligence Advanced Research Projects Activity, and the Leverhulme Trust. J.L.O.B. acknowledges a Royal Society Wolfson Merit Award.	Lanyon BP, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250505; Lu CY, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.250504; Matthews JCF, 2009, NAT PHOTONICS, V3, P346, DOI 10.1038/NPHOTON.2009.93; O'Brien JL, 2007, SCIENCE, V318, P1567, DOI 10.1126/science.1142892; Politi A, 2008, SCIENCE, V320, P646, DOI 10.1126/science.1155441; Shor P. W., 1994, Proceedings. 35th Annual Symposium on Foundations of Computer Science (Cat. No.94CH35717), P124, DOI 10.1109/SFCS.1994.365700; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a	7	313	322	6	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 4	2009	325	5945					1221	1221		10.1126/science.1173731	http://dx.doi.org/10.1126/science.1173731			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729649	Green Submitted			2022-12-28	WOS:000269523200029
J	Chen, P; Chuang, C				Chen, Ping-Hsien; Chuang, Chiao-Hsiung			Sigmoid Volvulus.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Ping-Hsien; Chuang, Chiao-Hsiung] Natl Cheng Kung Univ, Tainan 70101, Taiwan	National Cheng Kung University	Chen, P (corresponding author), Natl Cheng Kung Univ, Tainan 70101, Taiwan.			Chuang, Chiao-Hsiung/0000-0003-3283-9145					0	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					1009	1009		10.1056/NEJMicm0804991	http://dx.doi.org/10.1056/NEJMicm0804991			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19726775				2022-12-28	WOS:000269480400010
J	Cooper, ZN; McGuire, A; Jones, S; Le Grand, J				Cooper, Zachary N.; McGuire, Alistair; Jones, S.; Le Grand, J.			Equity, waiting times, and NHS reforms: retrospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHOICE	Objective To determine whether observable changes in waiting times occurred for certain key elective procedures between 1997 and 2007 in the English National Health Service and to analyse the distribution of those changes between socioeconomic groups as an indicator of equity. Design Retrospective study of population-wide, patient level data using ordinary least squares regression to investigate the statistical relation between waiting times and patients' socioeconomic status. Setting English NHS from 1997 to 2007. Participants 427 277 patients who had elective knee replacement, 406 253 who had elective hip replacement, and 2 568 318 who had elective cataract repair. Main outcome measures Days waited from referral for surgery to surgery itself; socioeconomic status based on Carstairs index of deprivation. Results Mean and median waiting times rose initially and then fell steadily over time. By 2007 variation in waiting times across the population tended to be lower. In 1997 waiting times and deprivation tended to be positively related. By 2007 the relation between deprivation and waiting time was less pronounced, and, in some cases, patients from the most deprived fifth were waiting less time than patients from the most advantaged fifth. Conclusions Between 1997 and 2007 waiting times for patients having elective hip replacement, knee replacement, and cataract repair in England went down and the variation in waiting times for those procedures across socioeconomic groups was reduced. Many people feared that the government's NHS reforms would lead to inequity, but inequity with respect to waiting times did not increase; if anything, it decreased. Although proving that the later stages of those reforms, which included patient choice, provider competition, and expanded capacity, was a catalyst for improvements in equity is impossible, the data show that these reforms, at a minimum, did not harm equity.	[Cooper, Zachary N.; McGuire, Alistair] London Sch Econ, London WC2A 2AE, England; [Jones, S.] Dr Foster Intelligence, London EC1A 9LA, England; [Le Grand, J.] London Sch Econ, Dept Social Policy, London, England	University of London; London School Economics & Political Science; University of London; London School Economics & Political Science	Cooper, ZN (corresponding author), London Sch Econ, Cowdray House, London WC2A 2AE, England.	z.cooper@lse.ac.uk	Jones, Simon/G-9975-2012	Jones, Simon/0000-0002-8267-5647	LSE doctoral studentship; Morris Finer PhD fellowship	LSE doctoral studentship; Morris Finer PhD fellowship	This research was funded through an LSE doctoral studentship and a Morris Finer PhD fellowship.	Appleby J., 2003, WHAT IS REAL COST MO; APPLEBY J, 2005, WAR WAITING HOSP TRE; Barr DA, 2008, J MED ETHICS, V34, P271, DOI 10.1136/jme.2006.019570; Bevan G, 2006, BMJ-BRIT MED J, V332, P419, DOI 10.1136/bmj.332.7538.419; Coulter A., 2005, PATIENTS EXPERIENCE; Darzi A., 2008, HIGH QUALITY CARE AL; *DEP HLTH, 2004, IMPL CHOIC REF CAT L; *DEP HLTH, 2003, BUILD BEST CHOIC RES; Department of Health, 2005, HLTH REF ENGL UPD NE; Dixon Anna, 2006, J Health Serv Res Policy, V11, P162, DOI 10.1258/135581906777641668; Klein R, 2006, NEW ENGL J MED, V355, P409, DOI 10.1056/NEJMhpr062747; Martin RM, 2003, BMJ-BRIT MED J, V326, P188, DOI 10.1136/bmj.326.7382.188; Morgan Oliver, 2006, Health Stat Q, P28; Oliver A, 2005, J MED ETHICS, V31, P187, DOI 10.1136/jme.2005.011809; PELL J, 2000, BMJ-BRIT MED J, V321, P15; Propper C., 2007, 07179 CMPO; *SECR STAT HLTH, 2000, NHS PLAN PLAN INV PL; Siciliani L, 2005, HEALTH POLICY, V72, P201, DOI 10.1016/j.healthpol.2004.07.003; Siciliani L, 2007, HEALTH ECON, V16, P763, DOI 10.1002/hec.1205; Stevens S, 2004, HEALTH AFFAIR, V23, P37, DOI 10.1377/hlthaff.23.3.37; STEVENS S, 2003, EQUITY HLTH HLTH CAR; 1998, ECONOMIST       0523, P51	22	66	67	2	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2009	339								b3264	10.1136/bmj.b3264	http://dx.doi.org/10.1136/bmj.b3264			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	491CI	19729415	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000269554100001
J	Zheng, JP; Birktoft, JJ; Chen, Y; Wang, T; Sha, RJ; Constantinou, PE; Ginell, SL; Mao, CD; Seeman, NC				Zheng, Jianping; Birktoft, Jens J.; Chen, Yi; Wang, Tong; Sha, Ruojie; Constantinou, Pamela E.; Ginell, Stephan L.; Mao, Chengde; Seeman, Nadrian C.			From molecular to macroscopic via the rational design of a self-assembled 3D DNA crystal	NATURE			English	Article							NUCLEIC-ACID JUNCTIONS; HOLLIDAY JUNCTION; CRYSTALLIZATION; SUBSTRATE; TRIANGLES	We live in a macroscopic three-dimensional (3D) world, but our best description of the structure of matter is at the atomic and molecular scale. Understanding the relationship between the two scales requires a bridge from the molecular world to the macroscopic world. Connecting these two domains with atomic precision is a central goal of the natural sciences, but it requires high spatial control of the 3D structure of matter(1). The simplest practical route to producing precisely designed 3D macroscopic objects is to form a crystalline arrangement by self-assembly, because such a periodic array has only conceptually simple requirements: a motif that has a robust 3D structure, dominant affinity interactions between parts of the motif when it self-associates, and predictable structures for these affinity interactions. Fulfilling these three criteria to produce a 3D periodic system is not easy, but should readily be achieved with well-structured branched DNA motifs tailed by sticky ends(2). Complementary sticky ends associate with each other preferentially and assume the well-known B-DNA structure when they do so(3); the helically repeating nature of DNA facilitates the construction of a periodic array. It is essential that the directions of propagation associated with the sticky ends do not share the same plane, but extend to form a 3D arrangement of matter. Here we report the crystal structure at 4 angstrom resolution of a designed, self-assembled, 3D crystal based on the DNA tensegrity triangle(4). The data demonstrate clearly that it is possible to design and self-assemble a well-ordered macromolecular 3D crystalline lattice with precise control.	[Zheng, Jianping; Birktoft, Jens J.; Wang, Tong; Sha, Ruojie; Constantinou, Pamela E.; Seeman, Nadrian C.] NYU, Dept Chem, New York, NY 10003 USA; [Chen, Yi; Mao, Chengde] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Ginell, Stephan L.] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	New York University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Energy (DOE); Argonne National Laboratory	Seeman, NC (corresponding author), NYU, Dept Chem, New York, NY 10003 USA.	mao@purdue.edu; ned.seeman@nyu.edu	Mao, Chengde/GPP-1546-2022; Chen, Yi/D-7943-2013	Chen, Yi/0000-0002-2310-1416	National Institute of General Medical Sciences; National Science Foundation [CCF-0622093]; Army Research Office; Office of Naval Research; W. M. Keck Foundation; NIH [1R21EB007472]; US Department of Energy [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007472] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Army Research Office; Office of Naval Research(Office of Naval Research); W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This research has been supported by grants to N. C. S. from the National Institute of General Medical Sciences, the National Science Foundation, the Army Research Office, the Office of Naval Research and the W. M. Keck Foundation. It has also been supported by NSF grant CCF-0622093 and NIH grant 1R21EB007472 to C. M. We thank W. Sherman for assistance in establishing the likely structural features of tensegrity triangles. We thank R. Sweet, M. Allaire, H. Robinson, A. Saxena and A. Heroux at the BNL-NSLS at beamlines X6A and X25 of the National Synchrotron Light Source. BNL-NSLS is supported principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy, and from the National Center for Research Resources of the National Institutes of Health. The use of the 19ID beamline at the Structural Biology Center/Advanced Photon Source is supported by the US Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357.	Birac JJ, 2006, J MOL GRAPH MODEL, V25, P470, DOI 10.1016/j.jmgm.2006.03.005; Ding B, 2006, SCIENCE, V314, P1583, DOI 10.1126/science.1131372; Eichman BF, 2000, P NATL ACAD SCI USA, V97, P3971, DOI 10.1073/pnas.97.8.3971; Furukawa H, 2008, J AM CHEM SOC, V130, P11650, DOI 10.1021/ja803783c; Gu HZ, 2009, NAT NANOTECHNOL, V4, P245, DOI [10.1038/NNANO.2009.5, 10.1038/nnano.2009.5]; Kawano M, 2007, J AM CHEM SOC, V129, P15418, DOI 10.1021/ja0752540; Liu D, 2004, J AM CHEM SOC, V126, P2324, DOI 10.1021/ja031754r; Mao CD, 1999, J AM CHEM SOC, V121, P5437, DOI 10.1021/ja9900398; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Paukstelis PJ, 2006, J AM CHEM SOC, V128, P6794, DOI 10.1021/ja061322r; Paukstelis PJ, 2004, CHEM BIOL, V11, P1119, DOI 10.1016/j.chembiol.2004.05.021; Qiu HX, 1997, J MOL BIOL, V267, P881, DOI 10.1006/jmbi.1997.0918; ROBINSON BH, 1987, PROTEIN ENG, V1, P295, DOI 10.1093/protein/1.4.295; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; SEEMAN NC, 1985, J BIOMOL STRUCT DYN, V3, P11, DOI 10.1080/07391102.1985.10508395; Sha RJ, 2002, BIOCHEMISTRY-US, V41, P5950, DOI 10.1021/bi020001z; Vargason JM, 2001, P NATL ACAD SCI USA, V98, P7265, DOI 10.1073/pnas.121176898; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c	24	669	702	18	426	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 3	2009	461	7260					74	77		10.1038/nature08274	http://dx.doi.org/10.1038/nature08274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490DT	19727196	Green Accepted			2022-12-28	WOS:000269478800032
J	Li, JX; Timko, MP				Li, Jianxiong; Timko, Michael P.			Gene-for-Gene Resistance in Striga-Cowpea Associations	SCIENCE			English	Article							GESNERIOIDES		[Li, Jianxiong; Timko, Michael P.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Virginia	Li, JX (corresponding author), Univ Virginia, Dept Biol, Gilmer Hall, Charlottesville, VA 22903 USA.	mpt9g@virginia.edu			NSF; Kirkhouse Charitable Trust	NSF(National Science Foundation (NSF)); Kirkhouse Charitable Trust	We thank J. Westwood for critical reading and commentary and members of the Timko laboratory for helpful comments and suggestions. Supported by funds from NSF and Kirkhouse Charitable Trust.	Ashfield T, 2004, PLANT CELL, V16, P309, DOI 10.1105/tpc.016725; Botanga CJ, 2006, GENOME, V49, P1351, DOI 10.1139/G06-086; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Ejeta G, 2007, INTEGRATING NEW TECH, P115; Lane J. A., 1997, P81; Ouedraogo JT, 2001, THEOR APPL GENET, V102, P1029, DOI 10.1007/s001220000499; Tameling WIL, 2007, PHYSIOL MOL PLANT P, V71, P126, DOI 10.1016/j.pmpp.2007.12.006; Timko MP, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-103	8	64	65	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1094	1094		10.1126/science.1174754	http://dx.doi.org/10.1126/science.1174754			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713520				2022-12-28	WOS:000269382300031
J	Jenkins, J; Hope-Gill, B				Jenkins, Jessica; Hope-Gill, Ben			Endgames Case Report Orthopnoea in a young woman	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SNIFF; PRESSURE		[Jenkins, Jessica; Hope-Gill, Ben] Univ Hosp Llandough, Dept Resp Med, Cardiff CF64 2XX, Wales		Hope-Gill, B (corresponding author), Univ Hosp Llandough, Dept Resp Med, Cardiff CF64 2XX, Wales.	Ben.Hope-Gill@CardiffandVale.wales.nhs.uk						Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Gibbs JSR, 2008, THORAX, V63, P1, DOI 10.1136/thx.2007.090480; Hagemans MLC, 2005, BRAIN, V128, P671, DOI 10.1093/brain/awh384; Hart N, 2003, J NEUROL NEUROSUR PS, V74, P1685, DOI 10.1136/jnnp.74.12.1685; HERITIER F, 1994, AM J RESP CRIT CARE, V150, P1678, DOI 10.1164/ajrccm.150.6.7952632; Hirschhorn R, 2001, METABOLIC MOL BASES, P3389; Kishnani PS, 2007, NEUROLOGY, V68, P99, DOI 10.1212/01.wnl.0000251268.41188.04; Laghi F, 2003, AM J RESP CRIT CARE, V168, P10, DOI 10.1164/rccm.2206020; LAROCHE CM, 1988, AM REV RESPIR DIS, V138, P598, DOI 10.1164/ajrccm/138.3.598; MILLER JM, 1985, CLIN SCI, V69, P91, DOI 10.1042/cs0690091; POLKEY M, 2003, RESP MED, P2010; SIMILOWSKI T, 1989, J APPL PHYSIOL, V67, P1311, DOI 10.1152/jappl.1989.67.4.1311; Simonneau G, 2004, J AM COLL CARDIOL, V43, p5S, DOI 10.1016/j.jacc.2004.02.037; Steier J, 2007, THORAX, V62, P975, DOI 10.1136/thx.2006.072884; WEST JB, 1990, RESPIRATORY PHYSL ES, P51; Zaiman A, 2005, AM J RESP CELL MOL, V33, P425, DOI 10.1165/rcmb.F307	16	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 26	2009	339								b3093	10.1136/bmj.b3093	http://dx.doi.org/10.1136/bmj.b3093			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AX	19710129				2022-12-28	WOS:000269393000001
J	Artyukhin, AB; Wu, LF; Altschuler, SJ				Artyukhin, Alexander B.; Wu, Lani F.; Altschuler, Steven J.			Only Two Ways to Achieve Perfection	CELL			English	Editorial Material							CELL	The functional repertoire of a network is determined by its topology. Ma et al. (2009) analyze enzyme networks with three nodes and take a reverse-engineering approach to ask how many core network topologies can establish perfect adaptation, the ability to reset after perturbation. Surprisingly, the answer is just two.	[Artyukhin, Alexander B.; Wu, Lani F.; Altschuler, Steven J.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Green Ctr Syst Biol, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Wu, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Green Ctr Syst Biol, Dept Pharmacol, Dallas, TX 75390 USA.	lani.wu@utsouthwestern.edu; steven.altschuler@utsouthwestern.edu			Welch Foundation [I-1619, I-1644]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081549] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support from the Welch Foundation I-1619 (L.F.W.) and I-1644 (S.J.A.).	Alon U, 2007, INTRO SYSTEMS BIOL D; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Francois P, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026009; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Ingalls B.P., 2006, SYSTEM MODELING CELL, P243; Knabe JF, 2008, BIOSYSTEMS, V94, P68, DOI 10.1016/j.biosystems.2008.05.012; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649	9	9	10	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					619	621		10.1016/j.cell.2009.08.010	http://dx.doi.org/10.1016/j.cell.2009.08.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703388	Bronze			2022-12-28	WOS:000269156100003
J	Fabbri, LM; Calverley, PMA; Izquierdo-Alonso, JL; Bundschuh, DS; Brose, M; Martinez, FJ; Rabe, KF				Fabbri, Leonardo M.; Calverley, Peter M. A.; Luis Izquierdo-Alonso, Jose; Bundschuh, Daniela S.; Brose, Manja; Martinez, Fernando J.; Rabe, Klaus F.		M2-127 Study Grp; M2-128 Study Grp	Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials	LANCET			English	Article							PDE4 INHIBITOR ROFLUMILAST; PHOSPHODIESTERASE-4 INHIBITORS; SALMETEROL; MANAGEMENT; THERAPY; THEOPHYLLINE; INFLAMMATION; FLUTICASONE; PREVENTION; PROPIONATE	Background Patients with chronic obstructive pulmonary disease (COPD) have few options for treatment. The efficacy and safety of the phosphodiesterase-4 inhibitor roflumilast have been investigated in studies of patients with moderate-to-severe COPD, but not in those concomitantly treated with longacting inhaled bronchodilators. The effect of roflumilast on lung function in patients with COPD that is moderate to severe who are already being treated with salmeterol or tiotropium was investigated. Methods In two double-blind, multicentre studies done in an outpatient setting, after a 4-week run-in, patients older than 40 years with moderate-to-severe COPD were randomly assigned to oral roflumilast 500 mu g or placebo once a day for 24 weeks, in addition to salmeterol (M2-127 study) or tiotropium (M2-128 study). The primary endpoint was change in prebronchodilator forced expiratory volume in 1s (FEV1). Analysis was by intention to treat. The studies are registered with ClinicalTrials.gov, number NCT00313209 for M2-127, and NCT00424268 for M2-128. Findings In the salmeterol plus roflumilast trial, 466 patients were assigned to and treated with roflumilast and 467 with placebo; in the tiotropium plus roflumilast trial, 371 patients were assigned to and treated with roflumilast and 372 with placebo. Compared with placebo, roflumilast consistently improved mean prebronchodilator FEV1 by 49 mL (p<0.0001) in patients treated with salmeterol, and 80 mL (p<0.0001) in those treated with tiotropium. Similar improvement in postbronchodilator FEV1 was noted in both groups. Furthermore, roflumilast had beneficial effects on other lung function measurements and on selected patient-reported outcomes in both groups. Nausea, diarrhoea, weight loss, and, to a lesser extent, headache were more frequent in patients in the roflumilast groups. These adverse events were associated with increased patient withdrawal. Interpretation Roflumilast improves lung function in patients with COPD treated with salmeterol or tiotropium, and could become an important treatment for these patients.	[Rabe, Klaus F.] Leiden Univ, Med Ctr, Dept Pulmonol, NL-2333 ZA Leiden, Netherlands; [Fabbri, Leonardo M.] Univ Modena & Reggio Emilia, Modena, Italy; [Calverley, Peter M. A.] Sch Clin Sci, Liverpool, Merseyside, England; [Luis Izquierdo-Alonso, Jose] Hosp GU, Guadalajara, Spain; [Bundschuh, Daniela S.; Brose, Manja] Nycomed, Constance, Germany; [Martinez, Fernando J.] Univ Michigan Hlth Syst, Ann Arbor, MI USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universita di Modena e Reggio Emilia; University of Liverpool; Nycomed GmbH; University of Michigan System; University of Michigan	Rabe, KF (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands.	k.f.rabe@lumc.nl	Rabe, Klaus F./AAW-6296-2021; Fabbri, Leonardo M/I-4055-2012; Bucca, Caterina/C-9886-2009; Barbé, Ferran/A-5988-2010; Hering, Thomas Dr./E-6482-2016; Roig, Jordi/W-4773-2019	Rabe, Klaus F./0000-0002-7020-1401; Fabbri, Leonardo M/0000-0001-8894-1689; Bucca, Caterina/0000-0002-9941-9236; Barbé, Ferran/0000-0002-2340-8928; Hering, Thomas Dr./0000-0001-6108-8382; Roig, Jordi/0000-0002-5593-7090; MacNee, William/0000-0002-3692-1448; Jose L, Izquierdo Alonso/0000-0002-1671-2243; Izquierdo Alonso, Jose Luis/0000-0002-0012-931X; TERZANO, CLAUDIO/0000-0002-9851-7731	Nycomed, Konstanz, Germany; Medical Research Council [G9900991B] Funding Source: researchfish	Nycomed, Konstanz, Germany; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	These studies were supported by Nycomed, Konstanz, Germany. We thank Dirk Bredenbroker (Limburg an der Lahn, Germany), Frank Cerasoli Jr (New York, NY, USA), and Tushar Shah (Sellersville, PA, USA) for their substantial contribution to the development of the protocols of the two studies reported here; all patients who took part in these trials; all the investigators at the 135 centres involved in the salmeterol plus roflumilast trial and 85 centres in the tiotropium plus roflumilast trial; and Jane Davies, Christine Groves, and Paul VVilmott of Caudex Medical, Oxford, UK (supported by Nycomed), and Elisa Veratelli (University of Modena and Reggio Emilia, Modena, Italy) for editorial assistance with the preparation of the report.	Barnes PJ, 2008, CHEST, V134, P1278, DOI 10.1378/chest.08-1385; Boswell-Smith V, 2006, J ALLERGY CLIN IMMUN, V117, P1237, DOI 10.1016/j.jaci.2006.02.045; Bundschuh DS, 2001, J PHARMACOL EXP THER, V297, P280; Calverley P, 2003, LANCET, V361, P449, DOI 10.1016/S0140-6736(03)12459-2; Calverley PMA, 2008, BRIT J PHARMACOL, V155, P487, DOI 10.1038/bjp.2008.362; Calverley PMA, 2007, AM J RESP CRIT CARE, V176, P154, DOI 10.1164/rccm.200610-1563OC; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Calverley PMA, 2009, LANCET, V374, P685, DOI 10.1016/S0140-6736(09)61255-1; Calverley PM, 2003, EUR RESPIR J, V22, P912, DOI 10.1183/09031936.03.00027003; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chen AM, 2008, ANN PHARMACOTHER, V42, P1832, DOI 10.1345/aph.1L250; Chow SC., 2009, ENCY BIOPHARMACEUTIC; Eakin EG, 1998, CHEST, V113, P619, DOI 10.1378/chest.113.3.619; Engelstaetter R., 2005, ANN ALLERG ASTHMA IM, V94, P169; Grootendorst DC, 2003, PULM PHARMACOL THER, V16, P115, DOI 10.1016/S1094-5539(02)00172-4; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Kumar RK, 2003, J PHARMACOL EXP THER, V307, P349, DOI 10.1124/jpet.103.053819; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; MAHLER DA, 1984, CHEST, V85, P751, DOI 10.1378/chest.85.6.751; Muise ES, 2002, BIOCHEM PHARMACOL, V63, P1527, DOI 10.1016/S0006-2952(02)00903-6; O'Donnell DE, 2008, CAN RESPIR J, V15, p1A, DOI 10.1155/2008/641965; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; RABE KF, 1995, EUR RESPIR J, V8, P637; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sin DD, 2007, CAN J PHYSIOL PHARM, V85, P141, DOI 10.1139/Y06-093; Singh S, 2009, ARCH INTERN MED, V169, P219, DOI 10.1001/archinternmed.2008.550; Spina D, 2008, BRIT J PHARMACOL, V155, P308, DOI 10.1038/bjp.2008.307; Szafranski W, 2003, EUR RESPIR J, V21, P74, DOI 10.1183/09031936.03.00031402; Tashkin DP, 2008, NEW ENGL J MED, V359, P1543, DOI 10.1056/NEJMoa0805800; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; ZuWallack RL, 2001, CHEST, V119, P1661, DOI 10.1378/chest.119.6.1661	33	420	439	0	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					695	703		10.1016/S0140-6736(09)61252-6	http://dx.doi.org/10.1016/S0140-6736(09)61252-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489LV	19716961				2022-12-28	WOS:000269422500025
J	Greer, G; Chau, K; Hinz, C; Thanenthiran, S				Greer, Gill; Chau, Katie; Hinz, Catherina; Thanenthiran, Sivananthi			Sex, rights, and politics-from Cairo to Berlin	LANCET			English	Editorial Material									[Greer, Gill] Int Planned Parenthood Federat, London SE1 3UZ, England; [Chau, Katie] Youth Coalit, Ottawa, ON, Canada; [Hinz, Catherina] German Fdn World Populat, Hannover, Germany; [Thanenthiran, Sivananthi] Asian Pacific Resource & Res Ctr Women, Kuala Lumpur, Malaysia		Greer, G (corresponding author), Int Planned Parenthood Federat, London SE1 3UZ, England.	ggreer@ippf.org						[Anonymous], REP GLOB AIDS EP EX; Goldberg Michelle, 2009, MEANS REPROD SEX POW; *OXF CAN, 2009, CONTR ARMS MED BRIEF; Speidel JJ, 2009, MAKING CASE US INT F; *UNFPA, 2007, SUPP AD YOUTH; *UNFPA, 2009, FAM PLANN REPR HLTH; World Health Organization, 2008, IMPR SEX REPR HLTH I	7	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2009	374	9691					674	675		10.1016/S0140-6736(09)61543-9	http://dx.doi.org/10.1016/S0140-6736(09)61543-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489LV	19716949				2022-12-28	WOS:000269422500009
J	Mancuso, K; Hauswirth, WW; Li, QH; Connor, TB; Kuchenbecker, JA; Mauck, MC; Neitz, J; Neitz, M				Mancuso, Katherine; Hauswirth, William W.; Li, Qiuhong; Connor, Thomas B.; Kuchenbecker, James A.; Mauck, Matthew C.; Neitz, Jay; Neitz, Maureen			Gene therapy for red-green colour blindness in adult primates	NATURE			English	Article							MOLECULAR-GENETICS; VISION; EXPRESSION; RETINA; DEFICIENCY; PIGMENTS	Red-green colour blindness, which results from the absence of either the long-(L) or the middle- (M) wavelength-sensitive visual photopigments, is the most common single locus genetic disorder. Here we explore the possibility of curing colour blindness using gene therapy in experiments on adult monkeys that had been colour blind since birth. A third type of cone pigment was added to dichromatic retinas, providing the receptoral basis for trichromatic colour vision. This opened a new avenue to explore the requirements for establishing the neural circuits for a new dimension of colour sensation. Classic visual deprivation experiments(1) have led to the expectation that neural connections established during development would not appropriately process an input that was not present from birth. Therefore, it was believed that the treatment of congenital vision disorders would be ineffective unless administered to the very young. However, here we show that the addition of a third opsin in adult red-green colour deficient primates was sufficient to produce trichromatic colour vision behaviour. Thus, trichromacy can arise from a single addition of a third cone class and it does not require an early developmental process. This provides a positive outlook for the potential of gene therapy to cure adult vision disorders.	[Mancuso, Katherine; Kuchenbecker, James A.; Neitz, Jay; Neitz, Maureen] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; [Hauswirth, William W.; Li, Qiuhong] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Hauswirth, William W.; Li, Qiuhong] Univ Florida, Powell Gene Therapy Ctr, Gainesville, FL 32610 USA; [Connor, Thomas B.; Mauck, Matthew C.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA	University of Washington; University of Washington Seattle; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Medical College of Wisconsin	Neitz, J (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485,1959 NE Pacific St, Seattle, WA 98195 USA.	jneitz@uw.edu		Neitz, Maureen/0000-0002-5404-3343; Neitz, Jay/0000-0003-3877-6712; hauswirth, william/0000-0002-3244-4947	National Institutes of Health [R01EY016861, R01EY11123]; Research Training Program in Vision Science [T32EY014537]; NEI Core Grants [P30EY01931, P30EY01730, P30EY08571]; Harry J. Heeb Foundation; Posner Foundation; Macular Vision Research Foundation; Foundation Fighting Blindness; Hope for Vision; Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008571, P30EY001931, R01EY011123, R01EY016861, P30EY001730, T32EY014537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Training Program in Vision Science; NEI Core Grants; Harry J. Heeb Foundation; Posner Foundation; Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); Hope for Vision; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health grants R01EY016861 (M. N.) and R01EY11123 (W. W. H.); Research Training Program in Vision Science Grant T32EY014537; NEI Core Grants for Vision Research P30EY01931, P30EY01730 and P30EY08571; the Harry J. Heeb Foundation, the Posner Foundation, the Macular Vision Research Foundation, the Foundation Fighting Blindness, Hope for Vision, and Research to Prevent Blindness. We would like to thank V. Chiodo, S. Boye, D. Conklyn, P. M. Summerfelt, K. Chmielewski and K. L. Gunther for technical assistance. J. N. is the Bishop Professor in Ophthalmology, M. N. is the Ray Hill Professor in Ophthalmology, and W. W. H. is Rybaczki-Bullard Professor of Ophthalmology.	Bainbridge JW, 2008, GENE THER, V15, P1191, DOI 10.1038/gt.2008.117; Buning H, 2008, J GENE MED, V10, P717, DOI 10.1002/jgm.1205; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; DEVALOIS RL, 1993, VISION RES, V33, P1053, DOI 10.1016/0042-6989(93)90240-W; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Jacobs GH, 1998, VISION RES, V38, P3307, DOI 10.1016/S0042-6989(97)00405-7; Kuchenbecker JA, 2008, VISUAL NEUROSCI, V25, P301, DOI 10.1017/S0952523808080474; Li QH, 2008, VISION RES, V48, P332, DOI 10.1016/j.visres.2007.07.026; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Makous W, 2007, SCIENCE, V318, DOI 10.1126/science.1146084; Mancuso K, 2007, J OPT SOC AM A, V24, P1411, DOI 10.1364/JOSAA.24.001411; Mancuso K, 2006, VISUAL NEUROSCI, V23, P695, DOI 10.1017/S0952523806233364; Mauck MC, 2008, VISUAL NEUROSCI, V25, P273, DOI 10.1017/S0952523808080577; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; REFFIN JP, 1991, COLOUR VISION DEFICI, V10, P69; REGAN BC, 1994, VISION RES, V34, P1279, DOI 10.1016/0042-6989(94)90203-8; Shapley R, 2006, J NEUROPHYSIOL, V95, P587, DOI 10.1152/jn.01054.2005; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	21	213	248	6	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 8	2009	461	7265					784	U34		10.1038/nature08401	http://dx.doi.org/10.1038/nature08401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	503OR	19759534	Green Accepted			2022-12-28	WOS:000270547500034
J	de Silva, R; Fox, KM				de Silva, Ranil; Fox, Kim M.			The changing horizon of acute coronary syndrome	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; RANDOMIZED-TRIALS; MORTALITY; GUIDELINES; MANAGEMENT; OUTCOMES; THERAPY; RISK		[de Silva, Ranil; Fox, Kim M.] Royal Brompton & Harefield NHS Fdn Trust, Dept Cardiol, London SW3 6NP, England; [de Silva, Ranil; Fox, Kim M.] Royal Brompton & Harefield NHS Fdn Trust, NIHR Biomed Res Unit, London SW3 6NP, England; [de Silva, Ranil; Fox, Kim M.] Univ London Imperial Coll Sci Technol & Med, Div Heart Sci, Natl Heart & Lung Inst, London, England	Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Imperial College London	de Silva, R (corresponding author), Royal Brompton & Harefield NHS Fdn Trust, Dept Cardiol, London SW3 6NP, England.	r.desilva@imperial.ac.uk						Agostoni P, 2004, J AM COLL CARDIOL, V44, P349, DOI 10.1016/j.jacc.2004.04.034; Antman EM, 2008, CIRCULATION, V117, P296, DOI 10.1161/CIRCULATIONAHA.107.188209; Budaj A, 2009, EUR HEART J, V30, P655, DOI 10.1093/eurheartj/ehn358; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7; Mehran R, 2009, EUR HEART J, V30, P1457, DOI 10.1093/eurheartj/ehp110; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Smith KJ, 2003, CARDIOVASC RES, V59, P538, DOI 10.1016/S0008-6363(03)00468-1; Spencer FA, 2007, CIRCULATION, V116, P2793, DOI 10.1161/CIRCULATIONAHA.107.694273; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Subherwal S, 2009, CIRCULATION, V119, P1873, DOI 10.1161/CIRCULATIONAHA.108.828541; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; Wang TY, 2008, CIRCULATION, V118, P2139, DOI 10.1161/CIRCULATIONAHA.108.787143; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	16	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 3	2009	374	9696					1125	1127		10.1016/S0140-6736(09)61564-6	http://dx.doi.org/10.1016/S0140-6736(09)61564-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	505IZ	19717183				2022-12-28	WOS:000270688200007
J	Dawson, MR; Duda, DG; Fukumura, D; Jain, RK				Dawson, Michelle R.; Duda, Dan G.; Fukumura, Dai; Jain, Rakesh K.			VEGFR1-activity-independent metastasis formation	NATURE			English	Letter							GROWTH-FACTOR RECEPTOR-1; CELLS; ANGIOGENESIS; TUMORS		[Dawson, Michelle R.; Duda, Dan G.; Fukumura, Dai; Jain, Rakesh K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Steele Lab, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Dawson, MR (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Steele Lab, Boston, MA 02114 USA.	jain@steele.mgh.harvard.edu	Jain, Rakesh K/I-1384-2017; Duda, Dan G/H-8523-2014; Dawson, Michelle R/Q-7217-2019	Jain, Rakesh K/0000-0001-7571-3548; Duda, Dan G/0000-0001-7065-8797; Dawson, Michelle R/0000-0002-2122-4711	NCI NIH HHS [T32 CA073479-11, R01 CA115767-02, T32 CA073479-08, R01 CA096915-04, R01 CA096915-06A1, R01 CA126642-02, R01 CA085140-08, R01 CA126642-01A1, R01 CA115767-01A1, T32 CA073479, R01 CA085140, R01 CA115767, P01 CA080124-06A2, T32 CA073479-10, T32 CA073479-09, R01 CA096915, P01 CA080124-08, R24 CA085140, T32 CA073479-12, R24 CA085140-05, P01 CA080124-07, R01 CA085140-07, R01 CA096915-05, P01 CA080124-09, R01 CA126642, P01 CA080124-05, R01 CA115767-03, P01 CA080124, R01 CA085140-09, R01 CA115767-04, R01 CA085140-06, R01 CA096915-07, R01 CA096915-08] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA115767, R01CA085140, R24CA085140, R01CA126642, P01CA080124, T32CA073479, R01CA096915] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Dawson MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006525; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Duda DG, 2006, BLOOD, V107, P2774, DOI 10.1182/blood-2005-08-3210; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Wu Y, 2006, CLIN CANCER RES, V12, P6573, DOI 10.1158/1078-0432.CCR-06-0831	13	434	452	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					E4	E5		10.1038/nature08254	http://dx.doi.org/10.1038/nature08254			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19759568	Bronze, Green Accepted			2022-12-28	WOS:000269828100049
J	Pradhan, AD; Everett, BM; Cook, NR; Rifai, N; Ridker, PM				Pradhan, Aruna D.; Everett, Brendan M.; Cook, Nancy R.; Rifai, Nader; Ridker, Paul M.			Effects of Initiating Insulin and Metformin on Glycemic Control and Inflammatory Biomarkers Among Patients With Type 2 Diabetes The LANCET Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; GLUCOSE CONTROL; RISK; MARKERS; MELLITUS; PREVENTION; COMPLICATIONS; PREDICTION; GLARGINE	Context As diabetes is in part an inflammatory condition, the initiation of insulin and/or metformin may beneficially reduce levels of inflammatory biomarkers such as high-sensitivity C-reactive protein (hsCRP). Objective To determine whether insulin alone or combined with metformin lowers levels of hsCRP, IL-6, and soluble tumor necrosis factor receptor 2 (sTNFr2) in patients with recent-onset type 2 diabetes mellitus. Design, Setting, and Participants Randomized 2 X 2 factorial trial of open-label insulin glargine and placebo-controlled metformin in 500 adults with type 2 diabetes (median time from diagnosis, 2.0 years), suboptimal glycemic control, and elevated hsCRP levels. Patients were recruited from US office-based practices between October 2006 and December 2008. Intervention Random allocation to 1 of 4 treatments (placebo metformin only, placebo metformin and insulin glargine, active metformin only, or active metformin and insulin glargine) with dose titration targeting fasting blood glucose less than 110 mg/dL. Main Outcome Measures Change in hsCRP level (primary end point) and change in IL-6 and sTNFr2 levels (secondary end points) from baseline to 14 weeks. Results Levels of glucose and glycated hemoglobin (HbA(1c)) were significantly reduced with active treatment vs placebo (all P values <.001). Levels of hsCRP were reduced in all 4 groups. There was no significant difference in hsCRP reduction among those allocated to insulin (-11.8%; 95% CI, -18.7% to -4.4%) or to no insulin (-17.5%; 95% CI, -23.9% to -10.5%) (P for difference=.25), or among those allocated to active metformin (-18.1%; 95% CI, -24.4% to -11.1%) or placebo metformin (-11.2%; 95% CI, -18.1% to -3.7%) (P for difference=.17). In the individual treatment groups, despite a differential impact on glucose control, reductions in hsCRP in the metformin (-16.1%; 95% CI, -25.1% to -6.1%) and metformin plus insulin (-20.1%; 95% CI, -28.8% to -10.4%) groups were no different than reductions with placebo alone (-19.0%; 95% CI, -27.8% to -9.1%; P=.67 and .87 vs placebo, respectively). By contrast, hsCRP reduction was attenuated with insulin alone (-2.9%, 95% CI, -13.2% to 8.6%; P=.03 vs placebo). Similar findings were noted for levels of IL-6 and sTNFr2. Conclusion In patients with recent-onset type 2 diabetes, treatment with insulin or metformin compared with placebo did not reduce inflammatory biomarker levels despite improving glucose control. Trial Registration clinicaltrials.gov Identifier: NCT00366301 JAMA. 2009; 302(11): 1186-1194	[Pradhan, Aruna D.; Everett, Brendan M.; Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; [Pradhan, Aruna D.; Everett, Brendan M.; Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Donald W Reynolds Ctr Cardiovasc Res, Boston, MA 02215 USA; [Ridker, Paul M.] Brigham & Womens Hosp, Leducq Ctr Mol & Genet Epidemiol Cardiovasc Disor, Boston, MA 02215 USA; [Everett, Brendan M.; Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02215 USA; [Pradhan, Aruna D.; Everett, Brendan M.; Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; [Rifai, Nader] Childrens Hosp, Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Pradhan, Aruna D.] Boston VA Med Ctr, Div Cardiovasc Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Pradhan, AD (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave E, Boston, MA 02215 USA.	apradhan@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768	Sanofi-Aventis	Sanofi-Aventis(Sanofi-Aventis)	Funding/Support: LANCET was an investigator-initiated trial funded by Sanofi-Aventis.	Aas AM, 2006, DIABETOLOGIA, V49, P872, DOI 10.1007/s00125-006-0205-8; Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; Caballero AE, 2004, J CLIN ENDOCR METAB, V89, P3943, DOI 10.1210/jc.2004-0019; Chu NV, 2002, DIABETES CARE, V25, P542, DOI 10.2337/diacare.25.3.542; Dandona P, 2009, J AM COLL CARDIOL, V53, pS14, DOI 10.1016/j.jacc.2008.10.038; De Jager J, 2005, J INTERN MED, V257, P100; Donath MY, 2003, J MOL MED-JMM, V81, P455, DOI 10.1007/s00109-003-0450-y; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Fonseca VA, 2006, J DIABETES COMPLICAT, V20, P14, DOI 10.1016/j.jdiacomp.2005.05.009; Freeman DJ, 2002, DIABETES, V51, P1596, DOI 10.2337/diabetes.51.5.1596; Fujimoto WY, 2007, DIABETES, V56, P1680, DOI 10.2337/db07-0009; Gerstein HC, 2008, AM HEART J, V155, P26, DOI 10.1016/j.ahj.2007.09.009; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Haffner S, 2005, DIABETES, V54, pA1; Hayden JM, 2000, CURR OPIN LIPIDOL, V11, P519, DOI 10.1097/00041433-200010000-00010; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hu FB, 2004, DIABETES, V53, P693, DOI 10.2337/diabetes.53.3.693; Kahn SE, 2009, JAMA-J AM MED ASSOC, V301, P1590, DOI 10.1001/jama.2009.511; Mao XM, 2009, DIABETES-METAB RES, V25, P435, DOI 10.1002/dmrr.968; Mathieu P, 2009, HYPERTENSION, V53, P577, DOI 10.1161/HYPERTENSIONAHA.108.110320; Nesto RW, 2008, CIRCULATION, V117, P990, DOI 10.1161/CIRCULATIONAHA.107.757450; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Reynolds LR, 2007, DIABETES RES CLIN PR, V77, P180, DOI 10.1016/j.diabres.2006.12.011; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Schaumberg DA, 2005, CIRCULATION, V111, P2446, DOI 10.1161/01.CIR.0000165064.31505.3B; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sinha A, 1996, DIABETIC MED, V13, P40, DOI 10.1002/(SICI)1096-9136(199601)13:1<40::AID-DIA991>3.3.CO;2-L; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	39	86	87	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1186	1194		10.1001/jama.2009.1347	http://dx.doi.org/10.1001/jama.2009.1347			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755697	Bronze			2022-12-28	WOS:000269797600028
J	Engebretsen, K; Grotle, M; Bautz-Holter, E; Sandvik, L; Juel, NG; Ekeberg, OM; Brox, JI				Engebretsen, Kaia; Grotle, Margreth; Bautz-Holter, Erik; Sandvik, Leiv; Juel, Niels G.; Ekeberg, Ole Marius; Brox, Jens Ivar			Radial extracorporeal shockwave treatment compared with supervised exercises in patients with subacromial pain syndrome: single blind randomised study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ROTATOR CUFF; WAVE THERAPY; IMPINGEMENT SYNDROME; SHOULDER PAIN; TENDINITIS; QUESTIONNAIRES; RELIABILITY; AGREEMENT; TRIALS	Objective To compare the effectiveness of radial extracorporeal shockwave treatment with that of supervised exercises in patients with shoulder pain. Design Single blind randomised study. Setting Outpatient clinic of physical medicine and rehabilitation department in Oslo, Norway. Participants 104 patients with subacromial shoulder pain lasting at least three months. Interventions Radial extracorporeal shockwave treatment: one session weekly for four to six weeks. Supervised exercises: two 45 minute sessions weekly for up to 12 weeks. Primary outcome measure Shoulder pain and disability index. Results A treatment effect in favour of supervised exercises at 6, 12, and 18 weeks was found. The adjusted treatment effect was -8.4 (95% confidence interval -16.5 to -0.6) points. A significantly higher proportion of patients in the group treated with supervised exercises improved-odds ratio 3.2 (1.3 to 7.8). More patients in the shockwave treatment group had additional treatment between 12 and 18 weeks-odds ratio 5.5 (1.3 to 26.4). Conclusion Supervised exercises were more effective than radial extracorporeal shockwave treatment for short term improvement in patients with subacromial shoulder pain.	[Engebretsen, Kaia; Bautz-Holter, Erik; Juel, Niels G.] Ullevaal Univ Hosp, Dept Phys Med & Rehabil, N-0407 Oslo, Norway; [Engebretsen, Kaia; Grotle, Margreth; Bautz-Holter, Erik; Juel, Niels G.; Brox, Jens Ivar] Univ Oslo, Fac Med, Oslo, Norway; [Grotle, Margreth] Ullevaal Univ Hosp, Div Neurosci & Musculoskeletal Med, FORMI, N-0407 Oslo, Norway; [Sandvik, Leiv] Ullevaal Univ Hosp, Epidemiol & Biostat Sect, N-0407 Oslo, Norway; [Brox, Jens Ivar] Univ Oslo, Natl Hosp, Dept Orthopaed, Sect Phys Med & Rehabil, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway	Engebretsen, K (corresponding author), Ullevaal Univ Hosp, Dept Phys Med & Rehabil, Kirkeveien 166, N-0407 Oslo, Norway.	kaiabe@medisin.uio.no	Ekeberg, Ole M/AAL-1478-2021; Brox, Jens Ivar/N-1601-2018		Health Region East, Norway	Health Region East, Norway	The study was supported by Health Region East, Norway.	Balding DJ, 2004, APPL LONGITUDINAL AN; Blaine TA, 2005, J SHOULDER ELB SURG, V14, p84S, DOI 10.1016/j.jse.2004.09.022; Bohmer Audhild S., 1998, Physiotherapy Theory and Practice, V14, P93, DOI 10.3109/09593989809057152; Brox JI, 2003, BEST PRACT RES CL RH, V17, P33, DOI 10.1016/S1521-6942(02)00101-8; BROX JI, 1993, BMJ-BRIT MED J, V307, P899, DOI 10.1136/bmj.307.6909.899; Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Cacchio A, 2006, PHYS THER, V86, P672, DOI 10.1093/ptj/86.5.672; Coghlan JA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005619.pub2; de Vet HCW, 2007, QUAL LIFE RES, V16, P131, DOI 10.1007/s11136-006-9109-9; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Ekeberg OM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-68; Faber E, 2006, J OCCUP REHABIL, V16, P7, DOI 10.1007/s10926-005-9003-2; FRISON L, 1992, STAT MED, V11, P1685, DOI 10.1002/sim.4780111304; Gerdesmeyer L, 2003, JAMA-J AM MED ASSOC, V290, P2573, DOI 10.1001/jama.290.19.2573; Gerdesmeyer L, 2004, J MINER STOFFWECHS, V11, P36; Green S, 1998, BRIT MED J, V316, P354, DOI 10.1136/bmj.316.7128.354; Green S, 2003, Cochrane Database Syst Rev, pCD004258; Guyatt GH, 1998, BRIT MED J, V316, P690, DOI 10.1136/bmj.316.7132.690; Harniman Elaine, 2004, J Hand Ther, V17, P132, DOI 10.1197/j.jht.2004.02.003; Hay EM, 2003, ANN RHEUM DIS, V62, P394, DOI 10.1136/ard.62.5.394; Holm I, 2003, SPINE, V28, P828, DOI 10.1097/00007632-200304150-00017; Lombardi I, 2008, ARTHRIT RHEUM-ARTHR, V59, P615, DOI 10.1002/art.23576; Michener Lori A, 2004, J Hand Ther, V17, P152, DOI 10.1197/j.jht.2004.02.004; PARK HB, 2005, J BONE JOINT SURG AM, V87, P1446, DOI DOI 10.2106/JBJS.D.02335; Roach K E, 1991, Arthritis Care Res, V4, P143, DOI 10.1002/art.1790040403; Schmitt J, 2001, J BONE JOINT SURG BR, V83B, P873, DOI 10.1302/0301-620X.83B6.11591; Speed CA, 2002, J BONE JOINT SURG BR, V84B, P509, DOI 10.1302/0301-620X.84B4.12318; Triffitt PD, 1999, ACTA ORTHOP SCAND, V70, P322, DOI 10.3109/17453679908997817; Tveita EK, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-53; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Vickers Andrew J, 2005, BMC Med Res Methodol, V5, P35, DOI 10.1186/1471-2288-5-35; VIRTA L, 2008, ADV PHYSIOTHER, V11, P1; WILLIAMS JW, 1995, J RHEUMATOL, V22, P727; Zheng XH, 2005, J CLIN EPIDEMIOL, V58, P823, DOI 10.1016/j.jclinepi.2005.01.011	34	57	58	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2009	339								b3360	10.1136/bmj.b3360	http://dx.doi.org/10.1136/bmj.b3360			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RR	19755551	Green Published, hybrid			2022-12-28	WOS:000269994600002
J	Jaddoe, VWV				Jaddoe, Vincent W. V.			Antenatal education programmes: do they work?	LANCET			English	Editorial Material							CHILDBIRTH; RATES		[Jaddoe, Vincent W. V.] Erasmus Univ, Med Ctr, Dept Epidemiol, Generat R Study Grp, NL-3000 CA Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus Univ, Med Ctr, Dept Paediat, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Jaddoe, VWV (corresponding author), Erasmus Univ, Med Ctr, Dept Epidemiol, Generat R Study Grp, NL-3000 CA Rotterdam, Netherlands.	v.jaddoe@erasmusmc.nl						Bergstrom M, 2009, BJOG-INT J OBSTET GY, V116, P1167, DOI 10.1111/j.1471-0528.2009.02144.x; Carroli G, 2001, LANCET, V357, P1565, DOI 10.1016/S0140-6736(00)04723-1; Cyna Allan M, 2006, BMC Pregnancy Childbirth, V6, P5, DOI 10.1186/1471-2393-6-5; Deave Toity, 2008, BMC Pregnancy Childbirth, V8, P30, DOI 10.1186/1471-2393-8-30; Dick-Read Grantly, 1944, CHILDBIRTH FEAR PRIN; Fabian HM, 2005, ACTA OBSTET GYN SCAN, V84, P436, DOI 10.1111/j.0001-6349.2005.00732.x; Gagnon AJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002869.pub2; Lamaze F., 1958, PAINLESS CHILDBIRTH; Su LL, 2007, BMJ-BRIT MED J, V335, P596, DOI 10.1136/bmj.39279.656343.55	9	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					863	864		10.1016/S0140-6736(09)61610-X	http://dx.doi.org/10.1016/S0140-6736(09)61610-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19748386				2022-12-28	WOS:000269943100010
J	Straathof, KC; Rao, K; Eyrich, M; Hale, G; Bird, P; Berrie, E; Brown, L; Adams, S; Schlegel, PG; Goulden, N; Gaspar, HB; Gennery, AR; Landais, P; Davies, EG; Brenner, MK; Veys, PA; Amrolia, PJ				Straathof, Karin C.; Rao, Kanchan; Eyrich, Matthias; Hale, Geoff; Bird, Prudence; Berrie, Eleanor; Brown, Lucinda; Adams, Stuart; Schlegel, Paul G.; Goulden, Nicholas; Gaspar, H. Bobby; Gennery, Andrew R.; Landais, Paul; Davies, E. G.; Brenner, Malcolm K.; Veys, Paul A.; Amrolia, Persis Jal			Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study	LANCET			English	Article							BONE-MARROW-TRANSPLANTATION; SEVERE COMBINED IMMUNODEFICIENCY; TOTAL-BODY IRRADIATION; ACUTE MYELOID-LEUKEMIA; REDUCED-INTENSITY; MONOCLONAL-ANTIBODIES; IMMUNE RECONSTITUTION; UNRELATED DONORS; CYCLOPHOSPHAMIDE; FLUDARABINE	Background Stem-cell transplantation can cure primary immunodeficiencies. However, in patients with pre-existing organ toxicity, patients younger than 1 year, and those with DNA or telomere repair disorders, chemotherapy-based conditioning is poorly tolerated and results in major morbidity and mortality. We tested a novel antibody-based minimal-intensity conditioning (MIC) regimen to assess whether this approach allowed curative donor stem-cell engraftment without non-haemopoietic toxicity. Methods 16 high-risk patients underwent stem-cell transplantation for primary immunodeficiencies with an MIC regimen consisting of two rat anti-CD45 monoclonal antibodies YTH24.5 and YTH 54.12 for myelosuppression, and alemtuzumab (anti-CD52) and fludarabine, and low dose cyclophosphamide for immunosuppression. Donors were matched siblings (n=5), and matched (9) and mismatched (2) unrelated donors. Findings Antibody-based conditioning was well tolerated, with only two cases of grade 3 and no grade 4 toxicity. Rates of clinically significant acute (n=6, 36%) and chronic graft-versus-host disease (GVHD) (n=5, 31%) were acceptable. 15 of 16 patients (94%) engrafted, of whom 11 (69%) achieved full or high-level mixed chimerism in both lymphoid and myeloid lineages, and three achieved engraftment in the T-lymphoid lineage only. One patient needed retransplantation. At a median of 40 months post-transplant, 13 of 16 patients (81%) in this high-risk cohort were alive and cured from their underlying disease. Interpretation Monoclonal antibody-based conditioning seems well tolerated and can achieve curative engraftment even in patients with severe organ toxicity or DNA repair defects, or both. This novel approach represents a shift from the paradigm that intensive chemotherapy or radiotherapy, or both, is needed for donor stem-cell engraftment. This antibody-based conditioning regimen may reduce toxicity and late effects and enable SCT in virtually any primary immunodeficiency patient with a matched donor.	[Amrolia, Persis Jal] Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplantat, London WC1N 3JH, England; [Eyrich, Matthias; Schlegel, Paul G.] Univ Wurzburg, Childrens Hosp, Wurzburg, Germany; [Hale, Geoff; Bird, Prudence; Berrie, Eleanor] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Gennery, Andrew R.] Newcastle Gen Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Landais, Paul] Hop Necker Enfants Malad, Paris, France; [Brenner, Malcolm K.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Wurzburg; University of Oxford; Newcastle General Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Baylor College of Medicine	Amrolia, PJ (corresponding author), Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplantat, Great Ormond St, London WC1N 3JH, England.	amrolp1@gosh.nhs.uk	Eyrich, Matthias/AAU-8273-2020; Brenner, Malcolm/Y-2509-2019	Eyrich, Matthias/0000-0002-8099-5903; Straathof, Karin/0000-0001-9673-8568; Hale, Geoff/0000-0001-9473-423X	IZKF Wuzburg [Z-2/7-28.06.04]; Elfirieda Albert Foundation [257/147/62012 -2006]; National Institute for Health Research [ACF-2007-18-021] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V0904] Funding Source: researchfish	IZKF Wuzburg; Elfirieda Albert Foundation; National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity	IMP (YTH 24.5 and 54.12 monoclonal antibodies) was provided free by the Therapeutic Antibody Centre. Analysis of immune reconstitution (TREC and immunoscope analysis) was supported in part by a programme project grant (Z-2/7-28.06.04) from IZKF Wuzburg to ME and PGS, and by a grant from the Elfirieda Albert Foundation (257/147/62012 -2006) to PGS.	Amrolia P, 2000, BLOOD, V96, P1239, DOI 10.1182/blood.V96.4.1239.h8001239_1239_1246; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; BINDON CI, 1985, TRANSPLANTATION, V40, P538, DOI 10.1097/00007890-198511000-00013; Brazzola P, 2005, BONE MARROW TRANSPL, V36, P1103, DOI 10.1038/sj.bmt.1705171; Buck D, 2006, EUR J IMMUNOL, V36, P224, DOI 10.1002/eji.200535401; Burroughs LM, 2007, BONE MARROW TRANSPL, V40, P633, DOI 10.1038/sj.bmt.1705778; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Dahlke MH, 2002, BLOOD, V99, P3566, DOI 10.1182/blood.V99.10.3566; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Eyrich M, 2003, BONE MARROW TRANSPL, V32, P379, DOI 10.1038/sj.bmt.1704158; Grigg AP, 2007, BIOL BLOOD MARROW TR, V13, P560, DOI 10.1016/j.bbmt.2006.12.449; Heitger A, 2000, TRANSPLANTATION, V69, P2366, DOI 10.1097/00007890-200006150-00026; Jacobsohn DA, 2004, LANCET, V364, P156, DOI 10.1016/S0140-6736(04)16628-2; Khouri IF, 2008, BLOOD, V111, P5530, DOI 10.1182/blood-2008-01-136242; Krance RA, 2003, BIOL BLOOD MARROW TR, V9, P273, DOI 10.1053/bbmt.2003.50024; Matthews DC, 1999, BLOOD, V94, P1237, DOI 10.1182/blood.V94.4.1237.416k34_1237_1247; Niederwieser D, 2003, BLOOD, V101, P1620, DOI 10.1182/blood-2002-05-1340; O'Driscoll M, 2001, MOL CELL, V8, P1175, DOI 10.1016/S1097-2765(01)00408-7; Pagel JM, 2006, BLOOD, V107, P2184, DOI 10.1182/blood-2005-06-2317; PANNETIER C, 1993, P NATL ACAD SCI USA, V90, P4319, DOI 10.1073/pnas.90.9.4319; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rao K, 2005, BLOOD, V105, P879, DOI 10.1182/blood-2004-03-0960; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Rocha V, 1998, BRIT J HAEMATOL, V103, P243, DOI 10.1046/j.1365-2141.1998.00949.x; Satwani P, 2008, PEDIATR BLOOD CANCER, V50, P1, DOI 10.1002/pbc.21303; Small TN, 1999, BLOOD, V93, P467, DOI 10.1182/blood.V93.2.467.402k22_467_480; TIGHE H, 1987, TRANSPLANTATION, V44, P818, DOI 10.1097/00007890-198712000-00020; van der Burg M, 2006, J CLIN INVEST, V116, P137, DOI 10.1172/JCI26121; Veys P, 2005, BONE MARROW TRANSPL, V35, pS45, DOI 10.1038/sj.bmt.1704846; Wulf GG, 2003, BLOOD, V101, P2434, DOI 10.1182/blood-2002-08-2379	30	84	84	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 12	2009	374	9693					912	920		10.1016/S0140-6736(09)60945-4	http://dx.doi.org/10.1016/S0140-6736(09)60945-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496BN	19729196				2022-12-28	WOS:000269943100030
J	Cairns, BR				Cairns, Bradley R.			The logic of chromatin architecture and remodelling at promoters	NATURE			English	Review							HISTONE H2A VARIANT; GENOME-WIDE; SACCHAROMYCES-CEREVISIAE; NUCLEOSOME ORGANIZATION; GENE-EXPRESSION; ACTIVE CHROMATIN; PHO5 PROMOTER; YEAST; TRANSCRIPTION; ACETYLATION	The regulation of gene transcription involves a dynamic balance between packaging regulatory sequences into chromatin and allowing transcriptional regulators access to these sequences. Access is restricted by the nucleosomes, but these can be repositioned or ejected by enzymes known as nucleosome remodellers. In addition, the DNA sequence can impart stiffness or curvature to the DNA, thereby affecting the position of nucleosomes on the DNA, influencing particular promoter 'architectures'. Recent genome-wide studies in yeast suggest that constitutive and regulated genes have architectures that differ in terms of nucleosome position, turnover, remodelling requirements and transcriptional noise.	Univ Utah, Sch Med, Huntsman Canc Inst, Howard Hughes Med Inst,Dept Oncol Sci, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Sch Med, Huntsman Canc Inst, Howard Hughes Med Inst,Dept Oncol Sci, Salt Lake City, UT 84112 USA.	brad.cairns@hci.utah.edu			US National Institutes of Health [GM60415]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060415] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank T. Parnell and C. Clapier for comments and assistance with figures. I am grateful for support from the US National Institutes of Health ( grant GM60415) and the Howard Hughes Medical Institute.	Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Corona DFV, 2002, EMBO REP, V3, P242, DOI 10.1093/embo-reports/kvf056; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; FASCHER KD, 1990, EMBO J, V9, P2523, DOI 10.1002/j.1460-2075.1990.tb07432.x; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Gelbart ME, 2005, GENE DEV, V19, P942, DOI 10.1101/gad.1298905; Grant PA, 1998, TRENDS CELL BIOL, V8, P193, DOI 10.1016/S0962-8924(98)01263-X; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hebbar PB, 2003, CHROMOSOMA, V111, P495, DOI 10.1007/s00412-003-0232-x; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Owen-Hughes T, 2003, BIOCHEM SOC T, V31, P893; Parnell TJ, 2008, EMBO J, V27, P100, DOI 10.1038/sj.emboj.7601946; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Segal E, 2009, CURR OPIN STRUC BIOL, V19, P65, DOI 10.1016/j.sbi.2009.01.004; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Whitehouse I, 2006, NAT STRUCT MOL BIOL, V13, P633, DOI 10.1038/nsmb1111; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036	63	323	330	0	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					193	198		10.1038/nature08450	http://dx.doi.org/10.1038/nature08450			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741699				2022-12-28	WOS:000269654600031
J	Christianson, AL				Christianson, Amy L.			Years of Stories	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Christianson AL, 2002, JAMA-J AM MED ASSOC, V288, P931, DOI 10.1001/jama.288.8.931; Girone JAC, 2004, ARCH PEDIAT ADOL MED, V158, P91, DOI 10.1001/archpedi.158.1.91; Scheetz A, 2000, JAMA-J AM MED ASSOC, V283, P1934, DOI 10.1001/jama.283.15.1934	3	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1042	1042		10.1001/jama.2009.1203	http://dx.doi.org/10.1001/jama.2009.1203			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738080				2022-12-28	WOS:000269616200001
J	Delbanco, T; Albertsen, PC				Delbanco, Tom; Albertsen, Peter C.			A 72-Year-Old Man With Localized Prostate Cancer-14 Years Later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RADICAL PROSTATECTOMY; OUTCOMES; MORTALITY; TRIAL											ALBERTSEN P, 1995, JAMA-J AM MED ASSOC, V274, P69, DOI 10.1001/jama.274.1.69; Albertsen PC, 2005, J NATL CANCER I, V97, P1248, DOI 10.1093/jnci/dji248; Albertsen PC, 2005, JAMA-J AM MED ASSOC, V293, P2095, DOI 10.1001/jama.293.17.2095; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766; FLEMING C, 1993, JAMA-J AM MED ASSOC, V269, P2650, DOI 10.1001/jama.269.20.2650; Hu JC, 2008, J CLIN ONCOL, V26, P2278, DOI 10.1200/JCO.2007.13.4528; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Klotz L, 2006, UROL ONCOL-SEMIN ORI, V24, P46, DOI 10.1016/j.urolonc.2005.07.002; Lu-Yao GL, 2008, JAMA-J AM MED ASSOC, V300, P173, DOI 10.1001/jama.300.2.173; Parker WR, 2009, CURR OPIN UROL, V19, P303, DOI 10.1097/MOU.0b013e328329eb00; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Zelefsky MJ, 2008, EUR UROL, V53, P1172, DOI 10.1016/j.eururo.2007.12.030	16	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1105	1106		10.1001/jama.2009.1281	http://dx.doi.org/10.1001/jama.2009.1281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738095				2022-12-28	WOS:000269616200029
J	Volkow, ND; Wang, GJ; Kollins, SH; Wigal, TL; Newcorn, JH; Telang, F; Fowler, JS; Zhu, W; Logan, J; Ma, YM; Pradhan, K; Wong, C; Swanson, JM				Volkow, Nora D.; Wang, Gene-Jack; Kollins, Scott H.; Wigal, Tim L.; Newcorn, Jeffrey H.; Telang, Frank; Fowler, Joanna S.; Zhu, Wei; Logan, Jean; Ma, Yeming; Pradhan, Kith; Wong, Christopher; Swanson, James M.			Evaluating Dopamine Reward Pathway in ADHD Clinical Implications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; NUCLEUS-ACCUMBENS; COCAINE BINDING; BRAIN DOPAMINE; CHILDREN; REINFORCEMENT; PET; AVAILABILITY; ADOLESCENTS	Context Attention-deficit/hyperactivity disorder (ADHD)-characterized by symptoms of inattention and hyperactivity-impulsivity-is the most prevalent childhood psychiatric disorder that frequently persists into adulthood, and there is increasing evidence of reward-motivation deficits in this disorder. Objective To evaluate biological bases that might underlie a reward/motivation deficit by imaging key components of the brain dopamine reward pathway (mesoaccumbens). Design, Setting, and Participants We used positron emission tomography to measure dopamine synaptic markers (transporters and D-2/D-3 receptors) in 53 nonmedicated adults with ADHD and 44 healthy controls between 2001-2009 at Brookhaven National Laboratory. Main Outcome Measures We measured specific binding of positron emission tomographic radioligands for dopamine transporters (DAT) using [C-11] cocaine and for D-2/D-3 receptors using [C-11]raclopride, quantified as binding potential (distribution volume ratio -1). Results For both ligands, statistical parametric mapping showed that specific binding was lower in ADHD than in controls (threshold for significance set at P < .005) in regions of the dopamine reward pathway in the left side of the brain. Region-of-interest analyses corroborated these findings. The mean (95% confidence interval [CI] of mean difference) for DAT in the nucleus accumbens for controls was 0.71 vs 0.63 for those with ADHD (95% CI, 0.03-0.13, P=.004) and in the midbrain for controls was 0.16 vs 0.09 for those with ADHD ( 95% CI, 0.03-0.12; P <=. 001); for D-2/D-3 receptors, the mean accumbens for controls was 2.85 vs 2.68 for those with ADHD( 95% CI, 0.06-0.30, P=.004); and in the midbrain, it was for controls 0.28 vs 0.18 for those with ADHD ( 95% CI, 0.02-0.17, P=.01). The analysis also corroborated differences in the left caudate: the mean DAT for controls was 0.66 vs 0.53 for those with ADHD ( 95% CI, 0.04-0.22; P=. 003) and the mean D-2/D-3 for controls was 2.80 vs 2.47 for those with ADHD ( 95% CI, 0.10-0.56; P=.005) and differences in D-2/D-3 in the hypothalamic region, with controls having a mean of 0.12 vs 0.05 for those with ADHD (95% CI, 0.02-0.12; P=.004). Ratings of attention correlated with D-2/D-3 in the accumbens (r=0.35; 95% CI, 0.15-0.52; P=.001), midbrain (r=0.35; 95% CI, 0.14-0.52; P=.001), caudate (r=0.32; 95% CI, 0.11-0.50; P=.003), and hypothalamic (r=0.31; CI, 0.10-0.49; P=.003) regions and with DAT in the midbrain (r=0.37; 95% CI, 0.16-0.53; P <= .001). Conclusion A reduction in dopamine synaptic markers associated with symptoms of inattention was shown in the dopamine reward pathway of participants with ADHD. JAMA. 2009;302(10):1084-1091 www.jama.com	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Ma, Yeming] NIAAA, Lab Neuroimaging, Bethesda, MD USA; [Wang, Gene-Jack; Fowler, Joanna S.; Logan, Jean; Pradhan, Kith; Wong, Christopher] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Wang, Gene-Jack; Fowler, Joanna S.; Logan, Jean; Pradhan, Kith; Wong, Christopher] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; [Wang, Gene-Jack; Newcorn, Jeffrey H.; Fowler, Joanna S.] Mt Sinai Med Ctr, Dept Psychiat, New York, NY 10029 USA; [Kollins, Scott H.] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA; [Wigal, Tim L.; Swanson, James M.] Univ Calif Irvine, Child Dev Ctr, Irvine, CA USA; [Zhu, Wei] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; Icahn School of Medicine at Mount Sinai; Duke University; University of California System; University of California Irvine; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Volkow, ND (corresponding author), Natl Inst Drug Abuse, 6001 Execut Blvd,Room 5274,MSC 9581, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov	Kollins, Scott/AAD-6291-2020; Kollins, Scott H/G-2965-2012	Kollins, Scott/0000-0001-6847-6935; Newcorn, Jeffrey/0000-0001-8993-9337; Logan, Jean/0000-0002-6993-9994	Brookhaven National Laboratory (BNL); Intramural Research Program of the National Institutes of Health (NIH) [MH66961-02]; Department of Energy; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA023464] Funding Source: NIH RePORTER	Brookhaven National Laboratory (BNL); Intramural Research Program of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was carried out at Brookhaven National Laboratory (BNL) and was supported in part by grant MH66961-02 from the Intramural Research Program of the National Institutes of Health (NIH), the National Institute of Mental Health and infrastructure support from the Department of Energy.	Agranat-Meged A, 2008, AM J MED GENET B, V147B, P1547, DOI 10.1002/ajmg.b.30842; Barkley R. A., 1998, ATTENTION DEFICIT HY, V2nd; Barkley Russell A, 2004, J Psychiatr Pract, V10, P39, DOI 10.1097/00131746-200401000-00005; Booth JR, 2005, J CHILD PSYCHOL PSYC, V46, P94, DOI 10.1111/j.1469-7610.2004.00337.x; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Castellanos FX, 2001, ARCH GEN PSYCHIAT, V58, P289, DOI 10.1001/archpsyc.58.3.289; Castellanos FX, 1996, ARCH GEN PSYCHIAT, V53, P607; Conners CK, 1998, J CLIN PSYCHIAT, V59, P24; Cortese S, 2006, SLEEP, V29, P504; Cortese S, 2008, MED HYPOTHESES, V71, P770, DOI 10.1016/j.mehy.2008.06.017; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dopheide JA, 2009, PHARMACOTHERAPY, V29, P656, DOI 10.1592/phco.29.6.656; Elkins IJ, 2007, ARCH GEN PSYCHIAT, V64, P1145, DOI 10.1001/archpsyc.64.10.1145; Ernst M, 1999, AM J PSYCHIAT, V156, P1209; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; FOWLER JS, 1989, SYNAPSE, V4, P371, DOI 10.1002/syn.890040412; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; GATLEY SJ, 1995, SYNAPSE, V20, P137, DOI 10.1002/syn.890200207; Gjedde A, 2005, INT REV NEUROBIOL, V63, P1, DOI 10.1016/S0074-7742(05)63001-2; Gurevich EV, 1999, NEUROPSYCHOPHARMACOL, V20, P60, DOI 10.1016/S0893-133X(98)00066-9; Guy W., 2000, HDB PSYCHIAT MEASURE, V1st; HAENLEIN M, 1987, J AM ACAD CHILD PSY, V26, P356, DOI 10.1097/00004583-198705000-00014; Johansen EB, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-7; Jucaite A, 2005, BIOL PSYCHIAT, V57, P229, DOI 10.1016/j.biopsych.2004.11.009; King JA, 1998, BIOL PSYCHIAT, V44, P72, DOI 10.1016/S0006-3223(97)00507-6; Kollins SH, 1997, PSYCHOL REC, V47, P25, DOI 10.1007/BF03395211; Kupfer DJ, 2000, J AM ACAD CHILD PSY, V39, P182, DOI 10.1097/00004583-200002000-00018; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lopez-Larson M, 2009, J CHILD ADOL PSYCHOP, V19, P31, DOI 10.1089/cap.2008.041; Lou HC, 2004, DEV MED CHILD NEUROL, V46, P179; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Neto PR, 2002, ANN NY ACAD SCI, V965, P434; Plichta MM, 2009, BIOL PSYCHIAT, V65, P7, DOI 10.1016/j.biopsych.2008.07.008; Qiu AQ, 2009, AM J PSYCHIAT, V166, P74, DOI 10.1176/appi.ajp.2008.08030426; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Sparrow E., 1999, ADULT ADHD RATING SC; Spencer TJ, 2007, BIOL PSYCHIAT, V62, P1059, DOI 10.1016/j.biopsych.2006.12.008; Strohle A, 2008, NEUROIMAGE, V39, P966, DOI 10.1016/j.neuroimage.2007.09.044; Swanson J, 2001, CLIN NEUROSCI RES, V1, P207, DOI 10.1016/S1566-2772(01)00007-X; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; Vaidya CJ, 2005, AM J PSYCHIAT, V162, P1605, DOI 10.1176/appi.ajp.162.9.1605; van Dyck CH, 2002, AM J PSYCHIAT, V159, P309, DOI 10.1176/appi.ajp.159.2.309; VOLKOW ND, 1995, J NUCL MED, V36, P1289; VOLKOW ND, 1993, J NUCL MED, V34, P609; Volkow ND, 2004, AM J PSYCHIAT, V161, P1173, DOI 10.1176/appi.ajp.161.7.1173; Volkow ND, 2007, ARCH GEN PSYCHIAT, V64, P932, DOI 10.1001/archpsyc.64.8.932; Volkow ND, 2007, NEUROIMAGE, V34, P1182, DOI 10.1016/j.neuroimage.2006.10.014; Waring ME, 2008, PEDIATRICS, V122, pE1, DOI 10.1542/peds.2007-1955; Winstanley CA, 2006, CLIN PSYCHOL REV, V26, P379, DOI 10.1016/j.cpr.2006.01.001; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Young DJ, 2009, CHILD PSYCHIAT HUM D, V40, P543, DOI 10.1007/s10578-009-0143-z; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9	57	394	398	6	84	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1084	1091		10.1001/jama.2009.1308	http://dx.doi.org/10.1001/jama.2009.1308			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491XH	19738093	Green Accepted, Bronze			2022-12-28	WOS:000269616200026
J	Hall, HE; Hawley, RS				Hall, Heather E.; Hawley, R. Scott			The Hows and Ys of Genome Integrity	CELL			English	Editorial Material							CHROMOSOME	Much of the Y chromosome consists of large palindromic arrays harboring genes that are critical for spermatogenesis. In this issue, Lange et al. (2009) show that although gene conversion within these arrays maintains their integrity, it also permits rare unequal sister chromatid-exchange events within palindromes that create unstable dicentric chromosomes, resulting in infertility, sex reversal, and Turner syndrome.	[Hall, Heather E.; Hawley, R. Scott] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Hawley, R. Scott] Univ Kansas, Med Ctr, Dept Physiol, Kansas City, KS 66160 USA; [Hawley, R. Scott] Amer Canc Soc, Atlanta, GA 30329 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; American Cancer Society	Hawley, RS (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	rsh@stowers.org		Hawley, R. Scott/0000-0002-6478-0494				Aitken RJ, 2002, NATURE, V415, P963, DOI 10.1038/415963a; Guedes AD, 2006, AM J MED GENET A, V140A, P1871, DOI 10.1002/ajmg.a.31363; Jacobs P, 1997, ANN HUM GENET, V61, P471, DOI 10.1017/S0003480097006507; Lahn BT, 2001, NAT REV GENET, V2, P207, DOI 10.1038/35056058; Page SL, 1998, CHROMOSOME RES, V6, P115, DOI 10.1023/A:1009286929145; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Wilson MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000568	7	3	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					830	832		10.1016/j.cell.2009.08.022	http://dx.doi.org/10.1016/j.cell.2009.08.022			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737510	Bronze			2022-12-28	WOS:000269564600008
J	Martinez-Hackert, E; Hendrickson, WA				Martinez-Hackert, Erik; Hendrickson, Wayne A.			Promiscuous Substrate Recognition in Folding and Assembly Activities of the Trigger Factor Chaperone	CELL			English	Article							RIBOSOMAL-PROTEIN S7; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; TRANSLATING RIBOSOMES; NASCENT POLYPEPTIDES; ISOMERASE ACTIVITY; FOLDED PROTEIN; DNAK; CHAINS; IDENTIFICATION	Trigger factor (TF) is a molecular chaperone that binds to bacterial ribosomes where it contacts emerging nascent chains, but TF is also abundant free in the cytosol where its activity is less well characterized. In vitro studies show that TF promotes protein refolding. We find here that ribosome-free TF stably associates with and rescues from misfolding a large repertoire of full-length proteins. We identify over 170 members of this cytosolic Escherichia coli TF substrate proteome, including ribosomal protein S7. We analyzed the biochemical properties of a TF: S7 complex from Thermotoga maritima and determined its crystal structure. Thereby, we obtained an atomic-level picture of a promiscuous chaperone in complex with a physiological substrate protein. The structure of the complex reveals the molecular basis of substrate recognition by TF, indicates how TF could accelerate protein folding, and suggests a role for TF in the biogenesis of protein complexes.	[Martinez-Hackert, Erik; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	wayne@convex.hhmi.columbia.edu		Martinez-Hackert, Erik/0000-0002-6182-7023	Lymphoma Society of America; Jane Elissa/Charlotte Meyers Endowment Fund; NIH [GM34102]; National Synchrotron Light Source (NSLS); New York Structural Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034102, R37GM034102] Funding Source: NIH RePORTER	Lymphoma Society of America; Jane Elissa/Charlotte Meyers Endowment Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Synchrotron Light Source (NSLS); New York Structural Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to M. Floer and C. J. Lusty for comments. We thank M. A. Gawinowicz for mass spectrometry; T. Mareeva and Y. Sykulev for Biacore measurements; H. Bernstein, P. Genevaux, C. Georgoplous, and F. U. Hartl for strains; P. Genevaux for anti-TF; G. Boel, R. Gonzales, J. Hunt, and A. Tzagoloff for help with polysome fractionation; M. Babu, A. Emili, and J. Greenblatt for TAP-tag TF data; and N. Belgado, J. Cheung, M. Collins, A. Duran, Q. Fan, G. Gregorio, J. Lidestri, Q. Liu, A. Korkut, A. Marina, C. Min, J. Moore, H. Xie, R. Xu, and Z. Zhang for assistance. This work was supported in part by fellowships from the Leukemia and Lymphoma Society of America (E.M.- H.) and the Jane Elissa/Charlotte Meyers Endowment Fund (E.M.- H.) and by NIH grant GM34102 (W. A. H.). Beamline X4A at the National Synchrotron Light Source (NSLS) is supported by the New York Structural Biology Center.	Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; CROOKE E, 1987, P NATL ACAD SCI USA, V84, P5216, DOI 10.1073/pnas.84.15.5216; CROOKE E, 1988, CELL, V54, P1003, DOI 10.1016/0092-8674(88)90115-8; Davis FP, 2005, BIOINFORMATICS, V21, P1901, DOI 10.1093/bioinformatics/bti277; DEAN D, 1981, CELL, V24, P413, DOI 10.1016/0092-8674(81)90331-7; Deuerling E, 2003, MOL MICROBIOL, V47, P1317, DOI 10.1046/j.1365-2958.2003.03370.x; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Ellis RJ, 2006, TRENDS BIOCHEM SCI, V31, P395, DOI 10.1016/j.tibs.2006.05.001; ELLIS RJ, 1994, CURR BIOL, V4, P633; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Ferbitz L, 2004, NATURE, V431, P590, DOI 10.1038/nature02899; Fredrick K, 2000, J MOL BIOL, V298, P379, DOI 10.1006/jmbi.2000.3563; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Hage AE, 2004, MOL MICROBIOL, V51, P189, DOI 10.1046/j.1365-2958.2003.03813.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; Hoffmann A, 2006, J BIOL CHEM, V281, P6539, DOI 10.1074/jbc.M512345200; Huang GC, 2000, PROTEIN SCI, V9, P1254, DOI 10.1110/ps.9.6.1254; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kandror O, 1997, P NATL ACAD SCI USA, V94, P4978, DOI 10.1073/pnas.94.10.4978; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lee HC, 2002, J BIOL CHEM, V277, P43527, DOI 10.1074/jbc.M205950200; Li ZY, 2001, FEBS LETT, V506, P108, DOI 10.1016/S0014-5793(01)02896-4; LILL R, 1988, CELL, V54, P1013, DOI 10.1016/0092-8674(88)90116-X; Liu CP, 2005, J BIOL CHEM, V280, P13315, DOI 10.1074/jbc.M414151200; Liu CP, 2004, BIOCHEM BIOPH RES CO, V313, P509, DOI 10.1016/j.bbrc.2003.11.142; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Maier R, 2001, J MOL BIOL, V314, P1181, DOI 10.1006/jmbi.2000.5192; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Martinez-Hackert E, 2007, ACTA CRYSTALLOGR D, V63, P536, DOI 10.1107/S090744490700964X; Merz F, 2008, EMBO J, V27, P1622, DOI 10.1038/emboj.2008.89; Merz F, 2006, J BIOL CHEM, V281, P31963, DOI 10.1074/jbc.M605164200; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Patzelt H, 2001, P NATL ACAD SCI USA, V98, P14244, DOI 10.1073/pnas.261432298; Raine A, 2006, J BIOL CHEM, V281, P28033, DOI 10.1074/jbc.M605753200; Rutkowska A, 2008, J BIOL CHEM, V283, P4124, DOI 10.1074/jbc.M708294200; Scholz C, 1997, EMBO J, V16, P54, DOI 10.1093/emboj/16.1.54; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; STOLLER G, 1995, EMBO J, V14, P4939, DOI 10.1002/j.1460-2075.1995.tb00177.x; Takagi F, 2003, P NATL ACAD SCI USA, V100, P11367, DOI 10.1073/pnas.1831920100; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Tomic S, 2006, FEBS LETT, V580, P72, DOI 10.1016/j.febslet.2005.11.050; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Wadell H, 1935, J GEOL, V43, P250, DOI 10.1086/624298	58	113	116	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					923	934		10.1016/j.cell.2009.07.044	http://dx.doi.org/10.1016/j.cell.2009.07.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737520	Bronze, Green Accepted			2022-12-28	WOS:000269564600018
J	Norman, MR				Norman, Michael R.			Chasing Arcs in Cuprate Superconductors	SCIENCE			English	Editorial Material							T-C SUPERCONDUCTOR; FERMI-SURFACE; BI2SR2CACU2O8+DELTA; PSEUDOGAP; EVOLUTION; STATE		Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA	United States Department of Energy (DOE); Argonne National Laboratory	Norman, MR (corresponding author), Argonne Natl Lab, Div Mat Sci, 9700 S Cass Ave, Argonne, IL 60439 USA.	norman@anl.gov	Norman, Michael R/C-3644-2013	Norman, Michael R/0000-0002-9459-078X				Chang J, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/10/103016; Doiron-Leyraud N, 2007, NATURE, V447, P565, DOI 10.1038/nature05872; Hufner S, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/6/062501; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Lee J, 2009, SCIENCE, V325, P1099, DOI 10.1126/science.1176369; Marshall DS, 1996, PHYS REV LETT, V76, P4841, DOI 10.1103/PhysRevLett.76.4841; Norman MR, 1998, NATURE, V392, P157, DOI 10.1038/32366; Pan SH, 2001, NATURE, V413, P282, DOI 10.1038/35095012; Pushp A, 2009, SCIENCE, V324, P1689, DOI 10.1126/science.1174338; Sebastian SE, 2008, NATURE, V454, P200, DOI 10.1038/nature07095; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Yang HB, 2008, NATURE, V456, P77, DOI 10.1038/nature07400	13	4	4	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 28	2009	325	5944					1080	1081		10.1126/science.1178841	http://dx.doi.org/10.1126/science.1178841			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713514				2022-12-28	WOS:000269382300025
J	Pearson, PN; Foster, GL; Wade, BS				Pearson, Paul N.; Foster, Gavin L.; Wade, Bridget S.			Atmospheric carbon dioxide through the Eocene-Oligocene climate transition	NATURE			English	Article							BORON ISOTOPE; ANTARCTIC GLACIATION; SEAWATER; EVOLUTION; CYCLE; SEA; CALIBRATION; GREENHOUSE; BOUNDARY; RECORD	Geological and geochemical evidence(1-3) indicates that the Antarctic ice sheet formed during the Eocene-Oligocene transition(4), 33.5-34.0 million years ago. Modelling studies(5,6) suggest that such ice-sheet formation might have been triggered when atmospheric carbon dioxide levels (p(CO2)(atm)) fell below a critical threshold of similar to 750 p. p. m. v., but the timing and magnitude of p(CO2)(atm) relative to the evolution of the ice sheet has remained unclear. Here we use the boron isotope pH proxy(7,8) on exceptionally well-preserved carbonate microfossils from a recently discovered geological section in Tanzania(9,10) to estimate p(CO2)(atm) before, during and after the climate transition. Our data suggest that a reduction in p(CO2)(atm) occurred before the main phase of ice growth, followed by a sharp recovery to pre-transition values and then a more gradual decline. During maximum ice-sheet growth, p(CO2)(atm) was between similar to 450 and similar to 1,500 p. p. m. v., with a central estimate of similar to 760 p. p. m. v. The ice cap survived the period of p(CO2)(atm) recovery, although possibly with some reduction in its volume, implying (as models predict(11)) a nonlinear response to climate forcing during melting. Overall, our results confirm the central role of declining p(CO2)(atm) in the development of the Antarctic ice sheet (in broad agreement with carbon cycle modelling(12)) and help to constrain mechanisms and feedbacks associated with the Earth's biggest climate switch of the past 65 Myr.	[Pearson, Paul N.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, Wales; [Foster, Gavin L.] Univ Bristol, Dept Earth Sci, Bristol Isotope Grp, Bristol BS8 1RJ, Avon, England; [Wade, Bridget S.] Texas A&M Univ, Dept Geol & Geophys, College Stn, TX 77843 USA	Cardiff University; University of Bristol; Texas A&M University System; Texas A&M University College Station	Pearson, PN (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3YE, Wales.	pearsonp@cardiff.ac.uk	Foster, Gavin/CAF-4654-2022; Wade, Bridget S/F-4987-2014; Foster, Gavin/W-5968-2019; Pearson, Paul N/B-2276-2009	Foster, Gavin/0000-0003-3688-9668; Wade, Bridget S/0000-0002-7245-8614; Pearson, Paul N/0000-0003-4628-9818	NERC	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NERC grants to P. N. P., B. S. W. and G. L. F. We thank the Tanzania Petroleum Development Corporation, the Tanzania Commission for Science and Technology and the Tanzania Drilling Project field team for support. We are grateful to T. Elliott for discussions.	Anand P, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000846; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Barrett P, 2009, DEV EARTH ENV SCI, V8, P33, DOI 10.1016/S1571-9197(08)00003-7; Bo S, 2009, NATURE, V459, P690, DOI 10.1038/nature08024; CANDE SC, 1995, J GEOPHYS RES-SOL EA, V100, P6093, DOI 10.1029/94JB03098; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; COXALL HK, 2007, MICROPALAEONTOLOGICA, P351; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto RM, 2008, NATURE, V455, P652, DOI 10.1038/nature07337; DICKSON AG, 1990, DEEP-SEA RES, V37, P755, DOI 10.1016/0198-0149(90)90004-F; Eldrett JS, 2009, NATURE, V459, P969, DOI 10.1038/nature08069; Foster GL, 2008, EARTH PLANET SC LETT, V271, P254, DOI 10.1016/j.epsl.2008.04.015; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; HEMMING NG, 1992, GEOCHIM COSMOCHIM AC, V56, P537, DOI 10.1016/0016-7037(92)90151-8; Horita J, 2002, GEOCHIM COSMOCHIM AC, V66, P3733, DOI 10.1016/S0016-7037(01)00884-5; Katz ME, 2008, NAT GEOSCI, V1, P329, DOI 10.1038/ngeo179; KENNETT JP, 1976, NATURE, V260, P513, DOI 10.1038/260513a0; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Klochko K, 2006, EARTH PLANET SC LETT, V248, P276, DOI 10.1016/j.epsl.2006.05.034; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Lemarchand D, 2002, CHEM GEOL, V190, P123, DOI 10.1016/S0009-2541(02)00114-6; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Merico A, 2008, NATURE, V452, P979, DOI 10.1038/nature06853; Nicholas CJ, 2006, J AFR EARTH SCI, V45, P431, DOI 10.1016/j.jafrearsci.2006.04.003; Palike H, 2006, SCIENCE, V314, P1894, DOI 10.1126/science.1133822; Pagani M, 2005, SCIENCE, V309, P600, DOI 10.1126/science.1110063; Pearson PN, 2008, GEOLOGY, V36, P179, DOI 10.1130/G24308A.1; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Pollard D, 2005, GLOBAL PLANET CHANGE, V45, P9, DOI 10.1016/j.gloplacha.2004.09.011; Rea DK, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001064; Salamy KA, 1999, PALAEOGEOGR PALAEOCL, V145, P61, DOI 10.1016/S0031-0182(98)00093-5; Simon L, 2006, CHEM GEOL, V225, P61, DOI 10.1016/j.chemgeo.2005.08.011; Tyrrell T, 2004, GEOCHIM COSMOCHIM AC, V68, P3521, DOI 10.1016/j.gca.2004.02.018; Wade BS, 2008, MAR MICROPALEONTOL, V68, P244, DOI 10.1016/j.marmicro.2008.04.002; WILKINSON BH, 1989, AM J SCI, V289, P1158, DOI 10.2475/ajs.289.10.1158; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571	38	275	291	4	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 22	2009	461	7267					1110	U204		10.1038/nature08447	http://dx.doi.org/10.1038/nature08447			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509BU	19749741				2022-12-28	WOS:000270987600041
J	Williams, TN; Uyoga, S; Macharia, A; Ndila, C; McAuley, CF; Opi, DH; Mwarumba, S; Makani, J; Komba, A; Ndiritu, MN; Sharif, SK; Marsh, K; Berkley, JA; Scott, JAG				Williams, Thomas N.; Uyoga, Sophie; Macharia, Alex; Ndila, Carolyne; McAuley, Charlotte F.; Opi, Daniel H.; Mwarumba, Salim; Makani, Julie; Komba, Albert; Ndiritu, Moses N.; Sharif, Shahnaaz K.; Marsh, Kevin; Berkley, James A.; Scott, J. Anthony G.			Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study	LANCET			English	Article							INFLUENZAE TYPE-B; PNEUMOCOCCAL-POLYSACCHARIDE IMMUNIZATION; ACUTE BACTERIAL-MENINGITIS; CONJUGATE VACCINE; ANTIBIOTIC-RESISTANCE; KILIFI DISTRICT; DISEASE; INFECTION; MALARIA; AFRICA	Background in sub-Saharan Africa, more than 90% of children with sickle-cell anaemia die before the diagnosis can be made. The causes of death are poorly documented, but bacterial sepsis is probably important. We examined the risk of invasive bacterial diseases in children with sickle-cell anaemia. Methods This study was undertaken in a rural area on the coast of Kenya, with a case-control approach. We undertook blood cultures on all children younger than 14 years who were admitted from within a defined study area to Kilifi District Hospital between Aug 1, 1998, and March 31, 2008; those with bacteraemia were defined as cases. We used two sets of controls: children recruited by random sampling in the same area into several studies undertaken between Sept 1, 1998, and Nov 30, 2005; and those born consecutively within the area between May 1, 2006, and April 30, 2008. Cases and controls were tested for sickle-cell anaemia retrospectively. Findings We detected 2157 episodes of bacteraemia in 38 441 admissions (6%). 1749 of these children with bacteraemia (81%) were typed for sickle-cell anaemia, of whom 108 (6%) were positive as were 89 of 13 492 controls (1%). The organisms most commonly isolated from children with sickle-cell anaemia were Streptococcus pneumoniae (44/108 isolates; 41%), non-typhi Salmonella species (19/108; 18%), Haemophilus influenzae type b (13/108; 12%), Acinetobacter species (seven of 108; 7%), and Escherichia coli (seven of 108; 7%). The age-adjusted odds ratio for bacteraemia in children with sickle-cell anaemia was 26.3 (95% CI 14.5-47.6), with the strongest associations for S pneumoniae (33.0, 17.4-62.8), non-typhi Salmonella species (35.5, 16.4-76.8), and H influenzae type b (28.1, 12.0-65.9). Interpretation The organisms causing bacteraemia in African children with sickle-cell anaemia are the same as those in developed countries. introduction of conjugate vaccines against S pneumoniae and H influenzae into the childhood immunisation schedules of African countries could substantially affect survival of children with sickle-cell anaemia.	[Williams, Thomas N.] KEMRI Wellcome Trust Programme, Ctr Geog Med Res Coast, Kilifi, Kenya; [Williams, Thomas N.; Marsh, Kevin; Berkley, James A.; Scott, J. Anthony G.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Williams, Thomas N.; McAuley, Charlotte F.] Univ Oxford, Dept Paediat, Oxford, England; [Williams, Thomas N.; Scott, J. Anthony G.] INDEPTH Network Demog Surveillance Sites, Accra, Ghana; [Makani, Julie; Komba, Albert] Muhimbili Univ Coll Hlth Sci, Dar Es Salaam, Tanzania; [Sharif, Shahnaaz K.] Minist Hlth, Nairobi, Kenya	University of Oxford; University of Oxford; INDEPTH Network; Muhimbili University of Health & Allied Sciences	Williams, TN (corresponding author), KEMRI Wellcome Trust Programme, Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.	twilliams@kilifi.kemri-wellcome.org	Makani, Julie/E-8525-2017; Makani, Julie/N-9370-2013	Makani, Julie/0000-0002-4801-6250; Makani, Julie/0000-0002-4801-6250; Berkley, James/0000-0002-1236-849X; Uyoga, Sophie/0000-0003-1746-7873	Kenya Medical Research Institute (KEMRI); Wellcome Trust, UK [076934, 072064, 077092, 083579, 081835]; EU; Bill & Melinda Gates Foundation	Kenya Medical Research Institute (KEMRI); Wellcome Trust, UK(Wellcome Trust); EU(European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This study was supported by the Kenya Medical Research Institute (KEMRI) and the Wellcome Trust, UK. TNW is supported by the Wellcome Trust (grant number 076934), the EU Network 6 BioMalpar Consortium, and the MalariaGen Consortium funded by the Bill & Melinda Gates Foundation. JM (grant number 072064), KM (grant number 077092), JAB (grant number 083579), and JAGS (grant number 081835) are supported by the Wellcome Trust, UK. We thank the patients and staff of Kilifi District Hospital and the KEM RI/Wellcome Trust Centre for their support with this study; Emily Orori, Adan Mohammed, Metrine Tendwa, and Johnstone Makale for laboratory support; Hussein Kivugo, Emmanuel Mabibo, Gideon Nyutu, and other members of the Genetics Team for field work and data management; and David Weatherall, Bob Snow, Charles Newton, and Kathryn Maitland for helpful comments on earlier drafts. This paper is published with the permission of the Director of the Kenya Medical Research Institute (KEMRI).	Adamkiewicz TV, 2003, J PEDIATR-US, V143, P438, DOI 10.1067/S0022-3476(03)00331-7; Aken'ova Y. A., 1998, Central African Journal of Medicine, V44, P102; AKINYANJU O, 1987, ANN TROP PAEDIATR, V7, P181, DOI 10.1080/02724936.1987.11748503; Akuse RM, 1996, J TROP PEDIATRICS, V42, P318, DOI 10.1093/tropej/42.6.318; AMMANN AJ, 1977, NEW ENGL J MED, V297, P897, DOI 10.1056/NEJM197710272971701; BARRETTCONNOR E, 1971, MEDICINE, V50, P97, DOI 10.1097/00005792-197103000-00002; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; DIGGS L. W., 1967, CLIN ORTHOP RELATED RES, V52, P119, DOI 10.1097/00003086-196700520-00011; EECKELS R, 1967, NATURE, V216, P382, DOI 10.1038/216382a0; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Goldblatt D, 1996, ARCH DIS CHILD, V75, P159, DOI 10.1136/adc.75.2.159; HODGES FJ, 1951, YB RADIOLOGY, P89; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kizito ME, 2007, ARCH DIS CHILD, V92, P21, DOI 10.1136/adc.2005.088807; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; MOLINEAUX L, 1979, ANN TROP MED PARASIT, V73, P301, DOI 10.1080/00034983.1979.11687263; Mwangi I, 2002, PEDIATR INFECT DIS J, V21, P1042, DOI 10.1097/00006454-200211000-00013; Mwangi TW, 2005, J INFECT DIS, V191, P1932, DOI 10.1086/430006; Ndiritu M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-132; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; OKUONGHAE HO, 1993, ANN TROP PAEDIATR, V13, P55, DOI 10.1080/02724936.1993.11747625; OVERTURF GD, 1982, AM J PEDIAT HEMATOL, V4, P25; POWARS D, 1983, PEDIATRICS, V71, P927; ROBINSON MG, 1966, NEW ENGL J MED, V274, P1006, DOI 10.1056/NEJM196605052741806; RUBIN LG, 1992, AM J DIS CHILD, V146, P340, DOI 10.1001/archpedi.1992.02160150080026; Serjeant GR, 2005, BRIT MED J, V330, P432, DOI 10.1136/bmj.330.7489.432; SMITH W S, 1953, Ohio State Med J, V49, P692; VANDEPITTE J, 1953, Ann Soc Belg Med Trop (1920), V33, P511; Waterfall CM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e119; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Wright J, 1997, J PEDIATR-US, V130, P394, DOI 10.1016/S0022-3476(97)70201-4; ZARKOWSKY HS, 1986, J PEDIATR-US, V109, P579, DOI 10.1016/S0022-3476(86)80216-5	36	161	161	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 17	2009	374	9698					1364	1370		10.1016/S0140-6736(09)61374-X	http://dx.doi.org/10.1016/S0140-6736(09)61374-X			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	512MW	19747721	Green Accepted, Green Published			2022-12-28	WOS:000271254600032
J	Peltzer, K				Peltzer, Karl			Traditional health practitioners in South Africa	LANCET			English	Editorial Material							HEALERS; MEDICINE		[Peltzer, Karl] Human Sci Res Council, ZA-0001 Pretoria, Gauteng Prov, South Africa; [Peltzer, Karl] Univ Free State, Dept Psychol, Bloemfontein, Free State Prov, South Africa	Human Sciences Research Council-South Africa; University of the Free State	Peltzer, K (corresponding author), Human Sci Res Council, ZA-0001 Pretoria, Gauteng Prov, South Africa.	kpeltzer@hsrc.ac.za	Peltzer, Karl/Q-7334-2019	Peltzer, Karl/0000-0002-5980-0876				Colvin M, 2003, INT J TUBERC LUNG D, V7, pS86; Devenish A, 2005, SOC DYNAMICS, V31, P243, DOI 10.1080/02533950508628715; Ensink K., 1999, TRANSCULT PSYCHIATRY, V36, P23, DOI [DOI 10.1177/13634615990, 10.1177/136346159903600102, DOI 10.1177/136346159903600102]; Gqaleni N., 2007, S AFR HLTH REV, V2007, P175; Kahn M.S., 2001, TRANSCULT PSYCHIATRY, V38, P35, DOI DOI 10.1177/136346150103800104; Meissner O, 2004, SAMJ S AFR MED J, V94, P901; Owira PMO, 2009, PHYTOTHER RES, V23, P147, DOI 10.1002/ptr.2595; PELTZER K, 2006, S AFRI J OBSTET GYNA, V16, P74; Peltzer K, 2006, AIDS BEHAV, V10, P683, DOI 10.1007/s10461-006-9110-x; Peltzer K, 2009, AFR J TRADIT COMPLEM, V6, P175; Sorsdahl K, 2009, J NERV MENT DIS, V197, P434, DOI 10.1097/NMD.0b013e3181a61dbc; 2008, GOVT GAZETTE    0110	12	25	26	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 19	2009	374	9694					956	957		10.1016/S0140-6736(09)61261-7	http://dx.doi.org/10.1016/S0140-6736(09)61261-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	498PK	19709734				2022-12-28	WOS:000270154100007
J	Tachibana, M; Sparman, M; Sritanaudomchai, H; Ma, H; Clepper, L; Woodward, J; Li, Y; Ramsey, C; Kolotushkina, O; Mitalipov, S				Tachibana, Masahito; Sparman, Michelle; Sritanaudomchai, Hathaitip; Ma, Hong; Clepper, Lisa; Woodward, Joy; Li, Ying; Ramsey, Cathy; Kolotushkina, Olena; Mitalipov, Shoukhrat			Mitochondrial gene replacement in primate offspring and embryonic stem cells	NATURE			English	Article							NEURODEGENERATIVE DISEASES; OXIDATIVE STRESS; DNA MUTATIONS; OOPLASMIC TRANSPLANTATION; GENOTYPE SEGREGATION; NUCLEAR TRANSFER; HUMAN OOCYTES; DONOR OOCYTE; DYSFUNCTION; MTDNA	Mitochondria are found in all eukaryotic cells and contain their own genome (mitochondrial DNA or mtDNA). Unlike the nuclear genome, which is derived from both the egg and sperm at fertilization, the mtDNA in the embryo is derived almost exclusively from the egg; that is, it is of maternal origin. Mutations in mtDNA contribute to a diverse range of currently incurable human diseases and disorders. To establish preclinical models for new therapeutic approaches, we demonstrate here that the mitochondrial genome can be efficiently replaced in mature non-human primate oocytes (Macaca mulatta) by spindle-chromosomal complex transfer from one egg to an enucleated, mitochondrial-replete egg. The reconstructed oocytes with the mitochondrial replacement were capable of supporting normal fertilization, embryo development and produced healthy offspring. Genetic analysis confirmed that nuclear DNA in the three infants born so far originated from the spindle donors whereas mtDNA came from the cytoplast donors. No contribution of spindle donor mtDNA was detected in offspring. Spindle replacement is shown here as an efficient protocol replacing the full complement of mitochondria in newly generated embryonic stem cell lines. This approach may offer a reproductive option to prevent mtDNA disease transmission in affected families.	[Tachibana, Masahito; Sparman, Michelle; Sritanaudomchai, Hathaitip; Ma, Hong; Clepper, Lisa; Woodward, Joy; Li, Ying; Ramsey, Cathy; Kolotushkina, Olena; Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Beaverton, OR 97006 USA; [Mitalipov, Shoukhrat] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Beaverton, OR 97006 USA	Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Mitalipov, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, 505 NW 185th Ave, Beaverton, OR 97006 USA.	mitalipo@ohsu.edu			Oregon National Primate Research Center; Oregon Stem Cell Center; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057121] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD047675] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR013632, P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044330] Funding Source: NIH RePORTER	Oregon National Primate Research Center; Oregon Stem Cell Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge the Division of Animal Resources, Surgical Team, Endocrine Technology Core, Imaging & Morphology Core and Molecular & Cellular Biology Core at the Oregon National Primate Research Center for providing expertise and services that contributed to this project. We are grateful to W. Sanger and M. Nelson for karyotyping services, C. Penedo for microsatellite analysis and S. Wong for providing Sendai virus. We thank J. Hennebold, R. Stouffer and D. Wolf for consulting, helpful discussions and critical reading of the manuscript. This study was supported by start-up funds from Oregon National Primate Research Center, Oregon Stem Cell Center and grants from the National Institutes of Health.	Barritt JA, 2001, HUM REPROD, V16, P513, DOI 10.1093/humrep/16.3.513; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Brenner CA, 2000, FERTIL STERIL, V74, P573, DOI 10.1016/S0015-0282(00)00681-6; Brown DT, 2006, LANCET, V368, P87, DOI 10.1016/S0140-6736(06)68972-1; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Cohen J, 1997, LANCET, V350, P186, DOI 10.1016/S0140-6736(05)62353-7; Cohen J, 1998, MOL HUM REPROD, V4, P269, DOI 10.1093/molehr/4.3.269; Cree LM, 2008, NAT GENET, V40, P249, DOI 10.1038/ng.2007.63; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Lanzendorf SE, 1999, FERTIL STERIL, V71, P575, DOI 10.1016/S0015-0282(98)00504-4; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Majamaa K, 1998, AM J HUM GENET, V63, P447, DOI 10.1086/301959; Meirelles FV, 1998, GENETICS, V148, P877; Meirelles FV, 1997, GENETICS, V145, P445; Mitalipov SM, 2007, HUM REPROD, V22, P2232, DOI 10.1093/humrep/dem136; Moraes CT, 2003, J MOL DIAGN, V5, P197, DOI 10.1016/S1525-1578(10)60474-6; Poulton J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b94; Reeve AK, 2008, ANN NY ACAD SCI, V1147, P21, DOI 10.1196/annals.1427.016; Roberts RM, 1999, AM J MED GENET, V87, P265, DOI 10.1002/(SICI)1096-8628(19991126)87:3<265::AID-AJMG14>3.0.CO;2-S; Sato A, 2005, P NATL ACAD SCI USA, V102, P16765, DOI 10.1073/pnas.0506197102; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; Solano A, 2001, SALUD PUBLICA MEXICO, V43, P151, DOI 10.1590/S0036-36342001000200010; Steffann J, 2006, J MED GENET, V43, P244, DOI 10.1136/jmg.2005.032326; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Takeuchi T, 2005, BIOL REPROD, V72, P584, DOI 10.1095/biolreprod.104.032391; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Thorburn DR, 2001, AM J MED GENET, V106, P102, DOI 10.1002/ajmg.1380; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Tsuboniwa N, 2001, HUM GENE THER, V12, P469, DOI 10.1089/104303401300042366; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Wolf DP, 2004, BIOL REPROD, V71, P486, DOI 10.1095/biolreprod.103.025932; ZEVIANI M, 1988, NEUROLOGY, V38, P1339	35	379	399	0	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					367	372		10.1038/nature08368	http://dx.doi.org/10.1038/nature08368			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19710649	Green Accepted			2022-12-28	WOS:000269828100033
J	Tsukahara, S; Kobayashi, A; Kawabe, A; Mathieu, O; Miura, A; Kakutani, T				Tsukahara, Sayuri; Kobayashi, Akie; Kawabe, Akira; Mathieu, Olivier; Miura, Asuka; Kakutani, Tetsuji			Bursts of retrotransposition reproduced in Arabidopsis	NATURE			English	Article							NON-CG METHYLATION; DNA METHYLATION; DIVERSITY; THALIANA; GENOME; TRANSPOSONS; MUTATION; ELEMENTS	Retrotransposons, which proliferate by reverse transcription of RNA intermediates, comprise a major portion of plant genomes(1,2). Plants often change the genome size and organization during evolution by rapid proliferation and deletion of long terminal repeat (LTR) retrotransposons(3,4). Precise transposon sequences throughout the Arabidopsis thaliana genome and the trans-acting mutations affecting epigenetic states make it an ideal model organism with which to study transposon dynamics(5-9). Here we report the mobilization of various families of endogenous A. thaliana LTR retrotransposons identified through genetic and genomic approaches with high-resolution genomic tiling arrays and mutants in the chromatin-remodelling gene DDM1 (DECREASE IN DNA METHYLATION1)(10,11). Using multiple lines of self-pollinated ddm1 mutant, we detected an increase in copy number, and verified this for various retrotransposons in a gypsy family (ATGP3) and copia families (ATCOPIA13, ATCOPIA21, ATCOPIA93), and also for a DNA transposon of a Mutator family, VANDAL21. A burst of retrotransposition occurred stochastically and independently for each element, suggesting an additional autocatalytic process. Furthermore, comparison of the identified LTR retrotransposons in related Arabidopsis species revealed that a lineage-specific burst of retrotransposition of these elements did indeed occur in natural Arabidopsis populations. The recent burst of retrotransposition in natural population is targeted to centromeric repeats, which is presumably less harmful than insertion into genes. The ddm1-induced retrotransposon proliferations and genome rearrangements mimic the transposon-mediated genome dynamics during evolution and provide experimental systems with which to investigate the controlling molecular factors directly.	[Tsukahara, Sayuri; Kobayashi, Akie; Kawabe, Akira; Miura, Asuka; Kakutani, Tetsuji] Natl Inst Genet, Dept Integrated Genet, Mishima, Shizuoka 4118540, Japan; [Tsukahara, Sayuri; Kakutani, Tetsuji] Grad Univ Adv Studies, Sch Life Sci, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Mathieu, Olivier] Univ Geneva, Dept Plant Biol, CH-1211 Geneva 4, Switzerland; [Mathieu, Olivier] Univ Clermont Ferrand 2, CNRS, INSERMU, GReD,UMR 6247,U931, F-63177 Clermont Ferrand, France	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Kakutani, T (corresponding author), Natl Inst Genet, Dept Integrated Genet, Yata 1111, Mishima, Shizuoka 4118540, Japan.	tkakutan@lab.nig.ac.jp	Kawabe, Akira/W-7485-2019; Mathieu, Olivier/AAV-6593-2021	Kawabe, Akira/0000-0001-5770-412X; Mathieu, Olivier/0000-0001-5302-1102	Takeda Science Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank A. Terui for technical assistance, M. Nakamura for plant materials, M. Morita and M. Tasaka for genetic marker information, H. Tsukaya for advice on the wvs phenotypes, and E. Richards for critical comments on the manuscript. This study was supported by the Takeda Science Foundation and a Grant-in-Aid for Scientific Research.	Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Havecker ER, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-225; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Hirochika H, 2000, PLANT CELL, V12, P357, DOI 10.1105/tpc.12.3.357; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Kakutani T, 1997, PLANT J, V12, P1447, DOI 10.1046/j.1365-313x.1997.12061447.x; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Kankel MW, 2003, GENETICS, V163, P1109; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kawabe A, 2007, J MOL EVOL, V64, P237, DOI 10.1007/s00239-006-0097-8; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; Lippman Z, 2003, PLOS BIOL, V1, P420, DOI 10.1371/journal.pbio.0000067; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; LUCAS H, 1995, EMBO J, V14, P2364, DOI 10.1002/j.1460-2075.1995.tb07231.x; Miura A, 2001, NATURE, V411, P212, DOI 10.1038/35075612; Peterson-Burch BD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r78; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vitte C, 2006, P NATL ACAD SCI USA, V103, P17638, DOI 10.1073/pnas.0605618103; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Yu ZH, 2000, GENETICS, V156, P2019	29	255	262	1	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					423	U125		10.1038/nature08351	http://dx.doi.org/10.1038/nature08351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19734880				2022-12-28	WOS:000269828100046
J	Vinther, BM; Buchardt, SL; Clausen, HB; Dahl-Jensen, D; Johnsen, SJ; Fisher, DA; Koerner, RM; Raynaud, D; Lipenkov, V; Andersen, KK; Blunier, T; Rasmussen, SO; Steffensen, JP; Svensson, AM				Vinther, B. M.; Buchardt, S. L.; Clausen, H. B.; Dahl-Jensen, D.; Johnsen, S. J.; Fisher, D. A.; Koerner, R. M.; Raynaud, D.; Lipenkov, V.; Andersen, K. K.; Blunier, T.; Rasmussen, S. O.; Steffensen, J. P.; Svensson, A. M.			Holocene thinning of the Greenland ice sheet	NATURE			English	Article							SEA-LEVEL CHANGES; TEMPERATURE; ELEVATION; RECORD; CORE	On entering an era of global warming, the stability of the Greenland ice sheet (GIS) is an important concern(1), especially in the light of new evidence of rapidly changing flow and melt conditions at the GIS margins(2). Studying the response of the GIS to past climatic change may help to advance our understanding of GIS dynamics. The previous interpretation of evidence from stable isotopes (delta O-18) in water from GIS ice cores was that Holocene climate variability on the GIS differed spatially(3) and that a consistent Holocene climate optimum-the unusually warm period from about 9,000 to 6,000 years ago found in many northern-latitude palaeoclimate records(4)-did not exist. Here we extract both the Greenland Holocene temperature history and the evolution of GIS surface elevation at four GIS locations. We achieve this by comparing delta O-18 from GIS ice cores(3,5) with delta O-18 from ice cores from small marginal icecaps. Contrary to the earlier interpretation of delta O-18 evidence from ice cores(3,6), our new temperature history reveals a pronounced Holocene climatic optimum in Greenland coinciding with maximum thinning near the GIS margins. Our delta O-18-based results are corroborated by the air content of ice cores, a proxy for surface elevation(7). State-of-the-art ice sheet models are generally found to be underestimating the extent and changes in GIS elevation and area; our findings may help to improve the ability of models to reproduce the GIS response to Holocene climate.	[Vinther, B. M.; Buchardt, S. L.; Clausen, H. B.; Dahl-Jensen, D.; Johnsen, S. J.; Andersen, K. K.; Blunier, T.; Rasmussen, S. O.; Steffensen, J. P.; Svensson, A. M.] Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, DK-2100 Copenhagen, Denmark; [Fisher, D. A.; Koerner, R. M.] Geol Survey Canada, Terrain Sci Div, Glaciol Sect, Ottawa, ON K1A 0E8, Canada; [Raynaud, D.] UJF, CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; [Lipenkov, V.] Arctic & Antarctic Res Inst, St Petersburg 199397, Russia	University of Copenhagen; Niels Bohr Institute; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Arctic & Antarctic Research Institute	Vinther, BM (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Ice & Climate, Juliane Maries Vej 30, DK-2100 Copenhagen, Denmark.	bo@gfy.ku.dk	Dahl-Jensen, Dorthe/N-4401-2016; raynaud, dominique/ABG-4718-2020; Raynaud, Dominique/H-9626-2016; Blunier, Thomas/M-4609-2014; Dahl-Jensen, Dorthe/AAO-6951-2020; Rasmussen, Sune/B-5560-2008; Lipenkov, Vladimir Y/Q-8262-2016; Rasmussen, Sune Olander/AAA-3190-2021; Svensson, Anders/A-2643-2010; Andersen, Katrine/B-4082-2016	Dahl-Jensen, Dorthe/0000-0002-1474-1948; Blunier, Thomas/0000-0002-6065-7747; Dahl-Jensen, Dorthe/0000-0002-1474-1948; Rasmussen, Sune/0000-0002-4177-3611; Lipenkov, Vladimir Y/0000-0003-4221-5440; Rasmussen, Sune Olander/0000-0002-4177-3611; Svensson, Anders/0000-0002-4364-6085; Andersen, Katrine/0000-0003-4178-2195; Steffensen, Jorgen Peder/0000-0002-5516-1093; Vinther, Bo/0000-0002-6078-771X	Carlsberg Foundation; Groupement de Recherche Europeen (GDRE) Vostok (Institut national des sciences de l'Univers (INSU)/Centre national de la recherche scientifique (CNRS); Russian Foundation for Basic Research (RFBR)-CNRS [05-05-66801]	Carlsberg Foundation(Carlsberg Foundation); Groupement de Recherche Europeen (GDRE) Vostok (Institut national des sciences de l'Univers (INSU)/Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Russian Foundation for Basic Research (RFBR)-CNRS(Russian Foundation for Basic Research (RFBR)Centre National de la Recherche Scientifique (CNRS))	We thank laboratory technician A. Boas, who meticulously performed most of the stable-isotope measurements presented in this paper during her 38 years at the Copenhagen stable isotope laboratory; W. Blake Jr for providing his insight, suggestions and corrections during the drafting of this paper; R. Greve for providing elevation data from his GIS modelling effort. B. M. V. thanks the Carlsberg Foundation for funding, and the Climatic Research Unit at University of East Anglia for hosting his research during all of 2007. V. L. and D. R. thank the Groupement de Recherche Europeen (GDRE) Vostok (Institut national des sciences de l'Univers (INSU)/Centre national de la recherche scientifique (CNRS) for funding and Russian Foundation for Basic Research (RFBR)-CNRS grant 05-05-66801) for support.	Alley RB, 2005, SCIENCE, V310, P456, DOI 10.1126/science.1114613; Blake Jr W., 1970, CAN J EARTH SCI, V7, P634, DOI DOI 10.1139/E70-065; Blake W, 1999, ANN GLACIOL-SER, V28, P40, DOI 10.3189/172756499781821814; Buchardt SL, 2007, ANN GLACIOL-SER, V45, P137, DOI 10.3189/172756407782282435; Cuffey KM, 1997, J GEOPHYS RES-OCEANS, V102, P26383, DOI 10.1029/96JC03981; DahlJensen D, 1998, SCIENCE, V282, P268, DOI 10.1126/science.282.5387.268; Dyke AS, 2000, GEOMORPHOLOGY, V32, P315, DOI 10.1016/S0169-555X(99)00102-6; Fisher DA, 1996, NATO ASI SER, V1, P297, DOI DOI 10.1007/978-3-642-61113-1_15; FUNDER S, 1978, GRONL GEOL UNDERS B, V129; Greve R, 2005, ANN GLACIOL-SER, V42, P424, DOI 10.3189/172756405781812510; HAMMER CU, 1980, NATURE, V288, P230, DOI 10.1038/288230a0; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; JOHNSEN SJ, 1995, TELLUS B, V47, P624, DOI 10.1034/j.1600-0889.47.issue5.9.x; JOHNSEN SJ, 2007, ENCY QUATERNARY SCI, V2, P1250; JOHNSON AK, 1992, J LAW SOCIAL WORK, V3, P29; Kaufman DS, 2004, QUATERNARY SCI REV, V23, P529, DOI 10.1016/j.quascirev.2003.09.007; KOERNER RM, 1990, NATURE, V343, P630, DOI 10.1038/343630a0; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lhomme N, 2005, QUATERNARY SCI REV, V24, P173, DOI 10.1016/j.quascirev.2004.08.020; Long AJ, 2008, EARTH PLANET SC LETT, V272, P8, DOI 10.1016/j.epsl.2008.03.042; Masson-Delmotte V, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005575; Rasmussen SO, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006079; Raynaud D, 1997, J GEOPHYS RES-OCEANS, V102, P26607, DOI 10.1029/97JC01908; RAYNAUD D, 1973, NATURE, V243, P283, DOI 10.1038/243283a0; REEH N, 1985, AM GEOPHYS UN GEOPHY, V33, P57; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Tarasov L, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001731; Vinther BM, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009143; Vinther BM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006921; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9	30	314	323	1	168	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					385	388		10.1038/nature08355	http://dx.doi.org/10.1038/nature08355			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19759618				2022-12-28	WOS:000269828100037
J	Gensichen, J; von Korff, M; Peitz, M; Muth, C; Beyer, M; Guthlin, C; Torge, M; Petersen, JJ; Rosemann, T; Konig, J; Gerlach, FM				Gensichen, Jochen; von Korff, Michael; Peitz, Monika; Muth, Christiane; Beyer, Martin; Guethlin, Corina; Torge, Marion; Petersen, Juliana J.; Rosemann, Thomas; Koenig, Jochem; Gerlach, Ferdinand M.		PRoMPT PRimary Care Monitoring Dep	Case Management for Depression by Health Care Assistants in Small Primary Care Practices A Cluster Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC ILLNESS CARE; COLLABORATIVE CARE; PSYCHIATRIC-DISORDER; DISEASE MANAGEMENT; PATIENT ASSESSMENT; MAJOR DEPRESSION; GENERAL-PRACTICE; MENTAL-HEALTH; UNITED-STATES; IMPROVE	Background: Case management by health care assistants in small primary care practices provides unclear benefit for improving depression symptoms. Objective: To determine whether case management provided by health care assistants in small primary care practices is more effective than usual care in improving depression symptoms and process of care for patients with major depression. Design: Cluster randomized, controlled trial. A central automated system generated the randomization scheme, which was stratified by urban and rural practices; allocation sequence was concealed until groups were assigned. Setting: 74 small primary care practices in Germany from April 2005 to September 2007. Patients: 626 patients age 18 to 80 years with major depression. Intervention: Structured telephone interview to monitor depression symptoms and support for adherence to medication, with feedback to the family physician. Measurements: Depression symptoms at 12 months, as measured by the Patient Health Questionnaire-9 (PHQ-9); secondary outcomes were patient assessment of chronic illness care, adherence to medication, and quality of life. Results: A total of 310 patients were randomly assigned to case management and 316 to usual care. At 12 months, 249 intervention recipients and 278 control patients were assessed; 555 patients were included in a modified intention-to-treat- analysis (267 intervention recipients vs. 288 control patients). Compared with control patients, intervention recipients had lower mean PHQ-9 values in depression symptoms (-1.41 [95% CI, -2.49 to -0.33]; P = 0.014), more favorable assessments of care (3.41 vs. 3.11; P = 0.011), and increased treatment adherence (2.70 vs. 2.53; P = 0.042). Quality-of-life scores did not differ between groups. Limitation: Patients, health care assistants, family physicians, and researchers were not blinded to group assignment, and 12-month follow-up of patients was incomplete. Conclusion: Case management provided by primary care practice based health care assistants may reduce depression symptoms and improve process of care for patients with major depression more than usual care.	Univ Jena, D-07743 Jena, Germany; Goethe Univ Frankfurt, Frankfurt, Germany; Univ Zurich, Zurich, Switzerland; Grp Hlth Ctr Hlth Studies, Seattle, WA USA; Johannes Gutenberg Univ Mainz, Mainz, Germany	Friedrich Schiller University of Jena; Goethe University Frankfurt; University of Zurich; Johannes Gutenberg University of Mainz	Gensichen, J (corresponding author), Univ Jena, Inst Gen Practice, Univ Hosp, Bachstr 18, D-07743 Jena, Germany.	jochen.gensichen@med.uni-jena.de	König, Jochem/T-3500-2019; Güthlin, Corina/AAP-2322-2020	König, Jochem/0000-0003-4683-0360; Güthlin, Corina/0000-0001-8490-467X; VonKorff, Michael/0000-0001-5386-8477	Ministry of Education and Research [01GK0302]	Ministry of Education and Research	By the German Ministry of Education and Research (grant 01GK0302).	*AM AC FAM PHYS, 2009, PRACT PROF FAM PHYS; Anderson B, 2007, AM J MANAG CARE, V13, pS103; Bilsker D, 2007, CAN J PSYCHIAT, V52, P86, DOI 10.1177/070674370705200203; Bodenheimer T, 2007, ANN INTERN MED, V146, P301, DOI 10.7326/0003-4819-146-4-200702200-00011; Bosley S, 2008, BRIT J GEN PRACT, V58, P118, DOI 10.3399/bjgp08X277032; Bower P, 2003, PSYCHOL MED, V33, P203, DOI 10.1017/S0033291702006979; Bramesfeld A, 2007, EUR J EPIDEMIOL, V22, P397, DOI 10.1007/s10654-007-9128-z; Bullinger M., 1995, J PUBLIC HEALTH-UK, V3, P21, DOI [DOI 10.1007/BF02959944, 10.1007/BF02959944]; Busse R, 2004, HEALTH AFFAIR, V23, P56, DOI 10.1377/hlthaff.23.3.56; Campbell M, 2000, J Health Serv Res Policy, V5, P12; Carpenter J, 2002, STAT MED, V21, P1043, DOI 10.1002/sim.1065; Casalino LP, 2003, ARCH INTERN MED, V163, P1958, DOI 10.1001/archinte.163.16.1958; Christensen H, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-25; Cole MG, 1999, AM J PSYCHIAT, V156, P1182; Daniels MJ, 2008, MONOGR STAT APPL PRO, V109, P1; Dietrich AJ, 2004, BMJ-BRIT MED J, V329, P602, DOI 10.1136/bmj.38219.481250.55; Dobscha SK, 2006, ANN INTERN MED, V145, P477, DOI 10.7326/0003-4819-145-7-200610030-00005; Fernandez A, 2007, BRIT J PSYCHIAT, V190, P172, DOI 10.1192/bjp.bp.106.023507; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fulton Maryann M, 2005, J Am Acad Nurse Pract, V17, P123, DOI 10.1111/j.1041-2972.2005.0020.x; Gensichen J, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-101; Gensichen J, 2006, PSYCHOL MED, V36, P7, DOI 10.1017/S0033291705005568; GENSICHEN J, ANN FAM MED IN PRESS; Gensichen Jochen, 2006, Z Arztl Fortbild Qualitatssich, V100, P375; *GERM MED ASS, 2009, HLTH CAR ASS; *GERM MED ASS, 2007, CURR HLTH CAR ASS PA; *GERM MIN HLTH, 2005, STAT POCK BOOK HLTH; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Gilchrist G, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-28; Glasgow RE, 2005, MED CARE, V43, P436, DOI 10.1097/01.mlr.0000160375.47920.8c; Greenberg PE, 2003, J CLIN PSYCHIAT, V64, P1465, DOI 10.4088/JCP.v64n1211; Greiner W, 2005, Eur J Health Econ, V6, P124, DOI 10.1007/s10198-004-0264-z; Grol R, 2000, BRIT J GEN PRACT, V50, P882; Kates N, 2007, CAN J PSYCHIAT, V52, P77, DOI 10.1177/070674370705200202; KATON W, 1992, GEN HOSP PSYCHIAT, V14, P237, DOI 10.1016/0163-8343(92)90094-Q; Katon W, 2001, ARCH GEN PSYCHIAT, V58, P241, DOI 10.1001/archpsyc.58.3.241; Katon WJ, 2008, J OCCUP ENVIRON MED, V50, P459, DOI 10.1097/JOM.0b013e318168efb7; LINDEN M, 2001, CONT PSYCHIAT, V1; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Lowe B., 2002, PRIME MD PATIENT HLT, V2nd; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Richards DA, 2008, PSYCHOL MED, V38, P279, DOI 10.1017/S0033291707001365; Rosemann T, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-77; Rosemann T, 2007, J EVAL CLIN PRACT, V13, P806, DOI 10.1111/j.1365-2753.2007.00786.x; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Stewart WF, 2003, JAMA-J AM MED ASSOC, V289, P3135, DOI 10.1001/jama.289.23.3135; Thiam S, 2007, JAMA-J AM MED ASSOC, V297, P380, DOI 10.1001/jama.297.4.380; Thielke S, 2007, PRIMARY CARE, V34, P571, DOI 10.1016/j.pop.2007.05.007; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; VANMARWIJK HWJ, 2003, HUISARTS WET, V46, P614; Von Korff M, 2001, BRIT MED J, V323, P948, DOI 10.1136/bmj.323.7319.948; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Wagner E H, 1996, Manag Care Q, V4, P12; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Ware JE, 1993, SF36 HLTH SURVEY MAN; Weich S, 1997, PSYCHOL MED, V27, P73, DOI 10.1017/S0033291796004023; WELLS KB, 1988, AM J PSYCHIAT, V145, P976; WENDTHERMAINSKI H, 2005, Z ALLGEMEINMED, V81, P565; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24	66	130	133	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6					369	W118		10.7326/0003-4819-151-6-200909150-00001	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-00001			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	501OB	19755362				2022-12-28	WOS:000270390100001
J	Magistretti, PJ				Magistretti, Pierre J.			Low-Cost Travel in Neurons	SCIENCE			English	Editorial Material							BRAIN WORK; METABOLISM; ASTROCYTES		[Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Magistretti, Pierre J.] UNIL CHUV Lausanne, Ctr Psychiat Neurosci, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Magistretti, PJ (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	pierre.magistretti@epfl.ch		Magistretti, Pierre Julius/0000-0002-6678-320X				Alle H, 2009, SCIENCE, V325, P1405, DOI 10.1126/science.1174331; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Buzsaki G, 2007, NEURON, V56, P771, DOI 10.1016/j.neuron.2007.11.008; Creutzfeldt OD., 1975, BRAIN WORK COUPLING, P21; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; Jolivet Renaud, 2009, Front Neuroenergetics, V1, P4, DOI 10.3389/neuro.14.004.2009; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; MAGISTRETTI PJ, 2008, FUNDAMENTAL NEUROSCI, P271; MATA M, 1980, J NEUROCHEM, V34, P213, DOI 10.1111/j.1471-4159.1980.tb04643.x; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Voutsinos-Porche B, 2003, NEURON, V37, P275, DOI 10.1016/S0896-6273(02)01170-4	17	35	35	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 11	2009	325	5946					1349	1351		10.1126/science.1180102	http://dx.doi.org/10.1126/science.1180102			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745140				2022-12-28	WOS:000269699100023
J	Aimanianda, V; Bayry, J; Bozza, S; Kniemeyer, O; Perruccio, K; Elluru, SR; Clavaud, C; Paris, S; Brakhage, AA; Kaveri, SV; Romani, L; Latge, JP				Aimanianda, Vishukumar; Bayry, Jagadeesh; Bozza, Silvia; Kniemeyer, Olaf; Perruccio, Katia; Elluru, Sri Ramulu; Clavaud, Cecile; Paris, Sophie; Brakhage, Axel A.; Kaveri, Srini V.; Romani, Luigina; Latge, Jean-Paul			Surface hydrophobin prevents immune recognition of airborne fungal spores	NATURE			English	Article							ASPERGILLUS-FUMIGATUS; CELL-WALL; ALVEOLAR MACROPHAGES; CLADOSPORIUM; RESPONSES; PROTEINS; ANTIGENS	The air we breathe is filled with thousands of fungal spores (conidia) per cubic metre, which in certain composting environments can easily exceed 10 9 per cubic metre. They originate from more than a hundred fungal species belonging mainly to the genera Cladosporium, Penicillium, Alternaria and Aspergillus(1-4). Although these conidia contain many antigens and allergens(5-7), it is not known why airborne fungal microflora do not activate the host innate immune cells continuously and do not induce detrimental inflammatory responses following their inhalation. Here we show that the surface layer on the dormant conidia masks their recognition by the immune system and hence prevents immune response. To explore this, we used several fungal members of the airborne microflora, including the human opportunistic fungal pathogen Aspergillus fumigatus, in in vitro assays with dendritic cells and alveolar macrophages and in in vivo murine experiments. In A. fumigatus, this surface 'rodlet layer' is composed of hydrophobic RodA protein covalently bound to the conidial cell wall through glycosylphosphatidylinositol-remnants. RodA extracted from conidia of A. fumigatus was immunologically inert and did not induce dendritic cell or alveolar macrophage maturation and activation, and failed to activate helper T-cell immune responses in vivo. The removal of this surface 'rodlet/hydrophobin layer' either chemically (using hydrofluoric acid), genetically (Delta rodA mutant) or biologically (germination) resulted in conidial morphotypes inducing immune activation. All these observations show that the hydrophobic rodlet layer on the conidial cell surface immunologically silences airborne moulds.	[Aimanianda, Vishukumar; Clavaud, Cecile; Paris, Sophie; Latge, Jean-Paul] Inst Pasteur, Unite Aspergillus, F-75015 Paris, France; [Bayry, Jagadeesh; Elluru, Sri Ramulu; Kaveri, Srini V.] Univ Paris 06, INSERM, UMR S 872, U872, F-75006 Paris, France; [Bayry, Jagadeesh; Elluru, Sri Ramulu; Kaveri, Srini V.] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, F-75006 Paris, France; [Bayry, Jagadeesh; Elluru, Sri Ramulu; Kaveri, Srini V.] Univ Paris 05, UMR S 872, F-75006 Paris, France; [Bozza, Silvia; Romani, Luigina] Univ Perugia, Dept Expt Med & Biochem Sci, I-06122 Perugia, Italy; [Perruccio, Katia] Univ Perugia, Dept Clin & Expt Med, I-06122 Perugia, Italy; [Kniemeyer, Olaf; Brakhage, Axel A.] Leibniz Inst Nat Prod Res & Infect Biol HKI, Dept Mol & Appl Microbiol, D-07745 Jena, Germany; [Kniemeyer, Olaf; Brakhage, Axel A.] Univ Jena, D-07745 Jena, Germany	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Perugia; University of Perugia; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Latge, JP (corresponding author), Inst Pasteur, Unite Aspergillus, F-75015 Paris, France.	jplatge@pasteur.fr	Kniemeyer, Olaf/K-1253-2013; Aimanianda, Vishukumar/E-9204-2011; Latge, Jean Paul/C-9846-2014; Romani, Luigina/O-9987-2018; Perruccio, Katia/ABF-8021-2020; Elluru, Sri Ramulu/B-1097-2009; Bayry, Jagadeesh/A-6589-2011	Kniemeyer, Olaf/0000-0002-9493-6402; Aimanianda, Vishukumar/0000-0001-5813-7497; Elluru, Sri Ramulu/0000-0001-9188-710X; Bayry, Jagadeesh/0000-0003-0498-9808; Romani, Luigina/0000-0002-1356-525X; Kaveri, Srini/0000-0002-0837-4053	Deutsche Forschungsgemeinschaft (DFG); EU-STREP [LSHB-CT-2004-511952, MANASP LSGBH37899]; INSERM; CNRS; Universities Paris 5 and 6	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); EU-STREP(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universities Paris 5 and 6	We thank J. Vani, Y. Repesse and C. Galeotti for help with dendritic cell experiments; and R. Winkler, S. Behnken and M. Potsch for help with the MALDI-TOF/TOF analysis. The research of O. K. and A. A. B. was supported by the Deutsche Forschungsgemeinschaft (DFG) Priority Programme 1160, and the EU-STREP Fungwall LSHB-CT-2004-511952 and MANASP LSGBH37899 were also awarded to J.-P. L., A. A. B. and L. R. J. B and S. V. K are supported by INSERM, CNRS and Universities Paris 5 and 6.	Bayry J, 2007, J IMMUNOL, V178, P4184, DOI 10.4049/jimmunol.178.7.4184; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; Boualem K, 2008, RES MICROBIOL, V159, P110, DOI 10.1016/j.resmic.2007.10.004; Bozza S, 2003, BLOOD, V102, P3807, DOI 10.1182/blood-2003-03-0748; Bozza S, 2002, J IMMUNOL, V168, P1362, DOI 10.4049/jimmunol.168.3.1362; Braedel S, 2004, BRIT J HAEMATOL, V125, P392, DOI 10.1111/j.1365-2141.2004.04922.x; Codina R, 2008, J INVEST ALLERG CLIN, V18, P156; Dague E, 2008, LANGMUIR, V24, P2955, DOI 10.1021/la703741y; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dubourdeau M, 2006, J IMMUNOL, V177, P3994, DOI 10.4049/jimmunol.177.6.3994; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; Glaser AG, 2009, ALLERGY, V64, P1144, DOI 10.1111/j.1398-9995.2009.02029.x; de Ana SG, 2006, J INVEST ALLERG CLIN, V16, P357; Graham LM, 2006, J IMMUNOL METHODS, V314, P164, DOI 10.1016/j.jim.2006.05.013; Hektor HJ, 2005, CURR OPIN BIOTECH, V16, P434, DOI 10.1016/j.copbio.2005.05.004; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Kasprzyk I, 2008, ANN AGR ENV MED, V15, P1; Kniemeyer O, 2006, CURR GENET, V49, P178, DOI 10.1007/s00294-005-0047-9; Lamarre C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-417; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; LATGE JP, 1988, CAN J MICROBIOL, V34, P1325, DOI 10.1139/m88-232; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee T, 2006, ATMOS ENVIRON, V40, P2902, DOI 10.1016/j.atmosenv.2006.01.011; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Sarfati J, 2006, DIAGN MICR INFEC DIS, V55, P279, DOI 10.1016/j.diagmicrobio.2006.02.002; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994	30	539	557	1	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 27	2009	460	7259					1117	+		10.1038/nature08264	http://dx.doi.org/10.1038/nature08264			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	487YE	19713928				2022-12-28	WOS:000269314000036
J	Lauer, MS				Lauer, Michael S.			Elements of Danger -- The Case of Medical Imaging.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		NHLBI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lauer, MS (corresponding author), NHLBI, Bldg 10, Bethesda, MD 20892 USA.		Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177				Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Farrell D, 2008, ACCOUNTING COST US H; Lauer MS, 1998, LANCET, V351, P615, DOI 10.1016/S0140-6736(97)07062-1; Lucas FL, 2006, CIRCULATION, V113, P374, DOI 10.1161/CIRCULATIONAHA.105.560433; Young LH, 2009, JAMA-J AM MED ASSOC, V301, P1547, DOI 10.1001/jama.2009.476	5	98	101	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 27	2009	361	9					841	843		10.1056/NEJMp0904735	http://dx.doi.org/10.1056/NEJMp0904735			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	487XV	19710480				2022-12-28	WOS:000269312700001
J	Currie, GP; Watt, SJ; Maskell, NA				Currie, Graeme P.; Watt, Stephen J.; Maskell, Nick A.			An overview of how asbestos exposure affects the lung	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MALIGNANT-PLEURAL-MESOTHELIOMA; PHASE-III; WORKERS; CANCER; EPIDEMIOLOGY; CISPLATIN; MORTALITY; BIOPSY		[Currie, Graeme P.; Watt, Stephen J.] Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland; [Maskell, Nick A.] Univ Bristol, Southmead Hosp, N Bristol Lung Ctr, Bristol BS10 5NB, Avon, England	University of Aberdeen; Southmead Hospital; University of Bristol	Currie, GP (corresponding author), Aberdeen Royal Infirm, Chest Clin C, Aberdeen AB25 2ZN, Scotland.	graeme.currie@nhs.net		maskell, nick/0000-0002-1276-6500				BRODY AR, 1981, AM REV RESPIR DIS, V123, P670; Davies HE, 2008, CURR OPIN PULM MED, V14, P326, DOI 10.1097/MCP.0b013e3282fcea50; Ferrante D, 2007, ENVIRON HEALTH PERSP, V115, P1401, DOI 10.1289/ehp.10195; FLETCHER D E, 1970, Clinical Radiology, V21, P355, DOI 10.1016/S0009-9260(70)80068-X; Flores RM, 2008, J THORAC CARDIOV SUR, V135, P620, DOI 10.1016/j.jtcvs.2007.10.054; Hodgson JT, 2005, BRIT J CANCER, V92, P587, DOI 10.1038/sj.bjc.6602307; KIPEN HM, 1987, BRIT J IND MED, V44, P96; Lee PN, 2001, OCCUP ENVIRON MED, V58, P145, DOI 10.1136/oem.58.3.145; Lynch D A, 1989, Radiographics, V9, P523; Mak V, 2008, THORAX, V63, P160, DOI 10.1136/thx.2006.066886; Maskell NA, 2003, LANCET, V361, P1326, DOI 10.1016/S0140-6736(03)13079-6; McLaughlin KM, 2009, LUNG CANCER, V65, P388, DOI 10.1016/j.lungcan.2009.05.005; MERCHANT JA, 1990, ENVIRON HEALTH PERSP, V88, P287, DOI 10.2307/3431090; Mukherjee S, 2000, AM J RESP CRIT CARE, V162, P1807, DOI 10.1164/ajrccm.162.5.9912012; Rake C, 2009, BRIT J CANCER, V100, P1175, DOI 10.1038/sj.bjc.6604879; Treasure T, 2007, J THORAC CARDIOV SUR, V133, P1414, DOI 10.1016/j.jtcvs.2007.02.014; Tweedale G, 1998, MED HIST, V42, P439, DOI 10.1017/S0025727300064346; van Meerbeeck JP, 2005, J CLIN ONCOL, V23, P6881, DOI 10.1200/JCO.20005.14.589; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Wagner GR, 1997, LANCET, V349, P1311, DOI 10.1016/S0140-6736(96)07336-9; Wagner GR, 2007, LANCET, V369, P973, DOI 10.1016/S0140-6736(07)60472-3; WAGNER J C, 1960, Br J Ind Med, V17, P260; WALSHE ADP, 1992, THORAX, V47, P734, DOI 10.1136/thx.47.9.734; Wiggins J, 2007, THORAX, V62, P1, DOI 10.1136/thx.2007.087619; Wood WB, 1930, LANCET, V1, P445	25	13	13	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2009	339								b3209	10.1136/bmj.b3209	http://dx.doi.org/10.1136/bmj.b3209			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AP	19703924				2022-12-28	WOS:000269392100002
J	Krajbich, I; Camerer, C; Ledyard, J; Rangel, A				Krajbich, Ian; Camerer, Colin; Ledyard, John; Rangel, Antonio			Using Neural Measures of Economic Value to Solve the Public Goods Free-Rider Problem	SCIENCE			English	Article							HUMAN BRAIN; PUNISHMENT; MECHANISMS; CORTEX	Every social group needs to decide when to provide public goods and how to allocate the costs among its members. Ideally, this decision would maximize the group's net benefits while also ensuring that every individual's benefit is greater than the cost he or she has to pay. Unfortunately, the economic theory of mechanism design has shown that this ideal solution is not feasible when the group leadership does not know the values of the individual group members for the public good. We show that this impossibility result can be overcome in laboratory settings by combining technologies for obtaining neural measures of value ( functional magnetic resonance imaging-based pattern classification) with carefully designed institutions that allocate costs based on both reported and neurally measured values.	[Camerer, Colin; Rangel, Antonio] CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA; [Krajbich, Ian; Camerer, Colin; Ledyard, John; Rangel, Antonio] CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Rangel, A (corresponding author), CALTECH, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	rangel@hss.caltech.edu			NSF-Integrative Graduate Education and Research Traineeship Program; Gordon and Betty Moore Foundation; Human Frontier Science Program	NSF-Integrative Graduate Education and Research Traineeship Program(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Human Frontier Science Program(Human Frontier Science Program)	Financial support from NSF-Integrative Graduate Education and Research Traineeship Program ( I. K.), Gordon and Betty Moore Foundation ( C. F. C., A. R.), and Human Frontier Science Program ( C. F. C.) is gratefully acknowledged.	ABREU D, 1992, ECONOMETRICA, V60, P1439, DOI 10.2307/2951529; CHEN Y, 2004, HDB EXPT EC; Diamantaras D., 2009, TOOLBOX EC DESIGN; Falkinger J, 2000, AM ECON REV, V90, P247, DOI 10.1257/aer.90.1.247; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Gailmard S, 2005, J PUBLIC ECON, V89, P1361, DOI 10.1016/j.jpubeco.2003.04.002; GIBBARD A, 1973, ECONOMETRICA, V41, P587, DOI 10.2307/1914083; GREEN J, 1977, ECONOMETRICA, V45, P427, DOI 10.2307/1911219; GROVES T, 1977, ECONOMETRICA, V45, P783, DOI 10.2307/1912672; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Ledyard J., 1995, HDB EXPT EC; Lindahl E., 1919, GERECHTIGKEIT BESTEU; Maskin E, 1999, REV ECON STUD, V66, P23, DOI 10.1111/1467-937X.00076; MOULIN H, 1994, REV ECON STUD, V61, P305, DOI 10.2307/2297983; Myerson R.B., 2008, NEW PALGRAVE DICT EC; O'Toole AJ, 2007, J COGNITIVE NEUROSCI, V19, P1735, DOI 10.1162/jocn.2007.19.11.1735; Pessoa L, 2007, CEREB CORTEX, V17, P691, DOI 10.1093/cercor/bhk020; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Smith A., 1776, INQUIRY NATURE CAUSE	25	44	45	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 23	2009	326	5952					596	599		10.1126/science.1177302	http://dx.doi.org/10.1126/science.1177302			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509LN	19745115				2022-12-28	WOS:000271019400048
J	Ravishankara, AR; Daniel, JS; Portmann, RW				Ravishankara, A. R.; Daniel, John S.; Portmann, Robert W.			Nitrous Oxide (N2O): The Dominant Ozone-Depleting Substance Emitted in the 21st Century	SCIENCE			English	Article							STRATOSPHERIC OZONE; MIDLATITUDES; REDUCTION; EMISSIONS	By comparing the ozone depletion potential-weighted anthropogenic emissions of N2O with those of other ozone-depleting substances, we show that N2O emission currently is the single most important ozone-depleting emission and is expected to remain the largest throughout the 21st century. N2O is unregulated by the Montreal Protocol. Limiting future N2O emissions would enhance the recovery of the ozone layer from its depleted state and would also reduce the anthropogenic forcing of the climate system, representing a win-win for both ozone and climate.	[Ravishankara, A. R.; Daniel, John S.; Portmann, Robert W.] NOAA, Div Chem Sci, Earth Syst Res Lab, Boulder, CO 80305 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Ravishankara, AR (corresponding author), NOAA, Div Chem Sci, Earth Syst Res Lab, 325 Broadway, Boulder, CO 80305 USA.	A.R.Ravishankara@noaa.gov	Portmann, Robert W/C-4903-2009; Ravishankara, Akkihebbal R/A-2914-2011; 孟, 宇辉/N-3031-2018; Daniel, John S/D-9324-2011	Portmann, Robert W/0000-0002-0279-6087; 孟, 宇辉/0000-0002-8543-0952; 	NOAA's Climate Goal Program	NOAA's Climate Goal Program	We are extremely grateful to S. Solomon for helpful discussion, suggestions for improving the paper, and encouragement and also thank S. Montzka for helpful suggestions and S. Montzka and G. Dutton of the Global Monitoring Division/Earth System Research Laboratory for providing us with mixing ratio observations from which we could infer emission data for several ODSs in 2008 and for helpful discussions. This work was supported in part by NOAA's Climate Goal Program.	[Anonymous], 1985, VIENNA CONVENTION PR; Bernstein L, 2008, CLIMATE CHANGE 2007; Chipperfield MP, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016353; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; CRUTZEN PJ, 1970, Q J ROY METEOR SOC, V96, P320, DOI 10.1002/qj.49709640815; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Jin X, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018458; JOHNSTON H, 1971, SCIENCE, V173, P517, DOI 10.1126/science.173.3996.517; KINNISON D, 1988, J GEOPHYS RES-ATMOS, V93, P14165, DOI 10.1029/JD093iD11p14165; Mickley LJ, 1997, J GEOPHYS RES-ATMOS, V102, P23573, DOI 10.1029/97JD01566; NAKICENOVIC N, 2008, SPECIAL REPORT EMISS; Portmann RW, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028252; Protocol M., 1987, MONTREAL PROTOCOL SU; Randeniya LK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014295; Smith P, 2007, CLIMATE CHANGE 2007; SOLOMON S, 1992, J GEOPHYS RES-ATMOS, V97, P825, DOI 10.1029/91JD02613; Solomon S, 1998, GEOPHYS RES LETT, V25, P1871, DOI 10.1029/98GL01293; Thomason L., 2006, 4 SPARC; van Vuuren DP, 2007, CLIMATIC CHANGE, V81, P119, DOI 10.1007/s10584-006-9172-9; Velders GJM, 2009, P NATL ACAD SCI USA, V106, P10949, DOI 10.1073/pnas.0902817106; Wayne R. P., 2000, CHEM ATMOSPHERE, P775; WMO: Scientific Assessment of Ozone Depletion, 2006, 50 WMO; WUEBBLES DJ, 1983, J GEOPHYS RES-OCEANS, V88, P1433, DOI 10.1029/JC088iC02p01433	23	2433	2616	100	1617	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 2	2009	326	5949					123	125		10.1126/science.1176985	http://dx.doi.org/10.1126/science.1176985			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501CA	19713491				2022-12-28	WOS:000270355600049
J	Chopra, M; Lawn, JE; Sanders, D; Barron, P; Karim, SSA; Bradshaw, D; Jewkes, R; Karim, QA; Flisher, AJ; Mayosi, BM; Tollman, SM; Churchyard, GJ; Coovadia, H				Chopra, Mickey; Lawn, Joy E.; Sanders, David; Barron, Peter; Karim, Salim S. Abdool; Bradshaw, Debbie; Jewkes, Rachel; Karim, Quarraisha Abdool; Flisher, Alan J.; Mayosi, Bongani M.; Tollman, Stephen M.; Churchyard, Gavin J.; Coovadia, Hoosen		Lancet S Africa Team	Health in South Africa 6 Achieving the health Millennium Development Goals for South Africa: challenges and priorities	LANCET			English	Article							PRIMARY-CARE; ANTIRETROVIRAL THERAPY; PUBLIC-HEALTH; HIV; TRANSITION; MANAGEMENT; SYSTEMS; ACCESS	15 years after liberation from apartheid, South Africans are facing new challenges for which the highest calibre of leadership, vision, and commitment is needed. The effect of the unprecedented HIV/AIDS epidemic has been immense. Substantial increases in mortality and morbidity are threatening to overwhelm the health system and undermine the potential of South Africa to attain the Millennium Development Goals (MDGs). However The Lancet's Series on South Africa has identified several examples of leadership and innovation that point towards a different future scenario. We discuss the type of vision, leadership, and priority actions needed to achieve such a change. We still have time to change the health trajectory of the country, and even meet the MDGs. The South African Government, installed in April, 2009, has the mandate and potential to address the public health emergencies facing the country-will they do so or will another opportunity and many more lives be lost?	[Chopra, Mickey; Lawn, Joy E.] MRC, Hlth Syst Res Unit, Cape Town, South Africa; [Bradshaw, Debbie] MRC, Burden Dis Unit, Cape Town, South Africa; [Chopra, Mickey; Sanders, David] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Lawn, Joy E.] Saving Newborn Lives Save Children, Cape Town, South Africa; [Barron, Peter; Jewkes, Rachel; Tollman, Stephen M.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Coovadia, Hoosen] Univ Witwatersrand, Reprod Hlth & HIV Res Unit, Johannesburg, South Africa; [Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Univ Kwazulu Natal, Ctr AIDS Programme Res S Africa, Durban, South Africa; [Coovadia, Hoosen] Univ Kwazulu Natal, Nelson Mandela Sch Med, Durban, South Africa; [Karim, Salim S. Abdool; Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, New York, NY USA; [Jewkes, Rachel] MRC, Gender & Hlth Res Unit, Pretoria, South Africa; [Flisher, Alan J.] Univ Cape Town, Div Child & Adolescent Psychiat, ZA-7925 Cape Town, South Africa; [Flisher, Alan J.] Univ Cape Town, Adolescent Hlth Res Unit, ZA-7925 Cape Town, South Africa; [Mayosi, Bongani M.] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Churchyard, Gavin J.] Aurum Inst Hlth Res, Johannesburg, South Africa	University of the Western Cape; Save the Children; University of Witwatersrand; University of Witwatersrand; University of Kwazulu Natal; University of Kwazulu Natal; Columbia University; University of Cape Town; University of Cape Town; University of Cape Town	Chopra, M (corresponding author), MRC, Hlth Syst Res Unit, Van Zyl Dr, Parow, Western Cape, South Africa.	mickeychopra28@gmail.com	Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Safurdeen Abdool/N-5947-2013; Lawn, Joy/ABE-6382-2020; Karim, Salim Abdool/P-3117-2019	Abdool Karim, Quarraisha/0000-0002-0985-477X; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133; Lawn, Joy/0000-0002-4573-1443; Karim, Salim Abdool/0000-0002-4986-2133; Tollman, Stephen/0000-0003-0744-7588; Mayosi, Bongani/0000-0001-6641-8950; Jewkes, Rachel/0000-0002-4330-6267; Churchyard, Gavin/0000-0002-4269-3699	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank Neff Walker and Ingrid Friberg of Johns Hopkins University, Baltimore, MD, USA, and John Stover of Futures Institute, Glastonbury, CT, USA, for assistance with the LiST modelling; Kumanan Rasanathan of WHO Department of Ethics, Equity; Trade and Human Rights, Geneva, Switzerland, and Anthony Zwi of University of New South Wales, Sydney, NSW Australia, for their comments; and clinicians and colleagues in South Africa who reviewed the assumptions for the economic modelling or provided data. No specific funding was received for this report. JEL is supported by a grant from the Bill & Melinda Gates Foundation to the Saving Newborn Lives programme of Save the Children USA.	Ashworth A, 2004, LANCET, V363, P1110, DOI 10.1016/S0140-6736(04)15894-7; Baek C., 2007, KEY FINDINGS EVALUAT; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; Benatar SR, 2004, NEW ENGL J MED, V351, P81, DOI 10.1056/NEJMhpr033471; Bergh AM, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-13; BLECHER M, 2008, S AFRICAN HLTH REV; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P643; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Daviauda E, 2008, B WORLD HEALTH ORGAN, V86, P46, DOI 10.2471/BLT.07.042283; *DEP HLTH S AFR MR, 2001, SUMM S AFR DEM HLTH; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Groenewald P, 2007, SAMJ S AFR MED J, V97, P674; Jewkes R, 2002, BRIT MED J, V324, P1252, DOI 10.1136/bmj.324.7348.1252; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; Karim SSA, 2009, LANCET, V374, P921, DOI 10.1016/S0140-6736(09)60916-8; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McCoy D, 2005, AM J PUBLIC HEALTH, V95, P18, DOI 10.2105/AJPH.2004.040121; McIntyre D, 2007, S AFRICAN HLTH REV; Mills A, 2004, SOC SCI MED, V59, P931, DOI 10.1016/j.socscimed.2003.12.015; *NAT DEP HLTH S AF, 2008, DEM HLTH SURV 2003; NORMAN R, 2003, S AFR MED J, V97, P637; Palmer N, 2003, HEALTH ECON, V12, P1005, DOI 10.1002/hec.792; Physicians for Human Rights, 2009, HLTH RUINS MAN MAD D; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Sanders D, 2006, AM J PUBLIC HEALTH, V96, P73, DOI 10.2105/AJPH.2005.062679; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Schneider H, 2006, REPROD HEALTH MATTER, V14, P12, DOI 10.1016/S0968-8080(06)27232-X; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; *STAT S AFR, 2008, MID POP EST STAT REL; Statistics South Africa, 2008, INC EXP HOUS 2005 20; Tollman SM, 2002, AM J PUBLIC HEALTH, V92, P1725, DOI 10.2105/AJPH.92.11.1725; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; WHO, 2008, PHARMAFORUM 0121; Wilkinson J, 2005, PUBLIC HEALTH, V119, P227, DOI 10.1016/j.puhe.2005.01.006	40	173	179	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 19	2009	374	9694					1023	1031		10.1016/S0140-6736(09)61122-3	http://dx.doi.org/10.1016/S0140-6736(09)61122-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	498PK	19709737				2022-12-28	WOS:000270154100033
J	Wynn, RF; Boelens, JJ				Wynn, Robert F.; Boelens, Joap Jan			Bone-marrow transplantation in non-malignant disease	LANCET			English	Editorial Material							STEM-CELL TRANSPLANTATION; ELDERLY-PATIENTS; INTERVENTION; MORTALITY; LEUKEMIA; CHILDREN		[Wynn, Robert F.] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 4HA, Lancs, England; [Boelens, Joap Jan] Univ Med Ctr Utrecht, Blood & Marrow Transplant Programme, Utrecht, Netherlands	Royal Manchester Children's Hospital; Utrecht University; Utrecht University Medical Center	Wynn, RF (corresponding author), Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 4HA, Lancs, England.	robert.wynn@cmft.nhs.uk		Wynn, robert/0000-0002-6046-8428; Boelens, Jaap Jan/0000-0003-2232-6952				Bartelink IH, 2009, BIOL BLOOD MARROW TR, V15, P231, DOI 10.1016/j.bbmt.2008.11.022; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Brennan BMD, 2002, BRIT J HAEMATOL, V118, P58, DOI 10.1046/j.1365-2141.2002.03527.x; Eapen M, 2007, LANCET, V369, P1947, DOI 10.1016/S0140-6736(07)60915-5; Elter T, 2009, ANN HEMATOL, V88, P121, DOI 10.1007/s00277-008-0566-9; Greenfield HM, 2006, PEDIATR BLOOD CANCER, V47, P200, DOI 10.1002/pbc.20604; Lee SJ, 2007, BLOOD, V110, P4576, DOI 10.1182/blood-2007-06-097386; Niederwieser D, 2006, BEST PRACT RES CL HA, V19, P825, DOI 10.1016/j.beha.2006.06.007; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Shapira MY, 2004, BONE MARROW TRANSPL, V34, P155, DOI 10.1038/sj.bmt.1704540; Sivaprakasain P, 2007, J PEDIAT HEMATOL ONC, V29, P81, DOI 10.1097/MPH.0b013e318030875e; Straathof KC, 2009, LANCET, V374, P912, DOI 10.1016/S0140-6736(09)60945-4; Vassiliou G, 2001, BEST PRACT RES CL HA, V14, P807, DOI 10.1053/beha.2001.0174; Wynn RF, 2009, J PEDIATR-US, V154, P609, DOI 10.1016/j.jpeds.2008.11.005	14	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 12	2009	374	9693					856	858		10.1016/S0140-6736(09)61070-9	http://dx.doi.org/10.1016/S0140-6736(09)61070-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496BN	19729197				2022-12-28	WOS:000269943100006
J	Major, EO				Major, Eugene O.			Reemergence of PML in Natalizumab-Treated Patients - New Cases, Same Concerns	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; ANTIBODY NATALIZUMAB; CELLS		NINDS, Lab Mol Med & Neurosci, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Major, EO (corresponding author), NINDS, Lab Mol Med & Neurosci, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS001983, Z01NS001983] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bonig H, 2008, BLOOD, V111, P3439, DOI 10.1182/blood-2007-09-112052; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Lindberg RLP, 2008, J NEUROIMMUNOL, V194, P153, DOI 10.1016/j.jneuroim.2007.11.007; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693; Zohren F, 2008, BLOOD, V111, P3893, DOI 10.1182/blood-2007-10-120329	5	71	72	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 10	2009	361	11					1041	1043		10.1056/NEJMp0906248	http://dx.doi.org/10.1056/NEJMp0906248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492LP	19741226				2022-12-28	WOS:000269659400004
J	Nuesch, E; Trelle, S; Reichenbach, S; Rutjes, AWS; Burgi, E; Scherer, M; Altman, DG; Juni, P				Nueesch, Eveline; Trelle, Sven; Reichenbach, Stephan; Rutjes, Anne W. S.; Buergi, Elizabeth; Scherer, Martin; Altman, Douglas G.; Jueni, Peter			The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							OSTEOARTHRITIC KNEE PAIN; SHORT-TERM EFFICACY; EMPIRICAL-EVIDENCE; MISSING DATA; STATISTICAL-METHODS; SYSTEMATIC REVIEWS; CONSORT STATEMENT; TREAT PRINCIPLE; METAANALYSIS; QUALITY	Objective To examine whether excluding patients from the analysis of randomised trials are associated with biased estimates of treatment effects and higher heterogeneity between trials. Design Meta-epidemiological study based on a collection of meta-analyses of randomised trials. Data sources 14 meta-analyses including 167 trials that compared therapeutic interventions with placebo or nonintervention control in patients with osteoarthritis of the hip or knee and used patient reported pain as an outcome. Methods Effect sizes were calculated from differences in means of pain intensity between groups at the end of follow-up, divided by the pooled standard deviation. Trials were combined by using random effects meta-analysis. Estimates of treatment effects were compared between trials with and trials without exclusions from the analysis, and the impact of restricting meta-analyses to trials without exclusions was assessed. Results 39 trials (23%) had included all patients in the analysis. In 128 trials (77%) some patients were excluded from the analysis. Effect sizes from trials with exclusions tended to be more beneficial than those from trials without exclusions (difference -0.13, 95% confidence interval -0.29 to 0.04). However, estimates of bias between individual meta-analyses varied considerably (tau(2)=0.07). Tests of interaction between exclusions from the analysis and estimates of treatment effects were positive in five meta-analyses. Stratified analyses indicated that differences in effect sizes between trials with and trials without exclusions were more pronounced in meta-analyses with high between trial heterogeneity, in meta-analyses with large estimated treatment benefits, and in meta-analyses of complementary medicine. Restriction of meta-analyses to trials without exclusions resulted in smaller estimated treatment benefits, larger P values, and considerable decreases in between trial heterogeneity. Conclusion Excluding patients from the analysis in randomised trials often results in biased estimates of treatment effects, but the extent and direction of bias is unpredictable. Results from intention to treat analyses should always be described in reports of randomised trials. In systematic reviews, the influence of exclusions from the analysis on estimated treatment effects should routinely be assessed.	[Trelle, Sven; Jueni, Peter] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [Trelle, Sven; Jueni, Peter] Univ Hosp Bern, CTU Bern, Bern, Switzerland; [Scherer, Martin] Univ Gottingen, Dept Gen Practice, D-3400 Gottingen, Germany; [Scherer, Martin] Med Univ Lubeck, Inst Social Med, Lubeck, Germany; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England	University of Bern; University of Bern; University Hospital of Bern; University of Gottingen; University of Lubeck; University of Oxford	Juni, P (corresponding author), Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland.	juni@ispm.unibe.ch	Rutjes, Anne/L-8750-2017; Trelle, Sven/D-3760-2009; Juni, Peter/Q-8700-2016; Altman, Douglas G/A-9714-2012	Rutjes, Anne/0000-0001-9782-779X; Trelle, Sven/0000-0002-8162-8910; Juni, Peter/0000-0002-5985-0670; Reichenbach, Stephan/0000-0001-8098-6567	Swiss National Science Foundation [4053-40-104762/3, 3200-066378, PBBEB-115067, 3233-066377]; Swiss Society of Internal Medicine; German Ministry of Education and Research [01 GK 0516]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Society of Internal Medicine; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Swiss National Science Foundation (grant Nos 4053-40-104762/3 and 3200-066378) to PJ and SR, and the Swiss Society of Internal Medicine to PJ. The study was part of the Swiss National Science Foundation's National Research Programme 53 on musculoskeletal health. SR was a recipient of a research fellowship funded by the Swiss National Science Foundation (grant No PBBEB-115067). MS was supported by a young investigators' award of the German Ministry of Education and Research (grant No 01 GK 0516). PJ was a PROSPER (programme for social medicine, preventive and epidemiological research) fellow funded by the Swiss National Science Foundation (grant No 3233-066377). The funders had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all data of the study and had final responsibility for the decision to submit for publication. None of the authors is affiliated with or funded by any manufacturer of any intervention used for osteoarthritis.	Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Avouac J, 2007, OSTEOARTHR CARTILAGE, V15, P957, DOI 10.1016/j.joca.2007.02.006; Balk EM, 2002, JAMA-J AM MED ASSOC, V287, P2973, DOI 10.1001/jama.287.22.2973; Baron G, 2005, ARTHRITIS RHEUM, V52, P1858, DOI 10.1002/art.21116; Baron G, 2008, ARTHRIT RHEUM-ARTHR, V59, P25, DOI 10.1002/art.23253; Bjordal JM, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-51; Bjordal JM, 2007, EUR J PAIN, V11, P125, DOI 10.1016/j.ejpain.2006.02.013; CANNER PL, 1980, NEW ENGL J MED, V303, P1038; Chodosh J, 2005, ANN INTERN MED, V143, P427, DOI 10.7326/0003-4819-143-6-200509200-00007; Christensen R, 2007, ANN RHEUM DIS, V66, P433, DOI 10.1136/ard.2006.065904; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; Elbourne DR, 2002, INT J EPIDEMIOL, V31, P140, DOI 10.1093/ije/31.1.140; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Fransen M, 2003, COCHRANE DB SYST REV; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Huwiler-Muntener K, 2002, JAMA-J AM MED ASSOC, V287, P2801, DOI 10.1001/jama.287.21.2801; Juni P, 2006, BEST PRACT RES CL RH, V20, P721, DOI 10.1016/j.berh.2006.05.002; Julious SA, 2008, PHARM STAT, V7, P142, DOI 10.1002/pst.311; Juni P, 2005, INT J EPIDEMIOL, V34, P87; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kim M, 2006, ARTHRITIS RHEUM, V54, P3741, DOI 10.1002/art.22251; Kjaergard LL, 2008, ANN INTERN MED, V149, P219, DOI 10.7326/0003-4819-149-3-200808050-00023; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115; Manheimer E, 2007, ANN INTERN MED, V146, P868, DOI 10.7326/0003-4819-146-12-200706190-00008; Melander H, 2003, BMJ-BRIT MED J, V326, P1171, DOI 10.1136/bmj.326.7400.1171; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Montori VM, 2005, BMJ-BRIT MED J, V330, P68, DOI 10.1136/bmj.38336.804167.47; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Reichenbach S, 2007, ANN INTERN MED, V146, P580, DOI 10.7326/0003-4819-146-8-200704170-00009; Rintelen B, 2006, ARCH INTERN MED, V166, P1899, DOI 10.1001/archinte.166.17.1899; SACKETT DL, 1979, NEW ENGL J MED, V301, P1410, DOI 10.1056/NEJM197912273012602; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Soares HP, 2004, BRIT MED J, V328, P22, DOI 10.1136/bmj.328.7430.22; Spiegelhalter DJ., 2004, BAYESIAN APPROACHES; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Streiner DL, 2002, CAN J PSYCHIAT, V47, P68; Tierney JF, 2005, INT J EPIDEMIOL, V34, P79, DOI 10.1093/ije/dyh300; Towheed TE, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004257.pub2; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	44	175	176	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 7	2009	339								b3244	10.1136/bmj.b3244	http://dx.doi.org/10.1136/bmj.b3244			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	493RB	19736281	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000269754500001
J	Eikelboom, JW; Weitz, JI				Eikelboom, John W.; Weitz, Jeffrey I.			Otamixaban in acute coronary syndromes	LANCET			English	Editorial Material							FACTOR XA INHIBITOR; FACTOR-IXA ACTIVITY; DOUBLE-BLIND; TRIAL; ASPIRIN		[Eikelboom, John W.] Hamilton Gen Hosp, Thrombosis Serv, Hamilton, ON L8L 2X2, Canada; [Eikelboom, John W.; Weitz, Jeffrey I.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Weitz, Jeffrey I.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Weitz, Jeffrey I.] Henderson Res Ctr, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University	Eikelboom, JW (corresponding author), Hamilton Gen Hosp, Thrombosis Serv, Hamilton, ON L8L 2X2, Canada.	eikelbj@mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019; Eikelboom, John/AAG-6117-2019	Weitz, Jeffrey/0000-0002-1092-7550; Eikelboom, John/0000-0003-4126-1285				Alexander JH, 2009, CIRCULATION, V119, P2877, DOI 10.1161/CIRCULATIONAHA.108.832139; Chan MY, 2008, CIRCULATION, V117, P2865, DOI 10.1161/CIRCULATIONAHA.107.745687; Cohen M, 2007, CIRCULATION, V115, P2642, DOI 10.1161/CIRCULATIONAHA.106.653428; Dyke CK, 2006, CIRCULATION, V114, P2490, DOI 10.1161/CIRCULATIONAHA.106.668434; Guertin KR, 2007, CURR MED CHEM, V14, P2471, DOI 10.2174/092986707782023659; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Rusconi CP, 2002, NATURE, V419, P90, DOI 10.1038/nature00963; Sabatine MS, 2009, LANCET, V374, P787, DOI 10.1016/S0140-6736(09)61454-9; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	11	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 5	2009	374	9692					762	764		10.1016/S0140-6736(09)61529-4	http://dx.doi.org/10.1016/S0140-6736(09)61529-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492QU	19717186				2022-12-28	WOS:000269675000006
J	Mann, J; Nye, ER				Mann, Jim; Nye, Edwin R.			Fad diets in Sweden, of all places	LANCET			English	Editorial Material							LOW CARBOHYDRATE-DIET		[Mann, Jim] Univ Otago, Dept Human Nutr, Dunedin 9054, New Zealand; [Mann, Jim; Nye, Edwin R.] Univ Otago, Dept Med, Dunedin 9054, New Zealand	University of Otago; University of Otago	Mann, J (corresponding author), Univ Otago, Dept Human Nutr, Dunedin 9054, New Zealand.	jim.mann@otago.ac.nz						[Anonymous], 2003, DIET NUTR PREV CHRON; Atkins RC, 1992, DR ATKINSNEW DIET RE; BRATT A, 2008, DAGENS NYHETER  0313; Brehm BJ, 2003, J CLIN ENDOCR METAB, V88, P1617, DOI 10.1210/jc.2002-021480; *DAHLQV BLOG, 2008, INTR LCHF MY DIET PR; HOLM LE, 2008, SOCIAL EXPERTS NUTR; LETMARK P, 2008, DAGENS NYHETER  0117; *LIVSM, STUD SAT FAT 2 LISTS; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; NARLID M, 2008, LAKARTIDNINGEN, V105, P191; SOHLANDER CA, 2008, AFTONBLADET     0322; Westman EC, 2002, AM J MED, V113, P30, DOI 10.1016/S0002-9343(02)01129-4; 2009, INT BEST SELLING BOO; CORPUSLIVLINAN SAVE	14	23	23	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 5	2009	374	9692					767	769		10.1016/S0140-6736(09)61575-0	http://dx.doi.org/10.1016/S0140-6736(09)61575-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492QU	19733769				2022-12-28	WOS:000269675000009
J	Merila, J				Merila, Juha			Genetic Constraints on Adaptation?	SCIENCE			English	Editorial Material							FISHERIES-INDUCED EVOLUTION; CLIMATE-CHANGE; RESPONSES; LATITUDE		Univ Helsinki, Dept Biol & Environm Sci, Ecol Genet Res Unit, FI-00014 Helsinki, Finland	University of Helsinki	Merila, J (corresponding author), Univ Helsinki, Dept Biol & Environm Sci, Ecol Genet Res Unit, POB 65, FI-00014 Helsinki, Finland.	merila@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072				Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Browman HI, 2008, SCIENCE, V320, P47, DOI 10.1126/science.320.5872.47b; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Feder ME, 2000, ANNU REV ECOL SYST, V31, P315, DOI 10.1146/annurev.ecolsys.31.1.315; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; Huey RB, 2009, P NATL ACAD SCI USA, V106, P3647, DOI 10.1073/pnas.0900934106; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; Kuparinen A, 2007, TRENDS ECOL EVOL, V22, P652, DOI 10.1016/j.tree.2007.08.011; Lynch M., 1998, GENETICS ANAL QUANTI; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328	13	9	9	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 4	2009	325	5945					1212	1213		10.1126/science.1179326	http://dx.doi.org/10.1126/science.1179326			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	490RY	19729644				2022-12-28	WOS:000269523200024
J	Fuchs, VR				Fuchs, Victor R.			Cost Shifting Does Not Reduce the Cost of Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fuchs, Victor R.] Stanford Univ, Dept Econ, Stanford, CA 94305 USA; [Fuchs, Victor R.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA	Stanford University; Stanford University	Fuchs, VR (corresponding author), Natl Bur Econ Res, 30 Alta Rd, Stanford, CA 94305 USA.	vfuchs@stanford.edu						[Anonymous], 2007, MED IM CAN; Canadian Institute for Health Information, 2007, CAN HLTH CAR PROV; Centers for Medicare and Medicaid, HIST NAT HLTH EXP DA; CONNOLLY C, 2009, WASHINGTON POST 0607; Emanuel E.J., 2007, 200711 BROOK I; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P1057, DOI 10.1001/jama.299.9.1057; Fujisawa R, OECD HLTH WORKING PA; *OECD STATEXTRACTS, OECD HLTH DAT 2008 S; *US BUR CENS, 2009, STAT ABSTR US, P110	9	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 2	2009	302	9					999	1000		10.1001/jama.2009.1278	http://dx.doi.org/10.1001/jama.2009.1278			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489TF	19724049				2022-12-28	WOS:000269444900027
J	Fischbach, MA; Walsh, CT				Fischbach, Michael A.; Walsh, Christopher T.			Antibiotics for Emerging Pathogens	SCIENCE			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; NATURAL-PRODUCTS; ANTIBACTERIAL DISCOVERY; DRUG DISCOVERY; MYCOBACTERIUM-TUBERCULOSIS; INHIBITOR; BIOSYNTHESIS; INFECTIONS; TARGET; POTENT	Antibiotic-resistant strains of pathogenic bacteria are increasingly prevalent in hospitals and the community. New antibiotics are needed to combat these bacterial pathogens, but progress in developing them has been slow. Historically, most antibiotics have come from a small set of molecular scaffolds whose functional lifetimes have been extended by generations of synthetic tailoring. The emergence of multidrug resistance among the latest generation of pathogens suggests that the discovery of new scaffolds should be a priority. Promising approaches to scaffold discovery are emerging; they include mining underexplored microbial niches for natural products, designing screens that avoid rediscovering old scaffolds, and repurposing libraries of synthetic molecules for use as antibiotics.	[Fischbach, Michael A.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Fischbach, Michael A.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Walsh, Christopher T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Fischbach, MA (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	fischbach@fischbachgroup.org; christopher_walsh@hms.harvard.edu		Fischbach, Michael/0000-0003-3079-8247	Department of Molecular Biology; Center for Computational and Integrative Biology; Massachusetts General Hospital; NIH [GM20011, GM49338]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020011, R01GM049338, R37GM020011] Funding Source: NIH RePORTER	Department of Molecular Biology; Center for Computational and Integrative Biology; Massachusetts General Hospital(General Electric); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research in the authors laboratories is supported by the Department of Molecular Biology and the Center for Computational and Integrative Biology at Massachusetts General Hospital (M.A.F.) and by NIH grants GM20011 and GM49338 (C.T.W.). C.T.W. is a member of the board of directors of Achaogen (South San Francisco, CA).	Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Baltz R. H., 2005, SIM NEWS, V55, P186; Baltz RH, 2006, J IND MICROBIOL BIOT, V33, P507, DOI 10.1007/s10295-005-0077-9; Banskota AH, 2006, J ANTIBIOT, V59, P533, DOI 10.1038/ja.2006.74; Bister B, 2004, ANGEW CHEM INT EDIT, V43, P2574, DOI 10.1002/anie.200353160; Boguski MS, 2009, SCIENCE, V324, P1394, DOI 10.1126/science.1169920; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Challis GL, 2008, J MED CHEM, V51, P2618, DOI 10.1021/jm700948z; Charest MG, 2005, SCIENCE, V308, P395, DOI 10.1126/science.1109755; Chen DZ, 2000, BIOCHEMISTRY-US, V39, P1256, DOI 10.1021/bi992245y; Cho SH, 2007, ANTIMICROB AGENTS CH, V51, P1380, DOI 10.1128/AAC.00055-06; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; Davidovich C, 2007, P NATL ACAD SCI USA, V104, P4291, DOI 10.1073/pnas.0700041104; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; DUNN GL, 1982, J ANTIMICROB CHEMOTH, V10, P1; Falagas ME, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-24; Freiberg C, 2005, ANTIMICROB AGENTS CH, V49, P749, DOI 10.1128/AAC.49.2.749-759.2005; Garau J., 1997, CLIN MICROBIOL INFEC, V3, pS87, DOI [DOI 10.1111/J.1469-0691.1997.TB00649.X, 10.1111/j.1469-0691.1997.tb00649.x]; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Gullo VP, 2006, J IND MICROBIOL BIOT, V33, P523, DOI 10.1007/s10295-006-0107-2; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Liu CI, 2008, SCIENCE, V319, P1391, DOI 10.1126/science.1153018; McAlpine JB, 2009, J NAT PROD, V72, P566, DOI 10.1021/np800742z; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; Mills SD, 2006, BIOCHEM PHARMACOL, V71, P1096, DOI 10.1016/j.bcp.2005.11.025; Nathan C, 2004, NATURE, V431, P899, DOI 10.1038/431899a; Nathan C, 2005, NAT REV DRUG DISCOV, V4, P887, DOI 10.1038/nrd1878; NEU HC, 1978, ANTIMICROB AGENTS CH, V13, P584, DOI 10.1128/AAC.13.4.584; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Noskin GA, 2005, CLIN INFECT DIS, V41, pS303, DOI 10.1086/431672; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Rosamond L, 2000, SCIENCE, V287, P1973, DOI 10.1126/science.287.5460.1973; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; Singh SB, 2007, CURR OPIN DRUG DISC, V10, P160; von Nussbaum F, 2006, ANGEW CHEM INT EDIT, V45, P5072, DOI 10.1002/anie.200600350; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; Watve MG, 2001, ARCH MICROBIOL, V176, P386, DOI 10.1007/s002030100345; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Wenzel SC, 2009, IDRUGS, V12, P220	51	1265	1330	17	612	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1089	1093		10.1126/science.1176667	http://dx.doi.org/10.1126/science.1176667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713519	Green Accepted			2022-12-28	WOS:000269382300030
J	Kumar, R; St John, J; Devendra, D				Kumar, Raekha; St John, Joan; Devendra, Devasenan			10-Minute Consultation Hirsutism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kumar, Raekha; Devendra, Devasenan] Cent Middlesex Hosp, Jeffrey Kelson Diabet Ctr, Imperial Coll Sch Med, London NW10 7NS, England; [St John, Joan] Law Med Practice Grp, Wembley HA9 6QQ, Middx, England	Imperial College London	Devendra, D (corresponding author), Cent Middlesex Hosp, Jeffrey Kelson Diabet Ctr, Imperial Coll Sch Med, London NW10 7NS, England.	d.devendra@imperial.ac.uk							0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2009	339								b3090	10.1136/bmj.b3090	http://dx.doi.org/10.1136/bmj.b3090			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AZ	19717498				2022-12-28	WOS:000269393200001
J	Chor, JSY; Ngai, KLK; Goggins, WB; Wong, MCS; Wong, SYS; Lee, N; Leung, TF; Rainer, TH; Griffiths, S; Chan, PKS				Chor, Josette S. Y.; Ngai, Karry L. K.; Goggins, William B.; Wong, Martin C. S.; Wong, Samuel Y. S.; Lee, Nelson; Leung, Ting-fan; Rainer, Timothy H.; Griffiths, Sian; Chan, Paul K. S.			Willingness of Hong Kong healthcare workers to accept pre-pandemic influenza vaccination at different WHO alert levels: two questionnaire surveys	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RATES; IMMUNIZATION; PREVALENCE; COUNTRIES; CHINESE	Objective To assess the acceptability of pre-pandemic influenza vaccination among healthcare workers in public hospitals in Hong Kong and the effect of escalation in the World Health Organization's alert level for an influenza pandemic. Design Repeated cross sectional studies using self administered, anonymous questionnaires Setting Surveys at 31 hospital departments of internal medicine, paediatrics, and emergency medicine under the Hong Kong Hospital Authority from January to March 2009 and in May 2009 Participants 2255 healthcare workers completed the questionnaires in the two studies. They were doctors, nurses, or allied health professionals working in the public hospital system. Main outcome measures Stated willingness to accept pre-pandemic influenza vaccination (influenza A subtypes H5N1 or H1N1) and its associating factors. Results The overall willingness to accept pre-pandemic H5N1 vaccine was only 28.4% in the first survey, conducted at WHO influenza pandemic alert phase 3. No significant changes in the level of willingness to accept pre-pandemic H5N1 vaccine were observed despite the escalation to alert phase 5. The willingness to accept pre-pandemic H1N1 vaccine was 47.9% among healthcare workers when the WHO alert level was at phase 5. The most common reasons for an intention to accept were "wish to be protected" and "following health authority's advice." The major barriers identified were fear of side effects and doubts about efficacy. More than half of the respondents thought nurses should be the first priority group to receive the vaccines. The strongest positive associating factors were history of seasonal influenza vaccination and perceived risk of contracting the infection. Conclusions The willingness to accept pre-pandemic influenza vaccination was low, and no significant effect was observed with the change in WHO alert level. Further studies are required to elucidate the root cause of the low intention to accept pre-pandemic vaccination.	[Chan, Paul K. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Chor, Josette S. Y.; Goggins, William B.; Wong, Martin C. S.; Wong, Samuel Y. S.; Griffiths, Sian] Chinese Univ Hong Kong, Prince Wales Hosp, Sch Publ Hlth & Primary Care, Sch Publ Hlth, Shatin, Hong Kong, Peoples R China; [Lee, Nelson] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Div Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Leung, Ting-fan] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Hong Kong, Hong Kong, Peoples R China; [Rainer, Timothy H.] Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	LEUNG, Ting Fan/E-7728-2013; Chan, Paul KS/J-9360-2013; Lee, Nelson/B-6418-2008; Rainer, Timothy/I-2591-2013; WONG, Samuel Yeung Shan/D-7311-2013; Wong, Martin/L-4568-2014	LEUNG, Ting Fan/0000-0002-6469-1926; Chan, Paul KS/0000-0002-6360-4608; Lee, Nelson/0000-0002-0783-6607; Rainer, Timothy/0000-0003-3355-3237; WONG, Samuel Yeung Shan/0000-0003-0934-6385; Wong, Martin/0000-0001-7706-9370				*AM COLL PHYS, 2006, ANN INTERN MED, V145, P135; Blank PR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-272; Christini AB, 2007, INFECT CONT HOSP EP, V28, P171, DOI 10.1086/511796; *DEP HLTH HONG KON, 2005, COMMUNICABLE DIS WAT, V2, P101; *EUR CDCP, 2007, TECHN REP EXP ADV GR; Goldstein AO, 2004, INFECT CONT HOSP EP, V25, P908, DOI 10.1086/502318; HOLLMEYER H, VACCINE IN PRESS; Jennings LC, 2008, LANCET INFECT DIS, V8, P650, DOI 10.1016/S1473-3099(08)70232-9; Kwan TTC, 2009, BJOG-INT J OBSTET GY, V116, P501, DOI 10.1111/j.1471-0528.2008.01988.x; Lau JTF, 2007, VACCINE, V25, P8279, DOI 10.1016/j.vaccine.2007.09.047; LAU JT, J INFECT DI IN PRESS; Leung CW, 1999, HONG KONG J PAEDIATR, V4, P59; Marlow LAV, 2009, VACCINE, V27, P2483, DOI 10.1016/j.vaccine.2009.02.057; *MIN HLTH NZ, 2007, H5N1 PREP VACC CONS; Mok E, 2006, PUBLIC HEALTH NURS, V23, P506, DOI 10.1111/j.1525-1446.2006.00590.x; *MSNBC, 2009, 1 BATCH SWIN FLU VAC; Nuno M, 2007, J R SOC INTERFACE, V4, P505, DOI 10.1098/rsif.2006.0186; Opstelten W, 2008, VACCINE, V26, P5918, DOI 10.1016/j.vaccine.2008.08.049; Pareek M, 2009, VACCINE, V27, P1242, DOI 10.1016/j.vaccine.2008.12.006; Qureshi AM, 2004, OCCUP MED-OXFORD, V54, P197, DOI 10.1093/occmed/kqg087; Schwartz KL, 2006, J GEN INTERN MED, V21, P346, DOI 10.1111/j.1525-1497.2006.00401.x; Straetemans M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-236; Traynor K, 2007, AM J HEALTH-SYST PH, V64, P2412, DOI 10.2146/news07070100; Van den Dool C, 2008, VACCINE, V26, P1297, DOI 10.1016/j.vaccine.2007.12.045; *WHO, GLOB AL RESP GAR WHO; *WHO, GLOB AL RESP GAR CUR; WHO (World Health Organization), 2011, GLOB AL RESP GAR INF	27	145	146	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 25	2009	339								b3391	10.1136/bmj.b3391	http://dx.doi.org/10.1136/bmj.b3391			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AS	19706937	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000269392500013
J	Salvage, AV; Quinn, B				Salvage, Ann V.; Quinn, Barry			Practice A Patient's Journey Cancer and chemotherapy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Quinn, Barry] Univ London St Georges Hosp, London SW17 0QT, England	St Georges University London	Quinn, B (corresponding author), Univ London St Georges Hosp, London SW17 0QT, England.	barry.quinn@stgeorges.nhs.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 24	2009	339								b2875	10.1136/bmj.b2875	http://dx.doi.org/10.1136/bmj.b2875			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AP	19703923				2022-12-28	WOS:000269392100001
J	Wang, JW; Czech, B; Weigel, D				Wang, Jia-Wei; Czech, Benjamin; Weigel, Detlef			miR156-Regulated SPL Transcription Factors Define an Endogenous Flowering Pathway in Arabidopsis thaliana	CELL			English	Article							FLORAL MERISTEM IDENTITY; MADS DOMAIN PROTEIN; BOX GENE SPL3; LOCUS-T; DNA-BINDING; TIME GENES; SBP-DOMAIN; INTEGRATOR FT; LEAFY; SIGNALS	The FT gene integrates several external and endogenous cues controlling flowering, including information on day length. A complex of the mobile FT protein and the bZIP transcription factor FD in turn has a central role in activating genes that execute the switch from vegetative to reproductive development. Here we reveal that microRNA156-targeted SQUAMOSA PROMOTER BINDING PROTEIN-LIKE (SPL) genes not only act downstream of FT/FD, but also define a separate endogenous flowering pathway. High levels of miR156 in young plants prevent precocious flowering. A subsequent day length-independent decline in miR156 abundance provides a permissive environment for flowering and is paralleled by a rise in SPL levels. At the shoot apex, FT/FD and SPLs converge on an overlapping set of targets, with SPLs directly activating flower-promoting MADS box genes, providing a molecular substrate for both the redundant activities and the feed-forward action of the miR156/SPL and FT/FD modules in flowering control.	[Wang, Jia-Wei; Czech, Benjamin; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Max Planck Society	Weigel, D (corresponding author), Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany.	weigel@weigelworld.org	Czech, Benjamin/AAJ-8592-2020; Weigel, Detlef/C-1418-2008; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/GSJ-0799-2022	Czech, Benjamin/0000-0001-8471-0007; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Wang, Jia-Wei/0000-0003-3885-6296	EMBO Long-Term Fellowship [ALTF 274-2006]; European Community FP6 IP SIROCCO [LSHG-CT-2006-037900];  [DFG-SFB 446 grant]	EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); European Community FP6 IP SIROCCO(European Commission); 	We thank the European Arabidopsis Stock Centre for seeds; Eunyoung Chae, Yasushi Kobayashi, Francois Parcy, Patrice Salome, Markus Schmid, the members of Weigelworld Team MiRNA, and Gang Wu and Scott Poethig for discussion; and Ayako Yamaguchi and Doris Wagner for the exchange of unpublished information. This work was supported by an EMBO Long-Term Fellowship to J.-W.W. (ALTF 274-2006), by a DFG-SFB 446 grant, and by European Community FP6 IP SIROCCO (contract LSHG-CT-2006-037900).	Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Balasubramanian S, 2006, NAT GENET, V38, P711, DOI 10.1038/ng1818; Baurle I, 2006, CELL, V125, P655, DOI 10.1016/j.cell.2006.05.005; Birkenbihl RP, 2005, J MOL BIOL, V352, P585, DOI 10.1016/j.jmb.2005.07.013; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Cardon G, 1999, GENE, V237, P91, DOI 10.1016/S0378-1119(99)00308-X; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Eriksson S, 2006, PLANT CELL, V18, P2172, DOI 10.1105/tpc.106.042317; Ferrandiz C, 2000, SCIENCE, V289, P436, DOI 10.1126/science.289.5478.436; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Hartmann U, 2000, PLANT J, V21, P351, DOI 10.1046/j.1365-313x.2000.00682.x; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Hepworth SR, 2002, EMBO J, V21, P4327, DOI 10.1093/emboj/cdf432; Hisamatsu T, 2008, J EXP BOT, V59, P3821, DOI 10.1093/jxb/ern232; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Izawa T, 2007, J EXP BOT, V58, P3091, DOI 10.1093/jxb/erm159; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lee J, 2008, PLANT J, V55, P832, DOI 10.1111/j.1365-313X.2008.03552.x; Li CX, 2008, PLANT J, V55, P543, DOI 10.1111/j.1365-313X.2008.03526.x; Li D, 2008, DEV CELL, V15, P110, DOI 10.1016/j.devcel.2008.05.002; Liang XW, 2008, BIOCHEMISTRY-US, V47, P3645, DOI 10.1021/bi701431y; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; Liu C, 2008, DEVELOPMENT, V135, P1481, DOI 10.1242/dev.020255; Liu C, 2007, DEVELOPMENT, V134, P1901, DOI 10.1242/dev.003103; LLOYD AM, 1994, SCIENCE, V266, P436, DOI 10.1126/science.7939683; Lohmann JU, 2002, DEV CELL, V2, P135, DOI 10.1016/S1534-5807(02)00122-3; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Mathieu J, 2007, CURR BIOL, V17, P1055, DOI 10.1016/j.cub.2007.05.009; Melzer S, 2008, NAT GENET, V40, P1489, DOI 10.1038/ng.253; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Michaels SD, 2005, PLANT PHYSIOL, V137, P149, DOI 10.1104/pp.104.052811; Michaels SD, 2003, PLANT J, V33, P867, DOI 10.1046/j.1365-313X.2003.01671.x; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Parcy F, 1998, NATURE, V395, P561, DOI 10.1038/26903; Parcy F, 2002, DEVELOPMENT, V129, P2519; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Ratcliffe OJ, 1999, DEVELOPMENT, V126, P1109; Reeves PH, 2001, PLANT PHYSIOL, V126, P1085, DOI 10.1104/pp.126.3.1085; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shimada S, 2009, PLANT J, V58, P668, DOI 10.1111/j.1365-313X.2009.03806.x; Takada S, 2003, PLANT CELL, V15, P2856, DOI 10.1105/tpc.016345; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Trevaskis B, 2007, TRENDS PLANT SCI, V12, P352, DOI 10.1016/j.tplants.2007.06.010; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Wagner D, 1999, SCIENCE, V285, P582, DOI 10.1126/science.285.5427.582; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang JW, 2008, PLANT CELL, V20, P1231, DOI 10.1105/tpc.108.058180; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Yamaguchi A, 2005, PLANT CELL PHYSIOL, V46, P1175, DOI 10.1093/pcp/pci151; Yang ZF, 2008, GENE, V407, P1, DOI 10.1016/j.gene.2007.02.034; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928; Yu H, 2002, P NATL ACAD SCI USA, V99, P16336, DOI 10.1073/pnas.212624599	80	938	1038	31	355	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 21	2009	138	4					738	749		10.1016/j.cell.2009.06.014	http://dx.doi.org/10.1016/j.cell.2009.06.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703399	Bronze			2022-12-28	WOS:000269156100015
J	Schunemann, H				Schuenemann, Holger			From BODE to ADO to outcomes in multimorbid COPD patients	LANCET			English	Editorial Material							DISEASE		McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada	McMaster University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Schunemann, H (corresponding author), McMaster Univ, Hlth Sci Ctr, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada.	schuneh@mcmaster.ca		Schunemann, Holger/0000-0003-3211-8479				Dahl M, 2008, AM J RESP CRIT CARE, V178, P906, DOI 10.1164/rccm.200804-549OC; Dahl M, 2007, AM J RESP CRIT CARE, V175, P250, DOI 10.1164/rccm.200605-713OC; Nannini LJ, 2007, COCHRANE DB SYST REV, V4; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Schunemann HJ, 2009, LANCET, V373, P774, DOI 10.1016/S0140-6736(08)61347-1; World Health Organization, 2008, 2008 2013 ACT PLAN G	7	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG-SEP	2009	374	9691					667	668		10.1016/S0140-6736(09)61539-7	http://dx.doi.org/10.1016/S0140-6736(09)61539-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	489LV	19716945				2022-12-28	WOS:000269422500005
J	Mossey, PA; Little, J; Munger, RG; Dixon, MJ; Shaw, WC				Mossey, Peter A.; Little, Julian; Munger, Ron G.; Dixon, Mike J.; Shaw, William C.			Cleft lip and palate	LANCET			English	Review							NONSYNDROMIC ORAL CLEFTS; GENE-ENVIRONMENT INTERACTION; FOLIC-ACID FORTIFICATION; EDGE EPITHELIAL-CELLS; FACTOR-ALPHA-GENE; TRANSFORMING GROWTH FACTOR-BETA-3; MATERNAL FOLATE INTAKE; OROFACIAL CLEFTS; BIRTH-DEFECTS; CONGENITAL-ANOMALIES	Clefts of the lip and palate are generally divided into two groups, isolated cleft palate and cleft lip with or without cleft palate, representing a heterogeneous group of disorders affecting the lips and oral cavity. These defects arise in about 1.7 per 1000 liveborn babies, with ethnic and geographic variation. Effects on speech, hearing, appearance, and psychology can lead to longlasting adverse outcomes for health and social integration. Typically, children with these disorders need multidisciplinary care from birth to adulthood and have higher morbidity and mortality throughout life than do unaffected individuals. This Seminar describes embryological developmental processes, epidemiology, known environmental and genetic risk factors, and their interaction. Although access to care has increased in recent years, especially in developing countries, quality of care still varies substantially. Prevention is the ultimate objective for clefts of the lip and palate, and a prerequisite of this aim is to elucidate causes of the disorders. Technological advances and international collaborations have yielded some successes.	[Mossey, Peter A.] Univ Dundee, Sch Dent, Dept Dent & Oral Hlth, Dundee, Scotland; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON, Canada; [Munger, Ron G.] Utah State Univ, Dept Nutr & Food Sci, Logan, UT 84322 USA; [Dixon, Mike J.] Univ Dent Hosp Manchester, Biomed Res Ctr, Manchester, Lancs, England; [Shaw, William C.] Univ Dent Hosp Manchester, Dept Oral Hlth & Dev, Manchester, Lancs, England	University of Dundee; University of Ottawa; Utah System of Higher Education; Utah State University; University of Manchester; University of Manchester	Mossey, PA (corresponding author), Univ Dundee, Dent Hosp & Sch, 1 Pk Pl, Dundee DD1 4HR, Scotland.	p.a.mossey@dundee.ac.uk	Little, Julian/AAR-6117-2020	Little, Julian/0000-0001-5026-5531; Mossey, Peter/0000-0002-9914-6901	Human Genome Epidemiology; MRC [G0400955] Funding Source: UKRI; Medical Research Council [G0400955] Funding Source: researchfish	Human Genome Epidemiology; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JL holds a Canada Research Chair in Human Genome Epidemiology.	ABRISHAMCHIAN AR, 1994, GENET EPIDEMIOL, V11, P343, DOI 10.1002/gepi.1370110404; Acs N, 2005, BIRTH DEFECTS RES A, V73, P989, DOI 10.1002/bdra.20195; Ashique AM, 2002, DEVELOPMENT, V129, P4647; ASLING CW, 1960, SURG GYNECOL OBSTET, V111, P19; Badovinac RL, 2007, BIRTH DEFECTS RES A, V79, P8, DOI 10.1002/bdra.20315; Barlow AJ, 1999, DEV DYNAM, V214, P291, DOI 10.1002/(SICI)1097-0177(199904)214:4<291::AID-AJA2>3.0.CO;2-E; Barrow LL, 2002, J MED GENET, V39, P559, DOI 10.1136/jmg.39.8.559; Beaty TH, 2002, GENET EPIDEMIOL, V22, P1, DOI 10.1002/gepi.1039; Berk N.W., 2002, CLEFT LIP PALATE ORI, P458; Bille C, 2007, EUR J EPIDEMIOL, V22, P173, DOI 10.1007/s10654-006-9099-5; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Blavier L, 2001, MOL BIOL CELL, V12, P1457, DOI 10.1091/mbc.12.5.1457; Botto LD, 2002, EPIDEMIOLOGY, V13, P485, DOI 10.1097/00001648-200207000-00019; Botto LD, 2006, BIRTH DEFECTS RES A, V76, P693, DOI 10.1002/bdra.20307; Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; Briggs R M, 1976, Clin Plast Surg, V3, P647; Calzolari E, 2004, CLEFT PALATE-CRAN J, V41, P244, DOI 10.1597/02-074.1; Calzolari E, 2007, AM J MED GENET A, V143A, P528, DOI 10.1002/ajmg.a.31447; Canfield MA, 2005, BIRTH DEFECTS RES A, V73, P679, DOI 10.1002/bdra.20210; Carmichael SL, 2007, EPIDEMIOLOGY, V18, P356, DOI 10.1097/01.ede.0000259986.85239.87; CARTER CO, 1982, J MED GENET, V19, P246, DOI 10.1136/jmg.19.4.246; Casey LM, 2006, DEV DYNAM, V235, P1830, DOI 10.1002/dvdy.20821; CASTILLA EE, 1990, INT J EPIDEMIOL, V19, P399, DOI 10.1093/ije/19.2.399; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Chen XK, 2007, HUM REPROD, V22, P1730, DOI 10.1093/humrep/dem043; Chevrier C, 2005, BIRTH DEFECTS RES A, V73, P114, DOI 10.1002/bdra.20103; Chevrier C, 2007, AM J MED GENET A, V143A, P248, DOI 10.1002/ajmg.a.31462; CHING GHS, 1974, AM J HUM GENET, V26, P162; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; Christensen K, 1999, AM J EPIDEMIOL, V149, P248; Clark JD, 2003, CLEFT PALATE-CRAN J, V40, P481, DOI 10.1597/1545-1569(2003)040<0481:SSAOCI>2.0.CO;2; Croen LA, 1998, AM J MED GENET, V79, P42, DOI 10.1002/(SICI)1096-8628(19980827)79:1<42::AID-AJMG11>3.0.CO;2-M; Cuervo R, 2004, DEVELOPMENT, V131, P15, DOI 10.1242/dev.00907; Cuervo R, 2002, DEV BIOL, V245, P145, DOI 10.1006/dbio.2002.0620; CURTIS EJ, 1961, AM J DIS CHILD, V102, P853, DOI 10.1001/archpedi.1961.02080010855007; Czeizel AE, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.6.e66; CZEIZEL AE, 1993, ANN NY ACAD SCI, V678, P266; Davalbhakta A, 2000, BRIT J PLAST SURG, V53, P298, DOI 10.1054/bjps.2000.3330; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; DOUGLAS B, 1958, Plast Reconstr Surg Transplant Bull, V22, P94, DOI 10.1097/00006534-195808000-00002; DRAVET C, 1992, NEUROLOGY, V42, P75; FITZPATRICK D, 1993, J CRAN GENET DEV BIO, V13, P230; FITZPATRICK DR, 1990, DEVELOPMENT, V109, P585; FitzPatrick DR, 2003, HUM MOL GENET, V12, P2491, DOI 10.1093/hmg/ddg248; Fogh-Andersen, 1942, INHERITANCE HARELIP; Forman D, 2004, LANCET, V364, P1193, DOI 10.1016/S0140-6736(04)17153-5; Fraser FC, 1998, TERATOLOGY, V57, P93, DOI 10.1002/(SICI)1096-9926(199802)57:2<93::AID-TERA8>3.0.CO;2-7; FRASER FC, 1985, J CRAN GENET DEV BIO, P85; Fryer A A, 1999, IARC Sci Publ, P303; FUJINO HIROSHI, 1963, KYUSHU J MED SCI, V14, P317; Garcia AM, 1998, AM J IND MED, V33, P232, DOI 10.1002/(SICI)1097-0274(199803)33:3&lt;232::AID-AJIM4&gt;3.0.CO;2-Y; Gato A, 2002, DEV BIOL, V250, P393, DOI 10.1006/dbio.2002.0792; Ghassibe M, 2005, EUR J HUM GENET, V13, P1239, DOI 10.1038/sj.ejhg.5201486; GLENNY AM, 2004, COCHRANE DB SYST REV, V3; GORDON JE, 1981, ARCH ENVIRON HEALTH, V36, P213, DOI 10.1080/00039896.1981.10667627; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Hartsfield JK, 2001, AM J MED GENET, V102, P21, DOI 10.1002/1096-8628(20010722)102:1<21::AID-AJMG1409>3.0.CO;2-T; Hasslof P, 2007, INT J PAEDIATR DENT, V17, P313, DOI 10.1111/j.1365-263X.2007.00847.x; Hernandez-Diaz S, 2000, NEW ENGL J MED, V343, P1608, DOI 10.1056/NEJM200011303432204; HILL L, 1988, J EPIDEMIOL COMMUN H, V42, P1, DOI 10.1136/jech.42.1.1; Honein MA, 2007, EPIDEMIOLOGY, V18, P226, DOI 10.1097/01.ede.0000254430.61294.c0; Hu D, 2003, DEVELOPMENT, V130, P1749, DOI 10.1242/dev.00397; HWANG SJ, 1995, AM J EPIDEMIOL, V141, P629, DOI 10.1093/oxfordjournals.aje.a117478; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; *INT CLEAR BIRTH D, 2001, ANN REP 2001 DAT 199; Ioannidis JPA, 2005, AM J EPIDEMIOL, V162, P302, DOI 10.1093/aje/kwi201; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Jakobsen LP, 2006, CLEFT PALATE-CRAN J, V43, P155, DOI 10.1597/05-008.1; Jiang RL, 2006, DEV DYNAM, V235, P1152, DOI 10.1002/dvdy.20646; Johnson CY, 2008, INT J EPIDEMIOL, V37, P1041, DOI 10.1093/ije/dyn098; Jugessur A, 2003, AM J EPIDEMIOL, V157, P1083, DOI 10.1093/aje/kwg097; Jugessur A, 2008, GENET EPIDEMIOL, V32, P413, DOI 10.1002/gepi.20314; Kaartinen V, 1997, DEV DYNAM, V209, P255, DOI 10.1002/(SICI)1097-0177(199707)209:3<255::AID-AJA1>3.0.CO;2-H; Kallen B, 2003, CLEFT PALATE-CRAN J, V40, P624, DOI 10.1597/02-077; KAUFMAN N, 2002, WOMEN TOBACCO EPIDEM, P69; KHOURY MJ, 1992, TERATOLOGY, V46, P69, DOI 10.1002/tera.1420460110; Kimonis VE, 1997, AM J MED GENET, V69, P299, DOI 10.1002/(SICI)1096-8628(19970331)69:3<299::AID-AJMG16>3.0.CO;2-M; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Krapels IPC, 2004, BJOG-INT J OBSTET GY, V111, P661, DOI 10.1111/j.1471-0528.2004.00171.x; Lammer EJ, 2004, BIRTH DEFECTS RES A, V70, P846, DOI 10.1002/bdra.20081; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; LECK I, 1995, J EPIDEMIOL COMMUN H, V49, P171, DOI 10.1136/jech.49.2.171; Lee SH, 2001, NATURE, V414, P909, DOI 10.1038/414909a; LITTLE J, 1986, SEMIN PERINATOL, V10, P50; Little J, 2008, CLEFT PALATE-CRAN J, V45, P428, DOI 10.1597/06-151.1; Little J, 2008, CLEFT PALATE-CRAN J, V45, P420, DOI 10.1597/06-150.1; Little J, 2004, CLEFT PALATE-CRAN J, V41, P381, DOI 10.1597/02-142.1; Little J, 2004, B WORLD HEALTH ORGAN, V82, P213; Lopez-Camelo JS, 2005, AM J MED GENET A, V135A, P120, DOI 10.1002/ajmg.a.30651; Maestri NE, 1997, AM J MED GENET, V73, P337, DOI 10.1002/(SICI)1096-8628(19971219)73:3<337::AID-AJMG21>3.0.CO;2-J; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MARAZITA ML, 1992, AM J HUM GENET, V51, P648; Martinez-Alvarez C, 2000, INT J DEV BIOL, V44, P331; Meyer KA, 2003, BIRTH DEFECTS RES A, V67, P509, DOI 10.1002/bdra.10057; Michailidis GD, 2001, CURR OPIN OBSTET GYN, V13, P207, DOI 10.1097/00001703-200104000-00016; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; MILLER TJ, 1972, TERATOLOGY, V6, P351, DOI 10.1002/tera.1420060313; MILLS LF, 1968, ANGLE ORTHOD, V38, P199; Mitchell LE, 1997, GENET EPIDEMIOL, V14, P231; Mitchell LE, 2003, AM J EPIDEMIOL, V158, P69, DOI 10.1093/aje/kwg102; Mitchell LE, 2001, AM J EPIDEMIOL, V153, P1007, DOI 10.1093/aje/153.10.1007; Mogass M, 2000, INT J DEV BIOL, V44, P317; Mossey P., 2003, GLOBAL REGISTRY DATA; Mossey P., 2002, CLEFT LIP PALATE, P127; Mossey PA, 1998, BRIT J ORAL MAX SURG, V36, P202, DOI 10.1016/S0266-4356(98)90498-3; Mossey PA, 2007, CLEFT PALATE-CRAN J, V44, P244, DOI 10.1597/06-002; Munger RG, 2004, BIRTH DEFECTS RES A, V70, P464, DOI 10.1002/bdra.20037; Neilson DE, 2002, AM J MED GENET, V108, P281, DOI 10.1002/ajmg.10165; Ngai CW, 2005, J MATERN-FETAL NEO M, V17, P203, DOI 10.1080/14767050500072854; NISWANDER JD, 1972, LANCET, V2, P858; Nopoulos P, 2007, ARCH PEDIAT ADOL MED, V161, P753, DOI 10.1001/archpedi.161.8.753; *OFF US SURG GEN, 2001, WOM SMOK REP SURG GE; Park JW, 2007, GENET MED, V9, P219, DOI 10.1097/GIM.0b013e3180423cca; Park-Wyllie L, 2000, TERATOLOGY, V62, P385, DOI 10.1002/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Ray JG, 2003, J PEDIATR-US, V143, P805, DOI 10.1067/S0022-3476(03)00495-5; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Rittler M, 2004, BIRTH DEFECTS RES A, V70, P13, DOI 10.1002/bdra.10131; Romitti PA, 1999, TERATOLOGY, V59, P39, DOI 10.1002/(SICI)1096-9926(199901)59:1<39::AID-TERA9>3.0.CO;2-7; Romitti PA, 2007, AM J EPIDEMIOL, V166, P775, DOI 10.1093/aje/kwm146; ROTHMAN KJ, 1995, NEW ENGL J MED, V333, P1369, DOI 10.1056/NEJM199511233332101; SANDHAM A, 1986, CLEFT PALATE J, V23, P206; Schliekelman P, 2002, AM J HUM GENET, V71, P1369, DOI 10.1086/344779; SHAW GM, 1995, LANCET, V346, P393, DOI 10.1016/S0140-6736(95)92778-6; Shaw GM, 2003, AM J EPIDEMIOL, V157, P475, DOI 10.1093/aje/kwg013; Shaw GM, 1996, AM J HUM GENET, V58, P551; Shaw GM, 1999, AM J MED GENET, V85, P84, DOI 10.1002/(SICI)1096-8628(19990702)85:1<84::AID-AJMG15>3.0.CO;2-V; SHAW GM, 1995, REPROD TOXICOL, V9, P97, DOI 10.1016/0890-6238(95)93875-J; Shaw GM, 1998, CLEFT PALATE-CRAN J, V35, P366, DOI 10.1597/1545-1569(1998)035<0366:ITAGOC>2.3.CO;2; Shaw WC, 2001, J CRANIO MAXILL SURG, V29, P131, DOI 10.1054/jcms.2001.0217; Sigler A, 1999, CLEFT PALATE-CRAN J, V36, P139, DOI 10.1597/1545-1569(1999)036<0139:NDAMCL>2.3.CO;2; Simmons CJ, 2004, BIRTH DEFECTS RES A, V70, P559, DOI 10.1002/bdra.20063; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Sozen MA, 2001, NAT GENET, V29, P141, DOI 10.1038/ng740; Sperber G. H., 2002, CLEFT LIP PALATE ORI, V1st, P5; Stoll C, 2000, ANN GENET-PARIS, V43, P11, DOI 10.1016/S0003-3995(00)00011-3; Sun DZ, 2000, DEV BIOL, V228, P337, DOI 10.1006/dbio.2000.9946; Suzuki K, 2000, NAT GENET, V25, P427, DOI 10.1038/78119; Tamura T, 2005, BIRTH DEFECTS RES A, V73, P612, DOI 10.1002/bdra.20179; Taya Y, 1999, DEVELOPMENT, V126, P3869; Thomason HA, 2008, DEV BIOL, V321, P273, DOI 10.1016/j.ydbio.2008.06.030; Tolarova MM, 1998, AM J MED GENET, V75, P126; Tudela C, 2002, INT J DEV BIOL, V46, P333; Ulrich M, 1999, EUR J OBSTET GYN R B, V87, P111, DOI 10.1016/S0301-2115(99)00085-8; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; van Rooij IALM, 2004, PREV MED, V39, P689, DOI 10.1016/j.ypmed.2004.02.036; van Rooij IALM, 2003, AM J EPIDEMIOL, V157, P583, DOI 10.1093/aje/kwg005; Van Rooij IALM, 2002, TERATOLOGY, V66, P260, DOI 10.1002/tera.10096; van Rooij IALM, 2001, EPIDEMIOLOGY, V12, P502, DOI 10.1097/00001648-200109000-00007; Vieira AR, 2007, AM J MED GENET A, V143A, P2075, DOI 10.1002/ajmg.a.31884; Vieira AR, 2006, AM J EPIDEMIOL, V163, P790, DOI 10.1093/aje/kwj103; Vieira AR, 2005, AM J MED GENET A, V135A, P220, DOI 10.1002/ajmg.a.30705; WARKANY J, 1972, TERATOLOGY, V5, P319, DOI 10.1002/tera.1420050307; Warkany J, 1940, SCIENCE, V92, P383, DOI 10.1126/science.92.2391.383; *WHO HUM GEN PROGR, 2002, GLOB STRAT RED HLTH; WINDSOR R, 2002, WOMEN TOBACCO EPIDEM, P147; Wong F. K., 2004, Hong Kong Medical Journal, V10, P331; Wong WY, 1999, TERATOLOGY, V60, P253, DOI 10.1002/(SICI)1096-9926(199911)60:5<253::AID-TERA4>3.0.CO;2-V; WOOLF CM, 1977, AM J HUM GENET, V29, P503; Wyszynski DF, 1998, AM J MED GENET, V79, P184, DOI 10.1002/(SICI)1096-8628(19980923)79:3<184::AID-AJMG6>3.0.CO;2-N; Xu X, 2006, DEV BIOL, V297, P238, DOI 10.1016/j.ydbio.2006.05.014; Yazdy MM, 2007, BIRTH DEFECTS RES A, V79, P16, DOI 10.1002/bdra.20319; Zeiger JS, 2005, CLEFT PALATE-CRAN J, V42, P58, DOI 10.1597/02-128.1; Zeiger JS, 2003, EUR J HUM GENET, V11, P835, DOI 10.1038/sj.ejhg.5201052; Zhang ZY, 2002, DEVELOPMENT, V129, P4135; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	170	891	939	4	177	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 21	2009	374	9703					1773	1785		10.1016/S0140-6736(09)60695-4	http://dx.doi.org/10.1016/S0140-6736(09)60695-4			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	525ID	19747722				2022-12-28	WOS:000272207700026
J	Lauchle, JO; Kim, D; Le, DT; Akagi, K; Crone, M; Krisman, K; Warner, K; Bonifas, JM; Li, Q; Coakley, KM; Diaz-Flores, E; Gorman, M; Przybranowski, S; Tran, M; Kogan, SC; Roose, JP; Copeland, NG; Jenkins, NA; Parada, L; Wolff, L; Sebolt-Leopold, J; Shannon, K				Lauchle, Jennifer O.; Kim, Doris; Le, Doan T.; Akagi, Keiko; Crone, Michael; Krisman, Kimberly; Warner, Kegan; Bonifas, Jeannette M.; Li, Qing; Coakley, Kristen M.; Diaz-Flores, Ernesto; Gorman, Matthew; Przybranowski, Sally; Tran, Mary; Kogan, Scott C.; Roose, Jeroen P.; Copeland, Neal G.; Jenkins, Nancy A.; Parada, Luis; Wolff, Linda; Sebolt-Leopold, Judith; Shannon, Kevin			Response and resistance to MEK inhibition in leukaemias initiated by hyperactive Ras	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; MALIGNANT MYELOID DISORDERS; BCR-ABL; HEMATOPOIETIC-CELLS; KINASE INHIBITORS; TYROSINE KINASE; BLAST CRISIS; BONE-MARROW; CHILDREN; PATHWAY	The cascade comprising Raf, mitogen-activated protein kinase kinase (MEK) and extracellular signal-regulated kinase (ERK) is a therapeutic target in human cancers with deregulated Ras signalling, which includes tumours that have inactivated the Nf1 tumour suppressor(1,2). Nf1 encodes neurofibromin, a GTPase-activating protein that terminates Ras signalling by stimulating hydrolysis of Ras-GTP. We compared the effects of inhibitors of MEK in a myeloproliferative disorder (MPD) initiated by inactivating Nf1 in mouse bone marrow and in acute myeloid leukaemias (AMLs) in which cooperating mutations were induced by retroviral insertional mutagenesis. Here we show that MEK inhibitors are ineffective in MPD, but induce objective regression of many Nf1-deficient AMLs. Drug resistance developed because of outgrowth of AML clones that were present before treatment. We cloned clone-specific retroviral integrations to identify candidate resistance genes including Rasgrp1, Rasgrp4 and Mapk14, which encodes p38 alpha. Functional analysis implicated increased RasGRP1 levels and reduced p38 kinase activity in resistance to MEK inhibitors. This approach represents a robust strategy for identifying genes and pathways that modulate how primary cancer cells respond to targeted therapeutics and for probing mechanisms of de novo and acquired resistance.	[Lauchle, Jennifer O.; Kim, Doris; Le, Doan T.; Crone, Michael; Krisman, Kimberly; Warner, Kegan; Bonifas, Jeannette M.; Diaz-Flores, Ernesto; Gorman, Matthew; Tran, Mary; Shannon, Kevin] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Li, Qing] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Coakley, Kristen M.; Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Kogan, Scott C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Akagi, Keiko] NCI, Mouse Canc Genet Program, Frederick, MD 21702 USA; [Przybranowski, Sally; Sebolt-Leopold, Judith] Pfizer Global Res & Dev, Ann Arbor, MI 48105 USA; [Copeland, Neal G.; Jenkins, Nancy A.] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Parada, Luis] Univ Texas SW, Dallas, TX 75235 USA; [Wolff, Linda] NCI, Cellular Oncol Lab, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pfizer; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Shannon, K (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	shannonk@peds.ucsf.edu		Roose, Jeroen/0000-0003-4746-2811; Kogan, Scott/0000-0002-2395-8479	National Institutes of Health [U01 CA84221, R37 CA72614, T32 CA09043, T32 HD044331, K08 CA119105]; Leukemia and Lymphoma Society [LLS 7019-04]; US Army Neurofibromatosis Research Program [DAMD 17-02-1-0638]; Ronald McDonald House Charities of Southern California/Couples Against Leukemia; Jeffrey and Karen Peterson Family Foundation; Frank A. Campini Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD044331] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA084221, T32CA009043, T32CA128583, R37CA072614, K08CA119105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); US Army Neurofibromatosis Research Program; Ronald McDonald House Charities of Southern California/Couples Against Leukemia; Jeffrey and Karen Peterson Family Foundation; Frank A. Campini Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to B. Braun, J. Downing, S. Lowe and C. Sawyers for discussion and advice throughout the project. We are thankful for C. Hartzell for studies on RasGRP protein expression. This work was supported by National Institutes of Health grants U01 CA84221, R37 CA72614, T32 CA09043, T32 HD044331 and K08 CA119105, by a Specialized Center of Research award from the Leukemia and Lymphoma Society (LLS 7019-04), by the US Army Neurofibromatosis Research Program (Project DAMD 17-02-1-0638), by the Ronald McDonald House Charities of Southern California/Couples Against Leukemia, by the Jeffrey and Karen Peterson Family Foundation and by the Frank A. Campini Foundation. S. C. K. is a Scholar of the Leukemia and Lymphoma Society of America. J. P. R. is a Kimmel Foundation Scholar. The Intramural Research Program of the National Cancer Institute's Center for Cancer Research supports research in the laboratory of L. W. at the National Institutes of Health.	Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Choi S, 2007, BLOOD, V110, P632, DOI 10.1182/blood-2007-01-067785; Curtiss NP, 2005, GENOMICS, V85, P600, DOI 10.1016/j.ygeno.2005.01.013; Das J, 2009, CELL, V136, P337, DOI 10.1016/j.cell.2008.11.051; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Lauchle JO, 2006, PEDIATR BLOOD CANCER, V46, P579, DOI 10.1002/pbc.20644; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Parmar S, 2004, J BIOL CHEM, V279, P25345, DOI 10.1074/jbc.M400590200; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; Stone JC, 2006, BIOCHEM SOC T, V34, P858, DOI 10.1042/BST0340858; Van Etten RA, 2004, CANCER CELL, V6, P547, DOI 10.1016/j.ccr.2004.12.004; Wolff L, 2003, J VIROL, V77, P4965, DOI 10.1128/JVI.77.8.4965-4971.2003	25	105	106	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					411	U110		10.1038/nature08279	http://dx.doi.org/10.1038/nature08279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19727076	Green Accepted			2022-12-28	WOS:000269828100043
J	Wiley, LF; Gostin, LO				Wiley, Lindsay F.; Gostin, Lawrence O.			The International Response to Climate Change An Agenda for Global Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global & Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global & Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Wiley, Lindsay/0000-0001-7918-329X				BALS C, 2008, POZNAN COPENHAGEN CL; Bates B.C., 2008, CLIMATE CHANGE WATER; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Brown, 2008, PLAN B 3 0; CONFALONIERI U, 2007, CLIMATE CHANGE 2007, P291; Gostin LO, 2007, JAMA-J AM MED ASSOC, V298, P89, DOI 10.1001/jama.298.1.89; HARMELING S, 2008, MAKING ADAPTATION FU; MAX A, 2009, HUFFINGTON POST 0329; NEIRA M, 2009, WORLD CONSERV, V1, P24; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Takacs D., 2009, HASTINGS WNWJ ENV L, V15, P39; Tanser FC, 2003, LANCET, V362, P1792, DOI 10.1016/S0140-6736(03)14898-2; *UN FAO, EN AGR CONTR CLIM CH; WOOD P, 2008, CLIMATE DILEMMA	14	14	15	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 16	2009	302	11					1218	1220		10.1001/jama.2009.1381	http://dx.doi.org/10.1001/jama.2009.1381			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494FR	19755701				2022-12-28	WOS:000269797600032
J	Cairns, JA				Cairns, John A.			In patients with atrial fibrillation, adding clopidogrel to aspirin reduced major vascular events but increased bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Cairns, JA (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.		Cairns, John/AAI-8744-2021					Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007	2	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 15	2009	151	6							JC3-8	10.7326/0003-4819-151-6-200909150-02008	http://dx.doi.org/10.7326/0003-4819-151-6-200909150-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	501OB	19755354				2022-12-28	WOS:000270390100025
J	Heath, I				Heath, Iona			Life and Death No power for the people	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												aque22@dsl.pipex.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 14	2009	339								b3735	10.1136/bmj.b3735	http://dx.doi.org/10.1136/bmj.b3735			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496RP	19752058				2022-12-28	WOS:000269994300021
J	Mooney, G; Gilson, L				Mooney, Gavin; Gilson, Lucy			The economic situation in South Africa and health inequities	LANCET			English	Editorial Material									[Mooney, Gavin; Gilson, Lucy] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, Western Cape, South Africa; [Gilson, Lucy] London Sch Hyg & Trop Med, London WC1, England	University of Cape Town; University of London; London School of Hygiene & Tropical Medicine	Mooney, G (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7925 Cape Town, Western Cape, South Africa.	g.mooney@westnet.com.au	Gilson, Lucy/R-8846-2019	Gilson, Lucy/0000-0002-2775-7703				MANUEL TA, 2009, COMMUNICATION   1211; *POL ORG ZA, 2008, FINMARK C POL ORG ZA; PRINGLE C, 2009, SA ENTERS RECESSION; *REP S AFR, ACC SHAR GROWTH IN S; *REP S AFR GOV 196, 1996, GROWTH EMPL RED MACR; Schwabe C., 2004, FACT SHEET POVERTY S; SEMONO N, 2009, S AFRICA GDP DROPS 6; STATISTICS SOUTH AFRICA, 2008, 010001 STAT S AFR; Zuma J., 2009, STATE NATION ADDRESS; 2009, BUSINESS REP    0527	10	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 12	2009	374	9693					858	859		10.1016/S0140-6736(09)61125-9	http://dx.doi.org/10.1016/S0140-6736(09)61125-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	496BN	19709735				2022-12-28	WOS:000269943100007
J	Wolitz, R; Emanuel, E; Shah, S				Wolitz, Rebecca; Emanuel, Ezekiel; Shah, Seema			Rethinking the responsiveness requirement for international research	LANCET			English	Editorial Material									[Shah, Seema] NIAID, HJF Liaison Off, Div Aids, Dept Bioeth,NIH,Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shah, S (corresponding author), NIAID, HJF Liaison Off, Div Aids, Dept Bioeth,NIH,Clin Ctr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.	shahse@mail.nih.gov		Shah, Seema/0000-0001-7726-1186				61st World Health Assembly, 61 WORLD HLTH ASSEMB; Barton JH, 2005, JAMA-J AM MED ASSOC, V294, P2075, DOI 10.1001/jama.294.16.2075; Carse AL, 2008, EXPLOITATION AND DEVELOPING COUNTRIES: THE ETHICS OF CLINICAL RESEARCH, P206; *CIOMS, 2002, INT ETH GUID BIOM RE; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Gbadegesin S, 2006, BIOETHICS, V20, P248, DOI 10.1111/j.1467-8519.2006.00501.x; Global Forum for Health Research, 2002, 10 90 REP HLTH RES 2; Grady Christine, 2006, Virtual Mentor, V8, P235, DOI 10.1001/virtualmentor.2006.8.4.pfor2-0604; Kant I., 1785, GROUNDWORK METAPHYSI; Kantor R, 2005, PLOS MED, V2, P325, DOI 10.1371/journal.pmed.0020112; KETTLER H, 2007, ETHICAL ISSUES INT B, P97; Kremer M, 2004, STRONG MED CREATING; Lie R., 2008, OXFORD TXB CLIN RES, P737; National Bioethics Advisory Commission, 2001, ETH POL ISS INT RES; Nuffield Council on Bioethics, 2002, ETH RES REL HEALTHC; Participants 2001 Conference Ethical, 2004, HASTINGS CENT REP, V34, P17; Pecoul B, 2004, PLOS MED, V1, P19, DOI 10.1371/journal.pmed.0010006; Resnik D B, 2001, Dev World Bioeth, V1, P11, DOI 10.1111/1471-8847.00004; Sachs J. D., 2005, END POVERTY EC POSSI; SCHELLING TC, 1973, J CONFLICT RESOLUT, V17, P381, DOI 10.1177/002200277301700302; Shapiro HT, 2001, NEW ENGL J MED, V345, P139, DOI 10.1056/NEJM200107123450212; Wertheimer Alan, 1996, EXPLOITATION; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124; 2008, ECONOMIST       1113	24	24	24	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 5	2009	374	9692					847	849		10.1016/S0140-6736(09)60320-2	http://dx.doi.org/10.1016/S0140-6736(09)60320-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	492QU	19733781				2022-12-28	WOS:000269675000032
J	Guerrier, S; Coutinho-Budd, J; Sassa, T; Gresset, A; Jordan, NV; Chen, K; Jin, WL; Frost, A; Polleux, F				Guerrier, Sabrice; Coutinho-Budd, Jaeda; Sassa, Takayuki; Gresset, Aurelie; Jordan, Nicole Vincent; Chen, Keng; Jin, Wei-Lin; Frost, Adam; Polleux, Franck			The F-BAR Domain of srGAP2 Induces Membrane Protrusions Required for Neuronal Migration and Morphogenesis	CELL			English	Article							GTPASE-ACTIVATING PROTEINS; RHO-GTPASES; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; PYRAMIDAL NEURONS; STRUCTURAL BASIS; CELL-MIGRATION; FILOPODIA; IRSP53; FAMILY	During brain development, proper neuronal migration and morphogenesis is critical for the establishment of functional neural circuits. Here we report that srGAP2 negatively regulates neuronal migration and induces neurite outgrowth and branching through the ability of its F-BAR domain to induce filopodia-like membrane protrusions resembling those induced by I-BAR domains in vivo and in vitro. Previous work has suggested that in nonneuronal cells filopodia dynamics decrease the rate of cell migration and the persistence of leading edge protrusions. srGAP2 knockdown reduces leading process branching and increases the rate of neuronal migration in vivo. Overexpression of srGAP2 or its F-BAR domain has the opposite effects, increasing leading process branching and decreasing migration. These results suggest that F-BAR domains are functionally diverse and highlight the functional importance of proteins directly regulating membrane deformation for proper neuronal migration and morphogenesis.	[Guerrier, Sabrice; Gresset, Aurelie; Jordan, Nicole Vincent; Polleux, Franck] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Guerrier, Sabrice; Sassa, Takayuki; Polleux, Franck] Univ N Carolina, Neurosci Res Ctr, Chapel Hill, NC 27599 USA; [Coutinho-Budd, Jaeda] Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA; [Chen, Keng; Jin, Wei-Lin] Shanghai Jiao Tong Univ, Inst Neurosci, Shanghai 200240, Peoples R China; [Frost, Adam] Yale Univ, Dept Mol Biophys & Biochem, Interdept Neurosci Program, New Haven, CT 06510 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Shanghai Jiao Tong University; Yale University	Polleux, F (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	polleux@med.unc.edu	SASSA, Takayuki/B-2519-2012; , UNC Neuroscience Microscopy Core/AAE-8305-2022; Jin, Wei-Lin/A-8355-2013; Polleux, Franck/H-9948-2014	SASSA, Takayuki/0000-0003-3145-9829; Jin, Wei-Lin/0000-0001-8011-2405; Frost, Adam/0000-0003-2231-2577; Polleux, Franck/0000-0003-4313-0481	Epilepsy Foundation; National Institutes of Health (NIH) Medical Scientist Training Program [TG 5T32GM07205]; NIH Predoctoral Fellowship [5F31NS052969-03]; North Carolina Developmental Biology Training [T32 HD046369]; National Institute of Neurological Disorders and Stroke Institutional Center; Neuroscience Research [P30 NS45892-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD046369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS067557, F31NS052969] Funding Source: NIH RePORTER	Epilepsy Foundation; National Institutes of Health (NIH) Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Developmental Biology Training; National Institute of Neurological Disorders and Stroke Institutional Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Neuroscience Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a Predoctoral Research Training Fellowship from the Epilepsy Foundation (A. F.) and a National Institutes of Health (NIH) Medical Scientist Training Program award (TG 5T32GM07205 to A. F.), an NIH Predoctoral Fellowship (5F31NS052969-03 to S. G.), University of North Carolina Developmental Biology Training Grant (T32 HD046369 to J. C. B.), a Pew Scholar Award in Biomedical Sciences (F. P.), and the National Institute of Neurological Disorders and Stroke Institutional Center Core Grant to Support Neuroscience Research (P30 NS45892-01).	Aspenstrom P, 2006, TRENDS BIOCHEM SCI, V31, P670, DOI 10.1016/j.tibs.2006.10.001; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Burnette DT, 2007, NAT CELL BIOL, V9, P1360, DOI 10.1038/ncb1655; Causeret F, 2009, CEREB CORTEX, V19, P861, DOI 10.1093/cercor/bhn133; Chitu V, 2005, MOL BIOL CELL, V16, P2947, DOI 10.1091/mbc.e04-10-0914; de Rouvroit CL, 2001, MECH DEVELOP, V105, P47, DOI 10.1016/S0925-4773(01)00396-3; Dent EW, 2007, NAT CELL BIOL, V9, P1347, DOI 10.1038/ncb1654; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Govek EE, 2004, NAT NEUROSCI, V7, P364, DOI 10.1038/nn1210; Gupta A, 2003, NAT NEUROSCI, V6, P1284, DOI 10.1038/nn1151; GUPTON SL, 2007, SCI STKE, pRE5, DOI DOI 10.1126/STKE.4002007RE5; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Heng JIT, 2008, NATURE, V455, P114, DOI 10.1038/nature07198; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Konno D, 2005, J BIOL CHEM, V280, P5082, DOI 10.1074/jbc.M408251200; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Li XF, 2006, J BIOL CHEM, V281, P28430, DOI 10.1074/jbc.M604135200; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Linkermann A, 2009, BBA-PROTEINS PROTEOM, V1794, P168, DOI 10.1016/j.bbapap.2008.10.013; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Mattar P, 2004, DEV BIOL, V273, P373, DOI 10.1016/j.ydbio.2004.06.013; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Millard TH, 2007, J CELL SCI, V120, P1663, DOI 10.1242/jcs.001776; Mitin N, 2007, NAT STRUCT MOL BIOL, V14, P814, DOI 10.1038/nsmb1290; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ohshima T, 2007, DEVELOPMENT, V134, P2273, DOI 10.1242/dev.02854; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; POLLEUX F, 2002, SCI STKE, pPL9; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Saarikangas J, 2008, J CELL SCI, V121, P1444, DOI 10.1242/jcs.027466; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shutes A, 2006, METHOD ENZYMOL, V407, P9, DOI 10.1016/S0076-6879(05)07002-3; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yao Q, 2008, CELL MOL NEUROBIOL, V28, P205, DOI 10.1007/s10571-007-9187-4; Yohe ME, 2007, J BIOL CHEM, V282, P13813, DOI 10.1074/jbc.M700185200; Yoshizawa M, 2005, J NEUROSCI, V25, P4406, DOI 10.1523/JNEUROSCI.4955-04.2005	67	230	239	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					990	1004		10.1016/j.cell.2009.06.047	http://dx.doi.org/10.1016/j.cell.2009.06.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737524	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000269564600023
J	Talkish, J; Woolford, JL				Talkish, Jason; Woolford, John L., Jr.			The Rea1 Tadpole Loses Its Tail	CELL			English	Editorial Material							NUCLEAR EXPORT; 60S SUBUNITS; MATURATION; RIBOSOME	More than 170 assembly factors aid the construction and maturation of yeast ribosomes. After these factors' functions are completed, they must be released from preribosomes. In this issue, Ulbrich et al. (2009) describe a mechanochemical process through which the AAA ATPase Rea1 induces release of an assembly protein complex from preribosomes.	[Talkish, Jason; Woolford, John L., Jr.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Woolford, JL (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	jw17@andrew.cmu.edu		Woolford, John/0000-0002-7553-7043				Galani K, 2004, J BIOL CHEM, V279, P55411, DOI 10.1074/jbc.M406876200; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Nissan TA, 2004, MOL CELL, V15, P295, DOI 10.1016/j.molcel.2004.06.033; NOMURA M, 1990, RIBOSOME, P3; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	6	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 4	2009	138	5					832	834		10.1016/j.cell.2009.08.019	http://dx.doi.org/10.1016/j.cell.2009.08.019			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	491FW	19737511	Bronze			2022-12-28	WOS:000269564600009
J	Tsai, TT; Nallamothu, BK; Prasad, A; Saint, S; Bates, ER				Tsai, Thomas T.; Nallamothu, Brahmajee K.; Prasad, Abhiram; Saint, Sanjay; Bates, Eric R.			A Change of Heart.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							APICAL BALLOONING SYNDROME; ACUTE MYOCARDIAL-INFARCTION; TAKO-TSUBO; CARDIOMYOPATHY; STRESS; THROMBOLYSIS; WOMEN		[Tsai, Thomas T.] Univ Colorado, Cardiol Sect 111B, Denver Vet Affairs Med Ctr, Denver, CO 80220 USA; [Tsai, Thomas T.] Univ Colorado, Dept Internal Med, Denver, CO 80220 USA; [Nallamothu, Brahmajee K.; Saint, Sanjay] Ann Arbor VA Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.; Saint, Sanjay; Bates, Eric R.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Prasad, Abhiram] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA; [Prasad, Abhiram] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA	University of Colorado System; University of Colorado Denver; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Denver; University of Michigan System; University of Michigan; Mayo Clinic; Mayo Clinic	Tsai, TT (corresponding author), Univ Colorado, Cardiol Sect 111B, Denver Vet Affairs Med Ctr, 1055 Clermont St, Denver, CO 80220 USA.	thomas.tsai@va.gov	Saint, Sanjay/AAF-5126-2019	Prasad, Abhiram/0000-0001-9252-5602				Bybee KA, 2004, AM J CARDIOL, V94, P343, DOI 10.1016/j.amjcard.2004.04.030; Bybee KA, 2008, CIRCULATION, V118, P397, DOI 10.1161/CIRCULATIONAHA.106.677625; Dote K, 1991, J Cardiol, V21, P203; Elesber AA, 2007, J AM COLL CARDIOL, V50, P448, DOI 10.1016/j.jacc.2007.03.050; Haley JH, 1999, MAYO CLIN PROC, V74, P901, DOI 10.4065/74.9.901; Hatzaras IS, 2007, AM J CARDIOL, V100, P1470, DOI 10.1016/j.amjcard.2007.06.039; Kimura K, 2007, CIRCULATION, V115, pE620, DOI 10.1161/CIRCULATIONAHA.106.673947; KONO T, 1994, J AM COLL CARDIOL, V24, P636, DOI 10.1016/0735-1097(94)90008-6; Larson DM, 2007, JAMA-J AM MED ASSOC, V298, P2754, DOI 10.1001/jama.298.23.2754; Mootha V K, 2000, Circulation, V102, pE11; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Sharkey SW, 2008, AM J CARDIOL, V101, P1723, DOI 10.1016/j.amjcard.2008.02.062; Sharkey SW, 2005, CIRCULATION, V111, P472, DOI 10.1161/01.CIR.0000153801.51470.EB; Tsuchihashi K, 2001, J AM COLL CARDIOL, V38, P11, DOI 10.1016/S0735-1097(01)01316-X; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	15	7	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 3	2009	361	10					1010	1016		10.1056/NEJMcps0903023	http://dx.doi.org/10.1056/NEJMcps0903023			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	490EI	19726776				2022-12-28	WOS:000269480400012
J	Mandel, LR				Mandel, Lee R.			Endocrine and Autoimmune Aspects of the Health History of John F. Kennedy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SYNDROME TYPE-II; POLYGLANDULAR SYNDROME; ADDISONS-DISEASE; AUTOANTIBODIES; FEATURES	At the age of 43 years, John F. Kennedy was the youngest man ever elected president. Throughout both his campaign and his presidency, he was portrayed as the epitome of youth and vigor. In fact, he had the most complex medical history of anyone to occupy the White House. The recent opening of his White House medical records has provided researchers greater insight into the multiple medical conditions that afflicted Kennedy. A recent review of these records, coupled with other available sources, allows new understanding of his health history that can now be explained in the context of a unifying autoimmune endocrine disorder.	[Mandel, Lee R.] USN, Med Corps, Chesapeake, VA USA	United States Department of Defense; United States Navy	Mandel, LR (corresponding author), Dept Hlth Serv, Div H, USS George HW Bush CVN 77, FPO, AE 09513 USA.	mandellr@cvn77.navy.mil						ADDISON T, 1849, LODN MED GAZ, V12, P535; Barton SH, 2008, GASTROENTEROL CLIN N, V37, P411, DOI 10.1016/j.gtc.2008.02.001; Bhasin S, 2006, J CLIN ENDOCR METAB, V91, P1995, DOI 10.1210/jc.2005-2847; BLAIR J, 1976, SEARCH JFK, P561; BLAIR J, 1976, SEARCH JFK, P579; Blair Joan, 1976, SEARCH JFK; Caturegli P, 2005, ENDOCR REV, V26, P599, DOI 10.1210/er.2004-0011; DALLEK R, 2003, UNFINISHED LIFE, P471; Falorni A, 2002, ENDOCRIN METAB CLIN, V31, P369, DOI 10.1016/S0889-8529(01)00010-X; Guo YK, 2007, EUR J RADIOL, V62, P126, DOI 10.1016/j.ejrad.2006.11.025; KENNEDY JF, 2001, COMMUNICATION   0313, P93; LAWRENCE WH, 1960, NY TIMES        0705, P19; LIVINGSTONE HE, 1992, HIGH TREASON, V2, P179; LUNDBERG GD, 1992, JAMA-J AM MED ASSOC, V268, P1736, DOI 10.1001/jama.268.13.1736; MACLAREN NK, 1985, DIABETES CARE, V8, P34, DOI 10.2337/diacare.8.1.S34; Majeroni BA, 2007, AM FAM PHYSICIAN, V75, P667; MURPHY WP, 1935, COMMUNICATION   1216; Myhre AG, 2002, J CLIN ENDOCR METAB, V87, P618, DOI 10.1210/jc.87.2.618; NEUFELD M, 1981, MEDICINE, V60, P355, DOI 10.1097/00005792-198109000-00003; NEUFELD M, 1980, PEDIATR ANN, V9, P43, DOI 10.3928/0090-4481-19800401-07; NICHOLAS JA, 1955, ARCH SURG-CHICAGO, V71, P737; Parkinson J, 1910, LANCET, V2, P543; REEVES R, 1993, PRESIDENT KENNEDY PR, P42; REEVES T, 1991, QUESTION CHARACTER L, P92; Robles DT, 2002, ENDOCRIN METAB CLIN, V31, P353, DOI 10.1016/S0889-8529(01)00015-9; ROITT IM, 1956, LANCET, V271, P820; Schatz DA, 2002, ENDOCRIN METAB CLIN, V31, P339, DOI 10.1016/S0889-8529(01)00012-3; Schmidt MB., 1926, VERH DTSCH GES PATHO, V21, P212; SCHWARTZ S, 2005, UNKNOWN REMARKABLE L, P177; TRAVELL J, 1966, COMMUNICATION   0120, P9; TRAVELL J, 1968, OFFICE HOURS DAY NIG, P6; TRAVELL J, 1960, COMMUNICATION   0711; TRAVELL J, 1960, COMMUNICATION   0705	33	13	13	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	2009	151	5					350	354		10.7326/0003-4819-151-5-200909010-00011	http://dx.doi.org/10.7326/0003-4819-151-5-200909010-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	492KB	19721023				2022-12-28	WOS:000269653100009
J	Yang, WL; Wang, J; Chan, CH; Lee, SW; Campos, AD; Lamothe, B; Hur, L; Grabiner, BC; Lin, X; Darnay, BG; Lin, HK				Yang, Wei-Lei; Wang, Jing; Chan, Chia-Hsin; Lee, Szu-Wei; Campos, Alejandro D.; Lamothe, Betty; Hur, Lana; Grabiner, Brian C.; Lin, Xin; Darnay, Bryant G.; Lin, Hui-Kuan			The E3 Ligase TRAF6 Regulates Akt Ubiquitination and Activation	SCIENCE			English	Article							HUMAN CANCER; PH DOMAIN; PATHWAY; MDM2; SURVIVAL; RECEPTOR	Akt signaling plays a central role in many biological functions, such as cell proliferation and apoptosis. Because Akt (also known as protein kinase B) resides primarily in the cytosol, it is not known how these signaling molecules are recruited to the plasma membrane and subsequently activated by growth factor stimuli. We found that the protein kinase Akt undergoes lysine-63 chain ubiquitination, which is important for Akt membrane localization and phosphorylation. TRAF6 was found to be a direct E3 ligase for Akt and was essential for Akt ubiquitination, membrane recruitment, and phosphorylation upon growth-factor stimulation. The human cancer-associated Akt mutant displayed an increase in Akt ubiquitination, in turn contributing to the enhancement of Akt membrane localization and phosphorylation. Thus, Akt ubiquitination is an important step for oncogenic Akt activation.	[Yang, Wei-Lei; Wang, Jing; Chan, Chia-Hsin; Lee, Szu-Wei; Grabiner, Brian C.; Lin, Xin; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Yang, Wei-Lei; Lee, Szu-Wei; Grabiner, Brian C.; Lin, Xin; Lin, Hui-Kuan] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Campos, Alejandro D.; Lamothe, Betty; Hur, Lana; Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Lin, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	hklin@mdanderson.org	Chan, Chia-Hsin/AAT-7782-2020; Yang, Wei-Lei/E-2598-2012; 高, 雨莉/HGU-8187-2022	Chan, Chia-Hsin/0000-0001-8506-7500	M. D. Anderson Trust Scholar Fund; NATIONAL CANCER INSTITUTE [R01CA149321] Funding Source: NIH RePORTER	M. D. Anderson Trust Scholar Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. C. Hung, D. Bohmann, M. Eiliers, A. M. Weissman, S. Lipkowitz, J. L. Wrana, X. Yang, W. C. Yeh, and T. Mak for reagents; M. C. Hung, D. Sarbassov, and M. H. Lee for insightful comments and suggestions; H. Li and S. Zhang for their technical support and sharing reagents; Z. Han for assistance in confocal microscopy; and V. M. Mohlere and T. Locke for their critical reading and editing of our manuscript. This work was supported by the M. D. Anderson Trust Scholar Fund to H.K.L.	Adhikary S, 2005, CELL, V123, P409, DOI 10.1016/j.cell.2005.08.016; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rong SB, 2001, J MED CHEM, V44, P898, DOI 10.1021/jm000493i; Varnai P, 2005, J CELL SCI, V118, P4879, DOI 10.1242/jcs.02606; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Yu HG, 2008, INT J CANCER, V122, P433, DOI 10.1002/ijc.23049; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	21	422	450	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 28	2009	325	5944					1134	1138		10.1126/science.1175065	http://dx.doi.org/10.1126/science.1175065			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	488WZ	19713527	Green Accepted			2022-12-28	WOS:000269382300043
J	Bijkerk, CJ; de Wit, NJ; Muris, JWM; Whorwell, PJ; Knottnerus, JA; Hoes, AW				Bijkerk, C. J.; de Wit, N. J.; Muris, J. W. M.; Whorwell, P. J.; Knottnerus, J. A.; Hoes, A. W.			Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOOD FREQUENCY QUESTIONNAIRE; QUALITY-OF-LIFE; GENERAL-PRACTITIONERS; RELATIVE VALIDITY; CLINICAL-TRIALS; ROME-II; MANAGEMENT; SYMPTOMS; BRAN; REPRODUCIBILITY	Objective To determine the effectiveness of increasing the dietary content of soluble fibre (psyllium) or insoluble fibre (bran) in patients with irritable bowel syndrome. Design Randomised controlled trial. Setting General practice. Participants 275 patients aged 18-65 years with irritable bowel syndrome. Interventions 12 weeks of treatment with 10 g psyllium (n=85), 10 g bran (n=97), or 10 g placebo ( rice flour) (n=93). Main outcome measures The primary end point was adequate symptom relief during at least two weeks in the previous month, analysed after one, two, and three months of treatment to assess both short term and sustained effectiveness. Secondary end points included irritable bowel syndrome symptom severity score, severity of abdominal pain, and irritable bowel syndrome quality of life scale. Results The proportion of responders was significantly greater in the psyllium group than in the placebo group during the first month (57% v 35%; relative risk 1.60, 95% confidence interval 1.13 to 2.26) and the second month of treatment (59% v 41%; 1.44, 1.02 to 2.06). Bran was more effective than placebo during the third month of treatment only ( 57% v 32%; 1.70, 1.12 to 2.57), but this was not statistically significant in the worst case analysis (1.45, 0.97 to 2.16). After three months of treatment, symptom severity in the psyllium group was reduced by 90 points, compared with 49 points in the placebo group (P=0.03) and 58 points in the bran group (P=0.61 versus placebo). No differences were found with respect to quality of life. Fifty four (64%) of the patients allocated to psyllium, 54 (56%) in the bran group, and 56 (60%) in the placebo group completed the three month treatment period. Early dropout was most common in the bran group; the main reason was that the symptoms of irritable bowel syndrome worsened. Conclusions Psyllium offers benefits in patients with irritable bowel syndrome in primary care. Trial registration Clinical trials NCT00189033.	[Bijkerk, C. J.; de Wit, N. J.; Hoes, A. W.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Muris, J. W. M.; Knottnerus, J. A.] Maastricht Univ, Dept Gen Practice, CAPHRI, NL-6200 MD Maastricht, Netherlands; [Whorwell, P. J.] Univ Manchester, Dept Med & Gastroenterol, Manchester M23 9LT, Lancs, England	Utrecht University; Utrecht University Medical Center; Maastricht University; University of Manchester	Bijkerk, CJ (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, POB 85500, NL-3508 GA Utrecht, Netherlands.	c.j.bijkerk-2@umcutrecht.nl	Knottnerus, Andre/F-4866-2013; Knottnerus, Johannes A/A-3829-2009	Whorwell, Peter/0000-0002-5220-8474; Muris, Jean/0000-0002-8780-476X	The Netherlands Organisation for Health Research and Development	The Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The Netherlands Organisation for Health Research and Development provided peer-reviewed funding for this study. The psyllium for this study was delivered by Pfizer BV, the Netherlands. The sponsors of this study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Agrawal A, 2006, BMJ-BRIT MED J, V332, P280, DOI 10.1136/bmj.332.7536.280; Bijkerk CJ, 2008, J CLIN EPIDEMIOL, V61, P1176, DOI 10.1016/j.jclinepi.2008.02.001; Bijkerk CJ, 2004, ALIMENT PHARM THER, V19, P245, DOI 10.1111/j.0269-2813.2004.01862.x; Bijkerk CJ, 2003, CAN J GASTROENTEROL, V17, P363, DOI 10.1155/2003/532138; Bijkerk CJ, 2003, AM J GASTROENTEROL, V98, P122; van der Horst H E, 2002, Ned Tijdschr Geneeskd, V146, P1516; *CLASS COMM WONCA, 1983, ICHPPC 2 DEF INT CLA; Dalrymple J, 2008, BRIT MED J, V336, P556, DOI [10.1136/bmj.39484.712616.AD, 10.1136/bmj.h1216]; Ford AC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2313; Francis CY, 1997, ALIMENT PHARM THERAP, V11, P395, DOI 10.1046/j.1365-2036.1997.142318000.x; FRANCIS CY, 1994, LANCET, V344, P39, DOI 10.1016/S0140-6736(94)91055-3; Irvine EJ, 2006, GASTROENTEROLOGY, V130, P1538, DOI 10.1053/j.gastro.2005.11.058; Janssen HAM, 2000, BRIT J GEN PRACT, V50, P375; Jones R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2213; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Longstreth GF, 2001, ALIMENT PHARM THER, V15, P959, DOI 10.1046/j.1365-2036.2001.01010.x; Mangel AW, 1998, J INT MED RES, V26, P76, DOI 10.1177/030006059802600203; Mearin F, 2001, SCAND J GASTROENTERO, V36, P1155; Miller V, 2006, DIGEST LIVER DIS, V38, P737, DOI 10.1016/j.dld.2006.06.015; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS37, DOI 10.1093/ije/26.suppl_1.S37; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Parisi G, 2005, DIGEST DIS SCI, V50, P1107, DOI 10.1007/s10620-005-2713-7; Patrick DL, 1998, DIGEST DIS SCI, V43, P400, DOI 10.1023/A:1018831127942; Rees G, 2005, J R SOC PROMO HEALTH, V125, P30, DOI 10.1177/146642400512500112; Ruigomez A, 1999, ALIMENT PHARM THERAP, V13, P1097; SNOOK J, 1994, ALIMENT PHARM THERAP, V8, P511; Thompson WG, 2000, GUT, V46, P78, DOI 10.1136/gut.46.1.78; vanderHorst HE, 1997, GUT, V41, P669, DOI 10.1136/gut.41.5.669; Vandvik PO, 2004, SCAND J GASTROENTERO, V39, P448, DOI 10.1080/00365520310008782; VANSTAVEREN WA, 1982, J AM DIET ASSOC, V80, P324; Woolthuis AHOK, 2004, SCAND J GASTROENTERO, V39, P17, DOI 10.1080/00855920410010942	31	129	135	0	19	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 27	2009	339								b3154	10.1136/bmj.b3154	http://dx.doi.org/10.1136/bmj.b3154			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	489AY	19713235	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000269393100003
J	Hui, EF; Johnson, CP; Yao, J; Dunning, FM; Chapman, ER				Hui, Enfu; Johnson, Colin P.; Yao, Jun; Dunning, F. Mark; Chapman, Edwin R.			Synaptotagmin-Mediated Bending of the Target Membrane Is a Critical Step in Ca2+-Regulated Fusion	CELL			English	Article							NEUROTRANSMITTER RELEASE; BAR DOMAIN; C2B DOMAIN; PENETRATION ACTIVITY; SNARE COMPLEX; CA2+; SIMULATION; BINDING; PORE; PHOSPHOLIPIDS	Decades ago it was proposed that exocytosis involves invagination of the target membrane, resulting in a highly localized site of contact between the bilayers destined to fuse. The vesicle protein synaptotagmin-I (syt) bends membranes in response to Ca2+, but whether this drives localized invagination of the target membrane to accelerate fusion has not been determined. Previous studies relied on reconstituted vesicles that were already highly curved and used mutations in syt that were not selective for membrane-bending activity. Here, we directly address this question by utilizing vesicles with different degrees of curvature. A tubulation-defective syt mutant was able to promote fusion between highly curved SNARE-bearing liposomes but exhibited a marked loss of activity when the membranes were relatively flat. Moreover, bending of flat membranes by adding an N-BAR domain rescued the function of the tubulation-deficient syt mutant. Hence, syt-mediated membrane bending is a critical step in membrane fusion.	[Hui, Enfu; Johnson, Colin P.; Yao, Jun; Dunning, F. Mark; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Hui, Enfu; Johnson, Colin P.; Yao, Jun; Dunning, F. Mark; Chapman, Edwin R.] Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA; [Hui, Enfu; Chapman, Edwin R.] Univ Wisconsin, Biophys Training Program, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Chapman, ER (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1300 Univ Ave,SMI 129, Madison, WI 53706 USA.	chapman@physiology.wisc.edu	Hui, Enfu/C-2806-2012	Yao, Jun/0000-0002-4916-3412; Chapman, Edwin/0000-0001-9787-8140; Johnson, Colin/0000-0002-6783-2835	US Institutes of Health [MH 61876]; American Heart Association [0440168N]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	US Institutes of Health; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J.D. Gaffaney and Z. Wang for providing materials and technical suggestions for experiments in Figure 3, R. Massey and M. Stowell for assistance and suggestions regarding tubulation assays, and D. McCaslin for ITC training. We also thank M. Jackson, J. Audhya, J. Weisshaar, and members of the Chapman lab for helpful discussions and critical comments. This study was supported by grants from the US Institutes of Health (MH 61876) and the American Heart Association (0440168N) to E. R. C. E. H. was supported by an American Heart Association predoctoral fellowship. E.R.C. is an Investigator of the Howard Hughes Medical Institute.	Arac D, 2006, NAT STRUCT MOL BIOL, V13, P209, DOI 10.1038/nsmb1056; Ayton GS, 2007, BIOPHYS J, V92, P3595, DOI 10.1529/biophysj.106.101709; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Chanturiya A, 2002, BIOPHYS J, V82, P3072, DOI 10.1016/S0006-3495(02)75648-8; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chapman ER, 1998, J BIOL CHEM, V273, P13995, DOI 10.1074/jbc.273.22.13995; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Gaffaney JD, 2008, J BIOL CHEM, V283, P31763, DOI 10.1074/jbc.M803355200; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; HEIMBURG T, 1994, BIOCHEMISTRY-US, V33, P9477, DOI 10.1021/bi00198a013; Kozlov MM, 2002, TRAFFIC, V3, P256, DOI 10.1034/j.1600-0854.2002.030403.x; LIU YC, 1991, NEURON, V6, P411, DOI 10.1016/0896-6273(91)90249-Y; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Mahal LK, 2002, J CELL BIOL, V158, P273, DOI 10.1083/jcb.200203135; Marrink SJ, 2003, J AM CHEM SOC, V125, P15233, DOI 10.1021/ja0352092; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; MONCK JR, 1994, NEURON, V12, P707, DOI 10.1016/0896-6273(94)90325-5; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Steenbergen R, 2006, BBA-MOL CELL BIOL L, V1761, P313, DOI 10.1016/j.bbalip.2006.03.005; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100	37	209	210	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					709	721		10.1016/j.cell.2009.05.049	http://dx.doi.org/10.1016/j.cell.2009.05.049			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703397	Bronze, Green Accepted			2022-12-28	WOS:000269156100013
J	O'Malley, MA; Elliott, KC; Haufe, C; Burian, RM				O'Malley, Maureen A.; Elliott, Kevin C.; Haufe, Chris; Burian, Richard M.			Philosophies of Funding	CELL			English	Editorial Material							HYPOTHESIS; BIOLOGY; DARWIN	Successful scientific practice encompasses broader and more varied modes of investigation than can be captured by focusing on hypothesis-driven research. We examine the emphases that major US and UK funding agencies place on particular modes of research practice and suggest that funding agency guidelines should be informed by a more dynamic and multidimensional account of scientific practice.	[O'Malley, Maureen A.] Univ Exeter, Egenis, Exeter EX4 4PJ, Devon, England; [Elliott, Kevin C.] Univ S Carolina, Dept Philosophy, Columbia, SC 29208 USA; [Haufe, Chris] Univ Chicago, Dept Philosophy, Chicago, IL 60637 USA; [Burian, Richard M.] Virginia Tech, Dept Philosophy, Blacksburg, VA 24061 USA	University of Exeter; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Chicago; Virginia Polytechnic Institute & State University	O'Malley, MA (corresponding author), Univ Exeter, Egenis, Exeter EX4 4PJ, Devon, England.	m.a.o'malley@exeter.ac.uk; rmburian@vt.edu	Burian, Richard M./AAF-3225-2019	Burian, Richard/0000-0003-2319-1308; O'Malley, Maureen/0000-0003-0367-7079	University of Exeter; Economic and Social Research Council [ES/F024738/1] Funding Source: researchfish; ESRC [ES/F024738/1] Funding Source: UKRI	University of Exeter; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We thank M. McGuire for assistance and the for helpful comments. M.A.O. is supported by UK's Economic and Social Research Council Egenis, at the University of Exeter.	Aebersold R, 2000, NAT BIOTECHNOL, V18, P359, DOI 10.1038/74325; [Anonymous], 2001, BIOESSAYS, V23, P1, DOI 10.1002/1521-1878(200101)23:1<1::AID-BIES1000>3.0.CO;2-O; Ayala FJ, 2009, P NATL ACAD SCI USA, V106, P10033, DOI 10.1073/pnas.0901404106; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Caldin Edward, 2002, HYLE, V8, P103; Franklin LR, 2005, PHILOS SCI, V72, P888, DOI 10.1086/508117; Gannon F, 2009, EMBO REP, V10, P1, DOI 10.1038/embor.2008.239; Glass D. J, 2006, EXPT DESIGN BIOL; Glass DJ, 2008, CELL, V134, P378, DOI 10.1016/j.cell.2008.07.033; Hodge Martin J. S., 1983, EVOLUTION MOL MEN, p[43, 45]; Kell DB, 2004, BIOESSAYS, V26, P99, DOI 10.1002/bies.10385; Laudan L., 1981, SCI HYPOTHESIS HIST; Popper K. R., 1963, CONJECTURES REFUTAT; Steinle F, 1997, PHILOS SCI, V64, pS65, DOI 10.1086/392587; Wilson Catherine, 1995, INVISIBLE WORLD EARL	15	34	35	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	AUG 21	2009	138	4					611	615		10.1016/j.cell.2009.08.008	http://dx.doi.org/10.1016/j.cell.2009.08.008			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	485WS	19703386	Bronze			2022-12-28	WOS:000269156100001
J	Arnold, DM; Anderson, J; Kearon, C				Arnold, Donald M.; Anderson, Julia; Kearon, Clive			Rational Testing Preoperative risk assessment for bleeding and thromboembolism	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HISTORY		[Arnold, Donald M.; Anderson, Julia; Kearon, Clive] McMaster Univ, Michael De Groote Sch Med, Hamilton, ON, Canada; [Anderson, Julia] Royal Infirm, Dept Haematol, Edinburgh EH3 9HB, Midlothian, Scotland; [Arnold, Donald M.] Canadian Red Cross Blood Transfus Serv, Hamilton, ON, Canada	McMaster University; Royal Infirmary of Edinburgh	Kearon, C (corresponding author), Hamilton Hlth Sci, Henderson Div, 711 Concess St, Hamilton, ON L8V 1C3, Canada.	kearonc@mcmaster.ca			Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: Medline	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chee YL, 2008, BRIT J HAEMATOL, V140, P496, DOI 10.1111/j.1365-2141.2007.06968.x; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Kadir RA, 1998, LANCET, V351, P485, DOI 10.1016/S0140-6736(97)08248-2; Lane DA, 1996, THROMB HAEMOSTASIS, V76, P651; Lane DA, 1996, THROMB HAEMOSTASIS, V76, P824; Noboa S, 2008, THROMB RES, V122, P624, DOI 10.1016/j.thromres.2007.12.026; Rodeghiero F, 2005, J THROMB HAEMOST, V3, P2619, DOI 10.1111/j.1538-7836.2005.01663.x; Segal JB, 2005, TRANSFUSION, V45, P1413, DOI 10.1111/j.1537-2995.2005.00546.x; SRAMEK A, 1995, ARCH INTERN MED, V155, P1409, DOI 10.1001/archinte.155.13.1409	9	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 3	2009	339								b2299	10.1136/bmj.b2299	http://dx.doi.org/10.1136/bmj.b2299			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	491CI	19729421				2022-12-28	WOS:000269554100006
J	Fennell, T; Deen, PP; Wildes, AR; Schmalzl, K; Prabhakaran, D; Boothroyd, AT; Aldus, RJ; McMorrow, DF; Bramwell, ST				Fennell, T.; Deen, P. P.; Wildes, A. R.; Schmalzl, K.; Prabhakaran, D.; Boothroyd, A. T.; Aldus, R. J.; McMorrow, D. F.; Bramwell, S. T.			Magnetic Coulomb Phase in the Spin Ice Ho2Ti2O7	SCIENCE			English	Article							FLUCTUATIONS; ENTROPY	Spin-ice materials are magnetic substances in which the spin directions map onto hydrogen positions in water ice. Their low-temperature magnetic state has been predicted to be a phase that obeys a Gauss' law and supports magnetic monopole excitations: in short, a Coulomb phase. We used polarized neutron scattering to show that the spin-ice material Ho2Ti2O7 exhibits an almost perfect Coulomb phase. Our result proves the existence of such phases in magnetic materials and strongly supports the magnetic monopole theory of spin ice.	[Fennell, T.; Schmalzl, K.] Forschungszentrum Julich, Inst Max Von Laue Paul Langevin, Inst Festkorperforsch,Julich Ctr Neutron Sci, F-38042 Grenoble, France; [Prabhakaran, D.; Boothroyd, A. T.] Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; [Aldus, R. J.; McMorrow, D. F.; Bramwell, S. T.] UCL, Dept Phys & Astron, London WC1H 0AH, England; [Aldus, R. J.; McMorrow, D. F.; Bramwell, S. T.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England	Institut Laue-Langevin (ILL); University of Oxford; University of London; University College London; University of London; University College London	Fennell, T (corresponding author), Forschungszentrum Julich, Inst Max Von Laue Paul Langevin, Inst Festkorperforsch,Julich Ctr Neutron Sci, F-38042 Grenoble, France.	fennell@ill.fr	McMorrow, Desmond Francis/M-9036-2019; Boothroyd, Andrew/AAA-7883-2021; Fennell, Tom/D-1912-2014; Schmalzl, Karin/M-2010-2017; McMorrow, Desmond/C-2655-2008; Deen, Pascale/C-6557-2015	McMorrow, Desmond Francis/0000-0002-4947-7788; Boothroyd, Andrew/0000-0002-3575-7471; Fennell, Tom/0000-0002-0063-7517; Schmalzl, Karin/0000-0003-4836-5642; McMorrow, Desmond/0000-0002-4947-7788; Wildes, Andrew/0000-0003-3957-2818; Deen, Pascale/0000-0002-0204-0802	Engineering and Physical Sciences Research Council; Science and Technology Facilities Council; Royal Society; EPSRC [EP/C534654/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C534654/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank P. Holdsworth, L. Jaubert, S. Calder, M. Harris, J. Chalker, C. Castelnovo, A. Fisher, L.- P. Regnault, and R. Moessner for valuable discussions and L. Fodinger, J. Previtali, O. Losserand, and A. Filhol for technical assistance with D7, IN12, cryogenics, and computation, respectively. We acknowledge the Engineering and Physical Sciences Research Council, Science and Technology Facilities Council, and Royal Society for funding.	Alet F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.030403; Ballou R, 1996, PHYS REV LETT, V76, P2125, DOI 10.1103/PhysRevLett.76.2125; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Bramwell ST, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.047205; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Clancy JP, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.014408; Diep HT, 2005, FRUSTRATED SPIN SYSTEMS, P1, DOI 10.1142/9789812567819; Fennell T, 2007, NAT PHYS, V3, P566, DOI 10.1038/nphys632; Fennell T, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.134408; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; Henley CL, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014424; Hermele M, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064404; Isakov SV, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.167204; Isakov SV, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.217201; Jaubert LDC, 2009, NAT PHYS, V5, P258, DOI 10.1038/NPHYS1227; Lee SH, 2002, NATURE, V418, P856, DOI 10.1038/nature00964; Moessner R, 1998, PHYS REV B, V58, P12049, DOI 10.1103/PhysRevB.58.12049; Pauling L, 1935, J AM CHEM SOC, V57, P2680, DOI 10.1021/ja01315a102; Ramirez AP, 1999, NATURE, V399, P333, DOI 10.1038/20619; Tabata Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.257205; Tomiyasu K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.177401; VILLAIN J, 1979, Z PHYS B CON MAT, V33, P31, DOI 10.1007/BF01325811; Yavors'kii T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037204; YOUNGBLOOD R, 1980, PHYS REV B, V21, P5212, DOI 10.1103/PhysRevB.21.5212; YOUNGBLOOD RW, 1981, PHYS REV B, V23, P232, DOI 10.1103/PhysRevB.23.232	26	425	425	3	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 16	2009	326	5951					415	417		10.1126/science.1177582	http://dx.doi.org/10.1126/science.1177582			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506ZM	19729619				2022-12-28	WOS:000270818600050
J	Huang, SMA; Mishina, YM; Liu, SM; Cheung, A; Stegmeier, F; Michaud, GA; Charlat, O; Wiellette, E; Zhang, Y; Wiessner, S; Hild, M; Shi, XY; Wilson, CJ; Mickanin, C; Myer, V; Fazal, A; Tomlinson, R; Serluca, F; Shao, WL; Cheng, H; Shultz, M; Rau, C; Schirle, M; Schlegl, J; Ghidelli, S; Fawell, S; Lu, C; Curtis, D; Kirschner, MW; Lengauer, C; Finan, PM; Tallarico, JA; Bouwmeester, T; Porter, JA; Bauer, A; Cong, F				Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Kirschner, Marc W.; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Bouwmeester, Tewis; Porter, Jeffery A.; Bauer, Andreas; Cong, Feng			Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling	NATURE			English	Article							BETA-CATENIN; COLORECTAL TUMORS; UBIQUITIN LIGASE; REGENERATION; PATHWAY; CANCER; APC; MUTATIONS; TELOMERES; COMPLEX	The stability of the Wnt pathway transcription factor beta-catenin is tightly regulated by the multi-subunit destruction complex. Deregulated Wnt pathway activity has been implicated in many cancers, making this pathway an attractive target for anticancer therapies. However, the development of targeted Wnt pathway inhibitors has been hampered by the limited number of pathway components that are amenable to small molecule inhibition. Here, we used a chemical genetic screen to identify a small molecule, XAV939, which selectively inhibits beta-catenin-mediated transcription. XAV939 stimulates beta-catenin degradation by stabilizing axin, the concentration-limiting component of the destruction complex. Using a quantitative chemical proteomic approach, we discovered that XAV939 stabilizes axin by inhibiting the poly-ADP-ribosylating enzymes tankyrase 1 and tankyrase 2. Both tankyrase isoforms interact with a highly conserved domain of axin and stimulate its degradation through the ubiquitin-proteasome pathway. Thus, our study provides new mechanistic insights into the regulation of axin protein homeostasis and presents new avenues for targeted Wnt pathway therapies.	[Huang, Shih-Min A.; Mishina, Yuji M.; Liu, Shanming; Cheung, Atwood; Stegmeier, Frank; Michaud, Gregory A.; Charlat, Olga; Wiellette, Elizabeth; Zhang, Yue; Wiessner, Stephanie; Hild, Marc; Shi, Xiaoying; Wilson, Christopher J.; Mickanin, Craig; Myer, Vic; Fazal, Aleem; Tomlinson, Ronald; Serluca, Fabrizio; Shao, Wenlin; Cheng, Hong; Shultz, Michael; Fawell, Stephen; Lu, Chris; Curtis, Daniel; Lengauer, Christoph; Finan, Peter M.; Tallarico, John A.; Porter, Jeffery A.; Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Rau, Christina; Schirle, Markus; Schlegl, Judith; Ghidelli, Sonja; Bouwmeester, Tewis; Bauer, Andreas] Cellzome AG, D-69117 Heidelberg, Germany; [Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Novartis; GlaxoSmithKline; Cellzome GmbH; Harvard University; Harvard Medical School	Cong, F (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	feng.cong@novartis.com		Wilson, Christopher/0000-0002-9146-522X				Bantscheff M, 2008, MOL CELL PROTEOMICS, V7, P1702, DOI 10.1074/mcp.M800029-MCP200; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Chang Anne B, 2005, Cough, V1, P7; Chang W, 2003, GENE DEV, V17, P1328, DOI 10.1101/gad.1077103; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Hsiao SJ, 2006, MOL CELL BIOL, V26, P2044, DOI 10.1128/MCB.26.6.2044-2054.2006; Hsiao SJ, 2008, BIOCHIMIE, V90, P83, DOI 10.1016/j.biochi.2007.07.012; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; MIYAKI M, 1994, CANCER RES, V54, P3011; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yeh TYJ, 2006, BIOCHEM J, V399, P415, DOI 10.1042/BJ20060713	29	1482	1594	5	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 1	2009	461	7264					614	620		10.1038/nature08356	http://dx.doi.org/10.1038/nature08356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500LH	19759537				2022-12-28	WOS:000270302600032
J	Tamguney, G; Miller, MW; Wolfe, LL; Sirochman, TM; Glidden, DV; Palmer, C; Lemus, A; DeArmond, SJ; Prusiner, SB				Tamgueney, Gueltekin; Miller, Michael W.; Wolfe, Lisa L.; Sirochman, Tracey M.; Glidden, David V.; Palmer, Christina; Lemus, Azucena; DeArmond, Stephen J.; Prusiner, Stanley B.			Asymptomatic deer excrete infectious prions in faeces	NATURE			English	Article							CHRONIC WASTING DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; MULE DEER; TRANSGENIC MICE; ODOCOILEUS-HEMIONUS; INCUBATION-TIME; TRANSMISSION; SCRAPIE; PROTEIN; SHEEP	Infectious prion diseases(1)-scrapie of sheep(2) and chronic wasting disease (CWD) of several species in the deer family(3,4)-are transmitted naturally within affected host populations. Although several possible sources of contagion have been identified in excretions and secretions from symptomatic animals(5-8), the biological importance of these sources in sustaining epidemics remains unclear. Here we show that asymptomatic CWD-infected mule deer (Odocoileus hemionus) excrete CWD prions in their faeces long before they develop clinical signs of prion disease. Intracerebral inoculation of irradiated deer faeces into transgenic mice overexpressing cervid prion protein (PrP) revealed infectivity in 14 of 15 faecal samples collected from five deer at 7-11 months before the onset of neurological disease. Although prion concentrations in deer faeces were considerably lower than in brain tissue from the same deer collected at the end of the disease, the estimated total infectious dose excreted in faeces by an infected deer over the disease course may approximate the total contained in a brain. Prolonged faecal prion excretion by infected deer provides a plausible natural mechanism that might explain the high incidence and efficient horizontal transmission of CWD within deer herds(3,4,9), as well as prion transmission among other susceptible cervids.	[Tamgueney, Gueltekin; Palmer, Christina; DeArmond, Stephen J.; Prusiner, Stanley B.] Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; [Tamgueney, Gueltekin; Prusiner, Stanley B.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Miller, Michael W.; Wolfe, Lisa L.; Sirochman, Tracey M.] Colorado Div Wildlife, Wildlife Res Lab, Ft Collins, CO 80526 USA; [Glidden, David V.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lemus, Azucena; DeArmond, Stephen J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	stanley@ind.ucsf.edu	Tamgüney, Gültekin/T-6333-2019; Glidden, David/AAD-4730-2020	Tamgüney, Gültekin/0000-0002-6933-5154; Glidden, David/0000-0001-5888-1419	Colorado Division of Wildlife; US Department of Defense National Prion Research Program [NP020152]; National Institutes of Health [AG02132]; Hillblom Foundation; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	Colorado Division of Wildlife; US Department of Defense National Prion Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hillblom Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	G. T. was supported by a fellowship from the Larry L. Hillblom Foundation. This work was supported by the Colorado Division of Wildlife and grants from the US Department of Defense National Prion Research Program (NP020152), the National Institutes of Health (AG02132) and the Hillblom Foundation. We thank P. Lessard and the staff of the Hunters Point animal facility for support with the transgenic animal experiments, K. Giles for screening transgenic animals, A. Serban for antibodies, K. Pomeroy for technical assistance, J. Safar for discussions, H. Nguyen for editorial assistance and B. Williams for insights on CWD transmission.	Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; ARTHUR WJ, 1979, J RANGE MANAGE, V32, P67, DOI 10.2307/3897389; ARTHUR WJ, 1980, J WILDLIFE MANAGE, V44, P750; Baeten LA, 2007, J WILDLIFE DIS, V43, P309, DOI 10.7589/0090-3558-43.2.309; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1972, J R STAT SOC B, V187, P220; Detwiler LA, 2003, REV SCI TECH OIE, V22, P121, DOI 10.20506/rst.22.1.1386; Diringer H, 1998, J GEN VIROL, V79, P609, DOI 10.1099/0022-1317-79-3-609; Dougherty R., 1964, TECHNIQUES EXPT VIRO, P169; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Judge J, 2005, AGR ECOSYST ENVIRON, V107, P267, DOI 10.1016/j.agee.2004.10.028; Konold T, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-14; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Miekka SI, 2003, VOX SANG, V84, P36, DOI 10.1046/j.1423-0410.2003.00256.x; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Muramoto T, 1997, NAT MED, V3, P750, DOI 10.1038/nm0797-750; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 2007, FIELDS VIROLOGY, P3059; Raymond GJ, 2000, EMBO J, V19, P4425, DOI 10.1093/emboj/19.17.4425; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; SCOTT M, 1993, CELL, V73, P979, DOI 10.1016/0092-8674(93)90275-U; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Tamguney G, 2009, J GEN VIROL, V90, P1035, DOI 10.1099/vir.0.007500-0; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; Vittinghoff E, 2005, STAT BIOL HEALTH, pVII; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; WILLIAMS ES, 2003, EPIDEMIOLOGY CHRONIC; Wolfe LL, 2007, J GEN VIROL, V88, P2078, DOI 10.1099/vir.0.82342-0	41	193	197	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 24	2009	461	7263					529	U90		10.1038/nature08289	http://dx.doi.org/10.1038/nature08289			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	497SP	19741608	Green Accepted, Green Submitted			2022-12-28	WOS:000270082900041
J	Albrecht, S; Reffert, S; Snellen, IAG; Winn, JN				Albrecht, Simon; Reffert, Sabine; Snellen, Ignas A. G.; Winn, Joshua N.			Misaligned spin and orbital axes cause the anomalous precession of DI Herculis	NATURE			English	Article							APSIDAL MOTION; BINARY; SYSTEM; ALIGNMENT; STARS	The orbits of binary stars precess as a result of general relativistic effects, forces arising from the asphericity of the stars, and forces from any additional stars or planets in the system. For most binaries, the theoretical and observed precession rates are in agreement(1). One system, however-DI Herculis-has resisted explanation for 30 years(2-4). The observed precession rate is a factor of four slower than the theoretical rate, a disagreement that once was interpreted as evidence for a failure of general relativity(5). Among the contemporary explanations are the existence of a circumbinary planet(6) and a large tilt of the stellar spin axes with respect to the orbit(7,8). Here we report that both stars of DI Herculis rotate with their spin axes nearly perpendicular to the orbital axis (contrary to the usual assumption for close binary stars). The rotationally induced stellar oblateness causes precession in the direction opposite to that of relativistic precession, thereby reconciling the theoretical and observed rates.	[Albrecht, Simon; Snellen, Ignas A. G.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Albrecht, Simon; Winn, Joshua N.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Albrecht, Simon; Winn, Joshua N.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Reffert, Sabine] Zent Astrophys Heidelberg, D-69117 Heidelberg, Germany	Leiden University; Leiden University - Excl LUMC; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Ruprecht Karls University Heidelberg	Albrecht, S (corresponding author), Leiden Univ, Leiden Observ, Postbus 9513, NL-2300 RA Leiden, Netherlands.	albrecht@space.mit.edu		Snellen, Ignas/0000-0003-1624-3667; Reffert, Sabine/0000-0002-0460-8289	Netherlands Organisation for Scientific Research (NWO); NASA [NNX09AD36G]; Optical Infrared Coordination network (OPTICON)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NASA(National Aeronautics & Space Administration (NASA)); Optical Infrared Coordination network (OPTICON)	We are grateful to A. Gimenez, E. Guinan and T. Mazeh for bringing DI Herculis to our attention. We thank J. Lub, R. Tubbs, C. Hopman, Y. Levin and D. Fabrycky for discussions about double stars and their properties. We also thank H. Reckman for essential help during one observing run. We are grateful to the Sophie team for building the spectrograph and reduction pipeline. This research hasmade use of the SIMBADdatabase, operated at CDS, Strasbourg, France, and the Vienna Atomic Line database (VALD) located at http://ams.astro.univie.ac.at/vald/. S. A. acknowledges support during part of this project by a Rubicon fellowship from the Netherlands Organisation for Scientific Research (NWO). J. N. W. acknowledges support from a NASA Origins grant (NNX09AD36G). S. A. and S. R. acknowledge funding from the Optical Infrared Coordination network (OPTICON).	Albrecht S, 2007, ASTRON ASTROPHYS, V474, P565, DOI 10.1051/0004-6361:20077953; CHELLI A, 1995, ASTRON ASTROPHYS SUP, V109, P401; Claret A, 1998, ASTRON ASTROPHYS, V330, P533; CLARET A, 1993, ASTRON ASTROPHYS, V277, P487; COMPANY R, 1988, ASTROPHYS J, V335, P962, DOI 10.1086/166981; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Gray D. F., 2005, OBSERVATION ANAL STE; GUINAN EF, 1985, ASTRON J, V90, P1519, DOI 10.1086/113865; GUINAN EF, 1994, INF B VAR STARS, V4101, P1; Holt J.R., 1893, A A, V12, P646; Hsuan K, 2006, ASTROPHYS SPACE SCI, V304, P243, DOI 10.1007/s10509-006-9121-0; Le Bouquin JB, 2009, ASTRON ASTROPHYS, V498, pL41, DOI 10.1051/0004-6361/200911854; Markwardt C. B., 2009, NONLINEAR LEAST SQUA; MARTYNOV DY, 1980, ASTROPHYS SPACE SCI, V71, P147, DOI 10.1007/BF00646915; McLaughlin DB, 1924, ASTROPHYS J, V60, P22, DOI 10.1086/142826; MOFFAT JW, 1984, ASTROPHYS J, V287, pL77, DOI 10.1086/184402; Perruchot S., 2008, SPIE C SER, V7014; POPPER DM, 1982, ASTROPHYS J, V254, P203, DOI 10.1086/159724; Press W, 1992, NUMERICAL RECIPES C, P689; Queloz D, 2000, ASTRON ASTROPHYS, V359, pL13; REISENBERGER MP, 1989, ASTRON J, V97, P216, DOI 10.1086/114972; Rossiter RA, 1924, ASTROPHYS J, V60, P15, DOI 10.1086/142825; SHAKURA NI, 1985, SOV ASTRON LETT+, V11, P224; VANDIEN E, 1948, JRAS CANADA, V42, P249; Winn JN, 2005, ASTROPHYS J, V631, P1215, DOI 10.1086/432571; Zeipel H.V., 1924, MNRAS, V84, P684	26	91	92	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 17	2009	461	7262					373	376		10.1038/nature08408	http://dx.doi.org/10.1038/nature08408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	494QB	19759615	Green Published, Green Submitted			2022-12-28	WOS:000269828100034
J	Stone, VE; Bounds, BC; Muse, VV; Ferry, JA				Stone, Valerie E.; Bounds, Brenna C.; Muse, Victorine V.; Ferry, Judith A.			Case 29-2009: An 81-Year-Old Man with Weight Loss, Odynophagia, and Failure to Thrive Diffuse large-B-cell lymphoma, consistent with primary hepatic lymphoma, occurring in a patient with HIV infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NON-HODGKINS-LYMPHOMA; EXTRAPULMONARY TUBERCULOSIS; PROGNOSTIC-FACTORS; PULMONARY-DISEASE; ORAL CANDIDIASIS; PATIENTS OLDER; AIDS; LIVER; HEALTH		[Stone, Valerie E.; Bounds, Brenna C.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Bounds, Brenna C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Muse, Victorine V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Ferry, Judith A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Stone, Valerie E.; Bounds, Brenna C.] Harvard Univ, Sch Med, Dept Med, Cambridge, MA 02138 USA; [Muse, Victorine V.] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Ferry, Judith A.] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Stone, VE (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Barat LIM, 1996, CLIN INFECT DIS, V23, P320, DOI 10.1093/clinids/23.2.320; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Bhavan Kavita P, 2008, Curr HIV/AIDS Rep, V5, P150, DOI 10.1007/s11904-008-0023-3; Biggar RJ, 2006, BLOOD, V108, P3786, DOI 10.1182/blood-2006-05-024109; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bronowicki JP, 2003, HEPATOLOGY, V37, P781, DOI 10.1053/jhep.2003.50121; Butt AA, 2001, SOUTH MED J, V94, P397, DOI 10.1097/00007611-200194040-00008; Centers for Disease Control and Prevention, 2008, HIV AIDS SURV REP 20, P1; Cote TR, 1997, INT J CANCER, V73, P645, DOI 10.1002/(SICI)1097-0215(19971127)73:5&lt;645::AID-IJC6&gt;3.0.CO;2-X; Eisner MD, 1996, CHEST, V110, P729, DOI 10.1378/chest.110.3.729; FEE MJ, 1995, CLIN INFECT DIS, V20, P938, DOI 10.1093/clinids/20.4.938; FERRY JA, 2009, SURG PATHOLOGY GI TR, P701; Gaidano G, 1998, AM J PATHOL, V152, P623; Havlir DV, 1999, NEW ENGL J MED, V340, P367, DOI 10.1056/NEJM199902043400507; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; Hwang S, 2004, DIAGN CYTOPATHOL, V30, P82, DOI 10.1002/dc.10416; KAUFFMAN CA, 2008, CLIN MANIFESTATIONS; KLEIN RS, 1984, NEW ENGL J MED, V311, P354, DOI 10.1056/NEJM198408093110602; Lim ST, 2005, J CLIN ONCOL, V23, P8477, DOI 10.1200/JCO.2005.02.9355; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindau ST, 2006, J WOMENS HEALTH, V15, P747, DOI 10.1089/jwh.2006.15.747; Loddenkemper C, 2007, VIRCHOWS ARCH, V450, P493, DOI 10.1007/s00428-007-0384-9; Mack KA, 1999, GERONTOLOGIST, V39, P687, DOI 10.1093/geront/39.6.687; Mack KA, 2003, JAIDS-J ACQ IMM DEF, V33, pS68, DOI 10.1097/00126334-200306012-00003; Memeo L, 1999, ACTA ONCOL, V38, P655; Mocroft A, 1998, ARCH INTERN MED, V158, P491, DOI 10.1001/archinte.158.5.491; Mounier N, 2006, BLOOD, V107, P3832, DOI 10.1182/blood-2005-09-3600; MURRAY JF, 1990, AM REV RESPIR DIS, V141, P1582, DOI 10.1164/ajrccm/141.6.1582; MURRAY JF, 1990, AM REV RESPIR DIS, V141, P1356, DOI 10.1164/ajrccm/141.5_Pt_1.1356; NAIDICH DP, 1987, SEMIN ROENTGENOL, V22, P14, DOI 10.1016/0037-198X(87)90019-8; OHSAWA M, 1992, DIGEST DIS SCI, V37, P1105, DOI 10.1007/BF01300294; OSBORNE BM, 1985, CANCER-AM CANCER SOC, V56, P2902, DOI 10.1002/1097-0142(19851215)56:12<2902::AID-CNCR2820561230>3.0.CO;2-W; PHILLIPS AN, 1991, J ACQ IMMUN DEF SYND, V4, P970; Rabkin C S, 1998, J Natl Cancer Inst Monogr, P23; RIEDER HL, 1990, AM REV RESPIR DIS, V141, P347, DOI 10.1164/ajrccm/141.2.347; Salmon JS, 2006, CLIN LYMPHOMA MYELOM, V6, P273, DOI 10.3816/CLM.2006.n.001; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; SHAFER RW, 1991, MEDICINE, V70, P384, DOI 10.1097/00005792-199111000-00004; Shay K, 1997, J AM GERIATR SOC, V45, P863, DOI 10.1111/j.1532-5415.1997.tb01517.x; SHIPP MA, 1993, NEW ENGL J MED, V329, P987, DOI 10.1056/nejm199309303291402; Skiest DJ, 1997, ARCH FAM MED, V6, P289, DOI 10.1001/archfami.6.3.289; Straus DJ, 1998, J CLIN ONCOL, V16, P3601, DOI 10.1200/JCO.1998.16.11.3601; SUFFREDINI AF, 1987, ANN INTERN MED, V107, P7, DOI 10.7326/0003-4819-107-1-7; SYRJANEN S, 1988, ORAL SURG ORAL MED O, V65, P36, DOI 10.1016/0030-4220(88)90188-0; TAVITIAN A, 1986, ANN INTERN MED, V104, P54, DOI 10.7326/0003-4819-104-1-54; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Vilchez RA, 2003, MEDICINE, V82, P77, DOI 10.1097/00005792-200303000-00001; Visco C, 2006, ANN ONCOL, V17, P1434, DOI 10.1093/annonc/mdl131; WALLACE JM, 1993, AM REV RESPIR DIS, V148, P1523, DOI 10.1164/ajrccm/148.6_Pt_1.1523; Wheat L. J., 1992, AIDS Clinical Care, V4, P1; WHEAT LJ, 1990, MEDICINE, V69, P361, DOI 10.1097/00005792-199011000-00004; WILCOX CM, 1995, AM J GASTROENTEROL, V90, P1938; Yang ZH, 2004, CLIN INFECT DIS, V38, P199, DOI 10.1086/380644; Zingmond DS, 2001, AM J PUBLIC HEALTH, V91, P1117, DOI 10.2105/AJPH.91.7.1117	54	2	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 17	2009	361	12					1189	1198		10.1056/NEJMcpc0900644	http://dx.doi.org/10.1056/NEJMcpc0900644			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	494QA	19759382				2022-12-28	WOS:000269828000012
J	Erlewyn-Lajeunesse, M; Brathwaite, N; Lucas, JSA; Warner, JO				Erlewyn-Lajeunesse, M.; Brathwaite, N.; Lucas, J. S. A.; Warner, J. O.			Recommendations for the administration of influenza vaccine in children allergic to egg	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ASTHMATIC-CHILDREN; ANAPHYLAXIS; SAFETY; PREVALENCE; SEVERITY		[Erlewyn-Lajeunesse, M.] Southampton Univ Hosp NHS Trust, Childrens Allergy Clin, Southampton SO16 6YD, Hants, England; [Brathwaite, N.] Kings Coll Hosp London, London, England; [Lucas, J. S. A.] Univ Southampton, Sch Med, Southampton, Hants, England; [Warner, J. O.] Univ London Imperial Coll Sci Technol & Med, London, England; [Warner, J. O.] Imperial Coll Healthcare Trust, London, England	University of Southampton; University Hospital Southampton NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Southampton; Imperial College London	Erlewyn-Lajeunesse, M (corresponding author), Southampton Univ Hosp NHS Trust, Childrens Allergy Clin, Southampton SO16 6YD, Hants, England.	mich.lajeunesse@soton.ac.uk	Warner, John/AAF-9587-2020; Lucas, Jane S/C-3620-2013	Erlewyn-Lajeunesse, Michel/0000-0003-1982-1397; Lucas, Jane/0000-0001-8701-9975	Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		ANOLIK R, 1992, ANN ALLERGY, V68, P69; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI 10.1586/ERV.09.19; BIERMAN CW, 1977, J INFECT DIS, V136, pS652, DOI 10.1093/infdis/136.Supplement_3.S652; Bohlke K, 2003, PEDIATRICS, V112, P815, DOI 10.1542/peds.112.4.815; Brown SGA, 2004, J ALLERGY CLIN IMMUN, V114, P371, DOI 10.1016/j.jaci.2004.04.029; Colver AF, 2005, ACTA PAEDIATR, V94, P689, DOI 10.1080/08035250510031566; Coop CA, 2008, INT ARCH ALLERGY IMM, V146, P85, DOI 10.1159/000112507; DAVIES R, 1976, J ALLERGY CLIN IMMUN, V57, P373, DOI 10.1016/0091-6749(76)90095-6; Eggesbo M, 2001, ALLERGY, V56, P403, DOI 10.1034/j.1398-9995.2001.056005403.x; Esposito S, 2008, VACCINE, V26, P4664, DOI 10.1016/j.vaccine.2008.06.095; Howard MK, 2008, BIOL CHEM, V389, P569, DOI 10.1515/BC.2008.060; James JM, 1998, J PEDIATR-US, V133, P624, DOI 10.1016/S0022-3476(98)70101-5; Kursteiner O, 2006, VACCINE, V24, P6632, DOI 10.1016/j.vaccine.2006.05.084; MARK C, 2006, PHARMEUR SCI NOTES, P27; MILLER JR, 1983, J ALLERGY CLIN IMMUN, V71, P568; MURPHY KR, 1985, J PEDIATR-US, V106, P931, DOI 10.1016/S0022-3476(85)80241-9; Nasser S, 2009, CLIN EXP ALLERGY, V39, P1288, DOI 10.1111/j.1365-2222.2009.03331.x; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; Peng MM, 2004, ARCH INTERN MED, V164, P317, DOI 10.1001/archinte.164.3.317; Pickering LK, 2006, RED BOOK 2006 REPORT, P9; Piquer-Gibert M, 2007, ALLERGOL IMMUNOPATH, V35, P209, DOI 10.1157/13110316; Pool V, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.6.e71; RATNER B, 1946, JAMA-J AM MED ASSOC, V132, P899, DOI 10.1001/jama.1946.02870500005002; RETAILLIAU HF, 1980, AM J EPIDEMIOL, V111, P270, DOI 10.1093/oxfordjournals.aje.a112896; Ruggeberg JU, 2007, VACCINE, V25, P5675, DOI 10.1016/j.vaccine.2007.02.064; Salisbury D, 2006, IMMUNISATION INFECT, V3rd; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Zeiger RS, 2002, J ALLERGY CLIN IMMUN, V110, P834, DOI 10.1067/mai.2002.129372	28	37	36	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 15	2009	339								b3680	10.1136/bmj.b3680	http://dx.doi.org/10.1136/bmj.b3680			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	496RR	19755545	Green Accepted			2022-12-28	WOS:000269994600018
J	Akagi, H; Otobe, T; Staudte, A; Shiner, A; Turner, F; Dorner, R; Villeneuve, DM; Corkum, PB				Akagi, H.; Otobe, T.; Staudte, A.; Shiner, A.; Turner, F.; Doerner, R.; Villeneuve, D. M.; Corkum, P. B.			Laser Tunnel Ionization from Multiple Orbitals in HCl	SCIENCE			English	Article							HIGH HARMONIC-GENERATION; QUANTUM INTERFERENCE; ALIGNED MOLECULES; DYNAMICS; SPECTROSCOPY; FIELDS	Tunneling, one of the most striking manifestations of quantum mechanics, influences the electronic structure of many molecules and solids and is responsible for radioactive decay. Much of the interaction of intense light pulses with matter commences with electrons tunneling from atoms or molecules to the continuum. Until recently, this starting point was assumed to be the highest occupied orbital of a given system. We have now observed tunneling from a lower-lying state in hydrogen chloride (HCl). Analyzing two independent experimental observables allowed us to isolate (via fragment ions), identify (via molecular frame photoelectron angular distributions), and, with the help of ab initio simulations, quantify the contribution of lower-lying orbitals to the total and angle-dependent tunneling current of the molecule. Our results bolster the emerging tenet that the coherent interaction between different orbitals-which can amplify the impact of lower orbitals-must be considered in tunneling processes.	[Akagi, H.; Staudte, A.; Shiner, A.; Turner, F.; Villeneuve, D. M.; Corkum, P. B.] Univ Ottawa, Joint Lab Attosecond Sci, Ottawa, ON K1A 0R6, Canada; [Akagi, H.; Staudte, A.; Shiner, A.; Turner, F.; Villeneuve, D. M.; Corkum, P. B.] CNR, Ottawa, ON K1A 0R6, Canada; [Akagi, H.; Otobe, T.] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Kyoto 6190215, Japan; [Turner, F.] Univ Waterloo, Waterloo, ON N2L 3G1, Canada; [Doerner, R.] Univ Frankfurt, Inst Kernphys, D-60438 Frankfurt, Germany	University of Ottawa; National Research Council Canada; Japan Atomic Energy Agency; University of Waterloo; Goethe University Frankfurt	Corkum, PB (corresponding author), Univ Ottawa, Joint Lab Attosecond Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	paul.corkum@nrc.ca	Villeneuve, David M/I-4140-2012; Otobe, Tomohito/D-8311-2014; Akagi, Hiroshi/J-5671-2016; Shiner, Andrew/J-8369-2012; Doerner, Reinhard/A-5340-2008	Villeneuve, David M/0000-0002-2810-3648; Otobe, Tomohito/0000-0002-9378-6326; Akagi, Hiroshi/0000-0002-8506-4294; Shiner, Andrew/0000-0003-3618-8204; Doerner, Reinhard/0000-0002-3728-4268; Staudte, Andre/0000-0002-8284-3831; Corkum, Paul/0000-0003-3394-5572	U. S. Air Force Office of Scientific Research; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft; Canadian Institute for Photonics Innovation; Natural Sciences and Engineering Research Council of Canada	U. S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institute for Photonics Innovation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Supported by the U. S. Air Force Office of Scientific Research, the Alexander von Humboldt Foundation, the Deutsche Forschungsgemeinschaft, the Canadian Institute for Photonics Innovation, and the Natural Sciences and Engineering Research Council of Canada. We thank B. Avery for technical assistance and M. Zimmer for help in preparing some of the graphics.	Alexander MH, 1998, CHEM PHYS, V231, P331, DOI 10.1016/S0301-0104(98)00069-X; Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Boutu W, 2008, NAT PHYS, V4, P545, DOI 10.1038/nphys964; Bryan WA, 2006, NAT PHYS, V2, P379, DOI 10.1038/nphys310; BUCKSBAUM PH, 1990, PHYS REV LETT, V64, P1883, DOI 10.1103/PhysRevLett.64.1883; Chen YJ, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3069511; CORKUM PB, 1989, PHYS REV LETT, V62, P1259, DOI 10.1103/PhysRevLett.62.1259; Delone N. B., 1998, Physics-Uspekhi, V41, P469, DOI 10.1070/PU1998v041n05ABEH000393; DIETRICH P, 1992, J CHEM PHYS, V97, P3187, DOI 10.1063/1.463006; Eckle P, 2008, SCIENCE, V322, P1525, DOI 10.1126/science.1163439; Ergler T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103004; Gertsvolf M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.243001; Kanai T, 2005, NATURE, V435, P470, DOI 10.1038/nature03577; Kitzler M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.253001; Li W, 2008, SCIENCE, V322, P1207, DOI 10.1126/science.1163077; Litvinyuk IV, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.033003; McFarland BK, 2008, SCIENCE, V322, P1232, DOI 10.1126/science.1162780; Meckel M, 2008, SCIENCE, V320, P1478, DOI 10.1126/science.1157980; NATALIS P, 1982, J ELECTRON SPECTROSC, V27, P267, DOI 10.1016/0368-2048(82)80009-1; Niikura H, 2002, NATURE, V417, P917, DOI 10.1038/nature00787; Otobe T, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.053404; Pavicic D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.243001; PRADHAN AD, 1991, J CHEM PHYS, V95, P9009, DOI 10.1063/1.461232; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Shafir D, 2009, NAT PHYS, V5, P412, DOI 10.1038/NPHYS1251; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; Staudte A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.033004; Ullrich J, 2003, REP PROG PHYS, V66, P1463, DOI 10.1088/0034-4885/66/9/203; Zhou XB, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073902	30	260	262	2	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 11	2009	325	5946					1364	1367		10.1126/science.1175253	http://dx.doi.org/10.1126/science.1175253			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492YO	19745145	Green Submitted			2022-12-28	WOS:000269699100030
J	Eccleston, A; Skipper, M				Eccleston, Alex; Skipper, Magdalena			TRANSCRIBING THE GENOME	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 10	2009	461	7261					185	185		10.1038/461185a	http://dx.doi.org/10.1038/461185a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	492KN	19741697	Bronze			2022-12-28	WOS:000269654600029
J	Gondor, A; Ohlsson, R				Gondor, Anita; Ohlsson, Rolf			Chromosome crosstalk in three dimensions	NATURE			English	Review							CONFORMATION CAPTURE; GENE-EXPRESSION; INTERCHROMOSOMAL ASSOCIATIONS; NUCLEAR ARCHITECTURE; CONTROL REGION; CTCF-BINDING; TRANSCRIPTION; CHROMATIN; ORGANIZATION; RNA	The genome forms extensive and dynamic physical interactions with itself in the form of chromosome loops and bridges, thus exploring the three-dimensional space of the nucleus. It is now possible to examine these interactions at the molecular level, and we have gained glimpses of their functional implications. Chromosomal interactions can contribute to the silencing and activation of genes within the three-dimensional context of the nuclear architecture. Technical advances in detecting these interactions contribute to our understanding of the functional organization of the genome, as well as its adaptive plasticity in response to environmental changes during development and disease.	[Gondor, Anita; Ohlsson, Rolf] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Gondor, A (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Nobels Vag 16,Box 280, SE-17177 Stockholm, Sweden.	anita.gondor@ki.se; rolf.ohlsson@ki.se		Gondor, Anita/0000-0002-1523-4411	Swedish Science Research Council; Swedish Cancer Research Foundation; Swedish Pediatric Cancer Foundation; Lundberg Foundation; European Union	Swedish Science Research Council; Swedish Cancer Research Foundation; Swedish Pediatric Cancer Foundation; Lundberg Foundation(European Commission); European Union(European Commission)	We most gratefully acknowledge I. Solovei, B. Joffe, P. Cook, G. Klein and E. Heard for discussions. This work was supported by the Swedish Science Research Council, the Swedish Cancer Research Foundation, the Swedish Pediatric Cancer Foundation, the Lundberg Foundation, and HEROIC and CHILL (European Union integrated projects).	Aladjem MI, 2007, NAT REV GENET, V8, P588, DOI 10.1038/nrg2143; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Bartlett O, 2006, BIOCHEM SOC SYMP, V73, P67, DOI 10.1042/bss0730067; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Cremer T, 2006, EUR J HISTOCHEM, V50, P223; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duncan IW, 2002, ANNU REV GENET, V36, P521, DOI 10.1146/annurev.genet.36.060402.100441; Faro-Trindade I, 2006, BIOCHEM SOC T, V34, P1133, DOI 10.1042/BST0341133; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Garrick D, 2008, BLOOD, V112, P3889, DOI 10.1182/blood-2008-06-161901; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Goendoer A, 2008, EMBO REP, V9, P327, DOI 10.1038/embor.2008.46; Gondor A, 2009, NAT REV GENET, V10, P269, DOI 10.1038/nrg2555; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; HASSAN AB, 1993, J CELL SCI, V105, P541; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Kim JH, 2009, GENOME RES, V19, P533, DOI 10.1101/gr.086496.108; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lanzuolo C, 2007, NAT CELL BIOL, V9, P1167, DOI 10.1038/ncb1637; Li QL, 2006, TRENDS GENET, V22, P197, DOI 10.1016/j.tig.2006.02.004; Li T, 2008, MOL CELL BIOL, V28, P6473, DOI 10.1128/MCB.00204-08; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Masui O, 2006, COLD SPRING HARB SYM, V71, P419, DOI 10.1101/sqb.2006.71.058; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Mehta IS, 2008, BIOCHEM SOC T, V36, P1384, DOI 10.1042/BST0361384; Misteli T, 2008, NATURE, V456, P333, DOI 10.1038/456333a; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Ohlsson R, 2007, SCIENCE, V318, P1077, DOI 10.1126/science.1150705; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Richter K, 2008, BBA-MOL CELL RES, V1783, P2100, DOI 10.1016/j.bbamcr.2008.07.017; Rippe K, 2001, TRENDS BIOCHEM SCI, V26, P733, DOI 10.1016/S0968-0004(01)01978-8; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; Stedman W, 2008, EMBO J, V27, P654, DOI 10.1038/emboj.2008.1; Steidl U, 2007, J CLIN INVEST, V117, P2611, DOI 10.1172/JCI30525; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Unneberg P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000254; Vernimmen D, 2007, EMBO J, V26, P2041, DOI 10.1038/sj.emboj.7601654; Walter J, 2006, CYTOGENET GENOME RES, V113, P109, DOI 10.1159/000090821; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wilson E.B., 1906, CELL DEV INHERITANCE; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Xu N, 2007, NAT GENET, V39, P1390, DOI 10.1038/ng.2007.5; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	70	116	121	0	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					212	217		10.1038/nature08453	http://dx.doi.org/10.1038/nature08453			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19741702				2022-12-28	WOS:000269654600034
J	Maida, Y; Yasukawa, M; Furuuchi, M; Lassmann, T; Possemato, R; Okamoto, N; Kasim, V; Hayashizaki, Y; Hahn, WC; Masutomi, K				Maida, Yoshiko; Yasukawa, Mami; Furuuchi, Miho; Lassmann, Timo; Possemato, Richard; Okamoto, Naoko; Kasim, Vivi; Hayashizaki, Yoshihide; Hahn, William C.; Masutomi, Kenkichi			An RNA-dependent RNA polymerase formed by TERT and the RMRP RNA	NATURE			English	Article							SMALL INTERFERING RNAS; CARTILAGE-HAIR-HYPOPLASIA; HEPATITIS-C VIRUS; HUMAN TELOMERASE; CATALYTIC SUBUNIT; HUMAN-CELLS; GENETIC ELEMENTS; MARROW FAILURE; IMMORTAL CELLS; MOUSE OOCYTES	Constitutive expression of telomerase in human cells prevents the onset of senescence and crisis by maintaining telomere homeostasis. However, accumulating evidence suggests that the human telomerase reverse transcriptase catalytic subunit ( TERT) contributes to cell physiology independently of its ability to elongate telomeres. Here we show that TERT interacts with the RNA component of mitochondrial RNA processing endoribonuclease (RMRP), a gene that is mutated in the inherited pleiotropic syndrome cartilage-hair hypoplasia. Human TERT and RMRP form a distinct ribonucleoprotein complex that has RNA-dependent RNA polymerase (RdRP) activity and produces double- stranded RNAs that can be processed into small interfering RNA in a Dicer ( also known as DICER1)-dependent manner. These observations identify a mammalian RdRP composed of TERT in complex with RMRP.	[Possemato, Richard; Hahn, William C.] Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Possemato, Richard; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Possemato, Richard; Hahn, William C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Masutomi, Kenkichi] Japan Sci & Technol Agcy, PREST, Kawaguchi, Saitama 3320012, Japan; [Maida, Yoshiko; Yasukawa, Mami; Furuuchi, Miho; Okamoto, Naoko; Kasim, Vivi; Masutomi, Kenkichi] Natl Canc Ctr, Canc Stem Cell Project, Chuo Ku, Tokyo 1040045, Japan; [Lassmann, Timo; Hayashizaki, Yoshihide] RIKEN, Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Japan Science & Technology Agency (JST); National Cancer Center - Japan; RIKEN	Hahn, WC (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu; kmasutom@ncc.go.jp	Hayashizaki, Yoshihide/N-6590-2015; Lassmann, Timo/HCH-4313-2022; Lassmann, Timo/A-8271-2008	Lassmann, Timo/0000-0002-0138-2691; Lassmann, Timo/0000-0002-0138-2691; Kasim, Vivi/0000-0001-9182-8230; Possemato, Richard/0000-0002-2401-0030	NIA NIH HHS [R01 AG023145-05, R01 AG23145, R01 AG023145] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG023145] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Artandi SE, 2002, P NATL ACAD SCI USA, V99, P8191, DOI 10.1073/pnas.112515399; Azuma-Mukai A, 2008, P NATL ACAD SCI USA, V105, P7964, DOI 10.1073/pnas.0800334105; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Behrens SE, 1996, EMBO J, V15, P12, DOI 10.1002/j.1460-2075.1996.tb00329.x; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Ford LP, 2001, J BIOL CHEM, V276, P32198, DOI 10.1074/jbc.M104469200; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; Gonzalez-Suarez E, 2001, EMBO J, V20, P2619, DOI 10.1093/emboj/20.11.2619; Guggenheim R, 2006, BONE MARROW TRANSPL, V38, P751, DOI 10.1038/sj.bmt.1705520; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Lee J, 2008, ONCOGENE, V27, P3754, DOI 10.1038/sj.onc.1211037; Lipardi C, 2001, CELL, V107, P297, DOI 10.1016/S0092-8674(01)00537-2; Liu JM, 2006, BLOOD, V107, P4583, DOI 10.1182/blood-2005-12-4831; Lue NF, 2005, P NATL ACAD SCI USA, V102, P9778, DOI 10.1073/pnas.0502252102; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Masutomi K, 2005, P NATL ACAD SCI USA, V102, P8222, DOI 10.1073/pnas.0503095102; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Moriarty TJ, 2002, MOL CELL BIOL, V22, P1253, DOI 10.1128/MCB.22.4.1253-1265.2002; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Nishikura K, 2001, CELL, V107, P415, DOI 10.1016/S0092-8674(01)00581-5; Pascale E, 2004, CANCER RES, V64, P7702, DOI 10.1158/0008-5472.CAN-04-1711; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; SEMLER BL, 2002, MOL BIOL PICORNAVIRU, P255; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Won J, 2004, P NATL ACAD SCI USA, V101, P11328, DOI 10.1073/pnas.0401801101; Yamashita T, 1998, J BIOL CHEM, V273, P15479, DOI 10.1074/jbc.273.25.15479; Yang N, 2006, NAT STRUCT MOL BIOL, V13, P763, DOI 10.1038/nsmb1141	49	284	293	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 10	2009	461	7261					230	U104		10.1038/nature08283	http://dx.doi.org/10.1038/nature08283			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	492KN	19701182	Green Accepted, Bronze			2022-12-28	WOS:000269654600037
J	McVeigh, ME; Mann, SJ				McVeigh, Marie E.; Mann, Stephen J.			The Journal Impact Factor Denominator Defining Citable (Counted) Items	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McVeigh, Marie E.; Mann, Stephen J.] Thomson Reuters, Philadelphia, PA 19104 USA	Clarivate	McVeigh, ME (corresponding author), Thomson Reuters, 3501 Market St, Philadelphia, PA 19104 USA.	marie.mcveigh@thomsonreuters.com	McVeigh, Marie E/A-9205-2008; McVeigh, Marie E/GXH-4743-2022	McVeigh, Marie E/0000-0003-0590-0537; McVeigh, Marie E/0000-0003-0590-0537				[Anonymous], WEB SCI; Bensman SJ, 2007, ANNU REV INFORM SCI, V41, P93, DOI 10.1002/aris.2007.1440410110; Falagas ME, 2008, ARCH IMMUNOL THER EX, V56, P223, DOI 10.1007/s00005-008-0024-5; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Golubic R, 2008, SCI ENG ETHICS, V14, P41, DOI 10.1007/s11948-007-9044-3; Lawrence PA, 2007, CURR BIOL, V17, pR583, DOI 10.1016/j.cub.2007.06.014; Pringle J, 2008, LEARN PUBL, V21, P85, DOI 10.1087/095315108X288901; Seglen PO, 1997, BRIT MED J, V314, P498	8	101	102	2	26	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 9	2009	302	10					1107	1109		10.1001/jama.2009.1301	http://dx.doi.org/10.1001/jama.2009.1301			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	491XH	19738096				2022-12-28	WOS:000269616200030
J	Hankey, GJ; Nelson, MR				Hankey, Graeme J.; Nelson, Mark R.			Practice Easily missed? Subarachnoid haemorrhage	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Stroke Unit, Perth, WA 6001, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Stroke Unit, Perth, WA 6009, Australia; [Nelson, Mark R.] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [Nelson, Mark R.] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia; University of Tasmania; University of Tasmania; Menzies Institute for Medical Research	Hankey, GJ (corresponding author), Royal Perth Hosp, Dept Neurol, Stroke Unit, Perth, WA 6001, Australia.	gjhankey@cyllene.uwa.edu.au	Scanlon, Andrew/E-9105-2015; Hankey, Graeme J/H-4968-2014	Scanlon, Andrew/0000-0002-5022-6783; Hankey, Graeme J/0000-0002-6044-7328				Anderson C, 2000, STROKE, V31, P1843; Dorhout MSM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006184.pub2; Dorhout Mees SM, 2007, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000277.PUB3; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Rinkel GJ, 2004, COCHRANE DB SYST REV, V4; van der Schaaf I, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003085.pub2; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; VANGIJN J, 2005, PRACT NEUROL, V5, P362	9	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2009	339								b2874	10.1136/bmj.b2874	http://dx.doi.org/10.1136/bmj.b2874			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486SE	19700506				2022-12-28	WOS:000269217200010
J	Kelly, CJ; Mir, FA				Kelly, Christopher J.; Mir, Fraz A.			Economics of biological therapies	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FOLLOW-ON BIOLOGICS; DRUGS; NICE		[Mir, Fraz A.] Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 0QQ, England; [Kelly, Christopher J.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Kelly, CJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 0QQ, England.	fam31@cam.ac.uk		Kelly, Christopher/0000-0002-1246-844X				Aggarwal S, 2007, NAT BIOTECHNOL, V25, P1097, DOI 10.1038/nbt1007-1097; [Anonymous], 2007, PHARM PRIC REG SCHEM; BERNDT E, 2007, DO AUTHORIZED GENERI; Claxton K, 2008, BMJ-BRIT MED J, V336, P251, DOI 10.1136/bmj.39434.500185.25; Covic A, 2007, INT UROL NEPHROL, V39, P261, DOI 10.1007/s11255-006-9167-5; CROW JM, 2008, CHEM WORLD      0424; *DAT, BIOG 2005 NEW LEV CO; *EUR MED AG, 2006, QUEST ANS REC REF MA; European Medicenes Agency, 2005, GUID SIM BIOL MED PR; *FED TRAD COMM, 2009, EM HLTH CAR ISS; Frank RG, 2007, NEW ENGL J MED, V357, P841, DOI 10.1056/NEJMp078095; Grabowski H, 2006, HEALTH AFFAIR, V25, P1291, DOI 10.1377/hlthaff.25.5.1291; JUDLOWE S, 2008, PROPOSED LEGISLATION; *LA MER BUS INT, TOP 20 BIOL 2007; Muller M, 2006, WIEN KLIN WOCHENSCHR, V118, P508, DOI 10.1007/s00508-006-0670-6; MUNDY A, 2009, WALL STREET J   0225; Raftery J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b67; ROYSTON J, 2008, BIOTECHNOL PROGR, V21, P11; SHAPIRO R, 2008, GENERIC BIOL TREATME; SHENOUDA M, 2008, POLITICAL UPDATE E S; Sikora K, 2007, J ROY SOC MED, V100, P166, DOI 10.1258/jrsm.100.4.166; Sleijfer S, 2009, CLIN PHARMACOL THER, V85, P136, DOI 10.1038/clpt.2008.245; Steinbrook R, 2008, NEW ENGL J MED, V359, P1977, DOI 10.1056/NEJMp0806862; *TUCK BIOG PAN, 2008, CAP MARK PERSP; U. S. Food and Drug Administration, FREQ ASK QUEST THER; *UBS INV BANK EQ R, 2005, INTR PHARM BIOT IND; Webb DJ, 2007, LANCET, V369, P1415, DOI 10.1016/S0140-6736(07)60648-5; Wright E, 2007, CHIM OGGI, V25, P4; YAKATAN S, 2005, BIOEXECUTIVE INT, V1, P2; 2008, PHARMA TIMES    0410; 2009, BBC NEWS        0616; 2009, BIOPHARMA TODAY 0519	32	21	21	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 21	2009	339								b3276	10.1136/bmj.b3276	http://dx.doi.org/10.1136/bmj.b3276			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	486SE	19700510				2022-12-28	WOS:000269217200005
